PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	ElAntak, L; Tzakos, AG; Locker, N; Lukavsky, PJ				ElAntak, Latifa; Tzakos, Andreas G.; Locker, Nicolas; Lukavsky, Peter J.			Structure of eIF3b RNA recognition motif and its interaction with eIF3j - Structural insights into the recruitment of eIF3b to the 40 S ribosomal subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 3; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; PROTEIN STRUCTURES; BINDING PROTEIN; PRT1 PROTEIN; COMPLEX; SUBUNITS; NMR	Mammalian eIF3 is a 700-kDa multiprotein complex essential for initiation of protein synthesis in eukaryotic cells. It consists of 13 subunits (eIF3a to -m), among which eIF3b serves as a major scaffolding protein. Here we report the solution structure of the N-terminal RNA recognition motif of human eIF3b (eIF3b-RRM) determined by NMR spectroscopy. The structure reveals a noncanonical RRM with a negatively charged surface in the beta-sheet area contradictory with potential RNA binding activity. Instead, eIF3j, which is required for stable 40 S ribosome binding of the eIF3 complex, specifically binds to the rear a-helices of the eIF3b-RRM, opposite to its beta-sheet surface. Moreover, we identify that an N-terminal 69-amino acid peptide of eIF3j is sufficient for binding to eIF3b-RRM and that this interaction is essential for eIF3b-RRM recruitment to the 40 S ribosomal subunit. Our results provide the first structure of an important subdomain of a core eIF3 subunit and detailed insights into protein-protein interactions between two eIF3 subunits required for stable eIF3 recruitment to the 40 S subunit.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology		pjl@mrc-lmb.cam.ac.uk	ELANTAK, Latifa/S-7004-2019; tzakos, Andreas/V-9624-2019; Tzakos, Andreas G./B-2875-2017	Tzakos, Andreas G./0000-0001-6391-0288; Locker, Nicolas/0000-0002-0053-2897	MRC [MC_U105170649] Funding Source: UKRI; Medical Research Council [MC_U105170649] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; Block KL, 1998, J BIOL CHEM, V273, P31901, DOI 10.1074/jbc.273.48.31901; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Goddard TD, 2004, SPARKY; Guntert P, 1997, Methods Mol Biol, V60, P157; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Kadlec J, 2004, NAT STRUCT MOL BIOL, V11, P330, DOI 10.1038/nsmb741; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KLOTZ IM, 1973, ANN NY ACAD SCI, V226, P18, DOI 10.1111/j.1749-6632.1973.tb20465.x; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shalev A, 2001, J BIOL CHEM, V276, P34948, DOI 10.1074/jbc.M102161200; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Volpon L, 2005, BIOCHEMISTRY-US, V44, P3708, DOI 10.1021/bi047450e; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	40	52	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8165	8174		10.1074/jbc.M610860200	http://dx.doi.org/10.1074/jbc.M610860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17190833	Green Published, hybrid			2022-12-27	WOS:000245081000049
J	Jung, WS; Hong, CK; Lee, S; Kin, CS; Kim, SJ; Kim, SI; Rhee, S				Jung, Woo-Suk; Hong, Chang-Ki; Lee, Sujin; Kin, Chung-Sei; Kim, Soon-Jong; Kim, Su-Il; Rhee, Sangkee			Structural and functional insights into intramolecular fructosyl transfer by inulin fructotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BETA-HELIX; PROTEIN; PURIFICATION; EXPRESSION; FOLD; FRUCTAN; CLONING; DOMAIN; GLYCOSYLTRANSFERASE	Inulin fructotransferase (IFTase), a member of glycoside hydrolase family 91, catalyzes depolymerization of beta-2,1-fructans inulin by successively removing the terminal difructosaccharide units as cyclic anhydrides via intramolecular fructosyl transfer. The crystal structures of IFTase and its substrate-bound complex reveal that IFTase is a trimeric enzyme, and each monomer folds into a right-handed parallel beta-helix. Despite variation in the number and conformation of its beta-strands, the IFTase beta-helix has a structure that is largely reminiscent of other beta-helix structures but is unprecedented in that trimerization is a prerequisite for catalytic activity, and the active site is located at the monomer-monomer interface. Results from crystallographic studies and site-directed mutagenesis provide a structural basis for the exolytic-type activity of IFTase and a functional resemblance to inverting-type glycosyltransferases.	Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotecnol, Seoul 151921, South Korea; Seoul Natl Univ, Coll Agr & Life Sci, Ctr Agr Biomat, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotecnol, Rm 7117,Bldg 200, Seoul 151921, South Korea.	srheesnu@snu.ac.kr						Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowen L, 2002, J COMPUT BIOL, V9, P261, DOI 10.1089/10665270252935458; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Haraguchi K, 2003, BIOTECHNOL LETT, V25, P1049, DOI 10.1023/A:1024138428965; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JURNAK F, 1994, CURR OPIN STRUC BIOL, V4, P802, DOI 10.1016/0959-440X(94)90259-3; JURNAK F, 1995, FASEB J, V9, P335; Kang SI, 1998, BIOSCI BIOTECH BIOCH, V62, P628, DOI 10.1271/bbb.62.628; Kim CH, 2005, LETT APPL MICROBIOL, V40, P228, DOI 10.1111/j.1472-765X.2005.01658.x; Kim CS, 2007, J MICROBIOL BIOTECHN, V17, P37; Kim KY, 2005, J BIOCHEM, V138, P27, DOI 10.1093/jb/mvi093; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; Larsson AM, 2003, STRUCTURE, V11, P1111, DOI 10.1016/S0969-2126(03)00147-3; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Momma M, 2003, ACTA CRYSTALLOGR D, V59, P2286, DOI 10.1107/S0907444903019140; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; TANIGUCHI T, 1982, CARBOHYD RES, V107, P255, DOI 10.1016/S0008-6215(00)80543-1; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; Van Riet L, 2006, J EXP BOT, V57, P213, DOI 10.1093/jxb/erj031; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; Yang SJ, 2002, BIOTECHNOL APPL BIOC, V35, P199, DOI 10.1042/BA20020008; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	50	38	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8414	8423		10.1074/jbc.M607143200	http://dx.doi.org/10.1074/jbc.M607143200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17192265	hybrid			2022-12-27	WOS:000245081000074
J	Scarselli, M; Li, B; Kim, SK; Wess, J				Scarselli, Marco; Li, Bo; Kim, Soo-Kyung; Wess, Juergen			Multiple residues in the second extracellular loop are critical for M-3 muscarinic acetylcholine receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD CYTOPLASMIC LOOP; RANDOM MUTAGENESIS; TRANSMEMBRANE SEGMENTS; MOLECULAR-MECHANISMS; BINDING-SITE; YEAST; IDENTIFICATION; MUTATIONS; LOCALIZATION	Recent studies suggest that the second extracellular loop (o2 loop) of bovine rhodopsin and other class I G protein-coupled receptors (GPCRs) targeted by biogenic amine ligands folds deeply into the transmembrane receptor core where the binding of cis-retinal and biogenic amine ligands is known to occur. In the past, the potential role of the o2 loop in agonist-dependent activation of biogenic amine GPCRs has not been studied systematically. To address this issue, we used the M-3 muscarinic acetylcholine receptor (M3R), a prototypic class I GPCR, as a model system. Specifically, we subjected the o2 loop of the M3R to random mutagenesis and subsequently applied a novel yeast genetic screen to identity single amino acid substitutions that interfered with M3R function. This screen led to the recovery of about 20 mutant M3Rs containing single amino acid changes in the o2 loop that were inactive in yeast. In contrast, application of the same strategy to the extracellular N-terminal domain of the M3R did not yield any single point mutations that disrupted M3R function. Pharmacological characterization of many of the recovered mutant M3Rs in mammalian cells, complemented by site-directed mutagenesis studies, indicated that the presence of several o2 loop residues is important for efficient agonist-induced M3R activation. Besides the highly conserved Cys(220) residue, Gln(207), Gly(211), Arg(213), Gly(218), Ile(222), Phe(224), Leu(225), and Pro(228) were found to be of particular functional importance. In general, mutational modification of these residues had little effect on agonist binding affinities. Our findings are therefore consistent with a model in which multiple o2 loop residues are involved in stabilizing the active state of the M3R. Given the high degree of structural homology found among all biogenic amine GPCRs, our findings should be of considerable general relevance.	NIDDK, Mol Signaling Sect, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; NIDDK, Mol Recognit Sect, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Lab Bioorgan Chem, NIH, Bldg 8A,Rm B1A-05,8 Ctr Dr,MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov		Scarselli, Marco/0000-0001-5087-3182	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031130] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Beukers MW, 2005, TRENDS PHARMACOL SCI, V26, P533, DOI 10.1016/j.tips.2005.08.005; Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Bradley KN, 2000, PHARMACOL THERAPEUT, V85, P87, DOI 10.1016/S0163-7258(99)00064-9; CADWELL RC, 1994, PCR METH APPL, V3, pS136; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Erlenbach I, 2001, J BIOL CHEM, V276, P29382, DOI 10.1074/jbc.M103203200; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; Karlsson E, 2000, BIOCHIMIE, V82, P793, DOI 10.1016/S0300-9084(00)01176-7; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Kukkonen A, 2004, J BIOL CHEM, V279, P50923, DOI 10.1074/jbc.M406424200; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; Minic J, 2005, CURR MED CHEM, V12, P961, DOI 10.2174/0929867053507261; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; Pausch Mark H., 1998, P196; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Schmidt C, 2003, J BIOL CHEM, V278, P30248, DOI 10.1074/jbc.M304991200; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Sommers CM, 1997, J MOL BIOL, V266, P559, DOI 10.1006/jmbi.1996.0816; SOMMERS CM, 1999, REC BIOCH M, P141; STEFAN CJ, 1994, MOL CELL BIOL, V14, P3339, DOI 10.1128/MCB.14.5.3339; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Zeng FY, 1999, J NEUROCHEM, V72, P2404, DOI 10.1046/j.1471-4159.1999.0722404.x	48	94	101	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7385	7396		10.1074/jbc.M610394200	http://dx.doi.org/10.1074/jbc.M610394200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213190	Green Submitted, hybrid, Green Accepted			2022-12-27	WOS:000245080900050
J	Webb, DJ; Zhang, HY; Majumdar, D; Horwitz, AF				Webb, Donna J.; Zhang, Huaye; Majumdar, Devi; Horwitz, Alan F.			alpha 5 integrin signaling regulates the formation of spines and synapses in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED PLASTICITY; DENDRITIC SPINES; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; ADHESION; RECEPTOR; GIT1; SRC; IDENTIFICATION; MORPHOGENESIS	The actin-based dynamics of dendritic spines play a key role in synaptic plasticity, which underlies learning and memory. Although it is becoming increasingly clear that modulation of actin is critical for spine dynamics, the upstream molecular signals that regulate the formation and plasticity of spines are poorly understood. In non-neuronal cells, integrins are critical modulators of the actin cytoskeleton, but their function in the nervous system is not well characterized. Here we show that alpha 5 integrin regulates spine morphogenesis and synapse formation in hippocampal neurons. Knockdown of alpha S integrin expression using small interfering RNA decreased the number of dendritic protrusions, spines, and synapses. Expression of constitutively active or dominant negative alpha 5 integrin also resulted in alterations in the number of dendritic protrusions, spines, and synapses. alpha 5 integrin signaling regulates spine morphogenesis and synapse formation by a mechanism that is dependent on Src kinase, Rac, and the signaling adaptor GIT1. Alterations in the activity or localization of these molecules result in a significant decrease in the number of spines and synapses. Thus, our results point to a critical role for integrin signaling in regulating the formation of dendritic spines and synapses in hippocampal neurons.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	Vanderbilt University; Vanderbilt University; University of Virginia	Webb, DJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	donna.webb@vanderbilt.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023244, R37GM023244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071674] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM023244, GM23244, R37 GM023244] Funding Source: Medline; NIMH NIH HHS [R01 MH071674, R01 MH071674-02, MH071674] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; BAHR BA, 1992, BIOCHEM J, V281, P137, DOI 10.1042/bj2810137; Bi XN, 2001, J COMP NEUROL, V435, P184, DOI 10.1002/cne.1201; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Cao ZJ, 1998, J BIOL CHEM, V273, P31670, DOI 10.1074/jbc.273.48.31670; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chun D, 2001, NEUROSCIENCE, V105, P815, DOI 10.1016/S0306-4522(01)00173-7; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Goslin K., 1998, CULTURING NERVE CELL, P339; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe R, 2002, J CELL SCI, V115, P1497; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Sastry SK, 1996, DEV BIOL, V180, P455, DOI 10.1006/dbio.1996.0319; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	33	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6929	6935		10.1074/jbc.M610981200	http://dx.doi.org/10.1074/jbc.M610981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213186	Green Accepted, hybrid			2022-12-27	WOS:000245080900004
J	Chosed, R; Tomchick, DR; Brautigam, CA; Mukherjee, S; Negi, VS; Machius, M; Orth, K				Chosed, Renee; Tomchick, Diana R.; Brautigam, Chad A.; Mukherjee, Sohini; Negi, Veera S.; Machius, Mischa; Orth, Kim			Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO; EFFECTOR; SYSTEM; ARABIDOPSIS; ENZYMES; DIVERSITY; TRANSPORT	XopD (Xanthomonas outer protein D), a type III secreted effector from Xanthomonas campestris pv. vesicatoria, is a desumoylating enzyme with strict specificity for its plant small ubiquitin-like modifier (SUMO) substrates. Based on SUMO sequence alignments and peptidase assays with various plant, yeast, and mammalian SUMOs, we identified residues in SUMO that contribute to XopD/SUMO recognition. Further predictions regarding the enzyme/substrate specificity were made by solving the XopD crystal structure. By incorporating structural information with sequence alignments and enzyme assays, we were able to elucidate determinants of the rigid SUMO specificity exhibited by the Xanthomonas virulence factor XopD.	Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas, SW Med Ctr, Dept Biol Mol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021; Tomchick, Diana/HGV-2018-2022	Orth, Kim/0000-0002-0678-7620; Brautigam, Chad/0000-0001-6563-1338; Tomchick, Diana/0000-0002-7529-4643; Chosed, Renee/0000-0002-0442-0833	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NIAID NIH HHS [AI056404] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bailey J.L., 1967, TECHNIQUES PROTEIN C; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chosed R, 2006, BIOCHEM J, V398, P521, DOI 10.1042/BJ20060426; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DeLano W.L, PYMOL MOL GRAPHICS S; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murtas G, 2003, PLANT CELL, V15, P2308, DOI 10.1105/tpc.015487; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	39	61	64	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6773	6782		10.1074/jbc.M608730200	http://dx.doi.org/10.1074/jbc.M608730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204475	hybrid			2022-12-27	WOS:000244867200087
J	Li, P; Jiang, N; Nagarajan, S; Wohlhueter, R; Selvaraj, P; Zhu, C				Li, Ping; Jiang, Ning; Nagarajan, Shanmugam; Wohlhueter, Robert; Selvaraj, Periasamy; Zhu, Cheng			Affinity and kinetic analysis of Fc gamma receptor IIIa (CD16a) binding to IgG ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; RIII; CELLS; IDENTIFICATION; CONCURRENT; ANTIBODIES; FRAGMENT; ADHESION; ISOFORMS; COMPLEX	Binding of pathogen-bound immunoglobulin IS (IgG) to cell surface Fc gamma receptors (FcyRs) triggers a wide variety of effector functions. The binding kinetics and affinities of IgG-Fc gamma R interactions are hence important parameters for understanding Fc gamma R-mediated immune functions. We have measured the kinetic rates and equilibrium dissociation constants of IgG binding to a soluble Fc gamma RIIIa fused with Ig Fc (sCD16a) using the surface plasmon resonance technique. sCE116a interacted with monomeric human IgG and its subtypes IgG1 and IgG3 as well as rabbit IgG with on-rates of 6.5 X 10(3) 8.2 X 10(3), 1.1 X 10(4) and 1.8 X 10(4)M(-1) s(-1), off-rates of 4.7 X 10(-3), 5.7 X 10(-3) 5.9 X 10(-3), and 1.9 X 10(-2) s(-1), and equilibrium dissociation constants of 0.72, 0.71, 0.56, and 1.1 mu m, respectively. The kinetics and affinities measured by surface plasmon resonance agreed with those obtained from real time flow cytometry and competition inhibition binding experiments using cell surface CD16a. These data add to our understanding of IgG-Fc gamma R interactions.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; Centers for Disease Control & Prevention - USA	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Jiang, Ning/M-5448-2017; Zhu, Cheng/A-5724-2011	Jiang, Ning/0000-0003-1103-5922; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038282, R29AI038282, R01AI049400] Funding Source: NIH RePORTER; NIAID NIH HHS [AI049400, AI38282] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLANSMITH M, 1968, J PEDIATR-US, V72, P276, DOI 10.1016/S0022-3476(68)80324-5; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chang KC, 1999, BIOPHYS J, V76, P1280, DOI 10.1016/S0006-3495(99)77291-7; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; CHAPPEL MS, 1993, J BIOL CHEM, V268, P25124; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; FRIDMAN WH, 1997, CELL MEDIATED EFFECT; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Joss L, 1998, ANAL BIOCHEM, V261, P203, DOI 10.1006/abio.1998.2744; Li P, 2002, MOL IMMUNOL, V38, P527, DOI 10.1016/S0161-5890(01)00088-8; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCHUGH RS, 1995, P NATL ACAD SCI USA, V92, P8059, DOI 10.1073/pnas.92.17.8059; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Miller KL, 1996, J EXP MED, V183, P2227, DOI 10.1084/jem.183.5.2227; Morton TA, 1998, METHOD ENZYMOL, V295, P268; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; PROPERT D, 1995, EXP CLIN IMMUNOGENET, V12, P198; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Riper JW, 1998, BIOPHYS J, V74, P492, DOI 10.1016/S0006-3495(98)77807-5; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; SELVARAJ P, 1988, NATURE, V333, P565, DOI 10.1038/333565a0; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Tamm A, 1996, J IMMUNOL, V157, P1576; van de Winkel JG, 1996, HUMAN IGG FC RECEPTO; VANCE BA, 1993, J IMMUNOL, V151, P6429; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Williams TE, 2000, BIOPHYS J, V79, P1867, DOI 10.1016/S0006-3495(00)76436-8; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200	36	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6210	6221		10.1074/jbc.M609064200	http://dx.doi.org/10.1074/jbc.M609064200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202140	hybrid			2022-12-27	WOS:000244867200027
J	Lawrence, CL; Maekarwa, H; Worthington, JL; Reiter, W; Wilkinson, CRM; Jones, N				Lawrence, Clare L.; Maekarwa, Hiromi; Worthington, Jessica L.; Reiter, Wolfgang; Wilkinson, Caroline R. M.; Jones, Nic			Regulation of Schizosaccharomyces pombe Atf 1 protein levels by Sty1-mediated phosphorylation and heterodimerization with Pcr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN ACTIVATION DOMAIN; FISSION YEAST; TRANSCRIPTION FACTOR; MAP KINASE; SEXUAL DEVELOPMENT; INFLAMMATORY CYTOKINES; ENVIRONMENTAL-STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; OSMOTIC-STRESS	The Atf1 transcription factor plays a vital role in the ability of Schizosaccharomyces pombe cells to respond to various stress conditions. It regulates the expression of many genes in a stress-dependent manner, and its function is dependent upon the stress-activated MAPK, Sty1/Spc1. Moreover, Atf1 is directly phosphorylated by Sty1. Here we have investigated the role of such phosphorylation. Atf1 protein accumulates following stress, and this accumulation is lost in a strain defective in the Sty1 signaling pathway. In addition, accumulation of a mutant Atf1 I protein that can no longer be phosphorylated is lost. Measurement of the half-life of Atf1 demonstrates that changes in Atf1 stability are responsible for this accumulation. Atf1 stability is also regulated by its heterodimeric partner, Pcr1. Similarly, Pcr1 levels are regulated by Atf1. Thus multiple pathways exist that ensure that Atf1 levels are appropriately regulated. Phosphorylation of Atf1 is important for cells to mount a robust response to H2O2 stress, because the Atf1 phospho-mutant displays sensitivity to this stress, and induction of gene expression is lower than that observed in wild-type cells. Surprisingly, however, loss of Atf1 I phosphorylation does not lead to the complete loss of stress-activated expression of Atf1 target genes. Accordingly, the Atf1 phospho-mutant does not display the same overall stress sensitivities as the atf1 deletion mutant. Taken together, these data suggest that Sty1 phosphorylation of Atf1 is not required for activation of Atf1 per se but rather for modulating its stability.	Univ Manchester, Paterson Inst Canc Res, Canc Res UK Cell Regulat Lab, Manchester M20 4BX, Lancs, England	Paterson Institute for Cancer Research; University of Manchester	Wilkinson, CRM (corresponding author), Heidelberg Univ, ZMBH, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	cwilkinson@picr.man.ac.uk; Njones@picr.man.ac.uk		Lawrence, Clare/0000-0003-0170-0079; Reiter, Wolfgang/0000-0003-1266-8975	Cancer Research UK [12485] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Firestein R, 1998, J BIOL CHEM, V273, P5892, DOI 10.1074/jbc.273.10.5892; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hecht A, 1999, METH MOL B, V119, P469; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rodriguez-Gabriel MA, 2003, EMBO J, V22, P6256, DOI 10.1093/emboj/cdg597; Seeger M, 1996, J MOL BIOL, V263, P423, DOI 10.1006/jmbi.1996.0586; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; Yamada K, 1999, YEAST, V15, P1125, DOI 10.1002/(SICI)1097-0061(199908)15:11<1125::AID-YEA442>3.0.CO;2-Z	48	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5160	5170		10.1074/jbc.M608526200	http://dx.doi.org/10.1074/jbc.M608526200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182615	hybrid			2022-12-27	WOS:000244482300010
J	Lesnyak, DV; Osipiuk, J; Skarina, T; Sergiev, PV; Bogdanov, AA; Edwards, A; Savchenko, A; Joachimiak, A; Dontsova, OA				Lesnyak, Dmitry V.; Osipiuk, Jerzy; Skarina, Tatiana; Sergiev, Petr V.; Bogdanov, Alexey A.; Edwards, Aled; Savchenko, Alexei; Joachimiak, Andrzej; Dontsova, Olga A.			Methyltransferase that modifies guanine 966 of the 16 S rRNA - Functional identification and tertiary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-STRUCTURE; M(5)C967 METHYLTRANSFERASE; SECONDARY-STRUCTURE; MODEL; PURIFICATION; DIFFRACTION; SUBUNIT; BINDING; NUCLEOTIDES	N-2-Methylguanine 966 is located in the loop of Escherichia coli 16 S rRNA helix 31, forming a part of the P-site tRNA-binding pocket. We found yhhF to be a gene encoding for m(2)G966 specific 16 S rRNA methyltransferase. Disruption of the yhhF gene by kanamycin resistance marker leads to a loss of modification at G966. The modification could be rescued by expression of recombinant protein from the plasmid carrying the yhhF gene. Moreover, purified m(2)G966 methyltransferase, in the presence of S-adenosylomethionine (AdoMet), is able to methylate 30 S ribosomal subunits that were purified from yhhF knock-out strain in vitro. The methylation is specific for G966 base of the 16 S rRNA. The m(2)G966 methyltransferase was crystallized, and its structure has been determined and refined to 2.05 angstrom. The structure closely resembles RsmC rRNA methyltransferase, specific for m(2)G1207 of the 16 S rRNA. Structural comparisons and analysis of the enzyme active site suggest modes for binding AdoMet and rRNA to m(2)G966 methyltransferase. Based on the experimental data and current nomenclature the protein expressed from the yhhF gene was renamed to RsmD. A model for interaction of RsmD with ribosome has been proposed.	Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; Moscow MV Lomonosov State Univ, Dept Bioinformat & Bioengn, Moscow 119992, Russia; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119992, Russia; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Lomonosov Moscow State University; University of Toronto; Lomonosov Moscow State University; Lomonosov Moscow State University	Joachimiak, A (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, 9700 S Cass Ave,Bldg 202, Argonne, IL 60439 USA.	andrzejj@anl.gov; dontsova@genebee.msu.su	Bogdanov, Alexey A/L-1407-2013; Sergiev, Petr V/D-7493-2012; Dontsova, Olga/T-6072-2019	Sergiev, Petr V/0000-0001-8866-1863; Edwards, Aled/0000-0002-4782-6016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, P50GM062414] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54 GM074942, P50 GM062414-01, GM074942, P50 GM062414, GM62414, U54 GM074942-04S2] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen NM, 2006, J MOL BIOL, V359, P777, DOI 10.1016/j.jmb.2006.04.007; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujnicki JM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-10; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PG, 2003, STRUCTURE, V11, P1609, DOI 10.1016/j.str.2003.10.014; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; Gu XR, 1999, BIOCHEMISTRY-US, V38, P4053, DOI 10.1021/bi982364y; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Huang Lan, 2002, Journal of Structural and Functional Genomics, V2, P121, DOI 10.1023/A:1021279113558; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; JEMIOLO DK, 1991, NUCLEIC ACIDS RES, V19, P4259, DOI 10.1093/nar/19.15.4259; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; Kowalak JA, 2000, J BIOL CHEM, V275, P24484, DOI 10.1074/jbc.M002153200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski Roman A., 2003, Journal of Structural and Functional Genomics, V4, P167, DOI 10.1023/A:1026127927612; Lesnyak DV, 2006, J MOL BIOL, V364, P20, DOI 10.1016/j.jmb.2006.09.009; Levy M, 1999, J MOL EVOL, V48, P631, DOI 10.1007/PL00006506; McCloskey JA, 2005, NUCLEIC ACIDS RES, V33, pD135, DOI 10.1093/nar/gki015; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; OGara M, 1997, EUR J BIOCHEM, V247, P1009, DOI 10.1111/j.1432-1033.1997.01009.x; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; POWERS T, 1988, J MOL BIOL, V200, P309, DOI 10.1016/0022-2836(88)90243-4; QORONFLEH MW, 1995, J BIOTECHNOL, V39, P119, DOI 10.1016/0168-1656(94)00149-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2000, J MOL BIOL, V299, P379, DOI 10.1006/jmbi.2000.3739; SERGIEV PV, 2006, J MOL BIOL, V364, P25; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tscherne JS, 1999, J BIOL CHEM, V274, P924, DOI 10.1074/jbc.274.2.924; Tscherne JS, 1999, BIOCHEMISTRY-US, V38, P1884, DOI 10.1021/bi981880l; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1168, DOI 10.1107/S0907444999003698; WEITZMANN C, 1991, NUCLEIC ACIDS RES, V19, P7089, DOI 10.1093/nar/19.25.7089; YOUVAN DC, 1981, NUCLEIC ACIDS RES, V9, P1723, DOI 10.1093/nar/9.7.1723; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	50	67	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5880	5887		10.1074/jbc.M608214200	http://dx.doi.org/10.1074/jbc.M608214200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189261	Green Accepted, hybrid			2022-12-27	WOS:000244482300084
J	Tang, WF; Yang, SY; Wu, BW; Jheng, JR; Chen, YL; Shih, CH; Lin, KH; Lai, HC; Tang, P; Horng, JT				Tang, Wen-Fang; Yang, Shing-Ying; Wu, Bin-Wen; Jheng, Jia-Rong; Chen, Yin-Li; Shih, Chung-Hsuan; Lin, Kwang-Huei; Lai, Hsin-Chi; Tang, Petrus; Horng, Jim-Tong			Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; POLIOVIRUS REPLICATION; RNA; VIRUS; COMPLEX; INDUCTION; MEMBRANES; GOLGI; PICORNAVIRUSES; ORGANIZATION	Enterovirus 71 is an enterovirus of the family Picornaviridae. The 2C protein of poliovirus, a relative of enterovirus 71, is essential for viral replication. The poliovirus 2C protein is associated with host membrane vesicles, which form viral replication complexes where viral RNA synthesis takes place. We have now identified a host-encoded 2C binding protein called reticulon 3, which we found to be associated with the replication complex through direct interaction with the enterovirus 71-encoded 2C protein. We observed that the N terminus of the 2C protein, which has both RNA- and membrane-binding activity, interacted with reticulon 3. This region of interaction was mapped to its reticulon homology domain, whereas that of 2C was encoded by the 25th amino acid, isoleucine. Reticulon 3 could also interact with the 2C proteins encoded by other enteroviruses, such as poliovirus and coxsackievirus A16, implying that it is a common factor for such viral replication. Reduced production of reticulon 3 by RNA interference markedly reduced the synthesis of enterovirus 71-encoded viral proteins and replicative double-stranded RNA, reducing plaque formation and apoptosis. Furthermore, reintroduction of nondegradable reticulon 3 into these knockdown cells rescued enterovirus 71 infectivity, and viral protein and double-stranded RNA synthesis. Thus, reticulon 3 is an important component of enterovirus 71 replication, through its potential role in modulation of the sequential interactions between enterovirus 71 viral RNA and the replication complex.	Chang Gung Univ, Dept Biochem, Tao Yuan 333, Taiwan; Chang Gung Univ, Chang Gung Bioinformat Ctr, Tao Yuan 333, Taiwan; Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 106, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Horng, JT (corresponding author), Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	jimtong@mail.cgu.edu.tw		Horng, Jim-Tong/0000-0001-6294-9981; Tang, Petrus/0000-0002-2779-0116				Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; *APPL BIOS, 2001, US B APPL BIOS, V2; ARGOS P, 1984, NUCLEIC ACIDS RES, V12, P7251, DOI 10.1093/nar/12.18.7251; Banerjee R, 2001, J GEN VIROL, V82, P2621, DOI 10.1099/0022-1317-82-11-2621; BIENZ K, 1983, VIROLOGY, V131, P39, DOI 10.1016/0042-6822(83)90531-7; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Bolten R, 1998, J VIROL, V72, P8578, DOI 10.1128/JVI.72.11.8578-8585.1998; CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Di Scala F, 2005, BIOCHEM J, V385, P125, DOI 10.1042/BJ20040458; ECHEVERRI AC, 1995, VIROLOGY, V208, P540, DOI 10.1006/viro.1995.1185; Egger D, 1996, J VIROL, V70, P8675, DOI 10.1128/JVI.70.12.8675-8683.1996; Franklin NM, 2000, AQUAT TOXICOL, V48, P275, DOI 10.1016/S0166-445X(99)00042-9; FRANSSEN H, 1984, EMBO J, V3, P855, DOI 10.1002/j.1460-2075.1984.tb01896.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; HANECAK R, 1982, P NATL ACAD SCI-BIOL, V79, P3973, DOI 10.1073/pnas.79.13.3973; Iwahashi J, 2002, BIOCHEM BIOPH RES CO, V293, P698, DOI 10.1016/S0006-291X(02)00282-6; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Lai MMC, 1998, VIROLOGY, V244, P1, DOI 10.1006/viro.1998.9098; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; PAUL AV, 1994, VIROLOGY, V199, P188, DOI 10.1006/viro.1994.1111; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Senden N, 1997, HISTOCHEM CELL BIOL, V108, P155, DOI 10.1007/s004180050157; Snove O, 2004, BIOCHEM BIOPH RES CO, V319, P256, DOI 10.1016/j.bbrc.2004.04.175; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; TERSHAK DR, 1984, J VIROL, V52, P777, DOI 10.1128/JVI.52.3.777-783.1984; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wong WR, 2005, LIFE SCI, V78, P82, DOI 10.1016/j.lfs.2005.04.076; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2	44	111	126	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5888	5898		10.1074/jbc.M611145200	http://dx.doi.org/10.1074/jbc.M611145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182608	hybrid			2022-12-27	WOS:000244482300085
J	Koivunen, P; Hirsila, M; Remes, AM; Hassinen, IE; Kivirikko, KI; Myllyharju, J				Koivunen, Peppi; Hirsila, Maija; Remes, Anne M.; Hassinen, Ilmo E.; Kivirikko, Kari I.; Myllyharju, Johanna			Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates - Possible links between cell metabolism and stabilization of HIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROLYL 4-HYDROXYLASE; OXYGEN SENSING PATHWAY; HEREDITARY PARAGANGLIOMA; PROLINE HYDROXYLATION; EXPRESSION; MUTATIONS; CANCER; ENZYMES; FAMILY; ALPHA	The stability and transcriptional activity of the hypoxia-inducible factors (HIFs) are regulated by two oxygen-dependent events that are catalyzed by three HIF prolyl 4-hydroxylases (HIF-P4Hs) and one HIF asparaginyl hydroxylase (FIH). We have studied possible links between metabolic pathways and HIF hydroxylases by analyzing the abilities of citric acid cycle intermediates to inhibit purified human HIF-P4Hs and FIH. Fumarate and succinate were identified as in vitro inhibitors of all three HIF-P4Hs, fumarate having K-i values of 50-80 mu M and succinate 350-460 mu M, whereas neither inhibited FIH. Oxaloacetate was an additional inhibitor of all three HIF-P4Hs with K-i values of 400-1000 mu M and citrate of HIF-P4H-3, citrate being the most effective inhibitor of FIH with a K-i of 110 mu M. Culturing of cells with fumarate diethyl or dimethyl ester, or a high concentration of monoethyl ester, stabilized HIF-1 alpha and increased production of vascular endothelial growth factor and erythropoietin. Similar, although much smaller, changes were found in cultured fibroblasts from a patient with fumarate hydratase (FH) deficiency and upon silencing FH using small interfering RNA. No such effects were seen upon culturing of cells with succinate diethyl or dimethyl ester. As FIH was not inhibited by fumarate, our data indicate that the transcriptional activity of HIF is quite high even when binding of the coactivator p300 is prevented. Our data also support recent suggestions that the increased fumarate and succinate levels present in the FH and succinate dehydrogenase-deficient tumors, respectively, can inhibit the HIF-P4Hs with consequent stabilization of HIF-alpha s and effects on tumor pathology.	Univ Oulu, Collagen Res Unit, FIN-90014 Oulu, Finland; Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Baysal BE, 2003, TRENDS ENDOCRIN MET, V14, P453, DOI 10.1016/j.tem.2003.08.004; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Dalgard CL, 2004, BIOCHEM J, V380, P419, DOI 10.1042/BJ20031647; Devlin AM, 2003, AM J PHYSIOL-RENAL, V284, pF753, DOI 10.1152/ajprenal.00252.2002; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; HIRSCHKAUFFMANN M, 1985, HUM GENET, V69, P332, DOI 10.1007/BF00291651; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Pavlicek V, 2000, EUR J APPL PHYSIOL, V81, P497, DOI 10.1007/s004210050074; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Remes AM, 2004, J MOL MED, V82, P550, DOI 10.1007/s00109-004-0563-y; SASAKI T, 1987, J BIOL CHEM, V262, P9397; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; TSCHANK G, 1991, BIOCHEM J, V275, P469, DOI 10.1042/bj2750469; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	43	380	403	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4524	4532		10.1074/jbc.M610415200	http://dx.doi.org/10.1074/jbc.M610415200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17182618	hybrid			2022-12-27	WOS:000244482000034
J	Mohammad, S; Baldini, G; Granell, S; Narducci, P; Martelli, AM; Baldini, G				Mohammad, Sameer; Baldini, Giovanna; Granell, Susana; Narducci, Paola; Martelli, Alberto M.; Baldini, Giulia			Constitutive traffic of melanocortin-4 receptor in neuro2A cells and immortalized hypothalamic neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ARRESTINS; INTRACELLULAR-LOCALIZATION; MEDIATED ENDOCYTOSIS; ACTIVATED RECEPTOR-1; THROMBIN RECEPTORS; MORBID-OBESITY; INTERNALIZATION; AGONIST; SNAP-25	Melanocortin-4 receptor (MC4R) is a G protein-coupled receptor (GPCR) that binds a-melanocyte-stimulating hormone (alpha-MSH) and has a central role in the regulation of appetite and energy expenditure. Most GPCRs are endocytosed following binding to the agonist and receptor desensitization. Other GPCRs are internalized and recycled back to the plasma membrane constitutively, in the absence of the agonist. In unstimulated neuroblastoma cells and immortalized hypothalamic neurons, epitopetagged MC4R was localized both at the plasma membrane and in an intracellular compartment. These two pools of receptors were in dynamic equilibrium, with MC4R being rapidly internalized and exocytosed. In the absence of a-MSH, a fraction of cell surface MC4R localized together with transferrin receptor and to clathrin-coated pits. Constitutive MC4R internalization was impaired by expression of a dominant negative dynamin mutant. Thus, MC4R is internalized together with transferrin receptor by clathrin-dependent endocytosis. Cell exposure to a-MSH reduced the amount of MC4R at the plasma membrane by blocking recycling of a fraction of internalized receptor, rather than by increasing its rate of endocytosis. The data indicate that, in neuronal cells, MC4R recycles constitutively and that a-MSH modulates MC4R residency at the plasma membrane by acting at an intracellular sorting step.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Univ Trieste, Dipartimento Morfol Umana Normale, I-34138 Trieste, Italy; Univ Bologna, Sez Anat, Cell Signalling Lab, Dipartimento Sci Anat Umane & Fisiopatol Apparato, I-40126 Bologna, Italy	University of Arkansas System; University of Arkansas Medical Sciences; University of Trieste; University of Bologna	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	gbaldini@uams.edu	Mohammad, Sameer/GWV-2875-2022; granell, susana/H-2734-2012	Mohammad, Sameer/0000-0002-1129-7685	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053293] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53293] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adan RAH, 1996, MOL BRAIN RES, V36, P37, DOI 10.1016/0169-328X(95)00236-L; Baldini G, 1998, J CELL BIOL, V140, P305, DOI 10.1083/jcb.140.2.305; Baratti-Elbaz C, 1999, MOL ENDOCRINOL, V13, P1751, DOI 10.1210/me.13.10.1751; Chen D, 1999, BIOCHEM BIOPH RES CO, V255, P340, DOI 10.1006/bbrc.1999.0173; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Clement Karine, 2002, Am J Pharmacogenomics, V2, P177, DOI 10.2165/00129785-200202030-00003; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Gao ZH, 2003, J PHARMACOL EXP THER, V307, P870, DOI 10.1124/jpet.103.055525; Hadley ME, 1999, ANN NY ACAD SCI, V885, P1; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Koticha DK, 2002, J CELL SCI, V115, P3341; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; MARTYS JL, 1995, J BIOL CHEM, V270, P25976, DOI 10.1074/jbc.270.43.25976; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Murphy B, 2000, J APPL PHYSIOL, V89, P273, DOI 10.1152/jappl.2000.89.1.273; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pooley RD, 2006, MOL BIOL CELL, V17, P3176, DOI 10.1091/mbc.E05-12-1127; ROSS J, 1975, TISSUE CELL, V7, P107, DOI 10.1016/S0040-8166(75)80010-3; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang GY, 1997, J CELL SCI, V110, P505; Washbourne P, 1999, J NEUROCHEM, V73, P2424, DOI 10.1046/j.1471-4159.1999.0732424.x; WEINER RI, 1992, FRONT NEUROENDOCRIN, V13, P95	48	45	46	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4963	4974		10.1074/jbc.m608283200	http://dx.doi.org/10.1074/jbc.m608283200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166828	hybrid			2022-12-27	WOS:000244482000079
J	Nishimasu, H; Fushinobu, S; Shoun, H; Wakagi, T				Nishimasu, Hiroshi; Fushinobu, Shinya; Shoun, Hirofumi; Wakagi, Takayoshi			Crystal structures of an ATP-dependent hexokinase with broad substrate specificity from the hyperthermophilic archaeon Sulfolobus tokodaii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN HEXOKINASE; INDUCED CONFORMATIONAL-CHANGE; N-ACETYLGLUCOSAMINE KINASE; ENTNER-DOUDOROFF PATHWAY; YEAST HEXOKINASE; SUGAR KINASES; GLUCOSE PHOSPHORYLATION; PYROCOCCUS-FURIOSUS; COMPLETE GENOME; ACTIVE-SITE	Hexokinase catalyzes the phosphorylation of glucose to glucose 6-phosphate by using ATP as a phosphoryl donor. Recently, we identified and characterized an ATP-dependent hexokinase (StHK) from the hyperthermophilic archaeon Sulfolobus tokodaii, which can phosphorylate a broad range of sugar substrates, including glucose, mannose, glucosamine, and N-acetylglucosamine. Here we present the crystal structures of StHK in four different forms: (i) apo-form, (ii) binary complex with glucose, (iii) binary complex with ADP, and i quaternary complex with xylose, Mg2+, and ADP. Forms i and iii are in the open state, and forms ii and iv are in the closed state, indicating that sugar binding induces a large conformational change, whereas ADP binding does not. The four different crystal structures of the same enzyme provide "snapshots" of the conformational. changes during the catalytic cycle. StHK exhibits a core fold characteristic of the hexokinase family, but the structures of several loop regions responsible for substrate binding are significantly different from those of other known hexokinase family members. Structural comparison of StHK with human N-acetylglucosamine kinase and other hexokinases provides an explanation for the ability of StHK to phosphorylate both glucose and N-acetylglucosamine. A Mg2+ ion and coordinating water molecules are well defined in the electron density of the quaternary complex structure. This structure represents the first direct visualization of the binding mode for magnesium to hexokinase and thus allows for a better understanding of the catalytic mechanism proposed for the entire hexokinase family.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Wakagi, T (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atwakag@mail.ecc.u-tokyo.jp	Wakagi, Takayoshi/AAJ-4145-2021; Fushinobu, Shinya/E-4987-2011	Fushinobu, Shinya/0000-0003-1346-6435				Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; ARORA KK, 1991, J BIOL CHEM, V266, P5359; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BENNETT WS, 1980, J MOL BIOL, V140, P183, DOI 10.1016/0022-2836(80)90102-3; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BORK P, 1993, PROTEIN SCI, V2, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; DeLano W.L, PYMOL MOL GRAPHICS S; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; Dorr C, 2003, J BIOL CHEM, V278, P18744, DOI 10.1074/jbc.M301914200; Grueninger D, 2006, J MOL BIOL, V359, P787, DOI 10.1016/j.jmb.2006.04.013; Hansen T, 2002, J BACTERIOL, V184, P5955, DOI 10.1128/JB.184.21.5955-5965.2002; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Hinderlich S, 1998, EUR J BIOCHEM, V252, P133, DOI 10.1046/j.1432-1327.1998.2520133.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Labes A, 2003, ARCH MICROBIOL, V180, P69, DOI 10.1007/s00203-003-0563-2; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Mukai T, 2004, J BIOL CHEM, V279, P50591, DOI 10.1074/jbc.M408126200; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Nishimasu H, 2006, J BACTERIOL, V188, P2014, DOI 10.1128/JB.188.5.2014-2019.2006; OLSEN LR, 1993, ARCH BIOCHEM BIOPHYS, V304, P242, DOI 10.1006/abbi.1993.1345; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rosano C, 1999, STRUCT FOLD DES, V7, P1427, DOI 10.1016/S0969-2126(00)80032-5; Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; STEITZ TA, 1976, J MOL BIOL, V104, P197, DOI 10.1016/0022-2836(76)90009-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Verhees CH, 2002, BIOCHEM J, V366, P121, DOI 10.1042/BJ20011597; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; Zeng CB, 1996, BIOCHEMISTRY-US, V35, P13157, DOI 10.1021/bi960750e; ZENG CB, 1995, J BIOL CHEM, V270, P10509, DOI 10.1074/jbc.270.18.10509; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200	62	41	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9923	9931		10.1074/jbc.M610678200	http://dx.doi.org/10.1074/jbc.M610678200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17229727	hybrid			2022-12-27	WOS:000245421700067
J	Shi, J; Kandror, KV				Shi, Jun; Kandror, Konstantin V.			The luminal Vps10p domain of sortilin plays the predominant role in targeting to insulin-responsive Glut4-containing vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; GLUT4 GLUCOSE-TRANSPORTER; NEWLY SYNTHESIZED GLUT4; TRANS-GOLGI NETWORK; 3T3-L1 ADIPOCYTES; ADIPOSE-CELLS; LYSOSOMAL TRAFFICKING; STORAGE COMPARTMENTS; REGULATED TRANSPORT; CYTOPLASMIC TAIL	-In fat and skeletal muscle cells, insulin-responsive vesicles, or IRVs, deliver glucose transporter Glut4 and several associated proteins to the plasma membrane in response to hormonal stimulation. Although the protein composition of the IRVs is well studied, the mechanism of their formation is unknown. It is believed, however, that the cytoplasmic tails of the IRV component proteins carry targeting information to this compartment. To test this hypothesis, we have studied targeting of sortilin, one of the major IRV constituents. We have found that the reporter protein consisting of the cytoplasmic tail of sortilin and EGFP is co-localized with ectopically expressed Glut4 in the perinuclear compartment of undifferentiated 3T3-L1 cells that do not form insulin-responsive vesicles. Upon cell differentiation, this reporter protein does not enter the IRVs; moreover, it loses its perinuclear localization and becomes randomly distributed throughout the whole intracellular space. In contrast, the tagged luminal Vps10p domain of sortilin demonstrates partial co-localization with Glut4 in both undifferentiated and differentiated cells and is targeted to the IRVs upon cell differentiation. Using chemical cross-linking and the yeast two-hybrid system, we show that sortilin interacts with Glut4 and IRAP in the vesicular lumen. Our results suggest that luminal interactions between component proteins play an important role in the process of IRV biogenesis.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K124D,715 Albany St, Boston, MA 02118 USA.	kandror@biochem.bumc.bu.edu		Kandror, Konstantin/0000-0002-8601-9313	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052057, R01DK056736, R56DK052057] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK56736, DK52057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1996, J BIOL CHEM, V271, P21703, DOI 10.1074/jbc.271.36.21703; KANDROR KV, 1995, BIOCHEM J, V307, P383, DOI 10.1042/bj3070383; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lampson MA, 2000, J CELL SCI, V113, P4065; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Malide D, 2000, J CELL SCI, V113, P4203; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Melvin DR, 1999, BIOCHEMISTRY-US, V38, P1456, DOI 10.1021/bi980988y; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; VERHEY KJ, 1995, J CELL BIOL, V130, P1071, DOI 10.1083/jcb.130.5.1071; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	42	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9008	9016		10.1074/jbc.M608971200	http://dx.doi.org/10.1074/jbc.M608971200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17220298	hybrid			2022-12-27	WOS:000245780300048
J	Meng, FY; Henson, R; Wehbe-Janek, H; Smith, H; Ueno, Y; Patel, T				Meng, Fanyin; Henson, Roger; Wehbe-Janek, Hania; Smith, Heather; Ueno, Yoshiyuki; Patel, Tushar			The microRNA let-7a modulates interieukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ACTIVATION; CELL-SURVIVAL; EXPRESSION; CANCER; GROWTH; CHOLANGIOCARCINOMA; SUPPRESSOR; RESISTANCE; APOPTOSIS; MYELOMA	The inflammation-associated cytokine interleukin-6 (IL-6) can contribute to tumor growth and resistance to therapy by the activation of survival mechanisms. In several human cancers, IL-6-activated survival signaling involves the signal transducers and activators of transcription (Stat) factors or protein kinase cascades. microRNAs (miRNAs) are endogenous regulators of gene expression that are altered in expression in many cancers. However, the effect of inflammatory cytokines on miRNA expression and the role of miRNA in modulating IL-6-mediated cell survival are unknown. We investigated the involvement of miRNA in malignant cholangiocytes stably transfected to overexpress IL-6, which enhances tumor growth in vivo by inhibition of apoptosis. We provide evidence that (i) miRNA expression both in vitro and in vivo is altered by overexpression of IL-6; (ii) selective miRNAs including let-7a are up-regulated and contribute to the survival effects of enforced IL-6 activity; and (iii) let-7a contributes to the constitutively increased phosphorylation of Stat-3 by a mechanism involving the neurofibromatosis 2 (NF2) gene. These findings reveal a novel mechanism by which IL-6 mediates tumor cell survival that may be therapeutically targeted and emphasize the presence of complex interrelationships between deregulated expression of miRNA and transcription factors in human cancers.	Texas A&M Univ Syst, Hlth Sci Ctr, Coll Med, Div Gastroenterol,Scott & White Clin, Temple, TX 76508 USA; Tohoku Univ, Div Gastroenterol, Sendai, Miyagi 9808577, Japan	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Tohoku University	Patel, T (corresponding author), Ohio State Univ, Med Ctr, Div Gastroenterol & Hepatol, N201 Doan Hall,410 W 10th Ave, Columbus, OH 43210 USA.	patel.lab@gmail.com	patel, tushar/J-3976-2013; patel, tushar/A-6382-2008; Ueno, Yoshiyuki/R-9242-2019	patel, tushar/0000-0001-7021-9532; Ueno, Yoshiyuki/0000-0001-5623-4250	NIDDK NIH HHS [R01 DK069370, R01 DK069370-02, DK069370] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frassanito MA, 2001, BLOOD, V97, P483, DOI 10.1182/blood.V97.2.483; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Javle MM, 2004, HEPATO-GASTROENTEROL, V51, P1653; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scoles DR, 2002, HUM MOL GENET, V11, P3179, DOI 10.1093/hmg/11.25.3179; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Tadlock L, 2003, AM J PHYSIOL-GASTR L, V284, pG924, DOI 10.1152/ajpgi.00355.2002; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Xu L, 1998, EXP CELL RES, V238, P231, DOI 10.1006/excr.1997.3843; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	31	169	193	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8256	8264		10.1074/jbc.M607712200	http://dx.doi.org/10.1074/jbc.M607712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17220301	hybrid			2022-12-27	WOS:000245081000058
J	Fagone, P; Sriburi, R; Ward-Chapman, C; Frank, M; Wang, J; Gunter, C; Brewer, JW; Jackowski, S				Fagone, Paolo; Sriburi, Rungtawan; Ward-Chapman, Cheryl; Frank, Matthew; Wang, Jina; Gunter, Christopher; Brewer, Joseph W.; Jackowski, Suzanne			Phospholipid biosynthesis program underlying membrane expansion during B-lymphocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; UNFOLDED PROTEIN RESPONSE; PLASMA-CELL DIFFERENTIATION; RAT-LIVER CTP; TRANSCRIPTION FACTOR XBP-1; FARNESOL-INDUCED APOPTOSIS; PHOSPHATIDYLCHOLINE SYNTHESIS; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; ANTIGEN-SPECIFICITY	Stimulated B-lymphocytes differentiate into plasma cells committed to antibody production. Expansion of the endoplasmic reticulum and Golgi compartments is a prerequisite for high rate synthesis, assembly, and secretion of immunoglobulins. The bacterial cell wall component lipopolysaccharide (LPS) stimulates murine B-cells to proliferate and differentiate into antibody-secreting cells that morphologically resemble plasma cells. LPS activation of CH12 B-cells augmented phospholipid production and initiated a genetic program, including elevated expression of the genes for the synthesis, elongation, and desaturation of fatty acids that supply the phospholipid acyl moieties. Likewise, many of the genes in phospholipid biosynthesis were up-regulated, most notably those encoding Lipin1 and choline phosphotransferase. In contrast, CTP:phosphocholine cytidylyltransferase alpha (CCT alpha) protein, a key control point in phosphatidylcholine biosynthesis, increased because of stabilization of protein turnover rather than transcriptional activation. Furthermore, an elevation in cellular diacylglycerol and fatty acid correlated with enhanced allosteric activation of CCTa by the membrane lipids. This work defines a genetic and biochemical program for membrane phospholipid biogenesis that correlates with an increase in the phospholipid components of the endoplasmic reticulum and Golgi compartments in LPS-stimulated B-cells.	St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Loyola Univ, Med Ctr, Dept Microbiol & Immunol, Maywood, IL 60153 USA	St Jude Children's Research Hospital; Loyola University Chicago	Jackowski, S (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; Frank, Matthew/0000-0002-4914-1440; Fagone, Paolo/0000-0002-0102-3701; sriburi, Rungtawan/0000-0002-8900-9233	NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM 45737, GM 61970] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; ARNOLD LW, 1983, J IMMUNOL, V131, P2064; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; CHARLES J, 1980, ANAL BIOCHEM, V104, P10; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; DeLong CJ, 2000, J BIOL CHEM, V275, P32325, DOI 10.1074/jbc.M004644200; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Golfman LS, 2001, J BIOL CHEM, V276, P43688, DOI 10.1074/jbc.M108170200; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; Gunn KE, 2006, J IMMUNOL, V177, P3791, DOI 10.4049/jimmunol.177.6.3791; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hirabayashi Y, 2004, PFLUG ARCH EUR J PHY, V447, P760, DOI 10.1007/s00424-003-1071-6; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; JAMIL H, 1992, J BIOL CHEM, V267, P1752; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; LIM P, 1986, BIOCHEM CELL BIOL, V64, P692, DOI 10.1139/o86-095; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCASCIO NJ, 1984, P NATL ACAD SCI-BIOL, V81, P2466, DOI 10.1073/pnas.81.8.2466; LOCASCIO NJ, 1984, J MOL CELL IMMUNOL, V1, P177; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; OVNIC M, 1987, J IMMUNOL, V138, P3075; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; RANDALL TD, 1993, MOL CELL BIOL, V13, P3929, DOI 10.1128/MCB.13.7.3929; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ridgway ND, 2003, BIOCHEM J, V372, P811, DOI 10.1042/BJ20030252; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; SRIBURI R, 2007, IN PRESS J BIOL CHEM, V282; STOCKDALE AM, 1987, J IMMUNOL, V139, P3527; UTAL AK, 1991, J BIOL CHEM, V266, P24084; Wadham C, 2004, CIRCULATION, V109, P2116, DOI 10.1161/01.CIR.0000127419.45975.26; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Wright MM, 2001, J BIOL CHEM, V276, P25254, DOI 10.1074/jbc.M011552200; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503; Zhou JM, 2003, J BIOL CHEM, V278, P37032, DOI 10.1074/jbc.M304316200	63	68	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7591	7605		10.1074/jbc.M608175200	http://dx.doi.org/10.1074/jbc.M608175200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213195	hybrid			2022-12-27	WOS:000245080900072
J	Zhou, J; Damdimopoulos, AE; Spyrou, G; Brune, B				Zhou, Jie; Damdimopoulos, Anastassios E.; Spyrou, Giannis; Bruene, Bernhard			Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR EXPRESSION; REDOX STATE; MAMMALIAN THIOREDOXIN; TRANSCRIPTION FACTOR; CELL-DEATH; HIF-1-ALPHA; OXYGEN; ACTIVATION; APOPTOSIS	Hypoxia inducible factor 1 (HIF-1), a key regulator for adaptation to hypoxia, is composed of HIF-1 alpha and HIF-1 beta. In this study, we present evidence that overexpression of mitochondria-located thioredoxin 2 (Trx2) attenuated hypoxia-evoked HIF-1 alpha accumulation, whereas cytosolic thioredoxin 1 (Trx1) enhanced HIF-1 alpha protein amount. Transactivation of HIF-1 is decreased by overexpression of Trx2 but stimulated by Trx1. Inhibition of proteasomal degradation of HIF-1 alpha in Trx2-overexpressing cells did not fully restore HIF-1 alpha protein levels, while HIF-1 alpha accumulation was enhanced in Trx1-overexpressing cells. Reporter assays showed that cap-dependent translation is increased by Trx1 and decreased by Trx2, whereas HIF-1 alpha mRNA levels remained unaltered. These data suggest that thioredoxins affect the synthesis of HIF-1 alpha. Trx1 facilitated synthesis of HIF-1a by activating Akt, p70S6K, and eIF-4E, known to control cap-dependent translation. In contrast, Trx2 attenuated activities of Akt, p70S6K, and eIF-4E and provoked an increase in mitochondrial reactive oxygen species production. MitoQ, a mitochondria specific antioxidant, reversed HIF-1 alpha accumulation as well as Akt activation under hypoxia in Trx2 cells, supporting the notion of translation control mechanisms in affecting HIF-1 alpha protein accumulation.	Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany; Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Acad Athens, Fdn Biomed Res, Athens 11527, Greece	Goethe University Frankfurt; Karolinska Institutet; Academy of Athens	Brune, B (corresponding author), Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bruene@zbc.kgu.de		Damdimopoulos, Anastasios/0000-0003-4425-1189				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Kim A, 2005, FREE RADICAL BIO MED, V38, P644, DOI 10.1016/j.freeradbiomed.2004.10.030; Kim WJ, 2005, INT J ONCOL, V26, P1049; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; NAKAMURA H, 1992, CANCER-AM CANCER SOC, V69, P2091, DOI 10.1002/1097-0142(19920415)69:8<2091::AID-CNCR2820690814>3.0.CO;2-X; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Psarra AMG, 2005, INT J BIOCHEM CELL B, V37, P2544, DOI 10.1016/j.biocel.2005.06.015; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rahmani M, 2005, CANCER RES, V65, P2422, DOI 10.1158/0008-5472.CAN-04-2440; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanjuan-Pla A, 2005, FEBS LETT, V579, P2669, DOI 10.1016/j.febslet.2005.03.088; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286; Wei SJ, 2000, CANCER RES, V60, P6688; Welsh SJ, 2002, CANCER RES, V62, P5089; Xu D, 2006, AM J PHYSIOL-LUNG C, V291, pL966, DOI 10.1152/ajplung.00045.2006; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437; Zhou Jie, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P189, DOI 10.2174/187152506777698344; Zhuang SG, 2003, ONCOGENE, V22, P4413, DOI 10.1038/sj.onc.1206604	47	56	60	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7482	7490		10.1074/jbc.M608289200	http://dx.doi.org/10.1074/jbc.M608289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17220299	hybrid			2022-12-27	WOS:000245080900061
J	Hamdane, D; Vasseur-Godbillion, C; Baudin-Creuza, V; Hoa, GHB; Marden, MC				Hamdane, Djemel; Vasseur-Godbillion, Corinne; Baudin-Creuza, Veronique; Hoa, Gaston Hui Bon; Marden, Michael C.			Reversible hexacoordination of alpha-hemoglobin-stabilizing protein (AHSP)/alpha-hemoglobin versus pressure - Evidence for protection of the alpha-chains by their chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; LIGAND-BINDING; BETA-CHAINS; HYDROSTATIC-PRESSURE; GLOBIN; NEUROGLOBIN; CYTOGLOBIN; MECHANISM; AHSP; METHEMOGLOBIN	Using high hydrostatic pressure or hydrogen peroxide as perturbing agents, we demonstrate a protective effect of the chaperone AHSP for the a-chains of Hb. High pressure induces an irreversible aggregation of the ferrous deoxy alpha-chains, whereas the AHSP/alpha-Hb complex shows reversible hexacoordination of the alpha-Hb without protein aggregation. Upon pressure release, the relaxation kinetics of the transition from the hexacoordinated to pentacoordinated form of alpha-Hb in the presence of AHSP exhibit a biphasic shape. High pressure did not induce dissociation of alpha-Hb from its chaperone, as evidenced by the ligand binding kinetics that show a unique rate for the AHSP/alpha-Hb complex. For both free alpha-Hb and the AHSP/alpha-Hb complex, the bimolecular rate constant of CO binding (k(on)(CO)) versus pressure exhibits a on bell shape, attributed to the transition of the rate-determining step from the chemical barrier to the migration of CO within the protein matrix. These results reveal a plasticity of the alpha-Hb active site in the presence of the chaperone and indicate that the AHSP was still active at 300 MPa. The ferric state of the AHSP/ alpha-Hb complex shows hexacoordination even at atmospheric pressures, indicating a His-Fe-His binding scheme as previously observed in neuroglobin and cytoglobin. The reaction with hydrogen peroxide of ferric alpha-Hb within the complex also demonstrates a protection against aggregation.	Univ Paris 11, INSERM, U779, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Marden, MC (corresponding author), Univ Paris 11, INSERM, U779, Rue 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	marden@kb.inserm.fr	BAUDIN-CREUZA, Véronique/K-7309-2017; Marden, Michael/AAA-5923-2020; Marden, Michael C/G-3139-2012; Vasseur, Corinne/AAV-1384-2021	BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Marden, Michael C/0000-0002-5254-6385; Vasseur, Corinne/0000-0002-4422-7069				ALDEN RG, 1989, J BIOL CHEM, V264, P1923; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; BISPO JA, 2006, IN PRESS BIOPHYS CHE; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FISHER MT, 1985, ARCH BIOCHEM BIOPHYS, V240, P456, DOI 10.1016/0003-9861(85)90050-5; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; GERACI G, 1969, J BIOL CHEM, V244, P4664; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hamdane D, 2005, FEBS J, V272, P2076, DOI 10.1111/j.1742-4658.2005.04635.x; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; JUNG C, 1995, EUR J BIOCHEM, V233, P600, DOI 10.1111/j.1432-1033.1995.600_2.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KORNBLATT JA, 1995, BIOCHEMISTRY-US, V34, P1218, DOI 10.1021/bi00004a015; KORNBLATT MJ, 1987, ARCH BIOCHEM BIOPHYS, V257, P277; Lardinois OM, 2004, BIOCHEMISTRY-US, V43, P4601, DOI 10.1021/bi036241b; Lardinois OM, 2003, J BIOL CHEM, V278, P36214, DOI 10.1074/jbc.M304726200; MESSANA C, 1978, BIOCHEMISTRY-US, V17, P3652, DOI 10.1021/bi00610a035; MORISHIMA I, 1983, J BIOL CHEM, V258, P4428; NEWMANN RC, 1973, J PHYS CHEM-US, V77, P2687; OGUNMOLA GB, 1976, P NATL ACAD SCI USA, V73, P4271, DOI 10.1073/pnas.73.12.4271; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; PIN S, 1990, BIOCHEMISTRY-US, V29, P9194, DOI 10.1021/bi00491a013; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; TAUBE DJ, 1990, J AM CHEM SOC, V112, P6880, DOI 10.1021/ja00175a023; TEW D, 1988, J BIOL CHEM, V263, P17880; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Uchida T, 2000, J BIOL CHEM, V275, P30309, DOI 10.1074/jbc.M910287199; UNNO M, 1991, BIOCHEMISTRY-US, V30, P10679, DOI 10.1021/bi00108a011; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; WILKS A, 1992, J BIOL CHEM, V267, P8827; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	37	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6398	6404		10.1074/jbc.M610543200	http://dx.doi.org/10.1074/jbc.M610543200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194704	hybrid			2022-12-27	WOS:000244867200047
J	Rosenberger, S; Thorey, IS; Werner, S; Boukamp, P				Rosenberger, Sabine; Thorey, Irmgard S.; Werner, Sabine; Boukamp, Petra			A novel regulator of telomerase - S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT GENE; ION-BINDING PROPERTIES; ULTRASTRUCTURAL-LOCALIZATION; INTERMEDIATE-FILAMENTS; EXTRACELLULAR CALCIUM; SKIN KERATINOCYTES; CELL-LINES; PROTEINS; EXPRESSION; COMPLEX	Recently we reported a differentiation-dependent inhibition of telomerase activity in human epidermis. Consistent with this observation we found that in keratinocyte cultures calcium-induced differentiation correlates with a decline in telomerase activity. To get further support for a role of calcium in the regulation of telomerase and to elucidate the underlying molecular mechanisms we investigated the effect of calcium on telomerase in the human epidermal keratinocyte line HaCaT. Treatment with thapsigargin, which increases intracellular calcium concentrations, inhibited telomerase activity without down-regulating the expression of hTERT (human telomerase reverse transcriptase). This observation together with the fact that increasing calcium reduced telomerase activity in cell-free extracts suggests that calcium directly interacts with the telomerase complex. This interaction could be mediated by the calcium-binding protein S100A8 as indicated by its ability to mimic the inhibitory effect of calcium. S100A8-induced reduction in telomerase activity was abrogated by S100A9. The ratio of both proteins remained constant in cells treated with thapsigargin, but their interactions were altered similarly in intact cells after thapsigargin treatment and in cell-free extracts in response to calcium. We hypothesize that calcium binds to S100A8/S100A9 complexes and alters their composition, thus enabling S100A8 to interact with the telomerase complex and inhibit its activity.	German Canc Res Ctr, D-69120 Heidelberg, Germany; THP GmbH, D-82347 Bernried, Germany; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich	Rosenberger, S (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	s.rosenberger@dkfz.de		Werner, Sabine/0000-0001-7397-8710				Avilion AA, 1996, CANCER RES, V56, P645; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; Bickenbach JR, 1998, J INVEST DERMATOL, V111, P1045, DOI 10.1046/j.1523-1747.1998.00420.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Cerezo A, 2003, J INVEST DERMATOL, V121, P110, DOI 10.1046/j.1523-1747.2003.12304.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Forslind B, 1987, Acta Derm Venereol Suppl (Stockh), V134, P1; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; GOEBELER M, 1993, J LEUKOCYTE BIOL, V53, P11, DOI 10.1002/jlb.53.1.11; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Hennings H, 1980, Curr Probl Dermatol, V10, P3; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Lansdown ABG, 2002, WOUND REPAIR REGEN, V10, P271, DOI 10.1046/j.1524-475X.2002.10502.x; LEE SH, 1992, J CLIN INVEST, V89, P530, DOI 10.1172/JCI115617; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MANI RS, 1983, BIOCHEMISTRY-US, V22, P3902, DOI 10.1021/bi00285a027; Marionnet C, 2003, J INVEST DERMATOL, V121, P1447, DOI 10.1111/j.1523-1747.2003.12629.x; MELY Y, 1990, ARCH BIOCHEM BIOPHYS, V279, P174, DOI 10.1016/0003-9861(90)90478-H; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; PILLAI S, 1993, J CELL PHYSIOL, V154, P101, DOI 10.1002/jcp.1041540113; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; ROTH J, 1993, BLOOD, V82, P1875; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; SAINTIGNY G, 1992, J INVEST DERMATOL, V99, P639, DOI 10.1111/1523-1747.ep12668098; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Smith SP, 1998, BIOCHEM CELL BIOL, V76, P324, DOI 10.1139/bcb-76-2-3-324; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; YUSPA SH, 1988, ANN NY ACAD SCI, V548, P191, DOI 10.1111/j.1749-6632.1988.tb18806.x; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhao XP, 1997, GENOMICS, V45, P250, DOI 10.1006/geno.1997.4952; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	52	40	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6126	6135		10.1074/jbc.M610529200	http://dx.doi.org/10.1074/jbc.M610529200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197440	hybrid			2022-12-27	WOS:000244867200018
J	Wei, YA; Zavilowitz, B; Satlin, LM; Wang, WH				Wei, Yuan; Zavilowitz, Beth; Satlin, Lisa M.; Wang, Wen-Hui			Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TYROSINE KINASE; APICAL MEMBRANE; NADPH OXIDASE; SKELETAL-MUSCLE; EXPRESSION; RAT; SECRETION; TRANSPORT; ACTIVATION	Base-line urinary potassium secretion in the distal nephron is mediated by small conductance rat outer medullary K (ROMK)like channels. We used the patch clamp technique applied to split-open cortical collecting ducts (CCDs) isolated from rats fed a normal potassium (NK) or low potassium (LK) diet to test the hypothesis that AngII directly inhibits ROMK channel activity. We found that AngII inhibited ROMK channel activity in LK but not NK rats in a dose-dependent manner. The AngII-induced reduction in channel activity was mediated by AT 1 receptor (AT1R) binding, because pretreatment of CCDs with losartan but not PD123319 AT1. and AT2 receptor antagonists, respectively, blocked the response. Pretreatment of CCDs with U73122 and calphostin C, inhibitors of phospholipase C (PLC) and protein kinase C (PKC), respectively, abolished the AngII-induced decrease in ROMK channel activity, confirming a role of the PLC-PKC pathway in this response. Studies by others suggest that AngII stimulates an Src family protein-tyrosine kinase (PTK) via PKC-NADPH oxidase. PTK has been shown to regulate the ROMK channel. Inhibition of NADPH oxidase with diphenyliodonium abolished the inhibitory effect of AngII or the PKC activator phorbol 12-myristate 13-acetate on ROMK channels. Suppression of PTK by herbimycin A significantly attenuated the inhibitory effect of AngII on ROMK channel activity. We conclude that AngII inhibits ROMK channel activity through PKC-, NADPH oxidase-, and PTK-dependent pathways under conditions of dietary potassium restriction.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	Icahn School of Medicine at Mount Sinai; New York Medical College	Wei, YA (corresponding author), Mt Sinai Sch Med, Dept Pediat, Box 1664,1 Gustave L Levy Pl, New York, NY 10029 USA.	yuan.wei@mssm.edu			NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051391, R01DK047402, R29DK047402, R01DK038470, R29DK038470, R01DK051391] Funding Source: NIH RePORTER; NCI NIH HHS [R24 CA095823, 5R24 CA095823-04] Funding Source: Medline; NIDDK NIH HHS [DK47402, DK51391, R01 DK047402-13, R01 DK047402, DK38470] Funding Source: Medline; PHS HHS [1 S10 RRO 9145-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Babilonia E, 2005, J BIOL CHEM, V280, P10790, DOI 10.1074/jbc.M414610200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; BRAAM B, 1993, AM J PHYSIOL, V264, pF891, DOI 10.1152/ajprenal.1993.264.5.F891; Braiman L, 1999, DIABETES, V48, P1922, DOI 10.2337/diabetes.48.10.1922; Burns KD, 1998, NEPHRON, V78, P73, DOI 10.1159/000044885; Carey RM, 2005, CURR OPIN NEPHROL HY, V14, P67, DOI 10.1097/00041552-200501000-00011; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Chabrashvili T, 2002, HYPERTENSION, V39, P269, DOI 10.1161/hy0202.103264; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; ENGELS F, 1992, FEBS LETT, V305, P254, DOI 10.1016/0014-5793(92)80680-F; Frank GD, 2000, ENDOCRINOLOGY, V141, P3120, DOI 10.1210/en.141.9.3120; FRINDT G, 1989, AM J PHYSIOL, V256, pF143, DOI 10.1152/ajprenal.1989.256.1.F143; FRINDT G, 1987, AM J PHYSIOL, V252, pF458, DOI 10.1152/ajprenal.1987.252.3.F458; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Giebisch G, 1998, AM J PHYSIOL-RENAL, V274, pF817, DOI 10.1152/ajprenal.1998.274.5.F817; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170, DOI 10.1152/ajprenal.1997.273.1.F170; Imanishi K, 2003, HYPERTENS RES, V26, P405, DOI 10.1291/hypres.26.405; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; LINAS SL, 1979, KIDNEY INT, V15, P601, DOI 10.1038/ki.1979.79; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; Najjar F, 2005, AM J PHYSIOL-RENAL, V289, pF922, DOI 10.1152/ajprenal.00057.2005; Navar LG, 2004, CURR OPIN NEPHROL HY, V13, P107, DOI 10.1097/00041552-200401000-00015; OKUSA MD, 1992, AM J PHYSIOL, V262, pF488, DOI 10.1152/ajprenal.1992.262.3.F488; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Ray PE, 2001, KIDNEY INT, V59, P1850, DOI 10.1046/j.1523-1755.2001.0590051850.x; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Schmidt A, 2001, NEPHROL DIAL TRANSPL, V16, P1034, DOI 10.1093/ndt/16.5.1034; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; STERLING H, 2004, AM J PHYSIOL, V26, pF1072; Toyz RM, 2002, BRAZ J MED BIOL RES, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Wang CT, 2003, J HYPERTENS, V21, P353, DOI 10.1097/00004872-200302000-00027; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Wang WH, 2004, ANNU REV PHYSIOL, V66, P547, DOI 10.1146/annurev.physiol.66.032102.112025; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wei Y, 2005, AM J PHYSIOL-RENAL, V289, pF1065, DOI 10.1152/ajprenal.00063.2005; Wei Y, 2002, AM J PHYSIOL-RENAL, V282, pF680, DOI 10.1152/ajprenal.00229.2001; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Woda CB, 2003, AM J PHYSIOL-RENAL, V285, pF629, DOI 10.1152/ajprenal.00191.2003; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Zeng WZ, 2003, J BIOL CHEM, V278, P16852, DOI 10.1074/jbc.M300619200	50	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6455	6462		10.1074/jbc.M607477200	http://dx.doi.org/10.1074/jbc.M607477200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194699	hybrid, Green Accepted			2022-12-27	WOS:000244867200053
J	Zheng, ZD; Chen, GZ; Joshi, S; Brutinel, ED; Yahr, TL; Chen, LL				Zheng, Zhida; Chen, Guozhou; Joshi, Shreyas; Brutinel, Evan D.; Yahr, Timothy L.; Chen, Lingling			Biochemical characterization of a regulatory cascade controlling transcription of the Pseudomonas aeruginosa type III secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSIVE-CARE UNITS; NOSOCOMIAL INFECTIONS; ANTI-ACTIVATOR; CHAPERONE; REGULON; STATES; EXSD	Many Gram-negative pathogens utilize type III secretion systems (T3SS) to translocate effector proteins into eukaryotic host cells. Expression of T3SS genes is highly regulated and is often coupled to type III secretory activity. Transcription of the Pseudomonas aeruginosa T3SS genes is coupled to secretion by a cascade of interacting regulatory proteins (ExsA, ExsD, ExsC, and ExsE). ExsA is an activator of type III gene transcription, ExsD binds ExsA to inhibit: transcription, ExsC inhibits ExsD activity, and ExsE inhibits ExsC activity. The entire process is coupled to secretion by virtue of the fact that ExsE is a secreted substrate of the T3SS. Changes in the intracellular concentration of ExsE are thought to govern formation of the ExsC-ExsE, ExsC-ExsD, and ExsD-ExsA complexes. Whereas formation of the ExsC-ExsE complex allows ExsD to bind ExsA and transcription of the T3SS is repressed, formation of the ExsC-ExsD complex sequesters ExsD from ExsA and transcription of the T3SS is induced. In this study, we characterized the self-association states of ExsC, ExsD, and ExsE and the binding interactions of ExsC with ExsE and ExsD. ExsC exists as a homodimer and binds one molecule of ExsE substrate. Dimeric ExsC also interacts directly with ExsD to form a heterotetrameric complex. The difference in binding affinities between the ExsC-ExsE (K-d 1nm) and ExsC-ExsD (K-d 18 nm) complexes supports a model in which ExsC preferentially binds cytoplasmic ExsE, resulting in the inhibition of T3SS gene transcription.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47405 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Iowa	Chen, LL (corresponding author), Indiana Univ, Dept Biol, 915 E 3rd St, Bloomington, IN 47405 USA.	linchen@indiana.edu	Joshi, Shreyas/M-6411-2019; Chen, Ling-Ling/AAY-3547-2021	Yahr, Timothy/0000-0001-9054-8704	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065260] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI055042, R01 AI055042] Funding Source: Medline; NIGMS NIH HHS [R01-GM065260-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; FRANK DW, 1991, J BACTERIOL, V173, P6460, DOI 10.1128/jb.173.20.6460-6468.1991; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; LEMAIRE M, 1989, ANAL BIOCHEM, V177, P50, DOI 10.1016/0003-2697(89)90012-2; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Van Holde K. E., 1998, PRINCIPLES PHYS BIOC, P194; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Wei CF, 2005, MOL MICROBIOL, V57, P520, DOI 10.1111/j.1365-2958.2005.04704.x	24	26	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6136	6142		10.1074/jbc.M611664200	http://dx.doi.org/10.1074/jbc.M611664200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197437	hybrid			2022-12-27	WOS:000244867200019
J	Beyea, MM; Heslop, CL; Sawyez, CG; Edwards, JY; Markle, JG; Hegele, RA; Huff, MW				Beyea, Michael M.; Heslop, Claire L.; Sawyez, Cynthia G.; Edwards, Jane Y.; Markle, Janet G.; Hegele, Robert A.; Huff, Murray W.			Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RETINOID-X-RECEPTOR; ATP-BINDING CASSETTE; LANOSTEROL CYCLASE; PHARMACOLOGICAL ACTIVATION; HYPERTRIGLYCERIDEMIC VLDL; CHOLESTEROL EFFLUX; ELEMENT; EXPRESSION; PROMOTER	Liver X receptor (LXR) activation represents a mechanism to prevent macrophage foam cell formation. Previously, we demonstrated that partial inhibition of oxidosqualene:lanosterol cyclase (OSC) stimulated synthesis of the LXR agonist 24(S),25-epoxycholesterol (24(S),25-epoxy) and enhanced ABCA1-mediated cholesterol efflux. In contrast to a synthetic, nonsteroidal LXR activator, TO-901317, triglyceride accumulation was not observed. In the present study, we determined whether endogenous 24(S),25-epoxy synthesis selectively enhanced expression of macrophage LXR-regulated cholesterol efflux genes but not genes that regulate fatty acid metabolism. THP-1 human macrophages incubated with the OSC inhibitor (OSCi) RO0714565 (15 mm) significantly reduced cholesterol synthesis and maximized synthesis of 24(S),25-epoxy. Endogenous 24(S),25-epoxy increased ABCA1, ABCG1, and APOE mRNA abundance and consequently increased cholesterol efflux to apoAI. In contrast, OSCi had no effect on LXR-regulated genes LPL (lipoprotein lipase) and FAS (fatty acid synthase). TO-901317 (>= 10 nm) significantly enhanced expression of all genes examined. OSCi and TO-901317 increased the mRNA and precursor form of SREBP-1c, a major regulator of fatty acid and triglyceride synthesis. However, conversion of the precursor to the active form (nSREBP-1c) was blocked by OSCi-induced 24(S),25-epoxy but not by TO-901317 (>= 10 nm), which instead markedly increased nSREBP-1c. Disruption of nSREBP-1c formation by 24(S),25-epoxy accounted for diminished FAS and LPL expression. In summary, endogenous synthesis of 24(S),25-epoxy selectively up-regulates expression of macrophage LXR-regulated cholesterol efflux genes without stimulating genes linked to fatty acid and triglyceride synthesis.	Univ Western Ontario, Robarts Res Inst, Vasc Biol Grp, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Biochem, London, ON N6A 5K8, Canada; Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Huff, MW (corresponding author), Rm 4-16,100 Perth Dr, London, ON N6A 5K8, Canada.	mhuff@uwo.ca	Markle, Janet/X-1975-2019; Hegele, Robert/G-3301-2011; Hegele, Robert/AAF-6482-2020; Huff, Murray/G-3307-2011	Hegele, Robert/0000-0003-2861-5325; Markle, Janet/0000-0003-2189-4368				Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Argmann CA, 2003, ARTERIOSCL THROM VAS, V23, P475, DOI 10.1161/01.ATV.0000058860.62870.6E; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Borradaile NM, 2003, DIABETES, V52, P2554, DOI 10.2337/diabetes.52.10.2554; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; EVANS AJ, 1993, J LIPID RES, V34, P703; Field FJ, 2001, J LIPID RES, V42, P1687; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huff MW, 2005, TRENDS PHARMACOL SCI, V26, P335, DOI 10.1016/j.tips.2005.05.004; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Langmann T, 2000, BBA-GENE STRUCT EXPR, V1494, P175, DOI 10.1016/S0167-4781(00)00215-3; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lehrke M, 2005, CELL METAB, V1, P297, DOI 10.1016/j.cmet.2005.04.005; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Morand OH, 1997, J LIPID RES, V38, P373; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Schoonjans K, 2000, J MOL BIOL, V304, P323, DOI 10.1006/jmbi.2000.4218; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; TAYLOR FR, 1986, J BIOL CHEM, V261, P5039; Telford DE, 2005, ARTERIOSCL THROM VAS, V25, P2608, DOI 10.1161/01.ATV.0000189158.28455.94; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Whitman SC, 1997, ARTERIOSCL THROM VAS, V17, P1707, DOI 10.1161/01.ATV.17.9.1707; Whitman SC, 1999, J LIPID RES, V40, P1017; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200	44	85	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5207	5216		10.1074/jbc.M611063200	http://dx.doi.org/10.1074/jbc.M611063200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17186944	hybrid			2022-12-27	WOS:000244482300015
J	Granneman, JG; Moore, HPH; Granneman, RL; Greenberg, AS; Obin, MS; Zhu, ZX				Granneman, James G.; Moore, Hsiao-Ping H.; Granneman, Rachel L.; Greenberg, Andrew S.; Obin, Martin S.; Zhu, Zhengxian			Analysis of lipolytic protein trafficking and interactions in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID STORAGE DROPLETS; PERILIPIN-A; 3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; FLUORESCENCE COMPLEMENTATION; MEDIATED LIPOLYSIS; KINASE	This work examined the colocalization, trafficking, and interactions of key proteins involved in lipolysis during brief cAMP-dependent protein kinase A (PKA) activation. Double label immunofluorescence analysis of 3T3-L1 adipocytes indicated that PKA activation increases the translocation of hormone-sensitive lipase (HSL) to perilipin A (Plin)-containing droplets and increases the colocalization of adipose tissue triglyceride lipase (Atgl) with its coactivator, Abhd5. Imaging of live 3T3-L1 preadipocytes transfected with Aquorea victoria-based fluorescent reporters demonstrated that HSL rapidly and specifically translocates to lipid droplets (LDs) containing Plin, and that this translocation is partially dependent on Plin phosphorylation. HSL closely, if not directly, interacts with Plin, as indicated by fluorescence resonance energy transfer (FRET) and bimolecular fluorescence complementation (BiFC) experiments. In contrast, tagged Atg1 did not support FRET or BiFC with Plin, although it did modestly translocate to LDs upon stimulation. Abhd5 strongly interacted with Plin in the basal state, as indicated by FRET and BiFC. PKA activation rapidly (within minutes) decreased FRET between Abhd5 and Plin, and this decrease depended upon Plin phosphorylation. Together, these results indicate that Plin mediates hormone-stimulated lipolysis via direct and indirect mechanisms. Plin indirectly controls Atg1 activity by regulating accessibility to its coactivator, Abhd5. In contrast, Plin directly regulates the access of HSL to substrate via close, if not direct, interactions. The differential interactions of HSL and Atg1 with Plin and Abhd5 also explain the findings that following stimulation, HSL and Atg1 are differentially enriched at specific LDs.	Wayne State Univ, Sch Med, Dept Psychiat, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Behav Neurosci, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48201 USA; Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Wayne State University; Wayne State University; Tufts University; United States Department of Agriculture (USDA)	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, Dept Psychiat, Ctr Integrat Metab & Endocrine Res, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			NIDDK NIH HHS [DK 62292] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062292, R01DK062292] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	33	232	241	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5726	5735		10.1074/jbc.M610580200	http://dx.doi.org/10.1074/jbc.M610580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189257	hybrid			2022-12-27	WOS:000244482300069
J	Rah, SY; Park, KH; Nam, TS; Kim, SJ; Kim, H; Im, MJ; Kim, UH				Rah, So-Young; Park, Kwang-Hyun; Nam, Tae-Sik; Kim, Sang-Jin; Kim, Hyuntae; Im, Mie-Jae; Kim, Uh-Hyun			Association of CD38 with nonmuscle myosin heavy chain IIA and Lck is essential for the internalization and activation of CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; INTRACELLULAR CA2+; TYROSINE KINASE; CALCIUM-RELEASE; CYCLASE; CELLS; PROTEIN; MESSENGERS; TRANSPORT; MOVEMENT	Activation of CD38 in lymphokine-activated killer (LAK) cells involves interleukin-8 (IL8)-mediated protein kinase G (PKG) activation and results in an increase in the sustained intracellular Ca2+ concentration ([Ca2+](i)), cADP-ribose, and LAK cell migration. However, direct phosphorylation or activation of CD38 by PKG has not been observed in vitro. In this study, we examined the molecular mechanism of PKG-mediated activation of CD38. Nonmuscle myosin heavy chain IIA (MHCIIA) was identified as a CD38-associated protein upon IL8 stimulation. The IL8-induced association of MHCIIA with CD38 was dependent on PKG-mediated phosphorylation of MHCIIA. Supporting these observations, IL8- or cell-permeable cGMP analog-induced formation of cADP-ribose, increase in [Ca2+](i), and migration of LAK cells were inhibited by treatment with the MHCIIA inhibitor blebbistatin. Binding studies using purified proteins revealed that the association of MHCIIA with CD38 occurred through Lck, a tyrosine kinase. Moreover, these three molecules co-immunoprecipitated upon IL8 stimulation of LAK cells. IL8 treatment of LAK cells resulted in internalization of CD38, which co-localized with MHCIIA and Lck, and blebbistatin blocked internalization of CD38. These findings demonstrate that the association of phospho-MHCIIA with Lck and CD38 is a critical step in the internalization and activation of CD38.	Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; Chonbuk Natl Univ, Sch Med, Cardiovasc Res Inst, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960				Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Cho YS, 2000, J BIOL CHEM, V275, P1685, DOI 10.1074/jbc.275.3.1685; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; De Flora Antonio, 1998, Cell Biochemistry and Biophysics, V28, P45; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Higashida H, 2000, BIOCHEM J, V352, P197, DOI 10.1042/0264-6021:3520197; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; Linz-McGillem LA, 2003, EXP EYE RES, V76, P543, DOI 10.1016/S0014-4835(03)00031-9; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; MAUPIN P, 1994, J CELL SCI, V107, P3077; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; MELDER RJ, 1988, CANCER RES, V48, P3461; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; SEBOK K, 1993, J IMMUNOL, V150, P1524; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Xie GH, 2003, BIOCHEM BIOPH RES CO, V307, P713, DOI 10.1016/S0006-291X(03)01240-3; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	41	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5653	5660		10.1074/jbc.M609478200	http://dx.doi.org/10.1074/jbc.M609478200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182620	hybrid			2022-12-27	WOS:000244482300062
J	Gupta, M; Trott, D; Porter, ACG				Gupta, Mita; Trott, Deborah; Porter, Andrew C. G.			Rescue of a human cell line from endogenous Cdk1 depletion by Cdk1 lacking inhibitory phosphorylation sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; FISSION YEAST; S-PHASE; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; MITOSIS; DNA; REPLICATION; ACTIVATION; EVENTS	Cells that transiently overexpress cyclin-dependent kinase 1 lacking inhibitory phosphorylation sites (Cdk1-AF) undergo premature and catastrophic mitosis, reflecting the key role for Cdk1 in promoting a timely transit from G, into mitosis. Conversely, cells depleted of Cdk1 undergo repeated S phases Without intervening mitoses (endoreduplication), reflecting a role for Cdk1 in preventing premature S phases. It is not known how Cdk1 prevents entry into S phase at times in G, when it does not promote mitosis. Also uncertain is the extent of redundancy between inhibitory phosphorylation and other mechanisms for controlling Cdk1 activity. We describe here human cells that not only tolerate stable Cdk1-AF expression but also rely on it for survival when endogenous Cdk1 is depleted. When residual endogenous Cdk1 expression is further depleted, however, proliferation of Cdk1-AF-rescued cells is inhibited. Interestingly, this inhibition is not accompanied by endoreduplication. These results are consistent with a two-threshold model for Cdk1 kinase activity, one for suppressing endoreduplication and one for promoting mitosis. They also indicate that inhibitory phosphorylation is indispensable for only a fraction of the total cellular complement of Cdk1.	Hammersmith Hosp, Imperial Coll Fac Med, Dept Haematol, Gene Targeting Grp, London W12 0NN, England; Univ London Imperial Coll Sci & Technol, Fac Med, Med Res Council Clin Sci Ctr, London W12 0NN, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Porter, ACG (corresponding author), Hammersmith Hosp, Imperial Coll Fac Med, Dept Haematol, Gene Targeting Grp, Du Cane Rd, London W12 0NN, England.	andy.porter@imperial.ac.uk						Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; Blasina A, 1997, MOL BIOL CELL, V8, P1013, DOI 10.1091/mbc.8.6.1013; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Fletcher L, 2002, CANCER RES, V62, P241; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; ITALIEN L, 2006, CELL CYCLE, V5, P984; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; KREK W, 1992, J CELL SCI, V102, P43; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; LEE MG, 1988, NATURE, V333, P676, DOI 10.1038/333676a0; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; PARIS J, 1994, J CELL SCI, V107, P615; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Stern B, 1996, TRENDS GENET, V12, P345; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5	35	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4301	4309		10.1074/jbc.M607910200	http://dx.doi.org/10.1074/jbc.M607910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164242	hybrid			2022-12-27	WOS:000244482000009
J	Li, HZ; Wang, XJ; Li, N; Qiu, JM; Zhang, YY; Cao, XT				Li, Hongzhe; Wang, Xiaojian; Li, Nan; Qiu, Jianming; Zhang, Yuanyuan; Cao, Xuetao			hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED APOPTOSIS; P27(KIP1) EXPRESSION; MEDIATED APOPTOSIS; GROWTH ARREST; LIGAND TRAIL; KINASE; PROGRESSION; SIGNAL; MECHANISMS; INHIBITION	The treatment options available for prostate cancer are limited because of its resistance to therapeutic agents. Thus, a better understanding of the underlying mechanisms of the resistance of prostate cancer will facilitate the discovery of more efficient treatment protocols. Human phosphatidylethanol-amine-binding protein 4 (hPEBP4) is recently identified by us as an anti-apoptotic molecule and a potential candidate target for breast cancer treatment. Here we found the expression levels of hPEBP4 were positively correlated with the severity of clinical prostate cancer. Furthermore, hPEBP4 was not expressed in TRAIL-sensitive DU145 prostate cancer cells, but was highly expressed in TRAIL-resistant LNCaP cells, which show highly activated Akt. Interestingly, hPEBP4 overexpression in TRAIL-sensitive DU145 cells promoted Akt activation but inhibited ERK1/2 activation. The hPEBP4-overexpressing DU145 cells became resistant to TRAIL-induced apoptosis consequently, which could be reversed by PI3K inhibitors. In contrast, silencing of hPEBP4 in TRAIL-resistant LNCaP cells inhibited Akt activation but increased ERK1/2 activation, resulting in their sensitivity to TRAIL-induced apoptosis that was restored by the MEK1 inhibitor. Therefore, hPEBP4 expression in prostate cancer can activate Akt and deactivate ERK1/2 signaling, leading to TRAIL resistance. We also demonstrated that hPEBP4-mediated resistance to TRAIL-induced apoptosis occurred downstream of caspase-8 and at the level of BID cleavage via the regulation of Akt and ERK pathways, and that hPEBP4-regulated ERK deactivation was upstream of Akt activation in prostate cancer cells. Considering that hPEBP4 confers cellular resistance to TRAIL-induced apoptosis and is abundantly expressed in poorly differentiated prostate cancer, silencing of hPEBP4 suggests a promising approach for prostate cancer treatment.	Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; Zhejiang Univ, Inst Immunol, Hangzhou 310031, Peoples R China; Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Tsinghua University	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn	zhang, yuanyuan/GYA-4428-2022					Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Corallini F, 2006, LEUKEMIA LYMPHOMA, V47, P1459, DOI 10.1080/10428190500513611; Festuccia C, 2005, ENDOCR-RELAT CANCER, V12, P983, DOI 10.1677/erc.1.00986; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gioeli D, 1999, CANCER RES, V59, P279; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Liu LH, 2006, EUR J CELL BIOL, V85, P367, DOI 10.1016/j.ejcb.2005.11.005; Ma YL, 2006, MOL CANCER THER, V5, P170, DOI 10.1158/1535-7163.MCT-05-0129; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Oka N, 2005, CANCER RES, V65, P7546, DOI 10.1158/0008-5472.CAN-05-1197; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Thakkar H, 2001, J BIOL CHEM, V276, P38361, DOI 10.1074/jbc.M103321200; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Uzgare AR, 2003, PROSTATE, V55, P128, DOI 10.1002/pros.10212; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Werner AB, 2002, J BIOL CHEM, V277, P40760, DOI 10.1074/jbc.M204351200; Xiao D, 2006, CARCINOGENESIS, V27, P533, DOI 10.1093/carcin/bgi228; Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445; Yu R, 2000, CANCER RES, V60, P2384; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang MC, 2007, BIOCHEM PHARMACOL, V73, P15, DOI 10.1016/j.bcp.2006.07.034	32	50	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4943	4950		10.1074/jbc.M609494200	http://dx.doi.org/10.1074/jbc.M609494200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178731	hybrid			2022-12-27	WOS:000244482000077
J	Tudor, C; Feige, JN; Pingali, H; Lohray, VB; Wahli, W; Desvergne, B; Engelborghs, Y; Gelman, L				Tudor, Cicerone; Feige, Jerome N.; Pingali, Harikishore; Lohray, Vidya Bhushan; Wahli, Walter; Desvergne, Beatrice; Engelborghs, Yves; Gelman, Laurent			Association with coregulators is the major determinant governing peroxisome proliferator-activated receptor mobility in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; RETINOID-X-RECEPTOR; ANDROGEN RECEPTOR; NUCLEAR RECEPTORS; GLUCOCORTICOID-RECEPTOR; CHROMATIN PROTEINS; HORMONE-RECEPTORS; BINDING-PROTEIN; DNA-BINDING; PPAR-GAMMA	The nucleus is an extxemely dynamic compartment, and protein mobility represents a key factor in transcriptional regulation. We showed in a previous study that the diffusion of peroxisome proliferator-activated receptors (PPARs), a family of nuclear receptors regulating major cellular and metabolic functions, is modulated by ligand binding. In this study, we combine fluorescence correlation spectroscopy, dual color fluorescence cross-correlation microscopy, and fluorescence resonance energy transfer to dissect the molecular mechanisms controlling PPAR mobility and transcriptional activity in living cells. First, we bring new evidence that in vivo a high percentage of PPARs and retinoid X receptors is associated even in the absence of ligand. Second, we demonstrate that coregulator recruitment (and not DNA binding) plays a crucial role in receptor mobility, suggesting that transcriptional complexes are formed prior to promoter binding. In addition, association with coactivators in the absence of a ligand in living cells, both through the N-terminal AB domain and the AF-2 function of the ligand binding domain, provides a molecular basis to explain PPAR constitutive activity.	Katholieke Univ Leuven, Lab Biomol Dynam, B-3001 Louvain, Belgium; Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Zydus Res Ctr, Ahmadabad 382210, Gujarat, India	KU Leuven; University of Lausanne	Engelborghs, Y (corresponding author), Katholieke Univ Leuven, Lab Biomol Dynam, Celestjnenlaan 200G, B-3001 Louvain, Belgium.	yves.engelborghs@fys.kuleuven.be; laurent.gelman@fmi.ch	Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Desvergne, Beatrice/0000-0001-5483-288X; Gelman, Laurent/0000-0003-3277-3115				Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Auwerx J, 1999, CELL, V97, P161; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dittrich P, 2001, BIOL CHEM, V382, P491, DOI 10.1515/BC.2001.061; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Gorski SA, 2006, CURR OPIN CELL BIOL, V18, P284, DOI 10.1016/j.ceb.2006.03.002; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; HUANG Q, 1994, J BIOL CHEM, V269, P8493; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; IJpenberg A, 2004, EMBO J, V23, P2083, DOI 10.1038/sj.emboj.7600209; Jankevics H, 2005, BIOCHEMISTRY-US, V44, P11676, DOI 10.1021/bi050744v; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; Keller H, 1997, BIOL CHEM, V378, P651, DOI 10.1515/bchm.1997.378.7.651; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Matsuda KI, 2002, MOL ENDOCRINOL, V16, P2215, DOI 10.1210/me.2002-0110; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Michalik L, 2005, MOL ENDOCRINOL, V19, P2335, DOI 10.1210/me.2005-0068; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Schaaf MJM, 2005, MOL ENDOCRINOL, V19, P1501, DOI 10.1210/me.2005-0050; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sohn YC, 2003, MOL ENDOCRINOL, V17, P366, DOI 10.1210/me.2002-0150; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Zhao Y, 2002, J BIOL CHEM, V277, P30031, DOI 10.1074/jbc.M203811200	55	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4417	4426		10.1074/jbc.M608172200	http://dx.doi.org/10.1074/jbc.M608172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164241	hybrid			2022-12-27	WOS:000244482000022
J	Wang, W; Bernard, K; Li, G; Kirk, KL				Wang, Wei; Bernard, Karen; Li, Ge; Kirk, Kevin L.			Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; ABC TRANSPORTER; R-DOMAIN; PHOSPHORYLATION; SITES; GENISTEIN; 2ND	Cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels are essential mediators of salt transport across epithelia. Channel opening normally requires ATP binding to both nucleotide-binding domains (NBDs), probable dimerization of the two NBDs, and phosphorylation of the R domain. How phosphorylation controls channel gating is unknown. Loss-of-function mutations in the CFTR gene cause cystic fibrosis; thus, there is considerable interest in compounds that improve mutant CFTR function. Here we investigated the mechanism by which CFTR is activated by curcumin, a natural compound found in turmeric. Curcumin opened CFTR channels by a novel mechanism that required neither ATP nor the second nucleotide-binding domain (NBD2). Consequently, this compound potently activated CF mutant channels that are defective for the normal ATP-dependent mode of gating (e.g. G551D and W1282X), including channels that lack NBD2. The stimulation of NBD2 deletion mutants by curcumin was strongly inhibited by ATP binding to NBD1, which implicates NBD1 as a plausible activation site. Curcumin activation became irreversible during prolonged exposure to this compound following which persistently activated channels gated dynamically in the absence of any agonist. Although CFTR activation by curcumin required neither ATP binding nor heterodimerization of the two NBDs, it was strongly dependent on prior channel phosphorylation by protein kinase A. Curcumin is a useful functional probe of CFTR gating that opens mutant channels by circumventing the normal requirements for ATP binding and NBD heterodimerization. The phosphorylation dependence of curcumin activation indicates that the R domain can modulate channel opening without affecting ATP binding to the NBDs or their heterodimerization.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, W (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, 717 MCLM, Birmingham, AL 35294 USA.	weiwang@uab.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK56796] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dragomir A, 2004, BIOCHEM BIOPH RES CO, V322, P447, DOI 10.1016/j.bbrc.2004.07.146; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; FRIZZELL RA, 1995, AM J RESP CRIT CARE, V151, pS54, DOI 10.1164/ajrccm/151.3_Pt_2.S54; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; GADSBY DC, 1999, PHYSIOL REV, V79, P577; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Gross CH, 2006, J BIOL CHEM, V281, P4058, DOI 10.1074/jbc.M511113200; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Kidd JF, 2004, J BIOL CHEM, V279, P41664, DOI 10.1074/jbc.M407666200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Quint A, 2005, AM J MED GENET A, V136A, P246, DOI 10.1002/ajmg.a.30823; Reiter TA, 2002, BIOCHEMISTRY-US, V41, P15404, DOI 10.1021/bi026317o; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Shim JS, 2003, CHEM BIOL, V10, P695, DOI 10.1016/S1074-5521(03)00169-8; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	40	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4533	4544		10.1074/jbc.M609942200	http://dx.doi.org/10.1074/jbc.M609942200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178710	hybrid			2022-12-27	WOS:000244482000035
J	Shimahara, H; Yoshida, T; Shibata, Y; Shimizu, M; Kyogoku, Y; Sakiyama, F; Nakazawa, T; Tate, S; Ohki, S; Kato, T; Moriyama, H; Kishida, K; Tano, Y; Ohkubo, T; Kobayashi, Y				Shimahara, Hideto; Yoshida, Takuya; Shibata, Yasutaka; Shimizu, Masato; Kyogoku, Yoshimasa; Sakiyama, Fumo; Nakazawa, Takashi; Tate, Shin-ichi; Ohki, Shin-ya; Kato, Takeshi; Moriyama, Hozumi; Kishida, Ken-ichi; Tano, Yasuo; Ohkubo, Tadayasu; Kobayashi, Yuji			Tautomerism of histidine 64 associated with proton transfer in catalysis of carbonic anhydrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; N-15 NMR-SPECTROSCOPY; ACTIVE-SITE; CHEMICAL-SHIFTS; MECHANISM; PROTEINS; ASSIGNMENT; DYNAMICS; C-13; BOND	The imidazole N-15 signals of histidine 64 (His(64)), involved in the catalytic function of human carbonic anhydrase II (hCAII), were assigned unambiguously. This was accomplished by incorporating the labeled histidine as probes for solution NMR analysis, with N-15 at ring-N-delta 1 and N-epsilon 2, C-13 at ring-C epsilon 1, C-13 and N-15 at all carbon and nitrogen, or N-15 at the amide nitrogen and the labeled glycine with C-13 at the carbonyl carbon. Using the pH dependence of ring-N-15 signals and a comparison between experimental and simulated curves, we determined that the tautomeric equilibrium constant (K-T) of His(64) is 1.0, which differs from that of other histidine residues. This unique value characterizes the imidazole nitrogen atoms of His(64) as both a general acid (a) and base (b): its epsilon 2-nitrogen as (a) releases one proton into the bulk, whereas its delta 1-nitrogen as another proton from a water molecule within the (b) extracts water bridge coupling to the zinc-bound water inside the cave. This accelerates the generation of zinc-bound hydroxide to react with the carbon dioxide. Releasing the productive bicarbonate ion from the inside separates the water bridge pathway, in which the next water molecules move into beside zinc ion. A new water molecule is supplied from the bulk to near the delta 1-nitrogen of His(64). These reconstitute the water bridge. Based on these features, we suggest here a catalytic mechanism for hCAII: the tautomerization of His(64) can mediate the transfers of both protons and water molecules at a neutral pH with high efficiency, requiring no time- or energy-consuming processes.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan; Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa 9231211, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Suita, Osaka 5650871, Japan; Nara Womens Univ, Dept Chem, Nara 6308506, Japan	Osaka University; Osaka University of Pharmaceutical Sciences; Japan Advanced Institute of Science & Technology (JAIST); Osaka University; Osaka University; Nara Womens University	Kobayashi, Y (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan.	kobayasi@gly.oups.ac.jp	Tate, Shin-ichi/E-3057-2015	Tate, Shin-ichi/0000-0002-5556-7712; Nakazawa, Takashi/0000-0002-2528-0200; Yoshida, Takuya/0000-0002-3491-9344				Ash EL, 1997, SCIENCE, V278, P1128, DOI 10.1126/science.278.5340.1128; BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; Bao DH, 1998, J AM CHEM SOC, V120, P3485, DOI 10.1021/ja972937e; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; BLOMBERG F, 1977, J AM CHEM SOC, V99, P8149, DOI 10.1021/ja00467a005; Bottoni A, 2004, J AM CHEM SOC, V126, P1542, DOI 10.1021/ja030336j; CAMPBELL ID, 1975, J MOL BIOL, V98, P597, DOI 10.1016/S0022-2836(75)80089-1; Chegwidden W. R., 2000, CARBONIC ANHYDRASES, DOI [10.1007/978-3-0348-8446-4_9, DOI 10.1007/978-3-0348-8446-4_9]; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Christianson DW, 1996, ACCOUNTS CHEM RES, V29, P331, DOI 10.1021/ar9501232; Duda D, 2001, BIOCHEMISTRY-US, V40, P1741, DOI 10.1021/bi002295z; Earnhardt JN, 1998, BIOCHEMISTRY-US, V37, P10837, DOI 10.1021/bi980046t; ELGUERO J, 1976, ADV HETEROCYCLIC CHE, P278; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; GRONENBORN AM, 1989, FEBS LETT, V243, P93, DOI 10.1016/0014-5793(89)81224-4; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; HUNT JB, 1977, ANAL BIOCHEM, V79, P614, DOI 10.1016/0003-2697(77)90444-4; Jackman JE, 1996, BIOCHEMISTRY-US, V35, P16421, DOI 10.1021/bi961786+; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KAINOSHO M, 1982, BIOCHEMISTRY-US, V21, P6273, DOI 10.1021/bi00267a036; KAKIUCHI K, 1971, J BIOCHEM, V69, P43, DOI 10.1093/oxfordjournals.jbchem.a129458; KAWANO K, 1975, CHEM LETT, P1305, DOI 10.1246/cl.1975.1305; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KISHIDA K, 1986, EXP EYE RES, V43, P981, DOI 10.1016/0014-4835(86)90076-X; KREBS JF, 1991, BIOCHEMISTRY-US, V30, P9153, DOI 10.1021/bi00102a005; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KYOGOKU Y, 1981, APPL SPECTROSC REV, V17, P279, DOI 10.1080/05704928108060407; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lu DS, 1998, PROTEINS, V33, P119, DOI 10.1002/(SICI)1097-0134(19981001)33:1<119::AID-PROT11>3.0.CO;2-O; Lu DS, 1998, J AM CHEM SOC, V120, P4006, DOI 10.1021/ja973397o; MAJUMDAR A, 1993, J BIOMOL NMR, V3, P387; Marino T, 2005, J AM CHEM SOC, V127, P4242, DOI 10.1021/ja045546q; Moriyama H., 1990, MED J OSAKA U, V42, P1; NAIR SK, 1991, BIOCHEM BIOPH RES CO, V181, P579, DOI 10.1016/0006-291X(91)91229-6; NAIR SK, 1991, J AM CHEM SOC, V113, P9455, DOI 10.1021/ja00025a005; NYMAN PO, 1964, BIOCHIM BIOPHYS ACTA, V85, P141, DOI 10.1016/0926-6569(64)90174-9; OSBORNE WRA, 1975, ANAL BIOCHEM, V64, P297, DOI 10.1016/0003-2697(75)90434-0; OZAKI Y, 1979, J CHEM SOC CHEM COMM, P76, DOI 10.1039/c39790000076; ROBERTS JD, 1982, J AM CHEM SOC, V104, P3945, DOI 10.1021/ja00378a027; ROTH DE, 1992, P NATL ACAD SCI USA, V89, P1804, DOI 10.1073/pnas.89.5.1804; SCHUSTER II, 1979, J ORG CHEM, V44, P3864, DOI 10.1021/jo01336a025; Scolnick LR, 1996, BIOCHEMISTRY-US, V35, P16429, DOI 10.1021/bi9617872; SHIBA K, 1984, J BACTERIOL, V160, P696, DOI 10.1128/JB.160.2.696-701.1984; Shimba N, 2003, BIOCHEMISTRY-US, V42, P9227, DOI 10.1021/bi0344679; Silhavy T. J., 1984, EXPT GENE FUSIONS; SILVERMAN DN, 1995, METHOD ENZYMOL, V249, P479; Smedarchina Z, 2003, J AM CHEM SOC, V125, P243, DOI 10.1021/ja0210594; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAOKA S, 1994, J BIOL CHEM, V269, P17988; Toba S, 1999, J AM CHEM SOC, V121, P2290, DOI 10.1021/ja983579y; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099	57	59	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9646	9656		10.1074/jbc.M609679200	http://dx.doi.org/10.1074/jbc.M609679200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17202139	hybrid			2022-12-27	WOS:000245421700038
J	Graubner, W; Schierhorn, A; Bruser, T				Graubner, Wenke; Schierhorn, Angelika; Brueser, Thomas			DnaK plays a pivotal role in Tat targeting of CueO and functions beside SlyD as a general Tat signal binding chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; PROTEIN TRANSLOCATION; TRIGGER FACTOR; LYSIS PROTEIN; SYSTEM; STEP; IDENTIFICATION; SECRETION; INSERTION; PEPTIDE	The Tat (twin-arginine translocation) system from Escherichia coli transports folded proteins with N-terminal twin-arginine signal peptides across the cytoplasmic membrane. The influence of general chaperones on Tat substrate targeting has not been clarified so far. Here we show that the chaperones SlyD and DnaK bind to a broad range of different Tat signal sequences in vitro and in vivo. initially, SlyD and GroEL were purified from DnaK-deficient extracts by their affinity to various Tat signal sequences. Of these, only SlyD bound Tat signal sequences also in the presence of DnaK. SlyD and DnaK also co-purified with Tat substrate precursors, demonstrating the binding to Tat signal sequences in vivo. Deletion of dnaKcompletely abolished Tat-dependent translocation of CueO, but not of DmsA, YcdB, or HiPIP, indicating that DnaK has an essential role specifically for CueO. DnaK was not required for stability of the CueO precursor and thus served in some essential step after folding. A CueO signal sequence fusion to HiPIP was Tat-dependently transported without the need of DnaK, indicating that the mature domain of CueO is responsible for the DnaK dependence. The overall results suggest that SlyD and DnaK are in the set of chaperones that can serve as general Tat signal-binding proteins. DnaK has additional functions that are indispensable for the targeting of CueO.	Univ Halle Wittenberg, Inst Microbiol, D-06120 Halle, Germany; Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Max Planck Society	Bruser, T (corresponding author), Univ Halle Wittenberg, Inst Microbiol, Kurt Mothes Str 3, D-06120 Halle, Germany.	t.brueser@mikrobiologie.uni-halle.de		Bruser, Thomas/0000-0002-5889-8306				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; Bernhardt TG, 2002, MOL MICROBIOL, V45, P99, DOI 10.1046/j.1365-2958.2002.02984.x; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubini A, 2003, FEBS LETT, V549, P141, DOI 10.1016/S0014-5793(03)00802-0; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Gutensohn M, 2004, MOL GENET GENOMICS, V272, P379, DOI 10.1007/s00438-004-1068-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kipping M, 2003, FEBS LETT, V550, P18, DOI 10.1016/S0014-5793(03)00804-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mitterauer T, 1999, BIOCHEM J, V342, P33, DOI 10.1042/0264-6021:3420033; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; ROOF WD, 1993, J BACTERIOL, V175, P3909, DOI 10.1128/JB.175.12.3909-3912.1993; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Sambasivarao D, 2001, J BIOL CHEM, V276, P20167, DOI 10.1074/jbc.M010369200; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Tree JJ, 2005, BIOCHEM BIOPH RES CO, V328, P1205, DOI 10.1016/j.bbrc.2005.01.084; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Walter S, 2002, CELL MOL LIFE SCI, V59, P1589, DOI 10.1007/PL00012485; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wild J, 1996, J BACTERIOL, V178, P3608, DOI 10.1128/jb.178.12.3608-3613.1996; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041	43	68	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7116	7124		10.1074/jbc.M608235200	http://dx.doi.org/10.1074/jbc.M608235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215254	hybrid			2022-12-27	WOS:000245080900023
J	Meissner, JD; Chang, KC; Kubis, HP; Nebreda, AR; Gros, G; Scheibe, RJ				Meissner, Joachim D.; Chang, Kin-Chow; Kubis, Hans-Peter; Nebreda, Angel R.; Gros, Gerolf; Scheibe, Renate J.			The p38 alpha/beta mitogen-activated protein kinases mediate recruitment of CREB-binding protein to preserve fast myosin heavy chain IId/x gene activity in myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE ENHANCER FACTOR-2; SKELETAL-MUSCLE DIFFERENTIATION; TO-SLOW TRANSFORMATION; P38 MAP KINASE; TRANSCRIPTION FACTOR; RETINOIC ACID; CALCINEURIN; CALCIUM; MEF2; EXPRESSION	In skeletal muscle, the transformation of fast into slow fib type is accompanied by shifts in fiber type-specific gene expression that includes down-regulation of the adult fast fiber myosin heavy chain Ild/x (MyHCIId/x) gene. Here, we report that the mitogen-activated protein kinases (MAPKs) p38 alpha/beta regulate MyHCIId/x gene expression. Electrical stimulation of rabbi skeletal muscle cells with a slow fiber type activity pattern an treatment of C2C12 myotubes with Ca2+-ionophore inhibited p38 alpha/beta MAPKs and reduced fast fiber type MyHC protein expression and promoter activity. Pharmacological inhibition of p38 alpha/beta also down-regulated MyHCII gene expression. In controls, binding of the myocyte enhancer factor-2 (MEF-2) isoforms C and D as a heterodimer to a proximal consensus site within the MyHCIId/x promoter and recruitment of a transcriptional coactivator, the CREB-binding protein CBP, were observed. Overexpression of wild type MEF-2C but not of a MEF-2C mutant that cannot be phosphorylated by p38 induced promoter activity. Mutation of the MEF-2-binding site decreased the inducing effect of overexpressed CBP. Inhibition of p38 alpha/beta MAPKs abolished CBP binding, whereas enforced induction of p38 by activated MAPK kinase 6 (MKK6EE) enhanced binding of CBP and increased promoter activity. Furthermore, knockdown of endogenous CBP by RNA interference eliminated promoter activation by MEF-2C or MKK6EE. In electrical stimulated and Ca2+-ionophore-treated myotubes, CBP was absent in complex formation at that site. Taken together, the data indicate that p38 alpha/beta MAPKs-mediated coactivator recruitment at a proximal MEF-2 site is important for MyHCIId/x gene regulation in skeletal muscle.	Hannover Med Sch, Dept Physiol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Biochem, D-30625 Hannover, Germany; Univ Glasgow, Sch Vet, Div Anim Prod & Publ Hlth, Glasgow G61 1QH, Lanark, Scotland; CNIO, Spanish Natl Canc Ctr, Madrid 28029, Spain	Hannover Medical School; Hannover Medical School; University of Glasgow; Centro Nacional de Investigaciones Oncologicas (CNIO)	Meissner, JD (corresponding author), Hannover Med Sch, Dept Physiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	meissner.joachim@mh-hannover.de	Nebreda, Angel Rodriguez/R-9594-2019; Chang, Kin Chow/H-1046-2011; Gros, Gerolf/K-8421-2012	Chang, Kin-Chow/0000-0002-6602-7447				Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Allen DL, 2002, J BIOL CHEM, V277, P45323, DOI 10.1074/jbc.M208302200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; Carroll S, 1999, AM J PHYSIOL-CELL PH, V277, pC1122, DOI 10.1152/ajpcell.1999.277.6.C1122; Chan HM, 2001, J CELL SCI, V114, P2363; Chin ER, 2004, P NUTR SOC, V63, P279, DOI 10.1079/PNS2004335; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Darby TG, 1997, ONCOGENE, V15, P3067, DOI 10.1038/sj.onc.1201503; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Gamble MJ, 2002, TRENDS BIOCHEM SCI, V27, P165, DOI 10.1016/S0968-0004(02)02076-5; Goldspink G, 2002, BIOCHEM SOC T, V30, P285, DOI 10.1042/bst0300285; Goodman RH, 2000, GENE DEV, V14, P1553; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Haneda M, 1999, EUR J PHARMACOL, V365, P1, DOI 10.1016/S0014-2999(98)00857-7; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kubis HP, 1997, P NATL ACAD SCI USA, V94, P4205, DOI 10.1073/pnas.94.8.4205; Kubis HP, 2002, J PHYSIOL-LONDON, V541, P835, DOI 10.1113/jphysiol.2002.017574; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Meissner JD, 2001, J PHYSIOL-LONDON, V533, P215, DOI 10.1111/j.1469-7793.2001.0215b.x; Meissner JD, 2000, J PHYSIOL-LONDON, V523, P19, DOI 10.1111/j.1469-7793.2000.t01-1-00019.x; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Puri PL, 2000, GENE DEV, V14, P574; Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SCHEIBE RJ, 1991, J BIOL CHEM, V266, P21300; Scimeca JC, 1997, ONCOGENE, V15, P717, DOI 10.1038/sj.onc.1201231; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Smith JL, 2003, J BIOL CHEM, V278, P41034, DOI 10.1074/jbc.M305615200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Terada H, 2003, J NEUROCHEM, V87, P1145, DOI 10.1046/j.1471-4159.2003.02098.x; Tran NQ, 2004, BIOCHEM J, V381, P267, DOI 10.1042/BJ20031653; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 1999, MOL CELL BIOL, V19, P21; [No title captured]	58	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7265	7275		10.1074/jbc.M609076200	http://dx.doi.org/10.1074/jbc.M609076200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210568	hybrid			2022-12-27	WOS:000245080900038
J	Paul, BD; Buchholz, DR; Fu, LZ; Shi, YB				Paul, Bindu D.; Buchholz, Daniel R.; Fu, Liezhen; Shi, Yun-Bo			SRC-p300 coactivator complex is required for thyroid hormone-induced amphibian metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS METAMORPHOSIS; STEROID-RECEPTOR COACTIVATOR-1; CREB-BINDING PROTEIN; IN-VIVO ANALYSIS; NUCLEAR-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR; HISTONE ACETYLTRANSFERASE; FROG METAMORPHOSIS; P160 COACTIVATOR; GLUCOCORTICOID-RECEPTOR	Gene activation by the thyroid hormone (T3) receptor (TR) involves the recruitment of specific coactivator complexes to T3-responsive promoters. A large number of coactivators for TR have been isolated and characterized in vitro. However, their roles and functions in vivo during development have remained largely unknown. We have utilized metamorphosis in Xenopus laevis to study the role of these coactivators during post-embryonic development. Metamorphosis is totally dependent on the thyroid hormone, and TR mediates a vast majority, if not all, of the developmental effects of the hormone. We have previously shown that TR recruits the coactivator SRC3 (steroid receptor coactivator-3) and that coactivator recruitment is essential for metamorphosis. To determine whether SRCs are indeed required, we have analyzed the in vivo role of the histone acetyltransferase p300/CREB-binding protein (CBP), which was reported to be a component of the SRC-coactivator complexes. Chromatin immunoprecipitation revealed that p300 is recruited to T3-responsive promoters, implicating a role of p300 in TR function. Further, transgenic tadpoles overexpressing a dominant negative form of p300, F-dnp300, containing only the SRC-interacting domain, displayed arrested or delayed metamorphosis. Molecular analyses of the transgenic F-dnp300 animals showed that F-dnp300 was recruited by TR (displacing endogenous p300) and inhibited the expression of T3-responsive genes. Our results thus suggest that p300 and/or its related CBP is an essential component of the TR-signaling pathway in vivo and support the notion that p300/CBP and SRC proteins are part of the same coactivator complex in vivo during postembryonic development.	NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bldg 18T,Room 106,LGRD, Bethesda, MD 20892 USA.	shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001901] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DODD MHI, 1976, BIOL METAMORPHOSIS, P467; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Fujii G, 1998, BBA-GENE STRUCT EXPR, V1443, P41, DOI 10.1016/S0167-4781(98)00179-1; Furlow JD, 1999, MOL ENDOCRINOL, V13, P2076, DOI 10.1210/me.13.12.2076; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Glass CK, 2000, GENE DEV, V14, P121; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jepsen K, 2002, J CELL SCI, V115, P689; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Laudet V., 2002, NUCL RECEPTOR FACTS; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; Parker D, 1996, MOL CELL BIOL, V16, P694; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul DB, 2003, CELL RES, V13, P459, DOI 10.1038/sj.cr.7290188; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; YAOITA Y, 1990, P NATL ACAD SCI USA, V87, P7090, DOI 10.1073/pnas.87.18.7090; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939	78	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7472	7481		10.1074/jbc.M607589200	http://dx.doi.org/10.1074/jbc.M607589200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218308	hybrid			2022-12-27	WOS:000245080900060
J	Takeda, K; Shimozono, R; Noguchi, T; Umeda, T; Morimoto, Y; Naguro, I; Tobiume, K; Saitoh, M; Matsuzawa, A; Ichijo, H				Takeda, Kohsuke; Shimozono, Rieko; Noguchi, Takuya; Umeda, Tsuyoshi; Morimoto, Yoshifumi; Naguro, Isao; Tobiume, Kei; Saitoh, Masao; Matsuzawa, Atsushi; Ichijo, Hidenori			Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; MOLECULAR-CLONING; MAP KINASES; B-RAF; STRESS; FAMILY; PATHWAYS; IMMUNITY; ERK	Apoptosis signal-regulating kinase (ASK) 1 is a mitogen-activated protein kinase kinase kinase (MAP3K) in the c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase pathways that play multiple important roles in cytokine and stress responses. Here we show that ASK2, a highly related serine/threonine kinase to ASK1, also functions as a MAP3K only in a heteromeric complex with ASK1. We found that endogenous ASK2 was constitutively degraded in ASK1-deficient cells, suggesting that ASK1 is required for the stability of ASK2. ASK2 in a heteromeric complex with a kinase-negative mutant of ASK1 (ASK1-KN) effectively activated MAP2K and was more competent to respond to oxidative stress than ASK2 alone. Knockdown of ASK2 revealed that ASK2 was required for oxidative stress-induced JNK activation. These results suggest that ASK2 forms a functional MAP3K complex with ASK1, in which ASK1 supports the stability and the active configuration of ASK2. Moreover, ASK2 was found to activate ASK1 by direct phosphorylation, suggesting that ASK1 and ASK2 in a heteromeric complex facilitate their activities to each other by distinct mechanisms. Such a formation of functional heteromeric complex between different MAP3Ks may be advantageous for cells to cope with a wide variety of stimuli by fine regulation of cellular responses.	Univ Tokyo, Lab Cell Signaling, Grad Sch Pharmaceut Sci, CREST,Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 1130033, Japan; Ctr Excellence Program, Strateg Approach Durg Discovery & Dev Pharmaceut, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Hiroshima Univ, Sch Biomed Sci, Dept Mucosal Immunol, Hiroshima 7348553, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Hiroshima University	Ichijo, H (corresponding author), Univ Tokyo, Lab Cell Signaling, Grad Sch Pharmaceut Sci, CREST,Japan Sci & Technol Corp,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Naguro, Isao/P-1337-2019; Matsuzawa, Atsushi/GLU-1387-2022; Noguchi, Takuya/T-6767-2019	Noguchi, Takuya/0000-0001-6187-6645; Takeda, Kohsuke/0000-0002-8359-8399; Matsuzawa, Atsushi/0000-0001-8303-3905; Ichijo, Hidenori/0000-0002-5005-6438; Naguro, Isao/0000-0002-0338-8026				Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kanamoto T, 2000, MOL CELL BIOL, V20, P196, DOI 10.1128/MCB.20.1.196-204.2000; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Su B, 2005, NAT IMMUNOL, V6, P541, DOI 10.1038/ni0605-541; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Uhlik MT, 2004, BIOCHEM CELL BIOL, V82, P658, DOI 10.1139/O04-114; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Wang XHSN, 1998, BIOCHEM BIOPH RES CO, V253, P33, DOI 10.1006/bbrc.1998.9749; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	28	87	114	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7522	7531		10.1074/jbc.M607177200	http://dx.doi.org/10.1074/jbc.M607177200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210579	hybrid			2022-12-27	WOS:000245080900065
J	Shanware, NP; Trinh, AT; Williams, LM; Tibbetts, RS				Shanware, Naval P.; Trinh, Anthony T.; Williams, Leah M.; Tibbetts, Randal S.			Coregulated ataxia telangiectasia-mutated and casein kinase sites modulate cAMP-response element-binding protein-coactivator interactions in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED PHOSPHORYLATION; MEDIATED GENE-EXPRESSION; GENOME-WIDE ANALYSIS; NUCLEAR FACTOR CREB; GENOTOXIC STRESS; KIX DOMAIN; ATM KINASE; ACTIVATION; P53; TRANSCRIPTION	The cyclic AMP-response element-binding protein (CREB) is a bZIP family transcription factor implicated as an oncoprotein and neuron survival factor. CREB is activated in response to cellular stimuli, including cAMP and Ca2+, via phosphorylation of Ser-133, which promotes interaction between the kinase-inducible domain (KID) of CREB and the KID-interacting domain of CREB-binding protein (CBP). We previously demonstrated that the interaction between CREB and CBP is inhibited by DNA-damaging stimuli through a mechanism whereby CREB is phosphorylated by the ataxia telangiectasia-mutated (ATM) protein kinase. We now show that the ATM phosphorylation sites in CREB are functionally intertwined with a cluster of coregulated casein kinase (CK) sites. We demonstrate that DNA damage-induced phosphorylation of CREB occurs in three steps. The initial event in the CREB phosphorylation cascade is the phosphorylation of Ser111, which is carried out by CK1 and CK2 under basal conditions and by ATM in response to ionizing radiation. The phosphorylation of Ser-111 triggers the CK2-dependent phosphorylation of Ser-108 and the CK1-dependent phosphorylation of Ser-114 and Ser-117. The phosphorylation of Ser-114 and Ser-117 by CK1 then renders CREB permissive for ATM-dependent phosphorylation on Ser-121. Mutation of Ser-121 alone abrogates ionizing radiation-dependent repression of CREB-CBP complexes, which can be recapitulated using a CK1 inhibitor. Our findings outline a complex mechanism of CREB phosphorylation in which coregulated ATM and CK sites control CREB transactivation potential by modulating its CBP-binding affinity. The coregulated ATM and CK sites identified in CREB may constitute a signaling motif that is common to other DNA damage-regulated substrates.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Mol & Cellular Pharmacol Program, 1300 Univ Ave, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067868] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM067868-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Parker D, 1996, MOL CELL BIOL, V16, P694; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Saeki K, 1999, BIOCHEM J, V338, P49, DOI 10.1042/0264-6021:3380049; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; SHILOH Y, 2003, TRENDS BIOCHEM SCI, V31, P402; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	50	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6283	6291		10.1074/jbc.M610674200	http://dx.doi.org/10.1074/jbc.M610674200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17209043	hybrid			2022-12-27	WOS:000244867200034
J	Chiu, PCN; Chung, MK; Koistinen, R; Koistinen, H; Seppala, M; Ho, PC; Ng, EHY; Lee, KF; Yeung, WSB				Chiu, Philip C. N.; Chung, Man-Kin; Koistinen, Riitta; Koistinen, Hannu; Seppala, Markku; Ho, Pak-Chung; Ng, Ernest H. Y.; Lee, Kai-Fai; Yeung, William S. B.			Cumulus oophorus-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FOLLICULAR-FLUID; IN-VITRO FERTILIZATION; INHIBITORY FACTOR-I; EXTRACELLULAR-MATRIX; PLACENTAL PROTEIN-14; OOCYTE MATURATION; ACROSOME REACTION; CELLS; CAPACITATION; PENETRATION	Spermatozoa have to swim through the oviduct and the cumulus oophorus before fertilization in vivo. In the oviduct, spermatozoa are exposed to glycodelin-A and -F that inhibit spermatozoa-zona pellucida binding. In this study, we determined whether these glycodelins would inhibit fertilization. The data showed that the spermatozoa without previous exposure to glycodelin-A and -F acquired glycodelin immunoreactivity during their passage through the cumulus oophorus. On the other hand, when glycodelin-A or -F-pretreated spermatozoa were exposed to the cumulus oophorus, the zona pellucida binding inhibitory activity of glycodelin-A and -F was not only removed, but the spermatozoa acquired enhanced zona pellucida binding ability. These actions of the cumulus oophorus were due to the presence of a cumulus isoform of glycodelin, designated as glycodelin-C. The cumulus cells could convert exogenous glycodelin-A and -F to glycodelin-C, which was then released into the surrounding medium. The protein core of glycodelin-C was identical to that in other glycodelin isoforms, as demonstrated by mass spectrum, peptide mapping, and affinity to anti-glycodelin antibody recognizing the protein core of glycodelin. In addition to having a smaller size and a higher isoelectric point, glycodelin-C also had lectin binding properties different from other isoforms. Glycodelin-C stimulated spermatozoazona pellucida binding in a dose-dependent manner, and it effectively displaced sperm-bound glycodelin-A and -F. In conclusion, the cumulus cells transform glycodelin-A and -F to glycodelin-C, which in turn removes the spermatozoazona binding inhibitory glycodelin isoforms and enhances the zona binding capacity of spermatozoa passing through the cumulus oophorus.	Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; Univ Helsinki, Dept Obstet & Gynaecol, Helsinki 00029, Finland; Univ Helsinki, Dept Clin Chem, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Helsinki 00029, Finland	University of Hong Kong; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Yeung, WSB (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hkucc.hku.hk	/C-7476-2009; Seppala, Markku/AAT-6618-2021; Chung, Man Kin/B-9613-2012; Chiu, Chi Ngong/C-4245-2009; Koistinen, Hannu/AGU-1279-2022; Lee, Calvin Kai Fai/C-4328-2009	Chung, Man Kin/0000-0003-4239-4311; Chiu, Chi Ngong/0000-0001-6217-1970; Koistinen, Hannu/0000-0003-0926-3109; Lee, Calvin Kai Fai/0000-0001-5957-439X; Ng, Ernest/0000-0002-7688-4557				Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; BASTIAS MC, 1993, HUM REPROD, V8, P1670, DOI 10.1093/oxfordjournals.humrep.a137911; BLUMENFELD Z, 1989, FERTIL STERIL, V51, P863; Brown SE, 2000, FERTIL STERIL, V74, P130, DOI 10.1016/S0015-0282(00)00586-0; CARRELL DT, 1993, ARCH ANDROLOGY, V31, P133, DOI 10.3109/01485019308988391; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; Chapman NR, 1996, MOL HUM REPROD, V2, P767, DOI 10.1093/molehr/2.10.767; CHEN C, 1986, ARCH ANDROLOGY, V16, P183, DOI 10.3109/01485018608986940; Chian RC, 1999, FERTIL STERIL, V71, P61, DOI 10.1016/S0015-0282(98)00416-6; Chiu PCN, 2005, J BIOL CHEM, V280, P25580, DOI 10.1074/jbc.M504103200; Chiu PCN, 2004, BIOL REPROD, V70, P1710, DOI 10.1095/biolreprod.103.023259; Chiu PCN, 2003, BIOL REPROD, V69, P365, DOI 10.1095/biolreprod.102.012658; Chiu PCN, 2003, J BIOL CHEM, V278, P13570, DOI 10.1074/jbc.M212086200; Chiu PCN, 2002, MOL REPROD DEV, V61, P205, DOI 10.1002/mrd.1149; Cordero OJ, 2001, EUR J BIOCHEM, V268, P3321, DOI 10.1046/j.1432-1327.2001.02237.x; Dirnfeld M, 1999, HUM REPROD, V14, P2562, DOI 10.1093/humrep/14.10.2562; DUBEY AK, 1995, FERTIL STERIL, V64, P787, DOI 10.1016/S0015-0282(16)57855-8; FAKIH H, 1990, FERTIL STERIL, V53, P515; Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8; FETTEROLF PM, 1994, BIOL REPROD, V51, P184, DOI 10.1095/biolreprod51.2.184; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P327, DOI 10.1016/S0167-4838(00)00169-2; FRASER LR, 1984, J REPROD FERTIL, V72, P373, DOI 10.1530/jrf.0.0720373; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GIORGETTI C, 1992, HUM REPROD, V7, P1121, DOI 10.1093/oxfordjournals.humrep.a137805; Goi G, 2000, FEBS LETT, V473, P89, DOI 10.1016/S0014-5793(00)01504-0; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hong SJ, 2004, HUM REPROD, V19, P1562, DOI 10.1093/humrep/deh281; Hong SJ, 2003, FERTIL STERIL, V79, P802, DOI 10.1016/S0015-0282(02)04832-X; Hossain AM, 1996, ARCH ANDROLOGY, V37, P7, DOI 10.3109/01485019608988495; Ish-Shalom E, 2006, GLYCOBIOLOGY, V16, P173, DOI 10.1093/glycob/cwj053; JULKUNEN M, 1986, AM J OBSTET GYNECOL, V154, P1076, DOI 10.1016/0002-9378(86)90754-4; Koistinen H, 1996, MOL HUM REPROD, V2, P759, DOI 10.1093/molehr/2.10.759; LAIRD SM, 1995, HUM REPROD, V10, P1346, DOI 10.1093/HUMREP/10.6.1346; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; MAGIER S, 1990, HUM REPROD, V5, P847, DOI 10.1093/oxfordjournals.humrep.a137196; Mencarelli S, 2005, FEBS LETT, V579, P5501, DOI 10.1016/j.febslet.2005.08.081; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Morales P, 2000, BIOL REPROD, V63, P635, DOI 10.1095/biolreprod63.2.635; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Munuce MJ, 2004, ANDROLOGIA, V36, P395, DOI 10.1111/j.1439-0272.2004.00638.x; Ng EHY, 2000, HUM REPROD, V15, P772; OBASAJU MF, 1993, HUM REPROD, V8, P1886, DOI 10.1093/oxfordjournals.humrep.a137954; OEHNINGER S, 1995, FERTIL STERIL, V63, P377; Ozgur K, 1998, MOL HUM REPROD, V4, P318, DOI 10.1093/molehr/4.4.318; PEREDA J, 1985, ANAT EMBRYOL, V173, P247, DOI 10.1007/BF00316305; RIITTINEN L, 1991, J IMMUNOL METHODS, V136, P85, DOI 10.1016/0022-1759(91)90253-C; ROBERTSON EF, 1987, ANAL BIOCHEM, V167, P290, DOI 10.1016/0003-2697(87)90166-7; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; Stanton PG, 1996, MOL CELL ENDOCRINOL, V125, P133, DOI 10.1016/S0303-7207(96)03958-5; SULLIVAN R, 1990, HUM REPROD, V5, P830, DOI 10.1093/oxfordjournals.humrep.a137193; Suzuki H, 2000, BIOL REPROD, V63, P723, DOI 10.1095/biolreprod63.3.723; TAJIK P, 1993, THERIOGENOLOGY, V40, P949, DOI 10.1016/0093-691X(93)90363-A; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; TESARIK J, 1989, J REPROD FERTIL, V87, P193; Tse JYM, 2002, MOL HUM REPROD, V8, P142, DOI 10.1093/molehr/8.2.142; VIRJI N, 1990, MOL REPROD DEV, V25, P339, DOI 10.1002/mrd.1080250405; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; WESTPHAL LM, 1993, HUM REPROD, V8, P1083, DOI 10.1093/oxfordjournals.humrep.a138197; Wojnar P, 2003, J BIOL CHEM, V278, P16209, DOI 10.1074/jbc.M210922200; World Health Organization, 1999, WHO LAB MAN EX HUM S; Yanagimachi R., 1994, P189; Yao YQ, 1996, HUM REPROD, V11, P1516; Yao YQ, 1998, HUM REPROD, V13, P2541, DOI 10.1093/humrep/13.9.2541; Yao YQ, 1999, FERTIL STERIL, V72, P1079, DOI 10.1016/S0015-0282(99)00420-3; Yeung WSB, 2006, MOL CELL ENDOCRINOL, V250, P149, DOI 10.1016/j.mce.2005.12.038; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310; ZHU JJ, 1994, FERTIL STERIL, V61, P1129; Zhuo LS, 2001, CELL STRUCT FUNCT, V26, P189, DOI 10.1247/csf.26.189; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	72	44	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5378	5388		10.1074/jbc.M607482200	http://dx.doi.org/10.1074/jbc.M607482200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192260	hybrid			2022-12-27	WOS:000244482300033
J	Lauren, J; Hu, FH; Chin, J; Liao, J; Airaksinen, MS; Strittmatter, SM				Lauren, Juha; Hu, Fenghua; Chin, Joanna; Liao, Ji; Airaksinen, Matti S.; Strittmatter, Stephen M.			Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON REGENERATION; GLYCOPROTEIN; RECOVERY; INHIBITION; GROWTH; OUTGROWTH; IDENTIFICATION; INTERACTS; PROTEINS; ANTIBODY	Nogo, MAG, and OMgp are myelin-associated proteins that bind to a neuronal Nogo-66 receptor (NgR/NgR1) to limit axonal regeneration after central nervous system injury. Within Nogo-A, two separate domains are known interact with NgR1. NgR1 is the founding member of the three-member NgR family, whereas Nogo-A (RTN4A) belongs to a four-member reticulon family. Here, we systematically mapped the interactions between these superfamilies, demonstrating novel nanomolar interactions of RTN2 and RTN3 with NgR1. Because RTN3 is expressed in spinal cord white matter, it may have a role in myelin inhibition of axonal growth. Further analysis of the Nogo-A and NgR1 interactions revealed a novel third interaction site between the proteins, suggesting a trivalent Nogo-A interaction with NgR1. We also confirmed here that MAG binds to NgR2, but not to NgR3. Unexpectedly, we found that OMgp interacts with MAG with a higher affinity compared with NgR1. To better define how these multiple structurally distinct ligands bind to NgR1, we examined a series of Ala-substituted NgR1 mutants for ligand binding activity. We found that the core of the binding domain is centered in the middle of the concave surface of the NgR1 leucine-rich repeat domain and surrounded by differentially utilized residues. This detailed knowledge of the molecular interactions between NgR1 and its ligands is imperative when assessing options for development of NgR1-based therapeutics for central nervous system injuries.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	Yale University; Yale University; University of Helsinki	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Airaksinen, Matti/0000-0002-7199-4984	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056485, R01NS039962, R37NS033020, R01NS042304] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042304-09, R37 NS033020, R01 NS056485, R01 NS039962-10, R01 NS042304, R37 NS033020-17, NS42304, NS39962, R01 NS056485-05, R01 NS039962] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Habib AA, 1998, J NEUROCHEM, V70, P1704; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Levy D, 1996, Essays Biochem, V31, P49; Li SX, 2003, J NEUROSCI, V23, P4219; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Niederost B, 2002, J NEUROSCI, V22, P10368; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Qi B, 2003, J CELL PHYSIOL, V196, P312, DOI 10.1002/jcp.10297; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou D, 2006, CELL MOL LIFE SCI, V63, P2260, DOI 10.1007/s00018-006-6184-6	41	66	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5715	5725		10.1074/jbc.M609797200	http://dx.doi.org/10.1074/jbc.M609797200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189258	Green Accepted, hybrid			2022-12-27	WOS:000244482300068
J	Oestreich, EA; Wang, HA; Malik, S; Kaproth-Joslin, KA; Blaxall, BC; Kelley, GG; Dirksen, RT; Smrcka, AV				Oestreich, Emily A.; Wang, Huan; Malik, Sundeep; Kaproth-Joslin, Katherine A.; Blaxall, Burns C.; Kelley, Grant G.; Dirksen, Robert T.; Smrcka, Alan V.			Epac-mediated activation of phospholipase C epsilon plays a critical role in 6-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE; CYCLIC-AMP; PROTEIN; RAP1; KINASE; HYPERTROPHY; EFFECTOR; RAS; IDENTIFICATION; CONTRACTION	Recently we demonstrated that PLC is an element of plays an important role in beta-adrenergic receptor (PAR) stimulation of Ca2+-induced Ca2+ release (CICR) in cardiac myocytes. Here we have reported for the first time that a pathway downstream of PAR involving the cAMP-dependent Rap GTP exchange factor, Epac, and PLGE regulates CICR in cardiac myocytes. To demonstrate a role for Epac in the stimulation of CICR, cardiac myocytes were treated with an Epac-selective cAMP analog, 8-4-(chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate (cpTOME). cpTOME treatment increased the amplitude of electrically evoked Ca2+ transients, implicating Epac for the first time in cardiac CICR. This response is abolished in PLC is an element of(-/-) cardiac myocytes but rescued by transduction with PLC is an element of, indicating that Epac is upstream of PLC is an element of. Furthermore, transduction of PLC is an element of(+/+) cardiac myocytes with a Rap inhibitor, RapGAP1, significantly inhibited isoproterenol-dependent CICR. Using a combination of cpTOME and PKA-selective activators and inhibitors, we have shown that PAR-dependent increases in CICR consist of two independent components mediated by PKA and the novel Epac/PLC is an element of pathway. We also show that Epac/PLC is an element of-dependent effects on CICR are independent of sarcoplasmic reticulum loading and Ca2+ clearance mechanisms. These data define a novel endogenous PKA-independent PAR-signaling pathway through cAMP-dependent Epac activation, Rap, and PLCE that enhances intracellular Ca2+ release in cardiac myocytes.	Univ Rochester, Sch Med, Dept Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Physiol, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Cardiovasc Res Inst, Rochester, NY 14642 USA; Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA; SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	University of Rochester; University of Rochester; University of Rochester; The Wistar Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Smrcka, AV (corresponding author), Univ Rochester, Sch Med, Dept Pharmacol, 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu	Blaxall, Burns/ABD-8289-2021		NIAMS NIH HHS [R01 AR044657, AR44657, R01 AR044657-10] Funding Source: Medline; NIDCR NIH HHS [T32 DE07202-15] Funding Source: Medline; NIDDK NIH HHS [DK56294] Funding Source: Medline; NIGMS NIH HHS [GM053536, R01 GM053536] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044657, R01AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brodde OE, 1999, PHARMACOL REV, V51, P651; Chang YJ, 2004, MOL PHARMACOL, V65, P589, DOI 10.1124/mol.65.3.589; Chen FL, 1997, P NATL ACAD SCI USA, V94, P12485, DOI 10.1073/pnas.94.23.12485; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; YULE DI, 1992, J BIOL CHEM, V267, P13830	30	136	141	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5488	5495		10.1074/jbc.M608495200	http://dx.doi.org/10.1074/jbc.M608495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178726	hybrid			2022-12-27	WOS:000244482300043
J	Orlandi, A; Francesconi, A; Marcellini, M; Di Lascio, A; Spagnoli, LG				Orlandi, Augusto; Francesconi, Arianna; Marcellini, Marcella; Di Lascio, Antonio; Spagnoli, Luigi Giusto			Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappa B activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; CORONARY ANGIOPLASTY; SIGNALING PATHWAY; ARTERIAL INJURY; RETINOIC ACID; HUMAN ATHEROSCLEROSIS; GROWTH-FACTOR; ACTIVATION; EXPRESSION; RESTENOSIS	Propionyl-L-carnitine (PLC) has been introduced among the therapeutic approaches of peripheral arterial disease, and more recently, an increase of intimal cell apoptosis has been demonstrated to contribute to its effectiveness in rabbit carotid postinjury myointimal hyperplasia prevention. How PLC mediates these effects on vascular smooth muscle cells (SMCs) remains poorly understood. We investigated the role of NF-kappa B in PLC-induced arterial remodeling. In vivo, daily PLC treatment 15 days after injury resulted in a reduction of relative rat aortic intimal volume, an increase of apoptosis, Bax up-regulation without changing the Bcl-2 level, and a reduction of NF-kappa B, vascular cell adhesion molecule-1, monocyte chemotactic protein-1, and survivin in myointimal thickening compared with controls. In the presence of 10% serum, a reduced G(1) -> S phase progression preceded PLC-induced intimal cell apoptosis; in 0.1% serum cultures, in a dose-dependent manner, PLC rapidly induced intimal cell apoptosis and reduced p65, p50, IAP-1, and IAP-2 expression. Inhibiting NF-kappa B activation through SN50 increased apoptotic rate and Bax expression in intimal but not in medial SMCs, and successive PLC treatment failed to induce a further increase in apoptotic rate. Bax antisense oligodeoxynucleotide reduced PLC-induced intimal cell apoptosis and cytochrome c release. The PLC-induced attenuation of NF-kappa B activity in intimal cells was also due to the increase of I kappa B-alpha bioavailability, as the result of a parallel induction of I kappa B-alpha synthesis and reduction of phosphorylation and degradation. Collectively, these findings document that NF-kappa B activity inhibition contributes to PLC-induced proliferative arrest and Bax-related apoptosis of intimal SMCs.	Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Inst Pathol Anat, I-00133 Rome, Italy; Sigma Tau Res Labs, I-00040 Rome, Italy	University of Rome Tor Vergata	Orlandi, A (corresponding author), Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Inst Pathol Anat, Via Montpellier 1, I-00133 Rome, Italy.	orlandi@uniroma2.it	Orlandi, Augusto/AHE-8753-2022	orlandi, augusto/0000-0001-7202-5854; Spagnoli, Luigi Giusto/0000-0002-0684-5501				ADAMS SS, 1992, J CLIN PHARMACOL, V32, P317, DOI 10.1002/j.1552-4604.1992.tb03842.x; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoki M, 2003, CURR DRUG TARGETS, V4, P613, DOI 10.2174/1389450033490830; Arsenian MA, 1997, PROG CARDIOVASC DIS, V40, P265, DOI 10.1016/S0033-0620(97)80037-0; Bellas RE, 1997, AM J PATHOL, V151, P891; BELLAS RE, 1995, J CLIN INVEST, V96, P2521, DOI 10.1172/JCI118313; BENNETT MR, 1995, J CLIN INVEST, V95, P2266, DOI 10.1172/JCI117917; Bhargava B, 2003, BMJ-BRIT MED J, V327, P274, DOI 10.1136/bmj.327.7409.274; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; Bourcier T, 1997, J BIOL CHEM, V272, P15817, DOI 10.1074/jbc.272.25.15817; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Brevetti G, 1999, J AM COLL CARDIOL, V34, P1618, DOI 10.1016/S0735-1097(99)00373-3; Cipolla MJ, 1999, J VASC SURG, V29, P1097, DOI 10.1016/S0741-5214(99)70251-X; CLOWES AW, 1988, J CELL BIOL, V107, P1939, DOI 10.1083/jcb.107.5.1939; CLOWES AW, 1983, LAB INVEST, V49, P208; CORSICO N, 1993, CARDIOVASC DRUG THER, V7, P241, DOI 10.1007/BF00878514; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Erl Wolfgang, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P135, DOI 10.2174/1568006043586134; FERRARI R, 1992, J MOL CELL CARDIOL, V24, P219, DOI 10.1016/0022-2828(92)93160-L; Fisher SA, 2000, CIRC RES, V87, P856, DOI 10.1161/01.RES.87.10.856; GABBIANI G, 1984, J CLIN INVEST, V73, P148, DOI 10.1172/JCI111185; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hayakawa Y, 1999, ARTERIOSCL THROM VAS, V19, P2066, DOI 10.1161/01.ATV.19.9.2066; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Kimmel SE, 1997, J AM COLL CARDIOL, V30, P193, DOI 10.1016/S0735-1097(97)00149-6; KOCHER O, 1984, LAB INVEST, V50, P645; Kopp CW, 2004, CURR VASC PHARMACOL, V2, P183, DOI 10.2174/1570161043476438; Landry DB, 1997, AM J PATHOL, V151, P1085; Lango R, 2001, CARDIOVASC RES, V51, P21, DOI 10.1016/S0008-6363(01)00313-3; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; LIN YC, 1995, EXP CELL RES, V221, P73, DOI 10.1006/excr.1995.1354; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Maier W, 1999, EUR HEART J, V20, P325; Matsumoto Y, 2004, ARTERIOSCL THROM VAS, V24, P181, DOI 10.1161/01.ATV.0000105053.46994.5B; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Neuville P, 1999, ARTERIOSCL THROM VAS, V19, P1430, DOI 10.1161/01.ATV.19.6.1430; Orlandi A, 2005, ARTERIOSCL THROM VAS, V25, P348, DOI 10.1161/01.ATV.0000152609.28569.e1; Orlandi A, 2002, ATHEROSCLEROSIS, V160, P81, DOI 10.1016/S0021-9150(01)00568-8; Orlandi A, 2001, ARTERIOSCL THROM VAS, V21, P1118, DOI 10.1161/hq0701.092144; ORLANDI A, 1994, ARTERIOSCLER THROMB, V14, P982, DOI 10.1161/01.ATV.14.6.982; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SACHS L, 1978, STAT METHODEN IHRE A; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; SPAGNOLI LG, 1995, ATHEROSCLEROSIS, V114, P29, DOI 10.1016/0021-9150(94)05460-Z; Stroh R, 1998, SHOCK, V9, P216, DOI 10.1097/00024382-199803000-00010; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; TASSANI V, 1994, BIOCHEM BIOPH RES CO, V199, P949, DOI 10.1006/bbrc.1994.1321; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Uberti D, 1998, EUR J NEUROSCI, V10, P246, DOI 10.1046/j.1460-9568.1998.00042.x; Walker A, 1997, CANCER RES, V57, P1939; WALKER LN, 1986, P NATL ACAD SCI USA, V83, P7311, DOI 10.1073/pnas.83.19.7311; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Weber C, 2000, CURR TOP CELL REGUL, V36, P217; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x	67	32	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4932	4942		10.1074/jbc.M606148200	http://dx.doi.org/10.1074/jbc.M606148200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178728	hybrid			2022-12-27	WOS:000244482000076
J	Osterloh, A; Kalinke, U; Weiss, S; Fleischer, B; Breloer, M				Osterloh, Anke; Kalinke, Ulrich; Weiss, Siegfried; Fleischer, Bernhard; Breloer, Minka			Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; IFN-GAMMA PRODUCTION; T-CELLS; IN-VIVO; HUMAN HEAT-SHOCK-PROTEIN-60; MEMBRANE EXPRESSION; ALPHA PRODUCTION; DANGER SIGNALS; RECEPTOR	Activation of professional antigen-presenting cells (APC) is a crucial step in the initiation of an efficient immune response. In this study we show that Hsp60 mediates immune stimulation by different mechanisms, dependent and independent of lipopolysaccharide (LPS). We have demonstrated earlier that both, Hsp60 and LPS, increase antigen-specific interferon (IFN) gamma release in T cells. Here we show that in contrast to LPS Hsp60 induces IFN alpha production in professional APC. Neutralization of IFNa as well as the absence of functional IFN alpha beta receptor on APC and T cells interfered with Hsp60-mediated IFN gamma secretion in antigen-dependent T cell activation, strongly suggesting that IFNa represents one factor contributing to Hsp60-specific immune stimulation. On the other hand, we show that Hsp60 bound to the cell surface of APC colocalizes with the LPS co-receptor CD14 and LPS binding sites. Hsp60 specifically binds bacterial LPS and both molecules synergistically enhanced IL-12p40 production in APC and IFN gamma release in antigen-dependent T cell activation. This effect was Hsp60-specific and dependent on LPS-binding by Hsp60. Furthermore, we show that Hsp60 exclusively binds to macrophages and DC but not to T or B lymphocytes and that both, T cell stimulation by Hsp60 as well as Hsp60/LPS complexes, strictly depends on the presence of professional APC and is not mediated by B cells. Taken together, our data support an extension of the concept of Hsp60 as an endogenous danger signal: besides its function as a classical danger signal indicating unplanned tissue destruction to the innate immune system, in the incident of bacterial infection extracellular Hsp60 may bind LPS and facilitate microbe recognition by lowering the threshold of pathogen-associated molecular pattern (PAMP) detection and enhancing Toll-like receptor (TLR) signaling.	Bernhard Nocht Inst Trop Med, Dept Immunol, D-20359 Hamburg, Germany; Paul Ehrlich Inst, Dept Immunol, D-63225 Langen, Germany; Helmholtz Ctr Infect Res, Dept Mol Immunol, HZI, D-38124 Braunschweig, Germany	Bernhard Nocht Institut fur Tropenmedizin; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Osterloh, A (corresponding author), Bernhard Nocht Inst Trop Med, Dept Immunol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	osterloh@bni.uni-hamburg.de	Osterloh, Anke/ABA-8626-2021; Breloer, Minka/F-3999-2018	Breloer, Minka/0000-0001-6199-4908; Kalinke, Ulrich/0000-0003-0503-9564				Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Belles C, 1999, INFECT IMMUN, V67, P4191, DOI 10.1128/IAI.67.8.4191-4200.1999; Breloer M, 1999, J IMMUNOL, V162, P3141; Breloer M, 2002, INT IMMUNOL, V14, P1247, DOI 10.1093/intimm/dxf090; Breloer M, 2001, EUR J IMMUNOL, V31, P2051, DOI 10.1002/1521-4141(200107)31:7<2051::AID-IMMU2051>3.0.CO;2-H; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Chen W, 1999, J IMMUNOL, V162, P3212; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gerlach N, 2006, J VIROL, V80, P3438, DOI 10.1128/JVI.80.7.3438-3444.2006; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; More SH, 2001, INT IMMUNOL, V13, P1121, DOI 10.1093/intimm/13.9.1121; Moseley P, 2000, IMMUNOPHARMACOLOGY, V48, P299, DOI 10.1016/S0162-3109(00)00227-7; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Sapozhnikov AM, 1999, CELL PROLIFERAT, V32, P363, DOI 10.1111/j.1365-2184.1999.tb01354.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Vendetti S, 2000, J EXP CLIN CANC RES, V19, P329; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Xu DM, 2004, CELL MOL IMMUNOL, V1, P239; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje	55	74	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4669	4680		10.1074/jbc.M608666200	http://dx.doi.org/10.1074/jbc.M608666200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164250	hybrid, Green Submitted			2022-12-27	WOS:000244482000048
J	Iwashita, S; Kobayashi, M; Kubo, Y; Hinohara, Y; Sezaki, M; Nakamura, K; Suzuki-Migishima, R; Yokoyama, M; Sato, S; Fukuda, M; Ohba, M; Kato, C; Adachi, E; Song, SY				Iwashita, Shintaro; Kobayashi, Mariko; Kubo, Yuya; Hinohara, Yoshimi; Sezaki, Mariko; Nakamura, Kenji; Suzuki-Migishima, Rika; Yokoyama, Minesuke; Sato, Showbu; Fukuda, Mitsunori; Ohba, Masayuki; Kato, Chieko; Adachi, Eijiro; Song, Si-Young			Versatile roles of R-Ras GAP in neurite formation of PC12 cells and embryonic vascular development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; INTEGRIN ACTIVATION; MUTATION; P120GAP; SYSTEM	Ras GTPase-activating proteins (GAP) are negative regulators of Ras that convert active Ras-GTP to inactive Ras-GDP. R-Ras GAP is a membrane-associated molecule with stronger GAP activity for R-Ras, an activator of integrin, than H-Ras. We found that R-Ras GAP is down-regulated during neurite formation in rat pheochromocytoma PC12 cells by nerve growth factor (NGF), which is blocked by the transient expression of R-Ras gap or dominant negative R-ras cDNA. By establishing a PC12 subclone that stably expresses exogenous R-Ras GAP, it was found that NGF reduced endogenous R-Ras GAP but not exogenous R-Ras GAP, suggesting that down-regulation of R-Ras GAP occurs at the transcription level. To clarify the physiological role of R-Ras GAP, we generated mice that express mutant Ras GAP with knocked down activity. While heterozygotes are normal, homozygous mice die at E12.5-13.5 of massive subcutaneous and intraparenchymal bleeding, probably due to underdeveloped adherens junctions between capillary endothelial cells. These results show essential roles of R-Ras GAP in development and differentiation: its expression is needed for embryonic development of blood vessel barriers, whereas its down-regulation facilitates NGF-induced neurite formation of PC12 cells via maintaining activated R-Ras.	Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2288555, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Yokohama National University; RIKEN; Kitasato University	Song, SY (corresponding author), Iwaki Meisei Univ, 5-5-1 Chuodai Lino, Iwaki, Fukushima 9708551, Japan.	sysong@kph.bunri-u.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Iwashita, Shintaro/0000-0001-8086-9192				Ahmadian MR, 2003, J MOL BIOL, V329, P699, DOI 10.1016/S0022-2836(03)00514-X; Biesebeke RT, 2001, BIOCHEMISTRY-US, V40, P7474, DOI 10.1021/bi010027a; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Ishiwata T, 2003, CIRC RES, V93, P857, DOI 10.1161/01.RES.0000100389.57520.1A; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; IWASHITA S, 1992, CELL SIGNAL, V4, P123, DOI 10.1016/0898-6568(92)90076-K; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Kim JH, 2003, J NEUROSCI, V23, P1119; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Li SW, 1997, J BIOL CHEM, V272, P19328, DOI 10.1074/jbc.272.31.19328; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879, DOI 10.1128/MCB.14.10.6879; Perez de Castro I, 2003, CANCER RES, V63, P1615; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; Self AJ, 2001, J CELL SCI, V114, P1357; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	26	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3413	3417		10.1074/jbc.C600293200	http://dx.doi.org/10.1074/jbc.C600293200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17179160	hybrid			2022-12-27	WOS:000244481900001
J	Perfetti, A; Oriente, F; Iovino, S; Alberobello, AT; Barbagallo, APM; Esposito, I; Fiory, F; Teperino, R; Ungaro, P; Miele, C; Formisano, P; Beguinot, F				Perfetti, Anna; Oriente, Francesco; Iovino, Salvatore; Alberobello, A. Teresa; Barbagallo, Alessia P. M.; Esposito, Iolanda; Fiory, Francesca; Teperino, Raffaele; Ungaro, Paola; Miele, Claudia; Formisano, Pietro; Beguinot, Francesco			Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-ZETA; DEATH-EFFECTOR DOMAIN; MALIGNANT GLIOMA-CELLS; ERK MAP KINASE; PKC-ZETA; GLUCOSE-TRANSPORT; FLIP EXPRESSION; MUSCLE-CELLS; PEA-15; PHOSPHORYLATION	Phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes (PED/PEA)-15 is an anti-apoptotic protein whose expression is increased in several cancer cells and following experimental skin carcinogenesis. Exposure of untransfected C5N keratinocytes and transfected HEK293 cells to phorbol esters (12-O-tetradecanoylphorbol-13-acetate (TPA)) increased PED/PEA-15 cellular content and enhanced its phosphorylation at serine 116 in a time-dependent fashion. Ser-116 -> Gly (PEDSS116G) but not Ser-104 -> Gly (PEDS104G) substitution almost completely abolished TPA regulation of PED/PEA-15 expression. TPA effect was also prevented by antisense inhibition of protein kinase C (PKC)-zeta and by the expression of a dominant-negative PKC-zeta mutant cDNA in HEK293 cells. Similar to long term TPA treatment, overexpression of wild-type PKC-zeta increased cellular content and phosphorylation of WT-PED/PEA-15 and PEDS101G but not of PEDS116G. These events were accompanied by the activation of Ca2+-calmodulin kinase (CaMK) II and prevented by the CaMK blocker, KN-93. At variance, the proteasome inhibitor lactacystin mimicked TPA action on PED/PEA-15 intracellular accumulation and reverted the effects of PKC-zeta and CaMK inhibition. Moreover, we show that PED/PEA-15 bound ubiquitin in intact cells. PED/PEA-15 ubiquitinylation was reduced by TPA and PKC-zeta overexpression and increased by KN-93 and PKC-zeta block. Furthermore, in HEK293 cells expressing PEDS116G, TPA failed to prevent ubiquitin-dependent degradation of the protein. Accordingly, in the same cells, TPA-mediated protection from apoptosis was blunted. Taken together, our results indicate that TPA increases PED/PEA-15 expression at the post-translational level by inducing phosphorylation at serine 116 and preventing ubiquitinylation and proteosomal degradation.	Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Formisano, P (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini,5, I-80131 Naples, Italy.	fpietro@unina.it	Formisano, Pietro/J-4237-2018; ORIENTE, Francesco/J-6652-2018	ORIENTE, Francesco/0000-0003-4375-4526; Formisano, Pietro/0000-0001-7020-6870; Teperino, Raffaele/0000-0001-8815-1409	Telethon [GGP04041] Funding Source: Medline	Telethon(Fondazione Telethon)		ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Caruso M, 2001, J BIOL CHEM, V276, P45088, DOI 10.1074/jbc.M105451200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; de Thonel A, 2001, BLOOD, V98, P3770, DOI 10.1182/blood.V98.13.3770; Dong G, 2001, CANCER RES, V61, P4797; Duke RC, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican1296-80; Estelles A, 1996, J BIOL CHEM, V271, P14800, DOI 10.1074/jbc.271.25.14800; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Hao CH, 2001, CANCER RES, V61, P1162; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V237, P336, DOI 10.1006/bbrc.1997.7061; Kubes M, 1998, J NEUROCHEM, V71, P1307; Leroy I, 2005, CELL SIGNAL, V17, P1149, DOI 10.1016/j.cellsig.2004.12.013; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Sharif A, 2003, ANN NY ACAD SCI, V1010, P43, DOI 10.1196/annals.1299.006; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Spitaler M, 1999, ANTICANCER RES, V19, P3969; Stassi G, 2005, CANCER RES, V65, P6668, DOI 10.1158/0008-5472.CAN-04-4009; Sur R, 2005, BIOCHEM J, V387, P315, DOI 10.1042/BJ20041713; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; WAYS DK, 1992, J BIOL CHEM, V267, P4799; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Xiao C, 2005, EXP CELL RES, V304, P244, DOI 10.1016/j.yexcr.2004.11.002; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; ZICK Y, 2005, SCI STKE 2005, V25, P268	45	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8648	8657		10.1074/jbc.M608359200	http://dx.doi.org/10.1074/jbc.M608359200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17227770	hybrid			2022-12-27	WOS:000245780300011
J	Matas, D; Juknat, A; Pier, M; Klin, Y; Vogel, Z				Matas, Devorah; Juknat, Ana; Pier, Maciej; Klin, Yael; Vogel, Zvi			Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; VANILLOID RECEPTOR-1; ADENYLATE-CYCLASE; DNA-SYNTHESIS; HUMAN TUMORS; CELL-DEATH; INHIBITION; BRAIN; PHOSPHATIDYLETHANOLAMINE	Anandamide (AEA) is a lipid molecule belonging to the family of endocannabinoids. Various studies report neuroprotective activity of AEA against toxic insults, such as ischemic conditions and excitotoxicity, whereas some show that AEA has pro-apoptotic effects. Here we have shown that AEA confers a protective activity in N18TG2 murine neuroblastoma cells subjected to low serum-induced apoptosis. We have demonstrated that the protection from apoptosis by AEA is not mediated via the CB1 receptor, the CB2 receptor, or the vanilloid receptor 1. Interestingly, breakdown of AEA by fatty acid amide hydrolase is required for the protective effect of AEA. Furthermore, the ethanolamine (EA) generated in this reaction is the metabolite responsible for the protective response. The elevation in the levels of reactive oxygen species during low serum-induced apoptosis is not affected by AEA or EA. On the other hand, AEA and EA reduce caspase 3/7 activity, and AEA attenuates the cleavage of PARP-1. Taken together, our results demonstrate a role for AEA and EA in the protection against low serum-induced apoptosis.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Vogel, Z (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	zvi.vogel@weizmann.ac.il						Abood ME, 1997, BIOCHEM PHARMACOL, V53, P207, DOI 10.1016/S0006-2952(96)00727-7; BASS DA, 1983, J IMMUNOL, V130, P1910; BAYEWITCH M, 1995, FEBS LETT, V375, P143, DOI 10.1016/0014-5793(95)01207-U; Bayewitch M, 1996, J BIOL CHEM, V271, P9902, DOI 10.1074/jbc.271.17.9902; Brand A, 2000, J NEUROCHEM, V74, P1596, DOI 10.1046/j.1471-4159.2000.0741596.x; Contassot E, 2004, J NEUROPATH EXP NEUR, V63, P956, DOI 10.1093/jnen/63.9.956; Contassot E, 2004, GYNECOL ONCOL, V93, P182, DOI 10.1016/j.ygyno.2003.12.040; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Derocq JM, 1998, FEBS LETT, V425, P419, DOI 10.1016/S0014-5793(98)00275-0; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hansen HH, 2001, J NEUROCHEM, V76, P39, DOI 10.1046/j.1471-4159.2001.00006.x; Hillard CJ, 1997, J LIPID RES, V38, P2383; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Jackson SJ, 2005, J NEUROL SCI, V233, P21, DOI 10.1016/j.jns.2005.03.002; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kiss Z, 1997, EUR J BIOCHEM, V250, P395, DOI 10.1111/j.1432-1033.1997.0395a.x; Kiss Z, 1996, FEBS LETT, V381, P67, DOI 10.1016/0014-5793(96)00084-1; Kiss Z, 1997, BIOCHEM J, V328, P383, DOI 10.1042/bj3280383; Ligresti A, 2003, GASTROENTEROLOGY, V125, P677, DOI 10.1016/S0016-5085(03)00881-3; Lopez-Rodriguez ML, 2005, MINI-REV MED CHEM, V5, P97, DOI 10.2174/1389557053402819; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Malewicz B, 1998, EUR J BIOCHEM, V253, P10, DOI 10.1046/j.1432-1327.1998.2530010.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; NAUJOKAITIS SA, 1984, J PHARM SCI, V73, P34, DOI 10.1002/jps.2600730109; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Petersen G, 2005, J NEUROCHEM, V93, P299, DOI 10.1111/j.1471-4159.2005.03013.x; RUIZCABELLO J, 1992, NMR BIOMED, V5, P226, DOI 10.1002/nbm.1940050506; Sarker KP, 2000, FEBS LETT, V472, P39, DOI 10.1016/S0014-5793(00)01425-3; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Schmid PC, 2002, LIPIDS, V37, P907, DOI 10.1007/s11745-002-0978-z; Shire D, 1996, BBA-GENE STRUCT EXPR, V1307, P132, DOI 10.1016/0167-4781(96)00047-4; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; SLIPETZ DM, 1995, MOL PHARMACOL, V48, P352; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; VOGEL Z, 1993, J NEUROCHEM, V61, P352, DOI 10.1111/j.1471-4159.1993.tb03576.x; Wiley JL, 2002, CHEM PHYS LIPIDS, V121, P57, DOI 10.1016/S0009-3084(02)00146-9; Yamaji K, 2003, THROMB HAEMOSTASIS, V89, P875, DOI 10.1055/s-0037-1613475	47	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7885	7892		10.1074/jbc.M608646200	http://dx.doi.org/10.1074/jbc.M608646200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227767	hybrid			2022-12-27	WOS:000245081000018
J	Santiago-Josefat, B; Esselens, C; Bech-Serra, JJ; Arribas, J				Santiago-Josefat, Belen; Esselens, Cary; Bech-Serra, Joan Josep; Arribas, Joaquin			Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast turnors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; MESSENGER-RNA EXPRESSION; AMYLOID PRECURSOR PROTEIN; RENAL-CELL CARCINOMA; INTRACELLULAR MATURATION; SECRETASE CLEAVAGE; TUMOR; EGFR; DISINTEGRIN; METALLOPROTEASES	ADAM17 is a transmembrane metalloprotease involved in the proteolytic release of the extracellular domain of many cell surface molecules, a process known as ectodomain shedding. Despite its likely participation in tumor progression and its current consideration as a therapeutic target, very little is known about the regulation of the expression of ADAM17. Here we show that long term treatment with epidermal growth factor (EGF) leads to a marked increase in the levels of ADAM17. EGF receptor activation does not affect the levels of the mRNA that encodes for, or the rate of synthesis of, ADAM17 but increases its half-life. The effect of EGF is biologically relevant because it increases the shedding of several substrates of ADAM17, including the desmosomal cadherin Dsg-2. Analysis of protein and mRNA levels in mammary tumor samples shows that in vivo the levels of ADAM17 can also be controlled post-transcriptionally. Finally, we show that both the shed extracellular domains of Dsg-2 and ADAM 17 are frequently expressed in tumors, further supporting the participation of the metalloprotease in malignant progression.	Vall Hebron Univ Hosp, Inst Res, Med Oncol Res Program, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron	Arribas, J (corresponding author), Vall Hebron Univ Hosp, Inst Res, Med Oncol Res Program, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	jarribas@ir.vhebron.net	Arribas, Joaquin/M-4482-2014; Bech-Serra, Joan Josep/AAA-2330-2020	Arribas, Joaquin/0000-0002-0504-0664; Bech-Serra, Joan Josep/0000-0003-3486-781X; Esselens, Cary/0000-0001-8876-634X				Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; de la Torre TV, 2004, BIOCHEM BIOPH RES CO, V314, P1028, DOI 10.1016/j.bbrc.2003.12.186; Ding X, 2004, WORLD J GASTROENTERO, V10, P2735, DOI 10.3748/wjg.v10.i18.2735; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hynes NE, 2006, CANCER CELL, V10, P7, DOI 10.1016/j.ccr.2006.06.012; Karan D, 2003, INT J ONCOL, V23, P1365; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Moasser MM, 2001, CANCER RES, V61, P7184; Obeid D, 2007, ONCOGENE, V26, P102, DOI 10.1038/sj.onc.1209779; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Roemer A, 2004, ONCOL REP, V11, P529; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Slack BE, 1997, BIOCHEM J, V327, P245, DOI 10.1042/bj3270245; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yoshimura T, 2002, J INFECT DIS, V185, P332, DOI 10.1086/338191; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	38	58	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8325	8331		10.1074/jbc.M608826200	http://dx.doi.org/10.1074/jbc.M608826200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227756	hybrid			2022-12-27	WOS:000245081000066
J	Tanaka, SI; Saito, K; Chon, H; Matsumura, H; Koga, Y; Takano, K; Kanaya, S				Tanaka, Shun-ichi; Saito, Kenji; Chon, Hyongi; Matsumura, Hiroyoshi; Koga, Yuichi; Takano, Kazufumi; Kanaya, Shigenori			Crystal structure of unautoprocessed precursor of subtilisin from a hyperthermophilic Archaeon - Evidence for Ca2+-induced folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; INTRAMOLECULAR CHAPERONE; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SERINE PROTEASES; PRO-SUBTILISIN; EGLIN-C; PROPEPTIDE; CALCIUM; COMPLEX	The crystal structure of an active site mutant of pro-Tk-subtilisin (pro-S324A) from the hyperthermophilic archaeon Thermococcus kodakaraensis was determined at 2.3 angstrom resolution. The overall structure of this protein is similar to those of bacterial subtilisin-propeptide complexes, except that the peptide bond linking the propeptide and mature domain contacts with the active site, and the mature domain contains six Ca2+ binding sites. The Ca-1 site is conserved in bacterial subtilisins but is formed prior to autoprocessing, unlike the corresponding sites of bacterial subtilisins. All other Ca2+-binding sites are unique in the pro-S324A structure and are located at the surface loops. Four of them apparently contribute to the stability of the central alpha beta alpha substructure of the mature domain. The CD spectra, 1-anilino-8-naphthalenesulfonic acid fluorescence spectra, and sensitivities to chymotryptic digestion of this protein indicate that the conformation of pro-S324A is changed from an unstable molten globule-like structure to a stable native one upon Ca2+ binding. Another active site mutant, pro-S324C, was shown to be autoprocessed to form a propeptide-mature domain complex in the presence of Ca2+. The CD spectra of this protein indicate that the structure of pro-S324C is changed upon Ca2+ -binding like pro-S324A but is not seriously changed upon subsequent autoprocessing. These results suggest that the maturation process of Tk-subtilisin is different from that of bacterial subtilisins in terms of the requirement of Ca2+ for folding of the mature domain and completion of the folding process prior to autoprocessing.	Osaka Univ, Dept Mat & Life Sci, Grad Sch Engn, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka 5650871, Japan; JST, CREST Sosho Project, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Kanaya, S (corresponding author), Osaka Univ, Dept Mat & Life Sci, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kanaya@mls.eng.osaka-u.ac.jp		Takano, Kazufumi/0000-0002-7548-7314; Matsumura, Hiroyoshi/0000-0003-0361-3796				Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Baier K, 1996, EUR J BIOCHEM, V241, P750, DOI 10.1111/j.1432-1033.1996.00750.x; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRYAN P, 1992, BIOCHEMISTRY-US, V31, P4937, DOI 10.1021/bi00136a003; BRYAN P, 1995, BIOCHEMISTRY-US, V34, P10310, DOI 10.1021/bi00032a026; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; DAVAIL S, 1994, J BIOL CHEM, V269, P17448; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Exterkate FA, 1999, APPL ENVIRON MICROB, V65, P1390; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; GALLAGHER T, 1993, PROTEINS, V16, P205, DOI 10.1002/prot.340160207; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; GROS P, 1989, J MOL BIOL, V210, P347, DOI 10.1016/0022-2836(89)90336-7; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang HW, 1997, PROTEIN ENG, V10, P1227, DOI 10.1093/protein/10.10.1227; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan Y, 2001, APPL ENVIRON MICROB, V67, P2445, DOI 10.1128/AEM.67.6.2445-2452.2001; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI YY, 1994, J BIOL CHEM, V269, P4169; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; Marie-Claire C, 1999, J MOL BIOL, V285, P1911, DOI 10.1006/jmbi.1998.2449; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Nirasawa S, 1999, BIOCHEM J, V341, P25, DOI 10.1042/0264-6021:3410025; ODonohue MJ, 1996, J BIOL CHEM, V271, P26477, DOI 10.1074/jbc.271.43.26477; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANTOLIANO MW, 1989, BIOCHEMISTRY-US, V28, P7205, DOI 10.1021/bi00444a012; PANTOLIANO MW, 1988, BIOCHEMISTRY-US, V27, P8311, DOI 10.1021/bi00422a004; Shinde U, 1996, ADV EXP MED BIOL, V379, P147; SHINDE U, 1995, J MOL BIOL, V252, P25, DOI 10.1006/jmbi.1995.0472; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; SMITH SM, 1989, J BIOL CHEM, V264, P20487; STRAUSBERG SL, 1995, BIO-TECHNOL, V13, P669, DOI 10.1038/nbt0795-669; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Tanaka S, 2006, ACTA CRYSTALLOGR F, V62, P902, DOI 10.1107/S1744309106030454; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOORDOUW G, 1976, BIOCHEMISTRY-US, V15, P3716, DOI 10.1021/bi00662a012; WINTHER JR, 1991, NUCLEIC ACIDS RES, V11, P7911; Yabuta Y, 2002, J BIOCHEM, V131, P31, DOI 10.1093/oxfordjournals.jbchem.a003074; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200	49	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8246	8255		10.1074/jbc.M610137200	http://dx.doi.org/10.1074/jbc.M610137200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237225	hybrid			2022-12-27	WOS:000245081000057
J	Cohen, RO; Nixon, PJ; Diner, BA				Cohen, Rachel O.; Nixon, Peter J.; Diner, Bruce A.			Participation of the C-terminal region of the D1-polypeptide in the first steps in the assembly of the Mn4Ca cluster of photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY-CHARGE SEPARATION; AMINO-ACID-RESIDUES; OXYGEN-EVOLVING COMPLEX; MANGANESE CLUSTER; CRYSTAL-STRUCTURE; D1 POLYPEPTIDE; ELECTRON-TRANSFER; REACTION CENTERS; SYNECHOCYSTIS; OXIDATION	Amino acid residue D1-Asp(170) of the D1-polypeptide of photo-system II was previously shown to be implicated in the binding and oxidation of the first manganese to be assembled into the Mn4Ca cluster of the oxygen-evolving complex (OEC). According to recent x-ray crystallographic structures of photosystem II, D1-Glu(333) is proposed to participate with D1-Asp(170) in the coordination of Mn4 of the OEC. Other residues in the C-terminal region of the D1-polypeptide are proposed to coordinate nearby manganese of the cluster. Site-directed replacements in Synechocystis sp. PCC 6803 at D1-His(332), D1-Glu(333), D1-Asp(342), D1-Ala(344), and D1-Ser(345) were examined with regard to their ability to influence the binding and oxidation of the first manganese in manganese-depleted photosystem II core complexes. Direct and indirect measurements reveal in all mutants, but most marked in D1-Glu(333) replaced by His, an impaired ability of Mn2+ to reduce Y-Z center dot, indicating a reduced ability (elevated K-m) compared with WT to bind and oxidize the first manganese of the OEC. The effect on the K-m of these mutations is, however, considerably weaker than some of those constructed at D1-Asp(170) (replacement by Asn, Ala, and Ser). These observations imply that the C-terminal residues ultimately involved in manganese coordination contribute to the high affinity binding at D1-Asp(170) likely through electrostatic interactions. That these residues are far from D1-Asp(170) in the primary structure of the D1-polypeptide, imply that the C terminus of the D1-polypeptide is already close to its mature conformation at the first stages of assembly of the Mn4Ca cluster.	EI duPont Nemours & Co, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA; Univ London Imperial Coll Sci Technol & Med, Div Biol, Fac Nat Sci, London SW7 2AZ, England	DuPont; Imperial College London	Diner, BA (corresponding author), EI duPont Nemours & Co, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.	bruce.a.diner@usa.dupont.com		Nixon, Peter/0000-0003-1952-6937	Biotechnology and Biological Sciences Research Council [BB/C507037/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ananyev GA, 2002, BIOCHEMISTRY-US, V41, P974, DOI 10.1021/bi011528z; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; BOERNER RJ, 1992, BIOCHEMISTRY-US, V31, P6660, DOI 10.1021/bi00144a005; Britt RD, 2004, BBA-BIOENERGETICS, V1655, P158, DOI 10.1016/j.bbabio.2003.11.009; BUTLER WL, 1973, BIOCHIM BIOPHYS ACTA, V292, P140, DOI 10.1016/0005-2728(73)90258-2; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5859, DOI 10.1021/bi00017a017; Debus RJ, 2005, ADV PHOTO RESPIRAT, V22, P261; Debus RJ, 2001, BBA-BIOENERGETICS, V1503, P164, DOI 10.1016/S0005-2728(00)00221-8; Dekker JP, 2000, PHOTOSYNTH RES, V63, P195, DOI 10.1023/A:1006468024245; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Diner BA, 1998, METHOD ENZYMOL, V297, P337; DINER BA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P134, DOI 10.1016/0005-2728(92)90196-9; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Diner BA, 2001, BBA-BIOENERGETICS, V1503, P147, DOI 10.1016/S0005-2728(00)00220-6; DINER BA, 1996, OXYGENIC PHOTOSYNTHE, P213; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Graige MS, 1996, J AM CHEM SOC, V118, P9005, DOI 10.1021/ja960056m; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; JOHNSON GN, 1995, BBA-BIOENERGETICS, V1229, P202, DOI 10.1016/0005-2728(95)00003-2; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MAUZERAL.D, 1972, P NATL ACAD SCI USA, V69, P1358, DOI 10.1073/pnas.69.6.1358; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; MOHAMED A, 1989, PLANT MOL BIOL, V13, P693, DOI 10.1007/BF00016024; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; NIXON PJ, 1994, BIOCHEM SOC T, V22, P338, DOI 10.1042/bst0220338; NUIJS AM, 1986, BIOCHIM BIOPHYS ACTA, V848, P167, DOI 10.1016/0005-2728(86)90038-1; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Robinson HH, 1984, ADV PHOTOSYNTHESIS R, V1, P477; ROGNER M, 1990, J BIOL CHEM, V265, P6189; Sauer K, 2005, PHOTOSYNTH RES, V85, P73, DOI 10.1007/s11120-005-0638-9; Sproviero EM, 2006, J CHEM THEORY COMPUT, V2, P1119, DOI 10.1021/ct060018l; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; VANGORKOM HJ, 1974, BIOCHIM BIOPHYS ACTA, V347, P439, DOI 10.1016/0005-2728(74)90081-4; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yachandra VK, 2005, ADV PHOTO RESPIRAT, V22, P235; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	49	22	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7209	7218		10.1074/jbc.M606255200	http://dx.doi.org/10.1074/jbc.M606255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17202088	hybrid			2022-12-27	WOS:000245080900033
J	Evrin, C; Straut, M; Slavova-Azmanova, N; Bucurenci, N; Onu, A; Assairi, L; Ionescu, M; Palibroda, N; Barzu, O; Gilles, AM				Evrin, Cecile; Straut, Monica; Slavova-Azmanova, Neli; Bucurenci, Nadia; Onu, Adrian; Assairi, Liliane; Ionescu, Mihaela; Palibroda, Nicolae; Barzu, Octavian; Gilles, Anne-Marie			Regulatory mechanisms differ in UMP kinases from gram-negative and gram-positive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE MONOPHOSPHATE KINASES; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ASPARTATE-TRANSCARBAMYLASE; GLUTAMINE HYDROLYSIS; PYROCOCCUS-FURIOSUS; PROVIDES INSIGHT; ADENYLATE KINASE; CTP SYNTHESIS	In this work, we examined the regulation by GTP and UTP of the UMP kinases from eight bacterial species. The enzyme from Gram-positive organisms exhibited cooperative kinetics with ATP as substrate. GTP decreased this cooperativity and increased the affinity for ATP. UTP had the opposite effect, as it decreased the enzyme affinity for ATP. The nucleotide analogs 5-bromo-UTP and 5-iodo-UTP were 5-10 times stronger inhibitors than the parent compound. On the other hand, UMP kinases from the Gram-negative organisms did not show cooperativity in substrate binding and catalysis. Activation by GTP resulted mainly from the reversal of inhibition caused by excess UMP, and inhibition by UTP was accompanied by a strong increase in the apparent K-m for UMP. Altogether, these results indicate that, depending on the bacteria considered, GTP and UTP interact with different enzyme recognition sites. In Gram-positive bacteria, GTP and UTP bind to a single site or largely overlapping sites, shifting the T reversible arrow R equilibrium to either the R or T form, a scenario corresponding to almost all regulatory proteins, commonly called K systems. In Gram-negative organisms, the GTP-binding site corresponds to the unique allosteric site of the Gram-positive bacteria. In contrast, UTP interacts cooperatively with a site that overlaps the catalytic center, i.e. the UMP-binding site and part of the ATP-binding site. These characteristics make UTP an original regulator of UMP kinases from Gram-negative organisms, beyond the common scheme of allosteric control.	Inst Pasteur, Unite Genet Genomes Bacteriens, F-75724 Paris 15, France; Cantacuzino Inst, Lab Enzymol & Appl Microbiol, Bucharest 050096, Romania; Ctr Univ Paris Sud, INSERM, Inst Curie Rech, U759, F-91405 Orsay, France; Inst Isotop & Mol Technol, Cluj Napoca 400293, Romania	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Cantacuzino Institute Bucharest; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; National Institute for Research & Development of Isotopic & Molecular Technologies Cluj-Napoca	Gilles, AM (corresponding author), Inst Pasteur, Unite Genet Genomes Bacteriens, 28 Rue Dr Roux, F-75724 Paris 15, France.	amgilles@pasteur.fr	Onu, Adrian/AAP-8415-2021; Onu, Adrian/G-1858-2016; Ionescu, Mihaela Ileana/S-9516-2017	Onu, Adrian/0000-0001-8724-9754; Onu, Adrian/0000-0001-8724-9754; Ionescu, Mihaela Ileana/0000-0002-8019-118X; Slavova-Azmanova, Neli/0000-0003-0800-2943				ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; ALBERTY RA, 1969, J BIOL CHEM, V244, P3290; ALBERTY RA, 1968, J BIOL CHEM, V243, P1337; BLONDIN C, 1994, ANAL BIOCHEM, V220, P219, DOI 10.1006/abio.1994.1326; BRABSON JS, 1975, J BIOL CHEM, V250, P8664; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; Bucurenci N, 1996, J BIOL CHEM, V271, P2856, DOI 10.1074/jbc.271.5.2856; Bucurenci N, 1998, J BACTERIOL, V180, P473, DOI 10.1128/JB.180.3.473-477.1998; Crowe J, 1994, Methods Mol Biol, V31, P371; DANCHIN A, 1984, MOL GEN GENET, V193, P473, DOI 10.1007/BF00382086; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; EVRIN C, 2006, THESIS U PARIS 7 PAR; Fassy F, 2004, BIOCHEM J, V384, P619, DOI 10.1042/BJ20040440; Gagyi C, 2004, CURR MICROBIOL, V48, P62, DOI 10.1007/s00284-003-4117-2; Gagyi C, 2003, EUR J BIOCHEM, V270, P3196, DOI 10.1046/j.1432-1033.2003.03702.x; GILLES AM, 1988, J BIOL CHEM, V263, P8204; Iyengar A, 2003, BIOCHEM J, V369, P497, DOI 10.1042/BJ20021110; Labesse G, 2002, BIOCHEM BIOPH RES CO, V294, P173, DOI 10.1016/S0006-291X(02)00450-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landais S, 1999, J BACTERIOL, V181, P833, DOI 10.1128/JB.181.3.833-840.1999; Li Y, 1996, J BIOL CHEM, V271, P28038, DOI 10.1074/jbc.271.45.28038; LIPSCOMB WN, 1994, ADV ENZYMOL RAMB, V68, P67; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; MOLLGAARD H, 1980, J BIOL CHEM, V255, P8216; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Picard V, 1997, Methods Mol Biol, V67, P183; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Sakamoto H, 2004, MICROBIOL-SGM, V150, P2153, DOI 10.1099/mic.0.26996-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SERINA L, 1995, BIOCHEMISTRY-US, V34, P5066, DOI 10.1021/bi00015a018; Serina L, 1996, BIOCHEMISTRY-US, V35, P7003, DOI 10.1021/bi960062v; Sinev MA, 1996, FEBS LETT, V397, P273, DOI 10.1016/S0014-5793(96)01195-7; SNAVELY MD, 1990, MET IONS BIOL SYST, V26, P155; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x	37	17	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7242	7253		10.1074/jbc.M606963200	http://dx.doi.org/10.1074/jbc.M606963200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210578	hybrid			2022-12-27	WOS:000245080900036
J	Shaw, AW; Pureza, VS; Sligar, SG; Morrissey, JH				Shaw, Andrew W.; Pureza, Vincent S.; Sligar, Stephen G.; Morrissey, James H.			The local phospholipid environment modulates the activation of blood clotting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR ACTIVITY; FACTOR-X; COAGULATION FACTOR; FACTOR VIIA; PROTEIN-BINDING; SUBSTRATE; SURFACE; EXPRESSION; MEMBRANES; FUSION	Examples abound of membrane-bound enzymes for which the local membrane environment plays an important role, including the ectoenzyme that triggers blood clotting, the plasma serine protease, factor VIIa, bound to the integral membrane protein, tissue factor. The activity of this enzyme complex is markedly influenced by lipid bilayer composition and further by tissue factor partitioning into membrane microdomains on some cell surfaces. Unfortunately, little is known about how membrane microdomain composition controls factor VIIa-tissue factor activity, as reactions catalyzed by membrane-tethered enzymes are typically studied under conditions in which the experimenter cannot control the composition of the membrane in the immediate vicinity of the enzyme. To overcome this problem, we used a nanoscale approach that afforded complete control over the membrane environment surrounding tissue factor by assembling the factor VIIa-tissue factor complex on stable bilayers containing 67 +/- 1 phospholipid molecules/leaflet (Nanodiscs). We investigated how local changes in phospholipid bilayer composition modulate the activity of the factor VIIa-tissue factor complex. We also addressed whether this enzyme requires a pool of membrane-bound protein substrate (factor X) for efficient catalysis, or alternatively if it could efficiently activate factor X, which binds directly to the membrane nanodomain adjacent to tissue factor. We have shown that full proteolytic activity of the factor VIIa-tissue factor complex requires extremely high local concentrations of anionic phospholipids and further that a large pool of membrane-bound factor X is not required to support sustained catalysis.	Univ Illinois, Coll Med, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Coll Med, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Coll Med, Dept Biochem, 417 Med Sci Bldg MC-714,506 S Mathews, Urbana, IL 61801 USA.	s-sligar@uiuc.edu	Morrissey, James H/H-4933-2011; Morrissey, James H./GLR-5645-2022	Morrissey, James H/0000-0002-1570-1569; 	NHLBI NIH HHS [R01 HL047014-15, HL47014, R01 HL047014] Funding Source: Medline; NIGMS NIH HHS [GM33775] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033775] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREE HAM, 1994, BIOCHEMISTRY-US, V33, P4368, DOI 10.1021/bi00180a034; BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; FORD NC, 1985, DYNAMIC LIGHT SCATTE, P7; FORMAN SD, 1986, P NATL ACAD SCI USA, V83, P4675, DOI 10.1073/pnas.83.13.4675; HATCHCOCK JJ, 2006, CELL MOL DIS, V36, P194; Hathcock JJ, 2005, BIOCHEMISTRY-US, V44, P8187, DOI 10.1021/bi050338b; HAVERSTICK DM, 1987, P NATL ACAD SCI USA, V84, P4475, DOI 10.1073/pnas.84.13.4475; HEYSEL S, 1995, PROTEIN SCI, V4, P2532, DOI 10.1002/pro.5560041210; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Mandal SK, 2005, BLOOD, V105, P153, DOI 10.1182/blood-2004-03-0990; Morrissey J. H., 2006, HEMOSTASIS THROMBOSI, P91; Morrissey JH, 1997, THROMB HAEMOSTASIS, V78, P112; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Mulder AB, 1996, BLOOD, V88, P3667, DOI 10.1182/blood.V88.9.3667.bloodjournal8893667; MULDER KM, 1990, J CELL PHYSIOL, V145, P501, DOI 10.1002/jcp.1041450316; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; NEUENSCHWANDER PF, 1993, J BIOL CHEM, V268, P21489; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; NEUENSCHWANDER PF, 1994, J BIOL CHEM, V269, P8007; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; Sevinsky JR, 1996, J CELL BIOL, V133, P293, DOI 10.1083/jcb.133.2.293; Shaw AW, 2004, FEBS LETT, V556, P260, DOI 10.1016/S0014-5793(03)01400-5; SMALL DM, 1967, J LIPID RES, V8, P551; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; TERRETTAZ S, 1993, LANGMUIR, V9, P1361, DOI 10.1021/la00029a033; Waters EK, 2006, BIOCHEMISTRY-US, V45, P3769, DOI 10.1021/bi052600m; WILSCHUT J, 1985, BIOCHEMISTRY-US, V24, P8, DOI 10.1021/bi00322a002; Yang L, 1996, BIOCHEMISTRY-US, V35, P13966, DOI 10.1021/bi9610008	38	119	126	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6556	6563		10.1074/jbc.M607973200	http://dx.doi.org/10.1074/jbc.M607973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200119	hybrid			2022-12-27	WOS:000244867200064
J	Escamilia-Powers, JR; Sears, RC				Escamilia-Powers, Julienne R.; Sears, Rosalie C.			A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SACCHAROMYCES-CEREVISIAE GENE; F-BOX; UBIQUITIN LIGASE; CELL-CYCLE; S-PHASE; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; SIGNALING PATHWAY; PROLYL ISOMERASE	The c-Myc transcription factor is a key regulator of cell proliferation and cell fate decisions. c-Myc overexpression is observed in a variety of human tumors, revealing the importance of maintaining normal levels of c-Myc protein. c-Myc protein stability in mammalian cells is controlled by interdependent and sequential phosphorylation and dephosphorylation events on two highly conserved residues, serine 62 and threonine 58. Here we show that these sequential phosphorylation and dephosphorylation events and their effect on c-Myc stability also occurs in the model system Saccharomyces cerevisiae. These results suggest the presence of a conserved pathway in yeast that controls protein turnover in response to a specific phospho-degron sequence. These findings have implications regarding conserved pathways for regulated protein degradation, and they validate the use of genetically tractable yeast for the study of the turnover of proteins such as c-Myc that contain this motif.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University	Sears, RC (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd,L103A, Portland, OR 97239 USA.	searsr@ohsu.edu			NCI NIH HHS [K01 CA086957, K01 CA086957-06, R01 CA100855, R01 CA100855-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA086957, R01CA100855] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Arvanitis C, 2005, CANCER LETT, V226, P95, DOI 10.1016/j.canlet.2004.10.043; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; BIANCHI MW, 1993, GENE, V134, P51, DOI 10.1016/0378-1119(93)90173-Z; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Casamayor A, 1996, YEAST, V12, P1013, DOI 10.1002/(SICI)1097-0061(199609)12:10B<1013::AID-YEA980>3.3.CO;2-X; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; ELION EA, 1991, COLD SPRING HARB SYM, V56, P41; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Goh PY, 1999, MOL CELL BIOL, V19, P5512; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; HARDY TA, 1995, BIOCHEM BIOPH RES CO, V208, P728, DOI 10.1006/bbrc.1995.1398; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lu KP, 1996, NATURE, V380, P544; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; PUZISS JW, 1994, MOL CELL BIOL, V14, P831, DOI 10.1128/MCB.14.1.831; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sherman F, 1986, LAB COURSE MANUAL ME; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Weiwad M, 2000, FEBS LETT, V478, P39, DOI 10.1016/S0014-5793(00)01794-4; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	53	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5432	5442		10.1074/jbc.M611437200	http://dx.doi.org/10.1074/jbc.M611437200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192266	Green Accepted, hybrid			2022-12-27	WOS:000244482300038
J	Horenstein, NA; McCormack, TJ; Stokes, C; Ren, K; Papke, RL				Horenstein, Nicole A.; McCormack, Thomas J.; Stokes, Clare; Ren, Ke; Papke, Roger L.			Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT; ACTIVATION; SUBUNIT; MUSCLE	Homomeric alpha 7 and heteromeric alpha 4 beta 2 nicotinic acetylcholine receptors (nAChR) can be distinguished by their pharmacological properties, including agonist specificity. We introduced point mutations of conserved amino acids within the C loop, a region of the receptor critical for agonist binding, and we examined the expression of the mutant receptors in Xenopus oocytes. Mutation of either a conserved C loop tyrosine (188) to phenylalanine or a nearby conserved aspartate (197) to alanine resulted in alpha 7 receptors for which the alpha 7-selective agonist 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) had roughly the same potency as for wild-type receptors, whereas the physiologic agonist acetylcholine (ACh) showed drastically reduced potency for these mutant receptors. Corresponding mutations in alpha 4 receptors co-expressed with 62 resulted in alpha 4 beta 2 receptors for which ACh potency was relatively unchanged, although the efficacy of the alpha 7-selective agonist 4OH-GTS-21 was increased greatly relative to that of ACh. We also investigated the significance of a conserved lysine (145 in alpha 7), proposed to form a stable salt bridge with Asp-197 in the resting state of the receptor. Mutations of this residue in both alpha 7 and alpha 4 resulted in receptors that were largely unresponsive to both ACh and 4OH-GTS-21. Our results suggest that initiation of gating depends both on specific interactions between residues in the C loop domain and, depending on receptor subtype, the physiochemical properties of the agonist, so that in the altered environment of the alpha 4Y190F-binding site, large hydrophobic benzylidene anabaseines may close the C loop and initiate channel gating more effectively than the polar agonist ACh.	Univ Florida, Dept Pharmacol & Therapeut, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Papke, RL (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Coll Med, POB 100267, Gainesville, FL 32610 USA.	rlpapke@ufl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000196, P01AG010485] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG10485, T32 AG00196] Funding Source: Medline; NIGMS NIH HHS [R01 GM57481] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Kem WR, 1997, J PHARMACOL EXP THER, V283, P979; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Papke RL, 2005, BIOORG MED CHEM LETT, V15, P3874, DOI 10.1016/j.bmcl.2005.05.118; Philipson KD, 2001, AM J PHYSIOL-CELL PH, V281, pC195, DOI 10.1152/ajpcell.2001.281.1.C195; Placzek AN, 2005, MOL PHARMACOL, V68, P1863, DOI 10.1124/mol.105.016402; SINE SM, 1994, J BIOL CHEM, V269, P8808; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Stokes C, 2004, MOL PHARMACOL, V66, P14, DOI 10.1124/mol.66.1.14; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	21	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5899	5909		10.1074/jbc.M609202200	http://dx.doi.org/10.1074/jbc.M609202200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189260	hybrid			2022-12-27	WOS:000244482300086
J	Jia, YP; Buehler, PW; Boykins, RA; Venable, RM; Alayash, AI				Jia, Yiping; Buehler, Paul W.; Boykins, Robert A.; Venable, Richard M.; Alayash, Abdu I.			Structural basis of peroxide-mediated changes in human hemoglobin - A novel oxidative pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME PROSTHETIC GROUP; HYDROGEN-PEROXIDE; CROSS-LINKING; METHIONINE OXIDATION; FREE-RADICALS; IN-VITRO; MYOGLOBIN; ACID; METMYOGLOBIN; DEGRADATION	Hydrogen peroxide (H2O2) triggers a redox cycle between ferric and ferryl hemoglobin (Hb) leading to the formation of a transient protein radical and a covalent hemeprotein cross-link. Addition of H2O2 to highly purified human hemoglobin (HbA(0)) induced structural changes that primarily resided within beta subunits followed by the internalization of the heme moiety within a subunits. These modifications were observed when an equal molar concentration of H2O2 was added to HbA(0) yet became more abundant with greater concentrations of H2O2. Mass spectrometric and amino acid analysis revealed for the first time that beta Cys-93 and beta Cys-112 were oxidized extensively and irreversibly to cysteic acid when HbA(0) was treated with H2O2. Oxidation of further amino acids in HbA(0) exclusive to the beta-globin chain included modification of beta Trp-15 to oxyindolyl and kynureninyl products as well as beta Met-55 to methionine sulfoxide. These findings may therefore explain the premature collapse of the beta subunits as a result of the H2O2 attack. Analysis of a tryptic digest of the main reversed phase-high pressure liquid chromatography fraction revealed two a-peptide fragments (alpha 128 - alpha 139) and a heme moiety with the loss of iron, cross-linked between alpha Ser-138 and the porphyrin ring. The novel oxidative pathway of HbA(0) modification detailed here may explain the diverse oxidative, toxic, and potentially immunogenic effects associated with the release of hemoglobin from red blood cells during hemolytic diseases and/or when cell-free Hb is used as a blood substitute.	Food & Drug Adm, Ctr Biol Evaluat & Res, Lab Biochem & Vasc Biol, Div Hematol, Bethesda, MD 20892 USA; Food & Drug Adm, Ctr Biol Evaluat & Res, Biophys Lab, Div Bacterial Parasit & Allergen Prod, Bethesda, MD 20892 USA; NHLBI, Membrane Biophys Sect, Lab Computat Biol, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Alayash, AI (corresponding author), Food & Drug Adm, Ctr Biol Evaluat & Res, Lab Biochem & Vasc Biol, Div Hematol, Bethesda, MD 20892 USA.	abdu.alayash@fda.hhs.gov						Adamson JG, 1998, TISS ENG, P62; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Alayash AI, 2001, ARTIF CELL BLOOD SUB, V29, P415, DOI 10.1081/BIO-100108547; AMICONI G, 1991, ADV EXP MED BIOL, V307, P185; AMICONI G, 1989, J BIOL CHEM, V264, P17745; Atassi MZ, 2005, PROTEIN J, V24, P51, DOI 10.1007/s10930-004-0605-x; BARKER PD, 1993, P NATL ACAD SCI USA, V90, P6542, DOI 10.1073/pnas.90.14.6542; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Boykins RA, 2005, PROTEINS, V59, P840, DOI 10.1002/prot.20453; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buehler PW, 2004, TRANSFUSION, V44, P1516, DOI 10.1111/j.1537-2995.2004.04081.x; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Fontana M, 2005, BIOCHEM J, V389, P233, DOI 10.1042/BJ20041696; FREI B, 1988, ANAL BIOCHEM, V175, P120, DOI 10.1016/0003-2697(88)90369-7; Griffiths SW, 2002, J BIOL CHEM, V277, P25486, DOI 10.1074/jbc.M203089200; Griffiths SW, 2002, J CHROMATOGR A, V942, P133, DOI 10.1016/S0021-9673(01)01350-4; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gunther MR, 2000, FREE RADICAL BIO MED, V28, P709, DOI 10.1016/S0891-5849(00)00164-7; He YY, 2003, PHOTOCHEM PHOTOBIOL, V77, P585, DOI 10.1562/0031-8655(2003)077<0585:UHRDBI>2.0.CO;2; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khor HK, 2004, J BIOL CHEM, V279, P19486, DOI 10.1074/jbc.M310045200; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; MARKS DH, 1987, MIL MED, V152, P473; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Mekecha TT, 2006, J AM SOC MASS SPECTR, V17, P923, DOI 10.1016/j.jasms.2006.01.004; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; OSAWA Y, 1993, BIOCHEM PHARMACOL, V46, P2299, DOI 10.1016/0006-2952(93)90621-3; Osawa Y, 1996, FREE RADICAL BIO MED, V21, P35, DOI 10.1016/0891-5849(95)02215-5; Patel MJ, 1998, BLOOD, V91, P710, DOI 10.1182/blood.V91.2.710.710_710_716; Ramirez DC, 2003, FREE RADICAL BIO MED, V34, P830, DOI 10.1016/S0891-5849(02)01437-5; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STEFFEK RP, 1991, FREE RADICAL RES COM, V12-3, P489; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Svistunenko DA, 2002, BIOPHYS J, V83, P2845, DOI 10.1016/S0006-3495(02)75293-4	47	116	119	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4894	4907		10.1074/jbc.M609955200	http://dx.doi.org/10.1074/jbc.M609955200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178725	hybrid			2022-12-27	WOS:000244482000072
J	Michalik, L; Zoete, V; Krey, G; Grosdidier, A; Gelman, L; Chodanowski, P; Feige, JN; Desvergne, B; Wahli, W; Michielin, O				Michalik, Liliane; Zoete, Vincent; Krey, Grigorios; Grosdidier, Aurelien; Gelman, Laurent; Chodanowski, Pierre; Feige, Jerome N.; Desvergne, Beatrice; Wahli, Walter; Michielin, Olivier			Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING-DOMAIN; MOLECULAR-FORCE FIELD; CONSTITUTIVE ANDROSTANE RECEPTOR; FREE-ENERGY DECOMPOSITION; PROTEIN DATA-BANK; PPAR-GAMMA; NUCLEAR RECEPTORS; FATTY-ACIDS; CRYSTAL-STRUCTURE; TRANSACTIVATION DOMAIN	The dynamic properties of helix 12 in the ligand binding domain of nuclear receptors are a major determinant of AF-2 domain activity. We investigated the molecular and structural basis of helix 12 mobility, as well as the involvement of individual residues with regard to peroxisome proliferator-activated receptor alpha (PPAR alpha) constitutive and ligand-dependent transcriptional activity. Functional assays of the activity of PPARa helix 12 mutants were combined with free energy molecular dynamics simulations. The agreement between the results from these approaches allows us to make robust claims concerning the mechanisms that govern helix 12 functions. Our data support a model in which PPAR alpha helix 12 transiently adopts a relatively stable active conformation even in the absence of a ligand. This conformation provides the interface for the recruitment of a coactivator and results in constitutive activity. The receptor agonists stabilize this conformation and increase PPAR alpha transcription activation potential. Finally, we disclose important functions of residues in PPAR alpha AF-2, which determine the positioning of helix 12 in the active conformation in the absence of a ligand. Substitution of these residues suppresses PPAR alpha constitutive activity, without changing PPARa ligand-dependent activation potential.	Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Lausanne, Natl Res Ctr Frontier Genet, CH-1015 Lausanne, Switzerland; Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; Agr Res Fdn, Fisheries Res Inst, GR-64007 Kavala, Greece; Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Natl Res Ctr Mol Oncol, CH-1066 Epalinges, Switzerland; Univ Lausanne Hosp, CePO, Multidisciplinary Oncol Ctr, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Wahli, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	walter.wahli@unil.ch; olivier.michielin@unil.ch	Michielin, Olivier/ABE-7924-2020; Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Grosdidier, Aurelien/0000-0001-9873-3461; Michalik, Liliane/0000-0003-2963-2100; Desvergne, Beatrice/0000-0001-5483-288X; Gelman, Laurent/0000-0003-3277-3115				AMIDON GL, 1975, J PHYS CHEM-US, V79, P2239, DOI 10.1021/j100588a008; Andersin T, 2003, MOL ENDOCRINOL, V17, P234, DOI 10.1210/me.2002-0263; Auwerx J, 1999, CELL, V97, P161; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; Elhaji YA, 2006, HUM MOL GENET, V15, P921, DOI 10.1093/hmg/ddl009; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Frank C, 2004, J BIOL CHEM, V279, P33558, DOI 10.1074/jbc.M403946200; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; GROSDIDIER A, 2007, IN PRESS PROTEINS; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P553, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<553::AID-JCC3>3.0.CO;2-T; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; Hasel W., 1988, TETRAHEDRON COMPUT M, V1, P103, DOI DOI 10.1016/0898-5529(88)90015-2; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; HERMANN RB, 1972, J PHYS CHEM-US, V76, P2754, DOI 10.1021/j100663a023; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Johnson BA, 2000, J MOL BIOL, V298, P187, DOI 10.1006/jmbi.2000.3636; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Keller H, 1997, BIOL CHEM, V378, P651, DOI 10.1515/bchm.1997.378.7.651; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Kuhn B, 2006, BIOORG MED CHEM LETT, V16, P4016, DOI 10.1016/j.bmcl.2006.05.007; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Lu IL, 2006, J MED CHEM, V49, P2703, DOI 10.1021/jm051129s; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahindroo N, 2006, J MED CHEM, V49, P6421, DOI 10.1021/jm060663c; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; REIHER WE, 1985, THESIS HARVARD U CAM; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sohn YC, 2003, MOL ENDOCRINOL, V17, P366, DOI 10.1210/me.2002-0150; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; THOMPSON SK, 1994, J MED CHEM, V37, P3100, DOI 10.1021/jm00045a015; TONE Y, 1994, J BIOL CHEM, V269, P31157; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yu CY, 2004, EUR J BIOCHEM, V271, P386, DOI 10.1046/j.1432-1033.2003.03937.x; Zhou YC, 1999, J BIOL CHEM, V274, P29874, DOI 10.1074/jbc.274.42.29874; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	91	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9666	9677		10.1074/jbc.M610523200	http://dx.doi.org/10.1074/jbc.M610523200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17200111	hybrid			2022-12-27	WOS:000245421700040
J	Hepburn, NJ; Williams, AS; Nunn, MA; Chamberlain-Banoub, JC; Hamer, J; Morgan, BP; Harris, CL				Hepburn, Natalie J.; Williams, Anwen S.; Nunn, Miles A.; Chamberlain-Banoub, Jayne C.; Hamer, John; Morgan, B. Paul; Harris, Claire L.			In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE MYASTHENIA-GRAVIS; ACUTE MYOCARDIAL-INFARCTION; MEMBRANE ATTACK; COMPLEMENT INHIBITOR; DISEASE SEVERITY; DEMYELINATION; PEXELIZUMAB; ECULIZUMAB; DEFICIENCY; ACTIVATION	The involvement of complement (C) in inflammatory diseases has driven the search for agents capable of inhibiting dysregulated complement activation. Many of these reagents inhibit the C3 convertases during the early stages of the cascade. However, a drawback of total systemic C inhibition, particularly in long-term treatment of chronic disease, is potentiation of infection and immune complex disease due to an inability to opsonize complexes and foreign cells and to lyse pathogens. Recent identification of a CS-binding protein in the salivary gland of the soft tick Ornithodoros moubata has enabled development of a terminal pathway-specific reagent, OmCl, with potential to ameliorate disease while leaving key physiological processes unaffected. Here we demonstrated that OmCl has broad cross-species activity. When given intravenously to rodents, OmCl totally ablated complement hemolytic activity, which gradually restored as C5 was resynthesized. The circulating half-life of OmCl was 30 h, demonstrating a much slower clearance than other small, biological agents. Using C5-sufficient and C5-deficient mice we showed that prolonged half-life was due to binding to plasma C5. Surface plasmon resonance analysis of C5 binding to OmCl confirmed a high binding affinity with a slow dissociation rate. OmCl was effective in preventing experimental autoimmune myasthenia gravis induced by passive transfer in normal Lewis rats. OmCI ablated clinical disease reduced C3 and C9 deposition at the neuro-muscular junction, and effected a marked reduction in cellular infiltration at this site. These data offer exciting prospects for targeted treatment of complement-mediated diseases without the detrimental inhibition of the opsonic roles of complement.	Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, Wales; NERC, Ctr Ecol & Hydrol, Oxford OX1 3SR, England; Evolutec Grp Plc, Reading RG2 6UG, Berks, England	Cardiff University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Harris, CL (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, Wales.	HarrisCL@cardiff.ac.uk	Nunn, Miles/E-9233-2010	Morgan, Paul/0000-0003-4075-7676	Natural Environment Research Council [CEH010021] Funding Source: researchfish; Wellcome Trust [068590, 068823] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Chamberlain-Banoub J, 2006, CLIN EXP IMMUNOL, V146, P278, DOI 10.1111/j.1365-2249.2006.03198.x; Fleisig AJ, 2005, EXPERT OPIN BIOL TH, V5, P833, DOI 10.1517/14712598.5.6.833; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Harris CL, 2000, IMMUNOLOGY, V100, P462, DOI 10.1046/j.1365-2567.2000.00066.x; Harris CL, 2002, BIOCHEM SOC T, V30, P1019, DOI 10.1042/bst0301019; Harris CL, 2002, CLIN EXP IMMUNOL, V129, P198, DOI 10.1046/j.1365-2249.2002.01924.x; Harrison R. A., 1996, WEIRS HDBH EXPT IMMU, VII; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Holers VM, 2003, CLIN IMMUNOL, V107, P140, DOI 10.1016/S1521-6616(03)00034-2; Kaplan Mariana, 2002, Curr Opin Investig Drugs, V3, P1017; Lazar HL, 2004, CIRCULATION, V110, pII274, DOI 10.1161/01.CIR.0000138315.99788.eb; Mahaffey KW, 2006, AM HEART J, V152, P291, DOI 10.1016/j.ahj.2006.03.027; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mead RJ, 2004, LAB INVEST, V84, P21, DOI 10.1038/labinvest.3700015; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Morgan BP, 2006, CLIN EXP IMMUNOL, V146, P294, DOI 10.1111/j.1365-2249.2006.03205.x; Morgan BP, 2003, MOL IMMUNOL, V40, P159, DOI 10.1016/S0161-5890(03)00111-1; MORGAN BP, 1994, SPRINGER SEMIN IMMUN, V15, P369, DOI 10.1007/BF01837366; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Morgan BP., 1999, COMPLEMENT REGULATOR; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Piddlesden SJ, 1996, J NEUROIMMUNOL, V71, P173, DOI 10.1016/S0165-5728(96)00144-0; Quigg RJ, 1998, J IMMUNOL, V160, P4553; RIBEIRO JMC, 1987, EXP PARASITOL, V64, P347, DOI 10.1016/0014-4894(87)90046-4; SISSONS JGP, 1977, J CLIN INVEST, V59, P704, DOI 10.1172/JCI108689; Szebeni J, 2003, SHOCK, V20, P347, DOI 10.1097/01.shk.0000082444.66379.17; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; WALLER D, 1994, PRINCIPLES MED PHARM, P26; Williams AS, 2004, ARTHRITIS RHEUM-US, V50, P3035, DOI 10.1002/art.20478	33	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8292	8299		10.1074/jbc.M609858200	http://dx.doi.org/10.1074/jbc.M609858200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17215252	hybrid			2022-12-27	WOS:000245081000062
J	Sano, H; Ishino, M; Kramer, H; Shimizu, T; Mitsuzawa, H; Nishitani, C; Kuroki, Y				Sano, Hitomi; Ishino, Masaho; Kramer, Helmut; Shimizu, Takeyuki; Mitsuzawa, Hiroaki; Nishitani, Chiaki; Kuroki, Yoshio			The microtubule-binding protein hook3 interacts with a cytoplasmic domain of scavenger receptor A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC TRAFFICKING; ALVEOLAR MACROPHAGES; CELLULAR TRAFFICKING; SURFACE EXPRESSION; SR-A; PHAGOCYTOSIS; ADHESION; DROSOPHILA; INFECTION; ENDOSOMES	The class A scavenger receptor (SR-A) is a multifunctional transmembrane glycoprotein that is implicated in atherogenesis, innate immunity, and cell adhesion. Despite extensive structure-function studies of the receptor, intracellar molecules that directly interact with SR-A and regulate the receptor trafficking have not been determined. In the current study, we have identified a microtubule-binding protein, Hook3, as a novel interacting partner of SR-A. The association between a rat Hook3 isoform and SR-A was suggested by yeast two-hybrid screening and mass spectrometry analysis of SR-A-cytoplasmic domain-bound proteins in rat alveolar macrophages. The binding of overexpressed and endogenous human Hook3 to SR-A was demonstrated by pull-down assay and co-immunoprecipitations. Furthermore, endogenous murine SR-A and HK3 co-sedimented from cell lysates isolated from Raw264.7 murine macrophage cells. The interaction of Hook3 with SR-A was significantly stimulated after SR-A had recognized the extracellular ligand. Studies using truncations demonstrated that the positively charged C-terminal Val(614)-Ala(717) region of human Hook3 was required for the interaction with the negatively charged residues, Glu(12), Asp(13), and Asp(15) in the human SR-A cytoplasmic domain. By transfecting small interfering RNA targeting Hook3, total and surface expression, receptor-mediated ligand uptake and protein stability of SR-A were significantly promoted, whereas the protein synthesis and maturation were not altered. We propose for the first time that Hook3 may participate in the turnover of the endocytosed scavenger receptor.	Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido 0608556, Japan; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; CREST, Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan	Sapporo Medical University; Sapporo Medical University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Japan Science & Technology Agency (JST)	Sano, H (corresponding author), South 1,West 17,Chuo Ku, Sapporo, Hokkaido 0608556, Japan.	sanohito@sapmed.ac.jp		Kramer, Helmut/0000-0002-1167-2676	NINDS NIH HHS [NS43406] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043406] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Daugherty A, 2000, J LIPID RES, V41, P1568; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; DOI T, 1993, J BIOL CHEM, V268, P2126; ELKHOURY J, 1994, J BIOL CHEM, V269, P10197; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Heider H, 2001, FEBS LETT, V505, P185, DOI 10.1016/S0014-5793(01)02819-8; Ishiguro T, 2001, AM J PATHOL, V158, P179, DOI 10.1016/S0002-9440(10)63956-9; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kramer H, 1999, GENETICS, V151, P675; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; MORI T, 1994, LAB INVEST, V71, P409; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Shotland Y, 2003, MOL MICROBIOL, V49, P1565, DOI 10.1046/j.1365-2958.2003.03668.x; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Tian G, 2004, J BIOL CHEM, V279, P39303, DOI 10.1074/jbc.M405219200; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923	37	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7973	7981		10.1074/jbc.M611537200	http://dx.doi.org/10.1074/jbc.M611537200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237231	hybrid			2022-12-27	WOS:000245081000027
J	Collins, CR; Withers-Martinez, C; Bentley, GA; Batchelor, AH; Thomas, AW; Blackman, MJ				Collins, Christine R.; Withers-Martinez, Chrislaine; Bentley, Graham A.; Batchelor, Adrian H.; Thomas, Alan W.; Blackman, Michael J.			Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-YOELII-YOELII; BLOOD-STAGE VACCINE; ERYTHROCYTE INVASION; SEQUENCE-ANALYSIS; PASSIVE-IMMUNIZATION; IMMUNE-RESPONSES; SURFACE-ANTIGEN; CLINICAL-TRIAL; PROTECTS MICE; I AMA-1	Antibodies that inhibit red blood cell invasion by the Plasmodium merozoite block the erythrocytic cycle responsible for clinical malaria. The invasion-inhibitory monoclonal antibody (mAb) 4G2 recognizes a conserved epitope in the ectodomain of the essential Plasmodium falciparum microneme protein and vaccine candidate, apical membrane antigen 1 (PfAMA1). Here we demonstrate that purified Fab fragments of 4G2 inhibit invasion markedly more efficiently than the intact mAb, suggesting that the invasion-inhibitory activity of this mAb is not due solely to steric effects and that the epitope lies within a functionally critical region of the molecule. We have taken advantage of a synthetic gene encoding a modified form of PfAMA1, and existing x-ray crystal structure data, to fully characterize this epitope. We first validate the gene by demonstrating that it fully complements the function of the authentic gene in P. falciparum. We then use it to identify a group of residues within the previously described domain 11 loop of PfAMA1 that are critical for recognition by mAb 4G2 and demonstrate that the epitope lies exclusively within this loop with no contributions from residues in other domains of the molecule. This is the first complete characterization of a conserved invasion-inhibitory epitope on PfAMA1. Our results will aid in the design of subunit vaccines designed to generate a broadly effective, focused anti-PfAMA1 protective immune response and may help elucidate the function of PfAMA1.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Inst Pasteur, Unite Immunol Struct, CNRS, URA 2185,Dept Biol Struct & Chim, F-75724 Paris 15, France; Biomed Primate Res Ctr, NL-2280 GH Rijswijk, Netherlands	MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	mblackm@nimr.mrc.ac.uk	Bentley, Graham/B-3623-2011		Medical Research Council [MC_U117532063] Funding Source: Medline; MRC [MC_U117532063] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; CHENG Q, 1994, MOL BIOCHEM PARASIT, V65, P183, DOI 10.1016/0166-6851(94)90127-9; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dutta S, 2005, INFECT IMMUN, V73, P2116, DOI 10.1128/IAI.73.4.2116-2122.2005; DUTTA S, 1995, MOL BIOCHEM PARASIT, V73, P267, DOI 10.1016/0166-6851(95)00112-E; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; EPSTEIN N, 1981, J IMMUNOL, V127, P212; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; HEIDRICH HG, 1982, J PARASITOL, V68, P443, DOI 10.2307/3280956; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kappe SHI, 1996, MOL BIOCHEM PARASIT, V78, P279, DOI 10.1016/S0166-6851(96)02619-9; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Langermans JAM, 2006, HUM VACCINES, V2, P222, DOI 10.4161/hv.2.5.3276; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; MARSHALL VM, 1989, MOL BIOCHEM PARASIT, V37, P281, DOI 10.1016/0166-6851(89)90160-6; Miao J, 2006, VACCINE, V24, P6187, DOI 10.1016/j.vaccine.2006.05.099; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Narum DL, 2006, INFECT IMMUN, V74, P5529, DOI 10.1128/IAI.00573-06; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; PETERSON MG, 1990, MOL BIOCHEM PARASIT, V39, P279, DOI 10.1016/0166-6851(90)90067-V; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; WATERS AP, 1991, MOL BIOCHEM PARASIT, V44, P141, DOI 10.1016/0166-6851(91)90230-4; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; Withers-Martinez C, 1999, PROTEIN ENG, V12, P1113, DOI 10.1093/protein/12.12.1113; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Zhou JL, 2006, EXP PARASITOL, V114, P329, DOI 10.1016/j.exppara.2006.04.012	65	79	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7431	7441		10.1074/jbc.M610562200	http://dx.doi.org/10.1074/jbc.M610562200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17192270	hybrid			2022-12-27	WOS:000245080900055
J	Jaubert, M; Lavergne, J; Fardoux, J; Hannibal, L; Vuillet, L; Adriano, JM; Bouyer, P; Pignol, D; Giraud, E; Vermeglio, A				Jaubert, Marianne; Lavergne, Jerome; Fardoux, Joel; Hannibal, Laure; Vuillet, Laurie; Adriano, Jean-Marc; Bouyer, Pierre; Pignol, David; Giraud, Eric; Vermeglio, Andre			A singular bacteriophytochrome acquired by lateral gene transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-TUMEFACIENS; BILIVERDIN CHROMOPHORE; HISTIDINE KINASES; PHYTOCHROME AGP1; BACTERIA; REVEALS; PHYCOCYANOBILIN; PHOTORECEPTORS; CYANOBACTERIAL; PERCEPTION	Bacteriophytochromes are phytochrome-like proteins that mediate photosensory responses in various bacteria according to their light environment. The genome of the photosynthetic and plant-symbiotic Bradyrhizobium sp. strain ORS278 revealed the presence of a genomic island acquired by lateral transfer harboring a bacteriophytochrome gene, BrBphP3.ORS278, and genes involved in the synthesis of phycocyanobilin and gas vesicles. The corresponding protein BrBphP3.ORS278 is phylogenetically distant from the other (bacterio)phytochromes described thus far and displays a series of unusual properties. It binds phycocyanobilin as a chromophore, a unique feature for a bacteriophytochrome. Moreover, its C-terminal region is short and displays no homology with any known functional domain. Its dark-adapted state absorbs maximally around 610 nm, an unusually short wavelength for (bacterio)phytochromes. This form is designated as Po for orange-absorbing form. Upon illumination, a photo-reversible switch occurs between the Po form and a red (670 nm)-absorbing form (Pr), which rapidly back-reacts in the dark. Because of this instability, illumination results in a mixture of the Po and Pr states in proportions that depend on the intensity. These uncommon features suggest that BrBphP3.ORS278 could be fitted to measure light intensity rather than color.	CEA, Cadarache DEVM, CNRS, Lab Bioenerget Cellulaire,UMR 6191, F-13108 St Paul Les Durance, France; INRA, Lab Symbioses Trop & Mediterraneennes, IRD, CIRAD,AGROM, F-34398 Montpellier, France	CEA; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Vermeglio, A (corresponding author), CEA, Cadarache DEVM, CNRS, Lab Bioenerget Cellulaire,UMR 6191, F-13108 St Paul Les Durance, France.	avermeglio@cea.fr	Giraud, Eric/GLS-1036-2022	PIGNOL, David/0000-0002-8070-0319				Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; DAMERVAL T, 1991, PLANT CELL, V3, P191; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Goller AH, 2005, CHEMPHYSCHEM, V6, P1259, DOI 10.1002/cphc.200400667; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; Lamparter T, 2004, FEBS LETT, V573, P1, DOI 10.1016/j.febslet.2004.07.050; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Li N, 1998, J BACTERIOL, V180, P2450, DOI 10.1128/JB.180.9.2450-2458.1998; Pfeifer F, 2002, J MOL MICROB BIOTECH, V4, P175; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; SINESHCHEKOV VA, 1995, BBA-BIOENERGETICS, V1228, P125, DOI 10.1016/0005-2728(94)00173-3; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	31	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7320	7328		10.1074/jbc.M611173200	http://dx.doi.org/10.1074/jbc.M611173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218312	hybrid			2022-12-27	WOS:000245080900043
J	Kawana, K; Quayle, AJ; Ficarra, M; Ibana, JA; Shen, L; Kawana, Y; Yang, HX; Marrero, L; Yavagal, S; Greene, SJ; Zhang, YX; Pyles, RB; Blumberg, RS; Schust, DJ				Kawana, Kei; Quayle, Alison J.; Ficarra, Mercedes; Ibana, Joyce A.; Shen, Li; Kawana, Yukiko; Yang, Huixia; Marrero, Luis; Yavagal, Sujata; Greene, Sheila J.; Zhang, You-Xun; Pyles, Richard B.; Blumberg, Richard S.; Schust, Danny J.			CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NKT CELLS; EXPRESSION; RECOGNITION; COMPLEX; ACTIVATION; PARADIGM	Chlamydia trachomatis is an obligate intracellular pathogen that can persist in the urogenital tract. Mechanisms by which C. trachomatis evades clearance by host innate immune responses are poorly described. CD1d is MHC-like, is expressed by epithelial cells, and can signal innate immune responses by NK and NKT cells. Here we demonstrate that C. trachomatis infection down-regulates surface-expressed CD1d in human penile urethral epithelial cells through proteasomal degradation. A chlamydial proteasome-like activity factor (CPAF) interacts with the CD1d heavy chain, and CPAF-associated CD1d heavy chain is then ubiquitinated and directed along two distinct proteolytic pathways. The degradation of immature glycosylated CD1d was blocked by the proteasome inhibitor lactacystin but not by MG132, indicating that degradation was not via the conventional proteasome. In contrast, the degradation of non-glycosylated CD1d was blocked by lactacystin and MG132, consistent with conventional cellular cytosolic degradation of N-linked glycoproteins. Immunofluorescent microscopy confirmed the interruption of CD1d trafficking to the cell surface, and the dislocation of CD1d heavy chains into both the cellular cytosol and the chlamydial inclusion along with cytosolic CPAF. C. trachomatis targeted CD1d toward two distinct proteolytic pathways. Decreased CD1d surface expression may help C. trachomatis evade detection by innate immune cells and may promote C. trachomatis persistence.	Boston Univ, Med Ctr, Div Reprod Biol, Dept Obstet & Gynecol,Sch Med, Boston, MA 02118 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; Boston Univ, Sch Med, Div Infect Dis, Dept Med, Boston, MA 02118 USA; Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, New Orleans, LA 70112 USA; Univ Texas, Med Branch, Dept Pediat & Expt Pathol, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol,Dept Med, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Boston University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Schust, DJ (corresponding author), Univ Missouri, Div Reprod Endocrinol & Fertil, Dept Obstet Gynecol & Womens Hlth, Sch Med,Columbia Reg Hosp, 402 Keene St,3rd Floor, Columbia, MO 65201 USA.	schustd@health.missouri.edu			NIAID NIH HHS [AI046518, R01 AI055869, U19AI061972] Funding Source: Medline; PHS HHS [KD44319] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI061972, P01AI046518] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALK SP, 1994, SCIENCE, V265, P259, DOI 10.1126/science.7517575; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Dong F, 2004, MOL MICROBIOL, V52, P1487, DOI 10.1111/j.1365-2958.2004.04072.x; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Taniguchi M, 2000, SEMIN IMMUNOL, V12, P543, DOI 10.1006/smim.2000.0270; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525	22	54	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7368	7375		10.1074/jbc.M610754200	http://dx.doi.org/10.1074/jbc.M610754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215251	hybrid			2022-12-27	WOS:000245080900048
J	Kreimeyer, A; Perret, A; Lechaplais, C; Vallenet, D; Medigue, C; Salanoubat, M; Weissenbach, J				Kreimeyer, Annett; Perret, Alain; Lechaplais, Christophe; Vallenet, David; Medigue, Claudine; Salanoubat, Marcel; Weissenbach, Jean			Identification of the last unknown genes in the fermentation pathway of lysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERMENTING CLOSTRIDIUM; FUSOBACTERIUM-NUCLEATUM; PURIFICATION; BREVIBACTERIUM; DEHYDROGENASE; DEGRADATION; CLONING; ACID; 3-KETO-5-AMINOHEXANOATE; 3,5-DIAMINOHEXANOATE	Although the proteins of the lysine fermentation pathway were biochemically characterized more than thirty years ago, the genes encoding the proteins that catalyze three steps of this pathway are still unknown. We combined gene context, similarity of enzymatic mechanisms, and molecular weight comparisons with known proteins to select candidate genes for these three orphan proteins. We used a wastewater metagenomic collection of sequences to find and characterize the missing genes of the lysine fermentation pathway. After recombinant protein production and purification following cloning in Escherichia coli, we demonstrated that these genes (named kdd, kce, and kal) encode a L-erythro-3,5-diaminohexanoate dehydrogenase, a 3-keto-5-aminohexanoate cleavage enzyme, and a 3-aminobutyryl-CoA ammonia lyase, respectively. Because all of the genes of the pathway are now identified, we used this breakthrough to detect lysine-fermenting bacteria in sequenced genomes. We identified twelve bacteria that possess these genes and thus are expected to ferment lysine, and their gene organization is discussed.	CNRS, UMR 8030, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Kreimeyer, A (corresponding author), CNRS, UMR 8030, 2 Rue Gaston Cremieux, F-91057 Evry, France.	akreimey@genoscope.cns.fr; aperret@genoscope.cns.fr		Vallenet, David/0000-0001-6648-0332; PERRET, Alain/0000-0002-8896-1978				BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAKER J J, 1974, Biochemistry, V13, P292, DOI 10.1021/bi00699a010; BAKER JJ, 1972, J BIOL CHEM, V247, P7724; BARKER HA, 1980, J BACTERIOL, V143, P1165, DOI 10.1128/JB.143.3.1165-1170.1980; BARKER HA, 1982, J BACTERIOL, V152, P201; BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F; Chang CH, 2000, J BIOL CHEM, V275, P106, DOI 10.1074/jbc.275.1.106; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; CorthesyTheulaz IE, 1997, J BIOL CHEM, V272, P25659, DOI 10.1074/jbc.272.41.25659; DOHNER PM, 1954, J BACTERIOL, V67, P608, DOI 10.1128/JB.67.5.608-611.1954; Herrmann G, 2005, FEBS J, V272, P813, DOI 10.1111/j.1742-4658.2004.04518.x; HONG SCL, 1972, J BACTERIOL, V112, P231, DOI 10.1128/JB.112.1.231-234.1972; HONG SL, 1973, J BIOL CHEM, V248, P41; JENG I, 1974, J BIOL CHEM, V249, P6578; LOESCHE WJ, 1968, ARCH ORAL BIOL, V13, P191, DOI 10.1016/0003-9969(68)90051-4; MORIYAMA T, 1971, J BIOL CHEM, V246, P3217; RIMERMAN EA, 1968, J BIOL CHEM, V243, P6151; Ruzicka FJ, 2000, J BACTERIOL, V182, P469, DOI 10.1128/JB.182.2.469-476.2000; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STADTMAN TC, 1973, ADV ENZYMOL RAMB, V38, P413; STADTMAN TC, 1954, J BACTERIOL, V67, P651, DOI 10.1128/JB.67.6.651-657.1954; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; YORIFUJI T, 1977, J BIOL CHEM, V252, P20	24	51	91	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7191	7197		10.1074/jbc.M609829200	http://dx.doi.org/10.1074/jbc.M609829200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17166837	hybrid			2022-12-27	WOS:000245080900031
J	Lemmers, B; Salmena, L; Bidere, N; Su, H; Matysiak-Zablocki, E; Murakami, K; Ohashi, PS; Jurisicova, A; Lenardo, M; Hakem, R; Hakem, A				Lemmers, Benedicte; Salmena, Leonardo; Bidere, Nicolas; Su, Helen; Matysiak-Zablocki, Elzvieta; Murakami, Kiichi; Ohashi, Pamela S.; Jurisicova, Andrea; Lenardo, Michael; Hakem, Razqallah; Hakem, Anne			Essential role for caspase-8 in toll-like receptors and NF kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL PROLIFERATION; BCL-2 FAMILY; ACTIVATION; APOPTOSIS; INNATE; KINASE; FADD; PHOSPHORYLATION; MITOCHONDRIA; STIMULATION	In addition to its pro-apoptotic function in the death receptor pathway, roles for caspase-8 in mediating T-cell proliferation, maintaining lymphocyte homeostasis, and suppressing immunodeficiency have become evident. Humans with a germline point mutation of CASPASE-8 have multiple defects in T cells, B cells, and NK cells, most notably attenuated activation and immunodeficiency. By generating mice with B-cell-specific inactivation of caspase-8 (bcasp8(-/-)), we show that caspase-8 is dispensable for B-cell development, but its loss in B cells results in attenuated antibody production upon in vivo viral infection. We also report an important role for caspase-8 in maintaining B-cell survival following stimulation of the Toll-like receptor (TLR)2,-3, and -4. In response to TLR4 stimulation, caspase-8 is recruited to a complex containing IKK alpha beta, and its loss resulted in delayed NF kappa B nuclear translocation and impaired NF kappa B transcriptional activity. Our study supports dual roles for caspase-8 in apoptotic and nonapoptotic functions and demonstrates its requirement for TLR signaling and in the regulation of NF kappa B function.	Univ Toronto, Adv Med Discovery Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 2X1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Hakem, R (corresponding author), Univ Toronto, Adv Med Discovery Inst, Ontario Canc Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.	rhakem@uhnres.utoronto.ca	Jurisicova, Andrea/E-4580-2013; Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008; Ohashi, Pamela S./0000-0003-2915-9317; Hakem, Razqallah/0000-0001-5948-7931; Salmena, Leonardo/0000-0003-4023-658X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000565, Z01AI000769, Z01AI000565] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akira S, 2003, J INFECT DIS, V187, pS356, DOI 10.1086/374749; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bannerman DD, 2004, AM J PATHOL, V165, P1423, DOI 10.1016/S0002-9440(10)63400-1; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Barnhart BC, 2005, CELL DEATH DIFFER, V12, P25, DOI 10.1038/sj.cdd.4401509; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Bertram EM, 2002, EUR J IMMUNOL, V32, P3376, DOI 10.1002/1521-4141(200212)32:12<3376::AID-IMMU3376>3.0.CO;2-Y; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Fehr T, 1996, CELL IMMUNOL, V168, P184, DOI 10.1006/cimm.1996.0065; Fehr T, 2000, INT IMMUNOL, V12, P1275, DOI 10.1093/intimm/12.9.1275; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Krakauer T, 2004, CLIN DIAGN LAB IMMUN, V11, P621, DOI 10.1128/CDLI.11.3.621-624.2004; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Mack A, 2002, EUR J IMMUNOL, V32, P1986, DOI 10.1002/1521-4141(200207)32:7<1986::AID-IMMU1986>3.0.CO;2-#; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Newton K, 1998, CURR OPIN GENET DEV, V8, P68, DOI 10.1016/S0959-437X(98)80064-6; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Vos Q, 2000, IMMUNOL REV, V176, P154; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Wang XD, 2001, GENE DEV, V15, P2922; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	52	125	127	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7416	7423		10.1074/jbc.M606721200	http://dx.doi.org/10.1074/jbc.M606721200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213198	Green Published, hybrid			2022-12-27	WOS:000245080900053
J	Uemura, T; Kashiwagi, K; Igarashi, K				Uemura, Takeshi; Kashiwagi, Keiko; Igarashi, Kazuei			Polyamine uptake by DUR3 and SAM3 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCES SPERMINE UPTAKE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; S-ADENOSYLMETHIONINE; VACUOLAR MEMBRANE; TRANSPORT PROTEIN; UPTAKE SYSTEM; PUTRESCINE; GENE; IDENTIFICATION	It has been reported that GAPI and AGP2 catalyze the uptake of polyamines together with amino acids in Saccharomyces cerevisiae. We have looked for polyamine-preferential uptake proteins in S. cerevisiae. DUR3 catalyzed the uptake of polyamines together with urea, and SAM3 was found to catalyze the uptake of polyamines together with S-adenosylmethionine, glutamic acid, and lysine. Polyamine uptake was greatly decreased in both DUR3- and SAM3-deficient cells. The K-m values for putrescine and spermidine of DUR3 were 479 and 21.2 mu m, respectively, and those of SAM3 were 433 and 20.7 mu m, respectively. Polyamine stimulation of cell growth of a polyamine requiring mutant, which is deficient in ornithine decarboxylase, was not influenced by the disruption of GAP1 and AGP2, but it was diminished by the disruption of DUR3 and SAM3. Furthermore, the polyamine stimulation of cell growth of a polyamine-requiring mutant was completely inhibited by the disruption of both DUR3 and SAM3. The results indicate that DUR3 and SAM3 are major polyamine uptake proteins in yeast. We previously reported that polyamine transport protein kinase 2 regulates polyamine transport. It was found that DUR3 (but not SAM3) was activated by phosphorylation of Thr(250), Ser(251), and Thr(684) by polyamine transport protein kinase 2.	Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; Chiba Inst Sci, Fac Pharm, Choshi, Chiba 2880025, Japan	Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@p.chiba-u.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187				ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Albertsen M, 2003, J BIOL CHEM, V278, P12820, DOI 10.1074/jbc.M210715200; Antognoni F, 1999, J BIOL CHEM, V274, P1942, DOI 10.1074/jbc.274.4.1942; Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE RL, 1983, J BIOL CHEM, V258, P2193; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; KAISER C, 1994, METHODS YEAST GENETI, P1; KAKINUMA Y, 1995, BIOCHEM BIOPH RES CO, V216, P985, DOI 10.1006/bbrc.1995.2717; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 2002, J BIOL CHEM, V277, P24212, DOI 10.1074/jbc.M202849200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; ROUSSELET G, 1995, FEBS LETT, V359, P215, DOI 10.1016/0014-5793(95)00038-B; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; SUZUKI T, 1993, EUR J BIOCHEM, V215, P247, DOI 10.1111/j.1432-1033.1993.tb18029.x; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tomitori H, 1999, J BIOL CHEM, V274, P3265, DOI 10.1074/jbc.274.6.3265; Tomitori H, 2001, BIOCHEM J, V353, P681, DOI 10.1042/0264-6021:3530681; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2004, BIOCHEM BIOPH RES CO, V315, P1082, DOI 10.1016/j.bbrc.2004.01.162; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; VANVUUREN HJJ, 1991, J BACTERIOL, V173, P7186, DOI 10.1128/jb.173.22.7186-7195.1991; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604	39	71	75	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7733	7741		10.1074/jbc.M611105200	http://dx.doi.org/10.1074/jbc.M611105200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218313	hybrid			2022-12-27	WOS:000245080900085
J	Agrewala, JN; Brown, DM; Lepak, NM; Duso, D; Huston, G; Swain, SL				Agrewala, Javed N.; Brown, Deborah M.; Lepak, Nancy M.; Duso, Debra; Huston, Gail; Swain, Susan L.			Unique ability of activated CD4(+) T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY VIRUS-INFECTIONS; SELECTIN GLYCOPROTEIN LIGAND-1; MEMORY CELLS; IN-VIVO; P-SELECTIN; T-HELPER-2 CELLS; INFLAMED SKIN; CLASS-II; ANTIGEN; SUBSETS	Recent studies suggest that effector T cells generated by immune responses migrate to multiple non-lymphoid sites, even those without apparent expression of antigen or inflammation. To investigate the ability of distinct CD4(+) T lymphocyte subsets to enter and persist in non-lymphoid, noninflamed compartments, we examined the migration and persistence of naive, effector, and rested effector CD4(+) T cells generated in vitro following transfer to nonimmunized adoptive hosts. Th1 and Th2 effectors migrated to both lymphoid and non-lymphoid organs (peritoneum, fat pads, and lung). In contrast, rested effectors and naive cells migrated only to lymphoid areas. Adhesion molecule expression, but not chemokine receptor expression, correlated with the ability to enter non-lymphoid sites. Donor cells persisted longer in lymphoid than in non-lymphoid sites. When hosts with naive and memory donor cells were challenged with antigen, effectors developed in situ, which also migrated to non-lymphoid sites. Memory cells showed an accelerated shift to non-lymphoid migration, in keeping. with memory effector formation. These results suggest that only recently activated effector T cells can disperse to non-lymphoid sites in the absence of antigen and inflammation, and as effectors return to rest, they lose this ability. These data also argue that memory cells in lymphoid sites are longer lived and not in equilibrium with those in non-lymphoid sites.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Swain, SL (corresponding author), Trudeau Inst Inc, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.	sswain@northnet.org	Agrewala, Javed Naim/AAS-8449-2021		NIAID NIH HHS [P01AI46530, T32AI49823] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046530, T32AI049823] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; BRADLEY LM, 1993, J IMMUNOL, V150, P3119; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Bradley LM, 1999, EUR J IMMUNOL, V29, P3273, DOI 10.1002/(SICI)1521-4141(199910)29:10<3273::AID-IMMU3273>3.0.CO;2-2; Bradley LM, 2003, CURR OPIN IMMUNOL, V15, P343, DOI 10.1016/S0952-7915(03)00043-8; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Haddad W, 2003, J EXP MED, V198, P369, DOI 10.1084/jem.20020691; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Swain SL, 2002, ADV EXP MED BIOL, V512, P113; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Swain SL, 1996, IMMUNOL REV, V150, P143, DOI 10.1111/j.1600-065X.1996.tb00700.x; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Xu BH, 2003, J EXP MED, V197, P1255, DOI 10.1084/jem.20010685; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	43	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6106	6115		10.1074/jbc.M608266200	http://dx.doi.org/10.1074/jbc.M608266200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197446	hybrid			2022-12-27	WOS:000244867200016
J	Easlon, E; Tsang, F; Dilova, I; Wang, C; Lu, SP; Skinner, C; Lin, SJ				Easlon, Erin; Tsang, Felicia; Dilova, Ivanka; Wang, Chen; Lu, Shu-Ping; Skinner, Craig; Lin, Su-Ju			The dihydrolipoamide acetyltransferase is a novel metabolic longevity factor and is required for calorie restriction-mediated life span extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; ACETYL-COA SYNTHETASE; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; GENE DISRUPTION; PROTEIN SIR2; BAKERS-YEAST; EXPRESSION; MITOCHONDRIA	Calorie restriction (CR) extends life span in a wide variety of species. Recent studies suggest that an increase in mitochondrial metabolism mediates CR-induced life span extension. Here we present evidence that Lat1 (dihydrolipoamide acetyltransferase), the E2 component of the mitochondrial pyruvate dehydrogenase complex, is a novel metabolic longevity factor in the CR pathway. Deleting the LAT1 gene abolishes life span extension induced by CR. Overexpressing Lat1 extends life span, and this life span extension is not further increased by CR. Similar to CR, life span extension by Lat1 overexpression largely requires mitochondrial respiration, indicating that mitochondrial metabolism plays an important role in CR. Interestingly, Lat1 overexpression does not require the Sir2 family to extend life span, suggesting that Lat1 mediates a branch of the CR pathway that functions in parallel to the Sir2 family. Lat1 is also a limiting longevity factor in nondividing cells in that overexpressing Lat1 extends cell survival during prolonged culture at stationary phase. Our studies suggest that Lat1 overexpression extends life span by increasing metabolic fitness of the cell. CR may therefore also extend life span and ameliorate age-associated diseases by increasing metabolic fitness through regulating central metabolic enzymes.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Microbiol Sect, 323 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			NIA NIH HHS [R01 AG024351-02, R01 AG024351-03, R01 AG024351, R01 AG024351-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brachmann CB, 1998, YEAST, V14, P115; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Burke D., 2000, METHODS YEAST GENETI, P171; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Choi CH, 2005, CELL MOL LIFE SCI, V62, P625, DOI 10.1007/s00018-005-4516-6; Choi CH, 2004, CELL CYCLE, V3, P114; Cruz F, 2001, J NEUROSCI RES, V66, P771, DOI 10.1002/jnr.10048; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Galasinski SK, 2000, MOL CELL BIOL, V20, P1923, DOI 10.1128/MCB.20.6.1923-1930.2000; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Guarente L, 2000, GENE DEV, V14, P1021; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Harmych S, 2002, MOL BIOCHEM PARASIT, V125, P135, DOI 10.1016/S0166-6851(02)00221-9; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JAMES AG, 1995, FEBS LETT, V373, P111, DOI 10.1016/0014-5793(95)01020-F; Jiang JC, 2000, FASEB J, V14, P2135; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; KRESZE GB, 1981, EUR J BIOCHEM, V119, P573, DOI 10.1111/j.1432-1033.1981.tb05646.x; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P11249, DOI 10.1021/bi00111a009; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2003, J BIOL CHEM, V278, P13390, DOI 10.1074/jbc.M212818200; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; MAENG CY, 1994, BIOCHEMISTRY-US, V33, P13801, DOI 10.1021/bi00250a034; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Meeusen SL, 2005, CURR OPIN CELL BIOL, V17, P389, DOI 10.1016/j.ceb.2005.06.014; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Park PU, 2002, METHOD ENZYMOL, V351, P468; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; SCHNEIDER JC, 1991, MOL CELL BIOL, V11, P4934, DOI 10.1128/MCB.11.10.4934; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; WARBURG O, 1956, SCIENCE, V124, P269; WEINDRUCH W, 1998, RETARDATION AGING DI; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	77	44	46	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6161	6171		10.1074/jbc.M607661200	http://dx.doi.org/10.1074/jbc.M607661200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200108	Green Accepted, hybrid			2022-12-27	WOS:000244867200022
J	Yao, JH; Kim, TW; Qin, JZ; Jiang, ZF; Qian, YC; Xiao, H; Lu, Y; Qian, W; Gulen, MF; Sizemore, N; DiDonato, J; Sato, S; Akira, S; Su, B; Li, XX				Yao, Jianhong; Kim, Tae Whan; Qin, Jinzhong; Jiang, Zhengfan; Qian, Youcun; Xiao, Hui; Lu, Yi; Qian, Wen; Gulen, Muhammet Fatih; Sizemore, Nywana; DiDonato, Joseph; Sato, Shintaro; Akira, Shizuo; Su, Bing; Li, Xiaoxia			Interleukin-1 (IL-1)-induced TAK1-dependent versus MEKK3-dependent NF kappa B activation pathways bifurcate at IL-1 receptor-associated kinase modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-BETA SUBUNIT; SIGNALING PATHWAY; ACCESSORY PROTEIN; JNK ACTIVATION; MICE LACKING; TAK1; IRAK; TAB2; PHOSPHORYLATION; COMPLEX	Interleukin-1 (IL-1) receptor-associated kinase (IRAK) is phosphorylated after it is recruited to the receptor, subsequently ubiquitinated, and eventually degraded upon IL-1 stimulation. Although a point mutation changing lysine 134 to arginine (K134R) in IRAK abolished IL-1-induced IRAK ubiquitination and degradation, mutations of serines and threonines adjacent to lysine 134 to alanines ((S/T)A (131-144)) reduced IL-1-induced IRAK phosphorylation and abolished IRAK ubiquitination. Through the study of these IRAK modification mutants, we uncovered two parallel IL-1-mediated signaling pathways for NF kappa B activation, TAKI-dependent and MEKK3-dependent, respectively. These two pathways bifurcate at the level of IRAK modification. The TAKI-dependent pathway leads to IKK alpha/beta phosphorylation and IKK beta activation, resulting in classical NF kappa B activation through I kappa B alpha phosphorylation and degradation. The TAK1-independent MEKK3-dependent pathway involves IKK gamma phosphorylation and IKK alpha activation, resulting in NF kappa B activation through I kappa B alpha phosphorylation and subsequent dissociation from NF kappa B but without I kappa B alpha degradation. These results provide significant insight to our further understanding of NF kappa B activation pathways.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA; Osaka Univ, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77054 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Japan Science & Technology Agency (JST); Osaka University; University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Hazen, Stanley L/ABD-5845-2021; Akira, Shizuo/C-3134-2009	Gulen, Muhammet/0000-0002-7139-6781; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Li QT, 2000, GENE DEV, V14, P1729; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Li XX, 1999, MOL CELL BIOL, V19, P4643; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LORD KA, 1990, ONCOGENE, V5, P1095; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	50	86	91	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6075	6089		10.1074/jbc.M609039200	http://dx.doi.org/10.1074/jbc.M609039200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197697	hybrid			2022-12-27	WOS:000244867200013
J	Freshour, J; Yokoyama, R; Mitchell, DR				Freshour, Judy; Yokoyama, Ruth; Mitchell, David R.			Chlamydomonas flagellar outer row dynein assembly protein Oda7 interacts with both outer row and I1 inner row dyneins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; HEAVY-CHAIN; LIGHT-CHAIN; NUCLEAR TRANSFORMATION; MOTOR DOMAIN; ARM DYNEIN; MUTANT; REINHARDTII; MOVEMENT; MOTILITY	We previously found that a mutation at the ODA7 locus in Chlamydomonas prevents axonemal outer row dynein assembly by blocking association of heavy chains and intermediate chains in the cytoplasm. We have now cloned the ODA 7 locus by walking in the Chlamydomonas genome from nearby molecular markers, confirmed the identity of the gene by rescuing the mutant phenotype with genomic clones, and identified the ODA7 gene product as a 58-kDa leucine-rich repeat protein unrelated to outer row dynein LC1. Oda7p is missing from oda7 mutant flagella but is present in flagella of other outer row or inner row dynein assembly mutants. However, Oda7 levels are greatly reduced in flagella that lack both outer row dynein and inner row 11 dynein. Biochemical fractionation and rebinding studies support a model in which Oda7 participates in a previously uncharacterized structural link between inner and outer row dyneins.	SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mitchell, DR (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, 1133 WH,750 E Adams St, Syracuse, NY 13210 USA.	mitcheld@upstate.edu		Mitchell, David/0000-0003-2821-7511	NIGMS NIH HHS [GM44228, R01 GM044228-15, R01 GM044228] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed NT, 2005, MOL BIOL CELL, V16, P5004, DOI 10.1091/mbc.E05-07-0627; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asai DJ, 2004, J EUKARYOT MICROBIOL, V51, P23, DOI 10.1111/j.1550-7408.2004.tb00157.x; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; BLOODGOOD RA, 1994, J CELL BIOL, V127, P803, DOI 10.1083/jcb.127.3.803; Bowman AB, 1999, J CELL BIOL, V146, P165; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; DiBella LM, 2004, MOL BIOL CELL, V15, P4633, DOI 10.1091/mbc.E04-06-0461; DiBella LM, 2004, J BIOL CHEM, V279, P21666, DOI 10.1074/jbc.M313540200; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; GIBBONS BH, 1973, J CELL SCI, V13, P337; GIBBONS I. R., 1965, ARCH BIOL, V76, P317; Kajava AV, 2002, PROTEIN SCI, V11, P1082, DOI 10.1110/ps.4010102; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kamiya R, 2002, INT REV CYTOL, V219, P115; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; KING SM, 1994, J BIOL CHEM, V269, P5452; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; Liu SM, 2004, CELL MOTIL CYTOSKEL, V59, P201, DOI 10.1002/cm.20034; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; MITCHELL DR, 1986, CELL MOTIL CYTOSKEL, V6, P510, DOI 10.1002/cm.970060510; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; Mitchell DR, 1999, J CELL BIOL, V144, P293, DOI 10.1083/jcb.144.2.293; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PFISTER KK, 1982, CELL MOTIL CYTOSKEL, V2, P525, DOI 10.1002/cm.970020604; PORTONI L, 2000, P SOC PHOTO-OPT INS, V1, P37; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SAGER R, 1953, ANN NY ACAD SCI, V466, P18; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; SAKAKIBARA H, 1989, J CELL SCI, V92, P77; SILFLOW CD, 1995, METHOD CELL BIOL, V47, P525, DOI 10.1016/S0091-679X(08)60856-0; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; TAKADA S, 1992, J BIOCHEM, V111, P758, DOI 10.1093/oxfordjournals.jbchem.a123832; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; Wu HW, 2003, BIOCHEMISTRY-US, V42, P57, DOI 10.1021/bi026762j; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200	44	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5404	5412		10.1074/jbc.M607509200	http://dx.doi.org/10.1074/jbc.M607509200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17194703	Green Accepted, hybrid			2022-12-27	WOS:000244482300035
J	Fujita, M; Sugama, S; Nakai, M; Takenouchi, T; Wei, JS; Urano, T; Inoue, S; Hashimoto, M				Fujita, Masayo; Sugama, Shuei; Nakai, Masaaki; Takenouchi, Takato; Wei, Jianshe; Urano, Tomohiko; Inoue, Satoshi; Hashimoto, Makoto			alpha-synuclein stimulates differentiation of osteosarcoma cells - Relevance to down-regulation of proteasome activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY DEMENTIA; PARKINSONS-DISEASE; GAMMA-SYNUCLEIN; BETA-SYNUCLEIN; PC12 CELLS; PROTEIN-DEGRADATION; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; LUNG-CANCER; GENE	Because a limited study previously showed that alpha-synuclein (alpha-syn), the major pathogenic protein for Parkinson disease, was expressed in differentiating brain tumors as well as various peripheral cancers, the main objective of the present study was to determine whether a-syn might be involved in the regulation of tumor differentiation. For this purpose, a-syn and its non-amyloidogenic homologue beta-syn were stably transfected to human osteosarcoma MG63 cell line. Compared with beta-syn-overexpressing and vector-transfected cells, alpha-syn-overexpressing cells exhibited distinct features of differentiated osteoblastic phenotype, as shown by up-regulation of alkaline phosphatase and osteocalcin as well as inductive matrix mineralization. Further studies revealed that proteasome activity was significantly decreased in a-syn-overexpressing cells compared with other cell types, consistent with the fact that proteasome inhibitors stimulate differentiation of various osteoblastic cells. In a-syn-overexpressing cells, protein kinase C (PKC) activity was significantly decreased, and reactivation of PKC by phorbol ester significantly restored the proteasome activity and abrogated cellular differentiation. Moreover, activity of lysosome was up-regulated in a-syn-overexpressing cells, and treatment of these cells with autophagy-lysosomal inhibitors resulted in a decrease of proteasome activity associated with up-regulation of a-syn expression, leading to enhance cellular differentiation. Taken together, these results suggest that the stimulatory effect of a-syn on tumor differentiation may be attributed to down-regulation of proteasome, which is further modulated by alterations of various factors, such as protein kinase C signaling pathway and a autophagy-lysosomal degradation system. Thus, the mechanism of a-syn regulation of tumor differentiation and neuropathological effects of a-syn may considerably overlap with each other.	Tokyo Metropolitan Inst Neurosci, Lab Chem & Metab, Fuchu, Tokyo 1838526, Japan; Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki 3058634, Japan; Univ Tokyo, Sch Med, Dept Geriatr & Gerontol, Tokyo 1138655, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; National Institute of Agrobiological Sciences - Japan; University of Tokyo	Hashimoto, M (corresponding author), Tokyo Metropolitan Inst Neurosci, Lab Chem & Metab, 2-6 Musashidai, Fuchu, Tokyo 1838526, Japan.	mhashimoto@tmin.ac.jp	Urano, Tomohiko/AFS-9574-2022					Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Giasson BI, 1999, J NEUROCHEM, V72, P1081, DOI 10.1046/j.1471-4159.1999.0721081.x; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Inaba S, 2005, BREAST CANCER RES TR, V94, P25, DOI 10.1007/s10549-005-6938-0; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Iwata A, 2001, J BIOL CHEM, V276, P45320, DOI 10.1074/jbc.M103736200; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2003, CANCER RES, V63, P3899; Kawashima M, 2000, ACTA NEUROPATHOL, V99, P154, DOI 10.1007/PL00007419; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lee SS, 2003, NEUROBIOL AGING, V24, P687, DOI 10.1016/S0197-4580(02)00196-3; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nakai M, 1998, CELL TISSUE RES, V294, P145, DOI 10.1007/s004410051164; Obin M, 1999, J BIOL CHEM, V274, P11789, DOI 10.1074/jbc.274.17.11789; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pasquini LA, 2003, J NEUROSCI, V23, P4635; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Snyder H, 2005, J BIOL CHEM, V280, P7562, DOI 10.1074/jbc.M412887200; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Stefanis L, 2001, J NEUROCHEM, V76, P1165, DOI 10.1046/j.1471-4159.2001.00114.x; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tanimoto Y, 2004, J BIOL CHEM, V279, P45926, DOI 10.1074/jbc.M404824200; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Wyke SM, 2006, LIFE SCI, V78, P2898, DOI 10.1016/j.lfs.2005.11.014; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhao W, 2006, INT J ONCOL, V28, P1081	59	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5736	5748		10.1074/jbc.M606175200	http://dx.doi.org/10.1074/jbc.M606175200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189270	hybrid			2022-12-27	WOS:000244482300070
J	Leveille, C; Bouillon, M; Guo, W; Bolduc, J; Sharif-Askari, E; El-Fakhry, Y; Reyes-Moreno, C; Lapointe, R; Merhi, Y; Wilkins, JA; Mourad, W				Leveille, Claire; Bouillon, Marlene; Guo, Wen; Bolduc, Julie; Sharif-Askari, Ehssan; El-Fakhry, Youssef; Reyes-Moreno, Carlos; Lapointe, Rejean; Merhi, Yahye; Wilkins, John A.; Mourad, Walid			CD40 ligand binds to alpha 5 beta 1 integrin and triggers cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN ARTICULAR CHONDROCYTES; INFLAMMATORY-BOWEL-DISEASE; HUMAN B-LYMPHOCYTES; HUMAN MONOCYTES; MAST-CELLS; CARDIOVASCULAR-DISEASE; COSTIMULATORY PATHWAY; FIBRONECTIN FRAGMENTS	It was originally thought that the critical role of the CD40 ligand (CD40L) in normal and inflammatory immune responses was mainly mediated through its interaction with the classic receptor, CD40. However, data from CD40L(-/-) and CD40(-/-) mice suggest that the CD40L-induced inflammatory immune response involves at least one other receptor. This hypothesis is supported by the fact that CD40L stabilizes arterial thrombi through an alpha IIb beta 3-dependent mechanism. Here we provide evidence that soluble CD40L (sCD40L) binds to cells of the undifferentiated human monocytic U937 cell line in a CD40- and alpha IIb beta 3-independent manner. Binding of sCD40L to U937 cells was inhibited by anti-CD40L monoclonal antibody 5C8, anti-alpha 5 beta 1 monoclonal antibody P1D6, and soluble alpha 5 beta 1. The direct binding of sCD40L to purified alpha 5 beta 1 was confirmed in a solid phase binding assay. Binding of sCD40L to alpha 5 beta 1 was modulated by the form of alpha 5 beta 1 expressed on the cell surface as the activation of alpha 5 beta 1 by Mn2+ or dithiothreitol resulted in the loss of sCD40L binding. Moreover, sCD40L induced the translocation of alpha 5 beta 1 to the Triton X-100-insoluble fraction of U937 cells, the rapid activation of the MAPK pathways ERK1/2, and interleukin-8 gene expression. The binding of sCD40L to CD40 on BJAB cells, an alpha 5 beta 1-negative B cell line, and the resulting activation of ERK1/2 was not inhibited by soluble alpha 5 beta 1, suggesting that sCD40L can bind concomitantly to both receptors. These results document the existence of novel CD40L-dependent pathways of physiological relevance for cells expressing multiple receptors (CD40, alpha 5 beta 1, and alpha IIb beta 3) for CD40L.	Ctr Hosp Univ Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Montreal, PQ H2X 1P1, Canada; CHU Laval, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; Ctr Hosp Univ Montreal, Hop Notre Dame, Montreal, PQ H2W 1T8, Canada; Univ Montreal, Inst Rech Cardiol, Montreal, PQ H1T 1C8, Canada; Univ Manitoba, Dept Med, Manitoba Ctr Proteom & Rheumat Dis Res Lab, Winnipeg, MB R3E 3P4, Canada; Univ Montreal, Dept Med, Montreal, PQ H3T 3J7, Canada	Universite de Montreal; Laval University; Universite de Montreal; Universite de Montreal; University of Manitoba; Universite de Montreal	Mourad, W (corresponding author), Ctr Hosp Univ Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Campus St Luc,Pavillon Edouard Asselin,264 Blvd R, Montreal, PQ H2X 1P1, Canada.	MW.Mourad@umontreal.ca		Mourad, Walid/0000-0002-1859-9387				Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Bajorath J, 1998, J BIOL CHEM, V273, P24603, DOI 10.1074/jbc.273.38.24603; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Crow AR, 2003, J THROMB HAEMOST, V1, P850, DOI 10.1046/j.1538-7836.2003.t01-1-00115.x; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Delmas Y, 2005, M S-MED SCI, V21, P825, DOI 10.1051/medsci/20052110825; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; DING L, 1995, J IMMUNOL, V155, P5124; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Goules A, 2006, J AUTOIMMUN, V26, P165, DOI 10.1016/j.jaut.2006.02.002; Grammer A C, 2000, Adv Immunol, V76, P61; Grammer AC, 2004, ARTHRITIS RES THER, V6, P28, DOI 10.1186/ar1155; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Houtman R, 2001, CLIN EXP ALLERGY, V31, P817, DOI 10.1046/j.1365-2222.2001.01104.x; Howard LM, 2004, AUTOIMMUNITY, V37, P411, DOI 10.1080/08916930410001716095; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Inoue Y, 2004, J IMMUNOL, V172, P2147, DOI 10.4049/jimmunol.172.4.2147; Jin Yinzhu, 2001, Journal of Medical and Dental Sciences, V48, P23; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Katsiari CG, 2002, LUPUS, V11, P370, DOI 10.1191/0961203302lu211oa; Kaufman J, 2004, J IMMUNOL, V172, P1862, DOI 10.4049/jimmunol.172.3.1862; KIENER PA, 1995, J IMMUNOL, V155, P4917; Krokhin OV, 2003, BIOCHEMISTRY-US, V42, P12950, DOI 10.1021/bi034726u; Leveille C, 1999, EUR J IMMUNOL, V29, P3516, DOI 10.1002/(SICI)1521-4141(199911)29:11<3516::AID-IMMU3516>3.3.CO;2-4; Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Liu MF, 2001, AUTOIMMUNITY, V34, P107, DOI 10.3109/08916930109001958; Mehlhop PD, 2000, AM J RESP CELL MOL, V23, P646, DOI 10.1165/ajrcmb.23.5.3954; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Ody C, 2001, MOL IMMUNOL, V38, P45, DOI 10.1016/S0161-5890(01)00030-X; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; Pearson LL, 2001, INT IMMUNOL, V13, P273, DOI 10.1093/intimm/13.3.273; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Qiang YW, 2000, EXP HEMATOL, V28, P1147, DOI 10.1016/S0301-472X(00)00521-X; Reyes-Moreno C, 2004, J BIOL CHEM, V279, P7799, DOI 10.1074/jbc.M313168200; Roman J, 2000, CYTOKINE, V12, P1581, DOI 10.1006/cyto.2000.0759; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Sidiropoulos PI, 2004, LUPUS, V13, P391, DOI 10.1191/0961203304lu1032oa; Stout RD, 1996, J IMMUNOL, V156, P8; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; TAKIZAWA T, 1995, CLIN EXP IMMUNOL, V101, P376; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vishnevetsky D, 2004, ANN PHARMACOTHER, V38, P1500, DOI 10.1345/aph.1D611; Wagner AH, 2004, ARTERIOSCL THROM VAS, V24, P715, DOI 10.1161/01.ATV.0000122853.99978.b1; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046	67	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5143	5151		10.1074/jbc.M608342200	http://dx.doi.org/10.1074/jbc.M608342200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182621	hybrid			2022-12-27	WOS:000244482300008
J	Werner, ME; Chen, F; Moyano, JV; Yehiely, F; Jones, JCR; Cryns, VL				Werner, Michael E.; Chen, Feng; Moyano, Jose V.; Yehiely, Fruma; Jones, Jonathan C. R.; Cryns, Vincent L.			Caspase proteolysis of the integrin beta 4 subunit disrupts hemidesmosome assembly, promotes apoptosis, and inhibits cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; N-END RULE; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; TRAIL-INDUCED APOPTOSIS; FACTOR-KAPPA-B; INTERMEDIATE-FILAMENTS; CYTOPLASMIC DOMAIN; ALPHA-6-BETA-4 INTEGRIN; MEDIATED DEGRADATION; PEMPHIGOID ANTIGEN	Caspases are a conserved family of cell death proteases that cleave intracellular substrates at Asp residues to modify their function and promote apoptosis. In this report we identify the integrin 134 subunit as a novel caspase substrate using an expression cloning strategy. Together with its alpha 6 partner, alpha 6 beta 4 integrin anchors epithelial cells to the basement membrane at specialized adhesive structures known as hemidesmosomes and plays a critical role in diverse epithelial cell functions including cell survival and migration. We show that integrin 134 is cleaved by caspase-3 and -7 at a conserved Asp residue (Asp(1109)) in vitro and in epithelial cells undergoing apoptosis, resulting in the removal of most of its cytoplasmic tail. Caspase cleavage of integrin 64 produces two products, 1) a carboxyl-terminal product that is unstable and rapidly degraded by the proteasome and 2) an amino-terminal cleavage product (amino acids 1-1109) that is unable to assemble into mature hemidesmosomes. We also demonstrate that caspase cleavage of integrin beta 4 sensitizes epithelial cells to apoptosis and inhibits cell migration. Taken together, we have identified a previously unrecognized proteolytic truncation of integrin beta 4 generated by caspases that disrupts key structural and functional properties of epithelial cells and promotes apoptosis.	Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Mol & Cell Biol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Cell Death Regulat Lab, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cryns, VL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Lurie 4-113,303 E Super St, Chicago, IL 60611 USA.	v-cryns@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	NATIONAL CANCER INSTITUTE [P50CA089018, R01CA097198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097198, P50 CA089018, P50CA89018, R01CA097198] Funding Source: Medline; NIAMS NIH HHS [R01 AR054184-17, R01 AR054184-18, R01 AR054184, R01AR054184] Funding Source: Medline; NIDDK NIH HHS [T32 DK007169, T32DK07169] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Benoit V, 2004, CANCER RES, V64, P2684, DOI 10.1158/0008-5472.CAN-03-2914; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chen F, 2004, J BIOL CHEM, V279, P27542, DOI 10.1074/jbc.M400971200; Chen F, 2003, J BIOL CHEM, V278, P6848, DOI 10.1074/jbc.M212021200; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gonzalez AM, 2001, J CELL SCI, V114, P4197; He YY, 2006, ONCOGENE, V25, P1521, DOI 10.1038/sj.onc.1209184; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kayalar C, 1996, P NATL ACAD SCI USA, V93, P2234, DOI 10.1073/pnas.93.5.2234; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Morishima N, 1999, GENES CELLS, V4, P401, DOI 10.1046/j.1365-2443.1999.00270.x; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Niessen CM, 1997, J CELL SCI, V110, P1705; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Rathore N, 2004, J BIOL CHEM, V279, P39358, DOI 10.1074/jbc.M406712200; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; SKALLI O, 1994, J CELL BIOL, V125, P159, DOI 10.1083/jcb.125.1.159; SOULE HD, 1990, CANCER RES, V50, P6075; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; Stahl S, 1997, J CELL SCI, V110, P55; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tikhomirov O, 2001, J BIOL CHEM, V276, P33675, DOI 10.1074/jbc.M101394200; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	66	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5560	5569		10.1074/jbc.M603669200	http://dx.doi.org/10.1074/jbc.M603669200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178732	hybrid, Green Accepted			2022-12-27	WOS:000244482300052
J	Galkin, A; Kulakova, L; Melamud, E; Li, L; Wu, C; Mariano, P; Dunaway-Mariano, D; Nash, TE; Herzberg, O				Galkin, Andrey; Kulakova, Liudmila; Melamud, Eugene; Li, Ling; Wu, Chun; Mariano, Patrick; Dunaway-Mariano, Debra; Nash, Theodore E.; Herzberg, Osnat			Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II ALDOLASES; ESCHERICHIA-COLI; ENERGY-METABOLISM; FUNCTIONAL-ROLE; MECHANISM; DATABASE; BINDING; PHOSPHOGLYCOLOHYDROXAMATE; DISCRIMINATION; SPECIFICITY	Class I and class II fructose-1,6-bisphosphate aldolases (FBPA), glycolytic pathway enzymes, exhibit no amino acid sequence homology and utilize two different catalytic mechanisms. The mammalian class I FBPA employs a Schiff base mechanism, whereas the human parasitic protozoan Giardia lamblia class II FBPA is a zinc-dependent enzyme. In this study, we have explored the potential exploitation of the Giardia FBPA as a drug target. First, synthesis of FBPA was demonstrated in Giardia trophozoites by using an antibody-based fluorescence assay. Second, inhibition of FBPA gene transcription in Giardia trophozoites suggested that the enzyme is necessary for the survival of the organism under optimal laboratory growth conditions. Third, two crystal structures of FBPA in complex with the transition state analog phosphoglycolohydroxamate (PGH) show that the enzyme is homodimeric and that its active site contains a zinc ion. In one crystal form, each subunit contains PGH, which is coordinated to the zinc ion through the hydroxamic acid hydroxyl and carbonyl oxygen atoms. The second crystal form contains PGH only in one subunit and the active site of the second subunit is unoccupied. Inspection of the two states of the enzyme revealed that it undergoes a conformational transition upon ligand binding. The enzyme cleaves D-fructose-1,6-bisphosphate but not D-tagatose-1,6-bisphosphate, which is a tight binding competitive inhibitor. The essential role of the active site residue Asp-83 in catalysis was demonstrated by amino acid replacement. Determinants of catalysis and substrate recognition, derived from comparison of the G. lamblia FBPA structure with Escherichia coli FBPA and with a closely related enzyme, E. coli tagatose-1,6-bisphosphate aldolase (TBPA), are described.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Herzberg, O (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA.	osnat@carb.nist.gov		Herzberg, Osnat/0000-0003-2823-7627	NIAID NIH HHS [R01 AI059733] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059733] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; Bernstein E, 2001, RNA, V7, P1509; BOREHAM PFL, 1988, T ROY SOC TROP MED H, V82, P104, DOI 10.1016/0035-9203(88)90278-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEN CI, 1980, Q REV BIOPHYS, V13, P317, DOI 10.1017/S0033583500001712; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLLINS KD, 1974, J BIOL CHEM, V249, P136; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; DeLano WL, 2002, PYMOL USERS MANUAL; DOBELI H, 1991, ACT LEIDENS, V60, P135; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hall DR, 1999, J MOL BIOL, V287, P383, DOI 10.1006/jmbi.1999.2609; Hall DR, 2002, J BIOL CHEM, V277, P22018, DOI 10.1074/jbc.M202464200; Henze K, 1998, GENE, V222, P163, DOI 10.1016/S0378-1119(98)00499-5; Izard T, 2004, J BIOL CHEM, V279, P11825, DOI 10.1074/jbc.M311375200; JARROLL EL, 1989, J PROTOZOOL, V36, P190, DOI 10.1111/j.1550-7408.1989.tb01073.x; Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KOBES RD, 1969, BIOCHEMISTRY-US, V8, P585, DOI 10.1021/bi00830a018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDMARK DG, 1980, MOL BIOCHEM PARASIT, V1, P1, DOI 10.1016/0166-6851(80)90037-7; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Mills SD, 2003, J ANTIMICROB CHEMOTH, V51, P749, DOI 10.1093/jac/dkg178; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plater AR, 1999, J MOL BIOL, V285, P843, DOI 10.1006/jmbi.1998.2376; Projan SJ, 2002, CURR OPIN PHARMACOL, V2, P513, DOI 10.1016/S1471-4892(02)00197-2; Qamar S, 1996, PROTEIN SCI, V5, P154; Ramsaywak PC, 2004, PROTEIN EXPRES PURIF, V37, P220, DOI 10.1016/j.pep.2004.05.011; RUTTER WJ, 1964, FED PROC, V23, P1248; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Wright Janelle M, 2003, Expert Opin Drug Saf, V2, P529, DOI 10.1517/14740338.2.6.529; Zaat JOM, 1997, TROP MED INT HEALTH, V2, P63, DOI 10.1046/j.1365-3156.1997.d01-132.x; Zgiby S, 2002, J MOL BIOL, V315, P131, DOI 10.1006/jmbi.2001.5237; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x	42	39	44	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4859	4867		10.1074/jbc.M609534200	http://dx.doi.org/10.1074/jbc.M609534200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166851	hybrid			2022-12-27	WOS:000244482000068
J	Nightingale, KP; Gendreizig, S; White, DA; Bradbury, C; Hollfelder, F; Turner, BM				Nightingale, Karl P.; Gendreizig, Susanne; White, Darren A.; Bradbury, Charlotte; Hollfelder, Florian; Turner, Bryan M.			Cross-talk between histone modifications in response to histone deacetylase inhibitors - MLL4 links histone H3 acetylation and histone H3K4 methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE GENES; DEMETHYLATION; CHROMATIN; LYSINE-4; PATTERN; K4	Histones are subject to a wide variety of post-translational modifications that play a central role in gene activation and silencing. We have used histone modification-specific antibodies to demonstrate that two histone modifications involved in gene activation, histone H3 acetylation and H3 lysine 4 methylation, are functionally linked. This interaction, in which the extent of histone H3 acetylation determines both the abundance and the "degree" of H3K4 methylation, plays a major role in the epigenetic response to histone deacetylase inhibitors. A combination of in vivo knockdown experiments and in vitro methyltransferase assays shows that the abundance of H3K4 methylation is regulated by the activities of two opposing enzyme activities, the methyltransferase MLL4, which is stimulated by acetylated substrates, and a novel and as yet unidentified H3K4me3 demethylase.	Univ Birmingham, Inst Biomed Res, Med Sch, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Birmingham; University of Cambridge	Turner, BM (corresponding author), Univ Birmingham, Inst Biomed Res, Med Sch, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England.	b.m.turner@bham.ac.uk		Hollfelder, Florian/0000-0002-1367-6312	Biotechnology and Biological Sciences Research Council [G20017] Funding Source: Medline; Medical Research Council [G0300332] Funding Source: Medline; MRC [G0300332] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; COVAULT J, 1980, J BIOL CHEM, V255, P9110; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; HENDZEL MJ, 1991, BIOCHEM J, V273, P753, DOI 10.1042/bj2730753; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819	32	154	156	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4408	4416		10.1074/jbc.M606773200	http://dx.doi.org/10.1074/jbc.M606773200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166833	hybrid			2022-12-27	WOS:000244482000021
J	Schleicher, E; Hitomi, K; Kay, CWM; Getzoff, ED; Todo, T; Weber, S				Schleicher, Erik; Hitomi, Kenichi; Kay, Christopher W. M.; Getzoff, Elizabeth D.; Todo, Takeshi; Weber, Stefan			Electron nuclear double resonance differentiates complementary roles for active site histidines in (6-4) photolyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; PARAMAGNETIC-RESONANCE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; SOLVENT POLARITY; FLAVIN COFACTOR; SPIN RESONANCE; X-BAND; SPECTROSCOPY	(6-4) photolyase catalyzes the light-dependent repair of UV-damaged DNA containing (6-4) photoproducts. Blue light excitation of the enzyme generates the neutral FAD radical, FADH(center dot), which is believed to be transiently formed during the enzymatic DNA repair. Here (6-4) photolyase has been examined by optical spectroscopy, electron paramagnetic resonance, and pulsed electron nuclear double resonance spectroscopy. Characterization of selected proton hyperfine couplings of FADH(center dot), namely those of H-8 alpha and H-1', yields information on the micropolarity at the site where the DNA substrate is expected to bind. Shifts in the hyperfine couplings as a function of structural modifications induced by point mutations and pH changes distinguish the protonation states of two highly conserved histidines, His(354) and His(358), in Xenopus laevis (6-4) photolyase. These are proposed to catalyze formation of the oxetane intermediate that precedes light-initiated DNA repair. The results show that at pH 9.5, where the enzymatic repair activity is highest, His 358 is deprotonated, whereas His(354) is protonated. Hence, the latter is likely the proton donor that initiates oxetane formation from the (6-4) photoproduct.	Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; UCL, Dept Biol, London WC1E 6BT, England; Kyoto Univ, Radiat Biol Ctr, Kyoto 6068501, Japan	Free University of Berlin; Scripps Research Institute; Scripps Research Institute; University of London; University College London; Kyoto University	Weber, S (corresponding author), Free Univ Berlin, Fachbereich Phys, Arnimallee 14, D-14195 Berlin, Germany.	Stefan.Weber@physik.fu-berlin.de	Kay, Christopher William Michael/C-2467-2008; Schleicher, Erik/C-9951-2010; Weber, Stefan/G-6164-2010	Kay, Christopher William Michael/0000-0002-5200-6004; Schleicher, Erik/0000-0003-2953-050X				Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Byrdin M, 2004, BBA-BIOENERGETICS, V1655, P64, DOI 10.1016/j.bbabio.2003.07.001; CARRINGTON A, 1967, INTRO MAGNETIC RESON, P83; DAVIES ER, 1974, PHYS LETT A, VA 47, P1, DOI 10.1016/0375-9601(74)90078-4; Deisenhofer J, 2000, MUTAT RES-DNA REPAIR, V460, P143, DOI 10.1016/S0921-8777(00)00023-9; EDMONDSON DE, 1983, TOP CURR CHEM, V108, P109; EKER APM, 1990, J BIOL CHEM, V265, P8009; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; FASANELL.EL, 1969, P NATL ACAD SCI USA, V62, P299, DOI 10.1073/pnas.62.2.299; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Garcia JI, 2002, J PHYS CHEM A, V106, P4729, DOI 10.1021/jp014696; HEELIS PF, 1990, BIOCHEMISTRY-US, V29, P5694, DOI 10.1021/bi00476a008; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; JORDAN SP, 1988, BIOCHEMISTRY-US, V27, P8915, DOI 10.1021/bi00425a007; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; Kato R, 1997, J BACTERIOL, V179, P6499, DOI 10.1128/jb.179.20.6499-6503.1997; Kay C.W.M., 2002, ELECT PARAMAGNETIC R, V18, P222; Kay CWM, 2005, MAGN RESON CHEM, V43, pS96, DOI 10.1002/mrc.1667; Kay CWM, 2003, J BIOL CHEM, V278, P10973, DOI 10.1074/jbc.M205509200; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; KHRAMTSOV VV, 1982, CHEM PHYS LETT, V91, P69, DOI 10.1016/0009-2614(82)87035-8; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; KIM ST, 1994, J BIOL CHEM, V269, P8535; KNAUER BR, 1976, J AM CHEM SOC, V98, P4395, DOI 10.1021/ja00431a010; KURRECK H, 1984, J AM CHEM SOC, V106, P737, DOI 10.1021/ja00315a048; Li J, 2006, J PHYS CHEM B, V110, P16724, DOI 10.1021/jp062998b; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Medina M, 1999, BIOPHYS J, V77, P1712, DOI 10.1016/S0006-3495(99)77017-7; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; PAYNE G, 1987, BIOCHEMISTRY-US, V26, P7121, DOI 10.1021/bi00396a038; SANCAR A, 1984, J MOL BIOL, V172, P223, DOI 10.1016/S0022-2836(84)80040-6; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; SANCAR GB, 1987, J BIOL CHEM, V262, P15457; Saracino GAA, 2002, J PHYS CHEM A, V106, P10700, DOI 10.1021/jp026492e; Schelvis JPM, 2003, J PHYS CHEM B, V107, P12352, DOI 10.1021/jp034209l; Schwartz RN, 1997, J PHYS CHEM B, V101, P8735, DOI 10.1021/jp970555p; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STONE EW, 1962, J CHEM PHYS, V37, P1326, DOI 10.1063/1.1733281; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Todo T, 1997, NUCLEIC ACIDS RES, V25, P764, DOI 10.1093/nar/25.4.764; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Weber S, 2005, CHEMPHYSCHEM, V6, P292, DOI 10.1002/cphc.200400377; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; Weber S, 2001, BIOPHYS J, V81, P1195, DOI 10.1016/S0006-3495(01)75777-3; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m; WILLIAMSSMITH DL, 1977, BIOCHEM J, V167, P593, DOI 10.1042/bj1670593; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580	54	69	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4738	4747		10.1074/jbc.M604734200	http://dx.doi.org/10.1074/jbc.M604734200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164245	hybrid			2022-12-27	WOS:000244482000055
J	Stephens, JL; Lee, SH; Paul, KS; Englund, PT				Stephens, Jennifer L.; Lee, Soo Hee; Paul, Kimberly S.; Englund, Paul T.			Mitochondrial fatty acid synthesis in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-CARRIER PROTEIN; VARIANT SURFACE GLYCOPROTEIN; NEUROSPORA-CRASSA MITOCHONDRIA; NADH-UBIQUINONE OXIDOREDUCTASE; 2-ENOYL THIOESTER REDUCTASES; LIPOATE BIOSYNTHETIC LOCUS; BLOOD-STREAM FORMS; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; ESCHERICHIA-COLI	Whereas other organisms utilize type I or type II synthases to make fatty acids, trypanosomatid parasites such as Trypanosoma brucei are unique in their use of a microsomal elongase pathway (ELO) for de novo fatty acid synthesis (FAS). Because of the unusual lipid metabolism of the trypanosome, it was important to study a second FAS pathway predicted by the genome to be a type II synthase. We localized this pathway to the mitochondrion, and RNA interference (RNAi) or genomic deletion of acyl carrier protein (ACP) and beta-ketoacyl-ACP synthase indicated that this pathway is likely essential for bloodstream and procyclic life cycle stages of the parasite. In vitro assays show that the largest major fatty acid product of the pathway is C16, whereas the ELO pathway, utilizing ELOs 1, 2, and 3, synthesizes up to C18. To demonstrate mitochondrial FAS in vivo, we radiolabeled fatty acids in cultured procyclic parasites with [C-14]pyruvate or [C-14]threonine, either of which is catabolized to [C-14]acetyl-CoA in the mitochondrion. Although some of the [C-14]acetyl-CoA may be utilized by the ELO pathway, a striking reduction in radiolabeled fatty acids following ACP RNAi confirmed that it is also consumed by mitochondrial FAS. ACP depletion by RNAi or gene knockout also reduces lipoic acid levels and drastically decreases protein lipoylation. Thus, octanoate (C8), the precursor for lipoic acid synthesis, must also be a product of mitochondrial FAS. Trypanosomes employ two FAS systems: the unconventional ELO pathway that synthesizes bulk fatty acids and a mitochondrial pathway that synthesizes specialized fatty acids that are likely utilized intramitochondrially.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Englund, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	penglund@jhmi.edu	Paul, Kimberly/AAO-4275-2020; Lee, Soo Hee/E-9494-2012	Guler, Jennifer/0000-0001-6301-4563	NIAID NIH HHS [AI21334] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Boesen CC, 2000, PROTEIN EXPRES PURIF, V20, P98, DOI 10.1006/prep.2000.1306; Bowman I.B.R., 1976, P435; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRUN R, 1979, ACTA TROP, V36, P289; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Cronan JE, 2006, CELL, V126, P641, DOI 10.1016/j.cell.2006.08.001; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; DIXON H, 1971, COMP BIOCHEM PHYSIOL, V39, P247, DOI 10.1016/0305-0491(71)90168-4; DOERING TL, 1993, J BIOL CHEM, V268, P9215; DURIEUX PO, 1991, MOL BIOCHEM PARASIT, V45, P19, DOI 10.1016/0166-6851(91)90023-Y; EFFRON PN, 1993, MOL BIOCHEM PARASIT, V59, P191, DOI 10.1016/0166-6851(93)90217-L; FAIRLAMB AH, 1992, MOL BIOCHEM PARASIT, V53, P223, DOI 10.1016/0166-6851(92)90024-E; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; GILBERT RJ, 1983, COMP BIOCHEM PHYS B, V74, P277, DOI 10.1016/0305-0491(83)90012-3; GILBERT RJ, 1984, COMP BIOCHEM PHYS B, V78, P595, DOI 10.1016/0305-0491(84)90104-4; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HAYDEN MA, 1992, J BIOL CHEM, V267, P9512; HERELD D, 1986, J BIOL CHEM, V261, P3813; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x; JACKMAN SA, 1990, EUR J BIOCHEM, V193, P91, DOI 10.1111/j.1432-1033.1990.tb19308.x; Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200; Jones SM, 2005, J MED CHEM, V48, P5932, DOI 10.1021/jm049067d; KLEIN RA, 1976, BIOCHEM SOC T, V4, P48, DOI 10.1042/bst0040048; KLEIN RA, 1982, MOL BIOCHEM PARASIT, V6, P93, DOI 10.1016/0166-6851(82)90068-8; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; LINSTEAD DJ, 1977, J GEN MICROBIOL, V101, P243, DOI 10.1099/00221287-101-2-243; MIKOLAJCZYK S, 1990, EUR J BIOCHEM, V187, P431, DOI 10.1111/j.1432-1033.1990.tb15322.x; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Motyka SA, 2006, J BIOL CHEM, V281, P18499, DOI 10.1074/jbc.M602880200; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Paul KS, 2004, EUKARYOT CELL, V3, P855, DOI 10.1128/EC.3.4.855-861.2004; Ragone G, 1999, MOL GEN GENET, V261, P690, DOI 10.1007/s004380050012; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; SHIMAKATA T, 1982, ARCH BIOCHEM BIOPHYS, V217, P144, DOI 10.1016/0003-9861(82)90488-X; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SULO P, 1993, J BIOL CHEM, V268, P17634; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; WEEKS G, 1968, J BIOL CHEM, V243, P1180; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yasuno R, 2004, J BIOL CHEM, V279, P8242, DOI 10.1074/jbc.M308894200; Young K, 2006, ANTIMICROB AGENTS CH, V50, P519, DOI 10.1128/AAC.50.2.519-526.2006; ZENSEN R, 1992, FEBS LETT, V310, P179, DOI 10.1016/0014-5793(92)81324-F; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang YM, 2004, LIPIDS, V39, P1055, DOI 10.1007/s11745-004-1330-3; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871	71	86	91	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4427	4436		10.1074/jbc.M609037200	http://dx.doi.org/10.1074/jbc.M609037200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166831	hybrid			2022-12-27	WOS:000244482000023
J	Jang, H; Choi, DE; Kim, H; Cho, EJ; Youn, HD				Jang, Hyonchol; Choi, Doo-Eun; Kim, Hyungsoo; Cho, Eun-Jung; Youn, Hong-Duk			Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE ENHANCER FACTOR-2; HISTONE H3; LYSINE-9 METHYLATION; DEACETYLASE; HP1; DIFFERENTIATION; DEMETHYLATION; CALCINEURIN; EXPRESSION; REGULATOR	Myocyte enhancer factor 2 ( MEF2) plays pivotal roles in various biological processes, and its transcriptional activity is regulated by histone acetylation/deacetylation enzymes in a calcium-dependent fashion. A calcineurin-binding protein 1 ( Cabin1) has been shown to participate in repression of MEF2 by recruiting mSin3 and its associated histone deacetylases. Here, we report that histone methylation also takes a part in Cabin1-mediated repression of MEF2. Immunoprecipitate of Cabin1 complex can methylate histone H3 by association with SUV39H1. SUV39H1 increased Cabin1-mediated repression of MEF2 transcriptional activity in MEF2-targeting promoters. The SUV39H1 was revealed to bind to the 501-900-amino acid region of Cabin1, which was distinct from its histone deacetylase-recruiting domain. In addition, the Gal4-Cabin1-( 501-900) alone repressed a constitutively active Gal4-tk-promoter, indicating that Cabin1 recruits SUV39H1 and represses transcriptional activity. Finally, both SUV39H1 and Cabin1 were shown to bind on the MEF2 target promoter in a calcium-dependent manner. Thus, Cabin1 recruits chromatin-modifying enzymes, both histone deacetylases and a histone methyltransferase, to repress MEF2 transcriptional activity.	Seoul Natl Univ, Coll Med, Dept Biochem & Mol Bil, Canc Res Inst,Interdisciplinary Program Genet Eng, Seoul 110799, South Korea; Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU)	Youn, HD (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Bil, Canc Res Inst,Interdisciplinary Program Genet Eng, 28 Yongon Dong, Seoul 110799, South Korea.	hdyoun@snu.ac.kr	Jang, Hyonchol/F-6217-2012; Youn, Hong-Duk/J-2774-2012; Cho, Eun-Jung/AAR-1785-2020	Cho, Eun-Jung/0000-0002-6610-5329; Kim, Hyungsoo/0000-0002-8189-5939; Jang, Hyonchol/0000-0003-1436-457X				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Featherstone M, 2002, CURR OPIN GENET DEV, V12, P149, DOI 10.1016/S0959-437X(02)00280-0; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Kim H, 2003, CANCER RES, V63, P6135; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	45	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2007	282	15					11172	11179		10.1074/jbc.M611199200	http://dx.doi.org/10.1074/jbc.M611199200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LG	17172641	hybrid			2022-12-27	WOS:000245941500038
J	Lucarelli, D; Russo, S; Garman, E; Milano, A; Meyer-Klaucke, W; Pohl, E				Lucarelli, Debora; Russo, Santina; Garman, Elspeth; Milano, Anna; Meyer-Klaucke, Wolfram; Pohl, Ehmke			Crystal structure and function of the zinc uptake regulator FurB from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC UPTAKE REGULATOR; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; PSEUDOMONAS-AERUGINOSA; IRON HOMEOSTASIS; PROTEIN; VIRULENCE; ZUR; IDENTIFICATION; MECHANISMS	Members of the ferric/zinc uptake regulator (Fur/Zur) family are the central metal-dependent regulator proteins in many Gram-negative and -positive bacteria. They are responsible for the control of a wide variety of basic physiological processes and the expression of important virulence factors in human pathogens. Therefore, Fur has gathered significant interest as a potential target for novel antibiotics. Here we report the crystal structure of FurB from Mycobacterium tuberculosis at a resolution of 2.7 angstrom, and we present biochemical and spectroscopic data that allow us to propose the functional role of this protein. Although the overall fold of FurB with an N-terminal DNA binding domain and a C-terminal dimerization domain is conserved among the Zur/Fur family, large differences in the spatial arrangement of the two domains with respect to each other can be observed. The biochemical and spectroscopic analysis presented here reveals that M. tuberculosis FurB is Zn(II)-dependent and is likely to control genes involved in the bacterial zinc uptake. The combination of the structural, spectroscopic, and biochemical results enables us to determine the structural basis for functional differences in this important family of bacterial regulators.	Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; Univ Oxford, Lab Mol Biophys, Dept Biochem, Oxford OX1 3QU, England; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Pavia; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Meyer-Klaucke, W (corresponding author), Hamburg Outstn, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany.	wolfram@embl-hamburg.de; ehmke.pohl@psi.ch	Meyer-Klaucke, Wolfram/G-1148-2010; Pohl, Ehmke/I-2408-2012	Pohl, Ehmke/0000-0002-9949-4471; Garman, Elspeth/0000-0001-8329-5665	EPSRC [EP/D032210/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D032210/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015940, R01AI015940] Funding Source: NIH RePORTER; NIAID NIH HHS [AI15940] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akiyama S, 2004, J MOL BIOL, V341, P651, DOI 10.1016/j.jmb.2004.06.040; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Gelfand MS, 2006, CURR OPIN STRUC BIOL, V16, P420, DOI 10.1016/j.sbi.2006.04.001; GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P797; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Korbas M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2209954; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; Outten CE, 2001, BIOCHEMISTRY-US, V40, P10417, DOI 10.1021/bi0155448; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; PETTIFER RF, 1985, J APPL CRYSTALLOGR, V18, P404, DOI 10.1107/S0021889885010627; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Pohl E, 1999, J MOL BIOL, V285, P1145, DOI 10.1006/jmbi.1998.2339; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wisedchaisri G, 2004, J MOL BIOL, V342, P1155, DOI 10.1016/j.jmb.2004.07.083; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	51	107	111	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9914	9922		10.1074/jbc.M609974200	http://dx.doi.org/10.1074/jbc.M609974200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17213192	hybrid, Green Published			2022-12-27	WOS:000245421700066
J	Currie, JC; Fortier, S; Sina, A; Galipeau, J; Cao, J; Annabi, B				Currie, Jean-Christophe; Fortier, Simon; Sina, Asmaa; Galipeau, Jacques; Cao, Jian; Annabi, Borhane			MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells - A molecular link between pro-MMP-2 activation, chemotaxis, and cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; DISEASE TYPE 1B; GROWTH-FACTOR; 1-MATRIX METALLOPROTEINASE; MORPHOGENIC DIFFERENTIATION; SPHINGOSINE 1-PHOSPHATE; NEUTROPHIL DYSFUNCTION; APOPTOTIC DEATH; GENE-THERAPY	Bone marrow-derived stromal cells (BMSC) are avidly recruited by experimental vascularizing tumors, which implies that they must respond to tumor-derived growth factor cues. In fact, BMSC chemotaxis and cell survival are regulated, in part, by the membrane type-1 matrix metalloproteinase (MT1-MMP), an MMP also involved in pro-MMP-2 activation and in degradation of the extracellular matrix (ECM). Given that impaired chemotaxis was recently observed in bone marrow cells isolated from a glucose 6-phosphate transporter-deficient (G6PT(-/-)) mouse model, we sought to investigate the potential MT1-MMP/G6PT signaling axis in BMSC. We show that MT1-MMP-mediated activation of pro-MMP-2 by concanavalin A (ConA) correlated with an increase in the sub-G(1) cell cycle phase as well as with cell necrosis, indicative of a decrease in BMSC survival. BMSC isolated from Egr-1(-/-) mouse or MT1-MMP gene silencing in BMSC with small interfering RNA (siMT1-MMP) antagonized both the ConA-mediated activation of pro-MMP-2 and the induction of cell necrosis. Overexpression of recombinant full-length MT1-MMP triggered necrosis and this was signaled through the cytoplasmic domain of MT1-MMP. ConA inhibited both the gene and protein expression of G6PT, while overexpression of recombinant G6PT inhibited MT1-MMP-mediated pro-MMP-2 activation but could not rescue BMSC from ConA-induced cell necrosis. Cell chemotaxis in response to the tumorigenic growth factor sphingosine 1-phosphate was significantly abrogated in siMT1-MMP BMSC and in chlorogenic acid-treated BMSC. Altogether, we provide evidence for an MT1-MMP/G6PT signaling axis that regulates BMSC survival, ECM degradation, and mobilization. This may lead to optimized clinical applications that use BMSC as a platform for the systemic delivery of therapeutic or anti-cancer recombinant proteins in vivo.	Univ Quebec, Oncol Mol Lab, Dept Chim, Ctr Biomed, Montreal, PQ H3C 3P8, Canada; Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada; SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA	University of Quebec; University of Quebec Montreal; Lady Davis Institute; McGill University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Annabi, B (corresponding author), Univ Quebec, Oncol Mol Lab, Dept Chim, Ctr Biomed, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	annabi.borhane@uclam.ca	Galipeau, Jacques/R-9909-2019	Galipeau, Jacques/0000-0002-9374-1996; Fortier, Simon/0000-0002-3492-0759				Abraham R, 2005, J BIOL CHEM, V280, P34123, DOI 10.1074/jbc.M508155200; Annabi B, 2001, BIOCHEM J, V353, P547, DOI 10.1042/0264-6021:3530547; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; Annabi B, 2003, EXP HEMATOL, V31, P640, DOI 10.1016/S0301-472X(03)00090-0; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Bandyopadhyay G, 2004, BLOOD, V104, P2514, DOI 10.1182/blood-2003-11-4065; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Belkaid A, 2006, FEBS LETT, V580, P3746, DOI 10.1016/j.febslet.2006.05.071; Biswas MHU, 2006, BIOCHEM BIOPH RES CO, V348, P1145, DOI 10.1016/j.bbrc.2006.07.173; Calderwood S, 2001, BLOOD, V97, P376, DOI 10.1182/blood.V97.2.376; Cao J, 2005, THROMB HAEMOSTASIS, V93, P770, DOI 10.1160/TH04-08-0555; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; Chen LY, 2003, HUM MOL GENET, V12, P2547, DOI 10.1093/hmg/ddg263; Chen PY, 1998, DIABETES, V47, P874, DOI 10.2337/diabetes.47.6.874; Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798; Cottler-Fox Michele H, 2003, Hematology Am Soc Hematol Educ Program, P419; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; Ding L, 1999, GENE THER, V6, P1611, DOI 10.1038/sj.gt.3300973; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Gervasi DC, 1996, BIOCHEM BIOPH RES CO, V228, P530, DOI 10.1006/bbrc.1996.1694; Gingras D, 2000, BBA-MOL CELL RES, V1497, P341, DOI 10.1016/S0167-4889(00)00071-9; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Gumin J, 2006, CANCER RES, V66; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Hinoue A, 2005, ANAT REC PART A, V282A, P130, DOI 10.1002/ar.a.20150; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hurwitz DR, 1997, HUM GENE THER, V8, P137, DOI 10.1089/hum.1997.8.2-137; KIM M, 1993, GLYCOBIOLOGY, V3, P447, DOI 10.1093/glycob/3.5.447; Kim SY, 2006, J BIOL CHEM, V281, P28794, DOI 10.1074/jbc.M604964200; Kurukulasuriya R, 2003, CURR MED CHEM, V10, P123, DOI 10.2174/0929867033368556; Langlois S, 2005, EXP CELL RES, V307, P452, DOI 10.1016/j.yexcr.2005.04.007; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Leuzzi R, 2003, BLOOD, V101, P2381, DOI 10.1182/blood-2002-08-2576; McLaughlin N, 2006, J NEURO-ONCOL, V80, P111, DOI 10.1007/s11060-006-9171-8; McLennan SV, 2000, DIABETOLOGIA, V43, P642, DOI 10.1007/s001250051353; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Miyamori H, 2000, BIOCHEM BIOPH RES CO, V267, P796, DOI 10.1006/bbrc.1999.2050; Mohle R, 2001, ANN NY ACAD SCI, V938, P26; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Preaux AM, 2002, HEPATOLOGY, V36, P615, DOI 10.1053/jhep.2002.35279; Saadane N, 2001, CAN J PHYSIOL PHARM, V79, P533, DOI 10.1139/cjpp-79-6-533; Sabbadini RA, 2006, BRIT J CANCER, V95, P1131, DOI 10.1038/sj.bjc.6603400; Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shimada T, 2000, CLIN EXP METASTAS, V18, P179, DOI 10.1023/A:1006749501682; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Ueno H, 1997, CANCER RES, V57, P2055; Vaananen HK, 2005, ANN MED, V37, P469, DOI 10.1080/07853890500371957; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; van de Werve G, 2000, EUR J BIOCHEM, V267, P1533, DOI 10.1046/j.1432-1327.2000.01160.x; Van Meter TE, 2004, NEURO-ONCOLOGY, V6, P188, DOI 10.1215/S1152851703000486; Wang JS, 2000, J THORAC CARDIOV SUR, V120, P999, DOI 10.1067/mtc.2000.110250; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yiu WH, 2007, GENE THER, V14, P219, DOI 10.1038/sj.gt.3302869; Yu M, 1997, FEBS LETT, V412, P568, DOI 10.1016/S0014-5793(97)00849-1; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X; Zhang XY, 2002, MOL THER, V5, P555, DOI 10.1006/mthe.2002.0585; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121; Zucker S, 2004, EXP CELL RES, V293, P164, DOI 10.1016/j.yexcr.2003.10.007; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	69	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8142	8149		10.1074/jbc.M610894200	http://dx.doi.org/10.1074/jbc.M610894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229722	hybrid			2022-12-27	WOS:000245081000046
J	Hernandez-Pigeon, H; Jean, C; Charruyer, A; Haure, MJ; Baudouin, C; Charveron, M; Quillet-Mary, A; Laurent, G				Hernandez-Pigeon, Helene; Jean, Christine; Charruyer, Alexandra; Haure, Marie-Jose; Baudouin, Caroline; Charveron, Marie; Quillet-Mary, Anne; Laurent, Guy			UVA induces granzyme B in human keratinocytes through MIF - Implication in extracellular matrix remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; ACQUIRE CELLULAR CYTOTOXICITY; P38 MAP KINASE; SIGNALING PATHWAYS; LEUKEMIC-CELLS; HAIRLESS MICE; SKIN; ACTIVATION; PERFORIN; TRANSCRIPTION	In a previous study, we have described that UVB induces granzyme B (GrB) in human keratinocyte cells, and that confers potent cellular cytotoxicity against various cellular models, including immune cells (Hernandez-Pigeon, H., Jean, C., Charruyer, A., Hall M. J., Titeux, M., Tonasso, L., Quillet-Mary, A., Baudouin, C., Charveron, M., and Laurent, G. (2006) J. Biol. Chem. 281, 13525-13532). Herein, we have found that, in contrast to UVB, UVA failed to enhance keratinocyte cellular cytotoxicity but was still able to trigger GrB production. We show that GrB is accumulated through a p38 MAPK-dependent transcriptional mechanism stimulated by redox-dependent migration inhibitory factor release. Moreover, GrB purified from UVA-treated cellular extracts was found to degrade fibronectin in vitro. Treatment with antisense oligonucleotide directed against GrB resulted in the inhibition of UVA-induced cell detachment and cell death and facilitated cell migration through fibronectin and vitronectin matrix upon UVA exposure. Altogether, these results suggest another function for GrB in the context of the UV response. Indeed, combined with our previous study, it appears that, whereas this enzyme mediates keratinocyte cellular cytotoxicity following UVB irradiation, GrB supports the capacity of keratinocyte to degrade extracellular matrix components following UVA irradiation. UV-medlated GrB production may thus have important consequences in photoaging and photocarcinogenesis.	Ctr Hosp Univ Purpan, INSERM, U563, CPTP, F-31024 Toulouse 3, France; Hop Hotel Dieu, Lab Biol Cellulaire Cutanee, Inst Rech Pierre Fabre, CERPER, F-31025 Toulouse 3, France; CHU Purpan, Hematol Serv, F-31059 Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Jean, C (corresponding author), Ctr Hosp Univ Purpan, INSERM, U563, CPTP, Bat B,Pavillon Lefebvre,Pl Dr Baylac,BP 3028, F-31024 Toulouse 3, France.	christine.jean@toulouse.inserm.fr	jean, christine/P-2920-2014; QUILLET-MARY, Anne/H-4690-2013	jean, christine/0000-0002-6936-289X; QUILLET-MARY, Anne/0000-0002-1849-6388				Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Berthou C, 1997, J IMMUNOL, V159, P5293; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; BOYER B, 1992, J PHOTOCH PHOTOBIO B, V14, P247, DOI 10.1016/1011-1344(92)85102-Z; Bruno AP, 2000, BLOOD, V96, P1914, DOI 10.1182/blood.V96.5.1914.h8001914_1914_1920; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Guilloton F, 2005, LEUKEMIA, V19, P2206, DOI 10.1038/sj.leu.2403952; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McIlroy D, 2003, P NATL ACAD SCI USA, V100, P2562, DOI 10.1073/pnas.0437935100; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; Santos LL, 2004, J RHEUMATOL, V31, P1038; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Watanabe H, 2004, J BIOL CHEM, V279, P1676, DOI 10.1074/jbc.M303650200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969	24	52	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8157	8164		10.1074/jbc.M607436200	http://dx.doi.org/10.1074/jbc.M607436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224449	hybrid			2022-12-27	WOS:000245081000048
J	Deeb, TZ; Carland, JE; Cooper, MA; Livesey, MR; Lambert, JJ; Peters, JA; Hales, TG				Deeb, Tarek Z.; Carland, Jane E.; Cooper, Michelle A.; Livesey, Matthew R.; Lambert, Jeremy J.; Peters, John A.; Hales, Tim G.			Dynamic modification of a mutant cytoplasmic cysteine residue modulates the conductance of the human 5-HT3A receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; ANGSTROM RESOLUTION; AMINO-ACIDS; ION-CHANNEL; DETERMINANTS; LOOP; PORE	Structural models suggest that Are 36 lies within five cytoplasmic portals of the 5-HT3A receptor. We tested both the accessibility of residue 436 and the influence of its charge on single channel conductance (gamma) by substituting Arg(436) with Cys and examining the effect of methanethiosulfonate (MTS) reagents on gamma. Inclusion of positively charged 2-aminoethyl-MTS (MTSEA) within the electrode solution reduced gamma of 5-HT3A(R436C) receptors in outside-out patches from 7.8 +/- 0.5 to 5.0 +/- 0.5 picosiemens (pS). To increase gamma, we substituted Arg(436) by Cys in the 5-HT3A(R432Q,R440A) mutant, yielding the 5-HT3A(QCA) construct with a gamma of 17.7 +/- 0.4 pS. Modification of 5-HT3A(QCA) receptors by MTSEA or 2-(trimethylammonium) ethyl-MTS reduced gamma to 8.7 +/- 0.5 and 6.7 +/- 0.4 pS, respectively, both significantly below that of channels exposed to nonpolar propyl-MTS. Extracellular MTSEA, but not 2-(trimethylammonium) ethyl-MTS, crossed the membrane and in so doing slowly (tau=94s) reduced gamma. MTSEA more rapidly (tau=15s) reduced the gamma of 5-HT3A(QCA) receptors in inside-out patches, an effect reversed by the reducing agent dithiothreitol. Cys(436) modification by negatively charged 2-carboxyethyl-MTS and 2-sulfconatoethyl-MTS increased gamma to 23 +/- 1.0 and 26 +/- 0.7 pS, respectively. MTS reagents did not affect gamma values for 5-HT3A(QDA) constructs with Cys substituted for Lys(431) predicted to be outside the entrance to the portals. Collectively, the data demonstrate that the dynamic modification of the charge of a cytoplasmic residue regulates gamma, consistent with the existence of cytoplasmic portals that impose a rate-limiting barrier to ion conduction in Cys loop receptors.	George Washington Univ, Dept Physiol & Pharmacol, Med Ctr, Washington, DC 20037 USA; George Washington Univ, Dept Anesthesiol & Crit Care Med, Washington, DC 20037 USA; Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland	George Washington University; George Washington University; University of Dundee	Hales, TG (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Med Ctr, 2300 Eye St,NW, Washington, DC 20037 USA.	phmtgh@gwumc.edu		Livesey, Matthew/0000-0002-3441-7977; Carland, Jane/0000-0002-1456-876X	Wellcome Trust [073388] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELLELI D, 1995, MOL PHARM, V48, P1054; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hanna MC, 2000, J NEUROCHEM, V75, P240, DOI 10.1046/j.1471-4159.2000.0750240.x; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kaplan RS, 2000, J BIOL CHEM, V275, P12009, DOI 10.1074/jbc.275.16.12009; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	20	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6172	6182		10.1074/jbc.M607698200	http://dx.doi.org/10.1074/jbc.M607698200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200121	hybrid			2022-12-27	WOS:000244867200023
J	Gao, XP; Zhu, XD; Fu, J; Liu, QH; Frey, RS; Malik, AB				Gao, Xiao-Pei; Zhu, Xiangdong; Fu, Jian; Liu, Qinghui; Frey, Randall S.; Malik, Asrar B.			Blockade of class IA phosphoinositide 3-kinase in neutrophils prevents NADPH oxidase activation- and adhesion-dependent inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ADHERENT HUMAN NEUTROPHILS; FACTOR-ALPHA; RESPIRATORY BURST; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOTHELIAL-CELLS; HUMAN EOSINOPHILS; REACTIVE OXYGEN; TNF RECEPTOR; LUNG INJURY	We examined the role of class IA phosphoinositide 3-kinase (PI3K) in the regulation of activation of NADPH oxidase in PMNs and the mechanism of PMN-dependent lung inflammation and microvessel injury induced by the pro-inflammatory cytokine TNF-alpha. TNF-alpha stimulation of PMNs resulted in superoxide production that was dependent on CD11b/CD18-mediated PMN adhesion. Additionally, TNF-a induced the association of CD11b/CD18 with the NADPH oxidase subunit Nox2 (gp91(phox)) and phosphorylation of p47(phox), indicating the CD11b/CD18 dependence of NADPH oxidase activation. Transduction of wild-type PMNs with Delta p85 protein, a dominant-negative form of the class IA PI3K regulatory subunit, p85 alpha, fused to HIV-TAT (TAT-Delta p85) prevented (i) CD11b/CD18-dependent PMN adhesion, (ii) interaction of CD11b/CD18 with Nox2 and phosphorylation of p47(phox), and (iii) PMN oxidant production. Furthermore, studies in mice showed that i.v. infusion of TAT Delta p85 significantly reduced the recruitment of pMNs in lungs and increase in lung microvascular permeability induced by TNF-a. We conclude that class IA PI3K serves as a nodal point regulating CD11b/CD18-integrin-dependent PMN adhesion and activation of NADPH oxidase, and leads to oxidant production at sites of PMN adhesion, and the resultant lung microvascular injury in mice.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	abmalik@uic.edu		zhu, xiangdong/0000-0002-5627-8082; Malik, Asrar/0000-0002-8205-7128	NHLBI NIH HHS [HL77806, HL45638, HL46350, HL64573] Funding Source: Medline; NIAID NIH HHS [AI52109] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064573, R01HL046350, P01HL077806, R01HL045638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI052109] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Balazovich KJ, 1996, BLOOD, V88, P690, DOI 10.1182/blood.V88.2.690.bloodjournal882690; BARNARD JW, 1995, J IMMUNOL, V155, P4876; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Boulven I, 2006, J IMMUNOL, V176, P7621, DOI 10.4049/jimmunol.176.12.7621; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Dang PMC, 1999, J BIOL CHEM, V274, P20704, DOI 10.1074/jbc.274.29.20704; DAPINO P, 1993, CLIN EXP IMMUNOL, V94, P533; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Ding ZM, 1999, J IMMUNOL, V163, P5029; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kitagawa Y, 1997, J APPL PHYSIOL, V82, P1397, DOI 10.1152/jappl.1997.82.5.1397; Korchak HM, 2001, BIOCHEM BIOPH RES CO, V281, P651, DOI 10.1006/bbrc.2001.4406; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LAUDANNA C, 1993, BIOCHEM BIOPH RES CO, V190, P935, DOI 10.1006/bbrc.1993.1139; Lin P, 2005, J IMMUNOL, V174, P2981, DOI 10.4049/jimmunol.174.5.2981; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mukherjee G, 1998, ARCH BIOCHEM BIOPHYS, V357, P164, DOI 10.1006/abbi.1998.0807; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Myou S, 2003, J IMMUNOL, V171, P4399, DOI 10.4049/jimmunol.171.8.4399; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; RICHTER J, 1995, J IMMUNOL, V154, P4142; Sano M, 2005, AM J RESP CELL MOL, V33, P65, DOI 10.1165/rcmb.2005-0076OC; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Serrander L, 1999, BBA-MOL CELL RES, V1452, P133, DOI 10.1016/S0167-4889(99)00123-8; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vaporciyan Ara A., 1993, Biological Signals, V2, P126; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WINDSOR ACJ, 1993, J CLIN INVEST, V91, P1459, DOI 10.1172/JCI116351; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Yamamori T, 2004, BIOCHEM BIOPH RES CO, V316, P720, DOI 10.1016/j.bbrc.2004.02.108; Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108	49	41	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6116	6125		10.1074/jbc.M610248200	http://dx.doi.org/10.1074/jbc.M610248200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197441	hybrid			2022-12-27	WOS:000244867200017
J	MacDonald, MJ				MacDonald, Michael J.			Synergistic potent insulin release by combinations of weak secretagogues in pancreatic islets and INS-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR ISOTOPOMER ANALYSIS; PERIFUSED RAT ISLETS; BETA-CELLS; MITOCHONDRIAL METABOLISM; GLYCERALDEHYDE PHOSPHATE; METHYL SUCCINATE; GLUCOSE; SECRETION; PYRUVATE; DEHYDROGENASE	Insulin secretion by the beta cell depends on anaplerosis in which insulin secretagogues are metabolized by mitochondria into molecules that are most likely exported to the extramitochondrial space where they have signaling roles. However, very little is known about the products of anaplerosis. We discovered an experimental paradigm that has begun to provide new information about these products. When various intracellular metabolites were applied in combination to overnight-cultured rat or human pancreatic islets or to INS-1 832/13 cells, they interacted synergistically to strongly stimulate insulin release. When these same metabolites were applied individually to these cells, insulin stimulation was poor. Discerning the contributions of the individual compounds to metabolism has begun to allow us to dissect some of the pathways involved in insulin secretion, which was not possible from studying individual secretagogues. Monomethyl succinate (MMS) combined with a barely stimulatory concentration of a-ketoisocaproate (KIC) (2 mm) stimulated insulin release in cultured rat islets 18-fold (versus 21-fold for 16.7 mM glucose). MMS plus low glucose (2 mm) or pyruvate (5 mM) gave 11- and 9-fold stimulations. These agents also potentiated MMS-induced insulin release in fresh islets, and KIC plus MMS gave synergistic insulin release in cultured human islets. In INS-1 cells, neither MMS nor KIC (10 mm) was an insulin secretagogue, but when added together KIC (2 mm) and MMS stimulated insulin release 7-fold (versus 12-fold for glucose). In islets and INS-1 cells, conditions that stimulated insulin release caused large relative increases in acetoacetate, which is a precursor of pathways to short chain acyl-CoAs. Liquid chromatography-tandem mass spectrometry measurements of acetyl-CoA, acetoacetyl-CoA, succinyl-CoA, hydroxymethyl-glutaryl-CoA, and malonyl-CoA confirmed that they were increased by insulin secretagogues. The results suggest a new mechanism of insulin secretion in which anaplerosis increases short chain acyl-CoAs that have roles in insulin exocytosis.	Univ Wisconsin, Sch Med, Childrens Diabet Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), 3459 Med Sci Ctr, 1300 Univ Ave, Madison, WI 53706 USA.	mjmacdon@wisc.edu			NIDDK NIH HHS [DK28348] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; GRILL V, 1991, ENDOCRINOLOGY, V128, P2195, DOI 10.1210/endo-128-4-2195; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; HELLMAN B, 1974, ARCH BIOCHEM BIOPHYS, V162, P448, DOI 10.1016/0003-9861(74)90204-5; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; LENZEN S, 1979, AM J PHYSIOL, V236, pE391, DOI 10.1152/ajpendo.1979.236.4.E391; LIANG Y, 1991, DIABETES, V40, P327, DOI 10.2337/diabetes.40.3.327; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MACDONALD MJ, 1991, J BIOL CHEM, V266, P1335; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MACDONALD MJ, 1990, AM J PHYSIOL, V259, pE548, DOI 10.1152/ajpendo.1990.259.4.E548; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P400, DOI 10.1016/0003-9861(89)90123-9; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2004, MOL CELL BIOCHEM, V258, P201, DOI 10.1023/B:MCBI.0000012856.31929.91; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1988, DIABETES, V37, P997, DOI 10.2337/diabetes.37.7.997; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MACDONALD MJ, 1991, J BIOL CHEM, V266, P22392; MALAISSE WJ, 1993, AM J PHYSIOL, V264, P434; Reszko AE, 2003, J BIOL CHEM, V278, P34959, DOI 10.1074/jbc.M302013200; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; SENER A, 1978, BIOCHEM J, V176, P217, DOI 10.1042/bj1760217; ZAWALICH WS, 1993, DIABETES, V42, P843, DOI 10.2337/diabetes.42.6.843	39	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6043	6052		10.1074/jbc.M606652200	http://dx.doi.org/10.1074/jbc.M606652200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17210580	hybrid			2022-12-27	WOS:000244867200009
J	Stella, L; Pallottini, V; Moreno, S; Leoni, S; De Maria, F; Turella, P; Federici, G; Fabrini, R; Dawood, KF; Lo Bello, M; Pedersen, JZ; Ricci, G				Stella, Lorenzo; Pallottini, Valentina; Moreno, Sandra; Leoni, Silvia; De Maria, Francesca; Turella, Paola; Federici, Giorgio; Fabrini, Raffaele; Dawood, Kutayba F.; Lo Bello, Mario; Pedersen, Jens Z.; Ricci, Giorgio			Electrostatic association of glutathione transferase to the nuclear membrane - Evidence of an enzyme defense barrier at the nuclear envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASES; HUMAN-LIVER; PEROXIDASE ACTIVITY; NITRIC-OXIDE; CLASS-MU; EXPRESSION; LOCALIZATION; AGGREGATION; PRODUCTS; CARRIERS	The possible nuclear compartmentalization of glutathione S-transferase (GST) isoenzymes has been the subject of contradictory reports. The discovery that the dinitrosyl-diglutathionyl-iron complex binds tightly to Alpha class GSTs in rat hepatocytes and that a significant part of the bound complex is also associated with the nuclear fraction (Pedersen, J. Z., De Maria, F., Turella, P., Federici, G., Mattei, M., Fabrini, R., Dawood, K. F., Massimi, M., Caccuri, A. M., and Ricci, G. (2007) 1. BioL Chem. 282, 6364 - 637 1) prompted us to reconsi-der the nuclear localization of GSTs in these cells. Surprisingly, we found that a considerable amount of GSTs corresponding to 10% of the cytosolic pool is electrostatically associated with the outer nuclear membrane, and a similar quantity is compartmentalized inside the nucleus. Mainly Alpha class GSTs, in particular GSTA1-1, GSTA2-2, and GSTA3-3, are involved in this double modality of interaction. Confocal microscopy, immunofluorescence experiments, and molecular modeling have been used to detail the electrostatic association in hepatocytes and liposomes. A quantitative analysis of the membrane-bound Alpha GSTs suggests the existence of a multilayer assembly of these enzymes at the outer nuclear envelope that could represent an amazing novelty in cell physiology. The interception of potentially noxious compounds to prevent DNA damage could be the possible physiological role of the perinuclear and intranuclear localization of Alpha GSTs.	Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma 3, Dept Biol, I-00146 Rome, Italy; Univ Roma La Sapienza, Dept Cellular & Dev Biol, I-00185 Rome, Italy; Childrens Hosp Bambin Gesu, I-00165 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Roma Tre University; Sapienza University Rome; IRCCS Bambino Gesu; University of Rome Tor Vergata	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci, I-00133 Rome, Italy.	riccig@uniroma2.it	Pallottini, Valentina/AAA-3218-2021; Dawood, Kutayba/E-1505-2019; Stella, Lorenzo/A-7996-2010; Moreno, Sandra/D-4254-2014; Leoni, Silvia/AAS-2786-2021	Pallottini, Valentina/0000-0003-2511-6168; Dawood, Kutayba/0000-0002-0762-9632; Stella, Lorenzo/0000-0002-5489-7381; Ricci, Giorgio/0000-0002-7108-2846; moreno, sandra/0000-0002-1079-3222				ABEI M, 1989, BIOCHIM BIOPHYS ACTA, V995, P279, DOI 10.1016/0167-4838(89)90047-2; Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23; Alberts B, 2002, MOL BIOL CELL, P661; Albi E, 1997, CELL BIOCHEM FUNCT, V15, P181; ARNOLD K, 1990, CHEM PHYS LIPIDS, V55, P301, DOI 10.1016/0009-3084(90)90168-Q; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; BENNETT CF, 1986, J CELL BIOL, V102, P600, DOI 10.1083/jcb.102.2.600; BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; CAMPBELL JAH, 1991, CANCER, V67, P1608, DOI 10.1002/1097-0142(19910315)67:6<1608::AID-CNCR2820670623>3.0.CO;2-S; CARUSO F, 2004, COLLOIDS COLLOID ASS, P246; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; DELBOCCIO G, 1991, J BIOL CHEM, V266, P13777; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Estes DJ, 2005, COLLOID SURFACE B, V42, P115, DOI 10.1016/j.colsurfb.2005.01.016; Hurst R, 1998, BIOCHEM J, V332, P97, DOI 10.1042/bj3320097; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; MANNERVIK B, 1986, CHEM SCRIPTA, V26B, P281; MCCUSKER FM, 1990, GLUTATHIONE S TRANFE; MORGENSTERN R, 1983, FEBS LETT, V160, P264, DOI 10.1016/0014-5793(83)80979-X; MORGENSTERN R, 1985, J BIOL CHEM, V260, P3976; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricci G, 2005, J BIOL CHEM, V280, P26397, DOI 10.1074/jbc.M503295200; Rogers LK, 2002, TOXICOL SCI, V69, P279, DOI 10.1093/toxsci/69.1.279; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; ROZELL B, 1993, XENOBIOTICA, V23, P835, DOI 10.3109/00498259309059412; SANDEEP K, 2001, BIOCHEM J, V360, P345; SIMONS PC, 1977, ANAL BIOCHEM, V82, P334, DOI 10.1016/0003-2697(77)90169-5; Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200; SOBOLL S, 1995, BIOCHEM J, V311, P889, DOI 10.1042/bj3110889; Stella L, 2004, BIOPHYS J, V86, P936, DOI 10.1016/S0006-3495(04)74169-7; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; STOCKMAN PK, 1987, BIOCHEM J, V244, P55, DOI 10.1042/bj2440055; Turella P, 2005, CANCER RES, V65, P3751, DOI 10.1158/0008-5472.CAN-04-3903; Turella P, 2006, J BIOL CHEM, V281, P23725, DOI 10.1074/jbc.M604372200; VIRTANEN I, 1978, CELL BIOL INT REP, V2, P33, DOI 10.1016/0309-1651(78)90082-6; YEH HI, 1995, BIOCHEM J, V308, P69, DOI 10.1042/bj3080069	41	36	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6372	6379		10.1074/jbc.M609906200	http://dx.doi.org/10.1074/jbc.M609906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197701	hybrid			2022-12-27	WOS:000244867200044
J	Tao, JC; Wang, HY; Malbon, CC				Tao, Jiangchuan; Wang, Hsien-yu; Malbon, Craig C.			Src docks to A-kinase anchoring protein gravin, regulating beta 2-adrenergic receptor resensitization and recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTORS; AGONIST-INDUCED DESENSITIZATION; TYROSINE KINASE; BETA(2)-ADRENERGIC RECEPTOR; C-SRC; SIGNALING COMPLEXES; MEMBRANE INTERACTIONS; COUPLED RECEPTORS; LINKED RECEPTORS; AKAP250 GRAVIN	Gravin (AKAP12) is a membrane-associated scaffold that provides docking for protein kinases, phosphatases, and adaptor molecules obligate for resensitization and recycling of beta(2)-adrenergic receptors. Gravin binds to the cell membrane in a Ca2+ sensitive manner and to receptors through well characterized protein-protein interactions. Although the interaction of serine/threonine, cyclic AMP-dependent protein kinase with protein kinase A-anchoring proteins is well described and involves a kinase regulatory subunit binding domain in the C terminus of these proteins, far less is known about tyrosine kinase docking to members of this family of scaffolds. The non-receptor-tyrosine kinase Src regulates resensitization of beta(2)-adrenergic receptors and docks to gravin. Gravin displays nine proline-rich domains distributed throughout the molecule. One class I ligand for Src homology domain 3 docking, found in the N terminus ((RXPXXP15)-R-10) of gravin, is shown to bind Src. Binding of Src to gravin activates the intrinsic tyrosine kinase of Src. Mutagenesis/deletion of the class I ligand (P15A,P16A) on the N terminus of gravin abolishes both the docking of Src to gravin as well as the receptor resensitization and recycling catalyzed by gravin. The Src-binding peptide-(1-51) of gravin behaves as a dominant-negative for AKAP gravin regulation of receptor resensitization/recycling. The tyrosine kinase Src plays an essential role in the AKAP gravin-mediated receptor resensitization and recycling, an essential aspect of receptor biology.	SUNY Stony Brook, Sch Med, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA; SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Hlth Sci Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA.	craig@pharm.sunysb.edu	malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK25410, T32 DK007521] Funding Source: Medline; NIGMS NIH HHS [GM69375] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025410, T32DK007521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069375] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Benovic Jeffrey L., 2002, Journal of Allergy and Clinical Immunology, V110, pS229, DOI 10.1067/mai.2002.129370; BUSHMAN WA, 1990, P NATL ACAD SCI USA, V87, P7462, DOI 10.1073/pnas.87.19.7462; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; DELAVIERKLUTCHKO C, 1984, FEBS LETT, V169, P151, DOI 10.1016/0014-5793(84)80308-7; Fan GF, 2001, J BIOL CHEM, V276, P24005, DOI 10.1074/jbc.M011199200; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; Karoor V, 1998, Adv Pharmacol, V42, P425; Karoor V, 1996, PROG NEUROBIOL, V48, P555, DOI 10.1016/0301-0082(96)00004-4; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Ma YC, 2002, CELL MOL LIFE SCI, V59, P456, DOI 10.1007/s00018-002-8438-2; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Shih ML, 1998, CELL SIGNAL, V10, P575, DOI 10.1016/S0898-6568(97)00195-2; Shih ML, 1996, J BIOL CHEM, V271, P21478, DOI 10.1074/jbc.271.35.21478; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Shumay E, 2004, J CELL SCI, V117, P593, DOI 10.1242/jcs.00890; Shumay E, 2002, MOL BIOL CELL, V13, P3943, DOI 10.1091/mbc.E02-03-0174; Streb JW, 2005, J BIOL CHEM, V280, P28007, DOI 10.1074/jbc.M414017200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; WANG HY, 1991, INT J BIOCHEM, V23, P7; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	42	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6597	6608		10.1074/jbc.M608927200	http://dx.doi.org/10.1074/jbc.M608927200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200117	hybrid			2022-12-27	WOS:000244867200069
J	Yamashita, T; Nakamaru-Ogiso, E; Miyoshi, H; Matsuno-Yagi, A; Yagi, T				Yamashita, Tetsuo; Nakamaru-Ogiso, Eiko; Miyoshi, Hideto; Matsuno-Yagi, Akemi; Yagi, Takao			Roles of bound quinone in the single subunit NADH-quinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTENONE-INSENSITIVE NADH; COMPLEX-I DEFECTS; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; INTERNAL NADH; UBIQUINONE OXIDOREDUCTASE; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-DEHYDROGENASE; PLANT-MITOCHONDRIA; ELECTRON-TRANSFER	To understand the biochemical basis for the function of the rotenone-insensitive internal NADH-quinone (ID) oxidoreductase (Ndil), we have overexpressed mature Ndi1- in Escherichia coli membranes. The Ndil purified from the membranes contained one FAD and showed enzymatic activities comparable with the original Ndil isolated from Saccharomyces cerevisiae. When extracted with Triton X-100, the isolated Ndil did not contain Q. The Q-bound form was easily reconstituted by incubation of the Q-free Ndil enzyme with ubiquinone-6. We compared the properties of Q-bound Ndil enzyme with those of Q-free Ndil enzyme, with higher activity found in the Q-bound enzyme. Although both are inhibited by low concentrations of ACO-11 (IC50 = 0.2 mu m), the inhibitory mode of ACO-11 on Q-bound Ndil was distinct from that of Q-free Ndil. The bound Q was slowly released from Ndil by treatment with NADH or dithionite under anaerobic conditions. This release of Q was prevented when Ndil was kept in the reduced state by NADH. When Ndil was incorporated into bovine heart: submitochondrial particles, the Q-bound form, but not the Q-free form, established the NADH-linked respiratory activity, which was insensitive to piericidin A but inhibited by KCN. Furthermore, Ndil produces H2O2 as isolated regardless of the presence of bound Q, and this H2O2 was eliminated when the Q-bound Ndil, but not the Q-free Ndil, was incorporated into submitochondrial particles. The data suggest that Ndil bears at least two distinct Q sites: one for bound Q and the other for catalytic Q.	Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Scripps Research Institute; Kyoto University	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, MEM 256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Tetsuo, Yamashita/0000-0002-4076-991X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM033712] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Bjorklof K, 2000, FEBS LETT, V467, P105, DOI 10.1016/S0014-5793(00)01130-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; JAWOROWSKI A, 1981, BIOCHEMISTRY-US, V20, P3621, DOI 10.1021/bi00515a049; Kerscher SJ, 1999, J CELL SCI, V112, P2347; Kitajima-Ihara T, 1998, FEBS LETT, V421, P37, DOI 10.1016/S0014-5793(97)01533-0; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MASSEY V, 1963, BIOCHEM Z, V338, P474; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Menz RI, 1996, J BIOL CHEM, V271, P23117, DOI 10.1074/jbc.271.38.23117; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; MEUNIER B, 1995, BIOCHEMISTRY-US, V34, P1076, DOI 10.1021/bi00003a044; Miyoshi H, 1999, J BIOCHEM, V125, P138, DOI 10.1093/oxfordjournals.jbchem.a022250; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nantapong N, 2005, BIOSCI BIOTECH BIOCH, V69, P149, DOI 10.1271/bbb.69.149; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Romagnoli S, 1996, BIOCHEM MOL BIOL INT, V39, P671; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schnermann MJ, 2006, J AM CHEM SOC, V128, P11799, DOI 10.1021/ja0632862; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Velazquez I, 2001, ARCH BIOCHEM BIOPHYS, V389, P7, DOI 10.1006/abbi.2001.2293; VIOLA RE, 1982, BIOCHEMISTRY-US, V21, P1295, DOI 10.1021/bi00535a029; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; YAGI T, 2004, RESP ARCHAEA BACTERI, P15; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	45	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6012	6020		10.1074/jbc.M610646200	http://dx.doi.org/10.1074/jbc.M610646200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200125	hybrid			2022-12-27	WOS:000244867200006
J	Casciola-Rosen, L; Garcia-Calvo, M; Bull, HG; Becker, JW; Hines, T; Thornberry, NA; Rosen, A				Casciola-Rosen, Livia; Garcia-Calvo, Margarita; Bull, Herbert G.; Becker, Joseph W.; Hines, Tonie; Thornberry, Nancy A.; Rosen, Antony			Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; MEDIATED CYTOTOXICITY; LYMPHOCYTE PROTEASE; CASPASE ACTIVATION; DNA FRAGMENTATION; DIRECT CLEAVAGE; KEY MEDIATORS; APOPTOSIS; SUBSTRATE	Granzyme B is an important mediator of cytotoxic lymphocyte granule-induced death of target cells, accomplishing this through cleavage of Bid and cleavage and activation of caspases as well as direct cleavage of downstream substrates. Significant controversy exists regarding the primary pathways used by granzyme B to induce cell death, perhaps arising from the use of different protease/substrate combinations in different studies. The primary sequence of human, rat, and mouse granzymes B is well conserved, and the substrate specificity and crystal structure of the human and rat proteases are extremely similar. Although little is known about the substrate specificity of mouse granzyme B, recent studies suggest that it may differ significantly from the human protease. In these studies we show that the specificities of human and mouse granzymes B differ significantly. Human and mouse granzyme B cleave species-specific procaspase-3 more efficiently than the unmatched substrates. The distinct specificities of human and mouse granzyme B highlight a previously unappreciated requirement for Asp(192) in the acquisition of catalytic activity upon cleavage of procaspase-3 at Asp(175). Although human granzyme B efficiently cleaves human or mouse Bid, these substrates are highly resistant to cleavage by the mouse protease, strongly indicating that the Bid pathway is not a major primary mediator of the effects of mouse granzyme B. These studies provide important insights into the substrate specificity and function of the granzyme B pathway in different species and highlight that caution is essential when designing and interpreting experiments with different forms of granzyme B.	Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21224 USA; Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21224 USA; Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21224 USA; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Merck & Company	Casciola-Rosen, L (corresponding author), Johns Hopkins Univ, Dept Med, Sch Med, Bayview Campus,Mason F Lord Bldg,Ctr Tower,Suite, Baltimore, MD 21224 USA.	lcr@jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 56091] Funding Source: Medline; NIAMS NIH HHS [AR 44684] Funding Source: Medline; NIDCR NIH HHS [DE 12354] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Bots M, 2006, IMMUNOL CELL BIOL, V84, P79, DOI 10.1111/j.1440-1711.2005.01417.x; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Browne KA, 2000, J BIOL CHEM, V275, P39262, DOI 10.1074/jbc.C000622200; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Estebanez-Perpina E, 2000, BIOL CHEM, V381, P1203, DOI 10.1515/BC.2000.148; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; Rotonda J, 2001, CHEM BIOL, V8, P357, DOI 10.1016/S1074-5521(01)00018-7; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Scovassi AI, 1999, MOL CELL BIOCHEM, V199, P125; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Thiery J, 2003, J IMMUNOL, V170, P5919, DOI 10.4049/jimmunol.170.12.5919; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Waugh SM, 2000, NAT STRUCT BIOL, V7, P762, DOI 10.1038/78992; Willoughby CA, 2002, BIOORG MED CHEM LETT, V12, P2197, DOI 10.1016/S0960-894X(02)00363-3	37	77	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4545	4552		10.1074/jbc.M606564200	http://dx.doi.org/10.1074/jbc.M606564200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179148	hybrid			2022-12-27	WOS:000244482000036
J	Liebscher, M; Jahreis, G; Lucke, C; Grabley, S; Raina, S; Schiene-Fischer, C				Liebscher, Markus; Jahreis, Guenther; Luecke, Christian; Grabley, Susanne; Raina, Satish; Schiene-Fischer, Cordelia			Fatty acyl benzamido antibacterials based on inhibition of DnaK-catalyzed protein folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAK; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE SYSTEM; TRIGGER FACTOR; SUBSTRATE-BINDING; BACTERIAL HSP70; GRPE; MACHINERY; SUSCEPTIBILITY; REPLICATION	We have reported that the hsp70 chaperone DnaK from Escherichia coli might assist protein folding by catalyzing the cis/trans isomerization of secondary amide peptide bonds in unfolded or partially folded proteins. In this study a series of fatty acylated benzamido inhibitors of the cis/trans isomerase activity of DnaK was developed and tested for antibacterial effects in E coli MC4100 cells. N-alpha-[Tetradecanoyl-(4-aminomethylbenzoyl)]-L-asparagine is the most effective antibacterial with a minimal inhibitory concentration of 100 +/- 20 mu g/ml. The compounds were shown to compete with fluorophore-labeled sigma(32)-derived peptide for the peptide binding site of DnaK and to increase the fraction of aggregated proteins in heat-shocked bacteria. Despite its inability to serve as a folding helper in vivo a DnaK-inhibitor complex was still able to sequester an unfolded protein in vitro. Structure activity relationships revealed a distinct dependence of DnaK-assisted refolding of luciferase on the fatty acyl chain length, whereas the minimal inhibitory concentration was most sensitive to the structural nature of the benzamido core. We conclude that the isomerase activity of DnaK is a major survival factor in the heat shock response of bacteria and that small molecule inhibitors can lead to functional inactivation of DnaK and thus will display antibacterial activity.	Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; Univ Geneva, Ctr Med, Dept Biochim Med, CH-1211 Geneva 4, Switzerland	Max Planck Society; Hans Knoll Institute (HKI); University of Geneva	Schiene-Fischer, C (corresponding author), Max Planck Res Unit Enzymol Prot Folding, Weinbergweg 22, D-06120 Halle, Germany.	schiene@enzyme-halle.mpg.de	Raina, Satish/AAU-9550-2021	Raina, Satish/0000-0003-3175-4932				Amsterdam D, 1996, ANTIBIOTICS LAB MED, V4, P52; Apfel CM, 2001, ANTIMICROB AGENTS CH, V45, P1058, DOI 10.1128/AAC.45.4.1058-1064.2001; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; CRAIG DA, 1993, TRENDS PHARMACOL SCI, V14, P89, DOI 10.1016/0165-6147(93)90070-Z; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Fischer G, 2006, MOL MICROBIOL, V61, P1388, DOI 10.1111/j.1365-2958.2006.05349.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GARBE TR, 1992, EXPERIENTIA, V48, P635, DOI 10.1007/BF02118308; Hanawa T, 1999, CELL STRESS CHAPERON, V4, P118, DOI 10.1379/1466-1268(1999)004<0118:TLMDCI>2.3.CO;2; HANCOCK REW, 1988, EUR J CLIN MICROBIOL, V7, P713, DOI 10.1007/BF01975036; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Kluck CJ, 2002, J BIOL CHEM, V277, P41060, DOI 10.1074/jbc.M206520200; Kohler S, 1996, MOL MICROBIOL, V20, P701, DOI 10.1111/j.1365-2958.1996.tb02510.x; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; McCarty JS, 1996, J MOL BIOL, V256, P829, DOI 10.1006/jmbi.1996.0129; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; ROCKABRAND D, 1995, J BACTERIOL, V177, P3695, DOI 10.1128/jb.177.13.3695-3703.1995; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schiene-Fischer C, 2002, BIOL CHEM, V383, P1865, DOI 10.1515/BC.2002.210; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; SPENCE J, 1990, J BACTERIOL, V172, P7157, DOI 10.1128/jb.172.12.7157-7166.1990; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takaya A, 2004, INFECT IMMUN, V72, P1364, DOI 10.1128/IAI.72.3.1364-1373.2004; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; THONUS IP, 1982, ANTIMICROB AGENTS CH, V22, P386, DOI 10.1128/AAC.22.3.386; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Vickery LE, 1997, PROTEIN SCI, V6, P1047, DOI 10.1002/pro.5560060511; Wolska KI, 2000, MICROB DRUG RESIST, V6, P119, DOI 10.1089/107662900419429; Yoshimune K, 2002, BIOCHEM BIOPH RES CO, V293, P1389, DOI 10.1016/S0006-291X(02)00403-5; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	46	26	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4437	4446		10.1074/jbc.M607667200	http://dx.doi.org/10.1074/jbc.M607667200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170117	hybrid			2022-12-27	WOS:000244482000024
J	Pan, ZQ; Rimando, AM; Baerson, SR; Fishbein, M; Duke, SO				Pan, Zhiqiang; Rimando, Agnes M.; Baerson, Scott R.; Fishbein, Mark; Duke, Stephen O.			Functional characterization of desaturases involved in the formation of the terminal double bond of an unusual 16 : 3 Delta(9,12,15) fatty acid isolated from Sorghum bicolor root hairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORGOLEONE; GENE; EXPRESSION; EXUDATE; STRATEGIES; INHIBITOR; DELTA-12; LOCATION; ENZYME	Sorgoleone, produced in root hair cells of sorghum (Sorghum bicolor), is likely responsible for much of the allelopathic properties of sorghum root exudates against broadleaf and grass weeds. Previous studies suggest that the biosynthetic pathway of this compound initiates with the synthesis of an unusual 16:3 fatty acid possessing a terminal double bond. The corresponding fatty acyl-CoA serves as a starter unit for polyketide synthases, resulting in the formation of 5-pentadecatrienyl resorcinol. This resorcinolic intermediate is then methylated by an S-adenosylmethionine-dependent O-methyltransferase and subsequently dihydroxylated, yielding the reduced (hydroquinone) form of sorgoleone. To characterize the corresponding enzymes responsible for the biosynthesis of the 16:3 fatty acyl-CoA precursor, we identified and cloned three putative fatty acid desaturases, designated SbDES1, SbDES2, and SbDES3, from an expressed sequence tag (EST) data base prepared from isolated root hairs. Quantitative real-time RT-PCR analyses revealed that these three genes were preferentially expressed in sorghum root hairs where the 16:2 and 16:3 fatty acids were exclusively localized. Heterologous expression of the cDNAs in Saccharomyces cerevisiae revealed that recombinant SbDES2 converted palmitoleic acid (16:1 Delta(9)) to hexadecadienoic acid (16:2 Delta(9,12)), and that recombinant SbDES3 was capable of converting hexadecadienoic acid into hexadecatrienoic acid (16:3 Delta(9,12,15)). Unlike other desaturases reported to date, the double bond introduced by SbDES3 occurred between carbons 15 and 16 resulting in a terminal double bond aliphatic chain. Collectively, the present results strongly suggest that these fatty acid desaturases represent key enzymes involved in the biosynthesis of the allelochemical sorgoleone.	USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA; Portland State Univ, Dept Biol, Portland, OR 97207 USA	United States Department of Agriculture (USDA); Portland State University	Pan, ZQ (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, POB 8048, University, MS 38677 USA.	zpan@msa-oxford.ars.usda.gov		Fishbein, Mark/0000-0003-3099-4387				Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Behrouzian B, 2002, CURR OPIN CHEM BIOL, V6, P577, DOI 10.1016/S1367-5931(02)00365-4; BROWSE J, 1993, J BIOL CHEM, V268, P16345; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Bucher M, 1997, PLANT MOL BIOL, V35, P497, DOI 10.1023/A:1005869717158; Burke D, 2000, METHODS YEAST GENETI, P103; CHANG M, 1986, J AM CHEM SOC, V108, P7858, DOI 10.1021/ja00284a074; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cordonnier-Pratt MM, 2004, COMP FUNCT GENOM, V5, P268, DOI 10.1002/cfg.399; Czarnota MA, 2003, INT J PLANT SCI, V164, P861, DOI 10.1086/378661; Czarnota MA, 2003, J CHEM ECOL, V29, P2073, DOI 10.1023/A:1025634402071; Czarnota MA, 2001, WEED TECHNOL, V15, P813, DOI 10.1614/0890-037X(2001)015[0813:MOALOP]2.0.CO;2; Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200; Domergue F, 2005, BIOCHEM J, V389, P483, DOI 10.1042/BJ20050111; Duke SO, 2002, J PESTIC SCI, V27, P298; Duke SO, 2003, TRENDS BIOTECHNOL, V21, P192, DOI 10.1016/S0167-7799(03)00056-8; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; EINHELLIG FA, 1993, J CHEM ECOL, V19, P369, DOI 10.1007/BF00993702; EINHELLIG FA, 1992, J CHEM ECOL, V18, P1, DOI 10.1007/BF00997160; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gonzalez VM, 1997, J AGR FOOD CHEM, V45, P1415, DOI 10.1021/jf960733w; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Horiguchi G, 2000, PLANT J, V24, P805, DOI 10.1046/j.1365-313x.2000.00925.x; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Kodama H, 1997, PLANT MOL BIOL, V33, P493, DOI 10.1023/A:1005726210977; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Martin CE, 2002, BIOCHEM SOC T, V30, P1080, DOI 10.1042/bst0301080; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; NETZLY DH, 1986, CROP SCI, V26, P775, DOI 10.2135/cropsci1986.0011183X002600040031x; NETZLY DH, 1988, WEED SCI, V36, P441, DOI 10.1017/S0043174500075172; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; RASMUSSEN JA, 1992, J CHEM ECOL, V18, P197, DOI 10.1007/BF00993753; Rimando AM, 1998, J NAT PROD, V61, P927, DOI 10.1021/np9800708; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Suga K, 2002, BIOSCI BIOTECH BIOCH, V66, P1314, DOI 10.1271/bbb.66.1314; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wallis JG, 2002, TRENDS BIOCHEM SCI, V27, P467, DOI 10.1016/S0968-0004(02)02168-0; Yang XH, 2004, J EXP BOT, V55, P2251, DOI 10.1093/jxb/erh252	47	30	35	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4326	4335		10.1074/jbc.M606343200	http://dx.doi.org/10.1074/jbc.M606343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178719	hybrid			2022-12-27	WOS:000244482000012
J	Naim, B; Brumfeld, V; Kapon, R; Kiss, V; Nevo, R; Reich, Z				Naim, Bracha; Brumfeld, Vlad; Kapon, Ruti; Kiss, Vladimir; Nevo, Reinat; Reich, Ziv			Passive and facilitated transport in nuclear pore complexes is largely uncoupled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; ARCHITECTURE; TRANSLOCATION; INHIBITION; BINDING; MACROMOLECULES; GLYCOPROTEINS; MECHANISMS; LOCATION	Nuclear pore complexes provide the sole gateway for the exchange of material between nucleus and cytoplasm of interphase eukaryotic cells. They support two modes of transport: passive diffusion of ions, metabolites, and intermediate-sized macromolecules and facilitated, receptor-mediated translocation of proteins, RNA, and ribonucleoprotein complexes. It is generally assumed that both modes of transport occur through a single diffusion channel located within the central pore of the nuclear pore complex. To test this hypothesis, we studied the mutual effects between transporting molecules utilizing either the same or different modes of translocation. We find that the two modes of transport do not interfere with each other, but molecules utilizing a particular mode of transport do hinder motion of others utilizing the same pathway. We therefore conclude that the two modes of transport are largely segregated.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Reich, Z (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ziv.reich@weizmann.ac.il						Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DABAUVALLE MC, 1988, EXP CELL RES, V174, P291, DOI 10.1016/0014-4827(88)90163-2; Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; Enss K, 2003, J MEMBRANE BIOL, V196, P147, DOI 10.1007/s00232-003-0632-0; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Feldherr CM, 1997, J CELL SCI, V110, P3065; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; GOLDBERG MW, 1993, J CELL SCI, V106, P261; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Kapon R, 2001, SINGLE MOL, V2, P85, DOI 10.1002/1438-5171(200107)2:2<85::AID-SIMO85>3.0.CO;2-6; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Nevo R., 2000, Single Molecules, V1, P109, DOI 10.1002/1438-5171(200006)1:2<109::AID-SIMO109>3.0.CO;2-O; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribbeck K, 1999, CURR BIOL, V9, P47, DOI 10.1016/S0960-9822(99)80046-3; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RIS H, 1991, EMSA B, V21, P54; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Rutherford SA, 1997, EXP CELL RES, V232, P146, DOI 10.1006/excr.1997.3487; Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com; Siebrasse JP, 2002, EMBO REP, V3, P887, DOI 10.1093/embo-reports/kvf171; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; STEVENS BJ, 1966, J CELL BIOL, V31, P55, DOI 10.1083/jcb.31.1.55; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WILKEN N, 1993, J CELL BIOL, V123, P1345, DOI 10.1083/jcb.123.6.1345; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	59	68	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3881	3888		10.1074/jbc.M608329200	http://dx.doi.org/10.1074/jbc.M608329200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17164246	hybrid			2022-12-27	WOS:000244481900052
J	Jackson, KA; Helston, RM; McKay, JA; O'Neill, ED; Mathers, JC; Ford, D				Jackson, Kelly A.; Helston, Rachel M.; McKay, Jill A.; O'Neill, Elaine D.; Mathers, John C.; Ford, Dianne			Splice variants of the human zinc transporter ZnT5 (SLC30A5) are differentially localized and regulated by zinc through transcription and mRNA stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DIETARY ZINC; ALKALINE-PHOSPHATASES; PEPTIDE TRANSPORTER; VERTEBRATE CELLS; FACTOR MTF-1; PROTEINS; RATS; COMPLEXES; MEMBRANE	Maintenance of cellular zinc homeostasis includes regulating the expression of cell membrane zinc transporters. Knowledge about the mechanisms underlying changes in mammalian zinc transporter mRNA abundance is poor. We demonstrated that when expressed in Chinese hamster ovary cells as N-terminal fusions to green fluorescent protein, two splice variants of ZnT5 adopt different subcellular locations ( either in the Golgi apparatus or throughout the cell, including at the plasma membrane) indicating discrete roles in cellular zinc homeostasis. We demonstrated, using a beta-galactosidase reporter gene, that both splice variants were expressed from a promoter region that was transcriptionally repressed by increased extracellular zinc ( 150 mu M compared with 3 mu M; similar to 40%) and by extracellular zinc depletion, using the chelator N, N, N', N'-tetrakis( 2- pyridylmethyl) ethylenediamine (similar to 20%). We mapped the zinc- responsive element to the region -154 to +50, relative to the predicted start of transcription, and showed that a consensus metal response element sequence (-410 to -404) was not responsible for these effects. Changes in ZnT5 mRNA abundance in Caco- 2 cells at different zinc concentrations were in parallel to the changes in promoter activity (similar to 40% reduction at 150 mu M zinc) but in the presence of actinomycin D, to prevent transcription, we observed a marked stabilization ( 1.7 - 2- fold accumulation over 24 h) of ZnT5 mRNA. We conclude that effects of zinc on ZnT5 transcription and mRNA stability act in opposition to balance mRNA abundance for cellular zinc homeostasis. To our knowledge, this is the first report that zinc affects the stability of a transcript with a direct role in cellular zinc homeostasis.	Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Ford, D (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	dianne.ford@ncl.ac.uk		Mathers, John/0000-0003-3406-3002; McKay, Jill Ann/0000-0002-2711-0301; Helston, Rachel/0000-0001-6022-6755; Jackson, Kelly/0000-0001-9116-3769	Biotechnology and Biological Sciences Research Council [D18271] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Blanchard RK, 2001, P NATL ACAD SCI USA, V98, P13507, DOI 10.1073/pnas.251532498; Blasie CA, 2002, BIOCHEMISTRY-US, V41, P15068, DOI 10.1021/bi026621h; Cousins RJ, 2003, P NATL ACAD SCI USA, V100, P6952, DOI 10.1073/pnas.0732111100; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P699, DOI 10.1016/j.bcp.2004.05.024; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; HELSTON RM, 2006, PLACENTA; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kim JR, 2002, ARCH BIOCHEM BIOPHYS, V397, P414, DOI 10.1006/abbi.2001.2691; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; TAYLOR GA, 1995, J CELL PHYSIOL, V162, P378, DOI 10.1002/jcp.1041620310; Tsui KH, 2006, INT J CANCER, V118, P609, DOI 10.1002/ijc.21411; Walker D, 1998, J PHYSIOL-LONDON, V507, P697, DOI 10.1111/j.1469-7793.1998.697bs.x; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587	29	76	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2007	282	14					10423	10431		10.1074/jbc.M610535200	http://dx.doi.org/10.1074/jbc.M610535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LB	17234632	hybrid			2022-12-27	WOS:000245941000033
J	Ballottari, M; Dall'Osto, L; Morosinotto, T; Bassi, R				Ballottari, Matteo; Dall'Osto, Luca; Morosinotto, Tomas; Bassi, Roberto			Contrasting behavior of higher plant photosystem I and II antenna systems during acclimation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC APPARATUS; ENERGY-DISSIPATION; LIGHT ENVIRONMENT; LOW-TEMPERATURE; PHOTOOXIDATIVE STRESS; ELECTRON-TRANSPORT; XANTHOPHYLL CYCLE; STATE TRANSITIONS	In this work we analyzed the photosynthetic apparatus in Arabidopsis thaliana plants acclimated to different light intensity and temperature conditions. Plants showed the ability to acclimate into different environments and avoid photoinhibition. When grown in high light, plants had a faster activation rate for energy dissipation (qE). This ability was correlated to higher accumulation levels of a specific photosystem II subunit, PsbS. The photosystem II antenna size was also regulated according to light exposure; smaller antenna size was observed in high light-acclimated plants with respect to low light plants. Different antenna polypeptides did not behave similarly, and Lhcb1, Lchb2, and Lhcb6 (CP24) are shown to undergo major levels of regulation, whereas Lhcb4 and Lhcb5 (CP29 and CP26) maintained their stoichiometry with respect to the reaction center in all growth conditions. The effect of acclimation on photosystem I antenna was different; in fact, the stoichiometry of any Lhca antenna proteins with respect to photosystem I core complex was not affected by growth conditions. Despite this stability in antenna stoichiometry, photosystem I light harvesting function was shown to be regulated through different mechanisms like the control of photosystem I to photosystem II ratio and the association or dissociation of Lhcb polypeptides to photosystem I.	Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; Univ Aix Marseille 2, Lab Genet & Biophys Plantes, F-13009 Marseille, France; Univ Padua, Dipartimento Biol, I-35131 Padua, Italy	University of Verona; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Str Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Morosinotto, Tomas/AAC-3188-2019; Dall'Osto, Luca/A-9384-2010; Ballottari, Matteo/N-1916-2019	Morosinotto, Tomas/0000-0002-0803-7591; Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446; Dall'Osto, Luca/0000-0001-9497-5156				ALLEN JF, 1992, TRENDS BIOCHEM SCI, V17, P12, DOI 10.1016/0968-0004(92)90418-9; ANDERSON JM, 1988, TRENDS BIOCHEM SCI, V13, P351, DOI 10.1016/0968-0004(88)90106-5; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; Bailey S, 2004, PLANTA, V218, P793, DOI 10.1007/s00425-003-1158-5; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; DAINESE P, 1992, RES PHOTOSYNTHESIS, V1, P287; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Davison PA, 2002, NATURE, V418, P203, DOI 10.1038/nature00861; Demmig-Adams B, 1998, PLANT CELL PHYSIOL, V39, P474, DOI 10.1093/oxfordjournals.pcp.a029394; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Finazzi G, 2004, P NATL ACAD SCI USA, V101, P12375, DOI 10.1073/pnas.0404798101; Garcia-Plazaola JI, 1999, PHYTOCHEM ANALYSIS, V10, P307, DOI 10.1002/(SICI)1099-1565(199911/12)10:6&lt;307::AID-PCA477&gt;3.0.CO;2-L; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gray GR, 1996, PLANT PHYSIOL, V110, P61, DOI 10.1104/pp.110.1.61; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; HURRY VM, 1994, PLANT PHYSIOL, V106, P983, DOI 10.1104/pp.106.3.983; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONG TY, 1984, PHOTOSYNTH RES, V5, P105, DOI 10.1007/BF00028524; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; LICHTENTHALER HK, 1982, PHYSIOL PLANTARUM, V56, P183, DOI 10.1111/j.1399-3054.1982.tb00322.x; Lindahl M, 1997, PHOTOSYNTH RES, V54, P227, DOI 10.1023/A:1005920730947; MAENPAA P, 1989, Z NATURFORSCH C, V44, P403; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OQUIST G, 1993, PLANT PHYSIOL, V101, P245, DOI 10.1104/pp.101.1.245; PETER GF, 1991, J BIOL CHEM, V266, P16745; Polle JEW, 2001, PLANT CELL PHYSIOL, V42, P482, DOI 10.1093/pcp/pce058; POLLOCK CJ, 1988, SYM SOC EXP BIOL, V42, P157; Rockholm DC, 1996, PLANT PHYSIOL, V110, P697, DOI 10.1104/pp.110.2.697; Rorat T, 2001, PHYSIOL PLANTARUM, V113, P72, DOI 10.1034/j.1399-3054.2001.1130110.x; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; SEEMANN JR, 1987, PLANT PHYSIOL, V84, P796, DOI 10.1104/pp.84.3.796; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Standfuss J, 2004, J BIOL CHEM, V279, P36884, DOI 10.1074/jbc.M402348200; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; WALTERS RG, 1994, PLANTA, V195, P248, DOI 10.1007/BF00199685; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	69	227	237	5	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8947	8958		10.1074/jbc.M606417200	http://dx.doi.org/10.1074/jbc.M606417200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17229724	hybrid			2022-12-27	WOS:000245780300041
J	Ghiorghi, YK; Zeller, KI; Dang, CV; Kaminski, PA				Ghiorghi, Yoan Konto; Zeller, Karen I.; Dang, Chi V.; Kaminski, P. Alexandre			The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5 '-monophosphate N-glycosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE; ACTIVE-SITE; LACTOBACILLUS-HELVETICUS; PYRIMIDINE NUCLEOTIDES; BLASTICIDIN-S; IDENTIFICATION; STREPTOMYCES; EXPRESSION; BIOSYNTHESIS; DEGRADATION	RCL is a c-Myc target with tumorigenic potential. Genome annotation predicted that RCL belonged to the N-deoxyribosyltransferase family. However, its putative relationship to this class of enzymes did not lead to its precise biochemical function. The purified native or N-terminal His-tagged recombinant rat RCL protein expressed in Escherichia coli exhibits the same enzyme activity, deoxynucleoside 5'-monophosphate N-glycosidase, never before described. dGMP appears to be the best substrate. RCL opens a new route in the nucleotide catabolic pathways by cleaving the N-glycosidic bond of deoxynucleoside 5'-monophosphates to yield two reaction products, deoxyribose 5-phosphate and purine or pyrimidine base. Biochemical studies show marked differences in the terms of the structure and catalytic mechanism between RCL and of its closest enzyme family neighbor, N-deoxyribosyltransferase. The reaction products of this novel enzyme activity have been implicated in purine or pyrimidine salvage, glycolysis, and angiogenesis, and hence are all highly relevant for tumorigenesis.	Inst Pasteur, Unite Chim Organ, CNRS, URA 2128, F-75724 Paris 15, France; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim Organ, CNRS, URA 2128, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	akaminsk@pasteur.fr	Dang, Chi/Y-3375-2019	Kaminski, Pierre Alexandre/0000-0001-9841-6837; Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [CA54197] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Anand R, 2004, BIOCHEMISTRY-US, V43, P2384, DOI 10.1021/bi035723k; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; Grochowski LL, 2006, CHEMBIOCHEM, V7, P957, DOI 10.1002/cbic.200600026; HOLGUINH.J, 1972, FEBS LETT, V20, P171, DOI 10.1016/0014-5793(72)80785-3; IMADA A, 1967, J GEN APPL MICROBIOL, V13, P267, DOI 10.2323/jgam.13.267; IMADA A, 1967, J GEN APPL MICROBIOL, V13, P255, DOI 10.2323/jgam.13.255; JYSSUM S, 1989, APMIS, V97, P343, DOI 10.1111/j.1699-0463.1989.tb00797.x; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; KUNINAKA A, 1957, KOSO KAGAKU SHINPOJI, V12, P65; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNG HB, 1984, J BIOL CHEM, V259, P6972; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lewis BC, 2000, CANCER RES, V60, P6178; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; MACNUTT WS, 1952, BIOCHEM J, V50, P384, DOI 10.1042/bj0500384; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; Rhodes DR, 2002, CANCER RES, V62, P4427; Short SA, 1996, J BIOL CHEM, V271, P4978; SMAR M, 1991, BIOCHEMISTRY-US, V30, P7908, DOI 10.1021/bi00246a006; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; UERKVITZ W, 1971, EUR J BIOCHEM, V23, P387, DOI 10.1111/j.1432-1033.1971.tb01632.x; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	30	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8150	8156		10.1074/jbc.M610648200	http://dx.doi.org/10.1074/jbc.M610648200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234634	hybrid			2022-12-27	WOS:000245081000047
J	Jell, J; Merali, S; Hensen, ML; Mazurchuk, R; Spernyak, JA; Diegelman, P; Kisiel, ND; Barrero, C; Deeb, KK; Alhonen, L; Patel, MS; Porter, CW				Jell, Jason; Merali, Salim; Hensen, Mary L.; Mazurchuk, Richard; Spernyak, Joseph A.; Diegelman, Paula; Kisiel, Nicholas D.; Barrero, Carlos; Deeb, Kristin K.; Alhonen, Leena; Patel, Mulchand S.; Porter, Carl W.			Genetically altered expression of spermidine/spermine N-1-acetyltransferase affects fat metabolism in mice via acetyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POLYAMINE CATABOLISM; SPERMINE N1-ACETYLTRANSFERASE; ORNITHINE-DECARBOXYLASE; TARGETED DISRUPTION; RECEPTOR-GAMMA; GENE; GROWTH; SENSITIVITY; TISSUE; HOMEOSTASIS	The acetylating enzyme, spermidine/spermine N-1-acetyltransferase, participates in polyamine homeostasis by regulating polyamine export and catabolism. Previously, we reported that overexpression of the enzyme in cultured tumor cells and mice activates metabolic flux through the polyamine pathway and depletes the N-1-acetyltransferase coenzyme and fatty acid precursor, acetyl-CoA. Here, we investigate this possibility in spermidine/spermine N-1-acetyltransferase transgenic mice in which the enzyme is systemically overexpressed and in spermidine/spermine N(-)(1)acetyltransferase knock-out mice. Tissues of the former were characterized by increased N-1-acetyltransferase activity, a marked elevation in tissue and urinary acetylated polyamines, a compensatory increase in polyamine biosynthetic enzyme activity, and an increase in metabolic flux through the polyamine pathway. These polyamine effects were accompanied by a decrease in white adipose acetyl- and malonyl-CoA pools, a major (20-fold) increase in glucose and palmitate oxidation, and a distinctly lean phenotype. In SSAT-ko mice, the opposite relationship between polyamine and fat metabolism was observed. In the absence of N-1-acetylation of polyamines, there was a shift in urinary and tissue polyamines indicative of a decline in metabolic flux. This was accompanied by an increase in white adipose acetyl- and malonyl-CoA pools, a decrease in adipose palmitate and glucose oxidation, and an accumulation of body fat. The latter was further exaggerated under a high fat diet, where knock-out mice gained twice as much weight as wild-type mice. A model is proposed whereby the expression status of spermidine/spermine N-1-acetyltransferase alters body fat accumulation by metabolically modulating tissue acetyl- and malonyl-CoA levels, thereby influencing fatty acid biosynthesis and oxidation.	Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Canc Biol, Buffalo, NY 14263 USA; Temple Univ, Sch Med, Fels Inst, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; Univ Kuopio, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland; SUNY Buffalo, Sch Med, Dept Biochem, Buffalo, NY 14214 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Eastern Finland; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Porter, CW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	carl.porter@roswellpark.org	Deeb, Kristin K/H-5619-2016	Barrero, Carlos/0000-0001-5779-6642	NATIONAL CANCER INSTITUTE [R01CA022153, R01CA076428, P30CA016056] Funding Source: NIH RePORTER; NCI NIH HHS [CA-076428, CA-CA09072, CA016056, CA-022153] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AGIUS L, 1985, EUR J BIOCHEM, V152, P699, DOI 10.1111/j.1432-1033.1985.tb09250.x; ATTWOOD PV, 1995, INT J BIOCHEM CELL B, V27, P231, DOI 10.1016/1357-2725(94)00087-R; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; CADHILL GF, 1958, AM J PHYSIOL, V192, P491; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; FogelPetrovic M, 1996, FEBS LETT, V391, P89, DOI 10.1016/0014-5793(96)00710-7; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; HENKELMAN RM, 1992, JMRI-J MAGN RESON IM, V2, P533; Janne J, 2006, J BIOCHEM, V139, P155, DOI 10.1093/jb/mvj035; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Johnson KR, 2003, GENOMICS, V81, P6, DOI 10.1016/S0888-7543(02)00013-7; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; KRAMER D, 1995, J BIOL CHEM, V270, P2124, DOI 10.1074/jbc.270.5.2124; Linsalata M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-191; Liu GS, 2003, ANAL CHEM, V75, P78, DOI 10.1021/ac0261505; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Niiranen K, 2002, J BIOL CHEM, V277, P25323, DOI 10.1074/jbc.M203599200; Niiranen K, 2006, J CELL MOL MED, V10, P933, DOI 10.2755/jcmm010.004.02; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; PAJUNEN AEI, 1982, J BIOL CHEM, V257, P8190; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; PORTER CW, 1991, CANCER RES, V51, P3715; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Rodriguez-Caso C, 2006, J BIOL CHEM, V281, P21799, DOI 10.1074/jbc.M602756200; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SEILER N, 1985, ANTICANCER RES, V5, P371; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; Tucker JM, 2005, CANCER RES, V65, P5390, DOI 10.1158/0008-5472.CAN-05-0229; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Wang AYH, 2005, AM J GASTROENTEROL, V100, P2717, DOI 10.1111/j.1572-0241.2005.00311.x; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433	39	100	102	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8404	8413		10.1074/jbc.M610265200	http://dx.doi.org/10.1074/jbc.M610265200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17189273	hybrid			2022-12-27	WOS:000245081000073
J	Meredith, TC; Mamat, U; Kaczynski, Z; Lindner, B; Holst, O; Woodard, RW				Meredith, Timothy C.; Mamat, Uwe; Kaczynski, Zbigniew; Lindner, Buko; Holst, Otto; Woodard, Ronald W.			Modification of lipopolysaccharide with colanic acid (M-antigen) repeats in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABINOSE 5-PHOSPHATE ISOMERASE; CAPSULAR POLYSACCHARIDE SYNTHESIS; ENTEROBACTERIAL COMMON ANTIGEN; LIPID A-CORE; O-ANTIGEN; STRUCTURAL-ANALYSIS; RCS PHOSPHORELAY; OUTER CORE; SALMONELLA-TYPHIMURIUM; BIOFILM FORMATION	Colanic acid (CA) or M-antigen is an exopolysaccharide produced by many enterobacteria, including the majority of Escherichia coli strains. Unlike other capsular polysaccharides, which have a close association with the bacterial surface, CA forms a loosely associated saccharide mesh that coats the bacteria, often within biofilms. Herein we show that a highly mucoid strain of E. coli K-12 ligates CA repeats to a significant proportion of lipopolysaccharide (LPS) core acceptor molecules, forming the novel LPS glycoform we call M-LPS.M-LPS biosynthesis is dependent upon (i) CA induction, (ii) LPS core biosynthesis, and (iii) the O-antigen ligase WaaL. Compositional analysis, mass spectrometry, and nuclear magnetic resonance spectroscopy of a purified MLPS sample confirmed the presence of a CA repeat unit identical in carbohydrate sequence, but differing at multiple positions in anomeric configuration and linkage, from published structures of extracellular CA. The attachment point was identified as O-7 of the L-glycero-D-manno-heptose of the outer LPS core, the same position used for O-antigen ligation. When O-antigen biosynthesis was restored in the K-12 background and grown under conditions meeting the above specifications, only MLPS was observed, suggesting E. coli can reversibly change its proximal covalently linked cell surface polysaccharide coat from O-antigen to CA in response to certain environmental stimuli. The identification of M-LPS has implications for potential underlying mechanisms coordinating the synthesis of various surface polysaccharides.	Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Leibniz Ctr Med & Biosci, Div Struct Biochem, D-23845 Borstel, Germany; Leibniz Ctr Med & Biosci, Div Immunochem, Res Ctr Borstel, D-23845 Borstel, Germany; Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Forschungszentrum Borstel; Fahrenheit Universities; University of Gdansk	Woodard, RW (corresponding author), Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA.	rww@umich.edu	Lindner, Buko/G-9731-2014; Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841; Woodard, Ronald/0000-0002-7472-3653; Kaczynski, Zbigniew/0000-0002-4590-4690	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061531] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI61531] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Cescutti P, 1999, CARBOHYD RES, V315, P159, DOI 10.1016/S0008-6215(98)00318-8; Cieslewicz M, 1997, MOL MICROBIOL, V26, P237, DOI 10.1046/j.1365-2958.1997.5651942.x; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DISCHE Z, 1948, J BIOL CHEM, V175, P595; El-Kazzaz W, 2004, MOL MICROBIOL, V51, P1117, DOI 10.1046/j.1365-2958.2003.03888.x; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GAREGG PJ, 1971, ACTA CHEM SCAND, V25, P2103, DOI 10.3891/acta.chem.scand.25-2103; GAREGG PJ, 1980, CARBOHYD RES, V78, P127, DOI 10.1016/S0008-6215(00)83666-6; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; GRANT WD, 1969, J BACTERIOL, V100, P1187, DOI 10.1128/JB.100.3.1187-1193.1969; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Haseley SR, 1997, EUR J BIOCHEM, V247, P815, DOI 10.1111/j.1432-1033.1997.00815.x; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HOLST O, 1991, CARBOHYD RES, V215, P323, DOI 10.1016/0008-6215(91)84031-9; JANN B, 1990, CURR TOP MICROBIOL, V150, P19; JANSSON PE, 1993, ACTA CHEM SCAND, V47, P711, DOI 10.3891/acta.chem.scand.47-0711; Kaczynski Z, 2006, CARBOHYD RES, V341, P285, DOI 10.1016/j.carres.2005.10.020; KANG S, 1967, J BACTERIOL, V93, P584, DOI 10.1128/JB.93.2.584-591.1967; Kaniuk NA, 2004, J BIOL CHEM, V279, P36470, DOI 10.1074/jbc.M401366200; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; LAWSON CJ, 1969, BIOCHEM J, V115, P947, DOI 10.1042/bj1150947; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; MACLACHLAN PR, 1993, J BACTERIOL, V175, P7515, DOI 10.1128/JB.175.23.7515-7522.1993; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Meredith TC, 2006, BIOCHEM J, V395, P427, DOI 10.1042/BJ20051828; Meredith TC, 2005, J BACTERIOL, V187, P6936, DOI 10.1128/JB.187.20.6936-6942.2005; Meredith TC, 2003, J BIOL CHEM, V278, P32771, DOI 10.1074/jbc.M303661200; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; PETERS H, 1985, INFECT IMMUN, V50, P459, DOI 10.1128/IAI.50.2.459-466.1985; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajagopal S, 2002, APPL ENVIRON MICROB, V68, P4117, DOI 10.1128/AEM.68.8.4117-4121.2002; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Sailer FC, 2003, FEMS MICROBIOL LETT, V226, P245, DOI 10.1016/S0378-1097(03)00616-5; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stout V, 1996, J BACTERIOL, V178, P4273, DOI 10.1128/jb.178.14.4273-4280.1996; SUTHERLAND IW, 1969, BIOCHEM J, V115, P935, DOI 10.1042/bj1150935; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2003, J ENDOTOXIN RES, V9, P244, DOI 10.1179/096805103225001440; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	65	68	70	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7790	7798		10.1074/jbc.M611034200	http://dx.doi.org/10.1074/jbc.M611034200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227761	hybrid			2022-12-27	WOS:000245081000007
J	Tyurina, YY; Basova, LV; Konduru, NV; Tyurin, VA; Potapovich, AI; Cai, P; Bayir, H; Stoyanovsky, D; Pitt, BR; Shvedova, AA; Fadeel, B; Kagan, VE				Tyurina, Yulia Y.; Basova, Liana V.; Konduru, Nagarjun V.; Tyurin, Vladimir A.; Potapovich, Ala I.; Cai, Peter; Bayir, Hulya; Stoyanovsky, Detcho; Pitt, Bruce R.; Shvedova, Anna A.; Fadeel, Bengt; Kagan, Valerian E.			Nitrosative stress inhibits the aminophospholipid translocase resulting in phosphatidylserine externalization and macrophage engulfment - Implications for the resolution of inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PHOSPHOLIPID SCRAMBLASE; RED-BLOOD-CELLS; NITRIC-OXIDE; APOPTOTIC CELLS; S-NITROSYLATION; TRANSBILAYER MOVEMENT; PLASMA-MEMBRANE; PHAGOCYTE RECOGNITION; NEUTROPHIL APOPTOSIS; REACTIVE OXYGEN	Macrophage recognition of apoptotic cells depends on externalization of phosphatidylserine (PS), which is normally maintained within the cytosolic leaflet of the plasma membrane by aminophospholipid translocase (APLT). APLT is sensitive to redox modifications of its -SH groups. Because activated macrophages produce reactive oxygen and nitrogen species, we hypothesized that macrophages can directly participate in apoptotic cell clearance by S-nitrosylation/oxidation and inhibition of APLT causing PS externalization. Here we report that exposure of target HL-60 cells to nitrosative stress inhibited APLT, induced PS externalization, and enhanced recognition and elimination of "nitrosatively" modified cells by RAW 264.7 macrophages. Using S-nitroso-L-cysteine-ethyl ester (SNCEE) and S-nitrosoglutathione (GSNO) that cause intracellular and extracellular trans-nitrosylation of proteins, respectively, we found that SNCEE (but not GSNO) caused significant S-nitrosylation/ oxidation of thiols in HL-60 cells. SNCEE also strongly inhibited APLT, activated scramblase, and caused PS externalization. However, SNCEE did not induce caspase activation or nuclear condensation/fragmentation suggesting that PS externalization was dissociated from the common apoptotic pathway. Dithiothreitol reversed SNCEE-induced S-nitrosylation, APLT inhibition, and PS externalization. SNCEE but not GSNO stimulated phagocytosis of HL-60 cells. Moreover, phagocytosis of target cells by lipopolysaccharide-stimulated macrophages was significantly suppressed by an NO center dot scavenger, DAF-2. Thus, macrophage-induced nitrosylation/oxidation plays an important role in cell clearance, and hence in the resolution of inflammation.	Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15219 USA; NIOSH, Morgantown, WV 26505 USA; Karolinska Inst, Inst Environm Med, Div Biochem Toxicol, S-17177 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Karolinska Institutet	Kagan, VE (corresponding author), Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA.	kagan@pitt.edu		Tyurin, Vladimir/0000-0002-3474-1697; Tyurina, Yulia/0000-0003-0287-2091; Stoyanovsky, Detcho/0000-0001-5591-4780; Kagan, Valerian E./0000-0002-7245-1885	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755, P01HL070807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009648] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL070807, HL70755] Funding Source: Medline; NIAID NIH HHS [U19 AI068021] Funding Source: Medline; NIEHS NIH HHS [ES09648] Funding Source: Medline; NIOSH CDC HHS [OH008282] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIOSH CDC HHS		Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bayir H, 2003, J CEREBR BLOOD F MET, V23, P51, DOI 10.1097/01.WCB.0000040399.30600.E3; Bianco Alberto, 2005, Current Drug Delivery, V2, P253, DOI 10.2174/1567201054367959; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Boullerne AI, 2002, J NEUROSCI, V22, P123, DOI 10.1523/JNEUROSCI.22-01-00123.2002; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown SB, 1999, J IMMUNOL, V162, P480; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; Clancy R, 2001, J MED CHEM, V44, P2035, DOI 10.1021/jm000463f; COLLEAU M, 1991, CHEM PHYS LIPIDS, V57, P29, DOI 10.1016/0009-3084(91)90046-E; CONNOR J, 1992, J BIOL CHEM, V267, P19412; CONNOR J, 1990, BIOCHEMISTRY-US, V29, P37, DOI 10.1021/bi00453a005; Corradi M, 2001, AM J RESP CRIT CARE, V163, P854, DOI 10.1164/ajrccm.163.4.2001108; Courtney J M, 2004, J Cyst Fibros, V3, P223, DOI 10.1016/j.jcf.2004.06.006; Crow J P, 1995, Adv Pharmacol, V34, P17; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Davies NM, 1997, ALIMENT PHARM THER, V11, P69, DOI 10.1046/j.1365-2036.1997.115286000.x; de Jong K, 2006, BRIT J HAEMATOL, V133, P427, DOI 10.1111/j.1365-2141.2006.06045.x; deJong K, 1997, BIOCHEMISTRY-US, V36, P6768, DOI 10.1021/bi962973a; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Diaz C, 1999, CELL DEATH DIFFER, V6, P218, DOI 10.1038/sj.cdd.4400484; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Fabisiak JP, 2000, BIOCHEMISTRY-US, V39, P127, DOI 10.1021/bi9912544; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadeel B, 2003, CELL MOL LIFE SCI, V60, P2575, DOI 10.1007/s00018-003-3145-1; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Forsberg AJ, 2004, ANTIOXID REDOX SIGN, V6, P203, DOI 10.1089/152308604322899279; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gleiss B, 2002, FEBS LETT, V519, P153, DOI 10.1016/S0014-5793(02)02743-6; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Hanayama R, 2006, CURR DIRECT AUTOIMMU, V9, P162; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Iyer R, 2000, CANCER RES, V60, P1290; Jourd'Heuil D, 2002, FREE RADICAL BIO MED, V33, P676, DOI 10.1016/S0891-5849(02)00955-3; Kagan VE, 2003, AM J PHYSIOL-LUNG C, V285, pL1, DOI 10.1152/ajplung.00365.2002; Kahlos K, 2003, MOL CELL BIOCHEM, V254, P47, DOI 10.1023/A:1027380828645; Kamp D, 2001, BIOCHEMISTRY-US, V40, P9438, DOI 10.1021/bi0107492; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; KONDURU NV, 2006, 1 INT C NAN BIOM ASP; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Melino G, 2000, CELL MOL LIFE SCI, V57, P612, DOI 10.1007/PL00000723; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Narayanan PK, 1997, CANCER RES, V57, P3963; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Pritchard MT, 2005, J LEUKOCYTE BIOL, V78, P630, DOI 10.1189/jlb.0404220; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Shao C, 2003, CANCER RES, V63, P8437; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Stamler JS, 2002, CURR OPIN CHEM BIOL, V6, P779, DOI 10.1016/S1367-5931(02)00383-6; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Torok NJ, 2002, CANCER RES, V62, P1648; Tyurin VA, 2002, METHOD ENZYMOL, V352, P347; Tyurin VA, 2001, CIRC RES, V88, P1210, DOI 10.1161/hh1101.092179; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Tyurina YY, 2004, ANTIOXID REDOX SIGN, V6, P209, DOI 10.1089/152308604322899288; Tyurina YY, 2004, J BIOL CHEM, V279, P6056, DOI 10.1074/jbc.M309929200; Uthaisang W, 2003, FEBS LETT, V545, P110, DOI 10.1016/S0014-5793(03)00508-8; van der Vliet A, 1998, J BIOL CHEM, V273, P30255, DOI 10.1074/jbc.273.46.30255; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Verhoeven AJ, 2006, VOX SANG, V91, P244, DOI 10.1111/j.1423-0410.2006.00822.x; Verhoven B, 1999, CELL DEATH DIFFER, V6, P262, DOI 10.1038/sj.cdd.4400491; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallace John L., 2006, Inflammation & Allergy Drug Targets, V5, P133, DOI 10.2174/187152806776383116; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao J, 1998, BIOCHEMISTRY-US, V37, P6361, DOI 10.1021/bi980218m; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhuang JG, 1998, J BIOL CHEM, V273, P15628, DOI 10.1074/jbc.273.25.15628; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	99	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8498	8509		10.1074/jbc.M606950200	http://dx.doi.org/10.1074/jbc.M606950200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229723	hybrid			2022-12-27	WOS:000245081000082
J	Kittur, FS; Lalgondar, M; Yu, HY; Bevan, DR; Esen, A				Kittur, Farooqahmed S.; Lalgondar, Mallikarjun; Yu, Hyun Young; Bevan, David R.; Esen, Asim			Maize beta-glucosidase-aggregating factor is a polyspecific jacalin-related chimeric lectin, and its lectin domain is responsible for beta-glucosidase aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; AGLYCONE SPECIFICITY; DISEASE-RESISTANCE; CRYSTAL-STRUCTURES; CALYSTEGIA-SEPIUM; DIRIGENT PROTEIN; PRISM FOLD; AGGLUTININ; REVEALS; COMPLEX	In certain maize genotypes, called "null," beta-glucosidase does not enter gels and therefore cannot be detected on zymograms after electrophoresis. Such genotypes were originally thought to be homozygous for a null allele at the glu1 gene and thus devoid of enzyme. We have shown that a beta-glucosidase-aggregating factor (BGAF) is responsible for the "null" phenotype. BGAF is a chimeric protein consisting of two distinct domains: the disease response or "dirigent" domain and the jacalin-related lectin (JRL) domain. First, it was not known whether the lectin domain in BGAF is functional. Second, it was not known which of the two BGAF domains is involved in beta-glucosidase binding and aggregation. To this end, we purified BGAF to homogeneity from a maize null inbred line called H95. The purified protein gave a single band on SDS-PAGE, and the native protein was a homodimer of 32-kDa monomers. Native and recombinant BGAF (produced in Escherichia coli) agglutinated rabbit erythrocytes, and various carbohydrates and glycoproteins inhibited their hemagglutination activity. Sugars did not have any effect on the binding of BGAF to the beta-glucosidase isozyme 1 (Glu 1), and the BGAF-Glu1 complex could still bind lactosyl-agarose, indicating that the sugar-binding site of BGAF is distinct from the beta-glucosidase-binding site. Neither the dirigent nor the JRL domains alone (produced separately in E. coli) produced aggregates of Glu1 based on results from pull-down assays. However, gel shift and competitive binding assays indicated that the JRL domain binds beta-glucosidase without causing it to aggregate. These results with those from deletion mutagenesis and replacement of the JRL domain of a BGAF homolog from sorghum, which does not bind Glul, with that from maize allowed us to conclude that the JRL domain of BGAF is responsible for its lectin and beta-glucosidase binding and aggregating activities.	Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Esen, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	aevatan@vt.edu	Kittur, Farooqahmed S/G-3832-2012	Kittur, Farooqahmed/0000-0002-2272-3387; Bevan, David/0000-0001-9974-1105				Astoul CH, 2002, BIOCHEM J, V367, P817, DOI 10.1042/BJ20020856; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6; Beyreuther K, 1980, BIOCHEM SOC T, V8, P675, DOI 10.1042/bst0080675; Blanchard DJ, 2001, J BIOL CHEM, V276, P11895, DOI 10.1074/jbc.M008872200; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Cicek M, 1999, BIOTECHNOL BIOENG, V63, P392, DOI 10.1002/(SICI)1097-0290(19990520)63:4&lt;392::AID-BIT2&gt;3.0.CO;2-M; Cicek M, 2000, J BIOL CHEM, V275, P20002, DOI 10.1074/jbc.M001609200; CULLEY DE, 1995, PLANT PHYSIOL, V107, P301, DOI 10.1104/pp.107.1.301; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ESEN A, 1990, BIOCHEM GENET, V28, P319, DOI 10.1007/BF02401422; Esen A, 2000, PLANT PHYSIOL, V122, P563, DOI 10.1104/pp.122.2.563; ESEN A, 1992, BETA GLUCOSIDASE, P1; Gallego De Sol F, 2005, J MOL BIOL, V353, P574, DOI [10.1016/j.jmb.2005.08.055, DOI 10.1016/J.JMB.2005.08.055]; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Halls SC, 2002, BIOCHEMISTRY-US, V41, P9455, DOI 10.1021/bi0259709; Hopkins TL, 2001, ARCH INSECT BIOCHEM, V47, P100, DOI 10.1002/arch.1040; HOSEL W, 1978, EUR J BIOCHEM, V84, P487, DOI 10.1111/j.1432-1033.1978.tb12190.x; HUI Y, 1993, J BIOL CHEM, V268, P5905; KAHLER AL, 1986, THEOR APPL GENET, V72, P15, DOI 10.1007/BF00261448; Kittur FS, 2003, FEBS LETT, V549, P147, DOI 10.1016/S0014-5793(03)00803-2; KLECZKOWSKI K, 1995, CRIT REV PLANT SCI, V14, P283, DOI 10.1080/07352689509382361; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafont V, 1996, J LEUKOCYTE BIOL, V59, P691, DOI 10.1002/jlb.59.5.691; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; MASSARDO F, 1994, PHYTOCHEMISTRY, V35, P873, DOI 10.1016/S0031-9422(00)90629-0; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Molina J, 2004, BBA-GEN SUBJECTS, V1674, P299, DOI 10.1016/j.bbagen.2004.07.002; Peumans WJ, 2000, FEBS LETT, V477, P186, DOI 10.1016/S0014-5793(00)01801-9; PHILLIPS DA, 1996, PLANT MICROBE INTERA, P236; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; Pratap JV, 2002, J MOL BIOL, V317, P237, DOI 10.1006/jmbi.2001.5432; Rosa JC, 1999, PROTEIN SCI, V8, P13; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Takahashi N, 1998, ANAL BIOCHEM, V255, P183, DOI 10.1006/abio.1997.2463; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; VanDamme EJM, 1996, FEBS LETT, V397, P352, DOI 10.1016/S0014-5793(96)01211-2; Williams CE, 2002, J CHEM ECOL, V28, P1411, DOI 10.1023/A:1016200619766; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; Zhang WL, 2000, PLANTA, V210, P970, DOI 10.1007/s004250050705	49	37	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7299	7311		10.1074/jbc.M607417200	http://dx.doi.org/10.1074/jbc.M607417200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210577	hybrid			2022-12-27	WOS:000245080900041
J	Merten, N; Lindner, D; Rabe, N; Rompler, H; Morl, K; Schoneberg, T; Beck-Sickinger, AG				Merten, Nicole; Lindner, Diana; Rabe, Nadine; Roempler, Holger; Moerl, Karin; Schoeneberg, Torsten; Beck-Sickinger, Annette G.			Receptor subtype-specific docking of Asp(6.59) with C-terminal arginine residues in Y receptor ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHOLECYSTOKININ-1 RECEPTOR; PANCREATIC-POLYPEPTIDE RECEPTOR; PROTEIN-COUPLED RECEPTORS; HUMAN NEUROPEPTIDE-Y; PEPTIDE-YY; GUINEA-PIG; BINDING-SITE; Y-1 RECEPTOR; FUNCTIONAL EXPRESSION; MOLECULAR EVOLUTION	Y receptors (YRs) are G protein-coupled receptors whose Y,R, Y2R, and Y5R subtypes preferentially bind neuropeptide Y (NPY) and peptide YY, whereas mammalian Y(4)Rs show a higher affinity for pancreatic polypeptide (PP). Comparison of YR orthologs; and paralogs; revealed Asp(6.59) to be fully conserved throughout all of the YRs reported so far. By replacing this conserved aspartic acid residue with alanine, asparagine, glutamate, and arginine, we now show that this residue plays a crucial role in binding and signal transduction of NPY/PP at all YRs. Sensitivity to distinct replacements is, however, receptor subtype-specific. Next, we performed a complementary mutagenesis approach to identify the contact site of the ligand. Surprisingly, this conserved residue interacts with two different ligand arginine residues by ionic interactions; although in Y2R and Y5R, Arg(33) is the binding partner of Asp(6.59), in Y1R and Y4R Arg(35) of human PP and NPY interacts with Asp(6.59). Furthermore, Arg(25) of PP and NPY is involved in ligand binding only at Y2R and Y5R. This suggests significant differences in the docking of YR ligands between Y1/4R and Y2/5R and provides new insights into the molecular binding mode of peptide agonists at GPCRs. Furthermore, the proposed model of a subtype-specific binding mode is in agreement with the evolution of YRs.	Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; Univ Leipzig, Fac Med, Inst Biochem Mol Biochem, D-04103 Leipzig, Germany	Leipzig University; Leipzig University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Bruderstr 34, D-04103 Leipzig, Germany.	beck-sickinger@uni-leipzig.de	Lindner, Diana/AAL-9856-2021; Bernhardt, Nadine/C-1779-2017	Lindner, Diana/0000-0001-5477-769X; Bernhardt, Nadine/0000-0002-3188-8431				Abrahamsson C, 2000, J CARDIOVASC PHARM, V36, P451, DOI 10.1097/00005344-200010000-00006; Archer-Lahlou E, 2005, J BIOL CHEM, V280, P10664, DOI 10.1074/jbc.M409451200; Bader R, 2001, J MOL BIOL, V305, P307, DOI 10.1006/jmbi.2000.4264; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; BECKSICKINGER AG, 1995, BIOPOLYMERS, V37, P123, DOI 10.1002/bip.360370207; Berglund MM, 2001, PEPTIDES, V22, P351, DOI 10.1016/S0196-9781(01)00337-0; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Cabrele C, 2002, BIOCHEMISTRY-US, V41, P8043, DOI 10.1021/bi0201421; Cabrele C, 2000, J BIOL CHEM, V275, P36043, DOI 10.1074/jbc.M000626200; Capurro D, 1999, EUR J PHARMACOL, V376, P251, DOI 10.1016/S0014-2999(99)00392-1; Cerda-Reverter JM, 2000, BIOCHEM CELL BIOL, V78, P371, DOI 10.1139/bcb-78-3-371; CLEARY J, 1994, BRAIN RES, V653, P210, DOI 10.1016/0006-8993(94)90391-3; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Eckard CP, 2000, CURR MED CHEM, V7, P897, DOI 10.2174/0929867003374552; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Eriksson H, 1998, REGUL PEPTIDES, V75-6, P29, DOI 10.1016/S0167-0115(98)00050-0; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Flanagan CA, 2000, BIOCHEMISTRY-US, V39, P8133, DOI 10.1021/bi000085g; FUHLENDORFF J, 1990, P NATL ACAD SCI USA, V87, P182, DOI 10.1073/pnas.87.1.182; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Gregor P, 1996, J BIOL CHEM, V271, P27776, DOI 10.1074/jbc.271.44.27776; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Henin J, 2006, BIOPHYS J, V90, P1232, DOI 10.1529/biophysj.105.070599; Hofliger MM, 2003, J RECEPT SIG TRANSD, V23, P351, DOI 10.1081/RRS-120026974; Kane JK, 2000, BIOCHEM BIOPH RES CO, V272, P959, DOI 10.1006/bbrc.2000.2880; Koglin N, 2003, J MED CHEM, V46, P4369, DOI 10.1021/jm0341251; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Larhammar D, 2004, NEUROPEPTIDES, V38, P141, DOI 10.1016/j.npep.2004.06.002; Larhammar D, 2001, PEPTIDES, V22, P295, DOI 10.1016/S0196-9781(01)00331-X; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; Lecklin A, 2002, BRIT J PHARMACOL, V135, P2029, DOI 10.1038/sj.bjp.0704667; Lundell I, 2002, J MOL ENDOCRINOL, V28, P225, DOI 10.1677/jme.0.0280225; Matsumoto M, 1996, J BIOL CHEM, V271, P27217, DOI 10.1074/jbc.271.44.27217; Mijares A, 2000, MOL PHARMACOL, V58, P373, DOI 10.1124/mol.58.2.373; Monks SA, 1996, J BIOMOL NMR, V8, P379; NAKAJIMA M, 1994, J PHARMACOL EXP THER, V268, P1010; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAU MYC, 1988, PHYSIOL BEHAV, V44, P797, DOI 10.1016/0031-9384(88)90065-0; Porter JE, 2000, J PHARMACOL EXP THER, V292, P440; Rist B, 1996, FEBS LETT, V394, P169, DOI 10.1016/0014-5793(96)00943-X; Robin-Jagerschmidt C, 1998, MOL CELL ENDOCRINOL, V139, P187, DOI 10.1016/S0303-7207(98)00060-4; ROSE PM, 1995, FEBS LETT, V361, P243, DOI 10.1016/0014-5793(95)00164-5; Sautel M, 1996, MOL PHARMACOL, V50, P285; SAUTEL M, 1995, MOL CELL ENDOCRINOL, V112, P215, DOI 10.1016/0303-7207(95)03603-5; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WALKER P, 1994, J BIOL CHEM, V269, P2863; Weinberg DH, 1996, J BIOL CHEM, V271, P16435, DOI 10.1074/jbc.271.28.16435	56	74	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7543	7551		10.1074/jbc.M608902200	http://dx.doi.org/10.1074/jbc.M608902200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17204471	hybrid			2022-12-27	WOS:000245080900067
J	Urra, S; Escudero, CA; Ramos, P; Lisbona, F; Allende, E; Covarrubias, P; Parraguez, JI; Zampieri, N; Chao, MV; Annaert, W; Bronfman, FC				Urra, Soledad; Escudero, Claudia A.; Ramos, Patricio; Lisbona, Fernanda; Allende, Edgardo; Covarrubias, Paulina; Parraguez, Jose I.; Zampieri, Niccolo; Chao, Moses V.; Annaert, Wim; Bronfman, Francisca C.			TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; REGULATED INTRAMEMBRANE PROTEOLYSIS; ALPHA-CONVERTING-ENZYME; ALZHEIMERS-DISEASE; NUCLEAR TRANSLOCATION; RETROGRADE TRANSPORT; SYMPATHETIC NEURONS; TERMINAL FRAGMENT; TRANSGENIC MICE; BETA PRODUCTION	Neurotrophins are trophic factors that regulate important neuronal functions. They bind two unrelated receptors, the Trk family of receptor-tyrosine kinases and the p75 neurotrophin receptor (p75). p75 was recently identified as a new substrate for gamma-secretase-mediated intramembrane proteolysis, generating a p75-derived intracellular domain (p75-ICD) with signaling capabilities. Using PC12 cells as a model, we studied how neurotrophins activate p75 processing and where these events occur in the cell. We demonstrate that activation of the TrkA receptor upon binding of nerve growth factor (NGF) regulates the metalloprotease-mediated shedding of p75 leaving a membrane-bound p75 C-terminal fragment (p75-CTF). Using subcellular fractionation to isolate a highly purified endosomal fraction, we demonstrate that p75-CTF ends up in endosomes where gamma-secretase-mediated p75-CTF cleavage occurs, resulting in the release of a p75-ICD. Moreover, we show similar structural requirements for gamma-secretase processing of p75 and amyloid precursor protein-derived CTFs. Thus, NGF-induced endocytosis regulates both signaling and proteolytic processing of p75.	Pontif Univ Catolica, Fac Biol Sci, Dept Physiol, Ctr Cellular Regulat & Pathol Joaquin V Luco, Santiago 8320000, Chile; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Gasthuisberg Katholieke Univ Leuven VIB, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium	Pontificia Universidad Catolica de Chile; New York University; New York University; Flanders Institute for Biotechnology (VIB); KU Leuven	Annaert, W (corresponding author), Pontif Univ Catolica, Fac Biol Sci, Dept Physiol, Ctr Cellular Regulat & Pathol Joaquin V Luco, Alameda 340, Santiago 8320000, Chile.	Willem.Annaert@med.kuleuven.be; fbronfman@bio.puc.cl	Ramos, Patricio/ABE-5961-2021; Ramos, Patricio/B-6665-2017	Ramos, Patricio/0000-0001-8341-314X; Chao, Moses/0000-0002-6969-3744; Urra, Soledad/0000-0003-4432-6582; Zampieri, Niccolo/0000-0002-2228-9453				AHMED Z, 2006, FASEB J; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BERG MM, 1992, J BIOL CHEM, V267, P13; Blagoveshchenskaya AD, 1999, J CELL BIOL, V145, P1419, DOI 10.1083/jcb.145.7.1419; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chao MV, 2004, J ALZHEIMERS DIS, V6, pS7; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; EICHHOLTZ T, 1992, J BIOL CHEM, V267, P22490; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grimes ML, 1996, J NEUROSCI, V16, P7950; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; Lichtenstein Y, 1998, P NATL ACAD SCI USA, V95, P11223, DOI 10.1073/pnas.95.19.11223; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Majdan M, 1997, J NEUROSCI, V17, P6988; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pasternak SH, 2004, J ALZHEIMERS DIS, V6, P53; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Podlesniy P, 2006, AM J PATHOL, V169, P119, DOI 10.2353/ajpath.2006.050787; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Saxena S, 2004, MOL CELL NEUROSCI, V26, P292, DOI 10.1016/j.mcn.2004.02.006; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Tuszynski MH, 2004, PROG BRAIN RES, V146, P441; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Yano H, 2004, J NEUROBIOL, V58, P244, DOI 10.1002/neu.10321; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	87	68	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7606	7615		10.1074/jbc.M610458200	http://dx.doi.org/10.1074/jbc.M610458200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215246	hybrid, Green Published			2022-12-27	WOS:000245080900073
J	Adams, KW; Cooper, GM				Adams, Kenneth W.; Cooper, Geoffrey M.			Rapid turnover of Mcl-1 couples translation to cell survival and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; MEDIATED MITOCHONDRIAL APOPTOSIS; CYCLOHEXIMIDE-INDUCED APOPTOSIS; INITIATION-FACTOR 2B; HUMAN MYELOMA CELLS; BCL-2 FAMILY; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION SITES; SIGNALING PATHWAYS	Inhibition of translation plays a role in apoptosis induced by a variety of stimuli, but the mechanism by which it promotes apoptosis has not been established. We have investigated the hypothesis that selective degradation of anti-apoptotic regulatory protein(s) is responsible for apoptosis resulting from translation inhibition. Induction of apoptosis by cycloheximide was detected within 2-4 hand blocked by proteasome inhibitors, indicating that degradation of shortlived protein(s) was required. Caspase inhibition and overexpression of Bcl-x(L) blocked cycloheximide-induced apoptosis. In addition, cycloheximide induced rapid activation of Bak and Bax, which required proteasome activity. Mcl-1 was degraded by the proteasome with a half-life of similar to 30 min following inhibition of protein synthesis, preceding Bak/Bax activation and the onset of apoptosis. Overexpression of Mcl-1 blocked apoptosis induced by cycloheximide, whereas RNA interference knockdown of Mcl-1 induced apoptosis. Knockdown of Bim and Bak, downstream targets of Mcl-1, inhibited cycloheximide-induced apoptosis, as did knockdown of Bax. Apoptosis resulting from inhibition of translation thus involves the rapid degradation of Mcl-1, leading to activation of Bim, Bak, and Bax. Because of its rapid turnover, Mcl-1 may serve as a convergence point for signals that affect global translation, coupling translation to cell survival and the apoptotic machinery.	Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Cooper, GM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA18689, R01 CA018689] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Alessenko AV, 1997, FEBS LETT, V416, P113, DOI 10.1016/S0014-5793(97)01161-7; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Blom WM, 1999, BIOCHEM PHARMACOL, V58, P1891, DOI 10.1016/S0006-2952(99)00268-3; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Erhardt P, 1996, J BIOL CHEM, V271, P17601, DOI 10.1074/jbc.271.30.17601; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gomez-Bougie P, 2005, ONCOGENE, V24, P8076, DOI 10.1038/sj.onc.1208949; Gomez-Bougie P, 2004, EUR J IMMUNOL, V34, P3156, DOI 10.1002/eji.200424981; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Morley SJ, 2005, CELL DEATH DIFFER, V12, P571, DOI 10.1038/sj.cdd.4401591; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Tang DM, 1999, J BIOL CHEM, V274, P7245, DOI 10.1074/jbc.274.11.7245; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Wei MC, 2000, GENE DEV, V14, P2060; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; YANG L, 1995, AUDIT NEUROSCI, V1, P1; Yao R, 1996, ONCOGENE, V13, P343; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	69	126	129	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6192	6200		10.1074/jbc.M610643200	http://dx.doi.org/10.1074/jbc.M610643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200126	Green Accepted, hybrid			2022-12-27	WOS:000244867200025
J	Doukov, TI; Hemmi, H; Drennan, CL; Ragsdale, SW				Doukov, Tzanko I.; Hemmi, Hisashi; Drennan, Catherine L.; Ragsdale, Stephen W.			Structural and kinetic evidence for an extended hydrogen-bonding network in catalysis of methyl group transfer - Role of an active site asparagine residue inactivation of methyl transfer by methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURINE NUCLEOSIDE PHOSPHORYLASE; COENZYME-M METHYLTRANSFERASE; IRON-SULFUR PROTEIN; DIHYDROFOLATE-REDUCTASE; CLOSTRIDIUM-THERMOACETICUM; METHIONINE SYNTHASE; CRYSTAL-STRUCTURE; MECHANISM; METHYLTETRAHYDROFOLATE; PROTONATION	The methyltetrahydrofolate (CH3-H(4)folate) corrinoid-iron-sulfur protein (CFeSP) methyltransferase (MeTr) catalyzes transfer of the methyl group of CH3-H(4)folate to cob(I)amide. This key step in anaerobic CO and CO, fixation is similar to the first half-reaction in the mechanisms of other cobalamin-dependent methyltransferases. Methyl transfer requires electrophilic activation of the methyl group of CH3-H(4)folate, which includes proton transfer to the N5 group of the pterin ring and poises the methyl group for reaction with the Co(I) nucleophile. The structure of the binary CH3-H(4)folate/MeTr complex (revealed here) lacks any obvious proton donor near the N5 group. Instead, an Asn residue and water molecules are found within H-bonding distance of N5. Structural and kinetic experiments described here are consistent with the involvement of an extended H-bonding network in proton transfer to N5 of the folate that includes an Asn (Asn-199 in MeTr), a conserved Asp (Asp-160), and a water molecule. This situation is reminiscent of purine nucleoside phosphorylase, which involves protonation of the purine N7 in the transition state and is accomplished by an extended H-bond network that includes water molecules, a Glu residue, and an Asn residue (Kicska, G. A., Tyler, P. C., Evans, G. B., Furneaux, R. H., Shi, W., Fedorov, A., Lewandowicz, A., Cahill, S. M., Almo, S. C., and Schramm, V. L. (2002) Biochemistry 41, 14489-14498). In MeTr, the Asn residue swings from a distant position to within H-bonding distance of the N5 atom upon CH3-H(4)folate binding. An N199A variant exhibits only similar to 20-fold weakened affinity for CH3-H(4)folate but a much more marked 20,000 - 40,000-fold effect on catalysis, suggesting that Asn-199 plays an important role in stabilizing a transition state or high energy intermediate for methyl transfer.	Univ Nebraska, Dept Biochem, Beadle Ctr, Lincoln, NE 68588 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	University of Nebraska System; University of Nebraska Lincoln; Massachusetts Institute of Technology (MIT)	Ragsdale, SW (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr, 1901 Vine St, Lincoln, NE 68588 USA.	sragsdale1@unl.edu	Hemmi, Hisashi/I-6868-2014	Hemmi, Hisashi/0000-0002-9538-809X	NCRR NIH HHS [P20 RR017675, 1P20RR17675] Funding Source: Medline; NIGMS NIH HHS [GM69857, R01 GM039451, GM39451, R01 GM069857, R37 GM039451] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039451, R01GM069857, R29GM039451, R01GM039451] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Babaoglu K, 2004, STRUCTURE, V12, P1705, DOI 10.1016/j.str.2004.07.011; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; Cannon WR, 1997, J MOL BIOL, V271, P656, DOI 10.1006/jmbi.1997.1173; Casarotto MG, 1999, BIOCHEMISTRY-US, V38, P8038, DOI 10.1021/bi990301p; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cummins PL, 2001, J AM CHEM SOC, V123, P3418, DOI 10.1021/ja0038474; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; Evans W, 1997, CHEM BRIT, V33, P22; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Ferrer S, 2003, J PHYS CHEM B, V107, P14036, DOI 10.1021/jp0354898; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hippler B, 1999, FEBS LETT, V449, P165, DOI 10.1016/S0014-5793(99)00429-9; HOWELL EE, 1986, SCIENCE, V231, P1123, DOI 10.1126/science.3511529; KICSKA GA, 2005, BIOCHEMISTRY-US, V41, P14489; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewandowicz A, 2005, J BIOL CHEM, V280, P30320, DOI 10.1074/jbc.M505033200; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; RAGSDALE SW, 2003, ENCY CATALYSIS, P452; Rod TH, 2003, J AM CHEM SOC, V125, P8718, DOI 10.1021/ja035272r; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauer K, 1997, EUR J BIOCHEM, V249, P280, DOI 10.1111/j.1432-1033.1997.t01-1-00280.x; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5736, DOI 10.1021/bi9824745; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5728, DOI 10.1021/bi982473c; Smith AE, 2000, BIOCHEMISTRY-US, V39, P13880, DOI 10.1021/bi001431x; SMITH AE, 2002, THESIS U MICHIGAN AN; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Taurog RE, 2006, BIOCHEMISTRY-US, V45, P5092, DOI 10.1021/bi060052m; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; ZHAO SY, 1995, BIOCHEMISTRY-US, V34, P15075, DOI 10.1021/bi00046a013; Zhao SY, 1996, BIOCHEMISTRY-US, V35, P2476, DOI 10.1021/bi952310d	39	34	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6609	6618		10.1074/jbc.M609828200	http://dx.doi.org/10.1074/jbc.M609828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17172470	hybrid, Green Accepted			2022-12-27	WOS:000244867200070
J	Kunkel, MT; Toker, A; Tsien, RY; Newton, AC				Kunkel, Maya T.; Toker, Alex; Tsien, Roger Y.; Newton, Alexandra C.			Calcium-dependent regulation of protein kinase D revealed by a genetically encoded kinase activity reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; FLUORESCENT REPORTER; LIVING CELLS; D ACTIVATION; PHOSPHORYLATION; SUBSTRATE; DOMAIN; CA2+; SPECIFICITY; RECEPTORS	Protein kinase D (PKD) regulates many diverse cellular functions in response to diacylglycerol. To monitor PKD signaling in live cells, we generated a genetically encoded fluorescent reporter for PKD activity, DKAR (D kinase activity reporter). DKAR expressed in mammalian cells undergoes reversible fluorescence resonance energy transfer changes upon activation and inhibition of endogenous PKD. Surprisingly, we find that agonist-evoked activation of PKD is driven not only by diacylglycerol production, but by Ca2+. Furthermore, elevation of intracellular Ca2+, in the absence of any other stimulus, is sufficient to activate PKD. Concurrent imaging of Ca2+, diacylglycerol, and PKD activity reveals that thapsigargin-mediated elevation of intracellular Ca2+ is closely followed by a robust increase in diacylglycerol production, in turn followed by PKD activation. The Ca2+-induced production of diacylglycerol and accompanying PKD activation is dependent on phospholipase C activity. These data reveal that Ca2+ is a major contributor to the initiation of PKD signaling through positive feedback regulation of diacylglycerol production, unveiling a new mechanism in PKD activation.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, Leichtag 282,9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			NCI NIH HHS [R01 CA075134-03, CA075134, R01 CA075134] Funding Source: Medline; NIDDK NIH HHS [P01 DK54441, T32 DK007233, DK07233, P01 DK054441, P01 DK054441-020003] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, T32DK007233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Brunschweiger A, 2006, CURR MED CHEM, V13, P289, DOI 10.2174/092986706775476052; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; EBERHARD DA, 1988, TRENDS NEUROSCI, V11, P517, DOI 10.1016/0166-2236(88)90174-9; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sato M, 2004, METHODS, V32, P451, DOI 10.1016/j.ymeth.2003.10.013; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	29	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6733	6742		10.1074/jbc.M608086200	http://dx.doi.org/10.1074/jbc.M608086200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17189263	Green Accepted, hybrid			2022-12-27	WOS:000244867200083
J	Rellos, P; Ivins, FJ; Baxter, JE; Pike, A; Nott, TJ; Parkinson, DM; Das, S; Howell, S; Fedorov, O; Shen, QY; Fry, AM; Knapp, S; Smerdon, SJ				Rellos, Peter; Ivins, Frank J.; Baxter, Joanne E.; Pike, Ashley; Nott, Timothy J.; Parkinson, Donna-Marie; Das, Sanjan; Howell, Steven; Fedorov, Oleg; Shen, Qi Yu; Fry, Andrew M.; Knapp, Stefan; Smerdon, Stephen J.			Structure and regulation of the human Nek2 centrosomal kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIMA-RELATED KINASE; CELL-CYCLE REGULATION; PROTEIN-KINASE; SUBSTRATE-SPECIFICITY; TYROSINE KINASE; PHOSPHORYLATION; EXPRESSION; INHIBITION; DEPENDS; MITOSIS	The dimeric Ser/Thr kinase Nek2 regulates centrosome cohesion and separation through phosphorylation of structural components of the centrosome, and aberrant regulation of Nek2 activity can lead to aneuploid defects characteristic of cancer cells. Mutational analysis of autophosphorylation sites within the kinase domain identified by mass spectrometry shows a complex pattern of positive and negative regulatory effects on kinase activity that are correlated with effects on centrosomal splitting efficiency in vivo. The 2.2-angstrom resolution x-ray structure of the Nek2 kinase domain in complex with a pyrrole-indolinone inhibitor reveals an inhibitory helical motif within the activation loop. This helix presents a steric barrier to formation of the active enzyme and generates a surface that may be exploitable in the design of specific inhibitors that selectively target the inactive state. Comparison of this "auto-inhibitory" conformation with similar arrangements in cyclin-dependent kinase 2 and epidermal growth factor receptor kinase suggests a role for dimerization-dependent allosteric regulation that combines with autophosphorylation and protein phosphatase 1c phosphatase activity to generate the precise spatial and temporal control required for Nek2 function in centrosomal maturation.	Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; Univ Oxford, Botnar Res Ctr, Struct Genom Consortium, Oxford OX3 7LD, England; Natl Inst Med Res, Med Res Council, Div Mol Struct, London NW7 1AA, England	University of Leicester; University of Oxford; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Fry, AM (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	amf5@leicester.ac.uk; Stefan.Knapp@sgc.ox.ac.uk; stephen.smerdon@nimr.mrc.ac.uk	Knapp, Stefan/AAG-2347-2019; Fedorov, Oleg Y./B-6412-2014	Knapp, Stefan/0000-0001-5995-6494; Fedorov, Oleg Y./0000-0001-9004-1815; Smerdon, Stephen/0000-0001-5688-8465; Nott, Timothy/0000-0002-5210-4931	MRC [MC_U117584228] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C000013/1] Funding Source: Medline; Medical Research Council [MC_U117584228] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; de Vos S, 2003, LAB INVEST, V83, P271, DOI 10.1097/01.LAB.0000053913.85892.E9; Di Agostino S, 2004, MOL BIOL CELL, V15, P1224, DOI 10.1091/mbc.E03-09-0638; Di Agostino S, 2002, DEVELOPMENT, V129, P1715; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eto M, 2002, J BIOL CHEM, V277, P44013, DOI 10.1074/jbc.M208035200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fletcher L, 2005, BBA-MOL CELL RES, V1744, P89, DOI 10.1016/j.bbamcr.2005.01.007; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Graf R, 2002, J CELL SCI, V115, P1919; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hames RS, 2002, BIOCHEM J, V361, P77, DOI 10.1042/0264-6021:3610077; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Heryanto B, 2003, REPRODUCTION, V125, P337, DOI 10.1530/reprod/125.3.337; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Liao AT, 2002, BLOOD, V100, P585, DOI 10.1182/blood-2001-12-0350; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; LU KP, 1994, J BIOL CHEM, V269, P6603; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Mayor T, 2002, J CELL SCI, V115, P3275; Meraldi P, 2001, J CELL SCI, V114, P3749; MORRIS NR, 1989, BIOESSAYS, V10, P196; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Prigent C, 2005, EXP CELL RES, V303, P1, DOI 10.1016/j.yexcr.2004.04.052; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Uto K, 1999, DEV BIOL, V208, P456, DOI 10.1006/dbio.1999.9231; Wai DH, 2002, INT J ONCOL, V20, P441; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Zhang W, 2005, J BIOL CHEM, V280, P42994, DOI 10.1074/jbc.M505450200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	53	80	98	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6833	6842		10.1074/jbc.M609721200	http://dx.doi.org/10.1074/jbc.M609721200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197699	Green Published, hybrid			2022-12-27	WOS:000244867200093
J	Chen, CJ; Kirshner, J; Sherman, MA; Hu, WD; Nguyen, T; Shively, JE				Chen, Charng-Jui; Kirshner, Julia; Sherman, Mark A.; Hu, Weidong; Nguyen, Tung; Shively, John E.			Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY GLYCOPROTEIN CD66A; C-CAM; CARCINOEMBRYONIC ANTIGENS; STRUCTURAL BASIS; EXPRESSION; PROTEINS; RECEPTOR; MODEL; MORPHOGENESIS; SYSTEM	CEACAM1-4S (carcinoembryonic antigen cell adhesion molecule 1, with 4 ectodomains and a short, 12-14 amino acid cytoplasmic domain) mediates lumen formation via an apoptotic and cytoskeletal reorganization mechanism when mammary epithelial cells are grown in a three-dimensional model of mammary morphogenesis. We show by quantitative yeast two-hybrid, BIAcore, NMR HSQC and STD, and confocal analyses that amino acids phenylalanine (Phe(454)) and lysine (Lys(456)) are key residues that interact with actin orchestrating the cytoskeletal reorganization. A CEACAM1 membrane model based on vitamin D-binding protein that predicts an interaction of Phe 454 at subdomain 3 of actin was supported by inhibition of binding of actin to vitamin D-binding protein by the cytoplasmic domain peptide. We also show that residues Thr(457) and/or Ser(419) are phosphorylated in CEACAM1-transfected cells grown in three-dimensional culture and that mutation analysis of these residues (T457A/S459A) or F454A blocks lumen formation. These studies demonstrate that a short cytoplasmic domain membrane receptor can directly mediate substantial intracellular signaling.	City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Beckman Res Inst, Dvi Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			NCI NIH HHS [CA84202] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blau DM, 2001, J VIROL, V75, P8173, DOI 10.1128/JVI.75.17.8173-8186.2001; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Edlund M, 1998, FEBS LETT, V425, P166, DOI 10.1016/S0014-5793(98)00222-1; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, J BIOL CHEM, V278, P50338, DOI 10.1074/jbc.M309115200; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kleinerman DI, 1996, CANCER RES, V56, P3431; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Luo WP, 1999, CANCER GENE THER, V6, P313, DOI 10.1038/sj.cgt.7700055; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Nollau P, 1997, CANCER RES, V57, P2354; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Otterbein LR, 2002, P NATL ACAD SCI USA, V99, P8003, DOI 10.1073/pnas.122126299; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Spaar A, 2003, BIOPHYS J, V85, P1576, DOI 10.1016/S0006-3495(03)74589-5; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; WALLACH DFH, 1976, J CELL PHYSIOL, V89, P769, DOI 10.1002/jcp.1040890440; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	40	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5749	5760		10.1074/jbc.M610903200	http://dx.doi.org/10.1074/jbc.M610903200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192268	hybrid			2022-12-27	WOS:000244482300071
J	Dial, JM; Petrotchenko, EV; Borchers, CH				Dial, J. Michael; Petrotchenko, Evgeniy V.; Borchers, Christoph H.			Inhibition of APC(Cdh1) activity by Cdh1/Acm1/Bmh1 ternary complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE CONTROL; S-PHASE; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; 14-3-3 PROTEINS; MITOTIC CYCLIN; PERSISTS UNTIL; DIRECT BINDING; CDC20	The anaphase-promoting complex (APC) is an essential E3 ubiquitin ligase responsible for catalyzing proteolysis of key regulatory proteins in the cell cycle. Cdh1 is a co-activator of the APC aiding in the onset and maintenance of G, phase, whereas phosphorylation of Cdh1 at the end of G, phase by cyclin-dependent kinases assists in the inactivation of APC (Cdh)1. Here, we suggest additional components are involved in the inactivation of APC(Cdh1) independent of Cdh1 phosphorylation. We have identified proteins known as Acm1 and Bmh1, which bind and form a ternary complex with Cdh1. The presence of phosphorylated Acm1 is critical for the ternary complex formation, and Acm1 is predominantly expressed in S phase when APC(Cdh1) is inactive. The assembly of the ternary complex inhibits ubiquitination of Clb2 in vitro by blocking the interaction of Cdh1 with Clb2. In vivo, lethality caused by overexpression of constitutively active Cdh1 is rescued by overexpression of Acm1. Partially phosphorylated Cdh1 in the absence of ACM1 still binds to and activates the APC. However, the addition of Acm1 decreases Clb2 ubiquitination when using either phosphorylated or nonphosphorylated Cdh1. Taken together, our results suggest an additional inactivation mechanism exists for APC(Cdh1) that is independent of Cdh1 phosphorylation.	Univ Victoria, Proteom Ctr, Vancouver Isl Technol Pk, Dept Biochem & Microbiol, Victoria, BC V8Z 7X8, Canada; Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Victoria; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Borchers, CH (corresponding author), Univ Victoria, Proteom Ctr, Vancouver Isl Technol Pk, Dept Biochem & Microbiol, 3101-4464 Markham St, Victoria, BC V8Z 7X8, Canada.	christoph@proteincentre.com	BORCHERS, Christoph/U-5964-2019					AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; HARPER JW, 2003, J BIOL CHEM, V278, P16698; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; McDonald ER, 2001, ANN MED, V33, P113, DOI 10.3109/07853890109002066; Michalides RJAM, 2002, HEAD NECK-J SCI SPEC, V24, P694, DOI 10.1002/hed.10109; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Parker Carol E., 2005, V301, P117; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pray TR, 2002, DRUG RESIST UPDATE, V5, P249, DOI 10.1016/S1368-7646(02)00121-8; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; van Hemert MJ, 2001, YEAST, V18, P889, DOI 10.1002/yea.739; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zeng Y, 1999, MOL CELL BIOL, V19, P7410	47	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5237	5248		10.1074/jbc.M606589200	http://dx.doi.org/10.1074/jbc.M606589200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178718	Green Published, hybrid			2022-12-27	WOS:000244482300018
J	Gerard, F; Cline, K				Gerard, Fabien; Cline, Kenneth			The thylakoid proton gradient promotes an advanced stage of signal peptide binding deep within the Tat pathway receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-TRANSPORT; DELTA-PH PATHWAY; TRANSLOCATION SYSTEM; PHOTOSYSTEM-II; SEC; CHLOROPLASTS; MEMBRANE; INTEGRATION; MACHINERY; EFFICIENT	Tat (twin arginine translocation) systems transport folded proteins across the thylakoid membrane of chloroplasts and the plasma membrane of most bacteria. Tat precursors are targeted by hydrophobic cleavable signal peptides with twin arginine (RR) motifs. Bacterial precursors possess an extended consensus, (S/T)RRXFLK, of which the two arginines and the phenylalanine are essential for efficient transport. Thylakoid Tat precursors possess twin arginines but lack the consensus phenylalanine. Here, we have characterized two stages of precursor binding to the thylakoid Tat signal peptide receptor, the 700-kDa cpTatC-Hcf106 complex. The OE17 precursor tOE17 binds to the receptor by RR-dependant electrostatic interactions and partially dissociates during blue native gel electrophoresis. In addition, the signal peptide of thylakoid-bound tOE17 is highly exposed to the membrane surface, as judged by accessibility to factor Xa of cleavage sites engineered into signal peptide flanking regions. By contrast, tOE17 containing a consensus phenylalanine in place of Val(-20) (V - 20F) binds the receptor more strongly and is completely stable during blue native gel electrophoresis. Thylakoid bound V - 20F is also completely protected from factor Xa at the identical sites. This suggests that the signal peptide is buried deeply in the cpTatC-Hcf106 binding site. We further provide evidence that the proton gradient, which is required for translocation, induces a tighter interaction between tOE17 and the cpTat machinery, similar to that exhibited by V - 20F. This implies that translocation involves a very intimate association of the signal peptide with the receptor complex binding site.	Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cline, K (corresponding author), Univ Florida, Dept Hort Sci, 1109 Fifield Hall,Box 110690, Gainesville, FL 32611 USA.	kcline@ufl.edu	Cline, Kenneth/J-6238-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048179] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM48179] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Li HM, 2006, FEMS MICROBIOL LETT, V255, P268, DOI 10.1111/j.1574-6968.2005.00081.x; MA X, 1999, THESIS U FLORIDA GAI; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Marques JP, 2004, J EXP BOT, V55, P1697, DOI 10.1093/jxb/erh191; Mori H, 1998, J BIOL CHEM, V273, P11405, DOI 10.1074/jbc.273.19.11405; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Ristvejova J, 2006, BIOCHEM BIOPH RES CO, V345, P287, DOI 10.1016/j.bbrc.2006.04.087; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Summer EJ, 2000, J BIOL CHEM, V275, P23483, DOI 10.1074/jbc.M004137200; Wexler M, 1998, FEBS LETT, V431, P339, DOI 10.1016/S0014-5793(98)00790-X	30	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5263	5272		10.1074/jbc.M610337200	http://dx.doi.org/10.1074/jbc.M610337200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17172598	hybrid			2022-12-27	WOS:000244482300021
J	Hirst-Jensen, BJ; Sahoo, P; Kieken, F; Delmar, M; Sorgen, PL				Hirst-Jensen, Bethany J.; Sahoo, Prangya; Kieken, Fabien; Delmar, Mario; Sorgen, Paul L.			Characterization of the pH-dependent interaction between the gap junction protein connexin43 carboxyl terminus and cytoplasmic loop domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMERIZATION DOMAIN; POTASSIUM CHANNELS; BINDING DOMAINS; COMMUNICATION; PEPTIDE; NMR; PHOSPHORYLATION; ACIDIFICATION; SPECTROSCOPY; DIMERIZATION	A prevailing view regarding the regulation of connexin43 (Cx43) gap junction channels is that, upon intracellular acidification, the carboxyl-terminal domain (Cx43CT) moves toward the channel opening to interact with specific residues acting as a receptor site. Previous studies have demonstrated a direct, pH-dependent interaction between the Cx43CT and a Cx43 cytoplasmic loop (Cx43CL) peptide. This interaction was dependent on alpha-helical formation for the peptide in response to acidification; more recent studies have shown that acidification also induces Cx43CT dimerization. Whether Cx43CT dimerization is an important structural component in Cx43 regulation remains to be determined. Here we used an assortment of complimentary biophysical techniques to characterize the binding of Cx43CT or its mutants to itself and/or to a more native-like Cx43CL construct (Cx43CL(100-155) residues 100-155). Our studies expand the observation that specific Cx43CT domains are important for dimerization. We further show that properties of the Cx43CL(100-155) are different from those of the Cx43CL peptide; solvent acidification leads to Cx43CL(100-155) oligomerization and a change in the stoichiometry and binding affinity for the Cx43CT. Homo-Cx43CT and Cx43CL(100-155) oligomerization as well as the Cx43CT/Cx43CL(100-155) interaction can occur under in vivo conditions; moreover, we show that Cx43CL(100-155) strongly affects resonance peaks corresponding to Cx43CT residues Arg-376-Asp-379 and Asn-343-Lys-346. Overall, our data indicate that many of the sites involved in Cx43CT dimerization are also involved in the Cx43CT/Cx43CL interaction; we further propose that chemically induced Cx43CT and Cx43CL oligomerization is important for the interaction between these cytoplasmic domains, which leads to chemically induced gating of Cx43 channels.	Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sorgen, PL (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, 600 S 42nd St, Omaha, NE 68198 USA.	psorgen@unmc.edu		Delmar, Mario/0000-0002-2085-5589	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057691, R01GM072631] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080602] Funding Source: Medline; NIGMS NIH HHS [GM072631, R01 GM072631, GM57691] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Calero G, 1998, CIRC RES, V82, P929, DOI 10.1161/01.RES.82.9.929; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; CASCIO WE, 1995, J CARDIOVASC ELECTR, V6, P1039, DOI 10.1111/j.1540-8167.1995.tb00381.x; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Francis D, 1999, DEV GENET, V24, P123, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<123::AID-DVG12>3.0.CO;2-H; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Li WEI, 2002, DEVELOPMENT, V129, P2031; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Peters NS, 1997, CIRCULATION, V95, P988; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rousset B, 1996, ANN ENDOCRINOL-PARIS, V57, P476; Saffitz JE, 2000, CARDIOVASC RES, V45, P807, DOI 10.1016/S0008-6363(99)00421-6; Seki A, 2004, CIRC RES, V95, P22, DOI 10.1161/01.RES.0000140737.62245.c5; Shibayama J, 2006, CIRC RES, V98, P1365, DOI 10.1161/01.RES.0000225911.24228.9c; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Sorgen PL, 2002, J BIOMOL NMR, V23, P245, DOI 10.1023/A:1019892719979; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; SPRAY DC, 1990, AM J PHYSIOL, V258, P195; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; TAI MH, 2003, PANCREAS, V26, P18; Torok K, 1997, BIOCHEM J, V326, P479; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; van Drogen-Petit A, 2004, J MOL BIOL, V336, P1195, DOI 10.1016/j.jmb.2003.12.062; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	44	73	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5801	5813		10.1074/jbc.M605233200	http://dx.doi.org/10.1074/jbc.M605233200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178730	hybrid			2022-12-27	WOS:000244482300076
J	Lange, A; Mills, RE; Lange, CJ; Stewart, M; Devine, SE; Corbett, AH				Lange, Allison; Mills, Ryan E.; Lange, Christopher J.; Stewart, Murray; Devine, Scott E.; Corbett, Anita H.			Classical nuclear localization signals: Definition, function, and interaction with importin alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GTPASE-ACTIVATING PROTEIN; PORE COMPLEX; STRUCTURAL BASIS; CRYSTALLOGRAPHIC ANALYSIS; NUCLEOTIDE EXCHANGE; SYSTEMS-ANALYSIS; EXPORT; RECOGNITION; SEQUENCE; RAN	The best understood system for the transport of macromolecules between the cytoplasm and the nucleus is the classical nuclear import pathway. In this pathway, a protein containing a classical basic nuclear localization signal (NLS) is imported by a heterodimeric import receptor consisting of the beta-karyopherin importin 13, which mediates interactions with the nuclear pore complex, and the adaptor protein importin a, which directly binds the classical NLS. Here we review recent studies that have advanced our understanding of this pathway and also take a bioinformatics approach to analyze the likely prevalence of this system in vivo. Finally, we describe how a predicted NLS within a protein of interest can be confirmed experimentally to be functionally important.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Emory University; MRC Laboratory Molecular Biology	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Mills, Ryan/F-4225-2010; Corbett, Anita/AAH-6106-2021	Mills, Ryan/0000-0003-3425-6998; Corbett, Anita/0000-0002-0461-6895	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: Medline; NHGRI NIH HHS [R01 HG002898, R01 HG002898-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM058728] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen TD, 2000, J CELL SCI, V113, P1651; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Blondel M, 1999, GENE DEV, V13, P2284, DOI 10.1101/gad.13.17.2284; BONNER WM, 1978, PROTEIN MIGRATION AC; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Damelin M, 2002, METHOD ENZYMOL, V351, P587; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog Birthe, 2002, Results Probl Cell Differ, V35, P25; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gilchrist D, 2003, J BIOL CHEM, V278, P51937, DOI 10.1074/jbc.M307371200; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729	61	825	939	5	143	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5101	5105		10.1074/jbc.R600026200	http://dx.doi.org/10.1074/jbc.R600026200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17170104	Green Accepted, hybrid			2022-12-27	WOS:000244482300002
J	Liu, Q; Kriksunov, IA; Graeff, R; Lee, HC; Hao, Q				Liu, Qun; Kriksunov, Irina A.; Graeff, Richard; Lee, Hon Cheung; Hao, Quan			Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; CYCLASE; NAADP	Human CD38 is a multifunctional ectoenzyme responsible for catalyzing the conversions from nicotinamide adenine dinucleotide (NAD) to cyclic ADP-ribose (cADPR) and from cADPR to ADP-ribose (ADPR). Both cADPR and ADPR are calcium messengers that can mobilize intracellular stores and activate influx as well. In this study, we determined three crystal structures of the human CD38 enzymatic domain complexed with cADPR at 1.5-angstrom resolution, with its analog, cyclic GDP-ribose (cGDPR) (1.68 angstrom) and with NGD (2.1 angstrom), a substrate analog of NAD. The results indicate that the binding of cADPR or cGDPR to the active site induces structural rearrangements in the dipeptide Glu(116)-Asp(147) by as much as 2.7 angstrom, providing the first direct evidence of a conformational change at the active site during catalysis. In addition, Glu(226) is shown to be critical not only in catalysis but also in positioning of cADPR at the catalytic site through strong hydrogen bonding interactions. Structural details obtained from these complexes provide a step-by-step description of the catalytic processes in the synthesis and hydrolysis of cADPR.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Cornell Univ, MacCHESS, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; University of Hong Kong	Lee, HC (corresponding author), Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA.	leehc@hku.hk; qh22@cornell.edu	Liu, Qun/A-8757-2011; Graeff, Richard Milton/B-3425-2011; Hao, Quan/C-4304-2009; Lee, Hon Cheung/C-4329-2009	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061568] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01646] Funding Source: Medline; NIGMS NIH HHS [GM061568] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff RM, 1996, BIOCHEMISTRY-US, V35, P379, DOI 10.1021/bi952083f; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; LEE HC, 1993, BIOCHEM BIOPH RES CO, V191, P639, DOI 10.1006/bbrc.1993.1265; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi CB, 1997, METHOD ENZYMOL, V280, P318; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Zwart PH, 2004, ACTA CRYSTALLOGR D, V60, P2230, DOI 10.1107/S0907444904012995	24	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5853	5861		10.1074/jbc.M609093200	http://dx.doi.org/10.1074/jbc.M609093200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182614	hybrid			2022-12-27	WOS:000244482300081
J	Wilson, EM; Rotwein, P				Wilson, Elizabeth M.; Rotwein, Peter			Selective control of skeletal muscle differentiation by Akt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; GROWTH-FACTOR-II; KINASE-B; PROTEIN-KINASE; SIGNALING PATHWAYS; MYOCYTE MATURATION; MAMMALIAN TARGET; CELL-SURVIVAL; MICE LACKING; ATROPHY	The phosphatidylinositol 3-kinase-Akt pathway plays a central role in growth, development, and metabolism in both normal and neoplastic cells. In skeletal muscle, Akt has been implicated in regulating regeneration and hypertrophy and in counteracting atrophy. Here we provide evidence that Akt1 and not Akt2 is essential for muscle differentiation. Using a robust model of MyoD-mediated muscle development, in which dominant-negative Akt blocked differentiation, we show that targeted loss of Akt1 was equally inhibitory. Selective elimination of Akt1 had no effect on myoblast viability or proliferation but prevented differentiation by impairing the transcriptional actions of Myol). In contrast, knockdown of Akt2 had no effect on myoblast survival or differentiation and minimally inhibited MyoD-regulated transcription. Our results define isoform-specific Akt-regulated signaling pathways in muscle cells that act through Akt1 to sustain muscle gene activation and promote differentiation.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Rd,Mail Code L224, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	NIDDK NIH HHS [R01 DK042748, R01 DK42748] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	37	92	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5106	5110		10.1074/jbc.C600315200	http://dx.doi.org/10.1074/jbc.C600315200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17218321	hybrid			2022-12-27	WOS:000244482300003
J	Cunha, SR; Bhasin, N; Mohler, PJ				Cunha, Shane R.; Bhasin, Naina; Mohler, Peter J.			Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGER; NA+/CA2+ EXCHANGER; NEONATAL CARDIOMYOCYTES; VENTRICULAR MYOCYTES; HEART-FAILURE; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; CYTOPLASMIC PROTONS; DYNAMIC PROPERTIES	Na/Ca exchanger activity is important for calcium extrusion from the cardiomyocyte cytosol during repolarization. Animal models exhibiting altered Na/Ca exchanger expression display abnormal cardiac phenotypes. In humans, elevated Na/Ca exchanger expression/activity is linked with pathophysiological conditions including arrhythmia and heart failure. Whereas the molecular mechanisms underlying Na/Ca exchanger biophysical properties are widely studied and generally well characterized, the cellular pathways and molecular partners underlying the specialized membrane localization of Na/Ca exchanger in cardiac tissue are essentially unknown. In this report, we present the first direct evidence for a protein pathway required for Na/Ca exchanger localization and stability in primary cardiomyocytes. We define the minimal structural requirements on ankyrin-B for direct Na/Ca exchanger interactions. Moreover, using ankyrin-B mutants that lack Na/Ca exchanger binding activity, and primary cardiomyocytes with reduced ankyrin-B expression, we demonstrate that direct interaction with the membrane adaptor ankyrin-B is required for the localization and post-translational stability of Na/Ca exchanger 1 in neonatal mouse cardiomyocytes. These results raise exciting new questions regarding potentially dynamic roles for ankyrin proteins in the biogenesis and maintenance of specialized membrane domains in excitable cells.	Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiol, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Physiol & Mol Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Mohler, PJ (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiol, Iowa City, IA 52242 USA.	peter-mohler@uiowa.edu			NHLBI NIH HHS [R01HL083422, R01HL084583] Funding Source: Medline; NIMH NIH HHS [T32MH065215] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084583, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AdachiAkahane S, 1997, J GEN PHYSIOL, V109, P717, DOI 10.1085/jgp.109.6.717; BEAUGE L, 1991, ANN NY ACAD SCI, V639, P147, DOI 10.1111/j.1749-6632.1991.tb17298.x; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1979, J BIOL CHEM, V254, P2533; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Birkeland JA, 2005, SCAND CARDIOVASC J, V39, P13, DOI 10.1080/14017430410004632; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bossuyt J, 2002, ANN NY ACAD SCI, V976, P197; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; CARONI P, 1983, EUR J BIOCHEM, V132, P451, DOI 10.1111/j.1432-1033.1983.tb07383.x; Chen FH, 1997, J MOL CELL CARDIOL, V29, P2621, DOI 10.1006/jmcc.1997.0475; CHEN FH, 1995, AM J PHYSIOL-CELL PH, V268, pC1126, DOI 10.1152/ajpcell.1995.268.5.C1126; Cho CH, 2000, MOL CELLS, V10, P712; Condrescu M, 2006, AM J PHYSIOL-CELL PH, V290, pC691, DOI 10.1152/ajpcell.00232.2005; Dipla K, 1999, CIRC RES, V84, P435, DOI 10.1161/01.RES.84.4.435; DIPOLO R, 1987, BIOCHIM BIOPHYS ACTA, V897, P347, DOI 10.1016/0005-2736(87)90432-9; DIPOLO R, 1994, AM J PHYSIOL, V267, pC307, DOI 10.1152/ajpcell.1994.267.1.C307; DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481; DOERING AE, 1994, J PHYSIOL-LONDON, V480, P9, DOI 10.1113/jphysiol.1994.sp020336; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Ebert AM, 2005, P NATL ACAD SCI USA, V102, P17705, DOI 10.1073/pnas.0502683102; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; Henderson SA, 2004, CIRC RES, V95, P604, DOI 10.1161/01.RES.0000142316.08250.68; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; KIEVAL RS, 1992, AM J PHYSIOL, V263, pC545, DOI 10.1152/ajpcell.1992.263.2.C545; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Langenbacher AD, 2005, P NATL ACAD SCI USA, V102, P17699, DOI 10.1073/pnas.0502679102; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; LI ZP, 1991, J BIOL CHEM, V266, P1014; LI ZP, 1993, J BIOL CHEM, V268, P11489; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Pogwizd SM, 1999, CIRC RES, V85, P1009; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; Reuter H, 2004, J PHYSIOL-LONDON, V554, P779, DOI 10.1113/jphysiol.2003.055046; Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shannon TR, 2004, ANN NY ACAD SCI, V1015, P28, DOI 10.1196/annals.1302.003; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; SHIRAHATA E, 2006, J NEUROPHYSIOL; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; Slodzinski MK, 1998, AM J PHYSIOL-CELL PH, V275, pC459, DOI 10.1152/ajpcell.1998.275.2.C459; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200	65	53	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4875	4883		10.1074/jbc.M607096200	http://dx.doi.org/10.1074/jbc.M607096200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178715	hybrid			2022-12-27	WOS:000244482000070
J	Tammenkoski, M; Moiseev, VM; Lahti, M; Ugochukwu, E; Brondijk, THC; White, SA; Lahti, R; Baykov, AA				Tammenkoski, Marko; Moiseev, Viktor M.; Lahti, Matti; Ugochukwu, Emilie; Brondijk, T. Harma C.; White, Scott A.; Lahti, Reijo; Baykov, Alexander A.			Kinetic and mutational analyses of the major cytosolic exopolyphosphatase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-II PYROPHOSPHATASES; ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; STREPTOCOCCUS-GORDONII; BACILLUS-SUBTILIS; RECJ EXONUCLEASE; PROTEIN; GENE; ION; PURIFICATION	Yeast exopolyphosphatase (scPPX) processively splits off the terminal phosphate group from linear polyphosphates longer than pyrophosphate. scPPX belongs to the DHH phosphoesterase superfamily and is evolutionarily close to the well characterized family II pyrophosphatase (PPase). Here, we used steady-state kinetic and binding measurements to elucidate the metal cofactor requirement for scPPX catalysis over the pH range 4.2-9.5. A single tight binding site for Mg2+ (K-d of 24 mu m) was detected by equilibrium dialysis. Steady-state kinetic analysis of tripolyphosphate hydrolysis revealed a second site that binds Mg2+ in the millimolar range and modulates substrate binding. This step requires two protonated and two deprotonated. enzyme groups with pK(a) values of 5.0-5.3 and 7.6-8.2, respectively. The catalytic step requiring two deprotonated groups (pK, of 4.6 and 5.6) is modulated by ionization of a third group (pK, of 8.7). Conservative mutations of Asp(127), His(148), His(149) (conserved in scPPX and PPase), and Asn(35) (His in PPase) reduced activity by a factor of 600-5000. N35H and D127E substitutions reduced the Mg2+ affinity of the tight binding site by 25-60-fold. Contrary to expectations, the N35H variant was unable to hydrolyze pyrophosphate, but markedly altered metal cofactor specificity, displaying higher catalytic activity with Co2+ bound to the weak binding site versus the Me2+-or Mn2+-bound enzyme. These results provide an initial step toward understanding the dynamics of scPPX catalysis and reveal significant functional differences between structurally similar scPPX and familly II PPase.	Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; Moscow MV Lomonosov State Univ, AN Belozersky Inst PhysicoChem Biol, Moscow 119899, Russia; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University; University of Birmingham	Lahti, R (corresponding author), Univ Turku, Dept Biochem, FIN-20014 Turku, Finland.	reijo.lahti@utu.fi; baykov@genebee.msu.su	Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012; Brondijk, Harma/AAD-6485-2019	Brondijk, Harma/0000-0002-0234-673X; White, Scott/0000-0002-0202-6154; Baykov, Alexander/0000-0002-2495-8200				Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; [Anonymous], 2004, BIOCH INORGANIC POLY; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; Belogurov GA, 2000, BIOCHEMISTRY-US, V39, P13931, DOI 10.1021/bi000895s; Cardona ST, 2002, APPL ENVIRON MICROB, V68, P4812, DOI 10.1128/AEM.68.10.4812-4819.2002; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano W.L, PYMOL MOL GRAPHICS S; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; FRAY CM, 1972, J AM CHEM SOC, V94, P8898; Halonen P., 2005, BIOCHEMISTRY-US, V44, P2088; KAPYLA J, 1995, BIOCHEMISTRY-US, V34, P792, DOI 10.1021/bi00003a012; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2002, ACTA CRYSTALLOGR D, V58, P1198, DOI 10.1107/S0907444902008417; Kulakovskaya TV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P990; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lichko LP, 2003, FEMS YEAST RES, V3, P233, DOI 10.1016/S1567-1356(02)00205-2; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; Nishii W, 2005, FEBS LETT, V579, P6846, DOI 10.1016/j.febslet.2005.11.026; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; PATEL RC, 1973, J PHYS CHEM-US, V77, P2318, DOI 10.1021/j100638a012; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; REIZER J, 1993, TRENDS BIOCHEM SCI, V18, P247, DOI 10.1016/0968-0004(93)90172-J; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Sambrook J., 2002, MOL CLONING LAB MANU; SHAFRANSKII YA, 1977, BIOKHIMIYA, V42, P1244; SILLEN LG, 1964, STABILITY CONSTANTS, P332; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Sutera VA, 1999, J BACTERIOL, V181, P6098, DOI 10.1128/JB.181.19.6098-6102.1999; UGOCHUKWU E, 2005, THESIS U BIRM; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; WURST H, 1994, J BIOL CHEM, V269, P10996; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102; Zyryanov AB, 2004, BIOCHEMISTRY-US, V43, P14395, DOI 10.1021/bi048470j; Zyryanov AB, 2004, BIOCHEMISTRY-US, V43, P1065, DOI 10.1021/bi0357513	39	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9302	9311		10.1074/jbc.M609423200	http://dx.doi.org/10.1074/jbc.M609423200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17215253	hybrid			2022-12-27	WOS:000245421700002
J	Angevine, CM; Herold, KAG; Vincent, OD; Fillingame, RH				Angevine, Christine M.; Herold, Kelly A. G.; Vincent, Owen D.; Fillingame, Robert H.			Aqueous access pathways in ATP synthase subunit a - Reactivity of cysteine substituted into transmembrane helices 1, 3, AND 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CROSS-LINKING; ROTARY MOTOR; PROTON TRANSLOCATION; POTASSIUM CHANNEL; ALPHA-SUBUNIT; C-RING; MEMBRANE; MUTAGENESIS; MUTATIONS	Subunit a is thought to play a key role in H+ transport-driven rotation of the subunit c ring in Escherichia coli F1F0 ATP synthase. In the membrane-traversing F-0 sector of the enzyme, H+ binding and release occurs at Asp-61 in the middle of the second transmembrane helix (TMH) of subunit c. Protons are thought to reach Asp-61 via aqueous channels formed at least in part by one or more of the five TMHs of subunit a. Aqueous access to surfaces of TMHs 2, 4, and 5 was previously suggested based upon the chemical reactivity of cysteine residues substituted into these helices. Here we have substituted Cys into TMH1 and TMH3 and extended the substitutions in TMH5 to the cytoplasmic surface. One region of TMH3 proved to be moderately Ag+-sensitive and may connect with the Ag+-sensitive region found previously on the periplasmic side of TMH2. A single Cys substitution in TMH1 proved to be both N-ethylmaleimide (NEM)-sensitive and Ag+-sensitive and suggests a possible packing interaction of TMH1 with TMH2 and TMH3. New Ag+- and NEM-sensitive residues were found at the cytoplasmic end of TMH5 and suggest a possible connection of this region to the NEM- and Ag+-sensitive region of TMH4 described previously. From the now complete pattern of TMH residue reactivity, we conclude that aqueous access from the periplasmic side of F-0 to cAsp-61 at the center of the membrane is likely to be mediated by residues of TMHs 2, 3, 4, and 5 at the center of a four-helix bundle. Further, aqueous access between cAsp-61 and the cytoplasmic surface is likely to be mediated by residues in TMH4 and TMH5 at the exterior of the four-helix bundle that are in contact with the c-ring.	Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Fillingame RH, 2000, J EXP BIOL, V203, P9; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; GAY NJ, 1981, NUCLEIC ACIDS RES, V9, P2187, DOI 10.1093/nar/9.9.2187; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HOWITT SM, 1988, BIOCHIM BIOPHYS ACTA, V936, P74, DOI 10.1016/0005-2728(88)90253-8; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; VIK SB, 1991, J BACTERIOL, V173, P4544, DOI 10.1128/JB.173.14.4544-4548.1991; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang D, 2003, BIOCHEMISTRY-US, V42, P331, DOI 10.1021/bi026649t	38	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9001	9007		10.1074/jbc.M610848200	http://dx.doi.org/10.1074/jbc.M610848200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17234633	hybrid			2022-12-27	WOS:000245780300047
J	Uemura, S; Kihara, A; Iwaki, S; Inokuchi, JI; Igarashi, Y				Uemura, Satoshi; Kihara, Akio; Iwaki, Soichiro; Inokuchi, Jin-ichi; Igarashi, Yasuyuki			Regulation of the transport and protein levels of the inositol phosphorylceramide mannosyltransferases Csg1 and Csh1 by the Ca2+ binding protein Csg2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; SPHINGOLIPID BIOSYNTHESIS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; LINKED GLYCOSYLATION; GOLGI-APPARATUS; PLANT DEFENSIN; AUR1 GENE	Complex sphingolipids in yeast are known to function in cellular adaptation to environmental changes. One of the yeast complex sphingolipids, mannosylinositol phosphorylceramide (MIPC), is produced by the redundant inositol phosphorylceramide (IPC) mannosyltransferases Csg1 and Csh1. The Ca2+-binding protein Csg2 can form a complex with either Csg1 or Csh1 and is considered to act as a regulatory subunit. However, the role of Csg2 in MIPC synthesis has remained unclear. In this study, we found that Csg1 and Csh1 are N-glycosylated with core-type and mannan-type structures, respectively. Further identification of the glycosylated residues suggests that both Csg1 and Csh1 exhibit membrane topology with their C termini in the cytosol and their mannosyltransferase domains in the lumen. After complexing with Csg2, both Csg1 and Csh1 function in the Golgi, and then are delivered to the vacuole for degradation. However, uncomplexed Csh1 cannot exit from the endoplasmic reticulum. We also demonstrated that Ca2+ stimulates IPC-to-MIPC conversion, because of a Csg2-dependent increase in Csg1 levels. Thus, Csg2 has several regulatory functions for Csg1 and Csh1, including stability, transport, and gene expression.	Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Tohoku Pharmaceut Univ, Div Glycopathol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama 3320012, Japan; Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University; Tohoku Medical & Pharmaceutical University; Japan Science & Technology Agency (JST); Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Inokuchi, Jin-ichi/AAW-9964-2020; KIHARA, AKIO/A-3802-2012	Inokuchi, Jin-ichi/0000-0002-0703-5746; KIHARA, AKIO/0000-0001-5889-0788				Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; Aerts AM, 2006, FEBS LETT, V580, P1903, DOI 10.1016/j.febslet.2006.02.061; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BEELER T, 1994, J BIOL CHEM, V269, P7279; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530; Brachmann CB, 1998, YEAST, V14, P115; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Lisman Q, 2004, J BIOL CHEM, V279, P1020, DOI 10.1074/jbc.M306119200; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; TAKITA Y, 1995, MOL GEN GENET, V246, P269, DOI 10.1007/BF00288599; Tani M, 2006, BIOCHEM J, V394, P237, DOI 10.1042/BJ20051354; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Uemura S, 2003, J BIOL CHEM, V278, P45049, DOI 10.1074/jbc.M305498200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Zink S, 2005, EUKARYOT CELL, V4, P879, DOI 10.1128/EC.4.5.879-889.2005	42	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8613	8621		10.1074/jbc.M606649200	http://dx.doi.org/10.1074/jbc.M606649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17220303	Green Published, hybrid			2022-12-27	WOS:000245780300007
J	Yatsunyk, LA; Rosenzweig, AC				Yatsunyk, Liliya A.; Rosenzweig, Amy C.			Cu(I) binding and transfer by the N terminus of the Wilson disease protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; MENKES-DISEASE; REGULATED TRAFFICKING; ATX1 METALLOCHAPERONE; BICINCHONINIC ACID; CATALYTIC-ACTIVITY; PRION PROTEIN; GENE HOMOLOG; APO FORMS; DOMAIN	Wilson and Menkes diseases are genetic disorders of copper metabolism caused by mutations in the Wilson (WND) and Menkes (MNK) copper-transporting P-1B-type ATPases. The N termini of these ATPases consist of six metal binding domains (MBDs). The MBDs interact with the copper chaperone Atox1 and are believed to play roles in catalysis and in copper-mediated cellular relocalization of WND and MNK. Although all six MBDs have similar folds and bind one Cu(I) ion via a conserved CXXC motif, biochemical and genetic data suggest that they have distinct functions. Most studies aimed at characterizing the MBDs have employed smaller polypeptides consisting of one or two domains. The role of each MBD is probably defined by its environment within the six-domain N terminus, however. To study the properties of the individual domains within the context of the intact Wilson N terminus (N-WND), a series of variants in which five of the six metal binding CXXC motifs are mutated to SXXS was generated. For each variant, the Cu(I) binding affinity and the ability to exchange Cu(I) with Atox1 were investigated. The results indicate that Atox1 can deliver Cu(I) to and remove Cu(I) from each MBD, that each MBD has stronger Cu(I) retention properties than Atox1, and that all of the MBDs as well as Atox1 have similar K-Cu. values of (2.2-6.3) x 10(10) (-1)(M). Therefore, the specific role of each MBD is not conferred by its position within the intact N-WND but may be related to interactions with other domains and partner proteins.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	amyr@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058518] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Bunce J, 2006, BBA-GEN SUBJECTS, V1760, P907, DOI 10.1016/j.bbagen.2006.02.005; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Chen XH, 2000, J BIOL INORG CHEM, V5, P93, DOI 10.1007/s007750050012; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; Llanos RM, 2002, DNA CELL BIOL, V21, P259, DOI 10.1089/104454902753759681; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Ralle M, 2004, J INORG BIOCHEM, V98, P765, DOI 10.1016/j.jinorgbio.2004.02.009; Ralle M, 1998, J AM CHEM SOC, V120, P13525, DOI 10.1021/ja982990i; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wimmer R, 1999, J BIOL CHEM, V274, P22597, DOI 10.1074/jbc.274.32.22597; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	50	102	103	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8622	8631		10.1074/jbc.M609533200	http://dx.doi.org/10.1074/jbc.M609533200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17229731	hybrid			2022-12-27	WOS:000245780300008
J	Yu, JS; Bippes, CA; Hand, GM; Muller, DJ; Sosinsky, GE				Yu, Jinshu; Bippes, Christian A.; Hand, Galen M.; Muller, Daniel J.; Sosinsky, Gina E.			Aminosulfonate modulated pH-induced conformational changes in connexin26 hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION; 3-DIMENSIONAL STRUCTURE; CHANNELS; TAURINE; INHIBITION; CALCIUM; COMMUNICATION; SURFACE; CONDUCTANCE; ISCHEMIA	Gap junction channels regulate cell-cell communication by passing metabolites, ions, and signaling molecules. Gap junction channel closure in cells by acidification is well documented; however, it is unknown whether acidification affects connexins or modulating proteins or compounds that in turn act on connexins. Protonated aminosulfonates directly inhibit connexin channel activity in an isoform-specific manner as shown in previously published studies. High-resolution atomic force microscopy of force-dissected connexin26 gap junctions revealed that in HEPES buffer, the pore was closed at pH < 6.5 and opened reversibly by increasing the pH to 7.6. This pH effect was not observed in non-aminosulfonate buffers. Increasing the protonated HEPES concentration did not close the pore, indicating that a saturation of the binding sites occurs at 10 mm HEPES. Analysis of the extracellular surface topographs reveals that the pore diameter increases gradually with pH. The outer connexon diameter remains unchanged, and there is a similar to 6.5 degrees rotation in connexon lobes. These observations suggest that the underlying mechanism closing the pore is different from an observed Ca2+-induced closure.	Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	University of California System; University of California San Diego; Technische Universitat Dresden	Sosinsky, GE (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, 1070 Basic Sci Bldg,MC 0608,9500 Gilman Dr, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665	NCRR NIH HHS [RR04050] Funding Source: Medline; NIGMS NIH HHS [GM065937, R01 GM065937, GM072881] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072881, R01GM065937] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER TS, 1983, J CELL BIOL, V96, P204, DOI 10.1083/jcb.96.1.204; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 1997, BIOPHYS J, V72, P2137, DOI 10.1016/S0006-3495(97)78856-8; BURT JM, 1987, AM J PHYSIOL, V253, pC607, DOI 10.1152/ajpcell.1987.253.4.C607; Chang EH, 2003, EAR HEARING, V24, P314, DOI 10.1097/01.AUD.0000079801.55588.13; Delmar M, 2000, CURR TOP MEMBR, V49, P223; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Francis D, 1999, DEV GENET, V24, P123, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<123::AID-DVG12>3.0.CO;2-H; FRANK J, 1988, J MICROSC-OXFORD, V150, P99, DOI 10.1111/j.1365-2818.1988.tb04602.x; Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1992, MOL BRAIN RES, V15, P269, DOI 10.1016/0169-328X(92)90118-U; HOH JH, 1993, BIOPHYS J, V65, P149, DOI 10.1016/S0006-3495(93)81074-9; HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; IKEDA K, 1989, ACTA OTO-LARYNGOL, V108, P88, DOI 10.3109/00016488909107397; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968, DOI 10.1152/ajpcell.1995.268.4.C968; Liu F, 2006, J BIOL CHEM, V281, P23207, DOI 10.1074/jbc.M605048200; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Nattel S, 2004, HEART RHYTHM, V1, P234, DOI 10.1016/j.hrthm.2004.04.003; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; Owens LM, 1996, CIRCULATION, V94, P10, DOI 10.1161/01.CIR.94.1.10; PAPARELLA MM, 1984, ANN OTO RHINOL LARYN, V93, P623, DOI 10.1177/000348948409300616; PASANTESMORALES H, 1985, BIOCHEM PHARMACOL, V34, P2205, DOI 10.1016/0006-2952(85)90419-8; PAUL DL, 1995, CURR OPIN CELL BIOL, V7, P665, DOI 10.1016/0955-0674(95)80108-1; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 2003, CELL COMMUN ADHES, V10, P233, DOI 10.1080/15419060390262958; Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Pfahnl A, 1998, BIOPHYS J, V75, P2323, DOI 10.1016/S0006-3495(98)77676-3; Pottek M, 2003, J COMP NEUROL, V466, P468, DOI 10.1002/cne.10897; PUTMAN CAJ, 1992, SPIE, V1639, P198; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Saltman AE, 2002, J THORAC CARDIOV SUR, V124, P371, DOI 10.1067/mtc.2002.124239; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; SPRAY DC, 1990, AM J PHYSIOL, V258, pC195, DOI 10.1152/ajpcell.1990.258.2.C195; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Tao L, 2005, BIOPHYS J, V88, p201A; Tao L, 2004, J BIOL CHEM, V279, P38544, DOI 10.1074/jbc.M405654200; Tappaz ML, 2004, NEUROCHEM RES, V29, P83, DOI 10.1023/B:NERE.0000010436.44223.f8; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; UNWIN PNT, 1983, J CELL BIOL, V97, P1459, DOI 10.1083/jcb.97.5.1459; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; Verselis VK, 2000, BRAZ J MED BIOL RES, V33, P379, DOI 10.1590/S0100-879X2000000400003; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507	73	55	59	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8895	8904		10.1074/jbc.M609317200	http://dx.doi.org/10.1074/jbc.M609317200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17227765	hybrid			2022-12-27	WOS:000245780300036
J	Maines, MD; Miralem, T; Lerner-Marmarosh, N; Shen, J; Gibbs, PEM				Maines, Mahin D.; Miralem, Tihomir; Lerner-Marmarosh, Nicole; Shen, Jenny; Gibbs, Peter E. M.			Human biliverdin reductase, a previously unknown activator of protein kinase C beta II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; IX-ALPHA REDUCTASE; HEME OXYGENASE-1; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; PLASMA-MEMBRANE; BINDING PROTEIN; MUSCLE CELLS; RAT-KIDNEY; IN-VIVO	Human biliverdin reductase (hBVR), a dual specificity kinase (Ser/Thr/Tyr) is, as protein kinase C (PKC) beta II, activated by insulin and free radicals (Miralem, T., Hu, Z., Torno, M. D., Lelli, K. M., and Maines, M. D. (2005) J. Biol. Chem. 280, 17084-17092; Lerner-Marmarosh, N., Shen, J., Torno, M. D., Kravets, A., Hu, Z., and Maines, M. D. (2005) Proc. Natl. Acad Sci. U.S.A. 102, 7109-7114). Here, by using 293A cells co-transfected with pcDNA3-hBVR and PKC beta II plasmids, we report the co-immunoprecipitation of the proteins and co-purification in the glutathione S-transferase (GST) pulldown assay. hBVR and PKC beta II, but not the reductase and PKC zeta, transphosphorylated in assay systems supportive of activity of only one of the kinases. PKC beta II K371R mutant protein ("kinase-dead") was also a substrate for hBVR. The reductase increased the V-max but not the apparent K-m values of PKC beta II for myelin basic protein; activation was independent of phospholipids and extended to the phosphorylation of S2, a PKC-specific substrate. The increase in substrate phosphorylation was blocked by specific inhibitors of conventional PKCs and attenuated by sihBVR. The effect of the latter could be rescued by subsequent overexpression of hBVR. To a large extent, the activation was a function of the hBVR N-terminal chain of valines and intact ATP-binding site and the cysteine-rich C-terminal segment. The cobalt protoporphyrin-activated hBVR phosphorylated a threonine in a peptide corresponding to the Thr(500) in the human PKC beta II activation loop. Neither serine nor threonine residues in peptides corresponding to other phosphorylation sites of the PKC beta II nor PKC C activation loop-derived peptides were substrates. The phosphorylation of Thr(500) was confirmed by immunoblotting of hBVR center dot PKC beta II immunocomplex. The potential biological relevance of the hBVR activation of PKC beta II was suggested by the finding that in cells transfected with the PKC beta II, hBVR augmented phorbol myristate acetate-mediated c-fos expression, and infection with sihBVR attenuated the response. Also, in cells overexpressing hBVR and PKC beta II, as well as in untransfected cells, upon treatment with phorbol myristate acetate, the PKC translocated to the plasma membrane and co-localized with hBVR. hBVR activation of PKC beta II underscores its potential function in propagation of signals relayed through PKCs.	Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14624 USA	University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14624 USA.	mahin_maines@urmc.rochester.edu	; Miralem, Tihomir/F-7576-2013	Shen, Jenny/0000-0003-0956-7209; Miralem, Tihomir/0000-0001-7705-0442	NIEHS NIH HHS [ES12187, ES004066] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012187, R01ES004066] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; BEALE SI, 1984, ARCH BIOCHEM BIOPHYS, V235, P371, DOI 10.1016/0003-9861(84)90210-8; BELL JE, 1988, ARCH BIOCHEM BIOPHYS, V263, P1, DOI 10.1016/0003-9861(88)90607-8; Borowski P, 1999, ARCH VIROL, V144, P687, DOI 10.1007/s007050050536; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Cacace AM, 1996, ONCOGENE, V13, P2517; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chalfant CE, 1996, MOL ENDOCRINOL, V10, P1273, DOI 10.1210/me.10.10.1273; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; CURRAN T, 1987, ONCOGENE, V2, P79; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; FAKHRAI H, 1992, J BIOL CHEM, V267, P4023; FARRAR WL, 1985, NATURE, V315, P233, DOI 10.1038/315233a0; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; Jirousek MR, 1996, J MED CHEM, V39, P2664, DOI 10.1021/jm950588y; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kawakami T, 2002, J BIOCHEM, V132, P677, DOI 10.1093/oxfordjournals.jbchem.a003273; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Maines MD, 2001, J PHARMACOL EXP THER, V296, P1091; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MESSINA JL, 1992, J BIOL CHEM, V267, P9223; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2003, MOL CELL BIOL, V23, P579, DOI 10.1128/MCB.23.2.579-593.2003; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MOCHLYROSEN D, 1992, BIOCHEMISTRY-US, V31, P8120, DOI 10.1021/bi00150a003; Nakamura J, 2001, DIABETOLOGIA, V44, P480, DOI 10.1007/s001250051646; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OHNO S, 1990, J BIOL CHEM, V265, P6296; ORR JW, 1994, J BIOL CHEM, V269, P27715; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2; WILLIAMS B, 1993, J CLIN INVEST, V92, P2889, DOI 10.1172/JCI116911	61	40	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8110	8122		10.1074/jbc.M513427200	http://dx.doi.org/10.1074/jbc.M513427200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227757	hybrid			2022-12-27	WOS:000245081000043
J	Yamamoto, H; Nakashima, N; Ikeda, Y; Uchiumi, T				Yamamoto, Hiroshi; Nakashima, Nobuhiko; Ikeda, Yuka; Uchiumi, Toshio			Binding mode of the first aminoacyl-tRNA in translation initiation mediated by Plautia stali intestine virus internal ribosorne entry site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC RIBOSOMES; STRUCTURAL ELEMENTS; CROSS-LINKING; HYGROMYCIN-B; ELONGATION; PROTEIN; LIVER; NUCLEOTIDES; ANTIBIOTICS; COMPLEX	Eukaryotic ribosomes directly bind to the intergenic region-internal ribosome entry site (IGR-IRES) of Plautia stali intestine virus (PSIV) and initiate translation without either initiation factors or initiator Met-tRNA. We have investigated the mode of binding of the first aminoacyl-tRNA in translation initiation mediated by the IGR-IRES. Binding ability of aminoacyl-tRNA to the first codon within the IGR-IRES/80 S ribosome complex was very low in the presence of eukaryotic elongation factor 1A (eEF1A) alone but markedly enhanced by the translocase eEF2. Moreover, eEF2-dependent GTPase activity of the IRES/80 S ribosome complex was 3-fold higher than that of the free 80 S ribosome. This activation was suppressed by addition of the antibiotics pactamycin and hygromycin B, which are inhibitors of translocation. The results suggest that translocation by the action of eEF2 is essential for stable tRNA binding to the first codon of the PSIV-IRES in the ribosome. Chemical probing analysis showed that IRES binding causes a conformational. change in helix 18 of 18 S rRNA at the A site such that IRES destabilizes the conserved pseudoknot within the helix. This conformational change caused by the PSIV-IRES may be responsible for the activation of eEF2 action and stimulation of the first tRNA binding to the P site without initiation factors.	Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan	Niigata University; National Institute of Agrobiological Sciences - Japan; Shinshu University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp	Yamamoto, Hiroshi/Z-5912-2019	Ikeda-Iwabu, Yuka/0000-0003-3550-7891				Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; DIONS G, 2004, MOL CELL, V16, P113; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; FOLK WR, 1971, BIOCHEMISTRY-US, V10, P1728, DOI 10.1021/bi00785a034; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; Hatakeyama Y, 2004, RNA, V10, P779, DOI 10.1261/rna.5208104; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iwasaki K, 1979, Methods Enzymol, V60, P657; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MIZUMOTO K, 1974, J BIOCHEM-TOKYO, V76, P1269, DOI 10.1093/oxfordjournals.jbchem.a130680; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; NISHIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V142, P133, DOI 10.1016/0005-2787(67)90522-9; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Sergiev PV, 2005, NUCLEIC ACIDS RES, V33, P6048, DOI 10.1093/nar/gki910; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; TOKIMATSU H, 1981, J MOL BIOL, V152, P397, DOI 10.1016/0022-2836(81)90250-3; Uchiumi T, 2000, J BIOL CHEM, V275, P35116, DOI 10.1074/jbc.M004596200; UCHIUMI T, 1986, J BIOL CHEM, V261, P9668; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; WOESE CR, 1989, P NATL ACAD SCI USA, V86, P3119, DOI 10.1073/pnas.86.9.3119; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1	39	41	41	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7770	7776		10.1074/jbc.M610887200	http://dx.doi.org/10.1074/jbc.M610887200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17209036	hybrid			2022-12-27	WOS:000245081000004
J	Solforosi, L; Bellon, A; Schaller, M; Cruite, JT; Abalos, GC; Williamson, RA				Solforosi, Laura; Bellon, Anne; Schaller, Monica; Cruite, Justin T.; Abalos, Gil C.; Williamson, R. Anthony			Toward molecular dissection of PrPC-PrPSc interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION PROTEIN; MONOCLONAL-ANTIBODIES; CELLULAR PRP; N-TERMINUS; REPLICATION; PROPAGATION; CONVERSION; STRAIN; CONFORMATION; DISEASE	Direct interaction between endogenous cellular prion protein (PrPC) and misfolded, disease-associated (PrPSc) conformers is a key event in prion propagation, which precedes templated conversion of PrPC into nascent PrPSc and prion infectivity. Although almost none of the molecular details of this pivotal process are understood, the persistence of individual prion strains suggests that assembly of the prion replicative complex is mechanistically precise. To systematically map defined regions of PrPC sequence that bind tightly to PrPSc, we have generated a comprehensive panel of over 45 motif-grafted antibodies containing overlapping peptide grafts collectively spanning PrP residues 19-231. Grafted antibody binding experiments, performed under stringent conditions, clearly identified only three distinct and independent high affinity PrPSc recognition motifs. The first of these binding motifs lies at the very N-terminal region of the mature PrP molecule within PrP-(23-33); the second motif lies within PrP-(98-110); and the third is contained within PrP-(136-158). Mutational analyses of these PrPSc-binding regions revealed that reactivity of the 23-33 and 98-110 segments are largely dependent upon the presence of multiple positively charged amino acid residues. These studies yield new insight into critical peptidic components composing one side of the prion replicative interface.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	anthony@scripps.edu		Schaller, Monica/0000-0002-5002-2238	NIA NIH HHS [AG004243] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Moroncini G, 2006, NEUROBIOL DIS, V23, P717, DOI 10.1016/j.nbd.2006.06.008; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Shaked Y, 2002, J NEUROCHEM, V82, P1, DOI 10.1046/j.1471-4159.2002.00995.x; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-222; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	29	74	76	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7465	7471		10.1074/jbc.M610051200	http://dx.doi.org/10.1074/jbc.M610051200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218310	hybrid			2022-12-27	WOS:000245080900059
J	Yuan, CB; O'Connell, RJ; Jacob, RF; Mason, RP; Treistman, SN				Yuan, Chunbo; O'Connell, Robert J.; Jacob, Robert F.; Mason, R. Preston; Treistman, Steven N.			Requiation of the gating of BKCa channel by lipid bilayer thickness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; PHOSPHOLIPID SURFACE-CHARGE; N-ACYL SPHINGOMYELINS; X-RAY; ADENOSINE-TRIPHOSPHATASE; SARCOPLASMIC-RETICULUM; MODEL MEMBRANES; CHAIN-LENGTH; CONDUCTANCE	Transmembrane segments of ion channels tend to match the hydrophobic thickness of lipid bilayers to minimize mismatch energy and to maintain their proper organization and function. To probe how ion channels respond to mismatch with lipid bilayers of different thicknesses, we examined the single channel activities of BKCa (hSlo alpha-subunit) channels in planar bilayers of binary mixtures of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) with phosphatidylcholines (PCs) of varying chain lengths, including PC 14:1, PC 18:1, PC 22:1, PC 24:1, and with porcine brain sphingomyelin. Bilayer thickness and structure was measured with small angle x-ray diffraction and atomic force microscopy. The open probability (P-o) of the BKCa channel was finely tuned by bilayer thickness, first decreasing with increases in bilayer thickness from PC 14:1 to PC 22:1 and then increasing from PC 22:1 to PC 24:1 and to porcine brain sphingomyelin. Single channel kinetic analyses revealed that the mean open time of the channel increased monotonically with bilayer thickness and, therefore, could not account for the biphasic changes in P-o. The mean closed time increased with bilayer thickness from PC 14:1 up to PC 22:1 and then decreased with further increases in bilayer thickness to PC 24:1 and sphingomyelin, correlating with changes in P-o. This is consistent with the proposition that bilayer thickness affects channel activity mainly through altering the stability of the closed state. We suggest a simple mechanical model that combines forces of lateral stress within the lipid bilayer with local hydrophobic mismatch between lipids and the protein to account for the biphasic modulation of BKCa gating.	Univ Massachusetts, Brudnick Neuropsychiat Res Inst, Sch Med, Worcester, MA 01604 USA; Elucida Res, Beverly, MA 01915 USA	University of Massachusetts System; University of Massachusetts Worcester	Treistman, SN (corresponding author), Univ Massachusetts, Brudnick Neuropsychiat Res Inst, Sch Med, 303 Belmont St, Worcester, MA 01604 USA.	Steven.Treistman@umassmed.edu	Yuan, Chunbo/E-9627-2011		NIAAA NIH HHS [AA12054] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012054] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Alvarez O., 1986, ION CHANNEL RECONSTI, P115; BALDWIN PA, 1985, BIOCHEMISTRY-US, V24, P2633, DOI 10.1021/bi00332a007; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; BERS DM, 1994, PRACTICAL GUIDE STUD, P3; BRAVOZEHNDER M, 1997, P NATL ACAD SCI USA, V37, P319; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; CARRUTHERS A, 1984, BIOCHEMISTRY-US, V23, P6901, DOI 10.1021/bi00321a096; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gribkoff V K, 1997, Adv Pharmacol, V37, P319; HERBETTE L, 1985, BIOCHIM BIOPHYS ACTA, V817, P103, DOI 10.1016/0005-2736(85)90073-2; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KILLIAN JA, 1909, BIOCHIM BIOPHYS ACTA, V1376, P40; Kuikka M, 2001, BIOPHYS J, V80, P2327, DOI 10.1016/S0006-3495(01)76203-0; Kunze WAA, 2000, J PHYSIOL-LONDON, V526, P375, DOI 10.1111/j.1469-7793.2000.00375.x; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; Maulik PR, 1995, BIOPHYS J, V69, P1909, DOI 10.1016/S0006-3495(95)80061-5; MAULIK PR, 1986, BIOPHYS J, V50, P1071, DOI 10.1016/S0006-3495(86)83551-2; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; Mobashery N, 1997, FEBS LETT, V412, P15, DOI 10.1016/S0014-5793(97)00709-6; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; OCONNELL RJ, 2007, IN PRESS J MEMBR BIO; Oliver D, 2003, J NEUROSCI, V23, P2141; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Pilot JD, 2001, BIOCHEMISTRY-US, V40, P8188, DOI 10.1021/bi0103258; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5713, DOI 10.1021/bi047338g; Qi Z, 2005, MOL MEMBR BIOL, V22, P519, DOI 10.1080/09687860500370703; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1998, J GEN PHYSIOL, V111, P751, DOI 10.1085/jgp.111.6.751; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Turnheim K, 1999, AM J PHYSIOL-CELL PH, V277, pC83, DOI 10.1152/ajpcell.1999.277.1.C83; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; WONDERLIN WF, 1990, BIOPHYS J, V58, P289, DOI 10.1016/S0006-3495(90)82376-6; WOOD WG, 1990, BIOCHIM BIOPHYS ACTA, V1025, P243, DOI 10.1016/0005-2736(90)90103-U; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678	63	55	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7276	7286		10.1074/jbc.M607593200	http://dx.doi.org/10.1074/jbc.M607593200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209047	hybrid			2022-12-27	WOS:000245080900039
J	Alford, KA; Glennie, S; Turrell, BR; Rawlinson, L; Saklatvala, J; Dean, JLE				Alford, Kate A.; Glennie, Sarah; Turrell, Bryony R.; Rawlinson, Lesley; Saklatvala, Jeremy; Dean, Jonathan L. E.			Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN; CYCLOOXYGENASE-2 MESSENGER-RNA; FACTOR INCREASE PHOSPHORYLATION; INDUCED CELL-DEATH; AU-RICH ELEMENTS; KAPPA-B PATHWAY; HUMAN HSP27; PROTECTIVE ACTIVITY; OXIDATIVE STRESS	Heat shock protein (HSP) 27 has long been known to be a component of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. p38 MAPK has important functions in the inflammatory response, but the role of HSP27 in inflammation has remained unknown. We have used small interfering RNAs to suppress HSP27 expression in HeLa cells and fibroblasts and found that it is required for pro-inflammatory cell signaling and the expression of pro-inflammatory genes. HSP27 is needed for the activation by interleukin (IL)-1 of TAK1 and downstream signaling by p38 MAPK, JNK, and their activators (MKK-3, -4, -6, -7) and IKK beta. IL-1-induced ERK activation appears to be independent of HSP27. HSP27 is required for both IL-1 and TNF-induced signaling pathways for which the most upstream common signaling protein is TAK1. HSP27 is also required for IL-1-induced expression of the pro-inflammatory mediators, cyclooxygenase-2, IL-6, and IL-8. FISP27 functions to drive cyclooxygenase-2 and IL-6 expression by augmenting the activation of the kinase downstream of p38 MAPK, MK2, resulting in stabilization of cyclooxygenase-2 and IL-6 mRNAs. The mechanism may not occur in cells of myeloid lineage because HSP27 protein was undetectable in human monocytes and murine macrophages.	Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, London W6 8LH, England	Imperial College London; University of Oxford	Dean, JLE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, 1 Aspenlea Rd, London W6 8LH, England.	jonathan.dean@imperial.ac.uk		Dean, Jonathan/0000-0002-0703-2756	MRC [G8623776] Funding Source: UKRI; Medical Research Council [G8623776] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD R, 1995, SCIENCE, V267, P682; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Finch A, 2001, BIOCHEM J, V353, P275, DOI 10.1042/0264-6021:3530275; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Garrido C, 1997, CANCER RES, V57, P2661; Guay J, 1997, J CELL SCI, V110, P357; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; HUOT J, 1991, CANCER RES, V51, P5245; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Ridley SH, 1998, FEBS LETT, V439, P75, DOI 10.1016/S0014-5793(98)01342-8; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAKLATVALA J, 1991, BIOCHEM J, V277, P635, DOI 10.1042/bj2770635; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969	53	104	108	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6232	6241		10.1074/jbc.M610987200	http://dx.doi.org/10.1074/jbc.M610987200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202147	hybrid			2022-12-27	WOS:000244867200029
J	Bruns, JB; Carattino, MD; Sheng, SH; Maarouf, AB; Weisz, OA; Pilewski, JM; Hughey, RP; Kleyman, TR				Bruns, James B.; Carattino, Marcelo D.; Sheng, Shaohu; Maarouf, Ahmad B.; Weisz, Ora A.; Pilewski, Joseph M.; Hughey, Rebecca P.; Kleyman, Thomas R.			Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; MEMBRANE TOPOLOGY; SURFACE EXPRESSION; ALPHA-SUBUNIT; PORE REGION; ENAC; MCAP1	Epithelial sodium channels (ENaC) are expressed in the apical membrane of high resistance Na+ transporting epithelia and have a key role in regulating extracellular fluid volume and the volume of airway surface liquids. Maturation and activation of ENaC subunits involves furin-dependent cleavage of the ectodomain at two sites in the alpha subunit and at a single site within the gamma subunit. We now report that the serine protease prostasin further activates ENaC by inducing cleavage of the gamma subunit at a site distal to the furin cleavage site. Dual cleavage of the gamma subunit is predicted to release a 43-amino acid peptide. Channels with a gamma subunit lacking this 43-residue tract have increased activity due to a high open probability. A synthetic peptide corresponding to the fragment cleaved from the gamma subunit is a reversible inhibitor of endogenous ENaCs in mouse corticalcollecting duct cells and in primary cultures of human airway epithelial cells. Our results suggest that multiple proteases cleave ENaC gamma subunits to fully activate the channel.	Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Div Pulm & Crit Care Med, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughey, RP (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, S933 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hughey@dom.pitt.edu	Sheng, Shaohu/G-7052-2016; Pilewski, Joseph/AAF-5149-2021	Sheng, Shaohu/0000-0002-7198-1702; 	NIDDK NIH HHS [P50 DK54690, P30 DK072506, DK065161] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161, R01DK065161, P30DK072506] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Iwashita K, 2003, J AM SOC NEPHROL, V14, P11, DOI 10.1097/01.ASN.0000043900.39397.48; Lavelle JP, 1997, AM J PHYSIOL-RENAL, V273, pF67, DOI 10.1152/ajprenal.1997.273.1.F67; Liu L, 2002, HYPERTENSION, V39, P860, DOI 10.1161/01.HYP.0000013055.48885.8D; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; RENARD S, 1994, J BIOL CHEM, V269, P12981; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2001, J BIOL CHEM, V276, P44091, DOI 10.1074/jbc.M108522200; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787	41	255	257	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6153	6160		10.1074/jbc.M610636200	http://dx.doi.org/10.1074/jbc.M610636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17199078	hybrid			2022-12-27	WOS:000244867200021
J	Gerber, R; Tahiri-Alaoui, A; Hore, PJ; James, W				Gerber, Remo; Tahiri-Alaoui, Abdessamad; Hore, P. J.; James, William			Oligomerization of the human prion protein proceeds via a molten globule intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR DIFFUSION MEASUREMENTS; CREUTZFELDT-JAKOB-DISEASE; MOLECULAR-BIOLOGY; CULTURED-CELLS; SCRAPIE; RECOMBINANT; SUSCEPTIBILITY; CONFORMATIONS; SPECTROSCOPY; TRANSITION	The conformational transition of the human prion protein from an alpha-helical to a beta-sheet-rich structure is believed to be the critical event in prion pathogenesis. The molecular mechanism of misfolding and the role of intermediate states during this transition remain poorly understood. To overcome the obstacle of insolubility of amyloid fibrils, we have studied a beta-sheet-rich misfolded isoform of the prion protein, the 6-oligomer, which shares some structural properties with amyloid, including partial proteinase resistance. We demonstrate here that the beta-oligomer can be studied by solution-state NMR spectroscopy and obtain insights into the misfolding mechanism via its transient monomeric precursor. It is often assumed that misfolding into beta-sheet-rich isoforms proceeds via a compatible precursor with a beta-sheet subunit structure. We show here, on the contrary, evidence for an almost natively alpha-helix-rich monomeric precursor state with molten globule characteristics, converting in vitro into the beta-oligomer. We propose a possible mechanism for the formation of the beta-oligomer, triggered by intermolecular contacts between constantly rearranging structures. It is concluded that the beta-oligomer is not preceded by precursors with beta-sheet structure but by a partially unfolded clearly distinguishable alpha-helical state.	Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Gerber, R (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	remo.gerber@chem.ox.ac.uk	Hore, Peter/R-1923-2017; james, william/H-4289-2013	Hore, Peter/0000-0002-8863-570X; james, william/0000-0002-2506-1198				Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Lu BY, 2001, BIOCHEMISTRY-US, V40, P13390, DOI 10.1021/bi011111t; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200; MCKINLEY MP, 1991, LAB INVEST, V65, P622; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nicholson EM, 2002, J MOL BIOL, V316, P807, DOI 10.1006/jmbi.2001.5347; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; OESCH B, 1985, CELL, V40, P7385; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Redfield C, 1999, CURR BIOL, V9, pR313, DOI 10.1016/S0960-9822(99)80199-7; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Tahiri-Alaoui A, 2005, PROTEIN SCI, V14, P942, DOI 10.1110/ps.041000905; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200; Weissmann C, 1996, FEBS LETT, V389, P3, DOI 10.1016/0014-5793(96)00610-2; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	46	69	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6300	6307		10.1074/jbc.M608926200	http://dx.doi.org/10.1074/jbc.M608926200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17210575	hybrid			2022-12-27	WOS:000244867200036
J	Lee, JG; Kay, EP				Lee, Jeong Goo; Kay, EunDuck P.			Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-kinase in response to fibroblast growth factor-2 stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL ENDOTHELIAL-CELLS; DEPENDENT KINASE INHIBITOR; MESENCHYMAL TRANSFORMATION; CYTOPLASMIC LOCALIZATION; CYCLE PROGRESSION; REGULATORY ROLE; NUCLEAR EXPORT; I COLLAGEN; P27(KIP1); DEGRADATION	The cyclin-dependent kinase inhibitor p27 regulates cell cycle progression. We investigated whether FGF-2 uses PI 3-kinase to facilitate phosphorylation of p27 on serine 10 (Ser-10) and threonine 187 (Thr-187) and whether the two phosphorylation sites were differentially regulated. FGF-2 stimulation dramatically increased p27 phosphorylation at Ser-10 and Thr-187 using differential kinetics, and the FGF-2-induced p27 phosphorylation was completely blocked at both sites by LY294002. We determined the physical and biochemical interaction of p27 with the Cdk2-cyclin E complex in response to FGF-2 stimulation. Maximal p27 binding to Cdk2-cyclin E occurred at 12 h; the maximal level of p27 phosphorylation at Thr-187 in the ternary complex was observed at 16 h; ubiquitination of the Thr-187-phosphorylated p27 (pp27Thr-187) was observed starting at 12 h and continuing up to 24 h. However, maximum p27 phosphorylation at Ser-10 occurred in the nucleus 6 h after FGF-2 stimulation; maximal export of Ser-10-phosphorylated p27 (pp27Ser-10) occurred 8 h after FGF-2 treatment, and pp27Ser-10 was simultaneously ubiquitinated. We further investigated which of the two phosphorylated p27 was involved in G(1)/S progression. LY294002 blocked 64% of the cell proliferation stimulated by FGF-2. Use of leptomycin B to block nuclear export of pp27Ser-10 greatly decreased the FGF-2-stimulated cell proliferation (44%), suggesting that phosphorylation of p27 at Ser-10 is the major mechanism for G(1)/S transition. Our results suggest that differential kinetics are observed in p27 phosphorylation at Ser-10 and Thr-187 and that pp27Thr-187 and pp27Ser-10 may represent two populations of p27 observed in the G(1) phase of the cell cycle.	Univ So Calif, Doheny Eye Inst, Keck Sch Med, Los Angeles, CA 90089 USA; Univ So Calif, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90089 USA	Doheny Eye Institute; University of Southern California; University of Southern California	Kay, EP (corresponding author), Univ So Calif, Doheny Eye Inst, Keck Sch Med, 1450 San Pablo St,DVRC 203, Los Angeles, CA 90089 USA.	ekay@usc.edu			NATIONAL EYE INSTITUTE [P30EY003040] Funding Source: NIH RePORTER; NEI NIH HHS [EY03040, EY06431] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; BROWN SI, 1966, ARCH OPHTHALMOL-CHIC, V75, P518; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KAY EDP, 1994, INVEST OPHTH VIS SCI, V35, P2427; KAY EP, 1982, J BIOL CHEM, V257, P7116; KAY EP, 1993, INVEST OPHTH VIS SCI, V34, P663; KAY EP, 1982, INVEST OPHTH VIS SCI, V22, P200; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Lee HT, 2003, INVEST OPHTH VIS SCI, V44, P1521, DOI 10.1167/iovs.02-0637; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Swanson C, 2000, P NATL ACAD SCI USA, V97, P7796, DOI 10.1073/pnas.97.14.7796; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Xu X, 1999, BIOCHEMISTRY-US, V38, P8713	36	35	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6444	6454		10.1074/jbc.M607808200	http://dx.doi.org/10.1074/jbc.M607808200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17209046	hybrid			2022-12-27	WOS:000244867200052
J	Shiroishi, M; Tsumoto, K; Tanaka, Y; Yokota, A; Nakanishi, T; Kondo, H; Kumagai, I				Shiroishi, Mitsunori; Tsumoto, Kouhei; Tanaka, Yoshikazu; Yokota, Akiko; Nakanishi, Takeshi; Kondo, Hidemasa; Kumagai, Izumi			Structural consequences of mutations in interfacial Tyr residues of a protein antigen-anti body complex - The case of HyHEL-10-HEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILYSOZYME MONOCLONAL-ANTIBODY; SALT BRIDGE FORMATION; EGG-WHITE LYSOZYME; ENTROPIC CONTRIBUTION; CRYSTAL-STRUCTURE; CHICKEN LYSOZYME; HOT-SPOT; FV; EPITOPE; FAB	Tyrosine is an important amino acid in protein-protein interaction hot spots. In particular, many Tyr residues are located in the antigen-binding sites of antibodies and endow high affinity and high specificity to these antibodies. To investigate the role of interfacial Tyr residues in protein-protein interactions, we performed crystallographic studies and thermodynamic analyses of the interaction between hen egg lysozyme (HEL) and the anti-HEL antibody HyHEL-10 Fv fragment. HyHEL-10 has six Tyr residues in its antigen-binding site, which were systematically mutated to Phe and Ala using site-directed mutagenesis. The crystal structures revealed several critical roles for these Tyr residues in the interaction between HEL and HyHEL-10 as follows: 1) the aromatic ring of Tyr-50 in the light chain (LTyr-50) was important for the correct ternary structure of variable regions of the immunoglobulin light chain and heavy chain and of HEL; 2) deletion of the hydroxyl group of Tyr-50 in the heavy chain (HTyr-50) resulted in structural changes in the antigen-antibody interface; and 3) the side chains of HTyr-33 and HTyr-53 may help induce fitting of the antibody to the antigen. Hot spot Tyr residues may contribute to the high affinity and high specificity of the antigen-antibody interaction through a diverse set of structural and thermodynamic interactions.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; Natl Inst Adv Ind Sci & Technol, Hokkaido Ctr, Sapporo, Hokkaido 0628517, Japan	Tohoku University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Tsumoto, K (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Yama 6-6-11, Sendai, Miyagi 9808579, Japan.	tsumoto@k.u-tokyo.ac.jp; kmiz@mail.tains.tohoku.ac.jp	Kondo, Hidemasa/M-7465-2018; Yokota, Akiko/M-1807-2018	Kondo, Hidemasa/0000-0003-2799-1775; Yokota, Akiko/0000-0002-5896-9899; Shiroishi, Mitsunori/0000-0002-3133-157X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; Kumagai I, 2003, J BIOL CHEM, V278, P24929, DOI 10.1074/jbc.M301149200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li YL, 2005, STRUCTURE, V13, P297, DOI 10.1016/j.str.2004.12.012; Li YL, 2003, BIOCHEMISTRY-US, V42, P11, DOI 10.1021/bi020589+; Li YL, 2000, BIOCHEMISTRY-US, V39, P6296, DOI 10.1021/bi000054l; Li YL, 2001, BIOCHEMISTRY-US, V40, P2011, DOI 10.1021/bi0014148; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Nishimiya Y, 2000, J BIOL CHEM, V275, P12813, DOI 10.1074/jbc.275.17.12813; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Rajpal A, 1998, PROTEIN SCI, V7, P1868, DOI 10.1002/pro.5560070903; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Shiroishi M, 2001, J BIOL CHEM, V276, P23042, DOI 10.1074/jbc.M100480200; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; UEDA Y, 1993, GENE, V129, P129; Yokota A, 2003, J BIOL CHEM, V278, P5410, DOI 10.1074/jbc.M210182200; YSERN X, 1994, J MOL BIOL, V238, P496	46	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6783	6791		10.1074/jbc.M605197200	http://dx.doi.org/10.1074/jbc.M605197200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17166830	hybrid			2022-12-27	WOS:000244867200088
J	Cuellar, K; Chuong, H; Hubbell, SM; Hinsdale, ME				Cuellar, Karen; Chuong, Hoa; Hubbell, Sherry M.; Hinsdale, Myron E.			Biosynthesis of chondroitin and heparan sulfate in Chinese hamster ovary cells depends on xylosyltransferase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER; XT-II; PROTEOGLYCANS; EXPRESSION; MUTANTS; GALACTOSYLTRANSFERASE; PURIFICATION; RECEPTORS; BINDING; CLONING	Xylosyltransferase (XylT) catalyzes the initial enzymatic reaction in the glycosaminoglycan assembly pathway for proteoglycan biosynthesis. Its activity is thought to be rate-limiting. Two xylosyltransferases have been found using genomic analyses, and one of these, XylT1, has been shown to have xylosyltransferase activity. On the other hand, the less studied XylT2 in recombinant form lacks xylosyltransferase activity and has no known function. Wild-type Chinese hamster ovary cells express abundant Xylt2 mRNA levels and lack detectable Xylt1 mRNA levels. Analysis of a previously described Chinese hamster ovary cell xylosyltransferase mutant (psgA-745) shows that it harbors an Xylt2 nonsense mutation and fails to assemble glycosaminoglycans onto recombinant biglycan. Transfection of this cell line with a murine Xylt2 minigene results in the production of recombinant chondroitin sulfate-modified biglycan core protein and restoration of fibroblast growth factor binding to cell surface-associated heparan sulfate. Expression analyses on 10 different human transformed cell lines detect exclusive XYLT2 expression in two and co-expression of XYLT1 and XYLT2 in the others but at disparate ratios where XYLT2 expression is greater than XYLT1 in most cell lines. These results indicate that XylT2 has a significant role in proteoglycan biosynthesis and that cell type may control which family member is utilized.	Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hinsdale, ME (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.	Myron-Hinsdale@omrf.ouhsc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR018758] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brunner A, 2006, GLYCOCONJUGATE J, V23, P543, DOI 10.1007/s10719-006-7633-z; Charnaux N, 2005, FEBS J, V272, P1937, DOI 10.1111/j.1742-4658.2005.04624.x; ESKO JD, 1986, J BIOL CHEM, V261, P5725; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GRASSEL S, 1995, MOL CELL BIOCHEM, V145, P61, DOI 10.1007/BF00925714; Gustafsson M, 2004, CURR OPIN LIPIDOL, V15, P505, DOI 10.1097/00041433-200410000-00003; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HINSDALE ME, 1993, GENOMICS, V16, P605, DOI 10.1006/geno.1993.1237; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; ISAACS RD, 1994, J CLIN INVEST, V93, P809, DOI 10.1172/JCI117035; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; Kuhn J, 2003, BIOCHEM BIOPH RES CO, V312, P537, DOI 10.1016/j.bbrc.2003.10.157; Liuzzo JP, 1996, BLOOD, V87, P245; Mahley RW, 1999, J LIPID RES, V40, P1; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; SCHWARTZ NB, 1974, BIOCHEM BIOPH RES CO, V56, P717, DOI 10.1016/0006-291X(74)90664-0; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; STOOLMILLER AC, 1972, J BIOL CHEM, V247, P3525; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2	29	55	55	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5195	5200		10.1074/jbc.M611048200	http://dx.doi.org/10.1074/jbc.M611048200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189266	hybrid			2022-12-27	WOS:000244482300013
J	Saiyed, T; Paarmann, I; Schmitt, B; Haeger, S; Sola, M; Schmalzing, G; Weissenhorn, W; Betz, H				Saiyed, Taslimarif; Paarmann, Ingo; Schmitt, Bertram; Haeger, Svenja; Sola, Maria; Schmalzing, Guenther; Weissenhorn, Winfried; Betz, Heinrich			Molecular basis of gephyrin clustering at inhibitory synapses - Role of G- and E-domain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; GABA(A) RECEPTOR SUBTYPES; GLYCINE RECEPTOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; POSTSYNAPTIC DENSITY; SPLICE VARIANTS; DEFICIENT MICE	Gephyrin is a bifunctional modular protein that, in neurons, clusters glycine receptors and gamma-aminobutyric acid, type A receptors in the postsynaptic membrane of inhibitory synapses. By x-ray crystallography and cross-linking, the N-terminal G-domain of gephyrin has been shown to form trimers and the C-terminal E-domain dimers, respectively. Gephyrin therefore has been proposed to form a hexagonal submembranous lattice onto which inhibitory receptors are anchored. Here, crystal structure-based substitutions at oligomerization interfaces revealed that both G-domain trimerization and E-domain dimerization are essential for the formation of higher order gephyrin oligomers and postsynaptic gephyrin clusters. Insertion of the alternatively spliced C5' cassette into the G-domain inhibited clustering by interfering with trimerization, and mutation of the glycine receptor beta-subunit binding region prevented the localization of the clusters at synaptic sites. Together our findings show that domain interactions mediate gephyrin scaffold formation.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Rhein Westfal TH Aachen, Dept Mol Pharmacol, D-52074 Aachen, Germany; European Mol Biol Lab, F-38042 Grenoble 9, France	Max Planck Society; RWTH Aachen University; European Molecular Biology Laboratory (EMBL)	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de		Sola, Maria/0000-0002-0838-9706				Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Craig AM, 1996, J NEUROSCI, V16, P3166; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Heck S, 1997, DEV BRAIN RES, V98, P211, DOI 10.1016/S0165-3806(96)00181-2; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Paarmann I, 2006, BIOCHEM SOC T, V34, P45, DOI 10.1042/BST0340045; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	43	57	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5625	5632		10.1074/jbc.M610290200	http://dx.doi.org/10.1074/jbc.M610290200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182610	hybrid			2022-12-27	WOS:000244482300059
J	Tal, R; Winter, G; Ecker, N; Klionsky, DJ; Abeliovich, H				Tal, Ruth; Winter, Gal; Ecker, Nitai; Klionsky, Daniel J.; Abeliovich, Hagai			Aup1p, a yeast mitochondrial protein phosphatase homolog, is required for efficient stationary phase mitophagy and cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; AMINOPEPTIDASE-I; GENE DELETION; AUTOPHAGY; DEATH; DEGRADATION; BIOGENESIS; PATHWAY; LOCALIZATION; CYTOPLASM	Autophagy is a catabolic membrane-trafficking process that occurs in all eukaryotic cells and leads to the hydrolytic degradation of cytosolic material in the vacuolar or lysosomal lumen. Mitophagy, a selective form of autophagy targeting mitochondria, is poorly understood at present. Several recent reports suggest that mitophagy is a selective process that targets damaged mitochondria, whereas other studies imply a role for mitophagy in cell death processes. In a screen for protein phosphatase homologs that functionally interact with the autophagy-dedicated protein kinase Atg1p in yeast, we have identified Aup1p, encoded by Saccharomyces cerevisiae reading frame YCR079w. Aup1p is highly similar to a family of protein phosphatase homologs in animal cells that are predicted to localize to mitochondria based on sequence analysis. Interestingly, we found that Aulp1p localizes to the mitochondrial intermembrane space and is required for efficient mitophagy in stationary phase cells. Viability studies demonstrate that Aup1p is required for efficient survival of cells in prolonged stationary phase cultures, implying a pro-survival role for mitophagy under our working conditions. Our data suggest that Aup1p may be part of a signal transduction mechanism that marks mitochondria for sequestration into autophagosomes.	Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Hebrew University of Jerusalem; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Abeliovich, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.	ahagai@agri.huji.ac.il	Winter, Gal/B-9188-2012	Winter, Gal/0000-0003-3789-395X	NIGMS NIH HHS [GM53396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Camougrand N, 2004, FEMS YEAST RES, V5, P133, DOI 10.1016/j.femsyr.2004.05.001; Campbell CL, 1998, J CELL SCI, V111, P2455; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; LVINE B, 2003, HARVEY LECT, V99, P47; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; RUAN H, 2006, IN PRESS FEMS YEAST; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; Velours G, 2002, FEMS MICROBIOL LETT, V207, P165, DOI 10.1111/j.1574-6968.2002.tb11046.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	52	211	219	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5617	5624		10.1074/jbc.M605940200	http://dx.doi.org/10.1074/jbc.M605940200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17166847	hybrid			2022-12-27	WOS:000244482300058
J	de Eugenio, LI; Garcia, P; Luengo, JM; Sanz, JM; San Roman, J; Garcia, JL; Prieto, MA				de Eugenio, Laura I.; Garcia, Pedro; Luengo, Jose M.; Sanz, Jesus M.; San Roman, Julio; Garcia, Jose Luis; Prieto, Maria A.			Biochemical evidence that phaZ gene encodes a specific intracellular medium chain length polyhydroxyalkanoate depolymerase in Pseudomonas putida KT2442 - Characterization of a paradigmatic enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; POLY(3-HYDROXYOCTANOIC ACID) P(3HO); 3-HYDROXYBUTYRATE-OLIGOMER HYDROLASE; OLEOVORANS INCLUSIONS; MICROBIAL SYNTHESIS; LONG ALKYL; DEGRADATION; POLY(3-HYDROXYBUTYRATE); PURIFICATION; IDENTIFICATION	Polyhydroxyalkanoates (PHAs) can be catabolized by many microorganisms using intra- or extracellular PHA depolymerases. Most of our current knowledge of these intracellular enzyme-coding genes comes from the analysis of short chain length PHA depolymerases, whereas medium chain length PHA (mcl-PHA) intracellular depolymerization systems still remained to be characterized. The phaZ gene of some Pseudomonas putida strains has been identified only by mutagenesis and complementation techniques as putative intracellular mcl-PHA depolymerase. However, none of their corresponding encoded PhaZ enzymes have been characterized in depth. In this study the PhaZ depolymerase from P. putida KT2442 has been purified and biochemically characterized after its overexpression in Escherichia coli. To facilitate these studies we have developed a new and very sensitive radioactive method for detecting PHA hydrolysis in vitro. We have demonstrated that PhaZ is an intracellular depolymerase that is located in PHA granules and that hydrolyzes specifically mcl-PHAs containing aliphatic and aromatic monomers. The enzyme behaves as a serine hydrolase that is inhibited by phenylmethylsulfonyl fluoride. We have modeled the three-dimensional structure of PhaZ complexed with a 3-hydroxyoctanoate dimer. Using this model, we found that the enzyme appears to be built up from a core alpha/beta hydrolase-type domain capped with a lid structure with an active site containing a catalytic triad buried near the connection between domains. All these data constitute the first biochemical characterization of PhaZ and allow us to propose this enzyme as the paradigmatic representative of intracellular endo/exo-mcl-PHA depolymerases.	CSIC, Ctr Invest Biol, Dept Mol Microbiol, E-28040 Madrid, Spain; Univ Leon, Dept Bioquim & Biol Mol, E-24007 Leon, Spain; Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Leon; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP)	Prieto, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Mol Microbiol, C Ramiro Maeztu 9, E-28040 Madrid, Spain.	auxi@cib.csic.es	Sanz, Jesus M/B-2244-2008; Prieto, María Auxiliadora/I-8092-2015; García, Pedro/L-2808-2017; Luengo, Jose M./E-1935-2016; Garcia Lopez, Jose Luis/G-9139-2015	Sanz, Jesus M/0000-0002-4421-9376; García, Pedro/0000-0001-6717-8717; Luengo, Jose M./0000-0002-4984-6256; Prieto Jimenez, M. Auxiliadora/0000-0002-8038-1223; Garcia Lopez, Jose Luis/0000-0002-9238-2485				Abe H, 1999, INT J BIOL MACROMOL, V25, P185, DOI 10.1016/S0141-8130(99)00033-1; Abe T, 2005, J BACTERIOL, V187, P6982, DOI 10.1128/JB.187.20.6982-6990.2005; Abraham GA, 2001, BIOMACROMOLECULES, V2, P562, DOI 10.1021/bm010018h; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Behrends A, 1996, FEMS MICROBIOL LETT, V143, P191, DOI 10.1016/0378-1097(96)00305-9; Bernstein HJ, 2000, TRENDS BIOCHEM SCI, V25, P453, DOI 10.1016/S0968-0004(00)01606-6; Braaz R, 2003, FEMS MICROBIOL LETT, V224, P107, DOI 10.1016/S0378-1097(03)00425-7; Cheeseman JD, 2004, ACTA CRYSTALLOGR D, V60, P1237, DOI 10.1107/S0907444904010522; Chung DM, 2001, INT J BIOL MACROMOL, V29, P243, DOI 10.1016/S0141-8130(01)00172-6; de Roo G, 2002, BIOTECHNOL BIOENG, V77, P717, DOI 10.1002/bit.10139; DESNUELLE P, 1960, BIOCHIM BIOPHYS ACTA, V37, P570, DOI 10.1016/0006-3002(60)90532-1; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Foster LJR, 1999, INT J BIOL MACROMOL, V26, P187, DOI 10.1016/S0141-8130(99)00081-1; Foster LJR, 1996, INT J BIOL MACROMOL, V19, P177, DOI 10.1016/0141-8130(96)01125-7; FOSTER LJR, 1994, FEMS MICROBIOL LETT, V118, P279, DOI 10.1111/j.1574-6968.1994.tb06841.x; FRITZSCHE K, 1990, INT J BIOL MACROMOL, V12, P85, DOI 10.1016/0141-8130(90)90058-I; FULLER RC, 1992, FEMS MICROBIOL LETT, V103, P279, DOI 10.1111/j.1574-6968.1992.tb05849.x; Fushinobu S, 2002, PROTEIN SCI, V11, P2184, DOI 10.1110/ps.0209602; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Gavrilescu M, 2005, BIOTECHNOL ADV, V23, P471, DOI 10.1016/j.biotechadv.2005.03.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Handrick R, 2000, J BACTERIOL, V182, P5916, DOI 10.1128/JB.182.20.5916-5918.2000; Handrick R, 2001, J BIOL CHEM, V276, P36215, DOI 10.1074/jbc.M101106200; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOROWITZ DM, 1994, J AM CHEM SOC, V116, P2695, DOI 10.1021/ja00086a001; HUISMAN GW, 1991, J BIOL CHEM, V266, P2191; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Kessler B, 2001, J BIOTECHNOL, V86, P97, DOI 10.1016/S0168-1656(00)00404-1; Kim DY, 2002, BIOMACROMOLECULES, V3, P291, DOI 10.1021/bm010113q; Kim HM, 2000, J BIOSCI BIOENG, V89, P196, DOI 10.1016/S1389-1723(00)88737-X; Kobayashi T, 2005, J BACTERIOL, V187, P5129, DOI 10.1128/JB.187.15.5129-5135.2005; Kobayashi T, 2003, J BACTERIOL, V185, P3485, DOI 10.1128/JB.185.12.3485-3490.2003; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Luengo JM, 2003, CURR OPIN MICROBIOL, V6, P251, DOI 10.1016/S1369-5274(03)00040-7; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; Miller J. H., 1972, EXPT MOL GENETICS, P431; Moldes C, 2004, APPL ENVIRON MICROB, V70, P3205, DOI 10.1128/AEM.70.6.3205-3212.2004; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Numata K, 2006, MACROMOL BIOSCI, V6, P41, DOI 10.1002/mabi.200500160; O'Leary ND, 2005, APPL ENVIRON MICROB, V71, P4380, DOI 10.1128/AEM.71.8.4380-4387.2005; PATHAK D, 1990, J MOL BIOL, V214, P497, DOI 10.1016/0022-2836(90)90196-S; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Prieto MA, 1999, APPL ENVIRON MICROB, V65, P3265; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; Ren Q, 2005, BIOMACROMOLECULES, V6, P2290, DOI 10.1021/bm050187s; Saegusa H, 2001, J BACTERIOL, V183, P94, DOI 10.1128/JB.183.1.94-100.2001; Sambrook J., 2001, MOL CLONING LAB MANU; Sandoval A, 2005, APPL MICROBIOL BIOT, V67, P97, DOI 10.1007/s00253-004-1752-x; SCHIRMER A, 1993, APPL ENVIRON MICROB, V59, P1220, DOI 10.1128/AEM.59.4.1220-1227.1993; SCHIRMER A, 1994, J BACTERIOL, V176, P7065, DOI 10.1128/JB.176.22.7065-7073.1994; Steinbuchel A, 2001, ADV BIOCHEM ENG BIOT, V71, P81; Stuart ES, 1996, INT J BIOL MACROMOL, V19, P171, DOI 10.1016/0141-8130(96)01124-5; van Pouderoyen G, 2001, J MOL BIOL, V309, P215, DOI 10.1006/jmbi.2001.4659; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; WITHOLT B, 1994, Patent No. 5344769; York GM, 2003, J BACTERIOL, V185, P3788, DOI 10.1128/JB.185.13.3788-3794.2003; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6	64	67	71	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4951	4962		10.1074/jbc.M608119200	http://dx.doi.org/10.1074/jbc.M608119200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170116	hybrid, Green Published			2022-12-27	WOS:000244482000078
J	Rong, JA; Li, SH; Sheng, GQ; Wu, M; Coblitz, B; Li, M; Fu, HA; Li, XJ				Rong, Juan; Li, Shihua; Sheng, Guoqing; Wu, Meng; Coblitz, Brian; Li, Min; Fu, Haian; Li, Xiao-Jiang			14-3-3 protein interacts with Huntingtin-associated protein 1 and regulates its trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN LIGHT-CHAIN; INTRACELLULAR TRAFFICKING; AXONAL-TRANSPORT; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; FEEDING-BEHAVIOR; HAP1 INTERACTS; IN-VITRO; BINDING; 14-3-3-PROTEINS	HAP1 (Huntingtin-associated protein 1) consists of two alternately spliced isoforms (HAP1A and HAP1B, which have unique C-terminal sequences) and participates in intracellular trafficking. The C terminus of HAP1A is phosphorylated, and this phosphorylation was found to decrease the association of HAP1A with kinesin light chain, a protein involved in anterograde transport in cells. It remains unclear how this phosphorylation functions to regulate the association of HAP1 with trafficking proteins. Using the yeast two-hybrid system, we found that HAP1 also interacts with 14-3-3 proteins, which are involved in the assembly of protein complexes and the regulation of protein trafficking. The interaction of HAP1 with 14-3-3 is confirmed by their immunoprecipitation and colocalization in mouse brain. Moreover, this interaction is specific to HAP1A and is increased by the phosphorylation of the C terminus of HAP1A. We also found that expression of 14-3-3 decreases the association of HAP1A with kinesin light chain. As a result, there is less HAP1A distributed in neurite tips of PC12 cells that overexpress 14-3-3. Also, overexpression of 14-3-3 reduces the effect of HAP1A in promoting neurite outgrowth of PC12 cells. We propose that the phosphorylation-dependent interaction of HAP1A with 14-3-3 regulates HAP1 function by influencing its association with kinesin light chain and trafficking in neuronal processes.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Emory University; Emory University; Johns Hopkins University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Wu, Meng/F-3958-2010	Wu, Meng/0000-0003-2222-0736	NIA NIH HHS [AG19206, R01 AG019206] Funding Source: Medline; NINDS NIH HHS [NS045016, R01 NS045016, NS36323, R01 NS036232] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036232, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Birkenfeld J, 2003, BIOCHEM BIOPH RES CO, V302, P526, DOI 10.1016/S0006-291X(03)00182-7; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Dai JG, 2003, J NEUROCHEM, V84, P23, DOI 10.1046/j.1471-4159.2003.01254.x; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Foucault I, 2003, J BIOL CHEM, V278, P7146, DOI 10.1074/jbc.M209509200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J NEUROCHEM, V71, P2178; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Martin EJ, 1999, J COMP NEUROL, V403, P421; McGuire JR, 2005, CURR GENOMICS, V6, P189, DOI 10.2174/1389202053971938; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Takeshita Y, 2006, HUM MOL GENET, V15, P2298, DOI 10.1093/hmg/ddl156; Tang SJ, 1998, J BIOL CHEM, V273, P25356, DOI 10.1074/jbc.273.39.25356; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van der Brug MP, 2002, BRAIN RES, V956, P110, DOI 10.1016/S0006-8993(02)03487-X; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Wu M, 2006, ANAL BIOCHEM, V349, P186, DOI 10.1016/j.ab.2005.11.030; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	59	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4748	4756		10.1074/jbc.M609057200	http://dx.doi.org/10.1074/jbc.M609057200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166838	hybrid			2022-12-27	WOS:000244482000056
J	Cuerrier, D; Moldoveanu, T; Campbell, RL; Kelly, J; Yoruk, B; Verhelst, SHL; Greenbaum, D; Bogyo, M; Davies, PL				Cuerrier, Dominic; Moldoveanu, Tudor; Campbell, Robert L.; Kelly, Jacqueline; Yoruk, Bilge; Verhelst, Steven H. L.; Greenbaum, Doron; Bogyo, Matthew; Davies, Peter L.			Development of calpain-specific inactivators by screening of positional scanning epoxide libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYSTEINE PROTEASES; CATHEPSIN-B; ACTIVE-SITE; CRYSTAL-STRUCTURES; ELECTRON-DENSITY; PEPTIDE EPOXIDES; IN-VITRO; INHIBITORS; CRYSTALLOGRAPHY	Calpains are calcium-dependent proteases that are required for numerous intracellular processes but also play an important role in the development of pathologies such as ischemic injury and neurodegeneration. Many current small molecule calpain inhibitors also inhibit other cysteine proteases, including cathepsins, and need improved selectivity. The specificity of inhibition of several calpains and papain was profiled using synthetic positional scanning libraries of epoxide-based compounds that target the active-site cysteine. These peptidomimetic libraries probe the P4, P3, and P2 positions, display (SS)- or (RR)-epoxide stereochemistries, and incorporate both natural and nonnatural amino acids. To facilitate library screening, an SDS-PAGE assay that measures the extent of hydrolysis of an inactive recombinant m-calpain was developed. Individual epoxide inhibitors were synthesized guided by calpain-specific preferences observed from the profiles and tested for inhibition against calpain. The most potent compounds were assayed for specificity against cathepsins B, L, and K. Several compounds demonstrated high inhibition specificity for calpains over cathepsins. The best of these inhibitors, WRH(RR), irreversibly inactivates m- and mu-calpain rapidly (k(2)/K-i = 131,000 and 16,500 M-1 s(-1), respectively) but behaves exclusively as a reversible and less potent inhibitor toward the cathepsins. X-ray crystallography of the proteolytic core of rat mu-calpain inactivated by the epoxide compounds WR gamma-cyano-alpha-aminobutyric acid (SS) and WR allylglycine (RR) reveals that the stereochemistry of the epoxide influences positioning and orientation of the P2 residue, facilitating alternate interactions within the S2 pocket. Moreover, the WR gamma-cyano-alpha-aminobutyric acid (SS)-complexed structure defines a novel hydrogen-bonding site within the S2 pocket of calpains.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Prot Funct Discovery Grp, Kingston, ON K7L 3N6, Canada; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Queens University - Canada; Queens University - Canada; Stanford University	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Botterell Hall, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Moldoveanu, Tudor/N-8173-2018	Moldoveanu, Tudor/0000-0003-0791-318X; Campbell, Robert/0000-0002-5473-5876; Verhelst, Steven/0000-0002-7400-1319; Bogyo, Matthew/0000-0003-3753-4412	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR20843] Funding Source: Medline; NIBIB NIH HHS [R01-EB005011] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Chatterjee S, 1998, J MED CHEM, V41, P2663, DOI 10.1021/jm980035y; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Chou FL, 1999, NEUROLOGY, V52, P1015, DOI 10.1212/WNL.52.5.1015; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; CRAWFORD C, 1988, BIOCHEM J, V253, P751, DOI 10.1042/bj2530751; Cuerrier D, 2006, BIOCHEMISTRY-US, V45, P7446, DOI 10.1021/bi060425j; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V62, P1989; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HIWASA T, 1990, CARCINOGENESIS, V11, P75, DOI 10.1093/carcin/11.1.75; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; James KE, 2004, J MED CHEM, V47, P1553, DOI 10.1021/jm0305016; Janossy J, 2004, BIOCHEM PHARMACOL, V67, P1513, DOI 10.1016/j.bcp.2003.12.021; Kambe A, 2005, BRAIN RES, V1040, P36, DOI 10.1016/j.brainres.2005.01.080; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QS, 2006, BIOCHEMISTRY-US, V45, P701, DOI 10.1021/bi052077b; MASON RW, 1985, BIOCHEM J, V226, P233, DOI 10.1042/bj2260233; Mathur P, 2000, CURR EYE RES, V21, P926, DOI 10.1076/ceyr.21.6.926.6990; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; PARKES C, 1985, BIOCHEM J, V230, P509, DOI 10.1042/bj2300509; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Schaschke N, 1998, FEBS LETT, V421, P80, DOI 10.1016/S0014-5793(97)01538-X; Schaschke N, 1997, BIOORGAN MED CHEM, V5, P1789, DOI 10.1016/S0968-0896(97)00105-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Verhelst SHL, 2005, CHEMBIOCHEM, V6, P824, DOI 10.1002/cbic.200400377; Wang K K, 1997, Adv Pharmacol, V37, P117; Wieczerzak E, 2005, J PEPT RES, V66, P1, DOI 10.1111/j.1747-0285.2006.00329.x; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x	57	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9600	9611		10.1074/jbc.M610372200	http://dx.doi.org/10.1074/jbc.M610372200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17218315	hybrid			2022-12-27	WOS:000245421700033
J	Mercer, AE; Maggs, JL; Sun, XM; Cohen, GM; Chadwick, J; O'Neill, PM; Park, BK				Mercer, Amy E.; Maggs, James L.; Sun, Xiao-Ming; Cohen, Gerald M.; Chadwick, James; O'Neill, Paul M.; Park, B. Kevin			Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-TRAPPING EVIDENCE; LEUKEMIC HL60 CELLS; QINGHAOSU ARTEMISININ; TRANSFERRIN RECEPTOR; TUMOR-CELLS; IN-VITRO; ANTIMALARIAL ENDOPEROXIDE; MONOCLONAL-ANTIBODY; BILIARY METABOLITES; SELECTIVE TOXICITY	Artemisinin and its derivatives are currently recommended as first-line antimalarials in regions where Plasmodium-falciparum is resistant to traditional drugs. The cytotoxic activity of these endoperoxides toward rapidly dividing human carcinoma cells and cell lines has been reported, and it is hypothesized that activation of the endoperoxide bridge by an iron(II) species, to form C-centered radicals, is essential for cytotoxicity. The studies described here have utilized artemisinin derivatives, dihydroartemisinin, 10 beta-(p-bromophenoxy)dihydroartemisinin, and 10 beta-(p-fluorophenoxy)dihydroartemisinin, to determine the chemistry of endoperoxide bridge activation to reactive intermediates responsible for initiating cell death and to elucidate the molecular mechanism of cell death. These studies have demonstrated the selective cytotoxic activity of the endoperoxides toward leukemia cell lines (HL-60 and Jurkat) over quiescent peripheral blood mononuclear cells. Deoxy10 beta-(p-fluorophenoxy)dihydroartemisinin, which lacks the endoperoxide bridge, was 50- and 130-fold less active in HL-60 and jurkat cells, respectively, confirming the importance of this functional group for cytotoxicity. We have shown that chemical activation is responsible for cytotoxicity by using liquid chromatography-mass spectrometry analysis to monitor endoperoxide activation by measurement of a stable rearrangement product of endoperoxide-derived radicals, which was formed in sensitive HL-60 cells but not in insensitive peripheral blood mononuclear cells. In HL-60 cells the endoperoxides induce caspase-dependent apoptotic cell death characterized by concentration- and time-dependent mitochondrial membrane depolarization, activation of caspases-3 and -7, sub-G(0)/G(1), DNA formation, and attenuation by benzyloxycarbonyl-VAD-fluoromethyI ketone, a caspase inhibitor. Overall, these results indicate that endoperoxide-induced cell death is a consequence of activation of the endoperoxide bridge to radical species, which triggers caspase-dependent apoptosis.	Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England; Univ Liverpool, Dept Chem, Liverpool L69 3GE, Merseyside, England; MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Liverpool; University of Liverpool; University of Leicester	Park, BK (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Sherrington Bldgs, Liverpool L69 3GE, Merseyside, England.	b.k.park@liv.ac.uk	Chadwick, Amy E/D-8633-2015; Cohen, Gerald M/A-1687-2008; Chadwick, James/A-7574-2017	Chadwick, Amy E/0000-0002-7399-8655; Chadwick, James/0000-0003-4456-0117	MRC [MC_U132615750] Funding Source: UKRI; Medical Research Council [MC_U132615750] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Beekman AC, 1998, PLANTA MED, V64, P615, DOI 10.1055/s-2006-957533; Beekman AC, 1997, J NAT PROD, V60, P325, DOI 10.1021/np9605495; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; BREWER TG, 1994, AM J TROP MED HYG, V51, P251, DOI 10.4269/ajtmh.1994.51.251; BURDON RH, 1993, FREE RADICAL RES COM, V18, P369, DOI 10.3109/10715769309147503; CHITAMBAR CR, 1986, J CLIN INVEST, V78, P1538, DOI 10.1172/JCI112746; CHITAMBAR CR, 1990, J LAB CLIN MED, V116, P345; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Creek DJ, 2005, J PHARM SCI-US, V94, P1820, DOI 10.1002/jps.20400; deVries PJ, 1996, DRUGS, V52, P818, DOI 10.2165/00003495-199652060-00004; Dinsdale D, 1999, AM J PATHOL, V155, P607, DOI 10.1016/S0002-9440(10)65156-5; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2001, INT J ONCOL, V18, P767; Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8; GALLAGHER R, 1979, BLOOD, V54, P713; Hachiya M, 2000, BBA-MOL CELL RES, V1495, P237, DOI 10.1016/S0167-4889(99)00168-8; Haynes RK, 2004, MICROBES INFECT, V6, P1339, DOI 10.1016/j.micinf.2004.09.002; Haynes RK, 1996, TETRAHEDRON LETT, V37, P253, DOI 10.1016/0040-4039(95)02141-8; HONG YL, 1994, MOL BIOCHEM PARASIT, V63, P121, DOI 10.1016/0166-6851(94)90014-0; Jahaniani F, 2005, PHYTOCHEMISTRY, V66, P1581, DOI 10.1016/j.phytochem.2005.04.035; Jeyadevan JP, 2004, J MED CHEM, V47, P1290, DOI 10.1021/jm030974c; Jung M, 1997, BIOORG MED CHEM LETT, V7, P1091, DOI 10.1016/S0960-894X(97)00169-8; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumar P, 2002, J MED MICROBIOL, V51, P832, DOI 10.1099/0022-1317-51-10-832; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; LAI H, 1995, CANCER LETT, V91, P41, DOI 10.1016/0304-3835(94)03716-V; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; LEBMAN D, 1982, BLOOD, V59, P671; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Li Y, 2001, BIOORG MED CHEM LETT, V11, P5, DOI 10.1016/S0960-894X(00)00578-3; Longo M, 2006, REPROD TOXICOL, V21, P83, DOI 10.1016/j.reprotox.2005.05.005; Maggs JL, 2000, DRUG METAB DISPOS, V28, P209; Maggs JL, 1997, DRUG METAB DISPOS, V25, P1200; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; O'Neill PM, 2000, J ORG CHEM, V65, P1578, DOI 10.1021/jo991585m; O'Neill PM, 2001, J MED CHEM, V44, P58, DOI 10.1021/jm000987f; Park BK, 1998, BRIT J CLIN PHARMACO, V46, P521, DOI 10.1046/j.1365-2125.1998.00838.x; PILARSKI LM, 1995, AM J HEMATOL, V49, P323, DOI 10.1002/ajh.2830490411; Posner GH, 2003, J MED CHEM, V46, P1060, DOI 10.1021/jm020461q; Posner GH, 1999, J MED CHEM, V42, P4275, DOI 10.1021/jm990363d; POSNER GH, 1992, J AM CHEM SOC, V114, P8328, DOI 10.1021/ja00047a076; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Raffray M, 1997, PHARMACOL THERAPEUT, V75, P153, DOI 10.1016/S0163-7258(97)00037-5; RIBIERIO IR, 1998, MED TROP, V58, P50; ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003; Sadava D, 2002, CANCER LETT, V179, P151, DOI 10.1016/S0304-3835(02)00005-8; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schmuck G, 2002, ANTIMICROB AGENTS CH, V46, P821, DOI 10.1128/AAC.46.3.821-827.2002; SEARLE J, 1982, PATHOL ANNU, V17, P229; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Smith SL, 1997, BIOCHEM PHARMACOL, V53, P5, DOI 10.1016/S0006-2952(96)00591-6; Smith SL, 1998, NEUROTOXICOLOGY, V19, P557; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Suzuki F, 2005, ANTICANCER RES, V25, P887; TAETLE R, 1985, J CLIN INVEST, V75, P1061, DOI 10.1172/JCI111768; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TRUMP BF, 1984, DRUG METABOLISM DRUG, P261; van Agtmael MA, 1999, TRENDS PHARMACOL SCI, V20, P199, DOI 10.1016/S0165-6147(99)01302-4; Wang DY, 2000, CHEM COMMUN, P2193, DOI 10.1039/b006906j; Williams DP, 1997, J PHARMACOL EXP THER, V283, P1375; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wu GD, 2004, VASC PHARMACOL, V41, P205, DOI 10.1016/j.vph.2004.11.001; Wu WM, 1998, J AM CHEM SOC, V120, P3316, DOI 10.1021/ja973080o; Wu WM, 1996, CHEM COMMUN, P2213, DOI 10.1039/cc9960002213; Wu YK, 2003, HELV CHIM ACTA, V86, P3074, DOI 10.1002/hlca.200390249; Wu YK, 2003, CHEM RES TOXICOL, V16, P1202, DOI 10.1021/tx034133k; Wu YK, 1999, ANGEW CHEM INT EDIT, V38, P2580, DOI 10.1002/(SICI)1521-3773(19990903)38:17&lt;2580::AID-ANIE2580&gt;3.0.CO;2-J; YANG YZ, 1993, BIOCHEM PHARMACOL, V46, P336, DOI 10.1016/0006-2952(93)90425-V; Zhuang JG, 1998, CELL DEATH DIFFER, V5, P953, DOI 10.1038/sj.cdd.4400440	76	153	175	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9372	9382		10.1074/jbc.M610375200	http://dx.doi.org/10.1074/jbc.M610375200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17227762	hybrid			2022-12-27	WOS:000245421700009
J	Vigneux, F; Zumbihl, R; Jubelin, G; Ribeiro, C; Poncet, J; Baghdiguian, S; Givaudan, A; Brehelin, M				Vigneux, Fabienne; Zumbihl, Robert; Jubelin, Gregory; Ribeiro, Carlos; Poncet, Joel; Baghdiguian, Stephen; Givaudan, Alain; Brehelin, Michel			The xaxAB genes encoding a new apoptotic toxin from the insect pathogen Xenorhabdus nematophila are present in plant and human pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM PHOTORHABDUS-LUMINESCENS; ESCHERICHIA-COLI; GENOME SEQUENCE; FULL VIRULENCE; FAMILY; CELLS; HEMOLYSIN; CLOSTRIDIUM; ACTIVATION; EXPRESSION	Xenorhabdus nematophila, a member of the Enterobacteriaceae, kills many species of insects by strongly depressing the immune system and colonizing the entire body. A peptide cytotoxin has been purified from X. nematophila broth growth, and the cytolytic effect on insect immunocytes and hemolytic effect on mammalian red blood cells of this toxin have been described (Ribeiro, C., Vignes, M., and Brehelin, M. (2003) J. Mal. Chem. 278, 3030-3039). We show here that this toxin, Xenorhabdus alpha-xenorhabdolysin (Xax), triggers apoptosis in both insect and mammalian cells. We also report the cloning and sequencing of two genes, xaxAB, encoding this toxin in X. nematophila. The expression of both genes in recombinant Escherichia coli led to the production of active cytotoxin/hemolysin. However, hemolytic activity was observed only if the two peptides were added in the appropriate order. Furthermore, we report here that inactivation of xaxAB genes in X. nematophila abolished the major cytotoxic activity present in broth growth, called C I. We also show that these genes are present in various entomopathogenic bacteria of the genera Xenorhabdus and Photorhabdus, in Pseudomonas entomophila, in the human pathogens Yersinia enterocolitica and Proteus mirabilis, and in the plant pathogen Pseudomonas syringae. This toxin cannot be classified in any known family of cytotoxins on the basis of amino acid sequences, locus organization, and activity features. It is, therefore, probably the prototype of a new family of binary toxins.	Univ Montpellier 2, INRA, UMR 1133, F-34095 Montpellier, France; Univ Montpellier 1, CNRS, UMR 5203, INSERM,U661, F-34094 Montpellier, France; Univ Montpellier 2, CNRS, UMR 5203, INSERM,U661, F-34094 Montpellier, France; Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, F-34095 Montpellier, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Givaudan, A (corresponding author), Univ Montpellier 2, INRA, UMR 1133, Pl Eugene Bataillon, F-34095 Montpellier, France.	givaudan@univ-montp2.fr; brehelin@univ-montp2.fr		Baghdiguian, Stephen/0000-0002-2992-9708; JUBELIN, Gregory/0000-0002-9902-0663				Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; BREHELIN M, 1989, INSECT BIOCHEM, V19, P301, DOI 10.1016/0020-1790(89)90076-0; Brillard J, 2003, FEMS MICROBIOL LETT, V218, P107, DOI 10.1111/j.1574-6968.2003.tb11505.x; Brillard J, 2002, J BACTERIOL, V184, P3871, DOI 10.1128/JB.184.14.3871-3878.2002; Brillard J, 2001, APPL ENVIRON MICROB, V67, P2515, DOI 10.1128/AEM.67.6.2515-2525.2001; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Cowles KN, 2005, CELL MICROBIOL, V7, P209, DOI 10.1111/j.1462-5822.2004.00448.x; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Hwang SY, 2003, INT J ONCOL, V22, P151; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; MENESTRINA G, 1994, MOL ASPECTS MED, V15, P79, DOI 10.1016/0098-2997(94)90043-4; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Morgan JAW, 2001, APPL ENVIRON MICROB, V67, P2062, DOI 10.1128/AEM.67.5.2062-2069.2001; Park Y, 2000, J INSECT PHYSIOL, V46, P1469, DOI 10.1016/S0022-1910(00)00071-8; Ribeiro C, 1999, J INSECT PHYSIOL, V45, P677, DOI 10.1016/S0022-1910(99)00043-8; Ribeiro C, 2003, J BIOL CHEM, V278, P3030, DOI 10.1074/jbc.M210353200; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; Tennant SM, 2005, INFECT IMMUN, V73, P6860, DOI 10.1128/IAI.73.10.6860-6867.2005; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Waterfield NR, 2004, NAT REV MICROBIOL, V2, P833, DOI 10.1038/nrmicro1008; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	34	89	92	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9571	9580		10.1074/jbc.M604301200	http://dx.doi.org/10.1074/jbc.M604301200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17229739	Green Published, hybrid			2022-12-27	WOS:000245421700030
J	Abdallah, BM; Boissy, P; Tan, QH; Dahlgaard, J; Traustadottir, GA; Kupisiewicz, K; Laborda, J; Delaisse, JM; Kassem, M				Abdallah, Basern M.; Boissy, Patrice; Tan, Qihua; Dahlgaard, Jesper; Traustadottir, Gunnhildur A.; Kupisiewicz, Katarzyna; Laborda, Jorge; Delaisse, Jean-Marie; Kassem, Moustapha			dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HOMEOTIC PROTEIN DLK; FETAL ANTIGEN-1; GROWTH; DIFFERENTIATION; INHIBITION; RECEPTORS; BIOLOGY; DISEASE; ALPHA	dlk1/FA1 (delta-like 1/fetal antigen-1) is a member of the epidermal growth factor-like homeotic protein family whose expression is known to modulate the differentiation signals of mesenchymal and hematopoietic stem cells in bone marrow. We have demonstrated previously that Dlk1 can maintain the human bone marrow mesenchymal stem cells (hMSC) in an undifferentiated state. To identify the molecular mechanisms underlying these effects, we compared the basal gene expression pattern in Dlk1-overexpressing hMSC cells (hMSC-dlk1) versus control hMSC (negative for Dlk1 expression) by using Affymetrix HG-U133A microarrays. In response to Dlk1 expression, 128 genes were significantly up-regulated (with > 2-fold; p < 0.001), and 24% of these genes were annotated as immune response-related factors, including pro-inflammatory cytokines, in addition to factors involved in the complement system, apoptosis, and cell adhesion. Also, addition of purified FA1 to hMSC up-regulated the same factors in a dose-dependent manner. As biological consequences of up-regulating these immune response-related factors, we showed that the inhibitory effects of dlk1 on osteoblast and adipocyte differentiation of hMSC are associated with Dlk1-induced cytokine expression. Furthermore, Dlk1 promoted B cell proliferation, synergized the immune response effects of the bacterial endotoxin lipopolysaccharide on hMSC, and led to marked transactivation of the NF-kappa B. Our data suggest a new role for Dlk1 in regulating the multiple biological functions of hMSC by influencing the composition of their microenvironment "niche." Our findings also demonstrate a role for Dlk1 in mediating the immune response.	Univ So Denmark, Dept Endocrinol & Metab, Ctr Med Biotechnol, Odense Univ Hosp,KMEB Lab, DK-5000 Odense C, Denmark; So Denmark Univ, Vejle Hosp, DK-7100 Vejle, Denmark; Odense Univ Hosp, Dept Clin Biochem & Genet, DK-5000 Odense, Denmark; Univ Castilla La Mancha, Sch Med, Dept Inorgan & Organ Chem & Biochem, Mol Biol Branch, Albacete 02006, Spain	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Odense University Hospital; Universidad de Castilla-La Mancha	Abdallah, BM (corresponding author), Univ So Denmark, Dept Endocrinol & Metab, Ctr Med Biotechnol, Odense Univ Hosp,KMEB Lab, DK-5000 Odense C, Denmark.	babdallah@health.sdu.dk	Kassem, Moustapha/O-3819-2019; Tan, Qihua/F-1349-2015; Tan, Qihua/AAG-2582-2019; Abdallah, Basem/G-5667-2017; Laborda, Jorge/L-5726-2014; Kassem, Moustapha/J-7688-2013	Kassem, Moustapha/0000-0003-1557-0869; Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Abdallah, Basem/0000-0003-0324-8055; Laborda, Jorge/0000-0002-9210-838X; Kassem, Moustapha/0000-0003-1557-0869; Boissy, Patrice/0000-0002-4025-1141; Traustadottir, Gunnhildur Asta/0000-0001-6044-0989; Delaisse, Jean-Marie/0000-0001-7370-1500; Dahlgaard, Jesper/0000-0002-1798-6799				Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Ahdjoudj S, 2004, HISTOL HISTOPATHOL, V19, P151, DOI 10.14670/HH-19.151; Andela VB, 2002, BIOCHEM BIOPH RES CO, V297, P237, DOI 10.1016/S0006-291X(02)02141-1; Andersen M, 2001, J CLIN ENDOCR METAB, V86, P5465, DOI 10.1210/jc.86.11.5465; Atkins GJ, 2000, BONE, V26, P653, DOI 10.1016/S8756-3282(00)00280-5; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bauer SR, 1998, MOL CELL BIOL, V18, P5247, DOI 10.1128/MCB.18.9.5247; Berends MJW, 1999, AM J MED GENET, V84, P76, DOI 10.1002/(SICI)1096-8628(19990507)84:1<76::AID-AJMG16>3.0.CO;2-F; Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Carlsson C, 1997, ENDOCRINOLOGY, V138, P3940, DOI 10.1210/en.138.9.3940; Carter RA, 2001, ARTHRITIS RHEUM-US, V44, P985, DOI 10.1002/1529-0131(200105)44:5<985::AID-ANR176>3.3.CO;2-G; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; Costaglioli P, 2001, FEBS LETT, V509, P413, DOI 10.1016/S0014-5793(01)03205-7; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deyama Y, 2001, BIOCHEM BIOPH RES CO, V282, P1080, DOI 10.1006/bbrc.2001.4693; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; FAY TN, 1988, EUR J OBSTET GYN R B, V29, P73, DOI 10.1016/0028-2243(88)90167-0; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; Graves DT, 1999, FRONT BIOSCI, V4, P571; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Harp JB, 2004, CURR OPIN LIPIDOL, V15, P303, DOI 10.1097/00041433-200406000-00010; Henderson B, 2003, TRENDS MICROBIOL, V11, P570, DOI 10.1016/j.tim.2003.10.005; Heyninck Karen, 2001, Molecular Cell Biology Research Communications, V4, P259, DOI 10.1006/mcbr.2001.0295; Hofmann WK, 2002, BLOOD, V100, P3553, DOI 10.1182/blood.V100.10.3553; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang CC, 2004, J PATHOL, V202, P172, DOI 10.1002/path.1505; Jensen CH, 2004, AM J PATHOL, V164, P1347, DOI 10.1016/S0002-9440(10)63221-X; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KASSEM M, 1993, J BONE MINER RES, V8, P1453; Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; MacKenzie S, 2006, MOL IMMUNOL, V43, P1340, DOI 10.1016/j.molimm.2005.09.005; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Marriott I, 2004, IMMUNOL RES, V30, P291, DOI 10.1385/IR:30:3:291; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Oakley F, 2003, J BIOL CHEM, V278, P24359, DOI 10.1074/jbc.M211051200; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rougier F, 1998, CYTOKINE, V10, P93, DOI 10.1006/cyto.1997.0262; Ruiz-Hidalgo MJ, 2002, EXP CELL RES, V274, P178, DOI 10.1006/excr.2001.5464; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Samulewicz SJ, 2002, WOUND REPAIR REGEN, V10, P215, DOI 10.1046/j.1524-475X.2002.10404.x; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; Shiffman D, 2000, J BIOL CHEM, V275, P37324, DOI 10.1074/jbc.M004732200; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Tanimizu N, 2004, GENE EXPR PATTERNS, V5, P209, DOI 10.1016/j.modgep.2004.08.003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	88	70	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7339	7351		10.1074/jbc.M607530200	http://dx.doi.org/10.1074/jbc.M607530200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17182623	hybrid			2022-12-27	WOS:000245080900045
J	Fan, WQ; Yanase, T; Morinaga, H; Okabe, T; Nomura, M; Daitoku, H; Fukamizu, A; Kato, S; Takayanagi, R; Nawata, H				Fan, WuQiang; Yanase, Toshihiko; Morinaga, Hidetaka; Okabe, Taijiro; Nomura, Masatoshi; Daitoku, Hiroaki; Fukamizu, Akiyoshi; Kato, Shigeaki; Takayanagi, Ryoichi; Nawata, Hajime			Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; NUCLEAR RECEPTOR; INHIBITS PROLIFERATION; FACTOR-I; EXPRESSION; TRANSACTIVATION; TRANSCRIPTION; SUPPRESSES; RESISTANCE; PROTEIN	The androgen-androgen receptor (AR) system plays vital roles in a wide array of biological processes, including prostate cancer development and progression. Several growth factors, such as insulin-like growth factor 1 (IGF1), can induce AR activation, whereas insulin resistance and hyperinsulinemia are correlated with an elevated incidence of prostate cancer. Here we report that Foxo1, a downstream molecule that becomes phosphorylated and inactivated by phosphatidylinositol 3-kinase/Akt kinase in response to IGF1 or insulin, suppresses ligand-mediated AR transactivation. Foxo1 reduces androgen-induced AR target gene expressions and suppresses the in vitro growth of prostate cancer cells. These inhibitory effects of Foxo1 are attenuated by IGF1 but are enhanced when it is rendered Akt-nonphosphorylatable. Foxo1 interacts directly with the C terminus of AR in a ligand-dependent manner and disrupts ligand-induced AR subnuclear compartmentalization. Foxo1 is recruited by liganded AR to the chromatin of AR target gene promoters, where it interferes with AR-DNA interactions. IGF1 or insulin abolish the Foxo1 occupancy of these promoters. Of interest, a positive feedback circuit working locally in an autocrine/intracrine manner may exist, because liganded AR up-regulates IGF1 receptor expression in prostate cancer cells, presumably resulting in higher IGF1 signaling tension and further enhancing the functions of the receptor itself. Thus, Foxo1 is a novel corepressor for AR, and IGF1/insulin signaling may confer stimulatory effects on AR by attenuating Foxo1 inhibition. These results highlight the potential involvement of metabolic syndrome and hyperinsulinemia in prostate diseases and further suggest that intervention of IGF1/insulin-phosphatidyl-inositol 3-kinase-Akt signaling may be of clinical value for prostate diseases.	Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	Kyushu University; University of Tsukuba; University of Tokyo	Yanase, T (corresponding author), Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	yanase@intmed3.med.kyushu-u.ac.jp	fukamizu, akiyoshi/J-5350-2012	fukamizu, akiyoshi/0000-0002-8786-6020				Amling CL, 2005, CURR OPIN UROL, V15, P167, DOI 10.1097/01.mou.0000165550.94663.fb; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Brinkmann AO, 2000, ADV PHARMACOL, V47, P317; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Castoria G, 2004, STEROIDS, V69, P517, DOI 10.1016/j.steroids.2004.05.001; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen GC, 2005, J BIOL CHEM, V280, P36355, DOI 10.1074/jbc.M506147200; CULIG Z, 1994, CANCER RES, V54, P5474; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; Fan WQ, 2004, MOL ENDOCRINOL, V18, P127, DOI 10.1210/me.2003-0110; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Grzmil M, 2004, J PATHOL, V202, P50, DOI 10.1002/path.1492; Hellawell GO, 2002, CANCER RES, V62, P2942; Hsing AW, 2003, J NATL CANCER I, V95, P67, DOI 10.1093/jnci/95.1.67; Huang HJ, 2004, J BIOL CHEM, V279, P13866, DOI 10.1074/jbc.M314143200; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McMenamin ME, 1999, CANCER RES, V59, P4291; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nickerson T, 2001, CANCER RES, V61, P6276; Orio F, 2002, MOL CELL ENDOCRINOL, V198, P105, DOI 10.1016/S0303-7207(02)00374-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollak M, 1998, CANCER METAST REV, V17, P383, DOI 10.1023/A:1006154108619; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Santos AF, 2004, STEROIDS, V69, P79, DOI 10.1016/j.steroids.2003.10.005; Stattin P, 2003, J NATL CANCER I, V95, P1086, DOI 10.1093/jnci/95.14.1086; Tao RH, 2006, MOL CELL ENDOCRINOL, V247, P150, DOI 10.1016/j.mce.2005.12.052; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Verras M, 2005, MOL ENDOCRINOL, V19, P391, DOI 10.1210/me.2004-0208; Wolk A, 1998, J NATL CANCER I, V90, P911, DOI 10.1093/jnci/90.12.911; Wu Y, 2006, MOL CELL BIOL, V26, P6633, DOI 10.1128/MCB.01534-05; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008	41	125	127	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7329	7338		10.1074/jbc.M610447200	http://dx.doi.org/10.1074/jbc.M610447200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17202144	hybrid			2022-12-27	WOS:000245080900044
J	Fraser, DA; Arora, M; Bohlson, SS; Lozano, E; Tenner, AJ				Fraser, Deborah A.; Arora, Meenakshi; Bohlson, Suzanne S.; Lozano, Encarnacion; Tenner, Andrea J.			Generation of inhibitory NF kappa B complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA TRANSCRIPTION; GENE-EXPRESSION; CYTOKINE SYNTHESIS; APOPTOTIC CELLS; IN-VITRO; ACTIVATION; CLQ; SUBCOMPONENT; ASSOCIATION; DISEASE	The interaction of C1q with specific cells of the immune system induces activities, such as enhancement of phagocytosis in monocytes and stimulation of superoxide production in neutrophils. In contrast to some other monocyte activators, C1q itself does not induce pro-inflammatory cytokine production, but rather inhibits the lipopolysaccharide (LPS)-stimulated induction of certain pro-inflammatory cytokines and induces expression of interleukin-10. To investigate the molecular mechanism by which C1q exerts this effect on gene expression, the influence of C1q on the activation of transcription factors of the NF kappa B family and cAMP response element-binding protein (CREB) was assessed. C1q treatment increased kappa B binding activity in freshly isolated human monocytes in a time-dependent fashion as assessed by electrophoretic mobility shift assays. In antibody supershift experiments, anti-p50 antibody supershifted the C1q-induced NF kappa B complex, whereas anti-p65 antibody had little effect, suggesting that C1q induced the translocation of NF kappa B p50p50 homodimers. This is in contrast to the dominant induction of p65 containing complexes in parallel monocyte cultures stimulated with LPS. C1q treatment also induced cAMP response element (CRE)-binding activity as demonstrated by electrophoretic mobility shift assay, increased phosphorylation of CREB, and induction of CRE driven gene expression. In contrast, CREB activation was not detected in LPS-treated monocytes. These results suggest that C1q may modulate the cytokine profile expressed in response to inflammatory stimuli (e.g. LPS), by triggering inhibitory and/or competing signals. Because C1q and other defense collagens have been shown to enhance clearance of apoptotic cells, this regulatory pathway may be beneficial in avoiding autoimmunity and/or resolving inflammation.	Univ Calif Irvine, Dept Mol Biol & Biochem, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Ctr Immunol, 3205 McGaugh Hall, Irvine, CA 92697 USA.	atenner@uci.edu	Lozano, Encarnacion/C-5161-2008	Lozano, Encarnacion/0000-0003-0254-0935	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041090] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00827] Funding Source: Medline; NIAID NIH HHS [AI41090] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barchowsky A, 1996, FREE RADICAL BIO MED, V21, P783, DOI 10.1016/0891-5849(96)00174-8; BOBAK DA, 1988, EUR J IMMUNOL, V18, P2001, DOI 10.1002/eji.1830181220; BOBAK DA, 1987, J IMMUNOL, V138, P1150; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; DIETZSCHOLD B, 1995, J NEUROL SCI, V130, P11, DOI 10.1016/0022-510X(94)00269-T; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fan R, 2004, EXP NEUROL, V185, P241, DOI 10.1016/j.expneurol.2003.09.023; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gee K, 2006, J BIOL CHEM, V281, P31647, DOI 10.1074/jbc.M512109200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldsmith SK, 1997, J NEUROCHEM, V68, P2046; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HANSEN SK, 1994, J BIOL CHEM, V269, P22230; HANSEN SK, 1994, MOL CELL BIOL, V14, P2593, DOI 10.1128/MCB.14.4.2593; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Korb LC, 1997, J IMMUNOL, V158, P4525; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Lionetti F. J., 1980, METHODS CELL SEPARAT; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mitchell DA, 2002, J IMMUNOL, V168, P2538, DOI 10.4049/jimmunol.168.5.2538; Miura-Shimura Y, 2002, J IMMUNOL, V169, P1334, DOI 10.4049/jimmunol.169.3.1334; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Nauta AJ, 2004, INT ARCH ALLERGY IMM, V134, P310, DOI 10.1159/000079261; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; OHMORI Y, 1994, J BIOL CHEM, V269, P17684; PLAKSIN D, 1993, J EXP MED, V177, P1651, DOI 10.1084/jem.177.6.1651; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; REID KBM, 1972, BIOCHEM J, V130, P749, DOI 10.1042/bj1300749; Rosseau S, 1999, J IMMUNOL, V163, P4495; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shumilla JA, 1998, ARCH BIOCHEM BIOPHYS, V349, P356, DOI 10.1006/abbi.1997.0470; Stamme C, 2000, AM J RESP CELL MOL, V23, P772, DOI 10.1165/ajrcmb.23.6.4083; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WALKER DG, 1992, MOL BRAIN RES, V14, P109, DOI 10.1016/0169-328X(92)90017-6; Walport MJ, 1998, IMMUNOBIOLOGY, V199, P265, DOI 10.1016/S0171-2985(98)80032-6; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; YOUNG KR, 1991, J IMMUNOL, V146, P3356; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhong WJ, 1998, J IMMUNOL, V161, P2533	63	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7360	7367		10.1074/jbc.M605741200	http://dx.doi.org/10.1074/jbc.M605741200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209050	hybrid			2022-12-27	WOS:000245080900047
J	Gabrielli, B; Chau, YQ; Giles, N; Harding, A; Stevens, F; Beamish, H				Gabrielli, Brian; Chau, Yu Qian; Giles, Nichole; Harding, Angus; Stevens, Frankie; Beamish, Heather			Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DNA-DAMAGE; RADIOSENSITIZING AGENT; MICROTUBULE ATTACHMENT; AURORA-B; CENP-E; MITOSIS; CATASTROPHE; SURVIVAL; MAD2	The spindle assembly checkpoint arrests cells in mitosis when defects in mitotic spindle assembly or partitioning of the replicated genome are detected. This checkpoint blocks exit from mitosis until the defect is rectified or the cell initiates apoptosis. In this study we have used caffeine to identify components of the mechanism that signals apoptosis in mitotic checkpoint-arrested cells. Addition of caffeine to spindle checkpoint-arrested cells induced > 40% apoptosis within 5 h. It also caused proteasome-mediated destruction of cyclin B1, a corresponding reduction in cyclin B1/cdk1 activity, and reduction in NIPM-2 reactivity. However, cells retained MAD2 staining at the kinetochores, an indication of continued spindle checkpoint function. Blocking proteasome activity did not block apoptosis, but continued spindle checkpoint function was essential for apoptosis. After systematically eliminating all known targets, we have identified p21-activated kinase PAK1, which has an anti-apoptotic function in spindle checkpoint-arrested cells, as a target for caffeine inhibition. Knockdown of PAKI. also increased apoptosis in spindle checkpoint-arrested cells. This study demonstrates that the spindle checkpoint not only regulates mitotic exit but apoptosis in mitosis through the activity of PAKI.	Univ Queensland, Ctr Immunol & Canc Res, Canc Biol Program, Brisbane, Qld 4102, Australia	University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Ctr Immunol & Canc Res, Canc Biol Program, Brisbane, Qld 4102, Australia.	bgabrielli@cicr.uq.edu.au	Gabrielli, Brian G/B-3655-2011	Gabrielli, Brian G/0000-0003-3933-1651; Stevens, Frankie/0000-0002-2556-473X				Anderson Hilary J, 2003, Prog Cell Cycle Res, V5, P423; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bozko P, 2005, MOL CANCER THER, V4, P2016, DOI 10.1158/1535-7163.MCT-05-0138; Burgess A, 2004, ONCOGENE, V23, P6693, DOI 10.1038/sj.onc.1207893; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kohn EA, 2003, CANCER RES, V63, P31; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1999, CURR BIOL, V9, pR562, DOI 10.1016/S0960-9822(99)80355-8; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vogel C, 2005, J BIOL CHEM, V280, P4025, DOI 10.1074/jbc.C400545200; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	47	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6954	6964		10.1074/jbc.M610104200	http://dx.doi.org/10.1074/jbc.M610104200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17182611	hybrid			2022-12-27	WOS:000245080900007
J	Li, YP; Zeng, SX; Landais, I; Lu, H				Li, Yanping; Zeng, Shelya X.; Landais, Igor; Lu, Hua			Human SSRP1 has Spt16-dependent and -independent roles in gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SERUM RESPONSE FACTOR; GROUP BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; TERMINAL DOMAIN; DNA-BINDING; FACT COMPLEX; IN-VIVO; C-FOS; CHROMATIN	The facilitating chromatin transcription (FACT) complex, a heterodimer of SSRP1 and Spt16, has been shown to regulate transcription elongation through a chromatin template in vitro and on specific genes in cells. However, its global role in transcription regulation in human cells remains largely elusive. We conducted spotted microarray analyses using arrays harboring 8308 human genes to assess the gene expression profile after knocking down SSRP1 or Spt16 levels in human non-small cell lung carcinoma (H1299) cells. Although the changes of these transcripts were surprisingly subtle, there were similar to 170 genes whose transcript levels were either reduced or induced > 1.5fold. Approximately 106 genes with > 1.2-fold change at the level of transcripts were the common targets of both SSRP1 and Spt16 (similar to 1.3%). A subset of genes was regulated by SSRP1 independent of Spt16. Further analyses of some of these genes not only verified this observation but also identified the serum-responsive gene, egr1, as a novel target for both SSRP1 and Spt16. We further showed that SSRP1 and Spt16 are important for the progression of elongation RNA pol II on the egr1 gene. These results suggest that SSRPI has Spt16-dependent and -independent roles in regulating gene transcription in human cells.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, Portland, OR 97239 USA	Oregon Health & Science University	Lu, H (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	luh@ohsu.edu			NCI NIH HHS [CA095441, CA93614, CA079721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079721, R01CA095441, R01CA093614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2003, CURR TOP MICROBIOL, V274, P171; Formosa T, 2002, GENETICS, V162, P1557; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Hertel L, 1997, BIOCHIMIE, V79, P717, DOI 10.1016/S0300-9084(97)86929-5; Jimeno-Gonzalez S, 2006, MOL CELL BIOL, V26, P8710, DOI 10.1128/MCB.01129-06; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Landais I, 2006, CELL DEATH DIFFER, V13, P1866, DOI 10.1038/sj.cdd.4401878; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; PAULSSON Y, 1987, EXP CELL RES, V171, P186, DOI 10.1016/0014-4827(87)90261-8; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schlesinger MB, 2000, GENETICS, V155, P1593; SHIRAKATA M, 1991, MOL CELL BIOL, V11, P4528, DOI 10.1128/MCB.11.9.4528; Singer RA, 2004, BIOCHEM CELL BIOL, V82, P419, DOI 10.1139/O04-050; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Svejstrup JQ, 2002, CURR OPIN GENET DEV, V12, P156, DOI 10.1016/S0959-437X(02)00281-2; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	52	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6936	6945		10.1074/jbc.M603822200	http://dx.doi.org/10.1074/jbc.M603822200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209051	hybrid			2022-12-27	WOS:000245080900005
J	Onoguchi, K; Yoneyama, M; Takemura, A; Akira, S; Taniguchi, T; Namiki, H; Fujita, T				Onoguchi, Kazuhide; Yoneyama, Mitsutoshi; Takemura, Azumi; Akira, Shizuo; Taniguchi, Tardatsugu; Namiki, Hideo; Fujita, Takashi			Viral infections activate types I and III interferon genes through a common mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; ANTIVIRAL ACTIVITY; ADAPTER PROTEIN; DENDRITIC CELLS; IFN-LAMBDA; KAPPA-B; VIRUS; INDUCTION; ROLES; IDENTIFICATION	Viral infections trigger innate immune responses, including the production of type I interferons (IFN-alpha and -beta) and other proinflammatory cytokines. Novel antiviral cytokines IFN-lambda 1, IFN-lambda 2, and IFN-lambda 3 are classified as type III IFNs and have evolved independently of type I IFNs. Type III IFN genes are regulated at the level of transcription and induced by viral infection. Although the regulatory mechanism of type I IFNs is well elucidated, the expression mechanism of IFN-lambda s is not well understood. Here, we analyzed the mechanism by which IFN-lambda gene expression is induced by viral infections. Loss- and gain-of-function experiments revealed the involvement of RIG-I (retinoic acid-inducible gene 1), IPS-1, TBK1, and interferon regulatory factor-3, key regulators of the virus-induced activation of type I IFN genes. Consistent with this, a search for the cis-regulatory element of the human ifn lambda 1 revealed a cluster of interferon regulatory factor-binding sites and a NF-kappa B-binding site. Functional analysis demonstrated that all of these sites are essential for gene activation by the virus. These results strongly suggest that types I and III IFN genes are regulated by a common mechanism.	Kyoto Univ, Inst Virus Res, Lab Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068507, Japan; Waseda Univ, Sch Educ, Dept Biol, Tokyo 1690051, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Osaka 5650871, Japan; Univ Tokyo, Dept Immunol, Grad Sch Med, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Kyoto University; Kyoto University; Waseda University; Osaka University; University of Tokyo; University of Tokyo	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Lab Mol Genet, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Akira, Shizuo/C-3134-2009; Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; De Maeyer E, 1998, Int Rev Immunol, V17, P53, DOI 10.3109/08830189809084487; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	23	273	302	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7576	7581		10.1074/jbc.M608618200	http://dx.doi.org/10.1074/jbc.M608618200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17204473	hybrid			2022-12-27	WOS:000245080900070
J	Perreault, A; Lemieux, C; Bachand, F				Perreault, Audrey; Lemieux, Caroline; Bachand, Francois			Regulation of the nuclear poly(A)-binding protein by arginine methylation in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; POLY(A) BINDING-PROTEIN; TAIL LENGTH CONTROL; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; IN-VITRO; EXPORT FACTORS; METHYLTRANSFERASE	Two structurally different poly(A)-binding proteins (PABP) bind the poly(A) tract of mRNAs in most mammalian cells: PABPC in the cytoplasm and PABP2/PABPN1 in the nucleus. Whereas yeast orthologs of the cytoplasmic PABP are characterized, a gene product homologous to mammalian PABP2 has not been identified in yeast. We report here the identification of a homolog of PABP2 as an arginine methyltransferase 1 (RMT1)-associated protein in fission yeast. The product of the Schizosaccharomyces pombe pab2 gene encodes a nonessential nuclear protein and demonstrates specific poly(A) binding in vitro. Consistent with a functional role in poly(A) tail metabolism, mRNAs from pab2-null cells displayed hyperaderylated 3'-ends. We also show that arginine residues within the C-terminal arginine-rich domain of Pab2 are modified by RMT1-dependent methylation. Whereas the arginine methylated and unmethylated forms of Pab2 behaved similarly in terms of subcellular localization, poly(A) binding, and poly(A) tail length control; Pab2 oligomerization levels were markedly increased when Pab2 was not methylated. Significantly, Pab2 overexpression reduced growth rate, and this growth inhibitory effect was exacerbated in rmt1-null cells. Our results indicate that the main cellular function of Pab2 is in poly(A) tail length control and support a biological role for arginine methylation in the regulation of Pab2 oligomerization.	Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Bachand, F (corresponding author), Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada.	f.bachand@usherbrooke.ca						Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Bird G, 2005, MOL CELL, V20, P747, DOI 10.1016/j.molcel.2005.11.009; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Dheur S, 2005, J BIOL CHEM, V280, P24532, DOI 10.1074/jbc.M504720200; Dower K, 2004, RNA, V10, P1888, DOI 10.1261/rna.7166704; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Dunn EF, 2005, GENE DEV, V19, P90, DOI 10.1101/gad.1267005; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Hosoda N, 2006, MOL CELL BIOL, V26, P3085, DOI 10.1128/MCB.26.8.3085-3097.2006; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Thakurta AG, 2002, YEAST, V19, P795, DOI 10.1002/yea.876; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wang QS, 2005, HUM MOL GENET, V14, P3673, DOI 10.1093/hmg/ddi395; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942	75	52	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7552	7562		10.1074/jbc.M610512200	http://dx.doi.org/10.1074/jbc.M610512200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213188	hybrid			2022-12-27	WOS:000245080900068
J	Chen, JX; Enns, CA				Chen, Juxing; Enns, Caroline A.			The cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; HEREDITARY HEMOCHROMATOSIS; IRON OVERLOAD; JUVENILE HEMOCHROMATOSIS; EXPRESSION; HEPCIDIN; INTERNALIZATION; BINDING; TFR2; DEGRADATION	Transferrin receptor 2 (TfR2) is a homolog of transferrin receptor 1 (TfR1), the receptor responsible for the uptake of iron-loaded transferrin (holo-Tf) into cells. Unlike the ubiquitous TfR1, TfR2 is predominantly expressed in the liver. Mutations in TfR2 gene cause a rare autosomal recessive form of the iron overload disease, hereditary hemochromatosis. Previous studies demonstrated that holo-Tf increases TfR2 levels by stabilizing TfR2 at the protein level. In this study we constructed two chimeras, one of which had the cytoplasmic domain of TfR2 and the remaining portion of TfR1 and the other with the cytoplasmic and transmembrane domain of TfR1 joined to the ectodomain of TfR2. Similar to TfR2, the levels of the chimera containing only the cytoplasmic domain of TfR2 increased in a time- and dose-dependent manner after the addition of holo-Tf to the medium. The half-life of the chimera increased 2.7-fold in cells exposed to holo-Tf like the endogenous TfR2 in HepG2 cells. Like TfR2 and unlike TfR1, the levels of the chimera did not respond to intracellular iron content. These results suggest that although holo-Tf binding to the ectodomain is necessary, the cytoplasmic domain of TfR2 is largely responsible for its stabilization by holo-Tf.	Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Blvd, Portland, OR 97239 USA.	ennsca@ohsu.edu			NIDDK NIH HHS [R01-DK072166] Funding Source: Medline; NIGMS NIH HHS [GM-192837] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Andrews NC, 2000, CURR OPIN PEDIATR, V12, P596, DOI 10.1097/00008480-200012000-00015; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; COX TM, 1989, EUR J HAEMATOL, V42, P113; Deaglio S, 2002, BLOOD, V100, P3782, DOI 10.1182/blood-2002-01-0076; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dubljevic V, 1999, BIOCHEM J, V341, P11, DOI 10.1042/0264-6021:3410011; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; FURUNO K, 1989, J BIOCHEM-TOKYO, V106, P717, DOI 10.1093/oxfordjournals.jbchem.a122922; Giannetti AM, 2003, PLOS BIOL, V1, P341, DOI 10.1371/journal.pbio.0000051; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; JOHNSON MB, 2007, IN PRESS MOL BIOL CE; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2000, J BIOL CHEM, V275, P16618, DOI 10.1074/jbc.M908846199; Kawabata H, 2004, BRIT J HAEMATOL, V127, P464, DOI 10.1111/j.1365-2141.2004.05224.x; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; Kawabata H, 2001, BLOOD, V98, P2714, DOI 10.1182/blood.V98.9.2714; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Syed BA, 2006, HEMOGLOBIN, V30, P69, DOI 10.1080/03630260500455318; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Wallace DF, 2002, BLOOD, V100, P692, DOI 10.1182/blood.V100.2.692; Warren RA, 1997, J BIOL CHEM, V272, P2116; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Zaliauskiene L, 2000, MOL BIOL CELL, V11, P2643, DOI 10.1091/mbc.11.8.2643	40	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6201	6209		10.1074/jbc.M610127200	http://dx.doi.org/10.1074/jbc.M610127200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202145	hybrid			2022-12-27	WOS:000244867200026
J	Jovanovic, J; Takagi, J; Choulier, L; Abrescia, NGA; Stuart, DI; van der Merwe, PA; Mardon, HJ; Handford, PA				Jovanovic, Jelena; Takagi, Junichi; Choulier, Laurence; Abrescia, Nicola G. A.; Stuart, David I.; van der Merwe, P. Anton; Mardon, Helen J.; Handford, Penny A.			alpha V beta 6 is a novel receptor for human fibrillin-1 - Comparative studies of molecular determinants underlying integrin-RGD affinityand specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-LIKE DOMAIN; V BETA 6; HUMAN FIBRONECTIN; CARCINOMA-CELLS; CALCIUM-BINDING; ADHESION; ALPHA(5)BETA(1); LIGAND; RECOGNITION; DYNAMICS	Human fibrillin-1, the major structural protein of connective tissue 10-12 nm microfibrils, contains multiple calcium binding epidermal growth factor-like domains interspersed with transforming growth factor beta-binding protein-like (TB) domains. TB4 contains a flexible RGD loop that mediates cell adhesion via alpha V beta 3 and alpha 5 beta 1 integrins. This study identifies integrin alpha V beta 6 as a novel cellular receptor for fibrillin-1 with a K-d of similar to 0.45 mu M. Analyses of this interaction by surface plasmon resonance and immunocytochemistry reveal different module requirements for alpha V beta 6 activation compared with those of alpha V beta 3, suggesting that a covalent linkage of an N-terminal calcium binding epidermal growth factor-like domain to TB4 can modulate alpha V integrin binding specificity. Furthermore, our data suggest alpha 5 beta 1 is a low affinity fibrillin-1 receptor (K-d > 1 mu M), thus providing a molecular explanation for the different alpha 5 beta 1 distribution patterns seen when human keratinocytes and fibroblasts are plated on recombinant fibrillin fragments versus those derived from the physiological ligand fibronectin. Non-focal contact distribution of alpha 5 beta 1 suggests that its engagement by fibrillin-1 may elicit a lesser degree and/or different type of intracellular signaling compared with that seen with a high affinity ligand.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Div Med Sci, Oxford OX3 9DU, England; Henry Wellcome Bldg Genom Med, Oxford OX3 7BN, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Osaka Univ, Inst Prot Res, Suita, Osaka 565087, Japan	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Osaka University	Handford, PA (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	penny.handford@bioch.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Abrescia, Nicola GA/F-5898-2011; Abrescia, Nicola Gerardo/AAY-2323-2020	Abrescia, Nicola Gerardo/0000-0001-5559-1918; Choulier, Laurence/0000-0003-1493-9775; Stuart, David/0000-0002-3426-4210	Medical Research Council [G9722488, G0500365, G0400926] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9722488, G0500365, G0400926] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Chen J, 1996, CELL ADHES COMMUN, V4, P237, DOI 10.3109/15419069609010769; D'Arrigo C, 1998, CONNECT TISSUE RES, V37, P29, DOI 10.3109/03008209809028898; DAVIS EC, 1993, TISSUE ENGINEERING, P26; Dzamba BJ, 2001, J INVEST DERMATOL, V117, P1612, DOI 10.1046/j.0022-202x.2001.01588.x; Huang XZ, 1998, J CELL SCI, V111, P2189; HUGHES PE, 1993, J BIOL CHEM, V268, P17727; Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670; Kemperman H, 1997, EXP CELL RES, V234, P156, DOI 10.1006/excr.1997.3599; KIELTY CM, 1992, J CELL SCI, V103, P445; Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; WEINACKER A, 1994, J BIOL CHEM, V269, P6940; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Zamir E, 2001, J CELL SCI, V114, P3583	33	63	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6743	6751		10.1074/jbc.M607008200	http://dx.doi.org/10.1074/jbc.M607008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17158881	hybrid			2022-12-27	WOS:000244867200084
J	Raschle, T; Arigoni, D; Brunisholz, R; Rechsteiner, H; Amrhein, N; Fitzpatrick, TB				Raschle, Thomas; Arigoni, Duilio; Brunisholz, Rene; Rechsteiner, Helene; Amrhein, Nikolaus; Fitzpatrick, Teresa B.			Reaction mechanism of pyridoxal 5 '-phosphate synthase - Detection of an enzyme-bound chromophoric intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; VITAMIN-B6 BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; COENZYME BIOSYNTHESIS; INCORPORATION PATTERN; GENE; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE; 4-(PHOSPHOHYDROXY)-L-THREONINE; PATHWAY; YEAST	Vitamin B6 is an essential metabolite in all. organisms. De novo synthesis of the vitamin can occur through either of two mutually exclusive pathways referred to as deoxyxylulose 5phosphate-dependent and deoxyxylulose 5-phosphate-independent. The latter pathway has only recently been discovered and is distinguished by the presence of two genes, Pdx1 and Pdx2, encoding the synthase and glutaminase subunit of PLP synthase, respectively. In the presence of ammonia, the synthase alone displays an exceptional polymorphic synthetic ability in carrying out a complex set of reactions, including pentose and triose isomerization, imine formation, ammonia addition, aldol-type condensation, cyclization, and aromatization, that convert C3 and C5 precursors into the cofactor B6 vitamer, pyridoxal 5'-phosphate. Here, employing the Bacillus subtilis proteins, we demonstrate key features along the catalytic path. We show that ribose 5-phosphate is the preferred C5 substrate and provide unequivocal evidence that the pent(ul)ose phosphate imine occurs at lysine 81 rather than lysine 149 as previously postulated. While this study was under review, corroborative crystallographic evidence has been provided for imine formation with the corresponding lysine group in the enzyme from Thermotoga maritima (Zein, F., Zhang, Y., Kang, Y.-N., Burns, K., Begley, T. P., and Ealick, S. E. (2006) Biochemistry 45,14609 14620). We have detected an unanticipated covalent reaction intermediate that occurs subsequent to imine formation and is dependent on the presence of Pdx2 and glutamine. This step most likely primes the enzyme for acceptance of the triose sugar, ultimately leading to formation of the pyridine ring. Two alternative structures are proposed for the chromophoric intermediate, both of which require substantial modifications of the proposed mechanism.	ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; ETH, Organ Chem Lab, CH-8092 Zurich, Switzerland; Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitzpatrick, TB (corresponding author), ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland.	tfitzpatrick@ethz.ch						Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Cane DE, 1998, J AM CHEM SOC, V120, P1936, DOI 10.1021/ja9742085; Cane DE, 1999, J AM CHEM SOC, V121, P7722, DOI 10.1021/ja9914947; Chaudhuri BN, 2003, BIOCHEMISTRY-US, V42, P7003, DOI 10.1021/bi034320h; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Dong YX, 2004, EUR J BIOCHEM, V271, P745, DOI 10.1111/j.1432-1033.2003.03973.x; Dorrestein PC, 2004, J AM CHEM SOC, V126, P3091, DOI 10.1021/ja039616p; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Gupta RN, 2001, J AM CHEM SOC, V123, P11353, DOI 10.1021/ja0113201; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; LAM HM, 1990, J BACTERIOL, V172, P6518, DOI 10.1128/jb.172.11.6518-6528.1990; LAM HM, 1992, J BACTERIOL, V174, P1554, DOI 10.1128/jb.174.5.1554-1567.1992; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; PIERCE J, 1985, J AM CHEM SOC, V107, P2448, DOI 10.1021/ja00294a041; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Voziyan PA, 2005, ANN NY ACAD SCI, V1043, P807, DOI 10.1196/annals.1333.093; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Yang Y, 1998, J BACTERIOL, V180, P4294, DOI 10.1128/JB.180.16.4294-4299.1998; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87; Zeidler J, 2003, J ORG CHEM, V68, P3486, DOI 10.1021/jo020730k; Zeidler J, 2002, J AM CHEM SOC, V124, P4542, DOI 10.1021/ja012708z; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang RG, 2003, J MOL BIOL, V332, P1083, DOI 10.1016/j.jmb.2003.08.009; ZHAO GS, 1994, J BACTERIOL, V176, P6134, DOI 10.1128/jb.176.19.6134-6138.1994; ZHAO GS, 1995, J BACTERIOL, V177, P2804, DOI 10.1128/jb.177.10.2804-2812.1995; Zhao GS, 1996, FEMS MICROBIOL LETT, V135, P275, DOI 10.1016/0378-1097(95)00466-1; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	37	43	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6098	6105		10.1074/jbc.M610614200	http://dx.doi.org/10.1074/jbc.M610614200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17189272	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000244867200015
J	Voglmeir, J; Voglauer, R; Wilson, IBH				Voglmeir, Josef; Voglauer, Regina; Wilson, Iain B. H.			XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-D-XYLOSE; BETA-D-XYLOSYLTRANSFERASE; RAY CRYSTAL-STRUCTURE; HEPARAN-SULFATE; CHONDROITIN SULFATE; CAENORHABDITIS-ELEGANS; LINKAGE REGION; BIOSYNTHESIS; PROTEOGLYCAN; PURIFICATION	Peptide O-xylosyltransferase (EC 2.4.2.26) is the first enzyme required for the generation of chondroitin and heparan sulfate glycosaminoglycan chains of proteoglycans. Cloning of cDNAs has previously shown that, whereas invertebrates, generally have a single xylosyltransferase gene, vertebrate genornes encode two similar proteins, xylosyltransferase I and II (XT-I and XT-II). To date enzymatic activity has only been demonstrated for the human XT-I, Caenorhabditis SQV-6, and Drosojghila OXT isoforms. In the present study, we demonstrate that a soluble form of human XT-II expressed in the xylosyltransferase-deficient pgsA-745 (S745) Chinese hamster ovary cell line is indeed capable of catalyzing the transfer of xylose to a variety of peptide substrates; its enzyme activity was also proven using a Pichia-expressed form of XT-II. Its pH, temperature, and cation dependences are similar to those of XT-I expressed in either mammalian cells or yeast. Our data suggest that XT-I and XT-II are, at least in vitro, functionally identical.	Univ Nat Resources & Appl Life Sci, Dept Chem, BOKU, A-1190 Vienna, Austria; Univ Nat Resources & Appl Life Sci, Inst Angew Mikrobiol, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Wilson, IBH (corresponding author), Univ Nat Resources & Appl Life Sci, Dept Chem, BOKU, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Wilson, Iain/B-3326-2009; Voglmeir, Josef/F-5722-2014	Wilson, Iain/0000-0001-8996-1518; Voglmeir, Josef/0000-0002-4096-4926; Grillari, Regina/0000-0002-5487-2838	Austrian Science Fund FWF [P 18447] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Berninsone PM, 2002, GLYCOCONJUGATE J, V19, P325, DOI 10.1023/A:1025364820713; Brinkmann T, 1997, J BIOL CHEM, V272, P11171; Brunner A, 2006, GLYCOCONJUGATE J, V23, P543, DOI 10.1007/s10719-006-7633-z; CAMPBELL P, 1984, ANAL BIOCHEM, V137, P505, DOI 10.1016/0003-2697(84)90119-2; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gotting C, 2004, J BIOL CHEM, V279, P42566, DOI 10.1074/jbc.M401340200; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GREBNER EE, 1966, BIOCHEM BIOPH RES CO, V22, P672, DOI 10.1016/0006-291X(66)90199-9; GREBNER EE, 1966, ARCH BIOCHEM BIOPHYS, V116, P391, DOI 10.1016/0003-9861(66)90045-2; GUILLAUMOND M, 1975, INT J BIOCHEM, V6, P491, DOI 10.1016/0020-711X(75)90029-4; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; Kuhn J, 2003, BIOCHEM BIOPH RES CO, V312, P537, DOI 10.1016/j.bbrc.2003.10.157; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Mulloy B, 2005, AN ACAD BRAS CIENC, V77, P651, DOI 10.1590/S0001-37652005000400007; NUWAYHID N, 1986, J BIOL CHEM, V261, P2936; Pak JE, 2006, METHOD ENZYMOL, V416, P30, DOI 10.1016/S0076-6879(06)16003-6; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; Pfeil U, 2000, GLYCOBIOLOGY, V10, P803, DOI 10.1093/glycob/10.8.803; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; ROBINSON HC, 1966, P NATL ACAD SCI USA, V56, P1859, DOI 10.1073/pnas.56.6.1859; Schon S, 2006, J MED GENET, V43, P745, DOI 10.1136/jmg.2006.040972; Schon S, 2006, OSTEOARTHR CARTILAGE, V14, P442, DOI 10.1016/j.joca.2005.11.004; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Schon S, 2005, KIDNEY INT, V68, P1483, DOI 10.1111/j.1523-1755.2005.00561.x; SCHWARTZ NB, 1975, ARCH BIOCHEM BIOPHYS, V171, P136, DOI 10.1016/0003-9861(75)90016-8; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; SELLECK SB, 2006, SCI STKE, pPE17; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; STOOLMILLER AC, 1972, J BIOL CHEM, V247, P3525; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200	42	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					5984	5990		10.1074/jbc.M608087200	http://dx.doi.org/10.1074/jbc.M608087200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194707	Green Accepted, hybrid			2022-12-27	WOS:000244867200003
J	Choi, MG; Carman, GM				Choi, Mal-Gi; Carman, George M.			Phosphorylation of human CTP synthetase 1 by protein kinase A - Identification of Thr(455) as a major site of phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE-TRIPHOSPHATE-SYNTHETASE; HUMAN CTP SYNTHETASE; YEAST SACCHAROMYCES-CEREVISIAE; CYCLOPENTENYL CYTOSINE; 5'-TRIPHOSPHATE SYNTHETASE; PHOSPHOLIPID BIOSYNTHESIS; PYROPHOSPHATE PHOSPHATASE; LYMPHOBLASTIC-LEUKEMIA; MUTATOR GENE; URA7 GENE	CTP synthetase is an essential enzyme that generates the CTP required for the synthesis of nucleic acids and membrane phospholipids. In this study, we examined the phosphorylation of the human CTPS1-encoded CTP synthetase 1 by protein kinase A. CTP synthetase 1 was expressed and purified from a Saccharomyces cerevisiae ura7 Delta ura8 Delta double mutant that lacks CTP synthetase activity. Using purified CTP synthetase I as a substrate, protein kinase A activity was time- and dose-dependent. The phosphorylation, which primarily occurred on a threonine residue, was accompanied by a 50% decrease in CTP synthetase 1 activity. The synthetic peptide LGKRRTLFQT that contains the protein kinase A motif for Thr(455) was a substrate for protein kinase A. A Thr(455) to Ala (T455A) mutation in CTP synthetase 1 was constructed by site-directed mutagenesis and was expressed and purified from the S. cerevisiae ura7 Delta ura8 Delta mutant. The T455A mutation caused a 78% decrease in protein kinase A phosphorylation and the loss of the phosphothreonine residue and a major phosphopeptide that were present in the purified wild type enzyme phosphorylated by protein kinase A. The CTP synthetase 1 activity of the T455A mutant enzyme was 2-fold higher than the wild type enzyme. In addition, the T455A mutation caused a 44% decrease in the amount of human CTP synthetase 1 that was phosphorylated in S. cerevisiae cells, and this was accompanied by a 2.5-fold increase in the cellular concentration of CTP and a 1.5-fold increase in the choline-dependent synthesis of phosphatidylcholine.	Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			NIGMS NIH HHS [R01 GM050679-14, R01 GM050679, GM-50679] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONOW B, 1984, J BIOL CHEM, V259, P9035; ARONOW B, 1987, J BIOL CHEM, V262, P5106; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CHOCK PB, 1980, ANNU REV BIOCHEM, V49, P813, DOI 10.1146/annurev.bi.49.070180.004121; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; CHU EHY, 1984, BIOCHEM GENET, V22, P701, DOI 10.1007/BF00485854; Dereuddre-Bosquet N, 2004, ANTIVIR RES, V61, P67, DOI 10.1016/j.antiviral.2003.08.002; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; FRAENKEL DG, 1982, MOL BIOL YEAST SACCH, P1; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; HINDENBURG AA, 1985, CANCER RES, V45, P3048; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KANG GJ, 1989, J BIOL CHEM, V264, P713; KAUFMAN ER, 1986, MUTAT RES, V161, P19, DOI 10.1016/0027-5107(86)90096-5; KIZAKI H, 1980, CANCER RES, V40, P3921; Krauss G., 2003, BIOCH SIGNAL TRANSDU; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3365, DOI 10.1021/bi00794a008; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; LEWIS DA, 1989, BIOCHEMISTRY-US, V28, P8454, DOI 10.1021/bi00447a027; LIEBERMAN I, 1956, J BIOL CHEM, V222, P765; LONG CW, 1967, J BIOL CHEM, V242, P4715; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; MEUTH M, 1982, SOMAT CELL GENET, V8, P423, DOI 10.1007/BF01538705; Mole ML, 1998, ANAL BIOCHEM, V259, P245, DOI 10.1006/abio.1998.2647; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Pappas A, 1998, J BIOL CHEM, V273, P15954, DOI 10.1074/jbc.273.26.15954; Pappas A, 1999, BIOCHEMISTRY-US, V38, P16671, DOI 10.1021/bi9920127; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; POLITI PM, 1995, CANCER CHEMOTH PHARM, V36, P513, DOI 10.1007/BF00685802; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; THOMAS PE, 1988, BIOCHIM BIOPHYS ACTA, V953, P334, DOI 10.1016/0167-4838(88)90042-8; TRUDEL M, 1984, J BIOL CHEM, V259, P2355; Van Kuilenburg ABP, 2000, ADV EXP MED BIOL, V486, P257; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; VANDENBERG AA, 1993, EUR J BIOCHEM, V216, P161; Verschuur AC, 1998, ADV EXP MED BIOL, V431, P667; Verschuur AC, 2000, EUR J CANCER, V36, P627, DOI 10.1016/S0959-8049(00)00021-6; Verschuur AC, 2000, BRIT J HAEMATOL, V110, P161, DOI 10.1046/j.1365-2141.2000.02136.x; VINCENT BRD, 1980, BIOCHIM BIOPHYS ACTA, V610, P352; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; Wadskov-Hansen SLL, 2001, J BIOL CHEM, V276, P38002; WEBER G, 1980, LIFE SCI, V27, P793, DOI 10.1016/0024-3205(80)90333-1; Weber G, 1978, Adv Enzyme Regul, V17, P1; YAMAUCHI M, 1990, EMBO J, V9, P2095, DOI 10.1002/j.1460-2075.1990.tb07377.x; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; ZHANG H, 1993, CANCER RES, V53, P5714	80	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5367	5377		10.1074/jbc.M610993200	http://dx.doi.org/10.1074/jbc.M610993200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189248	hybrid, Green Accepted			2022-12-27	WOS:000244482300032
J	Saparov, SM; Liu, K; Agre, P; Pohl, P				Saparov, Sapar M.; Liu, Kun; Agre, Peter; Pohl, Peter			Fast and selective ammonia transport by aquaporin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID BILAYERS; ION-CHANNEL FUNCTION; WATER CHANNEL; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RH GLYCOPROTEINS; XENOPUS OOCYTES; RAT HEPATOCYTES; VOLTAGE-CLAMP	The transport of ammonia/ammonium is fundamental to nitrogen metabolism in all forms of life. So far, no clear picture has emerged as to whether a protein channel is capable of transporting exclusively neutral NH3, while excluding H+ and NH4+. Our research is the first stoichiometric study to show the selective transport of NH3, by a membrane channel. The purified water channel protein aquaporin-8 was reconstituted into planar bilayers, and the exclusion of NH4+ or H+ was established by 4 ensuring a lack of current under voltage clamp conditions. The single channel water permeability coefficient of 1.2 X 10(-14) cm(3)/subunit/s was established by imposing an osmotic gradient across reconstituted planar bilayers, and resulting minute changes in ionic concentration close to the membrane surface were detected. It is more than 2-fold smaller than the single channel ammonia permeability (2.7 X 10(-14) cm(3)/subunit/s) that was derived by establishing a transmembrane ammonium concentration gradient and measuring the resulting concentration increases adjacent to the membrane. This permeability ratio suggests that electrically silent ammonia transport may be the main function of AQP8.	Johannes Kepler Univ, Inst Biophys, A-4040 Linz, Austria; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Johannes Kepler University Linz; Duke University	Pohl, P (corresponding author), Johannes Kepler Univ, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	peter.pohl@jku.at	Pohl, Peter/A-5361-2008	Pohl, Peter/0000-0002-1792-2314	Austrian Science Fund FWF [W 1201] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3; ANTONENKO YN, 1993, BIOPHYS J, V64, P1701, DOI 10.1016/S0006-3495(93)81542-X; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Boassa D, 2006, J NEUROSCI, V26, P7811, DOI 10.1523/JNEUROSCI.0525-06.2006; Calamita G, 2005, J BIOL CHEM, V280, P17149, DOI 10.1074/jbc.C400595200; Chambrey R, 2006, TRANSFUS CLIN BIOL, V13, P154, DOI 10.1016/j.tracli.2006.02.005; FINKELSTEIN A, 1987, WATER MOVEMENT LIPID, P10; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549; Liu K, 2006, BIOL CELL, V98, P153, DOI 10.1042/BC20050026; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ma TH, 1997, BIOCHEM BIOPH RES CO, V240, P324, DOI 10.1006/bbrc.1997.7664; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Mazzone A, 2006, HEPATOLOGY, V43, P287, DOI 10.1002/hep.21039; MONTAL M, 1981, Q REV BIOPHYS, V14, P1, DOI 10.1017/S0033583500002079; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Pohl P, 1997, BIOPHYS J, V72, P1711, DOI 10.1016/S0006-3495(97)78817-9; Pohl P, 2004, BIOL CHEM, V385, P921, DOI 10.1515/BC.2004.120; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Saparov SM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148101; Saparov SM, 2005, BIOL CELL, V97, P545; Saparov SM, 2004, P NATL ACAD SCI USA, V101, P4805, DOI 10.1073/pnas.0308309101; Saparov SM, 2001, J BIOL CHEM, V276, P31515, DOI 10.1074/jbc.M104267200; Shimbo K, 1995, BIOPHYS J, V69, P1819, DOI 10.1016/S0006-3495(95)80052-4; Tsunoda SP, 2004, J BIOL CHEM, V279, P11364, DOI 10.1074/jbc.M310881200; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Yang BX, 2006, AM J PHYSIOL-CELL PH, V291, pC417, DOI 10.1152/ajpcell.00057.2006; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Yang BX, 2005, AM J PHYSIOL-CELL PH, V288, pC1161, DOI 10.1152/ajpcell.00564.2004; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; ZAMPIGHI GA, 1985, P NATL ACAD SCI USA, V82, P8468, DOI 10.1073/pnas.82.24.8468; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	45	150	155	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5296	5301		10.1074/jbc.M609343200	http://dx.doi.org/10.1074/jbc.M609343200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189259	Green Accepted, hybrid			2022-12-27	WOS:000244482300024
J	Fiala, KA; Suo, ZC				Fiala, Kevin A.; Suo, Zucai			Sloppy bypass of an abasic lesion catalyzed by a Y-family DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS; CRYSTAL-STRUCTURE; ERROR-PRONE; ACTIVE-SITE; DUPLEX DNA; FIDELITY; MECHANISM; DPO4; ETA; IV	DNA damage that eludes cellular repair pathways can arrest the replication machinery and stall the cell cycle. However, this damage can be bypassed by the Y-family DNA polymerases. Here, Dpo4, an archetypal Y-family member from the thermophilic Sulfolobus solfataricus, was used to extend our kinetic studies of the bypass of an abasic site, one of the most mutagenic and ubiquitous cellular lesions. A short oligonucleotide sequencing assay is developed to directly sequence DNA bypass products synthesized by Dpo4. Our results show that incorporation upstream of the abasic lesion is replicated error-free; yet dramatically, once Dpo4 encounters the lesion, synthesis became sloppy, with bypass products containing a myriad of mutagenic events. Incorporation of dAMP (29%) and dCMP (53%) opposite the abasic lesion at 37 degrees C correlates exceptionally well with our kinetic results and demonstrates two dominant bypass pathways via the A-rule and the lesion loop-out mechanism. Interestingly, the percentage of overall frameshift mutations increased from 71 (37 degrees C) to 87% (75 degrees). Further analysis indicates that lesion bypass via the A-rule is strongly preferred over the lesion loop-out mechanism at higher temperatures and concomitantly reduces the occurrence of "-1 deletion" mutations observed opposite the lesion at lower temperatures. The bypass percentage via the latter pathway is confirmed by an enzymatic digestion assay, verifying the reliability of our sequencing assay. Our results demonstrate that an abasic lesion causes Dpo4 and possibly all Y-family members to switch from a normal to a very mutagenic mode of replication.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University	Suo, ZC (corresponding author), 740 Biol Sci,484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu						Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Efrati E, 1997, J BIOL CHEM, V272, P2559; EVANS J, 1993, MUTAT RES, V299, P147, DOI 10.1016/0165-1218(93)90092-R; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P6751, DOI 10.1021/bi049975c; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Gelfand CA, 1998, BIOCHEMISTRY-US, V37, P7321, DOI 10.1021/bi9803372; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nakamura J, 1999, CANCER RES, V59, P2522; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; STRAUSS B, 1982, BIOCHIMIE, V64, P829, DOI 10.1016/S0300-9084(82)80138-7; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Wang KY, 1997, BIOCHEMISTRY-US, V36, P11629, DOI 10.1021/bi971464l; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	42	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8199	8206		10.1074/jbc.M610719200	http://dx.doi.org/10.1074/jbc.M610719200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234630	hybrid			2022-12-27	WOS:000245081000052
J	Sengupta, P; Ruano, MJ; Tebar, F; Golebiewska, U; Zaitseva, I; Enrich, C; McLaughlin, S; Villalobo, A				Sengupta, Parijat; Jose Ruano, Maria; Tebar, Francesc; Golebiewska, Urszula; Zaitseva, Irina; Enrich, Carlos; McLaughlin, Stuart; Villalobo, Antonio			Membrane-permeable calmodulin inhibitors (e.g. W-7/W-13) bind to membranes, changing the electrostatic surface potential - Dual effect of W-13 on epidermal growth factor receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; MAPK SIGNALING PATHWAY; PROTEIN KINASE-C; PLASMA-MEMBRANE; EGF RECEPTOR; PHOSPHOLIPID-VESICLES; TARGET RECOGNITION; SPHINGOSINE KINASE; TYROSINE KINASES; DOWN-REGULATION	Membrane-permeable calmodulin inhibitors, such as the napthalenesulfonamide derivatives W-7/W-13, trifluoperazine, and calmidazolium, are used widely to investigate the role of calcium/calmodulin (Ca2+/CaM) in living cells. If two chemically different inhibitors (e.g. W-7 and trifluoperazine) produce similar effects, investigators often assume the effects are due to CaM inhibition. Zeta potential measurements, however, show that these amphipathic weak bases bind to phospholipid vesicles at the same concentrations as they inhibit Ca2+/CaM; this suggests that they also bind to the inner leaflet of the plasma membrane, reducing its negative electrostatic surface potential. This change will cause electrostatically bound clusters of basic residues on peripheral (e.g. Src and K-Ras4B) and integral (e.g. epidermal growth factor receptor (EGFR)) proteins to translocate from the membrane to the cytoplasm. We measured inhibitor-mediated translocation of a simple basic peptide corresponding to the calmodulin-binding juxtamembrane region of the EGFR on model membranes; W-7/W-13 causes translocation of this peptide from membrane to solution, suggesting that caution must be exercised when interpreting the results obtained with these inhibitors in living cells. We present evidence that they exert dual effects on autophosphorylation of EGFR; W-13 inhibits epidermal growth factor-dependent EGFR autophosphorylation under different experimental conditions, but in the absence of epidermal growth factor, W-13 stimulates autophosphorylation of the receptor in four different cell types. Our interpretation is that the former effect is due to W-13 inhibition of Ca2+/CaM, but the latter results could be due to binding of W-13 to the plasma membrane.	SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; Univ Autonoma Madrid, Inst Invest Biomed, E-28029 Madrid, Spain; Univ Autonoma Madrid, CSIC, E-28029 Madrid, Spain; Univ Barcelona, Fac Med, Dept Biol Cellular & Anat Patol, E-08036 Barcelona, Spain	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	McLaughlin, S (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Stuart.McLaughlin@stonybrook.edu; antonio.villalobo@iib.uam.es	Villalobo, Antonio/O-9621-2019; Tebar, Francesc/H-1498-2015; Villalobo, Antonio/K-2902-2017	Villalobo, Antonio/0000-0002-4200-374X; Tebar, Francesc/0000-0002-9522-9726; Enrich, Carlos/0000-0003-0382-2993	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024971, R01GM024971] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24971] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2002, CELL SIGNAL, V14, P1005, DOI 10.1016/S0898-6568(02)00034-7; Anfinogenova YJ, 2001, CELL PHYSIOL BIOCHEM, V11, P295, DOI 10.1159/000047816; APODACA G, 1994, J BIOL CHEM, V269, P19005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Buser CA, 1998, METH MOL B, V84, P267; CAFISO D, 1989, METHOD ENZYMOL, V171, P342; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P821, DOI 10.1113/jphysiol.1965.sp007733; Chapin SJ, 1996, J BIOL CHEM, V271, P1336, DOI 10.1074/jbc.271.3.1336; CHEYETTE TE, 1991, CELL REGUL, V2, P827, DOI 10.1091/mbc.2.10.827; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; DAVIS RJ, 1988, J BIOL CHEM, V263, P5373; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DILL K, 2003, MOL DRIVING FORCES, P369; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Ferguson KM, 2004, BIOCHEM SOC T, V32, P742, DOI 10.1042/BST0320742; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Helmholtz H., 1879, ANN PHYS CHEM, V243, P337, DOI DOI 10.1002/ANDP.18792430702; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 2006, CELL, V125, P1029, DOI 10.1016/j.cell.2006.05.028; HUGHES AR, 1991, MOL PHARMACOL, V40, P254; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Jan CR, 2000, PHARMACOL RES, V42, P323, DOI 10.1006/phrs.2000.0703; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2002, BIOCHEM J, V362, P499, DOI 10.1042/bj3620499; Li WP, 2004, J BIOL CHEM, V279, P4570, DOI 10.1074/jbc.M304334200; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND KA, 1990, J BIOL CHEM, V265, P20517; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1988, J PHYSIOL-LONDON, V396, P189, DOI 10.1113/jphysiol.1988.sp016958; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.biophys.18.1.113; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; McLaughlin S, 2006, SCIENCE, V314, P1402, DOI 10.1126/science.1136314; NISHIKAWA M, 1982, J CLIN INVEST, V69, P1348, DOI 10.1172/JCI110574; Okeley NM, 2004, J BIOL CHEM, V279, P21833, DOI 10.1074/jbc.M313469200; Osawa M, 1999, FEBS LETT, V442, P173, DOI 10.1016/S0014-5793(98)01637-8; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sengupta P, 2002, METHODS, V27, P374, DOI 10.1016/S1046-2023(02)00096-8; SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; SOROKIN A, 1995, ONCOGENE, V11, P1531; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Tebar F, 2002, FEBS LETT, V517, P206, DOI 10.1016/S0014-5793(02)02624-8; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Uyemura T, 2005, BIOPHYS J, V88, P3720, DOI 10.1529/biophysj.104.053330; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Watanabe H, 1999, BIOCHEM BIOPH RES CO, V265, P697, DOI 10.1006/bbrc.1999.1755; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Young KW, 2003, CELL CALCIUM, V33, P119, DOI 10.1016/S0143-4160(02)00205-1; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	86	50	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8474	8486		10.1074/jbc.M607211200	http://dx.doi.org/10.1074/jbc.M607211200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227773	hybrid, Green Accepted			2022-12-27	WOS:000245081000080
J	Turu, G; Simon, A; Gyombolai, P; Szidonya, L; Bagdy, G; Lenkei, Z; Hunyady, L				Turu, Gabor; Simon, Anne; Gyombolai, Pal; Szidonya, Laszlo; Bagdy, Gyorgy; Lenkei, Zsolt; Hunyady, Laszlo			The role of diacylglycerol lipase in constitutive and angiotensin AT(1) receptor-stimulated cannabinoid CB1 receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERSE AGONIST; ENDOCANNABINOID SYSTEM; SIGNALING PATHWAYS; EXPRESSION; PROTEIN; BRAIN; BINDS; MODEL; CELL	The cannabinoid CB1 receptor (CB1R) is,a G protein-coupled receptor, which couples to the G(i/o) family of heterotrimeric G proteins. The receptor displays both basal and agonist-induced signaling and internalization. Although basal activity of CBIRs is attributed to constitutive (agonist-independent) receptor activity, studies in neurons suggested a role of postsynaptic endocannabinoid (eCB) release in the persistent activity of presynaptic CB1Rs. To elucidate the role of eCBs in basal CB1R activity, we have investigated the role of diacylglycerol lipase (DAGL) in this process in Chinese hamster ovary (CHO) cells, which are not targeted specifically with I Agonist-induced G protein activation was determined by detecting dissociation G protein subunits expressed in CHO cells with bioluminescence resonance energy transfer (BRET), after labeling the alpha and beta subunits with Renilla luciferase and enhanced yellow fluorescent protein (EYFP), respectively. Pre-incubation of the cells with tetrahydrolipstatin (THL), a known inhibitor of DAGLs, caused inhibition of the basal activity of CBIR. Moreover, preincubation of CHO and cultured hippocampal neurons with THL increased the number of CBIRs on the cell membrane, which reflects its inhibitory action on CB1R internalization in non-simulated cells. In CHO cells co-expressing CB1R and angiotensin AT(1) receptors, angiotensin II-induced Go protein activation that was blocked by both a CBIR antagonist and THL. These data indicate that cell-derived I mediators have a general role in the basal activity of CB1Rs in non-neural cells and neurons, and that this mechanism can be stimulated by AT(1) receptor activation.	Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; Hungarian Acad Sci, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; Ecole Super Phys & Chim Ind Ville Paris, CNRS, Lab Neurobiol & Divers Cellulaire, UMR 7637, F-75013 Paris, France; Natl Inst Psychiat & Neurol, Lab Neurochem & Expt Med, H-1021 Budapest, Hungary; Hungarian Acad Sci, Grp Neuropsychopharmacol, H-1089 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	Hunyady@puskin.sote.hu	Bagdy, György/O-3893-2017; Szidonya, Laszlo/A-2271-2010; Lenkei, Zsolt/G-4369-2013	Bagdy, György/0000-0001-8141-3410; Lenkei, Zsolt/0000-0002-1142-5931; Turu, Gabor/0000-0002-4421-3812; Gyombolai, Pal/0000-0001-7117-6351				Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pan XH, 1998, MOL PHARMACOL, V54, P1064, DOI 10.1124/mol.54.6.1064; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V287, P1038; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Turu G, 2006, FEBS LETT, V580, P41, DOI 10.1016/j.febslet.2005.11.044; Vasquez C, 1999, J NEUROSCI, V19, P9271; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Zhu PJ, 2005, J NEUROSCI, V25, P6199, DOI 10.1523/JNEUROSCI.1148-05.2005	27	58	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7753	7757		10.1074/jbc.C600318200	http://dx.doi.org/10.1074/jbc.C600318200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227758	Green Published, hybrid			2022-12-27	WOS:000245081000002
J	Denisov, IG; Baas, BJ; Grinkova, YV; Sligar, SG				Denisov, Ilia G.; Baas, Bradley J.; Grinkova, Yelena V.; Sligar, Stephen G.			Cooperativity in cytochrome P450 3A4 - Linkages in substrate binding, spin state, uncoupling, and product formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANOSCALE LIPID-BILAYERS; MOLECULE HEIGHT MEASUREMENTS; P450 REDUCTASE; RECOGNITION SITE; LIGAND-BINDING; MICROSOMAL CYTOCHROME-P450; SCANNING MUTAGENESIS; CATALYTIC-ACTIVITY; MEMBRANE-PROTEINS; ESCHERICHIA-COLI	Understanding the detailed metabolic mechanisms of membrane-associated cytochromes P450 is often hampered by heterogeneity, ill-defined oligomeric state of the enzyme, and variation in the stoichiometry of the functional P450(.)reductase complexes in various reconstituted systems. Here, we describe the detailed characterization of a functionally homogeneous 1:1 complex of cytochrome P450 3A4 (CYP3A4) and cytochrome P450 reductase solubilized via self-assembly in a nanoscale phospholipid bilayer. CYP3A4 in this complex showed a nearly complete conversion from the low- to high-spin state when saturated with testosterone (TS) and no noticeable modulation due to the presence of cytochrome P450 reductase. Global analysis of equilibrium substrate binding and steady-state NADPH consumption kinetics provided precise resolution of the fractional contributions to turnover of CYP3A4 intermediates with one, two, or three TS molecules bound. The first binding event accelerates NADPH consumption but does not result in significant product formation due to essentially complete uncoupling. Binding of the second substrate molecule is critically important for catalysis, as the product formation rate reaches a maximum value with two TS molecules bound, whereas the third binding event significantly improves the coupling efficiency of redox equivalent usage with no further increase in product formation rate. The resolution of the fractional contributions of binding intermediates of CYP3A4 into experimentally observed overall spin shift and the rates of steady-state NADPH oxidation and product formation provide new detailed insight into the mechanisms of cooperativity and allosteric regulation in this human cytochrome P450.	Univ Illinois, Dept Biochem, Coll Med, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Coll Med, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, Coll Med, 116 Morrill Hall,MC-119,505 S Goodwin Ave, Urbana, IL 61801 USA.	s-sligar@uiuc.edu	Denisov, Ilia G/J-6590-2013	Denisov, Ilia G/0000-0002-7878-2626	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031756, R01GM033775] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM33775, R37 GM31756] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARLOTTO MP, 1991, METHOD ENZYMOL, V206, P454; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Bayburt TH, 2000, LANGMUIR, V16, P5993, DOI 10.1021/la991449c; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; BONOMO EA, 1988, J LIPID RES, V29, P380; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200; Di Cera E., 1995, THERMODYNAMIC THEORY; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Duan H, 2004, ARCH BIOCHEM BIOPHYS, V424, P141, DOI 10.1016/j.abb.2004.02.010; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gilep AA, 2001, ARCH BIOCHEM BIOPHYS, V390, P215, DOI 10.1006/abbi.2001.2372; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; IMAOKA S, 1992, BIOCHEMISTRY-US, V31, P6063, DOI 10.1021/bi00141a015; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Kim KH, 2003, BIOCHEMISTRY-US, V42, P15377, DOI 10.1021/bi035280k; Krauser JA, 2004, EUR J BIOCHEM, V271, P3962, DOI 10.1111/j.1432-1033.2004.04339.x; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Makris TM., 2005, CYTOCHROME P450, P149; NAKANO R, 1995, BBA-PROTEIN STRUCT M, V1252, P245, DOI 10.1016/0167-4838(95)00143-I; OMURA T, 1964, J BIOL CHEM, V239, P2379; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; PORTER TD, 1987, ARCH BIOCHEM BIOPHYS, V254, P353, DOI 10.1016/0003-9861(87)90111-1; Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390; SCHENKMAN JB, 2005, CYTOCHROME P450 PROT, V320, P11; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; SHEN ES, 1989, BIOCHEM PHARMACOL, V38, P4075, DOI 10.1016/0006-2952(89)90689-8; SHET MS, 1995, ARCH BIOCHEM BIOPHYS, V318, P314, DOI 10.1006/abbi.1995.1235; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Shou MG, 1999, BIOCHEM J, V340, P845, DOI 10.1042/0264-6021:3400845; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337	61	164	166	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7066	7076		10.1074/jbc.M609589200	http://dx.doi.org/10.1074/jbc.M609589200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213193	hybrid			2022-12-27	WOS:000245080900018
J	Ranjith-Kumar, CT; Miller, W; Jin, XO; Russell, WK; Lamb, R; Santos, J; Duffy, KE; Cleveland, L; Parv, M; Bhardwaj, K; Wu, ZX; Russell, DH; Sarisky, RT; Mbow, ML; Kao, CC				Ranjith-Kumar, C. T.; Miller, William; Jin Xiong; Russell, William K.; Lamb, Roberta; Santos, Jonathan; Duffy, Karen E.; Cleveland, Larissa; Parv, Mary; Bhardwaj, Kanchan; Wu, Zhaoxiang; Russell, David H.; Sarisky, Robert T.; Mbow, M. Lamine; Kao, C. Cheng			Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; RECOGNITION; RESIDUES; LOCALIZATION; ACTIVATION	The structure of the human Toll-like receptor 3 (TLR3) ectodomain (ECD) was recently solved by x-ray crystallography, leading to a number of models concerning TLR3 function (Choe, J., Kelker, M. S., and Wilson, I. A. (2005) Science 309, 581-585; Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., and Davies, D. R. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 10976-10980) The structure revealed four pairs of cysteines that are putatively involved in disulfide bond formation, several residues that are predicted to be involved in dimerization between ECD subunits, and surfaces that could bind to poly(I:C). In addition, there are two loops that protrude from the central solenoid structure of the protein. We examined the recombinant TLR3 ECD for disulfide bond formation, poly(I:Q binding, and protein-protein interaction. We also made over 80 mutations in the residues that could affect these features in the full-length TLR3 and examined their effects in TLR3-mediated NF-kappa B activation. A number of mutations that affected TLR3 activity also affected the ability to act as dominant negative inhibitors of wild type TLR3. Loss of putative RNA binding did not necessarily affect dominant negative activity. All of the results support a model where a dimer of TLR3 is the form that binds RNA and activates signal transduction.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, Lab Biol Mass Spectrometry, College Stn, TX 77843 USA; Centocor Res & Dev Inc, Discovery Res, Radnor, PA 19087 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Johnson & Johnson; Johnson & Johnson USA	Kao, CC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ckao@tamu.edu	Kumar CT, Ranjith/J-5701-2016; Wu, Zhaoxiang/D-5678-2012; Bhardwaj, Kanchan/CAH-2291-2022; Russell, David H/C-3618-2015	Bhardwaj, Kanchan/0000-0002-7331-7717; Russell, David H/0000-0003-0830-3914; Miller, William/0000-0002-1518-2973	NCRR NIH HHS [RR019587] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR019587] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Kim CH, 2000, NAT STRUCT BIOL, V7, P415, DOI 10.1038/75202; Lancaster GI, 2005, J PHYSIOL-LONDON, V563, P945, DOI 10.1113/jphysiol.2004.081224; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Park ZY, 2000, ANAL CHEM, V72, P2667, DOI 10.1021/ac991444k; RUIZ M, 2004, EUR J IMMUNOL, V34, P2541; Salio M, 2005, CURR BIOL, V15, pR336, DOI 10.1016/j.cub.2005.04.025; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Siegel RW, 1997, P NATL ACAD SCI USA, V94, P11238, DOI 10.1073/pnas.94.21.11238; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Uematsu S, 2006, EXPERT OPIN BIOL TH, V6, P203, DOI 10.1517/14712598.6.3.203; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	28	49	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7668	7678		10.1074/jbc.M610946200	http://dx.doi.org/10.1074/jbc.M610946200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209042	hybrid			2022-12-27	WOS:000245080900079
J	Wang, JH; Barke, RA; Roy, S				Wang, Jinghua; Barke, Roderick A.; Roy, Sabita			Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-EARLY REPRESSOR; PANCREATIC BETA-CELLS; MU-OPIOID RECEPTOR; CYCLIC-AMP; IL-2 GENE; MOLECULAR-BASIS; THE-180 SITE; DRUG-USERS; EXPRESSION; PROMOTER	Chronic morphine inhibits interleukin-2 (IL-2) at both the transcriptional and protein synthesis levels. The molecular mechanisms by which morphine decreases IL-2 are not fully understood. The production of IL-2 is tightly regulated by several transcription factors that bind to the IL-2 promoter. Herein, we show that chronic morphine treatment results in an increase in cAMP levels with a concurrent up-regulation of the cAMP inducible repressor inducible cAMP early repressor (ICER)/ cAMP response element modulator (CREM) and down-regulation of p-cAMP-response element-binding protein (CREB) in activated T cells. Furthermore, ICER competes for p-CREB binding to the cAMP-responsive elements (CREs) site. This leads to the uncoupling of CBP/p300 thereby abrogating IL-2 transcription. Overexpression of either antisense CREM or CREB plasmid rescued morphine-induced inhibition of IL-2 promoter activity and protein production. In addition, we also found that chronic morphine treatment inhibited the acetylation and trimethylation of histories and decreased both DNA demethylation and accessibility of the IL-2 promoter. These findings suggest that chronic morphine treatment may function through both transcriptional and epigenetic mechanisms to inhibit IL-2 production.	Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA; Vet Affairs Med Ctr, Dept Surg, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Roy, S (corresponding author), Univ Minnesota, Dept Pharmaceut, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	royxx002@umn.edu			NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007097, P50DA011806, K02DA015349, R01DA012104] Funding Source: NIH RePORTER; NIDA NIH HHS [T32DA07097, KO2DA015349, P50DA11806, R01DA12104] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bird A, 2003, NAT IMMUNOL, V4, P208, DOI 10.1038/ni0303-208; Bodor J, 2002, EUR J IMMUNOL, V32, P203, DOI 10.1002/1521-4141(200201)32:1<203::AID-IMMU203>3.0.CO;2-C; Bodor J, 1998, J BIOL CHEM, V273, P9544, DOI 10.1074/jbc.273.16.9544; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774, DOI 10.1002/jlb.67.6.774; Bodor J, 2001, J LEUKOCYTE BIOL, V69, P1053; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DellaFazia MA, 1997, FEBS LETT, V410, P22, DOI 10.1016/S0014-5793(97)00445-6; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Georges H, 1999, INTENS CARE MED, V25, P198, DOI 10.1007/s001340050816; Gordon RJ, 2005, NEW ENGL J MED, V353, P1945, DOI 10.1056/NEJMra042823; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Liu Y, 2006, J NEUROENDOCRINOL, V18, P42, DOI 10.1111/j.1365-2826.2005.01383.x; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Powell JD, 1999, J IMMUNOL, V163, P6631; Quaglio G, 2002, SCAND J INFECT DIS, V34, P574, DOI 10.1080/00365540110080791; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Roy S, 1997, CELL IMMUNOL, V179, P1, DOI 10.1006/cimm.1997.1147; Roy S, 2005, J IMMUNOL, V175, P6361, DOI 10.4049/jimmunol.175.10.6361; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Roy S, 2004, J NEUROIMMUNOL, V147, P78, DOI 10.1016/j.jneuroim.2003.10.016; Roy S, 2001, SURGERY, V130, P304, DOI 10.1067/msy.2001.116033; Roy S, 2006, J NEUROIMMUNE PHARM, V1, P77, DOI 10.1007/s11481-005-9009-8; Sacerdote P, 2003, ADV EXP MED BIOL, V521, P106; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Sharp BM, 1998, J NEUROIMMUNOL, V83, P45, DOI 10.1016/S0165-5728(97)00220-8; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; TSURUTA L, 1995, J IMMUNOL, V154, P5255; Wang JH, 2005, J IMMUNOL, V174, P426, DOI 10.4049/jimmunol.174.1.426; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Wang JH, 2002, J LEUKOCYTE BIOL, V71, P782; Wang JH, 2001, J LEUKOCYTE BIOL, V70, P527; Wang L, 2005, BIOCHEM BIOPH RES CO, V331, P589, DOI 10.1016/j.bbrc.2005.03.216; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923	47	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7164	7171		10.1074/jbc.M604367200	http://dx.doi.org/10.1074/jbc.M604367200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17227776	hybrid			2022-12-27	WOS:000245080900028
J	Niu, JG; Chang, Z; Peng, BL; Xia, QH; Lu, WQ; Huang, P; Tsao, MS; Chiao, PJ				Niu, Jiangong; Chang, Zhe; Peng, Bailu; Xia, Qianghua; Lu, Weiqin; Huang, Peng; Tsao, Ming-Sound; Chiao, Paul J.			Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappa B transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EXPRESSION; PANCREATIC ADENOCARCINOMA; GENE-EXPRESSION; ALPHA; PROTEINS; RECEPTOR; OVEREXPRESSION; AUTOREGULATION; IDENTIFICATION; SPECIFICITY	Keratinocyte growth factor (KGF)/fibroblast growth factor-7 (FGF-7) is a paracrine- and epithelium-specific growth,factor produced by cells of mesenchymal origin. It acts exclusively through FGF-7 receptor (FGFR2/IIIb), which is expressed predominantly by epithelial cells, but not by fibroblasts, suggesting that it might function as a paracrine mediator of mesenchymal-epithelial interactions. KGF/FGF-7 plays an essential role in the growth of epithelial cells and is frequently overexpressed in cancers of epithelial origin such as pancreatic cancer, switching paracrine stimulation of KGF/FGF-7 to an autocrine loop. Less is known, however, about the signaling pathways by which KGF/FGF-7 regulates the response of epithelial cells. To delineate the signaling pathways activated by KGF/FGF-7 and examine cellular response to KGF/ FGF-7 stimulation, we performed functional analysis of KGF/ FGF-7 action. In this report, we show that KGF/FGF-.7 activated nuclear factor kappa B (NF-kappa B), which in turn induced expression of VEGF, NIMP-9, and urokinase-type plasminogen activator and increased migration and invasion of KGF/FGF-7-stimulated human pancreatic ductal epithelial cells. Expression of phosphorylation-defective I kappa B alpha (I kappa B alpha S32A,S36A), which blocked NF-kappa B activation, inhibited KGF/FGF-7-induced gene expression and cell migration and invasion. Our results demonstrate for the first time that KGF/FGF-7 induces NF-kappa B activation and that NF-kappa B plays an essential role in regulation of KGF/FGF-7-inducible gene expression and KGF/FGF-7-initiated cellular responses. Thus, these findings identify one signaling pathway for KGF/FGF-7-regulated cell migration and invasion and suggest that paracrine sources of KGF/FGF-7 are one of the malignancy-contributing factors from tumor stroma.	Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, Houston Hlth Sci Ctr, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX 77030 USA; Univ Toronto, Hlth Network, Princess Margaret Hosp, Ontario Canc Inst,Dept Lab Med, Toronto, ON M5G 2M9, Canada; Univ Toronto, Hlth Network, Princess Margaret Hosp, Ontario Canc Inst,Dept Pathobiol, Toronto, ON M5G 2M9, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Chiao, PJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol Mol & Cellular Oncol, Unit 107,1515 Holcombe Blvd, Houston, TX 77030 USA.	pjchiao@mdanderson.org	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405	NATIONAL CANCER INSTITUTE [R01CA109405, R01CA097159] Funding Source: NIH RePORTER; NCI NIH HHS [CA097159, CA109405] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHEDID M, 1994, J BIOL CHEM, V269, P10753; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Fujioka S, 2003, ONCOGENE, V22, P1365, DOI 10.1038/sj.onc.1206323; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Furukawa T, 1996, AM J PATHOL, V148, P1763; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 1996, ONCOGENE, V13, P1367; Ishiwata T, 1998, AM J PATHOL, V153, P213, DOI 10.1016/S0002-9440(10)65562-9; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keller UAD, 2004, EUR J CELL BIOL, V83, P607; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; MaasSzabowski N, 1996, J INVEST DERMATOL, V107, P849, DOI 10.1111/1523-1747.ep12331158; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Niu JG, 2004, J BIOL CHEM, V279, P16452, DOI 10.1074/jbc.M309789200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ozes ON, 1999, NATURE, V401, P82; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Ray Prabir, 2005, Proc Am Thorac Soc, V2, P221, DOI 10.1513/pats.200502-012AC; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SIDDIQI I, 1995, BIOCHEM BIOPH RES CO, V215, P309, DOI 10.1006/bbrc.1995.2467; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; VAN AD, 1996, SCIENCE, V274, P787; Wang WX, 1999, ONCOGENE, V18, P4554, DOI 10.1038/sj.onc.1202833; Wang WX, 1999, CLIN CANCER RES, V5, P119; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; YI ES, 1994, AM J PATHOL, V145, P1015	44	74	85	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6001	6011		10.1074/jbc.M606878200	http://dx.doi.org/10.1074/jbc.M606878200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200110	hybrid			2022-12-27	WOS:000244867200005
J	Pedersen, JZ; De Maria, F; Turella, P; Federici, G; Mattei, M; Fabrini, R; Dawood, KF; Massimi, M; Caccuri, AM; Ricci, G				Pedersen, Jens Z.; De Maria, Francesca; Turella, Paola; Federici, Giorgio; Mattei, Maurizio; Fabrini, Raffaele; Dawood, Kutayba F.; Massimi, Mara; Caccuri, Anna Maria; Ricci, Giorgio			Glutathione transferases sequester toxic dinitrosyl-iron complexes in cells - A protection mechanism against excess nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC RESONANCE; S-TRANSFERASES; RAT HEPATOCYTES; IN-VIVO; LIVER; IDENTIFICATION; RELEASE; P1-1; SUPERFAMILY; SENSITIVITY	It is now well established that exposure of cells and tissues to nitric oxide leads to the formation of a dinitrosyl-iron complex bound to intracellular proteins, but little is known about how the complex is formed, the identity of the proteins, and the physiological role of this process. By using EPR spectroscopy and enzyme activity measurements to study the mechanism in hepatocytes, we here identify the complex as a dinitrosyl-diglutathionyl-iron complex (DNDGIC) bound to Alpha class glutathione S-transferases (GSTs) with extraordinary high affinity (K-D = 10(-10) m). This complex is formed spontaneously through NO-mediated extraction of iron from ferritin and transferrin, in a reaction that requires only glutathione. In hepatocytes, DNDGIC may reach concentrations of 0.19 mM, apparently entirely bound to Alpha class GSTs, present in the cytosol at a concentration of about 0.3 mM. Surprisingly, about 20% of the dinitrosyl-glutathionyl-iron complex-GST is found to be associated with subcellular components, mainly the nucleus, as demonstrated in the accompanying paper (Stella, L., Pallottini, V., Moreno, S., Leoni, S., De Maria, F., Turella, P., Federici, G., Fabrini, R., Dawood, K. F., Lo Bello, M., Pedersen, J. Z., and Ricci, G. (2007) J. Biol. Chem. 282, 6372-6379). DNDGIC is a potent irreversible inhibitor of glutathione reductase, but the strong complex-GST interaction ensures full protection of glutathione reductase activity in the cells, and in vitro experiments show that damage to the reductase only occurs when the DNDGIC concentration exceeds the binding capacity of the intracellular GST pool. Because Pi class GSTs may exert a similar role in other cell types, we suggest that specific sequestering of DNDGIC by GSTs is a physiological protective mechanism operating in conditions of excessive levels of nitric oxide.	Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Childrens Hosp Bambin Gesu, I-00165 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; Univ Aquila, Dept Appl Biol, I-67010 Laquila, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Bambino Gesu; University of Rome Tor Vergata; University of L'Aquila	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy.	riccig@uniroma2.it	Mattei, Maurizio/AAC-1303-2019; Dawood, Kutayba/E-1505-2019; massimi, mara/I-6076-2012; CACCURI, ANNA MARIA/AFU-2643-2022; Massimi, Mara/R-6836-2019	Mattei, Maurizio/0000-0002-0814-8873; Dawood, Kutayba/0000-0002-0762-9632; massimi, mara/0000-0002-9569-816X; CACCURI, ANNA MARIA/0000-0002-3756-4163; Ricci, Giorgio/0000-0002-7108-2846				ADANG AEP, 1990, BIOCHEM J, V269, P47, DOI 10.1042/bj2690047; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BUETLER TM, 1992, J ENVIRON SCI HEAL C, V10, P181; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; HARRIS LR, 1994, BIOCHEM J, V301, P385, DOI 10.1042/bj3010385; Incerpi S, 1996, AM J PHYSIOL-CELL PH, V270, pC841, DOI 10.1152/ajpcell.1996.270.3.C841; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; MANNERVIK B, 1986, CHEM SCRIPTA, V26B, P281; MEYER DJ, 1995, BIOCHEM J, V311, P739, DOI 10.1042/bj3110739; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; OPPENHEIMER JH, 1985, J CLIN INVEST, V75, P147, DOI 10.1172/JCI111667; PEDERSEN JZ, 1988, J MAGN RESON, V77, P369, DOI 10.1016/0022-2364(88)90186-2; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; REIF DW, 1990, ARCH BIOCHEM BIOPHYS, V283, P537, DOI 10.1016/0003-9861(90)90680-W; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; ROUIMI P, 1995, ANAL BIOCHEM, V229, P304, DOI 10.1006/abio.1995.1417; Sergent O, 1997, HEPATOLOGY, V25, P122, DOI 10.1002/hep.510250123; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; VANIN A F, 1967, Biofizika, V12, P829; Vanin AF, 1998, NITRIC OXIDE-BIOL CH, V2, P224, DOI 10.1006/niox.1998.0180; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; YEH HI, 1995, BIOCHEM J, V308, P69, DOI 10.1042/bj3080069	36	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6364	6371		10.1074/jbc.M609905200	http://dx.doi.org/10.1074/jbc.M609905200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197702	hybrid			2022-12-27	WOS:000244867200043
J	Nakajima, T; Hayashi, K; Viswanathan, PC; Kim, MY; Anghelescu, M; Barksdale, KA; Shuai, W; Balser, JR; Kupershmidt, S				Nakajima, Tadashi; Hayashi, Kenshi; Viswanathan, Prakash C.; Kim, Min-Young; Anghelescu, Mircea; Barksdale, Kate A.; Shuai, Wen; Balser, Jeffrey R.; Kupershmidt, Sabina			HERG is protected from pharmacological block by alpha-1,2-glucosyltransferase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; DEFECTIVE PROTEIN TRAFFICKING; LIPID-LINKED OLIGOSACCHARIDE; POTASSIUM CHANNEL; ENDOPLASMIC-RETICULUM; CARDIAC-ARRHYTHMIA; I-KS; EXPRESSION; GLYCOSYLATION; RECTIFIER	The HERG (human ether-A-go-go-related gene) protein, which underlies the cardiac repolarizing current I-Kr is the unintended target for many pharmaceutical agents. Inadvertent block Of IKr, known as the acquired long QT syndrome (aLQTS), is a leading cause for drug withdrawal by the United States Food and Drug Administration. Hence, an improved understanding of the regulatory factors that protect most individuals from aLQTS is essential for advancing clinical therapeutics in broad areas, from cancer chemotherapy to antipsychotics and antidepressants. Here, we show that the K+ channel regulatory protein KCR1, which markedly reduces I,,, drug sensitivity, protects HERG through glucosyltransferase function. KCR1 and the yeast alpha-1,2-glucosyltransferaseALG10 exhibit sequence homology, and like KCR1, ALG10 diminished HERG block by dofetilide. Inhibition of cellular glycosylation pathways with tunicamycin abrogated the effects of KCR1 as did expression in Lec1 cells (deficient in glycosylation). Moreover, KCR1 complemented the growth defect of an alg10-deficient yeast strain and enhanced glycosylation of an Alg10 substrate in yeast. HERG itself is not the target for KCR1-mediated glycosylation because the dofetilide response of glycosylation-deficient HERG(N598Q) was still modulated by KCR1. Nonetheless, our data indicate that the alpha-1,2-glucosyltransferase function is a key component of the molecular pathway whereby KCR1 diminishes I,, drug response. Incorporation of in vitro data into a computational model indicated that KCR1 expression is protective against arrhythmias. These findings reveal a potential new avenue for targeted prevention of aLQTS.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Univ Pittsburgh, Cardiovasc Res Inst, Pittsburgh, PA 15213 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kupershmidt, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, 2220 Pierce Ave,554 Preston Res Bldg, Nashville, TN 37232 USA.	sabina.kupershmidt@vanderbilt.edu	Kupershmidt, Sabina/AAO-5464-2021	Kupershmidt, Sabina/0000-0002-8119-2723	NHLBI NIH HHS [HL69914, P01 PPG HL46681] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069914, P01HL046681] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Aerssens J, 2005, PHARMACOGENOMICS, V6, P259, DOI 10.1517/14622416.6.3.259; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chiang Chern-En, 2004, Cardiol Rev, V12, P222, DOI 10.1097/01.crd.0000123842.42287.cf; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Kubota T, 2001, J CARDIOVASC ELECTR, V12, P1223, DOI 10.1046/j.1540-8167.2001.01223.x; Kupershmidt S, 2003, FASEB J, V17, P2263, DOI 10.1096/fj.02-1057fje; Kupershmidt S, 2002, CARDIOVASC RES, V56, P93, DOI 10.1016/S0008-6363(02)00498-4; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Rajamani S, 2002, CIRCULATION, V105, P2830, DOI 10.1161/01.CIR.0000019513.50928.74; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schulze-Bahr E, 2001, EUR HEART J SUPPL, V3, pK48, DOI 10.1016/S1520-765X(01)90006-9; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zou AR, 1997, AM J PHYSIOL-HEART C, V272, pH1309, DOI 10.1152/ajpheart.1997.272.3.H1309	48	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5506	5513		10.1074/jbc.M605976200	http://dx.doi.org/10.1074/jbc.M605976200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189275	hybrid			2022-12-27	WOS:000244482300045
J	Shikata, M; Ishikawa, F; Kanoh, J				Shikata, Miho; Ishikawa, Fuyuki; Kanoh, Junko			Te12 is required for activation of the Mrc1-mediated replication checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; TELOMERE LENGTH REGULATION; FORK PROTECTION COMPLEX; DOUBLE-STRAND BREAKS; CELL-CYCLE ARREST; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE	Proteins belonging to the Tel2/Rad-5/Clk-2 family are conserved among eukaryotes and are involved in various cellular processes, such as cell proliferation, telomere maintenance, the biological clock, and the DNA damage checkpoint. However, the molecular mechanisms underlying the functions of these molecules remain largely unclear. Here we report that in the fission yeast, Schizosaccharomycespombe, Te12 is required for efficient phosphorylation of Mrc1, a mediator of DNA replication checkpoint signaling, and for activation of Cds1, a replication checkpoint kinase, when DNA replication is blocked by hydroxyurea. In fact, Tel2 is required for survival of replication fork arrest and for the replication checkpoint in cells lacking Chk1, another checkpoint kinase the role of which overlaps that of Cds1 in cell cycle arrest by replication block. in addition, Tel2 plays important roles in entry into S phase and in genome stability. Tel2 is essential for vegetative cell growth, and the tel2A strain accumulated cells with IC DNA content after germination. In the absence of hydroxyurea, Tel2 is vital in the mutant lacking Swil, a component of the replication fork protection complex, and multiple Rad22 DNA repair foci were frequently observed in Tel2-repressed swil A cells especially at S phase. In contrast, the cds1 Delta swi1 Delta mutant did not show such lethality. These results indicate that S. pombe Tel2 plays important roles in the Mrc1-mediated replication checkpoint as well as in the Cds1-independent regulation of genome integrity.	Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Kanoh, J (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kitashirakawaoiwake Cho, Kyoto 6068502, Japan.	jkanoh@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021; Kanoh, Junko/AGM-9632-2022	Ishikawa, Fuyuki/0000-0002-5580-2305; 				Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Alfa C, 1993, EXPT FISSION YEAST L; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Benard C, 2001, DEVELOPMENT, V128, P4045; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Brondello JM, 1999, MOL CELL BIOL, V19, P4262; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HARTMAN PS, 1982, GENETICS, V102, P159; Hatanaka M, 2001, YEAST, V18, P207, DOI 10.1002/1097-0061(200102)18:3<207::AID-YEA661>3.0.CO;2-I; HEKIMI S, 1995, GENETICS, V141, P1351; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kota RS, 1998, NUCLEIC ACIDS RES, V26, P1528, DOI 10.1093/nar/26.6.1528; Kota RS, 1999, CHROMOSOMA, V108, P278, DOI 10.1007/s004120050379; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Rhind N, 2000, J CELL SCI, V113, P3889; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003	71	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5346	5355		10.1074/jbc.M607432200	http://dx.doi.org/10.1074/jbc.M607432200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189249	hybrid			2022-12-27	WOS:000244482300030
J	Cougot, D; Wu, YF; Cair, S; Caramel, J; Renard, CA; Levy, L; Buendia, MA; Neuveut, C				Cougot, Delphine; Wu, Yuanfei; Cair, Stefano; Caramel, Julie; Renard, Claire-Angelique; Levy, Laurence; Buendia, Marie Annick; Neuveut, Christine			The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET GENE ACTIVATION; DNA-BINDING; HBX PROTEIN; TRANSGENIC MICE; TRANSACTIVATION FUNCTION; BASIC REGION; PIVOTAL ROLE; CELL-DEATH; IN-VIVO; REPLICATION	The hepatitis B virus infects more than 350 million people worldwide and is a leading cause of liver cancer. The virus encodes a multifunctional regulator, the hepatitis B virus X protein (HBx), that is essential for virus replication. HBx is involved in modulating signal transduction pathways and transcription mediated by various factors, notably CREB that requires the recruitment of the coactivators CREB-binding protein (CBP)/p300. Here we investigated the role of HBx and its potential interaction with CBP/p300 in regulating CREB transcriptional activity. We show that HBx and CBP/p300 synergistically enhanced CREB, activity and that CREB phosphorylation by protein kinase A was a prerequisite for the cooperative action of HBx and CBP/p300. We further show that HBx interacted directly with CBP/p300 in vitro and in vivo. Using chromatin immunoprecipitation, we provide evidence that HBx physically occupied the CREB-binding domain of CREB-responsive promoters of endogenous cellular genes such as interleukin 8 and proliferating cell nuclear antigen. Moreover expression of HBx increased the recruitment of p300 to the interleukin 8 and proliferating cell nuclear antigen promoters in cells, and this is associated with increased gene expression. As recruitment of CBP/p300 is known to represent the limiting event for activating CREB target genes, HBx may disrupt this cellular regulation, thus predisposing cells to transformation.	Inst Pasteur, INSERM, U576, Unite Oncogenese & Virol Mol, F-75724 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Neuveut, C (corresponding author), Inst Pasteur, INSERM, U576, Unite Oncogenese & Virol Mol, F-75724 Paris 15, France.	cneuveut@pasteur.fr	Cairo, Stefano/O-2831-2016; LEVY, Laurence/AAF-5672-2021	Cairo, Stefano/0000-0002-4725-5970; Neuveut, Christine/0000-0001-6520-271X; Caramel, Julie/0000-0002-8883-918X				Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnabas S, 1997, J BIOL CHEM, V272, P20684, DOI 10.1074/jbc.272.33.20684; Barnabas S, 2000, J VIROL, V74, P83, DOI 10.1128/JVI.74.1.83-90.2000; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brockmann D, 2003, CURR TOP MICROBIOL, V272, P97; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Chan HM, 2001, J CELL SCI, V114, P2363; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gatza ML, 2005, ENVIRON MOL MUTAGEN, V45, P304, DOI 10.1002/em.20088; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAVIV I, 1995, MOL CELL BIOL, V15, P1079; HOHNE M, 1990, EMBO J, V9, P1137, DOI 10.1002/j.1460-2075.1990.tb08220.x; HUANG DY, 1994, MOL CELL BIOL, V14, P4233, DOI 10.1128/MCB.14.6.4233; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee SG, 2000, ONCOGENE, V19, P468, DOI 10.1038/sj.onc.1203312; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Leupin O, 2005, J VIROL, V79, P4238, DOI 10.1128/JVI.79.7.4238-4245.2005; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; MAHE Y, 1991, J BIOL CHEM, V266, P13759; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Neuveut C, 2002, FRONT BIOSCI-LANDMRK, V7, pD157, DOI 10.2741/neuveut; Perini G, 1999, J BIOL CHEM, V274, P13970, DOI 10.1074/jbc.274.20.13970; Pflum MKH, 2001, BIOCHEMISTRY-US, V40, P693, DOI 10.1021/bi0011936; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Schneider TL, 2001, BIOCHEMISTRY-US, V40, P2835, DOI 10.1021/bi002450+; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Sitterlin D, 1997, J VIROL, V71, P6194, DOI 10.1128/JVI.71.8.6194-6199.1997; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; Terradillos O, 1998, ONCOGENE, V17, P2115, DOI 10.1038/sj.onc.1202432; TRUANT R, 1995, J VIROL, V69, P1951; TRUJILLO MA, 1991, P NATL ACAD SCI USA, V88, P3797, DOI 10.1073/pnas.88.9.3797; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Yoo YG, 2004, FEBS LETT, V577, P121, DOI 10.1016/j.febslet.2004.10.004; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	69	161	169	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4277	4287		10.1074/jbc.M606774200	http://dx.doi.org/10.1074/jbc.M606774200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17158882	hybrid			2022-12-27	WOS:000244482000007
J	Fairn, GD; MacDonald, K; McMaster, CR				Fairn, Gregory D.; MacDonald, Kendra; McMaster, Christopher R.			A chemogenomic screen in Saccharomyces cerevisiae uncovers a primary role for the mitochondria in farnesol toxicity and its regulation by the Pkc1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; CELL INTEGRITY PATHWAY; PHOSPHATIDYLCHOLINE SYNTHESIS; CHEMICAL GENETICS; INDUCED APOPTOSIS; YEAST; INHIBITION; PROTEIN; CYTOTOXICITY; LOCALIZATION	The isoprenoid farnesol has been shown to preferentially induce apoptosis in cancerous cells; however, the mode of action of farnesol-induced death is not established. We used chemogenomic profiling using Saccharomyces cerevisiae to probe the core cellular processes targeted by farnesol. This screen revealed 48 genes whose inactivation increased sensitivity to farnesol. The gene set indicated a role for the generation of oxygen radicals by the Rieske iron-sulfur component of complex III of the electron transport chain as a major mediator of farnesol-induced cell death. Consistent with this, loss of mitochondrial DNA, which abolishes electron transport, resulted in robust resistance to farnesol. A genomic interaction map predicted interconnectedness between the Pkc1 signaling pathway and farnesol sensitivity via regulation of the generation of reactive oxygen species. Consistent with this prediction (i) Pkc1, Bck1, and Mkk1 relocalized to the mitochondria upon farnesol addition, (ii) inactivation of the only non-essential and non-redundant member of the Pkc1 signaling pathway, BCK1, resulted in farnesol sensitivity, and (iii) expression of activated alleles of PKC1, BCIC1, and MKK1 increased resistance to farnesol and hydrogen peroxide. Sensitivity to farnesol was not affected by the presence of the osmostabilizer sorbitol nor did farnesol affect phosphorylation of the ultimate Pkc1-responsive kinase responsible for controlling the cell wall integrity pathway, Slt2. The data indicate that the generation of reactive oxygen species by the electron transport chain is a primary mechanism by which farnesol kills cells. The Pkc1 signaling pathway regulates farnesol-mediated cell death through management of the generation of reactive oxygen species.	Dalhousie Univ, Dept Pediat & Biochem, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Dept Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pediat & Biochem, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776; Fairn, Greg/0000-0001-6508-168X				ADANY I, 1994, CANCER LETT, V79, P175, DOI 10.1016/0304-3835(94)90257-7; Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Beattie DS, 1999, J BIOENERG BIOMEMBR, V31, P215, DOI 10.1023/A:1005415611822; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Gille L, 2001, ARCH BIOCHEM BIOPHYS, V388, P34, DOI 10.1006/abbi.2000.2257; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Machida K, 1998, J BACTERIOL, V180, P4460, DOI 10.1128/JB.180.17.4460-4465.1998; Machida K, 1999, MICROBIOL-UK, V145, P293, DOI 10.1099/13500872-145-2-293; Mayer TU, 2003, TRENDS CELL BIOL, V13, P270, DOI 10.1016/S0962-8924(03)00077-1; Miquel K, 1998, J BIOL CHEM, V273, P26179, DOI 10.1074/jbc.273.40.26179; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons Ainslie B, 2003, Prog Cell Cycle Res, V5, P159; Rioja A, 2000, FEBS LETT, V467, P291, DOI 10.1016/S0014-5793(00)01168-6; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; TONG AH, 2005, METHOD MOL BIOL, V313, P717; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; VOZIYAN PA, 1995, BIOCHEM BIOPH RES CO, V212, P479, DOI 10.1006/bbrc.1995.1995; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Wright MM, 2001, J BIOL CHEM, V276, P25254, DOI 10.1074/jbc.M011552200; WRIGHT MM, 2005, FEBS J, V272, P5056; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200	34	48	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4868	4874		10.1074/jbc.M610575200	http://dx.doi.org/10.1074/jbc.M610575200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164236	hybrid			2022-12-27	WOS:000244482000069
J	Jilaveanu, LB; Oliver, DB				Jilaveanu, Lucia B.; Oliver, Donald B.			In vivo membrane topology of Escherichia coli SecA ATPase reveals extensive periplasmic exposure of multiple functionally important domains clustering on one face of SecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSLOCATION; PREPROTEIN TRANSLOCASE; BACTERIAL-MEMBRANE; BINDING DOMAIN; SIGNAL PEPTIDE; INNER MEMBRANE; DIMERIC SECA; BOUND SECA; WILD-TYPE; SECYEG	The Sec-dependent protein translocation pathway promotes the transport of proteins into or across the bacterial plasma membrane. SecA ATPase has been shown to be a nanomotor that associates with its protein cargo as well as the SecYEG channel complex and to undergo ATP-driven cycles of membrane insertion and retraction that promote stepwise protein translocation. previous studies have shown that both the 65-kDa N-domain and 30-kDa C-domain of SecA appear to undergo such membrane cycling. In the present study we performed in vivo sulfhydryl labeling of an extensive collection of monocysteine secA mutants under topologically specific conditions to identify regions of SecA that are accessible to the trans side of the membrane in its membrane-integrated state. Our results show that distinct regions of five of six SecA domains were labeled under these conditions, and such labeling clusters to a single face of the SecA structure. Our results demarcate an extensive face of SecA that interacts with SecYEG and is in fluid contact with the protein-conducting channel. The observed domain-specific labeling patterns should also provide important constraints on model building efforts in this dynamic system.	Wesleyan Univ, Dept Biochem & Mol Biol, Middletown, CT 06457 USA	Wesleyan University	Oliver, DB (corresponding author), Wesleyan Univ, Dept Biochem & Mol Biol, Middletown, CT 06457 USA.	doliver@wesleyan.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042033] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42033] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baud C, 2002, J BIOL CHEM, V277, P13724, DOI 10.1074/jbc.M200047200; BAYER EA, 1985, ANAL BIOCHEM, V149, P529, DOI 10.1016/0003-2697(85)90609-8; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jilaveanu LB, 2006, J BACTERIOL, V188, P335, DOI 10.1128/JB.188.1.335-338.2006; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; KIM YJ, 1994, CELL, V78, P845; KIMURA E, 1991, J BIOL CHEM, V266, P6600; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Musial-Siwek M, 2005, BIOCHEMISTRY-US, V44, P13987, DOI 10.1021/bi050882k; Nakatogawa H, 2000, J BIOL CHEM, V275, P33209, DOI 10.1074/jbc.C000550200; Natale P, 2005, BIOCHEMISTRY-US, V44, P6424, DOI 10.1021/bi047488r; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2; Rajapandi T, 1996, MOL MICROBIOL, V20, P43, DOI 10.1111/j.1365-2958.1996.tb02487.x; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; SADAIE Y, 1991, GENE, V98, P101; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Stewart JB, 2003, J BACTERIOL, V185, P5234, DOI 10.1128/JB.185.17.5234-5239.2003; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; van Voorst F, 2000, FEBS LETT, V486, P57, DOI 10.1016/S0014-5793(00)02209-2; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Wang LG, 2004, BIOCHEMISTRY-US, V43, P13185, DOI 10.1021/bi049485k; Zito CR, 2003, J BIOL CHEM, V278, P40640, DOI 10.1074/jbc.M308025200	60	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4661	4668		10.1074/jbc.M610828200	http://dx.doi.org/10.1074/jbc.M610828200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166834	hybrid			2022-12-27	WOS:000244482000047
J	Gafvelin, G; Parmley, S; Neimert-Andersson, T; Blank, U; Eriksson, TLJ; van Hage, M; Punnonen, J				Gafvelin, Guro; Parmley, Stephen; Neimert-Andersson, Theresa; Blank, Ulrich; Eriksson, Tove L. J.; van Hage, Marianne; Punnonen, Juha			Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEP-D 2; BIRCH POLLEN ALLERGEN; IGE-BINDING-CAPACITY; LEPIDOGLYPHUS-DESTRUCTOR; ANTIBODY-RESPONSES; MAJOR ALLERGEN; 3-DIMENSIONAL STRUCTURE; DISULFIDE BONDS; CELL EPITOPES; IN-VITRO	Allergen-specific immunotherapy is the only treatment that provides long lasting relief of allergic symptoms. Currently, it is based on repeated administration of allergen extracts. To improve the safety and efficacy of allergen extract-based immunotherapy, application of hypoallergens, i.e. modified allergens with reduced IgE binding capacity but retained T-cell reactivity, has been proposed. It may, however, be difficult to predict how to modify an allergen to create a hypoallergen. Directed molecular evolution by DNA shuffling and screening provides a means by which to evolve proteins having novel or improved functional properties without knowledge of structure - function relationships of the target molecules. With the aim to generate hypoallergens we applied multigene DNA shuffling on three group 2 dust mite allergen genes, two isoforms of Lep d 2 and Gly d 2. DNA shuffling yielded a library of genes from which encoded shuffled allergens were expressed and screened. A positive selection was made for full-length, high-expressing clones, and screening for low binding to IgE from mite allergic patients was performed using an IgE bead-based binding assay. Nine selected shuffled allergens revealed 80-fold reduced to completely abolished IgE binding compared with the parental allergens in IgE binding competition experiments. Two hypoallergen candidates stimulated allergen-specific T-cell proliferation and cytokine production at comparable levels as the wildtype allergens in patient peripheral blood mononuclear cell cultures. The two candidates also induced blocking Lep d 2-specific IgG antibodies in immunized mice. We conclude that directed molecular evolution is a powerful approach to generate hypoallergens for potential use in allergen-specific immunotherapy.	Karolinska Inst, Dept Med Clin Immunol & Allergy, S-17176 Stockholm, Sweden; Maxygen Inc, Redwood City, CA 94063 USA; INSERM, U699, F-75018 Paris, France; Univ Paris 07, Fac Med, F-75018 Paris, France	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Gafvelin, G (corresponding author), Karolinska Univ Hosp, Dept Med, Clin Immunol & Allergy Unit, Karolinska Inst, S-17176 Stockholm, Sweden.	guro.gafvelin@ki.se	van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596; Blank, Ulrich/0000-0002-2661-2983; Gafvelin, Guro/0000-0003-1618-4011				Adedoyin J, 2006, J IMMUNOL METHODS, V310, P117, DOI 10.1016/j.jim.2006.01.001; Akdis CA, 2001, TRENDS IMMUNOL, V22, P175, DOI 10.1016/S1471-4906(01)01862-2; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Ball T, 1999, EUR J IMMUNOL, V29, P2026, DOI 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2; Beezhold DH, 2001, J ALLERGY CLIN IMMUN, V107, P1069, DOI 10.1067/mai.2001.115482; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Drew AC, 2004, J IMMUNOL, V173, P5872, DOI 10.4049/jimmunol.173.9.5872; Elfman LHM, 1998, INT ARCH ALLERGY IMM, V117, P167, DOI 10.1159/000024006; Eriksson TLJ, 2001, CLIN EXP ALLERGY, V31, P1881, DOI 10.1046/j.1365-2222.2001.01242.x; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gafvelin G, 2001, J ALLERGY CLIN IMMUN, V107, P511, DOI 10.1067/mai.2001.112264; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; Johansson E, 1999, INT ARCH ALLERGY IMM, V120, P43, DOI 10.1159/000024218; Karamloo F, 2005, EUR J IMMUNOL, V35, P3268, DOI 10.1002/eji.200425522; Karisola P, 2004, J IMMUNOL, V172, P2621, DOI 10.4049/jimmunol.172.4.2621; Kronqvist M, 1999, CLIN EXP ALLERGY, V29, P35, DOI 10.1046/j.1365-2222.1999.00452.x; Kronqvist M, 2000, CLIN EXP ALLERGY, V30, P670, DOI 10.1046/j.1365-2222.2000.00822.x; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lazetic S, 2002, J BIOL CHEM, V277, P38660, DOI 10.1074/jbc.M205808200; Leong SR, 2003, P NATL ACAD SCI USA, V100, P1163, DOI 10.1073/pnas.0237327100; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; Moverare R, 2002, ALLERGY, V57, P423, DOI 10.1034/j.1398-9995.2002.13248.x; Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Olsson S, 1998, MOL IMMUNOL, V35, P1017, DOI 10.1016/S0161-5890(98)00101-1; Parvaneh S, 2002, CLIN EXP ALLERGY, V32, P80, DOI 10.1046/j.0022-0477.2001.01255.x; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Punnonen J, 2000, INT ARCH ALLERGY IMM, V121, P173, DOI 10.1159/000024315; Rabjohn P, 2002, INT ARCH ALLERGY IMM, V128, P15, DOI 10.1159/000057999; Robinson DS, 2003, PEDIATR PULM, V36, P369, DOI 10.1002/ppul.10375; Saarne T, 2005, CLIN EXP ALLERGY, V35, P657, DOI 10.1111/j.1365-2222.2005.02234.x; SCHMIDT M, 1995, FEBS LETT, V370, P11, DOI 10.1016/0014-5793(95)98164-E; Smith AM, 1996, MOL IMMUNOL, V33, P399, DOI 10.1016/0161-5890(95)00150-6; Soong NW, 2000, NAT GENET, V25, P436, DOI 10.1038/78132; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Spiegelberg HL, 2002, CURR OPIN ALLERGY CL, V2, P547, DOI 10.1097/00130832-200212000-00012; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Swoboda I, 2002, EUR J IMMUNOL, V32, P270, DOI 10.1002/1521-4141(200201)32:1<270::AID-IMMU270>3.0.CO;2-X; Takai T, 1997, NAT BIOTECHNOL, V15, P754, DOI 10.1038/nbt0897-754; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; Valenta R, 1999, BIOL CHEM, V380, P815, DOI 10.1515/BC.1999.101; Vrtala S, 1997, J CLIN INVEST, V99, P1673, DOI 10.1172/JCI119330; Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje; Westritschnig K, 2004, J IMMUNOL, V172, P5684, DOI 10.4049/jimmunol.172.9.5684; Wright A, 2005, HUM GENE THER, V16, P881, DOI 10.1089/hum.2005.16.881; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	50	30	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3778	3787		10.1074/jbc.M607938200	http://dx.doi.org/10.1074/jbc.M607938200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17170112	hybrid			2022-12-27	WOS:000244481900041
J	Strempel, JM; Vercelli, D				Strempel, Jannine M.; Vercelli, Donata			Functional dissection identifies a conserved noncoding sequence-1 core that mediates IL13 and IL4 transcriptional enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E1A-ASSOCIATED PROTEIN P300; ELEMENT-BINDING PROTEIN; CYCLIC-AMP; IL-4 GENE; CUTTING EDGE; COORDINATE REGULATOR; CHROMATIN; CREB; COACTIVATOR; EXPRESSION	Conserved noncoding sequence (CNS)-1 has been shown to coordinately regulate the expression of the Th2 cytokine genes IL4, IL13, and IL5. We have used the interaction between CNS-1 and the human IL13 and IL4 promoters as a model to pursue the molecular mechanisms underlying CNS-1-dependent regulation of Th2 cytokine gene transcription. CNS-1 potently enhanced the activity of IL13 and IL4 promoter reporter vectors upon full T cell activation. Analysis of CNS-1 deletion mutants mapped enhancer activity to a short core (CNS-1-(270-337)) that contains three closely spaced cyclic AMP-responsive elements (CRE). CRE site 2 bound CRE-binding protein (CREB) and activating transcription factor (ATF)-2 in vitro and was essential for CNS-1-dependent up-regulation of IL13 transcription. Cotransfection of an ILI3 reporter construct with expression vectors for wild type or mutant CREB and ATF-2 showed that CREB, but not ATF-2, regulates CNS-1 enhancer activity. Notably, chromatin immunoprecipitation analysis showed T cell activation recruits CREB and the coactivator CREB-binding protein (CBP)/p300 to the endogenous CNS-1. Moreover, CBP/ p300 activity was essential for CNS-1-mediated enhancement of IL13 transcription. Collectively, these data define the region within CNS-1 responsible for enhancement of IL13 and IL4 transcription and suggest CREB/CBP-dependent mechanisms play an important role in facilitating Th2 cytokine gene expression in response to T cell receptor signaling.	Univ Arizona, Arizona Resp Ctr, Arizona Hlth Sci Ctr, Funct Genom Lab,Coll Med, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Grad Interdisciplinary Program Genet, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Cell Biol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona	Vercelli, D (corresponding author), Univ Arizona, Arizona Resp Ctr, Arizona Hlth Sci Ctr, Funct Genom Lab,Coll Med, 1501 N Campbell Ave,Rm 2349, Tucson, AZ 85724 USA.	donata@arc.arizona.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066391] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66391] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baumann S, 2004, EUR J IMMUNOL, V34, P1961, DOI 10.1002/eji.200324826; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; ECKNER R, 1994, COLD SPRING HARB SYM, V59, P85, DOI 10.1101/SQB.1994.059.01.012; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hsueh YP, 1997, J IMMUNOL, V158, P85; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Ranganath S, 1998, J IMMUNOL, V161, P3822; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Shabalina SA, 2001, TRENDS GENET, V17, P373, DOI 10.1016/S0168-9525(01)02344-7; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yu CT, 2001, J IMMUNOL, V166, P284, DOI 10.4049/jimmunol.166.1.284; Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	39	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3738	3746		10.1074/jbc.M606615200	http://dx.doi.org/10.1074/jbc.M606615200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17166845	hybrid			2022-12-27	WOS:000244481900037
J	Fuse, C; Ishida, Y; Hikita, T; Asai, T; Oku, N				Fuse, Chiaki; Ishida, Yuuki; Hikita, Tomoya; Asai, Tomohiro; Oku, Naoto			Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; PROTEIN; FAMILY; IDENTIFICATION; MIGRATION; INTERACTS; INVASION; MEMBER; JAM-1; PET	The junctional adhesion molecule (JAM) family is a key molecule in a process called transendothelial migration or diapedesis. Here, we report implications of JAM-C in cancer metastasis. We first determined the mRNA expression of JAMs in 19 kinds of cancer cell lines. JAM-C was expressed in most of tumors having potent metastatic properties. Especially in murine K-1735 melanoma cell lines, the highly metastatic sublines (M2 and X21) strongly expressed JAM-C when compared with the poorly metastatic ones (C-10 and C23). Next, we investigated the role of JAM-C in cancer metastasis by using human JAM-C (hJAM-C) gene-transfected HT1080 fibrosarcoma cells. In comparison with mock-transfected HT 1080 cells, these cells showed a significant increase in the adhesion to various extracellular substrates and the invasion across a Matrigel(TM)-coated membrane. The knockdown of hJAM-C using small interfering RNA resulted in the suppression of both the adhesion and the invasion of HT1080 cells, suggesting that endogenous hJAM-C might be involved in tumor metastasis. Finally, we studied the role of hJAM-C in an in vivo experimental metastatic model. The results showed that the overexpression of hJAM-C in HT 1080 cells significantly decreased the life spans of the tumor-bearing mice. In contrast, the knockdown of hJAM-C in HT1080 cells suppressed the weight gain of the lungs with metastatic colonies. We conclude that the expression of JAM-C promotes metastasis by enhancing both the adhesion of cancer cells to extracellular matrices and the subsequent invasion.	Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem Med, Shizuoka 4228526, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Ctr Excellence Program 21st Century, Shizuoka 4228526, Japan	University of Shizuoka; University of Shizuoka	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem Med, 52-1 Yada, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp						Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Babinska A, 2002, THROMB HAEMOSTASIS, V88, P843, DOI 10.1055/s-0037-1613312; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chavakis T, 2003, THROMB HAEMOSTASIS, V89, P13; Chretien I, 1998, EUR J IMMUNOL, V28, P4094; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; Cunningham SA, 2002, J BIOL CHEM, V277, P27589, DOI 10.1074/jbc.C200331200; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; FIDLER IJ, 1981, J NATL CANCER I, V67, P947; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kikkawa H, 2002, CLIN EXP METASTAS, V19, P717, DOI 10.1023/A:1021356019563; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; KOIKE C, 1995, BBA-BIOMEMBRANES, V1238, P99, DOI 10.1016/0005-2736(95)00123-K; Lamagna C, 2005, CANCER RES, V65, P5703, DOI 10.1158/0008-5472.CAN-04-4012; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; Martinez-Estrada OM, 2001, J BIOL CHEM, V276, P9291, DOI 10.1074/jbc.M006991200; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Santoso S, 2005, J BIOL CHEM, V280, P36326, DOI 10.1074/jbc.M505059200; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Vestweber D, 2002, CURR OPIN CELL BIOL, V14, P587, DOI 10.1016/S0955-0674(02)00372-1; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yamakawa S, 2000, BIOL PHARM BULL, V23, P1264	37	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8276	8283		10.1074/jbc.M608836200	http://dx.doi.org/10.1074/jbc.M608836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227766	hybrid			2022-12-27	WOS:000245081000060
J	Gray, JP; Heck, DE; Mishin, V; Smith, PJS; Hong, JY; Thiruchelvam, M; Cory-Slechta, DA; Laskin, DL; Laskin, JD				Gray, Joshua P.; Heck, Diane E.; Mishin, Vladimir; Smith, Peter J. S.; Hong, Jun-Yan; Thiruchelvam, Mona; Cory-Slechta, Deborah A.; Laskin, Debra L.; Laskin, Jeffrey D.			Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H : paraquat oxidoreductase - Identification of the enzyme as thioredoxin reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT ALVEOLAR MACROPHAGES; HYPOXIA-INDUCIBLE FACTOR; PANCREATIC BETA-CELLS; OXIDATIVE STRESS; LIPID-PEROXIDATION; OXYGEN-CONSUMPTION; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; II CELLS; SUPEROXIDE-PRODUCTION	Pulmonary fibrosis is one of the most severe consequences of exposure to paraquat, an herbicide that causes rapid alveolar inflammation and epithelial cell damage. Paraquat is known to induce toxicity in cells by stimulating oxygen utilization via redox cycling and the generation of reactive oxygen intermediates. However, the enzymatic activity mediating this reaction in lung cells is not completely understood. Using self-referencing microsensors, we measured the effects of paraquat on oxygen flux into murine lung epithelial cells. Paraquat (10-100 mu m) was found to cause a 2-4-fold increase in cellular oxygen flux. The mitochondrial poisons cyanide, rotenone, and antimycin A prevented mitochondrial-but not paraquat-mediated oxygen flux into cells. In contrast, diphenyleneiodonium (10 mu m), an NADPH oxidase inhibitor, blocked the effects of paraquat without altering mitochondrial respiration. NADPH oxidases, enzymes that are highly expressed in lung epithelial cells, utilize molecular oxygen to generate superoxide anion. We discovered that lung epithelial cells possess a distinct cytoplasmic diphenyleneiodonium-sensitive NAD(P)H:paraquat oxidoreductase. This enzyme utilizes oxygen, requires NADH or NADPH, and readily generates the reduced paraquat radical. Purification and sequence analysis identified this enzyme activity as thioredoxin reductase. Purified paraquat reductase from the cells contained thioredoxin reductase activity, and purified rat liver thioredoxin reductase or recombinant enzyme possessed paraquat reductase activity. Reactive oxygen intermediates and subsequent oxidative stress generated from this enzyme are likely to contribute to paraquat-induced lung toxicity.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; Marine Biol Lab, Biocurrents Res Ctr, Woods Hole, MA 02543 USA; Univ Med & Dent New Jersey, Sch Publ Hlth, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Marine Biological Laboratory - Woods Hole; Rutgers State University New Brunswick; Rutgers State University Medical Center	Laskin, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	jlaskin@eohsi.rutgers.edu		Smith, Peter/0000-0003-4400-6853; Laskin, Debra/0000-0003-1832-7311; Gray, Joshua/0000-0002-9704-3845; Gray, Joshua/0000-0003-4146-7902	NCI NIH HHS [CA100994, CA093798] Funding Source: Medline; NCRR NIH HHS [RR001395] Funding Source: Medline; NIAMS NIH HHS [U54AR055073] Funding Source: Medline; NIEHS NIH HHS [ES004738, ES005022, ES006897, ES010791, ES003647] Funding Source: Medline; NIGMS NIH HHS [GM034310] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA093798, R01CA100994, R01CA093798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR055073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES006897, R01ES010791, R01ES003647, R01ES004738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034310] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM A, 1990, BIOCHEM PHARMACOL, V40, P1533, DOI 10.1016/0006-2952(90)90451-P; ADAM A, 1990, ENVIRON HEALTH PERSP, V85, P113, DOI 10.2307/3430673; Andersson M, 1996, J BIOL CHEM, V271, P10116, DOI 10.1074/jbc.271.17.10116; AUTOR AP, 1977, BIOCH MECH PARAQUAT, P21; Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CLEJAN L, 1989, BIOCHEM PHARMACOL, V38, P1779, DOI 10.1016/0006-2952(89)90412-7; CLEJAN LA, 1993, BIOCHEM J, V295, P781, DOI 10.1042/bj2950781; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; DICKER E, 1991, BIOCHEM PHARMACOL, V42, P529, DOI 10.1016/0006-2952(91)90315-V; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Fenton H.J.H., 1876, CHEM NEWS, V33; GAGE JC, 1968, BIOCHEM J, V109, P757, DOI 10.1042/bj1090757; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GAUDU P, 1994, EUR J BIOCHEM, V226, P459, DOI 10.1111/j.1432-1033.1994.tb20070.x; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; HAGEN TM, 1986, BIOCHEM PHARMACOL, V35, P4537, DOI 10.1016/0006-2952(86)90776-8; Han JF, 2006, TOXICOL SCI, V91, P42, DOI 10.1093/toxsci/kfj139; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; Higuchi A, 2003, TOXICOLOGY, V183, P143, DOI 10.1016/S0300-483X(02)00512-7; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hoffer E, 1996, TOXICOL LETT, V84, P7, DOI 10.1016/0378-4274(95)03446-3; HOLMGREN A, 1980, P NATL ACAD SCI-BIOL, V77, P5149, DOI 10.1073/pnas.77.9.5149; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Jung SK, 2000, BIOL BULL, V199, P197, DOI 10.2307/1542895; Jung SK, 2001, ANAL CHEM, V73, P3759, DOI 10.1021/ac010247u; Kang HJ, 2006, MOL CELLS, V22, P113; KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7; Karakashev P, 2000, NEOPLASMA, V47, P122; Karimpour S, 2002, ONCOGENE, V21, P6317, DOI 10.1038/sj.onc.1205749; KIMBROUGH RD, 1970, TOXICOL APPL PHARM, V17, P679, DOI 10.1016/0041-008X(70)90042-6; Kuo WY, 1998, FREE RADICAL BIO MED, V24, P1130, DOI 10.1016/S0891-5849(97)00413-9; Land SC, 1999, J EXP BIOL, V202, P211; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; MASON HS, 1957, ADV ENZYMOL REL S BI, V19, P79; MASON RP, 1990, ENVIRON HEALTH PERSP, V87, P237, DOI 10.2307/3431031; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Michaelis L, 1933, J AM CHEM SOC, V55, P1481, DOI 10.1021/ja01331a027; Mishin VA, 2004, BIOCHEM PHARMACOL, V68, P747, DOI 10.1016/j.bcp.2004.05.004; Mostert V, 2003, FEBS LETT, V541, P85, DOI 10.1016/S0014-5793(03)00309-0; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Porterfield DM, 2001, AM J PHYSIOL-LUNG C, V281, pL904, DOI 10.1152/ajplung.2001.281.4.L904; Porterfield DM, 2000, DIABETES, V49, P1511, DOI 10.2337/diabetes.49.9.1511; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Prabhakar NR, 2004, BIOL CHEM, V385, P217, DOI 10.1515/BC.2004.015; RANNELS DE, 1989, AM J PHYSIOL, V257, pL346, DOI 10.1152/ajplung.1989.257.6.L346; RASHBASTEP J, 1994, MOL PHARMACOL, V45, P150; ROSSOUW DJ, 1979, S AFR MED J, V55, P558; ROSSOUW DJ, 1979, S AFR MED J, V55, P20; ROSSOUW DJ, 1978, S AFR MED J, V54, P1101; ROSSOUW DJ, 1978, S AFR MED J, V54, P199; SCHWEICH MD, 1994, BIOCHEM PHARMACOL, V47, P1395, DOI 10.1016/0006-2952(94)90339-5; SENN H, 1987, EUR BIOPHYS J BIOPHY, V14, P301, DOI 10.1007/BF00254895; Shimada H, 2002, ARCH BIOCHEM BIOPHYS, V402, P149, DOI 10.1016/S0003-9861(02)00059-0; Sittipunt Chanchai, 2005, Respir Care, V50, P383; SMITH LL, 1982, BIOCHEM PHARMACOL, V31, P3029, DOI 10.1016/0006-2952(82)90075-2; SMITH LL, 1987, HUM TOXICOL, V6, P31, DOI 10.1177/096032718700600105; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; Tampo Y, 1999, FREE RADICAL BIO MED, V27, P588, DOI 10.1016/S0891-5849(99)00110-0; Tanaka Reiko, 2000, Journal of Toxicological Sciences, V25, P199; Towne V, 2004, ANAL BIOCHEM, V334, P290, DOI 10.1016/j.ab.2004.07.037; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; VANDERWAL NAA, 1990, BIOCHEM PHARMACOL, V39, P1665, DOI 10.1016/0006-2952(90)90109-X; Vetrano AM, 2005, J BIOL CHEM, V280, P35372, DOI 10.1074/jbc.M503991200; WADDELL WJ, 1980, TOXICOL APPL PHARM, V56, P127, DOI 10.1016/0041-008X(80)90138-6; Weidauer E, 2002, ARCH TOXICOL, V76, P89, DOI 10.1007/s00204-001-0303-9; Wenger RH, 1997, BIOL CHEM, V378, P609; WINTERBOURN CC, 1981, FEBS LETT, V128, P339, DOI 10.1016/0014-5793(81)80112-3; WITSCHI H, 1977, CHEM-BIOL INTERACT, V19, P143, DOI 10.1016/0009-2797(77)90027-8; Wolff DJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P73, DOI 10.1006/abbi.1996.9811; Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	82	52	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7939	7949		10.1074/jbc.M611817200	http://dx.doi.org/10.1074/jbc.M611817200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229725	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000245081000024
J	Kang, KR; Kim, YS; Wolff, EC; Park, MH				Kang, Kee Ryeon; Kim, Yeon Sook; Wolff, Edith C.; Park, Myung Hee			Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction - Identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HUMAN CANCER-CELLS; FACTOR 5A EIF5A; PROTEIN-SYNTHESIS; POSTTRANSLATIONAL SYNTHESIS; HYPUSINE FORMATION; NUCLEAR EXPORT; MESSENGER-RNA; RAT TESTIS; IN-VIVO	Deoxyhypusine hydroxylase (DOHH) is a novel metalloenzyme that catalyzes the final step of the post-translational synthesis of hypusine (N-epsilon-(4-amino-2-hydroxybutyl)lysine) in the eukaryotic translation initiation factor 5A (6175A). Hypusine synthesis is unique in that it occurs in only one protein, denoting the strict specificity of the modification enzymes toward the substrate protein. The specificity of the interaction between eIF5A and DOHH was investigated using human eIF5A (eIF5A-1 isoform) and human recombinant DOHH. DOHH displayed a strong preference for binding the deoxyhypusine-containing form of eIF5A, over the eIF5A precursor or the hypusine-containing eIF5A, indicating a role for the deoxyhypusine residue in binding. In addition to the deoxyhypusine residue, a large portion of the eIF5A polypeptide 1(> 20-90 amino acids) is required for effective modification by DOHH. We have identified the amino acid residues of DOHH that are critical for substrate binding by alanine substitution of 36 conserved amino 90 acid residues. Of these, alanilne substitution at Glu(57), Glu(90), GIU(208), GIU(241), Gly(63), or Gly(214) caused a severe impairment in eIF5A(Dhp) binding, with a complete loss of binding and activity in the E57A and E208A mutant enzymes. Only aspartate substitution mutants, E57D or E208D, retained partial activity and substrate binding, whereas alanine, glutamine, or asparagine mutants did not. These findings support a proposed model of DOHH-eIF5A binding in which the amino group(s) of the deoxyhypusine side chain of the substrate is primarily anchored by gamma-carboxyl groups of Glu(57) and Glu(208) at the DOHH active site.	NIDCR, OPCB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Park, MH (corresponding author), NIDCR, OPCB, NIH, Bldg 30,Rm 211, Bethesda, MD 20892 USA.	mhpark@nih.gov			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000608] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DE999999] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Andrus L, 1998, BIOCHEM PHARMACOL, V55, P1807, DOI 10.1016/S0006-2952(98)00053-7; BENNE R, 1978, J BIOL CHEM, V253, P3070; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Caraglia M, 2003, J BIOCHEM, V133, P757, DOI 10.1093/jb/mvg097; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Chen KY, 1997, BIOL SIGNAL, V6, P105; Clement PMJ, 2006, FEBS J, V273, P1102, DOI 10.1111/j.1742-4658.2006.05135.x; Clement PMJ, 2002, INT J CANCER, V100, P491, DOI 10.1002/ijc.10515; Facchiano AM, 2001, PROTEIN ENG, V14, P881, DOI 10.1093/protein/14.11.881; GERNER EW, 1986, BIOCHEM J, V239, P379, DOI 10.1042/bj2390379; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanauske-Abel HM, 2003, CURR MED CHEM, V10, P1005, DOI 10.2174/0929867033457601; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; HANAUSKEABEL HM, 1995, FEBS LETT, V366, P92, DOI 10.1016/0014-5793(95)00493-S; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; JOE YA, 1994, J BIOL CHEM, V269, P25916; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; KANG HA, 1994, J BIOL CHEM, V269, P3934; KANG KR, 1995, J BIOL CHEM, V270, P18408, DOI 10.1074/jbc.270.31.18408; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; Kim YS, 2006, J BIOL CHEM, V281, P13217, DOI 10.1074/jbc.M601081200; KIMATA Y, 1994, J BIOL CHEM, V269, P13497; Lee YB, 1999, BIOCHEM J, V340, P273, DOI 10.1042/0264-6021:3400273; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1984, J BIOL CHEM, V259, P2123; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1988, J BIOL CHEM, V263, P15264; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schatz O, 1998, P NATL ACAD SCI USA, V95, P1607, DOI 10.1073/pnas.95.4.1607; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; Spradling AC, 1999, GENETICS, V153, P135; Sugimoto A, 2004, DIFFERENTIATION, V72, P81, DOI 10.1111/j.1432-0436.2004.07202004.x; Thompson GM, 2003, FEBS LETT, V555, P464, DOI 10.1016/S0014-5793(03)01305-X; Valentini SR, 2002, GENETICS, V160, P393; Weir BA, 2004, MOL BIOL CELL, V15, P1656, DOI 10.1091/mbc.E03-06-0371; WOHL T, 1993, MOL GEN GENET, V241, P305; WOLFF EC, 1990, J BIOL CHEM, V265, P4793; WOLFF EC, 1995, J BIOL CHEM, V270, P8660, DOI 10.1074/jbc.270.15.8660; Xu AG, 2004, BIOCHEM J, V384, P585, DOI 10.1042/BJ20041232; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	55	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8300	8308		10.1074/jbc.M607495200	http://dx.doi.org/10.1074/jbc.M607495200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17213197	hybrid, Green Accepted			2022-12-27	WOS:000245081000063
J	Qiu, W; Zhou, M; Mazumdar, M; Azzi, A; Ghanmi, D; Luu-The, V; Labrie, F; Lin, SX				Qiu, Wei; Zhou, Ming; Mazumdar, Mausumi; Azzi, Arezki; Ghanmi, Dalila; Luu-The, Van; Labrie, Fernand; Lin, Sheng-Xiang			Structure-based inhibitor design for an enzyme that binds different steroids - A potent inhibitor for human type 5 17 beta-hydroxysteroid dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; KETO REDUCTASE AKR1C3; PROSTATE-CANCER; ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; CRYSTAL-STRUCTURES; LHRH AGONIST; EXPRESSION; LOCALIZATION; ESTRADIOL	Human type 5 17 beta-hydroxysteroid dehydrogenase plays a crucial role in local androgen formation in prostate tissue. Several chemicals were synthesized and tested for their ability to inhibit this enzyme, and a series of estradiol derivatives bearing a lactone on the D-ring were found to inhibit its activity efficiently. The crystal structure of the type 5 enzyme in complex with NADP and such a novel inhibitor, EM1404, was determined to a resolution of 1.30 angstrom. Significantly more hydrogen bonding and hydrophobic interactions were defined between EM1404 and the enzyme than in the substrate ternary complex. The lactone ring of EM1404 accounts for important interactions with the enzyme, whereas the amide group at the opposite end of the inhibitor contributes to the stability of three protein loops involved in the construction of the substrate binding site. EM1404 has a strong competitive inhibition, with a K-i of 6.9 +/- 1.4 nM, demonstrating 40 times higher affinity than that of the best inhibitor previously reported. This is observed despite the fact that the inhibitor occupies only part of the binding cavity. Attempts to soak the inhibitor into crystals of the binary complex with NADP were unsuccessful, yielding a structure with a polyethylene glycol fragment occupying the substrate binding site. The relative crystal packing is discussed. Combined studies of small molecule inhibitor synthesis, x-ray crystallography, enzyme inhibition, and molecular modeling make it possible to analyze the plasticity of the substrate binding site of the enzyme, which is essential for developing more potent and specific inhibitors for hormone-dependent cancer therapy.	Univ Laval, Res Ctr, CHU Quebec, Canadian Inst Hlth,Res Grp Mol Endocrinol, Quebec City, PQ G1V 4G2, Canada	Laval University	Lin, SX (corresponding author), Univ Laval, Res Ctr, CHU Quebec, Canadian Inst Hlth,Res Grp Mol Endocrinol, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	sxlin@crchul.ulaval.ca		Lin, Sheng-Xiang/0000-0001-9149-375X				ANDERSSON S, 1995, J ENDOCRINOL, V146, P197, DOI 10.1677/joe.0.1460197; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTSCH W, 1987, J STEROID BIOCHEM, V28, P35, DOI 10.1016/0022-4731(87)90121-X; Bauman DR, 2005, MOL PHARMACOL, V67, P60, DOI 10.1124/mol.104.006569; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Burczynski ME, 1998, BIOCHEMISTRY-US, V37, P6781, DOI 10.1021/bi972725u; Denmeade SR, 1996, PROSTATE, V28, P251; Desmond JC, 2003, CANCER RES, V63, P505; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; El-Alfy M, 1999, ENDOCRINOLOGY, V140, P1481, DOI 10.1210/en.140.3.1481; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangloff A, 2002, FASEB J, V16, P274, DOI 10.1096/fj.02-0397fje; Han Q, 2000, J BIOL CHEM, V275, P1105, DOI 10.1074/jbc.275.2.1105; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Koh E, 2002, PROSTATE, V53, P154, DOI 10.1002/pros.10139; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Krazeisen A, 2002, ADV EXP MED BIOL, V505, P151; Krazeisen A, 2001, MOL CELL ENDOCRINOL, V171, P151, DOI 10.1016/S0303-7207(00)00422-6; LABRIE F, 1985, J STEROID BIOCHEM, V23, P833, DOI 10.1016/S0022-4731(85)80024-8; LABRIE F, 1982, CLIN INVEST MED, V5, P267; Labrie F, 2003, M S-MED SCI, V19, P910, DOI 10.1051/medsci/20031910910; Labrie F, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01639-4; LABRIE F, 1999, Patent No. 9946279; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Lopez-Otin C, 1998, ENDOCR REV, V19, P365, DOI 10.1210/er.19.4.365; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940, DOI 10.1093/oxfordjournals.jbchem.a022211; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier G, 1999, J HISTOCHEM CYTOCHEM, V47, P731, DOI 10.1177/002215549904700602; Pelletier G, 2001, J ENDOCRINOL, V171, P373, DOI 10.1677/joe.0.1710373; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2001, MOL CELL ENDOCRINOL, V171, P137, DOI 10.1016/S0303-7207(00)00426-3; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; Qiu W, 1999, J STEROID BIOCHEM, V68, P239, DOI 10.1016/S0960-0760(99)00036-9; QIU W, 2002, THESIS LAVAL U QUEBE; Quinkler M, 2004, J ENDOCRINOL, V183, P331, DOI 10.1677/joe.1.05762; Rheault P, 1999, CYTOGENET CELL GENET, V84, P241, DOI 10.1159/000015267; SEGEL LA, 1976, J THEOR BIOL, V57, P23, DOI 10.1016/S0022-5193(76)80004-5; Soronen P, 2004, J STEROID BIOCHEM, V92, P281, DOI 10.1016/j.jsbmb.2004.10.004; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Zhou M, 2002, ACTA CRYSTALLOGR D, V58, P1048, DOI 10.1107/S0907444902005255; Zhu DW, 1996, J CRYST GROWTH, V168, P275, DOI 10.1016/0022-0248(96)00331-4	54	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8368	8379		10.1074/jbc.M606784200	http://dx.doi.org/10.1074/jbc.M606784200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17166832	hybrid			2022-12-27	WOS:000245081000070
J	Yang, ZY; Zheng, CY; Hayes, JJ				Yang, Zungyoon; Zheng, Chunyang; Hayes, Jeffrey J.			The core histone tail domains contribute to sequence-dependent nucleosome positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; TRANSCRIPTION FACTOR IIIA; YEAST PHO5 PROMOTER; N-TERMINAL TAIL; 5S RNA GENE; ORDERED RECRUITMENT; LINKER HISTONES; IN-VIVO; DNA; MECHANISM	The precise positioning of nucleosomes plays a critical role in the regulation of gene expression by modulating the DNA binding activity of trans-acting factors. However, molecular determinants responsible for positioning are not well understood. We examined whether the removal of the core histone tail domains from nucleosomes reconstituted with specific DNA fragments led to alteration of translational positions. Remarkably, we find that removal of tail domains from a nucleosome assembled on a DNA fragment containing a Xenopus borealis somatic-type 5S RNA gene results in repositioning of nucleosomes along the DNA, including two related major translational positions that move about 20 bp further upstream with respect to the 5S gene. In a nucleosome reconstituted with a DNA fragment containing the promoter of a Drosophila alcohol dehydrogenase gene, several translational positions shifted by about 10 bp along the DNA upon tail removal. However, the positions of nucleosomes assembled with a DNA fragment known to have one of the highest binding affinities for core histone proteins in the mouse genome were not altered by removal of core histone tail domains. Our data support the notion that the basic tail domains bind to nucleosomal DNA and influence the selection of the translational position of nucleosomes and that once tails are removed movement between translational positions occurs in a facile manner on some sequences. However, the effect of the N-terminal tails on the positioning and movement of a nucleosome appears to be dependent on the DNA sequence such that the contribution of the tails can be masked by very high affinity DNA sequences. Our results suggest a mechanism whereby sequence-dependent nucleosome positioning can be specifically altered by regulated changes in histone tail-DNA interactions in chromatin.	Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	jjhs@mail.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52426] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Aoyagi S, 2003, J BIOL CHEM, V278, P30562, DOI 10.1074/jbc.M304148200; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; CARY PD, 1982, EUR J BIOCHEM, V127, P137, DOI 10.1111/j.1432-1033.1982.tb06847.x; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Flaus A, 2003, BIOPOLYMERS, V68, P563, DOI 10.1002/bip.10323; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GRUNSTEIN M, 1992, SCI AM, V267, P68, DOI 10.1038/scientificamerican1092-68; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HAYES JJ, 1991, BIOCHEMISTRY-US, V30, P8434, DOI 10.1021/bi00098a022; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; JACKSON JR, 1993, NUCLEIC ACIDS RES, V21, P957, DOI 10.1093/nar/21.4.957; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Lee KM, 1999, METHOD ENZYMOL, V304, P231; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Panetta G, 1998, J MOL BIOL, V282, P683, DOI 10.1006/jmbi.1998.2087; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Pruss D, 1996, SCIENCE, V274, P614, DOI 10.1126/science.274.5287.614; RHODES D, 1985, EMBO J, V4, P3473, DOI 10.1002/j.1460-2075.1985.tb04106.x; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sera T, 1998, MOL CELL BIOL, V18, P3668, DOI 10.1128/MCB.18.7.3668; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P180, DOI 10.1093/nar/22.2.180; Thiriet C, 1998, J BIOL CHEM, V273, P21352, DOI 10.1074/jbc.273.33.21352; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; van Holde KE., 1989, SPRINGER SERIES MOL; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; Yang ZY, 2005, MOL CELL BIOL, V25, P241, DOI 10.1128/MCB.25.1.241-249.2005; Yang ZY, 2004, METHODS, V33, P25, DOI 10.1016/j.ymeth.2003.10.017; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200	69	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7930	7938		10.1074/jbc.M610584200	http://dx.doi.org/10.1074/jbc.M610584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234628	hybrid			2022-12-27	WOS:000245081000023
J	Li, G; Elder, RT; Qin, KF; Park, HU; Liang, D; Zhao, RY				Li, Ge; Elder, Robert T.; Qin, Kefeng; Park, Hyeon Ung; Liang, Doing; Zhao, Richard Y.			Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE-RESPONSE; CELL-CYCLE ARREST; YEAST SCHIZOSACCHAROMYCES-POMBE; PROTEIN PHOSPHATASE; CATALYTIC SUBUNIT; MOLECULAR-CLONING; OKADAIC ACID; VPR ARRESTS; G(2) PHASE; 2A	ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation. We demonstrate here that of these three agents only Vpr requires protein phosphatase type 2A (PP2A) to activate ATR for Chk1-Ser(345) phosphorylation. A requirement for PP2A by Vpr was first shown with the PP2A-specific inhibitor okadaic acid, which reduced Vpr-induced G(2) arrest and Cdk1-Tyr(15) phosphorylation. Using small interference RNA to down-regulate specific subunits of PP2A indicated that the catalytic beta-isoform PP2A(C beta) and the A regulatory alpha-isoform PP2A(A alpha) are involved in the G(2) induction, and these down-regulations decreased the Vpr-induced, ATR-dependent phosphorylations of Cdk1-Tyr(15) and Chk1-Ser(345). In contrast, the same down-regulations had no effect on hydroxyurea- or UV-activated ATR-dependent Chk1-Ser(345) phosphorylation. Vpr and hydroxyurea/UV all induce ATR-mediated gamma H2AX-Ser(139) phosphorylation and foci formation, but down-regulation of PP2A(A alpha) or PP2A(C beta) did not decrease gamma H2AX-Ser(139) phosphorylation by any of these agents or foci formation by Vpr. Conversely, H2AX down-regulation had little effect on PP2A(A alpha/C beta)-mediated G(2) arrest and Chk1-Ser(345) phosphorylation by Vpr. The expression of vpr increases the amount and phosphorylation of Claspin, an activator of Chk1 phosphorylation. Down-regulation of either PP2A(C,6) or PP2A(Act) had little effect on Claspin phosphorylation, but the amount of Claspin was reduced. Claspin may then be one of the phosphoproteins through which PP2A(A alpha/C beta) affects Chk1 phosphorylation when ATR is activated by human immunodeficiency virus-1 Vpr.	Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Chicago, IL 60614 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, 10 S Pine St,MSTF700A, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	NIAID NIH HHS [AI40891] Funding Source: Medline; NIGMS NIH HHS [GM63080] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040891, R29AI040891, R21AI040891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063080] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; Baumgartner M, 1999, MICROBES INFECT, V1, P1181, DOI 10.1016/S1286-4579(99)00244-0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P7330; Hrimech M, 2000, EMBO J, V19, P3956, DOI 10.1093/emboj/19.15.3956; Hrimech M, 2002, EMBO J, V21, P3918; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KHEWGOODALL Y, 1988, FEBS LETT, V238, P265, DOI 10.1016/0014-5793(88)80493-9; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Masuda M, 2000, J VIROL, V74, P2636, DOI 10.1128/JVI.74.6.2636-2646.2000; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; Nishijima H, 1997, J CELL BIOL, V138, P1105, DOI 10.1083/jcb.138.5.1105; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Recher C, 2004, CANCER RES, V64, P3191, DOI 10.1158/0008-5472.CAN-03-3005; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yuan HD, 2004, J VIROL, V78, P8183, DOI 10.1128/JVI.78.15.8183-8190.2004; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zhao LJ, 2003, GENE, V316, P137, DOI 10.1016/S0378-1119(03)00750-9; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; Zhou J, 2003, J BIOL CHEM, V278, P8617, DOI 10.1074/jbc.M211181200; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244; Zhou Y, 2001, VIROLOGY, V287, P133, DOI 10.1006/viro.2001.1031; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	67	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7287	7298		10.1074/jbc.M607951200	http://dx.doi.org/10.1074/jbc.M607951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210576	hybrid			2022-12-27	WOS:000245080900040
J	Mao, XQ; Kim, BE; Wang, FD; Eide, DJ; Petris, MJ				Mao, Xiaoqing; Kim, Byung-Eun; Wang, Fudi; Eide, David J.; Petris, Michael J.			A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACRODERMATITIS-ENTEROPATHICA; FUNCTIONAL EXPRESSION; GENE ENCODES; ENDOCYTOSIS; YEAST; FAMILY; PROTEINS; RECEPTOR; ZIP4; IDENTIFICATION	Zinc is an essential nutrient. Genetic evidence for this nutritional requirement in humans is the zinc deficiency disease, acrodermatitis enteropathica. This disorder is caused by mutations in hZIP4 (SLC39A4), a zinc importer required for zinc uptake in enterocytes and other cell types. Studies in mice have demonstrated that levels of the mZIP4 mRNA are reduced by elevated dietary zinc, resulting in a decreased abundance of the ZIP4 protein at the plasma membrane. Moreover, studies in cultured cells have demonstrated that low micromolar concentrations of zinc stimulate the endocytosis of the mZIP4 protein resulting in a reduction in cellular zinc uptake. In this study, we demonstrate an additional level of hZIP4 regulation involving ubiquitination and degradation of this transporter in elevated zinc concentrations. Mutational analysis identified a cytoplasmic histidine-rich domain that was essential for ubiquitin-dependent degradation of ZIP4 and protection against zinc toxicity. However, this motif was dispensable for zinc-induced endocytosis. These findings indicate that ubiquitin-mediated degradation of the ZIP4 protein is critical for regulating zinc homeostasis in response to the upper tier of physiological zinc concentrations, via a process that is distinct from zinc-stimulated endocytosis.	Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; Univ Missouri, Dept Nutr Sci, Columbia, MO 65211 USA; Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison	Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, 540D Life Sci Ctr, Columbia, MO 65211 USA.	petrism@missouri.edu	Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003	NIDDK NIH HHS [DK66333] Funding Source: Medline; NIGMS NIH HHS [GM56285] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK066333, R01DK066333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Huang ZL, 2006, DEV BIOL, V295, P571, DOI 10.1016/j.ydbio.2006.03.045; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Kury Sebastien, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9178; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	35	130	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6992	7000		10.1074/jbc.M610552200	http://dx.doi.org/10.1074/jbc.M610552200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17202136	hybrid			2022-12-27	WOS:000245080900011
J	Strehl, A; Munnix, ICA; Kuijpers, MJE; van der Meijden, PEJ; Cosemans, JMEM; Feijge, MAH; Nieswandt, B; Heemskerk, JWM				Strehl, Amrei; Munnix, Imke C. A.; Kuijpers, Marijke J. E.; van der Meijden, Paola E. J.; Cosemans, Judith M. E. M.; Feijge, Marion A. H.; Nieswandt, Bernhard; Heemskerk, Johan W. M.			Dual role of platelet protein kinase C in thrombus formation - Stimulation of pro-aggregatory and suppression of procoagulant activity in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRINOGEN RECEPTOR ACTIVATION; GLYCOPROTEIN-VI; IN-VIVO; INTEGRIN ALPHA(IIB)BETA(3); REVERSIBLE EXPOSURE; P2Y(12) RECEPTORS; FREE CALCIUM; COLLAGEN; ADHESION; ALPHA	Protein kinase C (PKC) isoforms regulate many platelet responses in a still incompletely understood manner. Here we investigated the roles of PKC in the platelet reactions implicated in thrombus formation as follows: secretion aggregate formation and coagulation-stimulating activity, using inhibitors with proven activity in plasma. In human and mouse platelets, PKC regulated aggregation by mediating secretion and contributing to alpha IIb beta 3 activation. Strikingly, PKC suppressed Ca2+ signal generation and Ca2+-dependent exposure of procoagulant phosphatidylserine. Furthermore, under coagulant conditions, PKC suppressed the thrombin-generating capacity of platelets. In flowing human and mouse blood, PKC contributed to platelet adhesion and controlled secretion-dependent thrombus formation, whereas it down-regulated Ca2+ signaling and procoagulant activity. In murine platelets lacking G(q)alpha, where secretion reactions were reduced in comparison with wild type mice, PKC still positively regulated platelet aggregation and down-regulated procoagulant activity. We conclude that platelet PKC isoforms have a dual controlling role in thrombus formation as follows: (i) by mediating secretion and integrin activation required for platelet aggregation under flow, and (ii) by suppressing Ca2+-dependent phosphatidylserine exposure, and consequently thrombin generation and coagulation. This platelet signaling protein is the first one identified to balance the pro-aggregatory and procoagulant functions of thrombi.	Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Human Biol, NL-6200 MD Maastricht, Netherlands; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany	Maastricht University; Maastricht University; University of Wurzburg	Nieswandt, B (corresponding author), Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands.	bernhard.nieswandt@virchow.uni-wuerzburg.de	Cosemans, Judith MEM/C-8161-2016; Heemskerk, Johan/AAM-8323-2021; Kuijpers, Marijke/AAN-9876-2021	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; van der Meijden, Paola/0000-0002-6532-2583				Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; Chen H, 2003, MOL CELL BIOL, V23, P4764, DOI 10.1128/MCB.23.14.4764-4777.2003; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Gruner S, 2003, BLOOD, V102, P4021, DOI 10.1182/blood-2003-05-1391; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 2001, J PHYSIOL-LONDON, V535, P625, DOI 10.1111/j.1469-7793.2001.00625.x; Hers I, 2000, ARTERIOSCL THROM VAS, V20, P1651, DOI 10.1161/01.ATV.20.6.1651; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; KING WG, 1989, J BIOL CHEM, V264, P6070; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Lecut C, 2004, ARTERIOSCL THROM VAS, V24, P1727, DOI 10.1161/01.ATV.0000137974.85068.93; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; ORR JW, 1992, J BIOL CHEM, V267, P15263; PACKHAM MA, 1993, BIOCHEM J, V290, P849, DOI 10.1042/bj2900849; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Polanowska-Grabowska R, 1999, ARTERIOSCL THROM VAS, V19, P3044, DOI 10.1161/01.ATV.19.12.3044; POLLOCK WK, 1987, FEBS LETT, V210, P132, DOI 10.1016/0014-5793(87)81322-4; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Reither G, 2006, J CELL BIOL, V174, P521, DOI 10.1083/jcb.200604033; RINK TJ, 1983, NATURE, V305, P317, DOI 10.1038/305317a0; Rosado JA, 2000, J PHYSIOL-LONDON, V529, P159, DOI 10.1111/j.1469-7793.2000.00159.x; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Schulte V, 2001, J BIOL CHEM, V276, P364, DOI 10.1074/jbc.M007536200; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; SIESS W, 1988, BIOCHEM J, V255, P309; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; TSUKUDA M, 1988, BIOCHEM BIOPH RES CO, V155, P1387, DOI 10.1016/S0006-291X(88)81295-6; van der Meijden PEJ, 2005, THROMB HAEMOSTASIS, V93, P1128, DOI 10.1160/TH04-09-0597; Vanschoonbeek K, 2004, J THROMB HAEMOST, V2, P476, DOI 10.1111/j.1538-7933.2004.00618.x; VANWILLIGEN G, 1991, BIOCHEM J, V273, P115, DOI 10.1042/bj2730115; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	50	52	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7046	7055		10.1074/jbc.M611367200	http://dx.doi.org/10.1074/jbc.M611367200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210570	hybrid			2022-12-27	WOS:000245080900016
J	Tossidou, I; Kardinal, C; Peters, I; Kriz, W; Shaw, A; Dikic, I; Tkachuk, S; Dumler, I; Haller, H; Schiffer, M				Tossidou, Irini; Kardinal, Christian; Peters, Imke; Kriz, Wilhelm; Shaw, Andrey; Dikic, Ivan; Tkachuk, Sergej; Dumler, Inna; Haller, Hermann; Schiffer, Mario			CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD2-ASSOCIATED PROTEIN; DOWN-REGULATION; ADAPTER PROTEIN; SLIT DIAPHRAGM; CD2AP; BINDING; PATHWAY; IDENTIFICATION; REARRANGEMENTS; CYTOSKELETON	Defects in podocyte signaling are the basis of many inherited glomerular diseases leading to glomerulosclerosis. CD2-associated protein (CD2AP) is highly expressed in podocytes and is considered to play an important role in the maintenance of the glomerular slit diaphragm. Mice deficient for CD2AP (CD2AP(-/-)) appear normal at birth but develop a rapid onset nephrotic syndrome at 3 weeks of age. We demonstrate that impaired intracellular signaling with subsequent podocyte damage is the reason for this delayed podocyte injury in CD2AP(-/-) mice. We document that CD2AP deficiency in podocytes leads to diminished signal initiation and termination of signaling pathways mediated by receptor tyrosine kinases (RTKs). In addition, we demonstrate that CIN85, a paralog of CD2AP, is involved in termination of RTK signaling in podocytes. CIN85 protein expression is increased in CD2AP(-/-) podocytes in vitro. Stimulation of CD2AP(-/-) podocytes with various growth factors, including insulin-like growth factor 1, vascular endothelial growth factor, and fibroblast growth factor, resulted in a significantly decreased phosphatidylinositol 3-kinase/AKT and ERK signaling response. Moreover, increased CIN85 protein is detectable in podocytes in diseased CD2AP(-/-) mice, leading to decreased base-line activation of ERK and decreased phosphorylation after growth factor stimulation in vivo. Because repression of CIN85 protein leads to a restored RTK signaling response, our results support an important role of CD2AP/CIN85 protein balance in the normal signaling response of podocytes.	Hannover Med Sch, Div Nephrol, Dept Med, D-30625 Hannover, Germany; Hannover Med Sch, Div Pediat Hematol & Oncol, D-30625 Hannover, Germany; Univ Heidelberg, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Goethe Univ, Sch Med, Dept Biochem 2, Mol Signaling Grp, D-60590 Frankfurt, Germany	Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; Washington University (WUSTL); Goethe University Frankfurt	Schiffer, M (corresponding author), Hannover Med Sch, Div Nephrol, Dept Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.	schiffer.mario@mh-hannover.de	Schiffer, Mario/U-7050-2019; Dikic, Ivan/O-4650-2015	Schiffer, Mario/0000-0002-8414-1470; Dikic, Ivan/0000-0001-8156-9511				Aissouni Y, 2005, BIOCHEM BIOPH RES CO, V338, P808, DOI 10.1016/j.bbrc.2005.10.032; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Foster RR, 2006, AM J PHYSIOL-RENAL, V291, pF196, DOI 10.1152/ajprenal.00431.2005; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Grunkemeyer JA, 2005, J BIOL CHEM, V280, P29677, DOI 10.1074/jbc.M504004200; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Peters I, 2006, J AM SOC NEPHROL, V17, P1644, DOI 10.1681/ASN.2005111209; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	29	33	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7457	7464		10.1074/jbc.M608519200	http://dx.doi.org/10.1074/jbc.M608519200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213204	hybrid			2022-12-27	WOS:000245080900058
J	Huang, WQ; Horvath, E; Eklund, EA				Huang, Weiqi; Horvath, Elizabeth; Eklund, Elizabeth A.			PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TARGETED DISRUPTION; TYPE-1 NEUROFIBROMATOSIS; GP91(PHOX) EXPRESSION; MYELOGENOUS LEUKEMIA; GENE; PROMOTER; PHOSPHORYLATION; MUTATIONS; GROWTH	Nfl (neurofibromin 1) is a Ras-GAP protein that regulates cytokine-induced proliferation of myeloid cells. In previous studies, we found that the interferon consensus sequence-binding protein (ICSBP; also referred to as interferon regulatory factor 8) activates transcription of the gene encoding Nfl (the NF1 gene) in differentiating myeloid cells. We also found that NF1 activation requires cytokine-stimulated phosphorylation of a conserved tyrosine residue in the interferon regulatory factor (IRF) domain of ICSBP/IRF8. In this study, we found that ICSBP/IRF8 cooperates with PU.1 and interferon regulatory factor 2 to activate a composite ets/IRF-cis element in the NF1 promoter. We found that PU.1 binds directly to the NF1-cis element, and DNA-bound PU.1 interacts with IRF2, recruiting IRF2 to the cis element. This interaction requires cytokine-induced phosphorylation of specific serine residues in the PUA PEST domain and of a conserved tyrosine residue in the IRF domain of IRF2. We found that ICSBP/IRF8 interaction with the NF1-cis element requires pre-binding of PUA and IRF2. The conserved IRF domain tyrosine in ICSBP/IRF8 is required for interaction with the DNA-bound PU.1-IRF2 heterodimer. NF1 deficiency in myeloid progenitor cells results in cytokine hypersensitivity and myeloproliferation. Therefore, these studies identify a target gene for the previously observed tumor-suppressor effect of PU.1. Additionally, these studies identify a tumor-suppressor function for the "oncogenic" transcription factor, IRF2.	Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, 710 N Fairbanks Ct,Olson 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Huang, Weiqi/E-4341-2010					Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Gross P, 1998, BIOCHEMISTRY-US, V37, P9802, DOI 10.1021/bi9731448; Guyot B, 2003, J LEUKOCYTE BIOL, V73, P263, DOI 10.1189/jlb.0502244; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Iida H, 2000, INT J HEMATOL, V71, P153; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; LARRICK JW, 1980, J IMMUNOL, V125, P6; Li SL, 1997, J BIOL CHEM, V272, P17802, DOI 10.1074/jbc.272.28.17802; Li SL, 2002, BLOOD, V99, P4578, DOI 10.1182/blood.V99.12.4578; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Lu D, 2003, CANCER-AM CANCER SOC, V97, P441, DOI 10.1002/cncr.11037; Luo W, 1996, J BIOL CHEM, V271, P23445, DOI 10.1074/jbc.271.38.23445; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Metcalf D, 2006, P NATL ACAD SCI USA, V103, P1486, DOI 10.1073/pnas.0510616103; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharf R, 1997, J BIOL CHEM, V272, P9785; Throm SL, 2003, J LEUKOCYTE BIOL, V74, P111, DOI 10.1189/jlb.0203061; Xi HK, 2003, MOL IMMUNOL, V39, P677, DOI 10.1016/S0161-5890(02)00214-6; Zhang YY, 1998, J EXP MED, V187, P1893, DOI 10.1084/jem.187.11.1893; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	47	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6629	6643		10.1074/jbc.M607760200	http://dx.doi.org/10.1074/jbc.M607760200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200120	hybrid			2022-12-27	WOS:000244867200072
J	Lu, H; Wu, JY; Beswick, EJ; Ohno, T; Odenbreit, S; Haas, R; Reyes, VE; Kita, M; Graham, DY; Yamaoka, Y				Lu, Hong; Wu, Jeng Yih; Beswick, Ellen J.; Ohno, Tomoyuki; Odenbreit, Stefan; Haas, Rainer; Reyes, Victor E.; Kita, Masakazu; Graham, David Y.; Yamaoka, Yoshio			Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; OUTER-MEMBRANE PROTEINS; CAG PATHOGENICITY ISLAND; HISTIDINE-DECARBOXYLASE PROMOTER; INFLAMMATION-ASSOCIATED CANCER; INTERLEUKIN-8 PRODUCTION; TYROSINE PHOSPHORYLATION; ACTIVATOR PROTEIN-1; EXPRESSION	Following adhesion of Helicobacterpylori to gastric epithelial cells, intracellular signaling leads to cytokine production, which causes H. pylori-related gastric injury. Two adjacent homologous genes (alpA and alpB), which encode H. pylori outer membrane proteins, are thought to be associated with adhesion and cytokine induction. We co-cultured gastric epithelial cells with wild type H. pylori strains and their corresponding alpA/alpB-deleted mutants (Delta alpAB). Results were confirmed by complementation. Flow cytometry confirmed that AlpAB was involved in cellular adhesion. Deletion of alpAB reduced interleukin (IL)-6 induction in gastric epithelial cells. Deletion of alpAB reduced IL-8 induction with East Asian but not with Western strains. All AlpAB-positive strains tested activated the extracellular signal-regulated kinase, c-Fos, and cAMP-responsive element-binding protein. Activation of the Jun-N-terminal kinase, c-Jun, and NF-kappa B was exclusive to AlpAB from East Asian strains. Delta alpAB mutants poorly colonized the stomachs of C57BL/6 mice and were associated with lower mucosal levels of KC and IL-6. Our results suggest that AlpAB may induce gastric injury by mediating adherence to gastric epithelial cells and by modulating proinflammatory intracellular signaling cascades. Known geographical differences in H. pylori-related clinical outcomes may relate to differential effects of East Asian and Western types of AlpAB on NF-kappa B-related proinflammatory signaling pathways.	Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; Michael E DeBakey Vet Affairs Med Ctr, Dept Med, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Dept Gastroenterol,Renji Hosp, Shanghai 200001, Peoples R China; Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung 807, Taiwan; Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; Kyoto Prefectural Univ Med, Dept Microbiol, Kyoto 6028566, Japan	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Shanghai Jiao Tong University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Munich; Kyoto Prefectural University of Medicine	Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med Gastroenterol, 2002 Holcombe Blvd, Houston, TX 77030 USA.	yyamaoka@bcm.tmc.edu	Wu, Jeng-Yih/D-4520-2009; Graham, David/AAL-2165-2021	Yamaoka, Yoshio/0000-0002-1222-5819	NIDDK NIH HHS [DK62813, R01 DK062813-03, DK50669, P30 DK056338, DK56338, R01 DK062813, R01 DK050669] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK050669, R01DK062813] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Beswick EJ, 2005, J IMMUNOL, V175, P171, DOI 10.4049/jimmunol.175.1.171; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Evans DJ, 2000, HELICOBACTER, V5, P183, DOI 10.1046/j.1523-5378.2000.00029.x; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Gan LM, 2000, FEBS LETT, V477, P89, DOI 10.1016/S0014-5793(00)01788-9; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Kudo T, 2005, INFECT IMMUN, V73, P7602, DOI 10.1128/IAi.73.11.7602-7612.2005; Kudo T, 2004, J CLIN MICROBIOL, V42, P2279, DOI 10.1128/JCM.42.5.2279-2281.2004; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; McDaniel TK, 2001, HELICOBACTER, V6, P15, DOI 10.1046/j.1523-5378.2001.00001.x; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Naumann M, 1999, J BIOL CHEM, V274, P31655, DOI 10.1074/jbc.274.44.31655; Odenbreit S, 2005, INT J MED MICROBIOL, V295, P317, DOI 10.1016/j.ijmm.2005.06.003; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P257, DOI 10.1078/1438-4221-00205; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P247, DOI 10.1078/1438-4221-00204; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Wessler S, 2002, FASEB J, V16, P417, DOI 10.1096/fj.01-0766fje; Wessler S, 2000, J BIOL CHEM, V275, P3629, DOI 10.1074/jbc.275.5.3629; Wu JY, 2006, CANCER RES, V66, P5111, DOI 10.1158/0008-5472.CAN-06-0383; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yamaoka Y, 2004, GASTROENTEROLOGY, V126, P1030, DOI 10.1053/j.gastro.2003.12.048; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074	41	54	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6242	6254		10.1074/jbc.M611178200	http://dx.doi.org/10.1074/jbc.M611178200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202133	Green Accepted, hybrid			2022-12-27	WOS:000244867200030
J	Ning, Y; Buranda, T; Hudson, LG				Ning, Yan; Buranda, Tione; Hudson, Laurie G.			Activated epidermal growth factor receptor induces integrin alpha 2 internalization via caveolae/raft-dependent endocytic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN EPITHELIAL CARCINOMA; EGF-RECEPTOR; SURFACE EXPRESSION; MESOTHELIAL CELLS; PLASMA-MEMBRANE; ADHESION; MIGRATION; KINASE; COLLAGEN; TYROSINE	Elevated expression or activity of the epidermal growth factor (EGF) receptor is common in ovarian cancer and is associated with poor patient prognosis. Our previous studies demonstrated that expression of the constitutively active mutant form of the EGF receptor (EGFRvIII) in ovarian cancer cells led to reduction in integrin alpha 2 surface expression, defects in cell spreading, and disruption of focal adhesions. Inhibition of EGFRvIII catalytic activity reversed the response, suggesting that EGF receptor activation regulates integrin alpha 2. In this study we found that EGF treatment resulted in a transient loss of integrin alpha 2 from the cell surface. Before EGF stimulation, integrin alpha 2 and EGF receptors were associated based on biochemical and immuno-colocalization approaches. After EGF treatment, EGF receptor and integrin alpha 2 were internalized and segregated into different compartments. Integrin alpha 2, but not EGF receptor, was associated with caveolin-1 and GM1 (Gal_1,3GaINAc_1,4(Neu5Ac-_ 2,3)Gal_1,4GIc_1,1-ceramide) gangliosides, suggesting caveolae-mediated endocytosis. Moreover, integrin alpha 2 was subsequently targeted to the Golgi apparatus and the endoplasmic reticulum. Together, these findings demonstrate that activated EGF receptor transiently modulates integrin alpha 2 cell surface expression and stimulates integrin alpha 2 trafficking via caveolae/ raft-mediated endocytosis, representing a novel mechanism by which the EGF receptor may regulate integrin-mediated cell behavior.	Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Hudson, LG (corresponding author), Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA.	lhudson@salud.unm.edu			NATIONAL CANCER INSTITUTE [R01CA090492, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI060036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES012072] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA118100, R01 CA90492] Funding Source: Medline; NIAID NIH HHS [K25 AI060036, K25 AI 60036] Funding Source: Medline; NIEHS NIH HHS [P30 ES-012072] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Auersperg N, 2003, GYNECOL ONCOL, V88, pS47, DOI 10.1006/gyno.2002.6683; Berryman S, 2005, J VIROL, V79, P8519, DOI 10.1128/JVI.79.13.8519-8534.2005; Burns AR, 2005, BIOPHYS J, V89, P1081, DOI 10.1529/biophysj.105.060327; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; CHEN JD, 1993, EXP CELL RES, V209, P216, DOI 10.1006/excr.1993.1304; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fishman DA, 1998, INVAS METAST, V18, P15, DOI 10.1159/000024495; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; GARDNER MJ, 1995, CANCER LETT, V91, P229, DOI 10.1016/0304-3835(95)03743-G; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARVEY W, 1983, J PATHOL, V139, P337, DOI 10.1002/path.1711390309; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Imelli N, 2004, J VIROL, V78, P3089, DOI 10.1128/JVI.78.6.3089-3098.2004; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Krensel K, 1999, INT J CANCER, V80, P546, DOI 10.1002/(SICI)1097-0215(19990209)80:4<546::AID-IJC11>3.0.CO;2-9; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; Maihle N J, 2002, Cancer Treat Res, V107, P247; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Moser TL, 1996, INT J CANCER, V67, P695, DOI 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.3.CO;2-2; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; NIEDBALA MJ, 1987, CLIN EXP METASTAS, V5, P181, DOI 10.1007/BF00058063; Ning Y, 2005, CANCER RES, V65, P9280, DOI 10.1158/0008-5472.CAN-05-0407; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Pang H, 2004, J CELL SCI, V117, P1421, DOI 10.1242/jcs.01009; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rezgui SS, 2000, INT J CANCER, V87, P360, DOI 10.1002/1097-0215(20000801)87:3<360::AID-IJC8>3.0.CO;2-9; Ringerike T, 2002, J CELL SCI, V115, P1331; SAWADA M, 1994, LAB INVEST, V70, P333; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Skubitz Amy P N, 2002, Cancer Treat Res, V107, P305; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SPIEGEL S, 1984, J CELL BIOL, V99, P1575, DOI 10.1083/jcb.99.5.1575; Stang E, 2000, J BIOL CHEM, V275, P13940, DOI 10.1074/jbc.275.18.13940; Strobel T, 1997, CANCER RES, V57, P1228; Thyberg J, 2000, LAB INVEST, V80, P915, DOI 10.1038/labinvest.3780095; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wong Alice S T, 2003, Reprod Biol Endocrinol, V1, P70, DOI 10.1186/1477-7827-1-70; Yu X, 2000, J CELL SCI, V113, P2139; ZHU GG, 1993, CANCER RES, V53, P5028	61	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6380	6387		10.1074/jbc.M610915200	http://dx.doi.org/10.1074/jbc.M610915200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17179151	hybrid			2022-12-27	WOS:000244867200045
J	Bayas, MV; Kearney, A; Avramovic, A; van der Merwe, PA; Leckband, DE				Bayas, Marco V.; Kearney, Alice; Avramovic, Adam; van der Merwe, P. Anton; Leckband, Deborah E.			Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT FORCE MEASUREMENTS; LOW-AFFINITY; PROTEIN INTERACTIONS; ANTIGEN RECOGNITION; CRYSTAL-STRUCTURE; CELL RECOGNITION; MOLECULE CD2; SURFACE; RECEPTOR; COMPLEX	This study describes quantitative investigations of the impact of single charge mutations on equilibrium binding, kinetics, and the adhesion strength of the CD2-CD58 interaction. Previously steered molecular dynamics simulations guided the selection of the charge mutants investigated, which include the CD2 mutants D31A, K41A, K51A, and K91A. This set includes mutations in which the previous cell aggregation and binding data either agreed or disagreed with the steered molecular dynamics predictions. Surface plasmon resonance measurements quantified the solution binding properties. Adhesion was quantified with the surface force apparatus, which was used previously to study the closely related CD2-CD48 interaction. The results reveal roles that these salt bridges play in equilibrium binding and adhesion. We discuss both the molecular basis of this behavior and its implications for cell adhesion.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Oxford; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	anton.vandermerwe@pathology.oxford.ac.uk; leckband@uiuc.edu			MRC [G9722488] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051338] Funding Source: NIH RePORTER; Medical Research Council [G19/31, G9722488] Funding Source: Medline; NIGMS NIH HHS [R01 GM51338] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARULANANDAM ARN, 1993, P NATL ACAD SCI USA, V90, P11613, DOI 10.1073/pnas.90.24.11613; ARULANANDAM ARN, 1994, J EXP MED, V180, P1861, DOI 10.1084/jem.180.5.1861; Bayas MV, 2003, BIOPHYS J, V84, P2223, DOI 10.1016/S0006-3495(03)75028-0; BEBBINGTON C R, 1991, Methods (Orlando), V2, P136, DOI 10.1016/S1046-2023(05)80214-2; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Evans E, 1998, FARADAY DISCUSS, V111, P1; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Ikemizu S, 1999, P NATL ACAD SCI USA, V96, P4289, DOI 10.1073/pnas.96.8.4289; ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; Israelachvilli J.N., 1992, INTERMOLECULAR SURFA, P312; KARLSSON R, 1995, ANAL BIOCHEM, V228, P274, DOI 10.1006/abio.1995.1350; Kim M, 2001, J MOL BIOL, V312, P711, DOI 10.1006/jmbi.2001.4980; KOYASU S, 1990, P NATL ACAD SCI USA, V87, P2603, DOI 10.1073/pnas.87.7.2603; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135, DOI 10.1515/zna-1968-1247; Lavrik N, 2000, LANGMUIR, V16, P1842, DOI 10.1021/la9904612; LECKBAND DE, 1994, BIOCHEMISTRY-US, V33, P4611, DOI 10.1021/bi00181a023; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Li F, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372493; Martel L, 2002, J PHYS IV, V12, P365, DOI 10.1051/jp4:20020245; MOIGNEON P, 1989, NATURE, V339, P312; Socci ND, 1999, P NATL ACAD SCI USA, V96, P2031, DOI 10.1073/pnas.96.5.2031; TINOCO I, 2002, PHYS CHEM PRINCIPLES, P33; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; YOO SH, 1995, BIOCHEMISTRY-US, V34, P632, DOI 10.1021/bi00002a030; Zhu BR, 2002, BIOCHEMISTRY-US, V41, P12163, DOI 10.1021/bi020296g	34	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5589	5596		10.1074/jbc.M607968200	http://dx.doi.org/10.1074/jbc.M607968200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17172599	hybrid			2022-12-27	WOS:000244482300055
J	Griffin, MJ; Wong, RHF; Pandya, N; Sul, HS				Griffin, Michael J.; Wong, Roger H. F.; Pandya, Niyati; Sul, Hei Sook			Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; HELIX-LOOP-HELIX; TANDEM AFFINITY PURIFICATION; ATP-CITRATE-LYASE; LIPOPROTEIN RECEPTOR GENE; ACETYL-COA CARBOXYLASE; UPSTREAM STIMULATORY FACTORS; NUCLEAR FACTOR-Y; BINDING PROTEIN; TRANSCRIPTION FACTOR	To understand the molecular mechanisms underlying transcriptional activation of fatty-acid synthase (FAS), we examined the relationship between upstream stimulatory factor (USF) and SREBP-1c, two transcription factors that we have shown previously to be critical for FAS induction by feeding/insulin. Here, by using a combination of tandem affinity purification and coinummoprecipitation, we demonstrate, for the first time, that USF and SREBP-1 interact in vitro and in vivo. Glutathione S-transferase pulldown experiments with various USF and sterol regulatory element-binding protein (SREBP) deletion constructs indicate that the basic helix-loop-helix domain of USF interacts directly with the basic helix-loop-helix and an N-terminal region of SREBP-1c. Furthermore, cotransfection of USF and SREBP-1c with an FAS promoter-luciferase reporter construct in Drosophila SL2 cells results in highly synergistic activation of the FAS promoter. We also show similar cooperative activation of the mitochondrial glycerol-3-phosphate acyltransferase promoter by USF and SREBP-1c. Chromatin immunoprecipitation analysis of mouse liver demonstrates that USF binds constitutively to the mitochondrial glycerol 3-phosphate acyltransferase promoter during fasting/refeeding in vivo, whereas binding of SREBP-1 is observed only during refeeding, in a manner identical to that of the FAS promoter. In addition, we show that the synergy we have observed depends on the activation domains of both proteins and that mutated USF or SREBP lacking the N-terminal activation domain could inhibit the transactivation of the other. Closely positioned E-boxes and sterol regulatory elements found in the promoters of several lipogenic genes suggest a common mechanism of induction by feeding/insulin.	Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, 219 Morgan Hall, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Wong, Hoi Fung Roger/F-2044-2013; Han, Zaiqi/AAI-2233-2019	Griffin, Michael/0000-0003-4252-2803	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036264] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK36264] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; Barber MC, 2003, BIOCHEM J, V375, P489, DOI 10.1042/BJ20030480; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Drakas R, 2005, PROTEOMICS, V5, P132, DOI 10.1002/pmic.200400919; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Gibson D M, 1972, Adv Enzyme Regul, V10, P187, DOI 10.1016/0065-2571(72)90014-3; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Guan GM, 1998, J BIOL CHEM, V273, P12526, DOI 10.1074/jbc.273.20.12526; Guan GM, 1997, J BIOL CHEM, V272, P10295; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; HOFFER MJV, 1993, BIOCHEM BIOPH RES CO, V191, P880, DOI 10.1006/bbrc.1993.1299; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Ikeda Y, 2001, J BIOL CHEM, V276, P34259, DOI 10.1074/jbc.M103848200; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.38.22135; Kardassis D, 2002, BIOCHEMISTRY-US, V41, P1217, DOI 10.1021/bi015618f; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KIM KS, 1994, BIOCHEM J, V302, P759, DOI 10.1042/bj3020759; KIRSCHBAUM BJ, 1992, MOL CELL BIOL, V12, P5094, DOI 10.1128/MCB.12.11.5094; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; LAKSHMAN.MR, 1972, P NATL ACAD SCI USA, V69, P3516, DOI 10.1073/pnas.69.12.3516; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Makaula S, 2006, ARCH BIOCHEM BIOPHYS, V446, P91, DOI 10.1016/j.abb.2005.10.025; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MISRA S, 1994, BIOCHEM J, V298, P575, DOI 10.1042/bj2980575; Moon YA, 2000, J BIOL CHEM, V275, P30280, DOI 10.1074/jbc.M001066200; Moon YS, 2000, J BIOL CHEM, V275, P10121, DOI 10.1074/jbc.275.14.10121; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V162, P340, DOI 10.1016/0003-9861(74)90191-X; Oh SY, 2003, J BIOL CHEM, V278, P28410, DOI 10.1074/jbc.M300553200; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; Roder K, 2002, J BIOL CHEM, V277, P30543, DOI 10.1074/jbc.M111891200; Rosenfeld JM, 1998, J BIOL CHEM, V273, P16112, DOI 10.1074/jbc.273.26.16112; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sirito Mario, 1992, Gene Expression, V2, P231; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; SUL HS, 1984, J BIOL CHEM, V259, P1201; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; SUL HS, 1984, J BIOL CHEM, V259, P555; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; VOLPE JJ, 1974, P NATL ACAD SCI USA, V71, P889, DOI 10.1073/pnas.71.3.889; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	75	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5453	5467		10.1074/jbc.M610566200	http://dx.doi.org/10.1074/jbc.M610566200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17197698	hybrid			2022-12-27	WOS:000244482300040
J	Lee, YH; Tamura, K; Maeda, M; Hoshino, M; Sakurai, K; Takahashi, S; Ikegami, T; Hase, T; Goto, Y				Lee, Young-Ho; Tamura, Kosuke; Maeda, Masahiro; Hoshino, Masaru; Sakurai, Kazumasa; Takahashi, Satoshi; Ikegami, Takahisa; Hase, Toshiharu; Goto, Yuji			Cores and pH-dependent dynamics of ferredoxin-NADP(+) reductase revealed by hydrogen/deuterium exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMIDE PROTON-EXCHANGE; HYDROGEN-EXCHANGE; PROTEIN DYNAMICS; NADP+ REDUCTASE; BINDING; STABILITY; IDENTIFICATION; DENATURATION; EVOLUTION; DOMAINS	NMR-detected hydrogen/deuterium (H/D) exchange of amide protons is a powerful way for investigating the residue-based conformational stability and dynamics of proteins in solution. Maize ferredoxin-NADP(+) reductase (FNR) is a relatively large protein with 314 amino acid residues, consisting of flavin adenine dinucleotide (FAD) and nicotinamide adenine dinucleotide phosphate (NADP(+))-binding domains. To address the structural stability and dynamics of FNR, H/D exchange of amide protons was performed using heteronuclear NMR at pD, values 8.0 and 6.0, physiologically relevant conditions mimicking inside of chloroplasts. At both pD, values, the exchange rate varied widely depending on the residues. The profiles of protected residues revealed that the highly protected regions matched well with the hydrophobic cores suggested from the crystal structure, and that the NADP(+)-binding domain can be divided into two subdomains. The global stability of FNR obtained by H/D exchange with NMR was higher than that by chemical denaturation, indicating that H/D exchange is especially useful for analyzing the residue-based conformational stability of large proteins, for which global unfolding is mostly irreversible. Interestingly, more dynamic conformation of the C-terminal subdomain of the NADP(+)-binding domain at pD, 8.0, the daytime pH in chloroplasts, than at pD, 6.0 is likely to be involved in the increased binding of NADP(+) for elevating the activity of FNR. In light of photosynthesis, the present study provides the first structure-based relationship of dynamics with function for the FNR-type family in solution.	Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Takahashi, Satoshi/AAC-5532-2019; Ikegami, Takahisa/I-9626-2017; Hase, Toshiharu/H-9271-2013	Takahashi, Satoshi/0000-0003-1506-9222; Ikegami, Takahisa/0000-0002-1429-1844; Tamura, Kousuke/0000-0002-3835-5507				Aliverti A, 2004, BBA-PROTEINS PROTEOM, V1696, P93, DOI 10.1016/j.bbapap.2003.09.011; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; CARRILLO N, 1981, J BIOL CHEM, V256, P6823; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; CARRILLO N, 1981, J BIOL CHEM, V256, P1058; Cioni P, 2002, BIOPHYS J, V82, P3246, DOI 10.1016/S0006-3495(02)75666-X; CLAKE J, 1998, CURR OPIN STRUC BIOL, V8, P112; CLARKE J, 1993, P NATL ACAD SCI USA, V90, P9837, DOI 10.1073/pnas.90.21.9837; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Freund C, 1996, BIOCHEMISTRY-US, V35, P8457, DOI 10.1021/bi952764a; GADDA G, 1990, J BIOL CHEM, V265, P11955; Gozu M, 2002, PROTEIN SCI, V11, P2792, DOI 10.1110/ps.0216602; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; JANDU SK, 1990, BIOCHEMISTRY-US, V29, P6264, DOI 10.1021/bi00478a022; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Karplus PA, 2004, PHOTOSYNTH RES, V81, P303, DOI 10.1023/B:PRES.0000036884.57303.2e; Katou H, 2001, J MOL BIOL, V310, P471, DOI 10.1006/jmbi.2001.4777; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; LOH SN, 1993, BIOCHEMISTRY-US, V32, P11022, DOI 10.1021/bi00092a011; LU JR, 1992, BIOCHEMISTRY-US, V31, P4749, DOI 10.1021/bi00135a002; Maeda M, 2005, BIOCHEMISTRY-US, V44, P10644, DOI 10.1021/bi050424b; Maeda M, 2002, J BIOL CHEM, V277, P17101, DOI 10.1074/jbc.M112002200; MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609; Milne JS, 1999, J MOL BIOL, V290, P811, DOI 10.1006/jmbi.1999.2924; Pace C N, 1986, Methods Enzymol, V131, P266; Polshakov VI, 2006, J MOL BIOL, V356, P886, DOI 10.1016/j.jmb.2005.11.084; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SHORTLE D, 1989, ARCH BIOCHEM BIOPHYS, V272, P103, DOI 10.1016/0003-9861(89)90200-2; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; SWINDELLS MB, 1995, PROTEIN SCI, V4, P103; SwintKruse L, 1996, BIOCHEMISTRY-US, V35, P171, DOI 10.1021/bi9517603; Whitten ST, 2005, P NATL ACAD SCI USA, V102, P4282, DOI 10.1073/pnas.0407499102; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; ZEHFUS MH, 1995, PROTEIN SCI, V4, P1188, DOI 10.1002/pro.5560040617; Zehfus MH, 1997, PROTEIN SCI, V6, P1210, DOI 10.1002/pro.5560060609	46	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5959	5967		10.1074/jbc.M608417200	http://dx.doi.org/10.1074/jbc.M608417200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192259	Green Published, hybrid			2022-12-27	WOS:000244482300091
J	Quintavalle, M; Sambucini, S; Summa, V; Orsatti, L; Talamo, F; De Francesco, R; Neddermann, P				Quintavalle, Manuela; Sambucini, Sonia; Summa, Vincenzo; Orsatti, Laura; Talamo, Fabio; De Francesco, Raffaele; Neddermann, Petra			Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5A; RNA REPLICATION; PHOSPHORYLATION; CULTURE; CELLS; DETERMINANTS; POLYPROTEIN; REPLICON; COMPLEX; GENOME	The hepatitis C virus encodes a single polyprotein that is processed by host and viral proteases to yield at least 10 mature viral proteins. The nonstructural (NS) protein 5A is a phosphoprotein, and experimental data indicate that the phosphorylation state of NS5A is important for the outcome of viral RNA replication. We were able to identify kinase inhibitors that specifically inhibit the formation of the hyperphosphorylated form of NS5A I in cells. These kinase inhibitors were used for inhibitor affinity chromatography in order to identify the cellular targets of these compounds. The kinases casein kinase II (CKI) p38 MAPK, CIT (Citron Rho-interacting kinase), GAK, JNK2, PKA, RSK 1/2, and RIPK2 were identified in the high affinity binding fractions of two NS5A hyperphosphorylation inhibitors I p58-i). Even though these kinases are targets of the NS5A-p58-i, the only kinase showing an effect on NS5A hyperphosphorylation was confirmed to be CKI-alpha. Although this finding does not exclude the possibility that other kinase(s) might be involved in basal or regulatory phosphorylation of NS5A, we show here that NS5A is a direct substrate of CKI-alpha. Moreover, in vitro phosphorylation of NS5A by CKI-alpha resulted for the first time in the production of basal and hyperphosphorylated forms resembling those produced in cells. In vitro kinase reactions performed with NS5A peptides show that Ser-2204 is a preferred substrate residue for CKI-alpha after pre-phosphorylation of Ser-2201.	Ist Ric Biol Mol P Angeletti, I-00040 Rome, Italy	Merck & Company	Neddermann, P (corresponding author), Ist Ric Biol Mol P Angeletti, Via Pontina Km 30-6, I-00040 Rome, Italy.	Petra_Neddermann@merck.com	De Francesco, Raffaele/J-6003-2012; Summa, Vincenzo/AHE-9025-2022	De Francesco, Raffaele/0000-0001-8754-5123; Summa, Vincenzo/0000-0002-6288-2681				Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Asabe SI, 1997, J VIROL, V71, P790, DOI 10.1128/JVI.71.1.790-796.1997; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004; DEFRANCESCO R, 2006, Patent No. 2006021449; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Graziani R, 2004, J GEN VIROL, V85, P1867, DOI 10.1099/vir.0.80006-0; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; Hidajat Rachmat, 2004, Kobe Journal of Medical Sciences, V50, P153; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Ide Y, 1997, GENE, V201, P151, DOI 10.1016/S0378-1119(97)00440-X; Kalamvoki M, 2006, J BIOL CHEM, V281, P13449, DOI 10.1074/jbc.M601124200; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kim J, 1999, BIOCHEM BIOPH RES CO, V257, P777, DOI 10.1006/bbrc.1999.0460; Koch JO, 1999, J VIROL, V73, P7138; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Trozzi C, 2003, J VIROL, V77, P3669, DOI 10.1128/JVI.77.6.3669-3679.2003; Wissing J, 2004, MOL CELL PROTEOMICS, V3, P1181, DOI 10.1074/mcp.M400124-MCP200	36	73	76	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5536	5544		10.1074/jbc.M610486200	http://dx.doi.org/10.1074/jbc.M610486200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17166835	hybrid, Green Published			2022-12-27	WOS:000244482300049
J	Yun, HM; Kim, S; Kim, HJ; Kostenis, E; Kim, JI; Seong, JY; Baik, JH; Rhim, H				Yun, Hyung-Mun; Kim, Sunoh; Kim, Hyun-Ji; Kostenis, Evi; Kim, Jae Il; Seong, Jae Young; Baik, Ja-Hyun; Rhim, Hyewhon			The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM FACILITATION; TYROSINE KINASE; MAP KINASE; RAT-BRAIN; SEROTONIN RECEPTOR; ALZHEIMERS-DISEASE; MOLECULAR-CLONING; MESSENGER-RNA; WATER MAZE; CAMP	The human 5-HT6 receptor (5-HT6R) is one of the latest cloned receptors among the known 5-HT receptors. Its abundant distribution in the limbic region, which participates in the control of mood and emotion and is involved in nervous system diseases such as depression and Alzheimer disease, has caused it to generate much interest. However, the cellular mechanisms of 5-HT6R are poorly understood. In the present study we found, using a yeast two-hybrid assay, that the carboxyl-terminal region of 5-HT6R interacts with the Fyn-tyrosine kinase. We also determined using a glutathione S-transferase pulldown assay that this interaction was mediated through the SH3 domain of Fyn and confirmed this by co-immunoprecipitation assays in two different transfected cell lines as well as in adult rat brains. Immunocyto(histo)chemistry also showed prominent co-localization between 5-HT6R and Fyn in transfected cells and a similar distribution between 5-HT6R and Fyn in the rat brain. Based on this interaction, we further examined the modulation of 5-HT6R by Fyn and vice versa. In addition, we demonstrated that the activation of 5-HT6R activated the extracellular signal-regulated kinase 1/2 via an Fyn-dependent pathway. These findings suggest that Fyn may play an important role in 5-HT(6)Rmediated signaling pathways in the central nervous system.	Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Inst Pharmaceut Biol, D-53115 Bonn, Germany; Korea Univ, Coll Med, Grad Sch Med, Seoul 136705, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Korea University; Korea University Medicine (KU Medicine)	Rhim, H (corresponding author), Korea Inst Sci & Technol, Biomed Res Ctr, 39-1 Hawholgok Dong, Seoul 136791, South Korea.	hrhim@kist.re.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924				BARE DJ, 1993, ONCOGENE, V8, P1429; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Boess FG, 1997, NEUROPHARMACOLOGY, V36, P713, DOI 10.1016/S0028-3908(97)00019-1; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Fernandez-Ballester G, 2004, J MOL BIOL, V335, P619, DOI 10.1016/j.jmb.2003.10.060; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grimaldi B, 1998, N-S ARCH PHARMACOL, V357, P393, DOI 10.1007/PL00005184; HOYER D, 1994, PHARMACOL REV, V46, P157; Kinsey AM, 2001, MOL BRAIN RES, V88, P194, DOI 10.1016/S0169-328X(01)00034-1; Klinger M, 2002, J BIOL CHEM, V277, P32490, DOI 10.1074/jbc.M200556200; Kohen R, 1996, J NEUROCHEM, V66, P47; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lorke DE, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-36; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Ma YC, 2002, CELL MOL LIFE SCI, V59, P456, DOI 10.1007/s00018-002-8438-2; MARTIN GR, 1994, PHARMACOL THERAPEUT, V62, P283, DOI 10.1016/0163-7258(94)90048-5; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Mitchell ES, 2005, PHARMACOL THERAPEUT, V108, P320, DOI 10.1016/j.pharmthera.2005.05.001; MIYAKAWA T, 1994, MOL BRAIN RES, V27, P179, DOI 10.1016/0169-328X(94)90201-1; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Norum JH, 2003, J BIOL CHEM, V278, P3098, DOI 10.1074/jbc.M206237200; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rogers DC, 2001, PSYCHOPHARMACOLOGY, V158, P114; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; RUAT M, 1993, P NATL ACAD SCI USA, V90, P8547, DOI 10.1073/pnas.90.18.8547; RUAT M, 1993, BIOCHEM BIOPH RES CO, V193, P268, DOI 10.1006/bbrc.1993.1619; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SHEN Y, 1993, J BIOL CHEM, V268, P18200; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tomidokoro Y, 2001, NEUROSCI LETT, V299, P169, DOI 10.1016/S0304-3940(00)01767-5; Tsai SJ, 1999, NEUROSCI LETT, V276, P138, DOI 10.1016/S0304-3940(99)00802-2; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WARD RP, 1995, NEUROSCIENCE, V64, P1105, DOI 10.1016/0306-4522(94)00439-C; Woolley ML, 2004, CNS NEUROL DISORD-DR, V3, P59, DOI 10.2174/1568007043482561; Woolley ML, 2001, NEUROPHARMACOLOGY, V41, P210, DOI 10.1016/S0028-3908(01)00056-9; Yau JLW, 1997, MOL BRAIN RES, V45, P182, DOI 10.1016/S0169-328X(97)00026-0; Yoshioka M, 1998, LIFE SCI, V62, P1473, DOI 10.1016/S0024-3205(98)00092-7; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	47	115	116	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5496	5505		10.1074/jbc.M606215200	http://dx.doi.org/10.1074/jbc.M606215200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189269	hybrid			2022-12-27	WOS:000244482300044
J	Barbolina, MV; Adley, BP; Ariztia, EV; Liu, YY; Stack, MS				Barbolina, Maria V.; Adley, Brian P.; Ariztia, Edgardo V.; Liu, Yueying; Stack, M. Sharon			Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC TYROSINE KINASE; EXTRACELLULAR-MATRIX; MESSENGER-RNA; I COLLAGEN; TRANSCRIPTION FACTORS; EPITHELIAL CARCINOMA; SEGREGATION ANALYSIS; ENDOTHELIAL-CELLS; MESOTHELIAL CELLS; BREAST-CANCER	Late stage ovarian cancer is characterized by disseminated intraperitoneal metastasis as secondary lesions anchor in the type I and III collagen-rich submesothelial matrix. Ovarian carcinoma cells preferentially adhere to interstitial collagen, and collagen-induced integrin clustering up-regulates the expression of the transmembrane collagenase membrane type 1 matrix metalloproteinase (MT1-MMP). Collagenolytic activity is important in intraperitoneal metastasis, potentiating invasion through the mesothelial cell layer and colonization of the submesothelial collagen-rich matrix. The objective of this study was to elucidate a potential mechanistic link between collagen adhesion and MT1-MMP expression. Our results indicate that culturing cells on three-dimensional collagen gels, but not thin layer collagen or synthetic three-dimensional hydrogels, results in rapid induction of the transcription factor EGR1. Integrin signaling through a SRC kinase-dependent pathway is necessary for EGR1 induction. Silencing of EGR1 expression using small interfering RNA abrogated collagen-induced MT1-MMP expression and inhibited cellular invasion of three-dimensional collagen gels. These data support a model for intraperitoneal metastasis wherein collagen adhesion and clustering of collagen binding integrins activates integrin-mediated signaling via SRC kinases to induce expression of EGR1, resulting in transcriptional activation of the MT1-MMP promoter and subsequent MT1-MMP-catalyzed collagen invasion. This model highlights the role of unique interactions between ovarian carcinoma cells and interstitial collagens in the ovarian tumor microenvironment in inducing gene expression changes that potentiate intraperitoneal metastatic progression.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center	Stack, MS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	stackm@missouri.edu			NATIONAL CANCER INSTITUTE [R01CA109545, R01CA086984] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA086984-10, R01 CA109545-03, R01 CA109545-02, R01 CA086984-09, R01CA86984, R01 CA109545, R01 CA086984, R01 CA086984-07, R01 CA086984-06, R01 CA109545-04, R01 CA086984-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; AUERSPERG N, 1995, OVARIAN CANC, V3, P157; Auranen A, 1998, BRIT J CANCER, V77, P1537, DOI 10.1038/bjc.1998.252; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CANNISTRA SA, 1995, GYNECOL ONCOL, V58, P216, DOI 10.1006/gyno.1995.1214; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Davidson B, 2001, AM J CLIN PATHOL, V115, P517; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Fishman DA, 1998, INVAS METAST, V18, P15, DOI 10.1159/000024495; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Ghosh Supurna, 2002, Cancer Treat Res, V107, P331; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Haas TL, 1999, J BIOL CHEM, V274, P22679, DOI 10.1074/jbc.274.32.22679; HARVEY W, 1983, J PATHOL, V139, P337, DOI 10.1002/path.1711390309; HOSKINS WJ, 1995, J CELL BIOCH S, V23, P189; HOULSTON RS, 1991, ANN HUM GENET, V55, P291, DOI 10.1111/j.1469-1809.1991.tb00856.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAZURENKO NN, 1992, EUR J CANCER, V28A, P372, DOI 10.1016/S0959-8049(05)80056-5; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser TL, 1996, INT J CANCER, V67, P695, DOI 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.3.CO;2-2; MOSER TL, 1994, INT J CANCER, V56, P552, DOI 10.1002/ijc.2910560415; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; NAROD SA, 1995, AM J HUM GENET, V56, P254; NIEDBALA MJ, 1987, CLIN EXP METASTAS, V5, P181, DOI 10.1007/BF00058063; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; PATWARDHAN S, 1991, ONCOGENE, V6, P917; Pengetnze Y, 2003, BIOCHEM BIOPH RES CO, V309, P377, DOI 10.1016/j.bbrc.2003.08.012; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; QURESHI SA, 1991, J BIOL CHEM, V266, P10802; QURESHI SA, 1991, J BIOL CHEM, V266, P20594; QURESHI SA, 1992, ONCOGENE, V7, P121; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; Sakata K, 2000, INT J ONCOL, V17, P673; SAWADA M, 1994, LAB INVEST, V70, P333; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; STACK MS, 2002, OVARIAN CANC CANC TR, P99; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Yamaguchi S, 2002, LAB INVEST, V82, P949, DOI 10.1097/01.LAB.0000020408.77307.E9; ZHU GG, 1993, CANCER RES, V53, P5028; Zipfel PF, 1997, BBA-GENE STRUCT EXPR, V1354, P134, DOI 10.1016/S0167-4781(97)00084-5	68	72	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4924	4931		10.1074/jbc.M608428200	http://dx.doi.org/10.1074/jbc.M608428200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17158885	hybrid			2022-12-27	WOS:000244482000075
J	Ye, ZY; Gan, YH				Ye, Zhiyong; Gan, Yunn-Hwen			Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; BACTERIAL FLAGELLIN; MURINE MACROPHAGES; IMMUNE-SYSTEM; IN-VIVO; STIMULATION; ACTIVATION; ADJUVANT	Heat shock proteins (Hsp) 60 and 70 have been intensively studied for their ability to activate innate immunity. Heat shock proteins had been shown to induce the activation of dendritic cells, T cells, and B cells. However, the possible contamination of endotoxin in heat shock protein preparations makes their function as an activator of immune system ambiguous. Here, we examined the ability of bacterial Hsp60 and Hsp70 to activate Jurkat T cells and primary T cells. We found that Burkholderia pseudomallei Hsp70 and Mycobacterium tuberculosis Hsp70 could costimulate Jurkat T cells to make IL-2 and signal through TLR5. This costimulatory activity is not due to endotoxin or contaminants signaling via TLR2 nor TLR4. However, recombinant Hsp70 expressed in Escherichia coli Delta fliC strain completely lost its ability to costimulate T cells. Thus, the activation of T cells by recombinant Hsp70 is ascribed to flagellin contamination.	Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Natl Univ Singapore, Program Immunol, Yong Loo Lin Sch Med, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Gan, YH (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Block MD7,05-10,8 Med Dr, Singapore 117597, Singapore.	bchganyh@nus.edu.sg	Gan, Yunn-Hwen/AAH-8515-2021					Bates D, 2005, MOL MICROBIOL, V57, P380, DOI 10.1111/j.1365-2958.2005.04693.x; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen K, 2004, J LEUKOCYTE BIOL, V75, P260, DOI 10.1189/jlb.0703341; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gobert AP, 2004, J BIOL CHEM, V279, P245, DOI 10.1074/jbc.M307858200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Harmala LAE, 2002, J IMMUNOL, V169, P5622, DOI 10.4049/jimmunol.169.10.5622; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	30	62	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4479	4484		10.1074/jbc.M606802200	http://dx.doi.org/10.1074/jbc.M606802200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178717	hybrid			2022-12-27	WOS:000244482000029
J	Cascio, S; Bartella, V; Garofalo, C; Russo, A; Giordano, A; Surmacz, E				Cascio, Sandra; Bartella, Viviana; Garofalo, Cecilia; Russo, Antonio; Giordano, Antonio; Surmacz, Eva			Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; ACTIVATOR PROTEIN-1 ACTIVITY; STEROID-HORMONE RECEPTORS; ALPHA GENE-EXPRESSION; CYCLIN D1; C-JUN; IGF-I; MEDIATED TRANSCRIPTION; SIGNALING PATHWAYS; ER-ALPHA	Cross-talk between insulin-like growth factor 1 (IGF-1) and estrogen receptor a (ER) regulates gene expression in breast cancer cells, but the underlying mechanisms remain unclear. Here, we studied how 17-beta-estradiol (E2) and IGF-1 affect ER transcriptional machinery in MCF-7 cells. E2 treatment stimulated ER loading on the estrogen response element (ERE) in the pS2 promoter and on the AP-1 motif in the cyclin D1 promoter. On ERE, similar amounts of liganded ER were found at 1-24-h time points, whereas on AP-1, ER binding fluctuated over time. At I h, liganded ER was recruited to ERE together with histone acetyltransferases SRC-1 and p300, ubiquitin ligase E6-AP, histone methyltransferase Carm1 (Carm), and polymerase (pol) II. This coincided with increased histone H3 acetylation and upregulation of pS2 mRNA levels. At the same time, E2 moderately increased cyclin D1 expression, which was associated with the recruitment of liganded ER, SRC-I, p300, ubiquitin ligase E6-AP (E6L), Mdm2, and pol II, but not other regulatory proteins, to AP-1. In contrast, at 1 h, IGF-1 increased the recruitment of the (ERSRC)-S-.-1(.)p300(.)E6L(.)Mdm2(.)Carm(.)pol II complex on AP-1, but not on ERE, and induced cyclin D1, but not pS2, mRNA expression. Notably, ER knockdown reduced the association of ER, E6L, Mdm2, Carm, and pol II with AP-1 and resulted in down-regulation of cyclin D1 expression. IGF-1 potentiated the effects of E2 on ERE but not to AP-1 and increased E2-dependent pS2, but not cyclin D1, mRNA expression. In conclusion, E2 and IGF-1 differentially regulate ER transcription at ERE and AP-1 sites.	Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; Univ Palermo, Dept Oncol, I-90047 Palermo, Italy; Univ Calabria, Dept Pharmacobiol, I-87036 Cosenza, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Palermo; University of Calabria	Surmacz, E (corresponding author), Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, 1900 N 12th St,Rm 446, Philadelphia, PA 19122 USA.	surmacz@temple.edu	Garofalo, Cecilia/B-3834-2017; Giordano, Antonio/F-1927-2010	Garofalo, Cecilia/0000-0001-5334-8930; Giordano, Antonio/0000-0002-5959-016X; Cascio, Sandra/0000-0003-4234-0508				ABI, 1997, ABI US B; Altucci L, 1996, ONCOGENE, V12, P2315; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Bannister AJ, 1995, ONCOGENE, V11, P2509; Button K, 2005, TRANSPORT POLICY, V12, P47, DOI 10.1016/j.tranpol.2004.09.003; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Cheung E, 2005, P NATL ACAD SCI USA, V102, P559, DOI 10.1073/pnas.0407113102; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; Dufourny B, 2000, J ENDOCRINOL, V166, P329, DOI 10.1677/joe.0.1660329; EDWARDS DP, 1993, BREAST CANCER RES TR, V27, P41, DOI 10.1007/BF00683192; Guvakova MA, 1997, EXP CELL RES, V231, P149, DOI 10.1006/excr.1996.3457; Hadsell DL, 2001, ADV EXP MED BIOL, V501, P79; Hamelers IHL, 2003, ENDOCR-RELAT CANCER, V10, P331, DOI 10.1677/erc.0.0100331; Hamelers IHL, 2002, J BIOL CHEM, V277, P47645, DOI 10.1074/jbc.M208727200; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Jerome L, 2004, SEMIN ONCOL, V31, P54, DOI 10.1053/j.seminoncol.2004.01.007; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim MY, 2001, EMBO J, V20, P6084, DOI 10.1093/emboj/20.21.6084; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Kushner P J, 2000, Novartis Found Symp, V230, P20, DOI 10.1002/0470870818.ch3; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lange CA, 2004, MOL ENDOCRINOL, V18, P269, DOI 10.1210/me.2003-0331; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Lee AV, 1997, J ENDOCRINOL, V152, P39, DOI 10.1677/joe.0.1520039; Lee SK, 1999, MOL ENDOCRINOL, V13, P1924, DOI 10.1210/me.13.11.1924; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Lewis JS, 2005, J MOL ENDOCRINOL, V34, P91, DOI 10.1677/jme.1.01599; Malara NM, 2006, BREAST, V15, P81, DOI 10.1016/j.breast.2004.12.008; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; REDDY KB, 1994, CELL GROWTH DIFFER, V5, P1275; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Salerno M, 1999, INT J CANCER, V81, P299; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; Stoica A, 2000, J CELL BIOCHEM, V76, P605, DOI 10.1002/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T; Stoica A, 2000, J ENDOCRINOL, V165, P371, DOI 10.1677/joe.0.1650371; Strobl JS, 1995, GEN PHARMACOL, V26, P1643, DOI 10.1016/0306-3623(95)00062-3; Surmacz E, 2004, J EXP CLIN CANC RES, V23, P385; Surmacz E, 2000, J MAMMARY GLAND BIOL, V5, P95, DOI 10.1023/A:1009523501499; Teyssier C, 2003, MOL ENDOCRINOL, V17, P287, DOI 10.1210/me.2002-0324; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Varma H, 2002, CANCER RES, V62, P3985; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang S, 2005, J MOL ENDOCRINOL, V35, P433, DOI 10.1677/jme.1.01858; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	64	47	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3498	3506		10.1074/jbc.M606244200	http://dx.doi.org/10.1074/jbc.M606244200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17166846	Green Published, hybrid			2022-12-27	WOS:000244481900012
J	Altenburg, M; Johnson, L; Wilder, J; Maeda, N				Altenburg, Michael; Johnson, Lance; Wilder, Jennifer; Maeda, Nobuyo			Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III HYPERLIPOPROTEINEMIA; CHOLESTEROL EFFLUX; MICE; ATHEROSCLEROSIS; LDL; HYPERCHOLESTEROLEMIA; INHIBITION; METABOLISM; APOE; REPLACEMENT	Apolipoprotein E (apoE) and the low density lipoprotein receptor (LDLr) are well recognized determinants of atherosclerosis. In addition to hepatocytes, where both are highly expressed and contribute to plasma lipoprotein clearance, they are expressed in vascular cells and macrophages. In this study, we examined the effects of human apoE isoforms and LDLr levels in atherogenic pathways in primary macrophages ex vivo and atherosclerosis development after bone marrow transfer in vivo using mice expressing human apoE isoformis and different levels of LDLr expression. Increases in LDLr expression significantly increased cholesterol delivery into macrophages in culture, and the effects were more prominent with lipoproteins containing apoE4 than those containing apoE3. Conversely, increased LDLr expression reduced cholesterol efflux in macrophages expressing apoE4 but not in macrophages expressing apoE3. Furthermore, apoE3 protected VLDL from oxidation in vitro more than did apoE4. In LDLr-deficient mice expressing the human apoE4 isoform, Apoe(4/4) Ldlr(-/-), the replacement of bone marrow cells with those expressing LDLr increased atherosclerotic lesions in a dose-dependent manner compared with mice transplanted with cells having no LDLr. In contrast, atherosclerosis in Apoe(3/3) Ldlr(-/-) mice, expressing the human apoE3 isoform, did not differ by the levels of macrophage LDLr expression. Our results demonstrate that apoE4, but not apoE3, in macrophages enhances atherosclerotic plaque development in mice in an LDLr-dependent manner and suggests that this interaction may contribute to the association of apoE4 with an increased cardiovascular risk in humans.	Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 701 Brinkhous Bulitt Bldg, Chapel Hill, NC 27599 USA.	nobuyo@med.unc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042630, R01HL042630, T32HL069768] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL042630, HL42630, R37 HL042630, T32HL69768] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bohnet K, 1996, J LIPID RES, V37, P1316; Costet P, 2000, J BIOL CHEM, V275, P28240; Cullen P, 1998, J CLIN INVEST, V101, P1670, DOI 10.1172/JCI119887; Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Farkas MH, 2003, J BIOL CHEM, V278, P9412, DOI 10.1074/jbc.M208026200; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Herijgers N, 1997, ARTERIOSCL THROM VAS, V17, P1995, DOI 10.1161/01.ATV.17.10.1995; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Knouff C, 2004, BBA-MOL CELL BIOL L, V1684, P8, DOI 10.1016/j.bbalip.2004.03.004; Knouff C, 2001, J BIOL CHEM, V276, P3856, DOI 10.1074/jbc.M009423200; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; KOO C, 1988, J CLIN INVEST, V81, P1332, DOI 10.1172/JCI113460; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Lucic D, 2007, J LIPID RES, V48, P366, DOI 10.1194/jlr.M600259-JLR200; Mabile L, 2003, J CELL BIOCHEM, V90, P766, DOI 10.1002/jcb.10697; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Malloy SI, 2004, ARTERIOSCL THROM VAS, V24, P91, DOI 10.1161/01.ATV.0000094963.07902.FB; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sacre SM, 2003, FEBS LETT, V540, P181, DOI 10.1016/S0014-5793(03)00261-8; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; TABAS I, 1987, J CLIN INVEST, V79, P418, DOI 10.1172/JCI112828; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Zeleny M, 2002, BIOCHEMISTRY-US, V41, P11820, DOI 10.1021/bi026202k; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	35	27	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7817	7824		10.1074/jbc.M610712200	http://dx.doi.org/10.1074/jbc.M610712200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234631	hybrid, Green Accepted, Green Submitted			2022-12-27	WOS:000245081000010
J	Block, K; Gorin, Y; Hoover, P; Williams, P; Chelmicki, T; Clark, RA; Yoneda, T; Abboud, HE				Block, Karen; Gorin, Yves; Hoover, Paul; Williams, Paul; Chelmicki, Tomasz; Clark, Robert A.; Yoneda, Toshiyuki; Abboud, Hanna E.			NAD(P)H Oxidases regulate HIF-2 alpha protein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RENAL-CARCINOMA CELLS; GROWTH SUPPRESSION; NADPH OXIDASES; UP-REGULATION; CANCER CELLS; OXYGEN; ACTIVATION; NOX4	Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary and sporadic renal cell carcinoma (RCC). In the absence of VHL, the alpha subunits of heterodimeric hypoxia-inducible transcription factors (HIT-1 alpha and HIF-2 alpha) are stabilized. Reactive oxygen species, generated by NAD(P)H oxidases, are involved in signaling cascades of malignant growth. We show that in VHL-deficient cells p22(phox), Nox4 protein levels and NADPH-dependent superoxide generation are increased. Reintroduction of VHL into the VHL-deficient cells down-regulates the expression of p22(phox) and NADPH-dependent superoxide generation. Inhibition of the 26 S proteasome in VHL-expressing cells increased p22(phox) protein levels, which correlated with an increase of NADPH-dependent superoxide generation. We also show that p22(phox) co-immunoprecipitates with VHL in vivo. Moreover, p22(phox) is a target of ubiquitination. Importantly, in VHL-deficient cells, diphenyleneiodonium chloride (DPI), an inhibitor of Nox oxidases, decreased the expression of HIF-2a. Down-regulation of Nox1, Nox4, and p22(phox) expression by small interfering RNA also decreased HIF-2 alpha protein expression and inhibited Akt and 4E-BP1 phosphorylation, suggesting that a translational mechanism is involved in maintaining HIF-2 alpha in VHL-deficient cells. Colony formation by RCC 786-O in soft agar was markedly inhibited by DPI. Moreover, DPI significantly inhibited RCC 786-O tumor formation in athymic mice. Collectively, the data demonstrate that VHL protein exerts its tumor suppressor action, at least partially, via inhibition of p22(phox)-based Nox4/Nox1 NADPH oxidase-dependent reactive oxygen species generation.	Univ Texas, Hlth Sci Ctr, George OBrien Kidney Res Ctr, Dep Med,Div Nephrol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, George OBrien Kidney Res Ctr, Dep Med,Div Endocrinol, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Block, K (corresponding author), Univ Texas, Hlth Sci Ctr, George OBrien Kidney Res Ctr, Dep Med,Div Nephrol, MC 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	block@uthscsa.edu	Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Chelmicki, Tomasz/0000-0003-0502-7360; Gorin, Yves/0000-0003-4048-6925				Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brar SS, 2001, AM J PHYSIOL-CELL PH, V280, pC659, DOI 10.1152/ajpcell.2001.280.3.C659; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; CHEN F, 1995, CANCER RES, V55, P4804; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Goyal P, 2004, FREE RADICAL BIO MED, V36, P1279, DOI 10.1016/j.freeradbiomed.2004.02.071; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Kanno H, 1997, CANCER RES, V57, P1035; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kim NH, 2006, AM J PHYSIOL-RENAL, V290, pF741, DOI 10.1152/ajprenal.00313.2005; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Lieubeau-Teillet B, 1998, CANCER RES, V58, P4957; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200; Zimmer M, 2004, MOL CANCER RES, V2, P89	31	95	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8019	8026		10.1074/jbc.M611569200	http://dx.doi.org/10.1074/jbc.M611569200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17200123	hybrid			2022-12-27	WOS:000245081000033
J	Wallis, R; Dodds, AW; Mitchell, DA; Sim, RB; Reid, KBM; Schwaeble, WJ				Wallis, Russell; Dodds, Alister W.; Mitchell, Daniel A.; Sim, Robert B.; Reid, Kenneth B. M.; Schwaeble, Wilhelm J.			Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; SURFACE-PLASMON RESONANCE; SERINE-PROTEASE; INTERNAL THIOESTER; SUBSTRATE SPECIFICITIES; CLASSICAL PATHWAY; COMPONENT C4; SYSTEM; RECOGNITION; COMPLEXES	Activation of component C3 is central to the pathways of complement and leads directly to neutralization of pathogens and stimulation of adaptive immune responses. The convertases that catalyze this reaction assemble from fragments of complement components via multistep reactions. In the lectin pathway, mannose-binding lectin (MBL) and ficolins bind to pathogens and activate MBL-associated serine protease-2 (MASP-2). MASP-2 cleaves C4 releasing C4a and generating C4b, which attaches covalently to the pathogen surface upon exposure of its reactive thioester. C2 binds to C4b and is also cleaved by MASP-2 to form the C3 convertase (C4b2a). To understand how this complex process is coordinated, we have analyzed the interactions between MASP-2, C4, C2, and their activation fragments and have compared MASP-2-catalyzed cleavage of C4b2 and C2. The data show that C2 binds tightly to C4b but not to C4, implying that C4 and C2 do not circulate as preformed complexes but that C2 is recruited only after prior activation of C4. Following cleavage of C4, C4b still binds to MASP-2 (K-D similar to 0.6 mu m) and dissociates relatively slowly (k(off) similar to 0.06 s(-1)) compared with the half-life of the thioester (<= 0.7 s) (Sepp, A., Dodds, A. W., Anderson, M. J., Campbell, R. D., Willis, A. C., and Law, S. K. (1993) Protein Sci. 2, 706 716). We propose that the C4b-MASP-2 interaction favors attachment of C4b near to the activating MBL.MASP complex on the bacterial surface so that, following recruitment of C2, the proximity of enzyme and substrate (C4b2) combined with more favorable reaction kinetics drive the formation of the C3 convertase, promoting complement activation.	Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; Univ Leicester, Dept Biochem, Leicester, Leics, England; Univ Oxford, Dept Biochem, Immunochem Unit, MRC, Oxford OX1 3QU, England; Warwick Med Sch, Clin Sci Res Inst, Coventry CV2 2DX, W Midlands, England	University of Leicester; University of Leicester; University of Oxford; University of Warwick	Wallis, R (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Med Sci Bldg,Univ Rd, Leicester, Leics, England.	rw73@le.ac.uk	Mitchell, Daniel A/A-6580-2009; Sim, Bob/A-1354-2008	Mitchell, Daniel A/0000-0003-0936-6212; Sim, Bob/0000-0002-2855-7455; Schwaeble, Wilhelm/0000-0001-8927-0864; Wallis, Russell/0000-0002-8705-5295; Dodds, Alister William/0000-0003-3396-1257	Wellcome Trust [077400, 060574] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; DODDS AW, 1990, BIOCHEM J, V265, P495, DOI 10.1042/bj2650495; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; JANATOVA J, 1980, BIOCHEMISTRY-US, V19, P4479, DOI 10.1021/bi00560a015; KERR MA, 1980, BIOCHEM J, V189, P173, DOI 10.1042/bj1890173; Laich A, 2001, BBA-PROTEIN STRUCT M, V1544, P96, DOI 10.1016/S0167-4838(00)00208-9; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Law SKA, 1997, PROTEIN SCI, V6, P263; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Minton AP, 1997, PROG COLL POL SCI S, V107, P11; Moller-Kristensen M, 2003, SCAND J IMMUNOL, V57, P556, DOI 10.1046/j.1365-3083.2003.01270.x; PORTER RR, 1978, NATURE, V275, P699, DOI 10.1038/275699a0; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rossi V, 2005, J BIOL CHEM, V280, P41811, DOI 10.1074/jbc.M503813200; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; SATO T, 1994, INT IMMUNOL, V6, P665, DOI 10.1093/intimm/6.4.665; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; SEPP A, 1993, PROTEIN SCI, V2, P706, DOI 10.1002/pro.5560020502; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; ZICCARDI RJ, 1981, J IMMUNOL, V126, P1769; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	35	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7844	7851		10.1074/jbc.M606326200	http://dx.doi.org/10.1074/jbc.M606326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17204478	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000245081000013
J	Alexander, RT; Malevanets, A; Durkan, AM; Kocinsky, HS; Aronson, PS; Orlowski, J; Grinstein, S				Alexander, R. Todd; Malevanets, Anatoly; Durkan, Anne M.; Kocinsky, Hetal S.; Aronson, Peter S.; Orlowski, John; Grinstein, Sergio			Membrane curvature alters the activation kinetics of the epithelial Na+/H+ exchanger, NHE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; HCO3-ABSORPTION; PH; AMILORIDE; ISOFORMS; CELLS; INHIBITION; MECHANISM; PHOSPHORYLATION; DEPENDENCE	The epithelial Na+/H+ exchanger, NHE3, was found to activate slowly following an acute cytosolic acidification. The sigmoidal course of activation could not be explained by the conventional two-state model, which postulates that activation results from protonation of an allosteric modifier site. Instead, mathematical modeling predicted the existence of three distinct states of the exchanger: two different inactive states plus an active form. The interconversion of the inactive states is rapid and dependent on pH, whereas the conversion between the second inactive state and the active conformation is slow and pH-independent but subject to regulation by other stimuli. Accordingly, exposure of epithelial cells to hypoosmolar solutions activated NHE3 by accelerating this latter transition. The number of surface-exposed exchangers and their association with the cytoskeleton were not affected by hypoosmolarity. Instead, NHE3 is activated by the membrane deformation, a result of cell swelling. This was suggested by the stimulatory effects of amphiphiles that induce a comparable positive (convex) deformation of the membrane. We conclude that NHE3 exists in multiple states and that different physiological parameters control the transitions between them.	Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University; Yale University; Yale University; McGill University; University of Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Program Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca	Durkan, Anne/AAP-4205-2020; Alexander, R. Todd/G-1373-2012	Durkan, Anne/0000-0003-3739-2290; Orlowski, John/0000-0001-7371-175X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK017433] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Ambuhl P, 1998, J CLIN INVEST, V101, P170, DOI 10.1172/JCI62; AMEMIYA M, 1995, AM J PHYSIOL-CELL PH, V269, pC126, DOI 10.1152/ajpcell.1995.269.1.C126; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; AZARANI A, 1995, J BIOL CHEM, V270, P20004, DOI 10.1074/jbc.270.34.20004; Biemesderfer D, 2001, J BIOL CHEM, V276, P10161, DOI 10.1074/jbc.M008098200; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Good DW, 2000, AM J PHYSIOL-CELL PH, V279, pC1443, DOI 10.1152/ajpcell.2000.279.5.C1443; GRINSTEIN S, 1984, J GEN PHYSIOL, V83, P341, DOI 10.1085/jgp.83.3.341; GRINSTEIN S, 1985, FED PROC, V44, P2508; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Hayashi H, 2002, J BIOL CHEM, V277, P11090, DOI 10.1074/jbc.M111868200; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee EM, 2003, AM J PHYSIOL-RENAL, V285, pF748, DOI 10.1152/ajprenal.00442.2002; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lorenz JN, 1999, AM J PHYSIOL-RENAL, V277, pF447, DOI 10.1152/ajprenal.1999.277.3.F447; Nath SK, 1996, AM J PHYSIOL-GASTR L, V270, pG431, DOI 10.1152/ajpgi.1996.270.3.G431; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; OTSU K, 1989, P NATL ACAD SCI USA, V86, P4818, DOI 10.1073/pnas.86.13.4818; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247; SOLEIMANI M, 1994, J BIOL CHEM, V269, P15613; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Turner JR, 2001, AM J PHYSIOL-CELL PH, V281, pC1533, DOI 10.1152/ajpcell.2001.281.5.C1533; VIGNE P, 1984, EMBO J, V3, P1865, DOI 10.1002/j.1460-2075.1984.tb02060.x; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; Watts BA, 1999, J CLIN INVEST, V104, P1593, DOI 10.1172/JCI7332; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101	42	29	29	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7376	7384		10.1074/jbc.M608557200	http://dx.doi.org/10.1074/jbc.M608557200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218318	Green Published, hybrid			2022-12-27	WOS:000245080900049
J	Nie, J; Pei, J; Blumenthal, M; Pei, DQ				Nie, Jing; Pei, Jing; Blumenthal, Malcolm; Pei, Duanqing			Complete restoration of cell surface activity of transmembrane-truncated MT1-MMP by a glycosylphosphatidylinositol anchor - Implications for MTI-MMP-mediated proMMP2 activation and collagenolysis in three-dimensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; DOMAIN; INVASION; PROGELATINASE; MT3-MMP; ENZYME	MT1-MMP is a potent collagenase not only required for skeletal development but also implicated in tumor invasion and metastasis. The mechanism through which cellsdeploy MT1-MMP to mediate collagenolysis remains largely unknown. C-terminally truncated MT1-MMP lacking its transmembrane and cytoplasmic domains, although proteolytic active in purified forms, is known to be deficient in cell-mediated proMMP2 activation and collagenolysis, suggesting that cells regulate its activity through both domains. Indeed, the cytoplasmic domain is recognized by the trafficking machinery that mediates its internalization and recycling. Here we demonstrate that its transmembrane domain can be functionally substituted by the glycosylphosphatidylinositol (GPI)-anchor of MT6-MMP. The GPI-anchored MT1-MMP, orMT1-GPI, activates proMMP2 on the cell surface and promotes cell growth in a three-dimensional type I collagen matrix. On the other hand, a GPI-anchored MMP13 with a functional furin activation signal fails to promote cell growth in a three-dimensional collagen matrix, whereas remaining competent in collagenolysis on a two-dimensional collagen matrix under serum-free conditions. alpha(2) macroglobulin (alpha M-2) or serum is sufficient to inhibit the collagenase activity of GPI-anchored active MMP13. Our results suggest that both membrane-tethering and proteolytic activity encoded by MT1-MMP are required for its ability to promote cell growth and invasion in a three-dimensional collagen matrix.	Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pei, DQ (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	peixx003@umn.edu			NCI NIH HHS [CA76308] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076308, R29CA076308] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kang TB, 2000, FASEB J, V14, P2559, DOI 10.1096/fj.00-0269com; Knauper V, 2002, FEBS LETT, V532, P127, DOI 10.1016/S0014-5793(02)03654-2; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Nie J, 2003, CANCER RES, V63, P6758; Pei DQ, 1998, PROTEIN EXPRES PURIF, V13, P277, DOI 10.1006/prep.1998.0894; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; TRAVIS J, 1988, AM J MED, V84, P37; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wang YH, 1999, J BIOL CHEM, V274, P33043, DOI 10.1074/jbc.274.46.33043; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	32	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6438	6443		10.1074/jbc.M607337200	http://dx.doi.org/10.1074/jbc.M607337200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17158888	hybrid			2022-12-27	WOS:000244867200051
J	Okino, N; Ito, M				Okino, Nozomu; Ito, Makoto			Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL CERAMIDASE; MOLECULAR-CLONING; BACTERIAL PHOSPHOLIPASES; ALKALINE CERAMIDASE; GENE; VIRULENCE; EXPRESSION; ERYTHROCYTES; LOCALIZATION; PURIFICATION	We previously reported the purification, molecular cloning, and characterization of a neutral ceramidase from Pseudomonas aeruginosa strain AN17 (Okino, N., Tani, M., Imayama, S., and Ito, M. (1998) J. Biol. Chem. 273,14368-14373; Okino, N., Ichinose, S., Omori, A., Imayama, S., Nakamura, T., and Ito, M. (1999) J. Biol. Chem. 274,36616-36622). Interestingly, the gene encoding the enzyme is adjacent to that encoding hemolytic phospholipase C (plcH) in the genome of Pseudomonas aeruginosa, which is a well known pathogen for opportunistic infections. We report here that simultaneous production of PlcH and ceramidase was induced by several lipids and PlcH-induced hemolysis was significantly enhanced by the action of the ceramidase. When the strain was cultured with sphingomyelin or phosphatidylcholine, production of both enzymes drastically increased, causing the increase of hemolytic activity in the cell-free culture supernatant. Ceramide and sphingosine were also effective in promoting the production of ceramidase but not that of PlcH. Furthermore, we found that the hemolytic activity of a Bacillus cereus sphingomyelinase was significantly enhanced by addition of a recombinant Pseudomonas ceramidase. TLC analysis of the erythrocytes showed that ceramide produced from sphingomyelin by the sphingomyelinase was partly converted to sphingosine by the ceramidase. A ceramidase-null mutant strain caused much less hemolysis of sheep erythrocytes than did the wild-type strain. Sphingosine was detected in the erythrocytes co-cultured with the wild-type strain but not the mutant strain. Finally, we found that the enhancement of PlcH-induced hemolysis by the ceramidase occurred in not only sheep but also human erythrocytes. These results may indicate that the ceramidase enhances the PlcH-induced cytotoxicity and provide new insights into the role of sphingolipid-degrading enzymes in the pathogenicity of P. aeruginosa.	Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University	Okino, N (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1,Hakozaki, Fukuoka 8128581, Japan.	nokino@agr.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021; Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818				Acharya U, 2004, P NATL ACAD SCI USA, V101, P1922, DOI 10.1073/pnas.0308693100; Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Barker AP, 2004, MOL MICROBIOL, V53, P1089, DOI 10.1111/j.1365-2958.2004.04189.x; BODEY GP, 1983, REV INFECT DIS, V5, P279; CHIN JC, 1988, J GEN MICROBIOL, V134, P2567; COLLEY CM, 1973, BIOCHIM BIOPHYS ACTA, V307, P74, DOI 10.1016/0005-2736(73)90026-6; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; FUJITA K, 1988, INFECT IMMUN, V56, P1385, DOI 10.1128/IAI.56.5.1385-1387.1988; Garcia-Sanchez A, 2004, VET MICROBIOL, V99, P67, DOI 10.1016/j.vetmic.2003.10.028; GATT S, 1963, J BIOL CHEM, V238, P3131; He XX, 2002, ANAL BIOCHEM, V306, P115, DOI 10.1006/abio.2002.5686; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; IGISU H, 1988, LIPIDS, V23, P345, DOI 10.1007/BF02537346; ITO M, 2003, CERAMIDE SIGNALING, P41; Komori H, 1999, J BIOL CHEM, V274, P8981, DOI 10.1074/jbc.274.13.8981; Komori H, 2000, FEBS LETT, V475, P247, DOI 10.1016/S0014-5793(00)01696-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; MEYERS DJ, 1992, TOXICON, V30, P161, DOI 10.1016/0041-0101(92)90469-L; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200; Monjusho H, 2003, BIOCHEM J, V376, P473, DOI 10.1042/BJ20030652; Nakagawa T, 2005, J LIPID RES, V46, P1103, DOI 10.1194/jlr.M400516-JLR200; NELSON GJ, 1967, BIOCHIM BIOPHYS ACTA, V144, P221, DOI 10.1016/0005-2760(67)90152-X; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; Okino N, 1999, J BIOL CHEM, V274, P36616, DOI 10.1074/jbc.274.51.36616; OSTROFF RM, 1990, J BACTERIOL, V172, P5915, DOI 10.1128/jb.172.10.5915-5923.1990; OSTROFF RM, 1989, INFECT IMMUN, V57, P1369, DOI 10.1128/IAI.57.5.1369-1373.1989; PRITCHARD AE, 1986, J BACTERIOL, V167, P291, DOI 10.1128/jb.167.1.291-298.1986; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; TAKETOMI T, 1970, J BIOCHEM-TOKYO, V68, P475, DOI 10.1093/oxfordjournals.jbchem.a129378; Tani M, 2005, J BIOL CHEM, V280, P36592, DOI 10.1074/jbc.M506827200; Tani M, 2004, J BIOL CHEM, V279, P29351, DOI 10.1074/jbc.M404012200; Tani M, 2000, J BIOL CHEM, V275, P11229, DOI 10.1074/jbc.275.15.11229; Tani M, 1998, ANAL BIOCHEM, V263, P183, DOI 10.1006/abio.1998.2781; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; VASIL ML, 1986, J PEDIATR-US, V108, P800, DOI 10.1016/S0022-3476(86)80748-X; VASIL ML, 1982, J BACTERIOL, V152, P431; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215	48	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6021	6030		10.1074/jbc.M603088200	http://dx.doi.org/10.1074/jbc.M603088200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202150	hybrid			2022-12-27	WOS:000244867200007
J	Ye, YZ; Quijano, C; Robinson, KM; Ricart, KC; Strayer, AL; Sahawneh, MA; Shacka, JJ; Kirk, M; Barnes, S; Accavitti-Loper, MA; Radi, R; Beckman, JS; Estevez, AG				Ye, Yaozu; Quijano, Celia; Robinson, Kristine M.; Ricart, Karina C.; Strayer, Amy L.; Sahawneh, Mary Anne; Shacka, John J.; Kirk, Marion; Barnes, Stephen; Accavitti-Loper, Mary Ann; Radi, Rafael; Beckman, Joseph S.; Estevez, Alvaro G.			Prevention of peroxynitrite-induced apoptosis of motor neurons and PC12 cells by tyrosine-containing peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NERVE GROWTH-FACTOR; MANGANESE-SUPEROXIDE-DISMUTASE; CARBONATE RADICAL-ANION; HEAT-SHOCK PROTEINS; NITRIC-OXIDE; IN-VIVO; OXIDATIVE STRESS; DNA-DAMAGE; NITROTYROSINE RESIDUES; CATALYZED OXIDATION	Although peroxynitrite stimulates apoptosis in many cell types, whether peroxynitrite acts directly as an oxidant or the induction of apoptosis is because of the radicals derived from peroxynitrite decomposition remains unknown. Before undergoing apoptosis because of trophic factor deprivation, primary motor neuron cultures become immunoreactive for nitrotyrosine. We show here using tyrosine-containing peptides that free radical processes mediated by peroxynitrite decomposition products were required for triggering apoptosis in primary motor neurons and in PC12 cells cultures. The same concentrations of tyrosine-containing peptides required to prevent the nitration and apoptosis of motor neurons induced by trophic factor deprivation and of PC12 cells induced by peroxynitrite also prevented peroxynitrite-mediated nitration, of motor neurons, brain homogenates, and PC12 cells. The heat shock protein 90 chaperone was nitrated in both trophic factor-deprived motor neurons and PC12 cells incubated with peroxynitrite. Tyrosine-containing peptides did not affect the induction of PC12 cell death by hydrogen peroxide. Tyrosine-containing peptides should protect by scavenging peroxynitrite-derived radicals and not by direct reactions with peroxynitrite as they neither increase the rate of peroxynitrite decomposition nor decrease the bimolecular peroxynitrite-mediated oxidation of thiols. These results reveal an important role for free radical-mediated nitration of tyrosine residues, in apoptosis induced by endogenously produced and exogenously added peroxynitrite; moreover, tyrosine-containing peptides may offer a novel strategy to neutralize the toxic effects of peroxynitrite.	Burke Med Res Inst, White Plains, NY 10605 USA; Univ Republica, Dept Bioquim, Fac Med, Montevideo, Uruguay; Univ Republica, Ctr Free Rad & Biomed Res, Fac Med, Montevideo, Uruguay; Oregon State Univ, Linus Pauling Inst Sci & Med, Corvallis, OR 97331 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Mass Spectrometry Facil, Ctr Comprehens Canc, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med Genet & Translat Med, Birmingham, AL 35294 USA; Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Oregon State University; Oregon State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University	Estevez, AG (corresponding author), Burke Med Res Inst, White Plains, NY 10605 USA.	age2002@med.cornell.edu			NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT002034] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR006487, S10RR013795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761] Funding Source: NIH RePORTER; NCCIH NIH HHS [AT02034] Funding Source: Medline; NCI NIH HHS [P30 CA13148] Funding Source: Medline; NCRR NIH HHS [RR06487, RR13795] Funding Source: Medline; NIEHS NIH HHS [ES00040] Funding Source: Medline; NINDS NIH HHS [NS36761] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez B, 2001, FREE RADICAL RES, V34, P467, DOI 10.1080/10715760100300411; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BECKMAN JS, 1996, NITRIC OXIDE PRINCIP, P1, DOI DOI 10.1016/B978-012435555-2/50002-4; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X; Chang W, 2002, J BIOL CHEM, V277, P30690, DOI 10.1074/jbc.M204930200; COMELLA JX, 1994, J NEUROSCI, V14, P2674; Crow JP, 1996, METHOD ENZYMOL, V269, P185; Crow JP, 1998, AM HEART MONOGR S, P315; Crow JP, 2000, FREE RADICAL BIO MED, V28, P1487, DOI 10.1016/S0891-5849(00)00249-5; Crow JP, 1997, J NEUROCHEM, V69, P1945; Crow JP, 1999, ARCH BIOCHEM BIOPHYS, V371, P41, DOI 10.1006/abbi.1999.1414; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Espey MG, 2002, P NATL ACAD SCI USA, V99, P3481, DOI 10.1073/pnas.062604199; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Estevez AG, 2000, FREE RADICAL BIO MED, V28, P437, DOI 10.1016/S0891-5849(99)00261-0; ESTEVEZ AG, 1995, J NEUROCHEM, V65, P1543; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Ferrer-Sueta G, 2002, METHOD ENZYMOL, V349, P23, DOI 10.1016/S0076-6879(02)49318-4; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Ferrer-Sueta G, 2006, FREE RADICAL BIO MED, V41, P503, DOI 10.1016/j.freeradbiomed.2006.04.028; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Go YM, 1999, AM J PHYSIOL-HEART C, V277, pH1647, DOI 10.1152/ajpheart.1999.277.4.H1647; Gow AJ, 1998, METH MOL B, V100, P291; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; GROVES JT, 1995, J AM CHEM SOC, V117, P9578, DOI 10.1021/ja00142a032; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Johnson BD, 2000, J BIOL CHEM, V275, P32499, DOI 10.1074/jbc.M005195200; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Martin LJ, 2003, J NEUROCHEM, V85, P234, DOI 10.1046/j.1471-4159.2003.01659.x; Martin LJ, 2002, NEUROCHEM RES, V27, P1093, DOI 10.1023/A:1020961006216; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; MILLIGAN CE, 1994, J NEUROBIOL, V25, P1005, DOI 10.1002/neu.480250809; Nauser T, 2002, J PHYS CHEM A, V106, P4084, DOI 10.1021/jp025518z; PADMAJA S, 1993, BIOCHEM BIOPH RES CO, V195, P539, DOI 10.1006/bbrc.1993.2079; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pfeiffer S, 2001, FASEB J, V15, P2355, DOI 10.1096/fj.01-0295com; Pfeiffer S, 1998, J BIOL CHEM, V273, P27280, DOI 10.1074/jbc.273.42.27280; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Radi R, 1996, METHOD ENZYMOL, V269, P354; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Ramezanian MS, 1996, CHEM RES TOXICOL, V9, P232, DOI 10.1021/tx950135w; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Robinson KM, 2005, METHOD ENZYMOL, V396, P207, DOI 10.1016/S0076-6879(05)96019-9; Robinson MB, 2005, J NEUROSCI, V25, P9735, DOI 10.1523/JNEUROSCI.1912-05.2005; Ross A. B., 1998, NDRL NIST SOLUTION K; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Shin JT, 1996, ARCH BIOCHEM BIOPHYS, V335, P32, DOI 10.1006/abbi.1996.0479; Spear N, 1997, J NEUROCHEM, V69, P53; Spear N, 1998, ARCH BIOCHEM BIOPHYS, V356, P41, DOI 10.1006/abbi.1998.0741; Spear Nathan, 1997, P32; Takakura K, 1999, ARCH BIOCHEM BIOPHYS, V369, P197, DOI 10.1006/abbi.1999.1374; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Ugolini G, 2003, J NEUROSCI, V23, P8526; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Viera L, 1999, METHOD ENZYMOL, V301, P373; Viera L., 1999, METHODS MOL MED SEPT, P159; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; YAN Q, 1988, J NEUROSCI, V8, P3481; Ye YZ, 1996, METHOD ENZYMOL, V269, P201; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang YM, 2004, EUR J NEUROSCI, V20, P1727, DOI 10.1111/j.1460-9568.2004.03651.x	107	51	52	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6324	6337		10.1074/jbc.M610800200	http://dx.doi.org/10.1074/jbc.M610800200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200124	hybrid			2022-12-27	WOS:000244867200039
J	Li, XQ; Zou, GZ; Yuan, WR; Lu, WY				Li, Xiangqun; Zou, Guozhang; Yuan, Weirong; Lu, Wuyuan			Defining the native disulfide topology in the somatomedin B domain of human vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TOTAL CHEMICAL-SYNTHESIS; CELL-MIGRATION; STRUCTURAL REQUIREMENTS; UROKINASE RECEPTOR; BINDING-PROTEIN; TUMOR-GROWTH; HUMAN-PLASMA; S-PROTEIN; PAI-1	The N-terminal 44 amino acid residues of the human plasma glycoprotein vitronectin, known as the somatomedin B (SMB) domain, mediates the interaction between vitronectin and plasminogen activator inhibitor 1 (PAI-1) in a variety of important biological processes. Despite the functional importance of the Cys-rich SMB domain, how its four disulfide bridges are arranged in the molecule remains highly controversial, as evidenced by three different disulfide connectivities reported by several laboratories. Using native chemical ligation and orthogonal protection of selected Cys residues, we chemically synthesized all three topological analogs of SMB with predefined disulfide connectivities corresponding to those previously published. In addition, we oxidatively folded a fully reduced SMB in aqueous solution, and prepared, by CNBr cleavage, the N-terminal segment of 51 amino acid residues of intact vitronectin purified from human blood. Proteolysis coupled with mass spectrometric analysis and functional characterization using a surface plasmon resonance based vitronectin-PAI-1-SMB competition assay allowed us to conclude that 1) only the Cys(5)-Cys(21), Cys(9)-Cys(39), Cys(19)-Cys(32), and Cys(25)-Cys(31) connectivity is present in native vitronectin; 2) only the native disulfide connectivity is functional; and 3) the native disulfide pairings can be readily formed during spontaneous (oxidative) folding of the SMB domain in vitro. Our results unequivocally define the native disulfide topology in the SMB domain of human vitronectin, providing biochemical as well as functional support to the structural findings on a recombinant SMB domain by Read and colleagues.	Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Lu, WY (corresponding author), Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA.	luw@umbi.umd.edu	Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R21AI058939] Funding Source: NIH RePORTER; NIAID NIH HHS [AI061482, AI058939] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; FRYKLUND L, 1978, FEBS LETT, V87, P55, DOI 10.1016/0014-5793(78)80132-X; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; Horn NA, 2004, J BIOL CHEM, V279, P35867, DOI 10.1074/jbc.M405716200; JENNE D, 1985, EMBO J, V4, P3153, DOI 10.1002/j.1460-2075.1985.tb04058.x; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kamikubo Y, 2004, BIOCHEMISTRY-US, V43, P6519, DOI 10.1021/bi049647c; Kamikubo Y, 2002, J BIOL CHEM, V277, P27109, DOI 10.1074/jbc.M200354200; Kjoller L, 1997, EXP CELL RES, V232, P420, DOI 10.1006/excr.1997.3540; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Li XQ, 2005, BIOCHEMISTRY-US, V44, P14688, DOI 10.1021/bi051519g; Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; MIMURO J, 1989, J BIOL CHEM, V264, P936; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Muir TW, 1997, METHOD ENZYMOL, V289, P266; Okumura Y, 2002, J BIOL CHEM, V277, P9395, DOI 10.1074/jbc.M111225200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Royle G, 2001, ANAL BIOCHEM, V296, P245, DOI 10.1006/abio.2001.5316; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SEIFFERT D, 1991, J BIOL CHEM, V266, P2824; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; WIMAN B, 1995, THROMB HAEMOSTASIS, V74, P71; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WIMAN B, 1988, THROMB HAEMOSTASIS, V59, P392; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2004, P NATL ACAD SCI USA, V101, P11587, DOI 10.1073/pnas.0404649101; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	45	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5318	5326		10.1074/jbc.M611396200	http://dx.doi.org/10.1074/jbc.M611396200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189256	hybrid			2022-12-27	WOS:000244482300027
J	Yanagida, K; Ishii, S; Hamano, F; Noguchi, K; Shimizu, T				Yanagida, Keisuke; Ishii, Satoshi; Hamano, Fumie; Noguchi, Kyoko; Shimizu, Takao			LPA(4)/p2y(9)/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTORS; NEURITE RETRACTION; PROSTANOID RECEPTOR; PROGENITOR CELLS; N1E-115 CELLS; BETA-CATENIN; P115 RHOGEF; ACTIVATION; G-ALPHA(13)	Lysophosphatidic acid (LPA) is a potent lipid mediator that evokes a variety of biological responses in many cell types via its specific G protein-coupled receptors. In particular, LPA affects cell morphology, cell survival, and cell cycle progression in neuronal cells. Recently, we identified p2y(9)/GPR23 as a novel fourth LPA receptor, LPA(4) (Noguchi, K., Ishii, S., and Shimizu, T. (2003) J. Biol. Chem. 278, 25600-25606). To assess the functions of LPA, in neuronal cells, we used rat neuroblastoma B103 cells that lack endogenous responses to LPA. In B103 cells stably expressing LPA(4), we observed G(q/11)-dependent calcium mobilization, but LPA did not affect adenylyl cyclase activity. In LPA, transfectants, LPA induced dramatic morphological changes, i.e. neurite retraction, cell aggregation, and cadherin-dependent cell adhesion, which involved Rho-mediated signaling pathways. Thus, our results demonstrated that LPA4 as well as LPA, couple to G(q/11) and G(12/13), whereas LPA(4) differs from LPA(1) in that it does not couple to G(i/o). Through neurite retraction and cell aggregation, LPA(4) may play a role in neuronal development such as neurogenesis and neuronal migration.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ishii, S (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mame@m.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021					An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen Q, 2005, J NEUROSCI, V25, P281, DOI 10.1523/JNEUROSCI.3692-04.2005; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chun J, 2005, PROSTAG OTH LIPID M, V77, P46, DOI 10.1016/j.prostaglandins.2004.09.009; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Couvillon AD, 2006, CELL SIGNAL, V18, P715, DOI 10.1016/j.cellsig.2005.06.012; DAS AK, 1989, LIPIDS, V24, P329, DOI 10.1007/BF02535172; Dawson J, 2003, J NEUROCHEM, V87, P947, DOI 10.1046/j.1471-4159.2003.02056.x; Fujino H, 2002, J BIOL CHEM, V277, P48786, DOI 10.1074/jbc.M209393200; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukushima N, 2004, J CELL BIOCHEM, V92, P993, DOI 10.1002/jcb.20093; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hasegawa H, 1997, BIOCHEM BIOPH RES CO, V234, P631, DOI 10.1006/bbrc.1997.6655; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Janssens R, 1997, BIOCHEM BIOPH RES CO, V236, P106, DOI 10.1006/bbrc.1997.6895; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; ODowd BF, 1997, GENE, V187, P75, DOI 10.1016/S0378-1119(96)00722-6; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Rhee HJ, 2006, NEUROREPORT, V17, P523; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Sayas CL, 2002, J NEUROSCI, V22, P6863; Seasholtz TM, 2004, J NEUROCHEM, V91, P501, DOI 10.1111/j.1471-4159.2004.02749.x; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sugiura T, 1999, BBA-MOL CELL BIOL L, V1440, P194, DOI 10.1016/S1388-1981(99)00127-4; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Ye XQ, 2002, NEUROREPORT, V13, P2169, DOI 10.1097/00001756-200212030-00002; ZUHERINGDORF DM, 2004, J CELL BIOCHEM, V92, P937	70	87	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5814	5824		10.1074/jbc.M610767200	http://dx.doi.org/10.1074/jbc.M610767200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17172642	hybrid			2022-12-27	WOS:000244482300077
J	Boswell, SA; Ongusaha, PP; Nghiem, P; Lee, SW				Boswell, Sarah A.; Ongusaha, Pat P.; Nghiem, Paul; Lee, Sam W.			The protective role of a small GTPase RhoE against UVB-induced DNA damage in keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN IMMORTALIZED KERATINOCYTES; RADIATION-INDUCED APOPTOSIS; EPIDERMAL-GROWTH-FACTOR; CELL-CYCLE PROGRESSION; MAP KINASES; ROCK-I; WAVELENGTH DEPENDENCE; MEDIATED APOPTOSIS; SIGNALING PATHWAY	RhoE, a p53 target gene, was identified as a critical factor for the survival of human keratinocytes in response to UVB. The Rho family of GTPases regulates many aspects of cellular behavior through alterations to the actin cytoskeleton, acting as molecular switches cycling between the active, GTP-bound and the inactive, GDP-bound conformations. Unlike typical Rho family proteins, RhoE (also known as Rnd3) is GTPase-deficient and thus expected to be constitutively active. In this study, we investigated the response of cultured human keratinocyte cells to UVB irradiation. RhoE protein levels increase upon exposure to UVB, and ablation of RhoE induction through small interfering RNA resulted in a significant increase in apoptosis and a reduction in the levels of the pro-survival targets p21, Cox-2, and cyclin D1, as well as an increase of reactive oxygen species levels when compared with control cells. These data indicate that RhoE is a pro-survival factor acting upstream of p38, JNK, p21, and cyclin D1. HaCat cells expressing small interfering RNA to p53 indicate that RhoE functions independently of its known associates, p53 and Rho-associated kinase I (ROCK I). Targeted expression of RhoE in epidermis using skin-specific transgenic mouse model resulted in a significant reduction in the number of apoptotic cells following UVB irradiation. Thus, RhoE induction counteracts UVB-induced apoptosis and may serve as a novel target for the prevention of UVB-induced photodamage regardless of p53 status.	Massachusetts Gen Hosp, CBRC, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Washington, Dermatol Div, Seattle, WA 98109 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Washington; University of Washington Seattle	Lee, SW (corresponding author), Massachusetts Gen Hosp, CBRC, Charlestown, MA 02129 USA.	sam.lee@cbrc2.mgh.harvard.edu	Nghiem, Paul T/A-9210-2011	Nghiem, Paul T/0000-0003-2784-963X; Boswell, Sarah/0000-0002-3118-3378	NATIONAL CANCER INSTITUTE [R01CA127247, R01CA097216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER; NCI NIH HHS [CA097216, CA127247, CA80058] Funding Source: Medline; NIAMS NIH HHS [AR007098-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adachi M, 2003, DNA CELL BIOL, V22, P665, DOI 10.1089/104454903770238148; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Assefa Z, 2000, J BIOL CHEM, V275, P21416, DOI 10.1074/jbc.M002634200; Bachelor MA, 2002, ONCOGENE, V21, P7092, DOI 10.1038/sj.onc.1205855; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BARTEK J, 1990, ONCOGENE, V5, P893; BODE AM, 2003, SCI STKE, pRE2; Bowen AR, 2003, J INVEST DERMATOL, V120, P48, DOI 10.1046/j.1523-1747.2003.12010.x; Chardin P, 2003, CURR BIOL, V13, pR702, DOI 10.1016/j.cub.2003.08.042; Chaturvedi V, 2005, ONCOGENE, V24, P5299, DOI 10.1038/sj.onc.1208650; Chaturvedi V, 2001, J DERMATOL SCI, V26, P67, DOI 10.1016/S0923-1811(00)00157-2; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; Decraene D, 2005, J INVEST DERMATOL, V125, P1026, DOI 10.1111/j.0022-202X.2005.23909.x; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P99, DOI 10.1093/carcin/bgg188; DOWELL SP, 1994, CANCER RES, V54, P2914; Driscoll B, 1997, AM J PHYSIOL-LUNG C, V273, pL941, DOI 10.1152/ajplung.1997.273.5.L941; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Henseleit U, 1997, J INVEST DERMATOL, V109, P722, DOI 10.1111/1523-1747.ep12340708; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kim HJ, 2003, MOL CELLS, V16, P331; KITANO Y, 1983, BRIT J DERMATOL, V108, P555, DOI 10.1111/j.1365-2133.1983.tb01056.x; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liberto M, 2002, ONCOGENE, V21, P1590, DOI 10.1038/sj.onc.1205242; Liu M, 1999, J INVEST DERMATOL, V113, P283, DOI 10.1046/j.1523-1747.1999.00657.x; Loignon M, 1997, CANCER RES, V57, P3390; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; OFSTER R, 1996, MOL CELL BIOL, V16, P2689; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Reagan-Shaw S, 2006, MOL CANCER THER, V5, P418, DOI 10.1158/1535-7163.MCT-05-0250; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Roovers K, 2003, MOL CELL BIOL, V23, P4283, DOI 10.1128/MCB.23.12.4283-4294.2003; ROSENBERG CL, 1993, ONCOGENE, V8, P519; Sauter ER, 1999, CANCER RES, V59, P4876; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Shimizu H, 1999, J INVEST DERMATOL, V112, P769, DOI 10.1046/j.1523-1747.1999.00582.x; Solomon DE, 2002, INT J EXP PATHOL, V83, P209, DOI 10.1046/j.1365-2613.2002.00238.x; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; TORNALETTI S, 1993, ONCOGENE, V8, P2051; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Welsh CF, 2004, BREAST CANCER RES TR, V84, P33, DOI 10.1023/B:BREA.0000018425.31633.07; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wikonkal NM, 1999, J INVEST DERM SYMP P, V4, P6, DOI 10.1038/sj.jidsp.5640173; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; ZHOU P, 1995, ONCOGENE, V11, P571; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	74	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4850	4858		10.1074/jbc.M610532200	http://dx.doi.org/10.1074/jbc.M610532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170105	hybrid			2022-12-27	WOS:000244482000067
J	Wu, Y; Termine, DJ; Swulius, MT; Moremen, KW; Sifers, RN				Wu, Ying; Termine, Daniel J.; Swulius, Matthew T.; Moremen, Kelley W.; Sifers, Richard N.			Human endoplasmic reticulum mannosidase I is subject to regulated proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN QUALITY-CONTROL; ALPHA-MANNOSIDASE; DEGRADATION; ER; ALPHA-1-ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN; INHIBITORS; EXPRESSION; CATALYSIS; MEMBRANE	In the early secretory pathway, opportunistic cleavage of asparagine-linked ofigosaccharides by endoplasmic reticulum (ER) mannosidase I targets misfolded glycoproteins for dislocation into the cytosol and destruction by 26 S proteasomes. The low basal concentration of the glycosidase is believed to coordinate the glycan cleavage with prolonged conformation-based ER retention, ensuring that terminally misfolded glycoproteins are preferentially targeted for destruction. Herein the intracellular fate of human ER mannosidase I was monitored to determine whether a post-translational process might contribute to the regulation of its intracellular concentration. The transiently expressed recombinant human glycosidase was subject to rapid intracellular turnover in mouse hepatoma cells, as was the endogenous mouse ortholog. Incubation with either chloroquine or leupeptin, but not lactacystin, led to intracellular stabilization, implicating the involvement of lysosomal acid hydrolases. Inhibition of protein synthesis with cycloheximide led to intracellular depletion of the glycosidase and concomitant ablation of asparagine-linked glycoprotein degradation, confirming the physiologic relevance of the destabilization process. Metabolic incorporation of radiolabeled phosphate, detection by anti-phosphoserine antiserum, and the stabilizing effect of general serine kinase inhibition implied that ER mannosidase I is subjected to regulated proteolysis. Stabilization in response to genetically engineered removal of the amino-terminal cytoplasmic tail, a postulated regulatory domain, and colocalization of green fluorescent protein fusion proteins with Lamp1 provided two additional lines of evidence to support the hypothesis. A model is proposed in which proteolytically driven checkpoint control of ER mannosidase I contributes to the establishment of an equitable glycoprotein quality control standard by which the efficiency of asparagine-linked glycoprotein conformational maturation is measured.	Baylor Coll Med, Dept Pathol Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Biophys, Houston, TX 77030 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol Mol & Cellular Biol, Houston, TX 77030 USA.	rsifers@bcm.tmc.edu	Moremen, Kelley/AAD-4661-2019; Sifers, Richard Norman/AGQ-7262-2022		NCI NIH HHS [U01 CA091295] Funding Source: Medline; NCRR NIH HHS [P41 RR005351, RR005351] Funding Source: Medline; NHLBI NIH HHS [HL62553, R01 HL062553] Funding Source: Medline; NIDDK NIH HHS [DK064232, R01 DK064232, R01 DK075322] Funding Source: Medline; NIGMS NIH HHS [R01 GM047533, GM47533] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA091295] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064232, R01DK075322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Amshoff C, 1999, BIOL CHEM, V380, P669, DOI 10.1515/BC.1999.083; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Choudhury P, 1997, J BIOL CHEM, V272, P13446, DOI 10.1074/jbc.272.20.13446; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Gerstein M, 2002, SCIENCE, V295, P284, DOI 10.1126/science.1068664; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; Gordon SR, 1999, EXP CELL RES, V246, P233, DOI 10.1006/excr.1998.4298; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Karaveg K, 2005, J BIOL CHEM, V280, P29837, DOI 10.1074/jbc.M505130200; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SIFERS RN, 1995, NAT STRUCT BIOL, V2, P355, DOI 10.1038/nsb0595-355; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Termine D, 2005, METHODS, V35, P348, DOI 10.1016/j.ymeth.2004.10.006; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Travers KJ, 2002, ADV PROTEIN CHEM, V59, P345; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Vallee F, 2000, J BIOL CHEM, V275, P41287, DOI 10.1074/jbc.M006927200; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	47	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4841	4849		10.1074/jbc.M607156200	http://dx.doi.org/10.1074/jbc.M607156200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166854	Green Accepted, hybrid			2022-12-27	WOS:000244482000066
J	Lei, HT; Venkatakrishnan, A; Yu, SY; Kaziauskas, A				Lei, Hetian; Venkatakrishnan, Annapurna; Yu, Soyoung; Kaziauskas, Andrius			Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY-DISEASE; IN-VIVO; OXIDATIVE STRESS; CELLS; PHOSPHORYLATION; HSP90; DYSFUNCTION; ACTIVATION; COMPLEX; ENOS	Diabetes mellitus (DM) and high glucose (HG) are known to reduce the bioavailability of nitric oxide (NO) by modulating endothelial nitric-oxide synthase (eNOS) activity. eNOS is regulated by several mechanisms including its interaction with heat shock protein (Hsp) 90. We previously discovered that DM in vivo and HG in vitro induced the translocation of Hsp90 alpha to the outside of aortic endothelial cells. In this report we tested the hypothesis that translocation of Hsp90a is responsible for the decline in NO production observed in HG-treated cells. We found that HG increased phosphorylation of Hsp90 alpha in a cAMP-dependent protein kinase A-dependent manner, and that this event was required for translocation of Hsp90a in porcine aortic endothelial cells. Furthermore, preventing translocation of Hsp90a protected from the HG-induced decline in eNOS-Hsp90a complex and NO production. Notably, DM increased phosphorylation of Hsp90ce and reduced its association with eNOS in the aortic endothelium of diabetic rats. These studies suggest that translocation of Hsp90a is a novel mechanism by which HG and DM impair eNOS activity and thereby reduce NO production.	Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Kaziauskas, A (corresponding author), 20 Staniford St, Boston, MA 02114 USA.	ak@eri.harvard.edu		Lei, Hetian/0000-0003-4091-1936				Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; Booth G, 2002, DIABETES, V51, P1556, DOI 10.2337/diabetes.51.5.1556; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; ERKELLERYUKSEL FM, 1992, J AUTOIMMUN, V5, P803, DOI 10.1016/0896-8411(92)90194-U; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Felaco M, 2001, ANN CLIN LAB SCI, V31, P179; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; JACKOWSKI MM, 1978, J CYCLIC NUCL PROT, V4, P323; Lash JM, 1999, AM J PHYSIOL-HEART C, V277, pH1513, DOI 10.1152/ajpheart.1999.277.4.H1513; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Maxwell AJ, 2002, NITRIC OXIDE-BIOL CH, V6, P101, DOI 10.1006/niox.2001.0394; MENDEZ R, 1992, J BIOL CHEM, V267, P11500; MENDEZ R, 1994, J BIOL CHEM, V269, P6170; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Rosenkranz S, 2000, J BIOL CHEM, V275, P9620, DOI 10.1074/jbc.275.13.9620; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Stalker TJ, 2003, FASEB J, V17, P1511, DOI 10.1096/fj.02-1213fje; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Tayebjee MH, 2005, DIABETIC MED, V22, P1628, DOI 10.1111/j.1464-5491.2005.01675.x; Tayebjee MH, 2005, AM J CARDIOL, V96, P339, DOI 10.1016/j.amjcard.2005.03.072; Tayebjee MH, 2005, CURR MED CHEM, V12, P917, DOI 10.2174/0929867053507270; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Wang Hwei-Zu, 1997, Kaohsiung Journal of Medical Sciences, V13, P566; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; ZAWALICH WS, 1975, DIABETOLOGIA, V11, P231, DOI 10.1007/BF00422327; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200; Zhao YG, 2001, J BIOL CHEM, V276, P32822, DOI 10.1074/jbc.M105562200; Zimmerman UJP, 1996, BBA-MOL CELL RES, V1311, P117, DOI 10.1016/0167-4889(95)00181-6; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	58	78	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9364	9371		10.1074/jbc.M608985200	http://dx.doi.org/10.1074/jbc.M608985200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17202141	hybrid			2022-12-27	WOS:000245421700008
J	Romero, S; Didry, D; Larquet, E; Boisset, N; Pantaloni, D; Carlier, MF				Romero, Stephane; Didry, Dominique; Larquet, Eric; Boisset, Nicolas; Pantaloni, Dominique; Carlier, Marie-France			How ATP hydrolysis controls filament assembly from profilin-actin - Implication for formin processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED END ELONGATION; F-ACTIN; STRUCTURAL BASIS; CAPPING PROTEIN; FISSION YEAST; ACANTHAMOEBA PROFILIN; BUNDLING ACTIVITY; HOMOLOGY PROTEIN; MOUSE FORMIN; NUCLEATION	Formins catalyze rapid filament growth from profilin-actin, by remaining processively bound to the elongating barbed end. The sequence of elementary reactions that describe filament assembly from profilin-actin at either free or formin-bound barbed ends is not fully understood. Specifically, the identity of the transitory complexes between profilin and actin terminal subunits is not known; and whether ATP hydrolysis is directly or indirectly coupled to profilin-actin assembly is not clear. We have analyzed the effect of profilin on actin assembly at free and FH1-FH2-bound barbed ends in the presence of ADP and non-hydrolyzable CrATP. Profilin blocked filament growth by capping the barbed ends in ADP and CrATP/ADP-P-i states, with a higher affinity when formin is bound. We confirm that, in contrast, profilin accelerates depolymerization of ADP-F-actin, more efficiently when FH1-FH2 is bound to barbed ends. To reconcile these data with effective barbed end assembly from profilin-MgATP-actin, the nature of nucleotide bound to both terminal and subterminal subunits must be considered. All data are accounted for quantitatively by a model in which a barbed end whose two terminal subunits consist of profilin-ATP-actin cannot grow until ATP has been hydrolyzed and P-1 released from the penultimate subunit, thus promoting the release of profilin and allowing further elongation. Formin does not change the activity of profilin but simply uses it for its processive walk at barbed ends. Finally, if profilin release from actin is prevented by a chemical cross-link, formin processivity is abolished.	CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; Univ Paris 06, Inst Mineral & Phys Mat Condensee, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Carlier, MF (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	carlier@lebs.cnrs-gif.fr	Romero, Stephane/K-5998-2017; Romero, Stephane/GLR-3472-2022; larquet, eric/ABB-3063-2021	Romero, Stephane/0000-0002-7358-3871; Romero, Stephane/0000-0002-7358-3871; larquet, eric/0000-0002-9994-6845				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; CARLIER MF, 1987, J BIOL CHEM, V262, P3052; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; DEPAMPHILIS ML, 1973, BIOCHEMISTRY-US, V12, P3714, DOI 10.1021/bi00743a022; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; GIESELMANN R, 1995, EUR J BIOCHEM, V229, P621, DOI 10.1111/j.1432-1033.1995.tb20506.x; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kang F, 1999, J BIOL CHEM, V274, P36963, DOI 10.1074/jbc.274.52.36963; Kato T, 2001, J CELL SCI, V114, P775; Kinosian HJ, 2002, BIOCHEMISTRY-US, V41, P6734, DOI 10.1021/bi016083t; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MALM B, 1984, FEBS LETT, V173, P399, DOI 10.1016/0014-5793(84)80813-3; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Nyman T, 2002, J BIOL CHEM, V277, P15828, DOI 10.1074/jbc.M112195200; OHM T, 1994, BBA-PROTEIN STRUCT M, V1208, P8, DOI 10.1016/0167-4838(94)90153-8; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PANTALONI D, 1984, J BIOL CHEM, V259, P6274; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; PERELROIZEN I, 1995, J BIOL CHEM, V270, P1501, DOI 10.1074/jbc.270.4.1501; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; TILNEY LG, 1983, J CELL BIOL, V97, P112, DOI 10.1083/jcb.97.1.112; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	58	60	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8435	8445		10.1074/jbc.M609886200	http://dx.doi.org/10.1074/jbc.M609886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17210567	hybrid			2022-12-27	WOS:000245081000076
J	Santarelli, VP; Eastwood, AL; Dougherty, DA; Horn, R; Ahern, CA				Santarelli, Vincent P.; Eastwood, Amy L.; Dougherty, Dennis A.; Horn, Richard; Ahern, Christopher A.			A cation-pi interaction discriminates among sodium channels that are either sensitive or resistant to tetrodotoxin block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL AMINO-ACIDS; BINDING-SITE; POTASSIUM CHANNEL; OUTER VESTIBULE; PORE REGION; NICOTINIC RECEPTOR; RAT SKELETAL; MUTAGENESIS; SAXITOXIN; SELECTIVITY	Voltage-gated sodium channels control the upstroke of the action potential in excitable cells of nerve and muscle tissue, making them ideal targets for exogenous toxins that aim to squelch electrical excitability. One such toxin, tetrodotoxin (TTX), blocks sodium channels with nanomolar affinity only when an aromatic Phe or Tyr residue is present at a specific location in the external vestibule of the ion-conducting pore. To test whether TTX is attracted to Tyr(401) of Na(V)1.4 through a cation-pi interaction, this aromatic residue was replaced with fluorinated derivatives of Phe using in vivo nonsense suppression. Consistent with a cation-pi interaction, increased fluorination of Phe, which reduces the negative electrostatic potential on the aromatic face, caused a monotonic increase in the inhibitory constant for block. Trifluorination of the aromatic ring decreased TTX affinity by similar to 50-fold, a reduction similar to that caused by replacement with the comparably hydrophobic residue Leu. Furthermore, we show that an energetically equivalent cation-pi interaction underlies both use-dependent and tonic block by TTX. Our results are supported by high level ab initio quantum mechanical calculations applied to a model of TTX binding to benzene. Our analysis suggests that the aromatic side chain faces the permeation pathway where it orients TTX optimally and interacts with permeant ions. These results are the first of their kind to show the incorporation of unnatural amino acids into a voltage-gated sodium channel and demonstrate that a cation-pi interaction is responsible for the obligate nature of an aromatic at this position in TTX-sensitive sodium channels.	Thomas Jefferson Univ, Jefferson Med Coll, Inst Hyperexcitabil, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Jefferson University; California Institute of Technology	Santarelli, VP (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Inst Hyperexcitabil, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA.	Christopher.Ahern@jefferson.edu	Tuluc, Petronel/C-2527-2011	Ahern, Christopher/0000-0002-7975-2744	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS034407] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM079427] Funding Source: Medline; NINDS NIH HHS [NS34407] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Boccaccio A, 1999, BIOPHYS J, V77, P229, DOI 10.1016/S0006-3495(99)76884-0; Bruhova I, 2005, BIOPHYS J, V89, P1020, DOI 10.1529/biophysj.105.062240; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; CHEN LQ, 1992, FEBS LETT, V309, P253, DOI 10.1016/0014-5793(92)80783-D; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Chiamvimonvat N, 1996, J PHYSIOL-LONDON, V491, P51, DOI 10.1113/jphysiol.1996.sp021195; Conti F, 1996, BIOPHYS J, V71, P1295, DOI 10.1016/S0006-3495(96)79330-X; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; EISENMAN G, 1962, Biophys J, V2, P259; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1975, BIOPHYS J, V15, P615, DOI 10.1016/S0006-3495(75)85842-5; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KONTIS KJ, 1993, MOL PHARMACOL, V43, P635; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McMenimen KA, 2006, ACS CHEM BIOL, V1, P227, DOI 10.1021/cb6000944; Mecozzi S, 1996, J AM CHEM SOC, V118, P2307, DOI 10.1021/ja9539608; Moran O, 2003, BIOPHYS J, V84, P2999, DOI 10.1016/S0006-3495(03)70026-5; Morikubo N, 2006, J AM CHEM SOC, V128, P13184, DOI 10.1021/ja063358p; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Penzotti JL, 1998, BIOPHYS J, V75, P2647, DOI 10.1016/S0006-3495(98)77710-0; Penzotti JL, 2001, BIOPHYS J, V80, P698, DOI 10.1016/S0006-3495(01)76049-3; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P4538, DOI 10.1021/bi00412a047; SALGADO VL, 1986, ANN NY ACAD SCI, V479, P84, DOI 10.1111/j.1749-6632.1986.tb15563.x; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Shahidullah M, 2003, BIOCHEMISTRY-US, V42, P11243, DOI 10.1021/bi034738f; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; WILLIAMS JH, 1993, ACCOUNTS CHEM RES, V26, P593, DOI 10.1021/ar00035a005; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	53	70	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8044	8051		10.1074/jbc.M611334200	http://dx.doi.org/10.1074/jbc.M611334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237232	hybrid, Green Accepted			2022-12-27	WOS:000245081000036
J	Farhan, H; Reiterer, V; Korkhov, VM; Schmid, JA; Freissmuth, M; Sitte, HH				Farhan, Hesso; Reiterer, Veronika; Korkhov, Vladimir M.; Schmid, Johannes A.; Freissmuth, Michael; Sitte, Harald H.			Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; OLIGOMER FORMATION; ORTHOSTATIC INTOLERANCE; FUNCTIONAL EXPRESSION; CARBOXYL-TERMINUS; C-TERMINUS; COPII; CARGO; PROTEINS; RECONSTITUTION	Re-uptake of gamma-aminobutyric acid (GABA) into presynaptic specializations is mediated by the GABA transporter 1 (GAT1), a member of the SLC6 gene family. Here, we show that a motif in the COOH terminus of GATI ((566) RL (567)), which is conserved in SLC6 family members, is a binding site for the COPII coat component Sec24D. We also identified residues in Sec24D (733 DD 734) that are required to support the interaction with GAT1 and two additional family members, i.e. the transporters for serotonin and dopamine. We used three strategies to prevent recruitment of Sec24D to GATI: knock-down of Sec24D by RNA interference, overexpression of Sec24D-VN (replacement of (DD734)-D-733 by (VN734)-V-733), and mutation of (RL567)-R-566 to (566)AS(567) (GATI-RL/AS). In each instance, endoplasmic reticulum (ER) export of GAT 1 was impaired: in the absence of Sec24D or upon coexpression of dominant negative Sec24D-VN, GAT1 failed to undergo concentrative ER export; GAT1-RL/AS also accumulated in the ER and exerted a dominant negative effect on cell surface targeting of wild type GATI. Our observations show that concentrative ER-export is contingent on a direct interaction of GATI with Sec24D; this also provides a mechanistic explanation for the finding that oligomeric assembly of transporters is required for their ER export: transporter oligomerization supports efficient recruitment of COPII components.	Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; Ctr Biomol Med & Pharmacol, Inst Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria		Freissmuth, M (corresponding author), Ctr Biomol Med & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Farhan, Hesso/C-7997-2012; Sitte, Harald/N-2681-2013; Schmid, Johannes A./C-7659-2009	Sitte, Harald/0000-0002-1339-7444; Farhan, Hesso/0000-0002-0889-8463; Sitte, Harald/0000-0002-1339-7444; Schmid, Johannes A./0000-0002-6586-3507; Freissmuth, Michael/0000-0001-9398-1765; Korkhov, Volodymyr/0000-0002-0962-9433				BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hahn MK, 2003, J NEUROSCI, V23, P4470; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Korkhov VM, 2004, J BIOL CHEM, V279, P55728, DOI 10.1074/jbc.M409449200; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; McHugh EM, 2004, MOL CELL NEUROSCI, V26, P406, DOI 10.1016/j.mcn.2004.03.006; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Sato K, 2003, MOL BIOL CELL, V14, P3055, DOI 10.1091/mbc.E03-02-0115; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135	33	85	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7679	7689		10.1074/jbc.M609720200	http://dx.doi.org/10.1074/jbc.M609720200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210573	hybrid			2022-12-27	WOS:000245080900080
J	Fok, PT; Huang, KC; Holland, PC; Nalbantoglu, J				Fok, Patrick T.; Huang, Kuo-Cheng; Holland, Paul C.; Nalbantoglu, Josephine			The coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BLADDER-CANCER; TIGHT JUNCTIONS; GENE-TRANSFER; B VIRUSES; EXPRESSION; CAR; ADHESION; DOMAIN; PROTEIN; CARCINOMA	The Coxsackie and adenovirus receptor (CAR), a cell adhesion molecule of the immunoglobulin superfamily, inhibits cell growth of a variety of tumors. The cytoplasmic domain of CAR has been implicated in decreased invasion and intracerebral growth of human U87 glioma cells. Using affinity binding, we identified tubulin as an interaction partner for the cytoplasmic domain of CAR. The interaction was specific; CAR and tubulin co-immunoprecipitated in cells expressing endogenous CAR and partially co-localized in situ. The binding of CAR to tubulin heterodimers and to microtubules was direct, with dissociation constants of similar to 1 mu M for tubulin and similar to 32 nM for in vitro assembled microtubules. Whereas CAR-expressing U87 glioma cells had decreased migration in a chemotactic assay in Boyden chambers as compared with control cells, an effect that depended on the presence of the cytoplasmic domain of CAR, the difference was abrogated at low, non-cytotoxic doses of the taxane paclitaxel, a microtubule-stabilizing agent. These results indicate that CAR may affect cell migration through its interaction with microtubules.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Expt Med, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Nalbantoglu, J (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	Josephine.nalbantoglu@mcgill.ca						Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Bazzoni G, 2005, J CELL SCI, V118, P623, DOI 10.1242/jcs.01661; Belotti D, 1996, CLIN CANCER RES, V2, P1725; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; CAHAN MA, 1994, CANCER CHEMOTH PHARM, V33, P441, DOI 10.1007/s002800050079; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chretien I, 1996, EUR J IMMUNOL, V26, P780, DOI 10.1002/eji.1830260409; Chretien I, 1998, EUR J IMMUNOL, V28, P4094; Cohen CJ, 2001, J BIOL CHEM, V276, P25392, DOI 10.1074/jbc.M009531200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; Freimuth P, 1999, J VIROL, V73, P1392, DOI 10.1128/JVI.73.2.1392-1398.1999; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fuxe J, 2003, INT J CANCER, V103, P723, DOI 10.1002/ijc.10891; Heath JK, 1997, P NATL ACAD SCI USA, V94, P469, DOI 10.1073/pnas.94.2.469; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Huang KC, 2005, INT J CANCER, V113, P738, DOI 10.1002/ijc.20623; Jee YS, 2002, ANTICANCER RES, V22, P2629; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Korn WM, 2006, CANCER GENE THER, V13, P792, DOI 10.1038/sj.cgt.7700947; Li DQ, 1999, CLIN CANCER RES, V5, P4175; Li YM, 1999, CANCER RES, V59, P325; Matsumoto K, 2005, UROLOGY, V66, P441, DOI 10.1016/j.urology.2005.02.033; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Nalbantoglu J, 1999, HUM GENE THER, V10, P1009, DOI 10.1089/10430349950018409; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Okegawa T, 2000, CANCER RES, V60, P5031; Okegawa T, 2001, CANCER RES, V61, P6592; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Pearson AS, 1999, CLIN CANCER RES, V5, P4208; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Perego C, 2002, J CELL SCI, V115, P3331; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Rauen KA, 2002, CANCER RES, V62, P3812; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Strohmaier AR, 2000, CELLS TISSUES ORGANS, V167, P1, DOI 10.1159/000016760; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; van't Hof W, 2002, J VIROL, V76, P6382, DOI 10.1128/JVI.76.12.6382-6386.2002; Wang XH, 1999, J VIROL, V73, P2559, DOI 10.1128/JVI.73.3.2559-2562.1999; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	60	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7512	7521		10.1074/jbc.M607230200	http://dx.doi.org/10.1074/jbc.M607230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210569	hybrid			2022-12-27	WOS:000245080900064
J	Katayama, H; Kusaka, Y; Yokota, H; Akao, T; Kojima, M; Nakamura, O; Mekada, E; Mizuki, E				Katayama, Hideki; Kusaka, Yoshitomo; Yokota, Haruo; Akao, Tetsuyuki; Kojima, Masayasu; Nakamura, Osamu; Mekada, Eisuke; Mizuki, Eiich			Parasporin-1, a novel cytotoxic protein from Bacillus thuringiensis, induces Ca2+ influx and a sustained elevation of the cytoplasmic Ca2+ concentration in toxin-sensitive cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION FACTOR-II; FACTOR RECEPTOR-BINDING; PLASMA-MEMBRANE; GROWTH-FACTOR; SF9 CELLS; CALCIUM-CHANNELS; CRYSTAL PROTEINS; DIPHTHERIA-TOXIN; SURAMIN ANALOGS; INHIBITS GROWTH	Parasporin-1 is a novel non-insecticidal inclusion protein from Bacillus thuringiensis that is cytotoxic to specific mammalian cells. In this study, we investigated the effects of parasporin-1 on toxinsensitive cell lines to elucidate the cytotoxic mechanism of parasporin-1. Parasporin-1 is not a membrane pore-forming toxin as evidenced by measurements of lactate dehydrogenase release, propidium iodide penetration, and membrane potential in parasporin-l-treated cells. Parasporin-1 decreased the level of cellular protein and DNA synthesis in parasporin-l-sensitive HeLa cells. The earliest change observed in cells treated with this toxin was a rapid elevation of the intracellular free-Ca2+ concentration; increases in the intracellular Ca2+ levels were observed 1-3 min following parasporin-1 treatment. Using four different cell lines, we found that the degree of cellular sensitivity to parasporin-1 was positively correlated with the size of the increase in the intracellular Ca2+ concentration. The toxin-induced elevation of the intracellular Ca2+ concentration was markedly decreased in low-Ca2+ buffer and was not observed in Ca2+-free buffer. Accordingly, the cytotoxicity of parasporin-1 decreased in the low-Ca2+ buffer and was restored by the addition of Ca2+ to the extracellular medium. Suramin, which inhibits trimeric G-protein signaling, suppressed both the Ca 21 influx and the cytotoxicity of parasporin-1. In parasporin-1-treated HeLa cells, degradation of pro-caspase-3 and poly(ADPribose) polymerase was observed. Furthermore, synthetic caspase inhibitors blocked the cytotoxic activity of parasporin-1. These results indicate that parasporin-1 activates apoptotic signaling in these cells as a result of the increased Ca2+ level and that the Ca2+ influx is the first step in the pathway that underlies parasporin-1 toxicity.	Fukuoka Ind Technol Ctr, Biotechnol & Food Res Inst, Kurume, Fukuoka 8390861, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390864, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Cell Biol, Suita, Osaka 5650871, Japan	Kurume University; Osaka University	Katayama, H (corresponding author), Fukuoka Ind Technol Ctr, Biotechnol & Food Res Inst, Kurume, Fukuoka 8390861, Japan.	hkatayam@fitc.pref.fukuoka.jp		Mekada, Eisuke/0000-0001-8858-4781				Beindl W, 1996, MOL PHARMACOL, V50, P415; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; CAHILL AL, 1988, NEUROSCI LETT, V84, P345, DOI 10.1016/0304-3940(88)90533-2; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P469, DOI 10.1113/jphysiol.1975.sp011026; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; GILL DL, 1989, CELL CALCIUM, V10, P363, DOI 10.1016/0143-4160(89)90062-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guihard G, 2000, J MEMBRANE BIOL, V175, P115, DOI 10.1007/s002320001060; GUNTER TE, 1990, AM J PHYSIOL, V258, P755; HOFTE H, 1989, MICROBIOL REV, V53, P242; HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310; Itagaki K, 2005, J LEUKOCYTE BIOL, V77, P181, DOI 10.1189/jlb.0704390; Ito A, 2004, J BIOL CHEM, V279, P21282, DOI 10.1074/jbc.M401881200; Katayama H, 2005, J BIOCHEM, V137, P17, DOI 10.1093/jb/mvi003; Kitada S, 2006, J BIOL CHEM, V281, P26350, DOI 10.1074/jbc.M602589200; KLOEN P, 1994, EUR J CANCER, V30A, P678, DOI 10.1016/0959-8049(94)90544-4; KOPP R, 1990, CANCER RES, V50, P6490; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DW, 2000, BIOCHEM BIOPH RES CO, V272, P218, DOI 10.1006/bbrc.2000.2765; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; MACKIE KP, 1989, J BIOL CHEM, V264, P1748; MCCARTHY RT, 1992, J NEUROSCI, V12, P2225; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; MEADOWS MP, 1992, APPL ENVIRON MICROB, V58, P1344, DOI 10.1128/AEM.58.4.1344-1350.1992; Mizuki E, 1999, J APPL MICROBIOL, V86, P477, DOI 10.1046/j.1365-2672.1999.00692.x; Mizuki E, 2000, CLIN DIAGN LAB IMMUN, V7, P625, DOI 10.1128/CDLI.7.4.625-634.2000; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; NAKAJIMA M, 1991, J BIOL CHEM, V266, P9661; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OHBA M, 1986, J INVERTEBR PATHOL, V47, P12, DOI 10.1016/0022-2011(86)90158-8; PAPINI E, 1988, EMBO J, V7, P3353, DOI 10.1002/j.1460-2075.1988.tb03207.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SPIGELMAN Z, 1987, CANCER RES, V47, P4694; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; UCHIDA T, 1973, J BIOL CHEM, V248, P3845; VACHON V, 1995, J MEMBRANE BIOL, V148, P57, DOI 10.1007/BF00234156; Villalon M, 1998, BBA-BIOMEMBRANES, V1368, P27, DOI 10.1016/S0005-2736(97)00184-3; VILLARROYA M, 1995, BRIT J PHARMACOL, V114, P369, DOI 10.1111/j.1476-5381.1995.tb13236.x; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Yamashita S, 2000, CAN J MICROBIOL, V46, P913, DOI 10.1139/cjm-46-10-913	52	35	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7742	7752		10.1074/jbc.M611382200	http://dx.doi.org/10.1074/jbc.M611382200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17204466	hybrid			2022-12-27	WOS:000245080900086
J	Morris, SA; Rao, B; Garcia, BA; Hake, SB; Diaz, RL; Shabanowitz, J; Hil, DF; Allis, CD; Lieb, JD; Strahl, BD				Morris, Stephanie A.; Rao, Bhargavi; Garcia, Benjamin A.; Hake, Sandra B.; Diaz, Robert L.; Shabanowitz, Jeffrey; Hil, Donald F.; Allis, C. David; Lieb, Jason D.; Strahl, Brian D.			Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL ELONGATION; ACETYLTRANSFERASE ACTIVITY; MASS-SPECTROMETRY; SAGA COMPLEX; GENOME-WIDE; METHYLATION; YEAST	Histone lysine acetylation is a major mechanism by which cells regulate the structure and function of chromatin, and new sites of acetylation continue to be discovered. Here we identify and characterize histone H3K36 acetylation (H3K36ac). By mass spectrometric analyses of H3 purified from Tetrahymena thermophila and Saccharomyces cerevisiae (yeast), we find that H3K36 can be acetylated or methylated. Using an antibody specific to H3K36ac, we show that this modification is conserved in mammals. In yeast, genome-wide ChIP-chip experiments show that H3K36ac is localized predominantly to the promoters of RNA polymerase II-transcribed genes, a pattern inversely related to that of H3K36 methylation. The pattern of H3K36ac localization is similar to that of other sites of H3 acetylation, including H3K9ac and H3K14ac. Using histone acetyltransferase complexes purified from yeast, we show that the Gcn5-containing SAGA complex that regulates transcription specifically acetylates H3K36 in vitro. Deletion of GCN5 completely abolishes H3K36ac in vivo. These data expand our knowledge of the genomic targets of Gcn5, show H3K36ac is highly conserved, and raise the intriguing possibility that the transition between H3K36ac and H3K36me acts as an "acetyl/methyl switch" governing chromatin function along transcription units.	Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; Rockefeller University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Strahl, BD (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Lieb, Jason/0000-0001-7601-8061	NIGMS NIH HHS [GM 68088, R01 GM072518-01A1, GM 072518, R01 GM037537, R01 GM068088, R01 GM072518-02, R01 GM072518, R01 GM040922, GM 37537, R01 GM068088-04, GM 40922] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, R01GM040922, R01GM068088, R01GM072518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Davie JR, 1999, J CELL BIOCHEM, P141; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; VANHOLDE KE, 1988, CHROMATIN, P111; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Yu YX, 2003, MOL CELL BIOL, V23, P1910, DOI 10.1128/MCB.23.6.1910-1921.2003; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	69	104	116	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7632	7640		10.1074/jbc.M607909200	http://dx.doi.org/10.1074/jbc.M607909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17189264	Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000245080900076
J	Ramya, TNC; Karmodiya, K; Surolia, A; Surolia, N				Ramya, T. N. C.; Karmodiya, Krishanpal; Surolia, Avadhesha; Surolia, Namita			15-deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION FACTOR-II; ENOYL-ACP REDUCTASE; MALARIA; INHIBITION; SEQUENCE; PHOSPHORYLATION; DEOXYSPERGUALIN; IDENTIFICATION; BIOSYNTHESIS; LOCALIZATION	15-Deoxyspergualin, an immunosuppressant with tumoricidal and antimalarial properties, has been implicated in the inhibition of a diverse array of cellular processes including polyamine synthesis and protein synthesis. Endeavoring to identify the mechanism of antimalarial action of this molecule, we examined its effect on Plasmodiunifalciparum protein synthesis, polyamine biosynthesis, and transport. 15-Deoxyspergualin stalled protein synthesis in P.falciparum through Hsp70 sequestration and subsequent phosphorylation of the eukaryotic initiation factor eff2a. However, protein synthesis inhibition as well as polyamine depletion were invoked only by high micromolar concentrations of 15-deoxyspergualin, in contrast to the submicromolar concentrations sufficient to inhibit parasite growth. Further investigations demonstrated that 15-deoxyspergualin in the malaria parasite primarily targets the hitherto underexplored process of trafficking of nucleus-encoded proteins to the apicoplast. Our finding that 15-deoxyspergualin kills the malaria parasite by interfering with targeting of nucleus-encoded. proteins to the apicoplast not only exposes a chink in the armor of the malaria parasite, but also reveals new realms in our endeavors to study this intriguing biological process.	Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; Indian Inst Sci, Bangalore 560012, Karnataka, India; Natl Inst Immunol, New Delhi 110067, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Surolia, N (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	surolia@nii.res.in	Chakravarthy, Ramya/F-8924-2010; SUROLIA, AVADESHA/C-5442-2009; Chakravarthy, Ramya T. N./AAJ-7507-2021	Karmodiya, Krishanpal/0000-0002-5714-0587				AMORIM HV, 1977, J AGR FOOD CHEM, V25, P957, DOI 10.1021/jf60212a047; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; HBATNAGAR P, 2001, PLANT PHYSIOL, V125, P2139; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kapoor M, 2001, BIOCHEM BIOPH RES CO, V289, P832, DOI 10.1006/bbrc.2001.6061; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; MATTS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2559, DOI 10.1073/pnas.80.9.2559; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Midorikawa Y, 1998, CHEMOTHERAPY, V44, P409, DOI 10.1159/000007152; Midorikawa Y, 1997, CHEMOTHERAPY, V43, P31, DOI 10.1159/000239532; Mohrle JJ, 1997, BIOCHEM J, V328, P677; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Nishimura K, 2002, BIOCHEM J, V363, P761, DOI 10.1042/0264-6021:3630761; PRICE NT, 1991, BIOCHEM BIOPH RES CO, V176, P993, DOI 10.1016/0006-291X(91)90380-P; Ramya TNC, 2007, BIOCHEM J, V401, P411, DOI 10.1042/BJ20060879; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P579, DOI 10.1016/j.bbrc.2006.07.127; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Sato S, 2002, CURR GENET, V40, P391, DOI 10.1007/s00294-002-0273-3; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; SUROLIA N, 1991, P NATL ACAD SCI USA, V88, P4786, DOI 10.1073/pnas.88.11.4786; Thulasiraman V, 1998, EUR J BIOCHEM, V255, P552, DOI 10.1046/j.1432-1327.1998.2550552.x; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	40	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6388	6397		10.1074/jbc.M610251200	http://dx.doi.org/10.1074/jbc.M610251200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194705	hybrid			2022-12-27	WOS:000244867200046
J	Watanabe, S; Yamada, M; Ohtsu, I; Makino, K				Watanabe, Seiya; Yamada, Masaki; Ohtsu, Iwao; Makino, Keisuke			alpha-Ketoglutaric semialclehyde dehydrogenase isozymes involved in metabolic pathways of D-glucarate, D-galactarate, and hydroxy-L-proline - Molecular and metabolic convergent evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINOSE METABOLISM; METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALTERNATIVE PATHWAY; VIBRIO-HARVEYI; BACILLUS-SUBTILIS; IDENTIFICATION; PSEUDOMONAS; CLONING; ENZYME	Azospirillum brasilense possesses an alternative pathway of L-arabinose metabolism in which alpha-ketoglutaric semialdehyde (alpha KGSA) dehydrogenase (KGSADH) is involved in the last step, the conversion of alpha KGSA to alpha-ketoglutarate. In the preceding studies, we identified a set of metabolic genes of the L-arabinose pathway including the KGSADH gene (Watanabe, S., Kodaki, T., and Makino, K. (2006) J. Biol. Chem. 281, 2612-2623; Watanabe, S., Kodaki, T., and Makino, K. (2006) J. Biol. Chem. 281, 28876-28888; Watanabe, S., Shimada, N., Tajima, K., Kodaki, T., and Makino, K. (2006) J. Biol. Chem. 281, 3352133536). Here, we describe that A. brasilense possesses two different KGSADH isozymes from L-arabinose-related enzyme (KGSADH-I); that is, D-glucarate/D-galactarate-inducible KGSADH-II and hydroxy-L-proline-inducible KGSADH-III. They were purified homogeneously from A. brasilense cells grown on D-galactarate or hydroxy-L-proline, respectively. When compared with KGSADH-I, amino acid sequences of KGSADH-II and KGSADH-III were significantly similar but not totally identical. Physiological characterization using recombinant enzymes revealed that KGSADH-II and KGSADH-III showed similar high substrate specificity for alpha KGSA and different coenzyme specificity; that is, NAD(+)-dependent KGSADH-II and NADP(+)-dependent KGSADH-III. In the phylogenetic tree of the aldehyde dehydrogenase (ALDH) superfamily, KGSADH-II and KGSADH-III were poorly related to the known ALDH subclasses including KGSADH-I. On the other hand, ALDH-like ycbD protein involved in D-glucarate/D-galactarate operon from Bacillus subtilis is closely related to the methylmalonyl semialdehyde dehydrogenase subclass but not A. brasilense KGSADH isozymes. To estimate the correct function, the corresponding gene was expressed, purified, and characterized. Kinetic analysis revealed the physiological role as NADP(+)-dependent KGSADH. We conclude that three different types of KGSADH appeared in the bacterial evolutional stage convergently. Furthermore, even the same pathway such as L-arabinose and D-glucarate/D-galactarate metabolism also evolved by the independent involvement of KGSADH.	Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; Kyoto Univ, Fac Engn, Saikyo Ku, Kyoto 6158530, Japan; Japan Sci & Technol Agcy, CREST, Uji, Kyoto 6110011, Japan; Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Life Sci Lab, Nakagyo Ku, Kyoto 6048511, Japan; Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Shimadzu Corporation; Kyoto University	Watanabe, S (corresponding author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	irab@iae.kyoto-u.ac.jp; kmak@iae.kyoto-u.ac.jp		Ohtsu, Iwao/0000-0002-3553-0306				ADAMS E, 1967, J BIOL CHEM, V242, P1802; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; BOGNAR AL, 1978, J BIOL CHEM, V253, P446; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; CHANG YF, 1977, J BIOL CHEM, V252, P7979; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; DAGLEY S, 1965, BIOCHEM J, V95, P48, DOI 10.1042/bj0950048; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DUNCAN MJ, 1979, J GEN MICROBIOL, V113, P177, DOI 10.1099/00221287-113-1-177; DUNCAN MJ, 1979, J BACTERIOL, V137, P415, DOI 10.1128/JB.137.1.415-419.1979; EKLUND H, 1984, BIOCHEMISTRY-US, V23, P5982, DOI 10.1021/bi00320a014; GENNADY PM, 2002, HDB DETECTION ENZYME, P27; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; Hosoya S, 2002, FEMS MICROBIOL LETT, V210, P193, DOI 10.1111/j.1574-6968.2002.tb11180.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; IMANAKA T, 1993, J FERMENT BIOENG, V76, P161, DOI 10.1016/0922-338X(93)90001-O; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; KEDISHVILI NY, 1992, J BIOL CHEM, V267, P19724; KOO PH, 1974, J BIOL CHEM, V249, P1704; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHIAS AL, 1989, J BACTERIOL, V171, P5206, DOI 10.1128/jb.171.9.5206-5209.1989; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Moore S, 1940, J BIOL CHEM, V133, P293; NOVICK NJ, 1982, J BACTERIOL, V149, P364, DOI 10.1128/JB.149.1.364-367.1982; PEDROSA FO, 1974, J BACTERIOL, V119, P336, DOI 10.1128/JB.119.1.336-338.1974; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; SINGH RMM, 1964, SCIENCE, V144, P67, DOI 10.1126/science.144.3614.67; STEPHENS C, 2007, IN PRESS J BACTERIOL; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; STRYER L, 1988, BIOCHEMISTRY-US, P805; Vedadi M, 1995, BIOCHEMISTRY-US, V34, P16725, DOI 10.1021/bi00051a022; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; WELMBERG R, 1955, J BIOL CHEM, V217, P607; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g	39	42	49	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6685	6695		10.1074/jbc.M611057200	http://dx.doi.org/10.1074/jbc.M611057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202142	hybrid			2022-12-27	WOS:000244867200078
J	Sen, A; Baxa, U; Simon, MN; Wall, JS; Sabate, R; Saupe, SJ; Steven, AC				Sen, Anindito; Baxa, Ulrich; Simon, Martha N.; Wall, Joseph S.; Sabate, Raimon; Saupe, Sven J.; Steven, Alasdair C.			Mass analysis by scanning transmission electron microscopy and electron diffraction validate predictions of stacked beta-solenoid model of HET-s prion fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS PODOSPORA-ANSERINA; IN-VITRO; HETEROKARYON INCOMPATIBILITY; HYDROGEN/DEUTERIUM EXCHANGE; PROTEIN; DOMAIN; URE2P; SUP35; FILAMENTS; ORGANIZATION	Fungal prions are infectious filamentous polymers of proteins that are soluble in uninfected cells. In its prion form, the HET-s protein of Podospora anserina participates in a fungal self/nonself recognition phenomenon called heterokaryon incompatibility. Like other prion proteins, HET-s has a so-called "prion domain" (its C-terminal region, HET-s-(218-289)) that is responsible for induction and propagation of the prion in vivo and for fibril formation in vitro. Prion fibrils are thought to have amyloid backbones of polymerized prion domains. A relatively detailed model has been proposed for prion domain fibrils of HET-s based on a variety of experimental constraints (Ritter, C., Maddelein, M. L., Siemer, A. B., Luhrs, T., Ernst, M., Meier, B. H., Saupe, S. J., and Riek, R. (2005) Nature 435, 844 - 848). To test specific predictions of this model, which envisages axial stacking of beta-solenoids with two coils per subunit, we examined fibrils by electron microscopy. Electron diffraction gave a prominent meridional reflection at (0.47 nm)(-1), indicative of cross-P structure, as predicted. STEM (scanning transmission electron microscopy) mass-per-unit-length measurements yielded 1.02 +/- 0.16 subunits per 0.94 nm, in agreement with the model prediction (I subunit per 0.94 nm). This is half the packing density of similar to I subunit per 0.47 nm previously obtained for fibrils of the yeast prion proteins, Ure2p and Sup35p, whence it follows that the respective amyloid architectures are basically different.	NIH, Struct Biol Lab, Bethesda, MD 20892 USA; NIH, NIAMSD, Bethesda, MD 20892 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Univ Bordeaux 2, CNRS, UMR 5095,Inst Biochim & Genet Cellulaire, Lab Genet Mol Champignons, F-33077 Bordeaux, France	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); Brookhaven National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Steven, AC (corresponding author), NIH, Struct Biol Lab, Bldg 50,Rm 1517,50 S Dr MSC 8025, Bethesda, MD 20892 USA.	Alasdair_Steven@nih.gov	; sabate, raimon/I-7849-2014	Baxa, Ulrich/0000-0002-7263-5078; sabate, raimon/0000-0003-3894-2362; saupe, sven/0000-0002-5589-721X	Intramural NIH HHS Funding Source: Medline; NIBIB NIH HHS [5 P41 EB2181] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002181] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Balguerie A, 2004, J CELL SCI, V117, P2599, DOI 10.1242/jcs.01116; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Derkatch IL, 1996, GENETICS, V144, P1375; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6; Nazabal A, 2005, J BIOL CHEM, V280, P13220, DOI 10.1074/jbc.M413185200; Nazabal A, 2003, BIOCHEMISTRY-US, V42, P8852, DOI 10.1021/bi0344275; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8; Trus BL, 1996, J STRUCT BIOL, V116, P61, DOI 10.1006/jsbi.1996.0011; TURCQ B, 1991, MOL GEN GENET, V228, P265, DOI 10.1007/BF00282475; Wall JS, 2000, METH MOL B, V148, P589; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002	41	71	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5545	5550		10.1074/jbc.M611464200	http://dx.doi.org/10.1074/jbc.M611464200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178708	hybrid			2022-12-27	WOS:000244482300050
J	Wu, CY; Chen, CL; Lee, YH; Cheng, YC; Wu, YC; Shu, HY; Gotz, F; Liu, ST				Wu, Cheng-Yeu; Chen, Chyi-Liang; Lee, Yu-Hsiu; Cheng, Yu-Chieh; Wu, Ying-Chung; Shu, Hung-Yu; Goetz, Friedrich; Liu, Shih-Tung			Nonribosomal synthesis of fengycin on an enzyme complex formed by fengycin synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIFUNCTIONAL PEPTIDE SYNTHETASES; GRAMICIDIN-S-SYNTHETASE; BACILLUS-SUBTILIS F-29-3; BIOCHEMICAL-CHARACTERIZATION; MACROCYCLIC PEPTIDES; CONDENSATION DOMAIN; POLYACRYLAMIDE-GELS; MODULAR STRUCTURE; ESCHERICHIA-COLI; BIOSYNTHESIS	Fengycin, a lipopeptidic antibiotic, is synthesized nonribosomally by five fengycin synthetases (FenC, FenD, FenE, FenA, and FenB) in Bacillus subtilis F29-3. This work demonstrates that these fengycin synthetases interlock to form a chain, which coils into a 14.5-nm structure. In this chain, fengycin synthetases are linked in the order FenC-FenD-FenE-FenA-FenB by interactions between the C-terminal region of an upstream enzyme and the N-terminal region of its downstream partner enzyme, with their amino acid activation modules arranged colinearly with the amino acids in fengycin. This work also reveals that fengycin is synthesized on this fengycin synthetase chain, explaining how fengycin is synthesized efficiently and accurately. The results from this investigation demonstrate that forming a peptide synthetase complex is crucial to nonribosomal peptide synthesis.	Chang Gung Univ, Dept Microbiol & Immunol, Mol Genet Lab, Tao Yuan 333, Taiwan; Univ Tubingen, Inst Biol, AG Mikbrobielle Genet, D-70276 Tubingen, Germany	Chang Gung University; Eberhard Karls University of Tubingen	Liu, ST (corresponding author), Chang Gung Univ, Dept Microbiol & Immunol, Mol Genet Lab, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	cgliu@mail.cgu.edu.tw	Chen, Chyi-Liang/GVT-1758-2022	Shu, Hung-Yu/0000-0002-2213-9324; Chen, Chyi-Liang/0000-0003-4591-0924; Wu, Cheng-Yeu/0000-0002-1545-0835				BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; CHANG LK, 1994, GENE, V150, P129; CHEN CL, 1995, MOL GEN GENET, V248, P121, DOI 10.1007/BF02190792; Chiocchini C, 2006, CHEM BIOL, V13, P899, DOI 10.1016/j.chembiol.2006.06.015; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P1293, DOI 10.1073/pnas.70.5.1293; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; Hoppert M, 2001, ARCH MICROBIOL, V176, P285, DOI 10.1007/s002030100324; Hori K, 1997, J BIOCHEM-TOKYO, V122, P606; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Klein DL, 1995, MICROB DRUG RESIST, V1, P49, DOI 10.1089/mdr.1995.1.49; Kleinkauf H, 1997, Prog Drug Res, V48, P27; Kleinkauf Horst, 2000, Biofactors, V11, P91; KOISCHWITZ H, 1976, BIOCHIM BIOPHYS ACTA, V429, P1041, DOI 10.1016/0005-2744(76)90349-1; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Li GH, 1998, J BACTERIOL, V180, P1338, DOI 10.1128/JB.180.5.1338-1341.1998; Lin TP, 2005, BBA-GENE STRUCT EXPR, V1730, P159, DOI 10.1016/j.bbaexp.2005.02.005; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Linne U, 2000, BIOCHEMISTRY-US, V39, P10439, DOI 10.1021/bi000768w; Linne U, 2003, BIOCHEMISTRY-US, V42, P5114, DOI 10.1021/bi034223o; LOEFFLER W, 1986, J PHYTOPATHOL, V115, P204, DOI 10.1111/j.1439-0434.1986.tb00878.x; Luo LS, 2002, BIOCHEMISTRY-US, V41, P9184, DOI 10.1021/bi026047+; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Sambrook J., 2001, MOL CLONING LAB MANU; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shu HY, 2002, BIOCHEM BIOPH RES CO, V292, P789, DOI 10.1006/bbrc.2002.6729; Sieber SA, 2004, ANGEW CHEM INT EDIT, V43, P493, DOI 10.1002/anie.200352787; Sieber SA, 2003, J BACTERIOL, V185, P7036, DOI 10.1128/JB.185.24.7036-7043.2003; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; STACHELHAUS T, 1995, FEMS MICROBIOL LETT, V125, P3, DOI 10.1111/j.1574-6968.1995.tb07328.x; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; Tschen J. S. M., 1987, Transactions of the Mycological Society of Japan, V28, P483; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; vonDohren H, 1997, CHEM REV, V97, P2675, DOI 10.1021/cr9600262	43	43	54	5	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5608	5616		10.1074/jbc.M609726200	http://dx.doi.org/10.1074/jbc.M609726200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182617	hybrid			2022-12-27	WOS:000244482300057
J	Zhang, LL; Pan, XY; Hershey, JWB				Zhang, Lili; Pan, Xiaoyu; Hershey, John W. B.			Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; NEOPLASTIC TRANSFORMATION; BINDING PROTEIN; TUMOR-FORMATION; UP-REGULATION; HELA-CELLS; EXPRESSION; AMPLIFICATION; BREAST	Transcriptional and post-transcriptional regulatory mechanisms are commonly accepted paradigms of tumorigenesis. The view is emerging that deregulation of translation contributes importantly to cancer development, a role not generally appreciated before. Eukaryotic initiation factor eIF3 contains at least thirteen non-identical subunits, named from eIF3a to eIF3m, and plays an essential role in the rate-limiting initiation phase of translation. Increased mRNA and protein levels of the eIF3a, -3b, -3c, -3h, and -3i subunits have been detected in a wide variety of human tumors and are frequently identified as prognostic biomarkers for poor clinical outcome. However, it remains to be established whether up-regulation of eIF3 subunits is a consequence or a cause of the malignant phenotypes. Here we report that ectopic expression of eIF3a, -3b, -3c, -3h, or -3i in stably transfected NlH3T3 cells leads to a number of oncogenic properties: decreased doubling times, increased clonogenicity and viability, facilitated S-phase entry, attenuation of apoptosis, formation of transformed foci, and anchorage-independent growth. Only overexpression of the transforming subunits results in a stimulation of initiation and global protein synthesis rates and enhanced translation of poorly translated mRNAs that encode growth-regulating proteins, including cyclinD1, c-Myc, fibroblast growth factor-2, and ornithine decarboxylase, which may be responsible for oncogenic malignancy in the transformed cell lines. Based on these results, we hypothesize that eIF3 contributes to hyperactivation of the translation initiation machinery and thereby may play an important role in neoplasia. Cancer cells appear to require an aberrantly activated translational state to survive, suggesting that the initiation factors may be promising therapeutic targets for treating cancer.	Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Mol & Cell Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hershey, JWB (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, 1 Shields Ave, Davis, CA 95616 USA.	jwhershey@ucdavis.edu						AVDULOV S, 2004, CANCER CELL, P553; Bachmann F, 1997, CANCER RES, V57, P988; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; BROWNLUEDI ML, 1982, BIOCHEMISTRY-US, V21, P4202, DOI 10.1021/bi00261a002; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; CHANG H, 1976, P NATL ACAD SCI USA, V73, P3206, DOI 10.1073/pnas.73.9.3206; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Joseph P, 2004, MOL CELL BIOCHEM, V255, P93, DOI 10.1023/B:MCBI.0000007265.38475.f7; Joseph P, 2002, CANCER RES, V62, P703; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lin L, 2001, J CELL BIOCHEM, V80, P483, DOI 10.1002/1097-4644(20010315)80:4<483::AID-JCB1002>3.0.CO;2-B; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Marchetti A, 2001, INT J ONCOL, V18, P175; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Miyazaki S, 1997, GENOMICS, V46, P155, DOI 10.1006/geno.1997.4996; Morris-Desbois C, 2001, J BIOL CHEM, V276, P45988, DOI 10.1074/jbc.M104966200; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Nupponen NN, 1999, AM J PATHOL, V154, P1777, DOI 10.1016/S0002-9440(10)65433-8; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Raught B, 1996, CANCER RES, V56, P4382; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Rothe M, 2000, AM J PATHOL, V157, P1597, DOI 10.1016/S0002-9440(10)64797-9; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saramaki O, 2001, AM J PATHOL, V159, P2089, DOI 10.1016/S0002-9440(10)63060-X; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zimmer SG, 2000, ANTICANCER RES, V20, P1343	48	151	164	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5790	5800		10.1074/jbc.M606284200	http://dx.doi.org/10.1074/jbc.M606284200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17170115	hybrid			2022-12-27	WOS:000244482300075
J	Xiong, Y; Collins, QF; An, J; Lupo, E; Liu, HY; Liu, DL; Robidoux, J; Liu, ZQ; Cao, WH				Xiong, Yan; Collins, Qu Fan; An, Jie; Lupo, Edgar, Jr.; Liu, Hui-Yu; Liu, Delong; Robidoux, Jacques; Liu, Zhenqi; Cao, Wenhong			p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-2; FATTY-ACID SYNTHESIS; STIMULATED GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; MAP-KINASE; RAT HEPATOCYTES; TRANSGENIC MICE; GLUT4 TRANSLOCATION; COACTIVATOR PGC-1	Hepatic lipogenesis is the principal route to convert excess carbohydrates into fatty acids and is mainly regulated by two opposing hormones, insulin and glucagon. Although insulin stimulates hepatic lipogenesis, glucagon inhibits it. However, the mechanism by which glucagon suppresses lipogenesis remains poorly understood. In this study, we have observed that p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. Levels of plasma triglyceride and triglyceride accumulation in the liver were both elevated when p38 activation was blocked. Expression levels of central lipogenic genes, including sterol regulatory element-binding protein-1 (SREBP-1), fatty acid synthase, hydroxy-3-methylglutaryl coenzyme A reductase, farnesyl pyrophosphate synthase, and cytochrome P-450-51, were decreased in liver by fasting and in primary hepatocytes by glucagon but increased by the inhibition of p38. In addition, we have shown that p38 can inhibit insulin-induced expression of key lipogenic genes in isolated hepatocytes. Our results in hepatoma cells demonstrate that p38 plays an inhibitory role in the activation of the SREBP-1c promoter. Finally, we have shown that transcription of the PGC-1 beta gene, a key coactivator of SREBP-lc, was reduced in liver by fasting and in isolated hepatocytes by glucagon. This reduction was significantly reversed by the blockade of p38. Insulin-induced expression of the PGC-1 gamma gene was enhanced by the inhibition of p38 but suppressed by the activation of p38. Together, we have identified an inhibitory role for p38 in the transcription of central lipogenic genes, SREBPs, and PGC-1 beta and hepatic lipogenesis.	Hammer Inst Hlth Sci, Endocrine Biol Program, Res Triangle Pk, NC 27709 USA; Hammer Inst Hlth Sci, Ctr Integrated Genom, Res Triangle Pk, NC 27709 USA; Cent S Univ, Sarah W Stedman Ctr Nutr & Metab, Changsha 410078, Peoples R China; Cent S Univ, Dept Pharmacol, Sch Pharmaceut Sci, Changsha 410078, Peoples R China; Univ Virginia, Hlth Sci Ctr, Dept Internal Med, Div Endocrinol, Charlottesville, VA 22908 USA; Duke Univ, Med Ctr, Dept Internal Med, Div Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; The Hamner Institutes for Health Sciences; Central South University; Central South University; University of Virginia; Duke University	Cao, WH (corresponding author), Hammer Inst Hlth Sci, Endocrine Biol Program, 6 Davis Dr,POB 12137, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org		Robidoux, JAcques/0000-0002-4809-4734				Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bazuine M, 2003, EUR J BIOCHEM, V270, P3891, DOI 10.1046/j.1432-1033.2003.03771.x; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Cahill GF., 1976, GLUCONEOGENESIS ITS, P515; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; COOPER AD, 1996, HEPATOLOGY TXB LIVER, V1, P92; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Harris R A, 1979, Adv Exp Med Biol, V111, P17; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; KEDDERIS GL, 1988, TOXICOL APPL PHARM, V93, P403, DOI 10.1016/0041-008X(88)90043-9; Konrad D, 2002, DIABETES, V51, P2719, DOI 10.2337/diabetes.51.9.2719; Kotzka J, 2000, J LIPID RES, V41, P99; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Kotzka J, 1998, BIOCHEM BIOPH RES CO, V249, P375, DOI 10.1006/bbrc.1998.9161; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lerin C, 2003, DIABETES, V52, P2221, DOI 10.2337/diabetes.52.9.2221; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; Miserez AR, 1997, GENOMICS, V40, P31, DOI 10.1006/geno.1996.4525; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Richter EA, 2004, P NUTR SOC, V63, P211, DOI 10.1079/PNS2004343; Rincon M, 2000, IMMUNOL CELL BIOL, V78, P166, DOI 10.1046/j.1440-1711.2000.00900.x; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Somwar R, 2002, J BIOL CHEM, V277, P50386, DOI 10.1074/jbc.M205277200; Spector MS, 1997, MOL CELL BIOL, V17, P3556, DOI 10.1128/MCB.17.7.3556; Suzuki T, 2001, J BIOL CHEM, V276, P27511, DOI 10.1074/jbc.M011726200; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	60	75	88	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4975	4982		10.1074/jbc.M606742200	http://dx.doi.org/10.1074/jbc.M606742200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17172644	hybrid			2022-12-27	WOS:000244482000080
J	Fan, XD; Patera, AC; Pong-Kennedy, A; Deno, G; Gonsiorek, W; Manfra, DJ; Vassileva, G; Zeng, M; Jackson, C; Sullivan, L; Sharif-Rodriguez, W; Opdenakker, G; Van Damme, J; Hedrick, JA; Lundell, D; Lira, SA; Hipkin, RW				Fan, Xuedong; Patera, Andriani C.; Pong-Kennedy, Amy; Deno, Gregory; Gonsiorek, Waldemar; Manfra, Denise J.; Vassileva, Galya; Zeng, Ming; Jackson, Craig; Sullivan, Lee; Sharif-Rodriguez, Wanda; Opdenakker, Ghislain; Van Damme, Jo; Hedrick, Joseph A.; Lundell, Daniel; Lira, Sergio A.; Hipkin, R. William			Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; COLLAGEN-INDUCED ARTHRITIS; BIOLOGICAL CHARACTERIZATION; CHEMOKINE RECEPTOR; IL-8 RECEPTOR; MOUSE HOMOLOG; CC-CHEMOKINE; IN-VITRO; NEUTROPHIL; CLONING	Functional interleuin-8 ( IL-8) receptors ( IL-8RA and IL-8RB: CXCR1 and CXCR2, respectively) have been described in human, monkey, dog, rabbit, and guinea pig. Although three IL-8R homologues have been found in rat, only one of these, rat CXCR2, appears to be functional based on responsiveness to ligands. Similarly, CXC chemokines induce biological responses through the murine homolog of CXCR2, but the identification of functional rodent CXCR1 homologues has remained elusive. We have identified and characterized the mouse CXCR1 homologue ( mCXCR1). Murine CXCR1 shares 68 and 88% amino acid identity with its human and rat counterparts, respectively. Similar to the tissue distribution pattern of rat CXCR1, we found murine CXCR1 mRNA expression predominantly in lung, stomach, bone marrow, and leukocyte-rich tissues. In contrast to previous reports, we determined that mCXCR1 is a functional receptor. We show predominant engagement of this receptor by mouse GCP-2/CXCL6, human GCP-2, and IL-8/CXCL8 by binding, stimulation of GTP gamma S exchange, and chemotaxis of mCXCR1-transfected cells. Furthermore, murine CXCR1 is not responsive to the human CXCR2 ligands ENA-78/CXCL5, NAP-2/CXCL7, GRO-alpha, -beta, -gamma/CXCL1-3, or rat CINC-1-3. In addition, we show concomitant elevation of mCXCR1 and its proposed major ligand, GCP-2, positively correlated with paw swelling in murine collagen-induced arthritis. This report represents the first description of a functional CXCR1-like receptor in rodents.	Schering Plough Res Inst, Dept Inflammat, Kenilworth, NJ 07033 USA; Schering Plough Res Inst, Discovery Technol Dept, Kenilworth, NJ 07033 USA; Univ Louvain, Lab Mol Immunol, Rega Inst Med Res, B-3000 Louvain, Belgium; Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Merck & Company; Schering-Plough Research Institute; Merck & Company; Schering-Plough Research Institute; KU Leuven; Icahn School of Medicine at Mount Sinai	Hipkin, RW (corresponding author), Schering Plough Res Inst, Dept Inflammat, K15 E332C-3945, Kenilworth, NJ 07033 USA.	william.hipkin@spcorp.com	Zeng, Ming/GXF-3628-2022; Vassileva, Galya/A-6807-2009; Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017	Zeng, Ming/0000-0003-2836-9240; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Van Damme, Jo/0000-0002-6707-1167				BOZIC CR, 1994, J BIOL CHEM, V269, P29355; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Catusse J, 2004, BIOCHEM PHARMACOL, V68, P1947, DOI 10.1016/j.bcp.2004.07.003; Catusse J, 2003, BIOCHEM PHARMACOL, V66, P1171, DOI 10.1016/S0006-2952(03)00459-3; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; CHATHAM WW, 1993, ARTHRITIS RHEUM, V36, P51; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chou CC, 2002, BRIT J PHARMACOL, V137, P663, DOI 10.1038/sj.bjp.0704907; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Cuzzocrea S, 2003, ARTHRITIS RHEUM-US, V48, P3544, DOI 10.1002/art.11351; Cuzzocrea S, 2005, ARTHRITIS RHEUM, V52, P940, DOI 10.1002/art.20875; Dunstan CAN, 1996, J BIOL CHEM, V271, P32770, DOI 10.1074/jbc.271.51.32770; Froyen G, 1997, EUR J BIOCHEM, V243, P762, DOI 10.1111/j.1432-1033.1997.00762.x; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Goczalik IM, 2005, J NEUROIMMUNOL, V161, P49, DOI 10.1016/j.jneuroim.2004.12.004; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Gonsiorek W, 2003, J IMMUNOL METHODS, V273, P15, DOI 10.1016/S0022-1759(02)00415-5; HARADA A, 1994, GENE, V142, P297, DOI 10.1016/0378-1119(94)90278-X; Hipkin RW, 1997, J BIOL CHEM, V272, P13869, DOI 10.1074/jbc.272.21.13869; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; LEE J, 1995, J IMMUNOL, V155, P2158; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nomiyama H, 2003, J INTERF CYTOK RES, V23, P37, DOI 10.1089/10799900360520432; Struyf S, 2001, BLOOD, V97, P2197, DOI 10.1182/blood.V97.8.2197; Svanborg C, 2001, ANN MED, V33, P563, DOI 10.3109/07853890109002101; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Van Coillie E, 2001, AM J PATHOL, V159, P1405, DOI 10.1016/S0002-9440(10)62527-8; Wuyts A, 2000, BIOCHEMISTRY-US, V39, P14549, DOI 10.1021/bi0011227; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1996, J IMMUNOL, V157, P1736; Wuyts A, 1997, BIOCHEMISTRY-US, V36, P2716, DOI 10.1021/bi961999z	36	155	158	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2007	282	16					11658	11666		10.1074/jbc.M607705200	http://dx.doi.org/10.1074/jbc.M607705200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LK	17197447	hybrid			2022-12-27	WOS:000245941900007
J	Schiffer, NW; Broadley, SA; Hirschberger, T; Tavan, P; Kretzschmar, HA; Giese, A; Haass, C; Hartl, FU; Schmid, B				Schiffer, Niclas W.; Broadley, Sarah A.; Hirschberger, Thomas; Tavan, Paul; Kretzschmar, Hans A.; Giese, Armin; Haass, Christian; Hartl, F. Ulrich; Schmid, Bettina			Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; IN-VIVO; MOLECULAR-DYNAMICS; DRUG DISCOVERY; BODY FORMATION; TOXICITY; THERAPEUTICS; DISORDERS	Several neurodegenerative diseases, including Huntington disease (HD), are associated with aberrant folding and aggregation of polyglutamine (polyQ expansion proteins. Here we established the zebrafish, Danio rerio, as a vertebrate HD model permitting the screening for chemical suppressors of polyQ aggregation and toxicity. Upon expression in zebrafish embryos, polyQ-expanded fragments of huntingtin (htt) accumulated in large SDS-insoluble inclusions, reproducing a key feature of HD pathology. Real time monitoring of inclusion formation in the living zebrafish indicated that inclusions grow by rapid incorporation of soluble htt species. Expression of mutant htt increased the frequency of embryos with abnormal morphology and the occurrence of apoptosis. Strikingly, apoptotic cells were largely devoid of visible aggregates, suggesting that soluble oligomeric precursors may instead be responsible for toxicity. As in nonvertebrate polyQ disease models, the molecular chaperones, Hsp40 and Hsp70, suppressed both polyQ aggregation and toxicity. Using the newly established zebrafish model, two compounds of the N'-benzylidene-benzohydrazide class directed against mammalian prion proved to be potent inhibitors of polyQ aggregation, consistent with a common structural mechanism of aggregation for prion and polyQ disease proteins.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; Univ Munich, Ctr Neuropathol & Prion Res, D-80336 Munich, Germany; Univ Munich, Chair BioMol Opt, Dept Phys, D-80538 Munich, Germany	Max Planck Society; University of Munich; University of Munich; University of Munich	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; Bettina.Schmid@med.uni-muenchen.de	Giese, Armin/F-3271-2010; Hartl, F. Ulrich/Y-8206-2019	Giese, Armin/0000-0002-8238-4102; 				Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bertsch U, 2005, J VIROL, V79, P7785, DOI 10.1128/JVI.79.12.7785-7791.2005; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Blader P, 1998, NATURE, V395, P112, DOI 10.1038/25836; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Creton R, 2004, DEV BRAIN RES, V151, P33, DOI 10.1016/j.devbrainres.2004.03.016; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Evans TG, 2005, CELL STRESS CHAPERON, V10, P66, DOI 10.1379/CSC-79R.1; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karlovich CA, 1998, GENE, V217, P117, DOI 10.1016/S0378-1119(98)00342-4; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang WF, 2005, NEUROBIOL DIS, V20, P500, DOI 10.1016/j.nbd.2005.03.026; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	37	79	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9195	9203		10.1074/jbc.M607865200	http://dx.doi.org/10.1074/jbc.M607865200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17170113	hybrid			2022-12-27	WOS:000245780300066
J	Grobler, JA; Dornadula, G; Rice, MR; Simcoe, AL; Hazuda, DJ; Miller, MD				Grobler, Jay A.; Dornadula, Geetha; Rice, Michele R.; Simcoe, Amy L.; Hazuda, Daria J.; Miller, Michael D.			HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(+)-STRAND DNA-SYNTHESIS; RIBONUCLEASE-H; MECHANISM; COMPLEX; ACID	Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are highly specific and potent allosteric inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. NNRTIs inhibit reverse transcription in a substrate length-dependent manner in biochemical assays and in cell-based HIV-1 replication assays, suggesting a stochastic inhibitory mechanism. Surprisingly, we observed that NNRTIs potently inhibited plus-strand initiation in vitro under conditions in which little or no inhibition of minus-strand DNA synthesis was observed. In assays that recapitulated the initiation of plus-strand DNA synthesis, greater inhibition was observed with an RNA PPT primer than with a DNA primer of corresponding sequence and with wild-type reverse transcriptase but not with NNRTI-resistant enzymes. Structural elements that dictate sensitivity to NNRTIs were revealed using modified plus-strand initiation substrates. The data presented here suggest that specific inhibition of plus-strand initiation may be an important mechanism by which NNRTIs block HIV-1 replication.	Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA	Merck & Company	Grobler, JA (corresponding author), Merck Res Labs, Dept Antiviral Res, POB 4,WP26A-3000, West Point, PA 19486 USA.	jay_grobler@merck.com						CARROLL SS, 1993, J BIOL CHEM, V268, P276; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; GOPALAKRISHNAN V, 1994, J BIOL CHEM, V269, P4110; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte M, 2001, J BIOL CHEM, V276, P6711, DOI 10.1074/jbc.M009097200; KOHISTAEDT LA, 1992, SCIENCE, V256, P1783; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; PALANIAPPAN C, 1995, J BIOL CHEM, V270, P4861, DOI 10.1074/jbc.270.9.4861; Quan YD, 1999, J VIROL, V73, P6700, DOI 10.1128/JVI.73.8.6700-6707.1999; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Telesnitsky A., 1997, P121	20	101	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8005	8010		10.1074/jbc.M608274200	http://dx.doi.org/10.1074/jbc.M608274200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17172472	hybrid			2022-12-27	WOS:000245081000031
J	Morita, T; Mayanagi, T; Yoshio, T; Sobue, K				Morita, Tsuyoshi; Mayanagi, Taira; Yoshio, Toshiyuki; Sobue, Kenji			Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; VIRUS-TRANSFORMED FIBROBLASTS; ALDRICH-SYNDROME PROTEIN; ACTIN-FILAMENTS; N-WASP; NONERYTHROID SPECTRIN; NONMUSCLE CALDESMON; BINDING PROTEIN; ALPHA-ACTININ; F-ACTIN	Podosomes are dynamic cell adhesion structures that degrade the extracellular matrix, permitting extracellular matrix remodeling. Accumulating evidence suggests that actin and its associated proteins play a crucial role in podosome dynamics. Caldesmon is localized to the podosomes, and its expression is down-regulated in transformed and cancer cells. Here we studied the regulatory mode of caldesmon in podosome formation in Rous sarcoma virus-transformed fibroblasts. Exogenous expression analyses revealed that caldesmon represses podosome formation triggered by the N-WASP-Arp2/3 pathway. Conversely, depletion of caldesmon by RNA interference induces numerous small-sized podosomes with high dynamics. Caldesmon competes with the Arp2/3 complex for actin binding and thereby inhibits podosome formation. p21-activated kinases (PAK) 1 and 2 are also repressors of podosome formation via phosphorylation of caldesmon. Consequently, phosphorylation of caldesmon by PAK1/2 enhances this regulatory mode of caldesmon. Taken together, we conclude that in Rous sarcoma virus-transformed cells, changes in the balance between PAK 1/2-regulated caldesmon and the Arp2/3 complex govern the formation of podosomes.	Osaka Univ, Grad Sch Med, Dept Neurosci, Suita, Osaka 5650871, Japan	Osaka University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci, D13,Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp	Yoshio, Toshiyuki/ABC-4723-2021	Yoshio, Toshiyuki/0000-0002-6546-0329				ASHINO N, 1987, J BIOCHEM-TOKYO, V101, P609, DOI 10.1093/jb/101.3.609; BOKOCH GM, 2003, ANNU REV BIOCHEM, V72, P30781; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Eppinga RD, 2006, CELL MOTIL CYTOSKEL, V63, P543, DOI 10.1002/cm.20144; Eves R, 2006, J CELL SCI, V119, P1691, DOI 10.1242/jcs.02881; Foster DB, 2000, J BIOL CHEM, V275, P1959, DOI 10.1074/jbc.275.3.1959; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; Hedges JC, 1998, AM J PHYSIOL-CELL PH, V275, pC527, DOI 10.1152/ajpcell.1998.275.2.C527; HETTASCH JM, 1991, J BIOL CHEM, V266, P11876; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; KOJIOWADA M, 1984, P NATL ACAD SCI USA, V81, P3133; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mizutani K, 2002, CANCER RES, V62, P669; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NOMURA M, 1987, EUR J BIOCHEM, V163, P467, DOI 10.1111/j.1432-1033.1987.tb10892.x; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Ory S, 2000, J CELL SCI, V113, P1177; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SOBUE K, 1989, EXP CELL RES, V181, P256, DOI 10.1016/0014-4827(89)90199-7; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SOBUE K, 1988, P NATL ACAD SCI USA, V85, P482, DOI 10.1073/pnas.85.2.482; SOBUE K, 1990, NEUROSCI RES, V13, P80; Takenawa T, 2001, J CELL SCI, V114, P1801; TANAKA J, 1993, J CELL SCI, V104, P595; TANAKA T, 1990, EUR J BIOCHEM, V188, P495, DOI 10.1111/j.1432-1033.1990.tb15427.x; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; VOROTNIKOV AV, 1988, FEBS LETT, V236, P321, DOI 10.1016/0014-5793(88)80047-4; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121	49	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8454	8463		10.1074/jbc.M609983200	http://dx.doi.org/10.1074/jbc.M609983200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224451	hybrid			2022-12-27	WOS:000245081000078
J	Spink, E; Cosgrove, S; Rogers, L; Hewage, C; Malthouse, JPG				Spink, Edward; Cosgrove, Sonya; Rogers, Louis; Hewage, Chandralal; Malthouse, J. Paul G.			C-13 and H-1 NMR studies of ionizations and hydrogen bonding in chymotrypsin-glyoxal inhibitor complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-MAGNETIC-RESONANCE; ACTIVE-CENTER HISTIDINE; CHLOROMETHYL KETONE INHIBITOR; OPTICAL BIOSENSOR TECHNOLOGY; ALPHA-CHYMOTRYPSIN; SERINE-PROTEASE; DELTA-CHYMOTRYPSIN; TRIFLUOROMETHYL KETONE; PEPTIDEBORONIC ACIDS; TETRAHEDRAL ADDUCTS	Benzyloxycarbonyl (Z)-Ala-Pro-Phe-glyoxal and Z-Ala-AlaPhe-glyoxal have both been shown to be inhibitors of a-chymotrypsin with minimal K-i values of 19 and 344 nm, respectively, at neutral pH. These Ki values increased at low and high pH with pK(alpha), values of similar to 4.0 and similar to 10.5, respectively. By using surface plasmon resonance, we show that the apparent association rate constant for Z-Ala-Pro-Phe-glyoxal is much lower than the value expected for a diffusion-controlled reaction. C-13 NMR has been used to show that at low pH the glyoxal keto carbon is sp(3)-hybridized with a chemical shift of similar to 100.7 ppm and that the aldehyde carbon is hydrated with a chemical shift of similar to 91.6 ppm. The signal at similar to 100.7 ppm is assigned to the hemiketal formed between the hydroxy group of serine 195 and the keto carbon of the glyoxal. In a slow exchange process controlled by a p, of similar to 4.5, the aldehyde carbon dehydrates to give a signal at similar to 205.5 ppm and the hemiketal forms an oxyanion at similar to 107.0 ppm. At higher pH, the re-hydration of the glyoxal aldehyde carbon leads to the signal at 107 ppm being replaced by a signal at 104 ppm (pK(a) similar to 9.2). On binding either Z-Ala-Pro-Phe-glyoxal or Z-AlaAla-Phe-glyoxal to alpha-chymotrypsin at 4 and 25 degrees C, H-1 NMR is used to show that the binding of these glyoxal inhibitors raises the pK(a) value of the imidazolium ion of histidine 57 to a value of > 11 at both 4 and 25 degrees C. We discuss the mechanistic significance of these results, and we propose that it is ligand binding that raises the pK(a) value of the imidazolium ring of histidine 57 allowing it to enhance the nucleophilicity of the hydroxy group of the active site serine 195 and lower the pK(a) value of the oxyanion forming a zwitterionic tetrahedral intermediate during catalysis.	Univ Coll Dublin, Conway Inst, Ctr Synth & Chem Biol, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Malthouse, JPG (corresponding author), Univ Coll Dublin, Conway Inst, Ctr Synth & Chem Biol, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	J.Paul.G.Malthouse@ucd.ie	Malthouse, Jonathan/AAP-8357-2020	HEWAGE, CHANDRALAL/0000-0002-6626-3829; Malthouse, Jonathan/0000-0002-8372-6549	Wellcome Trust [055637/Z/98] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADEBODUN F, 1989, J CELL BIOCHEM, V40, P249, DOI 10.1002/jcb.240400213; BACHOVCHIN WW, 1985, P NATL ACAD SCI USA, V82, P7948, DOI 10.1073/pnas.82.23.7948; Bao DH, 1999, J AM CHEM SOC, V121, P4684, DOI 10.1021/ja990180g; Bao DH, 1998, J AM CHEM SOC, V120, P3485, DOI 10.1021/ja972937e; BAUER CA, 1976, BIOCHEMISTRY-US, V15, P1291, DOI 10.1021/bi00651a019; BELL RP, 1956, T FARADAY SOC, V52, P1093, DOI 10.1039/tf9565201093; BRADY K, 1990, BIOCHEMISTRY-US, V29, P7600, DOI 10.1021/bi00485a009; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Cassidy CS, 2000, BIOCHEM BIOPH RES CO, V273, P789, DOI 10.1006/bbrc.2000.2986; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; CLELAND WW, 1992, BIOCHEMISTRY-US, V31, P317, DOI 10.1021/bi00117a001; Djurdjevic-Pahl A, 2005, BBA-PROTEINS PROTEOM, V1749, P33, DOI 10.1016/j.bbapap.2005.02.001; Djurdjevic-Pahl A, 2002, BIOCHEM J, V362, P339, DOI 10.1042/0264-6021:3620339; FEENEY J, 1979, J MAGN RESON, V33, P519, DOI 10.1016/0022-2364(79)90163-X; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P155; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; FINUCANE MD, 1992, BIOCHEM J, V286, P889, DOI 10.1042/bj2860889; FINUCANE MD, 1989, BIOCHEM J, V258, P853, DOI 10.1042/bj2580853; FISCHER G, 1984, BIOCHIM BIOPHYS ACTA, V791, P87, DOI 10.1016/0167-4838(84)90285-1; GAREL JR, 1970, J MOL BIOL, V47, P41, DOI 10.1016/0022-2836(70)90400-6; Kahyaoglu A, 2002, PROTEIN SCI, V11, P965, DOI 10.1110/ps.3890102; LIANG TC, 1987, BIOCHEMISTRY-US, V26, P7603, DOI 10.1021/bi00398a011; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lynas JF, 1998, BIOORG MED CHEM LETT, V8, P373, DOI 10.1016/S0960-894X(98)00030-4; Mac Sweeney A, 2000, ACTA CRYSTALLOGR D, V56, P280, DOI 10.1107/S0907444999016583; MALTHOUSE JPG, 1983, J AM CHEM SOC, V105, P1685, DOI 10.1021/ja00344a062; MALTHOUSE JPG, 1985, BIOCHEMISTRY-US, V24, P3478, DOI 10.1021/bi00335a014; Markgren PO, 2001, ANAL BIOCHEM, V291, P207, DOI 10.1006/abio.2001.5025; Markgren PO, 1998, ANAL BIOCHEM, V265, P340, DOI 10.1006/abio.1998.2927; Markley JL, 1996, BIOCHEMISTRY-US, V35, P11092, DOI 10.1021/bi961366k; OConnell TP, 1997, BIOCHEM J, V326, P861, DOI 10.1042/bj3260861; OCONNELL TP, 1995, BIOCHEM J, V307, P353, DOI 10.1042/bj3070353; Pol E, 2006, BIOCHEMISTRY-US, V45, P513, DOI 10.1021/bi0515523; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; ROBILLAR.G, 1974, J MOL BIOL, V86, P519, DOI 10.1016/0022-2836(74)90178-8; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Stratton JR, 2001, BIOCHEMISTRY-US, V40, P10411, DOI 10.1021/bi015542n; WALKER B, 1993, BIOCHEM J, V293, P321, DOI 10.1042/bj2930321; WEHRLI FW, 1988, INTERPRETATION CARBO, P33; ZHONG S, 1995, J AM CHEM SOC, V117, P7048, DOI 10.1021/ja00132a002	41	17	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7852	7861		10.1074/jbc.M611394200	http://dx.doi.org/10.1074/jbc.M611394200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17213185	hybrid			2022-12-27	WOS:000245081000014
J	Ohnishi, N; Kashino, Y; Satoh, K; Ozawa, S; Takahashi, Y				Ohnishi, Norikazu; Kashino, Yasuhiro; Satoh, Kazuhiko; Ozawa, Shin-ichiro; Takahashi, Yuichiro			Chloroplast-encoded polypeptide PsbT is involved in the repair of primary electron acceptor Q(A) of photosystem II during photoinhibition in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D1 PROTEIN; QUINONE ACCEPTOR; LIGHT; COMPLEX; OXYGEN; FTSH; PHOTODAMAGE; MECHANISM; SITE; PHOTOACTIVATION	PsbT is a small chloroplast-encoded hydrophobic polypeptide associated with the D1/D2 heterodimer of the photosystem II (PSII) reaction center and is required for the efficient posttranslational repair of photodamaged PSII. Here we addressed that role in detail in Chlamydomonas reinhardtii wild type and Delta psbT cells by analyzing the activities of PSII, the assembly of PSII proteins, and the redox components of PSII during photoinhibition and repair. Strong illumination of cells for 15 min decreased the activities of electron transfer through PSII and Q, photoreduction by 50%, and it reduced the amount of atomic manganese by 20%, but it did not affect the steadystate level of PSII proteins, photoreduction of pheophytin (pheo(D1)), and the amount of bound plastoquinone (Q,), indicating that the decrease in PSII activity resulted mainly from inhibition of the electron transfer from pheo(D1) to Q(A). In wild type cells, we observed parallel recovery of electron transfer activity through PSII and Q, photoreduction, suggesting that the recovery of Q, activity is one of the rate-limiting steps of PSII repair. In Delta psbT cells, the repairs of electron transfer activity through PSII and of QA photoreduction activity were both impaired, but PSII protein turnover was unaffected. Moreover, about half the QA was lost from the PSI1 core complex during purification. Since PsbT is intimately associated with the QA-binding region on D2, we propose that this polypeptide enhances the efficient recovery of QA photoreduction by stabilizing the structure of the Q.A-binding region.	Okayama Univ, Fac Sci, Dept Biol, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Okayama University	Takahashi, Y (corresponding author), Okayama Univ, Fac Sci, Dept Biol, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	taka@cc.okayama-u.ac.jp	Takahashi, Yuichiro/B-2062-2011; Ozawa, Shin-Ichiro/O-7408-2015	Takahashi, Yuichiro/0000-0001-6410-0447; Ozawa, Shin-Ichiro/0000-0001-7698-5350				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BARR R, 1971, PHOTOSYNTHESIS, P372; Debus RJ, 2001, BBA-BIOENERGETICS, V1503, P164, DOI 10.1016/S0005-2728(00)00221-8; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Hoshida H, 1997, BIOCHEMISTRY-US, V36, P12053, DOI 10.1021/bi9710885; ISOGAI Y, 1987, PLANT CELL PHYSIOL, V28, P1301; IWAI M, 2001, PS2001, pS22; JONES LW, 1966, PLANT PHYSIOL, V41, P1037, DOI 10.1104/pp.41.6.1037; JUNG J, 1990, PHOTOCHEM PHOTOBIOL, V52, P1003, DOI 10.1111/j.1751-1097.1990.tb01817.x; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kanervo E, 2003, BBA-BIOENERGETICS, V1607, P131, DOI 10.1016/j.bbabio.2003.09.007; Kashino Yasuhiro, 2003, Phycological Research, V51, P168, DOI 10.1111/j.1440-1835.2003.tb00184.x; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; KEREN N, 1998, MOL BIOL CHLOROPLAST, P569; KITAMURA K, 1994, FEBS LETT, V354, P113, DOI 10.1016/0014-5793(94)01089-7; KLIMOV VV, 1977, FEBS LETT, V82, P183, DOI 10.1016/0014-5793(77)80580-2; KLIMOV VV, 1980, FEBS LETT, V112, P97, DOI 10.1016/0014-5793(80)80137-2; KOIVUNIEMI A, 1993, FEBS LETT, V327, P343, DOI 10.1016/0014-5793(93)81017-T; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MONOD C, 1994, EMBO J, V13, P2747, DOI 10.1002/j.1460-2075.1994.tb06568.x; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NEALE PJ, 1986, J PHYCOL, V22, P531, DOI 10.1111/j.1529-8817.1986.tb02497.x; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Noguchi T, 2002, PLANT CELL PHYSIOL, V43, P1112, DOI 10.1093/pcp/pcf137; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Ohnishi N, 2001, J BIOL CHEM, V276, P33798, DOI 10.1074/jbc.M104454200; Rova EM, 1996, J BIOL CHEM, V271, P28918, DOI 10.1074/jbc.271.46.28918; Rova M, 1998, BIOCHEMISTRY-US, V37, P11039, DOI 10.1021/bi980381h; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; TAKAHASHI Y, 1986, BIOCHIM BIOPHYS ACTA, V848, P183, DOI 10.1016/0005-2728(86)90040-X; Takahashi Y, 1996, PLANT CELL PHYSIOL, V37, P161, DOI 10.1093/oxfordjournals.pcp.a028927; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; VANGORKOM HJ, 1975, BIOCHIM BIOPHYS ACTA, V408, P331, DOI 10.1016/0005-2728(75)90134-6; VANGORKOM HJ, 1974, BIOCHIM BIOPHYS ACTA, V347, P439, DOI 10.1016/0005-2728(74)90081-4; VANWIJK KJ, 1994, J BIOL CHEM, V269, P28382; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Zhang LX, 2001, J BIOL CHEM, V276, P37809; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	51	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7107	7115		10.1074/jbc.M606763200	http://dx.doi.org/10.1074/jbc.M606763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215255	hybrid			2022-12-27	WOS:000245080900022
J	Zissimopoulos, S; Docrat, N; Lai, FA				Zissimopoulos, Spyros; Docrat, Naadiya; Lai, F. Anthony			Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; KINASE-A PHOSPHORYLATION; SKELETAL-MUSCLE; CA2+ RELEASE; HEART-FAILURE; CALMODULIN-BINDING; OXIDATIVE STRESS; FKBP12.6-MEDIATED STABILIZATION; HYPERREACTIVE SULFHYDRYLS	The ryanodine receptor (RyR) calcium release channel functions as a redox sensor that is sensitive to channel modulators. The FK506-binding protein (FKBP) is an important regulator of channel activity, and disruption of the RyR2-FKBP12.6 association has been implicated in cardiac disease. In the present study, we investigated whether the RyR-FKBP association is redox-regulated. Using co-immunoprecipitation assays of solubilized native RyR2 from cardiac muscle sarcoplasmic reticulum (SR) with recombinant [S-35]FKBP12.6, we found that the sulfydryloxidizing agents, H2O2 and diamide, result in diminished RyR2FKBP12.6 binding. Co-sedimentation experiments of cardiac SR vesicles with [35S]FKBP12.6 also demonstrated that oxidizing reagents decreased FKBP binding. Matching results were obtained with skeletal muscle SR. Notably, H2O2 and diamide differentially affected the RyR2-FKBP12.6 interaction, decreasing binding to similar to 75 and similar to 50% of control, respectively. In addition, the effect of H2O2 was negligible when the channel was in its closed state or when applied after FKBP binding had occurred, whereas diamide was always effective. A cysteine-null mutant FKBP12.6 retained redox-sensitive interaction with RyR2, suggesting that the effect of the redox reagents is exclusively via sites on the ryanodine receptor. K201 (or JTV519), a drug that has been proposed to prevent FKBP12.6 dissociation from the RyR2 channel complex, did not restore normal FKBP binding under oxidizing conditions. Our results indicate that the redox state of the RyR is intimately connected with FKBP binding affinity.	Univ Cardiff Wales, Sch Med, Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, Wales	Cardiff University	Zissimopoulos, S (corresponding author), Univ Cardiff Wales, Sch Med, Heart Res Inst, Dept Cardiol, Cardiff CF14 4XN, Wales.	zissimopouloss@cardiff.ac.uk	Zissimopoulos, Spyros/GSD-9824-2022	Lai, Tony/0000-0003-2852-8547; Zissimopoulos, Spyros/0000-0001-5196-9450				ABRAMSON JJ, 1995, J BIOL CHEM, V270, P29644; Aghdasi B, 1997, J BIOL CHEM, V272, P3739, DOI 10.1074/jbc.272.6.3739; Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Bultynck G, 2001, J BIOL CHEM, V276, P47715, DOI 10.1074/jbc.M106573200; Cherednichenko G, 2004, CIRC RES, V94, P478, DOI 10.1161/01.RES.0000115554.65513.7C; Danila C, 2004, BIOPHYS J, V86, p242A; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Doi M, 2002, CIRCULATION, V105, P1374, DOI 10.1161/hc1102.105270; Eager KR, 1997, AM J PHYSIOL-CELL PH, V272, pC1908, DOI 10.1152/ajpcell.1997.272.6.C1908; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; George CH, 2003, BIOCHEM J, V370, P579, DOI 10.1042/BJ20021433; Hidalgo C, 2004, BIOL RES, V37, P539, DOI 10.4067/S0716-97602004000400007; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; KANEKO N, 1994, DRUG DEVELOP RES, V33, P429, DOI 10.1002/ddr.430330406; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; Lefer DJ, 2000, AM J MED, V109, P315, DOI 10.1016/S0002-9343(00)00467-8; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; LIU GH, 1994, J BIOL CHEM, V269, P33028; LIU GH, 1994, MOL PHARMACOL, V45, P189; Luo YQ, 2000, ANTIOXID REDOX SIGN, V2, P449, DOI 10.1089/15230860050192224; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Moore CP, 1999, J BIOL CHEM, V274, P36831, DOI 10.1074/jbc.274.52.36831; Oba T, 1998, AM J PHYSIOL-CELL PH, V274, pC914, DOI 10.1152/ajpcell.1998.274.4.C914; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Prestle J, 2001, CIRC RES, V88, P188; Qi Y, 1998, J BIOL CHEM, V273, P34813, DOI 10.1074/jbc.273.52.34813; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; Suko J, 2000, J MEMBRANE BIOL, V174, P105, DOI 10.1007/s002320001036; Sun JH, 2001, J BIOL CHEM, V276, P15625, DOI 10.1074/jbc.M100083200; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wu YL, 1997, J BIOL CHEM, V272, P25051, DOI 10.1074/jbc.272.40.25051; Xia RH, 2000, J BIOL CHEM, V275, P36556, DOI 10.1074/jbc.M007613200; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xiao BL, 2004, CIRC RES, V94, P487, DOI 10.1161/01.RES.0000115945.89741.22; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zable AC, 1997, J BIOL CHEM, V272, P7069, DOI 10.1074/jbc.272.11.7069; Zhang JZ, 1999, AM J PHYSIOL-CELL PH, V276, pC46; Zheng YM, 2004, CELL CALCIUM, V35, P345, DOI 10.1016/j.ceca.2003.09.006; Zima AV, 2004, J PHYSIOL-LONDON, V555, P727, DOI 10.1113/jphysiol.2003.055848; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529; Zissimopoulos S, 2006, BIOCHEM SOC T, V34, P919, DOI 10.1042/BST0340919; Zissimopoulos S, 2005, CELL BIOCHEM BIOPHYS, V43, P203, DOI 10.1385/CBB:43:2:203; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	68	56	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6976	6983		10.1074/jbc.M607590200	http://dx.doi.org/10.1074/jbc.M607590200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17200109	hybrid			2022-12-27	WOS:000245080900009
J	Akimzhanov, AM; Yang, XXO; Dong, C				Akimzhanov, Askar M.; Yang, Xuexian O.; Dong, Chen			Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGES; DISTINCT	During differentiation of naive CD4+ helper T (TH) cells into effector cells, specific cytokine gene loci undergo extensive changes in chromatin modification. A novel lineage of TH cells that is regulated by transforming growth factor-beta (TGFO) and interleukin-6 (IL-6) has been identified recently as promoting tissue inflammation. These inflammatory TH (THi) cells, also called TH17 or THIL-17 produce IL-17 and IL-17F, two highly homologous cytokines that have genes located in the same chromosomal region. Here, using chromatin immunoprecipitation techniques, we have demonstrated that similar to the regulation in TH1 and TH2 cell lineages, polarization of THi cells was accompanied by selective chromatin remodeling events. Histone H3 acetylation. and Lys-4 tri-methylation were specifically associated with IL-17 and IL-17F gene promoters in THi lineage. At an early stage of T cell activation, histone acetylation on these promoters was greatly promoted by a combination of TGFP and IL-6, suggesting their synergistic role in initiating chromatin accessibility for transcription factors. Furthermore, we identified multiple noncoding sequences within the IL-17-IL-17F locus conserved across species. These elements were also associated with hyperacetylated histone 3 in a lineage-specific manner and may thus serve as potential regulatory regions. In summary, our results demonstrate for the first time that THi cell differentiation is associated with epigenetic changes in the IL-17-IL-17F locus, which suggests novel mechanisms in T cell functional regulation.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin,Unit 906, Houston, TX 77030 USA.	cdong@mdanderson.org	Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009	Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130; Akimzhanov, Askar/0000-0002-5592-8215				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	13	215	219	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					5969	5972		10.1074/jbc.C600322200	http://dx.doi.org/10.1074/jbc.C600322200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17218320	hybrid			2022-12-27	WOS:000244867200001
J	Crepaldi, T; Bersani, F; Scuoppo, C; Accornero, P; Prunotto, C; Taulli, R; Forni, PE; Leo, C; Chiarle, R; Griffiths, J; Glass, DJ; Ponzetto, C				Crepaldi, Tiziana; Bersani, Francesca; Scuoppo, Claudio; Accornero, Paolo; Prunotto, Chiara; Taulli, Riccardo; Forni, Paolo E.; Leo, Christian; Chiarle, Roberto; Griffiths, Jennifer; Glass, David J.; Ponzetto, Carola			Conditional activation of MET in differentiated skeletal muscle induces atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION; UBIQUITIN LIGASES; AUTOCRINE LOOP; P38 MAPK; IN-VIVO; KAPPA-B; RECEPTOR; MICE; TRANSFORMATION	Skeletal muscle atrophy is a common debilitating feature of many systemic diseases, including cancer. Here we examined the effects of inducing expression of an oncogenic version of the Met receptor (Tpr-Met) in terminally differentiated skeletal muscle. A responder mouse containing the Tpr-Met oncogene and GFP (green fluorescent protein) as a reporter was crossed with a transactivator mouse expressing tTA under the control of the muscle creatine kinase promoter. Tpr-Met induction during fetal development and in young adult mice caused severe muscle wasting, with decreased fiber size and loss of myosin heavy chain protein. Concomitantly, in the Tpr-Met-expressing muscle the mRNA of the E3 ubiquitin ligases atrogin-1/MAFbx, MuRF1, and of the lysosomal protease cathepsin L, which are markers of skeletal muscle atrophy, was significantly increased. In the same muscles phosphorylation of the Met downstream effectors Akt, p38 MAPK, and I kappa B alpha was higher than in normal controls. Induction of Tpr-Met in differentiating satellite cells derived from the double transgenics caused aberrant cell fusion, protein loss, and myotube collapse. Increased phosphorylation of Met downstream effectors was also observed in the Tpr-Met-expressing myotubes cultures. Treatment of these cultures with either a proteasomal or a p38 inhibitor prevented Tpr-Met-mediated myotube breakdown, establishing accelerated protein degradation consequent to inappropriate activation of p38 as the major route for the Tpr-Met-induced muscle phenotype.	Univ Turin, Dept Anat Pharmacol & Forens Med, I-10126 Turin, Italy; Univ Turin, Dept Biomed Sci & Oncol, I-10126 Turin, Italy; Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy; Regeneron Pharmaceut Inc, Muscle Program, Tarrytown, NY 10591 USA	University of Turin; University of Turin; University of Turin; Regeneron	Crepaldi, T (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Corso M DAzeglio 52, I-10126 Turin, Italy.	tiziana.crepaldi@unito.it	crepaldi, tiziana/AAY-7207-2020; Accornero, Paolo/B-1396-2008; TAULLI, Riccardo/J-7347-2018; Glass, David/AAI-3910-2021; FORNI, PAOLO/C-3533-2011; Glass, David/C-4782-2012	crepaldi, tiziana/0000-0003-3410-947X; TAULLI, Riccardo/0000-0003-1277-6263; Bersani, Francesca/0000-0002-0343-7078; Glass, David/0000-0001-6187-4164; Forni, Paolo E./0000-0001-6547-3464; CHIARLE, Roberto/0000-0003-1564-8531	Telethon [D.095] Funding Source: Medline	Telethon(Fondazione Telethon)		Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bechet D, 2005, INT J BIOCHEM CELL B, V37, P2098, DOI 10.1016/j.biocel.2005.02.029; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bischoff R, 1997, DEV DYNAM, V208, P505, DOI 10.1002/(SICI)1097-0177(199704)208:4<505::AID-AJA6>3.0.CO;2-M; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Di Giovanni S, 2004, ANN NEUROL, V55, P195, DOI 10.1002/ana.10811; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Halevy O, 2004, EXP CELL RES, V297, P224, DOI 10.1016/j.yexcr.2004.03.024; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kamikura DM, 2000, MOL CELL BIOL, V20, P3482, DOI 10.1128/MCB.20.10.3482-3496.2000; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leshem Y, 2000, J CELL PHYSIOL, V184, P101, DOI 10.1002/(SICI)1097-4652(200007)184:1<101::AID-JCP11>3.0.CO;2-D; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Madhavan R, 2005, IUBMB LIFE, V57, P719, DOI 10.1080/15216540500338739; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Matsumoto T, 1999, BRIT J CANCER, V79, P764, DOI 10.1038/sj.bjc.6690123; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prunotto C, 2004, DEV DYNAM, V231, P582, DOI 10.1002/dvdy.20177; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Taulli R, 2005, CANCER GENE THER, V12, P456, DOI 10.1038/sj.cgt.7700815; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Vigna E, 2002, MOL THER, V5, P252, DOI 10.1006/mthe.2002.0542; Vigna E, 1999, ONCOGENE, V18, P4275, DOI 10.1038/sj.onc.1202791; Weston AD, 2003, J CELL SCI, V116, P2885, DOI 10.1242/jcs.00525; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000	56	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6812	6822		10.1074/jbc.M610916200	http://dx.doi.org/10.1074/jbc.M610916200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194700	hybrid			2022-12-27	WOS:000244867200091
J	Gao, L; Balakrishnan, M; Roques, BP; Bambara, RA				Gao, Lu; Balakrishnan, Mini; Roques, Bernard P.; Bambara, Robert A.			Insights into the multiple roles of pausing in HIV-1 reverse transcriptase-promoted strand transfers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 NUCLEOCAPSID PROTEIN; RNA SECONDARY STRUCTURE; PRIMER BINDING-SITE; VIRAL-DNA SYNTHESIS; STRONG-STOP DNA; RETROVIRAL RECOMBINATION; IN-VITRO; ACCEPTOR RNA; GENETIC-RECOMBINATION	We previously analyzed the role of pausing induced by hairpin structures within RNA templates in facilitating, strand transfer by HIV-1 RT (reverse transcriptase). We proposed a multistep transfer mechanism in which pause-induced RNase H cuts within the initial RNA template (donor) expose regions of cDNA. A second homologous RNA template (acceptor) can interact with the cDNA at such sites, initiating transfer. The acceptor-cDNA hybrid is thought to then propagate by branch-migration, eventually catching up with the primer terminus and completing the transfer. The prominent pause site in the template system facilitated acceptor invasion; however, very few of the transfers terminated at this pause. To examine the effects of homology on pause-promoted transfer, we increased template homology before the pause site, from 19 nucleotides (nt) in the initial template system to 52 nt in the new system. Significantly, the increased homology enhanced transfers 3-fold, with 32% of the transfers now terminating at the pause site. Additionally, the acceptor cleavage profile indicated the creation of a new invasion site in the added region of homology. NC (nucleocapsid) increased the strand transfer throughout the whole template. However, the prominent hot spot for internal transfer remained, which was still at the pause site. We interpret the new results to mean that pause sites can also serve to stall DNA synthesis, allowing acceptor invasions initiated earlier in the template to catch up with the primer terminus.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Ctr Canc, Rochester, NY 14642 USA; CNRS, INSERM, Dept Pharmacochim Mol & Struct, U266,UMR 8600,Fac Pharm 4, F-75270 Paris 06, France	University of Rochester; University of Rochester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 49573] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An WF, 2002, J VIROL, V76, P7897, DOI 10.1128/JVI.76.15.7897-7902.2002; Anderson JA, 1998, J VIROL, V72, P1186, DOI 10.1128/JVI.72.2.1186-1194.1998; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Chen Y, 2005, J BIOL CHEM, V280, P14443, DOI 10.1074/jbc.M412190200; Chen Y. H., 2003, J BIOL CHEM; CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989; COLICELLI J, 1987, VIROLOGY, V160, P518, DOI 10.1016/0042-6822(87)90030-4; Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100; Dang Q, 2001, J VIROL, V75, P809, DOI 10.1128/JVI.75.2.809-820.2001; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; Derebail SS, 2004, J BIOL CHEM, V279, P47446, DOI 10.1074/jbc.M408927200; Derebail SS, 2003, J BIOL CHEM, V278, P15702, DOI 10.1074/jbc.M211701200; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DeStefano JJ, 1996, J BIOL CHEM, V271, P16350; DESTEFANO JJ, 1994, J MOL BIOL, V243, P558, DOI 10.1016/0022-2836(94)90030-2; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; DeStefano JJ, 1997, ARCH VIROL, V142, P1797, DOI 10.1007/s007050050198; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; Galetto R, 2006, J BIOL CHEM, V281, P2711, DOI 10.1074/jbc.M505457200; GOODRICH DW, 1990, P NATL ACAD SCI USA, V87, P2052, DOI 10.1073/pnas.87.6.2052; GU ZX, 1995, J GEN VIROL, V76, P2601, DOI 10.1099/0022-1317-76-10-2601; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Harrison GP, 1998, NUCLEIC ACIDS RES, V26, P3433, DOI 10.1093/nar/26.14.3433; Heath MJ, 2005, BIOCHEMISTRY-US, V44, P3915, DOI 10.1021/bi0477945; Heilman-Miller SL, 2004, J BIOL CHEM, V279, P44154, DOI 10.1074/jbc.M401646200; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HU WS, 1992, J VIROL, V66, P4457, DOI 10.1128/JVI.66.7.4457-4463.1992; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P12209, DOI 10.1073/pnas.221289898; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1995, J VIROL, V69, P669, DOI 10.1128/JVI.69.2.669-674.1995; Kim JK, 1997, J BIOL CHEM, V272, P16769, DOI 10.1074/jbc.272.27.16769; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Klasens BIF, 1999, BBA-GENE STRUCT EXPR, V1444, P355, DOI 10.1016/S0167-4781(99)00011-1; Lanciault C, 2006, J VIROL, V80, P2483, DOI 10.1128/JVI.80.5.2483-2494.2006; Lanciault C, 2005, J BIOL CHEM, V280, P2413, DOI 10.1074/jbc.M410718200; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Ohi Y, 2000, J VIROL, V74, P8324, DOI 10.1128/JVI.74.18.8324-8334.2000; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Peeters M, 1999, J VIROL, V73, P7368, DOI 10.1128/JVI.73.9.7368-7375.1999; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Pfeiffer JK, 2001, J VIROL, V75, P11263, DOI 10.1128/JVI.75.23.11263-11274.2001; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Song M, 2006, J BIOL CHEM, V281, P24227, DOI 10.1074/jbc.M603097200; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12468, DOI 10.1021/bi971218+; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; Telesnitsky A., 1997, P121; TSUCHIHASHI Z, 1994, J VIROL, V68, P5863, DOI 10.1128/JVI.68.9.5863-5870.1994; Wooley DP, 1997, J VIROL, V71, P9650, DOI 10.1128/JVI.71.12.9650-9653.1997; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996; XU H, 1987, P NATL ACAD SCI USA, V84, P8553, DOI 10.1073/pnas.84.23.8553; Yin PD, 1997, J VIROL, V71, P2487, DOI 10.1128/JVI.71.3.2487-2494.1997; Zhang JY, 2000, J VIROL, V74, P2313, DOI 10.1128/JVI.74.5.2313-2322.2000; Zhang WH, 2002, J VIROL, V76, P7473, DOI 10.1128/JVI.76.15.7473-7484.2002; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6222	6231		10.1074/jbc.M610056200	http://dx.doi.org/10.1074/jbc.M610056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204480	hybrid			2022-12-27	WOS:000244867200028
J	Borgono, CA; Michael, IP; Komatsu, N; Jayakumar, A; Kapadia, R; Clayman, GL; Sotiropoulou, G; Diamandis, EP				Borgono, Carla A.; Michael, Iacovos P.; Komatsu, Nahoko; Jayakumar, Arumugam; Kapadia, Ravi; Clayman, Gary L.; Sotiropoulou, Georgia; Diamandis, Eleftherios P.			A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; HUMAN STRATUM-CORNEUM; ELASTASE-SPECIFIC INHIBITOR; AMINO-ACID-SEQUENCE; NETHERTON-SYNDROME; HUMAN SKIN; PROTEINASE-INHIBITOR; TRYPSIN-LIKE; BIOCHEMICAL-CHARACTERIZATION; TERMINAL DIFFERENTIATION	Desquamation of the stratum corneum is a serine protease-dependent process. Two members of the human tissue kallikrein (KLK) family of (chymo)tryptic-like serine proteases, KLK5 and KLK7, are implicated in desquamation by digestion of (corneo)desmosomes and inhibition by desquamation-related serine protease inhibitors (SPIs). However, the epidermal localization and specificity of additional KLKs also supports a role for these enzymes in desquamation. This study aims to delineate the probable contribution of KLK1, KLK5, KLK6, KLK13, and KLK14 to desquamation by examining their interactions, in vitro, with: 1) colocalized SPI, lympho-epithelial Kazal-type-related inhibitor (LEKTI, four recombinant fragments containing inhibitory domains 1-6 (rLEKTI(1-6)), domains 6-8 and partial domain 9 (rLEKTI(6 -9')), domains 9-12 (rLEKTI(9-12)), and domains 12-15 (rLEKTI(12-15)), secretory leukocyte protease inhibitor, and elafin and 2) their ability to digest the (corneo)desmosomal cadherin, desmoglein 1.KLK1 was not inhibited by any SPI tested. KLK5, KLK6, KLK13, and KLK14 were potently inhibited by rLEKTI(1-6), rLEKTI(6-9'), and rLEKTI(9-12) with K-i values in the range of 2.3-28.4 nM, 6.1-221 nM, and 2.7-416 nM for each respective fragment. Only KLK5 was inhibited by rLEKTI(12-15) (K-i = 21.8 nM). No KLK was inhibited by secretory leukocyte protease inhibitor or elafin. Apart from KLK13, all KLKs digested the ectodomain of desmoglein 1 within cadherin repeats, Ca2+ binding sites, or in the juxtamembrane region. Our study indicates that multiple KLKs may participate in desquamation through cleavage of desmoglein 1 and regulation by LEKTI. These findings may have clinical implications for the treatment of skin disorders in which KLK activity is elevated.	Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Patras, Sch Hlth Sci, Dept Pharm, Patras 26500, Greece	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Patras	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, 650 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca	Michael, Iacovos P/C-8695-2016	Michael, Iacovos P/0000-0001-7674-1233; Diamandis, Eleftherios/0000-0002-1589-820X; Jayakumar, Arumugam/0000-0002-1284-4222				Ahmed A, 2001, J PROTEIN CHEM, V20, P273, DOI 10.1023/A:1010902815953; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; Bourgeois L, 1997, J BIOL CHEM, V272, P29590, DOI 10.1074/jbc.272.47.29590; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; BRODY J, 1968, ACTA DERM-VENEREOL, V48, P290; Chao J., 2004, HDB PROTEOLYTIC ENZY, V2, P1577; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; COUBET C, 2004, J INVEST DERMATOL, V122, P1325; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; EGELRUD T, 1991, ARCH DERMATOL RES, V283, P108, DOI 10.1007/BF00371618; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; FIEDLER F, 1987, EUR J BIOCHEM, V163, P303, DOI 10.1111/j.1432-1033.1987.tb10801.x; Franzke CW, 1996, J BIOL CHEM, V271, P21886, DOI 10.1074/jbc.271.36.21886; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; GREENE SL, 1985, J AM ACAD DERMATOL, V13, P329, DOI 10.1016/S0190-9622(85)70170-3; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hanakawa Y, 2003, J INVEST DERMATOL, V121, P383, DOI 10.1046/j.1523-1747.2003.12362.x; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Jayakumar A, 2005, ARCH BIOCHEM BIOPHYS, V435, P89, DOI 10.1016/j.abb.2004.12.012; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kapadia C, 2004, CLIN CHIM ACTA, V339, P157, DOI 10.1016/j.cccn.2003.10.009; KING IA, 1987, J CELL BIOL, V105, P3053, DOI 10.1083/jcb.105.6.3053; KOCH PJ, 1992, P NATL ACAD SCI USA, V89, P353, DOI 10.1073/pnas.89.1.353; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Krebs M, 1999, J INVEST DERMATOL, V113, P32, DOI 10.1046/j.1523-1747.1999.00644.x; Kreutzmann P, 2004, J CHROMATOGR B, V803, P75, DOI 10.1016/j.jchromb.2003.07.016; Kurzen H, 1998, DIFFERENTIATION, V63, P295, DOI 10.1046/j.1432-0436.1998.6350295.x; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; LUNDSTROM A, 1991, ACTA DERM-VENEREOL, V71, P471; LUNDSTROM A, 1988, J INVEST DERMATOL, V91, P340, DOI 10.1111/1523-1747.ep12475679; LUNDSTROM A, 1990, J INVEST DERMATOL, V94, P216, DOI 10.1111/1523-1747.ep12874531; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Magert HJ, 2002, INT J BIOCHEM CELL B, V34, P573, DOI 10.1016/S1357-2725(01)00179-0; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Noe V, 2001, J CELL SCI, V114, P111; OHLSSON K, 1995, J ANDROL, V16, P64; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Oji V, 2006, BRIT J DERMATOL, V154, P860, DOI 10.1111/j.1365-2133.2005.07109.x; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Shimomura Y, 2005, BRIT J DERMATOL, V153, P1026, DOI 10.1111/j.1365-2133.2005.06900.x; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SKERROW CJ, 1989, J CELL SCI, V92, P667; SONDELL B, 1995, J INVEST DERMATOL, V104, P819, DOI 10.1111/1523-1747.ep12607007; SONDELL B, 1994, J HISTOCHEM CYTOCHEM, V42, P459, DOI 10.1177/42.4.7510318; Sotiropoulou G, 2003, ONCOL RES, V13, P381; Sprecher E, 2001, J INVEST DERMATOL, V117, P179, DOI 10.1046/j.1523-1747.2001.01389.x; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Suzuki Y, 1996, BRIT J DERMATOL, V134, P460, DOI 10.1046/j.1365-2133.1996.31794.x; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Talas U, 2000, J INVEST DERMATOL, V114, P165, DOI 10.1046/j.1523-1747.2000.00825.x; Tartaglia-Polcini A, 2006, J INVEST DERMATOL, V126, P315, DOI 10.1038/sj.jid.5700015; Whittock NV, 2003, CLIN EXP DERMATOL, V28, P410, DOI 10.1046/j.1365-2230.2003.01311.x; WIEDOW O, 1993, J INVEST DERMATOL, V101, P305, DOI 10.1111/1523-1747.ep12365430; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; YING QL, 1993, BIOCHEMISTRY-US, V32, P1866, DOI 10.1021/bi00058a021	84	209	220	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3640	3652		10.1074/jbc.M607567200	http://dx.doi.org/10.1074/jbc.M607567200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17158887	hybrid			2022-12-27	WOS:000244481900026
J	Sun, L; Stoecklin, G; Van Way, S; Hinkovska-Galcheva, V; Guo, RF; Anderson, P; Shanley, TP				Sun, Lei; Stoecklin, Georg; Van Way, Susan; Hinkovska-Galcheva, Vania; Guo, Ren-Feng; Anderson, Paul; Shanley, Thomas Patrick			Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; BINDING PROTEIN; SERINE/THREONINE PHOSPHATASE; INFLAMMATORY MEDIATORS; 3'-UNTRANSLATED REGION; NUCLEOTIDE-SEQUENCE; KINASE P38; DEGRADATION; EXPRESSION; REGULATOR	Tumor necrosis factor (TNF)-alpha is a major cytokine produced by alveolar macrophages in response to pathogen-associated molecular patterns such as lipopolysaccharide. TNF-alpha secretion is regulated at both transcriptional and post-transcriptional levels. Posttranscriptional regulation occurs by modulation of TNF-alpha mRNA stability via the binding of tristetraprolin (TTP) to the adenosine/ uridine-rich elements found in the 3'-untranslated region of the TNF-alpha transcript. Phosphorylation plays important roles in modulating mRNA stability, because activation of p38 MAPK by lipopolysaccharide stabilizes TNF-alpha mRNA. We hypothesized that the protein phosphatase 2A (PP2A) regulates this signaling pathway. Our results show that inhibition of PP2A by okadaic acid or small interference RNA significantly enhanced the stability of TNF-alpha mRNA. This result was associated with increased phosphorylation of p38 MAPK and MAPK-activated kinase 2 (MK-2). PP2A inhibition increased TTP phosphorylation and enhanced complex formation with chaperone protein 14-3-3. TTP physically interacted with PP2A in transfected mammalian cells. A functional consequence of TTP-14-3-3 complex formation appeared to be protection of TTP from dephosphorylation by inhibition of the binding of PP2A to phosphorylated TTP. Mutation of the MK-2 phosphorylation sites of TTP did not influence TNF-alpha adenosine/ uridine-rich element binding and did not alter the increased TNF-alpha T-untranslated region-dependent luciferase activity induced by PP2A-small interference RNA silencing. Our data indicate that, although phosphorylation stabilizes TNF-alpha mRNA, PP2A regulates the mRNA stability by modulating the phosphorylation state of members of the p38/MK-2/TTP pathway.	Univ Michigan, Sch Med, Dept Pediat, Div Crit Care, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shanley, TP (corresponding author), Univ Michigan, Sch Med, Dept Pediat, Div Crit Care, 109 Zina Pitcher Pl,4460 Basic Sci Res Bldg, Ann Arbor, MI 48109 USA.	tshanley@med.umich.edu	Huang, H/E-9490-2010	Stoecklin, Georg/0000-0001-9284-9834; Shanley, Thomas/0000-0001-8936-377X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066839] Funding Source: NIH RePORTER; NIGMS NIH HHS [7R01GM066839-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; BERG JT, 1993, J APPL PHYSIOL, V74, P2812, DOI 10.1152/jappl.1993.74.6.2812; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Buzby JS, 1999, J BIOL CHEM, V274, P33973, DOI 10.1074/jbc.274.48.33973; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Murata T, 2002, BIOCHEM BIOPH RES CO, V293, P1242, DOI 10.1016/S0006-291X(02)00363-7; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Sela-Brown A, 2000, J BIOL CHEM, V275, P7424, DOI 10.1074/jbc.275.10.7424; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; VARNUM BC, 1989, ONCOGENE, V4, P119; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	53	154	156	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3766	3777		10.1074/jbc.M607347200	http://dx.doi.org/10.1074/jbc.M607347200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17170118	hybrid			2022-12-27	WOS:000244481900040
J	Ellison, GM; Torella, D; Karakikes, I; Purushothaman, S; Curcio, A; Gasparri, C; Indolfi, C; Cable, NT; Goldspink, DF; Nadal-Ginard, B				Ellison, Georgina M.; Torella, Daniele; Karakikes, Ioannis; Purushothaman, Saranya; Curcio, Antonio; Gasparri, Cosimo; Indolfi, Ciro; Cable, N. Tim; Goldspink, David F.; Nadal-Ginard, Bernardo			Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; HEART-FAILURE; MYOCARDIAL-INFARCTION; PKA PHOSPHORYLATION; FAILING HEARTS; REGENERATION; APOPTOSIS; RELEASE; DEATH; HYPERTROPHY	A hyperadrenergic state is a seminal aspect of chronic heart failure. Also, " Takotsubo stress cardiomyopathy," is associated with increased plasma catecholamine levels. The mechanisms of myocyte damage secondary to excess catecholamine exposure as well as the consequence of this neurohumoral burst on cardiac stem cells ( CSCs) are unknown. Cardiomyocytes and CSCs were exposed to high doses of isoproterenol ( ISO), in vivo and in vitro. Male Wistar rats received a single injection of ISO ( 5 mg kg(-1)) and were sacrificed 1, 3, and 6 days later. In comparison with controls, LV function was impaired in rats 1 day after ISO and started to improve at 3 days. The fraction of dead myocytes peaked 1 day after ISO and decreased thereafter. ISO administration resulted in significant ryanodine receptor 2 ( RyR2) hyperphosphorylation and RyR2- calstabin dissociation. JTV519, a RyR2 stabilizer, prevented the ISO- induced death of adult myocytes in vitro. In contrast, CSCs were resistant to the acute neurohumoral overload. Indeed, CSCs expressed a decreased and inverted complement of beta(1)/beta(2)-adrenoreceptors and absence of RyR2, which may explain their survival to ISO insult. Thus, a single injection of ISO causes diffuse myocyte death through Ca2+ leakage secondary to the acutely dysfunctional RyR2. CSCs are resistant to the noxious effects of an acute hyperadrenergic state and through their activation participate in the response to the ISO- induced myocardial injury. The latter could contribute to the ability of the myocardium to rapidly recover from acute hyperadrenergic damage.	Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; Mt Sinai Sch Med, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; Liverpool John Moores Univ, Sport & Exercise Sci Res Inst, Liverpool L3 2ET, Merseyside, England; Magna Graecia Univ Catanzaro, Lab Mol & Cellular Cardiol, I-88100 Catanzaro, Italy; Ctr Nacl Invest Cardiovasc, E-28029 Madrid, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Liverpool John Moores University; Magna Graecia University of Catanzaro; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Nadal-Ginard, B (corresponding author), Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Box 1030,1 Gustave L Levy Pl, New York, NY 10029 USA.	bernardo.nadal-ginard@mssm.edu	Torella, Daniele/A-3296-2009; Curcio, Antonio/K-4822-2018; Ellison-Hughes, Georgina M./B-4597-2016	Ellison-Hughes, Georgina M./0000-0002-2733-3361; INDOLFI, Ciro/0000-0003-1241-6487; Curcio, Antonio/0000-0003-3213-4436; TORELLA, Daniele/0000-0002-4915-5084; Cable, Nigel/0000-0003-3766-9835; Karakikes, Ioannis/0000-0002-4348-600X	NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; British Heart Foundation [PG/06/053/20650] Funding Source: Medline; NCI NIH HHS [5R24 CA095823-04, R24 CA095823] Funding Source: Medline; NCRR NIH HHS [1 S10 RR0 9145-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); British Heart Foundation(British Heart Foundation); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Goldspink DF, 2004, EXP PHYSIOL, V89, P407, DOI 10.1113/expphysiol.2004.027482; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MARUYAMA R, 2006, AM J PHYSIOL, V290, P41493; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Nadal-Ginard B, 2003, J CLIN INVEST, V111, P1457, DOI 10.1172/JCI200318611; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SHANNON RP, 1993, AM J PHYSIOL, V265, pH801, DOI 10.1152/ajpheart.1993.265.3.H801; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; TAM SKC, 1995, ANN NY ACAD SCI, V752, P72, DOI 10.1111/j.1749-6632.1995.tb17407.x; TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105; Torella D, 2007, CELL MOL LIFE SCI, V64, P661, DOI 10.1007/s00018-007-6519-y; Torella D, 2005, TRENDS CARDIOVAS MED, V15, P229, DOI 10.1016/j.tcm.2005.06.006; Torella D, 2004, AM J PHYSIOL-HEART C, V287, pH2850, DOI 10.1152/ajpheart.01119.2003; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Torella Daniele, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS8, DOI 10.1038/ncpcardio0409; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, NAT REV DRUG DISCOV, V3, P565, DOI 10.1038/nrd1440; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Zaugg M, 2000, CIRCULATION, V102, P344; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	38	127	133	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2007	282	15					11397	11409		10.1074/jbc.M607391200	http://dx.doi.org/10.1074/jbc.M607391200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LG	17237229	Green Accepted, hybrid			2022-12-27	WOS:000245941500062
J	Otu, HH; Naxerova, K; Ho, K; Can, H; Nesbitt, N; Libermann, TA; Karp, SJ				Otu, Hasan H.; Naxerova, Kamila; Ho, Karen; Can, Handan; Nesbitt, Nicole; Libermann, Towia A.; Karp, Seth J.			Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HEPATOCYTE PROLIFERATION; REGENERATION; PROGENITORS; DELETION; REVEALS; PROTEIN; SYSTEM; GROWTH; TISSUE	Normal adult liver is uniquely capable of renewal and repair after injury. Whether this response represents simple hyperplasia of various liver elements or requires recapitulation of the genetic program of the developing liver is not known. To study these possibilities, we examined transcriptional programs of adult liver after partial hepatectomy and contrasted these with developing embryonic liver. Principal component analysis demonstrated that the time series of gene expression during liver regeneration does not segregate according to developmental transcription patterns. Gene ontology analysis revealed that liver restoration after hepatectomy and liver development differ dramatically with regard to transcription factors and chromatin structure modification. In contrast, the tissues are similar with regard to proliferation-associated genes. Consistent with these findings, real-time polymerase chain reaction showed transcription factors known to be important in liver development are not induced during liver regeneration. These three lines of evidence suggest that at a transcriptional level restoration of liver mass after injury is best described as hepatocyte hyperplasia and not true regeneration. We speculate this novel pattern of gene expression may underlie the unique capacity of the liver to repair itself after injury.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Genom Core, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; Yeditepe Univ, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey; Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Yeditepe University; Harvard University; Boston Children's Hospital	Karp, SJ (corresponding author), Transplant Ctr, 110 Francis St,7th Floor, Boston, MA 02215 USA.	skarp@bidmc.harvard.edu	Libermann, Towia/F-9866-2010; Ho, Karen/AHC-8328-2022	Libermann, Towia/0000-0002-4006-8179; Otu, Hasan/0000-0002-9253-8152; Naxerova, Kamila/0000-0001-7744-5110	NHLBI NIH HHS [2T32HL007734-11] Funding Source: Medline; NIDDK NIH HHS [DK64648] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064648] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai M, 2003, J BIOL CHEM, V278, P29813, DOI 10.1074/jbc.M212648200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Fukuhara Y, 2003, J HEPATOL, V38, P784, DOI 10.1016/S0168-8278(03)00077-1; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kelley-Loughnane N, 2002, HEPATOLOGY, V35, P525, DOI 10.1053/jhep.2002.31351; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Laurson J, 2005, INT J EXP PATHOL, V86, P1, DOI 10.1111/j.0959-9673.2005.00410.x; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Palis J, 1999, DEVELOPMENT, V126, P5073; Petkov PM, 2004, HEPATOLOGY, V39, P617, DOI 10.1002/hep.20088; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reimold AM, 2000, GENE DEV, V14, P152; Sasaki K, 2000, ARCH HISTOL CYTOL, V63, P137, DOI 10.1679/aohc.63.137; Servillo G, 1998, GENE DEV, V12, P3639, DOI 10.1101/gad.12.23.3639; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Sumazaki R, 2004, NAT GENET, V36, P83, DOI 10.1038/ng1273; Tornte LT, 2006, J HISTOCHEM CYTOCHEM, V54, P593, DOI 10.1369/jhc.5A6810.2006; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200	41	69	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2007	282	15					11197	11204		10.1074/jbc.M608441200	http://dx.doi.org/10.1074/jbc.M608441200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LG	17227769	hybrid			2022-12-27	WOS:000245941500041
J	Wang, Q; Wei, XC; Zhu, TH; Zhang, M; Shen, R; Xing, LP; O'Keefe, RJ; Chen, D				Wang, Qing; Wei, Xiaochao; Zhu, Tianhui; Zhang, Ming; Shen, Run; Xing, Lianping; O'Keefe, Regis J.; Chen, Di			Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; BETA INTERACTS; CBFA1; BINDING; EXPRESSION; CONTRIBUTES; INDUCTION; PROMOTER; DOMAIN	BMP-2 plays an essential role in osteoblast and chondrocyte differentiation, but its signaling mechanism has not been fully defined. In the present studies, we investigated the mechanism through which BMP-2 activates the Smad6 gene. A - 2006/ + 45 Smad6 promoter-luciferase construct was generated along with deletions and Runx2 binding site mutations to examine the role of Smad1 and Runx2 signaling following BMP-2 stimulation in osteoblasts. Transfection of Runx2 or treatment with BMP-2-stimulated promoter activity of the - 2006/ + 45 and - 1191/ + 45 reporters but not the - 829/ + 45 and - 374/ + 45 reporters. No Smad1/5 binding site is present in the - 1191/ + 829 region of the Smad6 promoter. Mutation of the OSE2-a site ( - 1036/ - 1031) completely abolished the stimulatory effect of Runx2 as well as BMP-2 on the - 2006/ + 45 and - 1191/ + 45 Smad6 reporters. Gel shift and chromatin immunoprecipitation ( ChIP) assays showed that Runx2 binds the OSE2-a element. ChIP assays demonstrated that Smad1 also interacts with the OSE2-a site at the Smad6 promoter through Runx2. The protein degradation of Runx2 is mediated by the E3 ubiquitin ligase Smurf1. In the present studies, we found that Smurf1 binds the OSE2-a site through Runx2 and inhibits Smad6 gene transcription. Treatment with BMP-2 and transfection of Smad1 abolished Smurf1 binding to the OSE2 site. These results show that Smad1 binding excludes Smurf1 interaction with the OSE2 site and promotes Smad6 gene transcription.	Univ Rochester, Med Ctr, Dept Orthopaed, Sch Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Pathol, Rochester, NY 14642 USA; Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	University of Rochester; University of Rochester; Nankai University	Chen, D (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed, Sch Med, Rochester, NY 14642 USA.	di_chen@urmc.rochester.edu	Zhang, Ming/H-6467-2011		NIAMS NIH HHS [R01 AR051189-03, R01 AR054465-01, R01 AR051189, R01 AR054465, K02 AR052411-01A2, K02 AR052411, R01 AR051189-02] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR052411, R01AR054465, R01AR051189] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Chikazu D, 2002, J BONE MINER RES, V17, P1430, DOI 10.1359/jbmr.2002.17.8.1430; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDLOS S, 1995, HUM MOL GENET, V4, P71, DOI 10.1093/hmg/4.1.71; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shen R, 2006, J BIOL CHEM, V281, P3569, DOI 10.1074/jbc.M506761200; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	31	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2007	282	14					10742	10748		10.1074/jbc.M610997200	http://dx.doi.org/10.1074/jbc.M610997200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LB	17215250	Green Accepted, hybrid			2022-12-27	WOS:000245941000068
J	Bohl, J; Brimer, N; Lyons, C; Pol, SBV				Bohl, Joanna; Brimer, Nicole; Lyons, Charles; Pol, Scott B. Vande			The stardust family protein MPP7 forms a tripartite complex with LIN7 and DLG1 that regulates the stability and localization of DLG1 to cell junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPILLOMAVIRUS E6 PROTEINS; LARGE TUMOR-SUPPRESSOR; ADENOVIRUS TYPE 9; HUMAN DISCS LARGE; DROSOPHILA-MELANOGASTER; POLARITY DEFECTS; EPITHELIAL-CELLS; MAMMARY-TUMORS; BINDING; DEGRADATION	MPP7, a previously uncharacterized member of the p55 Stardust family of membrane-associated guanylate kinase (MAGUK) proteins, was found in a tripartite complex with DLG1 and LIN7A or LIN7C. MPP7 dimerizes with all three LIN7 family members (LIN7A, -B, and -C) through interaction of the single L27 domain of LIN7 with the carboxyl-terminal L27 domain of MPP7, thereby stabilizing both proteins. The dimer of MPP7 with LIN7A or LIN7C associates with DLG I through an interaction requiring the amino-terminal L27 domain of MPP7. The amino-terminal L27 domain of MPP7 is not sufficient for interaction with DLG1 but interacts efficiently only if MPP7 is in a complex with LIN7A or -C. Thus the specificity of interaction of DLG I with the LIN7-MPP7 complex is determined by L27 interactions with both MPP7 and LIN7. The tripartite complex forms in a ratio of 1:1:1 and localizes to epithelial adherens junctions in a manner dependent upon MPP7. Expression of MPP7 stabilizes DLG1 in an insoluble compartment. Expression of MPP7 deleted of the PDZ or Src homology 3 domain redistributes MPP7, DLG1, and LIN7 out of adherens junctions and into the soluble cytoplasmic fraction without changing the localization of E-cadherin. Thus, the stability and localization of DLG1 to cell-cell junctions are complex functions determined by the expression and association of particular Stardust family members together with particular LIN7 family members.	Univ Virginia, Dept Pathol, Sch Med, Charlottesville, VA 22908 USA	University of Virginia	Pol, SBV (corresponding author), Univ Virginia, Dept Pathol, Sch Med, POB 800904, Charlottesville, VA 22908 USA.	vandepol@virginia.edu	Pol, Scott Vande/AAO-1068-2020	Pol, Scott Vande/0000-0002-0587-4802	NCI NIH HHS [CA69292, R01 CA069292-11, R01 CA069292, R01 CA120352, R01 CA120352-01A2, CA80931] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069292, R01CA120352, R29CA069292, R01CA080931] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANKERST J, 1974, INT J CANCER, V13, P286, DOI 10.1002/ijc.2910130303; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Hall WW, 2005, ONCOGENE, V24, P5965, DOI 10.1038/sj.onc.1208975; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; JAVIER R, 1991, J VIROL, V65, P3192, DOI 10.1128/JVI.65.6.3192-3202.1991; JAVIER R, 1992, SCIENCE, V257, P1267, DOI 10.1126/science.1519063; Jeong KW, 2007, ONCOGENE, V26, P487, DOI 10.1038/sj.onc.1209837; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Karnak D, 2002, J BIOL CHEM, V277, P46730, DOI 10.1074/jbc.M208781200; Katoh M, 2004, INT J MOL MED, V13, P333; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Weiss RS, 1997, J VIROL, V71, P7873, DOI 10.1128/JVI.71.10.7873-7880.1997; Wu HJ, 1998, J CELL SCI, V111, P2365; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333	38	46	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9392	9400		10.1074/jbc.M610002200	http://dx.doi.org/10.1074/jbc.M610002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17237226	hybrid			2022-12-27	WOS:000245421700011
J	Bentley, ML; Gaweska, H; Kielec, JM; McCafferty, DG				Bentley, Matthew L.; Gaweska, Helena; Kielec, Joseph M.; McCafferty, Dewey G.			Engineering the substrate specificity of Staphylococcurs aureus sortase A - The beta 6/beta 7 loop from SrtB confers NPQTN recognition to SrtA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PROTEINS; CELL-WALL; LISTERIA-MONOCYTOGENES; TRANSPEPTIDASE; GENE; IRON; SEQUENCE; DEHYDROGENASE; INACTIVATION; INTERNALIN	The Staphylococcus aureus transpepticlase Sortase A (SrtA) anchors virulence and colonization-associated surface proteins to the cell wall. SrtA selectively recognizes a C-terminal LPXTG motif, whereas the related transpeptidase Sortase B (SrtB) recognizes a C-terminal NPQTN motif. In both enzymes, cleavage occurs after the conserved threonine, followed by amide bond formation between threonine and the pentaglycine cross-bridge of cell wall peptidoglycan. Genetic and biochemical studies strongly suggest that SrtA and SrtB exhibit exquisite specificity for their recognition motifs. To better understand the origins of substrate specificity within these two isoforms, we used sequence and structural analysis to predict residues and domains likely to be involved in conferring substrate specificity. Mutational analyses and domain swapping experiments were conducted to test their function in substrate recognition and specificity. Marked changes in the specificity profile of SrtA were obtained by replacing the beta 6/beta 7 loop in SrtA with the corresponding domain from SrtB. The chimeric beta 6/beta 7 loop swap enzyme (SrtLS) conferred the ability to acylate NPQTN-containing substrates, with a k(cat)/K-mapp of 0.0062 +/- 0.003 M-1 s(-1). This enzyme was unable to perform the transpeptidation stage of the reaction, suggesting that additional domains are required for transpepticlation to occur. The overall catalytic specificity profile (k(cat)/K-m(app) (NPQTN)/k(cat)/K-m(app) (LPETG)) of SrtLS was altered 700,000-fold from SrtA. These results indicate that the beta 6/beta 7 loop is an important site for substrate recognition in sortases.	Duke Univ, Dept Chem, Durham, NC 27708 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA	Duke University; University of Pennsylvania; University of Pennsylvania	McCafferty, DG (corresponding author), Duke Univ, Dept Chem, B120 LSRC Bldg,Box 90317, Durham, NC 27708 USA.	dewey@duke.edu			NIAID NIH HHS [AI46611, R01 AI046611] Funding Source: Medline; NIGMS NIH HHS [T32 GM008275] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bolken TC, 2001, INFECT IMMUN, V69, P75, DOI 10.1128/IAI.69.1.75-80.2001; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Cazzola M, 2004, CURR OPIN PULM MED, V10, P204, DOI 10.1097/00063198-200405000-00010; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; Ma HC, 1999, P NATL ACAD SCI USA, V96, P11161, DOI 10.1073/pnas.96.20.11161; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MITTL PRE, 1994, PROTEIN SCI, V3, P1504, DOI 10.1002/pro.5560030916; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paterson GK, 2006, MICROBES INFECT, V8, P145, DOI 10.1016/j.micinf.2005.06.009; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Tendolkar PM, 2006, J BACTERIOL, V188, P2063, DOI 10.1128/JB.188.6.2063-2072.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; WIDERSTEN M, 1995, J MOL BIOL, V250, P115, DOI 10.1006/jmbi.1995.0362; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; Yamaguchi M, 2006, MICROBES INFECT, V8, P2791, DOI 10.1016/j.micinf.2006.08.010; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	44	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6571	6581		10.1074/jbc.M610519200	http://dx.doi.org/10.1074/jbc.M610519200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200112	hybrid			2022-12-27	WOS:000244867200066
J	Valnickova, Z; Petersen, SV; Nielsen, SB; Otzen, DE; Enghild, JJ				Valnickova, Zuzana; Petersen, Steen V.; Nielsen, Soren B.; Otzen, Daniel E.; Enghild, Jan J.			Heparin binding induces a conformational change in pigment epithelium-derived factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC ACTIVITY; I COLLAGEN; PEDF; SERPIN; CELLS; SITE; ANGIOGENESIS; PURIFICATION; INHIBITOR; PROTEINS	Pigment epithelium-derived factor (PEDF) is a noninhibitory serpin found in plasma and in the extracellular space. The protein is involved in different biological processes including cell differentiation and survival. In addition, it is a potent inhibitor of angiogenesis. The function is likely associated with binding to cell surface receptors in a heparin-dependent way (Alberdi, E. M., Weldon, J. E., and Becerra, S. P. (2003) BMC Biochem. 4, 1). We have investigated the structural basis for this observation and show that heparin induces a conformational change in the vicinity of Lys(178). This structural change was evident both when binding to intact heparin and specific heparin-derived oligosaccharides at physiological conditions or simply when exposing PEDF to low ionic strength. Binding to other glycosaminoglycans, heparin-derived oligosaccharides smaller than hexadecasaccharides (dp16), or type I collagen did not affect the structure of PEDF. The conformational change is likely to expose the epitope involved in binding to the receptor and thus regulates the interactions with cell surface receptors.	Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct, inSPIN, DK-8000 Aarhus C, Denmark; Univ Aalborg, Dept Life Sci, DK-9000 Aalborg, Denmark	Aarhus University; Aalborg University	Enghild, JJ (corresponding author), Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct, inSPIN, DK-8000 Aarhus C, Denmark.	jje@mb.au.dk		Otzen, Daniel/0000-0002-2918-8989; Vang Petersen, Steen/0000-0002-9338-911X; Enghild, Jan Johannes/0000-0001-9292-9172				Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chader GJ, 2001, P NATL ACAD SCI USA, V98, P2122, DOI 10.1073/pnas.061024098; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Maik-Rachline G, 2005, BLOOD, V105, P670, DOI 10.1182/blood-2004-04-1569; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stratikos E, 1996, PROTEIN SCI, V5, P2575, DOI 10.1002/pro.5560051220; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1989, INVEST OPHTH VIS SCI, V30, P1700; Wu YQ, 1996, INVEST OPHTH VIS SCI, V37, P1984; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558	24	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6661	6667		10.1074/jbc.M610471200	http://dx.doi.org/10.1074/jbc.M610471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202143	hybrid			2022-12-27	WOS:000244867200075
J	Strawn, MA; Marr, SK; Inoue, K; Inada, N; Zubieta, C; Wildermuth, MC				Strawn, Marcus A.; Marr, Sharon K.; Inoue, Kentaro; Inada, Noriko; Zubieta, Chloe; Wildermuth, Mary C.			Arabidopsis isochorismate synthase functional in pathogen-induced salicylate biosynthesis exhibits properties consistent with a role in diverse stress responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORISMATE-UTILIZING ENZYMES; ELICITED CELL-CULTURES; ESCHERICHIA-COLI; ANTHRANILATE SYNTHASE; YERSINIA-ENTEROCOLITICA; PSEUDOMONAS-AERUGINOSA; CATHARANTHUS-ROSEUS; 2,3-DIHYDROXYBENZOIC ACID; DISEASE RESISTANCE; SHIKIMATE PATHWAY	Salicylic acid (SA) is a phytohormone best known for its role in plant defense. It is synthesized in response to diverse pathogens and responsible for the large scale transcriptional induction of defense-related genes and the establishment of systemic acquired resistance. Surprisingly, given its importance in plant defense, an understanding of the underlying enzymology is lacking. In Arabidopsis thaliana, the pathogen-induced accumulation of SA requires isochorismate synthase (AtICS1). Here, we show that AtICS1 is a plastid-localized, stromal protein using chloroplast import assays and immunolocalization. AtICS1 acts as a monofunctional isochorismate synthase (ICS), catalyzing the conversion of chorismate to isochorismate (IC) in a reaction that operates near equilibrium (K-eq = 0.89). It does not convert chorismate directly to SA (via an IC intermediate) as does Yersinia enterocolitica Irp9. Using an irreversible coupled spectrophotometric assay, we found that AtICS1 exhibits an apparent K-m of 41.5 mu M and k(cat) = 38.7 min(-1) for chorismate. This affinity for chorismate would allow it to successfully compete with other pathogen-induced, chorismate-utilizing enzymes. Furthermore, the biochemical properties of AtICS1 indicate its activity is not regulated by light-dependent changes in stromal pH, Mg2+, or redox and that it is remarkably active at 4 degrees C consistent with a role for SA in cold-tolerant growth. Finally, our analyses support plastidic synthesis of stress-induced SA with the requirement for one or more additional enzymes responsible for the conversion of IC to SA, because non-enzyrnatic conversion of IC to SA under physiological conditions was negligible.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Stanford Univ, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; Stanford University	Wildermuth, MC (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	wildermuth@nature.berkeley.edu		INADA, NORIKO/0000-0002-9931-4063; Marr, Sharon/0000-0001-6958-5949; Zubieta, Chloe/0000-0003-4558-9333				ALSHEHBAZ IA, 2002, ARABIDOPSIS BOOK; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; BERNASCONI P, 1994, PLANT PHYSIOL, V106, P353, DOI 10.1104/pp.106.1.353; Brodersen P, 2005, PLANT PHYSIOL, V138, P1037, DOI 10.1104/pp.105.059303; Bruce BD, 1994, PLANT MOL BIOL MAN J, VJ1, P1; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Buss K, 2001, BBA-GENE STRUCT EXPR, V1522, P151, DOI 10.1016/S0167-4781(01)00325-6; Chen BS, 2005, BIOINFORMATICS, V21, P2698, DOI 10.1093/bioinformatics/bti348; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; CORNISHBOWDEN A, 1979, FUNDAMENTALS ENZYME, P39; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Dahm C, 1998, BBA-GEN SUBJECTS, V1425, P377, DOI 10.1016/S0304-4165(98)00089-0; Daruwala R, 1997, J BACTERIOL, V179, P3133, DOI 10.1128/jb.179.10.3133-3138.1997; DeClue MS, 2006, J AM CHEM SOC, V128, P2043, DOI 10.1021/ja056714x; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Entus R, 2002, PLANT PHYSIOL, V129, P1866, DOI 10.1104/pp.002626; Fall R, 1998, J GEOPHYS RES-ATMOS, V103, P25599, DOI 10.1029/98JD00808; Gaille C, 2003, J BIOL CHEM, V278, P16893, DOI 10.1074/jbc.M212324200; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Gross J, 2006, J BIOL CHEM, V281, P17189, DOI 10.1074/jbc.M601754200; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han YS, 2002, PHYTOCHEMISTRY, V59, P45, DOI 10.1016/S0031-9422(01)00296-5; Harrison AJ, 2006, J BACTERIOL, V188, P6081, DOI 10.1128/JB.00338-06; HERRMANN KM, 1995, PLANT CELL, V7, P907; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Kerbarh O, 2006, J MOL BIOL, V357, P524, DOI 10.1016/j.jmb.2005.12.078; Kerbarh O, 2005, J BACTERIOL, V187, P5061, DOI 10.1128/JB.187.15.5061-5066.2005; KOZLOWSKI MC, 1995, J AM CHEM SOC, V117, P2128, DOI 10.1021/ja00113a002; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; LEDUC C, 1991, PLANT CELL REP, V10, P334, DOI 10.1007/BF00193153; Leduc C, 1997, PLANTA, V202, P206, DOI 10.1007/s004250050120; Li J, 1996, PLANT PHYSIOL, V110, P51, DOI 10.1104/pp.110.1.51; LIU J, 1990, BIOCHEMISTRY-US, V29, P1417, DOI 10.1021/bi00458a012; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Mori T, 2003, BIOCHEM BIOPH RES CO, V306, P564, DOI 10.1016/S0006-291X(03)01005-2; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Muljono RAB, 2002, PLANT PHYSIOL BIOCH, V40, P231, DOI 10.1016/S0981-9428(02)01369-4; Muller R, 1996, FEBS LETT, V378, P131, DOI 10.1016/0014-5793(95)01436-5; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Payne RJ, 2005, ORG BIOMOL CHEM, V3, P1825, DOI 10.1039/b503800f; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Polya G., 2003, BIOCH TARGETS PLANT; POULSEN C, 1991, PHYTOCHEMISTRY, V30, P2873, DOI 10.1016/S0031-9422(00)98216-5; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; Rudolph F B, 1979, Methods Enzymol, V63, P138; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Sahr T, 2006, BIOCHEM J, V396, P157, DOI 10.1042/BJ20051851; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Sharma YK, 1996, P NATL ACAD SCI USA, V93, P5099, DOI 10.1073/pnas.93.10.5099; Stalman M, 2003, J PLANT PHYSIOL, V160, P607, DOI 10.1078/0176-1617-00773; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Tegelen LJP, 1999, PLANT PHYSIOL, V119, P705, DOI 10.1104/pp.119.2.705; van Tegelen LJP, 1999, PHYTOCHEMISTRY, V51, P263, DOI 10.1016/S0031-9422(98)00742-0; Verberne MC, 2000, NAT BIOTECHNOL, V18, P779, DOI 10.1038/77347; Viitanen PV, 2004, PLANT PHYSIOL, V136, P4048, DOI 10.1104/pp.104.050054; Volko SM, 1998, GENETICS, V149, P537; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wolfenden R, 1999, J AM CHEM SOC, V121, P7419, DOI 10.1021/ja991280p; YOUNG IG, 1969, BIOCHIM BIOPHYS ACTA, V177, P389, DOI 10.1016/0304-4165(69)90301-8; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	78	158	173	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5919	5933		10.1074/jbc.M605193200	http://dx.doi.org/10.1074/jbc.M605193200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17190832	hybrid			2022-12-27	WOS:000244482300088
J	Yao, PL; Lin, YC; Sawhney, P; Richburg, JH				Yao, Pei-Li; Lin, Yi-Chen; Sawhney, Pragati; Richburg, John H.			Transcriptional regulation of FasL expression and participation of sTNF-alpha in response to Sertoli cell injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; SITE-DIRECTED MUTAGENESIS; LIGAND GENE-EXPRESSION; YOUNG-RAT TESTES; MONO-(2-ETHYLHEXYL) PHTHALATE; TNF-ALPHA; INDUCED APOPTOSIS; INTERLEUKIN-8 EXPRESSION; PROTEIN EXPRESSION	The Fas/FasL signaling pathway has previously been demonstrated to be critical for triggering germ cell apoptosis in response to mono-(2-ethylhexyl)phthalate (MEHP)-induced Sertoli cell injury. Although Sertoli cells ubiquitously express the FasL protein, MEHP-induced germ cell apoptosis appears to tightly correlate with increased levels of Sertoli cell FasL. Here we characterize the transcriptional regulation of the murine FasL gene in Sertoli cells after MEHP exposure. A serial deletion strategy for 1.5 kb of the 5'-upstream activating sequence of the FasL promoter was used to determine transcriptional activity in response to MEHP. Luciferase activity of the FasL promoter in the rat Sertoli cell line ASC-17D revealed that two regions, - 500 to - 324 and - 1250 to - 1000, were necessary to drive the inducible transcription of FasL, Sequence analysis of these two regions revealed two cis-regulatory elements, NF-kappa B and Sp-1. By site-directed mutagenesis, electrophoretic mobility shift and chromatin immunoprecipitation assays, it was confirmed that MEHP-induced FasL expression is enhanced through the transcriptional regulation of both NF-kappa B and Sp-1. Experiments performed both in vitro and in vivo revealed that MEHP exposure results in an increased production of sTNF-alpha and that sTNF-alpha-mediated NF-kappa B activation causes robust increases in FasL levels in both the ASC-17D Sertoli cell line and in primary rat Sertoli cell/germ cell co-cultures. In the seminiferous epithelium, Sertoli cells express TNFR1, whereas germ cells produce TNF-alpha. Therefore, sTNF-alpha released by germ cells after MEHP-induced Sertoli cell injury acts upon Sertoli cell TNFRI and activates NF-kappa B and Sp-1 that consequently causes a robust induction of FasL expression. These novel findings point to a potential "feed-forward" signaling mechanism by which germ cells prompt Sertoli cells to trigger their apoptotic elimination.	Univ Texas, Coll Pharm, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Richburg, JH (corresponding author), 1 Univ Stn, Austin, TX 78712 USA.	john_richburg@mail.utexas.edu	Richburg, John H/P-4369-2014	Richburg, John H/0000-0001-6334-9777; Yao, Pei-Li/0000-0003-0832-3771	NIEHS NIH HHS [ES09145] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009145] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arnold R, 1999, J IMMUNOL, V162, P7140; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Chandrasekaran Y, 2005, BIOL REPROD, V72, P206, DOI 10.1095/biolreprod.104.030858; Chandrasekaran Y, 2006, BIOL REPROD, V74, P560, DOI 10.1095/biolreprod.105.045146; CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Crist SA, 2003, J BIOL CHEM, V278, P35950, DOI 10.1074/jbc.M306220200; D'Abrizio P, 2004, INT J ANDROL, V27, P304, DOI 10.1111/j.1365-2605.2004.00483.x; D'Alessio A, 2001, P NATL ACAD SCI USA, V98, P3316, DOI 10.1073/pnas.051566098; DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389; Delfino F, 1998, MOL ENDOCRINOL, V12, P1696, DOI 10.1210/me.12.11.1696; Delfino FJ, 1999, J BIOL CHEM, V274, P35607, DOI 10.1074/jbc.274.50.35607; Dunkel L, 1997, CELL DEATH DIFFER, V4, P171, DOI 10.1038/sj.cdd.4400234; Dzialo-Hatton R, 2001, J IMMUNOL, V166, P4534, DOI 10.4049/jimmunol.166.7.4534; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GEARING AJH, 1995, J LEUKOCYTE BIOL, V57, P774, DOI 10.1002/jlb.57.5.774; Giammona CJ, 2002, TOXICOL APPL PHARM, V185, P119, DOI 10.1006/taap.2002.9536; Hadziselimovic F, 1998, J UROLOGY, V160, P1158, DOI 10.1016/S0022-5347(01)62725-3; HALLECK MM, 1992, FREE RADICAL BIO MED, V12, P137, DOI 10.1016/0891-5849(92)90007-4; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hilton TL, 2003, J BIOL CHEM, V278, P12992, DOI 10.1074/jbc.M300412200; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Hu JH, 2003, CELL RES, V13, P361, DOI 10.1038/sj.cr.7290181; Hu XT, 1999, J IMMUNOL, V163, P3106; Ichimura T, 2003, TOXICOLOGY, V194, P35, DOI 10.1016/j.tox.2003.07.003; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Jing D, 2004, ELECTROPHORESIS, V25, P2439, DOI 10.1002/elps.200405994; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Koji T, 2003, ARCH HISTOL CYTOL, V66, P1, DOI 10.1679/aohc.66.1; Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Lin WW, 1997, FERTIL STERIL, V68, P1065, DOI 10.1016/S0015-0282(97)00372-5; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Lysiak Jeffrey J, 2004, Reprod Biol Endocrinol, V2, P9, DOI 10.1186/1477-7827-2-9; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mauduit C, 1998, ENDOCRINOLOGY, V139, P2863, DOI 10.1210/en.139.6.2863; McClure RF, 1999, J BIOL CHEM, V274, P7756, DOI 10.1074/jbc.274.12.7756; Mir MA, 2003, BIOORGAN MED CHEM, V11, P2791, DOI 10.1016/S0968-0896(03)00211-6; Morales V, 2003, ENDOCRINOLOGY, V144, P4763, DOI 10.1210/en.2003-0569; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ohta S, 2001, J RHEUMATOL, V28, P1756; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Ongeri EM, 2005, MOL ENDOCRINOL, V19, P1837, DOI 10.1210/me.2004-0487; Oya M, 2001, ONCOGENE, V20, P3888, DOI 10.1038/sj.onc.1204525; Peng YH, 2006, J SURG RES, V130, P58, DOI 10.1016/j.jss.2005.07.030; Pentikainen V, 2002, AM J PATHOL, V160, P205, DOI 10.1016/S0002-9440(10)64364-7; Pentikainen V, 2001, J CLIN ENDOCR METAB, V86, P4480, DOI 10.1210/jc.86.9.4480; Pinkoski MJ, 1999, CELL DEATH DIFFER, V6, P1174, DOI 10.1038/sj.cdd.4400611; Pinkoski MJ, 2002, J BIOL CHEM, V277, P42380, DOI 10.1074/jbc.M208167200; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Rasoulpour RJ, 2005, BIOL REPROD, V72, P479, DOI 10.1095/biolreprod.104.034363; RASOULPOUR RJ, 2006, IN PRESS BIOL REPROD; RICCIOLI A, 1995, P NATL ACAD SCI USA, V92, P5808, DOI 10.1073/pnas.92.13.5808; Riccioli A, 2003, ANDROLOGIA, V35, P64, DOI 10.1046/j.1439-0272.2003.00538.x; Richburg JH, 2003, TOXICOL LETT, V139, P1, DOI 10.1016/S0378-4274(02)00419-8; Richburg JH, 2002, TOXICOL LETT, V135, P167, DOI 10.1016/S0378-4274(02)00254-0; Richburg JH, 1999, TOXICOL APPL PHARM, V160, P271, DOI 10.1006/taap.1999.8786; Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055; Richburg JH, 2000, TOXICOL LETT, V112, P79, DOI 10.1016/S0378-4274(99)00253-2; ROBERTS KP, 1995, BIOL REPROD, V53, P1446, DOI 10.1095/biolreprod53.6.1446; Ruby J, 1997, J EXP MED, V186, P1591, DOI 10.1084/jem.186.9.1591; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Slongo ML, 2002, BIOL CHEM, V383, P235, DOI 10.1515/BC.2002.025; Soond SM, 2003, MOL CELL BIOL, V23, P8334, DOI 10.1128/mcb.23.22.8334-8344.2003; Suominen JS, 2004, EUR J ENDOCRINOL, V151, P629, DOI 10.1530/eje.0.1510629; Teixeiro E, 1999, EUR J IMMUNOL, V29, P745, DOI 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0; Wang RA, 1998, BIOL REPROD, V58, P1250, DOI 10.1095/biolreprod58.5.1250; XIONG YT, 1993, ENDOCRINOLOGY, V133, P2568, DOI 10.1210/en.133.6.2568; XIONG YT, 1993, ENDOCRINOLOGY, V132, P2438, DOI 10.1210/en.132.6.2438; Xu JP, 1999, AM J REPROD IMMUNOL, V42, P381; Yao PL, 2005, AM J RESP CELL MOL, V32, P540, DOI 10.1165/rcmb.2004-0223OC; Ziparo E, 1995, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY, VOL 100 - SUPPLEMENT N.1 - 1995, P553	91	51	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5420	5431		10.1074/jbc.M609068200	http://dx.doi.org/10.1074/jbc.M609068200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192273	hybrid			2022-12-27	WOS:000244482300037
J	Lin, YL; de Villiers, WJS; Garvy, B; Post, SR; Nagy, TR; Safadi, FF; Faugere, MC; Wang, GD; Malluche, HH; Williams, JP				Lin, Yi-Ling; de Villiers, Willem J. S.; Garvy, Beth; Post, Steven R.; Nagy, Tim R.; Safadi, Fayez F.; Faugere, Marie Claude; Wang, Guodong; Malluche, Hartmut H.; Williams, John P.			The effect of class A scavenger receptor deficiency in bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; COLONY-STIMULATING FACTOR; OSTEOCLAST DIFFERENTIATION; SR-A; EXPRESSION; MICE; MACROPHAGES; CELLS; GENE; INFILTRATION	Class A scavenger receptor (SR-A) is predominantly expressed by macrophages, and because osteoclasts are of monocyte/macrophage lineage, SR-A is of potential interest in osteoclast biology. In addition to modified low density lipoprotein uptake, SR-A is also important in cell attachment and signaling. In this study we evaluated the effect of SR-A deletion on bone. Knock-out animals have 40% greater body weight than wild type. Body composition analyses demonstrated that total lean and fat body mass were greater in knock-out animals, but there was no significant difference in percent fat and lean body mass. Bone mineral density and content were significantly greater in knock-out compared with wild type animals. Micro-computed tomography analyses confirmed that total volume, bone volume as well as trabecular number, thickness, and connectivity were significantly greater in knock-out mice. As expected, trabecular separation was greater in wild type mice. The phenotype appears to be explained by 60% fewer osteoclasts in females and 35% fewer in males compared to wild type mice with a paradoxical increase in nuclei/osteoclast in knock-out animals. Furthermore, there were no differences in adipocyte number and osteoblast number or activity. The addition of the soluble extracellular domain of SR-A to RAW264.7 cells stimulated a concentration-dependent increase in osteoclast differentiation that was receptor activator of nuclear factor-kappa B ligand (RANKL)-dependent. Soluble SR-A had no effect on cell proliferation in the presence of RANKL but stimulated a 40% increase in numbers in the absence of RANKL. We conclude that SR-A plays a role in normal osteoclast differentiation, suggesting a novel role for this receptor in bone biology.	Univ Kentucky, Dept Internal Med, Coll Dent, Lexington, KY 40536 USA; Univ Kentucky, Div Digest Dis & Nutr, Lexington, KY 40536 USA; Univ Kentucky, Div Nephrol Bone & Mineral Metab, Lexington, KY 40536 USA; Univ Kentucky, Dept Microbiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Immunol & Mol Genet, Lexington, KY 40536 USA; Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; Lexington Vet Affairs Med Ctr, Lexington, KY 40502 USA; Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Williams, JP (corresponding author), Univ Kentucky, Dept Internal Med, Coll Dent, 800 Rose St,MN521, Lexington, KY 40536 USA.	JohnWilliams@uky.edu	Safadi, Fayez/AAU-8699-2021	Post, Steven/0000-0002-4711-1723; Nagy, Tim/0000-0002-2371-7114	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30AR046031] Funding Source: Medline; NIDDK NIH HHS [P30DK56336] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asakura E, 1999, CELL PROLIFERAT, V32, P185, DOI 10.1046/j.1365-2184.1999.3240185.x; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Daugherty A, 1997, ARTERIOSCL THROM VAS, V17, P2369, DOI 10.1161/01.ATV.17.11.2369; De Rycke L, 2005, J PATHOL, V206, P17, DOI 10.1002/path.1758; DEVILLIERS WJS, 1994, J EXP MED, V180, P705, DOI 10.1084/jem.180.2.705; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Gordon S, 1999, IMMUNOL LETT, V65, P5, DOI 10.1016/S0165-2478(98)00116-3; Gough PJ, 1998, J LIPID RES, V39, P531; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Haschtmann D, 2005, MICROBES INFECT, V7, P1177, DOI 10.1016/j.micinf.2005.03.031; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Inoue M, 2000, ENDOCRINOLOGY, V141, P284, DOI 10.1210/en.141.1.284; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kamada N, 2001, J Atheroscler Thromb, V8, P1; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Laukkanen J, 2000, CIRCULATION, V101, P1091, DOI 10.1161/01.CIR.101.10.1091; Lees RL, 1999, J BONE MINER RES, V14, P937, DOI 10.1359/jbmr.1999.14.6.937; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; London GM, 2005, CURR OPIN NEPHROL HY, V14, P525, DOI 10.1097/01.mnh.0000168336.67499.c0; LORENZO JA, 1987, J CLIN INVEST, V80, P160, DOI 10.1172/JCI113042; Lowell CA, 1996, BLOOD, V87, P1780; Malluche HH, 1986, ATLAS MINERALIZED BO; MANAKA RC, 1981, COMPUT PROG BIOMED, V13, P191, DOI 10.1016/0010-468X(81)90098-2; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; Nelson-Dooley C, 2005, CURR MED CHEM, V12, P2215, DOI 10.2174/0929867054864886; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; PITAS RE, 1990, J BIOL CHEM, V265, P12722; Platt N, 2002, INT REV CYTOL, V212, P1; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; SHINAR DM, 1993, J BONE MINER RES, V8, P403; *SPSS INC, 1993, SPSS WIND BAS SYST U, P189; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SUDA T, 1995, BONE S2, V17, P87; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Tian G, 2004, J BIOL CHEM, V279, P39303, DOI 10.1074/jbc.M405219200; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Whitman SC, 2000, J LIPID RES, V41, P807; Whitman SC, 2002, J LIPID RES, V43, P1201, DOI 10.1194/jlr.M200116-JLR200; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Yang G, 2004, CANCER RES, V64, P2076, DOI 10.1158/0008-5472.CAN-03-4072; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9; ZHENG MH, 1991, PATHOL RES PRACT, V187, P117, DOI 10.1016/S0344-0338(11)81058-7	56	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4653	4660		10.1074/jbc.M608552200	http://dx.doi.org/10.1074/jbc.M608552200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166840	hybrid			2022-12-27	WOS:000244482000046
J	Mouzat, K; Prod'Homme, M; Volle, DH; Sion, B; Dechelotte, P; Gauthier, K; Vanacker, JM; Lobaccaro, JMA				Mouzat, Kevin; Prod'Homme, Magali; Volle, David H.; Sion, Benoit; Dechelotte, Pierre; Gauthier, Karine; Vanacker, Jean-Marc; Lobaccaro, Jean-Marc A.			Oxysterol nuclear receptor LXR beta regulates cholesterol homeostasis and contractile function in mouse uterus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTORS; UTERINE SMOOTH-MUSCLE; BODY-MASS INDEX; SKELETAL-MUSCLE; GENE-EXPRESSION; LIPID-ACCUMULATION; ALPHA; PREGNANCY; METABOLISM; MYOMETRIUM	The uterus is an organ where lipid distribution plays a critical role for its function. Here we show that nuclear receptor for oxysterols LXR beta prevents accumulation of cholesteryl esters in mouse myometrium by controlling expression of genes involved in cholesterol efflux and storage (abca1 and abcg1). Upon treatment with an LXR agonist that mimics activation by oxysterols, expression of these target genes was increased in wild-type mice, whereas under basal conditions, lxra;beta(-/-) mice exhibited a marked decrease in abcg1 accumulation. This change resulted in a phenotype of cholesteryl ester accumulation. Besides, a defect of contractile activity induced by oxytocin or PGF2 alpha was observed in mice lacking LXR beta. These results imply that LXR beta provides a safety valve to limit cholesteryl ester levels as a basal protective mechanism in the uterus against cholesterol accumulation and is necessary for a correct induction of contractions.	Univ Blaise Pascal, UMR 6547, CNRS, F-63177 Clermont Ferrand, France; Human Nutr Res Ctr, F-63177 Clermont Ferrand, France; Univ Auvergne, Lab Biol Dev & Reprod, F-63058 Clermont Ferrand, France; Hop Hotel Dieu, CHU Clermont Ferrand, Serv Anat Pathol, F-63058 Clermont Ferrand, France; EMI, INSERM, F-34298 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Lobaccaro, JMA (corresponding author), Univ Blaise Pascal, UMR 6547, CNRS, 24 Ave Landais, F-63177 Clermont Ferrand, France.	j-marc.lobaccaro@univ-bpclermont.fr	Lobaccaro, Jean-Marc/Q-3926-2019; Volle, David H/P-6155-2014; Lobaccaro, Jean-Marc A./U-1928-2019	Lobaccaro, Jean-Marc/0000-0001-9890-2392; Volle, David H/0000-0003-0843-0550; 				Andreasen KR, 2004, ACTA OBSTET GYN SCAN, V83, P1022, DOI 10.1111/j.0001-6349.2004.00624.x; Babiychuk EB, 2004, J MEMBRANE BIOL, V198, P95, DOI 10.1007/s00232-004-0663-1; Barau G, 2006, BJOG-INT J OBSTET GY, V113, P1173, DOI 10.1111/j.1471-0528.2006.01038.x; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Berto AGA, 2003, BBA-GEN SUBJECTS, V1619, P98, DOI 10.1016/S0304-4165(02)00446-4; Brizzi P, 1999, AM J OBSTET GYNECOL, V181, P430, DOI 10.1016/S0002-9378(99)70574-0; Buxton ILO, 2005, P W PHARMACOL SOC, V48, P126; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Costet P, 2000, J BIOL CHEM, V275, P28240; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; DALLE M, 1992, ARCH INT PHYSIOL BIO, V100, P251, DOI 10.3109/13813459208998110; Davies JD, 2005, J BIOL CHEM, V280, P3911, DOI 10.1074/jbc.M410075200; Di Renzo GC, 2005, CURR OPIN OBSTET GYN, V17, P598, DOI 10.1097/01.gco.0000191899.84567.4d; DOCKERY P, 1989, BAILLIERE CLIN OB GY, V3, P227, DOI 10.1016/S0950-3552(89)80020-3; Doherty DA, 2006, INT J GYNECOL OBSTET, V95, P242, DOI 10.1016/j.ijgo.2006.06.021; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Frenoux JM, 2004, J MOL ENDOCRINOL, V33, P361, DOI 10.1677/jme.1.01515; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grizard G, 2000, J CHROMATOGR B, V740, P101, DOI 10.1016/S0378-4347(00)00039-6; HOLMAN RT, 1991, P NATL ACAD SCI USA, V88, P4835, DOI 10.1073/pnas.88.11.4835; Horard B, 2004, J MOL ENDOCRINOL, V33, P87, DOI 10.1677/jme.0.0330087; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; HUSZAR G, 1982, AM J OBSTET GYNECOL, V142, P225, DOI 10.1016/S0002-9378(16)32341-9; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kabiru W, 2004, AM J OBSTET GYNECOL, V191, P928, DOI 10.1016/j.ajog.2004.06.051; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Komuves LG, 2002, J INVEST DERMATOL, V118, P25, DOI 10.1046/j.0022-202x.2001.01628.x; Mascrez B, 2004, EMBO REP, V5, P285, DOI 10.1038/sj.embor.7400094; MCCORMACK SA, 1980, ENDOCRINOLOGY, V106, P1634, DOI 10.1210/endo-106-5-1634; Mendelson CR, 2005, J STEROID BIOCHEM, V93, P113, DOI 10.1016/j.jsbmb.2004.12.027; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Myatt L, 2004, PROSTAG LEUKOTR ESS, V70, P137, DOI 10.1016/j.plefa.2003.04.004; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; POTTER J, 1978, CLIN CHIM ACTA, V87, P57, DOI 10.1016/0009-8981(78)90057-8; Pulkkinen MO, 1998, GYNECOL OBSTET INVES, V46, P220, DOI 10.1159/000010038; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Robertson KM, 2005, ENDOCRINOLOGY, V146, P2519, DOI 10.1210/en.2004-1413; Smith RD, 2005, AM J PHYSIOL-CELL PH, V288, pC982, DOI 10.1152/ajpcell.00120.2004; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003	52	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4693	4701		10.1074/jbc.M606718200	http://dx.doi.org/10.1074/jbc.M606718200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166844	hybrid			2022-12-27	WOS:000244482000050
J	Jalota-Badhwar, A; Kaul-Ghanekar, R; Mogare, D; Boppana, R; Paknikar, KM; Chattopadhyay, S				Jalota-Badhwar, Archana; Kaul-Ghanekar, Ruchika; Mogare, Devraj; Boppana, Ramanamurthy; Paknikar, Kishore M.; Chattopadhyay, Samit			SMAR1-derived p44 peptide retains its tumor suppressor function through modulation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CELL-CYCLE PROGRESSION; PROTEIN TRANSDUCTION; IN-VIVO; MAMMALIAN-CELLS; FUSION PROTEINS; CANCER-CELLS; TAT PROTEIN; GROWTH; DELIVERY	The use of pharmacologically active short peptide sequences is a better option in cancer therapeutics than the full-length protein. Here we report one such 44-mer peptide sequence of SMAR1 (TAT-SMAR1 wild type, P44) that retains the tumor suppressor activity of the full-length protein. The protein transduction domain of human immunodeficiency virus, type 1, Tat protein was used here to deliver the 33-mer peptide of SMAR1 into the cells. P44 peptide could efficiently activate p53 by mediating its phosphorylation at serine 15, resulting in the activation of p21. and in effect regulating cell cycle checkpoint. In vitro phosphorylation assays with point-mutated P44-derived peptides suggested that serine 347 of SMAR1 was indispensable for its activity and represented the substrate motif for the protein kinase C family of proteins. Using xenograft nude mice models, we further demonstrate that P44 was capable of inhibiting tumor growth by preventing cellular proliferation. P44 treatment to tumor-bearing mice prevented the formation of poorly organized tumor vasculature and an increase in hypoxia-inducible factor-la expression, both being signatures of tumor progression. The chimeric TAT-SMAR1-derived peptide, P44, thus has a strong therapeutic potential as an anticancer drug.	Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; Agharkar Res Inst, Pune 400004, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Department of Science & Technology (India); Agharkar Research Institute (ARI)	Chattopadhyay, S (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune 411007, Maharashtra, India.	samit@nccs.res.in	Paknikar, Kishore/A-4963-2010	Paknikar, Kishore/0000-0001-5602-7518; Jalota-Badhwar, Archana/0000-0002-7785-0965				Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Birner P, 2000, CANCER RES, V60, P4693; Bonfanti M, 1997, CANCER RES, V57, P1442; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Cussac D, 1999, FASEB J, V13, P31, DOI 10.1096/fasebj.13.1.31; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Donehower LA, 1997, CANCER SURV, V29, P329; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Egleton RD, 1997, PEPTIDES, V18, P1431, DOI 10.1016/S0196-9781(97)00242-8; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fahraeus R, 1998, ONCOGENE, V16, P587, DOI 10.1038/sj.onc.1201580; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fujimoto K, 2000, CANCER LETT, V159, P151, DOI 10.1016/S0304-3835(00)00536-X; Giorello L, 1998, CANCER RES, V58, P3654; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 1997, CANCER SURV, V29, P263; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Heppner C, 1998, J CLIN ENDOCR METAB, V83, P693, DOI 10.1210/jc.83.2.693; Ho A, 2001, CANCER RES, V61, P474; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Lee K., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P203, DOI 10.2174/1568016033477414; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; NISHIMURA H, 1994, BIOCHEM J, V302, P271, DOI 10.1042/bj3020271; OConnor PM, 1997, CANCER RES, V57, P4285; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Prives C, 1999, J PATHOL, V187, P112; Ryan HE, 2000, CANCER RES, V60, P4010; SCHELD WM, 1989, REV INFECT DIS S, V7, P1669; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seagroves T, 2002, CANCER CELL, V1, P211, DOI 10.1016/S1535-6108(02)00048-X; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Semenza GL, 2000, GENE DEV, V14, P1983; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vocero-Akbani A, 2001, METHOD ENZYMOL, V332, P36; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141	58	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9902	9913		10.1074/jbc.M608434200	http://dx.doi.org/10.1074/jbc.M608434200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17229733	hybrid			2022-12-27	WOS:000245421700065
J	Lagerstedt, JO; Budamagunta, MS; Oda, MN; Voss, JC				Lagerstedt, Jens O.; Budamagunta, Madhu S.; Oda, Michael N.; Voss, John C.			Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of ApoA-I in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; LOOP-GAP RESONATOR; LIPID-FREE; CRYSTAL-STRUCTURE; CONFORMATION; PROTEINS; BINDING; ORGANIZATION; CHOLESTEROL	Apolipoprotein A-I (apoA-I) is the major protein constituent of high density lipoprotein (HDL) and plays a central role in phospholipid and cholesterol metabolism. This 243-residue long protein is remarkably flexible and assumes numerous lipid-dependent conformations. Consequently, definitive structural determination of lipid-free apoA-I in solution has been difficult. Using electron paramagnetic spectroscopy of site-directed spin labels in the N-terminal domain of apoA-I (residues 1-98) we have mapped a mixture of secondary structural elements, the composition of which is consistent with findings from other insolution methods. Based on side chain mobility and their accessibility to polar and non-polar spin relaxers, the precise location of secondary elements for amino acids 14-98 was determined for both lipid-free and lipid-bound apoA-I. Based on intermolecular dipolar coupling at positions 26, 44, and 64, these secondary structural elements were arranged into a tertiary fold to generate a structural model for lipid-free apoA-I in solution.	Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Davis; University of California System; University of California Davis; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Voss, JC (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	jcvoss@ucdavis.edu	Lagerstedt, Jens/AAF-9567-2021; Budamagunta, Madhu S/C-4628-2011	Lagerstedt, Jens/0000-0002-4313-2666	NCRR NIH HHS [C06 RR-12088-01] Funding Source: Medline; NHLBI NIH HHS [HL077268, HL078615] Funding Source: Medline; NIA NIH HHS [R01 AG029246] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077268, R01HL078615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Frank PG, 2000, J LIPID RES, V41, P853; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Joy T, 2003, CLIN BIOCHEM, V36, P641, DOI 10.1016/S0009-9120(03)00110-3; KOKORIN AI, 1972, BIOFIZIKA+, V17, P34; LI WH, 1988, J LIPID RES, V29, P245; LIKHTENSHTEIN GI, 1993, BIOPHYSICAL LABELING; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1987, J LIPID RES, V28, P719; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oh KJ, 2000, METH MOL B, V145, P147; Okon M, 2001, FEBS LETT, V487, P390, DOI 10.1016/S0014-5793(00)02375-9; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; VITELLO LB, 1976, J BIOL CHEM, V251, P1131	34	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9143	9149		10.1074/jbc.M608717200	http://dx.doi.org/10.1074/jbc.M608717200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17204472	hybrid			2022-12-27	WOS:000245780300061
J	Chong, SAC; Lee, W; Arora, PD; Laschinger, C; Young, EWK; Simmons, CA; Manolson, M; Sodek, J; McCulloch, CA				Chong, Sandra A. C.; Lee, Wilson; Arora, Pam D.; Laschinger, Carol; Young, Edmond W. K.; Simmons, Craig A.; Manolson, Morris; Sodek, Jaro; McCulloch, Christopher A.			Methylglyoxal inhibits the binding step of collagen phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GINGIVAL FIBROBLASTS; CELL-MATRIX INTERACTIONS; AMINO-ACID-SEQUENCE; ADVANCED GLYCATION; ALPHA(2)BETA(1) INTEGRINS; PERIODONTAL TISSUES; ENDOTHELIAL-CELLS; PROTEIN GLYCATION; LIGAND-BINDING; BETA-1 SUBUNIT	Bacterial infection-induced fibrosis affects a wide variety of tissues, including the periodontium, but the mechanisms that dysregulate matrix turnover and mediate fibrosis are not defined. Since collagen turnover by phagocytosis is an important pathway for matrix remodeling, we studied the effect of the bacterial and eukaryotic cell metabolite, methylglyoxal. (NIGO), on the binding step of phagocytosis by periodontal fibroblasts. Type 1 collagen was treated with various concentrations of methylglyoxal, an important glucose metabolite that modifies Arg and Lys residues. The extent of MGO-induced modifications was authenticated by amino acid analysis, solubility, and cross-linking. Cells were incubated with fluorescent beads coated with collagen, and the percentage of phagocytic cells was estimated by flow cytometry. MGO inhibited collagen binding (20% of control for 10 mm MGO) in a time- and concentration-dependent manner. MGO-induced inhibition of binding was prevented by aminoguanidine, which blocks the formation of collagen cross-links. MGO reduced collagen binding strength and blocked intracellular calcium signaling. MGO modified the Arg residue in the critical alpha(2)beta(1) integrin-binding recognition sequence of triple helical collagen peptides, whereas MGO-induced cross-linking of Lys residues played only a small role in binding inhibition. Thus, MGO modifications of Arg residues in collagen could be a key factor in the impaired degradation of collagen that promotes fibrosis in chronic infections, such as periodontitis.	Univ Toronto, Canadian Inst, Hlth Res Grp, Dynam Dynam, Toronto, ON M5S 3E2, Canada; Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3E2, Canada	University of Toronto; University of Toronto	McCulloch, CA (corresponding author), Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mccculloch@utoronto.ca	Young, Edmond/B-4915-2011; Simmons, Craig/ABA-2015-2020; Simmons, Craig/A-5880-2008; Young, Edmond/AFN-7180-2022	Simmons, Craig/0000-0001-7729-1772; Simmons, Craig/0000-0001-7729-1772; Young, Edmond/0000-0002-1274-5478; Manolson, Morris/0000-0001-8755-5460				Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Baronas-Lowell D, 2004, J BIOL CHEM, V279, P952, DOI 10.1074/jbc.M305989200; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bishara NB, 2002, J CELL PHYSIOL, V193, P80, DOI 10.1002/jcp.10153; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Chou DHI, 1996, J IMMUNOL, V156, P4354; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Ferguson GP, 1998, J BACTERIOL, V180, P4314, DOI 10.1128/JB.180.16.4314-4318.1998; Glogauer M, 1997, J CELL SCI, V110, P11; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kashket S, 2003, J CLIN PERIODONTOL, V30, P364, DOI 10.1034/j.1600-051X.2003.00322.x; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; KNOWLES GC, 1991, J CELL SCI, V98, P551; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; MCKEOWN M, 1990, CELL TISSUE RES, V262, P523, DOI 10.1007/BF00305249; Mene P, 1999, J AM SOC NEPHROL, V10, P1478; MONNIER VM, 1984, P NATL ACAD SCI-BIOL, V81, P583, DOI 10.1073/pnas.81.2.583; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MOSKOW BS, 1991, J CLIN PERIODONTOL, V18, P534, DOI 10.1111/j.1600-051X.1991.tb00086.x; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; NGO TT, 1981, J BIOL CHEM, V256, P1313; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Paul RG, 1999, INT J BIOCHEM CELL B, V31, P653, DOI 10.1016/S1357-2725(99)00023-0; Pedchenko VK, 2005, DIABETES, V54, P2952, DOI 10.2337/diabetes.54.10.2952; PENDER N, 1991, J CELL SCI, V100, P187; Phares DJ, 2000, J FLUID MECH, V418, P351, DOI 10.1017/S002211200000121X; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Segal G, 2001, J CELL SCI, V114, P119; Sell DR, 2004, J BIOL CHEM, V279, P54173, DOI 10.1074/jbc.M408946200; SHAW SK, 1994, J BIOL CHEM, V269, P6016; SODEK J, 1988, COLLAGEN REL RES, V8, P11; SODEK J, 1978, J BIOL CHEM, V253, P1129; UITTO VJ, 1991, CRIT REV ORAL BIOL M, V2, P323, DOI 10.1177/10454411910020030301; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9	51	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8510	8520		10.1074/jbc.M609859200	http://dx.doi.org/10.1074/jbc.M609859200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229729	hybrid			2022-12-27	WOS:000245081000083
J	Kitagawa, H; Izumikawa, T; Mizuguchi, S; Dejima, K; Nomura, KH; Egusa, N; Taniguchi, F; Tamura, J; Gengyo-Ando, K; Mitani, S; Nomura, K; Sugahara, K				Kitagawa, Hiroshi; Izumikawa, Tomomi; Mizuguchi, Souhei; Dejima, Katsufumi; Nomura, Kazuko H.; Egusa, Noriyuki; Taniguchi, Fumiyasu; Tamura, Jun-ichi; Gengyo-Ando, Keiko; Mitani, Shohei; Nomura, Kazi; Sugahara, Kazuyuki			Expression of rib-1, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes, is indispensable for heparan sulfate synthesis and embryonic morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; N-ACETYLGLUCOSAMINE; MOLECULAR-CLONING; CHAIN INITIATION; CELL-DIVISION; TOUT-VELU; BIOSYNTHESIS; DROSOPHILA; PROTEOGLYCANS; PROTEINS	The proteins encoded by all of the five cloned human EXT family genes (EXT1, EXT2, EXTL1, EXTL2, and EXTL3), members of the hereditary multiple exostoses gene family of tumor suppressors, are glycosyltransferases required for the biosynthesis of heparan sulfate. In the Caenorhabditis elegans genome, only two genes, rib-1 and rib-2, homologous to the mammalian EXT genes have been identified. Although rib-2 encodes an N-acetylglucosaminyltransferase involved in initiating the biosynthesis and elongation of heparan sulfate, the involvement of the protein encoded by rib-1 in the biosynthesis of heparan sulfate remains unclear. Here we report that RIB-1 is indispensable for the biosynthesis and for embryonic morphogenesis. Despite little individual glycosyltransferase activity by RIB-1, the polymerization of heparan sulfate chains was demonstrated when RIB-1 was coexpressed with RIB-2 in vitro. In addition, RIB-1 and RIB-2 were demonstrated to interact by pultdown assays. To investigate the functions of RIB-1 in vivo, we depleted the expression of rib-1 by deletion mutagenesis. The null mutant worms showed reduced synthesis of heparan sulfate and embryonic lethality. Notably, the null mutant embryos showed abnormality at the gastrulation cleft formation stage or later and arrested mainly at the 1-fold stage. Nearly 100% of the embryos died before L1 stage, although the differentiation of some of the neurons and muscle cells proceeded normally. Similar phenotypes have been observed in rib-2 null mutant embryos. Thus, RIB-1 in addition to RIB-2 is indispensable for the biosynthesis of heparan sulfate in C elegans, and the two cooperate to synthesize heparan sulfate in vivo. These findings also show that heparan sulfate is essential for post-gastrulation morphogenic movement of embryonic cells and is indispensable for ensuring the normal spatial organization of differentiated tissues and organs.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	Kobe Pharmaceutical University; Kyushu University; Japan Science & Technology Agency (JST); Tottori University; Tokyo Women's Medical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp; smizuscb@mbox.nc.kyushu-u.ac.jp; k-sugar@sci.hokudai.ac.jp	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019; Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Brunner A, 2006, GLYCOCONJUGATE J, V23, P543, DOI 10.1007/s10719-006-7633-z; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Clines GA, 1997, GENOME RES, V7, P359, DOI 10.1101/gr.7.4.359; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Franks DM, 2006, DEV BIOL, V296, P409, DOI 10.1016/j.ydbio.2006.06.008; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hudson ML, 2006, DEV BIOL, V294, P352, DOI 10.1016/j.ydbio.2006.02.036; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2006, J BIOL CHEM, V281, P1929, DOI 10.1074/jbc.M509138200; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2002, J BIOL CHEM, V277, P13659, DOI 10.1074/jbc.M111630200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; McCormick C, 1999, MOL MED TODAY, V5, P481, DOI 10.1016/S1357-4310(99)01593-2; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P289; Morio H, 2003, BIOCHEM BIOPH RES CO, V301, P317, DOI 10.1016/S0006-291X(02)03031-0; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Siekmann AF, 2005, DEV DYNAM, V232, P498, DOI 10.1002/dvdy.20248; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200	53	25	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8533	8544		10.1074/jbc.M611107200	http://dx.doi.org/10.1074/jbc.M611107200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237233	hybrid			2022-12-27	WOS:000245081000085
J	Kreutzenbeck, P; Kroger, C; Lausberg, F; Blaudeck, N; Sprenger, GA; Freudl, R				Kreutzenbeck, Peter; Kroeger, Carsten; Lausberg, Frank; Blaudeck, Natascha; Sprenger, Georg A.; Freudl, Roland			Escherichia coli twin arginine (Tat) mutant translocases possessing relaxed signal peptide recognition specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; GENETIC-ANALYSIS; EXPORT PATHWAY; MEMBRANE; MUTATIONS; SEQUENCE; COMPLEX; REQUIREMENT; SECRETION; EVOLUTION	The twin arginine (Tat) secretion pathway allows the translocation of folded proteins across the cytoplasmic membrane of bacteria. Tat-specific signal peptides contain a characteristic amino acid motif ((S/T)RRXFLK) including two highly conserved consecutive arginine residues that are thought to be involved in the recognition of the signal peptides by the Tat translocase. Here, we have analyzed the specificity of Tat signal peptide recognition by using a genetic approach. Replacement of the two arginine residues in a Tat-specific precursor protein by lysine-glutamine resulted in an export-defective mutant precursor that was no longer accepted by the wild-type translocase. Selection for restored export allowed for the isolation of Tat translocases possessing single mutations in either the amino-terminal domain of TatB or the first cytosolic domain of TatC. The mutant Tat translocases still efficiently accepted the unaltered precursor protein, indicating that the substrate specificity of the translocases was not strictly changed; rather, the translocases showed an increased tolerance toward variations of the amino acids occupying the positions of the twin arginine residues in the consensus motif of a Tat signal peptide.	Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, Postfach 1913, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Kröger, Carsten/D-1863-2014; Freudl, Roland/N-4179-2017; Sprenger, Georg A./E-2384-2011	Kröger, Carsten/0000-0003-0461-1530; Freudl, Roland/0000-0003-0743-1279; Sprenger, Georg A./0000-0002-7879-8978				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BIEKER KL, 1990, TRENDS GENET, V6, P329, DOI 10.1016/0168-9525(90)90254-4; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Dassa E, 1997, RES MICROBIOL, V148, P389, DOI 10.1016/S0923-2508(97)83869-7; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; DUPLAY P, 1984, J BIOL CHEM, V259, P606; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HUMPHREYS GO, 1976, MOL GEN GENET, V145, P101, DOI 10.1007/BF00331564; Ize B, 2002, J MOL BIOL, V317, P327, DOI 10.1006/jmbi.2002.5431; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jaeger KE, 2001, APPL MICROBIOL BIOT, V55, P519, DOI 10.1007/s002530100643; MILLER JH, 1972, SHORT COURSE BACT GE; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Muller M, 2001, PROG NUCLEIC ACID RE, V66, P107; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; RYAN JP, 1985, J BIOL CHEM, V260, P4832; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179	36	57	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7903	7911		10.1074/jbc.M610126200	http://dx.doi.org/10.1074/jbc.M610126200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229735	hybrid			2022-12-27	WOS:000245081000020
J	Spurny, R; Abdoulrahman, K; Janda, L; Runzler, D; Kohler, G; Castanon, MJ; Wiche, G				Spurny, Radovan; Abdoulrahman, Kamaran; Janda, Lubomir; Ruenzler, Dominik; Koehler, Gottfried; Castanon, Maria J.; Wiche, Gerhard			Oxidation and nitrosylation of cysteines proximal to the intermediate filament (IF)-binding site of plectin - Effects on structure and vimentin binding and involvement in if collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; NITRIC-OXIDE SYNTHASE; EPIDERMOLYSIS-BULLOSA; KINASE; IDENTIFICATION; RECEPTOR; DESMIN; LOCALIZATION; INACTIVATION; ORGANIZATION	As an intermediate filament (IF)-based cytolinker protein, plectin plays a key role in the maintenance of cellular cytoarchitecture and serves at the same time as a scaffolding platform for signaling cascades. Consisting of six structural repeats (R1-6) and harboring binding sites for different IF proteins and proteins involved in signaling, the plectin C-terminal domain is of strategic functional importance. Depending on the species, it contains at least 13 cysteines, 4 of which reside in the R5 domain. To investigate the structural and biological functions of R5 cysteines, we used cysteine-to-serine mutagenesis and spectroscopic, biochemical, and functional analyses. Urea-induced unfolding experiments indicated that wild-type R5 in the oxidized, disulfide bond-mediated conformation was more stable than its cysteine-free mutant derivative. The binding affinity of R5 for vimentin was significantly higher, however, when the protein was in the reduced, more relaxed conformation. Of the four R5 cysteines, one (Cys4) was particularly reactive as reflected by its ability to form disulfide bridges with R5 Cys 1 and to serve as a target for nitrosylation in vitro. Using immortalized endothelial cell cultures from mice, we show that endogenous plectin is nitrosylated in vivo, and we found that NO donor-induced IF collapse proceeds dramatically faster in plectin-deficient compared with wild-type cells. Our data suggest an antagonistic role of plectin in nitrosylation (oxidative stress)mediated alterations of IF cytoarchitecture and a possible role of R5 Cys4 as a regulatory switch.	Univ Vienna, Dept Mol Cell Biol, Max F Perutz Labs, A-1030 Vienna, Austria; Univ Vienna, Dept Biomol Struct Chem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Wiche, G (corresponding author), Univ Vienna, Dept Mol Cell Biol, Max F Perutz Labs, Campus Vienna Bioctr,Dr Bohr Gasse 9, A-1030 Vienna, Austria.	gerhard.wiche@univie.ac.at	WICHE, Gerhard/AAA-3227-2021; Rünzler, Dominik/G-9393-2014; Wiche-Castanon, Maria/AAA-9914-2021; Janda, Lubomir/D-8048-2012	Rünzler, Dominik/0000-0002-6020-3411; Wiche, Gerhard/0000-0001-9550-5463; Janda, Lubomir/0000-0002-5406-4208; Castanon, Maria J./0000-0002-3266-478X	Austrian Science Fund FWF [P 17862] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Callsen D, 1999, FREE RADICAL BIO MED, V26, P1544, DOI 10.1016/S0891-5849(99)00015-5; CASELLI A, 1995, FEBS LETT, V374, P249, DOI 10.1016/0014-5793(95)01120-4; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; FOISNER R, 1987, J MOL BIOL, V198, P515, DOI 10.1016/0022-2836(87)90297-X; FRASER RDB, 1985, INT J BIOL MACROMOL, V7, P258, DOI 10.1016/0141-8130(85)90024-8; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; GIESE G, 1986, EUR J CELL BIOL, V40, P266; Green Kathleen J., 1992, Journal of Dermatology (Tokyo), V19, P765; Gregor M, 2006, J CELL SCI, V119, P1864, DOI 10.1242/jcs.02891; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janda L, 2001, BIOESSAYS, V23, P1064, DOI 10.1002/bies.1151; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KRIJNSELOCKER J, 1999, J CELL BIOL, V144, P267; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Lakowitz J., 1999, PRINCIPLES FLUORESCE; Lane P., 2001, SCI STKE, V86, pre1; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Li HG, 1998, MOL PHARMACOL, V53, P630, DOI 10.1124/mol.53.4.630; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Liu CG, 1996, P NATL ACAD SCI USA, V93, P4278, DOI 10.1073/pnas.93.9.4278; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Maatta A, 2000, J BIOL CHEM, V275, P19857, DOI 10.1074/jbc.M001028200; Martinez-Ruiz A, 2004, ARCH BIOCHEM BIOPHYS, V423, P192, DOI 10.1016/j.abb.2003.12.006; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; PARRY DAD, 1985, INT J BIOL MACROMOL, V7, P203, DOI 10.1016/0141-8130(85)90003-0; Peitsch WK, 2001, EUR J CELL BIOL, V80, P567, DOI 10.1078/0171-9335-00194; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; ROGERS KR, 1991, BIOCHEM J, V275, P789, DOI 10.1042/bj2750789; ROGERS KR, 1989, INT J TISSUE REACT, V11, P309; Schroder R, 2002, J NEUROPATH EXP NEUR, V61, P520, DOI 10.1093/jnen/61.6.520; Sevcik J, 2004, EUR J BIOCHEM, V271, P1873, DOI 10.1111/j.1432-1033.2004.04095.x; Shen BQ, 2001, J BIOL CHEM, V276, P5281, DOI 10.1074/jbc.M007969200; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Steinbock FA, 2000, J CELL SCI, V113, P483; TRAUB P, 1993, J MOL BIOL, V230, P837, DOI 10.1006/jmbi.1993.1205; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; Wiche G, 1998, J CELL SCI, V111, P2477; Xian M, 2000, BIOCHEM BIOPH RES CO, V268, P310, DOI 10.1006/bbrc.2000.2117; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102	55	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8175	8187		10.1074/jbc.M608473200	http://dx.doi.org/10.1074/jbc.M608473200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224453	hybrid			2022-12-27	WOS:000245081000050
J	Eley, HL; Tisdale, MJ				Eley, Helen L.; Tisdale, Michael J.			Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; UBIQUITIN-PROTEASOME PATHWAY; KINASE PKR; EUKARYOTIC INITIATION-FACTOR-2; MALIGNANT-TRANSFORMATION; CACHECTIC-FACTOR; MURINE MYOTUBES; IN-VITRO; ACTIVATION	Both proteolysis-inducing factor (PIF) and angiotensin II have been shown to produce a depression in protein synthesis in murine myotubes concomitant with an increased phosphorylation of eukaryotic initiation factor 2 (eIF2 alpha). Both PIF and angiotensin II were shown to induce autophosphorylation of the RNA-dependent protein kinase (PKR), and an inhibitor of this enzyme completely attenuated the depression in protein synthesis and prevented the induction of eIF2 alpha phosphorylation. The PKR inhibitor also completely attenuated the increase in protein degradation induced by PIF and angiotensin II and prevented the increase in proteasome expression and activity. To confirm these results myotubes were transfected with plasmids that express either wild-type PKR, or a catalytically inactive PKR variant, PKR Delta 6. Myotubes expressing PKRA6 showed no increase in eIF2 alpha phosphorylation in response to PIF or angiotensin II, no depression in protein synthesis, and no increase in protein degradation or increase in proteasome expression. Induction of the ubiquitin-proteasome pathway by PIF and angiotensin II has been linked to activation of the transcription factor nuclear factor-kappa B (NF-kappa B). Inhibition of PKR prevented nuclear migration of NF-kappa B in response to both PIF and angiotensin II, by preventing degradation of the inhibitor protein I-kappa B. Phosphorylation of PKR and eIF2 alpha was also significantly increased in the gastrocnemius muscle of weight losing mice bearing the MAC16 tumor, suggesting that a similar process may be operative in cancer cachexia. These results provide a link between the depression of protein synthesis in skeletal muscle and the increase in protein degradation.	Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Tisdale, MJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.j.tisdale@aston.ac.uk						ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ASHFORD AJ, 1986, J BIOL CHEM, V261, P4059; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Cooney RN, 1999, SHOCK, V11, P235, DOI 10.1097/00024382-199904000-00002; Donze O, 2004, EMBO J, V23, P564, DOI 10.1038/sj.emboj.7600078; EMERY PW, 1984, BRIT MED J, V289, P584, DOI 10.1136/bmj.289.6445.584; GARCIAMARTINEZ C, 1993, MOL CELL BIOCHEM, V125, P11, DOI 10.1007/BF00926829; Gil J, 2001, ONCOGENE, V20, P385, DOI 10.1038/sj.onc.1204109; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Gomes-Marcondes MCC, 2002, BRIT J CANCER, V86, P1628, DOI 10.1038/sj/bjc/6600236; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; Ishii T, 2001, ONCOGENE, V20, P1900, DOI 10.1038/sj.onc.1204267; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jeffrey IW, 2002, CANCER RES, V62, P2272; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; KIMBALL SR, 1990, J BIOL CHEM, V265, P16794; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Lorite MJ, 2001, BRIT J CANCER, V85, P297, DOI 10.1054/bjoc.2001.1879; LUNDHOLM K, 1976, EUR J CANCER, V12, P465, DOI 10.1016/0014-2964(76)90036-0; NIXON DW, 1980, AM J MED, V68, P683, DOI 10.1016/0002-9343(80)90254-5; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; PANNIERS R, 1983, J BIOL CHEM, V258, P7928; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Perkins DJ, 2004, MOL CELL BIOL, V24, P2025, DOI 10.1128/MCB.24.5.2025-2040.2004; PRICE N, 1994, BIOCHIMIE, V76, P748, DOI 10.1016/0300-9084(94)90079-5; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Russell ST, 2006, CELL SIGNAL, V18, P1087, DOI 10.1016/j.cellsig.2005.09.009; Russell ST, 2006, CANCER LETT, V231, P290, DOI 10.1016/j.canlet.2005.02.007; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Smith HJ, 1999, CANCER RES, V59, P5507; Smith HJ, 2004, BRIT J CANCER, V91, P408, DOI 10.1038/sj.bjc.6601981; Smith HJ, 2004, BRIT J CANCER, V90, P1850, DOI 10.1038/sj.bjc.6601767; Smith HJ, 2003, APOPTOSIS, V8, P161, DOI 10.1023/A:1022970609579; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; SVEN KCS, 2003, J BIOL CHEM, V278, P49819; Todorov PT, 1996, CANCER RES, V56, P1256; Whitehouse AS, 2003, BRIT J CANCER, V89, P1116, DOI 10.1038/sj.bjc.6601132; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Wyke SM, 2005, BRIT J CANCER, V92, P711, DOI 10.1038/sj.bjc.6602402; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	45	104	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7087	7097		10.1074/jbc.M610378200	http://dx.doi.org/10.1074/jbc.M610378200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213191	hybrid			2022-12-27	WOS:000245080900020
J	Wang, Y; Zhou, K; Zeng, XC; Lin, JX; Zhan, X				Wang, Ying; Zhou, Kang; Zeng, Xianchun; Lin, Jinxiu; Zhan, Xi			Tyrosine phosphorylation of missing in metastasis protein in implicated in platelet-derived growth factor-mediated cell shape changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG-RESPONSIVE GENE; SRC FAMILY; MIM-B; SIGNAL-TRANSDUCTION; SUPPRESSOR GENE; BLADDER-CANCER; ACTIN; RECEPTOR; EXPRESSION; KINASES	Missing in metastasis gene, or MTSS1, encodes an intracellular protein that is implicated in actin cytoskeleton reorganization and often down-regulated in certain types of tumor cells. In response to platelet-derived growth factor (PDGF), green fluorescent protein (GFP)-tagged murine Mtss1 (Mtss1-GFP) underwent redistribution from the cytoplasm to dorsal membrane ruffles along with phosphorylation at tyrosine residues in a time-dependent manner. Tyrosine phosphorylation of Mtss1-GFP was also elevated in cells where an oncogenic Src was activated but severely impaired in Src knock-out cells or cells treated with Src kinase inhibitor PP2. Mutagenesis analysis has revealed that phosphorylation occurs at multiple sites, including tyrosine residues Tyr-397 and Tyr-398. Mutation at both Tyr-397 and Tyr-398 abolished the PDGF-mediated tyrosine phosphorylation. Furthermore, recombinant Mtss1 protein was phosphorylated by recombinant Src in a manner dependent on Tyr-397 and Tyr-398. Efficient tyrosine phosphorylation of Mtss1 in response to PDGF also involves a coiled-coil domain, which is essential for a proper distribution to the cell leading edge and dorsal ruffles. Interestingly, overexpression of wild type Mtss1-GFP promoted the PDGF-induced dorsal ruffling, whereas overexpression of a mutant deficient in phosphorylation at Tyr-397 and Tyr-398 or a mutant with deletion of the coiled-coil domain impaired the formation of dorsal ruffles. These data indicate that Mtss1 represents a novel signaling pathway from PDGF receptor to the actin cytoskeleton via Src-related kinases.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Dept Pathol,Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou 350005, Peoples R China	University System of Maryland; University of Maryland Baltimore; Fujian Medical University	Zhan, X (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Dept Pathol,Marlene & Stewart Greenebaum Canc Ctr, 800 W Baltimore St, Baltimore, MD 21201 USA.	Hxzhan@som.umaryland.edu		Zeng, Xian-Chun/0000-0003-2675-2596	NCI NIH HHS [R01CA113809, R01CA091984] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113809, R01CA091984] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; CATLING AD, 1994, J VIROL, V68, P4392, DOI 10.1128/JVI.68.7.4392-4399.1994; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Loberg RD, 2005, INT J ONCOL, V26, P1699; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nixdorf S, 2004, CANCER LETT, V215, P209, DOI 10.1016/j.canlet.2004.05.002; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Utikal J, 2006, INT J CANCER, V119, P2287, DOI 10.1002/ijc.22106; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; WANG Y, 2007, IN PRESS CANC INVEST; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x	29	29	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7624	7631		10.1074/jbc.M608448200	http://dx.doi.org/10.1074/jbc.M608448200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17224454	hybrid			2022-12-27	WOS:000245080900075
J	Horigome, D; Satoh, H; Itoh, N; Mitsunaga, K; Oonishi, I; Nakagawa, A; Uchida, A				Horigome, Daisuke; Satoh, Hiroyuki; Itoh, Nobue; Mitsunaga, Katsuyoshi; Oonishi, Isao; Nakagawa, Atsushi; Uchida, Akira			Structural mechanism and photoprotective function of water-soluble chlorophyll-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LEPIDIUM-VIRGINICUM; ANGSTROM RESOLUTION; SINGLET OXYGEN; PHOTOSYSTEM-I; SYSTEM; CRYSTALLIZATION; PHOTOSYNTHESIS; FLUORESCENCE; SPECTROSCOPY	A water-soluble chlorophyll-binding protein (WSCP) is the single known instance of a putative chlorophyll (Chl) carrier in green plants. Recently the photoprotective function of WSCP has been demonstrated by EPR measurements; the light-induced singlet-oxygen formation of Chl in the WSCP tetramer is about four times lower than that of unbound Chl. This paper describes the crystal structure of the WSCP-Chl complex purified from leaves of Lepidium virginicum (Virginia pepperweed) to clarify the mechanism of its photoprotective function. The WSCP-Chl complex is a homotetramer comprising four protein chains of 180 amino acids and four Chl molecules. At the center of the complex one hydrophobic cavity is formed in which all of the four Chl molecules are tightly packed and isolated from bulk solvent. With reference to the novel Chl-binding mode, we propose that the photoprotection mechanism may be based on the inhibition of physical contact between the Chl molecules and molecular oxygen.	Toho Univ, Dept Biomol Sci, Funabashi, Chiba 2748510, Japan; Toho Univ, Fac Sci, Funabashi, Chiba 2748510, Japan; Toho Univ, Sch Pharmaceut Sci, Funabashi, Chiba 2748510, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Toho University; Toho University; Toho University; Osaka University	Uchida, A (corresponding author), Toho Univ, Dept Biomol Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	auchida@biomol.sci.toho-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861				Amerongen H, 2001, J PHYS CHEM B, V105, P604; Balaban TS, 2002, BBA-BIOENERGETICS, V1556, P197, DOI 10.1016/S0005-2728(02)00363-8; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dashdorj N, 2005, BIOPHYS J, V88, P4178, DOI 10.1529/biophysj.104.058693; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Drzewiecka-Matuszek A, 2005, J BIOL INORG CHEM, V10, P453, DOI 10.1007/s00775-005-0652-6; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HOOFT RW, 1996, NATURE, V381, P27; Horigome D, 2003, ACTA CRYSTALLOGR D, V59, P2283, DOI 10.1107/S0907444903019127; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; Hughes JL, 2006, J AM CHEM SOC, V128, P3649, DOI 10.1021/ja056576b; Ilami G, 1997, PHYTOCHEMISTRY, V45, P1, DOI 10.1016/S0031-9422(96)00788-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kamimura Y, 1997, PLANT CELL PHYSIOL, V38, P133, DOI 10.1093/oxfordjournals.pcp.a029143; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krauchenco S, 2003, BIOCHEM BIOPH RES CO, V312, P1303, DOI 10.1016/j.bbrc.2003.11.062; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Matile P, 1997, PLANTA, V201, P96, DOI 10.1007/BF01258685; MURATA T, 1981, BIOCHIM BIOPHYS ACTA, V635, P341, DOI 10.1016/0005-2728(81)90032-3; MURATA T, 1980, BIOCHIM BIOPHYS ACTA, V593, P167, DOI 10.1016/0005-2728(80)90018-3; Nishio N, 1997, PLANT PHYSIOL, V115, P841, DOI 10.1104/pp.115.2.841; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Oba T, 2002, PHOTOSYNTH RES, V74, P1, DOI 10.1023/A:1020816128794; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterman EJG, 1998, BIOPHYS J, V75, P389, DOI 10.1016/S0006-3495(98)77523-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Satoh H, 1998, J BIOL CHEM, V273, P30568, DOI 10.1074/jbc.273.46.30568; Satoh H, 2001, PLANT CELL PHYSIOL, V42, P906, DOI 10.1093/pcp/pce117; Schmidt K, 2003, BIOCHEMISTRY-US, V42, P7427, DOI 10.1021/bi034207r; SPIKES JD, 1991, CHLOROPHYLLS, P1181; SUGIYAMA KI, 1978, BIOCHIM BIOPHYS ACTA, V503, P107, DOI 10.1016/0005-2728(78)90165-2; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	41	79	83	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6525	6531		10.1074/jbc.M609458200	http://dx.doi.org/10.1074/jbc.M609458200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17170107	hybrid, Green Published			2022-12-27	WOS:000244867200060
J	Lee, MH; Atkinson, S; Murphy, G				Lee, Meng-Huee; Atkinson, Susan; Murphy, Gillian			Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; CATALYTIC DOMAIN; PROTEIN	Tissue inhibitor of metalloproteinases (TIMPs) are the endogenous inhibitors of the zinc-dependent endopeptidases of the matrix metalloproteinase families. There are four mammalian TIMPs (TIMP-1 to -4) but only TIMP-3 is sequestered to the extracellular matrix (ECM). The molecular basis for the TIMP-3:ECM association has never been fully investigated until now. In this report, we identify the unique amino acid configuration that constitutes the basis of the ECM binding motif in TIMP-3. By systematically exchanging the subdomains of the TIMPs and exhaustive mutation of TIMP-3, we have identified the surface residues directly responsible for ECM association. Contrary to the accepted view, we have found that TIMP-3 interacts with the ECM via both its N- and C-terminal domains. The amino acids involved in ECM binding are all basic in nature: Lys-26, Lys-27, Lys-30, Lys-76 of the N-terminal domain and Arg-163, Lys-165 of the C-terminal domain. Replacement of these residues with glutamate (E) and glutamine (Q) (K26/27/30/76E + R163/K165Q) resulted in a soluble TIMP-3 devoid of ECM-adhering ability. Using the ECM binding motif derived from TIMP-3, we have also created a TIMP-1 mutant (K26/27/30 + K76 transplant) capable of ECM association. This is the first instance of TIMPs being intentionally rendered soluble or ECM-bound. The ability to prepare TIMPs in soluble or ECM-bound forms also opens new avenues for future TIMP research.	Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Murphy, G (corresponding author), Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	gm290@cam.ac.uk			MRC [G0400637] Funding Source: UKRI; Medical Research Council [G0400637] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 1998, CANCER RES, V58, P2310; ALBERTS B, 2002, MOL BIOL CELL, P949; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; BLENIS J, 1984, J BIOL CHEM, V259, P1563; CARDIN AD, 1991, METHOD ENZYMOL, V203, P556; Caterina NCM, 1998, BBA-PROTEIN STRUCT M, V1388, P21, DOI 10.1016/S0167-4838(98)00158-7; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Janowska-Wieczorek A, 1999, BRIT J HAEMATOL, V105, P402, DOI 10.1046/j.1365-2141.1999.01352.x; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Langton KP, 1998, J BIOL CHEM, V273, P16778, DOI 10.1074/jbc.273.27.16778; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2002, BIOCHEM J, V364, P227, DOI 10.1042/bj3640227; Lorenz HM, 2002, ARTHRITIS RES THER, V4, pS17, DOI 10.1186/ar564; Majid MA, 2006, BRIT J OPHTHALMOL, V90, P1310, DOI 10.1136/bjo.2006.097246; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; van Deventer SJH, 2002, GUT, V51, P5, DOI 10.1136/gut.51.1.5; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLIAMSON RA, 1994, BIOCHEMISTRY-US, V33, P11745, DOI 10.1021/bi00205a010; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	26	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6887	6898		10.1074/jbc.M610490200	http://dx.doi.org/10.1074/jbc.M610490200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202148	hybrid			2022-12-27	WOS:000244867200098
J	Matsushita, M; Suzuki, NN; Obara, K; Fujioka, Y; Ohsumi, Y; Inagaki, F				Matsushita, Minako; Suzuki, Nobuo N.; Obara, Keisuke; Fujioka, Yuko; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Structure of Atg5 center dot Atg16, a complex essential for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR GRAPHICS; CRYSTAL-STRUCTURE; PROTEIN; SYSTEM; YEAST; MEMBRANE; MUTANTS; CELLS; CONJUGATE	Atg5 is covalently modified with a ubiquitin-like modifier, Atg12, and the Atg12-Atg5 conjugate further forms a complex with the multimeric protein Atg16. The Atg12-Atg5 center dot Atg16 multimeric complex plays an essential role in autophagy, the bulk degradation system conserved in all eukaryotes. We have reported here the crystal structure of Atg5 complexed with the N-terminal region of Atg16 at 1.97 angstrom resolution. Atg5 comprises two ubiquitin-like domains that flank a helix-rich domain. The N-terminal region of Atg16 has a helical structure and is bound to the groove formed by these three domains. In vitro analysis showed that Arg-35 and Phe-46 of Atg16 are crucial for the interaction. Atg16, with a mutation at these residues, failed to localize to the pre-autophagosomal structure and could not restore autophagy in Atg16-deficient yeast strains. Furthermore, these Atg16 mutants could not restore a severe reduction in the formation of the Atg8-phosphatidylethanolamine conjugate, another essential factor for autophagy, in Atg16-deficient strains under starvation conditions. These results taken together suggest that the direct interaction between Atg5 and Atg16 is crucial to the performance of their roles in autophagy.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0010021, Japan; Natl Inst Basic Biol, Div Mol Cell Biol, Okazaki, Aichi 4448585, Japan	Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-21,W-11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Noda, Nobuo/0000-0002-6940-8069; Fujioka, Yuko/0000-0002-6905-0669				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Matsushita M, 2006, ACTA CRYSTALLOGR F, V62, P1021, DOI 10.1107/S1744309106036232; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Stroupe ME, 2003, NAT STRUCT BIOL, V10, P1064, DOI 10.1038/nsb1007; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009	34	177	191	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6763	6772		10.1074/jbc.M609876200	http://dx.doi.org/10.1074/jbc.M609876200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17192262	Green Published, hybrid			2022-12-27	WOS:000244867200086
J	Ong, SJ; Hsu, HM; Liu, HW; Chu, CH; Tai, JH				Ong, Shiou-Jeng; Hsu, Hong-Ming; Liu, Hsing-Wei; Chu, Chien-Hsin; Tai, Jung-Hsiang			Activation of multifarious transcription of an adhesion protein ap65-1 gene by a novel Myb2 protein in the protozoan parasite Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; REGULATORY ELEMENTS; EXPRESSION; IRON; ENZYMES; CELLS; ADHERENCE; PROMOTER; COMPLEX; LOCALIZATION	Multifarious transcription of the adhesion protein ap65-1 gene in the human pathogen, Trichomonas vaginalis, is critically regulated by the coordination of two similar but opposite oriented DNA regulatory regions, MRE-1/MRE-2r and MRE-2f, both of which are binding sites for multiple Myb-like proteins. In the present study, MRE-1/MRE-2r was demonstrated to be composed of multiple overlapping promoter elements, among which the entire region is required for growth-related ap65-1 transcription, and the 5'-MRE-1 antagonizes the suppressive activity of the 3'-MRE-2r in iron-inducible transcription. The recombinant Myb2 protein derived from a previously identified myb2 gene was demonstrated to recognize distinct sequence contexts in MRE-2r and MRE-2f, whereas Myb2 in the nuclear lysate preferentially binds to MRE-2f to MRE-2r. Iron repletion resulted in persistent repression of the myb2 gene, and temporal activation/deactivation of Myb2 promoter entry, which was also activated by prolonged iron depletion. The hemagglutinin-tagged Myb2 when overexpressed during iron-depleted conditions facilitated basal and growth-related ap65-1 transcription to a level that was achieved in iron-replete cells, whereas iron-inducible ap65-1 transcription was abolished with knockdown of Myb2. These findings demonstrated that Myb2 is involved in activation of growth-related and iron-inducible transcription of the ap65-1 gene, possibly through differential promoter selection in competition with other Myb proteins.	Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tai, JH (corresponding author), Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan.	taijh@gate.sinica.edu.tw	Tai, Jung-Hsiang/S-7019-2018; Chu, Chu/T-6038-2019	Chu, Chien-Hsin/0000-0002-5490-8378; HSU, HONG-MING/0000-0002-7579-5106				ALDERETE JF, 1995, MOL MICROBIOL, V17, P69, DOI 10.1111/j.1365-2958.1995.mmi_17010069.x; Alderete JF, 2004, MICROB PATHOGENESIS, V36, P263, DOI 10.1016/j.micpath.2003.12.007; ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; Alderete JF, 1999, INFECT IMMUN, V67, P4298, DOI 10.1128/IAI.67.8.4298-4302.1999; Alderete JF, 2001, CELL MICROBIOL, V3, P359, DOI 10.1046/j.1462-5822.2001.00126.x; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Brugerolle G, 2000, PARASITOL RES, V86, P30, DOI 10.1007/PL00008503; Dolezal P, 2004, GENE, V329, P81, DOI 10.1016/j.gene.2003.12.022; Garcia AF, 2003, MOL MICROBIOL, V47, P1207, DOI 10.1046/j.1365-2958.2003.03366.x; HARLOW E, 1988, ANTIBODIES LAB MANUA, P92; HRDY I, 1995, J EUKARYOT MICROBIOL, V42, P593, DOI 10.1111/j.1550-7408.1995.tb05913.x; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Moreno-Brito V, 2005, CELL MICROBIOL, V7, P245, DOI 10.1111/j.1462-5822.2004.00455.x; Mundodi V, 2004, MOL MICROBIOL, V53, P1099, DOI 10.1111/j.1365-2958.2004.04192.x; Nilsson T, 2001, J VIROL, V75, P5796, DOI 10.1128/JVI.75.13.5796-5811.2001; Nishimura W, 2005, BIOCHEM J, V392, P181, DOI 10.1042/BJ20050970; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; Ong SJ, 2004, MOL MICROBIOL, V52, P1721, DOI 10.1111/j.1365-2958.2004.04088.x; Ortiz D, 2003, MOL BIOCHEM PARASIT, V128, P43, DOI 10.1016/S0166-6851(03)00043-4; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; QU XM, 2004, J BIOL CHEM, V279, P21021; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Solano R, 1997, J BIOL CHEM, V272, P2889, DOI 10.1074/jbc.272.5.2889; Sorvillo F, 2001, EMERG INFECT DIS, V7, P927, DOI 10.3201/eid0706.010603; Stoffler D, 2006, CAN J PHYSIOL PHARM, V84, P499, DOI 10.1139/Y06-001; Sulentic CEW, 2004, TOXICOLOGY, V200, P235, DOI 10.1016/j.tox.2004.03.015; Tsai CD, 2002, J BIOL CHEM, V277, P5153, DOI 10.1074/jbc.M110234200; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4	35	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6716	6725		10.1074/jbc.M610484200	http://dx.doi.org/10.1074/jbc.M610484200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202137	hybrid			2022-12-27	WOS:000244867200081
J	Kimura, K; Tanaka, N; Nakamura, N; Takano, S; Ohkuma, S				Kimura, Kenji; Tanaka, Nozomu; Nakamura, Nobuhiro; Takano, Syuichi; Ohkuma, Shoji			Knockdown of mitochondrial heat shock protein 70 promotes progeria-like phenotypes in Calenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMATIC RNAI SCREEN; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; RESPIRATORY-CHAIN; OXIDATIVE STRESS; MOLECULAR CHAPERONES; ELECTRON-TRANSPORT; ENERGY-METABOLISM; SENSITIVE MUTANT	Mitochondrial heat shock protein 70 (mthsp70) functions as a mitochondrial import motor and is essential in mitochondrial biogenesis and energy generation in eukaryotic cells. HSP-6 (hsp70F) is a nematode orthologue of mthsp70. Knockdown of HSP-6 by RNA interference in young adult nematodes caused a reduction in the levels of ATP-2, HSP-60 and CLK-1, leading to abnormal mitochondrial morphology and lower ATP levels. As a result, RNA interference-treated worms had lower motility, defects in oogenesis, earlier accumulation of autofluorescent material, and a shorter life span. These are the major phenotypes observed during the aging of worms, suggesting that the reduction of HSP-6 causes early aging or progeria-like phenotypes. The amount of HSP-6 became dramatically reduced at the expected mean life span in not only wild-type but also in long and short life span mutant worms (wild-type, daf-2, and daf-16). Mitochondrial HSP-60 and ATP-2 were also reduced following the reduction of HSP-6 during aging. These results suggest that the reduction of HSP-6 causes defects in mitochondrial function at the final stage of aging, leading to mortality.	Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Nakamura, N (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan.	osaru3@kenroku.kanazawa-u.ac.jp; takano@uthscsa.edu	Nakamura, Nobuhiro/F-7811-2011	Nakamura, Nobuhiro/0000-0002-8836-6714; Kimura, Kenji/0000-0002-0290-9627				Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Chaturvedi S, 2005, MED SCI MONITOR, V11, pRA238; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; Cummins JM, 2001, HUM REPROD UPDATE, V7, P217, DOI 10.1093/humupd/7.2.217; Curran SP, 2004, J BIOL CHEM, V279, P54655, DOI 10.1074/jbc.M409618200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Garigan D, 2002, GENETICS, V161, P1101; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kawai A, 2001, J CELL SCI, V114, P3565; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Ostergaard E, 2005, NEUROLOGY, V65, P931, DOI 10.1212/01.wnl.0000176065.80560.26; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Senoo-Matsuda N, 2003, J BIOL CHEM, V278, P22031, DOI 10.1074/jbc.M211377200; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Strub A, 2003, J MOL BIOL, V334, P1087, DOI 10.1016/j.jmb.2003.10.023; STUART RA, 1994, EXPERIENTIA, V50, P1002, DOI 10.1007/BF01923454; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TROCKEL U, 1986, J NEUROL NEUROSUR PS, V49, P645, DOI 10.1136/jnnp.49.6.645; Tsang WY, 2003, DEV DYNAM, V226, P719, DOI 10.1002/dvdy.10272; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Ventura N, 2005, AGING CELL, V4, P109, DOI 10.1111/j.1474-9726.2005.00149.x; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2003, EMBO REP, V4, P595, DOI 10.1038/sj.embor.embor855; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	62	81	90	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5910	5918		10.1074/jbc.M609025200	http://dx.doi.org/10.1074/jbc.M609025200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189267	hybrid			2022-12-27	WOS:000244482300087
J	Ponighaus, C; Ambrosius, M; Casanova, JC; Prante, C; Kuhn, J; Esko, JD; Kleesiek, K; Gotting, C				Poenighaus, Claudia; Ambrosius, Michael; Casanova, Javier Carrera; Prante, Christian; Kuhn, Joachim; Esko, Jeffrey D.; Kleesiek, Knut; Goetting, Christian			Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSYLTRANSFERASE; UDP-D-XYLOSE; PSEUDOXANTHOMA ELASTICUM PXE; PEPTIDE O-XYLOSYLTRANSFERASE; JAR CHORIOCARCINOMA CELLS; SERUM XYLOSYLTRANSFERASE; FIBROSIS MARKER; XT-II; EXPRESSION; POLYMORPHISMS	Human xylosyltransferase I (XT-I) initiates the biosynthesis of the glycosaminoglycan (GAG) linkage tetrasaccharide in proteoglycans. Xylosyltransferase 11 (XT-II) is a protein homologous to XT-I but with hitherto unknown activity or physiological function. Here, we report the enzymatic activity of XT-II and provide evidence that XT-II initiates the biosynthesis of both heparan sulfate and chondroitin sulfate GAGs. Transfection of the xylosyltransferase-deficient Chinese hamster ovary mutant pgsA-745 with XT-I or XT-II coding cDNA completely restored GAG biosynthesis. GAG disaccharide analysis revealed that XT-I- and XT-II-transfected pgsA-745 cells produced similar amounts of chondroitin sulfate and heparan sulfate. Furthermore, a high xylosyltransferase activity was measured after transfection with cDNAs encoding either isozyme. Analysis of the enzyme activity revealed that XT-II catalyzes the transfer of xylose to similar peptide acceptors as XT-I but with different efficiency. The optimal XT-II acceptor was observed using a bikunin-related peptide (K-m 5.2 mu m). Analysis of XT-I and XT-II mRNA expression in murine tissues showed a differential expression pattern for both enzymes. In particular, XT-II is highly expressed in liver tissue, where XT-I transcripts were not detected. This is the first report on the enzyme activity of XT-II and its involvement in chondroitin sulfate and heparan sulfate biosynthesis.	Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabeteszentrum Nordrhein Westfalen, D-32545 Bad Oeynhausen, Germany; Univ Calif San Diego, Dept Cellular & Mol Biol, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	Ruhr University Bochum; University of California System; University of California San Diego	Gotting, C (corresponding author), Ruhr Univ Bochum, Inst Lab & Transfus Med, Herz & Diabeteszentrum Nordrhein Westfalen, Georgstr 11, D-32545 Bad Oeynhausen, Germany.	cgoetting@hdz-nrw.de			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33063] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Brunner A, 2006, GLYCOCONJUGATE J, V23, P543, DOI 10.1007/s10719-006-7633-z; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; CAMPBELL P, 1984, ANAL BIOCHEM, V137, P505, DOI 10.1016/0003-2697(84)90119-2; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gotting C, 2004, J BIOL CHEM, V279, P42566, DOI 10.1074/jbc.M401340200; Gotting C, 1999, J INVEST DERMATOL, V112, P919, DOI 10.1046/j.1523-1747.1999.00590.x; Gotting C, 2005, J MOL MED, V83, P984, DOI 10.1007/s00109-005-0693-x; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kuhn J, 2003, J BIOTECHNOL, V103, P191, DOI 10.1016/S0168-1656(03)00102-0; Kuhn J, 2003, BIOCHEM BIOPH RES CO, V312, P537, DOI 10.1016/j.bbrc.2003.10.157; Kuhn J, 2005, BIOCHEM BIOPH RES CO, V333, P156, DOI 10.1016/j.bbrc.2005.05.087; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Kuhn J, 2006, CLIN CHEM, V52, P2243, DOI 10.1373/clinchem.2006.071167; LOZZO RV, 1998, ANNU REV BIOCHEM, V67, P609; Muller S, 2005, BIOCHEM J, V386, P227, DOI 10.1042/BJ20041206; Schon S, 2006, J MED GENET, V43, P745, DOI 10.1136/jmg.2006.040972; Schon S, 2006, OSTEOARTHR CARTILAGE, V14, P442, DOI 10.1016/j.joca.2005.11.004; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Schon S, 2005, KIDNEY INT, V68, P1483, DOI 10.1111/j.1523-1755.2005.00561.x; Schottler M, 2005, CLIN BIOCHEM, V38, P486, DOI 10.1016/j.clinbiomed.2005.02.004; Seo NS, 2005, J BIOL CHEM, V280, P42774, DOI 10.1074/jbc.M511531200; Vogel K, 2006, ELECTROPHORESIS, V27, P1363, DOI 10.1002/elps.200500578; Weilke C, 1997, CLIN CHEM, V43, P45; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200	30	78	80	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5201	5206		10.1074/jbc.M611665200	http://dx.doi.org/10.1074/jbc.M611665200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189265	hybrid			2022-12-27	WOS:000244482300014
J	Ray, K; Adipietro, KA; Chen, C; Northup, JK				Ray, Kausik; Adipietro, Kaylin A.; Chen, Claudia; Northup, John K.			Elucidation of the role of peptide linker in calcium-sensing receptor activation process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CA2+ RECEPTOR; METABOTROPIC GLUTAMATE-RECEPTOR; CALCIMIMETIC COMPOUND; TRANSMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; CHIMERIC RECEPTORS; DIMERIZATION; RECOGNITION; EXPRESSION; MUTATIONS	Family 3 G-protein-coupled receptors (GPCRs), which includes metabotropic glutamate receptors (mGluRs), sweet and "umami" taste receptors (T1Rs), and the extracellular calcium-sensing receptor (CaR), represent a distinct group among the superfamily of GPCRs characterized by large amino-terminal extracellular ligand-binding domains (ECD) with homology to bacterial periplasmic amino acid-binding proteins that are responsible for signal detection and receptor activation through as yet unresolved mechanism(s) via the seven-transmembrane helical domain (7TMD) common to all GPCRs. To address the mechanism(s) by which ligand-induced conformational changes are conveyed from the ECD to the 7TMD for G-protein activation, we altered the length and composition of a 14-amino acid linker segment common to all family 3 GPCRs except GABA(B) receptor, in the CaR by insertion, deletion, and site-directed mutagenesis of specific highly conserved residues. Small alterations in the length and composition of the linker impaired cell surface expression and abrogated signaling of the chimeric receptors. The exchange of nine amino acids within the linker of CaR with the homologous sequence of mGluR1, however, preserved receptor function. Ala substitution for the four highly conserved residues within this amino acid sequence identified a Len at position 606 of the CaR critical for cell surface expression and signaling. Substitution of Leu(606) for Ala resulted in impaired cell surface expression. However, Ile and Val substitutions displayed strong activating phenotypes. Disruption of the linker by insertion of nine amino acids of a random-coiled structure uncoupled the ECD from regulating the 7TMD. These data are consistent with a model of receptor activation in which the peptide linker, and particularly Leu(606), provides a critical interaction for the CaR signal transmission, a finding likely to be relevant for all family 3 GPCRs containing this conserved motif.	NIDCD, Lab Cellular Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ray, K (corresponding author), 5 Res Ct,Rm 2A11, Rockville, MD 20850 USA.	rayk@nidcd.nih.gov	Ray, Kausik/Z-2055-2019		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000068, Z01DC000068] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; Hu JX, 2000, J BIOL CHEM, V275, P16382, DOI 10.1074/jbc.M000277200; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Ray K, 2000, J BIOL CHEM, V275, P34245, DOI 10.1074/jbc.M005581200; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Ray K, 2005, J BIOL CHEM, V280, P37013, DOI 10.1074/jbc.M506681200; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; RAY K, 2001, INT ARCH BIOSCI, P1027; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Yu L, 2004, TRENDS BIOCHEM SCI, V29, P458, DOI 10.1016/j.tibs.2004.07.009	21	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5310	5317		10.1074/jbc.M609610200	http://dx.doi.org/10.1074/jbc.M609610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189274	hybrid			2022-12-27	WOS:000244482300026
J	Friedrich, ML; Cui, M; Hernandez, JB; Weist, BM; Andersen, HM; Zhang, XW; Huang, L; Walsh, CM				Friedrich, Monica L.; Cui, Meng; Hernandez, Jeniffer B.; Weist, Brian M.; Andersen, Hilde-Marie; Zhang, Xiaowu; Huang, Lan; Walsh, Craig M.			Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DAP KINASE; HOMOLOGOUS PROTEIN; T-CELLS; IN-VIVO; ACTIVATION; PHOSPHORYLATION; APOPTOSIS; BINDING; FAMILY	Death-associated protein-related apoptotic kinase-2 (DRAK2), a member of the death-associated protein-like family of serine/threonine kinases, is highly expressed in lymphoid organs and is a negative regulator of T cell activation. To investigate the regulation of DRAK2 activity in primary lymphocytes, we employed mass spectrometry to identify sites of autophosphorylation on DRAK2. These studies have revealed a key site of autophosphorylation on serine 12. Using a phospho-specific antibody to detect Ser(12) phosphorylation, we found that autophosphorylation is induced by antigen receptor stimulation in T and B cells. In Jurkat T cells, resting B cells and thymocytes, DRAK2 was hypophosphorylated on Ser(12) but rapidly phosphorylated with antigen receptor ligation. This increase in phosphorylation was dependent on intracellular calcium mobilization, because BAPTA-AM blocked DRAK2 kinase activity, whereas the SERCA inhibitor thapsigargin promoted Ser(12) phosphorylation. Our results show that DRAK2 kinase activity is regulated in a calcium-dependent manner and that Ser(12) phosphorylation is necessary for optimal suppression of T cell activation by this kinase, suggesting a potential feedback loop may act to modulate the activity of this kinase following antigen receptor signaling.	Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Phys & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Canc Res, Irvine, CA 92697 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Huang, L (corresponding author), Univ Calif Irvine, Ctr Immunol, 3215 McGaugh Hall, Irvine, CA 92697 USA.	lanhuang@uci.edu; cwalsh@uci.edu	Huang, Lan/C-3618-2011	Walsh, Craig/0000-0001-7808-2817	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007311, R01GM074830] Funding Source: NIH RePORTER; NIAID NIH HHS [AI063419] Funding Source: Medline; NIGMS NIH HHS [GM074830, T32GM007311] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arechiga AF, 2005, J IMMUNOL, V175, P7800, DOI 10.4049/jimmunol.175.12.7800; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Friedrich ML, 2005, INT IMMUNOL, V17, P1379, DOI 10.1093/intimm/dxh315; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Kogel D, 2001, BIOESSAYS, V23, P352, DOI 10.1002/bies.1050; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rosado JA, 2001, J BIOL CHEM, V276, P15659, DOI 10.1074/jbc.M009218200; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Schaefer BC, 2001, ANAL BIOCHEM, V297, P86, DOI 10.1006/abio.2001.5327; Schumacher AM, 2004, BIOCHEMISTRY-US, V43, P8116, DOI 10.1021/bi049589v; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shani G, 2001, EMBO J, V20, P1099, DOI 10.1093/emboj/20.5.1099; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; Tian JH, 2003, J BIOL CHEM, V278, P26265, DOI 10.1074/jbc.M300492200; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	29	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4573	4584		10.1074/jbc.M606675200	http://dx.doi.org/10.1074/jbc.M606675200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17182616	hybrid			2022-12-27	WOS:000244482000039
J	Lee, CW; Rivera, R; Dubin, AE; Chun, J				Lee, Chang-Wook; Rivera, Richard; Dubin, Adrienne E.; Chun, Jerold			LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-GAMMA-SUBUNITS; LYSOPHOSPHOLIPASE-D; CELLULAR-RESPONSES; ADENYLYL-CYCLASE; P115 RHOGEF; AUTOTAXIN; IDENTIFICATION; MOTILITY; STIMULATION	Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that signals through G protein-coupled receptors (GPCRs) to produce a range of biological responses. A recently reported fourth receptor, LPA(4)/GPR23, was notable for its low homology to the previously identified receptors LPA(1-3) and for its ability to increase intracellular concentrations of cAMP and calcium. However, the signaling pathways leading to LPA(4)-mediated induction of cAMP and calcium levels have not been reported. Using epitope-tagged LPA(4), pharmacological intervention, and G protein mini-genes, we provide independent confirmatory evidence that supports LPA(4) as a fourth LPA receptor, including LPA concentration-dependent responses and specific membrane binding. Importantly, we further demonstrate new LPA-dependent activities of LPA, that include the following: receptor internalization; G(12/13)- and Rho-mediated neurite retraction and stress fiber formation; G(q) protein and pertussis toxin-sensitive calcium mobilization and activation of a nonselective cation conductance; and cAMP increases mediated by G(s). The receptor is broadly expressed in embryonic tissues, including brain, as determined by Northern blot and reverse transcription-PCR analysis. Adult tissues have increased expression in skin, heart, and to a lesser extent, thymus. These data confirm the identification and extend the functionality of LPA(4) as an LPA receptor, bringing the number of independently verified LPA receptors to five, with both overlapping and distinct signaling properties and tissue expression.			Chun, J (corresponding author), Scripps Res Inst, Dept Mol Biol, Helen Lab Dorris Inst Neurol & Psychiat Disorders, 10550 N Torrey Pines Rd,ICND-118, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019	Lee, Chang-Wook/0000-0002-0907-8475	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699, K02MH001723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER; NICHD NIH HHS [R01-HD050685] Funding Source: Medline; NIMH NIH HHS [R01-MH51699, K02-MH01723] Funding Source: Medline; NINDS NIH HHS [R01-NS048478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dubin AE, 1999, J NEUROSCI, V19, P1371; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gilchrist A., 2002, SCI STKE, pPL1; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P957, DOI 10.1006/bbrc.2000.3570; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Pear Warren S., 1997, P41; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Witte Owen N, 2005, Science, V307, P206; Xu Y, 2006, NAT CELL BIOL, V8, P299; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Zhu K, 2005, J BIOL CHEM, V280, P43280	49	128	135	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4310	4317		10.1074/jbc.M610826200	http://dx.doi.org/10.1074/jbc.M610826200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166850	hybrid			2022-12-27	WOS:000244482000010
J	Mori, S; Shirahige, K				Mori, Saori; Shirahige, Katsuhiko			Perturbation of the activity of replication origin by meiosis-specific transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEIOTIC DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; S-PHASE; YEAST; PROTEINS; IDENTIFICATION; SPORULATION; INITIATION; COMPLEXES; DYNAMICS	We have determined the activity of all ARSs on the Saccharomyces cerevisiae chromosome VI as chromosomal replication origins in premeiotic S-phase by neutral/neutral two-dimensional gel electrophoresis. The comparison of origin activity of each origin in mitotic and premeiotic S-phase showed that one of the most efficient origins in mitotic S-phase, ARS605, was completely inhibited in premeiotic S-phase. ARS605 is located within the open reading frame of MSH4 gene that is transcribed specifically during an early stage of meiosis. Systematic analysis of relationships between MSH4 transcription and ARS605 origin activity revealed that transcription of MSH4 inhibited the ARS605 origin activity by removing origin recognition complex from ARS605. Deletion of UME6, a transcription factor responsible for repressing MSH4 during mitotic S-phase, resulted in inactivation of ARS605 in mitosis. Our finding is the first demonstration that the transcriptional regulation on the replication origin activity is related to changes in cell physiology. These results may provide insights into changes in replication origin activity in embryonic cell cycle during early developmental stages.	Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, Kanagawa 2300045, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Div Gene Res, Lab Genome Struct & Funct, Kanagawa 2268501, Japan	Yokohama City University; Tokyo Institute of Technology	Shirahige, K (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Kanagawa 2300045, Japan.	kshirahi@bio.titech.ac.jp		Shirahige, Katsuhiko/0000-0002-7862-1144				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BUDD ME, 1989, MOL CELL BIOL, V9, P365, DOI 10.1128/MCB.9.2.365; Cha RS, 2000, GENE DEV, V14, P493; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HOLLINGSWORTH RE, 1993, CHROMOSOMA, V102, P415, DOI 10.1007/BF00360406; Hori Y, 1996, MOL BIOL CELL, V7, P409, DOI 10.1091/mbc.7.3.409; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KUPIEC M, 1997, MOL CELLULAR BIOL YE, V3, P889; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Ofir Y, 2004, MOL BIOL CELL, V15, P2230, DOI 10.1091/mbc.E03-08-0617; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001; Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299; WILLIAMSON DH, 1983, EXP CELL RES, V145, P209, DOI 10.1016/S0014-4827(83)80022-6; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	34	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4447	4452		10.1074/jbc.M609671200	http://dx.doi.org/10.1074/jbc.M609671200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170106	hybrid			2022-12-27	WOS:000244482000025
J	Tatituri, RVV; Illarionov, PA; Dover, LG; Nigou, J; Gilleron, M; Hitchen, P; Krumbach, K; Morris, HR; Spencer, N; Dell, A; Eggeling, L; Besra, GS				Tatituri, Raju V. V.; Illarionov, Petr A.; Dover, Lynn G.; Nigou, Jerome; Gilleron, Martine; Hitchen, Paul; Krumbach, Karin; Morris, Howard R.; Spencer, Neil; Dell, Anne; Eggeling, Lothar; Besra, Gurdyal S.			Inactivation of Corynebacterium glutamicum NCgI0452 and the role of MgtA in the biosynthesis of a novel mannosylated glycolipid involved in-lipomannan biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODERATELY HALOPHILIC BACTERIUM; MYCOBACTERIUM-TUBERCULOSIS H37RV; MEMBRANE-ASSOCIATED LIPOMANNAN; CELL-WALL ARABINOGALACTAN; BACILLUS-CALMETTE-GUERIN; MYO-INOSITOL ANCHOR; PHOSPHATIDYLINOSITOL MANNOSIDE; MONOPHOSPHOMANNOSE SYNTHASE; CORYNEFORM BACTERIA; MICROCOCCUS-LUTEUS	Mycobacterium tuberculosis PimB has been demonstrated to catalyze the addition of a mannose residue from GDP-mannose to a monoacylated phosphatidyl-myo-inositol mannoside (Ac1PIM1) to generate Ac1PIM2. Herein, we describe the disruption of its probable orthologue Cg-pimB and the chemical analysis of glycolipids and lipoglycans isolated from wild type Corynebacterium glutamicum and the C. glutamicum::pimB mutant. Following a careful analysis, two related glycolipids, Gl-A and Gl-X, were found in the parent strain, but Gl-X was absent from the mutant. The biosynthesis of Gl-X was restored in the mutant by complementation with either Cg-pimB or Mt-pimB. Subsequent chemical analyses established Gl-X as 1,2-diO-C-16/C-18:1-(alpha-D-mannopyranosyl)-(1 -> 4)-(alpha-D-glucopyranosyluronic acid)-(1 -> 3)-glycerol (ManGlcAGroAc(2)) and Gl-A as the precursor, GlcAGroAc(2). In addition, C. glutamicum::pimB was still able to produce Ac1PIM2, suggesting that Cg-PimB catalyzes the synthesis of ManGlcAGroAc2 from GlcAGroAc(2). Isolation of lipoglycans from C. glutamicum led to the identification of two related lipoglycans. The larger lipoglycan possessed a lipoarabinomannan-like structure, whereas the smaller lipoglycan was similar to lipomannan (LM). The absence of MariGlcAGroAc(2) in C. glutamicum::pimB led to a severe reduction in LM. These results suggested that ManGlcAGroAc(2) was further extended to an LM-like molecule. Complementation of C. glutamicum::pimB with Cg-pimB and Mt-pimB led to the restoration of LM biosynthesis. As a result, Cg-PimB, which we have assigned as MgtA, is now clearly defined as a GDP-mannose-dependent alpha-mannosyltransferase from our in vitro analyses and is involved in the biosynthesis of ManGlcAGroAc(2).	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; CNRS, Inst Pharmacol & Biol Struct, UMR 5089, Toulouse, France; Res Ctr Juelich, Inst Biotechnol 1, D-52425 Julich, Germany; Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; MSCAN Mass Spect Res & Training Ctr, Wokingham RG41 2TZ, Berks, England; Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England	University of Birmingham; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Helmholtz Association; Research Center Julich; Imperial College London; University of Birmingham	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk	Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019; Nigou, Jérôme/D-6802-2019	Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Nigou, Jérôme/0000-0002-6233-2487; Besra, Gurdyal/0000-0002-5605-0395; GILLERON, Martine/0000-0002-2581-3302	MRC [G0500590] Funding Source: UKRI; Medical Research Council [G0500590] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; BRENNAN P, 1968, J BIOL CHEM, V243, P2975; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CHATTERJEE D, 1988, J BIOL CHEM, V263, P4092; CHATTERJEE D, 1987, J BIOL CHEM, V262, P3528; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COYLE MB, 1990, CLIN MICROBIOL REV, V3, P227, DOI 10.1128/CMR.3.3.227-246.1990; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Eggeling L, 2005, HDB CORYNEBACTERIUM, P535; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Gibson KJC, 2003, MICROBIOL-SGM, V149, P1437, DOI 10.1099/mic.0.26161-0; Gilleron M, 2000, J BIOL CHEM, V275, P677, DOI 10.1074/jbc.275.1.677; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; HILL DL, 1966, J BIOL CHEM, V241, P895; HUNTER SW, 1986, J BACTERIOL, V168, P917, DOI 10.1128/jb.168.2.917-922.1986; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Khoo KH, 1996, J BIOL CHEM, V271, P12333, DOI 10.1074/jbc.271.21.12333; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; LEOPOLD K, 1993, ANAL BIOCHEM, V208, P57, DOI 10.1006/abio.1993.1008; Ludwiczak P, 2002, MICROBIOL-SGM, V148, P3029, DOI 10.1099/00221287-148-10-3029; Luneberg E, 2000, INT J MED MICROBIOL, V290, P37; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; MCNEIL M, 1989, METHOD ENZYMOL, V179, P215; MINNIKIN DE, 1971, BIOCHIM BIOPHYS ACTA, V249, P651, DOI 10.1016/0005-2736(71)90148-9; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Nakamura Y, 2003, GENE, V317, P149, DOI 10.1016/S0378-1119(03)00653-X; Nigou J, 2000, J MOL BIOL, V299, P1353, DOI 10.1006/jmbi.2000.3821; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Pakkiri LS, 2005, GLYCOBIOLOGY, V15, P291, DOI 10.1093/glycob/cwi003; Pakkiri LS, 2004, GLYCOBIOLOGY, V14, P73, DOI 10.1093/glycob/cwh012; PELEG E, 1971, FEBS LETT, V15, P309, DOI 10.1016/0014-5793(71)80645-2; PIERINGER RA, 1989, MICROBIAL LIPIDS, V2, P51; RYU EK, 1979, J LIPID RES, V20, P561; Sahm H, 2000, BIOL CHEM, V381, P899, DOI 10.1515/BC.2000.111; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; STERN N, 1973, BIOCHIM BIOPHYS ACTA, V296, P136, DOI 10.1016/0005-2760(73)90053-2; STERN N, 1971, FEBS LETT, V19, P217, DOI 10.1016/0014-5793(71)80517-3; STERN N, 1973, BIOCHIM BIOPHYS ACTA, V296, P130, DOI 10.1016/0005-2760(73)90052-0; WILKINSON GS, 1968, BIOCHIM BIOPHYS ACTA, V152, P227; WILKINSON SG, 1968, BIOCHIM BIOPHYS ACTA, V164, P148, DOI 10.1016/0005-2760(68)90141-0; WILKINSON SG, 1969, BIOCHIM BIOPHYS ACTA, V187, P492, DOI 10.1016/0005-2760(69)90046-0; WOLUCKA BA, 1993, BIOCHIM BIOPHYS ACTA, V1170, P131, DOI 10.1016/0005-2760(93)90062-E	63	60	63	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4561	4572		10.1074/jbc.M608695200	http://dx.doi.org/10.1074/jbc.M608695200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179146	hybrid			2022-12-27	WOS:000244482000038
J	Pal, S; Leger, RJS; Wu, LP				Pal, Subhamoy; Leger, Raymond J. St.; Wu, Louisa P.			Fungal peptide destruxin a plays a specific role in suppressing the innate immune response in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS SURFACE-ANTIGEN; METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGUS; DEGRADATION ESTABLISHES; ANTIMICROBIAL PEPTIDE; DEFICIENCY IMD; TOLL; ACTIVATION; DEFENSE; PROTEIN	Destruxins are a class of insecticidal, anti-viral, and phytotoxic cyclic depsipeptides that are also studied for their toxicity to cancer cells. They are produced by various fungi, and a direct relationship has been established between Destruxin production and the virulence of the entomopathogen Metarhizium anisopliae. Aside from opening calcium channels, their in vivo mode of action during pathogenesis remains largely uncharacterized. To better understand the effects of a Destruxin, we looked at changes in gene expression following injection of Destruxin A into the fruit fly Drosophila melanogaster. Microarray results revealed reduced expression of various antimicrobial peptides that play a major role in the humoral immune response of the fly. Flies co-injected with a non-lethal dose of Destruxin A and the normally innocuous Gram-negative bacteria Escherichia coli, showed increased mortality and an accompanying increase in bacterial titers. Mortality due to sepsis was rescued through ectopic activation of components in the IMD pathway, one of two signal transduction pathways that are responsible for antimicrobial peptide induction. These results demonstrate a novel role for Destruxin A in specific suppression of the humoral immune response in insects.	Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Wu, LP (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, 5115 Plant Sci Bldg, College Pk, MD 20742 USA.	wul@umbi.umd.edu	St. Leger, Raymond/N-3219-2013; Pal, Subhamoy/A-8025-2011; Pal, Subhamoy/H-3166-2019; Pal, Subhamoy/A-9526-2015	Pal, Subhamoy/0000-0003-0133-8444; Pal, Subhamoy/0000-0003-0133-8444; Wu, Louisa/0000-0001-8609-3081	NIGMS NIH HHS [R01 GM62316] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062316] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Chen HC, 1997, ANTIVIR RES, V34, P137, DOI 10.1016/S0166-3542(97)01031-0; CHERTON JC, 1991, J CHROMATOGR-BIOMED, V566, P511, DOI 10.1016/0378-4347(91)80268-H; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DUMAS C, 1994, COMP BIOCHEM PHYS C, V108, P195, DOI 10.1016/1367-8280(94)90031-0; Dumas C, 1996, COMP BIOCHEM PHYS C, V114, P213, DOI 10.1016/0742-8413(96)00041-2; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; FARGUES J, 1985, ENTOMOPHAGA, V30, P353, DOI 10.1007/BF02372341; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Herndon JH, 2000, NEW ENGL J MED, V343, P503, DOI 10.1056/NEJM200008173430710; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hunter DM, 2001, B ENTOMOL RES, V91, P93; HUXHAM IM, 1989, J INSECT PHYSIOL, V35, P97, DOI 10.1016/0022-1910(89)90042-5; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Isaka M, 2005, ACCOUNTS CHEM RES, V38, P813, DOI 10.1021/ar040247r; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kershaw MJ, 1999, J INVERTEBR PATHOL, V74, P213, DOI 10.1006/jipa.1999.4884; KODAIRA Y, 1961, AGR BIOL CHEM TOKYO, V25, P261, DOI 10.1080/00021369.1961.10857803; LANGE C, 1992, RAPID COMMUN MASS SP, V6, P28, DOI 10.1002/rcm.1290060107; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Maniania NK, 2002, MYCOPATHOLOGIA, V155, P229, DOI 10.1023/A:1021177626246; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; MOTTA I, 1991, EUR J IMMUNOL, V21, P551, DOI 10.1002/eji.1830210304; PAIS M, 1981, PHYTOCHEMISTRY, V20, P715, DOI 10.1016/0031-9422(81)85160-6; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; QUIOT JM, 1980, CR ACAD SCI D NAT, V291, P763; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; ROBERTS DW, 1966, J INVERTEBR PATHOL, V8, P222, DOI 10.1016/0022-2011(66)90132-7; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAMUELS RI, 1988, COMP BIOCHEM PHYS C, V90, P403, DOI 10.1016/0742-8413(88)90018-7; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SUZUKI A, 1971, AGR BIOL CHEM TOKYO, V35, P1641, DOI 10.1080/00021369.1971.10860127; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; VEY A, 1985, C R ACAD SCI  SER, V3, P229; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P1149, DOI 10.1016/S0022-1910(97)00066-8; Vilcinskas A, 1997, J INSECT PHYSIOL, V43, P475, DOI 10.1016/S0022-1910(96)00120-5; Wright MS, 2005, J ECON ENTOMOL, V98, P1451, DOI 10.1603/0022-0493-98.5.1451; Yeh SF, 1996, BIOCHEM BIOPH RES CO, V229, P65, DOI 10.1006/bbrc.1996.1758	57	120	131	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8969	8977		10.1074/jbc.M605927200	http://dx.doi.org/10.1074/jbc.M605927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17227774	hybrid			2022-12-27	WOS:000245780300043
J	Shao, CH; Shi, XM; Wehbi, H; Zambonelli, C; Head, JF; Seaton, BA; Roberts, MF				Shao, Chenghua; Shi, Xiaomeng; Wehbi, Hania; Zambonelli, Carlo; Head, James F.; Seaton, Barbara A.; Roberts, Mary F.			Dimer structure of an interfacially impaired phosphatidylinositol-specific phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BACILLUS-CEREUS; ACTIVATION; BINDING; DIMERIZATION; MECHANISM; INSIGHT; COMPLEX; ENZYME	The crystal structure of the W47A/W242A mutant of phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus thuringiensis has been solved to 1.8 angstrom resolution. The W47A/ W242A mutant is an interfacially challenged enzyme, and it has been proposed that one or both tryptophan side chains serve as membrane interfacial anchors (Feng, J., Wehbi, H., and Roberts, M. F. (2002) J. Biol. Chem. 277,19867-19875). The crystal structure supports this hypothesis. Relative to the crystal structure of the closely related (97% identity) wild-type PI-PLC from Bacillus cereus, significant conformational differences occur at the membrane-binding interfacial region rather than the active site. The Trp -> Ala mutations not only remove the membrane-partitioning aromatic side chains but also perturb the conformations of the so-called helix B and rim loop regions, both of which are implicated in interfacial binding. The crystal structure also reveals a homodimer, the first such observation for a bacterial PI-PLC, with pseudo-2-fold symmetry. The symmetric dimer interface is stabilized by hydrophobic and hydrogen-bonding interactions, contributed primarily by a central swath of aromatic residues arranged in a quasiherringbone pattern. Evidence that interfacially active wild-type PI-PLC enzymes may dimerize in the presence of phosphatidylcholine vesicles is provided by fluorescence quenching of PI-PLC mutants with pyrene-labeled cysteine residues. The combined data suggest that wild-type PI-PLC can form similar homodimers, anchored to the interface by the tryptophan and neighboring membrane-partitioning residues.	Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02465 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Boston College; Boston University	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02465 USA.	mary.roberts@bc.edu		Seaton, Barbara/0000-0003-4654-7709; Head, James/0000-0002-6226-4146	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60418] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apiyo D, 2005, BIOCHEMISTRY-US, V44, P9980, DOI 10.1021/bi047896v; Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013; BRUENGER AT, 1909, ACTA CRYSTALLOGR, V54, P905; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; DeLano W.L, PYMOL MOL GRAPHICS S; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Heinz DW, 1996, BIOCHEMISTRY-US, V35, P9496, DOI 10.1021/bi9606105; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HENRICKSON HS, 1999, BIOCHIM BIOPHYS ACTA, V1440, P107; Hondal RJ, 1998, BIOCHEMISTRY-US, V37, P4568, DOI 10.1021/bi972646i; HU ML, 1994, METHOD ENZYMOL, V233, P380; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones T. A., 1992, MANUAL; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P248; LEWIS KA, 1993, BIOCHEMISTRY-US, V32, P8836, DOI 10.1021/bi00085a014; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; ROBERTS MF, 1998, ACS SYM SER, V718, P137, DOI DOI 10.1021/BK-1999-0718.CH009; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P11223, DOI 10.1021/bi971039s; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200; Zhang Y, 2006, MOL PHARMACOL, V70, P860, DOI 10.1124/mol.105.021923; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1999, J BIOL CHEM, V274, P2786, DOI 10.1074/jbc.274.5.2786; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	40	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9228	9235		10.1074/jbc.M610918200	http://dx.doi.org/10.1074/jbc.M610918200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17213187	hybrid			2022-12-27	WOS:000245780300069
J	dela Paz, NG; Simeonidis, S; Leo, C; Rose, DW; Collins, T				dela Paz, Nathaniel G.; Simeonidis, Simos; Leo, Christopher; Rose, David W.; Collins, Tucker			Regulation of NF-kappa B-dependent gene expression by the POU domain transcription factor Oct-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ENDOTHELIAL-CELLS; CREB-BINDING PROTEIN; E-SELECTIN; INTERLEUKIN-6 GENE; KINASE IKK; FACTOR-I; ACTIVATION; RECEPTOR; IL-6	Maintenance of the cells of the vessel wall in a quiescent state is an important aspect of normal vascular physiology. Transcriptional repressors are widely believed to regulate this process, yet the exact factors involved and the mechanism of repression are not known. Here, we report that the POU domain transcription factor Oct-1 represses the expression of E-selectin and vascular cell adhesion molecule (VCAM-1), two cytokine-inducible, NF-kappa B-dependent endothelial-leukocyte adhesion molecules that participate in the leukocyte recruitment phase of the inflammatory response. Co-transfection and microinjection studies demonstrate that Oct-1 blocks tumor necrosis factor alpha-stimulated E-selectin and VCAM-1 expression. Gene expression arrays indicate that control of tumor necrosis factor alpha-induced, NF-kappa B-dependent gene expression by Oct-1 is promoter-specific. A DNA-binding mutant of Oct-1 represses NF-kappa B-dependent reporter gene expression. Biochemically, Oct-1 interacts with p65, suggesting that Oct-1 is involved in the regulation of NF-kappa B transactivation function. NF-kappa B-dependent gene expression is more pronounced in Oct-1-deficient than in wild-type murine embryonic fibroblasts, and reintroduction of human Oct-1 abolishes these differences. Finally, the cytokine interleukin-6 induces Oct-1 gene expression, providing a biologically relevant means by which NF-kappa B-dependent gene expression can be selectively reverted by Oct-1 to quiescent levels.	Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Calif San Diego, Sch Med, Mol Pathol Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Collins, T (corresponding author), Childrens Hosp, Dept Pathol, 300 Longwood Ave, Boston, MA 02115 USA.	tcollins@rics.bwh.harvard.edu			NHLBI NIH HHS [T32 HL076115, F31HL-74452, HL-45462] Funding Source: Medline; NIDDK NIH HHS [DK-54802] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL074452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAUER J, 1988, BLOOD, V72, P1134; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Edelstein LC, 2005, J BIOL CHEM, V280, P11192, DOI 10.1074/jbc.M412997200; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Glass CK, 2000, GENE DEV, V14, P121; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HSU W, 1993, MOL CELL BIOL, V13, P2515, DOI 10.1128/MCB.13.4.2515; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kakizawa T, 1999, J BIOL CHEM, V274, P19103, DOI 10.1074/jbc.274.27.19103; Kakizawa T, 2001, J BIOL CHEM, V276, P9720, DOI 10.1074/jbc.M008531200; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MARCINKIEWICZ J, 1991, CYTOKINE, V3, P327, DOI 10.1016/1043-4666(91)90501-4; Matthias P, 1998, SEMIN IMMUNOL, V10, P155, DOI 10.1006/smim.1998.0117; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PODOR TJ, 1989, ANN NY ACAD SCI, V557, P374; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Read MA, 1996, J IMMUNOL, V157, P3472; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; Schwachtgen JL, 1998, BLOOD, V92, P1247, DOI 10.1182/blood.V92.4.1247.416k08_1247_1258; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SICA A, 1992, P NATL ACAD SCI USA, V89, P1740, DOI 10.1073/pnas.89.5.1740; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIRONI M, 1989, J IMMUNOL, V142, P549; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Subramaniam N, 1998, J BIOL CHEM, V273, P23567, DOI 10.1074/jbc.273.36.23567; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; Weiser MCM, 1997, MOL BIOL CELL, V8, P999, DOI 10.1091/mbc.8.6.999; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; WIDMER U, 1993, J IMMUNOL, V150, P4996; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	62	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8424	8434		10.1074/jbc.M606923200	http://dx.doi.org/10.1074/jbc.M606923200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17192276	hybrid			2022-12-27	WOS:000245081000075
J	Laramee, M; Chabot, C; Cloutier, M; Stenne, R; Holgado-Madruga, M; Wong, AJ; Royal, I				Laramee, Melanie; Chabot, Catherine; Cloutier, Monikca; Stenne, Raphaelle; Holgado-Madruga, Marina; Wong, Albert J.; Royal, Isabelle			The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; DOCKING PROTEIN GAB1; PHOSPHOLIPASE C-GAMMA; NITRIC-OXIDE SYNTHASE; KINASE-ACTIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; BINDING-SITE; FACTOR RECEPTOR-2; PH DOMAIN; ACTIVATION	Vascular endothelial growth factor (VEGF) is involved in the promotion of endothelial cell proliferation, migration, and capillary formation. These activities are mainly mediated by the VEGFR2 receptor tyrosine kinase that upon stimulation, promotes the activation of numerous proteins including phospholipase C gamma (PLC gamma), phosphatidylinositol 3-kinase (PI3K), Akt, Src, and ERK1/2. However, the VEGFR2-proximal signaling events leading to the activation of these targets remain ill defined. We have identified the Gab1 adapter as a novel tyrosine-phosphorylated protein in VEGF-stimulated cells. In bovine aortic endothelial cells, Gab1 associates with VEGFR2, Grb2, PI3K, SHP2, Shc, and PLC gamma, and its overexpression enhances VEGF-dependent cell migration. Importantly, silencing of Gab1 using small interfering RNAs leads to the impaired activation of PLC gamma, ERK1/2, Src, and Akt; blocks VEGF-induced endothelial cell migration; and perturbs actin reorganization and capillary formation. In addition, co-expression of VEGFR2 with Gab1 mutants unable to bind SHP2 or PI3K in human embryonic kidney 293 cells and bovine aortic endothelial cells mimics the defects observed in Gab1-depleted cells. Our work thus identifies Gabl as a novel critical regulatory component of endothelial cell migration and capillary formation and reveals its key role in the activation of VEGF-evoked signaling pathways required for angiogenesis.	CHUM, Ctr Rech, Hop Notre Dame de Bon Secours, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada; Stanford Univ, Med Ctr, Dept Neurosurg, Stanford, CA 94305 USA	Universite de Montreal; Universite de Montreal; Stanford University	Royal, I (corresponding author), CHUM, Ctr Rech, Hop Notre Dame de Bon Secours, Inst Canc Montreal, Pavillon JA Seve Y-4605,1560 Rue Sherbrooke Est, Montreal, PQ H2L 4M1, Canada.	isabelle.royal@umontreal.ca		Royal, Isabelle/0000-0002-7548-1182				Bardelli A, 1997, ONCOGENE, V15, P3103, DOI 10.1038/sj.onc.1201561; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dixit M, 2005, CIRC RES, V97, P1236, DOI 10.1161/01.RES.0000195611.59811.ab; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Holgado-Madruga M, 2004, CANCER RES, V64, P2007, DOI 10.1158/0008-5472.CAN-03-2886; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Ingham RJ, 2001, J BIOL CHEM, V276, P12257, DOI 10.1074/jbc.M010590200; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; KACHARY L, 2001, CARDIOVASC RES, V9, P568; Kallin A, 2004, J BIOL CHEM, V279, P17897, DOI 10.1074/jbc.M312996200; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamothe B, 2004, MOL CELL BIOL, V24, P5657, DOI 10.1128/MCB.24.13.5657-5666.2004; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Maeda K, 2004, BIOCHEM BIOPH RES CO, V323, P345, DOI 10.1016/j.bbrc.2004.08.095; Manes S, 1999, MOL CELL BIOL, V19, P3125; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 1999, J BIOL CHEM, V274, P31719, DOI 10.1074/jbc.274.44.31719; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Meyer RD, 2003, J BIOL CHEM, V278, P16347, DOI 10.1074/jbc.M300259200; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zachary I, 2005, EXP SUPPL, V94, P267; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	71	88	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7758	7769		10.1074/jbc.M611327200	http://dx.doi.org/10.1074/jbc.M611327200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17178724	hybrid			2022-12-27	WOS:000245081000003
J	Choi, WT; Kaul, M; Kumar, S; Wang, J; Kumar, IMK; Dong, CZ; An, J; Lipton, SA; Huang, ZW				Choi, Won-Tak; Kaul, Marcus; Kumar, Santosh; Wang, Jun; Kumar, I. M. Krishna; Dong, Chang-Zhi; An, Jing; Lipton, Stuart A.; Huang, Ziwei			Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 INFECTION; HETEROLOGOUS DESENSITIZATION; RECEPTOR CXCR4; FACTOR-I; AKT; PROTEIN; EXPRESSION; SURVIVAL; DEMENTIA	As the main coreceptors for human immunodeficiency virus type 1 (HIV-1) entry CXCR4 and CCR5 play important roles in HIV-associated dementia (HAD). HIV-1 glycoprotein gp120 contributes to HAD by causing neuronal damage and death, either directly by triggering apoptotic pathways or indirectly by stimulating glial cells to release neurotoxins. Here, to understand the mechanism of CXCR4 or CCR5 signaling in neuronal apoptosis associated with HAD, we have applied synthetically and modularly modified (SMM)-chemokine analogs derived from natural stromal cell-derived factor-la or viral macrophage inflammatory protein-II as chemical probes of the mechanism(s) whereby these SMM-chemokines prevent or promote neuronal apoptosis. We show that inherently neurotoxic natural ligands of CXCR4, such as stromal cell-derived factor-la or viral macrophage inflammatory protein-II, can be modified to protect neurons from apoptosis induced by CXCR4-preferring gp120(IIIB), and that the inhibition of CCR5 by antagonist SMM-chemokines, unlike neuroprotective CCR5 natural ligands, leads to neurotoxicity by activating a p38 mitogen-activated protein kinase (MAPK)-dependent pathway. Furthermore, we discover distinct signaling pathways activated by different chemokine ligands that are either natural agonists or synthetic antagonists, thus demonstrating a chemical, biology strategy of using chemically engineered inhibitors of chemokine receptors to study the signaling mechanism of neuronal apoptosis and survival.	Burnham Inst Med Sci, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Burnham Inst Med Sci, Ctr Canc, La Jolla, CA 92037 USA; Chemokine Pharmaceut Inc, Raylight Corp, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Sanford Burnham Prebys Medical Discovery Institute	Huang, ZW (corresponding author), Burnham Inst Med Sci, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ziweihuang@burnham.org	Kaul, Marcus/AAS-8955-2020	Lipton, Stuart/0000-0002-3490-1259; Dong, Changzhi/0000-0001-7927-6306	NEI NIH HHS [R01 EY09024] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline; NIGMS NIH HHS [R01 GM5776105] Funding Source: Medline; NINDS NIH HHS [R01 NS050621, R01 NS41207] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041207, R01NS050621] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bonini JA, 1997, DNA CELL BIOL, V16, P1023, DOI 10.1089/dna.1997.16.1023; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Coffer PJ, 1998, BIOCHEM J, V335, P1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dong CZ, 2005, J MED CHEM, V48, P7923, DOI 10.1021/jm050829u; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Forster R, 1998, J IMMUNOL, V160, P1522; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Hecht I, 2003, INT IMMUNOL, V15, P29, DOI 10.1093/intimm/dxg002; Heesen M, 1998, IMMUNOGENETICS, V47, P364, DOI 10.1007/s002510050371; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Honczarenko M, 2002, BLOOD, V100, P2321, DOI 10.1182/blood-2002-01-0248; KAISER PK, 1990, NEUROLOGY, V40, P1757, DOI 10.1212/WNL.40.11.1757; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2004, J NEUROVIROL, V10, P113; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; Lavi E, 1997, AM J PATHOL, V151, P1035; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; Oravecz T, 1996, J IMMUNOL, V157, P1329; Parolin C, 1998, J VIROL, V72, P1652, DOI 10.1128/JVI.72.2.1652-1656.1998; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Pleskoff O, 1997, J VIROL, V71, P3259, DOI 10.1128/JVI.71.4.3259-3262.1997; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rottman JB, 1997, AM J PATHOL, V151, P1341; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	51	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7154	7163		10.1074/jbc.M611599200	http://dx.doi.org/10.1074/jbc.M611599200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218311	hybrid			2022-12-27	WOS:000245080900027
J	Delprat, B; Schaert, D; Roy, S; Wang, J; Puel, JL; Geering, K				Delprat, Benjamin; Schaert, Daniele; Roy, Sophie; Wang, Jing; Puel, Jean-Luc; Geering, Kathi			FXYD6 is a novel regulator of Na,K-ATPase expressed in the inner ear	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; BETA-SUBUNIT; STRIA VASCULARIS; ION-TRANSPORT; GAMMA-SUBUNIT; FUNCTIONAL INTERACTION; COCHLEAR POTENTIALS; INTERMEDIATE CELLS; ALPHA-SUBUNIT; GUINEA-PIG	The exquisite sensitivity of the cochlea, which mediates the transduction of sound waves into nerve impulses, depends on the endolymph ionic composition and the endocochlear potential. A key protein in the maintenance of the electrochemical composition of the endolymph is the Na,K-ATPase. In this study, we have looked for the presence in the rat inner ear of members of the FXYD protein family, recently identified as tissue-specific modulators of Na,K-ATPase. Only FXYD6 is detected at the protein level. FXYD6 is expressed in various epithelial cells bordering the endolymph space and in the auditory neurons. FXYD6 co-localizes with Na,K-ATPase in the stria vascularis and can be co-immunoprecipitated with Na,K-ATPase. After expression in Xenopus oocytes, FXYD6 associates with Na,K-ATPase alpha 1-beta 1 and alpha 1-beta 2 isozymes, which are preferentially expressed in different regions of the inner ear and also with gastric and non-gastric H,K-ATPases. The apparent K+ and Na+ affinities of alpha 1-beta 1 and alpha 1-beta 2 isozymes are different. Association of FXYD6 with Na,K-ATPase alpha 1-beta 1 isozymes slightly decreases their apparent K+ affinity and significantly decreases their apparent Na+ affinity. On the other hand, association with alpha 1-beta 2 isozymes increases their apparent K+ and Na+ affinity. The effects of FXYD6 on the apparent Na+ affinity of Na,K-ATPase and the voltage dependence of its K+ effect are distinct from other FXYD proteins. In conclusion, this study defines the last FXYD protein of unknown function as a modulator of Na,K-ATPase. Among FXYD protein, FXYD6 is unique in its expression in the inner ear, suggesting a role in endolymph composition.	Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Montpellier, F-34091 Montpellier, France; Inst Neurosci Montpellier, Inst Natl Sante & Rech Med, U583, F-34091 Montpellier, France	University of Lausanne; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Geering, K (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Kaethi.Geering@unil.ch	Delprat, Benjamin/O-3791-2018	Puel, jean-luc/0000-0002-3772-5190; Delprat, Benjamin/0000-0002-2457-6923				Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; BOSHER SK, 1968, PROC R SOC SER B-BIO, V171, P227, DOI 10.1098/rspb.1968.0066; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, BIOCHEMISTRY-US, V41, P6723, DOI 10.1021/bi016063r; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Crambert G, 2005, MOL BIOL CELL, V16, P2363, DOI 10.1091/mbc.E04-10-0878; CRAMBERT G, 2003, SCI STKE, pRE1; DALLOS P, 1992, J NEUROSCI, V12, P4575; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; EYBALIN M, 1990, CR ACAD SCI III-VIE, V310, P639; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; IKEDA K, 1989, HEARING RES, V39, P279, DOI 10.1016/0378-5955(89)90047-6; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; Kadowaki K, 2004, MOL BRAIN RES, V125, P105, DOI 10.1016/j.molbrainres.2004.03.021; KUIJPERS W, 1970, PFLUG ARCH EUR J PHY, V320, P348, DOI 10.1007/BF00588213; KUIJPERS W, 1970, PFLUG ARCH EUR J PHY, V320, P359, DOI 10.1007/BF00588214; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MORGENSTERN C, 1982, AM J OTOLARYNG, V3, P323, DOI 10.1016/S0196-0709(82)80004-5; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Nie LP, 2005, J NEUROSCI, V25, P8671, DOI 10.1523/JNEUROSCI.1422-05.2005; Peters TA, 2001, EUR ARCH OTO-RHINO-L, V258, P67, DOI 10.1007/s004050000304; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Shibata T, 2006, AM J PHYSIOL-CELL PH, V291, pC1038, DOI 10.1152/ajpcell.00266.2006; SMITH CA, 1954, LARYNGOSCOPE, V64, P141; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Spicer SS, 2005, HEARING RES, V200, P87, DOI 10.1016/j.heares.2004.09.006; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Trigueiros-Cunha N, 2003, EUR J NEUROSCI, V18, P2653, DOI 10.1046/j.1460-9568.2003.02989.x	41	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7450	7456		10.1074/jbc.M609872200	http://dx.doi.org/10.1074/jbc.M609872200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209044	Green Submitted, hybrid			2022-12-27	WOS:000245080900057
J	Hill, K; Schaefer, M				Hill, Kerstin; Schaefer, Michael			TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL; ACTIVATION; RECEPTOR; COLD; INHIBITION; MECHANISM; HYPOXIA; TOXIN; CELLS	TRPA1, a poorly selective Ca2+-permeable cation channel, is expressed in peripheral sensory neurons, where it is considered to contribute to a variety of sensory processes such as the detection of painful stimuli. Furthermore, TRPA1 was also identified in hair cells of the inner ear, but its involvement in sensing mechanical forces is still being controversially discussed. Amphipathic molecules such as trinitrophenol and chlorpromazine have been shown to provide useful tools to study mechanosensitive channels. Depending on their charge, they partition in the inner or outer sheets of the lipid bilayer, causing a curvature of the membrane, which has been demonstrated to activate or inhibit mechanosensitive ion channels. In the present study, we investigated the effect of these molecules on TRPA1 gating. TRPA1 was robustly activated by the anionic amphipathic molecule trinitrophenol. The whole-cell and single channel properties resemble those previously described for TRPA1. Moreover, we could show that the toxin GsMTx-4 acts on TRPA1. In addition to its recently described role as an inhibitor of stretch-activated ion channels, it serves as a potent activator of TRPA1 channels. On the other hand, the positively charged drug chlorpromazine modulates activated TRPA1 currents in a voltage-dependent way. The exposure of activated TRPA1 channels to chlorpromazine led to a block at positive potentials and an increased open probability at negative potentials. The variability in the shape of the I-V curve gives a first indication that native mechanically activated TRPA1 currents must not necessarily exhibit the same biophysical properties as ligand-activated TRPA1 currents.	Univ Med Berlin, Inst Pharmakol, Charite, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schaefer, M (corresponding author), Univ Med Berlin, Inst Pharmakol, Charite, Campus Benjamin Franklin,Thielallee 67-73, D-14195 Berlin, Germany.	m.schaefer@charite.de						Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Buckler KJ, 2005, J PHYSIOL-LONDON, V562, P213, DOI 10.1113/jphysiol.2004.077503; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; Chen KH, 2002, ATHEROSCLEROSIS, V165, P5, DOI 10.1016/S0021-9150(01)00768-7; CHOI SY, 2001, BRIT J PHARMACOL, V2, P411; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Dreixler JC, 2000, EUR J PHARMACOL, V401, P1, DOI 10.1016/S0014-2999(00)00401-5; Fang J, 2006, NEUROSCI LETT, V404, P213, DOI 10.1016/j.neulet.2006.05.059; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V340, P633, DOI 10.1016/j.bbrc.2005.12.046; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; Lue AJC, 2001, OTOLARYNG HEAD NECK, V125, P71, DOI 10.1067/mhn.2001.116446; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Miller P, 2003, J PHYSIOL-LONDON, V548, P31, DOI 10.1113/jphysiol.2003.040048; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Qi Z, 2005, MOL MEMBR BIOL, V22, P519, DOI 10.1080/09687860500370703; SAH DWY, 1994, MOL PHARMACOL, V45, P84; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Thomas D, 2003, BRIT J PHARMACOL, V139, P567, DOI 10.1038/sj.bjp.0705283; TSENG GN, 1992, AM J PHYSIOL, V262, pC1056, DOI 10.1152/ajpcell.1992.262.4.C1056; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578	38	80	86	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7145	7153		10.1074/jbc.M609600200	http://dx.doi.org/10.1074/jbc.M609600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218316	hybrid			2022-12-27	WOS:000245080900026
J	Ouchane, S; Picaud, M; Therizols, P; Reiss-Husson, F; Astier, C				Ouchane, Soufian; Picaud, Martine; Therizols, Pierre; Reiss-Husson, Francoise; Astier, Chantal			Global regulation of photosynthesis and respiration by FnrL - The first two targets in the tetrapyrrole pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-SPHAEROIDES 2.4.1; COPROPORPHYRINOGEN-III OXIDASE; ISOCYCLIC RING FORMATION; GENE-EXPRESSION; RUBRIVIVAX-GELATINOSUS; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTION FACTOR; PURPLE BACTERIA	Fur is a regulator that controls the expression of a variety of genes in response to oxygen limitation in bacteria. To assess the role of Fnr in photosynthesis in Rubrivivax gelatinosus, a strain carrying a null mutation in fnrL was constructed. It was unable to grow anaerobically in the light, but, intriguingly, it was able to produce photosynthetic complexes under high oxygenation conditions. The mutant lacked all c-type cytochromes normally detectable in microaerobically-grown wild type cells and accumulated coproporphyrin Ill. These data suggested that the pleiotropic phenotype observed in FNR is primarily due to the control at the level of the HemN oxygen-independent coproporphyrinogen III dehydrogenase. hemN expression in trans partially suppressed the FNR phenotype, as it rescued heme and cytochrome syntheses. Nevertheless, these cells were photosynthetically deficient, and pigment analyses showed that they were blocked at the level of Mg2+-protoporphyrin monomethyl ester. Expression of both hemN and bchE in the FNR mutant restored synthesis of Mg2+-protochlorophyllide. We, therefore, conclude that FnrL controls respiration by regulating hemN expression and controls photosynthesis by regulating both hemN and bchE expression. A comprehensive picture of the control points of microaerobic respiration and photosynthesis by FnrL is provided, and the prominent role of this factor in activating alternative gene programs after reduction of oxygen tension in facultative aerobes is discussed.	Univ Paris 06, UPR 2167, Ctr Genet Mol, CNRS, F-91198 Gif Sur Yvette, France; Univ Paris 11, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ouchane, S (corresponding author), Univ Paris 06, UPR 2167, Ctr Genet Mol, CNRS, Batiment 26,Ave Terrasse, F-91198 Gif Sur Yvette, France.	souchane@cgm.cnrs-gif.fr	Therizols, Pierre/AAA-5515-2021; OUCHANE, Soufian/HHM-5430-2022; Ouchane, Soufian/ABE-2609-2020	Ouchane, Soufian/0000-0002-8161-3866; Therizols, Pierre/0000-0002-5916-0987				Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; HORIUCHI K, 1991, CLIN CHEM, V37, P1173; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Mason MG, 2001, APPL ENVIRON MICROB, V67, P4512, DOI 10.1128/AEM.67.10.4512-4519.2001; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Mouncey NJ, 1998, J BACTERIOL, V180, P2228, DOI 10.1128/JB.180.8.2228-2231.1998; O'Brian MR, 2002, ADV MICROB PHYSIOL, V46, P257, DOI 10.1016/S0065-2911(02)46006-7; Oh JI, 2001, MOL MICROBIOL, V39, P1116, DOI 10.1046/j.1365-2958.2001.02299.x; Oh JI, 2000, J BACTERIOL, V182, P3081, DOI 10.1128/JB.182.11.3081-3087.2000; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 1996, MOL GEN GENET, V252, P379, DOI 10.1007/BF02173002; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1998, EUR J BIOCHEM, V257, P185, DOI 10.1046/j.1432-1327.1998.2570185.x; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Roh JH, 2002, J BACTERIOL, V184, P5330, DOI 10.1128/JB.184.19.5330-5338.2002; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schobert M, 2002, J MOL MICROB BIOTECH, V4, P287; Smart JL, 2004, J MOL BIOL, V342, P1171, DOI 10.1016/j.jmb.2004.08.007; SMITH KM, 1975, PORPHYRINS METALLOPO, P872; Steunou AS, 2004, J BACTERIOL, V186, P3133, DOI 10.1128/JB.186.10.3133-3142.2004; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; TROUP B, 1994, J BACTERIOL, V176, P673, DOI 10.1128/jb.176.3.673-680.1994; TROUP B, 1995, J BACTERIOL, V177, P3326, DOI 10.1128/jb.177.11.3326-3331.1995; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; VERNON LP, 1966, CHLOROPHYLLS      ED, P147; Zeilstra-Ryalls JH, 1998, J BACTERIOL, V180, P1496, DOI 10.1128/JB.180.6.1496-1503.1998; Zeilstra-Ryalls JH, 1998, METHOD ENZYMOL, V297, P151; ZeilstraRyalls JH, 1996, J BACTERIOL, V178, P985, DOI 10.1128/jb.178.4.985-993.1996; ZEILSTRARYALLS JH, 1995, J BACTERIOL, V177, P6422, DOI 10.1128/jb.177.22.6422-6431.1995; ZeilstraRyalls JH, 1997, J BACTERIOL, V179, P7264, DOI 10.1128/jb.179.23.7264-7273.1997	41	14	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7690	7699		10.1074/jbc.M605985200	http://dx.doi.org/10.1074/jbc.M605985200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17178720	hybrid			2022-12-27	WOS:000245080900081
J	Yu, CF; Cresswell, J; Loffler, MG; Bogan, JS				Yu, Chenfei; Cresswell, James; Loffler, Michael G.; Bogan, Jonathan S.			The glucose transporter 4-regulating protein TUG is essential for highly insulin-responsive glucose uptake in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; GTPASE-ACTIVATING-PROTEIN; NEWLY SYNTHESIZED GLUT4; STORAGE COMPARTMENT; TRAFFICKING; VESICLES; CELLS; GLUCOSE-TRANSPORTER-4; FUSION; AMINOPEPTIDASE	Insulin stimulates glucose uptake in fat and muscle by redistributing GLUT4 glucose transporters from intracellular membranes to the cell surface. We previously proposed that, in 3T3-LI adipocytes, TUG retains GLUT4 within unstimulated cells and insulin mobilizes this retained GLUT4 by stimulating its dissociation from TUG. Yet the relative importance of this action in the overall control of glucose uptake remains uncertain. Here we report that transient, small interfering RNA-mediated depletion of TUG causes GLUT4 translocation and enhances glucose uptake in unstimulated 3T3-L1 adipocytes, similar to insulin. Stable TUG depletion or expression of a dominant negative fragment likewise stimulates GLUT4 redistribution and glucose uptake, and insulin causes a 2-fold further increase. Microscopy shows that TUG governs the accumulation of GLUT4 in perinuclear membranes distinct from endosomes and indicates that it is this pool of GLUT4 that is mobilized by TUG disruption. Interestingly, in addition to translocating GLUT4 and enhancing glucose uptake, TUG disruption appears to accelerate the degradation of GLUT4 in lysosomes. Finally, we find that TUG binds directly and specifically to a large intracellular loop in GLUT4. Together, these findings demonstrate that TUG is required to retain GLUT4 intracellularly in 3T3-L1 adipocytes in the absence of insulin and further implicate the insulin-stimulated dissociation of TUG and GLUT4 as an important action by which insulin stimulates glucose uptake.	Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, 333 Cedar St,POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Löffler, Michael/F-1748-2013; Bogan, Jonathan S/A-1575-2010	Löffler, Michael/0000-0002-6529-9723; Bogan, Jonathan S/0000-0001-6463-8466	NIDDK NIH HHS [R21 DK070812, P30 DK045735, R21 DK070812-02, P30 DK045735-159008, R21 DK070812-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R21DK070812] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2003, DIABETES MELLITUS FU, P917; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; HUANG X, 2004, KEYST S DIAB MELL BA; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; KIM SS, 1994, AM J PHYSIOL, V267, pE132, DOI 10.1152/ajpendo.1994.267.1.E132; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; VANDAM EM, 2005, MOL ENDOCRINOL; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182	39	65	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7710	7722		10.1074/jbc.M610824200	http://dx.doi.org/10.1074/jbc.M610824200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17202135	Green Accepted, hybrid			2022-12-27	WOS:000245080900083
J	Gillet, R; Kaur, S; Li, W; Hallier, M; Felden, B; Frank, J				Gillet, Reynald; Kaur, Sukhjit; Li, Wen; Hallier, Marc; Felden, Brice; Frank, Joachim			Scaffolding as an organizing principle in trans-translation - The roles of small protein band ribosomal protein S1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER-RNA; STALLED RIBOSOME; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SMPB SYSTEM; TMRNA; BINDING; SUBUNIT; VISUALIZATION; RESCUE	A eubacterial ribosome stalled on a defective mRNA can be released through a quality control mechanism referred to as trans-translation, which depends on the coordinating binding actions of transfer-messenger RNA, small protein B, and ribosome protein S1. By means of cryo-electron microscopy, we obtained a map of the complex composed of a stalled ribosome and small protein B, which appears near the decoding center. This result suggests that, when lacking a codon, the A-site on the small subunit is a target for small protein B. To investigate the role of S1 played in trans-translation, we obtained a cryo-electron microscopic map, including a stalled ribosome, transfermessenger RNA, and small protein Bs but in the absence of SI. In this complex, several connections between the 30 S subunit and transfer-messenger RNA that appear in the +S1 complex are no longer found. We propose the unifying concept of scaffolding for the roles of small protein B and S1 in binding of transfer-messenger RNA to the ribosome during trans-translation, and we infer a pathway of sequential binding events in the initial phase of trans-translation.	Univ Rennes 1, IFR 140, UPRES JE 2311, INSERM,U835, F-35043 Rennes, France; Hlth Res Inc, Howard Hughes Med Inst, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Wadsworth Ctr, Albany, NY 12201 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center	Gillet, R (corresponding author), Univ Rennes 1, IFR 140, UPRES JE 2311, INSERM,U835, 2 Ave Prof Leon Bernard, F-35043 Rennes, France.	bfelden@univ-rennes1.fr; joachim@wadsworth.org	Hallier, Marc/L-2031-2015; felden, brice/L-4825-2015		NIGMS NIH HHS [R37 GM029169-23, GM55440, R01 GM055440-08, GM 67624, R01 GM067624, R37 GM29169, R37 GM029169, R01 GM055440-09A1, R01 GM029169, R01 GM029169-29, R01 GM055440, R37 GM029169-24] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R01GM029169, R01GM067624, R37GM029169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bordeau V, 2002, BIOCHIMIE, V84, P723, DOI 10.1016/S0300-9084(02)01442-6; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Frank J, 2006, 3 DIMENSIONAL ELECT; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Hallier M, 2006, NUCLEIC ACIDS RES, V34, P1935, DOI 10.1093/nar/gkl097; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Ivanova N, 2005, NUCLEIC ACIDS RES, V33, P3529, DOI 10.1093/nar/gki666; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Maivali U, 2004, RNA, V10, P600, DOI 10.1261/rna.5220504; McGinness KE, 2004, P NATL ACAD SCI USA, V101, P13454, DOI 10.1073/pnas.0405521101; Metzinger L, 2005, NUCLEIC ACIDS RES, V33, P2384, DOI 10.1093/nar/gki534; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Okada T, 2004, BIOSCI BIOTECH BIOCH, V68, P2319, DOI 10.1271/bbb.68.2319; Saguy M, 2005, BIOCHIMIE, V87, P897, DOI 10.1016/j.biochi.2005.03.014; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shimizu Y, 2002, FEBS LETT, V514, P74, DOI 10.1016/S0014-5793(02)02333-5; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Wower J, 2002, BIOCHEMISTRY-US, V41, P8826, DOI 10.1021/bi0201365	30	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6356	6363		10.1074/jbc.M609658200	http://dx.doi.org/10.1074/jbc.M609658200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17179154	hybrid, Green Accepted			2022-12-27	WOS:000244867200042
J	Hock, TD; Liby, K; Wright, MM; McConnell, S; Schorpp-Kistner, M; Ryan, TM; Agarwal, A				Hock, Thomas D.; Liby, Karen; Wright, Marcienne M.; McConnell, Sean; Schorpp-Kistner, Marina; Ryan, Thomas M.; Agarwal, Anupam			JunB and JunD regulate human herne oxygenase-1 gene expression in renal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEME OXYGENASE-1; ANTIOXIDANT RESPONSE ELEMENT; CADMIUM-MEDIATED INDUCTION; NF-KAPPA-B; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; IN-VIVO; BINDING PROTEIN; GROWTH-FACTORS	Heme oxygenase-1 is a highly inducible gene, the product of which catalyzes breakdown of the prooxidant heme. The purpose of this study was to investigate the regulation of the human heme oxygenase-1 gene in renal epithelial cells. DNase I hypersensitivity studies identified three distal sites (HS-2, -3, and -4) corresponding to approximately -4.0, -7.2, and -9.2 kb, respectively, of the heme oxygenase-1 promoter in addition to one proximal region, HS-1, which we have shown previously to be an E box. In vivo dimethyl sulfate footprinting of the HS-2 region revealed six individual protected guanines. Two mutations within HS-2 combined with a third mutation of the proximal E box abolished hemin- and cadmium-driven heme oxygenase-1 promoter activation, suggesting that these three sites synergized for maximal heme oxygenase-1 induction. Jun proteins bound to the antioxidant response element in the HS-2 region in vitro and associated with the heme oxygenase-1 promoter in vivo. JunB and JunD contribute opposing effects; JunB activated whereas JunD repressed heme oxygenase-1 expression in human renal epithelial cells, results that were corroborated in junB(-/-) and junD(-/-) cells. We propose that heme oxygenase-1 induction is controlled by a dynamic interplay of regulatory proteins, and we provide new insights into the molecular control of the human heme oxygenase-1 gene.	Univ Alabama, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Dartmouth Coll Sch Med, Hanover, NH 03755 USA; Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Dartmouth College; Helmholtz Association; German Cancer Research Center (DKFZ)	Agarwal, A (corresponding author), Univ Alabama, Div Nephrol, Zeigler Res Bldg,Rm 614,703 19th St S, Birmingham, AL 35294 USA.	agarwal@uab.edu		Ryan, Thomas/0000-0002-8982-0253; Liby, Karen/0000-0003-3317-3437; McConnell, Sean/0000-0002-0988-5373	NHLBI NIH HHS [HL068157] Funding Source: Medline; NIDDK NIH HHS [DK059600, DK067472] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067472, R01DK059600] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal A, 1998, J AM SOC NEPHROL, V9, P1990; Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Andrecht S, 2002, J BIOL CHEM, V277, P35961, DOI 10.1074/jbc.M202847200; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; Deramaudt BMJM, 1999, J CELL BIOCHEM, V72, P311, DOI 10.1002/(SICI)1097-4644(19990301)72:3<311::AID-JCB1>3.3.CO;2-7; Deshane J, 2005, ACTA BIOCHIM POL, V52, P273; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dulak J, 2004, ANTIOXID REDOX SIGN, V6, P858, DOI 10.1089/1523086041797980; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hilfiker-Kleiner D, 2005, CIRCULATION, V112, P1470, DOI 10.1161/CIRCULATIONAHA.104.518472; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mellott JK, 2001, AM J PHYSIOL-LUNG C, V280, pL390, DOI 10.1152/ajplung.2001.280.3.L390; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; NGUYEN T, 1994, J BIOL CHEM, V269, P13656; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ricci R, 2005, GENE DEV, V19, P208, DOI 10.1101/gad.327005; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SATO M, 1990, EUR J BIOCHEM, V188, P231, DOI 10.1111/j.1432-1033.1990.tb15394.x; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Takahashi S, 1999, BBA-GENE STRUCT EXPR, V1447, P231, DOI 10.1016/S0167-4781(99)00156-6; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Volti GL, 2005, ANTIOXID REDOX SIGN, V7, P704, DOI 10.1089/ars.2005.7.704; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	61	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6875	6886		10.1074/jbc.M608456200	http://dx.doi.org/10.1074/jbc.M608456200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204476	hybrid			2022-12-27	WOS:000244867200097
J	Plaza-Menacho, I; van der Sluis, T; Hollema, H; Gimm, O; Buys, CHCM; Magee, AI; Isacke, CM; Hofstra, RMW; Eggen, BJL				Plaza-Menacho, Ivan; van der Sluis, Tineke; Hollema, Harry; Gimm, Oliver; Buys, Charles H. C. M.; Magee, Anthony I.; Isacke, Clare M.; Hofstra, Robert M. W.; Eggen, Bart J. L.			Ras/ERK1/2-mediated STAT3 Ser(727) phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PHOSPHORYLATION; CANCER-CELLS; KINASE; PHENOTYPE; PATHWAYS	The precise role of STAT3 Ser 727 phosphorylation in RET-mediated cell transformation and oncogenesis is not well understood. In this study, we have shown that familial medullary thyroid carcinoma (FMTC) mutants RETY791F and RETS891A induced, in addition to Tyr(705) phosphorylation, constitutive STAT3 Ser 727 phosphorylation. Using inhibitors and dominant negative constructs, we have demonstrated that RETY791F and RETS891A induce STAT3 Ser 727 phosphorylation via a canonical Ras/ERK1/2 pathway and that integration of the Ras/ERKI/2/ELK-1 and STAT3 pathways was required for up-regulation of the c-fos promoter by FMTC-RET. Moreover, inhibition of ERK1/2 had a more severe effect on cell proliferation and cell phenotype in HEK293 cells expressing REVS891A compared with control and RETWT-transfected cells. The transforming activity of RETY791F and RETS891A in NIH-3T3 cells was also inhibited by U0126, indicating a role of the ERK1/2 pathway in RET-mediated transformation. To investigate the biological significance of Ras/ERK1/2-induced STAT3 Ser 727 phosphorylation for cell proliferation and transformation, N-Ras-transformed NIH-3T3 cells were employed. These cells displayed elevated levels of activated ERK1/2 and Ser(727)-phosphorylated STAT3, which were inhibited by treatment with U0126. Importantly, overexpression of STAT3, in which the Ser 717 was mutated into Ala (STAT3(S727A)), rescued the transformed phenotype of N-Ras-transformed cells. Immunohistochemistry in tumor samples from FMTC patients showed strong nuclear staining of phosphorylated ERK1/2 and Ser 727 STAT3. These data show that FMTC-RET mutants activate a Ras/ERK1/2/STAT3 Ser(727) pathway, which plays an important role in cell mitogenicity and transformation.	Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; Univ Groningen, Dept Pathol, Med Ctr, NL-9713 GZ Groningen, Netherlands; Univ Halle Wittenberg, Dept Surg, D-06097 Halle, Germany; Univ London Imperial Coll Sci Technol & Med, Sect Mol & Cellular Med, London SW7 2AZ, England; Univ Groningen, Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Groningen; University of Groningen; Martin Luther University Halle Wittenberg; Imperial College London; University of Groningen	Plaza-Menacho, I (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	ivan.plaza-menacho@icr.ac.uk	Piris, Alejandro/D-3830-2014; Magee, Anthony/V-8345-2019; Plaza-Menacho, Ivan/K-8517-2017	Plaza-Menacho, Ivan/0000-0003-4666-9431; Hofstra, Robert/0000-0001-7498-3829; Isacke, Clare/0000-0002-9222-3345	Medical Research Council [G0100471] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline; MRC [G0100471] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Breast Cancer Now; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; BOER PH, 1990, BIOCHEM GENET, V28, P299, DOI 10.1007/BF02401419; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; de Groot JWB, 2006, SURGERY, V139, P806, DOI 10.1016/j.surg.2005.10.019; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Hwang JH, 2003, MOL ENDOCRINOL, V17, P1155, DOI 10.1210/me.2002-0401; Iwashita T, 1999, ONCOGENE, V18, P3919, DOI 10.1038/sj.onc.1202742; Jimenez C, 2004, J CLIN ENDOCR METAB, V89, P4142, DOI 10.1210/jc.2004-0041; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Marcos C, 1996, Int J Dev Biol, VSuppl 1, p137S; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Menacho IP, 2005, CANCER RES, V65, P1729, DOI 10.1158/0008-5472.CAN-04-2363; Mise N, 2006, ONCOGENE, V25, P6637, DOI 10.1038/sj.onc.1209669; PASINI A, 1999, ONCOGENE, V24, P393; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schuringa JJ, 2001, ONCOGENE, V20, P5350, DOI 10.1038/sj.onc.1204715; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Wang Y, 1998, CELL GROWTH DIFFER, V9, P513; Wierenga ATJ, 2003, EXP HEMATOL, V31, P398, DOI 10.1016/S0301-472X(03)00045-6; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004	28	51	52	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6415	6424		10.1074/jbc.M608952200	http://dx.doi.org/10.1074/jbc.M608952200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17209045	hybrid			2022-12-27	WOS:000244867200049
J	Tanno, M; Sakamoto, J; Miura, T; Shimamoto, K; Horio, Y				Tanno, Masaya; Sakamoto, Jun; Miura, Tetsuji; Shimamoto, Kazuaki; Horio, Yoshiyuki			Nucleocytoplasmic shuttling of the NAD(+)-dependent histone deacrtylase SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROMOTES CELL-SURVIVAL; NUCLEAR EXPORT SIGNAL; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; LIFE-SPAN; PROTEIN; P53; DEACETYLASE; LONGEVITY	Sir2 (silent information regulator 2) is an NAD(+)-dependent histone deacetylase that contributes to longevity in yeast. SIRT1, a mammalian Sir2 ortholog, deacetylates histones and various transcription factors, including p53, FOXO proteins, and peroxisome proliferator-activated receptor-gamma. We found that its subcellular localization varied in different tissues of the adult mouse. Some subsets of neurons predominantly expressed SIRT1 in the cytoplasm, but ependymal cells expressed it in both the nucleus and cytoplasm. On the other hand, spermatocytes expressed SIRT1 only in the nucleus. Cardiomyocytes in the day 12.5 mouse embryo expressed SIRT1 exclusively in the nucleus, but in the adult heart, they expressed it in both the cytoplasm and nucleus. C2C12 myoblast cells expressed SIRT1 in the nucleus, but it localized to the cytoplasm after differentiation. LY294002, an inhibitor of phosphoinositide 3-hydroxykinase, strongly inhibited the nuclear localization of SIRT1 in undifferentiated C2C12 cells. In a heterokaryon assay, SIRT1 shuttled between the nucleus and cytoplasm, and leptomycin B, an inhibitor of CRM1-mediated nuclear exportation, inhibited this shuttling. Two nuclear localization signals and two nuclear export signals were identified by deletion and site-directed mutation analyses. Overexpressed nuclear (but not cytoplasmic or dominant-negative) SIRT1 enhanced the deacetylation of histone H3 in C2C12 cells. Moreover, only the nuclear form suppressed the apoptosis of C2C12 cells induced by antimycin A, an oxidative stressor. These findings indicate that nucleocytoplasmic shuttling is a novel regulatory mechanism of SIRT1, which may participate in differentiation and in inhibition of cell death.	Sapporo Med Univ, Dept Pharmacol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Sapporo Med Univ, Dept Internal Med 2, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Dept Pharmacol, Chuo Ku, S1W16, Sapporo, Hokkaido 0608556, Japan.	horio@sapmed.ac.jp		Horio, Yoshiyuki/0000-0002-5021-5929				Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; RINE J, 1987, GENETICS, V116, P9; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331	36	549	582	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6823	6832		10.1074/jbc.M609554200	http://dx.doi.org/10.1074/jbc.M609554200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197703	hybrid			2022-12-27	WOS:000244867200092
J	Kapoor, M; Kojima, F; Qian, M; Yang, LH; Crofford, LJ				Kapoor, Mohit; Kojima, Fumiaki; Qian, Min; Yang, Lihua; Crofford, Leslie J.			Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma - Regulation by prostaglandin E-2 via the phosphatidylinositol 3-kinase and Akt pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANDOMIZED CONTROLLED-TRIAL; RHEUMATOID SYNOVIAL-CELLS; NITRIC-OXIDE; MICE LACKING; PPAR-GAMMA; EXPRESSION; CYCLOOXYGENASE-2; ARTHRITIS; INFLAMMATION; BIOSYNTHESIS	mPGES-1 (microsomal PGE synthase-1) is an inducible enzyme that acts downstream of cyclooxygenase (COX) and specifically catalyzes the conversion of prostaglandin (PG) H-2 to PGE(2) under basal as well as inflammatory conditions. In this study, using mouse embryo fibroblasts (MEFs) isolated from mice genetically deficient for the mPges-1 gene, we show basal elevation of peroxisome proliferator-activated receptor gamma (PPAR gamma) expression (protein and mRNA) and transcriptional activity associated with reduced basal PGE(2). We further show that basal mPGES-1-derived PGE, suppresses the expression of PPAR gamma through a cAMP-independent pathway involving phosphatidylinositol 3-kinase and Akt signaling. Using specific PPAR gamma agonist (rosiglitazone), PPAR gamma ligand (15-deoxy-Delta 12,14-PGJ(2)), and PPAR gamma inhibitor (GW9662), we confirm that activation of PPAR gamma blocks interleukin-1 beta-induced up-regulation of COX-2, mPGES-1, and their derived PGE(2). Furthermore, we demonstrate that up-regulation of PPAR gamma upon genetic deletion of mPGES-1 is responsible for reduced COX-2 expression under basal as well as interleukin-1 beta-stimulated conditions. This study provides evidence for the first time that mPGES-1 deletion not only decreases proinflammatory PGE(2) but also up-regulates anti-inflammatory PPAR gamma, which has the ability to suppress COX-2 and mPGES-1 expression and PGE(2) production. Thus, mPGES- I inhibition may limit inflammation by multiple mechanisms and is a potential therapeutic target.	Univ Kentucky, Div Rheumatol, Dept Internal Med, KY Clin, Lexington, KY 40536 USA; Univ Michigan, Sch Med, Div Cell & Dev Biol, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Kentucky; University of Michigan System; University of Michigan	Crofford, LJ (corresponding author), Univ Kentucky, Div Rheumatol, Dept Internal Med, KY Clin, Rm J-509, Lexington, KY 40536 USA.	lcrofford@uky.edu	Crofford, Leslie J/J-8010-2013	Crofford, Leslie J/0000-0002-6347-5738	NIAMS NIH HHS [R01 AR049010, R01 AR 049010] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Cheon H, 2006, J IMMUNOL, V177, P1092, DOI 10.4049/jimmunol.177.2.1092; Crofford LJ, 2003, ARTHRITIS RES THER, V5, P25, DOI 10.1186/ar620; Crofford LJ, 2001, GASTROENTEROL CLIN N, V30, P863, DOI 10.1016/S0889-8553(05)70217-X; Cuzzocrea S, 2002, MOL PHARMACOL, V61, P997, DOI 10.1124/mol.61.5.997; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Farrajota K, 2005, ARTHRITIS RHEUM-US, V52, P94, DOI 10.1002/art.20714; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gomez-Hernandez A, 2006, J CARDIOVASC PHARM, V47, P60; HONDA A, 1993, J BIOL CHEM, V268, P7759; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kapoor Mohit, 2005, Curr Opin Investig Drugs, V6, P461; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; Kino Y, 2005, PROSTAG LEUKOTR ESS, V73, P103, DOI 10.1016/j.plefa.2005.04.014; Kojima F, 2005, FUND CLIN PHARMACOL, V19, P255, DOI 10.1111/j.1472-8206.2005.00316.x; Kojima F, 2004, ARTHRITIS RES THER, V6, pR355, DOI 10.1186/ar1195; Kojima F, 2003, ARTHRITIS RHEUM, V48, P2819, DOI 10.1002/art.11261; Kojima F, 2002, J RHEUMATOL, V29, P1836; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Moulin D, 2006, BIORHEOLOGY, V43, P561; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Olschewski H, 1996, ANN INTERN MED, V124, P820, DOI 10.7326/0003-4819-124-9-199605010-00006; Peng Youming, 2005, Hemodial Int, V9 Suppl 1, pS15, DOI 10.1111/j.1542-4758.2005.01165.x; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Sanchez-Hidalgo M, 2005, BIOCHEM PHARMACOL, V69, P1733, DOI 10.1016/j.bcp.2005.03.024; Satoh K, 2000, NEUROSCI LETT, V283, P221, DOI 10.1016/S0304-3940(00)00926-5; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shiojiri T, 2002, EUR J PHARMACOL, V448, P231, DOI 10.1016/S0014-2999(02)01946-5; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3	48	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5356	5366		10.1074/jbc.M610153200	http://dx.doi.org/10.1074/jbc.M610153200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17186945	hybrid			2022-12-27	WOS:000244482300031
J	Paro, S; Rancour, DM; Bednarek, SY				Paro, Sookhee; Rancour, David M.; Bednarek, Sebastian Y.			Protein domain-domain interactions and requirements for the negative regulation of Arabidopsis CDC48/p97 by the plant ubiquitin regulatory X (UBX) domain-containing protein, PUX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; CONFORMATIONAL-CHANGES; P97-UFD1-NPL4 COMPLEX; MEMBRANE-FUSION; P97; BINDING; ER; P47; DEGRADATION; INVOLVEMENT	CDC48/p97 is an essential AAA-ATPase chaperone that functions in numerous diverse cellular activities through its interaction with specific adapter proteins. The ubiquitin regulatory X (UBX)-containing protein, PUX1, functions to regulate the hexameric structure and ATPase activity of AtCDC48. To characterize the biochemical mechanism of PUX1 action on AtCDC48, we have defined domains of both PUX1 and AtCDC48 that are critical for interaction and oligomer disassembly. Binding of PUX1 to AtCDC48 was mediated through a region containing both the UBX domain and the immediate C-terminal flanking amino acids (UBX-C). Like other UBX domains, the primary binding site for the UBX-C of PUX1 is the N-a domain of AtCDC48. Alternative plant PUX protein UBX domains also bind AtCDC48 through the N terminus but were found not to be able to substitute for the action imparted by the UBX-C of PUX1 in hexamer disassembly, suggesting unique features for the UBX-C of PUX1. We propose that the PUX1 UBX-C domain modulates a second binding site on AtCDC48 required for the N-terminal domain of PUX1 to interact with and promote dissociation of the AtCDC48 hexamer. Utilizing Atcdc48 ATP hydrolysis and binding mutants, we demonstrate that PUX1 binding was not affected but that hexamer disassembly was significantly influenced by the ATP status of AtCDC48. ATPase activity in both the D I and the D2 domains was critical for PUX1-mediated AtCDC48 hexamer disassembly. Together these results provide new mechanistic insight into how the hexameric status and ATPase activity of AtCDC48 are modulated.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bednarek, SY (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	bednarek@biochem.wisc.edu		Rancour, David/0000-0002-3624-5750				Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2005, BBA-MOL CELL RES, V1744, P108, DOI 10.1016/j.bbamcr.2005.03.011; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Rancour DM, 2002, PLANT PHYSIOL, V130, P1241, DOI 10.1104/pp.011742; Rienties IM, 2005, PLANTA, V221, P394, DOI 10.1007/s00425-004-1447-7; Rockel B, 2002, J MOL BIOL, V317, P673, DOI 10.1006/jmbi.2002.5448; Romisch K, 2006, TRENDS BIOCHEM SCI, V31, P24, DOI 10.1016/j.tibs.2005.11.004; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Roy L, 2000, MOL BIOL CELL, V11, P2529, DOI 10.1091/mbc.11.8.2529; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	43	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5217	5224		10.1074/jbc.M609042200	http://dx.doi.org/10.1074/jbc.M609042200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17190830	hybrid			2022-12-27	WOS:000244482300016
J	Du, JX; Yun, CC; Bialkowska, A; Yang, VW				Du, James X.; Yun, C. Chris; Bialkowska, Agnieszka; Yang, Vincent W.			Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Kruppel-like factor 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; RNA-POLYMERASE-II; INTERCHROMATIN GRANULE CLUSTERS; INTESTINAL EPITHELIAL-CELLS; TATA-BINDING PROTEIN; CELLULAR PROLIFERATION; DEOXYCYTIDINE KINASE; RIBONUCLEOPROTEIN F; SUMO-1 MODIFICATION; GENE-ACTIVATION	Kruppel-like factor 5 (KLF5) is a zinc finger-containing transcription factor that regulates proliferation of various cell types, including fibroblasts, smooth muscle cells, and intestinal epithelial cells. To identify proteins that interact with KLF5, we performed a yeast two-hybrid screen of a 17-day mouse embryo cDNA library with KLF5 as bait. The screen revealed 21 preys clustered in four groups as follows: proteins mediating gene expression, metabolism, trafficking, and signaling. Among them was protein inhibitor of activated STAT1(PIAS1), a small ubiquitin-like modifier (SUMO) ligase that regulates transcription factors through SUMOylation or physical interaction. Association between PIAS1 and KLF5 was verified by co-immunoprecipitation. Structural determination showed that the acidic domain of PIAS1 bound to both the amino- and carboxyl-terminal regions of KLF5 and that this interaction was inhibited by the amino terminus of PIAS1. Indirect immunofluorescence demonstrated that PIAS1 and KLF5 co-localized to the nucleus. Furthermore, the PIAS1-KLF5 complex was co-localized with the TATA-binding protein and was enriched in RNA polymerase II foci. Transient transfection of COS-7 cells by PIAS1 and KLF5 significantly increased the steady-state protein levels of each other. Luciferase reporter and chromatin immunoprecipitation assays showed that PIAS1 significantly activated the promoters of KLFS and PIAS1 and synergistically increased the transcriptional activity of KLF5 in activating the cyclin D1 and Cdc2 promoters. Importantly, PIAS1 increased the ability of KLF5 to enhance cell proliferation in transfected cells. These results indicate that PIAS1 is a functional partner of KLF5 and enhances the ability of KLF5 to promote proliferation.	Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Hematol & Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA.	vyang@emory.edu			NCI NIH HHS [R01 CA084197-07, R01 CA084197, R01 CA084197-08, CA84197, R01 CA084197-09] Funding Source: Medline; NIDDK NIH HHS [R01 DK052230-11, R01 DK071597-01A2, R01 DK052230, R01 DK061418, R24 DK064399-03, R01 DK052230-09, R24 DK064399, R24 DK064399-04, R01 DK071597-02, R24 DK064399-05, DK64399, R01 DK071597, R01 DK061418-05, DK52230, R01 DK052230-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052230, R01DK071597, R24DK064399, R01DK061418] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Antoine M, 2005, BIOCHEM BIOPH RES CO, V335, P146, DOI 10.1016/j.bbrc.2005.07.069; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Cromphout K, 2005, EUR J NEUROSCI, V22, P991, DOI 10.1111/j.1460-9568.2005.04266.x; Damen G, 2004, J PEDIATR GASTR NUTR, V38, P282, DOI 10.1097/00005176-200403000-00010; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; ERIKSSON S, 1991, FEBS LETT, V280, P363, DOI 10.1016/0014-5793(91)80332-W; Ferrier V, 2002, NAT CELL BIOL, V4, pE57, DOI 10.1038/ncb0302-e57; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Gamachi A, 2003, MODERN PATHOL, V16, P1124, DOI 10.1097/01.MP.0000092953.20717.48; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Handwerger KE, 2003, J CELL BIOL, V160, P495, DOI 10.1083/jcb.200212024; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hatzis P, 1998, J BIOL CHEM, V273, P30239, DOI 10.1074/jbc.273.46.30239; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Iborra FJ, 1996, J CELL SCI, V109, P1427; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Lee YS, 2005, EMBO REP, V6, P949, DOI 10.1038/sj.embor.7400511; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Mintz PJ, 2000, J STRUCT BIOL, V129, P241, DOI 10.1006/jsbi.2000.4213; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Morikawa Y, 1998, BLOOD, V92, P129, DOI 10.1182/blood.V92.1.129.413k07_129_135; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Nogami S, 2003, GENES CELLS, V8, P17, DOI 10.1046/j.1365-2443.2003.00612.x; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Prigge JR, 2006, J BIOL CHEM, V281, P12260, DOI 10.1074/jbc.M510835200; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Silins G, 1998, BIOCHEM BIOPH RES CO, V243, P273, DOI 10.1006/bbrc.1997.8091; Smith RK, 2002, DEVELOPMENT, V129, P71; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Watt AJ, 2001, MECH DEVELOP, V100, P205, DOI 10.1016/S0925-4773(00)00530-X; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yoshida T, 1999, GENES CELLS, V4, P707, DOI 10.1046/j.1365-2443.1999.00295.x; Yoshida T, 1999, FEBS LETT, V457, P251, DOI 10.1016/S0014-5793(99)01048-0; Yu VWC, 2006, ANN NY ACAD SCI, V1068, P131, DOI 10.1196/annals.1346.027; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; Zhang QB, 2005, GENE, V348, P25, DOI 10.1016/j.gene.2004.12.050	85	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4782	4793		10.1074/jbc.M603413200	http://dx.doi.org/10.1074/jbc.M603413200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178721	hybrid, Green Accepted			2022-12-27	WOS:000244482000060
J	Koide, K; Maegawa, S; Ito, K; Akiyama, Y				Koide, Kayo; Maegawa, Saki; Ito, Koreaki; Akiyama, Yoshinori			Environment of the active site region of RseP, an Escherichia coli regulated intramembrane proteolysis protease, assessed by site-directed cysteine alkylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-TETRACYCLINE/H+ ANTIPORTER; EXTRACYTOPLASMIC-STRESS-RESPONSE; GAMMA-SECRETASE COMPLEX; WATER-FILLED CHANNEL; ANTI-SIGMA FACTOR; PDZ DOMAIN; MEMBRANE; YAEL; CLEAVAGE; DEGRADATION	Regulated intramembrane proteolysis (RIP) plays crucial roles in both prokaryotic and eukaryotic organisms. Proteases for RIP cleave transmembrane regions of substrate membrane proteins. However, the molecular mechanisms for the proteolysis of membrane-embedded transmembrane sequences are largely unknown. Here we studied the environment surrounding the active site region of RseP, an Escherichia coli S2P ortholog involved in the sigma(E) pathway of extracytoplasmic stress responses. RseP has two presumed active site motifs, HEXXH and LDG, located in membrane-cytoplasm boundary regions. We examined the reactivity of cysteine residues introduced within or in the vicinity of these two active site motifs with membrane-impermeable thiol-alkylating reagents under various conditions. The active site positions were inaccessible to the reagents in the native state, but many of them became partially modifiable in the presence of a chaotrope, while requiring simultaneous addition of a chaotrope and a detergent for full modification. These results suggest that the active site of RseP is not totally embedded in the lipid phase but located within a proteinaceous structure that is partially exposed to the aqueous milieu.	Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Kyoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	yakiyama@virus.kyoto-u.ac.jp						AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Bohn C, 2004, MOL MICROBIOL, V52, P427, DOI 10.1111/j.1365-2958.2004.03985.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Davis R., 1980, ADV BACTERIAL GENETI; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kanehara K, 2003, EMBO J, V22, P6389, DOI 10.1093/emboj/cdg602; Kanehara K, 2001, GENE, V281, P71, DOI 10.1016/S0378-1119(01)00823-X; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kimura T, 1997, J BIOL CHEM, V272, P580; Kimura-Someya T, 1998, J BIOL CHEM, V273, P32806, DOI 10.1074/jbc.273.49.32806; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; Matson JS, 2005, P NATL ACAD SCI USA, V102, P16403, DOI 10.1073/pnas.0505818102; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	41	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4553	4560		10.1074/jbc.M607339200	http://dx.doi.org/10.1074/jbc.M607339200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179147	hybrid			2022-12-27	WOS:000244482000037
J	Lenburg, ME; Sinha, A; Faller, DV; Denis, GV				Lenburg, Marc E.; Sinha, Anupama; Faller, Douglas V.; Denis, Gerald V.			Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CREB BINDING-PROTEIN; HISTONE ACETYLTRANSFERASE; DROSOPHILA-MELANOGASTER; BROMODOMAIN PROTEIN; CYCLIN-A; TRITHORAX; TRANSLOCATION; TRANSCRIPTION; CHROMOSOME	The dual bromodomain protein Brd2 is closely related to the basal transcription factor TAF(II)250, which is essential for cyclin A transactivation and mammalian cell cycle progression. In transgenic mice, constitutive lymphoid expression of Brd2 causes a malignancy most similar to human diffuse large B cell lymphoma. We compare the genome-wide transcriptional expression profiles of these lymphomas with those of proliferating and resting normal B cells. Transgenic tumors reproducibly show differential expression of a large number of genes important for cell cycle control and lymphocyte biology; expression patterns are either tumor-specific or proliferation-specific. Several of their human orthologs have been implicated in human lymphomagenesis. Others correlate with human disease survival time. BRD2 is underexpressed in some subtypes of human lymphoma and these subtypes display a number of similarities to the BRD2-mediated murine tumors. We illustrate with a high degree of detail that cancer is more than rampant cellular proliferation, but involves the additional transcriptional mobilization of many genes, some of them poorly characterized, which show a tumor-specific pattern of gene expression.	Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA	Boston University; Boston University	Denis, GV (corresponding author), Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA.	gdenis@bu.edu	Lenburg, Marc/B-8027-2008	Lenburg, Marc/0000-0002-5760-4708; Denis, Gerald/0000-0001-9886-0401	NATIONAL CANCER INSTITUTE [R29CA075107, R03CA102889, R03CA128006] Funding Source: NIH RePORTER; NCI NIH HHS [R03 CA102889-01A1, R03 CA128006-02, CA102889, R03 CA102889-02, R03 CA102889, R03 CA128006, CA75107, R29 CA075107-04, R03 CA128006-01, R29 CA075107, R29 CA075107-05, R29 CA075107-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Beck S, 1992, DNA Seq, V2, P203, DOI 10.3109/10425179209020804; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Denis GV, 2001, FRONT BIOSCI, V6, pD1065; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; FORQUIGNON F, 1981, ROUX ARCH DEV BIOL, V190, P132, DOI 10.1007/BF00867798; French CA, 2003, CANCER RES, V63, P304; GANS M, 1980, GENETICS, V96, P887; Godwin JE, 2001, CLIN LYMPHOMA, V2, P155, DOI 10.3816/CLM.2001.n.021; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hennessy BT, 2004, LANCET ONCOL, V5, P341, DOI 10.1016/S1470-2045(04)01490-1; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horn PJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD1019, DOI 10.2741/Horn; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Lavau C, 2000, EMBO J, V19, P4655, DOI 10.1093/emboj/19.17.4655; Liedman D, 2001, CURR OPIN HEMATOL, V8, P218, DOI 10.1097/00062752-200107000-00007; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; MOZER BA, 1989, P NATL ACAD SCI USA, V86, P3738, DOI 10.1073/pnas.86.10.3738; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Wang EH, 1997, GENE DEV, V11, P2658, DOI 10.1101/gad.11.20.2658; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	38	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4803	4811		10.1074/jbc.M605870200	http://dx.doi.org/10.1074/jbc.M605870200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166848	Green Accepted, hybrid			2022-12-27	WOS:000244482000062
J	Bouly, JP; Schleicher, E; Dionisio-Sese, M; Vandenbussche, F; Van Der Straeten, D; Bakrim, N; Meier, S; Batschauer, A; Galland, P; Bittl, R; Ahmad, M				Bouly, Jean-Pierre; Schleicher, Erik; Dionisio-Sese, Maribel; Vandenbussche, Fillip; Van Der Straeten, Dominique; Bakrim, Nadia; Meier, Stefan; Batschauer, Alfred; Galland, Paul; Bittl, Robert; Ahmad, Margaret			Cryptochrome blue light photoreceptors are activated through interconversion of flavin redox states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAPROTEIN ELECTRON-TRANSFER; DNA PHOTOLYASE; ARABIDOPSIS CRYPTOCHROMES; ESCHERICHIA-COLI; HYPOCOTYL GROWTH; UV-A; INHIBITION; MECHANISM; PHYCOMYCES; ELONGATION	Cryptochromes are blue light-sensing photoreceptors found in Plants, animals, and humans. They are known to play key roles in the regulation of the circadian clock and in development. However, despite striking structural similarities to photolyase DNA repair enzymes, cryptochromes do not repair double-stranded DNA, and their mechanism of action is unknown. Recently, a blue light-dependent intramolecular electron transfer to the excited state flavin was characterized and proposed as the primary mechanism of light activation. The resulting formation of a stable neutral flavin semiquinone intermediate enables the photoreceptor to absorb green/yellow light (500 - 630 nm) in addition to blue light in vitro. Here, we demonstrate that Arabidopsis cryptochrome activation by blue light can be inhibited by green light in vivo consistent with a change of the cofactor redox state. We further characterize light-dependent changes in the cryptochromel (cry1) protein in living cells, which match photoreduction of the purified cryl in vitro. These experiments were performed using fluorescence absorption/emission and EPR on whole cells and thereby represent one of the few examples of the active state of a known photoreceptor being monitored in vivo. These results indicate that cryl activation via blue light initiates formation of a flavosemiquinone signaling state that can be converted by green light to an inactive form. In summary, cryptochrome activation via flavin photoreduction is a reversible mechanism novel to blue light photoreceptors. This photocycle may have adaptive significance for sensing the quality of the light environment in multiple organisms.	Univ Paris 06, FRE 2846, CNRS, F-75005 Paris, France; Univ Philippines, Los Banos Coll, Coll Arts & Sci, Inst Biol Sci, Laguna 4031, Philippines; Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; Univ Marburg, FB Biol Pflanzenphysiol, D-35032 Marburg, Germany; Univ Ghent, Unit Plant Hormone Signaling & Bioimaging, Dept Mol Genet, B-9000 Ghent, Belgium; Penn State Univ, Media, PA 19063 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of the Philippines System; University of the Philippines Los Banos; Free University of Berlin; Philipps University Marburg; Ghent University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Ahmad, M (corresponding author), Univ Paris 06, FRE 2846, CNRS, Casier 156,4 Pl Jussieu, F-75005 Paris, France.	ahmad@ccr.jussieu.fr	Bittl, Robert/I-8149-2013; Van Der Straeten, Dominique/E-7385-2016; Schleicher, Erik/C-9951-2010	Bittl, Robert/0000-0003-4103-3768; Van Der Straeten, Dominique/0000-0002-7755-1420; Ahmad, Margaret/0000-0003-4524-5813; Schleicher, Erik/0000-0003-2953-050X; Dionisio-Sese, Maribel/0000-0003-0954-0954				AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Ahmad M, 2002, PLANT PHYSIOL, V129, P774, DOI 10.1104/pp.010969; Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; AHMAD M, 2006, PLANTA, V224, P995; Banerjee R, 2005, PLANTA, V220, P498, DOI 10.1007/s00425-004-1418-z; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs W. R., 2006, PHOTOMORPHOGENESIS P, P171; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Byrdin M, 2004, BBA-BIOENERGETICS, V1655, P64, DOI 10.1016/j.bbabio.2003.07.001; Carell T, 2001, CURR OPIN CHEM BIOL, V5, P491, DOI 10.1016/S1367-5931(00)00239-8; Folta KM, 2004, PLANT PHYSIOL, V135, P1407, DOI 10.1104/pp.104.038893; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Frechilla S, 2000, PLANT CELL PHYSIOL, V41, P171, DOI 10.1093/pcp/41.2.171; Galland P, 2003, PLANTA, V217, P971, DOI 10.1007/s00425-003-1068-6; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; GOTO N, 1993, PHOTOCHEM PHOTOBIOL, V57, P867, DOI 10.1111/j.1751-1097.1993.tb09226.x; Green CB, 2004, CURR BIOL, V14, pR847, DOI 10.1016/j.cub.2004.09.040; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Kleiner O, 1999, EUR J BIOCHEM, V264, P161, DOI 10.1046/j.1432-1327.1999.00590.x; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; LI QH, 2006, IN PRESS PHOTOCHEM P; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; NEUMANN D, 1993, PLANTA, V190, P32, DOI 10.1007/BF00195672; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Saxena C, 2005, J AM CHEM SOC, V127, P7984, DOI 10.1021/ja0421607; Schmidt W, 1999, PLANTA, V208, P274, DOI 10.1007/s004250050559; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Van Gelder RN, 2002, J BIOL RHYTHM, V17, P110, DOI 10.1177/074873002129002401; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; YOUNG JC, 1992, PLANTA, V188, P106, DOI 10.1007/BF00198946; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	48	322	334	3	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9383	9391		10.1074/jbc.M609842200	http://dx.doi.org/10.1074/jbc.M609842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17237227	hybrid			2022-12-27	WOS:000245421700010
J	Coyne, HJ; Ciofi-Baffoni, S; Banci, L; Bertini, I; Zhang, LM; George, GN; Winge, DR				Coyne, H. Jerome, III; Ciofi-Baffoni, Simone; Banci, Lucia; Bertini, Ivano; Zhang, Limei; George, Graham N.; Winge, Dennis R.			The characterization and role of zinc binding in yeast Cox4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MOLECULAR-DYNAMICS SIMULATIONS; NMR STRUCTURE DETERMINATION; PROTON-TRANSFER; IDENTIFICATION; MITOCHONDRIA; SITE	Yeast Cox4 is a zinc binding subunit of cytochrome c oxidase. Cox4 is the only cofactor-containing subunit that is not directly part of the catalytic core of the enzyme located in the mitochondrial inner membrane. The Zn(II) site is shown to be distinct from the bovine ortholog, as it results from the x-ray structure of the entire cytochrome c oxidase in having a single histidyl residue and three conserved cysteines residues in the coordination sphere. Substitutions at the Cys ligand positions result in nonfunctional Cox4 proteins that fail to lead to cytochrome oxidase assembly. Limited function exists in His-119 mutants when overexpressed. Zn(II) binding in Cox4 is, therefore, important for the stability of the complex. The solution structure of yeast Cox4 elucidated by multidimensional NMR reveals a C-terminal globular domain consisting of two beta sheets analogous to the bovine ortholog except the loop containing the coordinating His in the yeast protein and the fourth Cys in the bovine protein are in different positions in the two structures. The conformation of this loop is dictated by the different sequence position of the fourth coordinating zinc ligand. The Zn(II) ion is buried within the domain, consistent with its role in structural stability. Potential functions of this matrix-facing subunit are discussed.	Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Florence, Ctr Risonanze Magnet, I-50019 Florence, Italy; Univ Saskatchewan, Saskatoon, SK S7N 5E2, Canada	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Florence; University of Saskatchewan	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Ciofi-Baffoni, Simone/AAH-9778-2021; George, Graham N/E-3290-2013; Winge, Dennis/G-3611-2010	Ciofi Baffoni, Simone/0000-0002-2376-3321; George, Graham/0000-0002-0420-7493; BANCI, LUCIA/0000-0003-0562-5774	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057375] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES03817] Funding Source: Medline; NIGMS NIH HHS [GM57375] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard A, 2002, BBA-BIOENERGETICS, V1555, P133, DOI 10.1016/S0005-2728(02)00268-2; Banci L, 2003, CURR OPIN CHEM BIOL, V7, P143, DOI 10.1016/S1367-5931(02)00014-5; Banci L, 2002, J MOL BIOL, V323, P883, DOI 10.1016/S0022-2836(02)01007-0; Beauvoit B, 1999, EUR J BIOCHEM, V263, P118, DOI 10.1046/j.1432-1327.1999.00475.x; BERTINI I, 1984, ADV INORGANIC BIOCH; BISSON R, 1987, J BIOL CHEM, V262, P5992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHEN YL, 1995, BIOCHEMISTRY-US, V34, P12265, DOI 10.1021/bi00038a022; COLEMAN JE, 1993, METHOD ENZYMOL, V227, P16; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gilderson G, 2003, BIOCHEMISTRY-US, V42, P7400, DOI 10.1021/bi0341298; Glerum DM, 1997, FEBS LETT, V412, P410, DOI 10.1016/S0014-5793(97)00799-0; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; MARET W, 1993, METHOD ENZYMOL, V226, P52; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; REHR JJ, 1992, PHYS REV LETT, V69, P3397, DOI 10.1103/PhysRevLett.69.3397; Suarez D, 2001, J AM CHEM SOC, V123, P3759, DOI 10.1021/ja003796a; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yoshikawa S, 2002, ADV PROTEIN CHEM, V60, P341; Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9	36	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8926	8934		10.1074/jbc.M610303200	http://dx.doi.org/10.1074/jbc.M610303200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17215247	hybrid			2022-12-27	WOS:000245780300039
J	Roumy, M; Lorenzo, C; Mazeres, S; Bouchet, S; Zajac, JM; Mollereau, C				Roumy, Michel; Lorenzo, Corinne; Mazeres, Serge; Bouchet, Stephanie; Zajac, Jean-Marie; Mollereau, Catherine			Physical association between neuropeptide FF and mu-opioid receptors as a possible molecular basis for anti-opioid activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA SH-SY5Y; PROTEIN-COUPLED RECEPTOR; RAT DORSAL RAPHE; CHEMOKINE RECEPTORS; PEPTIDE RECEPTORS; FRAP EXPERIMENTS; NPFF2 RECEPTOR; HETERODIMERIZATION; MEMBRANE; DELTA	Neuropeptide FF (NPFF) modulates the opioid system by exerting functional anti-opioid activity on neurons, the mechanism of which is unknown. By using a model of SH-SY5Y cells, we recently postulated that anti-opioid activity likely takes place upstream from the signaling cascade, suggesting that NPFF receptors could block opioid receptors by physical interaction. In the present study, fluorescence techniques were used to monitor the physical association and the dynamic of NPFF, and mu-opioid (MOP) receptors tagged with variants of the green fluorescent protein. Importantly, cyan fluorescent protein-tagged NPFF, receptors retained their capacity to antagonize opioid receptors. Fluorescence resonance energy transfer (FRET) and coimmunoprecipitation studies indicate that NPFF and MOP receptors are close enough to generate a basal FRET signal. The opioid agonist Tyr-D-Ala-Gly-NMe-Phe-Gly-ol disrupts by 20-30% this FRET signal, mainly because it concomitantly induces 40% internalization of receptors. In contrast, the NPFF analog IDMe significantly increases by 10-15% the basal FRET signal, suggesting an association between both receptors. In addition, IDMe reduces, by half, MOP receptor internalization, indicating that, besides a functional blockade of opioid receptors, the NPFF analog also inhibits their internalization. Finally, as a first report showing the modulation of the mobility of a G-protein-coupled receptor by another one, fluorescence recovery after photobleaching analysis reveals that IDMe modifies the lateral diffusion of MOP receptors in the cell membrane, changing them from a confined to a freely diffusing state. By promoting NPFF-MOP receptor heteromerization, IDMe could disrupt the domain organization of MOP receptors in the membrane, resulting in a reduction of opioid response.	CNRS, UMR 5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse 04, France; CNRS, UMR 5088, Lab Biol Cellulaire & Mol Controle Proliferat, F-31062 Toulouse 09, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Mollereau, C (corresponding author), CNRS, UMR 5089, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse 04, France.	catherine.mollereau-manaute@ipbs.fr	Zajac, jean-marie/E-5129-2010	Mollereau, Catherine/0000-0003-1543-5624				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200; Butour JL, 2004, BIOCHEM BIOPH RES CO, V325, P915, DOI 10.1016/j.bbrc.2004.10.125; CESSELIN F, 1995, FUND CLIN PHARMACOL, V9, P409, DOI 10.1111/j.1472-8206.1995.tb00517.x; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gouarderes C, 2002, NEUROSCIENCE, V115, P349, DOI 10.1016/S0306-4522(02)00419-0; Gregan B, 2004, J BIOL CHEM, V279, P27679, DOI 10.1074/jbc.M403601200; Gupta A, 2006, AAPS J, V8, pE153, DOI 10.1208/aapsj080118; Harrison LM, 1998, PEPTIDES, V19, P1603, DOI 10.1016/S0196-9781(98)00126-0; Horvat RD, 1999, BIOCHEM BIOPH RES CO, V255, P382, DOI 10.1006/bbrc.1999.0185; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; JOHANSSON B, 1993, J CELL BIOL, V121, P1281, DOI 10.1083/jcb.121.6.1281; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kersante F, 2006, PEPTIDES, V27, P980, DOI 10.1016/j.peptides.2005.07.025; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Marshall F H, 2001, Curr Opin Pharmacol, V1, P40, DOI 10.1016/S1471-4892(01)00001-7; Mauborgne A, 2001, EUR J PHARMACOL, V430, P273, DOI 10.1016/S0014-2999(01)01384-X; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; ROTHMAN RB, 1992, SYNAPSE, V12, P129, DOI 10.1002/syn.890120206; Roumy M, 1999, BRAIN RES, V845, P208, DOI 10.1016/S0006-8993(99)01965-4; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Roumy M, 2003, NEUROSCI LETT, V348, P159, DOI 10.1016/S0304-3940(03)00791-2; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Scott L, 2006, P NATL ACAD SCI USA, V103, P762, DOI 10.1073/pnas.0505557103; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Strock J, 2004, MOL PHARMACOL, V66, P1071, DOI 10.1124/mol.104.002261; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Takeuchi T, 2001, JPN J PHARMACOL, V86, P417, DOI 10.1254/jjp.86.417; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Toselli M, 1997, PFLUG ARCH EUR J PHY, V433, P587, DOI 10.1007/s004240050318; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Wang HL, 2005, J NEUROCHEM, V92, P1285, DOI 10.1111/j.1471-4159.2004.02921.x; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zajac JM, 2006, PEPTIDES, V27, P941, DOI 10.1016/j.peptides.2005.12.005; Zajac JM, 2001, TRENDS PHARMACOL SCI, V22, P63, DOI 10.1016/S0165-6147(00)01610-2; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005	64	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8332	8342		10.1074/jbc.M606946200	http://dx.doi.org/10.1074/jbc.M606946200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224450	hybrid			2022-12-27	WOS:000245081000067
J	Tullman-Ercek, D; DeLisa, MP; Kawarasaki, Y; Iranpour, P; Ribnicky, B; Palmer, T; Georgiou, G				Tullman-Ercek, Danielle; DeLisa, Matthew P.; Kawarasaki, Yasuaki; Iranpour, Pooya; Ribnicky, Brian; Palmer, Tracy; Georgiou, George			Export pathway selectivity of Escherichia coli twin arginine translocation signal peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSLOCATION; PERIPLASMIC PROTEIN; CYTOPLASMIC MEMBRANE; GENETIC-ANALYSIS; MATURE SEQUENCE; TAT PATHWAY; SPECIFICITY; SECRETION; REDUCTASE; RESIDUES	The Escherichia coli genome encodes at least 29 putative signal peptides containing a twin arginine motif characteristic of proteins exported via the twin arginine translocation (Tat) pathway. Fusions of the putative Tat signal peptides plus six to eight amino acids of the mature proteins to three reporter proteins (short-lived green fluorescent protein, maltose-binding protein (MBP), and alkaline phosphatase) and also data from the cell localization of epitope-tagged full-length proteins were employed to determine the ability of the 29 signal peptides to direct export through the Tat pathway, through the general secretory pathway (Sec), or through both. 27/29 putative signal peptides could export one or more reporter proteins through Tat. Of these, I I signal peptides displayed Tat specificity in that they could not direct the export of Sec-only reporter proteins. The rest (16/27) were promiscuous and were capable of directing export of the appropriate reporter either via Tat (green fluorescent protein, MBP) or via Sec (PhoA, MBP). Mutations that conferred a >=+1 charge to the N terminus of the mature protein abolished or drastically reduced routing through the Sec pathway without affecting the ability to export via the Tat pathway. These experiments demonstrate that the charge of the mature protein N terminus affects export promiscuity, independent of the effect of the folding state of the mature protein.	Univ Texas, Dept Chem, Austin, TX 78712 USA; Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA; Univ Texas, Inst Cell & Mol Biol, Austin, TX 78712 USA; Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Georgiou, G (corresponding author), Univ Texas, Dept Chem Engn, 1 Univ Stn C04000, Austin, TX 78712 USA.	gg@che.utexas.edu	Tullman-Ercek, Danielle/L-2792-2016; DeLisa, Matthew/AAE-7361-2019; Kawarasaki, Yasuaki/J-5910-2013	Kawarasaki, Yasuaki/0000-0002-7143-3159; Palmer, Tracy/0000-0001-9043-2592; DeLisa, Matthew/0000-0003-3226-1566	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069872] Funding Source: NIH RePORTER; MRC [G117/519] Funding Source: UKRI; Medical Research Council [G117/519] Funding Source: Medline; NIGMS NIH HHS [R01 GM069872, R01 GM069872-01A1, R0-01 GM069872] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON H, 1991, P NATL ACAD SCI USA, V88, P9751, DOI 10.1073/pnas.88.21.9751; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Blaudeck N, 2001, J BACTERIOL, V183, P604, DOI 10.1128/JB.183.2.604-610.2001; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Caldelari I, 2006, MOL PLANT MICROBE IN, V19, P200, DOI 10.1094/MPMI-19-0200; Chanal A, 2003, J MOL BIOL, V327, P563, DOI 10.1016/S0022-2836(03)00170-0; COLEMAN J, 1985, CELL, V43, P351, DOI 10.1016/0092-8674(85)90040-6; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; FISHER AC, 2006, PROTEIN SCI; GELLER B, 1993, J BIOL CHEM, V268, P9442; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gon S, 2000, J BACTERIOL, V182, P5779, DOI 10.1128/JB.182.20.5779-5786.2000; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ize B, 2004, J BIOL CHEM, V279, P47543, DOI 10.1074/jbc.M406910200; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kajava AV, 2000, J BACTERIOL, V182, P2163, DOI 10.1128/JB.182.8.2163-2169.2000; Kebir MO, 2002, BIOCHEMISTRY-US, V41, P5573, DOI 10.1021/bi015798t; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lequette Y, 2004, J BACTERIOL, V186, P3695, DOI 10.1128/JB.186.12.3695-3702.2004; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sambasivarao D, 2000, J BIOL CHEM, V275, P22526, DOI 10.1074/jbc.M909289199; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stanley NR, 2002, MOL MICROBIOL, V43, P1005, DOI 10.1046/j.1365-2958.2002.02797.x; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas G, 1999, FEMS MICROBIOL LETT, V174, P167, DOI 10.1111/j.1574-6968.1999.tb13564.x; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; YAMANE K, 1988, J BIOL CHEM, V263, P19690	47	100	134	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8309	8316		10.1074/jbc.M610507200	http://dx.doi.org/10.1074/jbc.M610507200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17218314	Green Accepted, hybrid			2022-12-27	WOS:000245081000064
J	Wyatt, CN; Mustard, KJ; Pearson, SA; Dallas, ML; Atkinson, L; Kumar, P; Peers, C; Hardie, DG; Evans, AM				Wyatt, Christopher N.; Mustard, Kirsty J.; Pearson, Selina A.; Dallas, Mark L.; Atkinson, Lucy; Kumar, Prem; Peers, Chris; Hardie, D. Grahame; Evans, A. Mark			AMP-activated protein kinase mediates carotid body excitation by hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; I CELLS; LARGE-CONDUCTANCE; POTASSIUM CHANNEL; K+ CURRENTS; ADENOSINE; CHEMORECEPTORS; IDENTIFICATION; SENSITIVITY; INHIBITION	Early detection of an O-2 deficit in the bloodstream is essential to initiate corrective changes in the breathing pattern of mammals. Carotid bodies serve an essential role in this respect; their type I cells depolarize when O-2 levels fall, causing voltage-gated Ca2+ entry. Subsequent neurosecretion elicits increased afferent chemosensory fiber discharge to induce appropriate changes in respiratory function (1). Although depolarization of type I cells by hypoxia is known to arise from K+ channel inhibition, the identity of the signaling pathway has been contested, and the coupling mechanism is unknown (2). We tested the hypothesis that AMP-activated protein kinase (AMPK) is the effector of hypoxic chemotransduction. AMPK is co-localized at the plasma membrane of type I cells with O-2-sensitive K+ channels. In isolated type I cells, activation of AMPK using 5-aminoimidazole-4-carboxamide riboside (AICAR) inhibited O-2-sensitive K+ currents (carried by large conductance Ca2+-activated (BKCa) channels and TASK (tandem pore, acid-sensing potassium channel)-like channels, leading to plasma membrane depolarization, Ca2+ influx, and increased chemosensory fiber discharge. Conversely, the AMPK antagonist compound C reversed the effects of hypoxia and AICAR on type I cell and carotid body activation. These results suggest that AMPK activation is both sufficient and necessary for the effects of hypoxia. Furthermore, AMPK activation inhibited currents carried by recombinant BKCa channels, whereas purified AMPK phosphorylated the a subunit of the channel in immunoprecipitates, an effect that was stimulated by AMP and inhibited by compound C. Our findings demonstrate a central role for AMPK in stimulus-response coupling by hypoxia and identify for the first time a link between metabolic stress and ion channel regulation in an O-2-sensing system.	Univ St Andrews, Div Biomed Sci, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; Univ Dundee, Div Mol Physiol, Coll Life Sci, Sir James Black Ctr, Dundee DD1 5EH, Scotland; Univ Birmingham, Sch Med, Dept Physiol, Birmingham B15 2TT, W Midlands, England; Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England	University of St Andrews; University of Dundee; University of Birmingham; University of Leeds	Evans, AM (corresponding author), Univ St Andrews, Div Biomed Sci, Sch Biol, Bute Bldg, St Andrews KY16 9TS, Fife, Scotland.	ame3@st-andrews.ac.uk	Dallas, Mark L/A-6654-2013; Hardie, David/Z-1979-2019; Dallas, Mark/Q-6117-2019	Dallas, Mark/0000-0002-5190-0522; Hardie, Grahame/0000-0002-8373-7379; Kumar, Prem/0000-0001-7524-6046; Peers, Chris/0000-0002-8354-346X	Wellcome Trust [070772] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; Conde SV, 2006, ADV EXP MED BIOL, V580, P179, DOI 10.1007/0-387-31311-7_27; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Donnelly DF, 1999, RESP PHYSIOL, V115, P151, DOI 10.1016/S0034-5687(99)00021-3; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hartness ME, 2003, J BIOL CHEM, V278, P51422, DOI 10.1074/jbc.M309463200; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; McCartney CE, 2005, P NATL ACAD SCI USA, V102, P17870, DOI 10.1073/pnas.0505270102; PEPPER DR, 1995, J PHYSIOL-LONDON, V485, P531, DOI 10.1113/jphysiol.1995.sp020749; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prabhakar NR, 2006, EXP PHYSIOL, V91, P17, DOI 10.1113/expphysiol.2005.031922; Vandier C, 1999, J PHYSIOL-LONDON, V515, P419, DOI 10.1111/j.1469-7793.1999.419ac.x; VOELKEL NF, 1986, AM REV RESPIR DIS, V133, P1186; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wyatt CN, 2006, ADV EXP MED BIOL, V580, P191, DOI 10.1007/0-387-31311-7_29; Wyatt CN, 2004, J PHYSIOL-LONDON, V556, P175, DOI 10.1113/jphysiol.2003.058131; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	35	118	120	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8092	8098		10.1074/jbc.M608742200	http://dx.doi.org/10.1074/jbc.M608742200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17179156	Green Accepted, hybrid			2022-12-27	WOS:000245081000041
J	Yamada, Y; Suzuki, NN; Hanada, T; Ichimura, Y; Kumeta, H; Fujioka, Y; Ohsumi, Y; Inagaki, F				Yamada, Yuya; Suzuki, Nobuo N.; Hanada, Takao; Ichimura, Yoshinobu; Kumeta, Hiroyuki; Fujioka, Yuko; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			The crystal structure of Atg3, an autophagy-related ubiquitin carrier protein (E2) enzyme that mediates Atg8 lipidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; CONJUGATING ENZYMES; SYSTEM; DOMAIN; CELLS; MICE	Atg3 is an E2-like enzyme that catalyzes the conjugation of Atg8 and phosphatidylethanolamine (PE). The Atg8-PE conjugate is essential for autophagy, which is the bulk degradation process of cytoplasmic components by the vacuolar/lysosomal system. We report here the crystal structure of Saccharomyces cerevisiae Atg3 at 2.5-angstrom resolution. Atg3 has an alpha/beta-fold, and its core region is topologically similar to canonical E2 enzymes. Atg3 has two regions inserted in the core region, one of which consists of similar to 80 residues and has a random coil structure in solution and another with a long a-helical structure that protrudes from the core region as far as 30 angstrom. In vivo and in vitro analyses suggested that the former region is responsible for binding Atg7, an E1-like enzyme, and that the latter is responsible for binding Atg8. A sulfate ion was bound near the catalytic cysteine of Atg3, suggesting a possible binding site for the phosphate moiety of PE. The structure of Atg3 provides a molecular basis for understanding the unique lipidation reaction that Atg3 carries out.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Natl Inst Basic Biol, Div Mol Cell Biol, Okazaki, Aichi 4448585, Japan	Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Fujioka, Yuko/0000-0002-6905-0669; Kumeta, Hiroyuki/0000-0003-3713-2122; Hanada, Takao/0000-0003-2732-4008; Noda, Nobuo/0000-0002-6940-8069				Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; COOK WJ, 1992, J BIOL CHEM, V267, P15116; COOK WJ, 1993, BIOCHEMISTRY-US, V32, P13809, DOI 10.1021/bi00213a009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Goddard T. D., SPARKY 3; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yamada Y, 2006, ACTA CRYSTALLOGR F, V62, P1016, DOI 10.1107/S1744309106036098	35	101	106	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8036	8043		10.1074/jbc.M611473200	http://dx.doi.org/10.1074/jbc.M611473200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227760	hybrid			2022-12-27	WOS:000245081000035
J	Gonzalez-Cabrera, PJ; Hla, T; Rosen, H				Gonzalez-Cabrera, Pedro J.; Hla, Timothy; Rosen, Hugh			Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AGONIST-PROMOTED UBIQUITINATION; DOWN-REGULATION; LYMPHOCYTE EGRESS; BETA-ARRESTIN; DEGRADATION; TRAFFICKING; INVOLVEMENT; INHIBITION; DISEASES	Sphingosine 1-phosphate subtype 1 (S1P(1)) receptor agonists alter lymphocyte trafficking and endothelial barrier integrity in vivo. Among these is the potent, non-selective agonist, FTY720-P, whose mechanism of action has been suggested to correlate with S1P(1) down-regulation. Discovery of the in vivo active S1P(1)-selective agonist, SEW2871, has broadened our understanding of minimal requirements for S1P(1) function while highlighting differences regarding agonist effect on S1P(1) fate, because SEW2871 does not degrade S1P(1). To further understand the mechanism of agonist-induced S1P(1) down-regulation, we compared signaling and fate of human S1P(1)-green fluorescent protein (GFP) in stable 293 cells, using AFD-R, a chiral analog of FTY720-P, SEW2871, and S1P. Although all agonists acutely internalized S1P(1) to late endosomal vesicles and activated GTP gamma S-35 binding and PERK to similar maxima, only AFD-R led to significant S1P(1) down-regulation, as shown by GFP immunoprecipitation studies. Down-regulation was time- and concentration-dependent, was partially blocked by proteasomal inhibition and reversed by chloroquine and an antagonist to S1P(1). All agonists induced a receptor-associated increase in ubiquitination, with AFD-R inducing 3-fold more accumulation than S1P and being 3-4 logs more potent than SEW2871. The formation of AFD-R-receptor ubiquitin complex was inhibited by antagonist and chloroquine and was enhanced by proteasomal inhibition. Identification of proteins by PAGE liquid chromatography-tandem mass spectrometry in cells treated with AFD-R confirmed the co-migration of ubiquitin peptides with those of S1P(1) and GFP, relative to vehicle alone. These data suggest that the hierarchy of ubiquitin recruitment to SIP1 (AFD-R > S1P > SEW2871) correlates with the efficiency of lysosomal receptor degradation and reflects intrinsic differences between agonists.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA	Scripps Research Institute; University of Connecticut	Rosen, H (corresponding author), Scripps Res Inst, Dept Immunol, ICND 118,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hrosen@scripps.edu	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	NHLBI NIH HHS [HL70694] Funding Source: Medline; NIAID NIH HHS [R01 AI055509] Funding Source: Medline; NIMH NIH HHS [MH 074404] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alfonso C, 2006, EUR J IMMUNOL, V36, P149, DOI 10.1002/eji.200535127; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chun J, 2006, CURR PHARM DESIGN, V12, P161, DOI 10.2174/138161206775193109; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lemieux B, 2004, ANAL BIOCHEM, V327, P247, DOI 10.1016/j.ab.2004.01.010; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Luttrell Louis M., 2006, V332, P3; MacLennan AJ, 2006, HEARING RES, V220, P38, DOI 10.1016/j.heares.2006.06.016; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese Adriano, 2004, Methods Mol Biol, V259, P299; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Prossnitz ER, 2004, LIFE SCI, V75, P893, DOI 10.1016/j.lfs.2004.04.003; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Singer II, 2005, J IMMUNOL, V175, P7151, DOI 10.4049/jimmunol.175.11.7151; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Zaslavsky A, 2006, BBA-MOL CELL BIOL L, V1761, P1200, DOI 10.1016/j.bbalip.2006.08.011	32	68	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7254	7264		10.1074/jbc.M610581200	http://dx.doi.org/10.1074/jbc.M610581200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218309	hybrid			2022-12-27	WOS:000245080900037
J	Ouellet, H; Ranguelova, K; LaBarre, M; Wittenberg, JB; Wittenberg, BA; Magliozzo, RS; Guertin, M				Ouellet, Hugues; Ranguelova, Kalina; LaBarre, Marie; Wittenberg, Jonathan B.; Wittenberg, Beatrice A.; Magliozzo, Richard S.; Guertin, Michel			Reaction of Mycobacterium tuberculosis truncated hemoglobin O with hydrogen peroxide - Evidence for peroxidatic activity and formation of protein-based radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; ELECTRON-PARAMAGNETIC-RESONANCE; SPERM-WHALE MYOGLOBIN; NUCLEAR DOUBLE-RESONANCE; TYROSINE CROSS-LINK; HORSERADISH-PEROXIDASE; CATALASE-PEROXIDASE; CRYSTAL-STRUCTURE; COMPOUND-I; ASCORBATE PEROXIDASE	In this work, we investigated the reaction of ferric Mycobacterium tuberculosis truncated hemoglobin O (trHbO) with hydrogen peroxide. Stopped-flow spectrophotometric experiments under single turnover conditions showed that trHbO reacts with H,O, to give transient intermediate(s), among which is an oxyferryl heme, different from a typical peroxidase Compound I (oxyferryl heme pi-cation radical). EPR spectroscopy indicated evidence for both tryptophanyl and tyrosyl radicals, whereas redox titrations demonstrated that the peroxide-treated protein product retains 2 oxidizing eq. We propose that Compound I formed transiently is reduced with concomitant oxidation of Trp(G8) to give the detected oxoferryl heme and a radical on Trp(G8) (detected by EPR of the trHbO Tyr(CD1)Phe mutant). In the wild-type protein, the Trp(G8) radical is in turn reduced rapidly by Tyr(CD1). In a second cycle, Trp(G8) may be reoxidized by the ferryl heme to yield ferric heme and two protein radicals. In turn, these migrate to form tyrosyl radicals on Tyr(55) and Tyr(115), which lead, in the absence of a reducing substrate, to oligomerization of the protein. Steady-state kinetics in the presence of H2O2 and the one-electron donor 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) indicated that trHbO has peroxidase activity, in accord with the presence of typical peroxidase intermediates. These findings suggest an oxidation/reduction function for trHbO and, by analogy, for other Group II trHbs.	Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada; CUNY, Dept Chem, Brooklyn Coll, Brooklyn, NY 11210 USA; CUNY, Dept Chem, Grad Ctr, New York, NY 10016 USA; CUNY, Dept Biochem, Grad Ctr, New York, NY 10016 USA; Albert Einstein Coll Med, Dept Phys & Biophys, Bronx, NY 10461 USA	Laval University; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Guertin, M (corresponding author), Univ Laval, Dept Biochem & Microbiol, Pavillon Marchand,Room 3145, Quebec City, PQ G1K 7P4, Canada.	mguertin@bcm.ulaval.ca			NIAID NIH HHS [1-R01-AI052258, AI060014] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060014, R01AI052258, R56AI060014] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365; BLUMBERG WE, 1968, J BIOL CHEM, V243, P1854; Bravo J, 1997, PROTEIN SCI, V6, P1016, DOI 10.1002/pro.5560060507; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; Diaz A, 2004, J MOL BIOL, V342, P971, DOI 10.1016/j.jmb.2004.07.027; DUNFORD HB, 1999, HEME PEROXIDASES, P141; Egawa T, 2000, J BIOL CHEM, V275, P34858, DOI 10.1074/jbc.M004026200; Egawa T, 2003, J BIOL CHEM, V278, P41597, DOI 10.1074/jbc.M210383200; ERMAN JE, 1975, BIOCHIM BIOPHYS ACTA, V393, P350, DOI 10.1016/0005-2795(75)90061-6; ERMAN JE, 1975, BIOCHIM BIOPHYS ACTA, V393, P343, DOI 10.1016/0005-2795(75)90060-4; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; GOODWIN DC, 1995, ANAL BIOCHEM, V231, P333, DOI 10.1006/abio.1995.0059; Hara I, 2001, J BIOL CHEM, V276, P36067, DOI 10.1074/jbc.C100371200; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; Hiner ANP, 2002, J INORG BIOCHEM, V91, P27, DOI 10.1016/S0162-0134(02)00390-2; Hiner ANP, 2001, EUR J BIOCHEM, V268, P3091, DOI 10.1046/j.1432-1327.2001.02208.x; HOFFMAN BM, 1981, J BIOL CHEM, V256, P6556; Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; KEILIN D, 1951, BIOCHEM J, V49, P88, DOI 10.1042/bj0490088; KEILIN D, 1950, NATURE, V166, P513, DOI 10.1038/166513a0; LaCount MW, 2000, J BIOL CHEM, V275, P18712, DOI 10.1074/jbc.M001194200; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; Lardinois OM, 2003, J BIOL CHEM, V278, P36214, DOI 10.1074/jbc.M304726200; Lawrence A, 2003, J BIOL CHEM, V278, P29410, DOI 10.1074/jbc.M300054200; Lebioda L, 1999, NATURE, V401, P445, DOI 10.1038/46728; Liang ZX, 2004, J AM CHEM SOC, V126, P2785, DOI 10.1021/ja038163l; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; MOREAU S, 1995, BBA-PROTEIN STRUCT M, V1251, P17, DOI 10.1016/0167-4838(95)00087-B; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Nagano S, 1996, BIOCHEMISTRY-US, V35, P14251, DOI 10.1021/bi961740g; NOBLE RW, 1970, J BIOL CHEM, V245, P2409; Osborne RL, 2004, BIOCHEM BIOPH RES CO, V324, P1194, DOI 10.1016/j.bbrc.2004.09.174; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Ozaki S, 2001, BIOCHEMISTRY-US, V40, P1044, DOI 10.1021/bi001579g; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Pogni R, 2005, BIOCHEMISTRY-US, V44, P4267, DOI 10.1021/bi047474l; RAO SI, 1993, J BIOL CHEM, V268, P803; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Savenkova MI, 1996, J BIOL CHEM, V271, P24598, DOI 10.1074/jbc.271.40.24598; SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4; Shi WJ, 2000, BIOCHEMISTRY-US, V39, P4112, DOI 10.1021/bi992561c; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; SPIRO TG, 1988, BIOL APPLICATIONS RA, V3, P39; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; TEW D, 1988, J BIOL CHEM, V263, P17880; Tsaprailis G, 2003, J BIOL INORG CHEM, V8, P248, DOI 10.1007/s00775-002-0407-6; TschirretGuth RA, 1996, ARCH BIOCHEM BIOPHYS, V335, P93, DOI 10.1006/abbi.1996.0485; WITTENBE.BA, 1967, BIOCHEMISTRY-US, V6, P1970, DOI 10.1021/bi00859a013; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; YONETANI T, 1965, J BIOL CHEM, V240, P4509; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	64	41	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7491	7503		10.1074/jbc.M609155200	http://dx.doi.org/10.1074/jbc.M609155200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17218317	hybrid			2022-12-27	WOS:000245080900062
J	Huang, JH; Lu, L; Lu, H; Chen, X; Jiang, SB; Chen, YH				Huang, Jing-He; Lu, Lu; Lu, Hong; Chen, Xi; Jiang, Shibo; Chen, Ying-Hua			Identification of the HIV-1 gp41 core-binding motif in the scaffolding domain of caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 GP41; MONOCLONAL-ANTIBODY; 6-HELIX BUNDLES; LIPID RAFTS; VIRAL ENTRY; INHIBITION; SUBDOMAIN; PROTEINS; MULTIPLE; ACTIN	The human immunodeficiency virus, type I (HIV-1) gp41 core plays an important role in fusion between viral and target cell membranes. A single chain polypeptide, N36(L8)C34, which forms a six-helix bundle in physiological solution, can be used as a model of gp41 core. Here we identified from a 12-mer phage peptide library a positive phage clone displaying a peptide sequence with high binding activity to the HIV-I gp41 core. The peptide sequence contains a putative gp41-binding motif, Phi XXXX Phi X Phi (X is any amino acid residue, and Phi is any one of the aromatic amino acid residues Trp, Phe, or Tyr). This motif also exists in the scaffolding domain of caveolin-1 (Cav-1), a known gp41-binding protein. Cav-1-(61-101) and Cav-l-(82-101), two recombinant fusion proteins containing the Cav-1 scaffolding domain, bound significantly to the gp41 expressed in mammalian cells and interacted with the polypeptide N36(L8)C34. These results suggest that the scaffolding domain of Cav-1 may bind to the gp41 core via the motif. This interaction may be essential for formation of fusion pore or endocytosis of HIV-I and affect the pathogenesis of HIV-1 infection. Further characterization of the gp41 core-binding motifs may shed light on the alternative mechanism by which HIV-1 enters into the target cell.	New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10021 USA; Tsinghua Univ, Immunol Lab, Dept Biol, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China	New York Blood Center; Tsinghua University	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10021 USA.	sjiang@nybloodcenter.org; chenyh@mail.tsinghua.edu.cn	Huang, Jinghe/P-8068-2019; lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Jiang, Shibo/L-4500-2014; Lu, Lu/K-7070-2014; Huang, Jinghe/O-1986-2015; chen, ying/HHS-8254-2022	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391; Huang, Jinghe/0000-0002-1968-871X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046221, R01AI046221] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46221] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Becker KA, 1999, J CELL SCI, V112, P97; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Fermin C, 2005, MICROSC RES TECHNIQ, V68, P149, DOI 10.1002/jemt.20228; Galli T, 2001, Sci STKE, V2001, pre1; Hovanessian AG, 2004, IMMUNITY, V21, P617, DOI 10.1016/j.immuni.2004.08.015; Huang JH, 2006, FEBS LETT, V580, P4807, DOI 10.1016/j.febslet.2006.07.067; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-6; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SATTENTAU QJ, 1993, PHILOS T R SOC B, V342, P59, DOI 10.1098/rstb.1993.0136; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Shu W, 2000, J BIOL CHEM, V275, P1839, DOI 10.1074/jbc.275.3.1839; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Wang SL, 2002, BIOCHEMISTRY-US, V41, P7283, DOI 10.1021/bi025648y; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	34	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6143	6152		10.1074/jbc.M607701200	http://dx.doi.org/10.1074/jbc.M607701200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197700	hybrid			2022-12-27	WOS:000244867200020
J	Kim, HM; Oh, SC; Lim, KJ; Kasamatsu, J; Heo, JY; Park, BS; Lee, H; Yoo, OJ; Kasahara, M; Lee, JO				Kim, Ho Min; Oh, Se Cheol; Lim, Ki Jung; Kasamatsu, Jun; Heo, Jin Young; Park, Beom Seok; Lee, Hayyoung; Yoo, Ook Joon; Kasahara, Masanori; Lee, Jie-Oh			Structural diversity of the hagfish variable lymphocyte receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; PROTEIN BINDING-SITES; TOLL-LIKE RECEPTOR-3; RIBONUCLEASE INHIBITOR; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; PREDICTION; ECTODOMAIN; SCAFFOLDS; SEQUENCES	Variable lymphocyte receptors (VLRs) are recently discovered leucine-rich repeat (LRR) family proteins that mediate adaptive immune responses in jawless fish. Phylogenetically it is the oldest adaptive immune receptor and the first one with a non-immunoglobulin fold. We present the crystal structures of one VLR-A and two VLR-B clones from the inshore hagfish. The hagfish VLRs have the characteristic horseshoe-shaped structure of LRR family proteins. The backbone structures of their LRR modules are highly homologous, and the sequence variation is concentrated on the concave surface of the protein. The conservation of key residues suggests that our structures are likely to represent the LRR structures of the entire repertoire of jawless fish VLRs. The analysis of sequence variability, prediction of protein interaction surfaces, amino acid composition analysis, and structural comparison with other LRR proteins suggest that the hypervariable concave surface is the most probable antigen binding site of the VLR.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Sci Biol, Taejon 305701, South Korea; Hokkaido Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; Chungnam Natl Univ, Inst Biotechnol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Hokkaido University; Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Yoo, Ook Joon/C-1860-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011; Lee, Jie-Oh/C-1581-2011; Kang, Jin Young/E-4384-2019; Kasahara, Masanori/G-7651-2011	Lee, Jie-Oh/0000-0001-6519-6049				Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; GILBERTSON P, 1986, DEV COMP IMMUNOL, V10, P1, DOI 10.1016/0145-305X(86)90039-X; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nygren PA, 1997, CURR OPIN STRUC BIOL, V7, P463, DOI 10.1016/S0959-440X(97)80108-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skerra A, 2000, J MOL RECOGNIT, V13, P167, DOI 10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.3.CO;2-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stumpp MT, 2003, J MOL BIOL, V332, P471, DOI 10.1016/S0022-2836(03)00897-0; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ZAPATA A, 1984, CELL TISSUE RES, V235, P691	38	91	100	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6726	6732		10.1074/jbc.M608471200	http://dx.doi.org/10.1074/jbc.M608471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17192264	hybrid			2022-12-27	WOS:000244867200082
J	Chen, L; Xiong, SG; She, HY; Lin, SW; Wang, JH; Tsukamoto, H				Chen, Li; Xiong, Shigang; She, Hongyun; Lin, Sharon W.; Wang, Jiaohong; Tsukamoto, Hidekazu			Iron causes interactions of TAK1, p21ras, and phosphatidylinositol 3-kinase in caveolae to activate I kappa B kinase in hepatic macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR IRON; FREE-RADICALS; SURVIVAL; PATHWAY; LIPOPOLYSACCHARIDE; EXPRESSION; P21(RAS); ALPHA; BAD; NO	We recently discovered a novel signaling phenomenon involving a rapid and transient rise in intracellular low molecular weight iron complex(es) in activation of licB kinase (IKK) in hepatic macrophages. We also showed direct treatment with ferrous iron substitutes for this event to activate IKK. The present study used this model to identify upstream kinases responsible for IKK activation. IKK activation induced by iron is abrogated by overexpression of a dominant negative mutant (DN) for transforming growth factor beta-activated kinase-1 (TAK1), NF-kappa B-inducing kinase, or phosphatidylinositol 3-kinase (PI3K) and by treatment with the mitogen-activated protein kinase (MAPK) kinase-1 (MEK1) inhibitor. Iron increases AKT phosphorylation that is prevented by DNTAK1 or DNp21ras. Iron causes ERK1/2 phosphorylation that is attenuated by DN-PI3K, prevented by DNp21ras, but unaffected by DNTAK1. Iron-induced TAK1 activity is not affected by the PI3K or MEK1 inhibitor, suggesting TAK1 is upstream of PI3K and MEK1. Iron increases interactions of TAK1 and PI3K with p21ras as demonstrated by co-immunoprecipitation and co-localization of these proteins with caveolin-1 as shown by immunofluorescent microscopy. Finally, filipin III, a caveolae inhibitor, abrogates iron-induced TAK1 and IKK activation. In conclusion, MEK1, TAK1, NF-kappa B-inducing kinase, and PI3K are required for iron-induced IKK activation in hepatic macrophages and TAK1, PI3K, and p21ras physically interact in caveolae to initiate signal transduction.	Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA; Dept Vet Affairs, Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 1333 San Pablo St,MMR-402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu			NIAAA NIH HHS [R24AA12885, P50AA11999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R24AA012885] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bonkovsky HL, 2002, J HEPATOL, V37, P848, DOI 10.1016/S0168-8278(02)00305-7; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; KENNEDY JI, 1986, CHEST, V89, pS123, DOI 10.1378/chest.89.3_Supplement.123S; Krajewska WM, 2004, CELL MOL BIOL LETT, V9, P195; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Li SP, 2003, CANCER RES, V63, P3473; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Park YC, 1997, BIOCHEM BIOPH RES CO, V240, P692, DOI 10.1006/bbrc.1997.7722; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; Stojanovic S, 2004, NITRIC OXIDE-BIOL CH, V11, P256, DOI 10.1016/j.niox.2004.09.007; Thomas KW, 2002, J BIOL CHEM, V277, P492, DOI 10.1074/jbc.M108107200; Tsukamoto H, 1999, AM J PHYSIOL-GASTR L, V277, pG1240, DOI 10.1152/ajpgi.1999.277.6.G1240; Uraz S, 2005, DIGEST DIS SCI, V50, P964, DOI 10.1007/s10620-005-2672-z; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yuan XM, 1999, FREE RADICAL RES, V30, P221, DOI 10.1080/10715769900300241; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	37	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5582	5588		10.1074/jbc.M609273200	http://dx.doi.org/10.1074/jbc.M609273200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17172471	hybrid			2022-12-27	WOS:000244482300054
J	Dror, N; Rave-Harel, N; Burchert, A; Azriel, A; Tamura, T; Tailor, P; Neubauer, A; Ozato, K; Levi, BZ				Dror, Natalie; Rave-Harel, Naama; Burchert, Andreas; Azriel, Aviva; Tamura, Tomohiko; Tailor, Prafullakumar; Neubauer, Andreas; Ozato, Keiko; Levi, Ben-Zion			Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; PML-RAR-ALPHA; TRANSCRIPTION FACTOR; PROGENITOR CELLS; ACTIVATED MACROPHAGES; PREMATURE SENESCENCE; PROMOTER ACTIVITY; DENDRITIC CELLS; ANTIBODY PG-M3; TARGET GENES	Interferon (IFN) regulatory factor-8 (IRF-8), previously known as ICSBP, is a myeloid cell essential transcription factor. Mice with null mutation in IRF-8 are defective in the ability of myeloid progenitor cells to mature toward macrophage lineage. Accordingly, these mice develop chronic myelogenous leukemia (CML). We demonstrate here that IRF-8 is an obligatory regulator of the promyelocytic leukemia (PML) gene in activated macrophages, leading to the expression of the PML-I isoform. This regulation is most effective together with two other transcription factors, IRF-1 and PU.1. PML is a tumor suppressor gene that serves as a scaffold protein for nuclear bodies. IRF-8 is not only essential for the IFN-gamma-induced expression of PML in activated macrophages but also for the formation of nuclear bodies. Reduced IRF-8 transcript levels were reported in CML patients, and a recovery to normal levels was observed in patients in remission following treatment with IFN-alpha. We demonstrate a significant correlation between the levels of IRF-8 and PML in these CML patients. Together, our results indicate that some of the myeloleukemia suppressor activities of IRF-8 are mediated through the regulation of PML. When IRF-8 levels are compromised, the reduced PML expression may lead to genome instability and eventually to the leukemic phenotype.	Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; Univ Klinikum Marburg & Giessen, Standort Marburg, Klin Hamatol Onkol, D-35033 Marburg, Germany; NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; University Hospital of Giessen & Marburg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Levi, BZ (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	blevi@technion.ac.il	Burchert, Andreas/S-9563-2017	Burchert, Andreas/0000-0002-8411-8844	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Boulware SL, 2000, J GEN VIROL, V81, P1773, DOI 10.1099/0022-1317-81-7-1773; BREEN FN, 1991, J IMMUNOL, V147, P1542; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Deng M, 2001, BLOOD, V97, P3491, DOI 10.1182/blood.V97.11.3491; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Eklund EA, 1999, J IMMUNOL, V163, P6095; FLENGHI L, 1995, BLOOD, V85, P1871, DOI 10.1182/blood.V85.7.1871.bloodjournal8571871; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Green WB, 1999, LEUKEMIA, V13, P1960, DOI 10.1038/sj.leu.2401596; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hashmueli S, 2003, INT IMMUNOL, V15, P807, DOI 10.1093/intimm/dxg077; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; Labbaye C, 1999, ONCOGENE, V18, P3529, DOI 10.1038/sj.onc.1202682; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Meraro D, 1999, J IMMUNOL, V163, P6468; Mu ZM, 1996, LEUKEMIA LYMPHOMA, V23, P277, DOI 10.3109/10428199609054830; Muller S, 1999, J VIROL, V73, P5137; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Stadler M, 1995, ONCOGENE, V11, P2565; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Tzoanopoulos D, 2002, BRIT J HAEMATOL, V119, P46, DOI 10.1046/j.1365-2141.2002.03829.x; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wang ZG, 1998, SCIENCE, V279, P1547; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zimonjic DB, 2000, P NATL ACAD SCI USA, V97, P13306, DOI 10.1073/pnas.97.24.13306	65	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5633	5640		10.1074/jbc.M607825200	http://dx.doi.org/10.1074/jbc.M607825200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189268	hybrid			2022-12-27	WOS:000244482300060
J	Im, YJ; Davis, AJ; Perera, IY; Johannes, E; Allen, NS; Boss, WF				Im, Yang Ju; Davis, Amanda J.; Perera, Imara Y.; Johannes, Eva; Allen, Nina S.; Boss, Wendy F.			The N-terminal membrane occupation and recognition nexus domain of Arabidopsis phosphatidylinositol phosphate kinase 1 regulates enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE D-ALPHA; PLASMA-MEMBRANE; PHOSPHOINOSITIDE KINASES; ENDOSOME TRAFFICKING; HYPEROSMOTIC STRESS; SUSPENSION-CULTURE; PROTEIN; CELLS; 4,5-BISPHOSPHATE; THALIANA	The type I B family of phosphatidylinositol phosphate kinases (PIPKs) contain a characteristic region of Membrane Occupation and Recognition Nexus (MORN) motifs at the N terminus. These MORN motifs are not found in PIPKs from other eukaryotes. To understand the impact of the additional N-terminal domain on protein function and subcellular distribution, we expressed truncated and full-length versions of AtPIPKI, one member of this family of PIPKs, in Escherichia coli and in tobacco cells grown in suspension culture. Deletion of the N-terminal MORN domain (amino acids 1-251) of AtPIPKI increased the specific activity of the remaining C-terminal peptide (Delta MORN) > 4-fold and eliminated activation by phosphatidic acid (PtdOH). PtdOH activation could also be eliminated by mutating Pro(396) to Ala (P396A) in the predicted linker region between the MORN and the kinase homology domains. AtPIPKI is product-activated and the MORN domain binds PtdIns(4,5)P-2. Adding back the MORN peptide to Delta MORN or to the PtdOH-activated full-length protein increased activity similar to 2-fold. Furthermore, expressing the MORN domain in vivo increased the plasma membrane PtdInsP kinase activity. When cells were exposed to hyperosmotic stress, the MORN peptide redistributed from the plasma membrane to a lower phase or endomembrane fraction. In addition, endogenous PtdInsP kinase activity increased in the endomembrane fraction of hyperosmotically stressed cells. We conclude that the MORN peptide can regulate both the function and distribution of the enzyme in a manner that is sensitive to the lipid environment.	N Carolina State Univ, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Boss, WF (corresponding author), N Carolina State Univ, Plant Biol Box 7649, Raleigh, NC 27695 USA.	wendy_boss@ncsu.edu		Johannes, Eva/0000-0001-6489-1015; Perera, Imara/0000-0001-9421-1420				CHEN H, 1994, BIOTECHNIQUES, V16, P664; CHO MH, 1993, PLANT PHYSIOL, V103, P637, DOI 10.1104/pp.103.2.637; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Ciruela A, 2000, BIOCHEM J, V346, P587, DOI 10.1042/0264-6021:3460587; Davis AJ, 2004, J LIPID RES, V45, P1783, DOI 10.1194/jlr.D400005-JLR200; DeWald DB, 2001, PLANT PHYSIOL, V126, P759, DOI 10.1104/pp.126.2.759; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hinchliffe KA, 1999, CURR BIOL, V9, P983, DOI 10.1016/S0960-9822(99)80429-1; IMAI A, 1986, BIOCHEM J, V240, P341, DOI 10.1042/bj2400341; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kunz J, 2002, J BIOL CHEM, V277, P5611, DOI 10.1074/jbc.M110775200; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; LING LE, 1989, J BIOL CHEM, V264, P5080; Ma H, 2004, PLANT MOL BIOL, V54, P295, DOI 10.1023/B:PLAN.0000028796.14336.24; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Perera IY, 1999, P NATL ACAD SCI USA, V96, P5838, DOI 10.1073/pnas.96.10.5838; Perera IY, 2005, FEBS LETT, V579, P3427, DOI 10.1016/j.febslet.2005.05.018; Perera IY, 2002, PLANT PHYSIOL, V129, P1795, DOI 10.1104/pp.003426; Persson S, 2002, PLANT PHYSIOL, V128, P341, DOI 10.1104/pp.010840; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Qin WS, 1997, J BIOL CHEM, V272, P28267, DOI 10.1074/jbc.272.45.28267; SANDELIUS AS, 1986, FEBS LETT, V201, P282, DOI 10.1016/0014-5793(86)80624-X; Sang YM, 2001, PLANT J, V28, P135, DOI 10.1046/j.1365-313X.2001.01138.x; Shimada H, 2004, PLANT CELL PHYSIOL, V45, P960, DOI 10.1093/pcp/pch130; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Westergren T, 2001, BIOCHEM J, V359, P583, DOI 10.1042/0264-6021:3590583; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	45	64	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5443	5452		10.1074/jbc.M611342200	http://dx.doi.org/10.1074/jbc.M611342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17197438	hybrid			2022-12-27	WOS:000244482300039
J	Shajahan, AN; Wang, AF; Decker, M; Minshall, RD; Liu, MC; Clarke, R				Shajahan, Ayesha N.; Wang, Aifen; Decker, Markus; Minshall, Richard D.; Liu, Minetta C.; Clarke, Robert			Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; UP-REGULATION; EPITHELIAL-CELLS; EXPRESSION; TAXOL; GROWTH; ACTIVATION; APOPTOSIS; P53; MICROTUBULES	Caveolin-1 (CAV1), a highly conserved membrane-associated protein, is a putative regulator of cellular transformation. CAV1 is localized in the plasmalemma, secretory vesicles, Golgi, mitochondria, and endoplasmic reticulum membrane and associates with the microtubule cytoskeleton. Taxanes such as paclitaxel (Taxol) are potent anti-tumor agents that repress the dynamic instability of microtubules and arrest cells in the G(2)/M phase. Src phosphorylation of Tyr-14 on CAV1 regulates its cellular localization and function. We report that phosphorylation of CAV1 on Tyr-14 regulates paclitaxel-mediated apoptosis in MCF-7 breast cancer cells. Befitting its role as a multitasking molecule, we show that CAV1 sensitizes cells to apoptosis by regulating cell cycle progression and activation of the apoptotic signaling molecules BCL2, p53, and p21. We demonstrate that phosphorylated CAV1 triggers apoptosis by inactivating BCL2 and increasing mitochondrial permeability more efficiently than non-phosphorylated CAV1. Furthermore, expression of p21, which correlates with taxane sensitivity, is regulated by CAV1 phosphorylation in a p53-dependent manner. Collectively, our findings underscore the importance of CAV1 phosphorylation in apoptosis and suggest that events that negate CAV1 tyrosine phosphorylation may contribute to anti-microtubule drug resistance.	Georgetown Univ, Coll Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; Georgetown Univ, Coll Med, Dept Physiol, Washington, DC 20057 USA; Georgetown Univ, Coll Med, Dept Biophys, Washington, DC 20057 USA; Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Dept Anesthesiol, Chicago, IL 60612 USA	Georgetown University; Georgetown University; Georgetown University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Clarke, R (corresponding author), Georgetown Univ, Coll Med, Dept Oncol, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd NW,NRB W405, Washington, DC 20057 USA.	clarker@georgeotown.edu	Clarke, Robert/A-6485-2008	Clarke, Robert/0000-0002-9278-0854; Shajahan-Haq, Ayesha/0000-0001-7616-320X				Barboule N, 1997, ONCOGENE, V15, P2867, DOI 10.1038/sj.onc.1201469; Belanger MM, 2003, ANTI-CANCER DRUG, V14, P281, DOI 10.1097/00001813-200304000-00005; BLAGOSKLONNY MV, 1995, CANCER RES, V55, P4623; Blagosklonny MV, 1997, CANCER RES, V57, P130; Boudny V, 2002, BRIT J CANCER, V86, P463, DOI 10.1038/sj.bjc.6600080; Chen T, 2005, MOL CANCER THER, V4, P217; Clavarezza M, 2006, ANN ONCOL, V17, pVII22, DOI 10.1093/annonc/mdl944; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Couet J, 2001, ADV DRUG DELIVER REV, V49, P223, DOI 10.1016/S0169-409X(01)00139-9; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Ghersi D, 2005, BRIT J CANCER, V93, P293, DOI 10.1038/sj.bjc.6602680; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Gligorov J, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-suppl_2-3; Haldar S, 1997, CANCER RES, V57, P229; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Kim YN, 2002, EXP CELL RES, V280, P134, DOI 10.1006/excr.2002.5623; Kiss AL, 2005, MOL CELL ENDOCRINOL, V245, P128, DOI 10.1016/j.mce.2005.11.005; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li SW, 1996, J BIOL CHEM, V271, P3863; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; MATSUOKA H, 1994, ANTICANCER RES, V14, P163; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Panno ML, 2006, FEBS LETT, V580, P2371, DOI 10.1016/j.febslet.2006.03.055; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Roussel E, 2004, ANTI-CANCER DRUG, V15, P961, DOI 10.1097/00001813-200411000-00005; Sagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Trock BJ, 1997, J NATL CANCER I, V89, P917, DOI 10.1093/jnci/89.13.917; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Xie ZH, 2003, CANCER RES, V63, P5370; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zajchowski DA, 2001, CANCER RES, V61, P5168	49	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5934	5943		10.1074/jbc.M608857200	http://dx.doi.org/10.1074/jbc.M608857200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17190831	hybrid			2022-12-27	WOS:000244482300089
J	Wang, SZE; Narasanna, A; Whitell, CW; Wu, FY; Friedman, DB; Arteaga, CL				Wang, Shizhen Emily; Narasanna, Archana; Whitell, Corbin W.; Wu, Frederick Y.; Friedman, David B.; Arteaga, Carlos L.			Convergence of p53 and transforming growth factor beta (TGF beta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY BREAST-CANCER; LUNG-CANCER; MUTANT P53; RECEPTOR; MOTILITY; ERBB2; PROGRESSION; ALPHA; TUMORIGENESIS; COOPERATION	Using two-dimensional difference gel electrophoresis, we identified the tumor suppressor gene maspin as a transforming growth factor beta (TGF beta) target gene in human mammary epithelial cells. TGF beta up-regulatesMaspin expression both at the RNA and protein levels. This up-regulation required Smad2/3 function and intact p53-binding elements in the Maspin promoter. DNA affinity immunoblot and chromatin immunoprecipitation revealed the presence of both Smads and p53 at the Maspin promoter in TGF beta-treated cells, suggesting that both transcription factors cooperate to induce Maspin transcription. TGF beta did not activate Maspin-luciferase reporter in p53-mutant MDA-MB-231 breast cancer cells, which exhibit methylation of the endogenous Maspin promoter. Expression of ectopic p53, however, restored ligand-induced association of Smad2/3 with a transfected Maspin promoter. Stable transfection of Maspin inhibited basal and TGF beta-stimulated MDA-MB-231 cell motility. Finally, knockdown of endogenous Maspin in p53 wild-type MCF10A/HER2 cells enhanced basal and TGF beta-stimulated motility. Taken together, these data support cooperation between the p53 and TGF beta tumor suppressor pathways in the induction of Maspin expression, thus leading to inhibition of cell migration.	Vanderbilt Univ, Sch Med, Div Oncol, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Arteaga, CL (corresponding author), Vanderbilt Univ, Sch Med, Div Oncol, Dept Canc Biol, 2220 Poerce Ave,777 PRB, Nashville, TN 37232 USA.	carlos.arteaga@vanderbilt.edu		Wang, Shizhen Emily/0000-0002-5036-8175	NATIONAL CANCER INSTITUTE [R00CA125892, R01CA062212, K99CA125892, R01CA080195, P50CA098131, P30CA068485] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA062212, P50 CA98131, K99 CA125892, P30 CA68485, R01CA62212, P50 CA098131, P30 CA068485, R00 CA125892, R01CA80195, R01 CA080195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Bakin AV, 2002, J CELL SCI, V115, P3193; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Ewan KB, 2002, CANCER RES, V62, P5627; FOEKENS JA, 1994, J CLIN ONCOL, V12, P1648, DOI 10.1200/JCO.1994.12.8.1648; FOEKENS JA, 1995, CANCER RES, V55, P1423; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Friedman DB, 2007, MOL CELL PROTEOMICS, V6, P150, DOI 10.1074/mcp.D600001-MCP200; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; HAMILTON JA, 1993, J IMMUNOL, V151, P5154; Kim S, 2004, CANCER RES, V64, P6900, DOI 10.1158/0008-5472.CAN-04-1657; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Odero-Marah VA, 2002, BIOCHEM BIOPH RES CO, V295, P800, DOI 10.1016/S0006-291X(02)00764-7; OLIFF A, 1985, J VIROL, V54, P864, DOI 10.1128/JVI.54.3.864-868.1985; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Reddy KB, 2001, ONCOGENE, V20, P6538, DOI 10.1038/sj.onc.1204796; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.25.11.4703-4715.2005; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; Zhang WG, 2002, INT J ONCOL, V20, P1145; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	40	31	32	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5661	5669		10.1074/jbc.M608499200	http://dx.doi.org/10.1074/jbc.M608499200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17204482	hybrid, Green Accepted			2022-12-27	WOS:000244482300063
J	Mazurov, D; Heidecker, G; Derse, D				Mazurov, Dmitriy; Heidecker, Gisela; Derse, David			The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE-4 SUPERFAMILY; PLASMA-MEMBRANE; METASTASIS SUPPRESSOR; ENRICHED MICRODOMAINS; SYNCYTIUM FORMATION; MOLECULAR CLONE; MATRIX PROTEIN; C33 ANTIGEN; HTLV-1 GAG; PALMITOYLATION	The tetraspanin superfamily proteins play important roles in organizing membrane protein complexes, modulating integrin function, and controlling T cell adhesion. Tetraspanins such as CD82 contain two extracellular loops with its N terminus, C terminus, and inner loop exposed to the cytoplasm. The matrix (MA) domain of human T cell lymphotrophic virus, type 1 (HTLV-1), Gag interacts with the cytoplasmic face of the plasma membrane and is concentrated at tetraspanin-enriched microdomains. To understand the basis of this association, we generated site-directed mutations in the various domains of CD82 and used coimmunoprecipitation and colocalization approaches to examine interactions with HTLV-1 MA. The large extracellular loop of CD82, which is important for interactions with integrins, was not required for the association with HTLV-1 MA. The cytoplasmic N terminus and C terminus of CD82 were also dispensable for CD82-MA interactions. In contrast, mutations of conserved amino acids in the inner loop of CD82 or of palmitoylated cysteines that flank the inner loop diminished CD82 association with MA. HTLV-1 MA also interacted with the inner loop of CD81. Thus, association of HTLV-1 Gag with tetraspanin-enriched microdomains is mediated by the inner loops of CD81 and CD82.	NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Derse, D (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA.	derse@ncifcrf.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010003, ZIABC010003] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bienstock RJ, 2001, MOL CARCINOGEN, V32, P139, DOI 10.1002/mc.1073; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Cannon KS, 2001, EMBO J, V20, P2443, DOI 10.1093/emboj/20.10.2443; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Christensen AM, 1996, J MOL BIOL, V264, P1117, DOI 10.1006/jmbi.1996.0700; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Delamater AM, 2002, HA CL HE PS, V1, P443; DERSE D, 1995, J VIROL, V69, P1907, DOI 10.1128/JVI.69.3.1907-1912.1995; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; Derse D, 1996, J ACQ IMMUN DEF SYND, V12, P1, DOI 10.1097/00042560-199605010-00001; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Heidecker G, 2004, J VIROL, V78, P6636, DOI 10.1128/JVI.78.12.6636-6648.2004; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; IMAI T, 1993, J IMMUNOL, V151, P6470; Lagaudriere-Gesbert C, 1998, EUR J IMMUNOL, V28, P4332, DOI 10.1002/(SICI)1521-4141(199812)28:12<4332::AID-IMMU4332>3.0.CO;2-8; Le Blanc I, 2002, J VIROL, V76, P905, DOI 10.1128/JVI.76.2.905-911.2002; Le Blanc I, 1999, J VIROL, V73, P1860, DOI 10.1128/JVI.73.3.1860-1867.1999; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4; Mazurov D, 2006, VIROLOGY, V346, P194, DOI 10.1016/j.virol.2005.10.033; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Pique C, 2000, VIROLOGY, V276, P455, DOI 10.1006/viro.2000.0538; Rayne F, 2004, J MOL BIOL, V343, P903, DOI 10.1016/j.jmb.2004.09.013; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Vogt AB, 2002, IMMUNOL REV, V189, P136, DOI 10.1034/j.1600-065X.2002.18912.x; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	45	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3896	3903		10.1074/jbc.M607322200	http://dx.doi.org/10.1074/jbc.M607322200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17166843	hybrid			2022-12-27	WOS:000244481900054
J	Paz, Y; Katz, A; Pick, U				Paz, Yakov; Katz, Adriana; Pick, Uri			Multicopper ferroxidase involved in iron binding to transferrins in Dunaliella salina plasma membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGA DUNALIELLA; CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; OXIDASE FET3P; PROTEIN; TRANSPORT; YEAST; HALOTOLERANCE; DEFICIENCY; PREDICTION	The halotolerant alga Dunaliella salina is unique among plants in that it utilizes a transferrin (TTf) to mediate iron acquisition (Fisher, M., Zamir, A., and Pick, U. (1998) J. Mal. Chem. 273, 17553-17558). Two new proteins that are induced by iron deprivation were identified in plasma membranes of D. salina as follows: a multicopper ferroxidase termed D-Fox and an internally duplicated glycoprotein (p130B). D-Fox and p130B are accessible to glycolytic, proteolytic, and biotin surface tagging treatments, suggesting that they are surface-exposed glycoproteins. Induction of D-Fox was also manifested by ferroxidase activity in plasma membrane preparations. These results are puzzling because ferroxidases in yeast and in Chlamydomonas reinhardtii function in redox-mediated iron uptake, a mechanism that is not known to operate in D. salina. Two lines of evidence suggest that D-Fox and p130B interact with D. salina triplicated transferrin (TTf). First, chemical cross-linking combined with mass spectroscopy analysis showed that D-Fox and p130B associate with TTf and with another plasma membrane transferrin. Second, detergent-solubilized D-Fox and p130B comigrated on blue native gels with plasma membrane transferrins. Fe-59 autoradiography indicated that this complex binds Fe3+ ions. Also, the induction of D-Fox and p130B is kinetically correlated with enhanced iron binding and uptake activities. These results suggest that D-Fox and p130B associate with plasma membrane transferrins forming a complex that enhances iron binding and iron uptake. We propose that the function of D-Fox in D. salina has been modified during evolution from redox-mediated to transferrin-mediated iron uptake, following a gene transfer event of transferrins from an ancestral animal cell.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Pick, U (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	uri.pick@weizmann.ac.il						ALLNUTT FCT, 1987, PLANT PHYSIOL, V85, P751, DOI 10.1104/pp.85.3.751; Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; BENDERLIEV KM, 1994, PLANTA, V193, P163; Boye M, 2000, MAR CHEM, V70, P277, DOI 10.1016/S0304-4203(00)00032-3; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; di Patti MCB, 2005, BIOCHEM BIOPH RES CO, V333, P432, DOI 10.1016/j.bbrc.2005.05.121; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Fisher M, 1997, J BIOL CHEM, V272, P1565, DOI 10.1074/jbc.272.3.1565; Fisher M, 1998, J BIOL CHEM, V273, P17553, DOI 10.1074/jbc.273.28.17553; FISHER M, 1994, PLANT PHYSIOL, V106, P1359, DOI 10.1104/pp.106.4.1359; GIBBS CR, 1976, ANAL CHEM, V48, P1197, DOI 10.1021/ac50002a034; Herbik A, 2002, PLANT PHYSIOL, V130, P2039, DOI 10.1104/pp.013060; Herbik A, 2002, PLANT SOIL, V241, P1, DOI 10.1023/A:1016037906516; Keshtacher-Liebson E, 1999, PLANT SOIL, V215, P175, DOI 10.1023/A:1004760613906; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lesuisse E, 1996, J BIOL CHEM, V271, P13578, DOI 10.1074/jbc.271.23.13578; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Premikumar L, 2005, P NATL ACAD SCI USA, V102, P7493, DOI 10.1073/pnas.0502829102; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarz M, 2003, J PLANT NUTR, V26, P2081, DOI 10.1081/PLN-120024266; Schwarz M, 2003, BBA-PROTEINS PROTEOM, V1649, P190, DOI 10.1016/S1570-9639(03)00185-7; SCHWARZ M, 2002, THESIS WEIZMANN I SC; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Varsano T, 2003, J PLANT NUTR, V26, P2197, DOI 10.1081/PLN-120024275; Wang TP, 2003, J BIOL INORG CHEM, V8, P611, DOI 10.1007/s00775-003-0456-5	29	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8658	8666		10.1074/jbc.M609756200	http://dx.doi.org/10.1074/jbc.M609756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17227764	hybrid			2022-12-27	WOS:000245780300012
J	Cho, YY; Yao, K; Bode, AM; Bergen, HR; Madden, BJ; Oh, SM; Ermakova, S; Kang, BS; Choi, HS; Shim, JH; Dong, ZG				Cho, Yong-Yeon; Yao, Ke; Bode, Ann M.; Bergen, H. Robert, III; Madden, Benjamin J.; Oh, Sang-Muk; Ermakova, Svetlana; Kang, Bong Seok; Choi, Hong Seok; Shim, Jung-Hyun; Dong, Zigang			RSK2 mediates muscle cell differentiation through regulation of NFAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFFIN-LOWRY-SYNDROME; ACTIVATED T-CELLS; GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; NF-ATC; PROTEIN-KINASES; NUCLEAR FACTOR; CYCLOSPORINE-A	RSK2, an ERK downstream kinase, is a novel mediator of skeletal muscle cell differentiation through its regulation of NFAT3 activity. We found that the N-terminal (amino acids (aa) 1-68) and C-terminal (aa 416-674) kinase domains of RSK2 directly interacted with nuclear localization signal 1, the Ser/Pro repeat, and the polyproline domains (aa 261-365) of NFAT3. Upon A23187 stimulation, RSK2 induced nuclear localization of NFAT3. RSK2 phosphorylated NFAT3 in vitro (K-m = 3.559 mu M), and activation of NFAT3 by RSK2 enhanced the promoter activity of NFAT3 downstream target genes in vivo. Furthermore, nuclear accumulation of NFAT3 was attenuated markedly in RSK2(-/-) cells compared with wild-type RSK2(+/+) cells. Notably, RSK2 and NFAT3 induced a significant differentiation of C2C12 myoblasts to multinucleated myotubes. Multinucleated myotube differentiation was inhibited by small interfering RNA against RSK2, ERK1/2, or NFAT3. These results demonstrate that RSK2 is an important kinase for NFAT3 in mediating myotube differentiation.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Mayo Clin, Coll Med, Mayo Proteom Res Ctr, Rochester, MN 55905 USA	University of Minnesota System; Mayo Clinic	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Ermakova, Svetlana P/G-2766-2013	Shim, Jung-Hyun/0000-0002-4062-4016; Ermakova, Svetlana/0000-0002-5905-2046; Cho, Yong-Yeon/0000-0003-1107-2651	NATIONAL CANCER INSTITUTE [R01CA077646, P01CA027502, P01CA088961, R37CA081064, R01CA081064] Funding Source: NIH RePORTER; NCI NIH HHS [CA88961, R37 CA081064, P01 CA088961-020003, P01 CA027502-270022, R01 CA077646, CA81064, R01 CA081064, P01 CA088961, CA27502, P01 CA027502, R01 CA077646-10, CA77646, R37 CA081064-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Cho YY, 2004, CANCER RES, V64, P3855, DOI 10.1158/0008-5472.CAN-04-0201; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; ISHIDA Y, 1992, CLIN ORTHOP RELAT R, P144; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Massin MM, 1999, ACTA PAEDIATR, V88, P468, DOI 10.1080/08035259950169909; McCandless SE, 2000, AM J MED GENET, V95, P93, DOI 10.1002/1096-8628(20001113)95:2<93::AID-AJMG1>3.0.CO;2-B; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nebreda AR, 1999, SCIENCE, V286, P1309, DOI 10.1126/science.286.5443.1309; Nelson GB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e197; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Penn BH, 2001, MOL CELL, V8, P245, DOI 10.1016/S1097-2765(01)00331-8; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; SHARMA KR, 1993, NEUROLOGY, V43, P527, DOI 10.1212/WNL.43.3_Part_1.527; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang T, 2001, J BIOL CHEM, V276, P39569, DOI 10.1074/jbc.M102961200; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	53	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8380	8392		10.1074/jbc.M611322200	http://dx.doi.org/10.1074/jbc.M611322200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17213202	Green Accepted, hybrid			2022-12-27	WOS:000245081000071
J	Todeschini, AR; Dos Santos, JN; Handa, K; Hakomori, S				Todeschini, Adriane Regina; Dos Santos, Jose Nilson; Handa, Kazuko; Hakomori, Sen-itiroh			Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM3 GANGLIOSIDE; CANCER-CELLS; MEMBRANE; RECEPTOR; MICRODOMAIN; METASTASIS; ADHESION; EXPRESSION; REVERSION; APOPTOSIS	Glycosphingolipids (GSLs) at the cell surface membrane are associated or complexed with signal transducers (Src family kinases and small G-proteins), tetraspanins, growth factor receptors, and integrins. Such organizational framework, defining GSL-modulated or -dependent cell adhesion, motility, and growth, is termed "glycosynapse" (Hakomori, S., and Handa, K. (2002) FEBS Lett. 531, 88-92; Hakomori, S. (2004) Ann, Braz. Acad. Sci. 76, 553-572). We describe here the functional organization of the glycosynaptic microdomain, and the mechanisms for control of cell motility and invasiveness, in normal bladder epithelial HCV29 cells versus highly invasive bladder cancer YTS1 cells, both derived from transitional epithelia. (i) Ganglioside GM2, but not GM3 or globoside, interacted specifically with tetraspanin CD82, and such a complex inhibited hepatocyte growth factor (HGF)-induced activation of Met tyrosine kinase in a dose-dependent manner. (ii) Depletion of GM2 in HCV29 cells by treatment with D-threo-1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (P4), or reduction of CD82 expression by RNA interference, significantly enhanced HGF-induced Met tyrosine kinase and cell motility. (iii) In contrast, YTS1 cells, lacking CD82, displayed HGF-independent activation of Met tyrosine kinase and high cell motility. Transfection of the CD82 gene to YTS1 inhibited HGF dose-dependent Met tyrosine kinase activity and cell motility, due to formation of the GM2-CD82 complex. (iv) Adhesion of YTS1 or YTS1/CD82 cells to laminin-5-coated plates, as compared with noncoated plates, strongly enhanced Met activation, and the degree of activation was further increased in association with GSL depletion by P4. Laminin-5-dependent Met activation was minimal in HCV29 cells. These findings indicate that GSL, particularly GM2, forms a complex with CD82, and that such complex interacts with Met and thereby inhibits HGF-induced Met tyrosine kinase activity, as well as integrin to Met cross-talk.	Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98122 USA; Univ Washington, Dept Microbiol, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Todeschini, AR (corresponding author), Pacific NW Res Inst, Div Biomembrane Res, 720 Broadway, Seattle, WA 98122 USA.	adrianet@biof.ufrg.br; hakomori@u.washington.edu	Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020	Todeschini, Adriane Regina/0000-0002-6049-2751; 	NCI NIH HHS [CA080054] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Bektas M, 2003, ANAL BIOCHEM, V320, P259, DOI 10.1016/S0003-2697(03)00388-9; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; DOHI T, 1988, CANCER RES, V48, P5680; FOLCH J, 1951, J BIOL CHEM, V191, P807; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hakomori S, 2005, P JPN ACAD B-PHYS, V81, P189, DOI 10.2183/pjab.81.189; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Kakizaki H., 1990, JPN J UROL, V81, P204; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kitamura S, 2000, BRIT J CANCER, V83, P668, DOI 10.1054/bjoc.2000.1301; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Longati P, 2001, CURR DRUG TARGETS, V2, P41, DOI 10.2174/1389450013348920; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mannion BA, 1996, J IMMUNOL, V157, P2039; MASTERS JRW, 1986, CANCER RES, V46, P3630; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; MIYAKE M, 1988, CANCER RES, V48, P6154; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; NAKAMURA K, 1991, J BIOCHEM-TOKYO, V110, P832, DOI 10.1093/oxfordjournals.jbchem.a123667; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Odintsova E, 2006, BIOCHEM J, V400, P315, DOI 10.1042/BJ20060259; Ono M, 1999, CANCER RES, V59, P2335; Ono M, 2001, BIOCHEMISTRY-US, V40, P6414, DOI 10.1021/bi0101998; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorice M, 1997, J LIPID RES, V38, P969; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Toledo MS, 2004, J BIOL CHEM, V279, P34655, DOI 10.1074/jbc.M403857200; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; YU RK, 1972, J LIPID RES, V13, P680; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	58	114	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8123	8133		10.1074/jbc.M611407200	http://dx.doi.org/10.1074/jbc.M611407200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17215249	hybrid			2022-12-27	WOS:000245081000044
J	Luttermann, C; Meyers, G				Luttermann, Christine; Meyers, Gregor			A bipartite sequence motif induces translation reinitiation in feline calicivirus RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAMES; MESSENGER-RNA; RIBOSOMAL-RNA; COUPLED TRANSLATION; INITIATION; VIRUS; PROTEIN; EXPRESSION; ADENOVIRUS; MECHANISM	The mechanism leading to reinitiation of translation after termination of protein synthesis in eukaryotes has not yet been resolved in detail. One open question concerns the way the post-termination ribosome is tethered to the mRNA to allow binding of the necessary initiation factors. In caliciviruses, a family of positive strand RNA viruses, the capsid protein VP2 is translated via a termination/reinitiation process. VP2 of the feline calicivirus is encoded in the 3'-terminal open reading frame 3 (ORF3) that overlaps with the preceding ORF2 by four nucleotides. In transient expression studies, the efficiency of VP2 expression was 20 times lower than that of the ORF2 proteins. The close vicinity of the ORF2 termination signal and the ORF3 AUG codon was crucial, whereas the AUG could be replaced by alternative codons. Deletion mapping revealed that the 3'-terminal 69 nucleotides of ORF2 are crucial for VP2 expression. This sequence contains two essential sequence motifs. The first motif is conserved among caliciviruses and complementary to part of the 18 S rRNA. In conclusion, VP2 is expressed in a translation termination/reinitiation process that is special because it requires a sequence element that could prevent dissociation of post-termination ribosomes via hybridization with 18 S rRNA.	Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Paul Ehrlich Str 28, D-72076 Tubingen, Germany.	gregor.meyers@fli.bund.de	Luttermann, Christine/L-5440-2019	Luttermann, Christine/0000-0002-6977-9900				Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; BONNEVILLE JM, 1989, CELL, V59, P1135, DOI 10.1016/0092-8674(89)90769-1; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Cuesta R, 2001, COLD SPRING HARB SYM, V66, P259, DOI 10.1101/sqb.2001.66.259; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; FUTTERER J, 1991, EMBO J, V10, P3887, DOI 10.1002/j.1460-2075.1991.tb04958.x; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; GOWDA S, 1989, P NATL ACAD SCI USA, V86, P9203, DOI 10.1073/pnas.86.23.9203; GREEN KY, 2000, VIRUS TAXONOMY, P725; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herbert TP, 1996, J GEN VIROL, V77, P123, DOI 10.1099/0022-1317-77-1-123; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; JACOB WF, 1987, P NATL ACAD SCI USA, V84, P4757, DOI 10.1073/pnas.84.14.4757; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sambrook J., 2001, MOL CLONING LAB MANU; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; Stacey SN, 2000, J VIROL, V74, P7284, DOI 10.1128/JVI.74.16.7284-7297.2000; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Thumfart JO, 2002, J VIROL, V76, P6398, DOI 10.1128/JVI.76.12.6398-6407.2002; Tranque P, 1998, P NATL ACAD SCI USA, V95, P12238, DOI 10.1073/pnas.95.21.12238; Wirblich C, 1996, J VIROL, V70, P7974, DOI 10.1128/JVI.70.11.7974-7983.1996; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xi QR, 2005, J VIROL, V79, P5676, DOI 10.1128/JVI.79.9.5676-5683.2005; Yueh A, 2000, GENE DEV, V14, P414	58	49	53	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7056	7065		10.1074/jbc.M608948200	http://dx.doi.org/10.1074/jbc.M608948200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213194	hybrid			2022-12-27	WOS:000245080900017
J	Ostling, P; Bjork, JK; Roos-Mattjus, P; Mezger, V; Sistonen, L				Ostling, Paivi; Bjork, Johanna K.; Roos-Mattjus, Pia; Mezger, Valerie; Sistonen, Lea			Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; MOLECULAR CHAPERONES; TARGETED DISRUPTION; ERYTHROLEUKEMIA-CELLS; FACTOR-II; IN-VIVO; STRESS; DIFFERENTIATION; ACTIVATION	The heat shock response is a defense reaction activated by proteotoxic damage induced by physiological or environmental stress. Cells respond to the proteotoxic damage by elevated expression of heat shock proteins (Hsps) that function as molecular chaperones and maintain the vital homeostasis of protein folds. Heat shock factors (HSFs) are the main transcriptional regulators of the stress-induced expression of hsp genes. Mammalian HSF I was originally identified as the transcriptional regulator of the heat shock response, whereas HSF2 has not been implicated a role in the stress response. Previously, we and others have demonstrated that HSF1 and HSF2 interact through their trimerization domains, but the functional consequence of this interaction remained unclear. We have now demonstrated on chromatin that both HSF1 and HSF2 were able to bind the hsp70 promoter not only in response to heat shock but also during hemin-induced differentiation of K562 erythroleukernia cells. In both cases an intact HSF1 was required in order to reach maximal levels of promoter occupancy, suggesting that HSF1 influences the DNA binding activity of HSF2. The functional consequence of the HSFI-HSF2 interplay was demonstrated by real-time reverse transcription-PCR analyses, which showed that HSF2 was able to modulate the HSFI-mediated expression of major hsp genes. Our results reveal, contrary to the predominant model, that HSF2 indeed participates in the transcriptional regulation of the heat shock response.	Abo Akad Univ, Turku Ctr Biotechnol, FI-20521 Turku, Finland; Turku Univ, FI-20521 Turku, Finland; Abo Akad Univ, Dept Biochem & Pharm, FI-20521 Turku, Finland; Abo Akad Univ, Dept Biol, FI-20521 Turku, Finland; Ecole Normale Super, CNRS, UMR8541, Lab Biol Mol Stress, F-75005 Paris, France	Abo Akademi University; University of Turku; University of Turku; Abo Akademi University; Abo Akademi University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Sistonen, L (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, POB 123, FI-20521 Turku, Finland.	lea.sistonen@btk.fi		Roos-Mattjus, Pia/0000-0002-7187-2012; Ostling, Paivi/0000-0001-5501-466X; Sistonen, Lea/0000-0003-1341-2867				ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Alastalo TP, 1998, EXP CELL RES, V240, P16, DOI 10.1006/excr.1997.3926; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Biamonti G, 2004, NAT REV MOL CELL BIO, V5, P493, DOI 10.1038/nrm1405; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; Eriksson M, 2000, INT J DEV BIOL, V44, P471; Gyrd-Hansen M, 2004, CELL CYCLE, V3, P1484, DOI 10.4161/cc.3.12.1287; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Hilgarth RS, 2004, CELL STRESS CHAPERON, V9, P214, DOI 10.1379/CSC-8R.1; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Hu YZ, 2006, MOL CELL BIOL, V26, P3282, DOI 10.1128/MCB.26.8.3282-3294.2006; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Morano KA, 1999, GENE EXPRESSION, V7, P271; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1054/csac.1998.0002; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; Paslaru L, 2003, J CELL MOL MED, V7, P425, DOI 10.1111/j.1582-4934.2003.tb00245.x; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pirkkala L, 1999, CELL STRESS CHAPERON, V4, P259, DOI 10.1379/1466-1268(1999)004<0259:ASAIIF>2.3.CO;2; Pirkkala L, 1999, FASEB J, V13, P1089, DOI 10.1096/fasebj.13.9.1089; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SHELDON LA, 1993, GENE DEV, V7, P1549, DOI 10.1101/gad.7.8.1549; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Takahashi Y, 2000, GENE DEV, V14, P804; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	61	162	167	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7077	7086		10.1074/jbc.M607556200	http://dx.doi.org/10.1074/jbc.M607556200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213196	hybrid			2022-12-27	WOS:000245080900019
J	Sun, XH; Flynn, DC; Castranova, V; Millecchia, LL; Beardsley, AR; Liu, J				Sun, Xing-Hui; Flynn, Daniel C.; Castranova, Vincent; Millecchia, Lyndell L.; Beardsley, Andrew R.; Liu, Jun			Identification of a novel domain at the N terminus of caveolin-1 that controls rear polarization of the protein and caveolae formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; MDCK CELLS; CHOLESTEROL TRAFFICKING; ENDOTHELIAL-CELLS; GOLGI-COMPLEX; LIPID RAFTS; GENE FAMILY; NULL MICE; IN-VIVO	When cells are migrating, caveolin-1, the principal protein component of caveolae, is excluded from the leading edge and polarized at the cell rear. The dynamic feature depends on a specific sequence motif that directs intracellular trafficking of the protein. Deletion mutation analysis revealed a putative polarization domain at the N terminus of caveolin-1, between amino acids 32-60. Alanine substitution identified a minimal sequence of 10 residues ((TKEIDLVNRD55)-T-46) necessary for caveolin-1 rear polarization. Interestingly, deletion of amino acids 1-60 did not prevent the polarization of caveolin-1 in human umbilical vein endothelial cells or wild-type mouse embryonic fibroblasts because of an interaction of Cav(61-178) mutant with endogenous caveolin-1. Surprisingly, expression of the depolarization mutant in caveolin-1 null cells dramatically impeded caveolae formation. Furthermore, knockdown of caveolae formation by methyl-beta-cyclodextrin failed to prevent wild-type caveolin-1 rear polarization. Importantly, genetic depletion of caveolin-1 led to disoriented migration, which can be rescued by full-length caveolin-1 but not the depolarization mutant, indicating a role of caveolin-1 polarity in chemotaxis. Thus, we have identified a sequence motif that is essential for caveolin-1 rear polarization and caveolae formation.	W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; W Virginia Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; W Virginia Univ, Hlth Sci Ctr, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; NIOSH, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA	West Virginia University; West Virginia University; West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Liu, J (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, POB 9229, Morgantown, WV 26506 USA.	junliu@hsc.wvu.edu			NCRR NIH HHS [RR016440] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Fielding CJ, 1997, J LIPID RES, V38, P1503; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Hailstones D, 1998, J LIPID RES, V39, P369; Isshiki M, 2002, J CELL SCI, V115, P475; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; SEVERS NJ, 1988, J CELL SCI, V90, P341; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zicha D, 1997, Methods Mol Biol, V75, P449	57	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7232	7241		10.1074/jbc.M607396200	http://dx.doi.org/10.1074/jbc.M607396200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213184	hybrid, Green Submitted			2022-12-27	WOS:000245080900035
J	Yamashita, D; Komori, H; Higuchi, Y; Yamaguchi, T; Osumi, T; Hirose, F				Yamashita, Daisuke; Komori, Hirofumi; Higuchi, Yoshiki; Yamaguchi, Tomohiro; Osumi, Takashi; Hirose, Fumiko			Human DNA replication-related element binding factor (hDREF) self-association via hATC domain is necessary for its nuclear accumulation and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPOSABLE ELEMENTS; TRANSCRIPTION FACTOR; IMPORTIN-ALPHA; IMAGINAL DISC; DREF; PROTEIN; EXPRESSION; SEQUENCE; IDENTIFICATION; COMMON	We previously demonstrated that hDREF, a human homologue of Drosophila DNA replication-related element binding factor (dDREF), is a DNA-binding protein predominantly distributed with granular structures in the nucleus. Here, glutathione S-transferase pulldown and chemical cross-linking assays showed that the carboxyl-terminal hATC domain of hDREF, highly conserved among hAT transposase family members, possesses self-association activity. Immunoprecipitation analyses demonstrated that hDREF self-associates in vivo, dependent on hATC domain. Moreover, analyses using a series of hDREF mutants carrying amino acid substitutions in the hATC domain revealed that conserved hydrophobic amino acids are essential for self-association. Immunofluorescence studies further showed that all hDREF mutants lacking self-association activity failed to accumulate in the nucleus. Self-association-defective hDREF mutants also lost association with endogenous importin beta 1. Moreover, electrophoretic gel-mobility shift assays revealed that the mutations completely abolished the DNA binding activity of hDREF. These results suggest that self-association of hDREF via the hATC domain is necessary for its nuclear accumulation and DNA binding. We also found that ZBED4/KIAA0637, another member of the human hAT family, also self-associates, again dependent on the hATC domain, with deletion resulting in loss of efficient nuclear accumulation. Thus, hATC domains of human hAT family members appear to have conserved functions in self-association that are required for nuclear accumulation.	Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Hirose, F (corresponding author), Univ Hyogo, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	fhirose@sci.u-hyogo.ac.jp		Hirose, Fumiko/0000-0003-4586-4892; Yamashita, Daisuke/0000-0001-6054-5617				Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Esposito T, 1999, HUM MOL GENET, V8, P61, DOI 10.1093/hmg/8.1.61; Essers L, 2000, PLANT CELL, V12, P211, DOI 10.1105/tpc.12.2.211; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hickman AB, 2005, NAT STRUCT MOL BIOL, V12, P715, DOI 10.1038/nsmb970; Hirose F, 1996, J BIOL CHEM, V271, P3930; Hirose F, 2002, MOL CELL BIOL, V22, P5182, DOI 10.1128/MCB.22.14.5182-5193.2002; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hyun JY, 2005, MOL CELL BIOL, V25, P5590, DOI 10.1128/MCB.25.13.5590-5598.2005; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Michel K, 2003, INSECT BIOCHEM MOLEC, V33, P959, DOI 10.1016/S0965-1748(03)00102-4; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Okada M, 2002, GENES CELLS, V7, P985, DOI 10.1046/j.1365-2443.2002.00577.x; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SAMBROOK J, 2001, MOL CLONING, V2; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Sawado T, 1998, J BIOL CHEM, V273, P26042, DOI 10.1074/jbc.273.40.26042; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H., 2003, MEMBRANE PROTEIN PUR, P105, DOI DOI 10.1016/B978-012361776-7/50006-1; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Spector DL, 2001, J CELL SCI, V114, P2891; Tachibana T, 2000, CELL STRUCT FUNCT, V25, P115, DOI 10.1247/csf.25.115; Takahashi Y, 1996, J BIOL CHEM, V271, P14541, DOI 10.1074/jbc.271.24.14541; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P15808, DOI 10.1074/jbc.270.26.15808; Yamasaki M, 1999, J BIOL CHEM, V274, P35293, DOI 10.1074/jbc.274.50.35293; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yoshida H, 2001, GENES CELLS, V6, P877, DOI 10.1046/j.1365-2443.2001.00473.x; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	45	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7563	7575		10.1074/jbc.M607180200	http://dx.doi.org/10.1074/jbc.M607180200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209048	hybrid			2022-12-27	WOS:000245080900069
J	Isin, EM; Guengerich, FP				Isin, Emre M.; Guengerich, F. Peter			Multiple sequential steps involved in the binding of inhibitors to cytochrome p450 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; SINGULAR VALUE DECOMPOSITION; DRUG-DRUG INTERACTIONS; HUMAN P-GLYCOPROTEIN; ACTIVE-SITE; LIGAND-BINDING; HUMAN-LIVER; IN-VITRO; ALPHA-NAPHTHOFLAVONE; ELECTRON-TRANSFER	Cytochrome P450 (P450) 3A4 is an extensively studied human enzyme involved in the metabolism of > 50% of drugs. The mechanism of the observed homotropic and heterotropic cooperativity in P450 3A4-catalyzed oxidations is not well understood, and together with the cooperative behavior, a detailed understanding of interaction of drug inhibitors with P450 3A4 is important in predicting clinical drug-drug interactions. The interactions of P450 3A4 with several structurally diverse inhibitors were investigated using both kinetic and thermodynamic approaches to resolve the steps involved in binding of these ligands. The results of pre-steady-state absorbance and fluorescence experiments demonstrate that inhibitor binding is clearly a multistep process, even more complex than the binding of substrates. Based on spectrophotometric equilibrium binding titrations as well as isothermal titration calorimetry experiments, the stoichiometry of binding appears to be 1:1 in the concentration ranges studied. Using a sequential-mixing stopped-flow approach, we were also able to show that the observed multiphasic binding kinetics is the result of sequential events as opposed to the existence of multiple enzyme populations in dynamic equilibrium that interact with ligands at different rates. We propose a three-step minimal model for inhibitor binding, developed with kinetic simulations, consistent with our previously reported model for the binding of substrates, although it is possible that even more steps are involved.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,23rd & Pierce Aves, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Isin, Emre/0000-0003-3402-7685	NCI NIH HHS [R37 CA090426] Funding Source: Medline; NIEHS NIH HHS [P30 ES000267] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Atkins WM, 2006, EXPERT OPIN DRUG MET, V2, P573, DOI 10.1517/17425255.2.4.573; Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; BUENING MK, 1978, BIOCHEM BIOPH RES CO, V82, P348, DOI 10.1016/0006-291X(78)90616-2; Cameron MD, 2005, BIOCHEMISTRY-US, V44, P14143, DOI 10.1021/bi051689t; CHAN TF, 1982, ACM T MATH SOFTWARE, V8, P72, DOI 10.1145/355984.355990; Cliff MJ, 2003, J MOL RECOGNIT, V16, P383, DOI 10.1002/jmr.648; Cliff MJ, 2004, J MOL RECOGNIT, V17, P513, DOI 10.1002/jmr.714; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Ekins S, 1997, PHARMACOGENETICS, V7, P165, DOI 10.1097/00008571-199706000-00001; Ekins S, 2003, TRENDS PHARMACOL SCI, V24, P161, DOI 10.1016/S0165-6147(03)00049-X; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fernando H, 2006, BIOCHEMISTRY-US, V45, P4199, DOI 10.1021/bi052491b; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; HE YA, 2006, 16 INT S MICR DRUG O, P114; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Hummel MA, 2004, BIOCHEM PHARMACOL, V67, P1831, DOI 10.1016/j.bcp.2004.01.017; Hutzler JM, 2001, DRUG METAB DISPOS, V29, P1029; Imai Y., 1978, CYTOCHROME P450, P37; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; KAPITULNIK J, 1977, CLIN PHARMACOL THER, V22, P475; Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644; KNUTSON JR, 1983, CHEM PHYS LETT, V102, P501, DOI 10.1016/0009-2614(83)87454-5; Koley AP, 1996, BIOCHIMIE, V78, P706, DOI 10.1016/S0300-9084(97)82528-X; Koley AP, 1997, BIOCHEM PHARMACOL, V53, P455, DOI 10.1016/S0006-2952(96)00836-2; Koley AP, 1997, J BIOL CHEM, V272, P3149, DOI 10.1074/jbc.272.6.3149; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01; Lampe JN, 2006, BIOCHEMISTRY-US, V45, P12204, DOI 10.1021/bi060083h; Locuson CW, 2006, ARCH BIOCHEM BIOPHYS, V449, P115, DOI 10.1016/j.abb.2006.02.004; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; MAEDER M, 1990, ANAL CHEM, V62, P2220, DOI 10.1021/ac00219a013; MATHESON IBC, 1989, COMPUT CHEM, V13, P299, DOI 10.1016/0097-8485(89)80036-1; MATHESON IBC, 1987, ANAL INSTRUM, V16, P345; MATHESON IBC, 1990, COMPUT CHEM, V14, P49, DOI 10.1016/0097-8485(90)80007-O; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; PALMER G, 1992, J BIOL CHEM, V267, P665; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; Roberts AG, 2005, BIOCHEMISTRY-US, V44, P1353, DOI 10.1021/bi0481390; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHIMADA T, 1989, P NATL ACAD SCI USA, V86, P462, DOI 10.1073/pnas.86.2.462; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Shou MG, 2002, METHOD ENZYMOL, V357, P261; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; UENG YF, 1997, BIOCHEMISTRY-US, V36, pS381; Venkatakrishnan K, 1998, J CLIN PHARMACOL, V38, P112, DOI 10.1002/j.1552-4604.1998.tb04399.x; Wanchana S, 2003, PHARM RES-DORDR, V20, P1401, DOI 10.1023/A:1025702009611; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhang QY, 1999, DRUG METAB DISPOS, V27, P804	74	61	61	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6863	6874		10.1074/jbc.M610346200	http://dx.doi.org/10.1074/jbc.M610346200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200113	hybrid			2022-12-27	WOS:000244867200096
J	Ohkawa, Y; Yoshimura, S; Higashi, C; Marfella, CGA; Dacwag, CS; Tachibana, T; Imbalzano, AN				Ohkawa, Yasuyuki; Yoshimura, Saori; Higashi, Chiduru; Marfella, Concetta G. A.; Dacwag, Caroline S.; Tachibana, Taro; Imbalzano, Anthony N.			Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; MUSCLE DIFFERENTIATION; SATELLITE CELLS; STEM-CELLS; MYOD; SPECIFICATION; ACTIVATION; MUTATION; DISTINCT; FAMILY	Many studies have examined transcriptional regulation during the initiation of skeletal muscle differentiation; however, there is less information regarding transcriptional control during adult myogenesis and during the maintenance of the differentiated state. MyoD and the mammalian SWI/SNF chromatinremodeling enzymes containing the Brg1 ATPase are necessary to induce myogenesis in cell culture models and in developing embryonic tissue, whereas myogenin and Brg1 are critical for the expression of the late genes that induce terminal muscle differentiation. Here, we demonstrate that myogenin also binds to its own promoter during the late stages of embryonic muscle development. As is the case during embryonic myogenesis, MyoD and Brg1 co-localize to the myogenin promoter in primary adult muscle satellite cells. However, in mature myofibers, myogenin and Brg1 are preferentially co-localized to the myogenin promoter. Thus, the myogenin promoter is occupied by different myogenic factors at different times of myogenesis. The relevance of myogenin in the continued expression from its own promoter is demonstrated in culture, where we show that myogenin, in the absence of MyoD, is capable of maintaining its own expression by recruiting the Brg1 ATPase to modify promoter chromatin structure and facilitate myogenin expression. Finally, we utilized in vivo electroporation to demonstrate that Brg1 is required for the continued production of the myogenin protein in newborn skeletal muscle tissue. These findings strongly suggest that the skeletal muscle phenotype is maintained by myogenin and the continuous activity of Brg1-based SWI/SNF chromatin-remodeling enzymes.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; Osaka City Univ, Dept Bioengn, Osaka 5588585, Japan	University of Massachusetts System; University of Massachusetts Worcester; Osaka Metropolitan University	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	anthony.imbalzano@umassmed.edu	Ohkawa, Yasuyuki/C-4087-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954	NIGMS NIH HHS [GM56244, R01 GM056244] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; CHENG TC, 1995, P NATL ACAD SCI USA, V92, P561, DOI 10.1073/pnas.92.2.561; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; EDMONDSON DG, 1991, J BIOL CHEM, V266, P21343; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Valdez MR, 2000, DEV BIOL, V219, P287, DOI 10.1006/dbio.2000.9621; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	38	61	64	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6564	6570		10.1074/jbc.M608898200	http://dx.doi.org/10.1074/jbc.M608898200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194702	hybrid			2022-12-27	WOS:000244867200065
J	Favari, E; Gomaraschi, M; Zanotti, I; Bernini, F; Lee-Rueckert, M; Kovanen, PT; Sirtori, CR; Franceschini, G; Calabresi, L				Favari, Elda; Gomaraschi, Monica; Zanotti, Ilaria; Bernini, Franco; Lee-Rueckert, Miriam; Kovanen, Petri T.; Sirtori, Cesare R.; Franceschini, Guido; Calabresi, Laura			A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I-Milano dimer effectively promotes ATP-binding cassette A1-mediated cell cholesterol efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; LIPID EFFLUX; SR-BI; IMILANO APOPROTEIN; HDL; ABCA1; ATHEROSCLEROSIS; ACYLTRANSFERASE; TRANSPORTERS; LECITHIN	Carriers of the apolipoprotein A-I-Milano (A-I-M) variant present with severe reductions of plasma HDL levels, not associated with premature coronary heart disease (CHD). Sera from 14 A-I-M. carriers and matched controls were compared for their ability to promote ABCA1-driven cholesterol efflux from J774 macrophages and human fibroblasts. When both cell types are stimulated to express ABCA1, the efflux of cholesterol through this pathway is greater with A-I-M than control sera (3.4 +/- 1.0% versus 2.3 +/- 1.0% in macrophages; 5.2 +/- 2.4% versus 1.9 +/- 0.1% in fibroblasts). A-I-M and control sera are instead equally effective in removing cholesterol from unstimulated cells and from fibroblasts not expressing ABCA1. The A-I-M sera contain normal amounts of apoA-I-containing pre beta-HDL and varying concentrations of a unique small HDL particle containing a single molecule of the A-I-M, dimer; chymase treatment of serum degrades both particles and abolishes ABCA1-mediated cholesterol efflux. The serum content of chymase-sensitive HDL correlates strongly and significantly with ABCA1-mediated cholesterol efflux (r = 0.542, p = 0.004). The enhanced capacity of A-I-M serum for ABCA1 cholesterol efflux is thus explained by the combined occurrence in serum of normal amounts of apoA-I-containing pre beta-HDL, together with a unique protease-sensitive, small HDL particle containing the A-I-M dimer, both effective in removing cell cholesterol via ABCA1.	Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Parma, Dept Pharmacol & Biol Sci, I-43100 Parma, Italy; Wihuri Res Inst, SF-00140 Helsinki, Finland	University of Milan; University of Parma; Wihuri Research Institute	Franceschini, G (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	Guido.Franceschini@unimi.it	Sirtori, Cesare/F-4658-2012; Bernini, Franco/B-6740-2011; Favari, Elda/B-6830-2011; Gomaraschi, Monica/A-3601-2014	Gomaraschi, Monica/0000-0003-3082-2120; FRANCESCHINI, GUIDO/0000-0003-2687-1771; Zanotti, Ilaria/0000-0003-2701-6021; Favari, Elda/0000-0002-5901-2482; Calabresi, Laura/0000-0001-5042-9532				Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Bielicki JK, 2002, BIOCHEMISTRY-US, V41, P2089, DOI 10.1021/bi011716p; Bielicki JK, 1997, ARTERIOSCL THROM VAS, V17, P1637, DOI 10.1161/01.ATV.17.9.1637; Calabresi L, 1997, BIOCHEM BIOPH RES CO, V232, P345, DOI 10.1006/bbrc.1997.6286; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Calabresi L, 1997, BIOCHEMISTRY-US, V36, P12428, DOI 10.1021/bi970505a; Calabresi L, 2001, J LIPID RES, V42, P935; Calabresi L, 1999, BIOCHEMISTRY-US, V38, P16307, DOI 10.1021/bi991246n; Chiesa G, 2002, CIRC RES, V90, P974, DOI 10.1161/01.RES.0000018422.31717.EE; Cho KH, 2006, EUR J CLIN INVEST, V36, P875, DOI 10.1111/j.1365-2362.2006.01737.x; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; DELALLERAMOYA M, 1994, ARTERIOSCLER THROMB, V14, P1056, DOI 10.1161/01.ATV.14.7.1056; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Favari E, 2002, BIOCHEM BIOPH RES CO, V299, P801, DOI 10.1016/S0006-291X(02)02745-6; FIELDING CJ, 1995, J LIPID RES, V36, P211; Franceschini G, 1999, ARTERIOSCL THROM VAS, V19, P1257, DOI 10.1161/01.ATV.19.5.1257; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; FRANCESCHINI G, 1985, ATHEROSCLEROSIS, V58, P159, DOI 10.1016/0021-9150(85)90063-2; FRANCESCHINI G, 1990, J BIOL CHEM, V265, P12224; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; GLOMSET JA, 1968, J LIPID RES, V9, P155; GUALANDRI V, 1985, AM J HUM GENET, V37, P1083; Hassan HH, 2005, J LIPID RES, V46, P1457, DOI 10.1194/jlr.M400477-JLR200; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Lee M, 2003, J LIPID RES, V44, P539, DOI 10.1194/jlr.M200420-JLR200; Lindstedt L, 2001, ATHEROSCLEROSIS, V155, P87, DOI 10.1016/S0021-9150(00)00544-X; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Perez-Mendez O, 2000, ATHEROSCLEROSIS, V148, P317, DOI 10.1016/S0021-9150(99)00279-8; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; ROMA P, 1993, J CLIN INVEST, V91, P1445, DOI 10.1172/JCI116349; RYE KA, 1994, J BIOL CHEM, V269, P10298; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; Sirtori CR, 2001, CIRCULATION, V103, P1949; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2508; Yancey PG, 2004, J LIPID RES, V45, P1724, DOI 10.1194/jlr.M400133-JLR200; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Yokoyama S, 2005, CURR OPIN LIPIDOL, V16, P269, DOI 10.1097/01.mol.0000169346.15450.90; Yu LQ, 2004, J LIPID RES, V45, P889, DOI 10.1194/jlr.M300461-JLR200	52	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5125	5132		10.1074/jbc.M609336200	http://dx.doi.org/10.1074/jbc.M609336200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17164237	hybrid			2022-12-27	WOS:000244482300006
J	Mazharian, A; Roger, S; Berrou, E; Adam, F; Kauskot, A; Nurden, P; Jandrot-Perrus, M; Bryckaert, M				Mazharian, Alexandra; Roger, Severine; Berrou, Eliane; Adam, Frederic; Kauskot, Alexandre; Nurden, Paquita; Jandrot-Perrus, Martine; Bryckaert, Marijke			Protease-activating receptor-4 induces full platelet spreading on a fibrinogen - Involvement of Erk2 and p38 and Ca2+ matrix mobilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; THROMBIN-RECEPTOR; MAP KINASE; AGGREGATION; COLLAGEN; SECRETION; KINETICS; ADHESION; PATHWAY; BINDING	Although the involvement of protease-activating receptor PAR I and PAR4 is well established in platelet aggregation, their role in platelet adhesion and spreading has yet to be characterized. We investigated platelet adhesion and spreading on a fibrinogen matrix after PARI and PAR4 stimulation in correlation with the activation of two MAPKs, ERK2 and p38. Of the two PAR-activating peptides (PAR-APs), PAR1-AP and PAR4-AP, which both induce adhesion, only PAR4-AP induced full platelet spreading. Although both PAR1-AP and PAR4-AP induced ADP secretion, which is required for platelet spreading, only PAR4-AP induced sustained Ca2+ mobilization. In these conditions of PAR4 induction, ERK2 and p38 activation were involved in platelet spreading but not in platelet adhesion. p38 phosphorylation was dependent on ADP signaling through P2Y12, its receptor. ERK2 phosphorylation was triggered through integrin aIIb beta 3 outside-in signaling and was dependent on the Rho pathway. ERK2 and p38 activation induced phosphorylation of the myosin light chain and actin polymerization, respectively, necessary for cytoskeleton reorganization. These findings provide the first evidence that thrombin requires PAR4 for the full spreading response. ERK2 and p38 and sustained Ca2+ mobilization, involved in PAR4-induced platelet spreading, contribute to the stabilization of platelet thrombi at sites of high thrombin production.	Hop Lariboisiere, INSERM, U689, IFR 139, F-75010 Paris, France; Hop Bichat Claude Bernard, INSERM, U698, F-75018 Paris, France; Hop Cardiol, Hematol Lab, IFR4, F-33604 Pessac, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux	Bryckaert, M (corresponding author), Hop Lariboisiere, INSERM, U689, IFR 139, 8 Rue Guy Patin, F-75010 Paris, France.	marijke.bryckaert@larib.inserm.fr	Jandrot-Perrus, Martine/GZM-1526-2022; Kauskot, Alexandre/J-6794-2015	Kauskot, Alexandre/0000-0002-4064-8114; Bryckaert, Marijke/0000-0003-3398-0976; ADAM, Frederic/0000-0001-6603-2687; JANDROT-PERRUS, Martine/0000-0002-8450-9247; Mazharian, Alexandra/0000-0002-0204-3325				Adam F, 2003, J THROMB HAEMOST, V1, P798, DOI 10.1046/j.1538-7836.2003.00138.x; Aharonovitz O, 1996, J BIOL CHEM, V271, P16494, DOI 10.1074/jbc.271.28.16494; BEZEAUD A, 1985, EUR J BIOCHEM, V153, P491, DOI 10.1111/j.1432-1033.1985.tb09328.x; Bugaud F, 1999, BLOOD, V94, P3800, DOI 10.1182/blood.V94.11.3800.423k25_3800_3805; Canobbio I, 2004, THROMB HAEMOSTASIS, V91, P102, DOI 10.1160/TH03-02-0083; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; Falker K, 2004, THROMB HAEMOSTASIS, V92, P114, DOI 10.1160/th03-12-0729; GANGULY P, 1979, BRIT J HAEMATOL, V42, P137, DOI 10.1111/j.1365-2141.1979.tb03706.x; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; HUNG DT, 1992, J BIOL CHEM, V267, P20831; JAMIESON GA, 1978, J CLIN INVEST, V61, P861, DOI 10.1172/JCI109000; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Mazharian A, 2005, J BIOL CHEM, V280, P26002, DOI 10.1074/jbc.M414083200; Minuz P, 2002, THROMB HAEMOSTASIS, V87, P888; Nadal F, 1997, J BIOL CHEM, V272, P22381, DOI 10.1074/jbc.272.36.22381; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; OKUMURA T, 1978, J BIOL CHEM, V253, P3435; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sakurai K, 2004, J RECEPT SIG TRANSD, V24, P283, DOI 10.1081/RRS-200040324; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Siljander P, 2001, ARTERIOSCL THROM VAS, V21, P618, DOI 10.1161/01.ATV.21.4.618; Simoes RL, 2005, J IMMUNOL, V175, P1843, DOI 10.4049/jimmunol.175.3.1843; Toth-Zsamboki E, 2003, J BIOL CHEM, V278, P46661, DOI 10.1074/jbc.M308452200; Vijayan KV, 2003, J BIOL CHEM, V278, P3860, DOI 10.1074/jbc.M208680200; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xiao DL, 2005, AM J PHYSIOL-HEART C, V288, pH2828, DOI 10.1152/ajpheart.01189.2004; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	43	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5478	5487		10.1074/jbc.M609881200	http://dx.doi.org/10.1074/jbc.M609881200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17200114	hybrid			2022-12-27	WOS:000244482300042
J	Ventadour, S; Jarzaguet, M; Wing, SS; Chambon, C; Combaret, L; Bechet, D; Attaix, D; Taillandier, D				Ventadour, Sophie; Jarzaguet, Marianne; Wing, Simon S.; Chambon, Christophe; Combaret, Lydie; Bechet, Daniel; Attaix, Didier; Taillandier, Daniel			A new method of purification of proteasome substrates reveals polyubiquitination of 20 S proteasome subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN; EXPRESSION; PROTEINS; BINDING	The 26 S proteasome is implicated in the control of many major biological functions but a reliable method for the identification of its major substrates, i.e. polyubiquitin (Ub) conjugates, is still lacking. Based on the steps present in cells, i.e. recognition and deubiquitination, we developed an affinity matrix-based purification of polyUb conjugates suitable for any biological sample. Ub-conjugates were first purified from proteasome inhibitor-treated C2C12 cells using the Ub binding domains of the S5a proteasome subunit bound to an affinity matrix and then deubiquitinated by the catalytic domain of the USP2 enzyme. This two step purification of proteasome substrates involving both protein-protein interactions and enzyme-mediated release allowed highly specific isolation of polyUb 26 S proteasome substrates, which were then resolved on two-dimensional gels post-deubiquitination. To establish our method, we focused on a gel area where spots were best resolved. Surprisingly, spot analysis by mass spectrometry identified alpha 2, alpha 6, alpha 7, beta 2, beta 3, beta 4, and beta 5 20 S proteasome subunits as potential substrates. Western blots using an anti-beta 3 proteasome subunit antibody confirmed that high molecular weight forms of beta 3 were present, particularly in proteasome inhibitor-treated cells. Sucrose gradients of cell lysates suggested that the proteasome was first disassembled before subunits were polyubiquitinated. Altogether, we provide a technique that enables large scale identification of 26 S proteasome substrates that should contribute to a better understanding of this proteolytic machinery in any living cell and/or organ/tissue. Furthermore, the data suggest that proteasome homeostasis involves an autoregulatory mechanism.	INRA, UMR1019, Human Nutr Unit, F-63122 Ceyrat, France; Human Nutr Res Ctr, Proteom Core Facil, F-63122 Ceyrat, France; McGill Univ, Dept Med, Montreal, PQ H3A 2B2, Canada	INRAE; McGill University	Taillandier, D (corresponding author), INRA, UMR1019, Human Nutr Unit, F-63122 Ceyrat, France.	taillandier@clermont.inra.fr	Bechet, Daniel/AAU-2874-2020; chambon, christophe/A-1788-2017; Attaix, Didier/H-5247-2011; Wing, Simon/D-2589-2012	Bechet, Daniel/0000-0002-3812-8099; chambon, christophe/0000-0003-0357-9807; Wing, Simon/0000-0001-8394-7563; Taillandier, Daniel/0000-0003-4520-0551; Attaix, Didier/0000-0002-0429-9957; Combaret, Lydie/0000-0001-6550-8700				Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Denison C, 2005, CURR OPIN CHEM BIOL, V9, P69, DOI 10.1016/j.cbpa.2004.10.010; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Somara S, 2004, AM J PHYSIOL-CELL PH, V286, pC1290, DOI 10.1152/ajpcell.00458.2003; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; ZHANG N, 1993, DEV BIOL, V157, P214, DOI 10.1006/dbio.1993.1125	25	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5302	5309		10.1074/jbc.M610005200	http://dx.doi.org/10.1074/jbc.M610005200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189251	Green Published, hybrid			2022-12-27	WOS:000244482300025
J	White, SN; Paine, ML; Ngan, AYW; Miklus, VG; Luo, W; Wang, HJ; Snead, ML				White, Shane N.; Paine, Michael L.; Ngan, Amanda Y. W.; Miklus, Vetea G.; Luo, Wen; Wang, HongJun; Snead, Malcolm L.			Ectopic expression of dentin sialoprotein during amelogenesis hardens bulk enamel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-TEETH; MECHANICAL-PROPERTIES; FRACTURE-TOUGHNESS; DENTINOENAMEL JUNCTION; INDENTATION; ZONE; PHOSPHOPROTEIN; COMPONENTS; MODULUS; MATRIX	Dentin sialophosphpoprotein (Dspp) is transiently expressed in the early stage of secretory ameloblasts. The secretion of ameloblast-derived Dspp is short-lived, correlates to the establishment of the dentinoenamel junction (DEJ), and is consistent with Dspp having a role in producing the specialized first-formed harder enamel adjacent to the DEJ. Crack diffusion by branching and dissipation within this specialized first-formed enamel close to the DEJ prevents catastrophic interfacial damage and tooth failure. Once Dspp is secreted, it is subjected to proteolytic cleavage that results in two distinct proteins referred to as dentin sialoprotein (Dsp) and dentin phosphoprotein (Dpp). The purpose of this study was to investigate the biological and mechanical contribution of Dsp and Dpp to enamel formation. Transgenic mice were engineered to overexpress either Dsp or Dpp in their enamel organs. The mechanical properties (hardness and toughness) of the mature enamel of transgenic mice were compared with genetically matched and age-matched nontransgenic animals. Dsp and Dpp contributions to enamel formation greatly differed. The inclusion of Dsp in bulk enamel significantly and uniformly increased enamel hardness (20%), whereas the inclusion of Dpp weakened the bulk enamel. Thus, Dsp appears to make a unique contribution to the physical properties of the DEJ. Dsp transgenic animals have been engineered with superior enamel mechanical properties.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles	Paine, ML (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA Rm 142, Los Angeles, CA 90033 USA.	paine@usc.edu			NIDCR NIH HHS [DE013404, DE013045, DE014189] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045, R01DE013404, K22DE014189] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x; Balooch G, 2004, J BIOMECH, V37, P1223, DOI 10.1016/j.jbiomech.2003.12.012; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Boyde A, 1997, CIBA F SYMP, V205, P18; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; Dong XD, 2003, J BIOMED MATER RES A, V66A, P103, DOI 10.1002/jbm.a.10541; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Elliott J C, 1994, J Xray Sci Technol, V4, P102, DOI 10.3233/XST-1994-4204; ELMOWAFY OM, 1986, J DENT RES, V65, P677, DOI 10.1177/00220345860650050901; EVANS AG, 1976, J AM CERAM SOC, V59, P371, DOI 10.1111/j.1151-2916.1976.tb10991.x; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Habelitz S, 2001, J STRUCT BIOL, V135, P294, DOI 10.1006/jsbi.2001.4409; HASSAN R, 1981, J DENT RES, V60, P820, DOI 10.1177/00220345810600040901; HOGAN B, 1986, MANIPULATING MOUSE E; IGNELZI MA, 1995, CRIT REV ORAL BIOL M, V6, P181, DOI 10.1177/10454411950060030201; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901; MacDougall M, 1998, CONNECT TISSUE RES, V39, P25, DOI 10.3109/03008209809023909; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200; Qin CL, 2003, CONNECT TISSUE RES, V44, P179, DOI 10.1080/03008200390152296; RASMUSSEN ST, 1984, J DENT RES, V63, P1279, DOI 10.1177/00220345840630110501; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Ritchie HH, 1997, EUR J ORAL SCI, V105, P405, DOI 10.1111/j.1600-0722.1997.tb02137.x; von Ebner V, 1906, ARCH MIKRO ANAT ENTW, V67, P18; von Korff K, 1906, ARCH MIKRO ANAT ENTW, V67, P1; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; WEIDENREICH F, 1925, ANAT ENTW GERSCH, V76, P218; White SN, 2005, J PROSTHET DENT, V94, P330, DOI 10.1016/j.prosdent.2005.08.013; White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x; White SN, 2001, J DENT RES, V80, P321, DOI 10.1177/00220345010800010501; Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Zaslansky P, 2006, J STRUCT BIOL, V153, P188, DOI 10.1016/j.jsb.2005.10.010; ZHANG J, 1994, J MATER SCI, V29, P4022, DOI 10.1007/BF00355964	38	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5340	5345		10.1074/jbc.M604814200	http://dx.doi.org/10.1074/jbc.M604814200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189271	hybrid			2022-12-27	WOS:000244482300029
J	Gong, HS; Murphy, A; McMaster, CR; Byers, DM				Gong, Huansheng; Murphy, Anne; McMaster, Christopher R.; Byers, David M.			Neutralization of acidic residues in helix II stabilizes the folded conformation of acyl carrier protein and variably alters its function with different enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; VIBRIO-HARVEYI; POLYKETIDE SYNTHASE; CATION-BINDING; BIOSYNTHESIS; SYNTHETASE; ACYLTRANSFERASE; IDENTIFICATION; SITE	Acyl carrier protein (ACP), a small protein essential for bacterial growth and pathogenesis, interacts with diverse enzymes during the biosynthesis of fatty acids, phospholipids, and other specialized products such as lipid A. NMR and hydrodynamic studies have previously shown that divalent cations stabilize native helical ACP conformation by binding to conserved acidic residues at two sites (A and B) at either end of the "recognition" helix II. To examine the roles of these amino acids in ACP structure and function, site-directed mutagenesis was used to replace individual site A (Asp-30, Asp-35, Asp-38) and site B (Glu-47, Glu-53, Asp-56) residues in recombinant Vibrio harveyi ACP with the corresponding amides, along with combined mutations at each site (SA, SB) or both sites (SA/SB). Like native V, harveyi ACP, all individual mutants were unfolded at neutral pH but adopted a helical conformation in the presence of millimolar Mg2+ or upon fatty acylation. Mg2+ binding to sites A or B independently stabilized native ACP conformation, whereas mutant SA/SB was folded in the absence of Mg2+, suggesting that charge neutralization is largely responsible for ACP stabilization by divalent cations. Asp-35 in site A was critical for holo-ACP synthase activity, while acyl-ACP synthetase and UDP-N-acetylglucosamine acyltransferase (LpxA) activities were more affected by mutations in site B. Both sites were required for fatty acid synthase activity. Overall, our results indicate that divalent cation binding site mutations have predicted effects on ACP conformation but unpredicted and variable consequences on ACP function with different enzymes.	Dalhousie Univ, Atlantic Res Ctr, Clin Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Clin Res Ctr, Dept Biochem, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Clin Res Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Byers, DM (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Clin Res Ctr, Dept Pediat, Rm C-305,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	david.byers@dal.ca		McMaster, Christopher/0000-0003-0822-5776				ABITA JP, 1971, EUR J BIOCHEM, V23, P412, DOI 10.1111/j.1432-1033.1971.tb01635.x; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; ANDREC M, 1995, PROTEIN SCI, V4, P983; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; BYERS DM, 1985, P NATL ACAD SCI USA, V82, P6085, DOI 10.1073/pnas.82.18.6085; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; FICE D, 1993, J BACTERIOL, V175, P1865, DOI 10.1128/JB.175.7.1865-1870.1993; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GEIGER O, 1991, J BACTERIOL, V173, P2872, DOI 10.1128/JB.173.9.2872-2878.1991; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jain NU, 2004, J MOL BIOL, V343, P1379, DOI 10.1016/j.jmb.2004.08.103; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KIM YM, 1990, J AM CHEM SOC, V112, P3707, DOI 10.1021/ja00165a092; Lambalot RH, 1997, METHOD ENZYMOL, V279, P254; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROCK CO, 1981, J BIOL CHEM, V256, P2669; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; RUMLEY MK, 1992, J BIOL CHEM, V267, P11806; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; SCHULZ H, 1969, J BIOL CHEM, V244, P6577; SCHULZ H, 1975, J BIOL CHEM, V250, P2299; SHEN B, 1992, J BACTERIOL, V174, P3818, DOI 10.1128/JB.174.11.3818-3821.1992; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; TENER DM, 1990, EUR J BIOCHEM, V189, P559, DOI 10.1111/j.1432-1033.1990.tb15523.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	48	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4494	4503		10.1074/jbc.M608234200	http://dx.doi.org/10.1074/jbc.M608234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179150	hybrid			2022-12-27	WOS:000244482000031
J	Del Re, DP; Miyamoto, S; Brown, JH				Del Re, Dominic P.; Miyamoto, Shigeki; Brown, Joan Heller			RhoA/Rho kinase up-regulate bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-ALPHA-Q; RAT VENTRICULAR MYOCYTES; CYTOCHROME-C RELEASE; MYOSIN LIGHT CHAIN-2; TUMOR-SUPPRESSOR P53; RHO-KINASE; GENE-EXPRESSION; CARDIAC MYOCYTES; CELL-DEATH; HEART-FAILURE	The small G-protein RhoA regulates the actin cytoskeleton, and its involvement in cell proliferation has also been established. In contrast, little is known about whether RhoA participates in cell survival or apoptosis. In cardiomyocytes in vitro, RhoA induces hypertrophic cell growth and gene expression. In vivo, however, RhoA expression leads to development of heart failure (Sah, V. P., Minamisawa, S., Tam, S. P., Wu, T. H., Dorn, G. W., Ross, J. Jr., Chien, K. R., and Brown, J. H. (1999) J. Clin. Investig. 103, 1627-1634), a condition widely associated with cardiomyocyte apoptosis. We demonstrate here that adenoviral overexpression of activated RhoA in cardiomyocytes induces hypertrophy, which transitions over time to apoptosis, as evidenced by caspase activation and nucleosomal DNA fragmentation. The Rho kinase inhibitors Y-27632 and HA-1077 and expression of a dominant negative Rho kinase block these responses. Caspase-9, but not caspase-8, is activated, and its inhibition prevents DNA fragmentation, consistent with involvement of a mitochondrial death pathway. Interestingly, RhoA expression induces a 3-4-fold up-regulation of the proapoptotic Bcl-2 family protein Bax. RhoA also increases levels of activated Bax and the amount of Bax protein localized at mitochondria. Bax mRNA is increased by RhoA, indicating transcriptional regulation, and the ability of a dominant negative p53 mutant to block Bax up-regulation implicates p53 in this response. The involvement of Bax in RhoA-induced apoptosis was examined by treatment with a Bax-inhibitory peptide, which was found to significantly attenuate DNA fragmentation and caspase-9 and -3 activation. The dominant negative p53 also prevents RhoA-induced apoptosis. We conclude that RhoA/Rho kinase activation up-regulates Bax through p53 to induce a mitochondrial death pathway and cardiomyocyte apoptosis.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Miyamoto, Shigeki/L-4004-2019	Del Re, Dominic/0000-0002-5504-9114	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028143, R37HL028143] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28143] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JW, 2000, CIRC RES, V87, P1180, DOI 10.1161/01.RES.87.12.1180; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; De Sarno L, 2005, BRAIN RES, V1041, P112, DOI 10.1016/j.brainres.2005.01.081; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Esteve P, 1998, ONCOGENE, V17, P1855, DOI 10.1038/sj.onc.1202082; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Hines WA, 1998, J MOL CELL CARDIOL, V30, P485, DOI 10.1006/jmcc.1997.0613; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LEE HR, 1988, J BIOL CHEM, V263, P7352; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Miao L, 2002, LIFE SCI, V71, P1175, DOI 10.1016/S0024-3205(02)01827-1; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Natori S, 1999, TRANSPLANTATION, V68, P89, DOI 10.1097/00007890-199907150-00018; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Regula KM, 2001, J MOL CELL CARDIOL, V33, P1435, DOI 10.1006/jmcc.2001.1405; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Satoh S, 2003, J MOL CELL CARDIOL, V35, P59, DOI 10.1016/S0022-2828(02)00278-X; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; SHUBEITA HE, 1992, P NATL ACAD SCI USA, V89, P1305, DOI 10.1073/pnas.89.4.1305; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200	56	119	121	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8069	8078		10.1074/jbc.M604298200	http://dx.doi.org/10.1074/jbc.M604298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234627	hybrid			2022-12-27	WOS:000245081000039
J	Huster, D; Purnat, TD; Burkhead, JL; Ralle, M; Fiehn, O; Stuckert, F; Olson, NE; Teupser, D; Lutsenko, S				Huster, Dominik; Purnat, Tina D.; Burkhead, Jason L.; Ralle, Martina; Fiehn, Oliver; Stuckert, Franziska; Olson, N. Erik; Teupser, Daniel; Lutsenko, Svetlana			High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; FATTY-ACID SYNTHASE; GENE-EXPRESSION; STATISTICAL-MODEL; MICROARRAY DATA; LIVER; IDENTIFICATION; TRANSCRIPTION; BINDING; PROTEIN	Copper is essential for human physiology, but in excess it causes the severe metabolic disorder Wilson disease. Elevated copper is thought to induce pathological changes in tissues by stimulating the production of reactive oxygen species that damage multiple cell targets. To better understand the molecular basis of this disease, we performed genome-wide mRNA profiling as well as protein and metabolite analysis for Atp7b(-/-) mice, an animal model of Wilson disease. We found that at the presymptomatic stages of the disease, copper-induced changes are inconsistent with widespread radical-mediated damage, which is likely due to the sequestration of cytosolic copper by metallothioneins that are markedly up-regulated in Atp7b(-/-) livers. Instead, copper selectively up-regulates molecular machinery associated with the cell cycle and chromatin structure and down-regulates lipid metabolism, particularly cholesterol biosynthesis. Specific changes in the transcriptome are accompanied by distinct metabolic changes. Biochemical and mass spectroscopy measurements revealed a 3.6-fold decrease of very low density lipoprotein cholesterol in serum and a 33% decrease of liver cholesterol, indicative of a marked decrease in cholesterol biosynthesis. Consistent with low cholesterol levels, the amount of activated sterol regulatory-binding protein 2 (SREBP-2) is increased in Atp7b(-/-) nuclei. However, the SREBP-2 target genes are dysregulated suggesting that elevated copper alters SREBP-2 function rather than its processing or re-localization. Thus, in Atp7b(-/-) mice elevated copper affects specific cellular targets at the transcription and/or translation levels and has distinct effects on liver metabolic function, prior to appearance of histopathological changes. The identification of the network of specific copper-responsive targets facilitates further mechanistic analysis of human disorders of copper misbalance.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Leipzig, Dept Med 2, D-04103 Leipzig, Germany; Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; VizX Labs, Seattle, WA 98119 USA	Oregon Health & Science University; Leipzig University; Leipzig University; University of California System; University of California Davis	Lutsenko, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L224,Sam Jackson Pk Rd, Portland, OR 97239 USA.	lutsenko@ohsu.edu	Burkhead, Jason/C-9612-2013; Ralle, Martina/H-2936-2019	Burkhead, Jason/0000-0001-5457-311X; PURNAT, Tina/0000-0002-0257-6631	NIGMS NIH HHS [P01 GM 067166-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALOTHMAN AA, 1992, J NUTR, V122, P1199, DOI 10.1093/jn/122.6.1199; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Bove KE, 2004, PEDIATR DEVEL PATHOL, V7, P315, DOI 10.1007/s10024-002-1201-8; Brewer GJ, 1998, AM J CLIN NUTR, V67, p1087S, DOI 10.1093/ajcn/67.5.1087S; Britton RS, 1996, SEMIN LIVER DIS, V16, P3, DOI 10.1055/s-2007-1007214; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cherian MG, 2006, EXP BIOL MED, V231, P138; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; COX D, 2006, WILSON DIS, P1601; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferenci P, 2004, METAB BRAIN DIS, V19, P229, DOI 10.1023/B:MEBR.0000043973.10494.85; Foretz M, 1999, BIOCHEM J, V341, P371, DOI 10.1042/0264-6021:3410371; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hu R, 2006, LIFE SCI, V79, P1944, DOI 10.1016/j.lfs.2006.06.019; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLER A, 2005, MOL SYST BIOL, V1, pE1; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Klein D, 2003, ARCH TOXICOL, V77, P568, DOI 10.1007/s00204-003-0493-4; Lampi KJ, 2002, INVEST OPHTH VIS SCI, V43, P216; Leong HX, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-37; Linder MC, 2001, MUTAT RES-FUND MOL M, V475, P141, DOI 10.1016/S0027-5107(01)00076-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudianos G, 2000, SEMIN LIVER DIS, V20, P353, DOI 10.1055/s-2000-9389; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Mutlib A, 2006, CHEM RES TOXICOL, V19, P1270, DOI 10.1021/tx060093j; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ng HH, 2005, GENOMICS, V86, P657, DOI 10.1016/j.ygeno.2005.07.005; Prabhu KS, 2003, ADV EXP MED BIOL, V525, P189; Riordan SM, 2001, J HEPATOL, V34, P165, DOI 10.1016/S0168-8278(00)00028-3; Rodo M, 2000, EUR J NEUROL, V7, P491; SCHEINBERG IH, 1984, WILSON DIS, P58; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; STREMMEL W, 1991, ANN INTERN MED, V115, P720, DOI 10.7326/0003-4819-115-9-720; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Wilson J, 1997, AM J PHYSIOL-ENDOC M, V272, pE1124, DOI 10.1152/ajpendo.1997.272.6.E1124; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Yamamoto A, 1996, MOL GEN GENET, V251, P1; Zhu QH, 2005, ENDOCRINOLOGY, V146, P3343, DOI 10.1210/en.2005-0204	48	169	173	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8343	8355		10.1074/jbc.M607496200	http://dx.doi.org/10.1074/jbc.M607496200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17205981	hybrid			2022-12-27	WOS:000245081000068
J	Taniguchi, M; Taoka, M; Itakura, M; Asada, A; Saito, T; Kinoshita, M; Takahashi, M; Isobe, T; Hisanaga, S				Taniguchi, Makoto; Taoka, Masato; Itakura, Makoto; Asada, Akiko; Saito, Taro; Kinoshita, Makoto; Takahashi, Masami; Isobe, Toshiaki; Hisanaga, Shin-ichi			Phosphorylation of adult type Sept5 (CDCrel-1) by cyclin-dependent kinase 5 inhibits interaction with syntaxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RAT-BRAIN SYNAPTOSOMES; MAMMALIAN SEPTINS; DOWN-REGULATION; NMDA RECEPTORS; CELL-DIVISION; BUDDING YEAST; MOUSE-BRAIN; CDK5; EXOCYTOSIS	Increasing evidence implicates cyclin-dependent kinase 5 (Cdk5) in neuronal synaptic function. We searched for Cdk5 substrates in synaptosomal fractions prepared from mouse brains. Mass spectrometric analysis after two-dimensional SDS-PAGE identified several synaptic proteins phosphorylated by Cdk5-p35; one protein identified was Sept5 (CDCrel-1). Although septins were isolated originally as cell division-related proteins in yeast, Sept5 is expressed predominantly in neurons and is implicated in exocytosis. We confirmed that Sept5 is phosphorylated by Cdk5p35 in vitro and identified Ser(17) of adult type Sept5 (Sept5_v1) as a major phosphorylation site. We found that Ser17 of Sept5_v1 is phosphorylated in mouse brains. Coimmunoprecipitation from synaptosomal fractions and glutathione S-transferase-syntaxin-1A pulldown assays of Sept5_v1 expressed in COS-7 cells showed that phosphorylation of Sept5_v1 by Cdk5-p35 decreases the binding to syntaxin-1. These results indicate that the interaction of Sept5 with syntaxin-1 is regulated by the phosphorylation of Sept_v1 at Ser(17) by Cdk5-p35.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan; Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan; Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, HMRO, Kyoto 6068501, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University; Kitasato University; Kyoto University	Taniguchi, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	taniguti-makoto@c.metro-u.ac.jp; hisanaga-shinichi@c.metro-u.ac.jp	Isobe, Toshiaki/Q-9279-2017	Taoka, Masato/0000-0001-5554-4951				Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Gil C, 2005, BIOCHEM BIOPH RES CO, V329, P117, DOI 10.1016/j.bbrc.2005.01.111; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Nikolic M, 2004, TRENDS CELL BIOL, V14, P1, DOI 10.1016/j.tcb.2003.10.010; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Rosales JL, 2004, J BIOL CHEM, V279, P53932, DOI 10.1074/jbc.M408467200; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; SANDERS SL, 1994, CURR BIOL, V4, P907, DOI 10.1016/S0960-9822(00)00201-3; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Toda S, 2000, BIOCHEM BIOPH RES CO, V273, P723, DOI 10.1006/bbrc.2000.3003; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Xin XN, 2004, J CELL SCI, V117, P4739, DOI 10.1242/jcs.01333; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	59	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7869	7876		10.1074/jbc.M609457200	http://dx.doi.org/10.1074/jbc.M609457200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224448	hybrid			2022-12-27	WOS:000245081000016
J	Wang, LX; Srinivasan, S; Theiss, AL; Merlin, D; Sitaraman, SV				Wang, Lixin; Srinivasan, Shanthi; Theiss, Arianne L.; Merlin, Didier; Sitaraman, Shanthi V.			Interleukin-6 induces keratin expression in intestinal epithelial cells - Potential role of keratin-8 in interleukin-6-induced barrier function alterations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERMEDIATE-FILAMENT PROTEINS; INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; HEMORRHAGIC-SHOCK; PLASMA-MEMBRANE; SHEAR-STRESS; IN-VITRO; MICE; IL-6	Keratin 8 1 and keratin-18 (K18) are the major intermediate filament proteins in the intestinal epithelia. The regulation and function of keratin in the intestinal epithelia is largely unknown. In this study we addressed the role and regulation of K8 and K18 expression by interleukin 6 (IL-6). Caco2-BBE cell line and IL-6 null mice were used to study the effect of IL-6 on keratin expression. Keratin expression was studied by Northern blot, Western blot, and confocal microscopy. Paracellular permeability was assessed by apical-to-basal transport of a fluorescein isothiocyanate dextran probe I K8 was silenced using the small interfering RNA approach. IL-6 significantly up-regulated mRNA and protein levels of K8 and K18. Confocal microscopy showed a reticular pattern of intracellular keratin localized to the subapical region after IL-6 treatment. IL-6 also induced serine phosphorylation of K8. IL-6 decreased paracellular flux of FD-4 compared with vehicle-treated monolayers. K8 silencing abolished the decrease in paracellular permeability induced by IL-6. Administration of dextran sodium sulfate (DSS) significantly increased intestinal permeability in IL-6(-/-) mice compared with wild type mice given DSS. Collectively, our data demonstrate that IL-6 regulates the colonic expression of K8 and K18, and K8/KI8 mediates barrier protection by IL-6 under conditions where intestinal barrier is compromised. Thus, our data uncover a novel function of these abundant cytoskeletal proteins, which may have implications in intestinal disorders such as inflammatory bowel disease wherein barrier dysfunction underlies the inflammatory response.	Emory Univ, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA	Emory University	Sitaraman, SV (corresponding author), Emory Univ, Div Digest Dis, Dept Med, Rm 201-F,615,Michael St,Whitehead Res Bldg, Atlanta, GA 30322 USA.	ssitar2@emory.edu	Srinivasan, Shanthi/A-6133-2013	Theiss, Arianne/0000-0003-2862-0933	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002831, K08DK067045, R24DK064399] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 02831, 5R24DK064399-02, DK 067045, DK06411] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameen NA, 2001, J CELL SCI, V114, P563; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Brembeck FH, 2003, CANCER RES, V63, P2005; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; CASANOVA L, 1995, J CELL SCI, V108, P811; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Hesse M, 2001, J CELL SCI, V114, P2569; Jaquemar D, 2003, J CELL BIOL, V161, P749, DOI 10.1083/jcb.200210004; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kimizuka K, 2004, AM J TRANSPLANT, V4, P482, DOI 10.1111/j.1600-6143.2004.00368.x; Komine M, 2000, J BIOL CHEM, V275, P32077, DOI 10.1074/jbc.M001253200; Krizanac-Bengez L, 2003, BRAIN RES, V977, P239, DOI 10.1016/S0006-8993(03)02689-1; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Leonard M, 2000, PHARM RES-DORDR, V17, P1181, DOI 10.1023/A:1026454427621; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Mangan JK, 2006, ONCOGENE, V25, P2489, DOI 10.1038/sj.onc.1209280; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MOLL R, 1982, PATHOL RES PRACT, V175, P146, DOI 10.1016/S0344-0338(82)80105-2; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLMENTI EP, 1993, J BIOL CHEM, V268, P14116; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Owens DW, 2004, J CELL SCI, V117, P1989, DOI 10.1242/jcs.01043; Owens DW, 2004, J PATHOL, V204, P377, DOI 10.1002/path.1646; Panja A, 1998, J IMMUNOL, V161, P3675; PANKOV R, 1994, MOL CELL BIOL, V14, P7744, DOI 10.1128/MCB.14.12.7744; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Rockman SP, 2001, J GASTROEN HEPATOL, V16, P991, DOI 10.1046/j.1440-1746.2001.02588.x; Rollwagen FM, 1996, CYTOKINE, V8, P121, DOI 10.1006/cyto.1996.0017; Rollwagen FM, 1997, MIL MED, V162, P366, DOI 10.1093/milmed/162.5.366; Salas PJI, 1997, J CELL BIOL, V137, P359, DOI 10.1083/jcb.137.2.359; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Tao GZ, 2006, J CELL SCI, V119, P1425, DOI 10.1242/jcs.02861; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Wald FA, 2005, MOL BIOL CELL, V16, P4096, DOI 10.1091/mbc.e05-03-0242; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Wang LX, 2005, GASTROENTEROLOGY, V128, pA659; Wang LX, 2004, AM J PHYSIOL-GASTR L, V287, pG1100, DOI 10.1152/ajpgi.00164.2004; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wang Q, 2000, CLIN SCI, V99, P489, DOI 10.1042/CS20000059; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Zhong BH, 2004, J CELL SCI, V117, P1709, DOI 10.1242/jcs.01016	68	72	79	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8219	8227		10.1074/jbc.M604068200	http://dx.doi.org/10.1074/jbc.M604068200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17213200	hybrid			2022-12-27	WOS:000245081000054
J	Chubanov, V; Schlingmann, KP; Waring, J; Heinzinger, J; Kaske, S; Waidegger, S; Schnitzler, MMY; Gudermann, T				Chubanov, Vladimir; Schlingmann, Karl P.; Waering, Janine; Heinzinger, Jolanta; Kaske, Silke; Waidegger, Siegfried; Schnitzler, Michael Mederos y; Gudermann, Thomas			Hypomagnesemia with secondary hypocalcemia due to a missense mutation in the putative pore-forming region of TRPM6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL KINASES TRPM6; MAGNESIUM; PROTEIN; CHANNELOPATHIES; ACTIVATION; MECHANISM; INSIGHTS; MUSCLE; GENES	Hypomagnesemia with secondary hypocalcemia is an autosomal recessive disorder caused by mutations in the TRPM6 gene. Current experimental evidence suggests that TRPM6 may function in a specific association with TRPM7 by means of heterooligomeric channel complex formation. Here, we report the identification and functional characterization of a new hypomagnesemia with secondary hypocalcemia missense mutation in TRPM6. The affected subject presented with profound hypomagnesemia and hypocalcemia caused by compound heterozygous mutation in the TRPM6 gene: 1208(-1)G > A affecting the acceptor splice site preceding exon 11, and 3050C > G resulting in the amino acid change (P1017R) in the putative pore-forming region of TRPM6. To assess the functional consequences of the P1017R mutation, TRPM6(P1017R) and wild-type TRPM6 were co-expressed with TRPM7 in Xenopus oocytes and HEK 293 cells, and currents were assessed by two-electrode voltage clamp and whole cell patch clamp measurements, respectively. Co-expression of wild-type TRPM6 and TRPM7 resulted in a significant increase in the amplitude of TRPM7-like currents. In contrast, TRPM6(P1017R) suppressed TRPM7 channel activity. In line with these observations, TRPM7, containing the corresponding mutation P1040R, displayed a dominant-negative effect upon co-expression with wild-type TRPM7. Confocal microscopy and fluorescence resonance energy transfer recordings demonstrated that the P1017R mutation neither affects assembly of TRPM6 with TRPM7, nor co-trafficking of heteromultimeric channel complexes to the cell surface. We conclude that a functional defect in the putative pore of TRPM6/7 channel complexes is sufficient to impair body magnesium homeostasis.	Univ Marburg, Inst Pharmacol & Toxicol, D-35033 Marburg, Germany; Univ Marburg, Univ Childrens Hosp, D-35033 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gudermann, T (corresponding author), Univ Marburg, Inst Pharmacol & Toxicol, Karl von Frisch Str 1, D-35033 Marburg, Germany.	guderman@staff.uni-marburg.de						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Chubanov V, 2005, N-S ARCH PHARMACOL, V371, P334, DOI 10.1007/s00210-005-1056-4; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-165; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Gums JG, 2004, AM J HEALTH-SYST PH, V61, P1569, DOI 10.1093/ajhp/61.15.1569; Hanna MG, 2006, NAT CLIN PRACT NEURO, V2, P252, DOI 10.1038/ncpneuro0178; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kass RS, 2005, J CLIN INVEST, V115, P1986, DOI 10.1172/JCI26011; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schlingmann KP, 2005, J AM SOC NEPHROL, V16, P3061, DOI 10.1681/ASN.2004110989; Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Touyz RM, 2006, AM J PHYSIOL-REG I, V290, pR73, DOI 10.1152/ajpregu.00515.2005; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901	49	73	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7656	7667		10.1074/jbc.M611117200	http://dx.doi.org/10.1074/jbc.M611117200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17197439	hybrid			2022-12-27	WOS:000245080900078
J	Garcia, BA; Hake, SB; Diaz, RL; Kauer, M; Morris, SA; Recht, J; Shabanowitz, J; Mishra, N; Strahl, BD; Allis, CD; Hunt, DF				Garcia, Benjamin A.; Hake, Sandra B.; Diaz, Robert L.; Kauer, Monika; Morris, Stephanie A.; Recht, Judith; Shabanowitz, Jeffrey; Mishra, Nilamadhab; Strahl, Brian D.; Allis, C. David; Hunt, Donald F.			Organismal differences in post-translational modifications in histones H3 and H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; LYSINE METHYLATION; ACTIVE CHROMATIN; DNA ELIMINATION; VARIANT H3.3; SET DOMAIN; ACETYLATION; HETEROCHROMATIN; TETRAHYMENA	Post-translational modifications (PTMs) of histories play an important role in many cellular processes, notably gene regulation. Using a combination of mass spectrometric and immunobiochemical approaches, we show that the PTM profile of histone H3 differs significantly among the various model organisms examined. Unicellular eukaryotes, such as Saccharomyces cerevisiae (yeast) and Tetrahymena thermophila (Tet), for example, contain more activation than silencing marks as compared with mammalian cells (mouse and human), which are generally enriched in PTMs more often associated with gene silencing. Close examination reveals that many of the better-known modified lysines (Lys) can be either methylated or acetylated and that the overall modification patterns become more complex from unicellular eukaryotes to mammals. Additionally, novel species-specific H3 PTMs from wild-type asynchronously grown cells are also detected by mass spectrometry. Our results suggest that some PTMs are more conserved than previously thought, including H3K9me1 and H4K20me2 in yeast and H3K27me1, -me2, and -me3 in Tet. On histone H4, methylation at Lys-20 showed a similar pattern as H3 methylation at Lys-9, with mammals containing more methylation than the unicellular organisms. Additionally, modification profiles of H4 acetylation were very similar among the organisms examined.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Rheumatol & Clin Immunol, Winston Salem, NC 27157 USA; Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA	Rockefeller University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Wake Forest Baptist Medical Center; University of Virginia	Hunt, DF (corresponding author), Rockefeller Univ, Lab Chromatin Biol, Box 78,1230 York Ave, New York, NY 10021 USA.	dfh@virginia.edu	Strahl, Brian/C-7601-2012; Hunt, Donald F/I-6936-2012	Strahl, Brian/0000-0002-4947-6259; Hunt, Donald F/0000-0003-2815-6368; Recht, Judith/0000-0003-3572-0457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068088, R01GM037537] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 68088, GM 40922, GM 37537] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Avramova ZV, 2002, PLANT PHYSIOL, V129, P40, DOI 10.1104/pp.010981; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cheung P, 2005, MOL ENDOCRINOL, V19, P563, DOI 10.1210/me.2004-0496; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chow JC, 2003, CELL MOL LIFE SCI, V60, P2586, DOI 10.1007/s00018-003-3121-9; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Pusarla RH, 2005, FEBS J, V272, P5149, DOI 10.1111/j.1742-4658.2005.04930.x; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yang YW, 2003, ENDOCRINOLOGY, V144, P5658, DOI 10.1210/en.2003-0798; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	52	237	252	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7641	7655		10.1074/jbc.M607900200	http://dx.doi.org/10.1074/jbc.M607900200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17194708	hybrid, Green Published			2022-12-27	WOS:000245080900077
J	Luo, B; Parker, GJ; Cooksey, RC; Soesanto, Y; Evans, M; Jones, D; McClain, DA				Luo, Bai; Parker, Glendon J.; Cooksey, Robert C.; Soesanto, Yucli; Evans, Mark; Jones, Deborah; McClain, Donald A.			Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; O-LINKED GLYCOSYLATION; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE; UPSTREAM KINASE; PATHWAY; BETA; ADIPONECTIN	The hexosamine biosynthesis pathway (HBP) serves as a nutrient sensor and has been implicated in the development of type 2 diabetes. We previously demonstrated that fatty acid oxidation was enhanced in transgenic mouse adipocytes, wherein the rate-limiting enzyme of the HBP, glutamine:fructose-6-phosphate amidotransferase (GFA), was overexpressed. To explore the molecular mechanism of the HBP-induced fatty acid oxidation in adipocytes, we studied AMP-activated protein kinase (AMPK), an energy sensor that stimulates fatty acid oxidation by regulating acetyl-CoA carboxylase (ACC) activity. Phosphorylation and activity of AMPK were increased in transgenic fat pads and in 3T3L1 adipocytes treated with glucosamine to stimulate hexosamine flux. Glucosamine also stimulated phosphorylation of ACC and fatty acid oxidation in 3T3L1 adipocytes, and these stimulatory effects were diminished by adenovirus-mediated expression of a dominant negative AMPK in 3T3L1 adipocytes. Conversely, blocking the HBP with a GFA inhibitor reduced AMPK activity, ACC phosphorylation, and fatty acid oxidation. These changes are not explained by alterations in the cellular AMP/ATP ratio. Further demonstrating that AMPK is regulated by the HBP, we found that AMPK was recognized by succinylated wheat germ agglutinin, which specifically binds O-GlcNAc. The levels of AMPK in succinylated wheat germ agglutinin precipitates correlated with hexosamine flux in mouse fat pads and 3T3L1 adipocytes. Moreover, removal of O-GlcNAc by hexosaminidase reduced AMPK activity. We conclude that chronically high hexosamine flux stimulates fatty acid oxidation by activating AMPK in adipocytes, in part through O-linked glycosylation.	Univ Utah, Div Endocrinol, Sch Med, Salt Lake City, UT 84132 USA; Vet Affairs Med Ctr, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McClain, DA (corresponding author), Univ Utah, Div Endocrinol, Sch Med, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043526, R01DK043526] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43526] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MARSHALL S, 2002, CURR OPIN ENDOCRINOL, V9, P160; Matejkova O, 2004, FEBS LETT, V569, P245, DOI 10.1016/j.febslet.2004.06.002; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; MCCLAIN DA, 2001, CURR OPIN ENDOCRINOL, V8, P186; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Obici S, 2002, J CLIN INVEST, V109, P1599, DOI 10.1172/JCI0215258; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Raile K, 2005, DIABETOLOGIA, V48, P1798, DOI 10.1007/s00125-005-1860-x; Rossetti L, 2000, ENDOCRINOLOGY, V141, P1922, DOI 10.1210/en.141.6.1922; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	54	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7172	7180		10.1074/jbc.M607362200	http://dx.doi.org/10.1074/jbc.M607362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17227772	hybrid			2022-12-27	WOS:000245080900029
J	Li, HM; Zhao, YW; Guo, Y; Li, Z; Eisele, L; Mourad, W				Li, Hongmin; Zhao, Yiwei; Guo, Yi; Li, Zhong; Eisele, Leslie; Mourad, Walid			Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHRITIDIS-DERIVED MITOGEN; TOXIC-SHOCK-SYNDROME; CELL-RECEPTOR-BINDING; MHC CLASS; CRYSTAL-STRUCTURE; HLA-DR; BACTERIAL SUPERANTIGENS; 3-DIMENSIONAL STRUCTURE; IMMUNOLOGICAL SYNAPSE; HIGH-AFFINITY	Dimerization of class 11 major histocompatibility complex (MHC) plays an important role in the MHC biological function. Mycoplasma arthritidis-derived mitogen (MAM) is a superantigen that can activate large fractions of T cells bearing specific T cell receptor V beta elements. Here we have used structural, sedimentation, and surface plasmon resonance detection approaches to investigate the molecular interactions between MAM and the class 11 MHC molecule HLA-DR1 in the context of a hemagglutinin peptide-(306-318) (HA). Our results revealed that zinc ion can efficiently induce the dimerization of the HLA-DR1/HA complex. Because the crystal structure of the MAM/HLA-DR1/hemagglutinin complex in the presence of EDTA is nearly identical to the structure of the complex crystallized in the presence of zinc ion, Zn2+ is evidently not directly involved in the binding between MAM and HLA-DRI. Sedimentation and surface plasmon resonance studies further revealed that MAM binds the HLA-DR1/HA complex with high affinity in a 1:1 stoichiometry, in the absence of Zn2+. However, in the presence of Zn2+, a dimerized MAM/HLA-DR1/HA complex can arise through the Zn2+-induced DR1 dimer. In the presence of Zn2+, cooperative binding of MAM to the DR1 dimer was also observed.	New York State Dept Hlth, Wadsworth ctr, Albany, NY 12208 USA; SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12208 USA; Univ Montreal, CHU Montreal, Montreal, PQ H2X 1P1, Canada	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Universite de Montreal	Li, HM (corresponding author), New York State Dept Hlth, Wadsworth ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	lih@wadsworth.org	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Mourad, Walid/0000-0002-1859-9387; Li, Zhong/0000-0002-1039-7000	NIAID NIH HHS [R21 AI064637-01, AI64637, R01 AI050628, R01 AI050628-01, AI50628, R21 AI064637] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050628, R21AI064637] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE J, 1992, P NATL ACAD SCI USA, V89, P4066, DOI 10.1073/pnas.89.9.4066; Baker HM, 2004, J BIOL CHEM, V279, P38571, DOI 10.1074/jbc.M406695200; Baker M, 2001, PROTEIN SCI, V10, P1268, DOI 10.1110/ps.330101; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernatchez C, 1997, INFECT IMMUN, V65, P2000, DOI 10.1128/IAI.65.6.2000-2005.1997; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CHEN ZZ, 1987, J IMMUNOL, V138, P2345; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; Cole B C, 1991, Curr Top Microbiol Immunol, V174, P107; COLE BC, 1991, IMMUNOL TODAY, V12, P271, DOI 10.1016/0167-5699(91)90125-D; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAMRUNDLES S, 1980, CLIN IMMUNOL IMMUNOP, V16, P115, DOI 10.1016/0090-1229(80)90172-5; Etongue-Mayer P, 2002, EUR J IMMUNOL, V32, P50, DOI 10.1002/1521-4141(200201)32:1<50::AID-IMMU50>3.0.CO;2-A; Fan QR, 2000, J BIOL CHEM, V275, P23700, DOI 10.1074/jbc.M003318200; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GOODMAN S, 1995, J IMMUNOL, V155, P1210; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARRISON RT, 1987, HARRISONS PRINCIPLES, V1, P455; Hayball JD, 2005, MOL CELL BIOCHEM, V273, P1, DOI 10.1007/s11010-005-5281-4; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; Hitzel C, 1999, J IMMUNOL, V162, P4671; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; HURLEY JM, 1995, J EXP MED, V181, P2229, DOI 10.1084/jem.181.6.2229; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kadima W, 1999, BIOCHEMISTRY-US, V38, P13443, DOI 10.1021/bi9903188; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; Langlois MA, 2000, EUR J IMMUNOL, V30, P1748, DOI 10.1002/1521-4141(200006)30:6<1748::AID-IMMU1748>3.0.CO;2-J; Langlois MA, 2003, J BIOL CHEM, V278, P22309, DOI 10.1074/jbc.M300823200; LENTNER C, 1981, GEIGY SCI TABLES, V3, P78; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 2007, MOL IMMUNOL, V44, P763, DOI 10.1016/j.molimm.2006.04.010; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; Lindstedt R, 2001, J IMMUNOL, V166, P800, DOI 10.4049/jimmunol.166.2.800; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nydam T, 1998, INT IMMUNOL, V10, P1237, DOI 10.1093/intimm/10.8.1237; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; PLOEGH H, 1993, NATURE, V364, P16, DOI 10.1038/364016d0; Renno T, 1996, IMMUNOL REV, V154, P175, DOI 10.1111/j.1600-065X.1996.tb00934.x; Roucard C, 1996, J BIOL CHEM, V271, P13993, DOI 10.1074/jbc.271.24.13993; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; SCHAFER PH, 1994, IMMUNITY, V1, P699, DOI 10.1016/1074-7613(94)90040-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sundstrom M, 1996, EMBO J, V15, P6832, DOI 10.1002/j.1460-2075.1996.tb01074.x; THORLACIUSUSSING O, 1987, NEUROENDOCRINOLOGY, V45, P233, DOI 10.1159/000124731; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yadati S, 1999, IMMUNOL LETT, V67, P47, DOI 10.1016/S0165-2478(98)00146-1; Yang JY, 2003, J BIOL CHEM, V278, P50412, DOI 10.1074/jbc.M306848200; Zhao YW, 2004, STRUCTURE, V12, P277, DOI 10.1016/j.str.2004.01.008; Zhao YW, 2004, ACTA CRYSTALLOGR D, V60, P353, DOI 10.1107/S090744490302763X	68	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					5991	6000		10.1074/jbc.M608482200	http://dx.doi.org/10.1074/jbc.M608482200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17166841	Green Accepted, hybrid			2022-12-27	WOS:000244867200004
J	Mesleh, MF; Shirley, WA; Heise, CE; Ling, N; Maki, RA; Laura, RP				Mesleh, Michael F.; Shirley, William A.; Heise, Christopher E.; Ling, Nicholas; Maki, Richard A.; Laura, Richard P.			NMR structural characterization of a minimal peptide antagonist bound to the extracellular domain of the corticotropin-releasing factor(1) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; TRANSFER DIFFERENCE NMR; PULSED-FIELD GRADIENTS; LIGAND-BINDING; G-PROTEIN; COMPETITIVE ANTAGONISTS; NONPEPTIDE ANTAGONISTS; DISULFIDE PATTERN; HORMONE-RECEPTOR; CRF RECEPTORS	Natural peptide agonists of corticotrophin-releasing factor (CRF) receptors bind to the receptor by a two-site mechanism as follows: the carboxyl end of the ligand binds the N-terminal extracellular domain (ECD) of the receptor and the amino portion of the ligand binds the extracellular face of the seven transmembrane region. Recently, peptide antagonists homologous to the 12 C-terminal residues of CRF have been derived, which bind the CRF1 receptor through an interaction with the ECD. Here we characterized the binding of a minimal 12-residue peptide antagonist while bound to the isolated ECD of the CRF, receptor. We have expressed and purified soluble and properly folded ECD independent from the seven-transmembrane region as a thioredoxin fusion protein in Escherichia coli. A model of the peptide antagonist, cyclic corticotrophin-releasing factor residues 30 - 41(cCRF(30 - 41)), was calculated while bound to the recombinant ECD using transferred nuclear Overhauser effect spectroscopy. Although the peptide is unstructured in solution, it adopts an a-helical conformation when bound to the ECD. Residues of cCRF(30-41) comprising the binding interface with the ECD were mapped using saturation transfer difference NMR. Two hydrophobic residues (Met(38) and Ile(41)) as well as two amide groups (Asn(34) and the C-terminal amide) on one face of the helix defined the binding epitope of the antagonist. This epitope may be used as a starting point for development of nonpeptide antagonists targeting the ECD of this receptor.	Neurosci Biosci Inc, Dept Discovery Biol, San Diego, CA 92130 USA; Neurosci Biosci Inc, Dept Med Chem, San Diego, CA 92130 USA; Neurosci Biosci Inc, Dept Pharmacol, San Diego, CA 92130 USA; Neurosci Biosci Inc, Dept Biol Chem, San Diego, CA 92130 USA	Neurocrine Biosciences; Neurocrine Biosciences; Neurocrine Biosciences; Neurocrine Biosciences	Maki, RA (corresponding author), Neurosci Biosci Inc, Dept Discovery Biol, 12790 El Camino Real, San Diego, CA 92130 USA.	rmaki@neurocrine.com						Barsukov IL, 1996, J MOL BIOL, V262, P543, DOI 10.1006/jmbi.1996.0534; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Behan DP, 1996, MOL PSYCHIATR, V1, P265; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; Chalmers DT, 1996, TRENDS PHARMACOL SCI, V17, P166, DOI 10.1016/0165-6147(96)81594-X; *CHEM COMP GROUP I, 2006, MOL OP ENV MOE; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Goddard T. D., 2006, SPARKY; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Grigoriadis DE, 2005, EXPERT OPIN THER TAR, V9, P651, DOI 10.1517/14728222.9.4.651; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Hoare SRJ, 2003, MOL PHARMACOL, V63, P751, DOI 10.1124/mol.63.3.751; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Kehne J, 2002, CNS NEUROL DISORD-DR, V1, P467, DOI 10.2174/1568007023339049; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; Klose J, 2004, PROTEIN SCI, V13, P2470, DOI 10.1110/ps.04835904; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Maaheimo H, 2000, BIOCHEMISTRY-US, V39, P12778, DOI 10.1021/bi000780o; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McCarthy JR, 1999, CURR PHARM DESIGN, V5, P289; Megy S, 2005, J BIOL CHEM, V280, P29107, DOI 10.1074/jbc.M501628200; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Nemeroff CB, 2005, J CLIN PSYCHIAT, V66, P5; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; PALLAI PV, 1983, P NATL ACAD SCI-BIOL, V80, P6770, DOI 10.1073/pnas.80.22.6770; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Saunders J, 2003, PROGR MED CHEM, V41, P195, DOI 10.1016/S0079-6468(02)41006-5; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SPIESS J, 1981, P NATL ACAD SCI-BIOL, V78, P6517, DOI 10.1073/pnas.78.10.6517; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+	56	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6338	6346		10.1074/jbc.M609816200	http://dx.doi.org/10.1074/jbc.M609816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17192263	hybrid			2022-12-27	WOS:000244867200040
J	Ranguelova, K; Girotto, S; Gerfen, GJ; Yu, SW; Suarez, J; Metlitsky, L; Magliozzo, RS				Ranguelova, Kalina; Girotto, Stefania; Gerfen, Gary J.; Yu, Shengwei; Suarez, Javier; Metlitsky, Leonid; Magliozzo, Richard S.			Radical sites in Mycobacterium tuberculosis KatG identified using electron paramagnetic resonance spectroscopy, the three-dimensional crystal structure, and electron transfer couplings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE KATG; HIGH-FIELD EPR; PROSTAGLANDIN-H SYNTHASE; CYTOCHROME-C PEROXIDASE; TRP CROSS-LINK; TYROSYL RADICALS; ISONIAZID ACTIVATION; HYDROGEN-PEROXIDE; BURKHOLDERIA-PSEUDOMALLEI; RIBONUCLEOTIDE REDUCTASE	Catalase-peroxidase (KatG) from Mycobacterium tuberculosis, a Class I peroxidase, exhibits high catalase activity and peroxidase activity with various substrates and is responsible for activation of the commonly used antitubercular drug, isoniazid (INH). KatG readily forms amino acid-based radicals during turnover with alkyl peroxides, and this work focuses on extending the identification and characterization of radicals forming on the millisecond to second time scale. Rapid freeze-quench electron paramagnetic resonance spectroscopy (RFQ-EPR) reveals a change in the structure of the initially formed radical in the presence of INK Heme pocket binding of the drug and knowledge that KatG[Y229F] lacks this signal provides evidence for radical formation on residue Tyr(229). High field RFQ-EPR spectroscopy confirmed a tryptophanyl radical signal, and new analyses of X-band RFQ-EPR spectra also established its presence. High field EPR spectroscopy also confirmed that the majority radical species is a tyrosyl radical. Site-directed mutagenesis, along with simulations of EPR spectra based on x-ray structural data for particular tyrosine and tryptophan residues, enabled assignments based on predicted hyperfine coupling parameters. KatG mutants W107F, Y229F, and the double mutant W107F/Y229F showed alteration in type and yield of radical species. Results are consistent with formation of a tyrosyl radical reasonably assigned to residue Tyr 229 within the first few milliseconds of turnover. This is followed by a mixture of tyrosyl and tryptophanyl radical species and finally to only a tyrosyl radical on residue Tyr 353, which lies more distant from the heme. The radical processing of enzyme lacking the Trp(107)Tyr(229) -Met(255) adduct (found as a unique structural feature of catalase-peroxidases) is suggested to be a reasonable assignment of the phenomena.	CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; CUNY, Grad Ctr, Dept Biochem, New York, NY 10016 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmaglioz@brooklyn.cuny.edu	Girotto, Stefania/F-5997-2012		NIAID NIH HHS [R01 AI060014, R01 AI043582-03, R56 AI060014, AI-43582, AI-060014] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043582, R56AI060014, R01AI060014] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Deemagarn T, 2005, J MOL BIOL, V345, P21, DOI 10.1016/j.jmb.2004.10.020; DEGRAY JA, 1992, J BIOL CHEM, V267, P23583; Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f; FESSENDEN RW, 1963, J CHEM PHYS, V39, P2147, DOI 10.1063/1.1701415; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, FEBS LETT, V552, P135, DOI 10.1016/S0014-5793(03)00901-3; Jakopitsch C, 2002, J INORG BIOCHEM, V91, P78, DOI 10.1016/S0162-0134(02)00374-4; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; Janovsky I, 2004, CHEM-EUR J, V10, P5524, DOI 10.1002/chem.200400401; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; KELMAN DJ, 1994, J BIOL CHEM, V269, P7458; Lendzian F, 2005, BBA-BIOENERGETICS, V1707, P67, DOI 10.1016/j.bbabio.2004.02.011; Liang ZX, 2004, J AM CHEM SOC, V126, P2785, DOI 10.1021/ja038163l; LOEWEN PC, 1990, MOL GEN GENET, V224, P147, DOI 10.1007/BF00259461; Marttila HJ, 1996, ANTIMICROB AGENTS CH, V40, P2187, DOI 10.1128/AAC.40.9.2187; Musser JM, 1996, EMERG INFECT DIS, V2, P1, DOI 10.3201/eid0201.960101; OMalley PJ, 1995, BBA-BIOENERGETICS, V1232, P175, DOI 10.1016/0005-2728(95)00102-6; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; RIGBY SEJ, 1994, BIOCHEMISTRY-US, V33, P1734, DOI 10.1021/bi00173a016; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Shi WJ, 2000, BIOCHEMISTRY-US, V39, P4112, DOI 10.1021/bi992561c; Sipe HJ, 2004, CHEM RES TOXICOL, V17, P226, DOI 10.1021/tx0341759; Smulevich G, 2006, J INORG BIOCHEM, V100, P568, DOI 10.1016/j.jinorgbio.2006.01.033; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Svistunenko DA, 2001, BBA-PROTEIN STRUCT M, V1546, P365, DOI 10.1016/S0167-4838(01)00157-1; Todorovic S, 1999, J AM CHEM SOC, V121, P10962, DOI 10.1021/ja9918674; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200	50	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6255	6264		10.1074/jbc.M607309200	http://dx.doi.org/10.1074/jbc.M607309200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204474	Green Accepted, hybrid			2022-12-27	WOS:000244867200031
J	Rivard, CJ; Brown, LM; Almeida, NE; Maunsbach, AB; Pihakaski-Maunsbach, K; Andres-Hernando, A; Capasso, JM; Berl, T				Rivard, Christopher J.; Brown, Lewis M.; Almeida, Nestor E.; Maunsbach, Arvid B.; Pihakaski-Maunsbach, Kaarina; Andres-Hernando, Ana; Capasso, Juan M.; Berl, Tomas			Expression of the calcium-binding protein S100A4 is markedly up-regulated by osmotic stress and is involved in the renal osmoadaptive response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; NONMUSCLE MYOSIN; PLASMA-PROTEOME; HEAVY-CHAIN; CELL-LINE; RAT; METASTASIS; GENE; P9KA; KINASE	Proteomic analysis of Inner Medullary Collecting Duct (IMCD3) cells adapted to increasing levels of tonicity (300,600, and 900 mosmol/kg H2O) by two-dimensional. difference gel electrophoresis and mass spectrometry revealed several proteins as yet unknown to be up-regulated in response to hypertonic stress. Of these proteins, one of the most robustly up-regulated (22-fold) was S100A4. The identity of the protein was verified by high pressure liquid chromatography-mass spectrometry. Western blot analysis confirmed increased expression with increased tonicity, both acute and chronic. S10OA4 protein expression was further confirmed by immunocytochemical analysis. Cells grown in isotonic conditions showed complete absence of immunostaining, whereas chronically adapted IMCD3 cells had uniform cytoplasmic localization. The protein is also regulated in vivo as in mouse kidney tissues S10OA4 expression was many -fold greater in the papilla as compared with the cortex and increased further in the papilla upon 36 h of thirsting. Increased expression of S10OA4 was also observed in the medulla and papilla, but not the cortex of a human kidney. Data from Affymetrix gene chip analysis and quantitative PCR also revealed increased S10OA4 message in IMCD3 cells adapted to hypertonicity. The initial expression of message increased at 8-10 h following exposure to acute sublethal hypertonic stress (550 mosmol/kg H2O). Protein and message half-life in IMCD3 cells were 85.5 and 6.8 h, respectively. Increasing medium tonicity with NaCl, sucrose, mannitol, and choline-chloride stimulated S10OA4 expression, whereas urea did not. Silencing of S10OA4 expression using a stable siRNA vector (pSM2; Open Biosystems) resulted in a 48-h delay in adaptation of IMCD3 cells under sublethal osmotic stress, suggesting S10OA4 is involved in the osmoadaptive response. In summary, we describe the heretofore unrecognized up-regulation of a small calcium-binding protein, both in vitro and in vivo, whose absence profoundly delays osmoadaptation and slows cellular growth under hypertonic conditions.	Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Sch Med, Denver, CO 80262 USA; Aarhus Univ, Dept Anat, Walter & Salt Res Ctr, DK-8000 Aarhus, Denmark	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Aarhus University	Berl, T (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Sch Med, 4200 E 9th Ave,MS C-281, Denver, CO 80262 USA.	tomas.berl@uchsc.edu	Almeida, Nestor/AAJ-9569-2020	Almeida, Nestor/0000-0001-6907-6028; Andres-Hernando, Ana/0000-0002-0676-0188	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066544, P01DK019928] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK066544-01A1S1, R01 DK066544-02, DK-66544, R01 DK066544-03, P01 DK019928-280021, DK-19928, P01 DK019928-270021, P01 DK019928-26A10021, R01 DK066544-01A1, P01 DK019928, R01 DK066544, R01 DK066544-03S1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Barraclough R, 1998, BBA-MOL CELL RES, V1448, P190, DOI 10.1016/S0167-4889(98)00143-8; Blake CA, 2005, EXP BIOL MED, V230, P800, DOI 10.1177/153537020523001104; Bustamante M, 2003, AM J PHYSIOL-RENAL, V285, pF336, DOI 10.1152/ajprenal.00003.2003; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Capasso JM, 2001, AM J PHYSIOL-RENAL, V280, pF768, DOI 10.1152/ajprenal.2001.280.5.F768; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; DAVIES BR, 1993, ONCOGENE, V8, P999; DAVIES M, 1995, DNA CELL BIOL, V14, P825, DOI 10.1089/dna.1995.14.825; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Ebner HL, 2005, AM J PHYSIOL-REG I, V289, pR877, DOI 10.1152/ajpregu.00170.2005; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; GIBBS FEM, 1995, J HISTOCHEM CYTOCHEM, V43, P169, DOI 10.1177/43.2.7822773; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kato C, 2005, BIOCHEM BIOPH RES CO, V326, P147, DOI 10.1016/j.bbrc.2004.11.010; KLAWITTER J, 2005, J AM SOC NEPHOL, V16, pA571; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Le Hir M, 2005, HISTOCHEM CELL BIOL, V123, P335, DOI 10.1007/s00418-005-0788-z; Levett D, 2002, AM J PATHOL, V160, P693, DOI 10.1016/S0002-9440(10)64889-4; Li XH, 2005, PROTEOMICS, V5, P3423, DOI 10.1002/pmic.200401226; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Mandinova A, 1998, J CELL SCI, V111, P2043; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mazzucchelli L, 2002, AM J PATHOL, V160, P7, DOI 10.1016/S0002-9440(10)64342-8; Pisitkun T, 2006, PHYSIOL GENOMICS, V25, P263, DOI 10.1152/physiolgenomics.00214.2005; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Rivard CJ, 2003, J AM SOC NEPHROL, V14, p56A; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Tian W, 2002, AM J PHYSIOL-RENAL, V283, pF388, DOI 10.1152/ajprenal.00031.2002; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2	36	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6644	6652		10.1074/jbc.M609432200	http://dx.doi.org/10.1074/jbc.M609432200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200116	Green Accepted, hybrid			2022-12-27	WOS:000244867200073
J	Berchiche, YA; Chow, KY; Lagane, B; Leduc, M; Percherancier, Y; Fujii, N; Tamamura, H; Bachelerie, F; Heveker, N				Berchiche, Yamina A.; Chow, Ken Y.; Lagane, Bernard; Leduc, Martin; Percherancier, Yann; Fujii, Nobutaka; Tamamura, Hirokazu; Bachelerie, Francoise; Heveker, Nikolaus			Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G alpha(i) activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; AGONIST; EFFICACY; MUTATION; MODELS	Ligand binding to G protein-coupled receptors (GPCRs) is thought to induce changes in receptor conformation that translate into activation of downstream effectors. The link between receptor conformation and activity is still insufficiently understood, as current models of GPCR activation fail to take an increasing amount of experimental data into account. To elucidate structure-function relationships in GPCR activation, we used bioluminescence resonance energy transfer to directly assess the conformation of mutants of the chemokine receptor CXCR4. We analyzed substitutions in the arginine cage DRY motif and in the conserved asparagine N(3.35)119, which are pivotal molecular switches for receptor conformation and activation. G alpha(i) activation of the mutants was either similar to wildtype CXCR4 (D133N, Y135A, and N119D) or resulted in loss of activity (R134A and N119K). Mutant N119S was constitutively active but further activated by agonist. Bioluminescence resonance energy transfer analysis suggested no simple correlation between conformational changes in response to ligand binding and activation of Gat by the mutants. Different conformations of active receptors were detected (for wild-type CXCR4, D133N, and N119S), suggesting that different receptor conformations are able to trigger Gai activity. Several conformations were also found for inactive mutants. These data provide biophysical evidence for different receptor conformations being active with respect to a single readout. They support models of GPCR structure-activity relationships that take this conformational flexibility of active receptors into account.	Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; Inst Pasteur, Unite Pathogenie Virale Mol, F-75015 Paris, France; Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; Tokyo Med & Dent Univ, Dept Mol Recognit, Inst Biomat & Bioengn, Tokyo 1010062, Japan	Universite de Montreal; Universite de Montreal; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Kyoto University; Tokyo Medical & Dental University (TMDU)	Heveker, N (corresponding author), Hop St Justine, Ctr Rech, 6737,3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca	Heveker, Nikolaus/G-5306-2012; BACHELERIE, FRANCOISE/F-8823-2013; Lagane, Bernard/AAA-2205-2019; Lagane, Bernard/K-8446-2016	BACHELERIE, FRANCOISE/0000-0002-0399-3277; Lagane, Bernard/0000-0002-3459-7867; percherancier, yann/0000-0002-2410-5806; Berchiche, Yamina/0000-0002-9559-9209				Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cotecchia S, 2003, ASSAY DRUG DEV TECHN, V1, P311, DOI 10.1089/15406580360545125; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin T, 2002, TRENDS PHARMACOL SCI, V23, P275, DOI 10.1016/S0165-6147(02)02036-9; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	23	41	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5111	5115		10.1074/jbc.C600270200	http://dx.doi.org/10.1074/jbc.C600270200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17197449	hybrid			2022-12-27	WOS:000244482300004
J	Tanaka, Y; Morikawa, K; Ohki, Y; Yao, M; Tsumoto, K; Watanabe, N; Ohta, T; Tanaka, I				Tanaka, Yoshikazu; Morikawa, Kazuya; Ohki, Yu; Yao, Min; Tsumoto, Kouhei; Watanabe, Nobuhisa; Ohta, Toshiko; Tanaka, Isao			Structural and mutational analyses of Drp35 from Staphylococcus aureus - A possible mechanism for its lactonase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOLIGO-VULGARIS; PYROCOCCUS-HORIKOSHII; SERUM PARAOXONASES; CRYSTAL-STRUCTURE; CALCIUM; DENSITY; RESOLUTION; BINDING; PON1; ATHEROSCLEROSIS	Drp35 is a protein induced by cell wall-affecting antibiotics or detergents; it possesses calcium-dependent lactonase activity. To determine the molecular basis of the lactonase activity, we first solved the crystal structures of Drp35 with and without Ca2+; these showed that the molecule has a six-bladed beta-propeller structure with two calcium ions bound at the center of the beta-propeller and surface region. Mutational analyses of evolutionarily conserved residues revealed that the central calcium-binding site is essential for the enzymatic activity of Drp35. Substitution of some other amino acid residues for the calcium-binding residues demonstrated the critical contributions of Glu(48), Asp(138), and Asp(236) to the enzymatic activity. Differential scanning calorimetric analysis revealed that the loss of activity of E48Q and D236N, but not D138N, was attributed to their inability to hold the calcium ion. Further structural analysis of the D138N mutant indicates that it lacks a water molecule bound to the calcium ion rather than the calcium ion itself. Based on these observations and structural information, a possible catalytic mechanism in which the calcium ion and its binding residues play direct roles was proposed for the lactonase activity of Drp35.	Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; Univ Tokyo, Frad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Microbiol, Tsukuba, Ibaraki 3058575, Japan	Hokkaido University; University of Tokyo; University of Tsukuba	Tanaka, I (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	tanaka@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; Watanabe, Nobuhisa/B-1187-2008; Ohki, Yu/U-2946-2019	yao, min/0000-0003-1687-5904; Watanabe, Nobuhisa/0000-0002-0118-5815; Morikawa, Kazuya/0000-0002-1503-7151; Tanaka, Yoshikazu/0000-0002-7893-3236				Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gonzalvo MC, 1998, J BIOCHEM MOL TOXIC, V12, P61, DOI 10.1002/(SICI)1099-0461(1998)12:1<61::AID-JBT8>3.0.CO;2-N; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hartleib J, 2001, BBA-PROTEIN STRUCT M, V1546, P312, DOI 10.1016/S0167-4838(01)00153-4; Hartleib J, 2001, BIOCHEM J, V353, P579, DOI 10.1042/0264-6021:3530579; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kuo CL, 1998, DRUG METAB DISPOS, V26, P653; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; KUROKI R, 1989, P NATL ACAD SCI USA, V86, P6903, DOI 10.1073/pnas.86.18.6903; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Morikawa K, 2005, FEMS MICROBIOL LETT, V249, P185, DOI 10.1016/j.femsle.2005.06.038; Murakami H, 1999, BIOCHEM BIOPH RES CO, V264, P348, DOI 10.1006/bbrc.1999.1388; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Sakai N, 2004, PROTEINS, V57, P869, DOI 10.1002/prot.20259; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Schuller DJ, 1996, ACTA CRYSTALLOGR D, V52, P425, DOI 10.1107/S0907444995013291; SCHUTZBACH JS, 1990, J BIOL CHEM, V265, P2546; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Szuwart M, 2006, PHYTOCHEMISTRY, V67, P1476, DOI 10.1016/j.phytochem.2006.05.021; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Versees W, 2001, J MOL BIOL, V307, P1363, DOI 10.1006/jmbi.2001.4548; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEBER DJ, 1994, BIOCHEMISTRY-US, V33, P8017, DOI 10.1021/bi00192a005; WILLIAMS RJP, 1992, CELL CALCIUM, V13, P355, DOI 10.1016/0143-4160(92)90049-X; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Yu BZ, 1998, BIOCHEMISTRY-US, V37, P12576, DOI 10.1021/bi9728607	51	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5770	5780		10.1074/jbc.M607340200	http://dx.doi.org/10.1074/jbc.M607340200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17166853	hybrid			2022-12-27	WOS:000244482300073
J	Lee, D; Schultz, JB; Knauf, PA; King, MR				Lee, Dooyoung; Schultz, Joanne B.; Knauf, Philip A.; King, Michael R.			Mechanical shedding of L-selectin from the neutrophil surface during rolling on sialyl Lewis x under flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; LYMPHOCYTE HOMING RECEPTOR; CELL-ADHESION; IN-VITRO; HYDRODYNAMIC SHEAR; DOWN-MODULATION; DEFICIENT MICE; CROSS-LINKING; IDENTIFICATION	The interaction of L-selectin expressed on leukocytes with endothelial cells leads to capture and rolling and is critical for the recruitment of leukocytes into sites of inflammation. It is known that leukocyte activation by chemoattractants, the change of osmotic pressure in cell media, or cross-linking of L-selectin all result in rapid shedding of L-selectin. Here we present a novel mechanism for surface cleavage of L-selectin on neutrophils during rolling on a sialyl Lewis x-coated surface that involves mechanical force. Flow cytometry and rolling of neutrophils labeled with Qdot (R)-L-selectin antibodies in an in vitro flow chamber showed that the mechanical shedding of L-selectin occurs during rolling and depends on the amount of shear applied. In addition, the mechanical L-selectin shedding causes an increase in cell rolling velocity with rolling duration, suggesting a gradual loss of L-selectin and is mediated by p38 mitogen-activated protein kinase activation. Thus, these data show that mechanical force induces the cleavage of L-selectin from the neutrophil surface during rolling and therefore decreases the adhesion of cells to a ligand-presenting surface in flow.	Univ Rochester, Dept Chem Engn, Rochester, NY 14642 USA; Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	King, MR (corresponding author), Univ Rochester, Dept Chem Engn, 601 Elmwood Ave, Rochester, NY 14642 USA.	mike_king@urmc.rochester.edu	Lee, Dooyoung/B-9925-2008; King, Michael/A-1138-2007		NHLBI NIH HHS [HL018208] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018208] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander SR, 2000, J LEUKOCYTE BIOL, V67, P415, DOI 10.1002/jlb.67.3.415; Allport JR, 1997, J IMMUNOL, V158, P4365; Bennett TA, 2000, J IMMUNOL, V164, P4120, DOI 10.4049/jimmunol.164.8.4120; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Detmers PA, 1998, J IMMUNOL, V161, P1921; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Fu H, 1997, IMMUNOL LETT, V59, P71, DOI 10.1016/S0165-2478(97)00103-X; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Green CE, 2003, AM J PHYSIOL-CELL PH, V284, pC705, DOI 10.1152/ajpcell.00331.2002; Greenberg AW, 2000, BIOPHYS J, V79, P2391, DOI 10.1016/S0006-3495(00)76484-8; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; IMAI Y, 1991, J CELL BIOL, V113, P1213, DOI 10.1083/jcb.113.5.1213; Jasuja RR, 2000, INT J IMMUNOPATH PH, V13, P1; JUTILA MA, 1989, J IMMUNOL, V143, P3318; Kaba NK, 2001, AM J PHYSIOL-CELL PH, V281, pC1403, DOI 10.1152/ajpcell.2001.281.4.C1403; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MCEVER RP, 1997, J CLIN INVEST, V100, P97; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mowery P, 2004, CHEM BIOL, V11, P725, DOI 10.1016/j.chembiol.2004.03.027; PALECANDA A, 1992, EUR J IMMUNOL, V22, P1279, DOI 10.1002/eji.1830220524; Preece G, 1996, J BIOL CHEM, V271, P11634, DOI 10.1074/jbc.271.20.11634; PURI KD, 1995, J CELL BIOL, V131, P261, DOI 10.1083/jcb.131.1.261; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; SPERTINI O, 1994, BLOOD, V84, P1249, DOI 10.1182/blood.V84.4.1249.bloodjournal8441249; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steeber DA, 1996, J IMMUNOL, V157, P1096; Stoddart JH, 1996, J IMMUNOL, V157, P5653; SUZUKI Y, 1993, BIOCHEM BIOPH RES CO, V190, P426, DOI 10.1006/bbrc.1993.1065; Taylor AD, 1996, BIOPHYS J, V71, P3488, DOI 10.1016/S0006-3495(96)79544-9; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; VARKI A, 1997, J CLIN INVEST, V100, P31; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WATSON SR, 1991, NATURE, V349, P164, DOI 10.1038/349164a0	46	66	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4812	4820		10.1074/jbc.M609994200	http://dx.doi.org/10.1074/jbc.M609994200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17172469	hybrid			2022-12-27	WOS:000244482000063
J	Montaville, P; Schlicker, C; Leonov, A; Zweckstetter, M; Sheldrick, GM; Becker, S				Montaville, Pierre; Schlicker, Christine; Leonov, Andrei; Zweckstetter, Markus; Sheldrick, George M.; Becker, Stefan			The C2A-C2B linker defines the high affinity Ca2+ binding mode of rabphilin-3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2B DOMAIN; PROTEIN; SYNAPTOTAGMIN; VESICLES; EXOCYTOSIS; SENSORS; SITES; IONS	The Ca2+ binding properties of C2 domains are essential for the function of their host proteins. We present here the first crystal structures showing an unexpected Ca2+ binding mode of the C2B domain of rabphilin-3A in atomic detail. Acidic residues from the linker region between the C2A and C2B domains of rabphilin-3A interact with the Ca2+-binding region of the C2B domain. Because of these interactions, the coordination sphere of the two bound Ca2+ ions is almost complete. Mutation of these acidic residues to alanine resulted in a 10-fold decrease in the intrinsic Ca2+ binding affinity of the C2B domain. Using NMR spectroscopy, we show that this interaction occurred only in the Ca2+-bound state of the C2B domain. In addition, this Ca2+ binding mode was maintained in the C2 domain tandem fragment. In NMR-based liposome binding assays, the linker was not released upon phospholipid binding. Therefore, this unprecedented Ca2+ binding mode not only shows how a C2 domain increases its intrinsic Ca2+ affinity, but also provides the structural base for an atypical protein-Ca2+-phospholipid binding mode of rabphilin-3A.	Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Becker, S (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	sabe@nmr.mpibpc.mpg.de		montaville, Pierre/0000-0002-9931-3482; Zweckstetter, Markus/0000-0002-2536-6581				Arribas M, 1997, EUR J CELL BIOL, V74, P209; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Coppola T, 2001, J CELL SCI, V114, P1757; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fukuda M, 2000, BIOCHEM BIOPH RES CO, V276, P626, DOI 10.1006/bbrc.2000.3520; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; GODDARD TD, 1989, SPARKY VERSION 3; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Joberty G, 1999, J CELL SCI, V112, P3579; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCOLASTICO C, 1987, Patent No. 8705024; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Staunton J, 2001, J NEUROSCI, V21, P9255, DOI 10.1523/JNEUROSCI.21-23-09255.2001; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329	42	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					5015	5025		10.1074/jbc.M606746200	http://dx.doi.org/10.1074/jbc.M606746200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166855	Green Published, hybrid			2022-12-27	WOS:000244482000084
J	Wang, X; Smith, DR; Jones, JW; Chapman, MR				Wang, Xuan; Smith, Daniel R.; Jones, Jonathan W.; Chapman, Matthew R.			In vitro polymerization of a functional Escherichia coli amyloid protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN AGGREGATIVE FIMBRIAE; CURLI FIBERS; ALZHEIMERS-DISEASE; COMMON MECHANISM; OLIGOMERS IMPLIES; BETA-PROTEIN; FIBRILS; FIBRILLOGENESIS; PEPTIDES; INTERNALIZATION	Amyloid formation is characterized by the conversion of Soluble proteins into biochemically and structurally distinct fibers. Although amyloid formation is traditionally associated with diseases such as Alzheimer disease, a number of biologically functional amyloids have recently been described. Curli are amyloid fibers produced by Escherichia coli that contribute to biofilm formation and other important physiological processes. We characterized the polymerization properties of the major curli subunit protein CsgA. CsgA polymerizes into an amyloid fiber in a sigmoidal kinetic fashion with a distinct lag, growth, and stationary phase. Adding sonicated preformed CsgA fibers to the polymerization reaction can significantly shorten the duration of the lag phase. We also demonstrate that the conversion of soluble CsgA into an insoluble fiber involves the transient formation of an intermediate similar to that characterized for several disease-associated amyloids. The CsgA core amyloid domain can be divided into five repeating units that share sequence and structural hallmarks. We show that peptides representing three of these repeating units are amyloidogenic in vitro. Although the defining characteristics of CsgA polymerization appear conserved with disease-associated amyloids, these proteins evolved in diverse systems and for different purposes. Therefore, amyloidogenesis appears to be an innate protein folding pathway that can be capitalized on to fulfill normal physiological tasks.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chapman, MR (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	chapmanm@umich.edu		Wang, Xuan/0000-0002-2910-8598; Chapman, Matthew/0000-0002-2645-1294	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI073847, R01 AI073847-01] Funding Source: Medline; PHS HHS [K22A1054967, P50-A608671] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Barnhart MM, 2006, J BACTERIOL, V188, P5212, DOI 10.1128/JB.00234-06; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; Coustou-Linares V, 2001, MOL MICROBIOL, V42, P1325, DOI 10.1046/j.1365-2958.2001.02707.x; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Galzitskaya OV, 2006, PROTEINS, V63, P144, DOI 10.1002/prot.20851; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Gophna U, 2002, FEMS MICROBIOL LETT, V212, P55, DOI 10.1111/j.1574-6968.2002.tb11244.x; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Johansson C, 2001, FEMS IMMUNOL MED MIC, V30, P21, DOI 10.1111/j.1574-695X.2001.tb01545.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rhoades E, 2003, BIOPHYS J, V84, P3480, DOI 10.1016/S0006-3495(03)70068-X; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	56	142	146	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3713	3719		10.1074/jbc.M609228200	http://dx.doi.org/10.1074/jbc.M609228200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17164238	Green Accepted, hybrid			2022-12-27	WOS:000244481900034
J	Matarrese, P; Falzano, L; Fabbri, A; Gambardella, L; Frank, C; Geny, B; Popoff, MR; Malorni, W; Fiorentini, C				Matarrese, Paola; Falzano, Loredana; Fabbri, Alessia; Gambardella, Lucrezia; Frank, Claudio; Geny, Blandine; Popoff, Michel R.; Malorni, Walter; Fiorentini, Carla			Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria - Involvement of ATP-sensitive mitochondrial potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYLORI VACUOLATING CYTOTOXIN; CEREBELLAR GRANULE NEURONS; NECROSIS-FACTOR-ALPHA; HELICOBACTER-PYLORI; NEISSERIA-GONORRHOEAE; DEATH PATHWAY; LETHAL TOXIN; NITRIC-OXIDE; K+ CHANNELS; RHO-GTPASES	Targeting to mitochondria is emerging as a common strategy that bacteria utilize to interact with these central executioners of apoptosis. Several lines of evidence have in fact indicated mitochondria as specific targets for bacterial protein toxins, regarded as the principal virulence factors of pathogenic bacteria. This work shows, for the first time, the ability of the Clostridium difficile toxin B (TcdB), a glucosyltransferase that inhibits the Rho GTPases, to impact mitochondria. In living cells, TcdB provokes an early hyperpolarization of mitochondria that follows a calcium-associated signaling pathway and precedes the final execution step of apoptosis (i.e. mitochondria depolarization). Importantly, in isolated mitochondria, the toxin can induce a calcium-dependent mitochondrial swelling, accompanied by the release of the proapoptogenic factor cytochrome c. This is consistent with a mitochondrial targeting that does not require the Rho-inhibiting activity of the toxin. Of interest, the mitochondrial ATP-sensitive potassium channels are also involved in the apoptotic response to TcdB and appear to be crucial for the cell death execution phase, as demonstrated by using specific modulators of these channels. To our knowledge, the involvement of these mitochondrial channels in the ability of a bacterial toxin to control cell fate is a hitherto unreported finding.	Ist Super Sanita, Dept Drug Res & Evaluat, I-00161 Rome, Italy; Inst Pasteur, Unite Toxines Microbiennes, F-75724 Paris 15, France	Istituto Superiore di Sanita (ISS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Fiorentini, C (corresponding author), Ist Super Sanita, Dept Drug Res & Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	carla.fiorentini@iss.it	Matarrese, Paola/A-4369-2014; Malorni, Walter/G-5874-2016; FRANK, CLAUDIO/A-6642-2015; Fiorentini, Carla/Q-2088-2015; Fabbri, Alessia/AAA-4594-2019; FIORENTINI, CARLA/AAG-8005-2019	FRANK, CLAUDIO/0000-0002-6016-5750; Fiorentini, Carla/0000-0003-1707-6282; Fabbri, Alessia/0000-0002-3075-3367; FIORENTINI, CARLA/0000-0003-1707-6282; malorni, walter/0000-0002-1223-7000; falzano, loredana/0000-0003-4074-180X				Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Blanke SR, 2005, TRENDS MICROBIOL, V13, P64, DOI 10.1016/j.tim.2004.12.007; Boquet P, 2003, TRENDS MICROBIOL, V11, P410, DOI 10.1016/S0966-842X(03)00211-7; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; COSSARIZZA A, 1995, EXP CELL RES, V220, P232, DOI 10.1006/excr.1995.1311; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 2003, CANCER RES, V63, P951; D HE, 2000, GASTROENTEROLOGY, V119, P139, DOI 10.1053/gast.2000.8526; Dahlem YA, 2004, BBA-BIOENERGETICS, V1656, P46, DOI 10.1016/j.bbabio.2004.01.003; Debska G, 2001, BRAIN RES, V892, P42, DOI 10.1016/S0006-8993(00)03187-5; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Eliseev RA, 2004, J BIOL CHEM, V279, P46748, DOI 10.1074/jbc.M406217200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiorentini C, 1998, INFECT IMMUN, V66, P2660, DOI 10.1128/IAI.66.6.2660-2665.1998; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Gerhard R, 2005, MICROB PATHOGENESIS, V38, P77, DOI 10.1016/j.micpath.2004.12.002; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; Gross GJ, 1999, CIRC RES, V84, P973, DOI 10.1161/01.RES.84.9.973; Guichon A, 2001, J BACTERIOL, V183, P1269, DOI 10.1128/JB.183.4.1269-1276.2001; Hamm EE, 2006, P NATL ACAD SCI USA, V103, P14176, DOI 10.1073/pnas.0604725103; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; He D, 2002, GASTROENTEROLOGY, V122, P1048, DOI 10.1053/gast.2002.32386; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lazebnik Y, 2001, CURR BIOL, V11, pR767, DOI 10.1016/S0960-9822(01)00465-1; Le SS, 2005, J NEUROCHEM, V94, P1025, DOI 10.1111/j.1471-4159.2005.03252.x; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Liu HP, 2002, AM J PHYSIOL-HEART C, V282, pH1380, DOI 10.1152/ajpheart.00348.2001; Liu YG, 1999, ANN NY ACAD SCI, V874, P27, DOI 10.1111/j.1749-6632.1999.tb09222.x; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Ma GZ, 2004, NEUROREPORT, V15, P1813, DOI 10.1097/01.wnr.0000135694.89237.3d; Malish HR, 2003, APOPTOSIS, V8, P179, DOI 10.1023/A:1022974710488; Matarrese P, 2003, J IMMUNOL, V170, P6006, DOI 10.4049/jimmunol.170.12.6006; Matarrese P, 2002, AM J PATHOL, V160, P1507, DOI 10.1016/S0002-9440(10)62577-1; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Perl A, 2004, METH MOLEC MED, V102, P87; Perry Mary Ellen, 2004, Cancer Res, V64, P7640, DOI 10.1158/0008-5472.CAN-04-1991; Petit P, 2003, CELL MICROBIOL, V5, P761, DOI 10.1046/j.1462-5822.2003.00309.x; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Wang YG, 2001, J MOL CELL CARDIOL, V33, P2037, DOI 10.1006/jmcc.2001.1468; Zamzami N, 2001, METHOD CELL BIOL, V65, P147, DOI 10.1016/S0091-679X(01)65009-X; Zhang AS, 2005, BLOOD, V105, P368, DOI 10.1182/blood-2004-06-2226	65	87	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9029	9041		10.1074/jbc.M607614200	http://dx.doi.org/10.1074/jbc.M607614200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17220295	hybrid			2022-12-27	WOS:000245780300050
J	Hummel, S; Christian, S; Osanger, A; Heid, H; Nimpf, J; Schneider, WJ				Hummel, Susanna; Christian, Sabine; Osanger, Andreas; Heid, Hans; Nimpf, Johannes; Schneider, Wolfgang J.			Identification of a novel chondroitin-sulfated collagen in the membrane separating theca and granulosa cells in chicken ovarian follicles - The granulosa-theca cell interface is nota bona fide basement membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RAPID GROWTH-PHASE; OOCYTE RECEPTOR; BASAL LAMINA; APOLIPOPROTEIN-B; GALLUS-DOMESTICUS; YOLK DEPOSITION; PROTEOGLYCANS; BINDING; GLYCOSAMINOGLYCANS	The membranous structure separating the granulosa from theca cells in the developing ovarian follicles of birds is generally perceived as a genuine basement membrane (BM). Previously, we suggested that this membrane is unusual in that it lacks several typical BM components, e.g. collagen IV, laminin B, perlecan, and fibronectin (Hummel, S., Osanger, A., Bajari, T. M., Balasubramani, M., Halfter, W., Nimpf, J., and Schneider, W. J. (2004) J. Biol. Chem. 279, 23486 -23494). We have now identified a novel chondroitin sulfate-modified collagen, tentatively termed ggBM1 (Gallus gallus basement membrane protein I) as a major component of the border between the vascularized theca and the epitheloid granulosa cells. In biosynthetic experiments using [H-3]proline and [S-35] sulfate, ggBM1 was shown to be synthesized by and secreted from the granulosa cells that support the developing oocyte. The acidic heterogeneous 135-kDa proteoglycan was converted to a protein with an apparent M-r of 95,000 by treatment with chondroitinase ABC and was completely degraded by collagenase. Sequencing of tryptic fragments revealed peptides typical of collagens. The follicular BM accumulated apolipoprotein B and apo-VLDLII, the major resident proteins of the yolk precursor very low density lipoprotein. Interestingly, and likely indicating an analogous situation to the follicle, ggBM1 is also a component of Bruch's membrane of the eye, which separates the vascularized choroid from retinal pigmented epithelial cells. Based on our data we propose that in addition to thecal perlecan, ggBM1 is involved in the transfer of yolk precursors from the thecal capillary bed to oocyte surface lipoprotein receptors mediating their uptake into oocytes.	Med Univ Vienna, Max F Perutz Labs, Dept Biochem Med, A-1030 Vienna, Austria; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Helmholtz Association; German Cancer Research Center (DKFZ)	Schneider, WJ (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dept Biochem Med, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	wolfgang.schneider@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492				Asem EK, 2000, COMP BIOCHEM PHYS C, V125, P189, DOI 10.1016/S0742-8413(99)00100-0; Asem EK, 2000, POULTRY SCI, V79, P589, DOI 10.1093/ps/79.4.589; BARBER DL, 1991, J BIOL CHEM, V266, P18761; Bausek N, 2000, J BIOL CHEM, V275, P28866, DOI 10.1074/jbc.275.37.28866; Bjornsson S, 2000, SCAND J CLIN LAB INV, V60, P27, DOI 10.1080/00365510050185010; BRUCKNER P, 1985, P NATL ACAD SCI USA, V82, P2608, DOI 10.1073/pnas.82.9.2608; Bujo H, 1997, J NUTR, V127, pS801, DOI 10.1093/jn/127.5.801S; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; EVANS AJ, 1979, BIOCHIM BIOPHYS ACTA, V573, P184, DOI 10.1016/0005-2760(79)90185-1; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; GEORGE R, 1987, J BIOL CHEM, V262, P16838; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; HAYES KC, 1989, INVEST OPHTH VIS SCI, V30, P225; Hermann M, 1997, J LIPID RES, V38, P1308; Hollborn M, 2004, INVEST OPHTH VIS SCI, V45, P2033, DOI 10.1167/iovs.03-0656; Hummel S, 2004, J BIOL CHEM, V279, P23486, DOI 10.1074/jbc.M312694200; HURTCAMEJO E, 1992, ARTERIOSCLER THROMB, V12, P569, DOI 10.1161/01.ATV.12.5.569; JACOBSEN L, 1995, J BIOL CHEM, V270, P6468, DOI 10.1074/jbc.270.12.6468; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Mahley R W, 1980, Ann N Y Acad Sci, V348, P265, DOI 10.1111/j.1749-6632.1980.tb21306.x; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; MULDER M, 1992, BIOCHEM BIOPH RES CO, V185, P582, DOI 10.1016/0006-291X(92)91664-C; NIMPF J, 1989, P NATL ACAD SCI USA, V86, P906, DOI 10.1073/pnas.86.3.906; NIMPF J, 1988, J LIPID RES, V29, P657; Olsson U, 2001, GLYCOCONJUGATE J, V18, P789, DOI 10.1023/A:1021155518464; PERRY MM, 1978, J ANAT, V125, P481; PERRY MM, 1979, J CELL SCI, V39, P257; Recheis B, 2005, CELL MOL LIFE SCI, V62, P1871, DOI 10.1007/s00018-005-5193-1; Schneider WJ, 1998, BIOL CHEM, V379, P965; Schonherr E, 2000, EUR J CELL BIOL, V79, P689, DOI 10.1078/0171-9335-00103; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; STEYRER E, 1990, J BIOL CHEM, V265, P19575; STIFANI S, 1991, J BIOL CHEM, V266, P19079; Tovar AMF, 1996, ATHEROSCLEROSIS, V126, P185, DOI 10.1016/0021-9150(96)05897-2; Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230; Watanabe K, 2004, DNA SEQUENCE, V15, P251, DOI 10.1080/10425170410001723921	38	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8011	8018		10.1074/jbc.M606029200	http://dx.doi.org/10.1074/jbc.M606029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17204479	hybrid			2022-12-27	WOS:000245081000032
J	Bogush, A; Pedrini, S; Pelta-Heller, J; Chan, T; Yang, Q; Mao, ZX; Sluzas, E; Gieringer, T; Ehrlich, ME				Bogush, Alexey; Pedrini, Steve; Pelta-Heller, Joshua; Chan, Tung; Yang, Qian; Mao, Zixu; Sluzas, Emily; Gieringer, Tracy; Ehrlich, Michelle E.			AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; HUNTINGTONS-DISEASE; PHOSPHATIDYLINOSITOL 3-KINASE; MOTOR-NEURONS; MOUSE MODEL; EXPRESSION; DOPAMINE; GENE; ACTIVATION; PHOSPHORYLATION	Mature striatal medium size spiny neurons express the dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa (DARPP-32), but little is known about the mechanisms regulating its levels or the specification of fully differentiated neuronal subtypes. Cell extrinsic molecules that increase DARPP-32 mRNA and/or protein levels include brain-derived neurotrophic factor (BDNF), retinoic acid, and estrogen. DARPP-32 induction by BDNF in vitro requires phosphatiaylinositide 3-kinase (PI3K), but inhibition of phosphorylation of protein kinase B/Akt does not entirely abolish expression of DARPP-32. Moreover, the requirement for Akt has not been established. Using pharmacologic inhibitors of PI3K, Akt, and cyclin-dependent kinase 5 (cdk5) and constitutively active and dominant negative PI3K, Akt, cdk5, and p35 viruses in cultured striatal neurons, we measured BDNF-induced levels of DARPP-32 protein and/or mRNA. We demonstrated that both the PI3K/Akt/mammalian target of rapamycin and the cdk5/p35 signal transduction pathways contribute to the induction of DARPP-32 protein levels by BDNF and that the effects are on both the transcriptional and translational levels. It also appears that PI3K is upstream of cdk5/p35, and its activation can lead to an increase in p35 protein levels. These data support the presence of multiple signal transduction pathways mediating expression of DARPP-32 in vitro, including a novel, important pathway via by which PI3K regulates the contribution of cdk5/p35.	Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Ctr Translat Res, Philadelphia, PA 19107 USA; Emory Univ, Sch Med, Dept Pharmacol & Neurol, Atlanta, GA 30322 USA	Jefferson University; Jefferson University; Jefferson University; Emory University	Ehrlich, ME (corresponding author), 900 Walnut St,JHN 411, Philadelphia, PA 19107 USA.	Michelle.Ehrlich@jefferson.edu		Chan, Tung/0000-0001-6574-9555; Pedrini, Steve/0000-0002-6409-8022	NIA NIH HHS [AG023695] Funding Source: Medline; NINDS NIH HHS [R01NS045942, R01NS048254] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254, R01NS045942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Belkhiri A, 2005, CANCER RES, V65, P6583, DOI 10.1158/0008-5472.CAN-05-1433; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Dluzen DE, 2004, ANN NY ACAD SCI, V1025, P205, DOI 10.1196/annals.1316.026; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; EHRLICH ME, 1990, DEV BRAIN RES, V54, P257, DOI 10.1016/0165-3806(90)90148-R; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fienberg AA, 2000, BRAIN RES REV, V31, P313, DOI 10.1016/S0165-0173(99)00047-8; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fryer HJL, 2000, J NEUROCHEM, V74, P582, DOI 10.1046/j.1471-4159.2000.740582.x; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Gerfen CR, 2000, ANN NEUROL, V47, pS42; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hansen C, 2006, EXP CELL RES, V312, P4011, DOI 10.1016/j.yexcr.2006.09.003; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Holleran JL, 2003, ANAL BIOCHEM, V323, P19, DOI 10.1016/j.ab.2003.08.030; Hu P, 2003, J NEUROCHEM, V84, P1421, DOI 10.1046/j.1471-4159.2003.01599.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Ivkovic S, 1997, NEUROSCIENCE, V79, P509, DOI 10.1016/S0306-4522(96)00684-7; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kesavapany S, 2004, BBA-PROTEINS PROTEOM, V1697, P143, DOI 10.1016/j.bbapap.2003.11.020; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Li Z, 2004, J BIOL CHEM, V279, P54438, DOI 10.1074/jbc.M411002200; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; NAKAO N, 1994, EXP BRAIN RES, V101, P291, DOI 10.1007/BF00228749; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Soliman GA, 2005, CURR OPIN LIPIDOL, V16, P317, DOI 10.1097/01.mol.0000169352.35642.06; Stroppolo A, 2004, NEUROENDOCRINOLOGY, V79, P259, DOI 10.1159/000079320; Stroppolo A, 2001, J NEUROCHEM, V79, P1027, DOI 10.1046/j.1471-4159.2001.00651.x; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tamura S, 2004, NEUROSCIENCE, V124, P261, DOI 10.1016/j.neuroscience.2003.11.036; Toresson H, 1999, DEVELOPMENT, V126, P1317; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wang HF, 2005, NEUROSCIENCE, V134, P97, DOI 10.1016/j.neuroscience.2005.04.008; Wang MSJ, 2005, INT J CLIN PRACT, V59, P58, DOI 10.1111/j.1742-1241.2004.00305.x; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zuccato C, 2005, PHARMACOL RES, V52, P133, DOI 10.1016/j.phrs.2005.01.001	68	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7352	7359		10.1074/jbc.M606508200	http://dx.doi.org/10.1074/jbc.M606508200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209049	hybrid			2022-12-27	WOS:000245080900046
J	Chen, BPC; Uematsu, N; Kobayashi, J; Lerenthal, Y; Krempler, A; Yajima, H; Lobrich, M; Shiloh, Y; Chen, DJ				Chen, Benjamin P. C.; Uematsu, Naoya; Kobayashi, Junya; Lerenthal, Yaniv; Krempler, Andrea; Yajima, Hirohiko; Loebrich, Markus; Shiloh, Yosef; Chen, David J.			Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; CELLULAR-RESPONSE; DAMAGE-RESPONSE; REPAIR; IDENTIFICATION; AUTOPHOSPHORYLATION; ARTEMIS; CELLS; CONNECTION	The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is rapidly phosphorylated at the Thr-2609 cluster and Ser-2056 upon ionizing radiation (IR). Furthermore, DNA-PKcs phosphorylation at both regions is critical for its role in DNA double strand break (DSB) repair as well as cellular resistance to radiation. IR-induced DNA-PKcs phosphorylation at Thr-2609 and Ser-2056, however, exhibits distinct kinetics indicating that they are differentially regulated. Although DNA-PKcs autophosphorylates itself at Ser-2056 after IR, we have reported here that ATM mediates DNA-PKcs phosphorylation at Thr-2609 as well as at the adjacent (S/T)Q motifs within the Thr-2609 cluster. In addition, our data suggest that DNA-PKcs and ATM-mediated DNA-PKcs phosphorylations are cooperative and required for the full activation of DNA-PKcs and the subsequent DSB repair. Elimination of DNA-PKcs phosphorylation at both regions severely compromises radioresistance and DSB repair. Finally, our result provides a possible mechanism for the direct involvement of ATM in non-homologous end joining-mediated DSB repair.	Univ Texas, SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; Kyoto Univ, Ctr Radiat Biol, Dept Genome Dynam, Kyoto 6068501, Japan; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet, IL-69978 Tel Aviv, Israel; Univ Saarland, Fachrichtung Biophys, D-66421 Homburg Saar, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Kyoto University; Tel Aviv University; Sackler Faculty of Medicine; Saarland University	Chen, DJ (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd, Dallas, TX 75390 USA.	david.chen@utsouthwestern.edu	Kobayashi, Junya/AAX-6390-2021; Classen, Scott/AAY-8176-2020	Kobayashi, Junya/0000-0003-4645-7500; 	NATIONAL CANCER INSTITUTE [R37CA050519, P01CA092584, R01CA086936, R01CA050519] Funding Source: NIH RePORTER; NCI NIH HHS [CA86936, CA50519, P01-CA92584] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Pike BL, 2004, MOL CELL BIOL, V24, P2779, DOI 10.1128/MCB.24.7.2779-2788.2004; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Soubeyrand S, 2003, CANCER RES, V63, P1198; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	31	225	232	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6582	6587		10.1074/jbc.M611605200	http://dx.doi.org/10.1074/jbc.M611605200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17189255	hybrid			2022-12-27	WOS:000244867200067
J	Knosp, WM; Saneyoshi, C; Shou, SM; Bachinger, HP; Stadler, HS				Knosp, Wendy M.; Saneyoshi, Chie; Shou, Siming; Bachinger, Hans Peter; Stadler, H. Scott			Elucidation, quantitative refinement, and in vivo utilization of the HOXA13 DNA binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOPERATIVE INTERACTIONS; DEVELOPMENTAL BASIS; PROTEINS; GENE; LIMB; EXPRESSION; PBX; SPECIFICITY; BMP; ULTRABITHORAX	Mutations in Hoxa13 cause malformations of the appendicular skeleton and genitourinary tract, including digit loss, syndactyly, and hypospadias. To determine the molecular basis for these defects, the DNA sequences bound by HOXA13 were empirically determined, revealing a novel high affinity binding site. Correlating the utilization of this high affinity binding site with genes exhibiting perturbed expression in Hoxa13 mutant limbs, we identified that HOXA13 suppresses the expression of the BMP antagonist, Sostdc1. In the absence of HOXA13 function, Sostdc1 is ectopically expressed in the distal limb, causing reduced expression of BMP-activated genes and decreased SMAD phosphorylation. Limb chromatin immunoprecipitation revealed HOXA13 binding at its high affinity site in two conserved Sostdc1 regulatory sites in vivo. In vitro, HOXA13 represses gene expression through the Sostdc1 high affinity binding sites in a dosage-dependent manner. Together, these findings confirm that the high affinity HOXA13 binding site deduced by quantitative analyses is used in vivo to facilitate HOXA13 target gene regulation, providing a critical advance toward understanding the molecular basis for defects associated with the loss of HOXA13 function.	Shriners Hosp Children, Div Res, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA	Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco	Stadler, HS (corresponding author), Shriners Hosp Children, Div Res, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hss@shcc.org			NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008617] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA69533] Funding Source: Medline; NIDDK NIH HHS [5R01DK066539-01] Funding Source: Medline; NIGMS NIH HHS [5T32GM008617-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENSON GV, 1995, MOL CELL BIOL, V15, P1591; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Capovilla M, 2001, DEVELOPMENT, V128, P1221; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Davis AP, 1996, DEVELOPMENT, V122, P1175; Favier B, 1996, DEVELOPMENT, V122, P449; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Galant R, 2002, DEVELOPMENT, V129, P3115; Godwin AR, 1998, P NATL ACAD SCI USA, V95, P13042, DOI 10.1073/pnas.95.22.13042; Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Healy C, 1996, ANN NY ACAD SCI, V785, P261, DOI 10.1111/j.1749-6632.1996.tb56278.x; Hinchliffe JR, 2002, INT J DEV BIOL, V46, P835; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; LEI H, 2006, P NATL CAD SCI US; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; PELLERIN I, 1994, MOL CELL BIOL, V14, P4532, DOI 10.1128/MCB.14.7.4532; Penkov D, 2000, J BIOL CHEM, V275, P16681, DOI 10.1074/jbc.M909345199; PHELAN ML, 1994, MOL CELL BIOL, V14, P5066, DOI 10.1128/MCB.14.8.5066; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shanmugam K, 1997, J BIOL CHEM, V272, P19081, DOI 10.1074/jbc.272.30.19081; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138; TREISMAN J, 1989, CELL, V59, P553; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang N, 2006, EMBO J, V25, P1469, DOI 10.1038/sj.emboj.7601037; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Williams TM, 2005, DEV BIOL, V279, P462, DOI 10.1016/j.ydbio.2004.12.015; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zhao YX, 2001, DEVELOPMENT, V128, P3197; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	64	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6843	6853		10.1074/jbc.M610775200	http://dx.doi.org/10.1074/jbc.M610775200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200107	hybrid			2022-12-27	WOS:000244867200094
J	Minami, H; Dubouzet, E; Iwasa, K; Sato, F				Minami, Hiromichi; Dubouzet, Emilyn; Iwasa, Kinuko; Sato, Fumihiko			Functional analysis of norcoclaurine synthase in Coptis japonica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; 1ST COMMITTED STEP; MOLECULAR-CLONING; HOMOSPERMIDINE SYNTHASE; 2-OXOGLUTARATE-DEPENDENT DIOXYGENASE; (S)-NORLAUDANOSOLINE SYNTHASE; STRICTOSIDINE SYNTHASE; CATHARANTHUS-ROSEUS; ESCHERICHIA-COLI; SENECIO-VULGARIS	(S)-Norcoclaurine is the entry compound in benzylisoquinoline alkaloid biosynthesis and is produced by the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) by norcoclaurine synthase (NCS) (EC 4.2.1.78). Although cDNA of the pathogenesis-related (PR) 10 family, the translation product of which catalyzes NCS reaction, has been isolated from Thalictrumflavum, its detailed enzymological properties have not yet been characterized. We report here that a distinct cDNA isotated from Coptisjaponica (CjNCS1) also catalyzed NCS reaction as well as a PR10 homologue of C. japonica (CjPR10A). Both recombinant proteins stereo-specifically produced (S)norcoclaurine by the condensation of dopamine and 4-HPAA. Because a CjNCS1 cDNA that encoded 352 amino acids showed sequence similarity to 2-oxoglutarate-dependent dioxygenases of plant origin, we characterized the properties of the native enzyme. Sequence analysis indicated that CjNCS1 only contained a Fe2+-binding site and lacked the 2-oxoglutarate-binding domain. In fact, NCS reaction of native NCS isolated from cultured C japonica cells did not depend on 2-oxoglutarate or oxygen, but did require ferrous ion. On the other hand, CjPR10A showed no specific motif The addition of o-phenanthroline inhibited NCS reaction of both native NCS and recombinant CjNCS1, but not that of CjPR10A. In addition, native NCS and recombinant CjNCS1 accepted phenylacetaldehyde and 3,4-dihydroxyphenylacetaldehyde, as well as 4-HPAA, for condensation with dopamine, whereas recombinant CjPR10A could use 4-hydroxyphenylpyruvate and pyruvate in addition to the above aldehydes. These results suggested that CjNCS1 is the major NCS in C japonica, whereas native NCS extracted from cultured C. japonica cells was more active and formed a larger complex compared with recombinant CjNCS1.	Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kyoto University; Kobe Pharmaceutical University	Sato, F (corresponding author), Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	fsato@lif.kyoto-u.ac.jp	Sato, Fumihiko/C-1078-2011	Sato, Fumihiko/0000-0001-9497-4452				Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Borovok I, 1996, BIOCHEMISTRY-US, V35, P1981, DOI 10.1021/bi951534t; Bouin J C, 1976, Methods Enzymol, V44, P478; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; DECAROLIS E, 1994, PHYTOCHEMISTRY, V36, P1093, DOI 10.1016/S0031-9422(00)89621-1; DONG JG, 1992, P NATL ACAD SCI USA, V89, P9789, DOI 10.1073/pnas.89.20.9789; Dubouzet JG, 2005, BIOSCI BIOTECH BIOCH, V69, P63, DOI 10.1271/bbb.69.63; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; HEDDEN P, 1992, BIOCHEM SOC T, V20, P373, DOI 10.1042/bst0200373; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Iwasa K, 2005, J NAT PROD, V68, P992, DOI 10.1021/np0402219; Kaiser A, 1999, PLANT J, V19, P195, DOI 10.1046/j.1365-313X.1999.00509.x; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Kristensen C, 2005, P NATL ACAD SCI USA, V102, P1779, DOI 10.1073/pnas.0409233102; KUTCHAN TM, 1988, FEBS LETT, V237, P40, DOI 10.1016/0014-5793(88)80167-4; KUTCHAN TM, 1986, PLANT PHYSIOL, V81, P161, DOI 10.1104/pp.81.1.161; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P2500, DOI 10.1016/j.phytochem.2005.04.044; MATSUDA J, 1991, J BIOL CHEM, V266, P9460; MCKNIGHT TD, 1990, NUCLEIC ACIDS RES, V18, P4939, DOI 10.1093/nar/18.16.4939; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; Nurhayati N, 2005, PHYTOCHEMISTRY, V66, P1346, DOI 10.1016/j.phytochem.2005.04.013; Ober D, 2000, PHYTOCHEMISTRY, V55, P305, DOI 10.1016/S0031-9422(00)00267-3; PERRY D, 1988, BIOCHEM J, V255, P345; Prescott AG, 1996, ANNU REV PLANT PHYS, V47, P245, DOI 10.1146/annurev.arplant.47.1.245; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; ROBERTS MF, 1983, ARCH BIOCHEM BIOPHYS, V222, P599, DOI 10.1016/0003-9861(83)90558-1; RUEFFER M, 1981, FEBS LETT, V129, P5, DOI 10.1016/0014-5793(81)80742-9; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Samanani N, 2001, PLANTA, V213, P898, DOI 10.1007/s004250100581; SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x; SATO F, 1984, PHYTOCHEMISTRY, V23, P281, DOI 10.1016/S0031-9422(00)80318-0; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; SCHUMACHER HM, 1983, PLANTA MED, V48, P212, DOI 10.1055/s-2007-969923; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; STADLER R, 1989, PHYTOCHEMISTRY, V28, P1083, DOI 10.1016/0031-9422(89)80187-6; STADLER R, 1987, TETRAHEDRON LETT, V28, P1251, DOI 10.1016/S0040-4039(00)95338-3; STADLER R, 1990, LIEBIGS ANN CHEM, V6, P555; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VazquezFlota F, 1997, PLANT MOL BIOL, V34, P935, DOI 10.1023/A:1005894001516; WILSON ML, 1975, J AM CHEM SOC, V97, P431, DOI 10.1021/ja00835a040	47	96	107	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6274	6282		10.1074/jbc.M608933200	http://dx.doi.org/10.1074/jbc.M608933200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204481	hybrid			2022-12-27	WOS:000244867200033
J	Burkhalter, J; Fiumelli, H; Erickson, JD; Martin, JL				Burkhalter, Julia; Fiumelli, Hubert; Erickson, Jeffrey D.; Martin, Jean-Luc			A critical role for system A amino acid transport in the regulation of dendritic development by brain-derived neurotrophic factor (BDNF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; LONG-TERM POTENTIATION; MOUSE CORTICAL-NEURONS; VISUAL-CORTEX; MICE LACKING; MOLECULAR-BIOLOGY; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; CRITICAL PERIOD; LATE-PHASE	Dendritic development is essential for the establishment of a functional nervous system. Among factors that control dendritic development, brain-derived neurotrophic factor (BDNF) has been shown to regulate dendritic length and complexity of cortical neurons. However, the cellular and molecular mechanisms that underlie these effects remain poorly understood. In this study, we examined the role of amino acid transport in mediating the effects of]BDNF on dendritic development. We show that BDNF increases System A amino acid transport in cortical neurons by selective up-regulation of the sodium-coupled neutral amino acid transporter (SNAT)1. Up-regulation of SNAT1 expression and System A activity is required for the effects of BDNF on dendritic growth and branching of cortical neurons. Further analysis revealed that induction of SNAT1 expression and System A activity by BDNF is necessary in particular to enhance synthesis of tissue-type plasminogen activator, a protein that we demonstrate to be essential for the effects of BDNF on cortical dendritic morphology. Together, these data reveal that stimulation of neuronal differentiation by BDNF requires the up-regulation of SNAT1 expression and System A amino acid transport to meet the increased metabolic demand associated with the enhancement of dendritic growth and branching.	Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Univ Lausanne, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland	University of Lausanne; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Lausanne	Martin, JL (corresponding author), Univ Lausanne, Dept Physiol, Rue Bugnon 7, CH-1005 Lausanne, Switzerland.	jean-luc.martin@unil.ch		Martin, Jean-Luc/0000-0002-5082-4687				Armano S, 2002, J BIOL CHEM, V277, P10467, DOI 10.1074/jbc.M110942200; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Burkhalter J, 2003, J NEUROSCI, V23, P8212; CHRISTENSEN HN, 1965, J BIOL CHEM, V240, P3609; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Fiumelli H, 1999, EUR J NEUROSCI, V11, P1639, DOI 10.1046/j.1460-9568.1999.00580.x; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Horch HW, 1999, NEURON, V23, P353; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; JESSELL TM, 2000, PRINCIPLES NEURAL SC, P1019; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; STELLA N, 1995, J NEUROSCI, V15, P3307; STURZEBECHER J, 1992, PROTEIN SCI, V1, P1007; Su TZ, 1997, BRAIN RES, V757, P69, DOI 10.1016/S0006-8993(97)00139-X; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Zhang Y, 2005, J NEUROSCI, V25, P1797, DOI 10.1523/jneurosci.4850-04.2005	38	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5152	5159		10.1074/jbc.M608548200	http://dx.doi.org/10.1074/jbc.M608548200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17179157	hybrid			2022-12-27	WOS:000244482300009
J	Fritz, M; Lokstein, H; Hackenberg, D; Welti, R; Roth, M; Zahringer, U; Fulda, M; Hellmeyer, W; Ott, C; Wolter, FP; Heinz, E				Fritz, Markus; Lokstein, Heiko; Hackenberg, Dieter; Welti, Ruth; Roth, Mary; Zaehringer, Ulrich; Fulda, Martin; Hellmeyer, Wiebke; Ott, Claudia; Wolter, Frank P.; Heinz, Ernst			Channeling of eukaryotic diacylglycerol into the biosynthesis of plastidial phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-CONTAINING PHOSPHATIDYLGLYCEROL; CHLOROPLAST ENVELOPE MEMBRANES; CHILLING SENSITIVITY; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; FATTY-ACIDS; PROTEIN; LIPIDS; ACYL; GENE	Plastidial glycolipids contain diacylglycerol (DAG) moieties, which are either synthesized in the plastids (prokaryotic lipids) or originate in the extraplastidial compartment (eukaryotic lipids) necessitating their transfer into plastids. In contrast, the only phospholipid in plastids, phosphatidylglycerol (PG), contains exclusively prokaryotic DAG backbones. PG contributes in several ways to the functions of chloroplasts, but it is not known to what extent its prokaryotic nature is required to fulfill these tasks. As a first step toward answering this question, we produced transgenic tobacco plants that contain eukaryotic PG in thylakoids. This was achieved by targeting a bacterial DAG kinase into chloroplasts in which the heterologous enzyme was also incorporated into the envelope fraction. From lipid analysis we conclude that the DAG kinase phosphorylated eukaryotic DAG forming phosphatidic acid, which was converted into PG. This resulted in PG with 2-3 times more eukaryotic than prokaryotic DAG backbones. In the newly formed PG the unique Delta 3-trans-double bond, normally confined to 3-transhexadecenoic acid, was also found in sn-2-bound cis-unsaturated C18 fatty acids. In addition, a lipidomics technique allowed the characterization of phosphatidic acid, which is assumed to be derived from eukaryotic DAG precursors in the chloroplasts of the transgenic plants. The differences in lipid composition had only minor effects on measured functions of the photosynthetic apparatus, whereas the most obvious phenotype was a significant reduction in growth.	Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; Max Planck Gesell, D-80539 Munich, Germany; Univ Potsdam, Inst Biochem & Biol, D-14476 Golm, Germany; Humboldt Univ, Inst Biol Pflanzenphysiol, D-10099 Berlin, Germany; Kansas State Univ, Div Biol, Kansas Lipidom Res Ctr, Manhattan, KS 66506 USA; Forschungszentrum Borstel, Leibniz Zentrum Med & Biowissenschaf, D-23845 Borstel, Germany; Univ Gottingen, Albrecht Von Haller Inst Pflanzenwissenschaf, D-37077 Gottingen, Germany; GVSmbH, Bundesverband Deutscher Pflanzenzuchter, Bonn, Germany	University of Hamburg; Max Planck Society; University of Potsdam; Humboldt University of Berlin; Kansas State University; Forschungszentrum Borstel; University of Gottingen	Fulda, M (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	mfulda@gwdg.de	Lokstein, Heiko/AAK-1930-2021; Lokstein, Heiko/P-2788-2019; Lokstein, Heiko/H-7702-2013	Lokstein, Heiko/0000-0001-6739-4612; Lokstein, Heiko/0000-0001-6739-4612; Welti, Ruth/0000-0003-4373-2538	NCRR NIH HHS [P20 RR16475] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andersson MX, 2007, J BIOL CHEM, V282, P1170, DOI 10.1074/jbc.M608124200; Andersson MX, 2004, BBA-MOL CELL BIOL L, V1684, P46, DOI 10.1016/j.bbalip.2004.06.003; Ariizumi T, 2002, PLANT CELL PHYSIOL, V43, P751, DOI 10.1093/pcp/pcf087; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BENSON AA, 1958, BIOCHIM BIOPHYS ACTA, V27, P189, DOI 10.1016/0006-3002(58)90308-1; BERTRAMS M, 1981, Z NATURFORSCH C, V36, P62; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Bovet L, 2001, BIOCHEM BIOPH RES CO, V289, P269, DOI 10.1006/bbrc.2001.5969; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Domergue F, 2002, EUR J BIOCHEM, V269, P4105, DOI 10.1046/j.1432-1033.2002.03104.x; DORNE AJ, 1990, P NATL ACAD SCI USA, V87, P71, DOI 10.1073/pnas.87.1.71; DORNE AJ, 1989, PLANT SCI, V60, P39, DOI 10.1016/0168-9452(89)90041-1; DUBERTRET G, 1994, EUR J BIOCHEM, V226, P473, DOI 10.1111/j.1432-1033.1994.tb20072.x; Frentzen M, 2004, CURR OPIN PLANT BIOL, V7, P270, DOI 10.1016/j.pbi.2004.03.001; FRITZ CC, 1993, GENE, V137, P271, DOI 10.1016/0378-1119(93)90019-Y; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Gomez-Merino FC, 2004, J BIOL CHEM, V279, P8230, DOI 10.1074/jbc.M312187200; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Hagio M, 2002, PLANT CELL PHYSIOL, V43, P1456, DOI 10.1093/pcp/pcf185; HAJRA AK, 1974, LIPIDS, V9, P502, DOI 10.1007/BF02532495; HAVERKATE F, 1965, BIOCHIM BIOPHYS ACTA, V106, P78; HEEMSKERK JWM, 1986, BIOCHIM BIOPHYS ACTA, V877, P281, DOI 10.1016/0005-2760(86)90305-X; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; HOPKINS CY, 1965, J CHEM SOC, P907, DOI 10.1039/jr9650000907; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kjellberg JM, 2000, BBA-MOL CELL BIOL L, V1485, P100, DOI 10.1016/S1388-1981(00)00040-8; Kjellberg JM, 2004, PLANT SCI, V166, P601, DOI 10.1016/j.plantsci.2003.10.019; Kohler RH, 2000, J CELL SCI, V113, P81; KOIWAI A, 1981, PLANT CELL PHYSIOL, V22, P1059; KONCZ C, 1987, P NATL ACAD SCI USA, V84, P131, DOI 10.1073/pnas.84.1.131; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIGHTNER VA, 1983, J BIOL CHEM, V258, P856; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H., 2002, BIOCHIM BIOPHYS ACTA, V1553, P93; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LOOMIS CR, 1985, J BIOL CHEM, V260, P4091; LUTHRIA DL, 1993, LIPIDS, V28, P561, DOI 10.1007/BF02536089; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; MALHERBE A, 1992, J BIOL CHEM, V267, P23546; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; MARECHAL E, 1994, J BIOL CHEM, V269, P5788; MCCOURT P, 1985, PLANT PHYSIOL, V78, P853, DOI 10.1104/pp.78.4.853; MIQUEL M, 1988, BIOCHIM BIOPHYS ACTA, V937, P219, DOI 10.1016/0005-2736(88)90244-1; Mongrand S, 2005, PHYTOCHEMISTRY, V66, P549, DOI 10.1016/j.phytochem.2004.12.021; Mongrand S, 2000, PLANT PHYSIOL, V122, P845, DOI 10.1104/pp.122.3.845; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P81, DOI 10.1093/oxfordjournals.pcp.a076516; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; OHNISHI M, 1991, ARCH BIOCHEM BIOPHYS, V288, P591, DOI 10.1016/0003-9861(91)90241-A; PLATTNER RD, 1976, LIPIDS, V11, P222, DOI 10.1007/BF02532861; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quoc KP, 1997, BBA-LIPID LIPID MET, V1346, P237; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; ROUGHAN PG, 1985, PLANT PHYSIOL, V77, P740, DOI 10.1104/pp.77.3.740; SAKAKI T, 1990, PLANT PHYSIOL, V94, P773, DOI 10.1104/pp.94.2.773; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; SEIFERT U, 1992, BOT ACTA, V105, P197, DOI 10.1111/j.1438-8677.1992.tb00287.x; SIEBERTZ HP, 1978, PLANT SCI LETT, V12, P119, DOI 10.1016/0304-4211(78)90144-X; SIEBERTZ HP, 1979, EUR J BIOCHEM, V101, P429, DOI 10.1111/j.1432-1033.1979.tb19736.x; Sperling P, 2000, EUR J BIOCHEM, V267, P3801, DOI 10.1046/j.1432-1327.2000.01418.x; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tietje C, 1998, PLANTA, V206, P72, DOI 10.1007/s004250050375; TREMOLIERES A, 1991, BIOCHIM BIOPHYS ACTA, V1059, P286, DOI 10.1016/S0005-2728(05)80214-2; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245, DOI 10.1007/BF00260489; VANTHOF R, 1993, J BIOL CHEM, V268, P4037; Wada H, 1998, LIPIDS PHOTOSYNTHESI, P65, DOI [10.1007/0-306-48087-5_4, DOI 10.1007/0-306-48087-5_4]; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Wanjie SW, 2005, LIPIDS, V40, P773, DOI 10.1007/s11745-005-1439-4; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Williams JP, 2000, BIOCHEM J, V349, P127, DOI 10.1042/0264-6021:3490127; WOLTER FP, 1992, EMBO J, V11, P4685, DOI 10.1002/j.1460-2075.1992.tb05573.x; WU JR, 1995, PLANT CELL, V7, P17, DOI 10.1105/tpc.7.1.17; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x	87	23	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4613	4625		10.1074/jbc.M606295200	http://dx.doi.org/10.1074/jbc.M606295200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17158889	hybrid			2022-12-27	WOS:000244482000042
J	Jacobs, RL; Lingrell, S; Dyck, JRB; Vance, DE				Jacobs, Rene L.; Lingrell, Susanne; Dyck, Jason R. B.; Vance, Dennis E.			Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CHINESE-HAMSTER OVARY; RAT-LIVER; CHOLINE DEFICIENCY; PHOSPHATIDYLETHANOLAMINE; CELLS; BIOSYNTHESIS; TRANSLOCATION; METABOLISM; METHYLATION	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAr), a commonly used indirect activator of AMP-activated protein kinase (AMPK), inhibits phosphatidylcholine (PC) biosynthesis in freshly isolated hepatocytes. In all nucleated mammalian cells, PC is synthesized from choline via the Kennedy (CDP-choline) pathway. The purpose of our study was to provide direct evidence that AMPK regulates phospholipid biosynthesis and to elucidate the mechanism(s) by which AMPK inhibits hepatic PC synthesis. Incubations of hepatocytes with AICAr resulted in a dose-dependent activation of AMPK and inhibition of PC biosynthesis. Surprisingly, adenoviral delivery of constitutively active AMPK did not alter PC biosynthesis. In addition, expression of dominant negative mutants of AMPK was unable to block the AICAr-dependent inhibition of PC biosynthesis, indicating that AICAr was acting independently of AMPK activation. Determination of aqueous intermediates of the CDPcholine pathway indicated that choline kinase, the first enzyme in the pathway, was inhibited by AICAr administration. Flux through the CDP-choline pathway was directly correlated to the level of intracellular ATP concentrations. Therefore, it is possible that inhibition of PC biosynthesis is another process by which the cell can reduce ATP consumption in times of energetic stress. However, unlike cholesterol and triacylglycerol biosynthesis, PC production is not regulated by AMPK.	Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Cardiovasc Res Grp, Dept Pediat, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Jacobs, Rene/0000-0002-5525-1355; Dyck, Jason/0000-0002-7045-2884				Aoyama C, 2000, J LIPID RES, V41, P452; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dolinsky VW, 2006, AM J PHYSIOL-HEART C, V291, pH2557, DOI 10.1152/ajpheart.00329.2006; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Houweling M, 1997, BBA-LIPID LIPID MET, V1346, P1, DOI 10.1016/S0005-2760(97)00011-8; Houweling M, 2002, BIOCHEM J, V362, P97, DOI 10.1042/0264-6021:3620097; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; JASWAL JS, 2006, AM J PHYSIOL, V291, pH188; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; Kitos TE, 2006, BBA-MOL CELL BIOL L, V1761, P272, DOI 10.1016/j.bbalip.2006.02.014; Kuipers F, 1997, Subcell Biochem, V28, P295; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P447, DOI 10.1016/0005-2760(84)90171-1; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; RIDGWAY ND, 1989, J BIOL CHEM, V264, P1203; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; SCHNEIDER WJ, 1978, EUR J BIOCHEM, V85, P181, DOI 10.1111/j.1432-1033.1978.tb12226.x; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; Sugiyama K, 1998, LIPIDS, V33, P235, DOI 10.1007/s11745-998-0201-2; Sugiyama K, 1997, J NUTR, V127, P600, DOI 10.1093/jn/127.4.600; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; UTAL AK, 1991, J BIOL CHEM, V266, P24084; Vance D.E., 2002, BIOCH LIPIDS LIPOPRO, P205; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P225; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; WEINHOLD PA, 1974, BIOCHEMISTRY-US, V13, P5135, DOI 10.1021/bi00722a013; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919; YAO ZM, 1990, J BIOL CHEM, V265, P4326; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200	51	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4516	4523		10.1074/jbc.M605702200	http://dx.doi.org/10.1074/jbc.M605702200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179149	hybrid			2022-12-27	WOS:000244482000033
J	Hong-Brown, LQ; Brown, CR; Huber, DS; Lang, CH				Hong-Brown, Ly Q.; Randell Brown, C.; Huber, Danuta S.; Lang, Charles H.			Alcohol regulates eukaryotic elongation factor 2 phosphorylation via an AMP-activated protein kinase-dependent mechanism in C2C12 skeletal myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II; MAMMALIAN TARGET; TRANSLATION ELONGATION; GENE-EXPRESSION; RAPAMYCIN; MTOR; EEF2; INHIBITION; GLUCOSE; MUSCLE	Ethanol decreases protein synthesis in cells, although the underlying regulatory mechanisms of this process are not fully established. In the present study incubation of C2C12 myocytes with 100 mm EtOH decreased protein synthesis while markedly increasing the phosphorylation of eukaryortic elongation factor 2 (eEF2), a key component of the translation machinery. Both mTOR and MEK pathways were found to play a role in regulating the effect of EtOH on eEF2 phosphorylation. Rapamycin, an inhibitor of mammalian target of rapamycin, and the MEK inhibitor PD98059 blocked the EtOH-induced phosphorylation of eEF2, whereas the p38 MAPK inhibitor SB202190 had no effect. Unexpectedly, EtOH decreased the phosphorylation and activity of the eEF2 upstream regulator eEF2 kinase. Likewise, treatment of cells with the inhibitor rottlerin did not block the stimulatory effect of EtOH on eEF2, suggesting that eEF2 kinase (eEF2K) does not play a role in regulating eEF2. In contrast, increased eEF2 phosphorylation was correlated with an increase in AMP-activated protein kinase (AMPK) phosphorylation and activity. Compound C, an inhibitor of AMPK, suppressed the effects of EtOH on eEF2 phosphorylation but had no effect on eEF2K, indicating that AMPK regulates eEF2 independent of eEF2K. Finally, EtOH decreased protein phosphatase 2A activity when either eEF2 or AMPK was used as the substrate. Thus, this later action may partially account for the increased phosphorylation of eEF2 in response to EtOH and the observed sensitivity of AMPK to rapamycin and PD98059 treatments. Collectively, the induction of eEF2 phosphorylation by EtOH is controlled by an increase in AMPK and a decrease in protein phosphatase 2A activity.	Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hong-Brown, LQ (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	lqh10@psu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011290] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA11209, R01 AA011290] Funding Source: Medline; NIDDK NIH HHS [DK072909-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; CELIS JE, 1990, P NATL ACAD SCI USA, V87, P4231, DOI 10.1073/pnas.87.11.4231; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Crozier SJ, 2005, AM J PHYSIOL-HEART C, V289, pH1242, DOI 10.1152/ajpheart.00859.2004; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hait WN, 1996, FEBS LETT, V397, P55, DOI 10.1016/S0014-5793(96)01140-4; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hong-Brown LQ, 2001, ALCOHOL CLIN EXP RES, V25, P1373; Hong-Brown LQ, 2006, ALCOHOL CLIN EXP RES, V30, P1297, DOI 10.1111/j.1530-0277.2006.00157.x; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Horman S, 2003, J BIOL CHEM, V278, P41970, DOI 10.1074/jbc.M302403200; Hue L, 2003, BIOCHEM SOC T, V31, P213, DOI 10.1042/bst0310213; Inamura N, 2005, J NEUROCHEM, V95, P1438, DOI 10.1111/j.1471-4159.2005.03466.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Lang CH, 2003, AM J PHYSIOL-ENDOC M, V285, pE1205, DOI 10.1152/ajpendo.00177.2003; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; McLeod LE, 2002, FEBS LETT, V531, P448, DOI 10.1016/S0014-5793(02)03582-2; MERRICK WC, 2000, TRANSLATIONAL CONTRO, P59; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; Proud CG, 2003, CURR TOP MICROBIOL, V279, P215; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Ren HN, 2005, CANCER RES, V65, P5841, DOI 10.1158/0008-5472.CAN-04-3141; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Rose AJ, 2005, J PHYSIOL-LONDON, V569, P223, DOI 10.1113/jphysiol.2005.097154; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Wang LJ, 2002, FEBS LETT, V531, P285, DOI 10.1016/S0014-5793(02)03536-6; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370	48	41	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3702	3712		10.1074/jbc.M606593200	http://dx.doi.org/10.1074/jbc.M606593200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17164244	hybrid			2022-12-27	WOS:000244481900033
J	Le, SB; Hailer, MK; Buhrow, S; Wang, Q; Flatten, K; Pediaditakis, P; Bible, KC; Lewis, LD; Sausville, EA; Pang, YP; Ames, MM; Lemasters, JJ; Holmuhamedov, EL; Kaufmann, SH				Le, Son B.; Hailer, M. Katie; Buhrow, Sarah; Wang, Qi; Flatten, Karen; Pediaditakis, Peter; Bible, Keith C.; Lewis, Lionel D.; Sausville, Edward A.; Pang, Yuan-Ping; Ames, Matthew M.; Lemasters, John J.; Holmuhamedov, Ekhson L.; Kaufmann, Scott H.			Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LEUKEMIA-CELLS; CARCINOMA-CELLS; MOLECULAR-DYNAMICS; CYTOCHROME BC(1); MAMMALIAN-CELLS; DT-DIAPHORASE; STEADY-STATE; COMPLEX-I; APOPTOSIS; RESISTANCE	Adaphostin is a dihydroquinone derivative that is undergoing extensive preclinical testing as a potential anticancer drug. Previous studies have suggested that the generation of reactive oxygen species (ROS) plays a critical role in the cytotoxicity of this agent. In this study, we investigated the source of these ROS. Consistent with the known chemical properties of dihydroquinones, adaphostin simultaneously underwent oxidation to the corresponding quinone and generated ROS under aqueous conditions. Interestingly, however, this quinone was not detected in intact cells. Instead, high performance liquid chromatography demonstrated that adaphostin was concentrated by up to 300-fold in cells relative to the extracellular medium and that the highest concentration of adaphostin (3000-fold over extracellular concentrations) was detected in mitochondria. Consistent with a mitochondrial site for adaphostin action, adaphostin-induced ROS production was diminished by >75% in MOLT-4 rho(o) cells, which lack mitochondrial electron transport, relative to parental MOLT-4 cells. In addition, inhibition of oxygen consumption was observed when intact cells were treated with adaphostin. Loading of isolated mitochondria to equivalent adaphostin concentrations caused inhibition of uncoupled oxygen consumption in mitochondria incubated with the complex I substrates pyruvate and malate or the complex II substrate succinate. Further analysis demonstrated that adaphostin had no effect on pyruvate or succinate dehydrogenase activity. Instead, adaphostin inhibited reduced decylubiquinone-induced cytochrome c reduction, identifying complex III as the site of inhibition by this agent. Moreover, adaphostin enhanced the production of ROS by succinate-charged mitochondria. Collectively, these observations demonstrate that mitochondrial respiration rather than direct redox cycling of the hydroquinone moiety is a source of adaphostin-induced ROS and identify complex III as a potential target for antineoplastic agents.	Mayo Clin, Div Oncol Res, Coll Med, Dept Oncol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Dartmouth Coll Sch Med, Dept Med, Lebanon, NH 03756 USA; Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; Dartmouth College; University System of Maryland; University of Maryland Baltimore	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Coll Med, Dept Oncol, Guggenheim 1342C,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu	Holmuhamedov, Ekhson L/P-5228-2016	Holmuhamedov, Ekhson L/0000-0002-0809-350X; Kaufmann, Scott/0000-0002-4900-7145; Pang, Yuan-Ping/0000-0003-0838-2560	NCI NIH HHS [R01 CA85972] Funding Source: Medline; NIDDK NIH HHS [R01 DK073336] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beall HD, 2000, FRONT BIOSCI-LANDMRK, V5, pD639, DOI 10.2741/Beall; CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5; Chandra J, 2006, BLOOD, V107, P2501, DOI 10.1182/blood-2005-07-2966; Chandra J, 2003, BLOOD, V102, P4512, DOI 10.1182/blood-2003-02-0562; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; COVEY JM, 1989, CANCER RES, V49, P5016; DAWSON TL, 1993, AM J PHYSIOL, V264, P961; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Frisch M. J., 1999, GAUSSIAN 03; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gutierrez PL, 2000, FREE RADICAL BIO MED, V29, P263, DOI 10.1016/S0891-5849(00)00314-2; HAMILTON PB, 1969, APPL MICROBIOL, V17, P102, DOI 10.1128/AEM.17.1.102-105.1969; Holmuhamedov E, 2003, MITOCHONDRION, V3, P13, DOI 10.1016/S1567-7249(03)00053-9; Holmuhamedov EL, 1999, J PHYSIOL-LONDON, V519, P347, DOI 10.1111/j.1469-7793.1999.0347m.x; Hose C, 2005, CLIN CANCER RES, V11, P6370, DOI 10.1158/1078-0432.CCR-05-0291; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kaufmann SH, 1996, J NATL CANCER I, V88, P734, DOI 10.1093/jnci/88.11.734; Kowaltowski AJ, 1999, J BIOENERG BIOMEMBR, V31, P581, DOI 10.1023/A:1005421112345; LAMPIDIS TJ, 1985, BIOMED PHARMACOTHER, V39, P220; Laupeze B, 2002, BRIT J HAEMATOL, V116, P834, DOI 10.1046/j.0007-1048.2002.03350.x; Le SB, 2006, CELL DEATH DIFFER, V13, P151, DOI 10.1038/sj.cdd.4401732; Li H, 1997, J NEUROCHEM, V69, P1530; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Long J, 2007, CANCER CHEMOTH PHARM, V59, P527, DOI 10.1007/s00280-006-0295-5; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; NADAKAVUKAREN KK, 1985, CANCER RES, V45, P6093; Okubo T, 1997, TOXICOL LETT, V90, P11, DOI 10.1016/S0378-4274(96)03823-4; Pang YP, 2001, J COMPUT CHEM, V22, P1750, DOI 10.1002/jcc.1129; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PETRONILLI V, 1986, EUR J BIOCHEM, V155, P423, DOI 10.1111/j.1432-1033.1986.tb09508.x; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Pflaum M, 1997, CARCINOGENESIS, V18, P2225, DOI 10.1093/carcin/18.11.2225; PORTEOUS JW, 1965, BIOCHEM J, V96, P159, DOI 10.1042/bj0960159; POTTER VR, 1952, J BIOL CHEM, V194, P287; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; RIESKE JS, 1976, BIOCHIM BIOPHYS ACTA, V456, P195, DOI 10.1016/0304-4173(76)90012-4; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Shanafelt TD, 2004, BLOOD, V103, P1202, DOI 10.1182/blood-2003-07-2281; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; SUN IL, 1992, P NATL ACAD SCI USA, V89, P11126, DOI 10.1073/pnas.89.23.11126; Svingen PA, 2000, CLIN CANCER RES, V6, P237; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; Walter RB, 2003, BLOOD, V102, P1466, DOI 10.1182/blood-2003-02-0396; WEISS MJ, 1987, P NATL ACAD SCI USA, V84, P5444, DOI 10.1073/pnas.84.15.5444; Xu GP, 2001, NEUROSCI LETT, V300, P141, DOI 10.1016/S0304-3940(01)01575-0; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yu CR, 2004, ONCOGENE, V23, P1364, DOI 10.1038/sj.onc.1207248; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	61	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8860	8872		10.1074/jbc.M611777200	http://dx.doi.org/10.1074/jbc.M611777200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17213201	Green Published, hybrid			2022-12-27	WOS:000245780300033
J	Barrientos, T; Frank, D; Kuwahara, K; Bezprozvannaya, S; Pipes, GCT; Bassel-Duby, R; Richardson, JA; Katus, HA; Olson, EN; Frey, N				Barrientos, Tomasa; Frank, Derk; Kuwahara, Koichiro; Bezprozvannaya, Svetlana; Pipes, G. C. Teg; Bassel-Duby, Rhonda; Richardson, James A.; Katus, Hugo A.; Olson, Eric N.; Frey, Norbert			Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; PRESSURE-OVERLOAD; Z-DISC; CARDIAC MYOCYTES; RHO-GTPASES; C-ELEGANS; ACTIVATION; TRANSCRIPTION; RECEPTOR	In addition to regulating cell motility, contractility, and cytokinesis, the actin cytoskeleton plays a critical role in the regulation of transcription and gene expression. We have previously identified a novel muscle-specific actin-binding protein, STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. To further dissect the STARS/SRF pathway, we performed a yeast two-hybrid screen of a skeletal muscle cDNA library using STARS as bait, and we identified two novel members of the ABLIM protein family, ABLIM-2 and -3, as STARS-interacting proteins. ABLIM-1, which is expressed in retina, brain, and muscle tissue, has been postulated to function as a tumor suppressor. ABLIM-2 and -3 display distinct tissue-specific expression patterns with the highest expression levels in muscle and neuronal tissue. Moreover, these novel ABLIM proteins strongly bind F-actin, are localized to actin stress fibers, and synergistically enhance STARS-dependent activation of SRF. Conversely, knockdown of endogenous ABLIM expression utilizing small interfering RNA significantly blunted SRF-dependent transcription in C2C12 skeletal muscle cells. These findings suggest that the members of the novel ABLIM protein family may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription.	Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Heidelberg Univ, Dept Internal Med 3, D-69115 Heidelberg, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ruprecht Karls University Heidelberg	Frey, N (corresponding author), Univ Texas, SW Med Ctr, Dept Biol Mol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Norbert.Frey@med.uni-heidelberg.de	Frey, Norbert/M-7749-2019; Kuwahara, Koichiro/AFK-1723-2022; Frey, Norbert/A-9695-2010	Frey, Norbert/0000-0001-7611-378X; Kuwahara, Koichiro/0000-0003-2670-7170; 				Aikawa R, 1999, CIRC RES, V84, P458, DOI 10.1161/01.RES.84.4.458; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hines WA, 1998, J MOL CELL CARDIOL, V30, P485, DOI 10.1006/jmcc.1997.0613; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Klimov E, 2005, BBA-GENE STRUCT EXPR, V1730, P1, DOI 10.1016/j.bbaexp.2005.05.001; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; Lu X, 2003, NEUROSCIENCE, V120, P121, DOI 10.1016/S0306-4522(03)00263-X; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Mahadeva H, 2002, FEBS LETT, V521, P100, DOI 10.1016/S0014-5793(02)02833-8; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Shibata M, 2004, J BIOL CHEM, V279, P40084, DOI 10.1074/jbc.M403844200; Sorokina EM, 2005, J CELL BIOCHEM, V94, P225, DOI 10.1002/jcb.20327; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Souchet M, 2002, J CELL SCI, V115, P629; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899; Torsoni AS, 2003, AM J PHYSIOL-CELL PH, V284, pC1411, DOI 10.1152/ajpcell.00098.2002; Vardar D, 2002, CELL MOTIL CYTOSKEL, V52, P9, DOI 10.1002/cm.10027; Vermeulen W, 2004, PROTEIN SCI, V13, P1276, DOI 10.1110/ps.03518104; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Wei L, 2001, DEVELOPMENT, V128, P2953; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125	52	60	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8393	8403		10.1074/jbc.M607549200	http://dx.doi.org/10.1074/jbc.M607549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17194709	hybrid			2022-12-27	WOS:000245081000072
J	Li, XL; Andersen, JB; Ezelle, HJ; Wilson, GM; Hassel, BA				Li, Xiao-Ling; Andersen, Jesper B.; Ezelle, Heather J.; Wilson, Gerald M.; Hassel, Bret A.			Post-transcriptional regulation of RNase-L expression is mediated by the 3 '-untranslated region of its mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; AU-RICH ELEMENTS; INTERFERON ACTION; 2-5A-DEPENDENT RNASE; BINDING PROTEINS; 2-5A SYSTEM; L INHIBITOR; CYCLIN B1; UV-LIGHT; HUR	RNase-L mediates critical cellular functions including antiviral, pro-apoptotic, and tumor suppressive activities; accordingly, its expression must be tightly regulated. Little is known about the control of RNASEL expression; therefore, we examined the potential regulatory role of a conserved 3'-untranslated region (3'-UTR) in its mRNA. The 3'-UTR mediated a potent decrease in the stability of RNase-L mRNA, and of a chimeric beta-globin-3'-UTR reporter mRNA. AU-rich elements (AREs) are cis-acting regulatory regions that modulate mRNA stability. Eight AREs were identified in the RNase-L 3'-UTR, and deletion analysis identified positive and negative regulatory regions associated with distinct AREs. In particular, AREs 7 and 8 served a strong positive regulatory function. HuR is an ARE-binding protein that stabilizes ARE-containing mRNAs, and a predicted HuR binding site was identified in the region comprising AREs 7 and 8. Co-transfection of HuR and RNase-L enhanced RNase-L expression and mRNA stability in a manner that was dependent on this 3'-UTR region. Immunoprecipitation demonstrated that RNase-L mRNA associates with a HuR containing complex in intact cells. Activation of endogenous HuR by cell stress, or during myoblast differentiation, increased RNase-L expression, suggesting that RNase-L mRNA is a physiologic target for HuR. HuR-dependent regulation of RNase-L enhanced its antiviral activity demonstrating the functional significance of this regulation. These findings identify a novel mechanism of RNase-L regulation mediated by its 3'-UTR.	Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Maryland, Grad Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hassel, BA (corresponding author), 655 W Baltimore St,9th Floor BRB, Baltimore, MD 21201 USA.	bhassel@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019	Andersen, Jesper B/0000-0003-1760-5244; Wilson, Gerald/0000-0002-1273-7507				Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Chandrasekaran K, 2004, BIOCHEM BIOPH RES CO, V325, P18, DOI 10.1016/j.bbrc.2004.10.016; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho NH, 2006, CANCER LETT, V232, P170, DOI 10.1016/j.canlet.2005.02.026; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Gealy C, 2005, J VIROL, V79, P472, DOI 10.1128/JVI.79.1.472-485.2005; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; LEROY F, 2005, J BIOL CHEM, V102, P14533; Lewis JA, 1996, J BIOL CHEM, V271, P13184, DOI 10.1074/jbc.271.22.13184; Lu Z, 2006, CLIN CANCER RES, V12, P2404, DOI 10.1158/1078-0432.CCR-05-1036; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mrena J, 2005, CLIN CANCER RES, V11, P7362, DOI 10.1158/1078-0432.CCR-05-0764; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Zhou AM, 2000, MAMM GENOME, V11, P989, DOI 10.1007/s003350010194; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	48	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7950	7960		10.1074/jbc.M607939200	http://dx.doi.org/10.1074/jbc.M607939200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237228	hybrid			2022-12-27	WOS:000245081000025
J	Morita, T; Yamashita, A; Kashima, I; Ogata, K; Ishiura, S; Ohno, S				Morita, Tomoko; Yamashita, Akio; Kashima, Isao; Ogata, Kazuhiro; Ishiura, Shoichi; Ohno, Shigeo			Distant N- and C-terminal domains are required for intrinsic kinase activity of SMG-1, a critical component of nonsense-mediated mRNA decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DNA-PKCS; CATALYTIC SUBUNIT; TYROSINE KINASE; 3-DIMENSIONAL STRUCTURE; SURVEILLANCE PROTEIN; CRYSTAL-STRUCTURE; INSULIN-RECEPTOR; COMPLEX; ATM	Phosphatidylinositol 3-kinase-related kinases (PIKKs) consisting of SMG-1, ATM, ATR, DNA-PKcs, and mTOR are a family of proteins involved in the surveillance of gene expression in eukaryotic cells. They are involved in mechanisms responsible for genome stability, mRNA quality, and translation. They share a large N-terminal domain and a C-terminal FATC domain in addition to the unique serine/threonine protein kinase (PIKK) domain that is different from classical protein kinases. However, structure-function relationships of PIKKs remain unclear. Here we have focused on one of the PIKK members, SMG-1, which is involved in RNA surveillance, termed nonsense-mediated mRNA decay (NMD), to analyze the roles of conserved and SMG-1-specific sequences on the intrinsic kinase activity. Analyses of sets of point and deletion mutants of SMG-1 in a purified system and intact cells revealed that the long N-terminal region and the conserved leucine in the FATC domain were essential for SMG-1 kinase activity. However, the conserved tryptophan in the TOR SMG-1 (TS) homology domain and the FATC domain was not. In addition, the long insertion region between PIKK and FATC domains was not essential for SMG-1 kinase activity. These results indicated an unexpected feature of SMG-1, i.e. that distantly located N- and C-terminal sequences were essential for the intrinsic kinase activity.	Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Yokohama City University; Yokohama City University; University of Tokyo	Ohno, S (corresponding author), Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, 3-9 Fuku ura, Yokohama, Kanagawa 2360004, Japan.	ohnos@med.yokohama-cu.ac.jp	Ohno, Shigeo/B-1768-2010	Ohno, Shigeo/0000-0002-1294-5269				Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brewerton SC, 2004, J STRUCT BIOL, V145, P295, DOI 10.1016/j.jsb.2003.11.024; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen ZZ, 2005, GENETICS, V171, P403, DOI 10.1534/genetics.105.045674; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Djordjevic S, 2002, TRENDS BIOCHEM SCI, V27, P426, DOI 10.1016/S0968-0004(02)02136-9; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002	39	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7799	7808		10.1074/jbc.M610159200	http://dx.doi.org/10.1074/jbc.M610159200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229728	hybrid			2022-12-27	WOS:000245081000008
J	Little, GH; Bai, Y; Williams, T; Poizat, C				Little, Gillian H.; Bai, Yan; Williams, Tyisha; Poizat, Coralie			Nuclear calcium/calmodulin-dependent protein kinase II delta preferentially transmits signals to histone deacetylase 4 in cardiac cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; CAM KINASE; DILATED CARDIOMYOPATHY; LOCALIZATION SIGNAL; HEART-FAILURE; RAT-HEART; HYPERTROPHY; PHOSPHORYLATION; EXPRESSION; ISOFORM	Class II histone deacetylases (HDACs) act as repressors of cardiac hypertrophy, an adaptative response of the heart characterized by a reprogramming of fetal cardiac genes. Prolonged hypertrophy often leads to dilated cardiomyopathy and heart failure. Upstream endogenous regulators of class II HDACs that regulate hypertrophic growth are just beginning to emerge. Here we demonstrate that the delta B isoform of calcium/calmodulin-dependent protein kinase II (CaMKII delta B), known to promote cardiac hypertrophy, transmits signals specifically to HDAC4 but not other class II HDACs. CaMKII delta B efficiently phosphorylates both a glutathione S-transferase (GST)-HDAC4 fragment spanning amino acids 207-311 and full-length FLAG-HDAC4 but not the equivalents in HDAC5. Although previous studies in skeletal muscle cells have shown that HDAC4 lacking serine 246 cannot be phosphorylated by CaMKI/IV, a similar mutant is still phosphorylated by CaMKII delta B. Importantly, mutation of serine 210 to alanine totally abolishes phosphorylation of the GST fragment and significantly reduces phosphorylation of full-length HDAC by CaMKII delta B. RNA interference knockdown of CaMKII delta B prevents the effects of hypertrophic stimuli. Overexpression of CaMKII delta B in primary neonatal cardiomyocytes increases the activity of the Mef2 transcription factor and completely rescues HDAC4-mediated repression of MEF2 but only partially rescues inhibition by HDAC5 or the HDAC4 S210A mutant. CaMKII delta B strongly interacts with HDAC4 in cells but not with HDAC5. These results demonstrate that CaMKII delta B preferentially targets HDAC4, and this involves serine 210. These findings identify HDAC4 as a specific downstream substrate of CaMKII delta B in cardiac cells and have broad applications for the signaling pathways leading to cardiac hypertrophy and heart failure.	Univ So Calif, Keck Sch Med, Inst Genet Med, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Poizat, C (corresponding author), Univ So Calif, Keck Sch Med, Inst Genet Med, Los Angeles, CA 90033 USA.	poizat@usc.edu			NCI NIH HHS [C06 CA62528-01] Funding Source: Medline; NCRR NIH HHS [C06 RR014514-01, C06 RR10600-01] Funding Source: Medline; NHLBI NIH HHS [HL-052771] Funding Source: Medline; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR010600, C06RR014514] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROCKE L, 1995, J NEUROSCI, V15, P6797; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hagemann D, 1999, J CELL BIOCHEM, V74, P202; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Heist EK, 1998, J BIOL CHEM, V273, P19763, DOI 10.1074/jbc.273.31.19763; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; SMITH DB, 1991, CURRENT PROTOCOLS MO, V2; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200	42	73	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7219	7231		10.1074/jbc.M604281200	http://dx.doi.org/10.1074/jbc.M604281200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17179159	hybrid			2022-12-27	WOS:000245080900034
J	Sivakumar, S; Rajagopal, R; Venkatesh, GR; Srivastava, A; Bhatnagar, RK				Sivakumar, Swaminathan; Rajagopal, Raman; Venkatesh, G. Raja; Srivastava, Anand; Bhatnagar, Raj K.			Knockdown of aminopeptidase-N from Helicoverpla armigera larvae and in transfected Sf21 cells by RNA interference reveals its functional interaction with Bacillus thuringiensis insecticidal protein Cry1Ac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDUCA-SEXTA; DELTA-ENDOTOXIN; BOMBYX-MORI; COTTON BOLLWORM; BINDING; RECEPTOR; TOXIN; MIDGUT; MEMBRANE; IDENTIFICATION	Aminopeptidase-N (APN) and cadherin proteins located at the midgut epithelium of Helicoverpa armigera have been implicated as receptors for the Cry1A subfamily of insecticidal proteins of Bacillus thuringiensis. Ligand blot analysis with heterologously expressed and purified H. armigera Bt receptor with three closely related Cry1A proteins tentatively identified HaAPN1 as an interacting ligand. However, to date there is no direct evidence of APN being a functional receptor to Cry1Ac in H. armigera. Sf21. insect cells expressing HaAPN1 displayed aberrant cell morphology upon overlaying with Cry1Ac protein. Down-regulating expression of HaAPN1 by RNA interference using double-stranded RNA correlated with a corresponding reduction in the sensitivity of HaAPN1-expressing cells to Cry1Ac protein. This clearly establishes that insect cells expressing the receptor recruit sensitivity to the insecticidal protein Cry1Ac, and their susceptibility is directly dependent on the amount of HaAPN1 protein expressed. Most importantly, silencing of HaAPN1 in H. armigera in vivo by RNA interference resulted in reduced transcript levels and a corresponding decrease in the susceptibility of larvae to Cry1Ac. BIAcore analysis of HaAPN1/Cry1Ac interaction further established HaAPN1 as a ligand for Cry1Ac. This is the first functional demonstration of insect aminopeptidase-N of H. armigera being a receptor of Cry1Ac protein of B. thuringiensis.	ICGEB, Insect Resistance Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Bhatnagar, RK (corresponding author), ICGEB, Insect Resistance Grp, POB 10504, New Delhi 110067, India.	raj@icgeb.res.in	Srivastava, Anand/AFY-2073-2022; Srivastava, Anand/AAD-2166-2019; GUO, Zhaoyu/AAS-5699-2020; SRIVASTAVA, ANAND/C-9609-2012	Srivastava, Anand/0000-0002-2031-4643; SRIVASTAVA, ANAND/0000-0002-2031-4643				Agrawal N, 2004, BIOCHEM BIOPH RES CO, V320, P428, DOI 10.1016/j.bbrc.2004.05.184; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Daniel A, 2002, APPL ENVIRON MICROB, V68, P2106, DOI 10.1128/AEM.68.5.2106-2112.2002; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Denolf P, 1997, EUR J BIOCHEM, V248, P748, DOI 10.1111/j.1432-1033.1997.t01-1-00748.x; ELFIORE CJ, 1994, BIOCHEM BIOPH RES CO, V200, P359; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; Gill M, 2002, INSECT MOL BIOL, V11, P619, DOI 10.1046/j.1365-2583.2002.00373.x; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hellmich RL, 2001, P NATL ACAD SCI USA, V98, P11925, DOI 10.1073/pnas.211297698; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 1999, J ECON ENTOMOL, V92, P547, DOI 10.1093/jee/92.3.547; JAMES C, 2005, 34 ISAAA; Jenkins JL, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-12; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; JOHNSON DE, 1994, J INVERTEBR PATHOL, V63, P123, DOI 10.1006/jipa.1994.1024; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Kwa MSG, 1998, J INVERTEBR PATHOL, V71, P121, DOI 10.1006/jipa.1997.4723; Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x; LEE MK, 1992, J BIOL CHEM, V267, P3115; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Malhotra P, 2002, MOL MICROBIOL, V45, P1245, DOI 10.1046/j.1365-2958.2002.03105.x; MCCARTHY WJ, 1994, INSECT CELL BIOTECHN, P71; MONETTE R, 1994, J INSECT PHYSIOL, V40, P273, DOI 10.1016/0022-1910(94)90067-1; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P718, DOI 10.1271/bbb.62.718; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Rajagopal R, 2003, BIOCHEM J, V370, P971, DOI 10.1042/BJ20021741; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SINGH AK, 1992, INSECT SCI APPL, V13, P333, DOI 10.1017/S1742758400013588; Tsuda Y, 2003, BIOCHEM J, V369, P697, DOI 10.1042/BJ20021401; VACHON V, 1995, J MEMBRANE BIOL, V148, P57, DOI 10.1007/BF00234156; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Yaoi K, 1997, EUR J BIOCHEM, V246, P652, DOI 10.1111/j.1432-1033.1997.t01-1-00652.x	37	87	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7312	7319		10.1074/jbc.M607442200	http://dx.doi.org/10.1074/jbc.M607442200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213205	hybrid			2022-12-27	WOS:000245080900042
J	Aguado, T; Carracedo, A; Julien, B; Velasco, G; Milman, G; Mechoulam, R; Alvarez, L; Guzman, M; Galve-Roperh, I				Aguado, Tania; Carracedo, Arkaitz; Julien, Boris; Velasco, Guillermo; Milman, Garry; Mechoulam, Raphael; Alvarez, Luis; Guzman, Manuel; Galve-Roperh, Ismael			Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN; NEURAL PROGENITORS; IN-VIVO; EXPRESSION; TUMORS; ANANDAMIDE; RECEPTOR; IDENTIFICATION; GLIOBLASTOMAS; ACTIVATION	Glioma stem-like cells constitute one of the potential origins of gliomas, and therefore, their elimination is an. essential factor for the development of efficient therapeutic strategies. Cannabinoids are known to exert an antitumoral action on gliomas that relies on at least two mechanisms: induction of apoptosis of transformed cells and inhibition of tumor angiogenesis. However, whether cannabinoids target human glioma stem cells and their potential impact in gliomagenesis are unknown. Here, we show that glioma stem-like cells derived from glioblastoma multiforme biopsies and the glioma cell lines U87MG and U373MG express cannabinoid type 1 (CB1) and type 2 (CB2) receptors and other elements of the endocannabinoid system. In gene array experiments, CB receptor activation altered the expression of genes involved in the regulation of stem cell proliferation and differentiation. The cannabinoid agonists HU-210 and JWH-133 promoted glial differentiation in a CB receptor-dependent manner as shown by the increased number of S-100 beta- and glial fibrillary acidic protein-expressing cells. In parallel, cannabinoids decreased the cell population expressing the neuroepithelial progenitor marker nestin. Moreover, cannabinoid challenge decreased the efficiency of glioma stem-like cells to initiate glioma formation in vivo, a finding that correlated with decreased neurosphere formation and cell proliferation in secondary xenografts. Gliomas derived from cannabinoid-treated cancer stem-like cells were characterized with a panel of neural markers and evidenced a more differentiated phenotype and a concomitant decrease in nestin expression. Overall, our results demonstrate that cannabinoids target glioma stem-like cells, promote their differentiation, and inhibit gliomagenesis, thus giving further support to their potential use in the management of malignant gliomas.	Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; Hebrew Univ Jerusalem, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel; La Paz Univ Hosp, Res Unit, E-28046 Madrid, Spain	Complutense University of Madrid; Hebrew University of Jerusalem; Hospital Universitario La Paz	Galve-Roperh, I (corresponding author), Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, C Jose Antonio Novais S-N, E-28040 Madrid, Spain.	igr@quim.ucm.es	Carracedo, Arkaitz/F-7029-2011; Galve-Roperh, Ismael/AAG-2369-2020; Velasco, Guillermo/H-5260-2012; AGUADO SANCHEZ, TANIA/ABD-6975-2021; Aguado, Tania/AAE-3972-2019; Velasco, Guillermo/AAU-9189-2020; Julien, Boris/E-2374-2012	Carracedo, Arkaitz/0000-0001-5957-1260; Velasco, Guillermo/0000-0002-1994-2386; AGUADO SANCHEZ, TANIA/0000-0003-4339-0443; Velasco, Guillermo/0000-0002-1994-2386; Guzman, Manuel/0000-0001-7475-118X				Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Blazquez C, 2004, CANCER RES, V64, P5617, DOI 10.1158/0008-5472.CAN-03-3927; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Daou MC, 2005, ACTA NEUROPATHOL, V110, P472, DOI 10.1007/s00401-005-1070-0; Englund C, 2005, NEUROPATH APPL NEURO, V31, P429, DOI 10.1111/j.1365-2990.2005.00665.x; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Jang TC, 2004, NEUROBIOL DIS, V15, P544, DOI 10.1016/j.nbd.2003.11.016; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Maccarrone M, 2001, J NEUROCHEM, V76, P594, DOI 10.1046/j.1471-4159.2001.00092.x; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Makriyannis A, 2005, NEUROPHARMACOLOGY, V48, P1068, DOI 10.1016/j.neuropharm.2005.03.012; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Petersen G, 2005, J NEUROCHEM, V93, P299, DOI 10.1111/j.1471-4159.2005.03013.x; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Rutka JT, 1999, INT J DEV NEUROSCI, V17, P503, DOI 10.1016/S0736-5748(99)00049-0; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanchez C, 2001, CANCER RES, V61, P5784; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Tunici P, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-25; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	42	89	96	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6854	6862		10.1074/jbc.M608900200	http://dx.doi.org/10.1074/jbc.M608900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202146	hybrid			2022-12-27	WOS:000244867200095
J	Basile, JR; Holmbeck, K; Bugge, TH; Gutkind, JS				Basile, John R.; Holmbeck, Kenn; Bugge, Thomas H.; Gutkind, J. Silvio			MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; CELL CARCINOMA; AXON GUIDANCE; EXPRESSION; PLEXIN; SURFACE; ACTIVATION; TRANSMEMBRANE	The semaphorins are a family of proteins originally identified as regulators of axon growth that recently have been implicated in blood vessel development. The plexins are high affinity receptors for the semaphorins and are responsible for initiation of signaling upon ligation. Emerging evidence indicates that many human cancers overexpress Semaphorin 4D, which promotes neovascularization upon stimulating its receptor, Plexin-B1, on endothelial cells. However, to exert its pro-angiogenic functions, Semaphorin 4D must be processed and released from its membrane bound form to act in a paracrine manner on endothelial cells. Here we show that Semaphorin 4D is a novel target for the membrane-tethered collagenase membrane type I-matrix metalloproteinase. We demonstrate that this metalloproteinase, which is not expressed in normal or immortal but non-tumorigenic epithelial cell lines, was present in several head and neck squamous cell carcinoma cell lines and was required for processing and release of Semaphorin 4D into its soluble form from these cells, thereby inducing endothelial cell chemotaxis in vitro and blood vessel growth in vivo. These results suggest that the proteolytic cleavage of Semaphorin 4D may provide a novel molecular mechanism by which membrane type 1-matrix metalloproteinase controls tumor-induced angiogenesis.	NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; NIDCR, Matrix Metalloprot Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Basile, JR (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	jbasile@mail.nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Holmbeck, Kenn/0000-0002-4472-3257	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551, ZIADE000676, ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551, Z01DE000558, Z01DE000676] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Autiero M, 2005, CARDIOVASC RES, V65, P629, DOI 10.1016/j.cardiores.2004.09.013; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brown CB, 2001, DEVELOPMENT, V128, P3071; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; COLOMA MJ, 1992, J IMMUNOL METHODS, V152, P89, DOI 10.1016/0022-1759(92)90092-8; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; Deryugina EI, 2002, CANCER RES, V62, P580; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fang JM, 2001, CANCER RES, V61, P5731; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fujisawa H, 1997, DEV NEUROSCI-BASEL, V19, P101, DOI 10.1159/000111192; GALARDY RE, 1994, CANCER RES, V54, P4715; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; LIOTTA LA, 1990, CANCER METAST REV, V9, P285, DOI 10.1007/BF00049519; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Noda K, 2005, INVEST OPHTH VIS SCI, V46, P3817, DOI 10.1167/iovs.04-1528; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Ottino P, 2004, MOL VIS, V10, P341; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; SATODA M, 1995, J NEUROSCI, V15, P942; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105	52	132	155	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6899	6905		10.1074/jbc.M609570200	http://dx.doi.org/10.1074/jbc.M609570200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204469	hybrid			2022-12-27	WOS:000244867200099
J	Hart, LS; Ornelles, D; Koumenis, C				Hart, Lori S.; Ornelles, David; Koumenis, Constantinos			The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE-1; CATALYTIC SUBUNIT; KINASE-ACTIVITY; CELL-DEATH; DEGRADATION; COMPLEX; P53; AUTOPHOSPHORYLATION	Adenoviral proteins interact with host-cell proteins to either exploit or inhibit cellular functions for the purpose of viral propagation. E4orf6, the 34-kDa gene product of the E4 gene, interacts with the double-strand break repair (DSBR) protein DNA-dependent protein kinase and cooperates with binding partner E1B-55K to degrade MIZE 11, preventing viral DNA concatemer formation. We previously demonstrated that E4orf6 radiosensitizes human tumor cells through the inhibition of DSBR, notably in the absence of E1B-55K. Here, we report that E4orf6 prolongs the signaling of DNA damage by inhibiting the activity of protein phosphatase 2A (PP2A), the phosphatase responsible for dephosphorylating gamma H2AX. The inhibition of PP2A occurs without significant disruption of the DNA re-ligation rate. Prolonged signaling of DNA damage in the presence of E4orf6 initiates caspase-dependent and independent cell death. This is accompanied by poly(ADP-ribose) polymerase (PARP) hyper-activation and the translocation of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus. Knockdown of AIF by shRNA rescues the radiosensitization induced by E4orf6. Taken together, these data suggest that E4orf6 disrupts cellular DSBR signaling by inhibiting PP2A, leading to prolonged H2AX phosphorylation, hyperactivation of PARP, and AIF translocation to the nucleus. The function of E4orf6 as an inhibitor of PP2A and activator of PARP in the absence of other adenoviral gene products is of importance in delineating the adenovirus-host cell interplay.	Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Neurosurg, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Radiat Oncol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Koumenis, C (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, 185 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	koumenis@xrt.upenn.edu	Koumenis, Constantinos/B-2002-2008	Koumenis, Costas/0000-0001-5945-4726	NCI NIH HHS [CA77342S1, CA77342] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077342] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASAI A, 1994, J NEURO-ONCOL, V19, P259, DOI 10.1007/BF01053280; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bernardi RJ, 2001, CLIN CANCER RES, V7, P4164; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hart LS, 2005, J BIOL CHEM, V280, P1474, DOI 10.1074/jbc.M409934200; Kienker LJ, 2000, NUCLEIC ACIDS RES, V28, P2752, DOI 10.1093/nar/28.14.2752; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kubota N, 2000, CANCER LETT, V161, P141, DOI 10.1016/S0304-3835(00)00614-5; Martin NMB, 2001, J PHOTOCH PHOTOBIO B, V63, P162, DOI 10.1016/S1011-1344(01)00213-5; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Sekiguchi JM, 1999, COLD SPRING HARB SYM, V64, P169, DOI 10.1101/sqb.1999.64.169; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	30	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6061	6067		10.1074/jbc.M610405200	http://dx.doi.org/10.1074/jbc.M610405200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17172468	hybrid			2022-12-27	WOS:000244867200011
J	Jagnandan, D; Church, JE; Banfi, B; Stuehr, DJ; Marrero, MB; Fulton, DJR				Jagnandan, Davin; Church, Jarrod E.; Banfi, Botond; Stuehr, Dennis J.; Marrero, Mario B.; Fulton, David J. R.			Novel mechanism of activation of NADPH oxidase 5 - Calcium sensitization via phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; REACTIVE OXYGEN; SUPEROXIDE; LOCALIZATION; PROTEIN; EXPRESSION; GENERATION; P67(PHOX); P47(PHOX); NOX3	In contrast to other Nox isoforms, the activity of Nox5 does not require the presence of accessory proteins and is entirely dependent on the elevation of intracellular calcium. Previous studies have shown that the EC50 of Nox5 for calcium is relatively high and raises the question of whether Nox5 can be sufficiently activated in cells that do not experience extreme elevations of intracellular calcium. In the current study, we have identified a novel mechanism governing the activity of Nox5. Exposure of cells expressing Nox5 to phorbol 12-myristate 13-acetate (PMA) resulted in a slow and sustained increase in ROS, which was markedly different from the rapid response to ionomycin. PMA greatly potentiated the activity of Nox5 in response to low concentrations of ionomycin. The ability of PMA to increase Nox5 activity was abolished by calcium chelation and was a direct effect on enzyme activity, since PMA increased the calcium sensitivity of Nox5 in a cell-free assay. PMA stimulated the time-dependent phosphordation of Nox5 on Thr(494) and Ser(498). Mutation of these residues to alanine abolished both PMA-dependent phosphorylation and calcium sensitization. Conversely, mutation of Thr(494) and Ser(498) to glutamic acid produced a gain of function mutant that had increased activity at low concentrations of ionomycin. Within the cell, Nox5 was detected in detergent-resistant microdomains of the endoplasmic reticulum. In summary, the phosphorylation of Nox5 at key residues facilitates enzyme activation at lower levels of intracellular calcium and may provide an avenue for enzyme activation in response to a greater variety of extracellular stimuli.	Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pharmacol, Augusta, GA 30912 USA; Univ Iowa, Coll Med, Dept Anat, Coralville, IA 52241 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Iowa; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fulton, DJR (corresponding author), Med Coll Georgia, Vasc Biol Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	dfulton@mcg.edu		Church, Jarrod/0000-0001-8266-4043; Banfi, Botond/0000-0001-9273-1318	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074279] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL74279] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Armstrong JS, 2002, INT J ANDROL, V25, P223, DOI 10.1046/j.1365-2605.2002.00351.x; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bayraktutan U, 2000, ARTERIOSCL THROM VAS, V20, P1903, DOI 10.1161/01.ATV.20.8.1903; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4	23	164	167	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6494	6507		10.1074/jbc.M608966200	http://dx.doi.org/10.1074/jbc.M608966200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17164239	hybrid			2022-12-27	WOS:000244867200057
J	Jones, MA; Feeney, KA; Kelly, SM; Christie, JM				Jones, Matthew A.; Feeney, Kevin A.; Kelly, Sharon M.; Christie, John M.			Mutational analysis of phototropin 1 provides insights into the mechanism underlying LOV2 signal transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT RECEPTOR; INDUCED STRUCTURAL-CHANGES; PAS DOMAIN; PHOTORECEPTOR PHOTOTROPIN; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; BINDING DOMAINS; KINASE; OXYGEN; PHOTOCYCLE	Phototropins (phot1 and phot2) are blue light-activated serine/threonine protein kinases that elicit a variety of photoresponses in plants. Light sensing by the phototropins is mediated by two flavin mononucleotide (FMN)-binding domains, designated LOV1 and LOV2, located in the N-terminal region of the protein. Exposure to light results in the formation of a covalent adduct between the FMN chromophore and a conserved cysteine residue within the LOV domain. LOV2 photoexcitation is essential for phot1 function in Arabidopsis and is necessary to activate photl kinase activity through light-induced structural changes within a conserved a-helix situated C-terminal to LOV2. Here we have used site-directed mutagenesis to identify further amino acid residues that are important for photl activation by light. Mutagenesis of bacterially expressed LOV2 and full-length phot1 expressed in insect cells indicates that perturbation of the conserved salt bridge on the surface of LOV2 does not play a role in receptor activation. However, mutation of a conserved glutamine residue (Gln 575) within LOV2, reported previously to be required to propagate structural changes at the LOV2 surface, attenuates light-induced autophosphorylation of photl expressed in insect cells without compromising FMN binding. These findings, in combination with double mutant analyses, indicate that Gln"' plays an important role in coupling light-driven cysteinyl adduct formation from within LOV2 to structural changes at the LOV2 surface that lead to activation of the C-terminal kinase domain.	Univ Glasgow, Plant Sci Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Christie, JM (corresponding author), Univ Glasgow, Plant Sci Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	J.Christie@bio.gla.ac.uk	Jones, Matt/W-8210-2019; Kelly, Sharon/K-4611-2013	Jones, Matt/0000-0002-3943-3968; Kelly, Sharon/0000-0002-3516-1387; Christie, John/0000-0002-9976-0055				Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Ataka K, 2003, BIOPHYS J, V84, P466, DOI 10.1016/S0006-3495(03)74866-8; Bednarz T, 2004, PHOTOCH PHOTOBIO SCI, V3, P575, DOI 10.1039/b400976b; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Celaya RB, 2005, PHOTOCHEM PHOTOBIOL, V81, P73, DOI 10.1562/2004-08-22-IR-282.1; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2001, J BIOL CHEM, V276, P11457, DOI 10.1074/jbc.R100004200; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Eitoku T, 2005, J AM CHEM SOC, V127, P13238, DOI 10.1021/ja052523i; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Iwata T, 2002, J AM CHEM SOC, V124, P11840, DOI 10.1021/ja020834c; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Watts KJ, 2006, J BACTERIOL, V188, P2154, DOI 10.1128/JB.188.6.2154-2162.2006; WISLON W, 2005, P NATL ACAD SCI USA, V102, P16596	46	72	77	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6405	6414		10.1074/jbc.M605969200	http://dx.doi.org/10.1074/jbc.M605969200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17164248	hybrid			2022-12-27	WOS:000244867200048
J	Sidani, SM; Kirchhoff, P; Socrates, T; Stelter, L; Ferreira, E; Caputo, C; Roberts, KE; Bell, RL; Egan, ME; Geibel, JP				Sidani, Shafik M.; Kirchhoff, Philipp; Socrates, Thenral; Stelter, Lars; Ferreira, Elisa; Caputo, Christina; Roberts, Kurt E.; Bell, Robert L.; Egan, Marie E.; Geibel, John P.			Delta F508 mutation results in impaired gastric acid secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CALCIUM-SENSING RECEPTOR; CYSTIC-FIBROSIS GENE; RECTIFYING CHLORIDE CHANNELS; PARIETAL-CELL; K+ CHANNEL; APICAL MEMBRANE; CL-CONDUCTANCES; HCO3-SECRETION; CFTR	The cystic fibrosis transmembrane conductance regulator (CFTR) is recognized as a multifunctional Protein that is involved in Cl- secretion, as well as acting as a regulatory protein. In order for acid secretion to take place a complex interaction of transport proteins and channels must occur at the apical pole of the parietal cell. Included in this process is at least one K+ and Cl- channel, allowing for both recycling of K+ for the H,K-ATPase, and Cl- secretion, necessary for the generation of concentrated HCl in the gastric gland lumen. We have previously shown that an ATP-sensitive potassium channel (K-ATP) is expressed in parietal cells. In the present study we measured secretagogue-induced acid secretion from wild-type and Delta F508-deficient mice in isolated gastric glands and whole stomach preparations. Secretagogue-induced acid secretion in wildtype mouse gastric glands could be significantly reduced with either glibenclamide or the specific inhibitor CFTR-inh172. In Delta F508-deficient mice, however, histamine-induced acid secretion was significantly less than in wild-type mice. Furthermore, immunofluorescent localization of sulfonylurea 1 and 2 failed to show expression of a sulfonylurea receptor in the parietal cell, thus further implicating CFTR as the ATP-binding cassette transporter associated with the K-ATP channels. These results demonstrate a regulatory role for the CFTR protein in normal gastric acid secretion.	Yale Univ, Dept Surg, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Dept Pediat, New Haven, CT 06520 USA; Univ Zurich, Dept Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland	Yale University; Yale University; University of Zurich	Geibel, JP (corresponding author), Yale Univ, Dept Surg, Dept Cellular & Mol Physiol, BML 265,310 Cedar St, New Haven, CT 06520 USA.	john.geibel@yale.edu	Roberts, Kurt E/I-2226-2012		NIDDK NIH HHS [DK17433, DK53428, DK07017-29, DK007259-26, DK50230] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053428, R01DK050230, P01DK017433, T32DK007017, T32DK007259] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Armand M, 2004, PEDIATR RES, V55, P457, DOI 10.1203/01.PDR.0000110522.78194.5B; ATERMAN K, 1961, AM J DIS CHILD, V101, P210, DOI 10.1001/archpedi.1961.04020030074012; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Busque SM, 2005, AM J PHYSIOL-GASTR L, V289, pG664, DOI 10.1152/ajpgi.00096.2005; Cahill P, 2000, J BIOL CHEM, V275, P16697, DOI 10.1074/jbc.M910205199; Cheng I, 1999, GASTROENTEROLOGY, V116, P118, DOI 10.1016/S0016-5085(99)70235-0; Clarke L L, 2001, JOP, V2, P263; Clarke LL, 1996, LAB ANIM SCI, V46, P612; Clarke LL, 1998, AM J PHYSIOL-GASTR L, V274, pG718, DOI 10.1152/ajpgi.1998.274.4.G718; Coakley R D, 2001, JOP, V2, P294; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cohn JA, 2005, J CLIN GASTROENTEROL, V39, pS70, DOI 10.1097/01.mcg.0000155522.89005.bf; COX KL, 1982, J PEDIATR GASTR NUTR, V1, P559, DOI 10.1097/00005176-198212000-00019; CUPPOLETTI J, 1993, AM J PHYSIOL, V264, pC1609, DOI 10.1152/ajpcell.1993.264.6.C1609; DiMagno EP, 2001, BEST PRACT RES CL GA, V15, P477, DOI 10.1053/bega.2001.0195; Dufner MM, 2005, AM J PHYSIOL-GASTR L, V289, pG1084, DOI 10.1152/ajpgi.00571.2004; Duman JG, 2002, J CELL SCI, V115, P1251; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; FIEDLER MA, 1992, AM J PHYSIOL, V262, pL779, DOI 10.1152/ajplung.1992.262.6.L779; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Forte JG, 2004, AM J PHYSIOL-CELL PH, V286, pC478, DOI 10.1152/ajpcell.00531.2003; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; GABRIEL SE, 1993, NATURE, V363, P263, DOI 10.1038/363263a0; Geibel JP, 2005, WORLD J GASTROENTERO, V11, P5259, DOI 10.3748/wjg.v11.i34.5259; Geibel JP, 2001, J BIOL CHEM, V276, P39549, DOI 10.1074/jbc.M107315200; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Hallberg K, 2001, SCAND J GASTROENTERO, V36, P121, DOI 10.1080/003655201750065852; HERSEY SJ, 1995, PHYSIOL REV, V75, P155, DOI 10.1152/physrev.1995.75.1.155; HONGRE AS, 1994, PFLUG ARCH EUR J PHY, V426, P284, DOI 10.1007/BF00374783; JOVOV B, 1995, J BIOL CHEM, V270, P29194, DOI 10.1074/jbc.270.49.29194; Kaur S, 2004, AM J PHYSIOL-GASTR L, V287, pG480, DOI 10.1152/ajpgi.00035.2004; KELLEY KA, 1992, GENOMICS, V13, P381, DOI 10.1016/0888-7543(92)90257-S; Kirchhoff P, 2006, PFLUG ARCH EUR J PHY, V451, P738, DOI 10.1007/s00424-005-1507-2; Kirchhoff P, 2003, AM J PHYSIOL-GASTR L, V285, pG1242, DOI 10.1152/ajpgi.00165.2003; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Lambrecht NWG, 2005, PHYSIOL GENOMICS, V21, P81, DOI 10.1152/physiolgenomics.00212.2004; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; LLOYDSTILL JD, 1983, TXB CYSTIC FIBROSIS, P227; Loussouarn G, 1996, AM J PHYSIOL-CELL PH, V271, pC1565, DOI 10.1152/ajpcell.1996.271.5.C1565; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; MALINOWSKA DH, 1995, AM J PHYSIOL-CELL PH, V268, pC191, DOI 10.1152/ajpcell.1995.268.1.C191; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; McNicholas CM, 1997, AM J PHYSIOL-RENAL, V273, pF843, DOI 10.1152/ajprenal.1997.273.5.F843; Mickle JE, 1998, CLIN CHEST MED, V19, P443, DOI 10.1016/S0272-5231(05)70092-7; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; REENSTRA WW, 1990, AM J PHYSIOL, V259, pG850, DOI 10.1152/ajpgi.1990.259.5.G850; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROCH B, 1995, PFLUG ARCH EUR J PHY, V429, P355, DOI 10.1007/BF00374150; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; ROULET M, 1980, PEDIATR RES, V14, P1360, DOI 10.1203/00006450-198012000-00019; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Ruknudin A, 1998, J BIOL CHEM, V273, P14165, DOI 10.1074/jbc.273.23.14165; Sangan P, 2002, J BIOL CHEM, V277, P9668, DOI 10.1074/jbc.M110852200; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; SCHWIEBERT EM, 1999, PHYSL REV S, V79, P145; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; SHEPPARD DN, 1992, J GEN PHYSIOL, V100, P573, DOI 10.1085/jgp.100.4.573; Sherry AM, 2001, AM J PHYSIOL-CELL PH, V280, pC1599, DOI 10.1152/ajpcell.2001.280.6.C1599; SINAASAPPEL M, 1995, NETH J MED, V46, P275, DOI 10.1016/0300-2977(95)00019-J; SINGH SK, 1995, P NATL ACAD SCI USA, V92, P11573, DOI 10.1073/pnas.92.25.11573; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0; WAISBREN SJ, 1994, AM J PHYSIOL, V266, pC1013, DOI 10.1152/ajpcell.1994.266.4.C1013; Winter C, 2004, P NATL ACAD SCI USA, V101, P2636, DOI 10.1073/pnas.0307321101; Witt H, 2003, GUT, V52, pII31, DOI 10.1136/gut.52.suppl_2.ii31; WOLOSIN JM, 1984, AM J PHYSIOL, V246, pC537, DOI 10.1152/ajpcell.1984.246.5.C537; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; Zeitlin PL, 2000, KIDNEY INT, V57, P832, DOI 10.1046/j.1523-1755.2000.00922.x; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627	83	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6068	6074		10.1074/jbc.M608427200	http://dx.doi.org/10.1074/jbc.M608427200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17178714	hybrid			2022-12-27	WOS:000244867200012
J	Takaluoma, K; Hyry, M; Lantto, J; Sormunen, R; Bank, RA; Kivirikko, KI; Myllyharju, J; Soininen, R				Takaluoma, Kati; Hyry, Marjo; Lantto, Juha; Sormunen, Raija; Bank, Ruud A.; Kivirikko, Kari I.; Myllyharju, Johanna; Soininen, Raija			Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; LEUCINE-RICH PROTEOGLYCANS; SYNDROME TYPE-VI; KYPHOSCOLIOTIC TYPE; MUSCULAR-DYSTROPHY; SKIN FRAGILITY; NULL MICE; IN-VITRO; GENE; IDENTIFICATION	We have generated mice with targeted inactivation of the Plod1 gene for lysyl hydroxylase 1 (LH1). Its human mutations cause Ehlers-Danlos syndrome VIA (EDS VIA) characterized by muscular hypotonia, joint laxity, and kyphoscoliosis. The Plod1(-/-) mice are flaccid and have gait abnormalities. About 15% of them died because of aortic rupture and smooth muscle cells in non-ruptured Plod1(-/-) aortas showed degenerative changes. Collagen fibrils in the Plod1(-/-) aorta and skin had an abnormal morphology. The LH activity level in the Plod1(-/-) skin and aorta samples was 35-45% of that in the wild type. The hydroxylysine content was decreased in all the Plod1(-/-) tissues, ranging from 22% of that in the wild type in the skin to 75 and 86% in the femur and lung. The hydroxylysylpyridinoline cross-links likewise showed decreases in all the Plod1(-/-) tissues, ranging from 28 and 33% of that in the wild type in the aorta and cornea to 47 and 59% in femur and tendon, while lysylpyridinolines were increased. The hydroxylysines found in the Plod1(-/-) collagens and their cross-links were evidently synthesized by the other two LH isoenzymes. Few data are available on abnormalities in EDS VIA tissues other than the skin. Plod1(-/-) mice offer an in vivo model for systematic analysis of the tissue-specific consequences of the lack of LH1 activity and may also provide a tool for analyzing the roles of connective tissue in muscle function and the complex interactions occurring in the proper assembly of the extracellular matrix.	Univ Oulu, Collagen Res Unit, Bioctr Oulu, Oulu 90014, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, Oulu 90014, Finland; Univ Oulu, Dept Pathol, Oulu 90014, Finland; Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, NL-1066 Amsterdam, Netherlands	University of Oulu; University of Oulu; University of Oulu; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, Bioctr Oulu, POB 5000, Oulu 90014, Finland.	johanna.myllyharju@oulu.fi						Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Bank RA, 1996, ANAL BIOCHEM, V240, P167, DOI 10.1006/abio.1996.0346; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; COLIGE A, 1999, AM J HUM GENET, V65, P9; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Giunta C, 2005, AM J MED GENET A, V133A, P158, DOI 10.1002/ajmg.a.30529; Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kobayasi T, 2004, EUR J DERMATOL, V14, P221; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Passoja K, 1998, FEBS LETT, V434, P145, DOI 10.1016/S0014-5793(98)00966-1; Pirskanen A, 1996, J BIOL CHEM, V271, P9398, DOI 10.1074/jbc.271.16.9398; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; TEINMANN B, 2002, CONNECTIVE TISSUE IT, P431; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Walker LC, 2005, J INVEST DERMATOL, V124, P914, DOI 10.1111/j.0022-202X.2005.23727.x; WATSON RB, 1992, J BIOL CHEM, V267, P9093; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Yeowell HN, 1999, MATRIX BIOL, V18, P179, DOI 10.1016/S0945-053X(99)00013-X; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	46	61	65	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6588	6596		10.1074/jbc.M608830200	http://dx.doi.org/10.1074/jbc.M608830200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197443	hybrid			2022-12-27	WOS:000244867200068
J	Kerns, SL; Torke, SJ; Benjamin, JM; McGarry, TJ				Kerns, Sarah L.; Torke, Susanna J.; Benjamin, Jacqueline M.; McGarry, Thomas J.			Geminin prevents rereplication during Xenopus development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LICENSING FACTOR CDT1; DNA RE-REPLICATION; CELL-CYCLE; INHIBITION; DESTRUCTION; PROTEOLYSIS; HOMOLOG; DOMAINS; PCNA	To maintain a stable genome, it is essential that replication origins fire only once per cell cycle. The protein Geminin is thought to prevent a second round of DNA replication by inhibiting the essential replication factor Cdt1. Geminin also affects the development of several different organs by binding and inhibiting transcription factors and chromatin-remodeling proteins. It is not known if the defects in Geminin-deficient organisms are due to overreplication or to effects on cell differentiation. We previously reported that Geminin depletion in Xenopus causes early embryonic lethality due to a Chk1-dependent G, cell cycle arrest just after the midblastula transition. Here we report that expressing a non-Geminin-binding Cdt1 mutant in Xenopus embryos exactly reproduces the phenotype of geminin depletion. Expressing the same mutant in replication extracts induces a partial second round of DNA replication within a single S phase. We conclude that Geminin is required to suppress a second round of DNA replication in vivo and that the phenotype of Geminin-depleted Xenopus embryos is caused by abnormal Cdt1 regulation. Expressing a nondegradable Cdt1 mutant in embryos also reproduces the Geminin-deficient phenotype. In cell extracts' the nondegradable mutant has no effect by itself but augments the amount of rereplication observed when Geminin is depleted. We conclude that Cdt1 is regulated both by Geminin binding and by degradation.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	McGarry, TJ (corresponding author), Tarry 15-703,300 E Super Ave, Chicago, IL 60611 USA.	t-mcgarry@northwestern.edu						Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Harlow E., 1988, ANTIBODIES LAB MANUA; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; HUTCHISON CJ, 1993, CELL CYCLE PRACTICAL, P188; Iwao Y, 2005, DEV GROWTH DIFFER, V47, P283; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry Thomas J., 2004, V296, P263; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	34	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5514	5521		10.1074/jbc.M609289200	http://dx.doi.org/10.1074/jbc.M609289200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17179155	hybrid			2022-12-27	WOS:000244482300046
J	Kim, K; McCully, ME; Bhattacharya, N; Butler, B; Sept, D; Cooper, JA				Kim, Kyoungtae; McCully, Michelle E.; Bhattacharya, Nandini; Butler, Boyd; Sept, David; Cooper, John A.			Structure/function analysis of the interaction of phosphatidylinositol 4,5-bisphosphate with actin-capping protein - Implications for how capping protein binds the actin filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED-END; MOLECULAR-DYNAMICS; IDENTIFICATION; CYTOSKELETON; MICROSCOPY; MOTILITY; GELSOLIN; MUSCLE	The heterodimeric actin-capping protein (CP) can be inhibited by polyphosphoinositides, which may be important for actin polymerization at membranes in cells. Here, we have identified a conserved set of basic residues on the surface of CP that are important for the interaction with phosphaticlylinositol 4,5-bisphosphate (PIP2). Computational docking studies predicted the identity of residues involved in this interaction, and functional and physical assays with site-directed mutants of CP confirmed the prediction. The PIP2 binding site overlaps with the more important of the two known actin-binding sites of CP. Correspondingly, we observed that loss of PIP2 binding correlated with loss of actin binding among the mutants. Using TIRF (total internal reflection fluorescence) microscopy, we observed that PIP2 rapidly converted capped actin filaments to a growing state, consistent with uncapping. Together, these results extend our understanding of how CP binds to the barbed end of the actin filament, and they support the idea that CP can "wobble" when bound to the barbed end solely by the C-terminal "tentacle" of its beta-subunit.	Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; Washington Univ, Ctr Computat Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cooper, JA (corresponding author), Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jcooper@wustl.edu	Sept, David/F-6497-2011; Cooper, John/E-9389-2012; Bhattacharya, Nandini/HGU-4374-2022; Cooper, John/D-4448-2014	Sept, David/0000-0003-3719-2483; Cooper, John/0000-0002-0933-4571	NHLBI NIH HHS [T32 HL007873] Funding Source: Medline; NIGMS NIH HHS [R01 GM038542, R01 GM067246, GM38542, GM067246, R01 GM038542-20] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542, R01GM067246] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; Huang SJ, 2006, MOL BIOL CELL, V17, P1946, DOI 10.1091/mbc.E05-09-0840; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Janmey PA, 1999, CHEM PHYS LIPIDS, V101, P93, DOI 10.1016/S0009-3084(99)00058-4; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kim K, 2006, MOL BIOL CELL, V17, P1354, DOI 10.1091/mbc.e05-10-0925; Kim SI, 2004, AM J TRANSPLANT, V4, P567; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mitra A, 2004, BIOCHEMISTRY-US, V43, P13955, DOI 10.1021/bi0487387; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 2003, CELL, V4, P463; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schafer DA, 1998, J CELL BIOL, V143, P1919, DOI 10.1083/jcb.143.7.1919; Smith J, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-30; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wear MA, 2004, J BIOL CHEM, V279, P14382, DOI 10.1074/jbc.M313412200; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; YU FX, 1992, J BIOL CHEM, V267, P14616	38	63	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5871	5879		10.1074/jbc.M609850200	http://dx.doi.org/10.1074/jbc.M609850200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182619	Green Accepted, hybrid			2022-12-27	WOS:000244482300083
J	Ma, DH; Tang, XD; Rogers, TB; Welling, PA				Ma, Donghui; Tang, Xiang D.; Rogers, Terry B.; Welling, Paul A.			An Andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; INWARD RECTIFICATION; KCNJ2 MUTATIONS; CLOSED STATE; PORE; DETERMINANTS; LOCALIZATION; TRAFFICKING; ACTIVATION; POLYAMINES	Loss-of-function mutations in the inward rectifier potassium channel, Kir2.1, cause Andersen-Tawil syndrome (ATS-1), an inherited disorder of periodic paralysis and ventricular arrhythmias. Here, we explore the mechanism by which a specific ATS-1 mutation (V302M) alters channel function. Val-302 is located in the G-loop, a structure that is believed to form a flexible barrier for potassium permeation at the apex of the cytoplasmic pore. Consistent with a role in stabilizing the G-loop in an open conformation, we found the V302M mutation specifically renders the channel unable to conduct potassium without altering subunit assembly or attenuating cell surface expression. As predicted by the position of the Val-302 side chain in the crystal structure, amino acid substitution analysis revealed that channel activity and phosphatidylinositol 4,5-bisphosphate (PIP2) sensitivity are profoundly sensitive to alterations in the size, shape, and hydrophobicity of side chains at the Val-302 position. The observations establish that the Val-302 side chain is a critical determinant of potassium conduction through the G-loop. Based on our functional studies and the cytoplasmic domain crystal structure, we suggest that Val-302 may influence PIP2 gating indirectly by translating PIP2 binding to conformational changes in the G-loop pore.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL70709] Funding Source: Medline; NIDDK NIH HHS [R01 DK54231] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Chen L, 2002, P NATL ACAD SCI USA, V99, P8430, DOI 10.1073/pnas.122682899; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Dong K, 2002, J BIOL CHEM, V277, P49366, DOI 10.1074/jbc.M208679200; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Welling PA, 1997, AM J PHYSIOL-RENAL, V273, pF825, DOI 10.1152/ajprenal.1997.273.5.F825; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zhang L, 2005, CIRCULATION, V111, P2720, DOI 10.1161/CIRCULATIONAHA.104.472498; Zhang YY, 2004, J GEN PHYSIOL, V124, P729, DOI 10.1085/jgp.200409166; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	39	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5781	5789		10.1074/jbc.M608776200	http://dx.doi.org/10.1074/jbc.M608776200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17166852	hybrid			2022-12-27	WOS:000244482300074
J	Sarkar, S; Davies, JE; Huang, ZB; Tunnacliffe, A; Rubinsztein, DC				Sarkar, Sovan; Davies, Janet E.; Huang, Zebo; Tunnacliffe, Alan; Rubinsztein, David C.			Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; AGGREGATE-PRONE PROTEINS; CELL-DEATH; POLYGLUTAMINE EXPANSIONS; PARKINSONS-DISEASE; PHOSPHATE SYNTHASE; MOUSE MODEL; GENE; DEGRADATION; INHIBITION	Trehalose, a disaccharide present in many non-mammalian species, protects cells against various environmental stresses. Whereas some of the protective effects may be explained by its chemical chaperone properties, its actions are largely unknown. Here we report a novel function of trehalose as an mTOR-independent autophagy activator. Trehalose-induced autophagy enhanced the clearance of autophagy substrates like mutant huntingtin and the A30P and A53T mutants of alpha-synuclein, associated with Huntington disease (HD) and Parkinson disease (PD), respectively. Furthermore, trehalose and mTOR inhibition by rapamycin together exerted an additive effect on the clearance of these aggregate-prone proteins because of increased autophagic activity. By inducing autophagy, we showed that trehalose also protects cells against subsequent pro-apoptotic insults via the mitochondrial pathway. The dual protective properties of trehalose (as an inducer of autophagy and chemical chaperone) and the combinatorial strategy with rapamycin may be relevant to the treatment of HD and related diseases, where the mutant proteins are autophagy substrates.	Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge B2 2XY, England; Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Hills Rd, Cambridge B2 2XY, England.	dcr1000@cam.ac.uk	Rubinsztein, David C/C-3472-2011; Sarkar, Sovan/F-8486-2017; Huang, Zebo/AAF-2382-2019	Sarkar, Sovan/0000-0002-9456-4362; Huang, Zebo/0000-0003-2431-3741; Tunnacliffe, Alan/0000-0001-8570-125X	Medical Research Council [G0600194(77639), G0000872, G0600194] Funding Source: Medline; Wellcome Trust [064354] Funding Source: Medline; MRC [G0600194, G0000872] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chen QF, 2003, J BIOL CHEM, V278, P49113, DOI 10.1074/jbc.M308652200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kandror O, 2004, MOL CELL, V13, P771, DOI 10.1016/S1097-2765(04)00148-0; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murphy MP, 2001, BBA-BIOENERGETICS, V1504, P1, DOI 10.1016/S0005-2728(00)00234-6; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Oesterreicher TJ, 2001, GENE, V270, P211, DOI 10.1016/S0378-1119(01)00474-7; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rankin J, 2000, BIOCHEM J, V348, P15, DOI 10.1042/0264-6021:3480015; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Simonson OE, 2005, CURR PHARM DESIGN, V11, P3671, DOI 10.2174/138161205774580813; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	48	836	872	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5641	5652		10.1074/jbc.M609532200	http://dx.doi.org/10.1074/jbc.M609532200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182613	hybrid			2022-12-27	WOS:000244482300061
J	Shimazu, T; Horinouchi, S; Yoshida, M				Shimazu, Tadahiro; Horinouchi, Sueharu; Yoshida, Minoru			Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3 '-end processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I-M; LARGE T-ANTIGEN; POLY(A) POLYMERASE; TRICHOSTATIN-A; ACETYLATION; CLEAVAGE; P53; TRANSCRIPTION; ACTIVATION; SUBUNIT	Trichostatin A (TSA), a specific inhibitor of histone deacetylases (HDACs), induces acetylation of various non-histone proteins such as p53 and alpha-tubulin. We purified several acetylated proteins by the affinity to an anti-acetylated lysine (AcLys) antibody from cells treated with TSA and identified them by mass spectrometry. Here we report on acetylation of CFIm25, a component of mammalian cleavage factor Im (CF Im), and poly(A) polymerase (PAP), a polyadenylating enzyme for the pre-mRNA 3'-end. The residues acetylated in these proteins were mapped onto the regions required for interaction with each other. Whereas CBP acetylated these proteins, HDAC1, HDAC3, HDAC10, SIRT1, and SIRT2 were involved in in vivo deacetylation. Acetylation of the CFIm25 occurred depending on the cleavage factor complex formation. Importantly, the interaction between PAP and CIF Im complex was decreased by acetylation. We also demonstrated that acetylation of PAP inhibited the nuclear localization of PAP by inhibiting the binding to the importin alpha/beta complex. These results suggest that C]BP and HDACs regulate the X-end processing machinery and modulate the localization of PAP through the acetylation and deacetylation cycle.	RIKEN, Chem Genet Lab, Discovery Res Inst, Wako, Saitama 3510198, Japan; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	RIKEN; University of Tokyo	Yoshida, M (corresponding author), RIKEN, Chem Genet Lab, Discovery Res Inst, Wako, Saitama 3510198, Japan.	yoshidam@riken.jp	SHIMAZU, Tadahiro/ABC-3950-2020; Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674				Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; IMAMOTO N, 1995, FEBS LETT, V368, P415; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim H, 2001, BIOCHEM BIOPH RES CO, V289, P513, DOI 10.1006/bbrc.2001.5992; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010	25	47	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4470	4478		10.1074/jbc.M609745200	http://dx.doi.org/10.1074/jbc.M609745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17172643	hybrid			2022-12-27	WOS:000244482000028
J	Ababou, A; Gautel, M; Pfuhl, M				Ababou, Abdessamad; Gautel, Mathias; Pfuhl, Mark			Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C - Structure and myosin binding of domain C2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; MUSCLE PROTEIN; REGULATORY DOMAIN; THICK FILAMENTS; MYBP-C; PHOSPHORYLATION; TITIN; SEQUENCE; MACROMOLECULES	Myosin-binding protein C (MyBP-C) binds to myosin with two binding sites, one close to the N terminus and the other at the C terminus. Here we present the solution structure of one part of the N-terminal binding site, the third immunoglobulin domain of the cardiac isoform of human MyBP-C (cC2) together with a model of its interaction with myosin. Domain cC2 has the beta-sandwich structure expected from a member of the immunoglobulin fold. The C-terminal part of the structure of cC2 is very closely related to telokin, the myosin binding fragment of myosin light chain kinase. Domain cC2 also contains two cysteines on neighboring strands F and G, which would be able to form a disulfide bridge in a similar position as in telokin. Using NMR spectroscopy and isothermal titration calorimetry we demonstrate that cC2 alone binds to a fragment of myosin, S2 Delta, with low affinity (k(D) = 1.1 mm) but exhibits a highly specific binding site. This consists of the C-terminal surface of the C'CFGA' beta-sheet, which includes Glu(301), a residue mutated to Gln in the disease familial hypertrophic cardiomyopathy. The binding site on S2 was identified by a combination of NMR binding experiments of cC2 with S2 Delta containing the cardiomyopathy-linked mutation R870H and molecular modeling. This mutation lowers the binding affinity and changes the arrangement of side chains at the interface. Our model of the cC2-S2 Delta complex gives a first glimpse of details of the MyBP-C-myosin interaction. Using this model we suggest that most key interactions are between polar amino acids, explaining why the mutations E301Q in cC2 and R870H in S2 Delta could be involved in cardiomyopathy. We expect that this model will stimulate future research to further refine the details of this interaction and their importance for cardiomyopathy.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Kings Coll London, Randall Ctr, Div Cardiovasc, London SE1 1L, England	University of Leicester	Pfuhl, M (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.	mp84@le.ac.uK	Gautel, Mathias/AAB-9860-2019	Gautel, Mathias/0000-0003-4027-9803; Pfuhl, Mark/0000-0001-9592-6639	MRC [G0600251] Funding Source: UKRI; Medical Research Council [G0600251] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anan R, 2000, Hum Mutat, V15, P584, DOI 10.1002/1098-1004(200006)15:6<584::AID-HUMU25>3.0.CO;2-R; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Case DAPD, 1999, AMBER 6; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DEBRA LS, 1997, J BIOL CHEM, V272, P25353; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dixon SL, 1997, J CHEM PHYS, V107, P879, DOI 10.1063/1.474386; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fong S, 1996, J MOL BIOL, V264, P624, DOI 10.1006/jmbi.1996.0665; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gogonea V, 1999, J PHYS CHEM A, V103, P5171, DOI 10.1021/jp990266w; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Kreishman-Deitrick M, 2003, BIOCHEMISTRY-US, V42, P8579, DOI 10.1021/bi034536j; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; LANGE G, 1994, STRUCTURE, V2, P469, DOI 10.1016/S0969-2126(00)00048-4; LE HB, 1994, J BIOMOL NMR, V4, P341; Levine R, 2001, BIOPHYS J, V81, P1070, DOI 10.1016/S0006-3495(01)75764-5; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; Miyamoto CA, 1999, J MUSCLE RES CELL M, V20, P703, DOI 10.1023/A:1005513312939; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; PFUHL M, 1995, STRUCTURE, V3, P391, DOI 10.1016/S0969-2126(01)00170-8; Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen NK, 1996, NAT STRUCT BIOL, V3, P581, DOI 10.1038/nsb0796-581; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; TRINICK J, 1994, TRENDS BIOCHEM SCI, V19, P405, DOI 10.1016/0968-0004(94)90088-4; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; VAJDA S, 1994, BIOCHEMISTRY-US, V33, P13977, DOI 10.1021/bi00251a004; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Winegrad S, 2000, CIRC RES, V86, P6, DOI 10.1161/01.RES.86.1.6; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920	54	57	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9204	9215		10.1074/jbc.M610899200	http://dx.doi.org/10.1074/jbc.M610899200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17192269	hybrid			2022-12-27	WOS:000245780300067
J	Liu, YD; Dore, J; Chen, XH				Liu, Yudan; Dore, Jules; Chen, Xihua			Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; FREE CATALYTIC SUBUNIT; METHYL-D-ASPARTATE; SUBSTANTIA-NIGRA; CA2+ CHANNELS; DEPENDENT FACILITATION; NONLINEAR RELATIONSHIP; NUCLEUS-ACCUMBENS; IMPULSE FLOW; IN-VIVO	Enhanced activity of the dopaminergic system originating in the ventral tegmental area is implicated in addictive and psychiatric disorders. Burst firing increases dopamine levels at the synapse to signal novelty and salience. We have previously reported a calcium-dependent burst firing of dopamine cells mediated by L-type channels following cholinergic stimulation; this paper describes a cellular mechanism resulting in burst firing following L-type channel activation. Calcium influx through L-type channels following FPL 64176 or (S)-(-)-Bay K8644 induced burst firing independent of dopamine, glutamate, or calcium from the internal stores. Burst firing induced as such was completely blocked by the substrate site protein kinase C (PKC) inhibitor chelerythrine but not by the diacylglycerol site inhibitor calphostin C. Western blotting analysis showed that FPL 64176 and (S)-(-)-Bay K8644 increased the cleavage of PKC to generate protein kinase M (PKM) and the specific calpain inhibitor MDL28170 blocked this increase. Prevention of PKM production by inhibiting calpain or depleting PKC blocked burst firing induction whereas direct loading of purified PKM into cells induced burst firing. Activation of the N-methyl-D-aspartic acid type glutamate or cholinergic receptors known to induce burst firing increased PKM expression. These results indicate that calcium influx through L-type channels activates a calcium dependent protease that cleaves PKC to generate constitutively active and labile PKM resulting in burst firing of dopamine cells, a pathway that is involved in glutamatergic or cholinergic modulation of the central dopamine system.	Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada; Mem Univ Newfoundland, Fac Med, Discipline Psychiat, St John, NF A1B 3V6, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Chen, XH (corresponding author), Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada.	xihuac@mun.ca						AL ZW, 1993, BIOCHEM J, V296, P675, DOI 10.1042/bj2960675; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonci A, 1998, J NEUROSCI, V18, P6693; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; CHERGUI K, 1994, NEUROSCIENCE, V62, P641, DOI 10.1016/0306-4522(94)90465-0; CRESSMAN CM, 1995, FEBS LETT, V367, P223, DOI 10.1016/0014-5793(95)00543-I; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; INOUE M, 1977, J BIOL CHEM, V252, P7610; Johnson SW, 2004, BRAIN RES, V1019, P293, DOI 10.1016/j.brainres.2004.06.022; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; KISHIMOTO A, 1983, J BIOL CHEM, V258, P1156; Koob GF, 2000, ANN NY ACAD SCI, V909, P170, DOI 10.1111/j.1749-6632.2000.tb06682.x; LACEY MG, 1989, J NEUROSCI, V9, P1233; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; MCARDLE CA, 1989, METHOD ENZYMOL, V168, P287; Melikian HE, 1999, J NEUROSCI, V19, P7699; Mercuri NB, 1996, NEUROSCIENCE, V74, P785, DOI 10.1016/0306-4522(96)00189-3; MERCURI NB, 1994, BRIT J PHARMACOL, V113, P831, DOI 10.1111/j.1476-5381.1994.tb17068.x; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Osten P, 1996, J NEUROSCI, V16, P2444; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SHEA TB, 1994, FEBS LETT, V350, P223, DOI 10.1016/0014-5793(94)00769-1; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Steketee JD, 1997, BRAIN RES BULL, V43, P565, DOI 10.1016/S0361-9230(97)00089-0; Steketee JD, 1998, NEUROPHARMACOLOGY, V37, P339, DOI 10.1016/S0028-3908(98)00022-7; STEKETEE JD, 1994, NEUROREPORT, V6, P69, DOI 10.1097/00001756-199412300-00019; STEKETEE JD, 1993, NEUROPHARMACOLOGY, V32, P1289, DOI 10.1016/0028-3908(93)90023-V; SUAUDCHAGNY MF, 1992, NEUROSCIENCE, V49, P63, DOI 10.1016/0306-4522(92)90076-E; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Takada M, 2001, EUR J NEUROSCI, V13, P757, DOI 10.1046/j.1460-9568.2001.01435.x; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; van der Heyden MAG, 2005, CARDIOVASC RES, V65, P28, DOI 10.1016/j.cardiores.2004.09.028; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; YOSHIHARA C, 1991, J NEUROSCI, V11, P690; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; Zhang L, 2005, J PHYSIOL-LONDON, V568, P469, DOI 10.1113/jphysiol.2005.094722	59	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8594	8603		10.1074/jbc.M610230200	http://dx.doi.org/10.1074/jbc.M610230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17237234	hybrid			2022-12-27	WOS:000245780300005
J	Ong, HL; Cheng, KT; Liu, XB; Bandyopadhyay, BC; Paria, BC; Soboloff, J; Pani, B; Gwack, Y; Srikanth, S; Singh, BB; Gill, D; Ambudkar, IS				Ong, Hwei Ling; Cheng, Kwong Tai; Liu, Xibao; Bandyopadhyay, Bidhan C.; Paria, Biman C.; Soboloff, Jonathan; Pani, Biswaranjan; Gwack, Yousang; Srikanth, Sonal; Singh, Brij B.; Gill, Donald; Ambudkar, Indu S.			Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx - Evidence for similarities in store-operated and calcium release-activated calcium channel components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; CRAC CHANNEL; GLAND CELLS; STIM1; PROTEIN; TRPC1; DEPLETION; RECEPTOR; ORAI1; CURRENTS	Store-operated calcium entry (SOCE) is a ubiquitous mechanism that is mediated by distinct SOC channels, ranging from the highly selective calcium release-activated Ca2+ (CRAG) channel in rat basophilic leukemia and other hematopoietic cells to relatively Ca2+-selective or non-selective SOC channels in other cells. Although the exact composition of these channels is not yet established, TRPC1 contributes to SOC channels and regulation of physiological function of a variety of cell types. Recently, Orai1 and STIM1 have been suggested to be sufficient for generating CRAC channels. Here we show that Orai1 and STIM1 are also required for TRPC1-SOC channels. Knockdown of TRPC1, Orai1, or STIM1 attenuated, whereas overexpression of TRPC1, but not Orai1 or STIM1, induced an increase in SOC entry and I-SOC in human salivary gland cells. All three proteins were co-localized in the plasma membrane region of cells, and thapsigargin increased co-immunoprecipitation of TRPC1 with STIM1, and Orai1 in human salivary gland cells as well as dispersed mouse submandibular gland cells. In aggregate, the data presented here reveal that all three proteins are essential for generation of I-SOC in these cells and that dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in activation of SOC channel in response to internal Ca2+ store depletion. Thus, these data suggest a common molecular basis for SOC and CRAC channels.	NIDCR, Secret Physiol Sect, Gene Therapy & Therapeut Branch, NIH, Bethesda, MD 20892 USA; Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR, Biomed Res Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Dakota Grand Forks; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Ambudkar, IS (corresponding author), NIDCR, Secret Physiol Sect, Gene Therapy & Therapeut Branch, NIH, Bldg 10,Rm 1N-113,10 Ctr Dr, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov	Soboloff, Jonathan/I-6995-2012; Pani, Biswaranjan/GLT-9217-2022; Bandyopadhyay, Bidhan/AAC-6828-2022	Soboloff, Jonathan/0000-0001-5192-1297; Bandyopadhyay, Bidhan/0000-0003-2364-8945; Singh, Brij/0000-0003-0535-5997; Ong, Hwei Ling/0000-0002-7551-6883	NCRR NIH HHS [P20 RR017699, P20 RR017699-077011] Funding Source: Medline; NIDCR NIH HHS [R01 DE017102-06A1, R01 DE017102-05, R01 DE017102-01A1, DE017102, R01 DE017102-02, R01 DE017102-03, R01 DE017102] Funding Source: Medline; NIGMS NIH HHS [GM07525] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOLOTINA VM, 2004, SCI STKE, pPE34; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HISATSUNE C, 2005, SCI STKE, pPE53, DOI DOI 10.1126/STKE.3132005PE53; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	46	318	327	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9105	9116		10.1074/jbc.M608942200	http://dx.doi.org/10.1074/jbc.M608942200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17224452	hybrid, Green Accepted			2022-12-27	WOS:000245780300058
J	Tafreshi, NK; Hosseinkhani, S; Sadeghizadeh, M; Sadeghi, M; Ranjbar, B; Naderi-Manesh, H				Tafreshi, Narges Kh.; Hosseinkhani, Saman; Sadeghizadeh, Majid; Sadeghi, Mehdi; Ranjbar, Bijan; Naderi-Manesh, Hossein			The influence of insertion of a critical residue (Arg(356)) in structure and bioluminescence spectra of firefly luciferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAILROAD-WORM; BACTERIAL LUCIFERASE; SEQUENCE-ANALYSIS; PH-SENSITIVITY; CLICK BEETLE; IN-VIVO; LIGHT; COLORS; LUMINESCENCE; EXPRESSION	The firefly bioluminescence reaction, which uses luciferin, Mg-ATP, and molecular oxygen to yield an electronically excited oxyluciferin, is carried out by luciferase and visible light is emitted. The bioluminescence color of firefly luciferases is determined by the luciferase structure and assay conditions. Among different beetle luciferases, those from Phrixothrix railroad worm emit either yellow or red bioluminescence colors. Sequence alignment analysis shows that the red-emitter luciferase from Phrixothrix hirtus has an additional Arg residue at 353, which is absent in firefly luciferases. We report here the construction and purification of a mutant at residue Arg(356), which is not conserved in beetle luciferases. By insertion of an additional residue (Arg(356)) using site-specific insertion mutagenesis in a green-emitter luciferase (Lampyris turkestanicus) the color of emitted light was changed to red and the optimum temperature of activity was also increased. Insertion of this Arg in an important flexible loop showed changes of the bioluminescence color and the luciferase reaction took place with relatively retention of its basic kinetic properties such as K-m and relative activity. Comparison of native and mutant luciferases using homology modeling reveals a significant conformational change of the flexible loop in the red mutant. Movement of flexible loop brought about a new ionic interaction concomitant with a change in polarity of the emitter site, thereby leading to red emission. It is worthwhile to note that the increased optimum temperature and emission of red light might make mutant luciferase a suitable reporter for the study of gene expression and bioluminescence imaging.	Tarbiat Modares Univ, Fac Basic Sci, Dept Genet, Tehran 14115175, Iran; Tarbiat Modares Univ, Fac Basic Sci, Dept Biochem, Tehran 14115175, Iran; Natl Inst Genet Engn & Biotechnol, Tehran 141556346, Iran	Tarbiat Modares University; Tarbiat Modares University	Hosseinkhani, S (corresponding author), Tarbiat Modares Univ, Fac Basic Sci, Dept Genet, Tehran 14115175, Iran.	saman_h@modares.ac.ir		Naderi-Manesh, Hossein/0000-0002-4227-171X				Alipour BS, 2004, BIOCHEM BIOPH RES CO, V325, P215, DOI 10.1016/bbrc.2004.10.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; BIGGLEY WH, 1967, J GEN PHYSIOL, V50, P1681, DOI 10.1085/jgp.50.6.1681; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branchini BR, 2004, BIOCHEMISTRY-US, V43, P7255, DOI 10.1021/bi036175d; CHINNUSAMY V, 2002, SCI STKE, pL10; COLEPICOLO NP, 1986, INSECT BIOCHEM, V16, P803; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DELUCA M, 1973, P NATL ACAD SCI USA, V70, P1664, DOI 10.1073/pnas.70.6.1664; DELUCA M, 1976, ADV ENZYMOL RAMB, V44, P37; DELUCA M, 1969, BIOCHEMISTRY-US, V8, P160, DOI 10.1021/bi00829a023; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hosseinkhani S, 2005, BIOCHEM J, V385, P575, DOI 10.1042/BJ20040863; Madvar AR, 2005, FEBS LETT, V579, P4701, DOI 10.1016/j.febslet.2005.07.040; McCapra F., 1994, BIOLUMINESCENCE CHEM, P387; MCCAPRA F, 1996, BIOLUMINESCENCE CHEM, P7; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Ohmiya Y, 1996, FEBS LETT, V384, P83; Orlova G, 2003, J AM CHEM SOC, V125, P6962, DOI 10.1021/ja021255a; Protasevich I, 1997, BIOCHEMISTRY-US, V36, P2017, DOI 10.1021/bi962538g; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Rehemtulla A, 2002, MOL IMAGING, V1, P43, DOI 10.1162/153535002753395707; SCHIPPERS PH, 1981, ANAL CHEM, V53, P778, DOI 10.1021/ac00229a008; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SELIGER HH, 1964, P NATL ACAD SCI USA, V52, P75, DOI 10.1073/pnas.52.1.75; SELIGER HH, 1964, J GEN PHYSIOL, V48, P95, DOI 10.1085/jgp.48.1.95; Shin JH, 2003, ONCOL REP, V10, P2063; Takakuwa T, 1985, ANAL SCI, V1, P215, DOI DOI 10.2116/ANALSCI.1.215; Ugarova NN, 2001, RUSS CHEM B+, V50, P1752, DOI 10.1023/A:1014365609421; Viviani VR, 2005, PHOTOCHEM PHOTOBIOL, V81, P843, DOI 10.1562/2004-12-09-RA-398R.1; Viviani VR, 2004, PROTEIN ENG DES SEL, V17, P113, DOI 10.1093/protein/gzh016; Viviani VR, 1997, ANN ENTOMOL SOC AM, V90, P389, DOI 10.1093/aesa/90.3.389; VIVIANI VR, 1993, PHOTOCHEM PHOTOBIOL, V58, P615, DOI 10.1111/j.1751-1097.1993.tb04941.x; Viviani VR, 1999, BIOCHEMISTRY-US, V38, P8271, DOI 10.1021/bi9900830; VIVIANI VR, 1995, PHOTOCHEM PHOTOBIOL, V62, P490, DOI 10.1111/j.1751-1097.1995.tb02373.x; Viviani VR, 2002, PHOTOCHEM PHOTOBIOL, V76, P538, DOI 10.1562/0031-8655(2002)076&lt;0538:TIOAGA&gt;2.0.CO;2; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; WHITE E H, 1971, Bioorganic Chemistry, V1, P92, DOI 10.1016/0045-2068(71)90009-5; WHITE EH, 1975, J AM CHEM SOC, V97, P1243, DOI 10.1021/ja00838a049; WOOD KV, 1989, SCIENCE, V244, P700, DOI 10.1126/science.2655091; WOOD KV, 1995, PHOTOCHEM PHOTOBIOL, V62, P662, DOI 10.1111/j.1751-1097.1995.tb08714.x; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	45	87	87	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8641	8647		10.1074/jbc.M609271200	http://dx.doi.org/10.1074/jbc.M609271200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17197704	hybrid			2022-12-27	WOS:000245780300010
J	Xu, D; Song, DY; Pedersen, LC; Liu, J				Xu, Ding; Song, Danyin; Pedersen, Lars C.; Liu, Jian			Mutational study of heparan sulfate 2-0-sulfotransferase and chondroitin sulfate 2-0-sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DERMATAN SULFATE; ESTROGEN SULFOTRANSFERASE; MOLECULAR-CLONING; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS; IN-VIVO; DROSOPHILA; 2-O-SULFOTRANSFERASE; 2-SULFOTRANSFERASE	Heparan sulfate (HS) and chondroitin sulfate (CS) are highly sulfated polysaccharides with a wide range of biological functions. Heparan sulfate 2-O-sulfotransferase (HS-2OST) transfers the sulfo group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the 2-OH position of the hexauronic acid that is adjacent to N-sulfated glucosamine, whereas chondroitin sulfate 2-O-sulfotransferase (CS-2OST) transfers the sulfo group to the hexauronic acid that is adjacent to N-acetylated galactosamine. Here we report a systematic mutagenesis study of HS-2OST and CS-2OST based on their structural homology to estrogen sulfotransferase and HS 3-O-sulfotransferase isoform 3 (3-OST3), for which crystal structures exist. We have identified six residues possibly involved in binding to PAPS. HS-2OST carrying mutations of these residues lacks sulfotransferase activity and the ability to bind 3'-phosphoadenosine 5'-phosphate, a PAPS analogue, as determined by isothermal titration calorimetry. Similar residues involved in binding to PAPS were also identified in CS-20ST. Additional residues that participate in carbohydrate substrate binding were also identified in both enzymes. Mutations at these residues led to the loss of sulfotransferase activity but maintained the ability to bind to phosphoadenosine 5'-phosphate. The catalytic function of HS-2OST appears to involve two histidine residues (His(140) and His(142)), whereas only one histidine (His(168)) of CS 2-OST is likely to be critical. This unique feature of HS 2-OST catalytic residues directed us to characterize the Drosophila heparan sulfate 2-O-sulfotransferase. The results from this study provide insight into the differences and similarities various residues play in the biological roles of the HS-2OST and CS-20ST enzymes.	Univ N Carolina, Div Med Chem & Nat Prod, Sch Pharm, Chapel Hill, NC 27599 USA; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, J (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Sch Pharm, Rm 309,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Pedersen, Lars/C-6173-2019; Xu, Ding/B-2493-2009	Pedersen, Lars/0000-0002-4488-4077; Xu, Ding/0000-0001-9380-2712	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI50050] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mizuguchi H, 1999, J BIOL CHEM, V274, P2166, DOI 10.1074/jbc.274.4.2166; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Pinto DO, 2004, GLYCOBIOLOGY, V14, P529, DOI 10.1093/glycob/cwh070; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Sen J, 2000, DEVELOPMENT, V127, P5541; Sergeev P, 2001, DEV DYNAM, V220, P122, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1094>3.0.CO;2-A; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu XJ, 2005, DEVELOPMENT, V132, P3813, DOI 10.1242/dev.01962	43	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8356	8367		10.1074/jbc.M608062200	http://dx.doi.org/10.1074/jbc.M608062200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227754	hybrid, Green Published			2022-12-27	WOS:000245081000069
J	Jacobson, DA; Weber, CR; Bao, SZ; Turk, J; Philipson, LH				Jacobson, David A.; Weber, Christopher R.; Bao, Shunzhong; Turk, John; Philipson, Louis H.			Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDEPENDENT PHOSPHOLIPASE A(2); TRANSFECTED INSULINOMA CELLS; K+ CHANNELS; INTRACELLULAR CA-2+; SECRETORY RESPONSES; OVEREXPRESS GROUP; GLUCOSE; CALCIUM; METABOLISM; INHIBITION	Glucose stimulates both insulin secretion and hydrolysis of arachidonic acid (AA) esterified in membrane phospholipids of pancreatic islet P-cells, and these processes are amplified by muscarinic agonists. Here we demonstrate that nonesterified AA regulates the biophysical activity of the pancreatic islet beta-cell-delayed rectifier channel, Kv2.1. Recordings of Kv2.1 currents from INS-1 insulinoma cells incubated with AA (5 mu M) and subjected to graded degrees of depolarization exhibit a significantly shorter time-to-peak current interval than do control cells. AA causes a rapid decay and reduced peak conductance of delayed rectifier currents from INS-1 cells and from primary beta-cells isolated from mouse, rat, and human pancreatic islets. Stimulating mouse islets with AA results in a significant increase in the frequency of glucose-induced [Ca2+] oscillations, which is an expected effect of Kv2.1 channel blockade. Stimulation with concentrations of glucose and carbachol that accelerate hydrolysis of endogenous AA from islet phosphoplipids also results in accelerated Kv2.1 inactivation and a shorter time-to-peak current interval. Group VIA phospholipase A(2) (iPLA(2)beta) hydrolyzes beta-cell membrane phospholipids to release nonesterified fatty acids, including AA, and inhibiting iPLA(2)beta prevents the muscarinic agonist-induced accelerated Kv2.1 inactivation. Furthermore, glucose and carbachol do not significantly affect Kv2.1 inactivation in beta-cells from iPLA(2)beta(-/-) mice. Stably transfected INS-1 cells that overexpress iPLA(2)beta hydrolyze phospholipids more rapidly than control INS-1 cells and also exhibit an increase in the inactivation rate of the delayed rectifier currents. These results suggest that Kv2.1 currents could be dynamically modulated in the pancreatic islet beta-cell by phospholipase-catalyzed hydrolysis of membrane phospholipids to yield non-esterified fatty acids, such as AA, that facilitate Ca2+ entry and insulin secretion.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Washington Univ, Sch Med, Med Dept Mass Spectrometry Facil, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Endocrinol Mateab & Lipid Res, St Louis, MO 63110 USA	University of Chicago; University of Chicago; Washington University (WUSTL); Washington University (WUSTL)	Philipson, LH (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	l-philipson@uchicago.edu		Weber, Christopher/0000-0002-2117-3184; Jacobson, David A./0000-0003-1816-5375	NCRR NIH HHS [P41 RR000954-30, P41 RR000954] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-07, P60 DK020595, R01 DK063493, R01 DK048494, P60-DK20579, DK63493, P60 DK020579, R37 DK034388, P60 DK020579-269005, P30 DK020595, P30-DK56341, R37 DK034388-23, DK44840, R37-DK34388, DK48494, DK20595, P30 DK056341-06, P30 DK056341-069003, P30 DK056341] Funding Source: Medline; NIGMS NIH HHS [P41 GM103422] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048494, P60DK020579, P30DK020595, P01DK044840, R37DK034388, P30DK056341, P60DK020595, R01DK063493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; CHAUDHRY A, 1987, J BIOL CHEM, V262, P17426; Dixon G, 2004, CLIN SCI, V106, P191, DOI 10.1042/CS20030261; DIXON JF, 1984, J BIOL CHEM, V259, P4418; Dukes ID, 1996, DIABETES, V45, P845, DOI 10.2337/diabetes.45.7.845; DUKES ID, 1990, J PHARMACOL EXP THER, V254, P560; EDDLESTONE GT, 1995, AM J PHYSIOL-CELL PH, V268, pC181, DOI 10.1152/ajpcell.1995.268.1.C181; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; GubitosiKlug RA, 1996, J BIOL CHEM, V271, P32519, DOI 10.1074/jbc.271.51.32519; GUBITOSIKLUG RA, 1995, J BIOL CHEM, V270, P2885, DOI 10.1074/jbc.270.7.2885; Hsu FF, 2000, J BIOL CHEM, V275, P16579, DOI 10.1074/jbc.M908342199; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Juhl K, 2003, BIOCHEM BIOPH RES CO, V310, P274, DOI 10.1016/j.bbrc.2003.09.018; KONRAD RJ, 1992, BIOCHIM BIOPHYS ACTA, V1135, P215, DOI 10.1016/0167-4889(92)90139-3; KONRAD RJ, 1992, BIOCHEM J, V287, P283, DOI 10.1042/bj2870283; LAYCHOCK SG, 1983, DIABETES, V32, P6, DOI 10.2337/diabetes.32.1.6; Ma ZM, 2001, LIPIDS, V36, P689, DOI 10.1007/s11745-001-0774-9; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; MCGEE R, 1988, J MEMBRANE BIOL, V102, P21, DOI 10.1007/BF01875350; McKay MC, 2001, AM J PHYSIOL-CELL PH, V281, pC1277, DOI 10.1152/ajpcell.2001.281.4.C1277; METZ SA, 1987, BIOCHEM BIOPH RES CO, V142, P251, DOI 10.1016/0006-291X(87)90478-5; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; PELIKANOVA T, 1991, METABOLISM, V40, P175, DOI 10.1016/0026-0495(91)90170-2; Pelikanova T, 2001, METABOLISM, V50, P1472, DOI 10.1053/meta.2001.27195; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; Ramanadham S, 1996, BIOCHEMISTRY-US, V35, P5464, DOI 10.1021/bi952652j; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; RAMANADHAM S, 1992, BIOCHEM BIOPH RES CO, V184, P647, DOI 10.1016/0006-291X(92)90638-2; Ramanadham S, 1997, BBA-LIPID LIPID MET, V1344, P153, DOI 10.1016/S0005-2760(96)00139-7; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; SALOMAA V, 1990, METABOLISM, V39, P1285, DOI 10.1016/0026-0495(90)90185-F; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Song HW, 2006, BIOCHEMISTRY-US, V45, P1061, DOI 10.1021/bi052065q; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; TURK J, 1987, PROG LIPID RES, V26, P125, DOI 10.1016/0163-7827(87)90010-5; TURK J, 1993, DIABETES, V42, P367, DOI 10.2337/diabetes.42.3.367; TURK J, 1984, BIOCHIM BIOPHYS ACTA, V794, P110, DOI 10.1016/0005-2760(84)90304-7; TURK J, 1985, BIOCHIM BIOPHYS ACTA, V835, P1, DOI 10.1016/0005-2760(85)90023-2; TURK J, 1988, DIABETES, V37, P992, DOI 10.2337/diabetes.37.7.992; TURK J, 1986, BIOCHEM J, V237, P259, DOI 10.1042/bj2370259; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; TURK J, 2006, COMMENTARIES PERSPEC, V2, P10; VACHER P, 1989, AM J PHYSIOL, V257, pE203, DOI 10.1152/ajpendo.1989.257.2.E203; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; WOLF BA, 1986, J BIOL CHEM, V261, P3501	69	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7442	7449		10.1074/jbc.M607858200	http://dx.doi.org/10.1074/jbc.M607858200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17197450	Green Accepted			2022-12-27	WOS:000245080900056
J	Liang, S; Wang, M; Tapping, RI; Stepensky, V; Nawar, HF; Triantafilou, M; Triantafilou, K; Connell, TD; Hajishengallis, G				Liang, Shuang; Wang, Min; Tapping, Richard I.; Stepensky, Vitaly; Nawar, Hesharn F.; Triantafilou, Martha; Triantafilou, Kathy; Connell, Terry D.; Hajishengallis, George			Ganglioside GD1 a is an essential coreceptor for toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-LABILE ENTEROTOXINS; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNE-SYSTEM; PATTERN-RECOGNITION; LT-IIB; PORPHYROMONAS-GINGIVALIS; REQUIRES COEXPRESSION; ADAPTER MOLECULE; CHOLERA-TOXIN; POLYOMA-VIRUS	Innate recognition and signaling by Toll-like receptors (TLRs) is facilitated by functionally associated coreceptors, although the cooperativity mechanisms involved are poorly understood. As a model we investigated TLR2 interactions with the GD1a ganglioside binding subunit of type IIb Escherichia coli enterotoxin (LT-IIb-B-5). Both LT-IIb-B-5 and a GD1a binding-defective mutant (LT-IIb-B-5(T13I)) could modestly bind to TLR2, but only the wild-type molecule displayed a dramatic increase in TLR2 binding activity in the presence of GD1a (although not in the presence of irrelevant gangliosides). Moreover, fluorescence resonance energy transfer experiments indicated that LT-IIb-B-5 induces lipid raft recruitment of TLR2 and TLR1 and their clustering with GD1a, in contrast to the GD1a binding-defective mutant, which moreover fails to activate TLR2 signaling. LT-IIb-B-5-induced cell activation was critically dependent upon the Toll/IL-1 receptor domain-containing adaptor protein, which was induced to colocalize with TLR2 and GD1a, as shown by confocal imaging. Therefore, GD1a provides TLR2 coreceptor function by enabling the ligand to recruit, bind, and activate TLR2. These findings establish a model of TLR2 coreceptor function and, moreover, suggest novel mechanisms of adjuvanticity by non-toxic derivatives of type II enterotoxins dependent upon GD1a/TLR2 cooperative activity.	Univ Louisville, Hlth Sci Ctr, Ctr Oral Hlth Syst Dis, Louisville, KY 40292 USA; Univ Louisville, Hlth Sci Ctr, Dept Periodont, Louisville, KY 40292 USA; Univ Louisville, Hlth Sci Ctr, Dept Microbiol Immunol, Louisville, KY 40292 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; SUNY Buffalo, Dept Microbiol & Immunol, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA; Univ Sussex, Sch Life Sci, Infect & Immun Grp, Brighton BN1 9QG, E Sussex, England	University of Louisville; University of Louisville; University of Louisville; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Sussex	Hajishengallis, G (corresponding author), Univ Louisville, Hlth Sci Ctr, Ctr Oral Hlth Syst Dis, 501 S Preston St,Room 206, Louisville, KY 40292 USA.	g0haji01@louisville.edu	Hajishengallis, George N./K-1117-2019	Hajishengallis, George N./0000-0001-7392-8852	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017138, R01DE015254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013833] Funding Source: NIH RePORTER; NIAID NIH HHS [AI052344] Funding Source: Medline; NIDCR NIH HHS [DE017138, DE13833, DE015254] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aman AT, 2001, P NATL ACAD SCI USA, V98, P8536, DOI 10.1073/pnas.161273098; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Christian AE, 1997, J LIPID RES, V38, P2264; Du JW, 2006, INVEST OPHTH VIS SCI, V47, P4810, DOI 10.1167/iovs.06-0250; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fraser SA, 2003, INFECT IMMUN, V71, P1527, DOI 10.1128/IAI.71.3.1527-1537.2003; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; Fujitani M, 2005, J NEUROCHEM, V94, P15, DOI 10.1111/j.1471-4159.2005.03121.x; FUKUTA S, 1988, INFECT IMMUN, V56, P1748, DOI 10.1128/IAI.56.7.1748-1753.1988; Galvan EM, 2004, J INFECT DIS, V189, P1556, DOI 10.1086/383349; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hajishengallis G, 2005, J DENT RES, V84, P1104, DOI 10.1177/154405910508401205; Hajishengallis G, 2005, J BIOL CHEM, V280, P38902, DOI 10.1074/jbc.M507326200; Hajishengallis G, 2005, INFECT IMMUN, V73, P1343, DOI 10.1128/IAI.73.3.1343-1349.2005; Hajishengallis G, 2004, INFECT IMMUN, V72, P6351, DOI 10.1128/IAI.72.11.6351-6358.2004; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Holmes RK, 1995, BACTERIAL TOXINS VIR, P225; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; Ogushi K, 2004, J BIOL CHEM, V279, P12213, DOI 10.1074/jbc.M307944200; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; ROGERS TB, 1981, J BIOL CHEM, V256, P2402; Rusnati M, 2002, P NATL ACAD SCI USA, V99, P4367, DOI 10.1073/pnas.072651899; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sorice M, 2001, FEBS LETT, V506, P55, DOI 10.1016/S0014-5793(01)02830-7; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Takebayashi M, 2004, SYNAPSE, V53, P90, DOI 10.1002/syn.20041; Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; Velupillai P, 2006, J IMMUNOL, V176, P1148, DOI 10.4049/jimmunol.176.2.1148; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yoshimura A, 1999, J IMMUNOL, V163, P1	59	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7532	7542		10.1074/jbc.M611722200	http://dx.doi.org/10.1074/jbc.M611722200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17227759	hybrid			2022-12-27	WOS:000245080900066
J	Sriburi, R; Bommiasamy, H; Buldak, GL; Robbins, GR; Frank, M; Jackowski, S; Brewer, JW				Sriburi, Rungtawan; Bommiasamy, Hemamalini; Buldak, Gerald L.; Robbins, Gregory R.; Frank, Matthew; Jackowski, Suzanne; Brewer, Joseph W.			Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1 (S)-induced endoplasmic reticulum biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PLASMA-CELL DIFFERENTIATION; RIBOSOME RECEPTOR; PHOSPHATIDYLCHOLINE SYNTHESIS; ER STRESS; CLONING; LIPIN; IRE1; OVEREXPRESSION	Development of the expansive endoplasmic reticulum (ER) present in specialized secretory cell types requires X-box-binding protein-1 (Xbp-1). Enforced expression of XBP-1(S), a transcriptional activator generated by unfolded protein response-mediated splicing of Xbp-1 mRNA, is sufficient to induce proliferation of rough ER. We previously showed that XBP-1(S)induced ER biogenesis in fibroblasts correlates with increased production of phosphatidylcholine (PtdCho), the primary phospholipid of the ER membrane, and enhanced activities of the choline cytidylyltransferase (CCT) and cholinephosphotransferase enzymes in the cytidine diphosphocholine (CDP-choline) pathway of PtdCho biosynthesis. Here, we report that the level and synthesis of CCT, the rate-limiting enzyme in the CDPcholine pathway, is elevated in fibroblasts overexpressing XBP-1(S). Furthermore, overexpression experiments demonstrated that raising the activity of CCT, but not cholinephosphotransferase, is sufficient to augment PtdCho biosynthesis in fibroblasts, indicating that XBP-1(S) increases the output of the CDP-choline pathway primarily via its effects on CCT. Finally, fibroblasts overexpressing CCT up-regulated PtdCho synthesis to a level similar to that in XBP-1(S)-transduced cells but exhibited only a small increase in rough ER and no induction of secretory pathway genes. The more robust XBP-1(S)-induced ER expansion was accompanied by induction of a wide array of genes encoding proteins that function either in the ER or at other steps in the secretory pathway. We propose that XBP-1(S) regulates ER abundance by coordinately increasing the supply of membrane phospholipids and ER proteins, the key ingredients for ER biogenesis.	Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Loyola University Chicago; St Jude Children's Research Hospital	Brewer, JW (corresponding author), Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA.	jbrewer@lumc.edu	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429; sriburi, Rungtawan/0000-0002-8900-9233; Frank, Matthew/0000-0002-4914-1440	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061970, R01GM045737] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIAID NIH HHS [T32 AI007508] Funding Source: Medline; NIGMS NIH HHS [GM 61970, R01 GM061970, GM 45737] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLENDER RP, 1974, J CELL BIOL, V61, P269, DOI 10.1083/jcb.61.2.269; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; GRASSO JA, 1978, J CELL SCI, V31, P165; Gunn KE, 2004, MOL IMMUNOL, V41, P919, DOI 10.1016/j.molimm.2004.04.023; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2005, J BIOL CHEM, V280, P853, DOI 10.1074/jbc.R400031200; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Langley R, 1998, DNA CELL BIOL, V17, P449, DOI 10.1089/dna.1998.17.449; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; LUCHE MM, 1993, ARCH BIOCHEM BIOPHYS, V301, P114, DOI 10.1006/abbi.1993.1122; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ridsdale R, 2004, J BIOL CHEM, V279, P55946, DOI 10.1074/jbc.M407670200; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; SHOHAT M, 1973, EUR J IMMUNOL, V3, P680, DOI 10.1002/eji.1830031106; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Wright MM, 2001, J BIOL CHEM, V276, P25254, DOI 10.1074/jbc.M011552200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	54	181	191	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7024	7034		10.1074/jbc.M609490200	http://dx.doi.org/10.1074/jbc.M609490200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213183	hybrid			2022-12-27	WOS:000245080900014
J	Shindou, H; Hishikawa, D; Nakanishiu, H; Harayama, T; Ishii, S; Taguchi, R; Shimizu, T				Shindou, Hideo; Hishikawa, Daisuke; Nakanishiu, Hiroki; Harayama, Takeshi; Ishii, Satoshi; Taguchi, Ryo; Shimizu, Takao			A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells - Cloning and characterization of acetyl-CoA : lyso-PAF acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); NF-KAPPA-B; FACTOR RECEPTOR; HUMAN-NEUTROPHILS; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; FACTOR ACETYLHYDROLASE; P388D(1) MACROPHAGES; II CELLS; LIPOPOLYSACCHARIDE; BIOSYNTHESIS	Platelet-activating factor (PAF) is a potent proinflammatory lipid mediator eliciting a variety of cellular functions. Lipid mediators, including PAF are produced from membrane phospholipids by enzymatic cascades. Although a G protein-coupled PAF receptor and degradation enzymes have been cloned and characterized, the PAF biosynthetic enzyme, aceyl-CoAdyso-PAF acetyltransferase, has not been identified. Here, we cloned lyso-PAF acetyltransferase, which is critical in stimulus-dependent formation of PAF. The enzyme is a 60-kDa microsomal protein with three putative membrane-spanning domains. The enzyme was induced by bacterial endotoxin (lipopolysaccharide), which was suppressed by dexamethasone treatment. Surprisingly, the enzyme catalyzed not only biosynthesis of PAF from lyso-PAF but also incorporation of arachidonoyl-CoA to produce PAF precursor membrane glycerophospholipids (lysophosphatidylcholine acyltransferase activity). Under resting conditions, the enzyme prefers arachidonoyl-CoA and contributes to membrane biogenesis. Upon acute inflammatory stimulation with lipopolysaccharide, the activated enzyme utilizes acetyl-CoA more efficiently and produces PAF. Thus, our findings provide a novel concept that a single enzyme catalyzes membrane biogenesis of inflammatory cells while producing prophlogistic mediator in response to external stimuli.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Dept Metabolome, Tokyo 1130033, Japan; Japan Sci & Technol Agcy, CREST, Tokyo 1130033, Japan; Japan Sci & Technol Agcy, PRESTO, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Harayama, Takeshi/AAD-8852-2022; Shimizu, Takao/AAV-7052-2021	Harayama, Takeshi/0000-0003-2255-4197; Nakanishi, Hiroki/0000-0002-5108-1598				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AOKI Y, 1995, J IMMUNOL METHODS, V186, P225, DOI 10.1016/0022-1759(95)00147-3; Arai H, 2002, PROSTAG OTH LIPID M, V68-9, P83, DOI 10.1016/S0090-6980(02)00023-0; Balsinde J, 2000, J BIOL CHEM, V275, P4783, DOI 10.1074/jbc.275.7.4783; BENIGNI A, 1992, LANCET, V339, P835, DOI 10.1016/0140-6736(92)90281-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; DOEBBER TW, 1987, P NATL ACAD SCI USA, V84, P7557, DOI 10.1073/pnas.84.21.7557; Fragopoulou E, 2005, MEDIAT INFLAMM, P263, DOI 10.1155/MI.2005.263; GOMEZCAMBRONERO J, 1986, BIOCHEM J, V237, P439, DOI 10.1042/bj2370439; Han SJ, 1999, EUR J IMMUNOL, V29, P1334, DOI 10.1002/(SICI)1521-4141(199904)29:04<1334::AID-IMMU1334>3.0.CO;2-0; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; KENNEDY EP, 1961, FED PROC, V20, P934; Kihara Y, 2005, J EXP MED, V202, P853, DOI 10.1084/jem.20050660; Kume K, 1997, ANAL BIOCHEM, V246, P118, DOI 10.1006/abio.1996.9959; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1963, J BIOL CHEM, V238, P898; LEE TC, 1984, J BIOL CHEM, V259, P5526; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MERKL I, 1963, J BIOL CHEM, V238, P905; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Owen JS, 2005, BBA-MOL CELL BIOL L, V1733, P120, DOI 10.1016/j.bbalip.2004.12.016; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; REINHOLD SL, 1989, J BIOL CHEM, V264, P21652; REMY E, 1989, BIOCHIM BIOPHYS ACTA, V1005, P87, DOI 10.1016/0005-2760(89)90035-0; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Smith JM, 2002, PEDIATR NEPHROL, V17, P1047, DOI 10.1007/s00467-002-0970-7; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VENABLE ME, 1993, J BIOL CHEM, V268, P7965; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	53	168	177	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6532	6539		10.1074/jbc.M609641200	http://dx.doi.org/10.1074/jbc.M609641200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17182612	hybrid			2022-12-27	WOS:000244867200061
J	Snyers, L; Vlcek, S; Dechat, T; Skegro, D; Korbei, B; Gajewski, A; Mayans, O; Schofer, C; Foisner, R				Snyers, Luc; Vlcek, Sylvia; Dechat, Thomas; Skegro, Darko; Korbei, Barbara; Gajewski, Andreas; Mayans, Olga; Schoefer, Christian; Foisner, Roland			Lamina-associated polypeptide 2-alpha forms homo-trimers via its C terminus, and oligomerization is unaffected by a disease-causing mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-STRUCTURE DYNAMICS; A-TYPE LAMINS; CHROMOSOME ASSOCIATION; LAP2-ALPHA; PROTEIN; BAF; CHROMATIN; ENVELOPE; REGION; DOMAIN	The nucleoplasmic protein, Lamina-associated polypeptide (LAP) 2 alpha, is one of six alternatively spliced products of the LAP2gene, which share a common N-terminal region. In contrast to the other isoforms, which also share most of their C termini, LAP2 alpha has a large unique C-terminal region that contains binding sites for chromatin, A-type lamins, and retinoblastorna protein. By immunoprecipitation analyses of LAP2a complexes from cells expressing differently tagged LAP2 alpha proteins and fragments, we demonstrate that LAP21y forms higher order structures containing multiple LAP2 alpha molecules in vivo and that complex formation is mediated by the C terminus. Solid phase binding assays using recombinant and in vitro translated LAP2 alpha fragments showed direct interactions of LAP2 alpha C termini. Cross-linking of LAP2 alpha complexes and multiangle light-scattering of purified LAP2 alpha revealed the existence of stable homo-trimers in vivo and in vitro. Finally, we show that, in contrast to the LAP2 alpha-lamin A interaction, its self-association is not affected by a disease-linked single point mutation in the LAP2 alpha C terminus.	Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria; Univ Basel, Biozentrum, Div Marine Biol, CH-4056 Basel, Switzerland	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Basel	Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019; Mayans, Olga/A-3954-2008	Foisner, Roland/0000-0003-4734-4647; Korbei, Barbara/0000-0002-0439-0435; Mayans, Olga/0000-0001-6876-8532; Schofer, Christian/0000-0001-9570-5692	Austrian Science Fund FWF [P 17871] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Foisner R, 2001, J CELL SCI, V114, P3791; Gajewski A, 2004, J BIOL CHEM, V279, P35813, DOI 10.1074/jbc.M402546200; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452; Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250; Vlcek S, 1999, EMBO J, V18, P6370, DOI 10.1093/emboj/18.22.6370; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200	22	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6308	6315		10.1074/jbc.M605782200	http://dx.doi.org/10.1074/jbc.M605782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17213199	hybrid			2022-12-27	WOS:000244867200037
J	Bonfils, C; Bec, N; Lacroix, B; Harricane, MC; Larroque, C				Bonfils, Claude; Bec, Nicole; Lacroix, Benjamin; Harricane, Marie-Cecile; Larroque, Christian			Kinetic analysis of tubulin assembly in the presence of the microtubule-associated protein TOGp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE 5'-TRIPHOSPHATE HYDROLYSIS; KINESIN-RELATED PROTEIN; MITOTIC SPINDLE; GTP HYDROLYSIS; FISSION YEAST; XENOPUS EGGS; PLUS-END; POLYMERIZATION; NUCLEATION; COMPONENT	The microtubule-associated protein TOGp, which belongs to a widely distributed protein family from yeasts to humans, is highly expressed in human tumors and brain tissue. From purified components we have determined the effect of TOGp on thermally induced tubulin association in vitro in the presence of 1 mm GTP and 3.4 m glycerol. Physicochemical parameters describing the mechanism of tubulin polymerization were deduced from the kinetic curves by application of the classical theoretical models of tubulin assembly. We have calculated from the polymerization time curves a range of parameters characteristic of nucleation, elongation, or steady state phase. In addition, the tubulin subunits turnover at microtubule ends was deduced from tubulin GTPase activity. For comparison, parallel experiments were conducted with colichicine and taxol, two drugs active on microtubules and with tau, a structural microtubule-associated protein from brain tissue. TOGp, which decreases the nucleus size and the tenth time of the reaction (the time required to produce 10% of the final amount of polymer), shortens the nucleation phase of microtubule assembly. In addition, TOGp favors microtubule formation by increasing the apparent first order rate constant of elongation. Moreover, TOGp increases the total amount of polymer by decreasing the tubulin critical concentration and by inhibiting depolymerization during the steady state of the reaction.	CLRC Val Aurelle Paul Lamarque, INSERM, EMI 229, F-34298 Montpellier 5, France; CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Bonfils, C (corresponding author), CLRC Val Aurelle Paul Lamarque, INSERM, EMI 229, Rue Apothicaires, F-34298 Montpellier 5, France.	bonfils@valdorel.fnclcc.fr	Lacroix, Benjamin/AAL-8428-2020	Lacroix, Benjamin/0000-0003-2533-9150; bec, nicole/0000-0001-7608-2434				Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; CARLIER MF, 1983, BIOCHEMISTRY-US, V22, P4814, DOI 10.1021/bi00289a031; CARLIER MF, 1981, BIOCHEMISTRY-US, V20, P1918, DOI 10.1021/bi00510a030; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Caudron N, 2002, J BIOL CHEM, V277, P50973, DOI 10.1074/jbc.M209753200; Charrasse S, 1998, J CELL SCI, V111, P1371; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Cullen CF, 2001, NAT CELL BIOL, V3, P637, DOI 10.1038/35083025; DAVIDPFEUTY T, 1977, P NATL ACAD SCI USA, V74, P5372, DOI 10.1073/pnas.74.12.5372; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; Dionne MA, 2000, J BIOL CHEM, V275, P12346, DOI 10.1074/jbc.275.16.12346; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Graf R, 2000, J CELL SCI, V113, P1747; Hall D, 2003, BIOPHYS CHEM, V104, P655, DOI 10.1016/S0301-4622(03)00040-1; HOUMEIDA A, 1995, BIOPHYS CHEM, V56, P201, DOI 10.1016/0301-4622(95)00038-Y; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; JOHNSON KA, 1977, J MOL BIOL, V117, P1, DOI 10.1016/0022-2836(77)90020-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; LIN CM, 1981, J BIOL CHEM, V256, P9242; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ohkura H, 2001, J CELL SCI, V114, P3805; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; RAGE F, 1992, ENDOCRINOLOGY, V130, P1056, DOI 10.1210/en.130.2.1056; ROBINSON J, 1982, J BIOL CHEM, V257, P5367; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SANDOVAL IV, 1981, J BIOL CHEM, V256, P8795; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; STERNLICHT H, 1979, J BIOL CHEM, V254, P540; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; VOTER WA, 1984, J BIOL CHEM, V259, P430; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376	50	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5570	5581		10.1074/jbc.M605641200	http://dx.doi.org/10.1074/jbc.M605641200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178729	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000244482300053
J	Kang, SH; Kim, GR; Seong, M; Baek, SH; Seol, JH; Bang, OS; Ovaa, H; Tatsumi, K; Komatsu, M; Tanaka, K; Chung, CH				Kang, Sung Hwan; Kim, Gi Ryang; Seong, Minu; Baek, Sung Hee; Seol, Jae Hong; Bang, Ok Sun; Ovaa, Huib; Tatsumi, Kanako; Komatsu, Masaaki; Tanaka, Keiji; Chung, Chin Ha			Two novel ubiquitin-fold modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; UBIQUITIN; PROTEIN; SUMO; UFM1	Ubiquitin-fold modifier I (Ufm1) is a recently identified new ubiquitin-like protein, whose tertiary structure displays a striking resemblance to ubiquitin. Similar to ubiquitin, it has a Gly residue conserved across species at the C-terminal region with extensions of various amino acid sequences that need to be processed in vivo prior to conjugation to target proteins. Here we report the isolation, cloning, and characterization of two novel mouse Ufm1-specific proteases, named UfSP1 and UfSP2. UfSP1 and UfSP2 are composed of 217 and 461 amino acids, respectively, and they have no sequence homology with previously known proteases. UfSP2 is present in most, if not all, of multicellular organisms including plant, nematode, fly, and mammal, whereas UfSP1 could not be found in plant and nematode upon data base search. UfSP1 and UfSP2 cleaved the C-terminal extension of Ufm1 but not that of ubiquitin or other ubiquitin-like proteins, such as SUMO-1 and ISG15. Both were also capable of releasing Ufm1 from Ufm1-conjugated cellular proteins. They were sensitive to inhibition by sulfhydryl-blocking agents, such as N-ethylmaleimide, and their active site Cys could be labeled with Ufm1-vinylmethylester. Moreover, replacement of the conserved Cys residue by Ser resulted in a complete loss of the UfSP1 and UfSP2 activities. These results indicate that UfSP1 and UfSP2 are novel thiol proteases that specifically process the C terminus of Ufm1.	Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Seoul National University (SNU); Netherlands Cancer Institute; Tokyo Metropolitan Institute of Medical Science	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	chchung@snu.ac.kr	Komatsu, Masaaki/B-8321-2011; ovaa, huib/M-2334-2016	Komatsu, Masaaki/0000-0001-7672-7722; ovaa, huib/0000-0002-0068-054X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang SH, 2005, METHOD ENZYMOL, V398, P500, DOI 10.1016/S0076-6879(05)98041-5; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tanaka K, 1998, MOL CELLS, V8, P503; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	31	91	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5256	5262		10.1074/jbc.M610590200	http://dx.doi.org/10.1074/jbc.M610590200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182609	hybrid			2022-12-27	WOS:000244482300020
J	Otter, S; Grimmler, M; Neuenkirchen, N; Chari, A; Sickmann, A; Fischer, U				Otter, Simon; Grimmler, Matthias; Neuenkirchen, Nils; Chari, Ashwin; Sickmann, Albert; Fischer, Utz			A comprehensive interaction map of the human survival of motor neuron (SMN) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SNRNP PROTEINS; GENE-PRODUCT; U-SNRNPS; IN-VITRO; COMPONENT; IDENTIFICATION; SPECIFICITY; EXPRESSION; SEVERITY	Assembly of the Sm-class of U-rich small nuclear ribonucleoprotein particles (U snRNPs) is a process facilitated by the macromolecular survival of motor neuron (SMN) complex. This entity promotes the binding of a set of factors, termed LSm/Sm proteins, onto snRNA to form the core structure of these particles. Nine factors, including the SMN protein, the product of the spinal muscular atrophy (SMA) disease gene, Gemins 2-8 and unrip have been identified as the major components of the SMN complex. So far, however, only little is known about the architecture of this complex and the contribution of individual components to its function. Here, we present a comprehensive interaction map of all core components of the SMN complex based upon in vivo and in vitro methods. Our studies reveal a modular composition of the SMN complex with the three proteins SMN, Gemin8, and Gemin7 in its center. Onto this central building block the other components are bound via multiple interactions. Furthermore, by employing a novel assay, we were able to reconstitute the SMN complex from individual components and confirm the interaction map. Interestingly, SMN protein carrying an SMA-causing mutation was severely impaired in formation of the SMN complex. Finally, we show that the peripheral component Gemin5 contributes an essential activity to the SMN complex, most likely the transfer of Sm proteins onto the U snRNA. Collectively, the data presented here provide a basis for the detailed mechanistic and structural analysis of the assembly machinery of U snRNPs.	Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany; Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Fischer, U (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Fischer, Utz/AAT-8422-2020; Chari, Ashwin/ABC-5304-2020; Sickmann, Albert/A-1010-2011; Fischer, Utz/A-4090-2016	Fischer, Utz/0000-0002-1465-6591; Chari, Ashwin/0000-0001-6220-9828; Sickmann, Albert/0000-0002-2388-5265; Fischer, Utz/0000-0002-1465-6591; Grimmler, Matthias/0000-0003-2860-3391				Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; GOLEMIS EA, 1999, CURRENT PROTOCOLS MO, V4, P40; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102	35	103	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5825	5833		10.1074/jbc.M608528200	http://dx.doi.org/10.1074/jbc.M608528200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178713	hybrid, Green Published			2022-12-27	WOS:000244482300078
J	Bonshtien, AL; Weiss, C; Vitlin, A; Niv, A; Lorimer, GH; Azem, A				Bonshtien, Anat L.; Weiss, Celeste; Vitlin, Anna; Niv, Adina; Lorimer, George H.; Azem, Abdussalam			Significance of the N-terminal domain for the function of chloroplast cpn20 chaperonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; MOLECULAR CHAPERONES; PROTEIN; GROES; BINDING; OVEREXPRESSION; IDENTIFICATION; AGGREGATION; SEQUENCE	Chaperonins cpn60 and cpn10 are essential proteins involved in cellular protein folding. Plant chloroplasts contain a unique version of the cpn10 co-chaperonin, cpn20, which consists of two homologous cpn10-like domains (N-cpn20 and C-cpn20) that are connected by a short linker region. Although cpn20 seems to function like other single domain cpn10 oligomers, the structure and specific functions of the domains are not understood. We mutated amino acids in the "mobile loop" regions of N-cpn20, C-cpn20 or both: a highly conserved glycine, which was shown to be important for flexibility of the mobile loop, and a leucine residue shown to be involved in binding of co-chaperonin to chaperonin. The mutant proteins were purified and their oligomeric structure validated by gel filtration, native gel electrophoresis, and circular dichroism. Functional assays of protein refolding and inhibition of GroEL ATPase both showed (i) mutation of the conserved glycine reduced the activity of cpn20, whether in N-cpn20 (G32A) or C-cpn20 (G130A). The same mutation in the bacterial cpn10 (GroES G24A) had no effect on activity. (ii) Mutations in the highly conserved leucine of N-cpn20 (L35A) and in the corresponding L27A of GroES resulted in inactive protein. (iii) In contrast, mutant L133A, in which the conserved leucine of C-cpn20 was altered, retained 55% activity. We conclude that the structure of cpn20 is much more sensitive to alterations in the mobile loop than is the structure of GroES. Moreover, only N-cpn20 is necessary for activity of cpn20. However, full and efficient functioning requires both domains.	Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Tel Aviv University; University System of Maryland; University of Maryland College Park	Weiss, C (corresponding author), Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	celeste@post.tau.ac.il; azema@tauex.tau.ac.il						AZEM A, 1994, BIOCHEMISTRY-US, V33, P6671, DOI 10.1021/bi00187a037; BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; Bertsch U, 1995, PLANT MOL BIOL, V29, P1039, DOI 10.1007/BF00014976; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Eisenstein E, 1998, METHOD ENZYMOL, V290, P119, DOI 10.1016/S0076-6879(98)90011-8; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; GEORGOPOULOS CP, 1973, J MOL BIOL, V76, P45, DOI 10.1016/0022-2836(73)90080-6; Goloubinoff P, 1997, FEBS LETT, V407, P215, DOI 10.1016/S0014-5793(97)00348-7; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Levy-Rimler G, 2002, FEBS LETT, V529, P1, DOI 10.1016/S0014-5793(02)03178-2; MILOS P, 1984, J CELL BIOCHEM, V24, P153, DOI 10.1002/jcb.240240206; Richardson A, 1999, GENETICS, V152, P1449; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; TILLY K, 1981, P NATL ACAD SCI-BIOL, V78, P1629, DOI 10.1073/pnas.78.3.1629; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158	28	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4463	4469		10.1074/jbc.M606433200	http://dx.doi.org/10.1074/jbc.M606433200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178727	hybrid			2022-12-27	WOS:000244482000027
J	Herget, M; Oancea, G; Schrodt, S; Karas, M; Tampe, R; Abele, R				Herget, Meike; Oancea, Giani; Schrodt, Susanne; Karas, Michael; Tampe, Robert; Abele, Rupert			Mechanism of substrate sensing and signal transmission within an ABC transporter - Use of a trojan horse strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PROCESSING TAP; MYOSIN MOTOR DOMAIN; PEPTIDE-BINDING; TRANSMEMBRANE DOMAINS; ARTIFICIAL PROTEASE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; P-GLYCOPROTEIN; ATP HYDROLYSIS; COMPLEX	By translocating proteasomal degradation products into the endoplasmic reticulum for loading of major histocompatibility complex I molecules, the ABC transporter TAP plays a focal role in the adaptive immunity against infected or malignantly transformed cells. A key question regarding the transport mechanism is how the quality of the incoming peptide is detected and how this information is transmitted to the ATPase domains. To identify residues involved in this process, we evolved a Trojan horse strategy in which a small artificial protease is inserted into antigenic epitopes. After binding, the TAP backbone in contact is cleaved, allowing the peptide sensor site to be mapped by mass spectrometry. Within this sensor site, we identified residues that are essential for tight coupling of peptide binding and transport. This sensor and transmission interface is restructured during the ATP hydrolysis cycle, emphasizing its important function in the cross-talk between the transmembrane and the nucleotide-binding domains. This allocrite sensor may be similarly positioned in other members of the ABC exporter family.	Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; Univ Frankfurt, Inst Pharmaceut Chem, Bioctr, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Tampe, R (corresponding author), Univ Frankfurt, Inst Biochem, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Chang G, 2003, J MOL BIOL, V330, P419, DOI 10.1016/S0022-2836(03)00587-4; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Datwyler SA, 2000, TRENDS BIOCHEM SCI, V25, P408, DOI 10.1016/S0968-0004(00)01652-2; Datwyler SA, 2001, MET IONS BIOL SYST, V38, P213; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; GHAIM JB, 1995, BIOCHEMISTRY-US, V34, P11311, DOI 10.1021/bi00036a002; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; HAYWARD MM, 1995, J ORG CHEM, V60, P3924, DOI 10.1021/jo00117a056; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; LUNARDI J, 1988, P NATL ACAD SCI USA, V85, P8958, DOI 10.1073/pnas.85.23.8958; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Neumann L, 2002, J MOL BIOL, V324, P965, DOI 10.1016/S0022-2836(02)01148-8; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; RANA TM, 1991, P NATL ACAD SCI USA, V88, P10578, DOI 10.1073/pnas.88.23.10578; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; Schmidt BD, 2002, BIOCHEMISTRY-US, V41, P4186, DOI 10.1021/bi015582r; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; Uebel S, 1999, CURR OPIN IMMUNOL, V11, P203, DOI 10.1016/S0952-7915(99)80034-X; UEBEL S, 1995, J BIOL CHEM, V270, P18512, DOI 10.1074/jbc.270.31.18512; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498	41	37	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3871	3880		10.1074/jbc.M608480200	http://dx.doi.org/10.1074/jbc.M608480200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17164240	hybrid			2022-12-27	WOS:000244481900051
J	Sarkar, SN; Elco, CP; Peters, KL; Chattopadhyay, S; Sen, GC				Sarkar, Saumendra N.; Elco, Christopher P.; Peters, Kristi L.; Chattopadhyay, Saurabh; Sen, Ganes C.			Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NECROSIS-FACTOR-ALPHA; P65 SUBUNIT; PHOSPHORYLATION; KINASE-1; DOMAIN; GENES; BETA; TRANSCRIPTION; MECHANISM	Innate immune response to viral infection is often triggered by Toll-like receptor 3 (TLR3)-mediated signaling by double-stranded (ds) RNA, which culminates in the activation of the transcription factor NF-kappa B and induction of NF-kappa B-driven genes. We demonstrated that dsRNA-induced phosphorylation of two specific tyrosine residues, 759 and 858, of TLR3 was necessary and sufficient for complete activation of the NF-kappa B pathway. When Tyr-759 of TLR3 was mutated, gene induction was inhibited, although NF-kappa B was partially activated. It was released from I kappa B and translocated to the nucleus but failed to bind to the kappa B site of the target A20 gene promoter. This defect could be attributed to incomplete phosphorylation of the RelA (p65) subunit of NF-kappa B, as revealed by two-dimensional gel analyses of p65, isolated from dsRNA-treated cells expressing either wild type TLR3 or the Tyr-759 -> Phe mutant TLR3. Thus, two phosphotyrosine residues of TLR3 activate two distinct pathways, one leading to NF-kappa B release and the other leading to its phosphorylation.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sen, GC (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	seng@ccf.org	Chattopadhyay, Saurabh/I-4091-2019; Sarkar, Saumendra N/B-5038-2011	Chattopadhyay, Saurabh/0000-0002-2930-1523; Sarkar, Saumendra N/0000-0002-2850-6121	NATIONAL CANCER INSTITUTE [P01CA062220, R01CA068782] Funding Source: NIH RePORTER; NCI NIH HHS [CA62220, CA68782] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Stetson DB, 2006, J EXP MED, V203, P1837, DOI 10.1084/jem.20061377; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	22	43	47	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3423	3427		10.1074/jbc.C600226200	http://dx.doi.org/10.1074/jbc.C600226200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17178723	hybrid			2022-12-27	WOS:000244481900003
J	Hey, S; Mayerhofer, H; Halford, NG; Dickinson, JR				Hey, Sandra; Mayerhofer, Hubert; Halford, Nigel G.; Dickinson, J. Richard			DNA sequences from arabidopsis, which encode protein kinases and function as upstream regulators of Snf1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON METABOLISM; PHOSPHORYLATION; ACTIVATION; REDUCTASE; PLANTS; SNRK1; CELLS; BETA	Sucrose nonfermenting-1 ( Snf1)-related protein kinase-1 ( SnRK1) of plants is a global regulator of carbon metabolism through the modulation of enzyme activity and gene expression. It is structurally and functionally related to the yeast protein kinase, Snf1, and to mammalian AMP-activated protein kinase. Two DNA sequences from Arabidopsis thaliana, previously known only by their data base accession numbers of NM_125448.3 ( protein ID NP_200863) and NM_114393.3 ( protein ID NP_ 566876) each functionally complemented a Saccharomyces cerevisiae elm1 sak1 tos3 triple mutant. This indicates that the Arabidopsis proteins are able to substitute for one of the missing yeast upstream kinases, which are required for activity of Snf1. Both plant proteins were shown to phosphorylate a peptide with the amino acid sequence of the phosphorylation site in the T-loop of SnRK1 and by inference SnRK1 in Arabidopsis. The proteins encoded by NM_125448.3 and NM_114393.3 have been named AtSnAK1 and AtSnAK2 ( Arabidopsis thaliana SnRK1-activating kinase), respectively. We believe this is the first time that upstream activators of SnRK1 have been described in any plant species.	Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales; Rothamsted Res, Dept Crop Performance & Improvement, Harpenden AL5 2JQ, Herts, England	Cardiff University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Dickinson, JR (corresponding author), Cardiff Univ, Cardiff Sch Biosci, POB 915, Cardiff CF10 3TL, Wales.	Dickinson@cardiff.ac.uk	Halford, Nigel/B-3872-2009	Halford, Nigel/0000-0001-6488-2530; Mayerhofer, Hubert/0000-0002-3291-2376	Biotechnology and Biological Sciences Research Council [BBS/E/C/00004150] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALDERSON A, 1991, P NATL ACAD SCI USA, V88, P8602, DOI 10.1073/pnas.88.19.8602; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Halford NG, 2006, ADV BOT RES, V43, P93, DOI 10.1016/S0065-2296(05)43002-5; Halford NG, 2003, PLANT BIOTECHNOL J, V1, P381, DOI 10.1046/j.1467-7652.2003.00046.x; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kulma A, 2004, PLANT J, V37, P654, DOI 10.1111/j.1365-313X.2003.01992.x; MACKINTOSH RW, 1992, EUR J BIOCHEM, V209, P923, DOI 10.1111/j.1432-1033.1992.tb17364.x; McKibbin RS, 2006, PLANT BIOTECHNOL J, V4, P409, DOI 10.1111/j.1467-7652.2006.00190.x; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Rubenstein EM, 2006, EUKARYOT CELL, V5, P620, DOI 10.1128/EC.5.4.620-627.2006; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	22	37	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2007	282	14					10472	10479		10.1074/jbc.M611244200	http://dx.doi.org/10.1074/jbc.M611244200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	160LB	17237223	hybrid, Green Published			2022-12-27	WOS:000245941000039
J	Mancuso, DJ; Han, XL; Jenkins, CM; Lehman, JJ; Sambandam, N; Sims, HF; Yang, JY; Yan, W; Yang, K; Green, K; Abendschein, DR; Saffitz, JE; Gross, RW				Mancuso, David J.; Han, Xianlin; Jenkins, Christopher M.; Lehman, John J.; Sambandam, Nandakumar; Sims, Harold F.; Yang, Jingyue; Yan, Wei; Yang, Kui; Green, Karen; Abendschein, Dana R.; Saffitz, Jeffrey E.; Gross, Richard W.			Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A(2)gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; DIACYLGLYCEROL ACYLTRANSFERASE; DOCOSAHEXAENOIC ACID; TRIACYLGLYCEROL SYNTHESIS; CELLULAR LIPIDOMES; INSULIN-RESISTANCE; SHOTGUN LIPIDOMICS; BIOLOGICAL SAMPLES; MASS-SPECTROMETRY; IDENTIFICATION	Previously, we identified calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) with multiple translation initiation sites and dual mitochondrial and peroxisomal localization motifs. To determine the role of iPLA(2)gamma in integrating lipid and energy metabolism, we generated transgenic mice containing the a-myosin heavy chain promoter (alpha MHC) placed proximally to the human iPLA(2)gamma coding sequence that resulted in cardiac myocyte-restricted expression of iPLA(2)gamma (TGiPLA(2)gamma). TGiPLA(2)gamma mice possessed multiple phenotypes including: 1) a dramatic -35% reduction in myocardial phospholipid mass in both the fed and mildly fasted states; 2) a marked accumulation of triglycerides during brief caloric restriction that represented 50% of total myocardial lipid mass; and 3) acute fasting-induced hemodynamic dysfunction. Biochemical characterization of the TGiPLA(2)gamma protein expressed in cardiac myocytes demonstrated over 25 distinct isoforms by two-dimensional SDS-PAGE Western analysis. Immunohistochemistry identified iPLA(2)gamma in the peroxisomal and mitochondrial compartments in both wild type and transgenic myocardium. Electron microscopy revealed the presence of loosely packed and disorganized mitochondrial cristae in TGiPLA(2)gamma mice that were accompanied by defects in mitochondrial function. Moreover, markedly elevated levels of 1-hydroxyl-2-arachidonoyl-sn-glycero-3-phosphocholine and 1-hydroxyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine were prominent in the TGiPLA(2)gamma myocardium identifying the production of signaling metabolites by this enzyme in vivo. Collectively, these results identified the participation of iPLA(2)gamma in the remarkable lipid plasticity of myocardium, its role in generating signaling metabolites, and its prominent effects in modulating energy storage and utilization in myocardium in different metabolic contexts.	Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			NHLBI NIH HHS [5P01HL57278-10] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-07, P30 DK056341-06, P30 DK056341] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abumrad N, 1998, J LIPID RES, V39, P2309; Ashmarina LI, 1996, BIOCHEM J, V315, P71, DOI 10.1042/bj3150071; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Elphick MR, 2001, PHILOS T R SOC B, V356, P381, DOI 10.1098/rstb.2000.0787; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Farooqui AA, 2003, ADV EXP MED BIOL, V544, P335; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Glomset J.A., 2006, SCI STKE, V2006, ppe6, DOI DOI 10.1126/STKE.3212006PE6; GROSS RW, 1984, BIOCHIM BIOPHYS ACTA, V802, P197, DOI 10.1016/0304-4165(84)90161-2; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hesselink MKC, 2003, OBES RES, V11, P1429, DOI 10.1038/oby.2003.192; Hirafuji M, 2003, J PHARMACOL SCI, V92, P308; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kwong KF, 1998, CIRC RES, V82, P604, DOI 10.1161/01.RES.82.5.604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewin TM, 2003, BBA-MOL CELL BIOL L, V1634, P63, DOI 10.1016/j.bbalip.2003.09.006; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Strokin M, 2004, INT J DEV NEUROSCI, V22, P551, DOI 10.1016/j.ijdevneu.2004.07.002; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	47	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9216	9227		10.1074/jbc.M607307200	http://dx.doi.org/10.1074/jbc.M607307200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17213206	hybrid			2022-12-27	WOS:000245780300068
J	Berro, R; de la Fuente, C; Klase, Z; Kehn, K; Parvin, L; Pumfery, A; Agbottah, E; Vertes, A; Nekhai, S; Kashanchi, F				Berro, Reem; de la Fuente, Cynthia; Klase, Zachary; Kehn, Kylene; Parvin, Lida; Pumfery, Anne; Agbottah, Emmanuel; Vertes, Akos; Nekhai, Sergei; Kashanchi, Fatah			Identifying the membrane proteome of HIV-1 latently infected cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BRUTONS TYROSINE KINASE; FACTOR-KAPPA-B; LIPID RAFTS; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN INHIBITOR; RNA EXPRESSION; LIVING CELLS; P-TEFB	Profiling integral plasma membrane proteins is of particular importance for the identification of new biomarkers for diagnosis and for drug development. We report in this study the identification of surface markers by performing comparative proteomics of established human immunodeficiency virus-1 (HIV-1) latent cell models and parental cell lines. To this end we isolated integral membrane proteins using a biotin-directed affinity purification method. Isolated proteins were separated by two-dimensional get electrophoresis and identified by matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) after in gel digestion. Seventeen different proteins were found to vary on the surface of T-cells due to HIV-1 infection. Of these proteins, 47% were integral membrane proteins, and 18% were membrane-associated. Through the use of complementary techniques such as Western blotting and fluorescent staining, we confirmed the differential expression of some of the proteins identified by MALDI-TOF including Bruton's tyrosine kinase and X-linked inhibitor of apoptosis. Finally, using phosphatidylinositol 3-kinase inhibitors and flavopiridol to inhibit Bruton's tyrosine kinase localization at the membrane and X-linked inhibitor of apoptosis protein expression, respectively, we showed that HIV-1 latently infected cells are more sensitive to these drugs than uninfected cells. This suggests that HIV-1 latently infected cells may be targeted with drugs that alter several pathways that are essential for the establishment and maintenance of latency.	George Washington Univ, Sch Med, Genet Program, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Immunol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Chem, Washington, DC 20037 USA; Howard Univ, Dept Biochem, Ctr Sickle Cell Dis, Washington, DC 20059 USA; Inst Genom Res, Rockville, MD 20850 USA	George Washington University; George Washington University; George Washington University; George Washington University; Howard University; J. Craig Venter Institute	Kashanchi, F (corresponding author), George Washington Univ, Sch Med, Genet Program, 2300 1St,NW,Ross Hall,Rm 551, Washington, DC 20037 USA.	bcmfxk@gwumc.edu	, nekhai/AAW-3105-2021; , nekhai/AFO-2652-2022; Kehn-Hall, Kylene/I-5752-2013; Vertes, Akos/B-7159-2008	Vertes, Akos/0000-0001-5186-5352; Kehn-Hall, Kylene/0000-0001-8036-7213	NIAID NIH HHS [R21 AI056973-02, AI043894, AI065236, R21 AI056973] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065236, R01AI043894, R21AI056973] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Anderson RW, 1998, J ACQ IMMUN DEF SYND, V17, P245, DOI 10.1097/00042560-199803010-00010; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; Blagosklonny MV, 2002, CANCER BIOL THER, V1, P420, DOI 10.4161/cbt.1.4.21; Bobe R, 2001, BLOOD, V97, P678, DOI 10.1182/blood.V97.3.678; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Carlson B. A., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P424; Carlson KA, 2004, J NEUROIMMUNOL, V147, P35, DOI 10.1016/j.jneuroim.2003.10.039; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Clark E, 2000, J VIROL, V74, P5040, DOI 10.1128/JVI.74.11.5040-5052.2000; Dai Y, 2003, ONCOGENE, V22, P7108, DOI 10.1038/sj.onc.1206863; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fernandez-Figueras MT, 2000, MODERN PATHOL, V13, P438, DOI 10.1038/modpathol.3880075; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Fuchigami T, 2002, BIOCHEM BIOPH RES CO, V293, P1107, DOI 10.1016/S0006-291X(02)00329-7; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Islam TC, 2000, IMMUNOL REV, V178, P49, DOI 10.1034/j.1600-065X.2000.17811.x; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; KEKOW J, 1990, P NATL ACAD SCI USA, V87, P8321, DOI 10.1073/pnas.87.21.8321; Lam LT, 2001, GENOME BIOL, V2; Li XD, 1996, VIROLOGY, V225, P196, DOI 10.1006/viro.1996.0588; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Peirce MJ, 2004, MOL CELL PROTEOMICS, V3, P56, DOI 10.1074/mcp.M300064-MCP200; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Rosato R, 2004, LEUKEMIA, V18, P1780, DOI 10.1038/sj.leu.2403491; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Ross TM, 2001, LEUKEMIA, V15, P332, DOI 10.1038/sj.leu.2402028; Schlaifer D, 1996, AM J PATHOL, V149, P177; Shapiro GI, 2004, CLIN CANCER RES, V10, p4270S, DOI 10.1158/1078-0432.CCR-040020; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Wittmann S, 2003, CANCER RES, V63, P93; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Yang YD, 2003, J VIROL, V77, P6700, DOI 10.1128/JVI.77.12.6700-6708.2003; Zhang W, 2003, ELECTROPHORESIS, V24, P2855, DOI 10.1002/elps.200305569; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004	51	52	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8207	8218		10.1074/jbc.M606324200	http://dx.doi.org/10.1074/jbc.M606324200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237230	hybrid			2022-12-27	WOS:000245081000053
J	Gao, YT; Panda, SP; Roman, LJ; Martasek, P; Ishimura, Y; Masters, BSS				Gao, Ying Tong; Panda, Satya Prakash; Roman, Linda J.; Martasek, Pavel; Ishimura, Yuzuru; Masters, Bettie Sue S.			Oxygen metabolism by neuronal nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENASE/FMN DOMAIN CONSTRUCTS; THYROID PLASMA-MEMBRANE; HYDROXY-L-ARGININE; ELECTRON-TRANSFER; SUPEROXIDE ANION; NITROXYL HNO; ISOCITRATE DEHYDROGENASE; HORSERADISH-PEROXIDASE; BIOLOGICAL-ACTIVITY; REDUCTASE DOMAIN	Nitric-oxide synthases (NOS) catalyze nitric oxide (NO) formation from the amino acid L-arginine. NOS is known to catalyze more than one reaction: the NO-producing reaction is considered to be the coupled reaction, and the uncoupled reactions are those that produce reactive (reduced) oxygen species (ROS), such as superoxide anion II and/or hydrogen peroxide (H2O2). As an oxygenase, NOS has been known for more than two decades, yet there is no complete description of oxygen stoichiometry. The present paper is focused on oxygen stoichiometry and the effects of cofactor binding on the neuronal isoform (nNOS) on oxygen uptake and product formation. Products of the uncoupled reactions are analyzed using diacetyldeuteroheme-substituted horseradish peroxidase as a trapping agent for both O-2(-) and H2O2. The addition of calmodulin not only stimulated the oxygen uptake rate but also changed the product of the uncoupled reaction, supporting the possibility of two different sites for electron leakage to molecular oxygen. Quantitative analysis of the uncoupled (substrate-free) reaction revealed a stoichiometry close to the theoretical value, and adding L-arginine not only initiates the coupled reaction, but also inhibits oxygen uptake. The presence of tetrahydrobiopterin affects oxygen metabolism by lowering the apparent K. value of nNOS for oxygen in the uncoupled reaction.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA; Charles Univ Prague, Sch Med, Dept Biol, Prague 2, Czech Republic; Charles Univ Prague, Sch Med, Dept Pediat, Prague 2, Czech Republic; Keio Univ, Sch Med, Dept Biochem & Integrated Biol, Tokyo 1088345, Japan	University of Texas System; University of Texas Health San Antonio; Charles University Prague; Charles University Prague; Keio University	Masters, BSS (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	masters@uthscsa.edu	Martásek, Pavel/G-6622-2017	Martásek, Pavel/0000-0001-6165-4444	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL030050, R01HL030050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30050] Funding Source: Medline; NIGMS NIH HHS [GM52419] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; Adak S, 2000, J BIOL CHEM, V275, P33554, DOI 10.1074/jbc.M004337200; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Cunningham MA, 1998, BIOPHYS J, V74, pA133; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; DESANDRO V, 1991, EUR J BIOCHEM, V201, P507; DUPUY C, 1991, J BIOL CHEM, V266, P3739; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Fridovich I, 1998, J EXP BIOL, V201, P1203; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Fukuto JM, 2005, ANNU REV PHARMACOL, V45, P335, DOI 10.1146/annurev.pharmtox.45.120403.095959; Fukuto JM, 2005, CHEM RES TOXICOL, V18, P790, DOI 10.1021/tx0496800; Fukuto JM, 2005, CHEMBIOCHEM, V6, P612, DOI 10.1002/cbic.200400271; Fukuto JM, 1997, ACCOUNTS CHEM RES, V30, P149, DOI 10.1021/ar960010y; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; Gorren ACF, 2005, METHOD ENZYMOL, V396, P456, DOI 10.1016/S0076-6879(05)96038-2; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; HAYAISHI O, 1970, OXGENASES; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Hurshman AR, 2003, BIOCHEMISTRY-US, V42, P13287, DOI 10.1021/bi035491p; Hurshman AR, 2002, BIOCHEMISTRY-US, V41, P3439, DOI 10.1021/bi012002h; Ishimura Y, 2005, BIOCHEM BIOPH RES CO, V338, P543, DOI 10.1016/j.bbrc.2005.07.202; KLUG D, 1972, J BIOL CHEM, V247, P4839; KORTH HG, 1994, J BIOL CHEM, V269, P17776; KWON NS, 1989, J BIOL CHEM, V264, P20496; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; MAKINO R, 1986, J BIOL CHEM, V261, P1444; MAKINO R, 1972, J BIOCHEM-TOKYO, V72, P655, DOI 10.1093/oxfordjournals.jbchem.a129943; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Masters B.S., 2000, NITRIC OXIDE BIOL PA, P91; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; MAYER B, 1991, FASEB J, V5, pA864; Migita CT, 1997, BIOCHEMISTRY-US, V36, P10987, DOI 10.1021/bi970823+; Miller RT, 1997, FASEB J, V11, pA787; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; NAKAMURA Y, 1989, J BIOL CHEM, V264, P4759; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; Porasuphatana S, 2003, COMP BIOCHEM PHYS C, V134, P281, DOI 10.1016/S1532-0456(02)00271-5; Pou S, 1999, J BIOL CHEM, V274, P9573, DOI 10.1074/jbc.274.14.9573; Poulos TL, 1999, CURR OPIN CHEM BIOL, V3, P131, DOI 10.1016/S1367-5931(99)80024-6; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; RAMAN CS, 2000, PORPHYRIN HDB, V4, P293; Reif A, 2001, FREE RADICAL BIO MED, V30, P803, DOI 10.1016/S0891-5849(01)00477-4; Reif A, 2004, FREE RADICAL BIO MED, V37, P988, DOI 10.1016/j.freeradbiomed.2004.07.005; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Rosen GM, 2002, J BIOL CHEM, V277, P40275, DOI 10.1074/jbc.M200853200; Rosen GM, 2002, CHEM REV, V102, P1191, DOI 10.1021/cr010187s; SALERNO JC, 1995, J BIOL CHEM, V270, P27423, DOI 10.1074/jbc.270.46.27423; Salerno JC, 1996, BIOCHEMISTRY-US, V35, P11839, DOI 10.1021/bi953015w; Salerno JC, 2006, NITRIC OXIDE-BIOL CH, V14, pA15, DOI 10.1016/j.niox.2006.04.052; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Smith SME, 2006, NITRIC OXIDE-BIOL CH, V14, pA70, DOI 10.1016/j.niox.2006.04.231; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; Song HJ, 2005, J PHARMACOL EXP THER, V312, P391, DOI 10.1124/jpet.104.074401; Sono M, 1999, BIOCHEMISTRY-US, V38, P15853, DOI 10.1021/bi991580j; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Tsai P, 2005, BIOCHEM PHARMACOL, V69, P971, DOI 10.1016/j.bcp.2004.12.009; Tsikas D, 2005, FREE RADICAL RES, V39, P797, DOI 10.1080/10715760500053651; Vasquez-Vivar J, 1999, J BIOL CHEM, V274, P26736, DOI 10.1074/jbc.274.38.26736; Weaver J, 2005, BBA-GEN SUBJECTS, V1726, P302, DOI 10.1016/j.bbagen.2005.08.012; Wei CC, 2002, J INORG BIOCHEM, V91, P618, DOI 10.1016/S0162-0134(02)00432-4; WINK DA, 1996, METHODS NITRIC OXIDE, P403; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200	81	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7921	7929		10.1074/jbc.M609814200	http://dx.doi.org/10.1074/jbc.M609814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229730	hybrid			2022-12-27	WOS:000245081000022
J	Immel, F; Jiang, Y; Wang, YQ; Marchal, C; Maillet, L; Perrett, S; Cullin, C				Immel, Francoise; Jiang, Yi; Wang, Yi-Qian; Marchal, Christelle; Maillet, Laurent; Perrett, Sarah; Cullin, Christophe			In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; URE3 PRION; STRUCTURAL-CHARACTERIZATION; GLUTATHIONE-PEROXIDASE; YEAST URE2P; DOMAIN; CONSERVATION; STABILITY; FILAMENTS	The yeast Saccharomyces cerevisiae contains in its proteome at least three prion proteins. These proteins (Ure2p, Sup35p, and Rnq1p) share a set of remarkable properties. In vivo, they form aggregates that self-perpetuate their aggregation. This aggregation is controlled by Hsp104, which plays a major role in the growth and severing of these prions. In vitro, these prion proteins form amyloid fibrils spontaneously. The introduction of such fibrils made from Ure2p or Sup35p into yeast cells leads to the prion phenotypes [URE3] and [PSI], respectively. Previous studies on evolutionary biology of yeast prions have clearly established that [URE3] is not well conserved in the hemiasco-mycetous yeasts and particularly in S. paradoxus. Here we demonstrated that the S. paradoxus Ure2p is able to form infectious amyloid. These fibrils are more resistant than S. cerevisiae Ure2p fibrils to shear force. The observation, in vivo, of a distinct aggregation pattern for GFP fusions confirms the higher propensity of SpUre2p to form fibrillar structures. Our in vitro and in vivo analysis of aggregation propensity of the S. paradoxus Ure2p provides an explanation for its loss of infective properties and suggests that this protein belongs to the non-prion amyloid world.	Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Univ Bordeaux 2, CNRS, IBGC, UMR 5095, F-33077 Bordeaux, France; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@iname.com; Christophe.Cullin@ibgc.u-bordeaux2.fr	Immel, Françoise/N-7079-2019; MAILLET, Laurent/K-7959-2015; Perrett, Sarah/AAS-9483-2020; Immel, Françoise/GNP-4167-2022; cullin, christophe/AAM-2179-2020	MAILLET, Laurent/0000-0002-8169-060X; Perrett, Sarah/0000-0003-0137-0997; Immel, Françoise/0000-0002-2028-902X; cullin, christophe/0000-0003-4110-4677				Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Baxa U, 2005, J STRUCT BIOL, V150, P170, DOI 10.1016/j.jsb.2005.02.007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fernandez-Bellot E, 2000, EMBO J, V19, P3215, DOI 10.1093/emboj/19.13.3215; Fernandez-Bellot E, 1999, BIOCHEM J, V338, P403, DOI 10.1042/0264-6021:3380403; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Giartosio A, 1996, J BIOL CHEM, V271, P17845, DOI 10.1074/jbc.271.30.17845; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Komar AA, 1997, FEBS LETT, V415, P6, DOI 10.1016/S0014-5793(97)01082-X; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Resende C, 2002, MICROBIOL-SGM, V148, P1049, DOI 10.1099/00221287-148-4-1049; Ripaud L, 2004, J BIOL CHEM, V279, P50962, DOI 10.1074/jbc.M408792200; Ripaud L, 2003, EMBO J, V22, P5251, DOI 10.1093/emboj/cdg488; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Talarek N, 2005, GENETICS, V171, P23, DOI 10.1534/genetics.105.043489; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; VUILLARD L, 1995, BIOCHEM J, V305, P337, DOI 10.1042/bj3050337; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	44	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7912	7920		10.1074/jbc.M608652200	http://dx.doi.org/10.1074/jbc.M608652200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234629	hybrid			2022-12-27	WOS:000245081000021
J	Peterson, FC; Deng, Q; Zettl, M; Prehoda, KE; Lim, WA; Way, M; Volkman, BF				Peterson, Francis C.; Deng, Qing; Zettl, Markus; Prehoda, Kenneth E.; Lim, Wendell A.; Way, Michael; Volkman, Brian F.			Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; X-LINKED THROMBOCYTOPENIA; DOMAIN-PEPTIDE COMPLEX; ACTIN NUCLEATION; ARP2/3 COMPLEX; CHEMICAL-SHIFT; WIP COMPLEX; CHEMOTAXIS; ACTIVATION; MUTATIONS	The WASP-interacting protein (WIP) targets WASP/WAVE proteins through a constitutive interaction with an amino-terminal enabled/VASP homology (EVH1) domain. Parallel investigations had previously identified two distinct N-WASP binding motifs corresponding to WIP residues 451-461 and 461-485, and we determined the structure of a complex between WIP-(461485) and the N-WASP EVH1 domain (Volkman, B. F., Prehoda, K. E., Scott, J. A., Peterson, F. C., and Lim, W. A. (2002) Cell 111, 565-576). The present results show that, when combined, the WIP-(451-485) sequence wraps further around the EVH1 domain, extending the interface observed previously. Specific contacts with three WIP epitopes corresponded to regions of high sequence conservation in the verprolin family. A central polyproline motif occupied the canonical binding site but in a reversed orientation relative to other EVH1 complexes. This interaction was augmented in the amino- and carboxyl-terminal directions by additional hydrophobic contacts involving WIP residues 454-459 and 475-478, respectively. Disruption of any of the three WIP epitopes reduced N-WASP binding in cells, demonstrating a functional requirement for the entire binding domain, which is significantly longer than the polyproline motifs recognized by other EVH1 domains.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; MRC, Cambridge CB2 2QH, England; Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; London Res Inst, Canc Res UK, Cell Motil Lab, London WC2A 3PX, England	Medical College of Wisconsin; University of Oregon; University of California System; University of California San Francisco; Cancer Research UK	Volkman, BF (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bvolkman@mcw.edu	Deng, Qing/G-3923-2011; Deng, Qing/AAC-1123-2020; Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Deng, Qing/0000-0002-9254-9951; Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Way, Michael/0000-0001-7207-2722	NIGMS NIH HHS [GM55940, GM62583] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM055940, R01GM062583] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspenstrom P, 2005, FEBS LETT, V579, P5253, DOI 10.1016/j.febslet.2005.08.053; Aspenstrom P, 2004, EXP CELL RES, V298, P485, DOI 10.1016/j.yexcr.2004.04.050; Ball LJ, 2002, FEBS LETT, V513, P45, DOI 10.1016/S0014-5793(01)03291-4; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Gallego MD, 2006, INT IMMUNOL, V18, P221, DOI 10.1093/intimm/dxh310; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Luthi JN, 2003, EXP HEMATOL, V31, P150, DOI 10.1016/S0301-472X(02)01023-8; Lutskiy MI, 2005, J IMMUNOL, V175, P1329, DOI 10.4049/jimmunol.175.2.1329; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Notarangelo LD, 2005, CURR OPIN ALLERGY CL, V5, P485, DOI 10.1097/01.all.0000191243.25757.ce; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rong SB, 2000, J MOL MED, V78, P530, DOI 10.1007/s001090000136; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Sawa M, 2006, BIOCHEM BIOPH RES CO, V340, P709, DOI 10.1016/j.bbrc.2005.12.056; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Tsuboi S, 2006, J IMMUNOL, V176, P6576, DOI 10.4049/jimmunol.176.11.6576; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	37	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8446	8453		10.1074/jbc.M609902200	http://dx.doi.org/10.1074/jbc.M609902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229736	hybrid			2022-12-27	WOS:000245081000077
J	Goulah, CC; Read, LK				Goulah, Christopher C.; Read, Laurie K.			Differential effects of arginine methylation on RBP16 mRNA binding, guide RNA (gRNA) binding, and gRNA-containing ribonucleoprotein complex (gRNP) formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI MITOCHONDRIA; COLD-SHOCK DOMAIN; Y-BOX PROTEINS; XENOPUS-OOCYTES; VACCINIA VIRUS; SM PROTEINS; IN-VITRO; TRANSCRIPTION; TRANSLATION; FAMILY	Mitochondrial gene expression in Trypanosoma brucei involves the coordination of multiple events including polycistronic transcript cleavage, polyadenylation, RNA stability, and RNA editing. Arg methylation of RNA binding proteins has the potential to influence many of these processes via regulation of protein-protein and protein-RNA interactions. Here we demonstrate that Arg methylation differentially regulates the RNA binding capacity and macromolecular interactions of the mitochondrial gene regulatory protein, RBP16. We show that, in T brucei mitochondria, RBP16 forms two major stable complexes: a 5 S multiprotein complex and an 11 S complex consisting of the 5 S complex associated with guide RNA (gRNA). Expression of a non-methylatable RBP16 mutant protein demonstrates that Arg methylation of RBP16 is required to maintain the protein-protein interactions necessary for assembly and/or stability of both complexes. Down-regulation of the major trypanosome type I protein arginine methyltransferase, TbPRMT1, disrupts formation of both the 5 and 11 S complexes, indicating that TbPRMT1-catalyzed methylation of RBP16 Arg-78 and Arg-85 is critical for complex formation. We also show that Arg methylation decreases the capacity of RBP16 to associate with gRNA. This is not a general effect on RBP16 RNA binding, however, since methylation conversely increases the association of the protein with mRNA. Thus, TbPRMT1-catalyzed Arg methylation has distinct effects on RBP16 gRNA and mRNA association and gRNA-containing ribonucleoprotein complex (gRNP) formation.	SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Sch Med, Dept Microbiol & Immunol, 138 Farber Hall, Buffalo, NY 14214 USA.	lread@acsu.buffalo.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060260] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; BHAT GJ, 1992, MOL BIOCHEM PARASIT, V52, P231, DOI 10.1016/0166-6851(92)90055-O; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; BOUVET P, 1995, J BIOL CHEM, V270, P28297; BRUN R, 1979, ACTA TROP, V36, P289; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; ENSINGER MJ, 1975, P NATL ACAD SCI USA, V72, P2525, DOI 10.1073/pnas.72.7.2525; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; HIGMAN MA, 1992, J BIOL CHEM, V267, P16430; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lukong KE, 2004, NAT STRUCT MOL BIOL, V11, P914, DOI 10.1038/nsmb1004-914; MASLOV DA, 1994, MOL CELL BIOL, V14, P8174, DOI 10.1128/MCB.14.12.8174; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Militello KT, 2000, INT J PARASITOL, V30, P643, DOI 10.1016/S0020-7519(00)00041-2; Militello KT, 1999, NUCLEIC ACIDS RES, V27, P1377, DOI 10.1093/nar/27.5.1377; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; Miller MM, 2003, EXP PARASITOL, V105, P140, DOI 10.1016/j.exppara.2003.12.002; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2000, NUCLEIC ACIDS RES, V28, P1266, DOI 10.1093/nar/28.5.1266; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Pelletier M, 2001, MOL BIOCHEM PARASIT, V118, P49, DOI 10.1016/S0166-6851(01)00367-X; POLLARD VW, 1991, MOL CELL BIOL, V11, P1668, DOI 10.1128/MCB.11.3.1668; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; RILEY GR, 1994, J BIOL CHEM, V269, P6101; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Stuart K, 2002, MOL MICROBIOL, V45, P591, DOI 10.1046/j.1365-2958.2002.03028.x; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Yurkova MS, 1997, J BIOL CHEM, V272, P10870	49	26	26	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7181	7190		10.1074/jbc.M609485200	http://dx.doi.org/10.1074/jbc.M609485200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17229732	hybrid			2022-12-27	WOS:000245080900030
J	Milgrom, E; Diab, H; Middleton, F; Kane, PM				Milgrom, Elena; Diab, Heba; Middleton, Frank; Kane, Patricia M.			Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; H+-ATPASE; GENE-EXPRESSION; PROTEIN OXIDATION; LIFE-SPAN; IRON; TRANSPORT; MUTANTS	Yeast mutants lacking vacuolar proton-translocating ATPas (V-ATPase) subunits (vma mutants) were sensitive to several different oxidants in a recent genomic screen (Thorpe, G. W. Fong, C. S., Alic, N., Higgins, V. J., and Dawes, 1. W. (2004) Proc Natl. Acad. Sci. U. S.A. 10 1, 6564 - 6569). We confirmed that mutants lacking a V, subunit (vma2 Delta), V. subunit, or either of the two V. a subunit isoforms are acutely sensitive to H2O2 and more sensitive to menadione and diamide than wild-type cells The vma2 Delta mutant contains elevated levels of reactive oxygen species and high levels of oxidative protein damage even in the absence of an applied oxidant, suggesting an endogenous source of oxidative stress. vma2 Delta mutants lacking mitochondrial DNA showed neither improved growth nor decreased sensitivity to peroxide, excluding respiration as the major source of the endogenous reactive oxygen species in the mutant. Double mutants lacking both VAM2 and components of the major cytosolic defense systems exhibited synthetic sensitivity to H2O2. Microarray analysis comparing wild-type and vma2 Delta mutant cells grown at pH 5, permissive conditions for the vma2 Delta mutant, indicated high level up-regulation of several iron uptake and metabolism genes that are part of the Aft1/Aft2 regulon. TSA2, which encodes an isoform of the cytosolic thioredoxin peroxidase, was strongly induced, but other oxidative stress defense systems were not induced. The results indicate that V-ATPase activity helps to protect cells from endogenous oxidative stress.	SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Neurosci, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Physiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Middleton, Frank/0000-0002-3107-7188	NIGMS NIH HHS [R01-GM50322, R01 GM050322] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHANG EC, 1991, J BIOL CHEM, V266, P4417; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LIU XF, 1992, J BIOL CHEM, V267, P18298; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Mimmack ML, 2004, BIOL PSYCHIAT, V55, P337, DOI 10.1016/j.biopsych.2003.09.007; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Sambrook J, 2001, MOL CLONING LAB MANU, P45; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; SUPEK F, 1994, J BIOL CHEM, V269, P26479; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	64	81	85	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7125	7136		10.1074/jbc.M608293200	http://dx.doi.org/10.1074/jbc.M608293200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215245	hybrid			2022-12-27	WOS:000245080900024
J	Kang, SG; Brown, AL; Chung, JH				Kang, Sung Gyun; Brown, Alexandra L.; Chung, Jay H.			Oxygen tension regulates the stability of insulin receptor substrate-1 (IRS-1) through caspase-mediated cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES PHOSPHATIDYLINOSITOL 3-KINASE; COOH-TERMINAL TRUNCATION; OBSTRUCTIVE SLEEP-APNEA; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; SERINE/THREONINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; INDUCED DEGRADATION	The insulin and insulin-like growth factor-1 (IGF-1) receptors mediate signaling for energy uptake and growth through insulin receptor substrates (IRSs), which interact with these receptors as well as with downstream effectors. Oxygen is essential not only for ATP production through oxidative phosphorylation but also for many cellular processes, particularly those involved in energy homeostasis. The oxygen tension in vivo is significantly lower than that in the air and can vary widely depending on the tissue as well as on perfusion and oxygen consumption. How oxygen tension affects IRSs and their functions is poorly understood. Our findings indicate that transient hypoxia (1% oxygen) leads to caspase-mediated cleavage of IRS-1 without inducing cell death. The IRS-1 protein level rebounds rapidly upon return to normoxia. Protein tyrosine phosphatases (PTPs) appear to be important for the IRS-1 cleavage because tyrosine phosphorylation of the insulin receptor was decreased in hypoxia and IRS-1 cleavage could be blocked either with H2O2 or with vanadate, each of which inhibits PTPs. Activity of Akt, a downstream effector of insulin and IGF-1 signaling that is known to suppress caspase activation, was suppressed in hypoxia. Overexpression of dominant-negative Akt led to IRS-1 cleavage even in normoxia, and overexpression of constitutively active Akt partially suppressed IRS-1 cleavage in hypoxia, suggesting that hypoxiamediated suppression of Akt may induce caspase-mediated IRS-1 cleavage. In conclusion, our study elucidates a mechanism by which insulin and IGF-1 signaling can be matched to the oxygen level that is available to support growth and energy metabolism.	NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA; Korea Ocean Res & Dev Inst, Marine Biotechnol Ctr, Seoul 425600, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Korea Institute of Ocean Science & Technology (KIOST)	Chung, JH (corresponding author), NHLBI, Lab Biochem Genet, NIH, Bldg 10,Rm 7D14,10 Ctr Dr, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002243, ZIAHL002243] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ANDO S, 1992, J BIOL CHEM, V267, P25709; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Delahaye L, 1998, ENDOCRINOLOGY, V139, P4911, DOI 10.1210/en.139.12.4911; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; Egawa K, 2000, ENDOCRINOLOGY, V141, P1930, DOI 10.1210/en.141.6.1930; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; FEENER EP, 1993, J BIOL CHEM, V268, P11256; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hale LP, 2002, AM J PHYSIOL-HEART C, V282, pH1467, DOI 10.1152/ajpheart.00682.2001; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; Hartman ME, 2001, BIOCHEM BIOPH RES CO, V280, P776, DOI 10.1006/bbrc.2000.4214; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; KELLER SR, 1993, MOL REPROD DEV, V35, P346, DOI 10.1002/mrd.1080350405; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; RICE KM, 1993, BIOCHEM BIOPH RES CO, V190, P961, DOI 10.1006/bbrc.1993.1143; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TIIHONEN M, 1993, J SLEEP RES, V2, P56, DOI 10.1111/j.1365-2869.1993.tb00062.x; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Vasilakos JP, 1997, APOPTOSIS, V2, P289, DOI 10.1023/A:1026489104188; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	58	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6090	6097		10.1074/jbc.M610659200	http://dx.doi.org/10.1074/jbc.M610659200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17179152	hybrid			2022-12-27	WOS:000244867200014
J	Gautron, J; Murayama, E; Vignal, A; Morisson, M; McKee, MD; Rehault, S; Labas, V; Belghazi, M; Vidal, ML; Nys, Y; Hincke, MT				Gautron, Joel; Murayama, Emi; Vignal, Alain; Morisson, Mireille; McKee, Marc D.; Rehault, Sophie; Labas, Valerie; Belghazi, Maya; Vidal, Mary-Laure; Nys, Yves; Hincke, Maxwell T.			Cloning of ovocalyxin-36, a novel chicken eggshell protein related to lipopolysaccharide-binding proteins, bactericidal permeability-increasing proteins, and plunc family proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEINS; ULTRASTRUCTURAL-LOCALIZATION; PROTEOMIC ANALYSIS; GENE-EXPRESSION; HEN; COMPONENT; OVIDUCT; CDNA; BPI; PURIFICATION	The avian eggshell is a composite biomaterial composed of noncalcifying eggshell membranes and the overlying calcified shell matrix. The shell is deposited in a uterine fluid where the concentration of different protein species varies at different stages of its formation. The role of avian eggshell proteins during shell formation remains poorly understood, and we have sought to identify and characterize the individual components in order to gain insight into their function during elaboration of the eggshell. In this study, we have used direct sequencing, immunochemistry, expression screening, and EST data base mining to clone and characterize a 1995-bp full-length cDNA sequence corresponding to a novel chicken eggshell protein that we have named Ovocalyxin-36 (OCX-36). Ovocalyxin-36 protein was only detected in the regions of the oviduct where eggshell formation takes place; uterine OCX-36 message was strongly up-regulated during eggshell calcification. OCX-36 localized to the calcified eggshell predominantly in the inner part of the shell, and to the shell membranes. BlastN data base searching indicates that there is no mammalian version of OCX-36; however, the protein sequence is 20-25% homologous to proteins associated with the innate immune response as follows: lipopolysaccharide-binding proteins, bactericidal permeability-increasing proteins, and Plunc family proteins. Moreover, the genomic organization of these proteins and OCX-36 appears to be highly conserved. These observations suggest that OCX-36 is a novel and specific chicken eggshell protein related to the superfamily of lipopolysaccharide-binding proteins/bactericidal permeability-increasing proteins and Plunc proteins. OCX-36 may therefore participate in natural defense mechanisms that keep the egg free of pathogens.	INRA, UR83, Unite Rech Avicoles, F-37380 Nouzilly, France; Inst Pasteur, Unite Macrophages & Dev Immun, F-75724 Paris, France; INRA, UR 444, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; INRA, UMR85, Serv Spectrometrie Masse & Proteom, F-37380 Nouzilly, France; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; McGill University; McGill University; INRAE; University of Ottawa	Gautron, J (corresponding author), INRA, UR83, Unite Rech Avicoles, F-37380 Nouzilly, France.	gautron@tours.inra.fr	McKee, Marc D/E-2187-2011; REHAULT-GODBERT, Sophie/Y-3890-2019; GAUTRON, Joël/A-1753-2017; Vignal, Alain/AAJ-5697-2021; Vignal, Alain/I-6253-2017	McKee, Marc D/0000-0001-8349-965X; GAUTRON, Joël/0000-0001-7800-0578; Vignal, Alain/0000-0002-6797-2125; Vignal, Alain/0000-0002-6797-2125; Murayama, Emi/0000-0002-5311-1594; Rehault-Godbert, Sophie/0000-0003-2800-3417				Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bingle CD, 2004, TRENDS IMMUNOL, V25, P53, DOI 10.1016/j.it.2003.11.007; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002; Carre W, 2006, PHYSIOL GENOMICS, V25, P514, DOI 10.1152/physiolgenomics.00207.2005; Carrino DA, 1997, CONNECT TISSUE RES, V36, P175, DOI 10.3109/03008209709160219; Fernandez MS, 2003, J STRUCT BIOL, V143, P171, DOI 10.1016/j.jsb.2003.08.007; Fernandez MS, 2001, MATRIX BIOL, V19, P793, DOI 10.1016/S0945-053X(00)00128-1; Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840; Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200; Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220; Gautron J., 2003, P 8 INT S BIOM KAN J, P163; GRAY PW, 1989, J BIOL CHEM, V264, P9505; Guerin-Dubiard C, 2006, J AGR FOOD CHEM, V54, P3901, DOI 10.1021/jf0529969; HARRIS ED, 1980, SCIENCE, V208, P55, DOI 10.1126/science.6102412; Hincke M.T., 2000, CHEM BIOL MINERALIZE, P13; Hincke MT, 2003, CONNECT TISSUE RES, V44, P16, DOI 10.1080/03008200390152025; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915; Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; Hubacek JA, 1997, BIOCHEM BIOPH RES CO, V236, P427, DOI 10.1006/bbrc.1997.6970; *I NAT RECH AGR, 1989, AL AN MOIN PORC LAP; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lavelin I, 2002, AM J PHYSIOL-REG I, V283, pR853, DOI 10.1152/ajpregu.00088.2002; Lavelin I, 2001, AM J PHYSIOL-REG I, V281, pR1169, DOI 10.1152/ajpregu.2001.281.4.R1169; Lavelin I, 1998, MATRIX BIOL, V17, P615, DOI 10.1016/S0945-053X(98)90112-3; Mann K, 2003, MATRIX BIOL, V22, P397, DOI 10.1016/S0945-053X(03)00072-6; Mann K, 1999, BIOCHEM MOL BIOL INT, V47, P997; Mann K, 1999, FEBS LETT, V463, P12, DOI 10.1016/S0014-5793(99)01586-0; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; Messens W, 2005, WORLD POULTRY SCI J, V61, P71, DOI 10.1079/WPS200443; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI [10.1051/gse:2002021, 10.1186/1297-9686-34-4-521]; NAU F, 2002, 11 EUR POULTR C BREM; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Pines M, 1995, MATRIX BIOL, V14, P765, DOI 10.1016/S0945-053X(05)80019-8; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; THIEDE MA, 1991, ENDOCRINOLOGY, V129, P1958, DOI 10.1210/endo-129-4-1958	42	91	98	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5273	5286		10.1074/jbc.M610294200	http://dx.doi.org/10.1074/jbc.M610294200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17179153	hybrid, Green Published			2022-12-27	WOS:000244482300022
J	Raman, P; Krukovets, I; Marinic, TE; Bornstein, P; Stenina, OI				Raman, Priya; Krukovets, Irene; Marinic, Tina E.; Bornstein, Paul; Stenina, Olga I.			Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; MYOCARDIAL-INFARCTION; HEXOSAMINE PATHWAY; INSULIN-RESISTANCE; DIABETES-MELLITUS; MESANGIAL CELLS; EXPRESSION; PROLIFERATION; STIMULATION; POLYMORPHISMS	Accelerated development of atherosclerotic lesions remains the most frequent and dangerous complication of diabetes, accounting for 80% of deaths among diabetics. However, our understanding of the pathways mediating glucose-induced gene expression in vascular cells remains controversial and incomplete. We have identified an intracellular metabolic pathway activated by high glucose in human aortic smooth muscle cells that mediates up-regulation of thrombospondin-1 (TSP-1). TSP-1 is a potent antiangiogenic and proatherogenic protein that may represent an important link between diabetes and vascular complications. Using different glucose analogs and metabolites sharing distinct, limited metabolic steps with glucose, we demonstrated that activation of TSP-1 transcription is mediated by the hexosamine pathway of glucose catabolism, possibly resulting in modulation of the activity of nuclear proteins activity through their glycosylation. Specific inhibitors of glutamine: fructose 6-phosphate amidotransferase (GFAT), an enzyme controlling the hexosamine pathway, as well as direct inhibitors of protein glycosylation efficiently inhibited TSP-1 transcription and the activity of a TSP-1 promoter-reporter construct stimulated by high glucose. Overexpression of recombinant GFAT resulted in increased TSP-1 levels. Pharmacological inhibition of GFAT or protein glycosylation inhibited increased proliferation of human aortic smooth muscle cells caused by glucose. We have demonstrated that the hexosamine metabolic pathway mediates up-regulation of TSP-1 by high glucose. Our results suggest that the hexosamine pathway and intracellular glycosylation may control important steps in initiation and development of atherosclerotic lesions.	Cleveland Clin Fdn, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stenina, OI (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	stenino@ccf.org		, Olga/0000-0002-1256-0545	NHLBI NIH HHS [P50 HL077107] Funding Source: Medline; NIDDK NIH HHS [R01 DK067532, K01 DK62128] Funding Source: Medline; PHS HHS [R01 45418] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062128, R01DK067532] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; Barzilay JI, 2001, DIABETES CARE, V24, P1233, DOI 10.2337/diacare.24.7.1233; BAYRAKTAR M, 1994, J INT MED RES, V22, P90, DOI 10.1177/030006059402200204; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; CODY M, 2005, CIRCULATION, V112, P164; Cui JX, 2004, ARTERIOSCL THROM VAS, V24, pE183, DOI 10.1161/01.ATV.0000147304.67100.ee; Faries PL, 2001, J VASC SURG, V33, P601, DOI 10.1067/mva.2001.111806; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guo NH, 1997, CANCER RES, V57, P1735; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Isenberg JS, 2005, MATRIX BIOL, V24, P110, DOI 10.1016/j.matbio.2005.01.002; James LR, 2000, AM J PHYSIOL-RENAL, V279, pF718, DOI 10.1152/ajprenal.2000.279.4.F718; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Kato T, 2003, CIRCULATION, V108, P712; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Marso S P, 1999, Semin Interv Cardiol, V4, P129; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nathan DM, 2003, NEW ENGL J MED, V348, P761; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Olson BA, 1999, PHARMACOLOGY, V58, P200, DOI 10.1159/000028282; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; POLET H, 1988, J CELL PHYSIOL, V135, P47, DOI 10.1002/jcp.1041350107; RAUGI GJ, 1990, AM J PATHOL, V137, P179; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Sajid M, 2001, J INVEST MED, V49, P398, DOI 10.2310/6650.2001.33784; Sayeski PP, 1996, J BIOL CHEM, V271, P15237, DOI 10.1074/jbc.271.25.15237; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Stouffer GA, 1998, CIRCULATION, V97, P907, DOI 10.1161/01.CIR.97.9.907; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Tschoepe D, 1997, HORM METAB RES, V29, P631, DOI 10.1055/s-2007-979115; Walton B, 2003, CIRCULATION, V108, P771; Wang SX, 2004, J BIOL CHEM, V279, P34311, DOI 10.1074/jbc.M401629200; Wang SX, 2003, DIABETES, V52, P2144, DOI 10.2337/diabetes.52.8.2144; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Weigert C, 2003, DIABETOLOGIA, V46, P852, DOI 10.1007/s00125-003-1122-8; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wessel J, 2004, AM HEART J, V147, P905, DOI 10.1016/j.ahj.2003.12.013; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Zhao XM, 2001, CIRCULATION, V103, P525, DOI 10.1161/01.CIR.103.4.525; Zwicker JI, 2006, BLOOD, V108, P1280, DOI 10.1182/blood-2006-04-015701	58	67	67	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5704	5714		10.1074/jbc.M610965200	http://dx.doi.org/10.1074/jbc.M610965200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17178709	hybrid			2022-12-27	WOS:000244482300067
J	Rocher, G; Letourneux, C; Lenormand, P; Porteu, F				Rocher, Geraldine; Letourneux, Claire; Lenormand, Philippe; Porteu, Francoise			Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; KINASE-B; CELL-TRANSFORMATION; REGULATORY SUBUNIT; EPITHELIAL-CELLS; BETA-CATENIN; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; ERK	The importance of PP2A in the regulation of Akt/PKB activity has long been recognized but the nature of the holoenzyme involved and the mechanisms controlling dephosphorylation are not yet known. We identified IEX-1, an early gene product with proliferative and survival activities, as a specific inhibitor of B56 regulatory subunit-containing PP2A. IEX-1 inhibits B56PP2A activity by allowing the phosphorylation of B56 by ERK. This leads to sustained ERK activation. IEX-1 has no effect on PP2A containing other B family subunits. Thus, studying IEX-1 contribution to signaling should help the discovery of new pathways controlled by B56-PP2A. By using overexpression and RNA interference, we show here that IEX-1 increases Akt/PKB activity in response to various growth factors by preventing Akt dephosphorylation on both Thr(308) and Ser(473) residues. PP2A-B56 beta and gamma subunits have the opposite effect and reverse IEX-1-mediated Akt activation. The effect of IEX-1 on Akt is ERK-dependent. Indeed: (i) a IEX-1 mutant deficient in ERK binding had no effect on Akt; (ii) ERK dominant-negative mutants reduced IEX-1-mediated increase in pAkt; (iii) a B56 beta mutant that cannot be phosphorylated in the ERK-IEX-1 complex showed an enhanced ability to compete with IEX-1. These results identify B56-containing PP2A holoenzymes as Akt phosphatases. They suggest that IEX-1 behaves as a general inhibitor of B56 activity, enabling the control of both ERK and Akt signaling downstream of ERK.	Inst Cochin Genet Mol, Dept Hematol, F-75014 Paris, France; INSERM, U567, F-75014 Paris, France; CNRS, UMR 8104, F-75014 Paris, France; Univ Paris Descartes, Fac Med Rene Descartes, UMR S 8104, F-75014 Paris, France; CNRS, UMR 6543, Ctr Antoine Lacassagne, Inst Signalling Dev Biol & Canc, F-06189 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne	Porteu, F (corresponding author), Hop Cochin, Bat G Roussy,27 Rue Fg St Jacques, F-75014 Paris, France.	Porteu@cochin.inserm.fr	PORTEU, Françoise/I-8445-2016; Lenormand, Philippe/N-5996-2018	PORTEU, Françoise/0000-0002-2403-4163; 				Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; CHARLES CH, 1993, ONCOGENE, V8, P797; Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Domachowske JB, 2000, J INFECT DIS, V181, P824, DOI 10.1086/315319; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia J, 2002, EMBO J, V21, P5151, DOI 10.1093/emboj/cdf488; Grill C, 2004, BIOCHEM J, V381, P635, DOI 10.1042/BJ20031688; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Porteu F, 1996, MOL CELL BIOL, V16, P2473; Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Schulze A, 2004, MOL BIOL CELL, V15, P3450, DOI 10.1091/mbc.E03-11-0807; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shen L, 2006, J BIOL CHEM, V281, P15304, DOI 10.1074/jbc.M600054200; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yamada T, 2001, J BIOL CHEM, V276, P5339, DOI 10.1074/jbc.M005685200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang YJ, 2003, ONCOGENE, V22, P6845, DOI 10.1038/sj.onc.1206707; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	50	64	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5468	5477		10.1074/jbc.M609712200	http://dx.doi.org/10.1074/jbc.M609712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17200115	hybrid			2022-12-27	WOS:000244482300041
J	Operana, TN; Tukey, RH				Operana, Theresa N.; Tukey, Robert H.			Oligomerization of the UDP-glucuronosyltransferase 1A proteins - Homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-METABOLIZING-ENZYMES; CYTOCHROME P450 REDUCTASE; HUMAN BILIRUBIN; LIVING CELLS; EXPRESSION; LOCALIZATION; ISOZYMES; PHENOL; GENE; INHIBITION	UDP-glucuronosyltransferases (UGTs) are membrane-bound proteins localized to the endoplasmic reticulum and catalyze the formation of beta-D-glucopyranosiduronic acids (glucuronides) using UDP-glucuronic acid and acceptor substrates such as drugs, steroids, bile acids, xenobiotics, and dietary nutrients. Recent biochemical evidence indicates that the UGT proteins may oligomerize in the membrane, but conclusive evidence is still lacking. In the present study, we have used fluorescence resonance energy transfer (FRET) to study UGT1A oligomerization in live cells. This technique demonstrated that UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10 self-oligomerize (homodimerize). Heterodimer interactions were also explored, and it was determined that UGT1A1 was capable of binding with UGT1A3, UGT1A4, UGT1A6, UGT1A7, UGT1A8, UGT1A9, and UGT1A10. In addition to the in vivo FRET analysis, UGT1A protein-protein interactions were demonstrated through co-immunoprecipitation experiments. Co-expression of hemagglutinin-tagged and cyan fluorescent protein-tagged UGT1A proteins, followed by immunoprecipitation with anti-hemagglutinin beads, illustrated the potential of each UGT1A protein to homodimerize. Co-immunoprecipitation results also confirmed that UGT1A1 was capable of forming heterodimer complexes with all of the UGT1A proteins, corroborating the FRET results in live cells. These preliminary studies suggest that the UGT1A family of proteins form oligomerized complexes in the membrane, a property that may influence function and substrate selectivity.	Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Tukey, RH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Lab Environm Toxicol, La Jolla, CA 92093 USA.	rtukey@ucsd.edu			NIGMS NIH HHS [GM49135] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049135] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; Beaulieu M, 1997, DNA CELL BIOL, V16, P1143, DOI 10.1089/dna.1997.16.1143; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; CHEN F, 1993, BIOCHEMISTRY-US, V32, P10648, DOI 10.1021/bi00091a015; Chouinard S, 2006, MOL PHARMACOL, V69, P908, DOI 10.1124/mol.105.015891; Clegg R.M., 1996, FLUORESCENCE IMAGING; Dutton G.F., 1980, GLUCURONIDATION DRUG; Fremont JJ, 2005, MOL PHARMACOL, V67, P260, DOI 10.1124/mol.104.006361; Ghosh SS, 2001, J BIOL CHEM, V276, P42108, DOI 10.1074/jbc.M106742200; HARDING D, 1990, ANN HUM GENET, V54, P17, DOI 10.1111/j.1469-1809.1990.tb00356.x; Heydel JM, 2001, MOL BRAIN RES, V90, P83, DOI 10.1016/S0169-328X(01)00080-8; Hum DW, 1999, J STEROID BIOCHEM, V69, P413, DOI 10.1016/S0960-0760(99)00061-8; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Ishii Y, 2005, FRONT BIOSCI-LANDMRK, V10, P887, DOI 10.2741/1583; Koiwai O, 1996, HUM MOL GENET, V5, P645, DOI 10.1093/hmg/5.5.645; Kurkela M, 2004, BIOCHEM PHARMACOL, V68, P2443, DOI 10.1016/j.bcp.2004.08.019; Kurkela M, 2003, J BIOL CHEM, V278, P3536, DOI 10.1074/jbc.M206136200; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Latif R, 2002, J BIOL CHEM, V277, P45059, DOI 10.1074/jbc.M206693200; Li Q, 1997, J BIOL CHEM, V272, P3272, DOI 10.1074/jbc.272.6.3272; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Monaghan G, 1997, MAMM GENOME, V8, P692, DOI 10.1007/s003359900539; MONAGHAN G, 1994, GENOMICS, V23, P496, DOI 10.1006/geno.1994.1531; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Schmid JA, 2001, BIOCHEM SOC T, V29, P732, DOI 10.1042/0300-5127:0290732; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; SIEGEL RM, 2000, SCI STKE, pL1; SRIVASTAVA DK, 1987, BIOCHEMISTRY-US, V26, P1240, DOI 10.1021/bi00379a006; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; Takeda S, 2006, DRUG METAB DISPOS, V34, P1277, DOI 10.1124/dmd.106.009738; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; Taura K, 2000, BIOCHEM BIOPH RES CO, V273, P1048, DOI 10.1006/bbrc.2000.3076; Thibaudeau J, 2006, CANCER RES, V66, P125, DOI 10.1158/0008-5472.CAN-05-2857; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405; van Kuppeveld FJM, 2002, J VIROL, V76, P9446, DOI 10.1128/JVI.76.18.9446-9456.2002; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	45	57	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4821	4829		10.1074/jbc.M609417200	http://dx.doi.org/10.1074/jbc.M609417200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179145	hybrid			2022-12-27	WOS:000244482000064
J	Sanchez, M; Sauve, K; Picard, N; Tremblay, A				Sanchez, Melanie; Sauve, Karine; Picard, Nathalie; Tremblay, Andre			The hormonal response of estrogen receptor beta is decreased by the phosphatidylinositol 3-kinase/Akt pathway via a phosphorylation-dependent release of CREB-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; ERBB RECEPTORS; TRANSCRIPTIONAL COACTIVATOR; NEOPLASTIC TRANSFORMATION; KINASE PATHWAY; LIVING CELLS; ALPHA; ACTIVATION; CBP; PROTEASOME	The hormonal response of estrogen receptors (ER) a and ER beta is controlled by a number of cofactors, including the general transcriptional coactivator CREB-binding protein (CBP). Growing evidence suggests that specific kinase signaling events also modulate the formation and activity of the ER coactivation complex. Here we show that ER beta activity and target gene expression are decreased upon activation of ErbB2/ErbB3 receptors despite the presence of CBP. This inhibition of ER beta involved activation of the phosphatidylinositol 3-kinase/Akt pathway, abrogating the potential of CBP to facilitate ER beta response to estrogen. Such reduced activity was associated with an impaired ability of ER beta to recruit CBP upon activation of Akt. Mutation of serine 255, an Akt consensus site contained in the hinge region of ERP, prevented the release of CBP and rendered ER beta transcriptionally more responsive to CBP coactivation, suggesting that Ser-255 may serve as a regulatory site to restrain ER beta activity in Akt-activated cells. In contrast, we found that CBP intrinsic activity was increased by Akt through threonine 1872, a consensus site for Akt in the cysteine- and histidine-rich 3 domain of CBP, indicating that such enhanced transcriptional potential of CBP did not serve to activate ER beta. Interestingly, nuclear receptors sharing a conserved Akt consensus site with ER beta also exhibit a reduced ability to be coactivated by CBP, whereas others missing that site were able to benefit from the activation of CBP by Akt. These results therefore outline a regulatory mechanism by which the phosphatidylinositol 3-kinase/Akt pathway may discriminate nuclear receptor response through coactivator transcriptional competence.	Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Biochem, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Tremblay, A (corresponding author), Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada.	andre.tremblay@recherche-ste-justine.qc.ca						Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Boisvert FM, 2001, J CELL BIOL, V152, P1099, DOI 10.1083/jcb.152.5.1099; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Goodman RH, 2000, GENE DEV, V14, P1553; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jaber Basem M, 2006, Mol Endocrinol, V20, P2695, DOI 10.1210/me.2005-0218; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Pearce ST, 2004, CRIT REV ONCOL HEMAT, V50, P3, DOI 10.1016/j.critrevonc.2003.09.003; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; SANCHEZ M, 2005, MOL GENETICS CANC, P149; Schaufele F, 2000, MOL ENDOCRINOL, V14, P2024, DOI 10.1210/me.14.12.2024; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Stal O, 2003, BREAST CANCER RES, V5, pR37, DOI 10.1186/bcr569; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tremblay A, 2001, J STEROID BIOCHEM, V77, P19, DOI 10.1016/S0960-0760(01)00031-0; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; von Mikecz A, 2000, J CELL BIOL, V150, P265, DOI 10.1083/jcb.150.1.265; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401	60	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4830	4840		10.1074/jbc.M607908200	http://dx.doi.org/10.1074/jbc.M607908200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17166829	hybrid			2022-12-27	WOS:000244482000065
J	Bhaskaran, M; Kolliputi, N; Wang, Y; Gou, DM; Chintagari, NR; Liu, L				Bhaskaran, Manoj; Kolliputi, Narasaiah; Wang, Yang; Gou, Deming; Chintagari, Narendranath Reddy; Liu, Lin			Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PULMONARY-FIBROSIS; C-MYC; MONOCLONAL-ANTIBODIES; CYCLE ARREST; EXPRESSION; RAT; PROLIFERATION; REPRESSION; INHIBITOR	Type II alveolar epithelial cells (AEC II) proliferate and trans-differentiate into type I alveolar epithelial cells (AEC I) when the normal AEC I population is damaged in the lung alveoli. We hypothesized that signaling by transforming growth factor beta 1 (TGF beta 1), through its downstream Smad proteins, is involved in keeping AEC II quiescent in normal cells and its altered signaling may be involved in the trans-differentiation of AEC II to AEC I. In the normal lung, TGF beta 1 and Smad4 were highly expressed in AEC II. Using an in vitro cell culture model, we demonstrated that the trans-differentiation of AEC II into AEC I-like cells began with a proliferative phase, followed by a differentiation phase. The expression of TGF beta 1, Smad2, and Samd3 and their phosphorylated protein forms, and cell cycle inhibitors, p15(Ink4b) and p21(Cip1), was lower during the proliferative phase but higher during the differentiation phase. Furthermore, cyclin-dependent kinases 2, 4, and 6 showed an opposite trend of expression. TGF beta 1 secretion into the media increased during the differentiation phase, indicating an autocrine regulation. The addition of TGF beta 1 neutralizing antibody after the proliferative phase and silencing of Smad4 by RNA interference inhibited the trans-differentiation process. In summary, our results suggest that the trans-differentiation of AEC II to AEC I is modulated by signaling through the Smad-dependent TGF beta 1 pathway by altering the expression of proteins that control the G, to S phase entry in the cell cycle.	Oklahoma State Univ, Coll Vet Med, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), 246 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Wang, Yang/G-4496-2014; Kolliputi, Narasaiah/I-6050-2012	Wang, Yang/0000-0002-2626-478X; Kolliputi, Narasaiah/0000-0002-2654-1900	NHLBI NIH HHS [R01 HL-052146, R01 HL-071628, R01 HL-083188] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083188, R01HL052146, R01HL071628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON IYR, 1974, LAB INVEST, V30, P35; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Buckley S, 1996, AM J PHYSIOL-LUNG C, V271, pL54, DOI 10.1152/ajplung.1996.271.1.L54; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; CORRIN B, 1994, HISTOPATHOLOGY, V24, P145, DOI 10.1111/j.1365-2559.1994.tb01293.x; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; EVANS MJ, 1973, AM J PATHOL, V70, P175; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Iavarone A, 1997, NATURE, V387, P417; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1993, J CLIN INVEST, V92, P1812, DOI 10.1172/JCI116771; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moustakas A, 2001, J CELL SCI, V114, P4359; Narasaraju TA, 2006, J CELL BIOCHEM, V97, P984, DOI 10.1002/jcb.20653; Paine R, 1996, AM J PHYSIOL-LUNG C, V270, pL484, DOI 10.1152/ajplung.1996.270.4.L484; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Warburton David, 2004, Paediatr Respir Rev, V5 Suppl A, pS283, DOI 10.1016/S1526-0542(04)90052-8; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Xu YD, 2003, AM J PHYSIOL-LUNG C, V285, pL527, DOI 10.1152/ajplung.00298.2002; YAMAMOTO T, 1994, EUR J ENDOCRINOL, V130, P302, DOI 10.1530/eje.0.1300302; Zen K, 1998, AM J PHYSIOL-LUNG C, V275, pL172, DOI 10.1152/ajplung.1998.275.1.L172; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC	50	65	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3968	3976		10.1074/jbc.M609060200	http://dx.doi.org/10.1074/jbc.M609060200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17158884	hybrid			2022-12-27	WOS:000244481900061
J	Raue, U; Oellerer, S; Rospert, S				Raue, Uta; Oellerer, Stefan; Rospert, Sabine			Association of protein biogenesis factors at the yeast ribosomal tunnel exit is affected by the translational status and nascent polypeptide sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; RETRACTED ARTICLE. SEE; SACCHAROMYCES-CEREVISIAE; TRIGGER FACTOR; ESCHERICHIA-COLI; COMPLEX; CHAPERONES; HSP70; INTERACTS; REQUIRES	Ribosome-associated protein biogenesis factors (RPBs) act during a short but critical period of protein biogenesis. The action of RPBs starts as soon as a nascent polypeptide becomes accessible from the outside of the ribosome and ends upon termination of translation. In yeast, RPBs include the chaperones Ssb1/2 and ribosome-associated complex, signal recognition particle, nascent polypeptide-associated complex (NAC), the aminopeptidases Map1 and Map2, and the N-terminal acetyltransferase NatA. Here, we provide the first comprehensive analysis of RPB binding at the yeast ribosomal tunnel exit as a function of translational status and polypeptide sequence. We measured the ratios of RPBs to ribosomes in yeast cells and determined RPB occupation of translating and non-translating ribosomes. The combined results imply a requirement for dynamic and coordinated interactions at the tunnel exit. Exclusively, NAC was associated with the majority of ribosomes regardless of their translational status. All other RPBs occupied only ribosomal subpopulations, binding with increased apparent affinity to randomly translating ribosomes as compared with non-translating ones. Analysis of RPB interaction with homogenous ribosome populations engaged in the translation of specific nascent polypeptides revealed that the affinities of Ssb 1/2, NAC, and, as expected, signal recognition particle, were influenced by the amino acid sequence of the nascent polypeptide. Complementary cross-linking data suggest that not only affinity of RPBs to the ribosome but also positioning can be influenced in a nascent polypeptide-dependent manner.	Zentrum Biochem & Mol Zellforsch, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Rospert, S (corresponding author), Zentrum Biochem & Mol Zellforsch, Inst Biochem & Mol Biol, Herrmann Herder Str 7, D-79104 Freiburg, Germany.	sabine.rospert@biochemie.uni-freiburg.de		Rospert, Sabine/0000-0002-3089-9614				Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; CAPLAN S, 1991, GENETICS, V127, P299; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; George R, 2002, FEBS LETT, V516, P213, DOI 10.1016/S0014-5793(02)02528-0; George R, 1998, P NATL ACAD SCI USA, V95, P2296, DOI 10.1073/pnas.95.5.2296; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grallath S, 2006, EMBO REP, V7, P78, DOI 10.1038/sj.embor.7400551; HAID A, 1983, METHOD ENZYMOL, V96, P192; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Maier T, 2005, CURR OPIN STRUC BIOL, V15, P204, DOI 10.1016/j.sbi.2005.03.005; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; ROSPERT S, 2005, PROTEIN FOLDING HDB, V2, P429; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Vetro JA, 2002, J CELL BIOCHEM, V85, P678, DOI 10.1002/jcb.10161; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	50	91	91	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7809	7816		10.1074/jbc.M611436200	http://dx.doi.org/10.1074/jbc.M611436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229726	hybrid			2022-12-27	WOS:000245081000009
J	Rizzo, JM; Tarsio, M; Martinez-Munoz, GA; Kane, PM				Rizzo, Jason M.; Tarsio, Maureen; Martinez-Munoz, Gloria A.; Kane, Patricia M.			Diploids heterozygous for a vma13 Delta mutation in Saccharomyces cerevisiae highlight the importance of V-ATPase subunit balance in supporting vacuolar acidification and silencing cytosolic V-1-ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; GENETIC-ANALYSIS; DELTA-SUBUNIT; IN-VIVO; YEAST; MEMBRANE; LETHAL; PHENOTYPE; MUTANTS; PURIFICATION	The V-ATPase H subunit (encoded by the VMA13 gene) activates ATP-driven proton pumping in intact V-ATPase complexes and inhibits MgATPase activity in cytosolic V, sectors (Parra, K. J., Keenan, K. L., and Kane, P. M. (2000) J. Biol. Chem. 275, 21761-21767). Yeast diploids heterozygous for a vma13 Delta mutation show the pH- and calcium-dependent conditional lethality characteristic of mutants lacking V-ATPase activity, although they still contain one wild-type copy of VAM13. Vacuolar vesicles from this strain have similar to 50% of the ATPase activity of those from a wild-type diploid but do not support formation of a proton gradient. Compound heterozygotes with a second heterozygous deletion in another V-1 subunit gene exhibit improved growth, vacuolar acidification, and ATP-driven proton transport in vacuolar vesicles. In contrast, compound heterozygotes with a second deletion in a V-o subunit grow even more poorly than the vma13 Delta heterozygote, have very little vacuolar acidification, and have very low levels of V-ATPase subunits in isolated vacuoles. In addition, cytosolic V-1 sectors from this strain and from the strain containing only the heterozygous vma13 Delta mutation have elevated MgATPase activity. The results suggest that balancing levels of subunit H with those of other V-ATPase subunits is critical, both for allowing organelle acidification and for preventing unproductive hydrolysis of cytosolic ATP.	SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu			NIGMS NIH HHS [R01 GM50322, R01 GM050322] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Borthwick KJ, 2002, CURR OPIN NEPHROL HY, V11, P563, DOI 10.1097/00041552-200209000-00013; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P16305, DOI 10.1074/jbc.M513805200; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FENG Y, 1992, J BIOL CHEM, V267, P19769; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Gruber G, 2001, J EXP BIOL, V204, P2597; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; HO MN, 1993, J BIOL CHEM, V268, P18286; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Oka T, 2000, J BIOL CHEM, V275, P29556, DOI 10.1074/jbc.M002756200; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; SHERMAN F, 1982, METHODS YEAST GENETI, P177; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Xiao Y, 2000, J BIOL CHEM, V275, P6963, DOI 10.1074/jbc.275.10.6963; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	42	16	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8521	8532		10.1074/jbc.M607092200	http://dx.doi.org/10.1074/jbc.M607092200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17234635	hybrid			2022-12-27	WOS:000245081000084
J	Stoj, CS; Augustine, AJ; Solomon, EI; Kosman, DJ				Stoj, Christopher S.; Augustine, Anthony J.; Solomon, Edward I.; Kosman, Daniel J.			Structure-function analysis of the cuprous oxidase activity in Fet3p from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PLASMA-MEMBRANE; HUMAN CERULOPLASMIN; IRON UPTAKE; MULTICOPPER OXIDASES; NEURODEGENERATIVE DISEASE; FERROXIDASE ACTIVITY; ELECTRON-TRANSFER; ESCHERICHIA-COLI; COPPER OXIDASE; TRACE COPPER	The Fet3 protein from Saccharomyces cerevisiae is a multi-copper oxidase with specificity toward Fe(II) and Cu(I). Fet3p turnover of Fe(II) supports high affinity iron uptake across the yeast plasma membrane, whereas its turnover of Cu(I) contributes to copper resistance in yeast. The structure of Fet3p has been used to identify possible amino acid residues responsible for this protein's reactivity with Cu(I), and structure-function analyses have confirmed this assignment. Fet3p Met(345) is required for the enzyme's reactivity toward Cu(I). Although the Fet3pM345A mutant exhibits wild type spectral and electrochemical behavior, the kinetic constants for Cu(I) turnover and for single-turnover electron transfer from Cu(I) to the enzyme are significantly reduced. The specificity constant with Cu(I) as substrate is reduced by one-fifth, whereas the electron transfer rate from Cu(I) is reduced 50-fold. This mutation has little effect on the reactivity toward Fe(II), indicating that Met 345 contributes specifically to Fet3p reactivity with the cuprous ion. These kinetic defects render the Fet3pM345A unable to support wild type cellular copper resistance, suggesting that there is a finely tuned copper redox balance at the yeast plasma membrane.	SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Stanford University	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, 140 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	camkos@buffalo.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031450, R37DK031450, R01DK053820] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31450, DK53820] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BETTS JN, 1992, J AM CHEM SOC, V114, P4043, DOI 10.1021/ja00037a004; Blackburn NJ, 2000, BIOCHEMISTRY-US, V39, P2316, DOI 10.1021/bi992334a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; FREIDEN E, 1976, ADV EXP MED BIOL, V74, P505; Frieden E, 1974, Adv Exp Med Biol, V48, P235; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Harris ZL, 1998, AM J CLIN NUTR, V67, p972S, DOI 10.1093/ajcn/67.5.972S; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Kosman DJ, 2002, ADV PROTEIN CHEM, V60, P221; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; Machonkin TE, 2000, J AM CHEM SOC, V122, P12547, DOI 10.1021/ja002339r; Machonkin TE, 2001, J AM CHEM SOC, V123, P5507, DOI 10.1021/ja003975s; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; NAKANO M, 1993, EUR NEUROL, V33, P44, DOI 10.1159/000118537; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 2002, J NEUROSCI, V22, P6578; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854; Quintanar L, 2004, J AM CHEM SOC, V126, P6579, DOI 10.1021/ja049220t; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sayre LM, 1999, CURR OPIN CHEM BIOL, V3, P220, DOI 10.1016/S1367-5931(99)80035-0; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Shi XL, 2003, J BIOL CHEM, V278, P50309, DOI 10.1074/jbc.M307019200; Singh A, 2006, J BIOL CHEM, V281, P13355, DOI 10.1074/jbc.M512042200; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stoj C, 2003, FEBS LETT, V554, P422, DOI 10.1016/S0014-5793(03)01218-3; Stoj C.S., 2006, ENCYCL INORG CHEM, DOI [10.1002/0470862106.ia055, DOI 10.1002/0470862106.IA055]; Stoj CS, 2006, BIOCHEMISTRY-US, V45, P12741, DOI 10.1021/bi061543+; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; Urbanski NK, 2000, ACTA BIOCHIM POL, V47, P951; Wang TP, 2003, J BIOL INORG CHEM, V8, P611, DOI 10.1007/s00775-003-0456-5; White AR, 2004, J BIOL INORG CHEM, V9, P269, DOI 10.1007/s00775-004-0521-8; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018	47	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7862	7868		10.1074/jbc.M609766200	http://dx.doi.org/10.1074/jbc.M609766200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17220296	hybrid			2022-12-27	WOS:000245081000015
J	Anderson, SG; Williams, CR; O'Donnell, M; Bloom, LB				Anderson, Stephen G.; Williams, Christopher R.; O'Donnell, Mike; Bloom, Linda B.			A function for the psi subunit in loading the Escherichia coli DNA polymerase sliding clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; III ACCESSORY PROTEINS; CELL NUCLEAR ANTIGEN; GAMMA-COMPLEX; LOADER COMPLEX; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; BETA-SUBUNIT; STRUCTURAL-ANALYSIS	Crystal structures of an Escherichia coli clamp loader have provided insight into the mechanism by which this molecular machine assembles ring-shaped sliding clamps onto DNA. The contributions made to the clamp loading reaction by two subunits, chi and psi, which are not present in the crystal structures, were determined by measuring the activities of three forms of the clamp loader, gamma(3)delta delta', gamma(3)delta delta'psi, and gamma(3)delta delta'psi chi. The psi subunit is important for stabilizing an ATP-induced conformational. state with high affinity for DNA, whereas the X subunit does not contribute directly to clamp loading in our assays lacking single-stranded DNA-binding protein. The psi subunit also increases the affinity of the clamp loader for the clamp in assays in which ATP gamma S is substituted for ATP. Interestingly, the affinity of the gamma(3)delta delta' complex for beta is no greater in the presence than in the absence of ATP gamma S. A role for psi in stabilizing or promoting ATP- and ATP gamma S-induced conformational changes may explain why large conformational differences were not seen in gamma(3)delta delta' structures with and without bound ATP gamma S. The beta clamp partially compensates for the activity of psi when this subunit is not present and possibly serves as a scaffold on which the clamp loader adopts the appropriate conformation for DNA binding and clamp loading. Results from our work and others suggest that the psi subunit may introduce a temporal order to the clamp loading reaction in which clamp binding precedes DNA binding.	Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	State University System of Florida; University of Florida; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014		NIGMS NIH HHS [GM055596, R01 GM055596, GM38839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1988, BIOCHEMISTRY-US, V27, P5210, DOI 10.1021/bi00414a040; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 2004, EUR J BIOCHEM, V271, P439, DOI 10.1046/j.1432-1033.2003.03944.x; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jarvis TC, 2005, J BIOL CHEM, V280, P40465, DOI 10.1074/jbc.M508310200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; MAKI S, 1988, J BIOL CHEM, V263, P6555; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Podobnik M, 2003, STRUCTURE, V11, P253, DOI 10.1016/S0969-2126(03)00027-3; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Williams CR, 2004, J BIOL CHEM, V279, P4376, DOI 10.1074/jbc.M310429200; WILLIAMS CR, 2003, THESIS U FLORIDA GAI; XIAO H, 1993, J BIOL CHEM, V268, P11779; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhuang Z, 2004, NAT STRUCT MOL BIOL, V11, P580, DOI 10.1038/nsmb0704-580	52	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7035	7045		10.1074/jbc.M610136200	http://dx.doi.org/10.1074/jbc.M610136200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210572	hybrid			2022-12-27	WOS:000245080900015
J	Hou, ZB; He, LS; Qi, RZ				Hou, Zhibo; He, Lisheng; Qi, Robert Z.			Regulation of S6 kinase 1 activation by phosphorylation at Ser-411	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CYCLIN-DEPENDENT KINASE-5; PROTEIN-KINASE; MAMMALIAN TARGET; IN-VIVO; RAPAMYCIN; P70(S6K); MTOR; CDK5; SITES	Ribosomal S6 kinase 1 (S6K1), as a key regulator of mRNA translation, plays an important role in cell cycle progression through the G, phase of proliferating cells and in the synaptic plasticity of terminally differentiated neurons. Activation of S6K1 involves the phosphorylation of its multiple Ser/Thr residues, including the proline-directed sites (Ser-411, Ser-418, Thr-421, and Ser-424) in the autoinhibitory domain near the C terminus. Phosphorylation at Thr-389 is also a crucial event in S6K1 activation. Here, we report that S6K1 phosphorylation at Ser-411 is required for the rapamycin-sensitive phosphorylation of Thr-389 and the subsequent activation of S6KI. Mutation of Ser-411 to Ala ablated insulin-induced Thr-389 phosphorylation and S6K1 activation, whereas mutation mimicking Ser-411 phosphorylation did not show any effect. Furthermore, phosphomimetic mutation of Thr-389 overcame the inhibitory effect of the mutation S411A. Thus, Ser-411 phosphorylation regulates S6K1 activation via the control of Thr-389 phosphorylation. In nervous system neurons, Cdk5-p35 kinase associates with S6K1 via the direct interaction between p35 and S6K1 and catalyzes S6KI phosphorylation specifically at Ser-411. Inhibition of the Cdk5 activity or suppression of Cdk5 expression blocked S6K1 phosphorylation at Ser-411 and Thr-389, resulting in S6K1 inactivation. Similar results were obtained by treating asynchronous populations of proliferating cells with the CDK inhibitor compound roscovitine. Altogether, our findings suggest a novel mechanism by which the CDK-mediated phosphorylation regulates the activation of S6K1.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Qi, Robert Zhong/0000-0001-5596-8172				Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; CHEATHAM L, 1995, P NATL ACAD SCI USA, V92, P11696, DOI 10.1073/pnas.92.25.11696; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; FERRARI S, 1993, J BIOL CHEM, V268, P16091; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Johnson K, 2005, J NEUROCHEM, V93, P538, DOI 10.1111/j.1471-4159.2004.03004.x; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Lim ACB, 2004, J BIOL CHEM, V279, P46668, DOI 10.1074/jbc.M404760200; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621	40	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6922	6928		10.1074/jbc.M607836200	http://dx.doi.org/10.1074/jbc.M607836200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17220300	hybrid			2022-12-27	WOS:000245080900003
J	Liu, CX; Ranganathan, S; Robinson, S; Strickland, DK				Liu, Chun-Xiang; Ranganathan, Sripriya; Robinson, Susan; Strickland, Dudley K.			gamma-secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; REGULATED INTRAMEMBRANE PROTEOLYSIS; PRESENILIN/GAMMA-SECRETASE; NUCLEAR-LOCALIZATION; CYTOPLASMIC DOMAIN; F-SPONDIN; CLEAVAGE; LRP1B; NOTCH; GENE	The low density lipoprotein receptor related protein 1B (LRP1B) is a large endocytic receptor that was first identified as a candidate tumor suppressor gene. In the current investigation we demonstrate that LRP1B undergoes regulated intramembrane proteolysis in gamma-secretase-dependent process. The released intracellular domain (ICD) then translocates to the nucleus via a nuclear localization signal that is present within this domain. ICD release first requires shedding of the LRP1B ectodomain, which appears to be catalyzed by a member of the metalloproteinase family. Employing site-directed mutagenesis studies, we identified lysine residues 4432 and 4435 and arginine 4442 as key amino acids important for ectodomain shedding of LRP1B. We also demonstrate that an LRP1B minireceptor as well as the ICD domain alone suppresses anchorage-independent growth of LRP1B-deficient neuroglioma cells (H4 cells). Interestingly, abrogating ectodomain shedding resulted in a loss of the ability of LRP1B minireceptors to suppress anchorage-independent growth. Together, these studies reveal that LRP1B has tumor suppression function that is mediated by proteolytic processing of the receptor resulting in ICD release.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu			NHLBI NIH HHS [HL50784, HL54710] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054710, R01HL050784] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Hirai Y, 2004, AM J OBSTET GYNECOL, V191, P1173, DOI 10.1016/j.ajog.2004.04.015; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Langbein S, 2002, LAB INVEST, V82, P639, DOI 10.1038/labinvest.3780458; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Li YH, 2005, BIOCHEM BIOPH RES CO, V333, P868, DOI 10.1016/j.bbrc.2005.05.170; Liu CX, 2000, GENOMICS, V69, P271, DOI 10.1006/geno.2000.6331; Liu CX, 2000, CANCER RES, V60, P1961; Liu CX, 2001, J BIOL CHEM, V276, P28889, DOI 10.1074/jbc.M102727200; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Pastrana DV, 2005, BBA-MOL BASIS DIS, V1741, P234, DOI 10.1016/j.bbadis.2005.06.007; Pineau P, 2003, HEPATOLOGY, V37, P852, DOI 10.1053/jhep.2003.50138; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schulz JG, 2003, J BIOL CHEM, V278, P48651, DOI 10.1074/jbc.M308424200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tanaga K, 2004, ARTERIOSCL THROM VAS, V24, P1422, DOI 10.1161/01.ATV.0000133607.80554.09; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Wilhelmsen K, 2004, MOL CELL BIOL, V24, P454, DOI 10.1128/MCB.24.1.454-464.2004; Yano K, 2000, BIOCHEM BIOPH RES CO, V270, P171, DOI 10.1006/bbrc.2000.2392; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	46	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7504	7511		10.1074/jbc.M608088200	http://dx.doi.org/10.1074/jbc.M608088200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17227771	hybrid			2022-12-27	WOS:000245080900063
J	Pushkar, Y; Yano, J; Glatzel, P; Messinger, J; Lewis, A; Sauer, K; Bergmann, U; Yachandra, V				Pushkar, Yulia; Yano, Junko; Glatzel, Pieter; Messinger, Johannes; Lewis, Azul; Sauer, Kenneth; Bergmann, Uwe; Yachandra, Vittal			Structure and orientation of the Mn4Ca cluster in plant photosystem II membranes studied by polarized range-extended X-ray absorption spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; ELECTRON-PARAMAGNETIC-RES; MANGANESE MODEL COMPOUNDS; WATER-OXIDATION COMPLEX; EXCHANGE INTERACTIONS; MN CLUSTER; CALCIUM; EXAFS; EPR; EVOLUTION	X-ray absorption spectroscopy has provided important insights into the structure and function of the Mn4Ca cluster in the oxygen-evolving complex of Photosystem II (PS II). The range of manganese extended x-ray absorption fine structure data collected from PS II until now has been, however, limited by the presence of iron in PS II. Using a crystal spectrometer with high energy resolution to detect solely the manganese K alpha fluorescence, we are able to extend the extended x-ray absorption fine structure range beyond the onset of the iron absorption edge. This results in improvement in resolution of the manganese-backscatterer distances in PS II from 0.14 to 0.09 angstrom. The high resolution data obtained from oriented spinach PS II membranes in the S-1 state show that there are three di-mu-oxo-bridged manganese-manganese distances of similar to 2.7 and similar to 2.8 angstrom in a 2:1 ratio and that these three manganese-manganese vectors are aligned at an average orientation of similar to 60 degrees relative to the membrane normal. Furthermore, we are able to observe the separation of the Fourier peaks corresponding to the similar to 3.2 angstrom manganese-manganese and the similar to 3.4 angstrom manganese-calcium interactions in oriented PS II samples and determine their orientation relative to the membrane normal. The average of the manganese-calcium vectors at similar to 3.4 angstrom is aligned along the membrane normal, while the similar to 3.2 angstrom manganese-manganese vector is oriented near the membrane plane. A comparison of this structural information with the proposed Mn4Ca cluster models based on spectroscopic and diffraction data provides input for refining and selecting among these models.	Lawrence Berkeley Natl Lab, Melvin Calvin Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Synchrotron Radiation Facility (ESRF); Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Yano, J (corresponding author), Lawrence Berkeley Natl Lab, Melvin Calvin Lab, Phys Biosci Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jyano@lbl.gov; vkyachandra@lbl.gov	Glatzel, Pieter/E-9958-2010; Messinger, Johannes/AAC-4221-2019	Glatzel, Pieter/0000-0001-6532-8144; Messinger, Johannes/0000-0003-2790-7721	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM055302, R01GM065440, R01GM055302] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-08630, P41 RR008630] Funding Source: Medline; NIGMS NIH HHS [GM-65440, R01 GM065440, R56 GM055302, R01 GM055302] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ananyev GM, 1997, BIOCHEMISTRY-US, V36, P11342, DOI 10.1021/bi970626a; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; BERGMANN U, 1998, SPIE P, V3448, P198; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BOUSSAC A, 1988, CHEM SCRIPTA, V28A, P123; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; BOUSSAC A, 1985, BIOCHIM BIOPHYS ACTA, V808, P231, DOI 10.1016/0005-2728(85)90004-0; Britt RD, 2004, BBA-BIOENERGETICS, V1655, P158, DOI 10.1016/j.bbabio.2003.11.009; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; CHRISTOU G, 1988, METAL CLUSTERS PROTE, P238; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; Cinco RM, 1999, INORG CHEM, V38, P5988, DOI 10.1021/ic991003j; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; CRAMER SP, 1988, XRAY ABSORPTION, P257; Darovsky A, 1996, INORG CHEM, V35, P6916, DOI 10.1021/ic9610391; DAU H, 1995, BIOCHEMISTRY-US, V34, P5274, DOI 10.1021/bi00015a043; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEROSE VJ, 1994, J AM CHEM SOC, V116, P5239, DOI 10.1021/ja00091a031; DEROSE VJ, 1995, CHEM PHYS, V194, P443, DOI 10.1016/0301-0104(95)00043-N; DUA H, 2001, BIOCHIM BIOPHYS ACTA, V1503, P24; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GEORGE GN, 1989, SCIENCE, V243, P789, DOI 10.1126/science.2916124; Glatzel P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014117; Glatzel P, 2004, J AM CHEM SOC, V126, P9946, DOI 10.1021/ja038579z; Grove GN, 1998, BIOCHEMISTRY-US, V37, P1532, DOI 10.1021/bi971356z; Hasegawa K, 1999, CHEM PHYS LETT, V300, P9, DOI 10.1016/S0009-2614(98)01369-4; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Kusunoki M, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P251; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; Law NA, 1999, ADV INORG CHEM, V46, P305; LIANG W, 1994, BIOCHEMISTRY-US, V33, P4923, DOI 10.1021/bi00182a022; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; MUKERJI I, 1994, BIOCHEMISTRY-US, V33, P9712, DOI 10.1021/bi00198a042; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; ORT DR, 1996, OXYGENIC PHOTOSYNTHE; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Pence LE, 1996, INORG CHEM, V35, P3069, DOI 10.1021/ic951448h; Penner-Hahn JE, 1998, STRUCT BOND, V90, P1; Pizarro SA, 2004, J BIOL INORG CHEM, V9, P247, DOI 10.1007/s00775-003-0520-1; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Robblee JH, 2002, J AM CHEM SOC, V124, P7459, DOI 10.1021/ja011621a; Rutherford A.W., 1992, PHOTOSYSTEMS STRUCTU, P179; RUTHERFORD AW, 1985, BIOCHIM BIOPHYS ACTA, V807, P189, DOI 10.1016/0005-2728(85)90122-7; Sauer K, 2005, PHOTOSYNTH RES, V85, P73, DOI 10.1007/s11120-005-0638-9; Schiller H, 1998, BIOCHEMISTRY-US, V37, P7340, DOI 10.1021/bi972329b; SCOTT RA, 1984, STRUCTURAL RESONANCE, P295; Teo, 1986, EXAFS BASIC PRINCIPL; VINCENT JB, 1987, J CHEM SOC CHEM COMM, P236, DOI 10.1039/c39870000236; WIEGHARDT K, 1989, ANGEW CHEM INT EDIT, V28, P1153, DOI 10.1002/anie.198911531; Wydrzynski T. J., 2005, PHOTOSYSTEM; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Yachandra VK, 2005, ADV PHOTO RESPIRAT, V22, P235; YACHANDRA VK, 1995, METHOD ENZYMOL, V246, P638; YACHANDRA VK, 1993, SCIENCE, V260, P675, DOI 10.1126/science.8480177; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	66	83	83	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7198	7208		10.1074/jbc.M610505200	http://dx.doi.org/10.1074/jbc.M610505200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17190828	Green Accepted, hybrid			2022-12-27	WOS:000245080900032
J	Radcliffe, CM; Arnold, JN; Suter, DM; Wormald, MR; Harvey, DJ; Royle, L; Mimura, Y; Kimura, Y; Sim, RB; Inoges, S; Rodriguez-Calvillo, M; Zabalegui, N; de Cerio, ALD; Potter, KN; Mockridge, CI; Dwek, RA; Bendandi, M; Rudd, PM; Stevenson, FK				Radcliffe, Catherine M.; Arnold, James N.; Suter, David M.; Wormald, Mark R.; Harvey, David J.; Royle, Louise; Mimura, Yusuke; Kimura, Yoshinobu; Sim, Robert B.; Inoges, Susana; Rodriguez-Calvillo, Mercedes; Zabalegui, Natalia; Lopez-Diaz de Cerio, Ascension; Potter, Kathleen N.; Mockridge, C. Ian; Dwek, Raymond A.; Bendandi, Maurizio; Rudd, Pauline M.; Stevenson, Freda K.			Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; C-TYPE LECTINS; RHEUMATOID-ARTHRITIS; GLYCOSYLATION SITES; DENDRITIC CELLS; IMMUNE-SYSTEM; SURFACE-IMMUNOGLOBULIN; BURKITTS-LYMPHOMA; VARIABLE REGION; FAB FRAGMENT	Expression of surface immunoglobulin appears critical for the growth and survival of B-cell lymphomas. In follicular lymphoma, we found previously that the Ig variable (V) regions in the B-cell receptor express a strikingly high incidence of N-glycosylation sequons, NX(S/T). These potential glycosylation sites are introduced by somatic mutation and are lymphoma-specific, pointing to their involvement in tumor pathogenesis. Analysis of the V region sugars from lymphoma-derived IgG/IgM reveals that they are mostly oligomannose and, remarkably, are located in the antigen-binding site, possibly precluding conventional antigen binding. The Fc region contains complex glycans, confirming that the normal glycan processing pathway is intact. Binding studies indicate that the oligomannose glycans occupying the V regions are accessible to mannose-binding lectin. These findings suggest a potential contribution to lymphoma pathogenesis involving antigen-independent interaction of surface immunoglobulin of the B-cell receptor with mannose-binding molecules of innate immunity in the germinal center.	Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England; Univ Oxford, Med Res Council Immunochem Unit, Dept Biochem, Oxford OX1 3QU, England; Okayama Univ, Dept Biofunct Chem, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; Univ Clin Navarre, Pamplona 31008, Spain; Ctr Appl Med Res, Pamplona 31008, Spain; Univ Southampton, Hosp Trust, Mol Immunol Grp, Tenovus Lab,Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Oxford; University of Oxford; Okayama University; University of Navarra; University of Navarra; University of Southampton	Rudd, PM (corresponding author), Univ Coll Dublin, Conway Inst, NIBRT, Dublin Oxford Glycobiol Lab, Dublin 4, Ireland.	pauline.rudd@nibrt.ie	Wormald, Mark R/G-2785-2011; Inogés, Susana/AAW-6785-2021; Arnold, James/ABE-3900-2021; Sim, Bob/A-1354-2008; Suter, David/S-9210-2019; Harvey, David/A-5579-2013	Wormald, Mark R/0000-0002-4853-2773; Arnold, James/0000-0002-6949-0613; Sim, Bob/0000-0002-2855-7455; Suter, David/0000-0001-5644-4899; Stevenson, Freda/0000-0002-0933-5021; Harvey, David/0000-0003-0544-771X				Arnold JN, 2005, J BIOL CHEM, V280, P29080, DOI 10.1074/jbc.M504528200; Arnold JN, 2004, J IMMUNOL, V173, P6831, DOI 10.4049/jimmunol.173.11.6831; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; CHANG SC, 1993, THESIS U OXFORD; CHAPMAN A, 1979, J BIOL CHEM, V254, P824; Chapman CJ, 1996, BLOOD, V88, P3562, DOI 10.1182/blood.V88.9.3562.bloodjournal8893562; Choe J, 2000, J IMMUNOL, V164, P56, DOI 10.4049/jimmunol.164.1.56; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; DEWK RA, 1996, CHEM REV, V96, P683; Downing I, 2003, IMMUNOLOGY, V109, P360, DOI 10.1046/j.1365-2567.2003.01675.x; ENDO T, 1995, MOL IMMUNOL, V32, P931, DOI 10.1016/0161-5890(95)00078-S; Fukuta K, 2000, ARCH BIOCHEM BIOPHYS, V378, P142, DOI 10.1006/abbi.2000.1806; Gala FA, 2004, J IMMUNOL, V172, P5489, DOI 10.4049/jimmunol.172.9.5489; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Goodarzi MT, 1998, GLYCOCONJUGATE J, V15, P469, DOI 10.1023/A:1006930902625; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; HE XM, 1992, P NATL ACAD SCI USA, V89, P7154, DOI 10.1073/pnas.89.15.7154; Inoges S, 2003, HAEMATOLOGICA, V88, P1438; Kabat EA, 1991, SEQUENCES PROTEINS I; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; MIZUTANI R, 1995, J MOL BIOL, V254, P208, DOI 10.1006/jmbi.1995.0612; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAREKH RB, 1987, EMBO J, V6, P1233, DOI 10.1002/j.1460-2075.1987.tb02359.x; PAREKH RB, 1988, LANCET, V1, P966; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Radcliffe CM, 2002, J BIOL CHEM, V277, P46415, DOI 10.1074/jbc.M202466200; Rodriguez-Calvillo M, 2004, CRIT REV ONCOL HEMAT, V52, P1, DOI 10.1016/j.critrevonc.2004.05.002; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Smith SH, 2004, MOL CELL, V14, P696, DOI 10.1016/j.molcel.2004.06.015; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; TANDAI M, 1991, ARCH BIOCHEM BIOPHYS, V291, P339, DOI 10.1016/0003-9861(91)90144-8; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; YUNIS JJ, 1987, NEW ENGL J MED, V316, P79, DOI 10.1056/NEJM198701083160204; Zabalegui N, 2004, HAEMATOLOGICA, V89, P541; ZELENETZ AD, 1992, J EXP MED, V176, P1137, DOI 10.1084/jem.176.4.1137; Zhu D, 2003, BRIT J HAEMATOL, V120, P217, DOI 10.1046/j.1365-2141.2003.04064.x; Zhu DL, 2002, BLOOD, V99, P2562, DOI 10.1182/blood.V99.7.2562	57	100	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7405	7415		10.1074/jbc.M602690200	http://dx.doi.org/10.1074/jbc.M602690200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17197448	Green Published, hybrid			2022-12-27	WOS:000245080900052
J	Clizbe, DB; Owens, ML; Masuda, KR; Shackelford, JE; Krisans, SK				Clizbe, Daun B.; Owens, Michelle L.; Masuda, Kimberly R.; Shackelford, Janis E.; Krisans, Skaidrite K.			IDI2, a second lsopentenyl diphosphate isomerase in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL PYROPHOSPHATE ISOMERASE; ISOPRENOID BIOSYNTHESIS; REDUCTASE DEGRADATION; STEROL-METABOLISM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; GENE-EXPRESSION; ENZYME; PEROXISOMES	We recently described the identification of a novel isopentenyl diphosphate isomerase, IDI2 in humans and mice. Our current data indicate that, in humans, IDI2 is expressed only in skeletal muscle. Expression constructs of human IDI2 in Saccharomyces cerevisiae can complement isomerase function in an idi1-deficient yeast strain. Furthermore, IDI2 has the ability to catalyze the isomerization of [C-14]IPP to [C-14]DMAPP. Enzyme kinetic analysis of partially purified IDI2 demonstrate the novel isozyme has a maximal relative specific activity of 1.2 X 10(-1) +/- 0.3 mu mol min(-1) mg(-1) at pH 8.0 with a K-m(IPP) value of 22.8 mu m IPP. Both isozymes, IDI1 and IDI2 are localized to the peroxisome by a PTS1-dependent pathway. Finally, our data suggest that IDI2 is regulated independently from IDI1, by a mechanism that may involve PPAR alpha.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Krisans, SK (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skrisans@sciences.sdsu.edu			NIDDK NIH HHS [DK58238, DK58040] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058238, R01DK058040] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aboushadi N, 1998, J LIPID RES, V39, P1781; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Breitling R, 2003, J MOL EVOL, V57, P282, DOI 10.1007/s00239-003-2476-8; BRUENGER E, 1986, ARCH BIOCHEM BIOPHYS, V248, P620, DOI 10.1016/0003-9861(86)90516-3; Brunmair B, 2004, J PHARMACOL EXP THER, V311, P109, DOI 10.1124/jpet.104.068312; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Carrigan CN, 2003, J AM CHEM SOC, V125, P9008, DOI 10.1021/ja0350381; Durbecq V, 2001, EMBO J, V20, P1530, DOI 10.1093/emboj/20.7.1530; ELGERSMA Y, 1996, J BIOL CHEM, V271, P26357; Engfelt WH, 1997, J BIOL CHEM, V272, P24579, DOI 10.1074/jbc.272.39.24579; Fliesler SJ, 1999, INVEST OPHTH VIS SCI, V40, P1792; Fliesler SJ, 2000, LIPIDS, V35, P289, DOI 10.1007/s11745-000-0525-y; Hahn FM, 1996, ARCH BIOCHEM BIOPHYS, V332, P30, DOI 10.1006/abbi.1996.0312; Hahn FM, 1999, J BACTERIOL, V181, P4499, DOI 10.1128/JB.181.15.4499-4504.1999; HAHN FM, 1995, J BIOL CHEM, V270, P11298, DOI 10.1074/jbc.270.19.11298; Hildebrandt AL, 2000, AM J PHYSIOL-ENDOC M, V278, pE1078, DOI 10.1152/ajpendo.2000.278.6.E1078; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4; Landrier JF, 2004, J BIOL CHEM, V279, P45512, DOI 10.1074/jbc.M407461200; LYNEN F, 1959, ANGEW CHEM INT EDIT, V71, P657, DOI 10.1002/ange.19590712102; Maynard EL, 2004, PROTEINS, V55, P856, DOI 10.1002/prot.20112; Meigs TE, 1997, ARCH BIOCHEM BIOPHYS, V345, P1, DOI 10.1006/abbi.1997.0200; Meigs TE, 1996, J BIOL CHEM, V271, P7916, DOI 10.1074/jbc.271.14.7916; Murthy S, 2005, J BIOL CHEM, V280, P41793, DOI 10.1074/jbc.M504101200; Nakamura A, 2001, FEBS LETT, V506, P61, DOI 10.1016/S0014-5793(01)02870-8; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Paton VG, 1997, J BIOL CHEM, V272, P18945, DOI 10.1074/jbc.272.30.18945; POPJAK G, 1970, NATURAL SUBSTANCES F, P17; SAGAMI H, 1983, J BIOCHEM-TOKYO, V94, P975, DOI 10.1093/oxfordjournals.jbchem.a134441; SATTERWHITE DM, 1985, METHOD ENZYMOL, V110, P92; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; SPURGEON SL, 1981, BIOSYNTHESIS ISOPREN, V1, P2; STREET IP, 1994, BIOCHEMISTRY-US, V33, P4212, DOI 10.1021/bi00180a014; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Wouters J, 2004, PROTEINS, V54, P216, DOI 10.1002/prot.10573	36	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6668	6676		10.1074/jbc.M610922200	http://dx.doi.org/10.1074/jbc.M610922200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202134	hybrid			2022-12-27	WOS:000244867200076
J	Serrano, M; Robatzek, S; Torres, M; Kombrink, E; Somssich, IE; Robinson, M; Schulze-Lefert, P				Serrano, Mario; Robatzek, Silke; Torres, Martha; Kombrink, Erich; Somssich, Imre E.; Robinson, Mike; Schulze-Lefert, Paul			Chemical interference of pathogen-associated molecular pattern-triggered immune responses in Arabidopsis reveals a potential role for fatty-acid synthase type II complex-derived lipid signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PHOSPHATIDIC-ACID; GENE-EXPRESSION; BACTERIAL FLAGELLIN; DISEASE RESISTANCE; INNATE IMMUNITY; THALIANA; PLANTS; ENDOCYTOSIS; SYSTEM	We describe an experimental setup using submerged cultures of Arabidopsis seedlings in 96-well microtiter plates that permits chemical intervention of rapid elicitor-mediated immune responses. Screening of a chemical library comprising 120 small molecules with known biological activities revealed four compounds reducing cellulysin- or flg22-activated gene expression of the early pathogen-associated molecular patterns (PAMP)responsive ATL2 gene. One chemical, oxytriazine, was found to induce ATL2 gene expression in the absence of PAMP. By monitoring additional flg22-triggered immediate early plant responses, we present evidence that two compounds, triclosan and fluazinam, interfere with the accumulation of reactive oxygen species and internalization of the activated plasma membrane resident FLS2 immune receptor. Using triclosan structure types and enzyme activity inhibition assays, Arabidopsis MOD1 enoyl-acyl carrier protein reductase, a subunit of the fatty-acid synthase type II (FAS II) complex, was identified as a likely cellular target of triclosan. Inhibition of all tested elicitor-triggered early immune responses by triclosan indicates a potential role for signaling lipids in flg22-triggered immunity. Chemical profiling of eca mutants, each showing deregulated ATL2 gene expression, with the identified compounds revealed mutant-specific response patterns and allowed us to deduce tentative action sites of ECA genes relative to the compound targets.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Syngenta Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England	Max Planck Society; Syngenta	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Somssich, Imre/GLT-3738-2022; Serrano, Mario/E-8719-2012; Schulze-Lefert, Paul/A-7746-2008; Bruening, Stefan/B-8505-2011; Robatzek, Silke/B-6844-2013; Schulze-Lefert, Paul/B-6707-2011	Somssich, Imre/0000-0003-3066-5794; Serrano, Mario/0000-0002-1510-756X; 				Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Armstrong JI, 2004, P NATL ACAD SCI USA, V101, P14978, DOI 10.1073/pnas.0404312101; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Blakley R L, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P23; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gross A, 2005, NEW PHYTOL, V165, P215, DOI 10.1111/j.1469-8137.2004.01245.x; Gutierrez RA, 2002, P NATL ACAD SCI USA, V99, P11513, DOI 10.1073/pnas.152204099; Heath RJ, 2002, APPL MICROBIOL BIOT, V58, P695, DOI 10.1007/s00253-001-0918-z; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KATER MM, 1994, PLANT MOL BIOL, V25, P771, DOI 10.1007/BF00028873; KEPPLER LD, 1989, PHYTOPATHOLOGY, V79, P974, DOI 10.1094/Phyto-79-974; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Mou ZL, 2000, PLANT CELL, V12, P405, DOI 10.1105/tpc.12.3.405; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Poghosyan ZP, 2005, PLANT PHYSIOL BIOCH, V43, P37, DOI 10.1016/j.plaphy.2004.12.002; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; SLABAS AR, 1986, BIOCHIM BIOPHYS ACTA, V877, P271, DOI 10.1016/0005-2760(86)90304-8; Smukste I, 2005, ANNU REV GENOM HUM G, V6, P261, DOI 10.1146/annurev.genom.6.080604.162136; Sprenger-Haussels M, 2000, PLANT J, V22, P1, DOI 10.1046/j.1365-313x.2000.00687.x; Surpin M, 2005, P NATL ACAD SCI USA, V102, P4902, DOI 10.1073/pnas.0500222102; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	45	59	63	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6803	6811		10.1074/jbc.M608792200	http://dx.doi.org/10.1074/jbc.M608792200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17166839	hybrid			2022-12-27	WOS:000244867200090
J	Wrighton, KH; Liang, M; Bryan, B; Luo, KX; Liu, MY; Feng, XH; Lin, X				Wrighton, Katharine H.; Liang, Min; Bryan, Brad; Luo, Kunxin; Liu, Mingyao; Feng, Xin-Hua; Lin, Xia			Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SKI PROTOONCOGENE; MUSCLE DIFFERENTIATION; SKELETAL-MUSCLE; CDNA-CLONES; MICE; TRANSCRIPTION; DEGRADATION; ACTIVATION; INHIBITOR	Recent progress has been made on the role of oncoproteins c-Ski and related SnoN in the control of cellular transformation. c-Ski/SnoN potently repress transforming growth factor-beta (TGF-beta) antiproliferative signaling through physical interaction with signal transducers called Smads. Overexpression of c-Ski/SnoN also induces skeletal muscle differentiation, but how c-Ski/SnoN function in myogenesis is largely unknown. During our investigation on the role of sumoylation in TGF-beta signaling, we inadvertently found that SnoN is modified by small ubiquitin-like modifier-1 (SUMO-1). Here, we biochemically characterize SnoN sumoylation in detail and report the physiological function of the modification. Sumoylation occurs primarily at lysine 50 (Lys-50). PIAS1 and PIASx proteins physically interact with SnoN to stimulate its surnoylation, thus serving as SUMO-protein isopeptide ligases (E3) for SnoN surnoylation. SnoN surnoylation does not alter its metabolic stability or its ability to repress TGF-beta signaling. Notably, loss of surnoylation in the Lys-50 site (via a Lys-to-Arg point mutation) potently activates muscle-specific gene expression and enhances myotube formation. Our study suggests a novel role for SUMO modification in the regulation of myogenic differentiation.	Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, Houston, TX 77030 USA; Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California Berkeley	Lin, X (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	xialin@bcm.edu		Liu, Mingyao/0000-0001-7339-5048; Wrighton, Katharine/0000-0001-7075-3399	NCI NIH HHS [R21CA11293, R01CA108454] Funding Source: Medline; NHLBI NIH HHS [R01HL06792] Funding Source: Medline; NIDDK NIH HHS [P50DK064233] Funding Source: Medline; NIGMS NIH HHS [R01GM63773] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; BOYER PL, 1993, ONCOGENE, V8, P457; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; ENGERT JC, 1995, NUCLEIC ACIDS RES, V23, P2988, DOI 10.1093/nar/23.15.2988; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Stroschein SL, 2001, GENE DEV, V15, P2822; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3	18	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6517	6524		10.1074/jbc.M610206200	http://dx.doi.org/10.1074/jbc.M610206200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202138	hybrid			2022-12-27	WOS:000244867200059
J	Deka, RK; Brautigam, CA; Tomson, FL; Lumpkins, SB; Tomchick, DR; Machius, M; Norgard, MV				Deka, Rani K.; Brautigam, Chad A.; Tomson, Farol L.; Lumpkins, Sarah B.; Tomchick, Diana R.; Machius, Mischa; Norgard, Michael V.			Crystal structure of the Tp34 (TP0971) lipoprotein of Treponema pallidum - Implications of its metal-bound state and affinity for human lactoferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI LIPOPROTEINS; 34-KILODALTON MEMBRANE IMMUNOGEN; MEDIATED ELECTRON-TRANSFER; OUTER-MEMBRANE; SUPEROXIDE REDUCTASE; BINDING PROTEIN; ATP-BINDING; IRON ACQUISITION; L-METHIONINE; SEQUENCE	The Tp34 (TP0971) membrane lipoprotein of Treponema pallidum, an obligate human pathogen and the agent of syphilis, was previously reported to have lactoferrin binding properties. Given the non-cultivatable nature of T. pallidum, a structure-to-function approach was pursued to clarify further potential relationships between the Tp34 structural and biochemical properties and its propensity to bind human lactorferrin. The crystal structure of a nonacylated, recombinant form of Tp34 (rTp34), solved to a resolution of 1.9 angstrom, revealed two metal-occupied binding sites within a dimer; the identity of the ion most likely was zinc. Residues from both of the monomers contributed to the interfacial metal-binding sites; a novel feature was that the delta-sulfur of methionine coordinated the zinc ion. Analytical ultracentrifugation showed that, in solution, rTp34 formed a metal-stabilized dimer and that rTp34 bound human lactorferrin with a stoichiometry of 2:1. Isothermal titration calorimetry further revealed that rTp34 bound human lactoferrin at high (submicromolar) affinity. Finally, membrane topology studies revealed that native Tp34 is not located on the outer surface (outer membrane) of T. pallidum but, rather, is periplasmic. How propensity of Tp34 to bind zinc and the iron-sequestering lactoferrin may relate overall to the biology of T. pallidum infection in humans is discussed.	Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Oklahoma, Norman, OK 73019 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman	Norgard, MV (corresponding author), Univ Texas, SW Med Ctr, Dept Microbiol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.norgard@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643; Brautigam, Chad/0000-0001-6563-1338	NIAID NIH HHS [AI-56305] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056305] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akins DR, 1997, J BACTERIOL, V179, P5076, DOI 10.1128/jb.179.16.5076-5086.1997; ALDERETE JF, 1988, GENITOURIN MED, V64, P359; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; Auchere F, 2006, J BIOL INORG CHEM, V11, P433, DOI 10.1007/s00775-006-0090-0; Auchere F, 2004, J BIOL INORG CHEM, V9, P839, DOI 10.1007/s00775-004-0584-6; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BECKER PS, 1994, INFECT IMMUN, V62, P1381, DOI 10.1128/IAI.62.4.1381-1391.1994; BELTRAMI JF, 2006, MMWR-MORBID MORTAL W, V55, P269; Bertini I., 1994, BIOINORG CHEM, P37; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brautigam CA, 2004, J BIOL CHEM, V279, P11948, DOI 10.1074/jbc.M312015200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; CHAKRABARTI P, 1989, BIOCHEMISTRY-US, V28, P6081, DOI 10.1021/bi00440a052; CHAMBERLAIN NR, 1989, INFECT IMMUN, V57, P2872, DOI 10.1128/IAI.57.9.2872-2877.1989; Clarke Teresa E., 2001, Current Topics in Medicinal Chemistry, V1, P7, DOI 10.2174/1568026013395623; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; COX DL, 1990, APPL ENVIRON MICROB, V56, P3063, DOI 10.1128/AEM.56.10.3063-3072.1990; COX DL, 1995, MOL MICROBIOL, V15, P1151, DOI 10.1111/j.1365-2958.1995.tb02288.x; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Deka RK, 2004, J BIOL CHEM, V279, P55644, DOI 10.1074/jbc.M409263200; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Hardham JM, 1997, GENE, V197, P47, DOI 10.1016/S0378-1119(97)00234-5; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JONES SA, 1984, J EXP MED, V160, P1404, DOI 10.1084/jem.160.5.1404; Jovanovic T, 2000, J BIOL CHEM, V275, P28439, DOI 10.1074/jbc.M003314200; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lombard M, 2000, J BIOL CHEM, V275, P27021; MASSON PL, 1968, EUR J BIOCHEM, V6, P579, DOI 10.1111/j.1432-1033.1968.tb00484.x; MIETZNER TA, 1994, ANNU REV NUTR, V14, P471, DOI 10.1146/annurev.nu.14.070194.002351; Moore SA, 1997, J MOL BIOL, V274, P222, DOI 10.1006/jmbi.1997.1386; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; RADOLF JD, 1995, J IMMUNOL, V154, P2866; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; Radolf Justin D., 1994, Trends in Microbiology, V2, P307, DOI 10.1016/0966-842X(94)90446-4; ROBERTSON SM, 1982, INFECT IMMUN, V36, P1076, DOI 10.1128/IAI.36.3.1076-1085.1982; Santos-Silva T, 2006, J BIOL INORG CHEM, V11, P548, DOI 10.1007/s00775-006-0104-y; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; STAGGS TM, 1994, MOL MICROBIOL, V12, P613, DOI 10.1111/j.1365-2958.1994.tb01048.x; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; SWANCUTT MA, 1989, INFECT IMMUN, V57, P3314, DOI 10.1128/IAI.57.11.3314-3323.1989; SWANCUTT MA, 1990, INFECT IMMUN, V58, P384, DOI 10.1128/IAI.58.2.384-392.1990; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Theil E. C., 1994, BIOINORG CHEM, P1; THURNIGER A, 2006, PROTEINS, V62, P827; WEIGEL LM, 1994, P NATL ACAD SCI USA, V91, P11611, DOI 10.1073/pnas.91.24.11611; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	89	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5944	5958		10.1074/jbc.M610215200	http://dx.doi.org/10.1074/jbc.M610215200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192261	hybrid			2022-12-27	WOS:000244482300090
J	Gusdon, AM; Votyakova, TV; Reynolds, IJ; Mathews, CE				Gusdon, Aaron M.; Votyakova, Tatyana V.; Reynolds, Ian J.; Mathews, Clayton E.			Nuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME GENE-EXPRESSION; BETA-CELL DESTRUCTION; UBIQUINONE OXIDOREDUCTASE; NITRIC-OXIDE; COMPLEX-I; ANTIOXIDANT DEFENSE; FAS LIGAND; AUTOIMMUNE DESTRUCTION; ALLOXAN-RESISTANT; PANCREATIC-ISLETS	NADH dehydrogenase subunit 2, encoded by the mtDNA, has been associated with resistance to autoimmune type I diabetes (T1D) in a case control study. Recently, we confirmed a role for the mouse ortholog of the protective allele (mt-Nd2(a)) in resistance to T1D using genetic analysis of outcrosses between T1D-resistant ALR and T1D-susceptible NOD mice. We sought to determine the mechanism of disease protection by elucidating whether mt-Nd2(a) affects basal mitochondrial function or mitochondrial function in the presence of oxidative stress. Two fines of reciprocal conplastic mouse strains were generated: one with ALR nuclear DNA and NOD mtDNA (ALR.Mt(NOD)) and the reciprocal with NOD nuclear DNA and ALR mtDNA (NOD.Mt(ALR)). Basal mitochondrial respiration, transmembrane potential, and electron transport system enzymatic activities showed no difference among the strains. However, ALR.MtNOD mitochondria supported by either complex I or complex 11 substrates produced significantly more reactive oxygen species when compared with both parental strains, NOD.mt(ALR) or C57BL/6 controls. Nitric oxide inhibited respiration to a similar extent for mitochondria from the five strains due to competitive antagonism with molecular oxygen at complex IV. Superoxide and hydrogen peroxide generated by xanthine oxidase did not significantly decrease complex I function. The protein nitrating agents peroxynitrite or nitrogen dioxide radicals significantly decreased complex I function but with no significant difference among the five strains. In summary, mt-Nd2(a) does not confer elevated resistance to oxidative stress; however, it plays a critical role in the control of the mitochondrial reactive oxygen species production.	Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Diabet Inst,Rangos Res Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mathews, CE (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Diabet Inst,Rangos Res Ctr, 3460 5th Ave, Pittsburgh, PA 15213 USA.	cem65@pitt.edu	Reynolds, Ian Jeffery/ABH-3197-2020; Reynolds, Ian/C-4358-2008	Reynolds, Ian/0000-0003-3028-5070	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074656, R56DK074656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020899] Funding Source: NIH RePORTER; NIAID NIH HHS [AI056374] Funding Source: Medline; NIA NIH HHS [AG20899] Funding Source: Medline; NIDDK NIH HHS [DK074656, R01 DK074656] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bertera S, 2003, DIABETES, V52, P387, DOI 10.2337/diabetes.52.2.387; BIRCHMACHIN M, 2001, MITOCHONDRIA; Briehl M M, 1995, Cell Death Differ, V2, P41; Briehl MM, 1996, CELL DEATH DIFFER, V3, P63; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Flemming D, 2005, J MOL MICROB BIOTECH, V10, P208, DOI 10.1159/000091566; Friedrich T, 1998, BBA-BIOENERGETICS, V1365, P215, DOI 10.1016/S0005-2728(98)00070-X; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Gale E A, 1996, Horm Res, V45 Suppl 1, P39; Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; HORIO F, 1994, DIABETOLOGIA, V37, P22; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Itoh N, 1997, J EXP MED, V186, P613, DOI 10.1084/jem.186.4.613; Jekabsone A, 2003, J MOL CELL CARDIOL, V35, P803, DOI 10.1016/S0022-2828(03)00137-8; Kokaze A, 2004, J HUM HYPERTENS, V18, P41, DOI 10.1038/sj.jhh.1001632; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lizard G, 1998, FASEB J, V12, P1651, DOI 10.1096/fasebj.12.15.1651; Marques FD, 2003, BRAIN RES, V964, P153, DOI 10.1016/S0006-8993(02)04118-5; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8; Mathews CE, 2003, IMMUNOGENETICS, V55, P491, DOI 10.1007/s00251-003-0603-8; Mathews CE, 1999, DIABETES, V48, P2189, DOI 10.2337/diabetes.48.11.2189; Mathews CE, 2001, P NATL ACAD SCI USA, V98, P235, DOI 10.1073/pnas.98.1.235; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500; NERUP J, 1988, DIABETES CARE, V11, P16; Nomura K, 2001, BIOL SIGNAL RECEPT, V10, P81; Petrovsky N, 2002, ANN NY ACAD SCI, V958, P204; Pomerleau DP, 2005, DIABETES, V54, P1603, DOI 10.2337/diabetes.54.5.1603; Raha S, 2002, FREE RADICAL BIO MED, V32, P421, DOI 10.1016/S0891-5849(01)00816-4; Ringquist S, 2004, HUM IMMUNOL, V65, P163, DOI 10.1016/j.humimm.2003.11.003; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SEKIGUCHI F, 1990, EXP ANIM TOKYO, V39, P269, DOI 10.1538/expanim1978.39.2_269; Silva DG, 2003, ANN NY ACAD SCI, V1005, P161, DOI 10.1196/annals.1288.018; Silva DG, 2003, J IMMUNOL, V170, P4996, DOI 10.4049/jimmunol.170.10.4996; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Suarez-Pinzon WL, 2000, DIABETOLOGIA, V43, P1149, DOI 10.1007/s001250051506; Suarez-Pinzon WL, 2001, J AUTOIMMUN, V16, P449, DOI 10.1006/jaut.2001.0507; Tabatabaie T, 2000, BIOCHEM BIOPH RES CO, V273, P699, DOI 10.1006/bbrc.2000.2959; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Uchigata Y, 2002, DIABETES CARE, V25, P2106, DOI 10.2337/diacare.25.11.2106; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yao YG, 2002, HUM GENET, V111, P462, DOI 10.1007/s00439-002-0826-z; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103	60	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5171	5179		10.1074/jbc.M609367200	http://dx.doi.org/10.1074/jbc.M609367200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189252	hybrid			2022-12-27	WOS:000244482300011
J	Klein, DC				Klein, David C.			Arylalkylamine N-acetyltransferase: "the timezyme"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MELATONIN RHYTHM ENZYME; PROTEIN-KINASE-C; HYDROXYINDOLE-O-METHYLTRANSFERASE; BETA-ADRENERGIC STIMULATION; RETINAL PHOTORECEPTOR CELLS; MAMMALIAN PINEAL-GLAND; OTX2 HOMEOBOX GENE; RAT PINEALOCYTES; EC 2.3.1.87; E-BOX	Arylalkylamine N-acetyltransferase controls daily changes in melatonin production by the pineal gland and thereby plays a unique role in biological timing in vertebrates. Arylalkylamine N-acetyltransferase is also expressed in the retina, where it may play other roles in addition to signaling, including neurotransmission and detoxification. Large changes in activity reflect cyclic 3,5'-adenosine monophosphate-dependent phosphorylation of arylalkylamine N-acetyltransferase, leading to formation of a regulatory complex with 14-3-3 proteins. This activates the enzyme and prevents proteosomal. proteolysis. The conserved features of regulatory systems that control arylalkylamine N-acetyltransferase are a circadian clock and environmental lighting.	NICHD, Off Sci Director, Sect Neuroendocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Klein, DC (corresponding author), NICHD, Off Sci Director, Sect Neuroendocrinol, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Klein, David/0000-0002-1792-5806	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008836] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200; Appelbaum L, 2004, MOL ENDOCRINOL, V18, P1210, DOI 10.1210/me.2003-0439; Arendt J., 1995, MELATONIN MAMMALIAN; Baler R, 1999, BIOL CELL, V91, P699, DOI 10.1016/S0248-4900(00)88533-0; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Bernard M, 2001, J NEUROCHEM, V79, P248, DOI 10.1046/j.1471-4159.2001.00555.x; BERNARD M, 1995, BRAIN RES, V696, P37, DOI 10.1016/0006-8993(95)00651-6; Besseau L, 2006, EXP EYE RES, V82, P620, DOI 10.1016/j.exer.2005.08.025; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Burke Z, 1999, J NEUROCHEM, V73, P1343, DOI 10.1046/j.1471-4159.1999.0731343.x; Chansard M, 2006, J PINEAL RES, V41, P85, DOI 10.1111/j.1600-079X.2006.00341.x; Chaurasia SS, 2006, MOL VIS, V12, P215; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 1999, J BIOL CHEM, V274, P9076, DOI 10.1074/jbc.274.13.9076; Coon SL, 2002, J CLIN ENDOCR METAB, V87, P4699, DOI 10.1210/jc.2002-020683; Coon SL, 2001, J BIOL CHEM, V276, P24097, DOI 10.1074/jbc.M011298200; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Falcon J, 2003, J NEUROENDOCRINOL, V15, P378, DOI 10.1046/j.1365-2826.2003.00993.x; Ferry G, 2004, PROTEIN EXPRES PURIF, V38, P84, DOI 10.1016/j.pep.2004.07.004; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Ferry G, 2000, J BIOL CHEM, V275, P39799; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; Fukuhara C, 2005, J NEUROCHEM, V93, P156, DOI 10.1111/j.1471-4159.2004.03008.x; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Ganguly S, 2002, CELL TISSUE RES, V309, P127, DOI 10.1007/s00441-002-0579-y; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Ganguly S, 2001, J BIOL CHEM, V276, P47239, DOI 10.1074/jbc.M107222200; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hintermann E, 1996, P NATL ACAD SCI USA, V93, P12315, DOI 10.1073/pnas.93.22.12315; Ho AK, 2006, CHRONOBIOL INT, V23, P361, DOI 10.1080/07420520500464536; HO AK, 1988, J BIOL CHEM, V263, P9292; HO AK, 1987, J BIOL CHEM, V262, P11764; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Iuvone PM, 1997, BIOL SIGNAL, V6, P217; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; KLEIN DC, 1985, CIBA F SYMP, V117, P38; Klein DC, 2004, J BIOL RHYTHM, V19, P264, DOI 10.1177/0748730404267340; Klein DC, 2002, BIOCHEM SOC T, V30, P365, DOI 10.1042/bst0300365; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; KLEIN DC, 1983, P NATL ACAD SCI-BIOL, V80, P599, DOI 10.1073/pnas.80.2.599; Klein DC, 1998, HDB BEHAV STATE CONT, P45; Korf HW, 2003, CHRONOBIOL INT, V20, P697, DOI 10.1081/CBI-120022415; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Mesangeau C, 2003, J ENZYM INHIB MED CH, V18, P119, DOI 10.1080/1475636031000093552; Munoz E, 2003, CHRONOBIOL INT, V20, P371, DOI 10.1081/CBI-120022525; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; NAMBOODIRI MAA, 1982, J BIOL CHEM, V257, P30; NAMBOODIRI MAA, 1980, J BIOL CHEM, V255, P6032; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pozdeyev N, 2006, J NEUROSCI, V26, P9153, DOI 10.1523/JNEUROSCI.1384-06.2006; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Schomerus C, 2000, J NEUROCHEM, V75, P2123, DOI 10.1046/j.1471-4159.2000.0752123.x; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Stehle JH, 2003, J NEUROENDOCRINOL, V15, P383, DOI 10.1046/j.1365-2826.2003.01001.x; SUGDEN AL, 1986, J BIOL CHEM, V261, P1608; SUGDEN D, 1985, NATURE, V314, P359, DOI 10.1038/314359a0; SUGDEN LA, 1987, J BIOL CHEM, V262, P741; Tsuboi S, 2002, J BIOL CHEM, V277, P44229, DOI 10.1074/jbc.M203305200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wolf E, 2002, J MOL BIOL, V317, P215, DOI 10.1006/jmbi.2001.5371; YU L, 1993, J NEUROCHEM, V60, P1436, DOI 10.1111/j.1471-4159.1993.tb03306.x; Zheng WP, 2005, J BIOL CHEM, V280, P10462, DOI 10.1074/jbc.M412283200; Zheng WP, 2003, NAT STRUCT BIOL, V10, P1054, DOI 10.1038/nsb1005; Zilberman-Peled B, 2006, BRAIN RES, V1073, P220, DOI 10.1016/j.brainres.2005.12.028	89	302	315	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4233	4237		10.1074/jbc.R600036200	http://dx.doi.org/10.1074/jbc.R600036200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164235	hybrid			2022-12-27	WOS:000244482000002
J	Kruglik, SG; Lambry, JC; Cianetti, S; Martin, JL; Eady, RR; Andrew, CR; Negrerie, M				Kruglik, Sergei G.; Lambry, Jean-Christophe; Cianetti, Simona; Martin, Jean-Louis; Eady, Robert R.; Andrew, Colin R.; Negrerie, Michel			Molecular basis for nitric oxide dynamics and affinity with Alcaligenes xylosoxidans cytochrome c '	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; RESOLVED RESONANCE RAMAN; HEME-BASED SENSORS; SP NCIB 11015; LIGAND-BINDING; GEMINATE RECOMBINATION; RHODOBACTER-CAPSULATUS; MYOGLOBIN MUTANT; NO; SPECTROSCOPY	The bacterial heme protein cytochrome c' from Alcaligenes xylosoxidans (AXCP) reacts with nitric oxide (NO) to form a 5-coordinate ferrous nitrosyl heme complex. The crystal structure of ferrous nitrosyl AXCP has previously revealed that NO is bound in an unprecedented manner on the proximal side of the heme. To understand how the protein structure of AXCP controls NO dynamics, we performed absorption and Raman time-resolved studies at the heme level as well as a molecular computational dynamics study at the entire protein structure level. We found that after NO dissociation from the heme iron, the structure of the proximal heme pocket of AXCP confines NO close to the iron so that an ultrafast (7 ps) and complete (99 +/- 1%) geminate rebinding occurs, whereas the proximal histidine does not rebind to the heme iron on the timescale of NO geminate rebinding. The distal side controls the initial NO binding, whereas the proximal heme pocket controls its release. These dynamic properties allow the trapping of NO within the protein core and represent an extreme behavior observed among heme proteins.	Ecole Polytech, Lab Opt Biosci, INSERM, U696, F-91128 Palaiseau, France; Univ Paris 06, CNRS, UMR 7033, BioMoCeTi, F-91030 Evry, France; INSERM, U696, F-91128 Palaiseau, France; John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; Eastern Oregon Univ, Dept Chem & Biochem, La Grande, OR 97850 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Eastern Oregon University	Negrerie, M (corresponding author), Ecole Polytech, Lab Opt Biosci, INSERM, U696, F-91128 Palaiseau, France.	michel.negrerie@polytechnique.fr	Negrerie, Michel/L-2283-2018; Kruglik, Sergei/F-7042-2012	Negrerie, Michel/0000-0001-9918-031X; Kruglik, Sergei/0000-0002-2945-3092; Lambry, Jean-Christophe/0000-0001-8264-0391				ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; AMBLER RP, 1973, BIOCHEM J, V135, P751, DOI 10.1042/bj1350751; Andrew CR, 2005, BIOCHEMISTRY-US, V44, P8664, DOI 10.1021/bi050428g; Andrew CR, 2003, J AM CHEM SOC, V125, P9548, DOI 10.1021/ja035105r; Andrew CR, 2002, BIOCHEMISTRY-US, V41, P2353, DOI 10.1021/bi011419k; Andrew CR, 2001, BIOCHEMISTRY-US, V40, P4115, DOI 10.1021/bi0023652; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunori M, 1999, BIOPHYS J, V76, P1259, DOI 10.1016/S0006-3495(99)77289-9; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Choi PS, 2005, J BACTERIOL, V187, P4077, DOI 10.1128/JB.187.12.4077-4085.2005; Chowdhury PK, 2003, J PHYS CHEM B, V107, P9122, DOI 10.1021/jp030106r; Cianetti S, 2004, J AM CHEM SOC, V126, P13932, DOI 10.1021/ja046442i; Cross R, 2000, J BACTERIOL, V182, P1442, DOI 10.1128/JB.182.5.1442-1447.2000; Cross R, 2001, J BACTERIOL, V183, P3050, DOI 10.1128/JB.183.10.3050-3054.2001; Decatur SM, 1996, BIOCHEMISTRY-US, V35, P4939, DOI 10.1021/bi951661p; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DUPRAT AF, 1995, BIOCHEMISTRY-US, V34, P2634, DOI 10.1021/bi00008a030; FINDSEN EW, 1988, J PHYS CHEM-US, V92, P307, DOI 10.1021/j100313a014; Franzen S, 2002, P NATL ACAD SCI USA, V99, P16754, DOI 10.1073/pnas.252590999; George SJ, 2001, J AM CHEM SOC, V123, P9683, DOI 10.1021/ja0158307; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; IKEDASAITO M, 1993, J BIOL CHEM, V268, P6855; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kholodenko Y, 1999, BIOCHEMISTRY-US, V38, P5918, DOI 10.1021/bi983022v; Kruglik SG, 2001, J PHYS CHEM B, V105, P5018, DOI 10.1021/jp004207q; LAMBRY JC, 1997, THESIS PARIS SUD U O; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Marti MA, 2005, J AM CHEM SOC, V127, P7721, DOI 10.1021/ja042870c; MARTIN JL, 1992, ANNU REV BIOPH BIOM, V21, P199, DOI 10.1146/annurev.bb.21.060192.001215; Mayburd AL, 2002, BIOCHEMISTRY-US, V41, P11582, DOI 10.1021/bi020058l; Meuwly M, 2002, BIOPHYS CHEM, V98, P183, DOI 10.1016/S0301-4622(02)00093-5; Negrerie M, 2006, J BIOL CHEM, V281, P10389, DOI 10.1074/jbc.M513375200; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Negrerie M, 1999, J BIOL CHEM, V274, P24694, DOI 10.1074/jbc.274.35.24694; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; NORRIS GE, 1979, J MOL BIOL, V135, P309, DOI 10.1016/0022-2836(79)90357-7; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PARTHASARATHI N, 1987, J AM CHEM SOC, V109, P3865, DOI 10.1021/ja00247a009; PETRICH JW, 1994, J MOL BIOL, V238, P437, DOI 10.1006/jmbi.1994.1302; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; PETRICH JW, 1991, BIOCHEMISTRY-US, V30, P3975, DOI 10.1021/bi00230a025; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Romao M. J., 2001, HDB METALLOPROTEINS, P44; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; YOSHIMURA T, 1986, BIOCHEMISTRY-US, V25, P2436, DOI 10.1021/bi00357a021; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	54	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					5053	5062		10.1074/jbc.M604327200	http://dx.doi.org/10.1074/jbc.M604327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17158883	hybrid			2022-12-27	WOS:000244482000088
J	Visser, F; Valsecchi, V; Annunziato, L; Lytton, J				Visser, Frank; Valsecchi, Valeria; Annunziato, Lucio; Lytton, Jonathan			Analysis of ion interactions with the K+-dependent Na+/Ca2+ exchangers NCKX2, NCKX3, and NCKX4 - Identification of THR-551 as a key residue in defining the apparent K+ affinity of NCKX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; BINDING POCKET; GENE FAMILY; CA2+; TOPOLOGY; MUTAGENESIS; TRANSPORT; SEGMENTS	K+-dependent Na+/Ca2+ exchangers (NCKX) catalyze cytosolic Ca2+ extrusion and are particularly important for neuronal Ca2+ signaling. Of the five mammalian isoforms, the detailed functional characteristics have only been reported for NCKX1 and -2. In the current study, the functional characteristics of recombinant NCKX3 and -4 expressed in HEK293 cells were determined and compared with those of NCKX2. Although the apparent affinities of the three isoforms for Ca2+ and Na+ were similar, NCKX3 and -4 displayed similar to 40-fold higher affinities for K+ ions than NCKX2. Functional analysis of various NCKX2 mutants revealed that mutation of Thr-551 to Ala, the corresponding residue in NCKX4, resulted in an apparent K+ affinity shift to one similar to that of NCKX4 without a parallel shift in apparent Ca2+ affinity. In the converse situation, when Gln-476 of NCKX4 was converted to Lys, the corresponding residue in NCKX2, both the K+ and Ca2+ affinities were reduced. These results indicate that the apparently low K+ affinity of NCKX2 requires a Thr residue at position 551 that may reduce the conformational flexibility and/or K+ liganding strength of side-chain moieties on critical neighboring residues. This interaction appears to be specific to the structural context of the NCKX2 K+ binding pocket, because it was not possible to recreate the K+-specific low affinity phenotype with reciprocal mutations in NCKX4. The results of this study provide important information about the structure and function of NCKX proteins and will be critical to understanding their roles in neuronal Ca2+ signaling.	Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Naples Federico II, Div Pharmacol, Dept Neurosci, Sch Med, I-80131 Naples, Italy	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Naples Federico II	Lytton, J (corresponding author), Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada.	jlytton@ucalgary.ca		Lytton, Jonathan/0000-0003-4770-2512; valsecchi, valeria/0000-0003-3625-8495; ANNUNZIATO, LUCIO/0000-0002-8534-8270				Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AUSUBEL FM, 2006, CURRNET PROTOCOLS MO; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cai XJ, 2002, J BIOL CHEM, V277, P48923, DOI 10.1074/jbc.M208818200; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; FONTANA G, 1995, J PHYSIOL-LONDON, V485, P349, DOI 10.1113/jphysiol.1995.sp020734; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iwamoto T, 1999, J BIOL CHEM, V274, P23094, DOI 10.1074/jbc.274.33.23094; Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; KOMURO I, 1992, P NATL ACAD SCI USA, V89, P4769, DOI 10.1073/pnas.89.10.4769; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee JY, 2006, J BIOL CHEM, V281, P39205, DOI 10.1074/jbc.M606287200; Lee SH, 2002, J NEUROSCI, V22, P6891; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Quednau BD, 2004, PFLUG ARCH EUR J PHY, V447, P543, DOI 10.1007/s00424-003-1065-4; REEVES JP, 1983, J BIOL CHEM, V258, P3178; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P189; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P22975; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	41	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4453	4462		10.1074/jbc.M610582200	http://dx.doi.org/10.1074/jbc.M610582200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17172467	hybrid			2022-12-27	WOS:000244482000026
J	Altimimi, HF; Schnetkamp, PPM				Altimimi, Haider F.; Schnetkamp, Paul P. M.			Na+-dependent inactivation of the retinal cone/brain Na+/Ca2+-K+ exchanger NCKX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; SODIUM-CALCIUM EXCHANGER; NA/CA-K EXCHANGER; MOLECULAR-CLONING; NA+-CA2+ EXCHANGER; POSTTETANIC POTENTIATION; CONE PHOTORECEPTORS; CA2+ CONCENTRATION; BINDING POCKET; AXON TERMINALS	The SLC24 gene family Na+/Ca2+-K+ exchangers (NCKX) are bidirectional plasma membrane transporters whose main function is the extrusion of Ca2+ from the cytosol. In this study, we used human embryonic kidney 293 cells expressing human retinal cone/brain NCKX2 to examine its Na+ affinity and kinetic parameters of Ca2+ transport. With the use of the ionophore gramicidin to control alkali cation concentrations across the plasma membrane, application of high intracellular Na+ promoted large NCKX2-mediated increases in intracellular free Ca2+ in the 15-20 mu M range; this also resulted in inactivation of NCKX2 transport, the first description of this novel kinetic state. The affinity of NCKX2 for internal Na+ was found to be sigmoidal, with a Hill coefficient of 2.6 and K-d = 50 mm. The time-dependent (t1/2 similar to 40s) inactivation of NCKX2 required high intracellular Na+ levels (K-d > 50 mM) as well as high occupancy of the extracellular Ca2+-binding site. Also reported are two residues whose substitution resulted in an increase in internal Na+ affinity to values of similar to 19 mm; these mutants also displayed enhanced inactivation, suggesting that inactivation requires binding of Na+ to its intracellular transport sites. These findings are the first report of a regulatory kinetic state of Ca2+ transport via NCKX2 Na+/Ca2+-K+ exchangers that may play a prominent role in regulation of Ca2+ extrusion in cellular environments such as neuronal synapses that experience frequent and dynamic Ca2+ fluxes.	Univ Calgary, Dept Physiol & Biophys, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Calgary	Schnetkamp, PPM (corresponding author), Univ Calgary, Dept Physiol & Biophys, Fac Med, Hotchkiss Brain Inst, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pschnetk@ucalgary.ca	Altimimi, Haider/K-8658-2012	Altimimi, Haider/0000-0002-4516-141X				Bogeski I, 2006, CELL CALCIUM, V40, P1, DOI 10.1016/j.ceca.2006.03.003; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Cooper CB, 2000, METHOD ENZYMOL, V315, P847; Dong H, 2001, J BIOL CHEM, V276, P25919, DOI 10.1074/jbc.M103401200; Garcia-Chacon LE, 2006, J PHYSIOL-LONDON, V574, P663, DOI 10.1113/jphysiol.2006.110841; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; Kang K, 2003, BIOCHEMISTRY-US, V42, P9438, DOI 10.1021/bi0342261; Kang KJ, 2005, J BIOL CHEM, V280, P6834, DOI 10.1074/jbc.M412933200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kim MH, 2003, J NEUROSCI, V23, P11673; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee SH, 2002, J NEUROSCI, V22, P6891; LEE SL, 1994, J BIOL CHEM, V269, P14849; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; LI ZP, 1994, J BIOL CHEM, V269, P17434; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Opuni K, 2000, J BIOL CHEM, V275, P21549, DOI 10.1074/jbc.M003158200; Paillart C, 2007, J GEN PHYSIOL, V129, P1, DOI 10.1085/jgp.200609652; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Prinsen CFM, 2002, ADV EXP MED BIOL, V514, P237; Quednau BD, 2004, PFLUG ARCH EUR J PHY, V447, P543, DOI 10.1007/s00424-003-1065-4; REGEHR WG, 1994, J NEUROSCI, V14, P523; SCHNETKAMP PPM, 1991, J GEN PHYSIOL, V98, P555, DOI 10.1085/jgp.98.3.555; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P189; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P22983; SCHNETKAMP PPM, 1995, AM J PHYSIOL-CELL PH, V269, pC1153, DOI 10.1152/ajpcell.1995.269.5.C1153; SCHNETKAMP PPM, 1991, J BIOL CHEM, V266, P22975; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; SCHNETKAMP PPM, 1995, J BIOL CHEM, V270, P13231, DOI 10.1074/jbc.270.22.13231; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; SCHNETKAMP PPM, 1995, BIOCHEMISTRY-US, V34, P7282, DOI 10.1021/bi00021a045; Sheng JZ, 2000, BIOPHYS J, V79, P1945, DOI 10.1016/S0006-3495(00)76443-5; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Tanneur V, 2002, PFLUG ARCH EUR J PHY, V445, P74, DOI 10.1007/s00424-002-0859-0; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; YAU KW, 1984, NATURE, V309, P352, DOI 10.1038/309352a0; Zhong N, 2001, J NEUROSCI, V21, P9598, DOI 10.1523/JNEUROSCI.21-24-09598.2001	47	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3720	3729		10.1074/jbc.M609285200	http://dx.doi.org/10.1074/jbc.M609285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17164249	hybrid			2022-12-27	WOS:000244481900035
J	Jiang, HY; Jiang, L; Wek, RC				Jiang, Hao-Yuan; Jiang, Li; Wek, Ronald C.			The eukaryotic initiation factor-2 kinase pathway facilitates differential GADD45a expression in response to environmental stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 2-ALPHA KINASE; NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; INDUCED GENE-EXPRESSION; CELL-CYCLE; GENOMIC INSTABILITY; ARSENIC TRIOXIDE; RISK-ASSESSMENT; ALPHA-SUBUNIT	Phosphorylation of eukaryotic initiation factor-2 (eIF2) regulates general and gene-specific translation in response to diverse environmental stresses. Central to gene expression induced by eIF2 phosphorylation is the preferential translation of ATF4, a basic zipper transcription activator. Phosphorylation of eIF2 and its attendant induction of ATF4 can lead to different patterns of gene expression depending on the environmental stress. This is of fundamental importance because eIF2 kinases can induce the expression of genes involved in survival as well as in apoptosis. In this report, we explore the molecular basis for why there can be differential expression of GADD45a, a stress-responsive protein that regulates genome stability, apoptosis, and immune responses. We find that whereas ATF4 is required for GADD45a transcription during many different environmental stresses, GADD45a protein accumulates only during a limited number of stress arrangements. The basis for this difference between measurable GADD45a mRNA and protein lies in the observation that GADD45a protein is labile. Those stress agents that enhance ATF4-directed GADD45a transcription and impede the turnover of GADD45a protein by blocking ubiquitin/proteasome-mediated degradation elevate GADD45a protein levels. By comparison, those stress arrangements that trigger ATF4 levels and GADD45a transcription, but do not perturb the proteasome pathway, only elevate GADD45a mRNA levels. This study highlights the molecular mechanisms by which environmental stresses can differentially control central regulatory proteins targeted by the eIF2 kinase pathway.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu						Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; Antman KH, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_2-1; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hildesheim J, 2002, CLIN CANCER RES, V8, P2475; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jiang HY, 2002, J VIROL, V76, P5737, DOI 10.1128/JVI.76.11.5737-5747.2002; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; KLEMPERER NS, 1989, J BIOL CHEM, V264, P19245; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Owen CR, 2005, J NEUROCHEM, V94, P1235, DOI 10.1111/j.1471-4159.2005.03276.x; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Rust DM, 2001, ONCOLOGIST, V6, P29, DOI 10.1634/theoncologist.6-suppl_2-29; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Sheikh MS, 2000, BIOCHEM PHARMACOL, V59, P43, DOI 10.1016/S0006-2952(99)00291-9; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; Tchounwou PB, 2004, MOL CELL BIOCHEM, V255, P47, DOI 10.1023/B:MCBI.0000007260.32981.b9; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; Zhan QM, 1996, DNA CELL BIOL, V15, P805, DOI 10.1089/dna.1996.15.805; ZHAN QM, 1994, CANCER RES, V54, P2755	62	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3755	3765		10.1074/jbc.M606461200	http://dx.doi.org/10.1074/jbc.M606461200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17170114	hybrid			2022-12-27	WOS:000244481900039
J	Ma, CP; Lu, XZ; Shi, C; Li, JB; Gu, YC; Ma, YM; Chu, Y; Han, F; Gong, QH; Yu, WG				Ma, Cuiping; Lu, Xinzhi; Shi, Chao; Li, Jingbao; Gu, Yuchao; Ma, Yiming; Chu, Yan; Han, Feng; Gong, Qianhong; Yu, Wengong			Molecular cloning and characterization of a novel beta-agarase, AgaB, from marine Pseudoalteromonas sp CY24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SEQUENCE-BASED CLASSIFICATION; SP STRAIN JT0107; PSEUDOMONAS-ATLANTICA; GLYCOSYL HYDROLASES; BACILLUS-LICHENIFORMIS; ALPHA-AGARASE; ACTIVE-SITE; CARBOXYLIC RESIDUES; NUCLEOTIDE-SEQUENCE	Agarases are generally classified into glycoside hydrolase families 16, 50, and 86 and are found to degrade agarose to frequently generate neoagarobiose, neoagarotetraose, or neoagarohexaose as the main products. In this study we have cloned a novel endo-type beta-agarase gene, agaB, from marine Pseudoalteromonas sp. CY24. The novel agarase encoded by agaB gene has no significant sequence similarity with any known proteins including all glycoside hydrolases. It degrades agarose to generate neoagarooctaose and neoagarodecaose as the main end products. Based on the analyses of enzymatic kinetics and degradation patterns of different oligosaccharides, the agarase AgaB appears to have a large substrate binding cleft that accommodates 12 sugar units, with 8 sugar units toward the reducing end spanning subsites + 1 to + 8 and 4 sugar units toward the non-reducing end spanning subsites -4 to -1, and enzymatic cleavage taking place between subsites -1 and +1. In addition, H-1 NMR analysis shows that this enzyme hydrolyzes the glycosidic bond with inversion of anomeric configuration, in contrast to other known agarases that are retaining. Altogether, AgaB is structurally and functionally different from other known agarases and appears to represent a new family of glycoside hydrolase.	Ocean Univ China, Dept Mol Biol, Marine Drug & Food Inst, Qingdao 266003, Peoples R China	Ocean University of China	Yu, WG (corresponding author), Ocean Univ China, Dept Mol Biol, Marine Drug & Food Inst, 5 Yushan Rd, Qingdao 266003, Peoples R China.	yuwg66@ouc.edu.cn		Ma, Cuiping/0000-0001-5491-7269				Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Araki T, 1998, J MAR BIOTECHNOL, V6, P193; ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6; BELAS R, 1989, J BACTERIOL, V171, P602, DOI 10.1128/jb.171.1.602-605.1989; BELAS R, 1988, APPL ENVIRON MICROB, V54, P30, DOI 10.1128/AEM.54.1.30-37.1988; BUTTNER MJ, 1987, MOL GEN GENET, V209, P101, DOI 10.1007/BF00329843; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DUCKWORTH M, 1969, BIOCHEM J, V113, P693, DOI 10.1042/bj1130693; GEBLER J, 1992, J BIOL CHEM, V267, P12559; GROLEAU D, 1977, CAN J MICROBIOL, V23, P672, DOI 10.1139/m77-100; Ha JC, 1997, BIOTECHNOL APPL BIOC, V26, P1; Hassairi I, 2001, BIORESOURCE TECHNOL, V79, P47, DOI 10.1016/S0960-8524(01)00037-2; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; Kandra L, 2003, FEBS LETT, V544, P194, DOI 10.1016/S0014-5793(03)00495-2; Kandra L, 2002, FEBS LETT, V518, P79, DOI 10.1016/S0014-5793(02)02649-2; Kobayashi R, 1997, BIOSCI BIOTECH BIOCH, V61, P162, DOI 10.1271/bbb.61.162; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAYE M, 1989, CARBOHYD RES, V190, P249, DOI 10.1016/0008-6215(89)84129-1; LAHAYE M, 1986, THESIS MCGILL U; MALMQVIST M, 1978, BIOCHIM BIOPHYS ACTA, V537, P31, DOI 10.1016/0005-2795(78)90600-1; MEULEN HJ, 1975, ANTON LEEUW INT J G, V41, P431; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2001, J BIOL CHEM, V276, P40202, DOI 10.1074/jbc.M100670200; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MORRICE LM, 1983, EUR J BIOCHEM, V137, P149, DOI 10.1111/j.1432-1033.1983.tb07808.x; MORRICE LM, 1983, EUR J BIOCHEM, V135, P553, DOI 10.1111/j.1432-1033.1983.tb07688.x; Ohta Y, 2004, APPL MICROBIOL BIOT, V64, P505, DOI 10.1007/s00253-004-1573-y; Ohta Y, 2005, CURR MICROBIOL, V50, P212, DOI 10.1007/s00284-004-4435-z; OLIVER JD, 1982, DEEP-SEA RES, V29, P795, DOI 10.1016/0198-0149(82)90007-3; OSCAR L, 1992, APPL ENVIRON MICROB, V58, P4060; Pitson SM, 1997, CARBOHYD RES, V303, P207, DOI 10.1016/S0008-6215(97)00159-6; PLANAS A, 1992, FEBS LETT, V308, P141, DOI 10.1016/0014-5793(92)81262-K; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; POTIN P, 1993, EUR J BIOCHEM, V214, P599, DOI 10.1111/j.1432-1033.1993.tb17959.x; ROCHAS C, 1986, CARBOHYD RES, V148, P199, DOI 10.1016/S0008-6215(00)90388-4; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schroeder DC, 2003, MICROBIOL-SGM, V149, P2919, DOI 10.1099/mic.0.26513-0; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SUGANO Y, 1993, APPL ENVIRON MICROB, V59, P1549; SUGANO Y, 1994, BBA-GENE STRUCT EXPR, V1218, P105, DOI 10.1016/0167-4781(94)90109-0; Vera J, 1998, APPL ENVIRON MICROB, V64, P4378; Weinberger F, 2001, J PHYCOL, V37, P418, DOI 10.1046/j.1529-8817.2001.037003418.x; YOSHIZAWA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P1933, DOI 10.1271/bbb.59.1933; Yu GL, 2002, CARBOHYD RES, V337, P433, DOI 10.1016/S0008-6215(02)00009-5; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001; Zverlov VV, 1998, FEMS MICROBIOL LETT, V164, P337, DOI 10.1016/S0378-1097(98)00236-5	52	77	90	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3747	3754		10.1074/jbc.M607888200	http://dx.doi.org/10.1074/jbc.M607888200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17166842	hybrid			2022-12-27	WOS:000244481900038
J	Dwyer, JR; Sever, N; Carlson, M; Nelson, SF; Beachy, PA; Parhami, F				Dwyer, Jennifer R.; Sever, Navdar; Carlson, Marc; Nelson, Stanley F.; Beachy, Philip A.; Parhami, Farhad			Oxysterols pathway in are novel activators of the hedgehog pluripotent mesenchymal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; OSTEOBLASTIC DIFFERENTIATION; SIGNAL-TRANSDUCTION; BONE; PROLIFERATION; EXPRESSION; STIMULATE; SENSORS; ROLES; ACTS	Pluripotent mesenchymal cells form a population of precursors to a variety of cell types, including osteoblasts and adipocytes. Aging tilts the balance in favor of adipocyte differentiation at the expense of osteoblast differentiation, resulting in reduced bone formation and osteopenic disorders, including osteoporosis, in humans and animals. Understanding the mechanisms involved in causing this apparent shift in differentiation and identifying factors that stimulate osteoblast formation while inhibiting adipogenesis are of great therapeutic interest. In this study we report that specific, naturally occurring oxysterols, previously shown to direct pluripotent mesenchymal cells toward an osteoblast lineage, exert their osteoinductive effects through activation of Hedgehog signaling pathway. This was demonstrated by 1) oxysterol-induced expression of the Hh target genes Gli-1 and Patched, 2) oxysterol-induced activation of a luciferase reporter driven by a multimerized Gli-responsive element, 3) inhibition of oxysterol effects by the hedgehog pathway inhibitor, cyclopamine, and 4) unresponsiveness of Smoothened(-/-) mouse embryonic fibroblasts to oxysterols. Using Patched(-/-) cells that possess high baseline Gli activity, we found that oxysterols did not dramatically shift the IC50 concentration of cyclopamine needed to inhibit Gli activity in these cells. Furthermore, binding studies showed that oxysterols did not compete with fluorescently labeled cyclopamine, BODIPY-cyclopamine, for direct binding to Smoothened. These findings demonstrate that oxysterols stimulate hedgehog pathway activity by indirectly activating the seven-transmembrane pathway component Smoothened. Osteoinductive oxysterols are, therefore, novel activators of the hedgehog pathway in pluripotent mesenchymal cells, and they may be important modulators of this critical signaling pathway that regulates numerous developmental and postdevelopmental processes.	Univ Calif Los Angeles, Hlth Sci Ctr, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University	Parhami, F (corresponding author), Univ Calif Los Angeles, Hlth Sci Ctr, David Geffen Sch Med, Dept Med, BH-307,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	fparhami@mednet.ucla.edu	Sever, Navdar/AAB-7906-2022; Nelson, Stanley F/D-4771-2009	Sever, Navdar/0000-0001-9462-7979; Nelson, Stanley F/0000-0002-2082-3114; Dwyer, Jennifer/0000-0002-5893-6026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050426] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30568] Funding Source: Medline; NIAMS NIH HHS [R01AR050426] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Edwards PA, 2002, J LIPID RES, V43, P2; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; Kha HT, 2004, J BONE MINER RES, V19, P830, DOI 10.1359/JBMR.040115; Krishnan V, 2001, ENDOCRINOLOGY, V142, P940, DOI 10.1210/en.142.2.940; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li C., 2003, ANAL GENE EXPRESSION, P120; Lin YY, 2003, J STEROID BIOCHEM, V85, P57, DOI 10.1016/S0960-0760(03)00137-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; RICHARDSON JA, 2006, IN PRESS J CELL BIOC; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhou QH, 2006, GENETICS, V173, P2049, DOI 10.1534/genetics.106.061036	42	228	244	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					8959	8968		10.1074/jbc.M611741200	http://dx.doi.org/10.1074/jbc.M611741200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17200122	hybrid			2022-12-27	WOS:000245780300042
J	Ciulli, A; Chirgadze, DY; Smith, AG; Blundell, TL; Abell, C				Ciulli, Alessio; Chirgadze, Dimitri Y.; Smith, Alison G.; Blundell, Tom L.; Abell, Chris			Crystal structure of Escherichia coli ketopantoate reductase in a ternary complex with NADP(+) and pantoate bound - Substrate recognition, conformational change, and cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; COENZYME-A; DEHYDROGENASE; BIOSYNTHESIS; INSIGHTS; SPECIFICITY; RESOLUTION; PROTEINS; TOOLS	Ketopantoate reductase (KPR, EC 1.1.1.169) catalyzes the NADPH-dependent reduction of ketopantoate to pantoate, an essential step for the biosynthesis of pantothenate (vitamin B.). Inhibitors of the enzymes of this pathway have been proposed as potential antibiotics or herbicides. Here we present the crystal structure of Escherichia coli KPR in a precatalytic ternary complex with NADP(+) and pantoate bound, solved to 2.3 angstrom of resolution. The asymmetric unit contains two protein molecules, each in a ternary complex; however, one is in a more closed conformation than the other. A hinge bending between the N- and C-terminal domains is observed, which triggers the switch of the essential Lys(176) to form a key hydrogen bond with the C2 hydroxyl of pantoate. Pantoate forms additional interactions with conserved residues Ser(244), Asn(98), and Asn(180) and with two conservatively varied residues, Asn(194) and Asn(241). The steady-state kinetics of active site mutants R31A, K72A, N98A, K176A, S244A, and E256A implicate Asn(98) as well as Lys(176) and Glu(256) in the catalytic mechanism. Isothermal titration calorimetry studies with these mutants further demonstrate the importance of Ser244 for substrate binding and of Arg(31) and Lys(72) for cofactor binding. Further calorimetric studies show that KPR discriminates binding of ketopantoate against pantoate only with NADPH bound. This work provides insights into the roles of active site residues and conformational changes in substrate recognition and catalysis, leading to the proposal of a detailed molecular mechanism for KPR activity.	Univ Chem Lab, Cambridge CB2 1EW, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge; University of Cambridge; University of Cambridge	Abell, C (corresponding author), Univ Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	ca26@cam.ac.uk	Ciulli, Alessio/A-6279-2011	Ciulli, Alessio/0000-0002-8654-1670; Chirgadze, Dimitri/0000-0001-9942-0993; Smith, Alison Gail/0000-0001-6511-5704	BBSRC [BB/D005817/1, BB/D006104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005817/1, BB/D006104/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALMARSSON O, 1993, J AM CHEM SOC, V115, P2125, DOI 10.1021/ja00059a005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Begley TP, 2001, VITAM HORM, V61, P157; Biou V, 1997, EMBO J, V16, P3405, DOI 10.1093/emboj/16.12.3405; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P141; Branden C I, 1980, Experientia Suppl, V36, P40; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ciulli A, 2005, BIOCHEM SOC T, V33, P767, DOI 10.1042/BST0330767; Ciulli A, 2006, J MED CHEM, V49, P4992, DOI 10.1021/jm060490r; Ciulli A, 2007, ACTA CRYSTALLOGR D, V63, P171, DOI 10.1107/S0907444906044465; COLONNACESARI F, 1986, J BIOL CHEM, V261, P5273; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, J BIOL CHEM, V281, P31031, DOI 10.1074/jbc.M605926200; FERSHT A, 1999, STRUCTURE MECH PROTE, P458; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Jackowski S, 1996, CELLULAR MOL BIOL, P687; KING HL, 1974, J BIOL CHEM, V249, P4689; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; LAMZIN VS, 1994, J MOL BIOL, V236, P759, DOI 10.1006/jmbi.1994.1188; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Lobley CMC, 2005, BIOCHEMISTRY-US, V44, P8930, DOI 10.1021/bi0502036; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; Matak-Vinkovic D, 2001, BIOCHEMISTRY-US, V40, P14493, DOI 10.1021/bi011020w; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; Ottenhof HH, 2004, PLANT J, V37, P61, DOI 10.1046/j.1365-313X.2003.01940.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Scapin G, 1998, BIOCHEMISTRY-US, V37, P3278, DOI 10.1021/bi9727949; SIEGEL JM, 1959, ARCH BIOCHEM BIOPHYS, V82, P288, DOI 10.1016/0003-9861(59)90124-9; Stillman TJ, 1999, J MOL BIOL, V285, P875, DOI 10.1006/jmbi.1998.2335; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; TAHILIANI AG, 1991, VITAM HORM, V46, P165; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Zheng RJ, 2003, BIOCHEMISTRY-US, V42, P11289, DOI 10.1021/bi030101k; Zheng RJ, 2000, BIOCHEMISTRY-US, V39, P16244, DOI 10.1021/bi002134v; Zheng RJ, 2000, BIOCHEMISTRY-US, V39, P3708, DOI 10.1021/bi992676g	47	32	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8487	8497		10.1074/jbc.M611171200	http://dx.doi.org/10.1074/jbc.M611171200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17229734	hybrid			2022-12-27	WOS:000245081000081
J	Decca, MB; Carpio, MA; Bosc, C; Galiano, MR; Job, D; Andrieux, A; Hallak, ME				Decca, Maria B.; Carpio, Marcos A.; Bosc, Christophe; Galiano, Mauricio R.; Job, Didier; Andrieux, Annie; Hallak, Marta E.			Post-translational arginylation of calreticulin - A new isospecies of calreticulin component of stress granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-PROTEIN TRANSFERASE; MESSENGER-RNA; RAT-BRAIN; CALCIUM; BINDING; EXPRESSION; INCREASES; ARGININE; GENE; RECEPTOR	Post-translational arginylation consists of the covalent union of an arginine residue to a Glu, Asp, or Cys amino acid at the N-terminal position of proteins. This reaction is catalyzed by the enzyme arginyl-tRNA. protein transferase. Using mass spectrometry, we have recently demonstrated in vitro the post-translational incorporation of arginine into the calcium-binding protein calreticulin (CRT). To further study arginylated CRT we raised an antibody against the peptide (RDPAIYFK) that contains an arginine followed by the first 7 N-terminal amino acids of mature rat CRT. This antibody specifically recognizes CRT obtained from rat soluble fraction that was arginylated in vitro and also recognizes endogenous arginylated CRT from NIH 3T3 cells in culture, indicating that CRT arginylation takes place in living cells. Using this antibody we found that arginylation of CRT is Ca2+ -regulated. In vitro and in NIH 3T3 cells in culture, the level of arginylated CRT increased with the addition of a Ca2+ chelator to the medium, whereas a decreased arginine incorporation into CRT was found in the presence of Ca2+. The arginylated CRT was observed in the cytosol, in contrast to the non-arginylated CRT that is in the endoplasmic reticulum. Under stress conditions, arginylated CRT was found associated to stress granules. These results suggest that CRT arginylation occurs in the cytosolic pool of mature CRT (defined by an Asp acid N-terminal) that is probably retrotranslocated from the endoplasmic reticulum.	Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC,Fac Ciencias Quim, CONICET,Dept Quim Biol, RA-5000 Cordoba, Argentina; CEA, INSERM U366, Lab Cytosquelette, F-38054 Grenoble, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hallak, ME (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC,Fac Ciencias Quim, CONICET,Dept Quim Biol, RA-5000 Cordoba, Argentina.	mhallak@mail.fcq.unc.edu.ar	Bosc, Christophe/P-3401-2017; Bosc, Christophe/Q-8877-2019; ANDRIEUX, ANNIE/B-2134-2017	Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Galiano, Mauricio/0000-0002-8245-1715				Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Anderson P, 2002, J CELL SCI, V115, P3227; ATREYA CD, 1995, J VIROL, V69, P3848, DOI 10.1128/JVI.69.6.3848-3851.1995; BALZI E, 1990, J BIOL CHEM, V265, P7464; BARRA HS, 1973, J NEUROCHEM, V20, P97, DOI 10.1111/j.1471-4159.1973.tb12108.x; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BOHLEY P, 1991, BIOMED BIOCHIM ACTA, V50, P343; Bongiovanni G, 1995, NEUROREPORT, V7, P326, DOI 10.1097/00001756-199512000-00078; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Chen MH, 1999, J VIROL, V73, P3386, DOI 10.1128/JVI.73.4.3386-3403.1999; Cheng ST, 1996, J IMMUNOL, V156, P4484; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Denning GM, 1997, BLOOD, V90, P372; Dunand-Sauthier I, 2002, MOL BIOL CELL, V13, P1626, DOI 10.1091/mbc.01-06-0301; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; GONDA DK, 1989, J BIOL CHEM, V264, P16700; HALLAK ME, 1991, J NEUROCHEM, V57, P1735, DOI 10.1111/j.1471-4159.1991.tb06375.x; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; KAJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P477; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; Kwon YT, 1999, MOL CELL BIOL, V19, P182; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; LIU NG, 1994, J BIOL CHEM, V269, P28635; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Pugachev KV, 1998, J VIROL, V72, P641, DOI 10.1128/JVI.72.1.641-650.1998; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; SOFFER RL, 1968, BIOCHIM BIOPHYS ACTA, V155, P228, DOI 10.1016/0005-2787(68)90352-3; SOFFER RL, 1971, J BIOL CHEM, V246, P1602; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547	48	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8237	8245		10.1074/jbc.M608559200	http://dx.doi.org/10.1074/jbc.M608559200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17197444	Green Submitted, Green Accepted, hybrid			2022-12-27	WOS:000245081000056
J	Hebbar, PB; Archer, TK				Hebbar, Pratibha B.; Archer, Trevor K.			Chromatin-dependent cooperativity between site-specific transcription factors in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; TUMOR VIRUS PROMOTER; BREAST-CANCER CELLS; GLUCOCORTICOID-RECEPTOR; GENE FAMILY; NUCLEAR RECEPTORS; SWI/SNF COMPLEX; MAMMARY-GLAND; ACTIVATION; EXPRESSION	Accessing binding sites in DNA wrapped around histories in condensed chromatin is an obstacle that transcription factors must overcome to regulate gene expression. Here we demonstrate cooperativity between two transcription factors, the glucocorticoid receptor (GR) and nuclear factor 1 (NF1) to bind the mouse mammary tumor virus promoter organized as regular chromatin in vivo. This cooperativity is not observed when the promoter is introduced transiently into cells. Using RNA interference to deplete NF1 protein levels in the cells, we confirmed that NF1 promotes binding of GR to the promoter. Furthermore, we observed a similar synergism between GR and NF1 binding on the endogenous 11 beta-hydroxysteroid dehydrogenase promoter, also regulated by GR and NF1. Our results suggest that the chromatin architecture of the promoters does not permit strong association of GR in the absence of NF1. Therefore we propose that cooperativity among DNA binding factors in binding to their cognate recognition sites in chromatin may be an important feature in the regulation of gene expression.	Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, NIH, 111 Alexander Dr,MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999, Z01 ES071006-09] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Archer TK, 1997, METHODS, V11, P235, DOI 10.1006/meth.1996.0410; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Ferrari S, 2004, J BIOL CHEM, V279, P55520, DOI 10.1074/jbc.M410346200; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; Fryer CJ, 1998, J BIOL CHEM, V273, P1175, DOI 10.1074/jbc.273.2.1175; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hager GL, 2000, BIOCHEM SOC T, V28, P405, DOI 10.1042/0300-5127:0280405; Hebbar PB, 2003, CHROMOSOMA, V111, P495, DOI 10.1007/s00412-003-0232-x; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Kane R, 2000, ADV EXP MED BIOL, V480, P117; Kinyamu HK, 2000, J BIOL CHEM, V275, P20061, DOI 10.1074/jbc.M001142200; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; LANGST G, 2004, BIOCHIM BIOPHYS ACTA, V677, P58; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Murtagh J, 2003, J MAMMARY GLAND BIOL, V8, P241, DOI 10.1023/A:1025909109843; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; SCHMID W, 1995, J STEROID BIOCHEM, V53, P33, DOI 10.1016/0960-0760(95)00038-2; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217	36	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8284	8291		10.1074/jbc.M610554200	http://dx.doi.org/10.1074/jbc.M610554200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17186943	Green Accepted, hybrid			2022-12-27	WOS:000245081000061
J	Singh, I; Knezevic, N; Ahmmed, GU; Kini, V; Malik, AB; Mehta, D				Singh, Itender; Knezevic, Nebojsa; Ahmmed, Gias U.; Kini, Vidisha; Malik, Asrar B.; Mehta, Dolly			G alpha(q)-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR POTENTIAL CHANNELS; CALCIUM-ENTRY; DEPENDENT ACTIVATION; TRPC1 EXPRESSION; BARRIER FUNCTION; CATION CHANNELS; FUNCTIONAL-ROLE; P115 RHOGEF; ALPHA	RhoA activation and increased intracellular Ca2+ concentration mediated by the activation of transient receptor potential channels (TRPC) both contribute to the thrombin-induced increase in endothelial cell contraction, cell shape change, and consequently to the mechanism of increased endothelial permeability. Herein, we addressed the possibility that TRPC signals RhoA activation and thereby contributes in actinomyosin-mediated endothelial cell contraction and increased endothelial permeability. Transduction of a constitutively active G alpha(q) mutant in human pulmonary arterial endothelial cells induced RhoA activity. Preventing the increase in intracellular Ca2+ concentration by the inhibitor of Gaq or phospholipase C and the Ca2+ chelator, BAPTA-AM, abrogated thrombin-induced RhoA activation. Depletion of extracellular Ca2+ also inhibited RhoA activation, indicating the requirement of Ca2+ entry in the response. RhoA activation could not be ascribed to store-operated Ca2+ (SOC) entry because SOC entry induced with thapsigargin or small interfering RNA-mediated inhibition of TRPC1 expression, the predominant SOC channel in these endothelial cells, failed to alter RhoA activity. However, activation of receptor-operated Ca2+ entry by oleoyl-2-acetyl-sn-glycerol, the membrane permeable analogue of the Ga-q-phospholipase C product diacylglycerol, induced RhoA activity. Receptor-operated Ca2+ activation was mediated by TRPC6 because small interfering RNA-induced TRPC6 knockdown significantly reduced Ca2+ entry. TRPC6 knockdown also prevented RhoA activation, myosin light chain phosphorylation, and actin stress fiber formation as well as inter-endothelial-junctional gap formation in response to either oleoyl-2-acetyl-snglycerol or thrombin. TRPC6-mediated RhoA activity was shown to be dependent on PKC alpha activation. Our results demonstrate that Gaq activation of TRPC6 signals the activation of PKC alpha, and thereby induces RhoA activity and endothelial cell contraction.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu	Knezevic, Nebojsa Nick/H-9921-2019	Knezevic, Nebojsa Nick/0000-0001-8028-1495; Malik, Asrar/0000-0002-8205-7128	NHLBI NIH HHS [R01 HL084153, R01 HL071794, HL 45638] Funding Source: Medline; PHS HHS [71794, 084153] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045638, R01HL071794, R01HL084153] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Albert AP, 2003, J PHYSIOL-LONDON, V552, P789, DOI 10.1113/jphysiol.2003.052977; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Carbajal JM, 1999, AM J PHYSIOL-CELL PH, V277, pC955, DOI 10.1152/ajpcell.1999.277.5.C955; Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Gamberucci A, 2002, BIOCHEM J, V364, P245, DOI 10.1042/bj3640245; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Javaid K, 2003, CIRC RES, V92, P1089, DOI 10.1161/01.RES.0000072971.88704.CB; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moers A, 2004, J BIOL CHEM, V279, P45354, DOI 10.1074/jbc.M408962200; Moore T, 1998, CHEST, V114, p36S, DOI 10.1378/chest.114.1_Supplement.36S; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Reither G, 2006, J CELL BIOL, V174, P521, DOI 10.1083/jcb.200604033; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200	51	162	167	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7833	7843		10.1074/jbc.M608288200	http://dx.doi.org/10.1074/jbc.M608288200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17197445	hybrid			2022-12-27	WOS:000245081000012
J	Zhao, YG; Conze, DB; Hanover, JA; Ashwell, JD				Zhao, Yongge; Conze, Dietrich B.; Hanover, John A.; Ashwell, Jonathan D.			Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; UP-REGULATION; TNF-ALPHA; T-CELLS; IN-VIVO; APOPTOSIS; TRAF2; DEGRADATION; LIGASE; MICE	TRAF2 and ASK1 play essential roles in tumor necrosis factor alpha (TNF-alpha)-induced mitogen-activated protein kinase signaling. Stimulation through TNF receptor 2 (TNFR2) leads to TRAF2 ubiquitination and subsequent proteasomal degradation. Here we show that TNFR2 signaling also leads to selective ASK1 ubiquitination and degradation in proteasomes. c-IAP1 was identified as the ubiquitin protein ligase for ASK1 ubiquitination, and studies with primary B cells from c-IAP1 knock-out animals revealed that c-IAP1 is required for TNFR2-induced TRAF2 and ASK1 degradation. Moreover, in the absence of c-IAP1 TNFR2-mediated p38 and JNK activation was prolonged. Thus, the ubiquitin protein ligase activity of c-IAP1 is responsible for regulating the duration of TNF signaling in primary cells expressing TNFR2.	NCI, Lab Immune Cell Biol, Canc Res Ctr, Bethesda, MD 20892 USA; NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Canc Res Ctr, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010779, Z01BC010779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060102, Z01DK060102, ZIADK060101, Z01DK060101] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alsalameh S, 1999, J RHEUMATOL, V26, P645; Bette M, 2003, J COMP NEUROL, V465, P417, DOI 10.1002/cne.10877; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Huang HK, 2000, J BIOL CHEM, V275, P26661; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Munitic I, 2005, J IMMUNOL, V174, P4010, DOI 10.4049/jimmunol.174.7.4010; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Shi CS, 1999, J IMMUNOL, V163, P3279; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Weiss T, 1997, J IMMUNOL, V158, P2398; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	39	68	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7777	7782		10.1074/jbc.M609146200	http://dx.doi.org/10.1074/jbc.M609146200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17220297	hybrid			2022-12-27	WOS:000245081000005
J	Contreras, L; Gomez-Puertas, P; Iijima, M; Kobayashi, K; Saheki, T; Satrustegui, J				Contreras, Laura; Gomez-Puertas, Paulino; Iijima, Mikio; Kobayashi, Keiko; Saheki, Takeyori; Satrustegui, Jorgina			Ca2+ activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin - Role in the heart malate-aspartate NADH shuttle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; RAT-LIVER MITOCHONDRIA; CARDIAC MITOCHONDRIA; FUNCTIONAL-CHARACTERIZATION; CALMODULIN SUPERFAMILY; METABOLITE TRANSPORT; BACTERIAL EXPRESSION; REDUCING EQUIVALENTS; TISSUE DISTRIBUTION; MOLECULAR-CLONING	Ca2+ regulation of the Ca2+ binding mitochondrial carriers for aspartate/glutamate (AGCs) is provided by their N-terminal extensions, which face the intermembrane space. The two mammalian AGCs, aralar and citrin, are members of the malate-aspartate NADH shuttle. We report that their N-terminal extensions contain up to four pairs of EF-hand motifs plus a single vestigial EF-hand, and have no known homolog. Aralar and citrin contain one fully canonical EF-hand pair and aralar two additional halfpairs, in which a single EF-hand is predicted to bind Ca2+. Shuttle activity in brain or skeletal muscle mitochondria, which contain aralar as the major AGC, is activated by Ca2+ with S-0.5 values of 280-350 nM; higher than those obtained in liver mitochondria (100-150 nM) that contain citrin as the major AGC. We have used aralar- and citrin-deficient mice to study the role of the two isoforms in heart, which expresses both AGCs. The S-0.5 for Ca2+ activation of the shuttle in heart mitochondria is about 300 nm, and it remains essentially unchanged in citrin-deficient mice, although it undergoes a drastic reduction to about 100 nm in aralar-deficient mice. Therefore, aralar and citrin, when expressed as single isoforms in heart, confer differences in Ca2+ activation of shuttle activity, probably associated with their structural differences. In addition, the results reveal that the two AGCs fully account for shuttle activity in mouse heart mitochondria and that no other glutamate transporter can replace the AGCs in this pathway.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, CSIC, E-28049 Madrid, Spain; Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Metab & Biochem Genet, Kagoshima 8908544, Japan	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Kagoshima University	Satrustegui, J (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, CSIC, E-28049 Madrid, Spain.	jsatrustegui@cbm.uam.es	Contreras, Laura/ABG-7620-2021; Contreras, Laura/A-2296-2015; Satrustegui, Jorgina/R-6732-2019; Gomez-Puertas, Paulino/G-8821-2014	Contreras, Laura/0000-0003-1157-4942; Gomez-Puertas, Paulino/0000-0003-3131-729X; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667				APRILLE JR, 1988, FASEB J, V2, P2547, DOI 10.1096/fasebj.2.10.3290024; APRILLE JR, 1993, J BIOENERG BIOMEMBR, V25, P473, DOI 10.1007/BF01108404; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Atlante A, 1999, J NEUROCHEM, V73, P237, DOI 10.1046/j.1471-4159.1999.0730237.x; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; Cuezva JM, 2002, CANCER RES, V62, P6674; del Arco A, 2005, BIOCHEM J, V389, P647, DOI 10.1042/BJ20050283; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; DIERKS T, 1988, BIOCHIM BIOPHYS ACTA, V943, P231, DOI 10.1016/0005-2736(88)90555-X; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Griffin JL, 2000, AM J PHYSIOL-CELL PH, V279, pC1704, DOI 10.1152/ajpcell.2000.279.6.C1704; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HAYNES RC, 1986, J BIOL CHEM, V261, P6121; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; LANOUE KF, 1974, J BIOL CHEM, V249, P7514; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; LANOUE KF, 1973, J BIOL CHEM, V248, P7171; LANOUE KF, 1974, ARCH BIOCHEM BIOPHYS, V161, P544, DOI 10.1016/0003-9861(74)90337-3; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; MARTINEZ A, 1988, NEUROSCI LETT, V88, P336, DOI 10.1016/0304-3940(88)90234-0; MARTINEZSERRANO A, 1992, MOL BIOL CELL, V3, P235, DOI 10.1091/mbc.3.2.235; Mashima H, 2003, J BIOL CHEM, V278, P9520, DOI 10.1074/jbc.M208398200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Natter S, 1998, FASEB J, V12, P1559, DOI 10.1096/fasebj.12.14.1559; NICHOLS BJ, 1995, MOL CELL BIOCHEM, V149, P203, DOI 10.1007/BF01076578; NOSEK MT, 1990, J BIOL CHEM, V265, P8444; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Ralphe JC, 2004, J MOL CELL CARDIOL, V37, P33, DOI 10.1016/j.yjmcc.2004.04.008; Ralphe JC, 2005, AM J PHYSIOL-HEART C, V288, pH2521, DOI 10.1152/ajpheart.00991.2004; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Rupert BE, 2000, J MOL CELL CARDIOL, V32, P2287, DOI 10.1006/jmcc.2000.1257; SAFER B, 1971, J MOL CELL CARDIOL, V2, P111, DOI 10.1016/0022-2828(71)90065-4; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scholz TD, 1998, AM J PHYSIOL-CELL PH, V274, pC780, DOI 10.1152/ajpcell.1998.274.3.C780; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; Scholz TD, 2000, J MOL CELL CARDIOL, V32, P1, DOI 10.1006/jmcc.1999.1047; Seguchi H, 2005, CELL CALCIUM, V38, P1, DOI 10.1016/j.ceca.2005.03.004; Sinasac DS, 2004, MOL CELL BIOL, V24, P527, DOI 10.1128/MCB.24.2.527-536.2004; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; TISCHLER ME, 1976, ARCH BIOCHEM BIOPHYS, V173, P448, DOI 10.1016/0003-9861(76)90282-4; Truong K, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-1; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Weber FE, 1997, P NATL ACAD SCI USA, V94, P8509, DOI 10.1073/pnas.94.16.8509; Yamasaki Y, 1997, ANAT REC, V248, P70; Yu X, 1996, BIOCHEMISTRY-US, V35, P6963, DOI 10.1021/bi960199l; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	68	75	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7098	7106		10.1074/jbc.M610491200	http://dx.doi.org/10.1074/jbc.M610491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17213189	hybrid			2022-12-27	WOS:000245080900021
J	Williams, LM; Sarma, U; Willets, K; Smallie, T; Brennan, F; Foxwell, BMJ				Williams, Lynn M.; Sarma, Usha; Willets, Kate; Smallie, Tim; Brennan, Fionula; Foxwell, Brian M. J.			Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TNF-ALPHA PRODUCTION; RHEUMATOID-ARTHRITIS; TYROSINE PHOSPHORYLATION; INFLAMMATORY CYTOKINE; DNA-BINDING; CHRONIC ENTEROCOLITIS; INTRACELLULAR DOMAIN; DENDRITIC CELLS	There is general agreement that signal transducer and activation of transcription 3 (STAT3) is required to mediate the antiinflammatory activities of interleukin (IL)-10. However, STAT3 is activated by multiple factors that do not share the anti-inflammatory activity of IL-10. The question remains whether STAT3 is sufficient for the anti-inflammatory effects or whether there are other signals required, as had been suggested previously. We set out to map the human IL-10 receptor and to identify the key elements involved in transducing the cytokine-suppressive effects of IL-10. We were able to show an absolute requirement for both of the tyrosine residues found within the YXXQ-STAT3-docking site within the IL-10 receptor I and that no other signals appeared to be required. We used a constitutively active STAT3 to determine whether expression of this factor could suppress lipopolysaccharide-induced tumor necrosis factor and IL-6 production. Our data show that STAT3 activity can suppress both IL-6 and tumor necrosis factor production in lipopolysaccharide-stimulated macrophages. However, in synovial fibroblasts, STAT3 did not suppress IL-6 production, suggesting that the cellular environment plays an important role in dictating whether STAT3 drives a pro- or anti-inflammatory response.	Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London W6 8LH, England	Imperial College London; University of Oxford	Williams, LM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, ARC Bldg,1 Aspenlea Rd, London W6 8LH, England.	b.foxwell@imperial.ac.uk			Medical Research Council [G0700128] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0700128] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andreakos E, 2003, ARTHRITIS RHEUM, V48, P1901, DOI 10.1002/art.11044; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Besser D, 1999, MOL CELL BIOL, V19, P1401; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; CHANG CH, 1995, EUR J IMMUNOL, V25, P394, DOI 10.1002/eji.1830250213; Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q; Crawley JB, 1996, J BIOL CHEM, V271, P16357, DOI 10.1074/jbc.271.27.16357; Cua DJ, 1996, J IMMUNOL, V157, P2830; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; DING L, 1993, J IMMUNOL, V151, P1224; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Foey AD, 1998, J IMMUNOL, V160, P920; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HO ASY, 1995, MOL CELL BIOL, V15, P5043; Hoentjen F, 2005, BLOOD, V105, P689, DOI 10.1182/blood-2004-04-1309; JOYCE DA, 1994, EUR J IMMUNOL, V24, P2699, DOI 10.1002/eji.1830241119; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Keystone E, 1998, RHEUM DIS CLIN N AM, V24, P629, DOI 10.1016/S0889-857X(05)70030-2; Kolb H, 1997, AUTOIMMUNITY, V26, P1, DOI 10.3109/08916939709009544; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; LIU Y, 1994, J IMMUNOL, V152, P1821; LUTFALLA G, 1992, J BIOL CHEM, V267, P2802; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; Walmsley M, 1996, ARTHRITIS RHEUM-US, V39, P495, DOI 10.1002/art.1780390318; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WeberNordt RM, 1996, BLOOD, V88, P809; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	61	80	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6965	6975		10.1074/jbc.M609101200	http://dx.doi.org/10.1074/jbc.M609101200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17194701	hybrid			2022-12-27	WOS:000245080900008
J	Gimenez, I; Forbush, B				Gimenez, Ignacio; Forbush, Biff			The residues determining differences in ion affinities among the alternative splice variants F, A, and B of the mammalian renal Na-K-Cl cotransporter (NKCC2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; CATION-TRANSPORT; REVEALS; CHANNEL; BINDING; DOMAIN; TOPOLOGY; HOMOLOG; KINASE; LOCUS	Three alternatively spliced variants of the renal Na-K-Cl cotransporter (NKCC2) are found in distinct regions of the thick ascending limb of the mammalian kidney; these variants mediate Na(+)K(+)2Cl(-) transport with different ion affinities. Here, we examine the specific residues involved in the variant-specific affinity differences, utilizing a mutagenic approach to change the NKCC2B variant into the A or F variant, with functional expression in Xenopus oocytes. The splice region contains the second transmembrane domain (TM2) and the putative intracellular loop (ICL1) connecting TM2 and TM3. It is found that the B variant is functionally changed to the F variant by replacement of six residues, half of the effect brought about by three TM2 residues and half by three ICL1 residues. The involvement of the ICL1 residues strongly suggests that this region of ICL1 may actually be part of a membrane-embedded domain. Changing six residues is also sufficient to bring about the smaller functional change from the B to the A variant; three residues in TM2 appear to be primarily responsible, two of which correspond to residues involved in the B-to-F changes. A B-variant mutation reported in a mild case of Bartter disease was found to render the cotransporter inactive. These results identify the combination of amino acid variations responsible for the differences among the three splice variants of NKCC2, and they support a model in which a reentrant loop following TM2 contributes to the chloride binding and translocation domains.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06511 USA	Yale University	Gimenez, I (corresponding author), Univ Zaragoza, Fac Med, Dept Physiol & Pharmacol, Domingo Miral SN, E-50009 Zaragoza, Spain.	igimenez@unizar.es	Giménez, Ignacio/B-6322-2013	Giménez, Ignacio/0000-0002-6043-4869	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-17433] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Castrop H, 2005, AM J PHYSIOL-RENAL, V289, pF1185, DOI 10.1152/ajprenal.00455.2004; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Gagnon E, 2005, J BIOL CHEM, V280, P32555, DOI 10.1074/jbc.M505511200; Gagnon E, 2004, J BIOL CHEM, V279, P5648, DOI 10.1074/jbc.M311218200; Gagnon E, 2003, AM J PHYSIOL-CELL PH, V284, pC365, DOI 10.1152/ajpcell.00262.2002; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Gerelsaikhan T, 2006, BIOCHEMISTRY-US, V45, P12060, DOI 10.1021/bi061126x; Gimenez I, 2002, FASEB J, V16, pA52; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; Grant GA, 2000, BIOCHEMISTRY-US, V39, P7316, DOI 10.1021/bi000218y; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Isenring P, 1998, P NATL ACAD SCI USA, V95, P7179, DOI 10.1073/pnas.95.12.7179; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	35	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6540	6547		10.1074/jbc.M610780200	http://dx.doi.org/10.1074/jbc.M610780200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17186942	hybrid			2022-12-27	WOS:000244867200062
J	Imai, H; Kefalov, V; Sakurai, K; Chisaka, O; Ueda, Y; Onishi, A; Morizumi, T; Fu, YB; Ichikawa, K; Nakatani, K; Honda, Y; Chen, J; Yau, KW; Shichida, Y				Imai, Hiroo; Kefalov, Vladimir; Sakurai, Keisuke; Chisaka, Osamu; Ueda, Yoshiki; Onishi, Akishi; Morizumi, Takefumi; Fu, Yingbin; Ichikawa, Kazuhisa; Nakatani, Kei; Honda, Yoshihito; Chen, Jeannie; Yau, King-Wai; Shichida, Yoshinori			Molecular properties of rhodopsin and rod function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL PIGMENT; ABSORPTION MAXIMUM; METARHODOPSIN-II; BINDING PROTEIN; DARK-ADAPTATION; TRANSGENIC MICE; AMINO-ACIDS; LIGHT; CONES; PHOTOTRANSDUCTION	Signal transduction in rod cells begins with photon absorption by rhodopsin and leads to the generation of an electrical response. The response profile is determined by the molecular properties of the phototransduction components. To examine how the molecular properties of rhodopsin correlate with the rod-response profile, we have generated a knock-in mouse with rhodopsin replaced by its E122Q mutant, which exhibits properties different from those of wild-type (WT) rhodopsin. Knock-in mouse rods with E122Q rhodopsin exhibited a photosensitivity about 70% of WT. Correspondingly, their single-photon response had an amplitude about 80% of WT, and a rate of decline from peak about 1.3 times of WT. The overall 30% lower photosensitivity of mutant rods can be explained by a lower pigment photosensitivity (0.9) and the smaller single-photon response (0.8). The slower decline of the response, however, did not correlate with the 10-fold shorter lifetime of the meta-II state of E122Q rhodopsin. This shorter lifetime became evident in the recovery phase of rod cells only when arrestin was absent. Simulation analysis of the photoresponse profile indicated that the slower decline and the smaller amplitude of the single-photon response can both be explained by the shift in the meta-I/meta-II equilibrium of E122Q rhodopsin toward meta-I. The difference in meta-III lifetime between WT and E122Q mutant became obvious in the recovery phase of the dark current after moderate photobleaching of rod cells. Thus, the present study clearly reveals how the molecular properties of rhodopsin affect the amplitude, shape, and kinetics of the rod response.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kyoto 6068502, Japan; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Kyoto 6068507, Japan; Kanazawa Inst Technol, Dept Brain & Bioinformat Sci, Ishikawa 9240838, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tsukuba, Ibaraki 3058572, Japan; Univ So Calif, Keck Sch Med, Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90033 USA	Kyoto University; Japan Science & Technology Agency (JST); Johns Hopkins University; Kyoto University; Kyoto University; Kanazawa Institute of Technology; University of Tsukuba; Japan Science & Technology Agency (JST); Doheny Eye Institute; University of Southern California	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	shichida@vision-kyoto-u.jp	Morizumi, Takefumi/AAA-2063-2021	Morizumi, Takefumi/0000-0002-2785-209X; Kefalov, Vladimir/0000-0002-1659-008X; Imai, Hiroo/0000-0003-0729-0322	NEI NIH HHS [R01 EY006837, R01 EY006837-19, R01 EY014596-05, F32 EY006837, R01 EY006837-20A1, R01 EY014596-02, R01 EY006837-18, R01 EY014596, R01 EY014596-03, R01 EY014596-01, R01 EY006837-17, R37 EY006837, R01 EY006837-16A1, R01 EY014596-04, EY 06837] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-02, R01 DC006904, R01 DC006904-01, R01 DC006904-03] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014596, R37EY006837, F32EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cha KW, 1997, P NATL ACAD SCI USA, V94, P10577, DOI 10.1073/pnas.94.20.10577; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; DOWLING JE, 1963, J GEN PHYSIOL, V46, P1287, DOI 10.1085/jgp.46.6.1287; Govardovskii VI, 2000, J GEN PHYSIOL, V116, P791, DOI 10.1085/jgp.116.6.791; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; ICHIKAWA K, 1994, NEUROSCI RES, V19, P201, DOI 10.1016/0168-0102(94)90144-9; Ichikawa K, 2005, NEUROINFORMATICS, V3, P49, DOI 10.1385/NI:3:1:049; Ichikawa K, 2001, BIOINFORMATICS, V17, P483, DOI 10.1093/bioinformatics/17.5.483; IMAI H, 1994, BIOCHEMISTRY-US, V33, P14351, DOI 10.1021/bi00251a049; Imai H, 2005, PHOTOCH PHOTOBIO SCI, V4, P667, DOI 10.1039/b416731g; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; Kuwayama S, 2005, BIOCHEMISTRY-US, V44, P2208, DOI 10.1021/bi047994g; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MATTINGLY M, 1999, JUVENILE JUSTICE UPD, V5, P13; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Nagata T, 1998, BIOCHEMISTRY-US, V37, P17216, DOI 10.1021/bi9810149; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; OKANO T, 1992, PHOTOCHEM PHOTOBIOL, V56, P995, DOI 10.1111/j.1751-1097.1992.tb09722.x; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; SAKAMOTO T, 1995, P NATL ACAD SCI USA, V92, P249, DOI 10.1073/pnas.92.1.249; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Shichida Y, 2000, METHOD ENZYMOL, V315, P347; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; SHICHIDA Y, 1987, BIOCHEMISTRY-US, V26, P4422, DOI 10.1021/bi00388a035; SHICHIDA Y, 1994, BIOCHEMISTRY-US, V33, P9040, DOI 10.1021/bi00197a002; Sommer ME, 2006, VISION RES, V46, P4532, DOI 10.1016/j.visres.2006.08.031; SUZUKI T, 1993, ZOOL SCI, V10, P425; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; Zimmermann K, 2004, J BIOL CHEM, V279, P48112, DOI 10.1074/jbc.M406856200	51	56	56	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6677	6684		10.1074/jbc.M610086200	http://dx.doi.org/10.1074/jbc.M610086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17194706	hybrid, Green Accepted			2022-12-27	WOS:000244867200077
J	Menon, S; Lee, J; Abplanalp, WA; Yoo, SE; Agui, T; Furudate, S; Kim, PS; Arvan, P				Menon, Shekar; Lee, Jaemin; Abplanalp, William A.; Yoo, Sung-Eun; Agui, Takashi; Furudate, Sen-ichi; Kim, Paul S.; Arvan, Peter			Oxidoreductase interactions include a role for ERp72 engagement with mutant thyroglobulin from the rdw/rdw rat dwarf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; CONGENITAL HYPOTHYROID GOITER; RETICULUM STORAGE DISEASES; MISSENSE MUTATION G2320R; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; RDW RATS; HEREDITARY DWARFISM; COMMON MECHANISM	Newly synthesized thyroglobulin (Tg), the secretory glycoprotein that serves as precursor in thyroid hormone synthesis, normally forms transient covalent protein complexes with oxidoreductases of the endoplasmic reticulum (ER). The Tg-G2320R mutation is responsible for congenital hypothyroidism in rdw/rdw rats, in which a lack of secondary thyroid enlargement (goiter) implicates death of thyrocytes as part of disease pathogenesis. We found that mutant Tg-G2320R was retained within the ER with no detectable synthesis of thyroxine, had persistent exposure of free cysteine thiols, and was associated with activated ER stress response but incomplete ER-associated degradation (ERAD). Tg-G2320R associated with multiple ER resident proteins, most notably ERp72, including covalent Tg-ERp72 interactions. In PC C13 thyrocytes, inducible overexpression of ERp72 increased the ability of cells to maintain Tg cysteines in a reduced state. Noncovalent interactions of several ER chaperones with newly synthesized Tg-G2320R diminished over time in parallel with ERAD of the mutant protein, yet a small ERAD-resistant Tg fraction remained engaged in covalent association with ERp72 even 2 days post-synthesis. Such covalent protein aggregates may set the stage for apoptotic thyrocyte cell death, preventing thyroid goiter formation in rdw/rdw rats.	Univ Michigan, Sch Med, Div Endocrinol Diabet & Metab, Med Ctr, Ann Arbor, MI 48109 USA; Univ Cincinnati, Cell & Mol Biol Program, Cincinnati, OH 45267 USA; Univ Cincinnati, Div Endocrinol, Cincinnati, OH 45267 USA; Hokkaido Univ, Grad Sch Vet Med, Lab Expt Anim Sci, Sapporo, Hokkaido 0600818, Japan; Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 2288555, Japan	University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Hokkaido University; Kitasato University	Arvan, P (corresponding author), Univ Michigan, Sch Med, Div Endocrinol Diabet & Metab, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021; Kim, Paul/GYV-3258-2022	Kim, Paul/0000-0003-0943-4924; Lee, Jaemin/0000-0002-0224-7141	NIDDK NIH HHS [R01 DK040344, DK52076, DK40344, R01 DK040344-20] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040344, R01DK052076, R01DK040344] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlbom BE, 2002, HUM GENET, V110, P145, DOI 10.1007/s00439-002-0680-z; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carelli S, 1997, SCIENCE, V277, P1681, DOI 10.1126/science.277.5332.1681; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; DIJESO B, 2004, THYROID; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; KOTO M, 1988, EXP ANIM TOKYO, V37, P21, DOI 10.1538/expanim1978.37.1_21; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; Labat-Moleur F, 1999, THYROID, V9, P483, DOI 10.1089/thy.1999.9.483; LUNDSTROMLJUNG J, 1995, FEBS LETT, V357, P305, DOI 10.1016/0014-5793(94)01386-F; McCracken AA, 2005, CURR TOP MICROBIOL, V300, P17; MedeirosNeto G, 1996, J CLIN INVEST, V98, P2838, DOI 10.1172/JCI119112; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oh-Ishi M, 1998, ENDOCRINOLOGY, V139, P1288, DOI 10.1210/en.139.3.1288; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Perlmutter David H, 2003, Methods Mol Biol, V232, P39; RUPP K, 1994, J BIOL CHEM, V269, P2501; Russell TA, 2003, J CLIN INVEST, V112, P1697, DOI 10.1172/JCI200318616; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Sakai Y, 2000, ANAT REC, V259, P60; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Umezu M, 1998, LAB ANIM SCI, V48, P496; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840	48	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6183	6191		10.1074/jbc.M608863200	http://dx.doi.org/10.1074/jbc.M608863200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17200118	hybrid, Green Accepted			2022-12-27	WOS:000244867200024
J	Kasahara, K; Nakayama, Y; Nakazato, Y; Ikeda, K; Kuga, T; Yamaguchi, N				Kasahara, Kousuke; Nakayama, Yuji; Nakazato, Yoshimi; Ikeda, Kikuko; Kuga, Takahisa; Yamaguchi, Naoto			Src signaling regulates completion of abscission in cytokinesis through ERK/MAPK activation at the midbody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYN TYROSINE KINASE; MAP KINASE; C-SRC; MITOTIC ACTIVATION; CLEAVAGE FURROW; RECEPTOR; REQUIREMENT; PHOSPHORYLATION; INHIBITOR; MITOSIS	Src family non-receptor-type tyrosine kinases regulate a wide variety of cellular events including cell cycle progression in G(2)/M phase. Here, we show that Src signaling regulates the terminal step in cytokinesis called abscission in HeLa cells. Abscission failure with an unusually elongated intercellular bridge containing the midbody is induced by treatment with the chemical Src inhibitors PP2 and SU6656 or expression of membrane-anchored Csk chimeras. By anti-phosphotyrosine immunofluorescence and live cell imaging, completion of abscission requires Src-mediated tyrosine phosphorylation during early stages of mitosis (before cleavage furrow formation), which is subsequently delivered to the midbody through Rab11-driven vesicle transport. Treatment with U0126, a MEK inhibitor, decreases tyrosine phosphorylation levels at the midbody, leading to abscission failure. Activated ERK by MEK-catalyzed dual phosphorylation on threonine and tyrosine residues in the TEY sequence, which is strongly detected by anti-phosphotyrosine antibody, is transported to the midbody in a Rab11-dependent manner. Src kinase activity during the early mitosis mediates ERK activation in late cytokinesis, indicating that Src-mediated signaling for abscission is spatially and temporally transmitted. Thus, these results suggest that recruitment of activated ERK, which is phosphorylated by MEK downstream of Src kinases, to the midbody plays an important role in completion of abscission.	Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Chiba University	Yamaguchi, N (corresponding author), Inohana 1-8-1,Chuo Ku, Chiba 2608675, Japan.	nyama@p.chiba-u.ac.jp	Kuga, Takahisa/AAX-9334-2020	Nakayama, Yuji/0000-0001-7882-0066				Akiyama N, 2005, CELL SIGNAL, V17, P597, DOI 10.1016/j.cellsig.2004.10.005; Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; BAGRODIA S, 1991, NATURE, V349, P172, DOI 10.1038/349172a0; BAGRODIA S, 1994, J BIOL CHEM, V269, P10247; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; Finger FP, 2002, CELL, V108, P727, DOI 10.1016/S0092-8674(02)00668-2; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hirao A, 1998, J BIOL CHEM, V273, P10004, DOI 10.1074/jbc.273.16.10004; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Honda Z, 1997, J BIOL CHEM, V272, P25753, DOI 10.1074/jbc.272.41.25753; Horne MM, 2003, J CELL BIOL, V161, P1021, DOI 10.1083/jcb.200304144; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; LAW CL, 1994, J BIOL CHEM, V269, P12310; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; Moasser MM, 1999, CANCER RES, V59, P6145; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; OHSATO Y, 1994, JPN J CANCER RES, V85, P1023, DOI 10.1111/j.1349-7006.1994.tb02900.x; Otegui MS, 2005, TRENDS CELL BIOL, V15, P404, DOI 10.1016/j.tcb.2005.06.003; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sasabe M, 2006, GENE DEV, V20, P1004, DOI 10.1101/gad.1408106; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Uyeda TQP, 2004, CURR OPIN CELL BIOL, V16, P55, DOI 10.1016/j.ceb.2003.11.004; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yamaguchi N, 2001, J CELL SCI, V114, P1631; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	56	82	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5327	5339		10.1074/jbc.M608396200	http://dx.doi.org/10.1074/jbc.M608396200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189253	hybrid			2022-12-27	WOS:000244482300028
J	Qin, H; Yu, TX; Qing, TT; Liu, YX; Zhao, Y; Cai, J; Li, J; Song, ZH; Qu, XX; Zhou, P; Wu, J; Ding, MX; Deng, HK				Qin, Han; Yu, Tianxin; Qing, Tingting; Liu, Yanxia; Zhao, Yang; Cai, Jun; Li, Jian; Song, Zhihua; Qu, Xiuxia; Zhou, Peng; Wu, Jiong; Ding, Mingxiao; Deng, Hongkui			Regulation of apoptosis and differentiation by p53 in human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; SELF-RENEWAL; MUTATION FREQUENCY; HUMAN BLASTOCYSTS; RNA INTERFERENCE; PROTECTS MICE; ACTIVIN-A; ES CELLS; EXPRESSION; NANOG	The essentially infinite expansion potential and pluripotency of human embryonic stem cells (hESCs) makes them attractive for cell-based therapeutics. In contrast to mouse embryonic stem cells (mESCs), hESCs normally undergo high rates of spontaneous apoptosis and differentiation, making them difficult to maintain in culture. Here we demonstrate that p53 protein accumulates in apoptotic hESCs induced by agents that damage DNA. However, despite the accumulation of p53, it nevertheless fails to activate the transcription of its target genes. This inability of p53 to activate its target genes has not been observed in other cell types, including mESCs. We further demonstrate that p53 induces apoptosis of hESCs through a mitochondrial pathway. Reducing p53 expression in hESCs in turn reduces both DNA damage-induced apoptosis as well as spontaneous apoptosis. Reducing p53 expression also reduces spontaneous differentiation and slows the differentiation rate of hESCs. Our studies reveal the important roles of p53 as a critical mediator of human embryonic stem cells survival and differentiation.	Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China; Cell Signaling Technol Inc, Danvers, MA 01923 USA	Peking University; Peking University; University Town of Shenzhen	Ding, MX (corresponding author), Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Yiheyuan Rd 5, Beijing 100871, Peoples R China.	dingmx01@pku.edu.cn; hongkui_deng@pku.edu.cn	Liu, Yanxia/T-1338-2019; Cai, Jun/D-4118-2012					Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barley RDC, 1998, ONCOGENE, V17, P533, DOI 10.1038/sj.onc.1202271; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braithwaite AW, 2005, CARCINOGENESIS, V26, P1161, DOI 10.1093/carcin/bgi091; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guillouf C, 1998, INT J ONCOL, V13, P107; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Haupt Ygal, 1997, Leukemia (Basingstoke), V11, P337; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Johkura K, 2004, J ANAT, V205, P247, DOI 10.1111/j.0021-8782.2004.00336.x; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy ME, 2004, CELL CYCLE, V3, P836; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Scolnick DM, 1997, CANCER RES, V57, P3693; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Hoffen A, 2003, TOXICOLOGY, V193, P79, DOI 10.1016/j.tox.2003.06.001; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	63	195	210	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5842	5852		10.1074/jbc.M610464200	http://dx.doi.org/10.1074/jbc.M610464200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17179143	hybrid			2022-12-27	WOS:000244482300080
J	Wrzaczek, M; Rozhon, W; Jonak, C				Wrzaczek, Michael; Rozhon, Wilfried; Jonak, Claudia			A proteasome-regulated glycogen synthase kinase-3 modulates disease response in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; SUBSTRATE-SPECIFICITY; SIGNALING PATHWAY; MULTIGENE FAMILY; GENE-EXPRESSION; INNATE IMMUNITY; 26S PROTEASOME; RESISTANCE	Glycogen synthase kinase-3 (GSK-3) is a key player in various important signaling pathways in animals. The activity of GSK-3 is known to be modulated by protein phosphorylation and differential complex formation. However, little information is available regarding the function and regulation of plant GSK-3/shaggy-like kinases (GSKs). Analysis of the in vivo kinase activity of MsK1, a GSK from Medicago sativa, revealed that MsK1 is active in healthy plants and that MsK1 activity is down-regulated by the elicitor cellulase in a time- and dose-dependent manner. Surprisingly, cellulase treatment triggered the degradation of the MsK1 protein in a proteasome-dependent manner suggesting a novel mechanism of GSK-3 regulation. Inhibition of MsK1 kinase activity and degradation of the protein were two successive processes that could be uncoupled. In a transgenic approach, stimulus-induced inhibition of MsK1 was impeded by constant replenishment of MsK1 by a strong constitutive promoter. MsK1 overexpressing plants exhibited enhanced disease susceptibility to the virulent bacterial pathogen Pseudomonas syringae. MAP kinase activation in response to pathogen infection was compromised in plants with elevated MsK1 levels. These data strongly suggest that tight regulation of the plant GSK-3, MsK1, may be important for innate immunity to limit the severity of virulent bacterial infection.	Univ Vienna, Max F Perutz Labs, Vienna Bioctr, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Jonak, C (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Vienna Bioctr, Dr Bohrgasse 3, A-1030 Vienna, Austria.	claudia.jonak@gmi.oeaw.ac.at	Wrzaczek, Michael/AAU-5105-2020; Rozhon, Wilfried/AFK-4445-2022; Rozhon, Wilfried/AAG-3162-2022; Jonak, Claudia/G-1362-2016	Wrzaczek, Michael/0000-0002-5946-9060; Rozhon, Wilfried/0000-0003-0659-0593; Rozhon, Wilfried/0000-0003-0659-0593; Jonak, Claudia/0000-0001-9605-6751				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Charrier B, 2002, PLANT PHYSIOL, V130, P577, DOI 10.1104/pp.009175; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; DECROOCQFERRANT V, 1995, PLANT J, V7, P897, DOI 10.1046/j.1365-313X.1995.07060897.x; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Dornelas MC, 1999, PLANT MOL BIOL, V39, P137, DOI 10.1023/A:1006102812280; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; EINZENBERGER E, 1995, BBA-GENE STRUCT EXPR, V1260, P315, DOI 10.1016/0167-4781(94)00229-V; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; HE JX, 2002, P NATL ACAD SCI USA, V11, P11; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Jonak C, 2000, PLANT CELL, V12, P1467, DOI 10.1105/tpc.12.8.1467; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; JONAK C, 1995, PLANT MOL BIOL, V27, P217, DOI 10.1007/BF00019194; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KEMPA S, 2007, IN PRESS PLANT J; Kim HS, 2002, PLANT CELL, V14, P1469, DOI 10.1105/tpc.001867; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; PAY A, 1993, PLANT J, V3, P847, DOI 10.1111/j.1365-313X.1993.00847.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Piao HL, 1999, PLANT PHYSIOL, V119, P1527, DOI 10.1104/pp.119.4.1527; Piao HL, 2001, PLANT J, V27, P305, DOI 10.1046/j.1365-313x.2001.01099.x; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Richard O, 2005, J MOL EVOL, V61, P99, DOI 10.1007/s00239-004-0302-6; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sullivan JA, 2003, NAT REV GENET, V4, P948, DOI 10.1038/nrg1228; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Tichtinsky G, 1998, BBA-GENE STRUCT EXPR, V1442, P261, DOI 10.1016/S0167-4781(98)00187-0; van Amerongen R, 2005, CELL CYCLE, V4, pE89; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Volko SM, 1998, GENETICS, V149, P537; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; WRZACZEK M, 2004, MSKI GLYCOGEN SYNTHA; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yoo MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-3; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918	74	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5249	5255		10.1074/jbc.M610135200	http://dx.doi.org/10.1074/jbc.M610135200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17179144	Green Published, hybrid			2022-12-27	WOS:000244482300019
J	Mishra, S; Mishra, JP; Kumar, A				Mishra, Sasmita; Mishra, Jyoti P.; Kumar, Ashok			Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells - Involvement of antiapoptotic BCL2 and c-IAP1 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VPR; NF-KAPPA-B; SIGNAL-TRANSDUCTION; TERMINAL KINASE; ALPHA-HELIX; T-CELLS; TRANSCRIPTION; EXPRESSION; SUPPRESSION; INDUCTION	Human immunodeficiency virus (HIV) accessory protein viral protein R (Vpr) plays a key role in virus replication and induces cell cycle arrest and apoptosis in various cell types including T cells and neuronal and tumor cells following infection with Vpr-expressing HIV isolates or exposure to the extracellular Vpr protein. The C-terminal Vpr peptide encompassing amino acids 52-96 (Vpr-(52-96)) is required for exerting the apoptotic effects, whereas the N-terminal Vpr-(1-45) peptide is responsible for virus transcription. We demonstrate that Vpr-(52-96) induced apoptosis in human promonocytic THP-1 cells and primary monocytes through the mitochondrial pathway in a caspase-dependent manner. To understand the regulation of Vpr-induced apoptosis, we investigated the signaling pathways, particularly the MAPKs, and the transcription factors involved. Although both Vpr-(52-96) and Vpr-(1-45) peptides induced phosphorylation of all the three members of the MAPKs, Vpr(52-96)-activated JNK selectively induced apoptosis in monocytic cells through the mitochondrial pathway as determined by using JNK inhibitors SP60025, dexamethasone, curcumin, and JNK-specific small interfering RNAs. Furthermore Vpr-(5296)-induced apoptosis was mediated by inhibition of downstream antiapoptotic Bcl2 and c-IAP1 genes whose expression could be restored following pretreatment with JNK-specific inhibitors. Overall the results suggest that Vpr-(52-96)-activated JNK plays a key role in inducing apoptosis through the down-regulation of antiapoptotic Bcl2 and c-IAP1 genes.	Univ Ottawa, Childrens Hosp Eastern Ontario, Div Virol, Res Inst, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Childrens Hosp Eastern Ontario, Infect Dis & Vaccine Res Ctr, Res Inst, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Dept Pathol, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Dept Lab Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa	Kumar, A (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Div Virol, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	akumar@uottawa.ca						Arunagiri C, 1997, APOPTOSIS, V2, P69, DOI 10.1023/A:1026487609215; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; Coeytaux E, 2003, J BIOL CHEM, V278, P18110, DOI 10.1074/jbc.M300248200; Conze D, 2002, J EXP MED, V195, P811, DOI 10.1084/jem.20011508; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong Z, 2002, BIOCHEM J, V364, P413, DOI 10.1042/BJ20011431; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fleischer A, 2006, MOL IMMUNOL, V43, P1065, DOI 10.1016/j.molimm.2005.07.013; Goh WC, 2004, VIROLOGY, V318, P337, DOI 10.1016/j.virol.2003.10.007; Gupta S, 2005, IMMUNOL REV, V205, P114, DOI 10.1111/j.0105-2896.2005.00261.x; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hirasawa N, 1998, J IMMUNOL, V161, P4939; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Kino T, 2002, J VIROL, V76, P9724, DOI 10.1128/JVI.76.19.9724-9734.2002; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Lum JJ, 2003, CURR HIV RES, V1, P261, DOI 10.2174/1570162033485203; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; MACREADIE IG, 1995, P NATL ACAD SCI USA, V92, P2770, DOI 10.1073/pnas.92.7.2770; Mahalingam S, 1997, J VIROL, V71, P6339, DOI 10.1128/JVI.71.9.6339-6347.1997; Mishra S, 2005, J BIOL CHEM, V280, P37536, DOI 10.1074/jbc.M504971200; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Muthumani K, 2004, AIDS, V18, P739, DOI 10.1097/00002030-200403260-00004; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Nie ZL, 1998, J VIROL, V72, P4104, DOI 10.1128/JVI.72.5.4104-4115.1998; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Ramanathan MP, 2002, J BIOL CHEM, V277, P47854, DOI 10.1074/jbc.M203905200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sade H, 2003, EUR J IMMUNOL, V33, P913, DOI 10.1002/eji.200323782; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Sawaya BE, 2000, J VIROL, V74, P4877, DOI 10.1128/JVI.74.10.4877-4881.2000; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tao YX, 2001, J BIOL CHEM, V276, P2329, DOI 10.1074/jbc.C000526200; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Wilson DJ, 1999, CELL IMMUNOL, V194, P67, DOI 10.1006/cimm.1999.1486; Yoshizuka N, 2005, J VIROL, V79, P11366, DOI 10.1128/JVI.79.17.11366-11381.2005; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	61	24	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4288	4300		10.1074/jbc.M608307200	http://dx.doi.org/10.1074/jbc.M608307200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17158886	hybrid			2022-12-27	WOS:000244482000008
J	Li, Z; Xu, MJ; Xing, S; Ho, WT; Ishii, T; Li, QS; Fu, XQ; Zhao, ZZJ				Li, Zhe; Xu, Mingjiang; Xing, Shu; Ho, Wanting Tina; Ishii, Takefumi; Li, Qingshan; Fu, Xueqi; Zhao, Zhizhuang Joe			Erlotinib effectively inhibits JAK2(V617F) activity and polycythemia vera cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE MUTATION; ABL-POSITIVE CELLS; MYELOPROLIFERATIVE-DISORDERS; JAK2 MUTATION; ACTIVATING MUTATION; MYELOID-LEUKEMIA; LUNG-CANCER; IMATINIB; MYELOFIBROSIS; IDENTIFICATION	JAK2(V617F), a mutant of tyrosine kinase JAK2, is found in most patients with polycythemia vera (PV) and a substantial proportion of patients with idiopathic myelofibrosis or essential thrombocythemia. The JAK2 mutant displays a much increased kinase activity and generates a PV-like phenotype in mouse bone marrow transplant models. This study shows that the anticancer drug erlotinib (Tarceva (TM)) is a potent inhibitor of JAK2(V617F) activity. In vitro colony culture assays revealed that erlotinib at micro-molar concentrations effectively suppresses the growth and expansion of PV hematopoietic progenitor cells while having little effect on normal cells. Furthermore, JAK2(V617F)-positive cells from PV patients show greater susceptibility to the inhibitor than their negative counterparts. Similar inhibitory effects were found with the JAK2(V617F)-positive human erythroleukemia HEL cell line. These data suggest that erlotinib may be used for treatment of JAK2(V617F)-positive PV and other myeloproliferative disorders.	Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; Jilin Univ, Coll Life Sci, Edmond H Fischer Signal Transduct Lab, Changchun 130023, Peoples R China; Univ Illinois, Coll Med, Ctr Canc, Hematol Oncol Sect, Chicago, IL 60612 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, ZZJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA.	joe-zhao@ouhsc.edu	li, zhe/B-6882-2011	Xing, Shu/0000-0001-5449-4497	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079441, R01HL076309] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL079441, HL076309, R01 HL076309-05, R01 HL079441-02, R01 HL076309, R01 HL079441] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2006, BLOOD, V107, P3339, DOI 10.1182/blood-2005-09-3917; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Oehler L, 2003, BLOOD, V102, P2240, DOI 10.1182/blood-2003-03-0676; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Silver RT, 2003, LEUKEMIA, V17, P1186, DOI 10.1038/sj.leu.2402938; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xu XS, 2007, BLOOD, V109, P339, DOI 10.1182/blood-2006-03-009472; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	26	96	108	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3428	3432		10.1074/jbc.C600277200	http://dx.doi.org/10.1074/jbc.C600277200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17178722	Green Accepted, hybrid			2022-12-27	WOS:000244481900004
J	Takahashi, H; Kumagai, T; Kitani, K; Mori, M; Matoba, Y; Sugiyama, M				Takahashi, Hitoshi; Kumagai, Takanori; Kitani, Kyoko; Mori, Miwako; Matoba, Yasuyuki; Sugiyama, Masanori			Cloning and characterization of a Streptomyces single module type non-ribosomal peptide synthetase catalyzing a blue pigment synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATION DOMAINS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; INDIGOIDINE; BLEOMYCIN; DNA; POLYKETIDE; EPOTHILONE; BACTERIUM; OXIDATION	In the present study, we cloned a gene, designated bpsA, which encodes a single module type non-ribosomal peptide synthetase (NRPS) from a D-cycloserine (DCS)-producing Streptomyces lavendulae ATCC11924. A putative oxidation domain is significantly integrated into the adenylation domain of the NRPS, and the condensation domain is absent from the module. When S. lividans was transformed with a plasmid carrying bpsA, the transformed cells produced a blue pigment, suggesting that bpsA is responsible for the blue pigment synthesis. However, to produce the blue pigment in Escherichia coli, the existence of the 4'-phosphopantetheinyl transferase (PPTase) gene from Streptomyces was necessary, in addition to bpsA. The chemical structure of the pigment was determined as 5,5'-diamino-4,4'dihydroxy-3,3'-diazadiphenoquinone-(2,2'), called indigoidine. The bpsA gene product, designated BPSA, was overproduced in an E. coli host-vector system and purified to homogeneity, demonstrating that the recombinant enzyme prefers L-Gln as a substrate. The in vitro experiment using L-Gln also showed that the blue pigment was formed by the purified BPSA only when the enzyme was phosphopantetheinylated by adding a Streptomyces PPTase purified from E. coli cells. Each site-directed mutagenesis experiment of Lys(598), Tyr(601), Ser(603), and Tyr6os, which are seen in the oxidation domain of BPSA, suggests that these residues are essential for the binding of FMN to the protein and the synthesis of the blue pigment.	Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Minami Ku, Hiroshima 7348551, Japan; Hiroshima Univ, Frontier Ctr Microbiol, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University; Hiroshima University	Sugiyama, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp						Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Challis GL, 2004, CURR OPIN STRUC BIOL, V14, P748, DOI 10.1016/j.sbi.2004.10.005; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen HW, 2001, CHEM BIOL, V8, P899, DOI 10.1016/S1074-5521(01)00064-3; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Du LC, 2003, BIOCHEMISTRY-US, V42, P9731, DOI 10.1021/bi034817r; Du LC, 2000, FEMS MICROBIOL LETT, V189, P171, DOI 10.1016/S0378-1097(00)00274-3; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Ehmann DE, 2000, P NATL ACAD SCI USA, V97, P2509, DOI 10.1073/pnas.040572897; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Hughes MS, 1997, FEMS MICROBIOL LETT, V156, P31, DOI 10.1016/S0378-1097(97)00398-4; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; KUHN R, 1965, ARCH MIKROBIOL, V51, P71, DOI 10.1007/BF00406851; Levin I, 2005, PROTEINS, V59, P864, DOI 10.1002/prot.20420; MORTIMER PS, 1966, APPL MICROBIOL, V14, P870; PINSKER KL, 1976, AM J HOSP PHARM, V33, P275, DOI 10.1093/ajhp/33.3.275; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; YANAGIMOTO M, 1983, J FERMENT TECHNOL, V61, P545	31	83	89	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9073	9081		10.1074/jbc.M611319200	http://dx.doi.org/10.1074/jbc.M611319200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17237222	Green Published, hybrid			2022-12-27	WOS:000245780300054
J	Mustafa, T; Grimaldi, M; Eiden, LE				Mustafa, Tomris; Grimaldi, Maurizio; Eiden, Lee E.			The hop cassette of the PAC1 receptor confers coupling to Ca2+ elevation required for pituitary adenylate cyclase-activating polypeptide-evoked neurosecretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CATECHOLAMINE RELEASE; 4 SPLICE VARIANTS; CHROMAFFIN CELLS; SIGNALING PATHWAYS; PAC(1) RECEPTOR; GENE-TRANSCRIPTION; MOLECULAR-CLONING; CALCIUM-CHANNELS; EXPRESSION; SECRETION	We have identified the single PAC1 receptor variant responsible for Ca2+ mobilization from intracellular stores and influx through voltage-gated Ca2+ channels in bovine chromaffin cells and the domain of this receptor variant that confers coupling to [Ca2+](i) elevation. This receptor (bPAC1(hop)) contains a 28-amino acid "hop" insertion in the third intracellular loop, with a full-length 171-amino acid N terminus. Expression of the bPAC1(hop) receptor in NG108-15 cells, which lack endogenous PAC1 receptors, reconstituted high affinity PACAP binding and PACAP-dependent elevation of both cAMP and intracellular Ca2+ concentrations ([Ca2+](i)). Removal of the hop domain and expression of this receptor (bPAC1(null)) in NG108-15 cells reconstituted high affinity PACAP binding and PACAP-dependent cAMP generation but without a corresponding [Ca2+](i) elevation. PC12-G cells express sufficient levels of PAC1 receptors to provide PACAP-saturable coupling to adenylate cyclase and to drive PACAP-dependent differentiation but do not express PAC1 receptors at levels found in postmitotic neuronal and endocrine cells and do not support PACAP-mediated neurosecretion. Expression of bPAC1(hop), but not bPAC1(null), at levels comparable with those of bPAC1(hop) in bovine chromaffin cells resulted in acquisition by PC12-G cells of PACAP-dependent [Ca2+]i increase and extracellular Ca2+ influx. In addition, PC12-G cells expressing bPAC1(hop) acquired the ability to release [3 H]norepinephrine in a Ca2+ influx-dependent manner in response to PACAP. Expression of PACAP receptors in neuroendocrine rather than nonneuroendocrine cells reveals key differences between PAC1(hop) and PAC1(null) coupling, indicating an important and previously unrecognized role of the hop cassette in PAC1-mediated Ca2+ signaling in neuroendocrine cells.	NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; So Res Inst, Neuropharmacol Lab, Dept Biochem, Drug Discovery Div, Birmingham, AL 35205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bldg 49,Rm 5A-68,9000 Rockville Pike, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Eiden, Lee/0000-0001-7524-944X; Grimaldi, Maurizio/0000-0002-7331-7055; Mustafa, Tomris/0000-0002-0836-2159	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002386] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 MH002386-22, ZIA MH002386-23, Z01 MH002386-21] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aoyagi K, 2001, BIOCHEM BIOPH RES CO, V286, P646, DOI 10.1006/bbrc.2001.5443; Babinski K, 1996, NEUROPEPTIDES, V30, P572, DOI 10.1016/S0143-4179(96)90041-4; Baldelli P, 2004, MOL NEUROBIOL, V29, P73, DOI 10.1385/MN:29:1:73; Beaudet MM, 1998, J NEUROBIOL, V36, P325, DOI 10.1002/(SICI)1097-4695(19980905)36:3<325::AID-NEU2>3.0.CO;2-Y; Beaudet MM, 2000, J NEUROSCI, V20, P7353; Braas KM, 1999, J BIOL CHEM, V274, P27702, DOI 10.1074/jbc.274.39.27702; Braas KM, 1996, ANN NY ACAD SCI, V805, P204; Brandish PE, 2005, NEURON, V45, P861, DOI 10.1016/j.neuron.2005.02.006; Carbone E, 2001, PFLUG ARCH EUR J PHY, V442, P801, DOI 10.1007/s004240100607; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; CAVALLARO S, 1995, MOL PHARMACOL, V48, P56; Chatterjee TK, 1996, J BIOL CHEM, V271, P32226, DOI 10.1074/jbc.271.50.32226; Daniel PB, 2001, J BIOL CHEM, V276, P12938, DOI 10.1074/jbc.M009941200; Dautzenberg FM, 1999, J NEUROENDOCRINOL, V11, P941; Dennis E., 2003, HDB CELL SIGNALING, P375; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Dziema H, 2002, J NEUROPHYSIOL, V88, P1374, DOI 10.1152/jn.2002.88.3.1374; EIDEN LE, 1987, J NEUROCHEM, V49, P65, DOI 10.1111/j.1471-4159.1987.tb03395.x; EIDEN LE, 1984, P NATL ACAD SCI-BIOL, V81, P3949, DOI 10.1073/pnas.81.13.3949; FENWICK EM, 1978, J CELL BIOL, V76, P12, DOI 10.1083/jcb.76.1.12; Fukushima Y, 2001, AM J PHYSIOL-REG I, V281, pR495, DOI 10.1152/ajpregu.2001.281.2.R495; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Geng GJ, 1997, AM J PHYSIOL-REG I, V273, pR1339, DOI 10.1152/ajpregu.1997.273.4.R1339; Grimaldi M, 2003, J NEUROSCI, V23, P4737; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hahm SH, 1998, J MOL NEUROSCI, V11, P43, DOI 10.1385/JMN:11:1:43; Hamelink C, 2002, J NEUROSCI, V22, P5310; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hamelink C., 2003, PITUITARY ADENYLATE, P227, DOI [10.1007/978-1-4615-0243-2_10, DOI 10.1007/978-1-4615-0243-2_10]; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; ISOBE K, 1993, ENDOCRINOLOGY, V132, P1757, DOI 10.1210/en.132.4.1757; Lamouche S, 1999, AM J PHYSIOL-REG I, V276, pR162, DOI 10.1152/ajpregu.1999.276.1.R162; Lee HW, 1999, J NEUROCHEM, V73, P1769, DOI 10.1046/j.1471-4159.1999.731769.x; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Marley PD, 2003, PHARMACOL THERAPEUT, V98, P1, DOI 10.1016/S0163-7258(03)00002-0; Marley PD, 1996, J AUTONOM NERV SYST, V60, P141, DOI 10.1016/0165-1838(96)00044-6; May V, 1998, ANN NY ACAD SCI, V865, P164, DOI 10.1111/j.1749-6632.1998.tb11175.x; Mazzocchi G, 2002, J CLIN ENDOCR METAB, V87, P2575, DOI 10.1210/jc.87.6.2575; McCulloch DA, 2001, MOL PHARMACOL, V59, P1523, DOI 10.1124/mol.59.6.1523; MIYAMOTO Y, 1994, BBA-GENE STRUCT EXPR, V1218, P297, DOI 10.1016/0167-4781(94)90181-3; MOTULSKY HJ, 2003, PRACTICAL GUIDE CURV, P222; Mustafa T, 2001, J NEUROCHEM, V76, P1679, DOI 10.1046/j.1471-4159.2001.00166.x; Mustafa T, 2006, HDB NEUROCHEMISTRY M, P463; OFarrell M, 1997, N-S ARCH PHARMACOL, V356, P536, DOI 10.1007/PL00005088; Osipenko ON, 2000, J BIOL CHEM, V275, P16626, DOI 10.1074/jbc.M909636199; Pantaloni C, 1996, J BIOL CHEM, V271, P22146, DOI 10.1074/jbc.271.36.22146; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; Pisegna JR, 1996, ANN NY ACAD SCI, V805, P54; Powelka AM, 2001, FEBS LETT, V501, P47; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; RAUSCH DM, 1988, MOL ENDOCRINOL, V2, P921, DOI 10.1210/mend-2-10-921; Ravni A, 2006, J NEUROCHEM, V98, P1229, DOI 10.1111/j.1471-4159.2006.03962.x; Ronaldson E, 2002, REGUL PEPTIDES, V109, P193, DOI 10.1016/S0167-0115(02)00204-5; Sabban EL, 1995, ANN NY ACAD SCI, V771, P327, DOI 10.1111/j.1749-6632.1995.tb44692.x; Shibuya I, 1998, J NEUROENDOCRINOL, V10, P31, DOI 10.1046/j.1365-2826.1998.00168.x; Shioda S, 2000, ANN NY ACAD SCI, V921, P211; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Tanaka K, 1996, ENDOCRINOLOGY, V137, P956, DOI 10.1210/en.137.3.956; Tanaka K, 1997, ENDOCRINOLOGY, V138, P4086, DOI 10.1210/en.138.10.4086; Taupenot L, 1996, NEUROSCIENCE, V72, P377, DOI 10.1016/0306-4522(96)83172-1; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; Turquier V, 2001, MOL PHARMACOL, V60, P42, DOI 10.1124/mol.60.1.42; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wallace DJ, 2002, J PHYSIOL-LONDON, V540, P921, DOI 10.1113/jphysiol.2001.013370; WATANABE T, 1992, BIOCHEM BIOPH RES CO, V182, P403, DOI 10.1016/S0006-291X(05)80159-7; Wong AOL, 2005, ENDOCRINOLOGY, V146, P5407, DOI 10.1210/en.2005-0294; MINI HDB, P31	69	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8079	8091		10.1074/jbc.M609638200	http://dx.doi.org/10.1074/jbc.M609638200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17213203	Green Accepted, hybrid			2022-12-27	WOS:000245081000040
J	Tippens, AL; Lee, A				Tippens, Alyssa L.; Lee, Amy			Caldendrin, a neuron-specific modulator of Ca(v)1.2 (L-type) Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; VISININ-LIKE PROTEIN-2; LONG-TERM DEPRESSION; CA2+-DEPENDENT INACTIVATION; CALMODULIN-BINDING; CA(V)2.1 CHANNELS; CA2+-BINDING PROTEIN-1; HIPPOCAMPAL-NEURONS; SPLICE ISOFORMS; IQ DOMAIN	EF-hand Ca2+-binding proteins such as calmodulin and CaBP1 have emerged as important regulatory subunits of voltage-gated Ca2+ channels. Here, we show that caldendrin, a variant of CaBP1 enriched in the brain, interacts with and distinctly modulates Ca(v)1.2 (L-type) voltage-gated Ca2+ channels relative to other Ca2+-binding proteins. Caldendrin binds to the C-terminal IQ-domain of the pore-forming alpha(1)-subunit of Ca(v)1.2 (alpha(1),1.2) and competitively displaces calmodulin and CaBP1 from this site. Compared with CaBP1, caldendrin causes a more modest suppression of Ca2+-dependentin activation of Ca(v)1.2 through a different subset of molecular determinants. Caldendrin does not bind to the N-terminal domain of alpha(1)1.2, a site that is critical for functional interactions of the channel with CaBP1. Deletion of the N-terminal domain inhibits CaBPI, but spares caldendrin modulation of Ca(v)1.2 inactivation. In contrast, mutations of the IQ-domain abolish physical and functional interactions of caldendrin and Ca(v)1.2, but do not prevent channel modulation by CaBP1. Using antibodies specific for caldendrin and Ca(v)1.2, we show that caldendrin coimmunoprecipitates with Ca(v)1.2 from the brain and colocalizes with Ca(v)1.2 in somatodendritic puncta of cortical neurons in culture. Our findings reveal functional diversity within related Ca2+-binding proteins, which may enhance the specificity of Ca2+ signaling by Ca(v)1.2 channels in different cellular contexts.	Emory Univ, Sch Med, Dept Pharmacol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Emory University	Lee, A (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Ctr Neurodegenerat Dis, 5123 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.	alee@pharm.emory.edu		Lee, Amy/0000-0001-8021-0443	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044922] Funding Source: NIH RePORTER; NINDS NIH HHS [NS044922] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bernstein HG, 2003, J HISTOCHEM CYTOCHEM, V51, P1109, DOI 10.1177/002215540305100816; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHRISTIE BR, 1994, NEUROSCI LETT, V167, P41, DOI 10.1016/0304-3940(94)91023-5; Christie BR, 1996, HIPPOCAMPUS, V6, P17, DOI 10.1002/(SICI)1098-1063(1996)6:1<17::AID-HIPO4>3.0.CO;2-4; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Ferreira G, 1997, J GEN PHYSIOL, V109, P449, DOI 10.1085/jgp.109.4.449; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; GALLI A, 1994, BIOPHYS J, V67, P2296, DOI 10.1016/S0006-3495(94)80715-5; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; HUANG YY, 1993, J NEUROSCI, V13, P568; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; JOHNSON BD, 1994, PFLUG ARCH EUR J PHY, V429, P14, DOI 10.1007/BF02584025; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Landwehr M, 2003, FEBS LETT, V547, P189, DOI 10.1016/S0014-5793(03)00713-0; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Menger N, 1999, CELL TISSUE RES, V298, P21, DOI 10.1007/s004419900060; Meuth S, 2002, EUR J NEUROSCI, V15, P1603, DOI 10.1046/j.1460-9568.2002.01999.x; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schultz K, 2004, J COMP NEUROL, V479, P84, DOI 10.1002/cne.20314; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Seldenbecher CI, 2004, J MOL BIOL, V336, P957, DOI 10.1016/j.jmb.2003.12.054; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; Smalla KH, 2003, MOL BRAIN RES, V116, P159, DOI 10.1016/S0169-328X(03)00235-3; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Stewart AE, 2001, J NEUROPHYSIOL, V85, P1412, DOI 10.1152/jn.2001.85.4.1412; Stout AK, 1996, J PHYSIOL-LONDON, V492, P641, DOI 10.1113/jphysiol.1996.sp021334; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wu YJ, 2001, J PHYSIOL-LONDON, V535, P679, DOI 10.1111/j.1469-7793.2001.t01-1-00679.x; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	58	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8464	8473		10.1074/jbc.M611384200	http://dx.doi.org/10.1074/jbc.M611384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17224447	hybrid			2022-12-27	WOS:000245081000079
J	Kang, HR; Cho, SJ; Lee, CG; Homer, RJ; Elias, JA				Kang, Hye-Ryun; Cho, Soo Jung; Lee, Chun Geun; Homer, Robert J.; Elias, Jack A.			Transforming growth factor (TGF)-beta(1) stimulates pulmonary fibrosis and inflammation via a bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-MEDIATED APOPTOSIS; MICE LACKING SMAD3; TGF-BETA; EPITHELIAL-CELLS; DEFICIENT MICE; DEATH; EXPRESSION; TGF-BETA-1; PROTEINS; EMPHYSEMA	Fibrosis, apoptosis, and the exaggerated production of transforming growth factor (TGF)-beta(1) are juxtaposed in a variety of pulmonary diseases including the interstitial lung diseases and asthma. In these disorders, the relationships between these responses are not well defined. In addition, the apoptosis pathways that contribute to these responses and the mechanism(s) of their contribution have not been described. We hypothesized that BH3 domain-only protein-induced apoptosis plays an important role in the pathogenesis of TGF-beta(1)-induced pulmonary responses. To test this hypothesis, we characterized the effects of transgenic TGF-beta(1) in mice with wild type (WT) and null Bax loci. To investigate the mechanisms of Bax activation and its effector functions, we also compared the effects of TGF-beta(1), in mice with WT and null Bid and matrix metalloproteinase (MMP)-12 loci, respectively. These studies demonstrate that TGF-beta(1) is a potent stimulator of Bax, Bid, and MMP-12. The studies also demonstrate that Bax and Bid play key roles in the pathogenesis of TGF-beta(1)-induced inflammation, fibrosis, and apoptosis; that TGF-beta(1) stimulates MMP-12, TIMP-1, and cathepsins and inhibits MMP-9 and p21. via Bax- and Bid-dependent mechanisms; and that TGF-beta(1) stimulated pulmonary fibrosis is ameliorated in MMP-12-deficient animals. Finally, they demonstrate that Bax, Bid, and MMP-12 play similar roles in bleomycin-induced fibrosis, thereby highlighting the importance of this Bid-activated, Baxmediated pathway and downstream MMP-12 in a variety of fibrogenic settings.	Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University; Yale University	Elias, JA (corresponding author), Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA.	jack.elias@yale.edu	Lee, Chun Geun/AAC-2838-2021; homer, robert/P-3884-2019	homer, robert/0000-0002-2055-5885; Lee, Chun Geun/0000-0002-9514-3658	NHLBI NIH HHS [HL-064242, HL-078744, HL-084225, HL-56389] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078744, R01HL084225, P01HL056389, R01HL064242, P50HL056389] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; ANTONIOU KM, 2006, IN PRESS PULM PHARM; Antoshina Elena, 1997, In Vitro Cellular and Developmental Biology Animal, V33, P212; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashcroft GS, 2000, CYTOKINE GROWTH F R, V11, P125, DOI 10.1016/S1359-6101(99)00036-2; Baskin-Bey ES, 2005, AM J PHYSIOL-GASTR L, V289, pG987, DOI 10.1152/ajpgi.00371.2005; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Chen P, 2006, AM J RESP CELL MOL, V34, P464, DOI 10.1165/rcmb.2005-0344OC; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Edwards DR, 2004, J PATHOL, V202, P391, DOI 10.1002/path.1548; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Gajewska M, 2004, COMP BIOCHEM PHYS C, V139, P65, DOI 10.1016/j.cca.2004.09.006; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Howell JE, 2006, CURR DRUG TARGETS, V7, P547, DOI 10.2174/138945006776818692; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Joza N, 2002, TRENDS GENET, V18, P142, DOI 10.1016/S0168-9525(01)02618-X; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Kandasamy K, 2003, CANCER RES, V63, P1712; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee JH, 2002, CURR EYE RES, V25, P147, DOI 10.1076/ceyr.25.3.147.13475; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Li XP, 2004, J APPL PHYSIOL, V97, P1535, DOI 10.1152/japplphysiol.00519.2004; Ling EM, 2002, CLIN EXP ALLERGY, V32, P175, DOI 10.1046/j.1365-2222.2002.01287.x; Lu Qing, 2005, Keio Journal of Medicine, V54, P184, DOI 10.2302/kjm.54.184; Ma B, 2005, J CLIN INVEST, V115, P3460, DOI 10.1172/JCI24858; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Massague J, 1999, NAT CELL BIOL, V1, pE117, DOI 10.1038/12944; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Noble PW, 2006, CLIN CHEST MED, V27, pS11, DOI 10.1016/j.ccm.2005.08.003; Noble PW, 2004, CLIN CHEST MED, V25, P749, DOI 10.1016/j.ccm.2004.04.003; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; RAGHU G, 1998, FISHMANS PULMONARY D, P1035; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Ruffolo SC, 2000, CELL DEATH DIFFER, V7, P1101, DOI 10.1038/sj.cdd.4400739; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Senior RM, 1998, FISHMANS PULMONARY D, P659; Steen V, 2006, AUTOIMMUN REV, V5, P122, DOI 10.1016/j.autrev.2005.09.003; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tan RJ, 2006, AM J RESP CELL MOL, V35, P289, DOI 10.1165/rcmb.2005-0471OC; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Trautmann A, 2005, INT ARCH ALLERGY IMM, V138, P142, DOI 10.1159/000088436; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106	65	147	156	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7723	7732		10.1074/jbc.M610764200	http://dx.doi.org/10.1074/jbc.M610764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209037	hybrid			2022-12-27	WOS:000245080900084
J	Rainaldi, M; Yamniuk, AP; Murase, T; Vogel, HJ				Rainaldi, Mario; Yamniuk, Aaron P.; Murase, Tomohiko; Vogel, Hans J.			Calcium-dependent and -independent binding of soybean calmodulin isoforms to the calmodulin binding domain of tobacco MAPK phosphatase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ENTHALPY-ENTROPY COMPENSATION; C-TERMINAL DOMAIN; TARGET RECOGNITION; PEPTIDE INTERACTION; GLUTAMATE-DECARBOXYLASE; STRUCTURAL BASIS; PROTEIN-BINDING; APO-CALMODULIN; SIDE-CHAINS	The recent finding of an interaction between calmodulin (CaM) and the tobacco mitogen-activated protein kinase phosphatase-1 (NtMKP1) establishes an important connection between Ca2+ signaling and the MAPK cascade, two of the most important signaling pathways in plant cells. Here we have used different biophysical techniques, including fluorescence and NMR spectroscopy as well as microcalorimetry, to characterize the binding of soybean CaM isoforms, SCaM-1 and -4, to synthetic peptides derived from the CaM binding domain of NtMKP1. We find that the actual CaM binding region is shorter than what had previously been suggested. Moreover, the peptide binds to the SCaM C-terminal domain even in the absence of free Ca2+ with the single Trp residue of the NtMKP1 peptides buried in a solvent-inaccessible hydrophobic region. In the presence of Ca2+, the peptides bind first to the C-terminal lobe of the SCaMs with a nanomolar affinity, and at higher peptide concentrations, a second peptide binds to the N-terminal domain with lower affinity. Thermodynamic analysis demonstrates that the formation of the peptide-bound complex with the Ca2+-loaded SCaMs is driven by favorable binding enthalpy due to a combination of hydrophobic and electrostatic interactions. Experiments with CaM proteolytic fragments showed that the two domains bind the peptide in an independent manner. To our knowledge, this is the first report providing direct evidence for sequential binding of two identical peptides of a target protein to CaM. Discussion of the potential biological role of this interaction motif is also provided.	Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca						Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Censarek P, 2004, FEBS LETT, V577, P465, DOI 10.1016/j.febslet.2004.10.048; Censarek P, 2002, BIOCHEMISTRY-US, V41, P8598, DOI 10.1021/bi025681k; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin D, 1997, J BIOL CHEM, V272, P5510, DOI 10.1074/jbc.272.9.5510; Cho MJ, 1998, BIOCHEMISTRY-US, V37, P15593, DOI 10.1021/bi981497g; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Csiszar A, 2006, BIOESSAYS, V28, P465, DOI 10.1002/bies.20411; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; FARAH CS, 1994, J BIOL CHEM, V269, P5230; Faria TQ, 2004, J BIOL CHEM, V279, P48680, DOI 10.1074/jbc.M408806200; Gomes AV, 2000, ARCH BIOCHEM BIOPHYS, V379, P28, DOI 10.1006/abbi.2000.1827; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Hu HT, 2004, J BIOL CHEM, V279, P50895, DOI 10.1074/jbc.M404233200; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; ITAKURA M, 1992, J BIOCHEM, V112, P183, DOI 10.1093/oxfordjournals.jbchem.a123875; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Ligterink W, 2001, INT REV CYTOL, V201, P209, DOI 10.1016/S0074-7696(01)01004-X; LKURA M, 1992, SCIENCE, V256, P632; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mori M, 2003, BIOCHEM BIOPH RES CO, V307, P290, DOI 10.1016/S0006-291X(03)01183-5; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Sheehan JH, 2006, J BIOL CHEM, V281, P2876, DOI 10.1074/jbc.M509886200; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; URBAUER JL, 1995, BIOCHEMISTRY-US, V34, P8099, DOI 10.1021/bi00025a016; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yamniuk AP, 2005, BIOCHEMISTRY-US, V44, P3101, DOI 10.1021/bi047770y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 1998, BIOCHEMISTRY-US, V37, P3187, DOI 10.1021/bi9716579; Yuan T, 1999, BIOCHEMISTRY-US, V38, P1446, DOI 10.1021/bi9816453; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHANG MJ, 1994, J MOL BIOL, V239, P545, DOI 10.1006/jmbi.1994.1393; Zhang MJ, 1997, PROTEIN PEPTIDE LETT, V4, P291; ZHANG MJ, 1995, J BIOL CHEM, V270, P20901, DOI 10.1074/jbc.270.36.20901	68	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6031	6042		10.1074/jbc.M608970200	http://dx.doi.org/10.1074/jbc.M608970200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202149	hybrid			2022-12-27	WOS:000244867200008
J	Wlodarski, P; Zhang, Q; Liu, XB; Kasprzycka, M; Marzec, M; Wasik, MA				Wlodarski, Pawel; Zhang, Qian; Liu, Xiaobin; Kasprzycka, Monika; Marzec, Michal; Wasik, Mariusz A.			PU.1 activates transcription of SHP-1 gene in hematopoietic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MACROPHAGE DEVELOPMENT; MOTH-EATEN; EXPRESSION; MUTATIONS; ETS-2; DEPHOSPHORYLATION; DIFFERENTIATION; METHYLATION; MYB	Protein-tyrosine phosphatase SHP-1 is the key negative regulator of numerous signaling pathways. SHP-1 is expressed in the hematopietic and epithelial cells as two structurally similar mRNA transcripts controlled by two different promoters designated P2 and P1, respectively. Whereas the transcriptional regulation of the SHP-1 gene P1 promoter has been partially elucidated, the structure and functional control of the P2 promoter remain unknown despite the critical role played by SHP-1 in the normal and malignant lymphoid and other hematopoetic cells. Using luciferase reporter assays with the set of constructs that contained a gradually truncated intron 1 of the SHP-1 gene, we identified the minimal (< 120 bp) fragment that is able to fully activate expression of the reporter gene. Furthermore, we found that PU.1 (a member of the Ets transcription factor family that plays a crucial role in differentiation and function of the lymphoid and myeloid cells) binds to the identified P2 promoter both in vitro and in vivo. PUA also activates the promoter in the sequence specific manner and is critical for its expression as evidenced by the profound supression of the SHP-1 gene transcription upon the siRNA-mediated depletion of PU.1. These findings provide an insight into the structure of the hematopoietic cell-specific P2 promoter of the SHP-1 gene and identify PUA as the transcriptional activator of the P2 promoter.	Univ Penn, Med Ctr, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Lab Med, Philadelphia, PA 19104 USA; Warsaw Med Univ, Dept Histol & Embryol, PL-02004 Warsaw, Poland; Warsaw Med Univ, Dept Clin Immunol, PL-02004 Warsaw, Poland	University of Pennsylvania; University of Pennsylvania; Medical University of Warsaw; Medical University of Warsaw	Wasik, MA (corresponding author), Univ Penn, Med Ctr, Dept Pathol & Lab Med, 3400 Spruce St,7-106 Founders Pavil, Philadelphia, PA 19104 USA.	wasik@mail.med.upenn.edu	Marzec, Michal/O-6387-2016	Marzec, Michal/0000-0001-9698-6019; Wlodarski, Pawel/0000-0002-0683-1791	NCI NIH HHS [R01-CA89194, R01-CA96856] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA096856, R01CA089194] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Frank C, 2004, J BIOL CHEM, V279, P11375, DOI 10.1074/jbc.M309096200; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; Henkel GW, 1996, BLOOD, V88, P2917, DOI 10.1182/blood.V88.8.2917.bloodjournal8882917; McIvor Z, 2003, EXP HEMATOL, V31, P39, DOI 10.1016/S0301-472X(02)01017-2; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mena-Duran AV, 2005, BRIT J HAEMATOL, V129, P791, DOI 10.1111/j.1365-2141.2005.05516.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Oh IH, 1997, J BIOL CHEM, V272, P21432, DOI 10.1074/jbc.272.34.21432; Oka T, 2002, CANCER RES, V62, P6390; OPREY J, 1993, MOL CELL BIOL, V13, P6290, DOI 10.1128/MCB.13.10.6290; Ratajczak MZ, 1998, BLOOD, V91, P1934, DOI 10.1182/blood.V91.6.1934.1934_1934_1946; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Tsui HW, 2002, EUR J BIOCHEM, V269, P3057, DOI 10.1046/j.1432-1033.2002.02986.x; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; WEN SC, 1995, EXP CELL RES, V217, P8, DOI 10.1006/excr.1995.1057; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102	28	22	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6316	6323		10.1074/jbc.M607526200	http://dx.doi.org/10.1074/jbc.M607526200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17218319	hybrid			2022-12-27	WOS:000244867200038
J	Harada, H; Takahashi, M				Harada, Hosami; Takahashi, Masaaki			CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; LYSOSOMAL HYALURONIDASE; PLASMA HYALURONIDASE; SYNOVIAL-FLUID; TUMOR-GROWTH; EXPRESSION; CELLS; RECEPTOR; HYAL2; CD44	Hyaluronic acid (HA) is a high molecular weight glycosaminoglycan involved in a wide variety of cellular functions. However, its turnover in living cells remains largely unknown. In this study, CD44, a receptor for HA, and hyaluronidase-1, -2, and -3 (Hyal-1, -2 and -3) were stably expressed in HEK 293 cells and the mechanism of HA catabolism was systematically investigated using fluorescein-labeled HA. CD44 was essential for HA degradation by both endogenous and exogenously expressed hyaluronidases. Hyal-1 was not able to cleave HA in living cells in the absence of CD44. Intracellular HA degradation was predominantly mediated by Hyal-1 after incorporation of HA by CD44. Although Hyal-1 was active only in intracellular space in vivo, a certain amount of the enzyme was secreted to extracellular space. This extracellular Hyal-1 was found to be incorporated by cells and such uptake of Hyal-1 was, in part, involved in the intracellular degradation of HA. Hyal-2 was involved in the extracellular degradation of HA. Hyal-2 activity was also dependent on the expression of CD44 in both living cells and enzyme assays. Immunofluorescent microscopy demonstrated that both Hyal-2 and CD44 are present on the cell surface. Without CD44 expression, Hyal-2 existed in a granular pattern, and did not show hyaluronidase activity, suggesting that localization change could contribute to Hyal-2 function. A convenient and quantitative enzyme assay was established for the measurement of Hyal-2 activity. Hyal-2 activity was detected in the membrane fraction of cells co-expressing Hyal-2 and CD44. The pH optimum for Hyal-2 was 6.0-7.0. The membrane fraction of cells expressing Hyal-2 alone did not show hyaluronidase activity. Hyal-3 did not show any hyaluronidase activity in our experimental conditions. Based on these findings, Hyal-1 and -2 contribute to intracellular and extracellular catabolism of HA, respectively, in a CD44-dependent manner, and their HA degradation occurs independently from one another.	Sankyo Co Ltd, Lead Discovery Res Labs, Shinagawa Ku, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited	Takahashi, M (corresponding author), Sankyo Co Ltd, Lead Discovery Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	mtakah@sankyo.co.jp						AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; DAY AJ, 2002, J BIOL CHEM, V277, P4575; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Flannery CR, 1998, BIOCHEM BIOPH RES CO, V251, P824, DOI 10.1006/bbrc.1998.9561; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; GHOSH P, 1994, CLIN EXP RHEUMATOL, V12, P75; HUA Q, 1993, J CELL SCI, V106, P365; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Natowicz MR, 1996, AM J MED GENET, V65, P209, DOI 10.1002/(SICI)1096-8628(19961028)65:3<209::AID-AJMG7>3.0.CO;2-K; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Novak U, 1999, CANCER RES, V59, P6246; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Sly W S, 1978, Prog Clin Biol Res, V23, P547; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Strobl B, 1998, GENOMICS, V53, P214, DOI 10.1006/geno.1998.5472; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; TOOLE BP, 1991, CELL BIOL EXTRACELLU, P61; TURLEY EA, 1980, NATURE, V283, P268, DOI 10.1038/283268a0; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223	43	235	248	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5597	5607		10.1074/jbc.M608358200	http://dx.doi.org/10.1074/jbc.M608358200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17170110	hybrid			2022-12-27	WOS:000244482300056
J	Gawenis, LR; Bradford, EM; Prasad, V; Lorenz, JN; Simpson, JE; Clarke, LL; Woo, AL; Grisham, C; Sanford, LP; Doetschman, T; Miller, ML; Shull, GE				Gawenis, Lara R.; Bradford, Emily M.; Prasad, Vikram; Lorenz, John N.; Simpson, Janet E.; Clarke, Lane L.; Woo, Alison L.; Grisham, Christina; Sanford, L. Philip; Doetschman, Thomas; Miller, Marian L.; Shull, Gary E.			Colonic anion secretory defects and metabolic acidosis in mice lacking the NBC1Na(+)/HCO3- cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; SODIUM-BICARBONATE COTRANSPORTER; CARBONIC-ANHYDRASE-IV; K-CL COTRANSPORTER; CYSTIC-FIBROSIS; MURINE DUODENUM; NA+/H+ EXCHANGER; ION-TRANSPORT; OCULAR ABNORMALITIES; FUNCTIONAL-ANALYSIS	The NBC1 Na+/HCO3- cotransporter is expressed in many tissues, including kidney and intestinal epithelia. NBC1 mutations cause proximal renal tubular acidosis in humans, consistent with its role in HCO3- absorption in the kidney. In intestinal and colonic epithelia, NBC1 localizes to basolateral membranes and is thought to function in anion secretion. To test the hypothesis that NBC1 plays a role in transepithelial HCO3- secretion in the intestinal tract, null mutant (NBC1(-/-)) mice were prepared by targeted disruption of its gene (Slc4a4). NBC1(-/-) mice exhibited severe metabolic acidosis, growth retardation, reduced plasma Na+, hyperaldosteronism, splenomegaly, abnormal dentition, intestinal obstructions, and death before weaning. Intracellular pH (pH;) was not altered in cAMP-stimulated epithelial cells of NBC1(-/-) cecum, but pH(i) regulation during sodium removal and readdition was impaired. Bioelectric measurements of NBC1(-/-) colons revealed increased amiloride-sensitive Na+ absorption. In Ringer solution containing both Cl- and HCO3-, the magnitude of cAMP-stimulated anion secretion was normal in NBC1(-/-) distal colon but increased in proximal colon, with the increase largely supported by enhanced activity of the basolateral NKCC1 Na+-K+-2Cl(-) cotransporter. Anion substitution studies in which carbonic anhydrase was inhibited and transepithelial anion conductance was limited to HCO3- revealed a sharp decrease in both cAMP-stimulated HCO3- secretion and SITS-sensitive current in NBC1(-/-) proximal colon. These results are consistent with the known function of NBC1 in HCO3- absorption in the kidney and demonstrate that NBC1 activity is a component of the basolateral mechanisms for HCO3- uptake during cAMP-stimulated anion secretion in the proximal colon.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Mol & Cellular Pharmacol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,ML524, Cincinnati, OH 45267 USA.	shullge@ucmail.uc.edu	Clarke, Lane L/AAK-2866-2020	Clarke, Lane L/0000-0002-4938-6261; Bradford, Emily/0000-0002-4711-5628	NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048816, R01DK050594, R01DK057552, R01DK048816, F32DK067749, R56DK048816, R37DK050594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NCRR NIH HHS [T32-RR-07004] Funding Source: Medline; NHLBI NIH HHS [HL61974] Funding Source: Medline; NIDDK NIH HHS [DK48816, DK57552, DK50594, DK67749] Funding Source: Medline; NIEHS NIH HHS [ES06096] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Arquitt CK, 2002, J DENT RES, V81, P492, DOI 10.1177/154405910208100712; Bachmann O, 2006, AM J PHYSIOL-GASTR L, V291, pG650, DOI 10.1152/ajpgi.00376.2005; Bachmann O, 2003, AM J PHYSIOL-GASTR L, V284, pG37, DOI 10.1152/ajpgi.00209.2002; Baschat AA, 1999, AM J OBSTET GYNECOL, V181, P190, DOI 10.1016/S0002-9378(99)70458-8; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Bonillo A, 1998, AM J PERINAT, V15, P115, DOI 10.1055/s-2007-993909; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; Brandao-Burch A, 2005, CALCIFIED TISSUE INT, V77, P167, DOI 10.1007/s00223-004-0285-8; BUKHAVE K, 1980, GASTROENTEROLOGY, V78, P32; Clarke LL, 1996, LAB ANIM SCI, V46, P612; Clarke LL, 1998, AM J PHYSIOL-GASTR L, V274, pG718, DOI 10.1152/ajpgi.1998.274.4.G718; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Epple HJ, 2000, AM J PHYSIOL-GASTR L, V278, pG718, DOI 10.1152/ajpgi.2000.278.5.G718; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gawenis LR, 2005, GASTROENTEROLOGY, V128, pA44; Gawenis LR, 2003, GASTROENTEROLOGY, V125, P1148, DOI 10.1016/S0016-5085(03)01212-5; Gawenis LR, 2001, BIOL TRACE ELEM RES, V83, P69, DOI 10.1385/BTER:83:1:69; Gawenis LR, 2004, AM J PHYSIOL-GASTR L, V286, pG1015, DOI 10.1152/ajpgi.00468.2003; GAWENIS LR, 2002, AM J PHYSIOL-GASTR L, V282, pG766; Gross E, 2002, AM J PHYSIOL-RENAL, V283, pF876, DOI 10.1152/ajprenal.00148.2002; Gross E, 1996, J MEMBRANE BIOL, V152, P245, DOI 10.1007/s002329900102; Hanlon-Lundberg KM, 1999, AM J OBSTET GYNECOL, V181, P196, DOI 10.1016/S0002-9378(99)70459-X; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713, DOI 10.1681/ASN.V124713; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; Jacob P, 2000, GASTROENTEROLOGY, V119, P406, DOI 10.1053/gast.2000.9358; JENSEN OM, 1986, SCAND J HAEMATOL, V36, P263; Krieger NS, 2003, SEMIN DIALYSIS, V16, P463, DOI 10.1046/j.1525-139X.2003.16100.x; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lucioni A, 2002, AM J PHYSIOL-GASTR L, V283, pG51, DOI 10.1152/ajpgi.00529.2001; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Praetorius J, 2001, AM J PHYSIOL-GASTR L, V280, pG332, DOI 10.1152/ajpgi.2001.280.3.G332; Pushkin A, 2000, BBA-GENE STRUCT EXPR, V1493, P215, DOI 10.1016/S0167-4781(00)00149-4; Romero MF, 1999, ANNU REV PHYSIOL, V61, P699, DOI 10.1146/annurev.physiol.61.1.699; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Roussa E, 2004, BIOCHEM BIOPH RES CO, V314, P382, DOI 10.1016/j.bbrc.2003.12.099; Satoh H, 2003, AM J PHYSIOL-CELL PH, V284, pC729, DOI 10.1152/ajpcell.00166.2002; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Seidler U, 2001, JOP, V2, P247; SHELDON RJ, 1989, J PHARMACOL EXP THER, V249, P572; Simpson JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1241, DOI 10.1152/ajpgi.00493.2004; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; Spicer Z, 2001, AM J PHYSIOL-GASTR L, V281, pG1369, DOI 10.1152/ajpgi.2001.281.6.G1369; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; WINSNES A, 1979, ACTA PAEDIATR SCAND, V68, P861	59	127	130	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2007	282	12					9042	9052		10.1074/jbc.M607041200	http://dx.doi.org/10.1074/jbc.M607041200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	158GS	17192275	hybrid			2022-12-27	WOS:000245780300051
J	Into, T; Kanno, Y; Dohkan, J; Nakashima, M; Inomata, M; Shibata, K; Lowenstein, CJ; Matsushita, K				Into, Takeshi; Kanno, Yosuke; Dohkan, Jun-ichi; Nakashima, Misako; Inomata, Megumi; Shibata, Ken-ichiro; Lowenstein, Charles J.; Matsushita, Kenji			Pathogen recognition by toll-like receptor 2 activates Weibel-Palade body exocytosis in human aortic endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; BRUTONS TYROSINE KINASE; PHOSPHOLIPASE C-GAMMA; STAPHYLOCOCCUS-AUREUS; LIPOTEICHOIC ACID; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDE; SIGNAL-TRANSDUCTION; PROTEIN	The endothelial cell-specific granule Weibel-Palade body releases vasoactive substances capable of modulating vascular inflammation. Although innate recognition of pathogens,by Toll-like receptors (TLRs) is thought to play a crucial role in promotion of inflammatory responses, the molecular basis for early-phase responses of endothelial cells to bacterial pathogens has not fully been understood. We here report that human aortic endothelial cells respond to bacterial lipoteichoic acid (LTA) and synthetic bacterial lipopeptides, but not lipopolysaccharide or peptidoglycan, to induce Weibel-Palade body exocytosis, accompanied by release or externalization of the storage components von Willebrand factor and P-selectin. LTA could activate rapid Weibel-Palade body exocytosis through a TLR2- and MyD88-dependent mechanism without de novo protein synthesis. This process was at least mediated through MyD88-dependent phosphorylation and activation of phospholipase C gamma. Moreover, LTA activated interleukin-1 receptor-associated kinase-1-dependent delayed exocytosis with de novo protein synthesis and phospholipase C gamma-dependent activation of the NF-kappa B pathway. Increased TLR2 expression by transfection or interferon-gamma treatment increased TLR2-mediated Weibel-Palade body exocytosis, whereas reduced TLR2 expression under laminar flow decreased the response. Thus, we propose a novel role for TLR2 in induction of a primary proinflammatory event in aortic endothelial cells through Weibel-Palade body exocytosis, which may be an important step for linking innate recognition of bacterial pathogens to vascular inflammation.	Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Oral Dis Res, Obu, Aichi 4748522, Japan; Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Lab Oral Mol Microbiol, Sapporo, Hokkaido 0608586, Japan; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	National Center for Geriatrics & Gerontology; Hokkaido University; Johns Hopkins University; Johns Hopkins University	Into, T (corresponding author), Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Oral Dis Res, Obu, Aichi 4748522, Japan.	into@nils.go.jp	Shibata, Ken-ichiro/A-4814-2012	Lowenstein, Charles/0000-0003-0485-7514				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bermpohl D, 2005, J CLIN INVEST, V115, P1607, DOI 10.1172/JCI23223; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Chun J, 2006, J IMMUNOL, V177, P1330, DOI 10.4049/jimmunol.177.2.1330; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Danesh J, 1999, AM HEART J, V138, pS434, DOI 10.1016/S0002-8703(99)70270-X; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Dunzendorfer S, 2004, CIRC RES, V95, P684, DOI 10.1161/01.RES.0000143900.19798.47; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; HOFFMANN P, 1988, IMMUNOBIOLOGY, V177, P158, DOI 10.1016/S0171-2985(88)80036-6; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Into T, 2005, CELL MICROBIOL, V7, P1305, DOI 10.1111/j.1462-5822.2005.00558.x; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lee CW, 2004, AM J PHYSIOL-LUNG C, V286, pL921, DOI 10.1152/ajplung.00124.2003; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Mullaly SC, 2004, CIRC RES, V95, P657, DOI 10.1161/01.RES.0000144806.19585.5b; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Reed KA, 2002, J BIOL CHEM, V277, P13346, DOI 10.1074/jbc.M200149200; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Tobias P, 2005, J LIPID RES, V46, P404, DOI 10.1194/jlr.R400015-JLR200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yipp BG, 2002, J IMMUNOL, V168, P4650, DOI 10.4049/jimmunol.168.9.4650	55	45	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8134	8141		10.1074/jbc.M609962200	http://dx.doi.org/10.1074/jbc.M609962200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227763	hybrid			2022-12-27	WOS:000245081000045
J	Leon, S; Subramani, S				Leon, Sebastien; Subramani, Suresh			A conserved cysteine residue of Pichia pastoris Pex20p is essential for its recycling from the peroxisome to the cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TYPE-1 RECEPTOR; PROTEIN IMPORT; MATRIX; MECHANISM; UBIQUITINATION; BIOGENESIS; PEX5P	We identified a cysteine residue, conserved near the N terminus of Pex5p- and Pex20p-like proteins, that is essential for the cytosolic relocation of peroxisomal Pex20p. Surprisingly, this residue is not completely essential for the function of the protein; its point mutation into a serine in Pex20p(C8S) causes the accumulation of the protein at the peroxisome membrane, but this is quickly followed by its subsequent degradation by an ubiquitin-dependent quality control pathway called RADAR (receptor accumulation and degradation in the absence of recycling). This degradative pathway allows partial growth of the Pex20p(C8S) mutant on peroxisome-requiring medium. Mutation of cysteine 8 (C8S) and lysine 19 (K19R), the target residue of the RADAR pathway within Pex20p, leads to a stable but non-functional protein because it fails to recycle to the cytosol. This suggests a role for Cys-8 in Pex20p recycling and that constitutive degradation of peroxisomal receptors can be a partially functional alternative to receptor recycling. In addition, expression of this mutant protein in wild-type cells confers a dominant-negative, oleate-specific growth defect, which is a useful tool for a better understanding of peroxisomal receptor recycling.	Univ Calif San Diego, Sect Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Leon, S (corresponding author), Inst Jacques Monod, CNRS, UMR 7592, 2 Pl Jussieu, F-75251 Paris 05, France.	leon@ijm.jussieu.fr; ssubramani@ucsd.edu	LEON, Sebastien/A-5441-2008	LEON, Sebastien/0000-0002-2536-8595	NIDDK NIH HHS [R37 DK041737-16, DK41737, R56 DK041737, R37 DK041737, R01 DK041737] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041737, R01DK041737, R56DK041737] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Elgersma Y, 1998, J CELL BIOL, V140, P807, DOI 10.1083/jcb.140.4.807; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Kunau WH, 2001, CURR BIOL, V11, pR659, DOI 10.1016/S0960-9822(01)00386-4; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; THOMS S, 2006, BIOCHIM BIOPHYS ACTA, V1763, P1621; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0	19	67	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7424	7430		10.1074/jbc.M611627200	http://dx.doi.org/10.1074/jbc.M611627200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209040	hybrid, Green Accepted			2022-12-27	WOS:000245080900054
J	Yoshida, Y; Murakami, A; Iwai, K; Tanaka, K				Yoshida, Yukiko; Murakami, Arisa; Iwai, Kazuhiro; Tanaka, Keiji			A neural-specific F-box protein Fbs1 functions as a chaperone suppressing glycoprotein aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNIZES SUGAR CHAINS; SCF UBIQUITIN-LIGASE; QUALITY-CONTROL; STRUCTURAL BASIS; COMPLEX; PROTEOLYSIS; KINETOCHORE; DEGRADATION; RHODOPSIN; AUTOPHAGY	Fbs1 is an F-box protein present abundantly in the nervous system. Similar to the ubiquitously expressed Fbs2, Fbs1 recognizes N-glycans at the innermost position as a signal for unfolded glycoproteins, probably in the endoplasmic reticulum-associated degradation pathway. Here, we show that the in vivo majority of Fbs1 is present as Fbs1-Skp1 heterodimers or Fbs1 monomers but not SCFFbs1 complex. The inefficient SCF complex formation of Fbs1 and the restricted presence of SCFFbs1 bound on the endoplasmic reticulum membrane were due to the short linker sequence between the F-box domain and the sugar-binding domain. In vitro, Fbsl prevented the aggregation of the glycoprotein through the N-terminal unique sequence of Fbs1. Our results suggest that Fbsl assists clearance of aberrant glycoproteins in neuronal cells by suppressing aggregates formation, independent of ubiquitin ligase activity, and thus functions as a unique chaperone for those proteins.	Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 1138613, Japan; Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Abeno Ku, Osaka 5458585, Japan	Tokyo Metropolitan Institute of Medical Science; Osaka Metropolitan University	Yoshida, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	yyosida@rinshoken.or.jp	IWAI, KAZUHIRO/GSN-7385-2022; Yoshida, Yukiko/ABB-7218-2020	Yoshida, Yukiko/0000-0002-0629-0219; Iwai, Kazuhiro/0000-0001-5620-5951				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Paquet ME, 2005, METHODS, V35, P338, DOI 10.1016/j.ymeth.2004.10.005; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Saliba RS, 2002, J CELL SCI, V115, P2907; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2005, EMBO REP, V6, P239, DOI 10.1038/sj.embor.7400351; Yoshida Y, 2005, METHOD ENZYMOL, V398, P159, DOI 10.1016/S0076-6879(05)98014-2	30	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7137	7144		10.1074/jbc.M611168200	http://dx.doi.org/10.1074/jbc.M611168200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17215248	hybrid			2022-12-27	WOS:000245080900025
J	Zhao, LY; Santiago, A; Liu, JL; Liao, DQ				Zhao, Lisa Y.; Santiago, Aleixo; Liu, Jilin; Liao, Daiqing			Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; 55-KILODALTON ONCOPROTEIN; ACTIVATION; PROTEIN; APOPTOSIS; DOMAIN; MDM2; IDENTIFICATION; TRANSFORMATION	The Ad EIB 55-kDa protein (E1B) is a potent transcriptional repressor. In vitro biochemical studies revealed that direct p53E1B interaction is essential for E1B to block p53-activated transcription and a corepressor may be involved. To understand how E1B represses p53-mediated transcription in vivo, we expressed E1B in several tumor cell lines that express wild type p53. Here we show that E1B strongly suppresses the expression of p53 target genes such as p21 and Puma-alpha in normal growth conditions or after cells were treated with p53-activating chemotherapeutic agents, suggesting that E1B-mediated gene repression is dominant and cannot be reversed via p53 activation. Interestingly, we found that E1B binds to corepressor mSin3A. Mutagenesis analysis indicated that the sequence motif "LHLLA" near the NH2 terminus of E1B is responsible for mSin3A binding, and this motif is conserved among E1B proteins from different Ad serotypes. The conserved paired amphipathic helix domain 1 of mSin3A is critical for mSin3A-E1B interaction. Surprisingly, E1B mutants that cannot bind to mSin3A can still repress p53 target genes, indicating that it is not the corepressor required for E1B-mediated gene repression. In support of this notion, repression of p53 target genes by E1B is insensitive to HDAC inhibitor trichostatin A. We further show that both the NH2- and COOH-terminal domains of E1B are required for the repression function. Therefore, E1B employs a unique repression mechanism to block p53-mediated transcription.	Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Shands Canc Ctr, Program Canc Genet, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Shands Canc Ctr, Program Epigenet, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Shands Canc Ctr, Program Tumor Virol, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Shands Canc Ctr, Program Cell Signaling Apoptosis & Canc, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liao, DQ (corresponding author), 1376 Mowry Rd, Gainesville, FL 32611 USA.	dliao@ufl.edu	Liao, Daiqing/A-8941-2008		NATIONAL CANCER INSTITUTE [R01CA092236] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA92236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BECK GR, 1998, HUMAN TUMOR VIRUSES, P51; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cowley SM, 2004, MOL CELL BIOL, V24, P2698, DOI 10.1128/MCB.24.7.2698-2709.2004; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; James P, 1996, GENETICS, V144, P1425; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liao DQ, 1996, J BACTERIOL, V178, P4089, DOI 10.1128/jb.178.14.4089-4098.1996; Liao DQ, 1999, VIROLOGY, V254, P11, DOI 10.1006/viro.1998.9512; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu Y, 2000, MOL CELL BIOL, V20, P5540, DOI 10.1128/MCB.20.15.5540-5553.2000; Martin MED, 1999, MOL CELL BIOL, V19, P3403; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Nead MA, 1998, HUMAN TUMOR VIRUSES, P225; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Punga T, 2000, FEBS LETT, V476, P248, DOI 10.1016/S0014-5793(00)01739-7; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; STEEGENGA WT, 1995, VIROLOGY, V212, P543, DOI 10.1006/viro.1995.1512; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Trepel M, 1998, J NEURO-ONCOL, V39, P19, DOI 10.1023/A:1005910323338; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weller M, 1997, INT J CANCER, V73, P707, DOI 10.1002/(SICI)1097-0215(19971127)73:5<707::AID-IJC16>3.3.CO;2-5; White E, 2006, CELL DEATH DIFFER, V13, P1371, DOI 10.1038/sj.cdd.4401941; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Zhao LY, 2006, CANCER RES, V66, P9445, DOI 10.1158/0008-5472.CAN-06-1713; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhao LY, 2003, J VIROL, V77, P13171, DOI 10.1128/JVI.77.24.13171-13181.2003; Zhao LY, 2003, ONCOGENE, V22, P8316, DOI 10.1038/sj.onc.1206916; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	51	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7001	7010		10.1074/jbc.M610749200	http://dx.doi.org/10.1074/jbc.M610749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209038	hybrid			2022-12-27	WOS:000245080900012
J	Zito, CI; Qin, H; Blenis, J; Bennett, AM				Zito, Christina I.; Qin, Hui; Blenis, John; Bennett, Anton M.			SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; TYROSINE PHOSPHATASE SHP-2; MAMMALIAN TARGET; CYCLE PROGRESSION; RAPAMYCIN MTOR; ELONGATION-FACTOR-2 KINASE; SIGNALING PATHWAY; PHOSPHORYLATION; TRANSLATION	Cell growth (accumulation in cell mass) ensues through the promotion of macromolecular biosynthesis. S 6 ribosomal kinase 1 (S6K1), which is activated by the mammalian target of rapamycin, is critical for cell growth. The early events that control S6K1 signaling remain unclear. Here we show that SHP-2 suppresses S6K1 activity under conditions of growth factor deprivation. We show that under conditions of growth factor deprivation, S6K1 activity was increased in fibroblasts lacking functional SHP-2 and in cells where knock down of SHP-2 expression was established by small interference RNA. Consistent with these findings, fibroblasts lacking functional SHP-2 exhibited increased cell size as compared with wild type cells. Growth factor deprivation reduces cellular energy, and the energy-sensing 5'-AMP-activated protein kinase (AMPK) negatively regulates S6K1. We found that SHP-2 promoted AMPK activity under conditions of growth factor deprivation (low energy), suggesting that SHP-2 negatively regulates S6K1 via an AMPK-dependent pathway. These results implicate SHP-2 as an early mediator in the S6K1 signaling pathway to limit cell growth in low energy states.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yale University; Harvard University; Harvard Medical School	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu		Bennett, Anton/0000-0001-5187-7599	NIAMS NIH HHS [AR46504] Funding Source: Medline; NIGMS NIH HHS [GM51405] Funding Source: Medline; NINDS NIH HHS [T32 NS07136] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007136] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kontaridis MI, 2002, MOL CELL BIOL, V22, P3875, DOI 10.1128/MCB.22.11.3875-3891.2002; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Marin P, 1997, J NEUROSCI, V17, P3445; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Proud CG, 2001, BIOCHEM SOC T, V29, P541, DOI 10.1042/BST0290541; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Uhlen P, 2006, P NATL ACAD SCI USA, V103, P2160, DOI 10.1073/pnas.0510876103; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	50	12	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					6946	6953		10.1074/jbc.M608338200	http://dx.doi.org/10.1074/jbc.M608338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17229738	hybrid			2022-12-27	WOS:000245080900006
J	Dey, M; Cao, C; Sicheri, F; Dever, TE				Dey, Madhusudan; Cao, Chune; Sicheri, Frank; Dever, Thomas E.			Conserved intermolecular salt bridge required for activation of protein kinases PKR, GCN2, and PERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; FUNCTIONALLY SUBSTITUTE; TRANSLATIONAL CONTROL; EIF-2-ALPHA KINASE; UNFOLDED-PROTEIN; DIMERIZATION; BINDING; YEAST; AUTOPHOSPHORYLATION; ELF2-ALPHA	The protein kinases PKR, GCN2, and PERK phosphorylate translation initiation factor eIF2 alpha to regulate general and gene-specific protein synthesis under various cellular stress conditions. Recent x-ray crystallographic structures of PKR and GCN2 revealed distinct dimeric configurations of the kinase domains. Whereas PKR kinase domains dimerized in a back-to-back and parallel orientation, the GCN2 kinase domains displayed an antiparallel orientation. The dimerization interfaces on PKR and GCN2 were localized to overlapping surfaces on the N-terminal lobes of the kinase domains but utilized different intermolecular contacts. A key feature of the PKR dimerization interface is a salt bridge interaction between Arg(262) from one protomer and Asp(266) from the second protomer. Interestingly, these two residues are conserved in all eIF2 alpha kinases, although in the GCN2 structure, the two residues are too remote to interact. To test the importance of this potential salt bridge interaction in PKR, GCN2, and PERK, the residues constituting the salt bridge were mutated either independently or together to residues with the opposite charge. Single mutations of the Asp (or Glu) and Arg residues blocked kinase function both in yeast cells and in vitro. However, for all three kinases, the double mutation designed to restore the salt bridge interaction with opposite polarity resulted in a functional kinase. Thus, the salt bridge interaction and dimer interface observed in the PKR structure is critical for the activity of all three eIF2 alpha kinases. These results are consistent with the notion that the PKR structure represents the active state of the eIF2 alpha kinase domain, whereas the GCN2 structure may represent an inactive state of the kinase.	NICHD, Lab Gene Regulat & Dev, NICHD, Bethesda, MD 20892 USA; Mt Sinai Hosp, Program Mol Biol & Canc, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dever, TE (corresponding author), NICHD, Lab Gene Regulat & Dev, NICHD, Bldg 6A,Rm B1A-03, Bethesda, MD 20892 USA.	tdever@nih.gov	Dever, Thomas/GSE-0966-2022; Sicheri, Frank/F-8856-2013	Dever, Thomas/0000-0001-7120-9678	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DeLano WL, 2004, PYMOL USERS MANUAL; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; HARASHIMA S, 1987, GENETICS, V117, P409; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; YANG JM, 1992, J BIOL CHEM, V267, P20519; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	33	45	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6653	6660		10.1074/jbc.M607897200	http://dx.doi.org/10.1074/jbc.M607897200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202131	hybrid			2022-12-27	WOS:000244867200074
J	Li, T; Chalifour, LE; Paudel, HK				Li, Tong; Chalifour, Lorraine E.; Paudel, Hernant K.			Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GENE ZIF268; GLYCOGEN-SYNTHASE KINASE-3-BETA; BOVINE BRAIN; NEURITE OUTGROWTH; CATALYTIC SUBUNIT; KINASE KINASE; INDUCTION; CDK5; P35; EXPRESSION	The transcription factor Egr-1 activates cyclin-dependent protein kinase 5 (Cdk5) during nerve growth factor (NGF)-induced differentiation of PC12 cells into neurons (Harada, T. Morooka, T., Ogawa, S., and Nishida, E. (2001) Nat. Cell Biol. 3, 453-459). The downstream target of Cdk5 in the Egr-1/Cdk5 pathway is not clear. In this study, we observed that phosphorylation of protein phosphatase 1 (PP1) on Thr(320) is reduced in brain extracts from Egr-1(-/-) mice, indicating that a kinase downstream of Egr-1 phosphorylates PP1. In HEK 293 cells co-transfected with PP1. and Cdk5, Cdk5 phosphorylates PP1. In vitro, Cdk5 purified from bovine brain phosphorylates bacterially expressed recombinant PP1. In NGF-treated PC12 cells, inhibition of Cdk5 by olomoucine or silencing Cdk5 expression by small interfering RNA strategy, suppresses PP1 phosphorylation. Silencing Cdk5 expression by small interfering RNA also blocks NGF-induced neurite outgrowth. Overexpression of PP1 (wild type) promotes NGF-induced differentiation of PC12 cells, whereas that of PP1 (T320A) has no effect. Our data indicate that PP1 is a downstream target of the NGF/Egr-1/Cdk5 pathway during NGF-induced differentiation of PC12 cells and suggest that PP1 phosphorylation promotes neuronal differentiation.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Div Expt Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Paudel, HK (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca						Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Allen PB, 2000, J NEUROSCI, V20, P3537, DOI 10.1523/JNEUROSCI.20-10-03537.2000; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Berndt N., 1999, FRONT BIOSCI, V4, pD22, DOI DOI 10.2741/BERNDT;PMID:9872729; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Chen F, 2004, CANCER RES, V64, P5425, DOI 10.1158/0008-5472.CAN-04-0806; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; Dohadwala M, 1998, METH MOL B, V93, P191; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hallows JL, 2003, J NEUROSCI, V23, P10633; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEW J, 1992, J BIOL CHEM, V267, P13383; LEW J, 1995, NEUROBIOL AGING, V16, P263, DOI 10.1016/0197-4580(95)00014-6; Li BS, 2000, J NEUROSCI, V20, P6055, DOI 10.1523/JNEUROSCI.20-16-06055.2000; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Puntoni F, 1997, ARCH BIOCHEM BIOPHYS, V340, P177, DOI 10.1006/abbi.1997.9889; Rosales JL, 2000, J CELL BIOCHEM, V78, P151, DOI 10.1002/(SICI)1097-4644(20000701)78:1<151::AID-JCB14>3.0.CO;2-L; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Schipper HM, 1999, NEUROSCIENCE, V93, P585, DOI 10.1016/S0306-4522(99)00120-7; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; YAN GZ, 1995, J NEUROSCI, V15, P6200	48	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6619	6628		10.1074/jbc.M606347200	http://dx.doi.org/10.1074/jbc.M606347200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17202132	hybrid			2022-12-27	WOS:000244867200071
J	Matsuoka, H; Hirooka, K; Fujita, Y				Matsuoka, Hiroshi; Hirooka, Kazutake; Fujita, Yasutaro			Organization and function of the YsiA regulon of Bacillus subtilis involved in fatty acid degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MICROARRAY ANALYSIS; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; FADR; BIOSYNTHESIS; GENE; SEQUENCE; GENOME; METABOLISM; EXPRESSION	The organization and function of the Bacillus subtilis YsiA regulon involved in fatty acid degradation were investigated. Northern and primer extension analyses indicated that this regulon comprises five operons, i.e. lcfA-ysiA-B-etfB-A, ykuF-G, yhfL, yusM-L-K-J, and ywjF-acdA-rpoE. YusJ and AcdA, YsiB and YusL, and YusK presumably encode acyl-CoA dehydrogenases, 3-hydroxyl-CoA dehydrogenase/enoyl-CoA hydratase complexes, and acetyl-CoA C-acyltransferase, respectively, which are directly involved in the fatty acid,beta-oxidation cycle. In addition, LcfA and YhfL are likely to encode long chain acyl-CoA ligases. On gel retardation and footprinting analyses involving the purified YsiA protein, we identified cis-sequences for YsiA binding (YsiA boxes) in the promoter regions upstream of ysiA, ykuF, yusL, yhfL, and ywjF, the equilibrium dissociation constants (K-d) for YsiA binding being 20, 21, 37, 43, and 65 nm, respectively. YsiA binding was specifically inhibited by long chain acyl-CoAs with 14-20 carbon atoms, acyl-CoAs with 18 carbon atoms being more effective; out of long chain acyl-CoAs tested, monounsaturated oleoyl-CoA, and branched chain 12-metyltetradecanoyl-CoA were most effective. These in vitro findings were supported by the in vivo observation that the knock-out of acyl-CoA dehydrogenation through yusJ, et A, or etfB disruption resulted in YsiA inactivation, probably because of the accumulation of long chain acyl-CoAs in the cells. Furthermore, the disruption of yusL, yusK, yusJ, etfA, etfB, or ykuG affected the utilization of palmitic acid, a representative long chain fatty acid. Based on this work, ysiA, ysiB,.ykuF, ykuG, yhjL, yusM, yusL, yusK, yusJ, and ywjF can be renamed fadR, fadB, fadH,fadG, lcfB, fadM, fadN, fadA, fadE, and fadF.	Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima 7290292, Japan	Fukuyama University	Fujita, Y (corresponding author), Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, 985 Sanzo, Fukuyama, Hiroshima 7290292, Japan.	yfujita@bt.fubt.fukuyama-u.ac.jp	Hirooka, Kazutake/K-9827-2017; Matsuoka, Hiroshi/AAI-8629-2020	Hirooka, Kazutake/0000-0001-5879-936X; Matsuoka, Hiroshi/0000-0001-9423-5473				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bryan EM, 1996, J BACTERIOL, V178, P4778, DOI 10.1128/jb.178.16.4778-4786.1996; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; de Mendoza D., 2001, BACILLUS SUBTILIS IT, P43; De Mendoza Diego, 1993, P411; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DiRusso CC, 1998, MOL MICROBIOL, V27, P1, DOI 10.1046/j.1365-2958.1998.00645.x; FUJITA Y, 1981, J BACTERIOL, V145, P760, DOI 10.1128/JB.145.2.760-767.1981; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Koburger T, 2005, MOL GENET GENOMICS, V274, P1, DOI 10.1007/s00438-005-1119-8; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; NUNN WD, 1986, MICROBIOL REV, V50, P179, DOI 10.1128/MMBR.50.2.179-192.1986; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; ROCK CO, 1996, BIOCHIM BIOPHYS ACTA, V1320, P1; Sambrook J., 2001, MOL CLONING LAB MANU; Schilling CH, 2000, J MOL MICROB BIOTECH, V2, P495; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; SEUBERT W, 1960, BIOCHEM PREP, V7, P80; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Yoshida K, 2000, MICROBIOL-UK, V146, P573, DOI 10.1099/00221287-146-3-573; Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P683, DOI 10.1093/nar/29.3.683; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Yoshida KI, 2002, J BACTERIOL, V184, P983, DOI 10.1128/jb.184.4.983-991.2002	40	75	88	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5180	5194		10.1074/jbc.M606831200	http://dx.doi.org/10.1074/jbc.M606831200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189250	hybrid			2022-12-27	WOS:000244482300012
J	Qin, ZJ; Hu, DM; Han, SB; Reaney, SH; Monte, DA; Fink, AL				Qin, Zhijie; Hu, Dongmei; Han, Shubo; Reaney, Stephen H.; Di Monte, Donato A.; Fink, Anthony L.			Effect of 4-hydroxy-2-nonenal modification alpha-synuclein aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; FATTY-ACIDS; FIBRIL FORMATION; BINDING; MICE; ASSOCIATION; MUTATION; MODEL	Several observations have implicated oxidative stress and aggregation of the presynaptic protein alpha-synuclein in the pathogenesis of Parkinson disease. alpha-Synuclein has been shown to have affinity for unsaturated fatty acids and membranes enriched in polyunsaturated fatty acids, which are especially sensitive to oxidation under conditions of oxidative stress. One of the most important products of lipid oxidation is 4-hydroxy-2-nonenal (HNE), which has been implicated in the pathogenesis of Parkinson disease. Consequently, we investigated the effects of the interaction of HNE with a-synuclein. Incubation of HNE with alpha-synuclein at PH 7.4 and 37 degrees C resulted in covalent modification of the protein, with up to six HNE molecules incorporated as Michael addition products. Fourier transform infrared and CD spectra indicated that HNE modification of alpha-synuclein resulted in a major conformational change involving increased beta-sheet. HNE modification of alpha-synuclein led to inhibition of fibrillation in an HNE concentration-dependent manner. This inhibition of fibrillation was shown to be due to the formation of soluble oligomers based on size exclusion high pressure liquid chromatography and atomic force microscope data. Small angle x-ray scattering analysis indicated that the HNE-induced oligomers were compact and tightly packed. Treatment with guanidinium chloride demonstrated that the HNE-induced oligomers were very stable with an extremely slow rate of dissociation. Addition of 5 mu M HNE-modified oligomers to primary mesencephalic cultures caused marked neurotoxicity because the integrity of dopaminergic and GABAergic neurons was reduced by 95 and 85%, respectively. Our observations indicate that HNE modification of alpha-synuclein prevents fibrillation but may result in toxic oligomers, which could therefore contribute to the demise of neurons subjected to oxidative damage.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Fayetteville State Univ, Dept Nat Sci, Fayetteville, NC 28301 USA; Parkinsons Inst, Sunnyvale, CA 94089 USA	University of California System; University of California Santa Cruz; University of North Carolina; Fayetteville State University	Fink, AL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	enzyme@ucsc.edu	Han, Shubo/ABA-4350-2021	Han, Shubo/0000-0002-0216-5111; Di Monte, Donato/0000-0002-8296-836X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039985] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39985] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; DRISCOLL BF, 1991, J NEUROCHEM, V56, P1201, DOI 10.1111/j.1471-4159.1991.tb11411.x; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; FINK AL, 1999, INFRARED ANAL PEPTID, P132; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gerson EA, 1999, PHYTOCHEM ANALYSIS, V10, P322, DOI 10.1002/(SICI)1099-1565(199911/12)10:6&lt;322::AID-PCA468&gt;3.0.CO;2-W; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lev N, 2001, ISRAEL MED ASSOC J, V3, P435; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lewy F.H., 2017, HDB NEUROLOGIE, V3, P920; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Markesbery WR, 1999, ARCH NEUROL-CHICAGO, V56, P1449, DOI 10.1001/archneur.56.12.1449; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; SHIMODA K, 1992, BRAIN RES, V586, P319, DOI 10.1016/0006-8993(92)91642-R; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith MP, 2007, NEUROSCIENCE, V144, P1057, DOI 10.1016/j.neuroscience.2006.10.004; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Trostchansky A, 2006, BIOCHEM J, V393, P343, DOI 10.1042/BJ20051277; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wang DS, 2003, BIOCHEM BIOPH RES CO, V310, P236, DOI 10.1016/j.bbrc.2003.09.003; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	57	146	159	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5862	5870		10.1074/jbc.M608126200	http://dx.doi.org/10.1074/jbc.M608126200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189262	hybrid			2022-12-27	WOS:000244482300082
J	Ghosh-Choudhury, N; Mandal, CC; Choudhury, GG				Ghosh-Choudhury, Nandini; Mandal, Chandi Charan; Choudhury, Goutam Ghosh			Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA REDUCTASE INHIBITORS; NF-KAPPA-B; BMP-2 GENE; TUMOR-SUPPRESSOR; RETINOBLASTOMA PROTEIN; MESANGIAL CELLS; DNA-SYNTHESIS; C-FOS; KINASE; TRANSCRIPTION	Lovastatin promotes osteoblast differentiation by increasing bone morphogenetic protein-2 (BMP-2) expression. We demonstrate that lovastatin stimulates tyrosine phosphorylation of the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K), leading to an increase in its kinase activity in osteoblast cells. Inhibition of PI3K ameliorated expression of the osteogenic markers alkaline phosphatase, type I collagen, osteopontin, and BMP-2. Expression of dominant-negative PI3K and PTEN, an inhibitor of PI3K signaling, significantly attenuated lovastatin-induced transcription of BMP-2. Akt kinase was also activated in a PI3K-dependent manner. However, our data suggest involvement of an additional signaling pathway. Lovastatin-induced Erk1/2 activity contributed to BMP-2 transcription. Inhibition of PI3K abrogated Erk1/2 activity in response to lovastatin, indicating the presence of a signal relay between them. We provide, as a mechanism of this cross-talk, the first evidence that lovastatin stimulates rapid activation of Ras, which associates with and activates PI3K in the plasma membrane, which in turn regulates Akt and Erk1/2 to induce BMP-2 expression for osteoblast differentiation.	Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA; S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education & Clinical Center	Ghosh-Choudhury, N (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pathol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	NIAMS NIH HHS [R01 AR52425] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; Choudhury GG, 1999, BIOCHEM BIOPH RES CO, V258, P490, DOI 10.1006/bbrc.1999.0599; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Choundhury GG, 1999, J BIOL CHEM, V274, P10897; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jcem.85.3.6476; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; Edwards CJ, 2001, CALCIFIED TISSUE INT, V69, P63, DOI 10.1007/s00223-001-2017-7; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Ghosh-Choudhury N, 2000, BIOCHEM BIOPH RES CO, V272, P705, DOI 10.1006/bbrc.2000.2844; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Ghosh-Choudhury N, 2000, BBA-MOL CELL RES, V1497, P186, DOI 10.1016/S0167-4889(00)00060-4; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury NG, 2003, J BIOL CHEM, V278, P21998, DOI 10.1074/jbc.M302277200; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; GhoshChoudhury N, 1997, BIOCHEM BIOPH RES CO, V231, P196, DOI 10.1006/bbrc.1996.5962; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hatano Hiroshi, 2003, J Orthop Sci, V8, P842, DOI 10.1007/s00776-003-0724-9; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; HAYASHI H, 1993, J BIOL CHEM, V268, P7107; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; KAVANAUGH WM, 1994, BIOCHEMISTRY-US, V33, P11046, DOI 10.1021/bi00202a026; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4; Maeda N, 2005, J VIROL, V79, P4440, DOI 10.1128/JVI.79.7.4440-4450.2005; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Maeda T, 2001, BIOCHEM BIOPH RES CO, V280, P874, DOI 10.1006/bbrc.2000.4232; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahimainathan L, 2005, AM J PHYSIOL-RENAL, V289, pF72, DOI 10.1152/ajprenal.00277.2004; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Oxlund H, 2004, BONE, V34, P609, DOI 10.1016/j.bone.2003.12.014; Ozes ON, 1999, NATURE, V401, P82; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; SJOLANDER A, 1991, P NATL ACAD SCI USA, V88, P7908, DOI 10.1073/pnas.88.18.7908; Skaletz-Rorowski A, 2003, CARDIOVASC RES, V57, P253, DOI 10.1016/S0008-6363(02)00618-1; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	51	115	130	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4983	4993		10.1074/jbc.M606706200	http://dx.doi.org/10.1074/jbc.M606706200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17179158	hybrid			2022-12-27	WOS:000244482000081
J	Volkmer, T; Schneider, D; Bernat, G; Kirchhoff, H; Wenk, SO; Rogner, M				Volkmer, Thomas; Schneider, Dirk; Bernat, Gabor; Kirchhoff, Helmut; Wenk, Stephan-Olav; Roegner, Matthias			Ssr2998 of Synechocystis sp PCC 6803 is involved in regulation of cyanobacterial electron transport and associated with the cytochrome b(6)f complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; SP PCC 6803; THYLAKOID MEMBRANES; PHOTOSYSTEM-I; STATE TRANSITIONS; PLASMA-MEMBRANE; REDOX STATE; PROTEINS; PHOTOSYNTHESIS; FLUORESCENCE	To analyze the function of a protein encoded by the open reading frame ssr2998 in Synechocystis sp. PCC 6803, the corresponding gene was disrupted, and the generated mutant strain was analyzed. Loss of the 7.2-kDa protein severely reduced the growth of Synechocystis, especially under high light conditions, and appeared to impair the function of the cytochrome b(6)f complex. This resulted in slower electron donation to cytochrome f and photosystem 1 and, concomitantly, over-reduction of the plastoquinone pool, which in turn had an impact on the photosystem I to photosystem 2 stoichiometry and state transition. Furthermore, a 7.2-kDa protein, encoded by the open reading frame ssr2998, was co-isolated with the cytochrome b(6)f complex from the cyanobacterium Synechocystis sp. PCC 6803. ssr2998 seems to be structurally and functionally associated with the cytochrome b(6)f complex from Synechocystis, and the protein could be involved in regulation of electron transfer processes in Synechocystis sp. PCC 6803.	Ruhr Univ Bochum, D-44780 Bochum, Germany; Univ Freiburg, Zentrum Biochem & Mol Zellforsch, D-79104 Freiburg, Germany; Inst Bot, D-48149 Munster, Germany	Ruhr University Bochum; University of Freiburg	Rogner, M (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	matthias.roegner@rub.de	Kirchhoff, Helmut/AAN-6695-2020; Bernat, Gabor/J-6333-2017; Kirchhoff, Helmut/A-6177-2008	Kirchhoff, Helmut/0000-0001-5874-3681; Bernat, Gabor/0000-0001-6147-9391; 				ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; Emlyn-Jones D, 1999, MOL MICROBIOL, V33, P1050, DOI 10.1046/j.1365-2958.1999.01547.x; FORK DC, 1983, PHOTOCHEM PHOTOBIOL, V37, P421, DOI 10.1111/j.1751-1097.1983.tb04495.x; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; Hamel P, 2000, J BIOL CHEM, V275, P17072, DOI 10.1074/jbc.M001468200; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Kaneko T, 1996, DNA Res, V3, P109; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kirchhoff H, 2000, BBA-BIOENERGETICS, V1459, P148, DOI 10.1016/S0005-2728(00)00143-2; KRUIP J, 1994, PHOTOSYNTH RES, V40, P279, DOI 10.1007/BF00034777; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Mao HB, 2003, FEBS LETT, V553, P68, DOI 10.1016/S0014-5793(03)00973-6; Mao HB, 2002, FEBS LETT, V519, P82, DOI 10.1016/S0014-5793(02)02715-1; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V34, P339, DOI 10.1016/0003-9861(51)90012-4; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Mullineaux CW, 2002, TRENDS PLANT SCI, V7, P237, DOI 10.1016/S1360-1385(02)02283-5; MURAKAMI A, 1993, PLANT CELL PHYSIOL, V34, P1175; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Nakamura Y, 1999, NUCLEIC ACIDS RES, V27, P66, DOI 10.1093/nar/27.1.66; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; OSIEWACZ HD, 1992, ARCH MICROBIOL, V157, P336, DOI 10.1007/BF00248678; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; ROGNER M, 1990, J BIOL CHEM, V265, P6189; Rogner M, 1996, TRENDS BIOCHEM SCI, V21, P44, DOI 10.1016/0968-0004(96)80862-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200; Sazuka T, 1999, ELECTROPHORESIS, V20, P2160, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2160::AID-ELPS2160>3.0.CO;2-#; Schluchter WM, 1996, PHOTOCHEM PHOTOBIOL, V64, P53, DOI 10.1111/j.1751-1097.1996.tb02421.x; Schneider D, 2004, J BIOL CHEM, V279, P39383, DOI 10.1074/jbc.M406288200; Schneider D, 2002, J BIOL CHEM, V277, P10949, DOI 10.1074/jbc.M104076200; Schneider D, 2001, J BIOL CHEM, V276, P16780, DOI 10.1074/jbc.M009503200; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Wang YC, 2000, ELECTROPHORESIS, V21, P1746, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1746::AID-ELPS1746>3.3.CO;2-F; Wenk SO, 2005, FEBS J, V272, P582, DOI 10.1111/j.1742-4658.2004.04501.x; WITTMERSHAUS BP, 1992, PHOTOSYNTH RES, V31, P75, DOI 10.1007/BF00028785	42	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2007	282	6					3730	3737		10.1074/jbc.M604948200	http://dx.doi.org/10.1074/jbc.M604948200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CW	17166849	hybrid			2022-12-27	WOS:000244481900036
J	Choi, JM; Kang, SY; Bae, WJ; Jin, KS; Ree, M; Cho, Y				Choi, Jung Min; Kang, Sung Yun; Bae, Won Jin; Jin, Kyeong Sik; Ree, Moonhor; Cho, Yunje			Probing the roles of active site residues in the 3 '-5 ' exonuclease of the Werner syndrome protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE; EXONUCLEASE; CELLS; WRN; RECOMBINATION; INVITRO	Werner syndrome is a premature aging disease caused by mutations in the WS gene and a deficiency in the function of Werner protein (WRN). The lack of WRN results in a cellular phenotype of genomic instability. WRN belongs to the RecQ DNA helicase family, but unlike other RecQ family members it possesses a functional exonuclease domain. We determined the crystal structure of mWRNexo (residues 31-238) bound to Zn2+ and the sulfate ion. Compared with the structure of human WRNexo (hWRNexo), notable conformational changes were observed in several active site residues in an H5-H6 loop and in helices H6 and H7 of mWRNexo, presumably because of the presence of sulfate, which mimics the phosphate of substrate DNA. In particular, the side chains of Lys(185) and Tyr(206) were reoriented toward the Zn2+ ion, whereas the side chain of Arg(190) pointed away from the active site center. Mutational analysis of these conserved residues abolished WRN exonuclease activity, suggesting that these residues play a critical role in the WRNexo activity. Based on substrate modeling and mutational analyses, we propose a mechanism by which WRNexo becomes activated upon substrate DNA binding. We also describe the low resolution trimeric structure of mouse WRNexo (mWRNexoL, residues 31-330), as elucidated by small angle x-ray scattering (SAXS) analyses.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbook, South Korea; Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Pohang 790784, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Chem, Natl Res Lab Polymer Synth & Phys,Polymer Res Ins, Pohang Accelerator Lab,Ctr Integrated Mol Syst, Kyungbuk 790784, South Korea; Pohang Univ Sci & Technol, BK Sch Mol Sci, Kyungbuk 790784, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Cho, Y (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Hyo Ja Dong,San 31, Pohang 790784, Kyungbook, South Korea.	yunje@postech.ac.kr	kang, sung un/AAK-8050-2021; Ree, Moonhor/F-5347-2013	Choi, Jung Min/0000-0003-2450-3916				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolze J, 2002, MACROMOL RES, V10, P2, DOI 10.1007/BF03218282; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG RZ, 1990, MUTAT RES, V237, P259, DOI 10.1016/0921-8734(90)90008-F; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Glatter O., 1982, SMALL ANGLE XRAY SCA, P119; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; HOLM L, 1996, METHOD ENZYMOL, V266, P635; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MARTIN GM, 1970, LAB INVEST, V23, P86; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; SALK D, 1985, ADV EXP MED BIOL, V190, P305; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VLADIMIR VV, 2003, J APPL CRYSTALLOGR, V36, P860; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015	36	20	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2007	282	13					9941	9951		10.1074/jbc.M609657200	http://dx.doi.org/10.1074/jbc.M609657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	153HA	17229737	hybrid			2022-12-27	WOS:000245421700069
J	Goytain, A; Hines, RM; El-Husseini, A; Quamme, GA				Goytain, Angela; Hines, Rochelle M.; El-Husseini, Alaa; Quamme, Gary A.			NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; IDENTIFICATION; DELETION; FAMILY; GENES	Mutations in the NIPA1(SPG6) gene, named for "nonimprinted in Prader-Willi/Angelman" has been implicated in one form of autosomal dominant hereditary spastic paraplegia (HSP), a neurodegenerative disorder characterized by progressive lower limb spasticity and weakness. However, the function of NIPA1 is unknown. Here, we show that reduced magnesium concentration enhances expression of NIPA1 suggesting a role in cellular magnesium metabolism. Indeed NIPA1 mediates Mg2+ uptake that is electrogenic, voltage-dependent, and saturable with a Michaelis constant of 0.69 +/- 0.21 mm when expressed in Xenopus oocytes. Subcellular localization with immunofluorescence showed that endogenous NIPA1 protein associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. As expected of a magnesium-responsive gene, we find that altered magnesium concentration leads to a redistribution between the endosomal compartment and the plasma membrane; high magnesium results in diminished cell surface NIPA1 whereas low magnesium leads to accumulation in early endosomes and recruitment to the plasma membrane. The mouse NIPA1 mutants, T39R and G100R, corresponding to the respective human mutants showed a loss-of-function when expressed in oocytes and altered trafficking in transfected COS7 cells. We conclude that NIPA1 normally encodes a Mg2+ transporter and the loss-of function of NIPA1(SPG6) due to abnormal trafficking of the mutated protein provides the basis of the HSP phenotype.	Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Quamme, GA (corresponding author), Univ British Columbia, Dept Med, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	quamme@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020	Hines, Rochelle/0000-0002-0459-7911				Butler MG, 2004, PEDIATRICS, V113, P565, DOI 10.1542/peds.113.3.565; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen SQ, 2005, HUM MUTAT, V25, P135, DOI 10.1002/humu.20126; DAI LJ, 1991, J CLIN INVEST, V88, P1255, DOI 10.1172/JCI115429; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; FINK JK, 1995, NEUROLOGY, V45, P325, DOI 10.1212/WNL.45.2.325; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 2003, ARCH NEUROL-CHICAGO, V60, P1045, DOI 10.1001/archneur.60.8.1045; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Hedera P, 2005, NEURORADIOLOGY, V47, P730, DOI 10.1007/s00234-005-1415-3; Kaneko S, 2006, MOVEMENT DISORD, V21, P1531, DOI 10.1002/mds.21005; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Munhoz RP, 2006, MOVEMENT DISORD, V21, P279, DOI 10.1002/mds.20775; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Reed JA, 2005, NEUROGENETICS, V6, P79, DOI 10.1007/s10048-004-0209-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHAFIK IM, 1989, AM J PHYSIOL, V257, pF974, DOI 10.1152/ajprenal.1989.257.6.F974; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	23	96	105	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8060	8068		10.1074/jbc.M610314200	http://dx.doi.org/10.1074/jbc.M610314200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17166836	hybrid			2022-12-27	WOS:000245081000038
J	Novinec, M; Grass, RN; Stark, WJ; Turk, V; Baici, A; Lenarcic, B				Novinec, Marko; Grass, Robert N.; Stark, Wendelin J.; Turk, Vito; Baici, Antonio; Lenarcic, Brigita			Interaction between human cathepsins K, L, and S and elastins - Mechanism of elastinolysis and inhibition by macromolecular inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; CYSTATIN-C DEFICIENCY; CYSTEINE PROTEASE; ESCHERICHIA-COLI; REDUCES ATHEROSCLEROSIS; ALVEOLAR MACROPHAGES; INCREASED EXPRESSION; PROTEINASES; ELASTOLYSIS; COLLAGEN	Proteolytic degradation of elastic fibers is associated with a broad spectrum of pathological conditions such as atherosclerosis and pulmonary emphysema. We have studied the interaction between elastins and human cysteine cathepsins K, L, and S, which are known to participate in elastinolytic activity in vivo. The enzymes showed distinctive preferences in degrading elastins from bovine neck ligament, aorta, and lung. Different susceptibility of these elastins to proteolysis was attributed to morphological differences observed by scanning electron microscopy. Kinetics of cathepsin binding to the insoluble substrate showed that the process occurs in two steps. The enzyme is initially adsorbed on the elastin surface in a nonproductive manner and then rearranges to form a catalytically competent complex. In contrast, soluble elastin is bound directly in a catalytically productive manner. Studies of enzyme partitioning between the phases showed that cathepsin K favors adsorption on elastin; cathepsin L prefers the aqueous environment, and cathepsin S is equally distributed among both phases. Our results suggest that elastinolysis by cysteine cathepsins proceeds in cycles of enzyme adsorption, binding of a susceptible peptide moiety, hydrolysis, and desorption. Alternatively, the enzyme may also form a new catalytic complex without prior desorption and re-adsorption. In both cases the active center of the enzymes remains at least partly accessible to inhibitors. Elastinolytic activity was readily abolished by cystatins, indicating that, unlike enzymes such as leukocyte elastase, pathological elastinorlytic cysteine cathepsins might represent less problematic drug targets. In contrast, thyropins were relatively inefficient in preventing elastincilysis by cysteine cathepsins.	Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, SI-1000 Ljubljana, Slovenia; Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland; Jozef Stefan Inst, Dept Biochem & Mol Biol, SI-1000 Ljubljana, Slovenia	University of Ljubljana; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Lenarcic, B (corresponding author), Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Jamova 39, SI-1000 Ljubljana, Slovenia.	brigita.lenarcic@fkkt.uni-lj.si	Grass, Robert N/A-5607-2008; Novinec, Marko/J-9789-2019; Stark, Wendelin J./A-8680-2008	Grass, Robert N/0000-0001-6968-0823; Novinec, Marko/0000-0003-1824-1649; Baici, Antonio/0000-0002-2980-0541; Lenarcic, Brigita/0000-0002-2508-3776				Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; BAICI A, 1990, BIOCHIM BIOPHYS ACTA, V1040, P355, DOI 10.1016/0167-4838(90)90133-Z; BAICI A, 1992, CURR T REH, P81; BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; Bengtsson E, 2005, ARTERIOSCL THROM VAS, V25, P2151, DOI 10.1161/01.ATV.0000179600.34086.7d; BERG OG, 2002, INTERFACIAL ENZYME K, P47; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Buhling F, 1999, AM J RESP CELL MOL, V20, P612; CARDOSO WV, 1993, AM REV RESPIR DIS, V147, P975, DOI 10.1164/ajrccm/147.4.975; Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f; Cheng XW, 2004, AM J PATHOL, V164, P243, DOI 10.1016/S0002-9440(10)63114-8; D'Alessio KJ, 1999, PROTEIN EXPRES PURIF, V15, P213, DOI 10.1006/prep.1998.1013; Dehrmann FM, 1995, ARCH BIOCHEM BIOPHYS, V324, P93, DOI 10.1006/abbi.1995.9924; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Helske S, 2006, ARTERIOSCL THROM VAS, V26, P1791, DOI 10.1161/01.ATV.0000228824.01604.63; HORNEBECK W, 1984, ADV EXP MED BIOL, V167, P111; HORNEBECK W, 1982, H-S Z PHYSIOL CHEM, V363, P455; JANOFF A, 1985, ANNU REV MED, V36, P207; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kielty CM, 2002, J CELL SCI, V115, P2817; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; KIRSCHKE H, 1982, BIOCHEM J, V201, P367, DOI 10.1042/bj2010367; Kopitar G, 1996, EUR J BIOCHEM, V236, P558, DOI 10.1111/j.1432-1033.1996.00558.x; KRAMPS JA, 1987, SCAND J CLIN LAB INV, V47, P405; LENARCIC B, 1991, FEBS LETT, V280, P211, DOI 10.1016/0014-5793(91)80295-E; Lenarcic B, 1998, BIOL CHEM, V379, P105; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu J, 2006, ATHEROSCLEROSIS, V186, P411, DOI 10.1016/j.atherosclerosis.2005.08.001; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; MASON RW, 1986, BIOCHEM J, V233, P925, DOI 10.1042/bj2330925; Meh P, 2005, BIOL CHEM, V386, P75, DOI 10.1515/BC.2005.010; MORRISON HM, 1990, AM J RESP CELL MOL, V2, P263, DOI 10.1165/ajrcmb/2.3.263; POL E, 1995, BIOCHEM J, V311, P275, DOI 10.1042/bj3110275; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; RAO NV, 1991, J BIOL CHEM, V266, P9540; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; REILLY JJ, 1989, BIOCHEM J, V257, P493, DOI 10.1042/bj2570493; ROBERT B, 1974, BIOCHIMIE, V56, P239, DOI 10.1016/S0300-9084(74)80383-4; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; ROSENBLOOM J, 1984, LAB INVEST, V51, P605; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; SCHWABE C, 1973, ANAL BIOCHEM, V53, P484, DOI 10.1016/0003-2697(73)90098-5; Segel I. H, 1975, ENZYME KINETICS, P106; SHI GP, 1992, J BIOL CHEM, V267, P7258; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P1251, DOI 10.3748/wjg.v11.i9.1251; STARKEY PM, 1976, BIOCHEM J, V155, P273, DOI 10.1042/bj1550273; Sukhova GK, 2005, CIRC RES, V96, P368, DOI 10.1161/01.RES.0000155964.34150.F7; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; TAKAHASHI H, 1993, AM REV RESPIR DIS, V147, P1562, DOI 10.1164/ajrccm/147.6_Pt_1.1562; WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Ying QL, 2002, AM J RESP CELL MOL, V26, P356, DOI 10.1165/ajrcmb.26.3.4704	62	76	76	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7893	7902		10.1074/jbc.M610107200	http://dx.doi.org/10.1074/jbc.M610107200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227755	hybrid			2022-12-27	WOS:000245081000019
J	Kee, HJ; Kim, JR; Nam, KI; Park, HY; Shin, S; Kim, JC; Shimono, Y; Takahashi, M; Jeong, MH; Kim, N; Kim, KK; Kook, H				Kee, Hae Jin; Kim, Ju-Ryoung; Nam, Kwang-Il; Park, Hye Young; Shin, Sera; Kim, Jeong Chul; Shimono, Yohei; Takahashi, Masahide; Jeong, Myung Ho; Kim, Nacksung; Kim, Kyung Keun; Kook, Hyun			Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; CELL-LINE; MYOGENIN; EZH2; DROSOPHILA; GROWTH; PROLIFERATION; ANGIOGENESIS	Homeodomain only protein, Hop, is an unusual small protein that modulates target gene transcription without direct binding to DNA. Here we show that Hop interacts with Enhancer of Polycomb1 (Epc1), a homolog of a Drosophila polycomb group gene product that regulates transcription, to induce the skeletal muscle differentiation. Yeast two-hybrid assay with the human adult heart cDNA library revealed that Hop can associate with Epc1. The amino-terminal domain of Epc1 as well as full Epc1 physically interacted with Hop in mammalian cells and in yeast. Epc1 is highly expressed in the embryonic heart and adult skeletal muscles. Serum deprivation induced differentiation of H9c2, a myoblast cell line, into skeletal myocytes, and Epc1 was up-regulated. Differentiation of H9c2 was induced by Epc1 overexpression, although it was severely impaired in Epc1-in-knockdown cells. Co-transfection of Hop potentiated Epc1-induced transactivation of myogenin and myotube formation. Hop knock-out mice elicited a decrease in myosin heavy chain and myogenin expressions in skeletal muscle and showed delay in hamstring muscle healing after injury. Differentiation was impaired in skeletal myoblasts from Hop knock-out mice. These results suggest that Epc1 plays a role in the initiation of skeletal muscle differentiation, and its interaction with Hop is required for the full activity.	Chonnam Natl Univ, Sch Med, Dept Pharmacol, Kwangju 501746, South Korea; Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea; Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju 501746, South Korea; Chonnam Natl Univ Hosp, Dept Surg, Kwangju 501746, South Korea; Chonnam Natl Univ, Sch Med, Brain Korea Project 21, Ctr Biomed Human Resources, Kwangju 501746, South Korea; Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501746, South Korea; Nagoya Univ, Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Nagoya University	Kook, H (corresponding author), Chonnam Natl Univ, Sch Med, Dept Pharmacol, 5 Hak Dong, Kwangju 501746, South Korea.	kookhyun@chonnam.ac.kr	TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020; Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021; Nam, Kwang Il/C-4580-2019	Takahashi, Masahide/0000-0002-2803-2683; Kook, Hyun/0000-0002-0740-1806; Shimono, Yohei/0000-0002-6256-4704; Kee, Hae Jin/0000-0002-9774-4828; Nam, Kwang Il/0000-0001-5380-6815				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Ding L, 2006, CANCER RES, V66, P4095, DOI 10.1158/0008-5472.CAN-05-4300; HAYES PH, 1984, P NATL ACAD SCI-BIOL, V81, P545, DOI 10.1073/pnas.81.2.545; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; Kashour T, 2003, J MOL CELL CARDIOL, V35, P937, DOI 10.1016/S0022-2828(03)00176-7; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Koh JT, 2004, EXP CELL RES, V294, P172, DOI 10.1016/j.yexcr.2003.11.008; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; L'Ecuyer T, 2001, MOL GENET METAB, V74, P370, DOI 10.1006/mgme.2001.3243; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lindon C, 2001, DEV BIOL, V240, P574, DOI 10.1006/dbio.2001.0435; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Movassagh M, 2006, J PHARM PHARMACOL, V58, P73, DOI 10.1211/jpp.58.1.0009; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; Saramaki OR, 2006, GENE CHROMOSOME CANC, V45, P639, DOI 10.1002/gcc.20327; SATO T, 1985, DEV BIOL, V110, P53, DOI 10.1016/0012-1606(85)90063-6; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; Stankunas K, 1998, DEVELOPMENT, V125, P4055; Takahashi T, 2003, GENE THER, V10, P612, DOI 10.1038/sj.gt.3301900; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	35	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7700	7709		10.1074/jbc.M611198200	http://dx.doi.org/10.1074/jbc.M611198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17192267	hybrid			2022-12-27	WOS:000245080900082
J	Vogel, RO; Dieteren, CEJ; van den Heuvel, LPWJ; Willems, PHGM; Smeitink, JAM; Koopman, WJH; Nijtmans, LGJ				Vogel, Rutger O.; Dieteren, Cindy E. J.; van den Heuvel, Lambert P. W. J.; Willems, Peter H. G. M.; Smeitink, Jan A. M.; Koopman, Werner J. H.; Nijtmans, Leo G. J.			Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BLUE-NATIVE-ELECTROPHORESIS; BOVINE HEART-MITOCHONDRIA; DNA-ENCODED SUBUNITS; RESPIRATORY NADH; STRUCTURAL ORGANIZATION; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE; ENZYME; DEFICIENCY	Biogenesis of human mitochondrial complex I (CI) requires the coordinated assembly of 45 subunits derived from both the mitochondrial and nuclear genome. The presence of CI subcomplexes in CI-deficient cells suggests that assembly occurs in distinct steps. However, discriminating between products of assembly or instability is problematic. Using an inducible NDUFS3-green fluorescent protein (GFP) expression system in HEK293 cells, we here provide direct evidence for the stepwise assembly of CI. Upon induction, six distinct NDUFS3-GFP-containing subcomplexes gradually appeared on a blue native Western blot also observed in wild type HEK293 mitochondria. Their stability was demonstrated by differential solubilization and heat incubation, which additionally allowed their distinction from specific products of CI instability and breakdown. Inhibition of mitochondrial translation under conditions of steady state labeling resulted in an accumulation of two of the NDUFS3-GFP-containing subcomplexes (100 and 150 kDa) and concomitant disappearance of the fully assembled complex. Lifting inhibition reversed this effect, demonstrating that these two subcomplexes are true assembly intermediates. Composition analysis showed that this event was accompanied by the incorporation of at least one mitochondrial DNA-encoded subunit, thereby revealing the first entry point of these subunits.	Radboud Univ Nijmegen, Med Ctr, Dept Paediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Membrane Biochem, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Microscopial Imaging Ctr, Nijmegen Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Nijtmans, LGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Paediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands.	l.nijtmans@cukz.umcn.nl	Smeitink, Jan/C-1351-2013; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Koopman, Werner J.H./D-3592-2009; Dieteren, Cindy E.J./D-6042-2011; Willems, P.H.G.M./L-4759-2015; Nijtmans, L.G.J./L-4549-2015; Smeitink, Jan A.M./D-6064-2011; Koopman, Werner J.H./AAC-9668-2020	van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747				Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Clark MA, 1998, CURR MICROBIOL, V37, P356, DOI 10.1007/s002849900392; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Galante Y M, 1978, Methods Enzymol, V53, P15; Grigorieff N, 1999, CURR OPIN STRUC BIOL, V9, P476, DOI 10.1016/S0959-440X(99)80067-0; HALL RE, 1990, J BIOL CHEM, V265, P16484; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kashani-Poor N, 2001, BBA-BIOENERGETICS, V1504, P363, DOI 10.1016/S0005-2728(00)00266-8; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Potluri P, 2004, EUR J BIOCHEM, V271, P3265, DOI 10.1111/j.1432-1033.2004.04260.x; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHULTE U, 1994, BBA-BIOENERGETICS, V1187, P121, DOI 10.1016/0005-2728(94)90096-5; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; TUSCHEN G, 1990, J MOL BIOL, V213, P845, DOI 10.1016/S0022-2836(05)80268-2; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Videira A, 2001, J BIOENERG BIOMEMBR, V33, P197, DOI 10.1023/A:1010778802236; Vogel R, 2004, CURR OPIN NEUROL, V17, P179, DOI 10.1097/00019052-200404000-00016; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200	41	122	123	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7582	7590		10.1074/jbc.M609410200	http://dx.doi.org/10.1074/jbc.M609410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17209039	hybrid, Green Published			2022-12-27	WOS:000245080900071
J	Yoo, YD; Wu, XY; Guan, JL				Yoo, Youngdong; Wu, Xiaoyang; Guan, Jun-Lin			A novel role of the actin-nucleating Arp2/3 complex in the regulation of RNA polymerase II-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; N-WASP; MESSENGER-RNA; FILAMENT NUCLEATION; INTERPHASE NUCLEI; BETA-ACTIN; PROTEIN; LOCALIZATION; MOTILITY; FAMILY	It has been well documented that actin is present in the nucleus and involved in numerous nuclear functions including regulation of transcription. The actin-nucleating Arp2/3 complex is an essential, evolutionarily conserved seven-subunit protein complex that promotes actin cytoskeleton assembly in the cytoplasm upon stimulation by WASP family proteins. Our recent study indicates that the nuclear localized neural Wiskott-Aldrich syndrome protein (N-WASP) can induce de novo actin polymerization in the nucleus, and this function is important for the role of N-WASP in the regulation of RNA polymerase II-dependent transcription. Here, we have presented evidence to show that the Arp2/3 complex is also localized in the nucleus and plays an essential role in mediating nuclear actin polymerization induced by N-WASP. We have also demonstrated that the Arp2/3 complex physically associates with RNA polymerase 11 and is involved in the RNA polymerase II-dependent transcriptional regulation both in vivo and in vitro. Together, these data provide strong support for the hypothesis that N-WASP and the Arp2/3 complex regulate transcription, at least in part, through the regulation of nuclear actin polymerization in a manner similar to their function in the cytoplasm.	Univ Michigan, Sch Med, Div Med & Mol Genet, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Cornell Univ, Dept Mol Med, New York, NY 14853 USA	University of Michigan System; University of Michigan; Cornell University	Guan, JL (corresponding author), Univ Michigan, Sch Med, Div Med & Mol Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.	jlguan@umich.edu			NIGMS NIH HHS [GM48050] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMANKWAH KS, 1994, EXP CELL RES, V210, P315, DOI 10.1006/excr.1994.1044; Archer SK, 2005, BIOESSAYS, V27, P388, DOI 10.1002/bies.20200; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Chhabra D, 2005, BIOPHYS J, V89, P1902, DOI 10.1529/biophysj.105.062083; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Deeks MJ, 2005, NAT REV MOL CELL BIO, V6, P954, DOI 10.1038/nrm1765; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Didichenko SA, 2001, J BIOL CHEM, V276, P48135, DOI 10.1074/jbc.M104610200; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Kimura T, 2000, GENES CELLS, V5, P289, DOI 10.1046/j.1365-2443.2000.00326.x; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NAKAYASU H, 1985, EXP CELL RES, V160, P319, DOI 10.1016/0014-4827(85)90179-X; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725; Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Reutzel R, 2004, J STRUCT BIOL, V146, P291, DOI 10.1016/j.jsb.2003.12.006; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SAHLAS DJ, 1993, J CELL SCI, V105, P347; Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takenawa T, 2001, J CELL SCI, V114, P1801; Van Impe K, 2003, J BIOL CHEM, V278, P17945, DOI 10.1074/jbc.M209946200; Vetterkind S, 2002, J BIOL CHEM, V277, P87, DOI 10.1074/jbc.M104555200; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	59	91	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7616	7623		10.1074/jbc.M607596200	http://dx.doi.org/10.1074/jbc.M607596200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17220302	hybrid			2022-12-27	WOS:000245080900074
J	McCool, KW; Xu, XJ; Singer, DB; Murdoch, FE; Fritsch, MK				McCool, Kevin W.; Xu, Xiaojie; Singer, Don B.; Murdoch, Fern E.; Fritsch, Michael K.			The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; ERYTHROID-DIFFERENTIATION; CHROMATIN DOMAIN; X-INACTIVATION; TRANSCRIPTION; MOUSE; CODE; ENHANCERS; PROTEINS; ELEMENTS	We have examined the role of histone acetylation in the very earliest steps of differentiation of mouse embryonic stem cells in response to withdrawal of leukemia inhibitory factor (LIF) as a differentiation signal. The cells undergo dramatic changes in morphology and an ordered program of gene expression changes representing differentiation to all three germ layers over the first 3-5 days of LIF withdrawal. We observed a global increase in acetylation on histone H4 and to a lesser extent on histone H3 over this time period. Treatment of the cells with trichostatin A (TSA), a histone deacetylase inhibitor, induced changes in morphology, gene expression, and histone acetylation that mimicked differentiation induced by withdrawal of LIF. We examined localized histone acetylation in the regulatory regions of genes that were transcriptionally either active in undifferentiated cells, induced during differentiation, or inactive under all treatments. There was striking concordance in the histone acetylation patterns of specific genes induced by both TSA and LIF withdrawal. Increased histone acetylation in local regions correlated best with induction of gene expression. Finally, TSA treatment did not support the maintenance or progression of differentiation. Upon removal of TSA, the cells reverted to the undifferentiated phenotype. We concluded that increased histone acetylation at specific genes played a role in their expression, but additional events are required for maintenance of differentiated gene expression and loss of the pluripotent state.	Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fritsch, MK (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 5250 MSC,1300 Univ Ave, Madison, WI 53706 USA.	mkfritsch@wisc.edu		MURDOCH, FERN/0000-0001-5724-9681	NIDDK NIH HHS [R01DK64243] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064243] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bresnick EH, 1997, P NATL ACAD SCI USA, V94, P4566, DOI 10.1073/pnas.94.9.4566; Cerny J, 2004, J CELL PHYSIOL, V201, P1, DOI 10.1002/jcp.20071; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Dasen JS, 1999, CURR OPIN GENET DEV, V9, P566, DOI 10.1016/S0959-437X(99)00015-5; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gregory RI, 2002, J BIOL CHEM, V277, P11728, DOI 10.1074/jbc.M105775200; Hu X, 2003, P NATL ACAD SCI USA, V100, P1111, DOI 10.1073/pnas.0337404100; Huang D, 1998, DEVELOPMENT, V125, P3235; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Huang MC, 2002, DNA CELL BIOL, V21, P561, DOI 10.1089/104454902320308933; Huebert DJ, 2005, CURR OPIN GENET DEV, V15, P476, DOI 10.1016/j.gde.2005.08.001; Im H, 2002, BIOCHEMISTRY-US, V41, P15152, DOI 10.1021/bi026786q; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Keohane AM, 1998, DEV GENET, V22, P65, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;65::AID-DVG7&gt;3.0.CO;2-5; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Levings PP, 2006, FEBS J, V273, P746, DOI 10.1111/j.1742-4658.2005.05107.x; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Long LY, 2004, GENOMICS, V83, P694, DOI 10.1016/j.ygeno.2003.09.009; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Luster TA, 2003, GENE, V323, P163, DOI 10.1016/j.gene.2003.09.019; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rasmussen Theodore P, 2003, Reprod Biol Endocrinol, V1, P100, DOI 10.1186/1477-7827-1-100; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sauter CN, 2005, EXP CELL RES, V311, P251, DOI 10.1016/j.yexcr.2005.09.005; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Thompson JR, 1998, CELL GROWTH DIFFER, V9, P969; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; WILES MV, 1991, DEVELOPMENT, V111, P259; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Xu XJ, 2004, GENE, V328, P143, DOI 10.1016/j.gene.2003.12.003	54	47	51	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6696	6706		10.1074/jbc.M609519200	http://dx.doi.org/10.1074/jbc.M609519200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204470	hybrid			2022-12-27	WOS:000244867200079
J	Nasser, MW; Raghuwanshi, SK; Malloy, KM; Gangavarapu, P; Shim, JY; Rajarathnam, K; Richardson, RM				Nasser, Mohd W.; Raghuwanshi, Sandeep K.; Malloy, Kimberly M.; Gangavarapu, Pavani; Shim, Joong-Youn; Rajarathnam, Krishna; Richardson, Ricardo M.			CXCR1 and CXCR2 activation and regulation - Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; INTERLEUKIN-8 RECEPTOR; SIGNAL-TRANSDUCTION; CHEMOATTRACTANT RECEPTORS; CHEMOKINE RECEPTORS; CROSS-REGULATION; PHOSPHOLIPASE-D; BETA-ARRESTIN; NADPH OXIDASE; C-TERMINUS	CXCL8 (interleukin-8) interacts with two receptors, CXCR1 and CXCR2, to activate leukocytes. Upon activation, CXCR2 internalizes very rapidly relative to CXCR1 (similar to 90% versus similar to 10% after 5 min). The C termini of the receptors have been shown to be necessary for internalization but are not sufficient to explain the distinct kinetics of down-regulation. To determine the structural determinant(s) that modulate receptor internalization, various chimeric and point mutant receptors were generated by progressively exchanging specific domains or amino acids between CXCR1 and CXCR2. The receptors were stably expressed in rat basophilic leukemia 2H3 cells and characterized for receptor binding, intracellular Ca2+ mobilization, phosphoinositide hydrolysis, phosphorylation, internalization, and MAPK activation. The data herein indicate that the second extracellular loop (2ECL) of the receptors is critical for the distinct rate of internalization. Replacing the 2ECL of CXCR2 with that of CXCR1 (B(2ECL)A) or Asp(199) with its CXCR1 valine counterpart (B(D199V)A) delayed CXCR2 internalization similarly to CXCR1. Replacing Asp(199) with Asn (B-D199N) restored CXCR2 rapid internalization. Structure modeling of the 2ECL of the receptors also suggested that Asp(199) plays a critical role in stabilizing and modulating CXCR2 rapid internalization relative to CXCR1. BD199N internalized rapidly but migrated as a single phosphorylated form like CXCR1 (similar to 75 kDa), whereas B(2ECL)A and B(D199V)A showed slow and fast migrating forms like CXCR2 (similar to 45 and similar to 65 kDa, respectively) but internalized like CXCR1. These data further undermine the role of receptor oligomerization in CXCL8 receptor internalization. Like CXCR1, B(D199V)A also induced sustained ERK activation and cross-desensitized Ca2+ mobilization to CCR5 relative to BD199N and CXCR2. Altogether, the data suggest that the 2ECL of the CXCL8 receptors is important in modulating their distinct rate of down-regulation and thereby signal length and post-internalization activities.	N Carolina Cent Univ, L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; N Carolina Cent Univ, Dept Biol, Durham, NC 27707 USA; Univ Texas, Dept Biochem & Mol Biol, Med Branch, Galveston, TX 77555 USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University; University of Texas System; University of Texas Medical Branch Galveston	Richardson, RM (corresponding author), N Carolina Cent Univ, L Chambers Biomed Biotechnol Res Inst, 1801 Fayetteville St, Durham, NC 27707 USA.	mrrichardson@nccu.edu	Sawant, Kirti V/H-3778-2013; Nasser, Mohd/Y-3355-2019		NIAID NIH HHS [R01 AI069152, AI-38910, AI-069152] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152, R01AI038910, R29AI038910] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Ali H, 1996, J BIOL CHEM, V271, P3200, DOI 10.1074/jbc.271.6.3200; ALI H, 1993, J BIOL CHEM, V268, P24247; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 2000, IMMUNOL REV, V177, P5, DOI 10.1034/j.1600-065X.2000.17722.x; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; Brown SL, 2006, J IMMUNOL, V177, P3242, DOI 10.4049/jimmunol.177.5.3242; Catusse J, 2003, BIOCHEM PHARMACOL, V65, P813, DOI 10.1016/S0006-2952(02)01619-2; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; DING HQ, 1992, J CHEM PHYS, V97, P4309, DOI 10.1063/1.463935; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; LHEUREUX GP, 1995, BLOOD, V85, P522, DOI 10.1182/blood.V85.2.522.bloodjournal852522; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Ludwig A, 2000, J IMMUNOL, V165, P1044, DOI 10.4049/jimmunol.165.2.1044; MAPLE JR, 1994, ISRAEL J CHEM, V34, P195; Matityahu E, 2002, EUR J IMMUNOL, V32, P3525, DOI 10.1002/1521-4141(200212)32:12<3525::AID-IMMU3525>3.0.CO;2-1; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nasser MW, 2005, J IMMUNOL, V174, P6927, DOI 10.4049/jimmunol.174.11.6927; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Richardson RM, 2000, J BIOL CHEM, V275, P9201, DOI 10.1074/jbc.275.13.9201; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Shyamala V, 1998, BIOCHEMISTRY-US, V37, P15918, DOI 10.1021/bi9811415; Trettel F, 2003, J BIOL CHEM, V278, P40980, DOI 10.1074/jbc.M306815200; Vaidehi N, 2006, J BIOL CHEM, V281, P27613, DOI 10.1074/jbc.M601389200; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Zhao M, 2004, J BIOL CHEM, V279, P49259, DOI 10.1074/jbc.M405118200	48	37	37	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6906	6915		10.1074/jbc.M610289200	http://dx.doi.org/10.1074/jbc.M610289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204468	hybrid			2022-12-27	WOS:000244867200100
J	Storm, MP; Bone, HK; Beck, CG; Bourillot, PY; Schreiber, V; Damiano, T; Nelson, A; Savatier, P; Welham, MJ				Storm, Mike P.; Bone, Heather K.; Beck, Craig G.; Bourillot, Pierre-Yves; Schreiber, Valerie; Damiano, Teresa; Nelson, Adam; Savatier, Pierre; Welham, Melanie J.			Regulation of nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; MOUSE; PLURIPOTENCY; ACTIVATION; DIFFERENTIATION; PROLIFERATION; MAINTENANCE; 3-KINASE; KINASES	Embryonic stem (ES) cell pluripotency is regulated by a combination of extrinsic and intrinsic factors. Previously we have demonstrated that phosphoinositide 3-kinase (PI3K)dependent signaling is required for efficient self-renewal of murine ES cells. In the study presented here, we have investigated the downstream molecular mechanisms that contribute to the ability of PI3Ks to regulate pluripotency. We show that inhibition of PI3K activity with either pharmacological or genetic tools results in decreased expression of RNA for the homeodomain transcription factor Nanog and decreased Nanog protein levels. Inhibition of glycogen synthase kinase 3 (GSK-3) activity by PI3Ks plays a key role in regulation of Nanog expression, because blockade of GSK-3 activity effectively reversed the effects of PI3K inhibition on Nanog RNA, and protein expression and self-renewal under these circumstances were restored. Furthermore, GSK-3 mutants mimicked the effects of PI3K or GSK-3 inhibition on Nanog 'expression. Importantly, expression of an inducible form of Nanog prevented the loss of self-renewal observed upon inhibition of PI3Ks, supporting a functional relationship between PI3Ks and Nanog expression. In addition, expression of a number of putative Nanog target genes was sensitive to PI3K inhibition. Thus, the new evidence provided in this study shows that PI3K-dependent regulation of ES cell self-renewal is mediated, at least in part, by the ability of PI3K signaling to maintain Nanog expression. Regulation of GSK-3 activity by PI3Ks appears to play a key role in this process.	Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; Univ Lyon, F-69003 Lyon, France; INSERM, U846, F-69500 Bron, France; Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Bath; University of Bath; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Leeds	Welham, MJ (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	M.J.Welham@bath.ac.uk	Storm, Mike/AAC-8733-2020; Bourillot, Pierre-Yves/M-6956-2014; SAVATIER, Pierre/J-4663-2014	Bourillot, Pierre-Yves/0000-0003-1657-8555; Nelson, Adam/0000-0003-3886-363X	Biotechnology and Biological Sciences Research Council [BB/C516528/1] Funding Source: Medline; Engineering and Physical Sciences Research Council [GR/S99419/01] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boeuf H, 2001, J BIOL CHEM, V276, P46204, DOI 10.1074/jbc.M106718200; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Branford WW, 2004, CURR BIOL, V14, pR341, DOI 10.1016/j.cub.2004.04.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; Craddock BL, 2001, J BIOL CHEM, V276, P24274, DOI 10.1074/jbc.M009098200; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Hallmann D, 2003, J BIOL CHEM, V278, P5099, DOI 10.1074/jbc.M208451200; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kuo GH, 2003, J MED CHEM, V46, P4021, DOI 10.1021/jm030115o; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Vallier L, 2001, P NATL ACAD SCI USA, V98, P2467, DOI 10.1073/pnas.041617198; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	54	103	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6265	6273		10.1074/jbc.M610906200	http://dx.doi.org/10.1074/jbc.M610906200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204467	hybrid			2022-12-27	WOS:000244867200032
J	Uemoto, Y; Suzuki, SI; Terada, N; Ohno, N; Ohno, S; Yamanaka, S; Komada, M				Uemoto, Yoko; Suzuki, So-ichiro; Terada, Nobuo; Ohno, Nobuhiko; Ohno, Shinichi; Yamanaka, Shinya; Komada, Masayuki			Specific role of the truncated beta IV-spectrin Sigma 6 in sodium channel clustering at axon initial segments and nodes of Ranvier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-G; PROTEIN; SITE; DOMAINS; BINDING; CELLS; CDNA	At axon initial segments and nodes of Ranvier in neurons, the spectrin membrane skeleton plays roles in physically stabilizing the plasma membrane integrity and in clustering voltage-gated sodium channels for proper conduction of the action potential. beta IV-Spectrin, an essential component of the membrane skeleton at these sites, has an N-terminal-truncated isoform, 16, which is expressed at much higher levels than the full-length isoform Sigma 1. To investigate the role of beta IV-spectrin Sigma 6, we generated Sigma 1-deficient mice with a normal level of Sigma 6 expression (Sigma 1(-/-) mice), and compared their phenotypes with those of previously generated mice lacking both Sigma 1 and Sigma 6 (Sigma 1 Sigma 6(-/-) mice). The gross neurological defects observed in Sigma 1 Sigma 6(-/-) mice, such as hindleg contraction, were apparently ameliorated in Sigma 1(-/-) mice. At cellular levels, Sigma 1 Sigma 6(-/-) and Sigma 1(-/-) neurons similarly exhibited waving and swelling of the plasma membrane at axon initial segments and nodes of Ranvier. By contrast, the levels of ankyrin G and voltage-gated sodium channels at these sites, which are significantly reduced in Sigma 1 Sigma 6(-/-) mice, were substantially recovered in Sigma 1(-/-) mice. We conclude that the truncated beta IV-spectrin isoform Sigma 6 plays a specific role in clustering voltage-gated sodium channels, whereas it is dispensable for membrane stabilization at axon initial segments and nodes of Ranvier.	Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; Univ Yamanashi, Dept Anat, Interdisciplinary Grad Sch Med & Engn, Yamanashi 4093898, Japan; Kyoto Univ, Ints Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan	Tokyo Institute of Technology; University of Yamanashi; Kyoto University	Komada, M (corresponding author), 4259-B-16 Nagatsuta,Midori Ku, Yokohama, Kanagawa 2268501, Japan.	makomada@bio.titech.ac.jp						Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; DELAUNAY J, 2006, IN PRESS BLOOD REV; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; KENNEDY SP, 1994, J BIOL CHEM, V269, P11400; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tse WT, 2001, J BIOL CHEM, V276, P23974, DOI 10.1074/jbc.M009307200; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; VIEL A, 1994, P NATL ACAD SCI USA, V91, P10839, DOI 10.1073/pnas.91.23.10839; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004	28	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6548	6555		10.1074/jbc.M609223200	http://dx.doi.org/10.1074/jbc.M609223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197442	hybrid			2022-12-27	WOS:000244867200063
J	Zhang, XM; Boot-Handford, RP; Huxley-Jones, J; Forse, LN; Mould, AP; Robertson, DL; Li, L; Athiyal, M; Sarras, MP				Zhang, Xiaoming; Boot-Handford, Raymond P.; Huxley-Jones, Julie; Forse, Lorna N.; Mould, A. Paul; Robertson, David L.; Li, Li; Athiyal, Matthews; Sarras, Michael P., Jr.			The collagens of hydra provide insight into the evolution of metazoan extracellular matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE FIBRILLAR COLLAGEN; EXPRESSION; INVERTEBRATE; MORPHOGENESIS; ADHESION; LAMININ; FAMILY; FORM	A collagen-based extracellular matrix is one defining feature of all Metazoa. The thick sheet-like extracellular matrix (mesoglia) of the diploblast, hydra, has characteristics of both a basement membrane and an interstitial matrix. Several genes associated with mesoglea have been cloned including a basement membrane and fibrillar collagen and an A and B chain of laminin. Here we report the characterization of a further three fibrillar collagen genes (Hcol2, Hcol3, and Hcol5) and the partial sequence of a collagen gene with a unique structural organization consisting of multiple von Willebrand factor A domains interspersed with interrupted collagenous triple helices (Hcol6) from Hydra vulgaris. Hcol2 and -5 have major collagenous domains of classical length (similar to 1020 amino acid residues), whereas the equivalent domain in Hcol3 is shorter (969 residues). The N-propeptide of Hcol2 contains a whey acid protein four-cysteine repeat (WAP) domain, and the equivalent domain of Hcol3 contains two WAP and two von Willebrand factor A domains. Phylogenetic analyses reveal that the hydra fibrillar collagen genes form a distinct clade that appears related to the protostome/deuterostome A clade of fibrillar collagens. Data base searches reveal Hcol2, -5, and -6 are highly conserved in Hydra magnipapillata, which also provided preliminary evidence for the expression of a B-clade fibrillar collagen. All four of the H, vulgaris collagens are expressed specifically by the ectoderm. The expression pattern for Hcol2 is similar to that previously reported for Hcol1 (Deutzmann, R., Fowler, S., Zhang, X., Boone, K., Dexter, S., Boot-Handford, R. P., Rachel, R., and Sarras, M. P., Jr. (2000) Development 127, 4669 - 4680) but distinct from the pattern shared by Hcol3 and Hcol5. The characterization of multiple collagen genes in relatively simple diploblastic organisms provides new insights into the molecular evolution of collagens and the origins of the collagen-based extracellular matrix found throughout the multicellular animal kingdom.	Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	University of Manchester; University of Kansas; University of Kansas Medical Center; Rosalind Franklin University Medical & Science	Boot-Handford, RP (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	ray.boot-handford@manchester.ac.uk		Boot-Handford, Raymond/0000-0002-6167-8419; Mould, Paul/0000-0003-0076-6228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK065123] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aouacheria A, 2004, J BIOL CHEM, V279, P47711, DOI 10.1074/jbc.M408950200; Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Ayad S, 1998, EXTRACELLULAR MATRIX, V2nd, P69; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; FELSENSTEIN JP, 1993, PHYLOGENETIC ANAL US; Fowler SJ, 2000, J BIOL CHEM, V275, P39589, DOI 10.1074/jbc.M005871200; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Huelsenbeck J. P., 2000, MRBAYES BAYESIAN INF; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lenhoff H.M., 1983, P29; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; SARRAS MP, 1991, DEV BIOL, V148, P481, DOI 10.1016/0012-1606(91)90266-6; SARRAS MP, 1993, DEV BIOL, V157, P383, DOI 10.1006/dbio.1993.1143; Sarras MP, 2001, BIOESSAYS, V23, P716, DOI 10.1002/bies.1101; SARRAS MP, 1994, DEV BIOL, V164, P312, DOI 10.1006/dbio.1994.1201; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Shimizu H, 2002, DEVELOPMENT, V129, P1521; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WOOD RL, 1961, BIOLOGY HYDRA, P51; Zhang XM, 2002, DEV GENES EVOL, V212, P159, DOI 10.1007/s00427-002-0225-4	32	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6792	6802		10.1074/jbc.M607528200	http://dx.doi.org/10.1074/jbc.M607528200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17204477	hybrid			2022-12-27	WOS:000244867200089
J	Liang, FB; Liang, J; Wang, WQ; Sun, AP; Udho, E; Zhang, ZY				Liang, Fubo; Liang, Jiao; Wang, Wei-Qing; Sun, An-Peng; Udho, Eshwar; Zhang, Zhong-Yin			PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; COLORECTAL-CANCER; MOLECULAR TARGETS; CARCINOMA CELLS; KINASE-ACTIVITY; IN-VIVO; C-SRC; METASTASIS; EXPRESSION; MIGRATION	Phosphatase of regenerating liver 3 (PRL3) is overexpressed in a variety of tumors, and high levels of PRL3 expression are associated with tumorigenesis and metastasis. Consistent with an oncogenic role for PRL3, we show that ectopic PRL3 expression promotes cell proliferation and invasion. However, little is known about the molecular basis for PRL3 function. Obtaining this knowledge is vital for understanding PRL3-mediated disease processes and for the development of novel anticancer therapies targeted to PRL3. Here we report that up-regulation of PRL3 activates the Src kinase, which initiates a number of signal pathways culminating in the phosphorylation of ERK1/2, STAT3, and p130(Cas). The activation of these pathways likely contributes to the increased cell growth and motility of PRL3 cells. We provide evidence that PRL3 induces Src activation through down-regulation of Csk, a negative regulator of Src. Importantly, Src activation and Csk down-regulation are also observed in colon cancer cells expressing a higher level of PRL3. Thus, we have revealed a biochemical mechanism for the PRL3-mediated cell invasion and proliferation in which elevated PRL3 expression causes a reduction in Csk level, leading to Src activation.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, ZY (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu	SUN, JINPENG/F-9551-2013		NCI NIH HHS [CA69202] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arena S, 2005, CELL MOL LIFE SCI, V62, P2092, DOI 10.1007/s00018-005-5205-1; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kubens BS, 1998, CANCER LETT, V131, P55, DOI 10.1016/S0304-3835(98)00201-8; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schwering I, 2003, MOL MED, V9, P85, DOI 10.1007/BF03402041; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	45	135	143	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5413	5419		10.1074/jbc.M608940200	http://dx.doi.org/10.1074/jbc.M608940200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192274	hybrid			2022-12-27	WOS:000244482300036
J	Nogami, K; Shima, M; Matsumoto, T; Nishiya, K; Tanaka, I; Yoshioka, A				Nogami, Keiji; Shima, Midori; Matsumoto, Tomoko; Nishiya, Katsumi; Tanaka, Ichiro; Yoshioka, Akira			Mechanisms of plasmin-catalyzed inactivation of factor VIII - A crucial role for proteolytic cleavage at Arg(336) responsible for plasmin-catalyzed factor VIII inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; VON-WILLEBRAND-FACTOR; INTRINSIC-FACTOR XASE; LIGHT-CHAIN; FACTOR-IXA; VONWILLEBRAND-FACTOR; HEAVY-CHAIN; A2 SUBUNIT; A1 SUBUNIT; FACTOR-V	Plasmin not only functions as a key enzyme in the fibrinolytic system but also directly inactivates factor VIII and other clotting factors such as factor V. However, the mechanisms of plasmin-catalyzed factor VIII inactivation are poorly understood. In this study, levels of factor VIII activity increased similar to 2-fold within 3 min in the presence of plasmin, and subsequently decreased to undetectable levels within 45 min. This time-dependent reaction was not affected by von Willebrand factor and phospholipid. The rate constant of plasmin-catalyzed factor VIIIa inactivation was similar to 12- and similar to 3.7-fold greater than those mediated by factor Xa and activated protein C, respectively. SDS-PAGE analysis showed that plasmin cleaved the heavy chain of factor VIII into two terminal products, Al37-336 and A2 subunits, by limited proteolysis at Lys(36), Arg(336), Arg(372), and Arg(740). The 80-kDa light chain was converted into a 67-kDa subunit by cleavage at Arg(1689) and Arg(1721), identical to the pattern induced by factor Xa. Plasmin-catatyzed cleavage at Arg(336) proceeded faster than that at Arg(372), in contrast to proteolysis by factor Xa. Furthermore, breakdown was faster than that in the presence of activated protein C, consistent with rapid inactivation of factor VIII. The cleavages at Arg(336) and Lys(36) occurred rapidly in the presence of A2 and A3-C1-C2 subunits, respectively. These results strongly indicated that cleavage at Arg(336) was a central mechanism of plasmin-catalyzed factor VIII inactivation. Furthermore, the cleavages at Arg(336) and Lys(36) appeared to be selectively regulated by the A2 and A3-C1-C2 domains, respectively, interacting with plasmin.	Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan	Nara Medical University	Shima, M (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	mshima@naramed-u.ac.jp						Bick RL, 1999, HAEMOSTASIS, V29, P111; BLOOM AL, 2000, HAEMOSTASIS THROMBOS, P275; BLOOM AL, 1994, HAEMOSTASIS THROMBOS, P969; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASILLAS G, 1971, COAGULATION, V4, P107; CHURCH WR, 1984, P NATL ACAD SCI-BIOL, V81, P6934, DOI 10.1073/pnas.81.22.6934; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; GILES AR, 1990, THROMB HAEMOSTASIS, V63, P476; HOLMBERG L, 1983, THROMB RES, V31, P41, DOI 10.1016/0049-3848(83)90006-3; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Kalafatis M, 2001, J BIOL CHEM, V276, P18614, DOI 10.1074/jbc.M007134200; KOEDAM JA, 1990, EUR J BIOCHEM, V189, P229, DOI 10.1111/j.1432-1033.1990.tb15481.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; Liu ML, 2000, BLOOD, V96, P979, DOI 10.1182/blood.V96.3.979.015k42a_979_987; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; MANN KG, 1990, BLOOD, V76, P1; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Nogami K, 2005, J BIOL CHEM, V280, P18476, DOI 10.1074/jbc.M412778200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Nogami K, 2002, BLOOD, V99, P3993, DOI 10.1182/blood.V99.11.3993; O'Brien LM, 2000, BLOOD, V95, P1714, DOI 10.1182/blood.V95.5.1714.005k40_1714_1720; OBrien LM, 1997, BLOOD, V90, P3943, DOI 10.1182/blood.V90.10.3943; OMAR MN, 1987, J BIOL CHEM, V262, P9750; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; REGAN LM, 1994, J BIOL CHEM, V269, P9445; RICK ME, 1986, BLOOD, V67, P1649; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Samis JA, 2000, BLOOD, V95, P943, DOI 10.1182/blood.V95.3.943.003k34_943_951; SHIMA M, 1992, BRIT J HAEMATOL, V81, P533, DOI 10.1111/j.1365-2141.1992.tb02988.x; TAYLOR FB, 1992, BLOOD, V79, P1720; VANWERSCH JWJ, 1991, HAEMOSTASIS, V21, P117; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALKER FJ, 1990, J BIOL CHEM, V265, P1484; WEINSTEI.MJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P577, DOI 10.1016/0005-2744(72)90250-1; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; WYSHOCK EG, 1995, THROMB RES, V80, P377, DOI 10.1016/0049-3848(95)00190-3	51	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5287	5295		10.1074/jbc.M607816200	http://dx.doi.org/10.1074/jbc.M607816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17189254	hybrid			2022-12-27	WOS:000244482300023
J	Murayama, K; Shirouzu, M; Kawasaki, Y; Kato-Murayama, M; Hanawa-Suetsugu, K; Sakamoto, A; Katsura, Y; Suenaga, A; Toyama, M; Terada, T; Taiji, M; Akiyama, T; Yokoyama, S				Murayama, Kazutaka; Shirouzu, Mikako; Kawasaki, Yoshihiro; Kato-Murayama, Miyuki; Hanawa-Suetsugu, Kyoko; Sakamoto, Ayako; Katsura, Yasuhiro; Suenaga, Atsushi; Toyama, Mitsutoshi; Terada, Takaho; Taiji, Makoto; Akiyama, Tetsu; Yokoyama, Shigeyuki			Crystal structure of the Rac activator, Asef, reveals its autoinhibitory mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; RHO-GTPASES; MOLECULAR-DYNAMICS; SH3 DOMAINS; COMPLEX; COLLYBISTIN; MIGRATION; SYSTEM; CDC42; APC	The Rac-specific guanine nucleotide exchange factor (GEF) Asef is activated by binding to the tumor suppressor adenomatous polyposis coli mutant, which is found in sporadic and familial colorectal tumors. This activated Asef is involved in the migration of colorectal tumor cells. The GEFs for Rho family GTPases contain the Dbl homology (DH) domain and the pleckstrin homology (PH) domain. When Asef is in the resting state, the GEF activity of the DH-PH module is intramolecularly inhibited by an unidentified mechanism. Asef has a Src homology 3 (SH3) domain in addition to the DH-PH module. In the present study, the three-dimensional structure of Asef was solved in its autoinhibited state. The crystal structure revealed that the SH3 domain binds intramolecularly to the DH domain, thus blocking the Rac-binding site. Furthermore, the RT-loop and the C-terminal region of the SH3 domain interact with the DH domain in a manner completely different from those for the canonical binding to a polyproline-peptide motif. These results demonstrate that the blocking of the Rac-binding site by the SH3 domain is essential for Asef autoinhibition. This may be a common mechanism in other proteins that possess an SH3 domain adjacent to a DH-PH module.	RIKEN Genom Sci Ctr, Yokohama Inst, Yokohama, Kanagawa, Japan; Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808575, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	RIKEN; Tohoku University; University of Tokyo; University of Tokyo	Yokoyama, S (corresponding author), RIKEN Genom Sci Ctr, Yokohama Inst, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Taiji, Makoto/N-1077-2014; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Taiji, Makoto/0000-0002-5317-0500; Yokoyama, Shigeyuki/0000-0003-3133-7338				BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; TAIJI M, 2004, P HOT CHIPS, V16; TAIJI M, 2003, P SUPERCOMPUTING; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494	28	44	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4238	4242		10.1074/jbc.C600234200	http://dx.doi.org/10.1074/jbc.C600234200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17190834	hybrid			2022-12-27	WOS:000244482000003
J	Xie, ZC; Dong, YL; Maeda, U; Xia, WM; Tanzi, RE				Xie, Zhongcong; Dong, Yuanlin; Maeda, Uta; Xia, Weiming; Tanzi, Rudolph E.			RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and A beta generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SECRETASE; CLEAVAGE; X11-ALPHA; GAMMA; APP; PHOSPHORYLATION; METABOLISM; MECHANISMS; BRAIN	The amyloid precursor protein (APP) and its pathogenic by-product amyloid-beta protein (A beta) play central roles in Alzheimer disease (AD) neuropathogenesis. APP can be cleaved by beta-secretase (BACE) and alpha-secretase to produce APP-C99 and APP-C83. These C-terminal fragments can then be cleaved by gamma-secretase to produce A beta and p3, respectively. p3 has been reported to promote apoptosis, and A beta is the key component of senile plaques in AD brain. APP adaptor proteins with phosphotyrosine-binding domains, including ShcA (SHC1), ShcC (SHC3), and Fe65 (APBB1), can bind to and interact with the conserved YENPTY motif in the APP-C terminus. Here we have described for the first time the effects of RNA interference (RNAi) silencing of ShcA, ShcC, and Fe65 expression on APP processing and A beta production. RNAi silencing of ShcC led to reductions in the levels of APP-C-terminal fragments (APP-CTFs) and A beta in H4 human neuroglioma cells stably overexpressing full-length APP (H4-FL-APP cells) but not in those expressing APP-C99 (H4-APP-C99 cells). RNAi silencing of ShcC also led to reductions in BACE levels in H4-FL-APP cells. In contrast, RNAi silencing of the homologue ShcA had no effect on APP processing or A beta levels. RNAi silencing of Fe65 increased APP-CTF levels, although also decreasing A beta levels in H4-FL-APP cells. These findings suggest that pharmacologically blocking interaction of APP with ShcC and Fe65 may provide novel therapeutic strategies against AD.	Harvard Univ, Massachusetts Gen Hosp, Med Sch, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Med Sch, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tanzi, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Med Sch, Genet & Aging Res Unit, 114 16th St,C3009, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; xia, weiming/E-5465-2016	Tanzi, Rudolph/0000-0002-7032-1454; xia, weiming/0000-0002-7463-3295; Dong, Yuanlin/0000-0002-4760-0519	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG008812, K12AG000294, R01AG014713] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG 014713-07, P60 AG 008812-15, K12 AG 000294-17] Funding Source: Medline; NIMH NIH HHS [R01 MH 60009-03] Funding Source: Medline; NINDS NIH HHS [K08 NS 048140-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Biederer T, 2002, J NEUROSCI, V22, P7340; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Guenette SY, 1999, J NEUROCHEM, V73, P985, DOI 10.1046/j.1471-4159.1999.0730985.x; Hedera P, 2002, NEUROL CLIN, V20, P779, DOI 10.1016/S0733-8619(01)00020-2; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Russo C, 2002, ANN NY ACAD SCI, V973, P323, DOI 10.1111/j.1749-6632.2002.tb04660.x; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Wolfe MS, 2003, CURR TOP DEV BIOL, V54, P233, DOI 10.1016/S0070-2153(03)54011-X; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2004, NEURODEGENER DIS, V1, P29, DOI 10.1159/000076667; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	33	43	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4318	4325		10.1074/jbc.M609293200	http://dx.doi.org/10.1074/jbc.M609293200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170108	hybrid			2022-12-27	WOS:000244482000011
J	Bouzakri, K; Zierath, JR				Bouzakri, Karim; Zierath, Juleen R.			MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; RNA INTERFERENCE; KINASE; ACTIVATION; CELLS; RISK; IDENTIFICATION; PATHOGENESIS; EXPRESSION; GLUCOSE	Tumor necrosis factor-alpha (TNF-alpha) induces skeletal muscle insulin resistance by impairing insulin signaling events involved in GLUT4 translocation. We tested whether mitogenic-activated protein kinase kinase kinase kinase isoform 4 (MAP4K4) causes the TNF-alpha-induced negative regulation of extracellular signal-regulated kinase-1/2 (ERK-1/2), c-Jun NH2-terminal kinase (JNK), and the insulin receptor substrate-1 (IRS-1) on the insulin signaling pathway governing glucose metabolism. Using small interfering RNA (siRNA) to suppress the expression of MAP4K4 protein 85% in primary human skeletal muscle cells, we provide evidence that TNF-a-induced insulin resistance on glucose uptake was completely prevented. MAP4K4 silencing inhibited TNF-a-induced negative signaling inputs by preventing excessive JNK and ERK-1/2 phosphorylation, as well as IRS-1 serine phosphorylation. These results highlight the MAPK4K4/JNK/ERK/IRS module in the negative regulation of insulin signaling to glucose transport in response to TNF-alpha. Depletion of MAP4K4 also prevented TNF-alpha-induced insulin resistance on Akt and the Akt substrate 160 (AS160), providing evidence that appropriate insulin signaling inputs for glucose metabolism were rescued. Silencing of MAP2K1 and MAP2K4, signaling proteins downstream of MAP4K4, recapitulated the effect of MAP4K4 siRNA in TNF-alpha-treated cells. Thus, strategies to inhibit MAP4K4 may be efficacious in the prevention of TNF-a-induced inhibitory signals that cause skeletal muscle insulin resistance on glucose metabolism in humans. Moreover, in myotubes from insulin-resistant type II diabetic patients, siRNA against MAP4K4, MAP2K4, or MAIP2K1 restored insulin action on glucose uptake to levels observed in healthy subjects. Collectively, our results demonstrate that MAP4K4 silencing prevents insulin resistance in human skeletal muscle and restores appropriate signaling inputs to enhance glucose uptake.	Karolinska Univ Hosp, Dept Mol Med & Surg, Karolinska Inst, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Sect Integrat Physiol, Von Eulers Vag 4,4th Fl, S-17177 Stockholm, Sweden.	Juleen.Zierath@ki.se		Zierath, Juleen/0000-0001-6891-7497				Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bouzakri K, 2004, DIABETOLOGIA, V47, P1314, DOI 10.1007/s00125-004-1428-1; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Machida N, 2004, J BIOL CHEM, V279, P15711, DOI 10.1074/jbc.C300542200; Mack KD, 2005, IMMUNOL LETT, V96, P129, DOI 10.1016/j.imlet.2004.08.004; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rangaswami H, 2005, J BIOL CHEM, V280, P19381, DOI 10.1074/jbc.M414204200; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Winkler G, 1998, DIABETES CARE, V21, P1778, DOI 10.2337/diacare.21.10.1778; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; YKIJARVINEN H, 1995, DIABETOLOGIA, V38, P1378, DOI 10.1007/BF00400597; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	26	98	129	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7783	7789		10.1074/jbc.M608602200	http://dx.doi.org/10.1074/jbc.M608602200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227768	hybrid			2022-12-27	WOS:000245081000006
J	Fiala, KA; Hypes, CD; Suo, ZC				Fiala, Kevin A.; Hypes, Cameron D.; Suo, Zucai			Mechanism of abasic lesion bypass catalyzed by a Y-family DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS P2; NUCLEOTIDE INCORPORATION OPPOSITE; DUPLEX DNA; DEOXYRIBONUCLEIC ACID; ALPHA-DEOXYADENOSINE; LOW FIDELITY; SITE; ETA; IV; CONFORMATION	The 3 million-base pair genome of Sulfolobus solfataricus likely undergoes depurination/depyrimidination frequently in vivo. These unrepaired abasic lesions are expected to be bypassed by Dpo4, the only Y-family DNA polymerase from S. solfataricus. Interestingly, these error-prone Y-family enzymes have been shown to be physiologically vital in reducing the potentially negative consequences of DNA damage while paradoxically promoting carcinogenesis. Here we used Dpo4 as a model Y-family polymerase to establish the mechanistic basis for DNA lesion bypass. While showing efficient bypass, Dpo4 paused when incorporating nucleotides directly opposite and one position downstream from an abasic lesion because of a drop of several orders of magnitude in catalytic efficiency. Moreover, in disagreement with a previous structural report, Dpo4-catalyzed abasic bypass involves robust competition between the A-rule and the lesion loop-out mechanism and is governed by the local DNA sequence. Analysis of the strong pause sites revealed biphasic kinetics for incorporation indicating that Dpo4 primarily formed a nonproductive complex with DNA that converted slowly to a productive complex. These strong pause sites are mutational hot spots with the embedded lesion even affecting the efficiency of five to six downstream incorporations. Our results suggest that abasic lesion bypass requires tight regulation to maintain genomic stability.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University	Suo, ZC (corresponding author), 740 Biol Sci,484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu						Ayadi L, 1999, BIOPHYS J, V77, P3218, DOI 10.1016/S0006-3495(99)77152-3; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beger RD, 1998, J BIOL CHEM, V273, P15565, DOI 10.1074/jbc.273.25.15565; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; Cramer J, 2005, J BIOL CHEM, V280, P40552, DOI 10.1074/jbc.M504481200; CUNIASSE P, 1990, J MOL BIOL, V213, P303, DOI 10.1016/S0022-2836(05)80192-5; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Gelfand CA, 1998, BIOCHEMISTRY-US, V37, P7321, DOI 10.1021/bi9803372; GROLJER I, 1995, J BIOL CHEM, V270, P22980; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; IDE H, 1995, BIOCHEMISTRY-US, V34, P6947, DOI 10.1021/bi00021a006; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; MANOHARAN M, 1988, J AM CHEM SOC, V110, P1620, DOI 10.1021/ja00213a044; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ren RXF, 1996, J AM CHEM SOC, V118, P7671, DOI 10.1021/ja9612763; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Shimizu H, 1997, NUCLEIC ACIDS RES, V25, P597, DOI 10.1093/nar/25.3.597; STRAUSS B, 1982, BIOCHIMIE, V64, P829, DOI 10.1016/S0300-9084(82)80138-7; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; VESNAVER G, 1989, P NATL ACAD SCI USA, V86, P3614, DOI 10.1073/pnas.86.10.3614; Wang KY, 1997, BIOCHEMISTRY-US, V36, P11629, DOI 10.1021/bi971464l; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; WILDE JA, 1989, J AM CHEM SOC, V111, P1894, DOI 10.1021/ja00187a062; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	42	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					8188	8198		10.1074/jbc.M610718200	http://dx.doi.org/10.1074/jbc.M610718200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17210571	hybrid			2022-12-27	WOS:000245081000051
J	Gioannini, TL; Teghanemt, A; Zhang, DS; Prohinar, P; Levis, EN; Munford, RS; Weiss, JP				Gioannini, Theresa L.; Teghanemt, Athmane; Zhang, DeSheng; Prohinar, Polonca; Levis, Erika N.; Munford, Robert S.; Weiss, Jerrold P.			Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by acyloxyacyl hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; ESCHERICHIA-COLI; EXTRACELLULAR COMPONENTS; NEISSERIA-MENINGITIDIS; MONOMERIC ENDOTOXIN; LEUKOCYTE ENZYME; CELL ACTIVATION; LPS; MD-2; COMPLEXES	Acyloxyacyl hydrolase (AOAH) is an eukaryotic lipase that partially deacylates and detoxifies Gram-negative bacterial lipopolysaccharides and lipooligosaccharides (LPSs or LOSs, endotoxin) within intact cells and inflammatory fluids. In cell lysates or as purified enzyme, in contrast, detergent is required for AOAH to act on LPS or LOS (Erwin, A. L., and Munford, R. S. (1990) J. BioL Chem. 265, 16444-16449 and Katz, S. S., Weinrauch, Y., Munford, R. S., Elsbach, P., and Weiss, J. (1999) 1. BioL Chem. 274, 36579-36584). We speculated that the sequential interactions of endotoxin (E) with endotoxin-binding proteins (lipopolysaccharide-binding protein (LBP), CD14, and MD-2) might produce changes in endotoxin presentation that would allow AOAH greater access to its substrate, lipid A. To test this hypothesis, we measured the activity of purified AOAH against isolated, metabolically labeled meningococcal LOS and Escherichia coli LPS that were presented either as aggregates (LOSagg or LPSagg) +/- LBP or as monomeric protein (sCD14 or MD-2)-endotoxin complexes. Up to 100-fold differences in the efficiency of endotoxin deacylation by AOAH were observed, with the following rank order of susceptibility to AOAH: E:sCD14 >= endotoxin aggregates (E-agg):LBP (molar ratio of E/LBP 100:1) >> E-agg, E-agg:LBP (E/LBP similar to 1, mol/mol), or E:MD-2. AOAH treatment of LOS-sCD14 produced partially deacylated LOS still complexed with sCD14. The underacylated LOS complexed to sCD14 transferred to MD-2 and thus formed a complex capable of preventing TLR4 activation. These findings strongly suggest that LBP- and CD14-dependent extraction and transfer of endotoxin monomers are accompanied by increased exposure of fatty acyl chains within lipid A and that the acyl chains are then sequestered when LOS binds MD-2. The susceptibility of the monomeric endotoxin-CD14 complex to AOAH may help constrain endotoxin-induced TLR4 activation when endotoxin and membrane CD14 are present in excess of MD-2/TLR-4.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Coralville, IA 52241 USA; Vet Affairs Med Ctr, Inflammat Program, Coralville, IA 52241 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gioannini, TL (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Oakdale Res Campus,2501 Crosspk Rd, Coralville, IA 52241 USA.	theresa-gioannini@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372, R56AI018188, R01AI018188, R37AI018188] Funding Source: NIH RePORTER; NIAID NIH HHS [AI59372, AI18188] Funding Source: Medline; PHS HHS [P0144642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ERWIN AL, 1990, J BIOL CHEM, V265, P16444; Feulner JA, 2004, INFECT IMMUN, V72, P3171, DOI 10.1128/IAI.72.6.3171-3178.2004; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Gutsmann T, 2001, BIOL CHEM, V382, P425, DOI 10.1515/BC.2001.052; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Katz SS, 1999, J BIOL CHEM, V274, P36579, DOI 10.1074/jbc.274.51.36579; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Lu MF, 2003, J EXP MED, V197, P1745, DOI 10.1084/jem.20030420; LUCHI M, 1993, J IMMUNOL, V151, P959; MUNFORD RS, 1986, METHOD FIND EXP CLIN, V8, P63; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; MUNFORD RS, 1992, METHOD ENZYMOL, V209, P485; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; MUNFORD RS, 1989, J BIOL CHEM, V264, P15613; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; RIEDO FX, 1990, J IMMUNOL, V144, P3506; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; STAAB JF, 1994, J BIOL CHEM, V269, P23736; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Thompson PA, 2003, J BIOL CHEM, V278, P28367, DOI 10.1074/jbc.M302921200; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Weinrauch Y, 1999, INFECT IMMUN, V67, P3376, DOI 10.1128/IAI.67.7.3376-3382.1999; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	46	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7877	7884		10.1074/jbc.M605031200	http://dx.doi.org/10.1074/jbc.M605031200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17227775	hybrid			2022-12-27	WOS:000245081000017
J	Han, SW; Ritzenthaler, JD; Winger, B; Rivera, HN; Roman, J				Han, ShouWei; Ritzenthaler, Jeffrey D.; Winger, Byron; Rivera, Hilda N.; Roman, Jesse			Extracellular matrix fibronectin increases prostaglandin E-2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways - The role of AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; TRANSCRIPTIONAL REGULATION; CANCER CELLS; GROWTH; CYCLOOXYGENASE-2; INTEGRIN; PROLIFERATION	We have previously demonstrated that fibronectin (Fn) stimulates the proliferation of non-small cell lung carcinoma (NSCLC) cell growth through the induction of cyclooxygenase-2 (COX-2) and prostaglandin E-2 secretion. Here, we demonstrate that NSCLC cells express mRNA and protein for the prostaglandin E-2 receptor EP4 and that Fn enhances its stimulatory effect by inducing the expression of EP4, but not of EP1, EP2, and EP3 receptor subtypes. The effect of Fn on EP4 was inhibited by an antibody against alpha 5 beta 1 integrin and by inhibitors of phosphoinositide 3-kinase (wortmannin) and extracellular signal-regulated kinase (PD98095), but not by inhibitors of protein kinase C (calphostin Q, of protein kinase A (H-89), or of mammalian target of rapamycin (rapamycin). A COX-2 small interfering RNA was also inhibitory. Fn significantly increased AP-2 binding activity in the promoter of the EP4 gene, and AP-2 antisense oligonucleotides blocked Fn-induced EP4 expression. Using full-length and mutated EP4 promoter constructs, we found that Fn stimulation of EP4 gene expression was inhibited when one AP-2 site (-1000 bp) was mutated. Fn induced nuclear AP-2 alpha protein expression through multiple signaling pathways. Our results indicate that Fn-induced NSCLC cell proliferation is mediated through EP4. Furthermore, they show that Fn induces EP4 expression through the activation of a5B1-dependent signals that include induction of extracellular signal-regulated kinase and phosphoinositide 3-kinase pathways as well as expression of COX-2. These events lead to activation of the transcription factor AP-2a, which interacts with specific regions in the EP4 gene promoter, leading to transcription of the EP4 gene.	Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Dept Med, Atlanta, GA 30322 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA	Emory University; Michigan State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Han, SW (corresponding author), Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Dept Med, Whitehead Biores Bldg,615 Michael St,Suite 205-M, Atlanta, GA 30322 USA.	shan2@emory.edu						Antico G, 2006, J CELL PHYSIOL, V207, P553, DOI 10.1002/jcp.20604; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Asano T, 2002, CLIN CANCER RES, V8, P1157; Campbell M, 2004, CIRC RES, V95, P380, DOI 10.1161/01.RES.0000138019.82184.5d; Chien EK, 2003, AM J OBSTET GYNECOL, V189, P1501, DOI 10.1067/S0002-9378(03)00764-6; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Foord SM, 1996, GENOMICS, V35, P182, DOI 10.1006/geno.1996.0337; Franke FE, 2003, ANTICANCER RES, V23, P4261; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Guccione M, 2002, AM J PHYSIOL-RENAL, V282, pF164, DOI 10.1152/ajprenal.0318.2000; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Han SW, 2001, CANCER RES, V61, P3998; Han SW, 2005, J BIOL CHEM, V280, P33240, DOI 10.1074/jbc.M507617200; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Han SW, 2005, CANCER LETT, V219, P71, DOI 10.1016/j.canlet.2004.07.040; Han SW, 2004, INT J CANCER, V111, P322, DOI 10.1002/ijc.20281; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Han SW, 2004, BIOCHEM BIOPH RES CO, V314, P1093, DOI 10.1016/j.bbrc.2004.01.007; Han SW, 2003, CLIN CANCER RES, V9, P4627; Han SW, 1996, ENDOCRINOLOGY, V137, P1791, DOI 10.1210/en.137.5.1791; Hatae N, 2003, J BIOL CHEM, V278, P17977, DOI 10.1074/jbc.M301312200; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Ishikawa T, 2006, ENDOCRINOLOGY, V147, P1706, DOI 10.1210/en.2005-1576; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; Khan ZA, 2005, EXP LUNG RES, V31, P701, DOI 10.1080/01902140591007236; Kijima T, 2003, J CELL MOL MED, V7, P157; Kirtikara K, 2000, MOL CELL BIOCHEM, V203, P41, DOI 10.1023/A:1007045600664; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200; Liu C, 2004, MOL CANCER THER, V3, P793; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Makino H, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019782.37851.BF; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; McCarthy TL, 1996, J BIOL CHEM, V271, P6666, DOI 10.1074/jbc.271.12.6666; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Micali A, 1996, CELL IMMUNOL, V174, P99, DOI 10.1006/cimm.1996.0298; Michaelson JE, 2002, AM J PHYSIOL-LUNG C, V282, pL291, DOI 10.1152/ajplung.00445.2000; Mutoh M, 2002, CANCER RES, V62, P28; Okano M, 2006, IMMUNOLOGY, V118, P343, DOI 10.1111/j.1365-2567.2006.02376.x; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rintoul RC, 2002, CLIN SCI, V102, P417, DOI 10.1042/CS20010216; Roman J, 2000, CYTOKINE, V12, P1581, DOI 10.1006/cyto.2000.0759; Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Turner BC, 1998, CANCER RES, V58, P5466; Wang CY, 2002, BIOCHEM PHARMACOL, V64, P177, DOI 10.1016/S0006-2952(02)01106-1; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wei XC, 2005, J BONE MINER RES, V20, P1136, DOI 10.1359/JBMR.050206; Yang L, 2006, CANCER RES, V66, P9665, DOI 10.1158/0008-5472.CAN-06-1271	59	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2007	282	11					7961	7972		10.1074/jbc.M610308200	http://dx.doi.org/10.1074/jbc.M610308200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148ND	17237224	hybrid			2022-12-27	WOS:000245081000026
J	Whittaker, MM; Pan, HY; Yukl, ET; Whittaker, JW				Whittaker, Mei M.; Pan, Heng-Yen; Yukl, Erik T.; Whittaker, James W.			Burst kinetics and redox transformations of the active site manganese ion in oxalate oxidase - Implications for the catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; BACILLUS-SUBTILIS; DECARBOXYLASE REACTION; ESCHERICHIA-COLI; PHOTOSYSTEM-II; CARBON-DIOXIDE; MN CLUSTER; METAL-ION; BARLEY; PURIFICATION	Oxalate oxidase (EC 1.2.3.4) catalyzes the oxidative cleavage of oxalate to carbon dioxide and hydrogen peroxide. In this study, unusual nonstoichiometric burst kinetics of the steady state reaction were observed and analyzed in detail, revealing that a reversible inactivation process occurs during turnover, associated with a slow isomerization of the substrate complex. We have investigated the underlying molecular mechanism of this kinetic behavior by preparing recombinant barley oxalate oxidase in three distinct oxidation states (Mn(II), Mn(III), and Mn(IV)) and producing a nonglycosylated variant for detailed biochemical and spectroscopic characterization. Surprisingly, the fully reduced Mn(II) form, which represents the majority of the as-isolated native enzyme, lacks oxalate oxidase activity, but the activity is restored by oxidation of the metal center to either Mn(III) or Mn(IV) forms. All three oxidation states appear to interconvert under turnover conditions, and the steady state activity of the enzyme is determined by a balance between activation and inactivation processes. In O-2-saturated buffer, a turnover-based redox modification of the enzyme forms a novel superoxidized mononuclear Mn(IV) biological complex. An oxalate activation role for the catalytic metal ion is proposed based on these results.	Oregon Hlth & Sci Univ, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA	Oregon Health & Science University	Whittaker, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Environm & Biomol Syst, 20000 NW Walker Rd, Beaverton, OR 97006 USA.	jim@ebs.ogi.edu		Yukl, Erik/0000-0001-6519-6938	NIGMS NIH HHS [GM42680] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042680] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ALBERTY RA, 1995, J PHYS CHEM-US, V99, P11028, DOI 10.1021/j100027a051; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Badarau A, 2006, BIOCHEMISTRY-US, V45, P11012, DOI 10.1021/bi0610146; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Campbell KA, 2000, J AM CHEM SOC, V122, P3754, DOI 10.1021/ja000142t; Chang CH, 2004, J BIOL CHEM, V279, P52840, DOI 10.1074/jbc.M402345200; Cho M, 2004, APPL ENVIRON MICROB, V70, P1129, DOI 10.1128/AEM.70.2.1129-1134.2004; Escutia MR, 2005, APPL ENVIRON MICROB, V71, P3608, DOI 10.1128/AEM.71.7.3608-3616.2005; Gennaro A, 1996, J AM CHEM SOC, V118, P7190, DOI 10.1021/ja960605o; GREENWOOD NN, 1984, CHEM ELEMENTS, P8; HAYNES LV, 1967, ANAL CHEM, V39, P332, DOI 10.1021/ac60247a013; Hislop KA, 1999, ENVIRON SCI TECHNOL, V33, P3119, DOI 10.1021/es9810134; IVANCICH A, 1995, BIOCHEMISTRY-US, V34, P6628, DOI 10.1021/bi00020a008; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KESSISSOGLOU DP, 1987, INORG CHEM, V26, P2487, DOI 10.1021/ic00262a030; Kotsira VP, 1997, ARCH BIOCHEM BIOPHYS, V340, P239, DOI 10.1006/abbi.1997.9896; KOYAMA H, 1988, AGR BIOL CHEM TOKYO, V52, P743; LANE BG, 1994, FASEB J, V8, P294, DOI 10.1096/fasebj.8.3.8143935; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCELVOY JP, 2006, CHEM REV, V106, P4455; Messinger J, 2000, BBA-BIOENERGETICS, V1459, P481, DOI 10.1016/S0005-2728(00)00187-0; Muthusamy M, 2006, BIOCHEMISTRY-US, V45, P10667, DOI 10.1021/bi060460q; OHLSSON JT, 1974, BIOCHIM BIOPHYS ACTA, V350, P48, DOI 10.1016/0005-2744(74)90201-0; Opaleye O, 2006, J BIOL CHEM, V281, P6428, DOI 10.1074/jbc.M510256200; PAGE MGP, 1993, BIOCHEM J, V295, P295, DOI 10.1042/bj2950295; Parsell TH, 2006, J AM CHEM SOC, V128, P8728, DOI 10.1021/ja062332v; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; REISFELD MJ, 1971, J MOL SPECTROSC, V39, P8, DOI 10.1016/0022-2852(71)90270-0; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; SEGEL IH, 1975, ENZYME KINETICS, P28; SUGIURA M, 1979, CHEM PHARM BULL, V27, P2003; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; Vineyard D, 2006, BIOCHEMISTRY-US, V45, P11432, DOI 10.1021/bi060809+; WAGMAN DD, 1982, J PHYS CHEM REF D S2, V11, P83; WALEY SG, 1991, BIOCHEM J, V279, P87, DOI 10.1042/bj2790087; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4466; WHITTAKER JW, 1991, J AM CHEM SOC, V113, P5528, DOI 10.1021/ja00015a003; Whittaker MM, 1996, BIOCHEMISTRY-US, V35, P6762, DOI 10.1021/bi960088m; Whittaker MM, 2003, EUR J BIOCHEM, V270, P1102, DOI 10.1046/j.1432-1033.2003.03459.x; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281; Whittaker MM, 1998, BIOCHEMISTRY-US, V37, P8426, DOI 10.1021/bi980328t; Woo EJ, 1998, FEBS LETT, V437, P87, DOI 10.1016/S0014-5793(98)01203-4; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33	47	29	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2007	282	10					7011	7023		10.1074/jbc.M609374200	http://dx.doi.org/10.1074/jbc.M609374200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148NC	17210574	hybrid			2022-12-27	WOS:000245080900013
J	Dahl, R; Iyer, SR; Owens, KS; Cuylear, DD; Simon, MC				Dahl, Richard; Iyer, Sangeeta R.; Owens, Kristin S.; Cuylear, Dorothy D.; Simon, M. Celeste			The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein lnteraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; COLONY-STIMULATING FACTOR; T-CELL LYMPHOMAGENESIS; C-JUN; LINEAGE COMMITMENT; FACTOR-RECEPTOR; C/EBP-ALPHA; DNA-BINDING; EXPRESSION; DIFFERENTIATION	Mice lacking the zinc finger transcriptional repressor protein GFI-1 are neutropenic. These mice generate abnormal immature myeloid cells exhibiting characteristics of both macrophages and granulocytes. Furthermore, Gfi-1(-/-) mice are highly susceptible to bacterial infection. Interestingly, Gfi-1(-/-) myeloid cells overexpress target genes of the PU. I transcription factor such as the macrophage colony-stimulating factor receptor and PU.1 itself. We therefore determined whether GFI-1 modulates the transcriptional activity of PU.1. Our data demonstrate that GFI-1 physically interacts with PU.1, repressing PU.1-dependent transcription. This repression is functionally significant, as GFI-1 blocked PU.1-induced macrophage differentiation of a multipotential hematopoietic progenitor cell line. Retroviral expression of GFI-1 in primary murine hematopoietic progenitors increased granulocyte differentiation at the expense of macrophage differentiation. We interbred Gfi-1(+/-) and PU.1(+/-) mice and observed that heterozygosity at the PU.I locus partially rescued the Gfi-1(-/-) mixed myeloid lineage phenotype, but failed to restore granulocyte differentiation. Our data demonstrate that GFI-1 represses PUA activity and that lack of this repression in Gfi-1(-/-) myeloid cells contributes to the observed mixed lineage phenotype.	Univ New Mexico, Canc Res Facil, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dahl, R (corresponding author), Univ New Mexico, Canc Res Facil, Dept Internal Med, Hlth Sci Ctr, 915 Camino Salud,CRF 117, Albuquerque, NM 87131 USA.	RDahl@salud.unm.edu	Simon, Celeste/AAG-3941-2021	Dahl, Richard/0000-0002-6341-5604	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL076595] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32HL076595, T35 HL076595] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aittomaki S, 2002, BLOOD, V100, P1078, DOI 10.1182/blood-2001-12-0236; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Heydemann A, 1996, MOL CELL BIOL, V16, P1676; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Maitra S, 2000, MOL CELL BIOL, V20, P1911, DOI 10.1128/MCB.20.6.1911-1922.2000; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Perkel JM, 1998, J IMMUNOL, V160, P241; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Rangatia J, 2002, MOL CELL BIOL, V22, P8681, DOI 10.1128/MCB.22.24.8681-8694.2002; Rao S, 1999, J BIOL CHEM, V274, P11115, DOI 10.1074/jbc.274.16.11115; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; ZHANG DE, 1994, J IMMUNOL, V153, P3276; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zornig M, 1996, ONCOGENE, V12, P1789; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	40	62	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6473	6483		10.1074/jbc.M607613200	http://dx.doi.org/10.1074/jbc.M607613200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197705	hybrid, Green Accepted			2022-12-27	WOS:000244867200055
J	Kimura, Y; Alric, J; Vermeglio, A; Masuda, S; Hagiwara, Y; Matsuura, K; Shimada, K; Nagashima, KVP				Kimura, Yasuaki; Alric, Jean; Vermeglio, Andre; Masuda, Shinji; Hagiwara, Yuuki; Matsuura, Katsumi; Shimada, Keizo; Nagashima, Kenji V. P.			A new membrane-bound cytochrome c works as an electron donor to the photosynthetic reaction center complex in the purple bacterium, Rhodovulum sulfidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; RHODOBACTER-SPHAEROIDES; RUBRIVIVAX-GELATINOSUS; RHODOPSEUDOMONAS-VIRIDIS; INTERACTION SITE; UNUSUAL TRIHEME; SUBUNIT; SEQUENCE; GROWTH; GENES	A new type of membrane-bound cytochrome c was found in a marine purple photosynthetic bacterium, Rhodovulum sulfidophilum. This cytochrome c was significantly accumulated in cells growing under anaerobic photosynthetic conditions and showed an apparent molecular mass of similar to 100 kDa when purified and analyzed by SDS-PAGE. The midpoint potential of this cytochrome c was 369 mV. Flash-induced kinetic measurements showed that this new cytochrome c can work as an electron donor to the photosynthetic reaction center. The gene coding for this cytochrome c was cloned and analyzed. The deduced molecular mass was nearly equal to 50 kDa. Its C-terminal heme-containing region showed the highest sequence identity to the water-soluble cytochrome c, although its predicted secondary structure resembles that of cytochrome c(y). Phylogenetic analyses suggested that this new cytochrome c has evolved from cytochrome c, We, thus, propose its designation as cytochrome C-2m. Mutants lacking this cytochrome or cytochrome c(2) showed the same growth rate as the wild type. However, a double mutant lacking both cytochrome c(2) and c(2). showed no growth under photosynthetic conditions. It was concluded that either the membrane-bound cytochrome c(2). or the water-soluble cytochrome c(2) work as a physiological electron carrier in the photosynthetic electron transfer pathway of Rvu. sulfidophilum.	Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; CNRS, UMR 7141, Inst Biol Physicochim, F-75005 Paris, France; CEA Aix Marseille II, CNRS, UMR 6191, DEVM,Lab Bioenerget Cellulaire,CEA Cadarache, F-13108 St Paul Les Durance, France; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	Tokyo Metropolitan University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Tokyo Institute of Technology	Nagashima, KVP (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, 1-1 Hachioji, Hachioji, Tokyo 1920397, Japan.	nagashima-kenji@c.metro-u.ac.jp	Alric, Jean/E-3538-2013; Masuda, Shinji/A-2703-2014; Nagashima, Kenji V. P./M-2208-2017	Alric, Jean/0000-0003-3574-2234; Masuda, Shinji/0000-0002-5349-4927; Nagashima, Kenji V. P./0000-0002-4526-6625				Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BOTT M, 1991, J BACTERIOL, V173, P6766, DOI 10.1128/jb.173.21.6766-6772.1991; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DONOHUE TJ, 1988, BIOCHEMISTRY-US, V27, P1918, DOI 10.1021/bi00406a018; DRACHEVA S, 1991, BIOCHEMISTRY-US, V30, P11451, DOI 10.1021/bi00112a012; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; KNAFF DB, 1991, BIOCHEMISTRY-US, V30, P1303, DOI 10.1021/bi00219a021; KUROWSKI B, 1987, J BIOL CHEM, V262, P13805; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCASTER CRD, 1995, ANOXYGENIC PHOTOSYNT; Masuda S, 1999, J BIOL CHEM, V274, P10795, DOI 10.1074/jbc.274.16.10795; Masuda S, 1999, J BACTERIOL, V181, P4205, DOI 10.1128/JB.181.14.4205-4215.1999; Masuda S, 2002, BIOCHEMISTRY-US, V41, P11211, DOI 10.1021/bi0258492; MATSUURA K, 1986, BIOCHIM BIOPHYS ACTA, V852, P9, DOI 10.1016/0005-2728(86)90050-2; MATSUURA K, 1994, J PLANT RES, V107, P191, DOI 10.1007/BF02346017; Menin L, 1999, BIOCHEMISTRY-US, V38, P15238, DOI 10.1021/bi991146h; Meyer TE, 1995, ANOXYGENIC PHOTOSYNT, P725; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Nagashima KVP, 1998, PHOTOSYNTH RES, V55, P349, DOI 10.1023/A:1005912810674; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Osyczka A, 1999, BIOCHEMISTRY-US, V38, P15779, DOI 10.1021/bi990907d; Osyczka A, 1999, BIOCHEMISTRY-US, V38, P2861, DOI 10.1021/bi982747w; Osyczka A, 1998, BIOCHEMISTRY-US, V37, P11732, DOI 10.1021/bi980910h; Osyczka A, 2001, J BIOL CHEM, V276, P24108, DOI 10.1074/jbc.M101141200; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; SCHOEPP B, 1995, BIOCHEMISTRY-US, V34, P11736, DOI 10.1021/bi00037a010; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Tsukatani Y, 2004, PHOTOSYNTH RES, V79, P83, DOI 10.1023/B:PRES.0000011922.56394.92; TURBA A, 1995, EUR J BIOCHEM, V231, P259, DOI 10.1111/j.1432-1033.1995.0259f.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yamada M, 2005, J BACTERIOL, V187, P1702, DOI 10.1128/JB.187.5.1702-1709.2005; Yoshida MT, 2001, BBA-BIOENERGETICS, V1506, P23, DOI 10.1016/S0005-2728(01)00177-3; Zeng XH, 2003, J BACTERIOL, V185, P6171, DOI 10.1128/JB.185.20.6171-6184.2003	39	5	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6463	6472		10.1074/jbc.M604452200	http://dx.doi.org/10.1074/jbc.M604452200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17197696	hybrid			2022-12-27	WOS:000244867200054
J	Malo, ME; Li, L; Fliegel, L				Malo, Mackenzie E.; Li, Liang; Fliegel, Larry			Mitogen-activated protein kinase-dependent activation of the Na+/H+ exchanger is mediated through phosphorylation of amino acids Ser(770) and Ser(771)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT-IV; NHE1; IDENTIFICATION; MECHANISM; MYOCARDIUM; EXPRESSION; INHIBITORS; ISOFORM-1; THERAPY; DOMAIN	We investigated regulation of the type I isoform of the Na+/H+ exchanger by phosphorylation. Four specific groups of serine and threonine residues in the regulatory carboxyl-terminal tail were mutated to alanine residues: group 1, S693A; group 2, T718A and S723A/S726A/S729A; group 3, S766A/S770A/ S771A; and group 4, T779A and S785A. The proteins were expressed in Na+/H+ exchanger-deficient cells, and the activity was characterized. All of the mutants had proper expression, localization, and normal basal activity relative to wild type NHEI. Sustained intracellular acidosis was used to activate NHE1 via an ERK-dependent pathway that could be blocked with the MEK inhibitor U0126. Immunoprecipitation of 32p-labeled Na+/H+ exchanger from intact cells showed that sustained intracellular acidosis increased Na+/H+ exchanger phosphorylation in vivo. This was blocked by U0126. The Na+/H+ exchanger activity of mutants 1 and 2 was stimulated similar to wild type Na+/H+ exchanger. Mutant 4 showed a partially reduced level of activation. However, mutant 3 was not stimulated by sustained intracellular acidosis, and loss of stimulation of activity correlated to a loss of sustained acidosis-mediated phosphorylation in vivo. Mutation of the individual amino acids within mutant 3, Ser766, Ser171, and Ser771, showed that Ser770 and Ser771 are responsible for mediating increases in NHE1 activity through sustained acidosis. Both intact Ser770 and Ser771 were required for sustained acidosis-mediated activation of NHEL Our results suggest that amino acids Ser770 and Ser771 mediate ERK-dependent activation of the Na+/H+ exchanger in vivo.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Chem, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca	Li, Liang/D-1822-2011	E Malo, Mackenzie/0000-0002-9118-0806				Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; Baldursson O, 2000, AM J PHYSIOL-LUNG C, V279, pL835, DOI 10.1152/ajplung.2000.279.5.L835; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; FLIEGEL L, 1992, BIOCHEM J, V282, P139, DOI 10.1042/bj2820139; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hayashi H, 2002, J BIOL CHEM, V277, P11090, DOI 10.1074/jbc.M111868200; KARMAZYN M, 2005, HAEMATOL DISORD, V5, P323; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Liu HZ, 2004, ANAL CHEM, V76, P4223, DOI 10.1021/ac035231d; Martin SW, 2006, CELL CALCIUM, V39, P275, DOI 10.1016/j.ceca.2005.11.002; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Moor AN, 2001, J BIOL CHEM, V276, P16113, DOI 10.1074/jbc.M100519200; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Smith JA, 2005, CANCER RES, V65, P1027; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Van Linden AA, 2005, BIOCHEMISTRY-US, V44, P6980, DOI 10.1021/bi050058w; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wang H, 1997, BIOCHEMISTRY-US, V36, P9151, DOI 10.1021/bi970802f; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	29	74	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6292	6299		10.1074/jbc.M611073200	http://dx.doi.org/10.1074/jbc.M611073200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17209041	hybrid			2022-12-27	WOS:000244867200035
J	Wu, SR; Haag, L; Hammar, L; Wu, B; Garoft, H; Xing, L; Murata, K; Cheng, RH				Wu, Shang-Rung; Haag, Lars; Hammar, Lena; Wu, Bomu; Garoft, Henrik; Xing, Li; Murata, Kazuyoshi; Cheng, R. Holland			The dynamic envelope of a fusion Class II virus - Prefusion stages of Semliki Forest virus revealed by electron cryomicroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; LOW PH; CRYOELECTRON MICROSCOPY; GLYCOPROTEIN SHELL; SPIKE PROTEIN; STEM REGION; LIFE-CYCLE; VISUALIZATION; ORGANIZATION; SEQUENCE	Semliki Forest virus is among the prototypes for Class II virus fusion and targets the endosomal membrane. Fusion protein E1 and its envelope companion E2 are both anchored in the viral membrane and form an external shell with protruding spikes. In acid environments, mimicking the early endosomal milieu, surface epitopes in the virus rearrange along with exposure of the fusion loop. To visualize this transformation into a fusogenic stage, we determined the structure of the virus at gradually lower pH values. The results show that while the fusion loop is available for external interaction and the shell and stalk domains of the spike begin to deteriorate, the E1 and E2 remain in close contact in the spike head. This unexpected observation points to E1 and E2 cooperation beyond the fusion loop exposure stage and implies a more prominent role for E2 in guiding membrane close encounter than has been earlier anticipated.	Karolinska Inst, Dept Biosci & Nutr, S-14157 Stockholm, Sweden; Univ Calif Davis, Davis, CA 95616 USA; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Kyoto 1350064, Japan	Karolinska Institutet; University of California System; University of California Davis; National Institute of Advanced Industrial Science & Technology (AIST)	Wu, SR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14157 Stockholm, Sweden.	suw@biosci.ki.se	Cheng, Holland/A-8973-2008	Murata, Kazuyoshi/0000-0001-9446-3652				Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; Chanel-Vos C, 2004, J VIROL, V78, P13543, DOI 10.1128/JVI.78.24.13543-13552.2004; Chanel-Vos C, 2006, J VIROL, V80, P6115, DOI 10.1128/JVI.00167-06; CHENG RH, 1995, CELL, V80, P621; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; GAROFF H, 1980, NATURE, V288, P236, DOI 10.1038/288236a0; Gibbons DL, 2004, J VIROL, V78, P3514, DOI 10.1128/JVI.78.7.3514-3523.2004; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Haag L, 2002, EMBO J, V21, P4402, DOI 10.1093/emboj/cdf442; HAAG L, 2006, THESIS KAROLINSKA I; Hammar L, 2003, J BIOL CHEM, V278, P7189, DOI 10.1074/jbc.M206015200; HAMMAR L, 2004, CONFORMATIONAL PROTE, P78; JENG TW, 1989, J MOL BIOL, V205, P251, DOI 10.1016/0022-2836(89)90379-3; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Kielian M, 2000, Subcell Biochem, V34, P409; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; Liao MF, 2006, J VIROL, V80, P11362, DOI 10.1128/JVI.01679-06; Liao MF, 2006, J VIROL, V80, P9599, DOI 10.1128/JVI.01054-06; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; WENGLER G, 1992, VIROLOGY, V191, P880, DOI 10.1016/0042-6822(92)90263-O; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264	34	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2007	282	9					6752	6762		10.1074/jbc.M609125200	http://dx.doi.org/10.1074/jbc.M609125200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	145LS	17192272	hybrid			2022-12-27	WOS:000244867200085
J	Baidoobonso, SM; Guidi, BW; Myers, LC				Baidoobonso, Shamara M.; Guidi, Benjamin W.; Myers, Lawrence C.			Med19(Rox3) regulates intermodule interactions in the Saccharomyces cerevisiale mediator complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATOR GCN4P; YEAST MEDIATOR; GENE-EXPRESSION; SRB MEDIATOR; PROTEINS; HOLOENZYME; MODULE; ROX3; DOMAIN	The Saccharomyces cerevisiae Mediator is a 25-subunit complex that facilitates both transcriptional activation and repression. Structural and functional studies have divided Mediator subunits into four distinct modules. The Head, Middle, and Tail modules form the core functional Mediator complex, whereas a fourth, the Cyc-C module, is variably associated with the core. By purifying Mediator from a strain lacking the Medl9(Rox3) subunit, we have found that a complex missing only the Med19(Rox3) subunit can be isolated under mild conditions. Additionally, we have established that the entire Middle module is released when the Amed19(rox3) Mediator is purified under more stringent conditions. In contrast to most models of the modular structure of Mediator, we show that release of the Middle module in the Amed]9(rox3) Mediator leaves a stable complex made up solely of Head and Tail subunits. Both the intact and Head-Tail Delta medl 9(rox3) Mediator complexes have defects in enhanced basal transcription, enhanced TFIIH phosphorylation of the CTD, as well as binding of RNA Pol II and the CTD. The largely intact Delta med19(rox3) complex facilitates activated transcription at levels similar to the wild type Mediator. In the absence of the Middle module, however, the Amed19(rox3) Mediator is unable to facilitate activated transcription. Although the Middle module is unnecessary for holding the Head and Tail modules together, it is required for the complex to function as a conduit between activators and the core transcription machinery.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Myers, LC (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.	larry.myers@dartmouth.edu			NIGMS NIH HHS [GM62483, R01 GM062483] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062483] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becerra M, 2002, MOL MICROBIOL, V43, P545, DOI 10.1046/j.1365-2958.2002.02724.x; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; BROWN TA, 1995, J BACTERIOL, V177, P6836, DOI 10.1128/jb.177.23.6836-6843.1995; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Gustafsson CM, 1997, J BIOL CHEM, V272, P48; Han SJ, 1999, MOL CELL BIOL, V19, P979; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; JIANG YW, 1995, GENETICS, V140, P47; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; ROSENBLUMVOS LS, 1991, MOL CELL BIOL, V11, P5639, DOI 10.1128/MCB.11.11.5639; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; Song WJ, 1996, MOL CELL BIOL, V16, P115; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; Takagi Y, 2005, J BIOL CHEM, V280, P31200, DOI 10.1074/jbc.C500150200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang X, 2004, GENETICS, V168, P747, DOI 10.1534/genetics.104.029611; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	41	47	74	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5551	5559		10.1074/jbc.M609484200	http://dx.doi.org/10.1074/jbc.M609484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17192271	Green Published, hybrid			2022-12-27	WOS:000244482300051
J	Kishibe, M; Bando, Y; Terayama, R; Namikawa, K; Takahashi, H; Hashimoto, Y; Ishida-Yamamoto, A; Jiang, YP; Mitrovic, B; Perez, D; Iizuka, H; Yoshida, S				Kishibe, Mari; Bando, Yoshio; Terayama, Ryuji; Namikawa, Kazuhiko; Takahashi, Hidetoshi; Hashimoto, Yoshio; Ishida-Yamamoto, Akerni; Jiang, Ying-Ping; Mitrovic, Branka; Perez, Daniel; Iizuka, Hajime; Yoshida, Shigetaka			Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; HUMAN TISSUE KALLIKREINS; STRATUM-CORNEUM; SERINE-PROTEASE; HUMAN EPIDERMIS; NEUROPSIN; EXPRESSION; MICE; DIFFERENTIATION; RECOMBINANT	Kallikrein type serine proteases, KLK8/neuropsin, KLK6, and KLK7, have been implicated in the proliferation and differentiation of epidermal keratinocytes and in the pathogenesis of psoriasis. However, their mechanistic roles in these processes remain largely unknown. We applied 12-O-tetradecanoylphorbol-13-acetate on the wild type (WT) and the Klk8 gene-disrupted (Klk8(-/-)) mouse skin, inducing keratinocyte proliferation similar to the human psoriatic lesion. Klk8 mRNA as well as Klk6 and Klk7 mRNA were up-regulated after 12-O-tetradecanoylphorbol-13-acetate application in the WT mice. In contrast, Klk8(-/-) mice showed minimum increases of Klk6 and Klk7 transcripts, the proteins, and enzymatic activities. Relative to the WT, the Klk8(-/-) skin showed less proliferation and an increase in the number of cell layers in the stratum corneum. However, overexpression of Klk8 by adenovirus vector in knock-out keratinocytes did not result in an increase in Klk6 or Klk7 mRNA. The inefficient cleavage of adhesion molecules DSG1 and CDSN in Klk8(-/-) skin contributes to a delay in corneocyte shedding, resulting in the hyperkeratosis phenotype. We propose that in psoriatic lesion, KLK8 modulates hyperproliferation and prevents excessive hyperkeratosis by shedding the corneocytes.	Asahikawa Med Coll, Dept Struct Anat & Neurosci, Asahikawa, Hokkaido 0788510, Japan; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; Berlex Biosci, Dept Immunol, Richmond, CA 94804 USA	Asahikawa Medical College; Asahikawa Medical College	Yoshida, S (corresponding author), Asahikawa Med Coll, Dept Struct Anat & Neurosci, 2-1-1-1 Midrorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	syoshida@asahikawa-med.ac.jp						Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Diamandis EP, 2002, CLIN CHEM, V48, P1198; EGELRUD T, 1993, ACTA DERM-VENEREOL, V73, P181; Ekholm E, 1999, ARCH DERMATOL RES, V291, P195, DOI 10.1007/s004030050393; EVANS BA, 1987, J BIOL CHEM, V262, P8027; Fluhr JW, 2004, J INVEST DERMATOL, V123, P140, DOI 10.1111/j.0022-202X.2004.22726.x; Gan L, 2000, GENE, V257, P119, DOI 10.1016/S0378-1119(00)00382-6; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200; Hirata A, 2001, MOL CELL NEUROSCI, V17, P600, DOI 10.1006/mcne.2000.0945; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kirihara T, 2003, BRIT J DERMATOL, V149, P700, DOI 10.1046/j.1365-2133.2003.05484.x; Kitayoshi H, 1999, ARCH DERMATOL RES, V291, P333, DOI 10.1007/s004030050418; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Matsui H, 2000, J BIOL CHEM, V275, P11050, DOI 10.1074/jbc.275.15.11050; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Momota Y, 1998, EUR J NEUROSCI, V10, P760, DOI 10.1046/j.1460-9568.1998.00068.x; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Terayama R, 2005, NEUROSCI LETT, V382, P82, DOI 10.1016/j.neulet.2005.03.022; YOUSEF G, 2000, BIOCHEM BIOPH RES CO, V276, P25; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388; Zhen YX, 1999, ARCH DERMATOL RES, V291, P555, DOI 10.1007/s004030050453	27	49	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5834	5841		10.1074/jbc.M607998200	http://dx.doi.org/10.1074/jbc.M607998200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17182622	Green Submitted, hybrid			2022-12-27	WOS:000244482300079
J	Oka, T; Nemoto, T; Jigami, Y				Oka, Takuji; Nemoto, Tadashi; Jigami, Yoshifumi			Functional analysis of Arabidopsis thaliana RHM2/MUM4, a multidomain protein involved in UDP-D-glucose to UDP-L-rhamnose conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DTDP-L-RHAMNOSE; D-GLUCURONATE 4-EPIMERASE; GDP-L-FUCOSE; SACCHAROMYCES-CEREVISIAE; RHAMNOGALACTURONAN-II; NOVO SYNTHESIS; PLANT-CELL; SEED COAT; MUR1 GENE; BIOSYNTHESIS	UDP-L-rhamnose is required for the biosynthesis of cell wall rhamnogalacturonan-I, rhamnogalacturonan-II, and natural compounds in plants. It has been suggested that the RHM2/MUM4 gene is involved in conversion of UDP-D-glucose to UDP-L-rhamnose on the basis of its effect on rhamnogalacturonan-l-directed development in Arabidopsis thaliana. RHM2/MUM4-related genes, RHM1 and RHM3, can be found in the A. thaliana genome. Here we present direct evidence that all three RHM proteins have UDP-D-glucose 4,6-dehydratase, UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase, and UDP-4-keto-Lrhamnose 4-keto-reductase activities in the cytoplasm when expressed in the yeast Saccharomyces cerevisiae. Functional domain analysis revealed that the N-terminal region of RHM2 (RHM2-N; amino acids 1-370) has the first activity and the C-terminal region of RHM2 (RHM2-C; amino acids 371-667) has the two following activities. This suggests that RHM2 converts UDP-D-glucose to UDP-L-rhamnose via an UDP-4-keto-6-deoxy-D-glucose intermediate. Site-directed mutagenesis of RHM2 revealed that mucilage defects in MUM4-1 and MUM4-2 mutant seeds of A. thaliana are caused by abolishment of RHM2 enzymatic activity in the mutant strains and furthermore, that the GXXGXX(G/A) and YXXXK motifs are important for enzymatic activity. Moreover, a kinetic analysis of purified His(6)-tagged RHM2-N protein revealed 5.9-fold higher affinity of RHM2 for UDP-D-glucose than for dTDP-D-glucose, the preferred substrate for dTDP-D-glucose 4,6-dehydratase from bacteria. RHM2-N activity is strongly inhibited by UDP-L-rhamnose, UDP-D-xylose, and UDP but not by other sugar nucleotides, suggesting that RHM2 maintains cytoplasmic levels of UDP-D-glucose and UDP-L-rhamnose via feedback inhibition by UDP-L-rhamnose and UDP-D-xylose.	Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Jigami, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan.	jigami.yoshi@aist.go.jp	Nemoto, Tadashi/M-3256-2018	Nemoto, Tadashi/0000-0002-5405-267X; Oka, Takuji/0000-0002-5691-654X				Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Barber C, 2006, J BIOL CHEM, V281, P17276, DOI 10.1074/jbc.M512727200; Bindschedler LV, 2005, PLANT MOL BIOL, V57, P285, DOI 10.1007/s11103-004-7795-7; Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brachmann CB, 1998, YEAST, V14, P115; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Dong C, 2003, BIOCHEM SOC T, V31, P532, DOI 10.1042/BST0310532; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Ikan R, 1999, NATURALLY OCCURRING; JIANG XM, 1991, MOL MICROBIOL, V5, P695, DOI 10.1111/j.1365-2958.1991.tb00741.x; JONES EW, 1991, METHOD ENZYMOL, V194, P429; KAMSTEEG J, 1978, FEBS LETT, V91, P281, DOI 10.1016/0014-5793(78)81192-2; Kang YB, 2006, BIOTECHNOL BIOENG, V93, P21, DOI 10.1002/bit.20648; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pattathil S, 2005, PLANTA, V221, P538, DOI 10.1007/s00425-004-1471-7; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; ROSSMANN MG, 1978, MOL CELL BIOCHEM, V21, P161; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; Usadel B, 2004, FEBS LETT, V569, P327, DOI 10.1016/j.febslet.2004.06.005; Usadel B, 2004, PLANT PHYSIOL, V134, P286, DOI 10.1104/pp.103.034314; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519	42	123	137	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2007	282	8					5389	5403		10.1074/jbc.M610196200	http://dx.doi.org/10.1074/jbc.M610196200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CZ	17190829	hybrid			2022-12-27	WOS:000244482300034
J	Ahuatzi, D; Riera, A; Pelaez, R; Herrero, P; Moreno, F				Ahuatzi, Deifilia; Riera, Alberto; Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando			Hxk2 regulates the phosphorylation state of Mig1 and therefore its nucleocytoplasmic distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNF1 PROTEIN-KINASE; CARBON CATABOLITE REPRESSION; SACCHAROMYCES-CEREVISIAE; YEAST SNF1; SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; SIGNAL-TRANSDUCTION; GLUCOSE REPRESSION; PHOSPHATASE 1; HEXOKINASE 2	Mig1 and Hxk2 are two major mediators of glucose repression in Saccharomyces cerevisiae. However, the mechanism by which Hxk2 participates in the glucose repression signaling pathway is not completely understood. Recently, it has been demonstrated that Hxk2 interacts with Mig1 to generate a repressor complex located in the nucleus of S. cerevisiae. However, the mechanism by which Mig1 favors the presence of Hxk2 in the nucleus is not clear, and the function of Hxk2 at the nuclear repressor complex level is still unknown. Here, we report that serine 311 of Mig1 is a critical residue for interaction with Hxk2 and that this interaction is regulated by glucose. Our findings suggest that Snf1 interacts constitutively with the Hxk2 component of the repressor complex at high and low glucose conditions. Furthermore, we show that Snf1 binds to Mig1 under low glucose conditions and that binding is largely abolished after a shift to high glucose medium. We found that phosphorylation of serine 311 of Mig1 by Snf1 kinase is essential for Mig1 protein nuclear export and derepression of the SUC2 gene in glucose-limited cells. These results allow postulating that the Hxk2 operates by interacting both with Mig1 and Snf1 to inhibit the Mig1 phosphorylation at serine 311 during high glucose grown.	Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Moreno, F (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Peláez, Rafael/R-9458-2019	Peláez, Rafael/0000-0002-4047-6017				Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Alms GR, 1999, EMBO J, V18, P4157, DOI 10.1093/emboj/18.15.4157; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GASCON S, 1968, J BIOL CHEM, V243, P1573; GUELMAN R, 2002, BONE, V30, P23; Hedbacker K, 2004, MOL CELL BIOL, V24, P8255, DOI 10.1128/MCB.24.18.8255-8263.2004; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ostling J, 1996, MOL CELL BIOL, V16, P753; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Palomino A, 2005, BIOCHEM J, V388, P697, DOI 10.1042/BJ20050160; Portillo F, 2005, FEBS LETT, V579, P512, DOI 10.1016/j.febslet.2004.12.019; Proft M, 1995, EMBO J, V14, P6116, DOI 10.1002/j.1460-2075.1995.tb00302.x; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Tettelin H, 1997, NATURE, V387, P81, DOI 10.1038/387s081; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6	42	110	112	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4485	4493		10.1074/jbc.M606854200	http://dx.doi.org/10.1074/jbc.M606854200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178716	hybrid			2022-12-27	WOS:000244482000030
J	Cho, S; Szeto, HH; Kim, E; Kim, H; Tolhurst, AT; Pinto, JT				Cho, Sunghee; Szeto, Hazel H.; Kim, Eunhee; Kim, Hyunjoo; Tolhurst, Aaron T.; Pinto, John T.			A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B SCAVENGER RECEPTOR; LOW-DENSITY LIPOPROTEINS; FATTY-ACID TRANSLOCASE; HUMAN SKELETAL-MUSCLE; OXIDIZED LDL; CEREBRAL-ISCHEMIA; PPAR-GAMMA; CEREBROSPINAL-FLUID; GLUTATHIONE ANALOG; OXIDATIVE STRESS	Oxidative stress is implicated in the pathogenesis of ischemia/reperfusion injury. Recently, we demonstrated that activation of CD36, a class B scavenger receptor, mediates free radical production and tissue injury in cerebral ischemia (1). Oxidized low density lipoproteins (oxLDL) are among the ligands that bind to CD36 and are elevated in acute cerebral infarction. SS31 is a cell-permeable antioxidant peptide that reduces intracellular free radicals and inhibits LDL oxidation/lipid peroxidation (2). The current study was designed to investigate whether treatment with SS31 normalizes ischemia-induced redox changes and attenuates CD36-mediated tissue injury. C57BL/6 mice were subjected to transient middle cerebral artery occlusion (MCAO). Redox status and infarct volume were measured in animals treated with either saline or SS31. Oxidative stress induced by ischemia/reperfusion profoundly depleted glutathione (GSH) concentrations in the ipsilateral cortex and striatum. Treating mice with SS31 immediately after reperfusion significantly attenuated ischemia-induced GSH depletion in the cortex and reduced infarct size. By contrast, the protective effect of SS31 was absent in CD36 knock-out mice, indicating that SS31 is acting through inhibition of CD36. Treating C57BL/6 mice with SS31 reduced CD36 expression in postischemic brain and mouse peritoneal macrophages (MPM). Further in vitro studies revealed that SS31 attenuated oxLDL-induced CD36 expression and foam cell formation in MPM. These in vivo and in vitro studies indicate that the down-regulation of CD36 by novel class antioxidant peptides may be a useful strategy to treat ischemic stroke victims.	Cornell Univ, Dept Neurosci, Weill Med Coll, Burke Med Res Inst, White Plains, NY 10605 USA; Cornell Univ, Weill Med Coll, Dept Neurol Sci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Cho, S (corresponding author), Cornell Univ, Dept Neurosci, Weill Med Coll, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	suc2002@med.cornell.edu			NHLBI NIH HHS [R01 HL082511] Funding Source: Medline; NIDA NIH HHS [P01 DA08924] Funding Source: Medline; NINDS NIH HHS [R21 NS048295] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008924] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Castro M, 2001, J NEUROCHEM, V78, P815, DOI 10.1046/j.1471-4159.2001.00461.x; Chabowski A, 2006, MOL CELL BIOCHEM, V288, P201, DOI 10.1007/s11010-006-9140-8; Chabowski A, 2006, FEBS LETT, V580, P3617, DOI 10.1016/j.febslet.2006.05.045; CHO J, 2006, IN PRESS CORON ART D; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; COOPER AJL, 1980, J NEUROCHEM, V35, P1242, DOI 10.1111/j.1471-4159.1980.tb07882.x; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng JW, 2000, J LIPID RES, V41, P688; Fuhrman B, 2002, ATHEROSCLEROSIS, V161, P307, DOI 10.1016/S0021-9150(01)00646-3; Gambert S, 2006, MOL CELL BIOCHEM, V283, P147, DOI 10.1007/s11010-006-2518-9; GOTOH O, 1994, ACTA NEUROCHIR, P318; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; JNABI M, 2000, ARTERIOSCLER THROMB, V280, P1953; KUNZ A, 2006, IN PRESS J CEREB BLO; Lakritz J, 1997, ANAL BIOCHEM, V247, P63, DOI 10.1006/abio.1997.2032; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Maxeiner H, 1998, J EXP MED, V188, P2257, DOI 10.1084/jem.188.12.2257; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Namba K, 2001, J NEUROSURG ANESTH, V13, P131, DOI 10.1097/00008506-200104000-00010; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Petri S, 2006, J NEUROCHEM, V98, P1141, DOI 10.1111/j.1471-4159.2006.04018.x; Pilitsis JG, 2003, BRAIN RES, V985, P198, DOI 10.1016/S0006-8993(03)03044-0; Pilitsis JG, 2002, J NEUROSURG, V97, P272, DOI 10.3171/jns.2002.97.2.0272; Pinto JT, 2005, J NEUROCHEM, V94, P1087, DOI 10.1111/j.1471-4159.2005.03255.x; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Roepstorff C, 2004, P NUTR SOC, V63, P239, DOI 10.1079/PNS2004332; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Shie FS, 2004, AM J PATHOL, V164, P1173, DOI 10.1016/S0002-9440(10)63205-1; Song WH, 2005, CORONARY ARTERY DIS, V16, P407, DOI 10.1097/00019501-200509000-00011; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Uno M, 2003, J NEUROL NEUROSUR PS, V74, P312, DOI 10.1136/jnnp.74.3.312; VANELLA A, 1993, NEUROCHEM RES, V18, P1337, DOI 10.1007/BF00975056; Venugopal SK, 2004, ATHEROSCLEROSIS, V175, P213, DOI 10.1016/j.atherosclerosis.2004.03.012; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Wu CL, 2002, AM J PHYSIOL-HEART C, V283, pH783, DOI 10.1152/ajpheart.00193.2002; YAMAMOTO M, 1993, RES COMMUN CHEM PATH, V81, P221; Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	50	129	160	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4634	4642		10.1074/jbc.M609388200	http://dx.doi.org/10.1074/jbc.M609388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178711	hybrid			2022-12-27	WOS:000244482000044
J	Fries, B; Heukeshoven, J; Hauber, I; Gruttner, C; Stocking, C; Kehlenbach, RH; Hall, J; Chemnitz, J				Fries, Barbara; Heukeshoven, Jochen; Hauber, Ilona; Gruettner, Cordula; Stocking, Carol; Kehlenbach, Ralph H.; Hall, Joachim; Chemnitz, Jan			Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; ACIDIC NUCLEAR-PROTEIN; T-CELL STIMULATION; DENDRITIC CELLS; MAMMALIAN-CELLS; B-LYMPHOCYTES; SOLUBLE FORM; RICH; PHOSPHORYLATION; SYSTEM	Dendritic cells (DC) are the most potent antigen-presenting cells of the immune system and are able to sensitize even naive T cells. Mature DC are characterized by expression of CD83, a surface molecule that is proposed to be involved in efficient T cell activation. It has been recently shown that CD83 mRNA is transported from the nucleus to the cytoplasm in a HuR- and CRM1-dependent manner. Therefore we here investigated the impact of two known protein ligands of HuR, pp32 and APRIL, on CD83 expression. Both pp32 (ANP32A) and APRIL (ANP32B) are shuttle proteins, and it has been reported earlier that these HuR ligands can act as adaptors that link HuR and the CRM1-specific nuclear export pathway. By employing RNA interference (RNAi) technology we demonstrate that pp32 is dispensable for CD83 expression, whereas APRIL contributes to the nuclear export and subsequent translation of CD83 mRNA. Furthermore, we have determined the nuclear import signal (NLS) as well as the nuclear export signal (NES) of human APRIL. Moreover, we analyzed the status of phosphorylation of endogenous APRIL and identified threonine 244 to be an as yet unrecognized phosphate acceptor. Finally, we were able to show that phosphorylation of this specific amino acid residue regulates the nuclear export of APRIL. In sum, we report here the signal sequences in APRIL that mediate its intracellular trafficking and provide evidence that this protein ligand of HuR is an important player in the post-transcriptional regulation of CD83 expression by affecting the nucleocytoplasmic translocation of CD83 mRNA.	Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Gottingen, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	Heinrich Pette Institute; University of Gottingen	Chemnitz, J (corresponding author), Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.	jan.chemnitz@hpi.uni-hamburg.de		Kehlenbach, Ralph/0000-0003-4920-9916				Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Erkmann JA, 2004, EXP CELL RES, V296, P12, DOI 10.1016/j.yexcr.2004.03.015; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heger P, 1999, ONCOGENE, V18, P4080, DOI 10.1038/sj.onc.1202762; Hock BD, 2006, TISSUE ANTIGENS, V67, P57, DOI 10.1111/j.1399-0039.2005.00524.x; Hock BD, 2004, LEUKEMIA RES, V28, P237, DOI 10.1016/S0145-2126(03)00255-8; Hock BD, 2001, INT IMMUNOL, V13, P959, DOI 10.1093/intimm/13.7.959; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; ISHIDA R, 1982, CANCER RES, V42, P4000; Izaurralde E, 2004, NAT STRUCT MOL BIOL, V11, P210, DOI 10.1038/nsmb0304-210; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2003, NAT GENET, V33, P111, DOI 10.1038/ng0203-111; Kimura T, 2004, J CELL SCI, V117, P2259, DOI 10.1242/jcs.01076; KOZLOW EJ, 1993, BLOOD, V81, P454, DOI 10.1182/blood.V81.2.454.454; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2002, INT ARCH ALLERGY IMM, V129, P113, DOI 10.1159/000065883; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Matsubae M, 2000, FEBS LETT, V468, P171, DOI 10.1016/S0014-5793(00)01218-7; McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Prechtel AT, 2006, J BIOL CHEM, V281, P10912, DOI 10.1074/jbc.M510306200; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Scholler N, 2002, J IMMUNOL, V168, P2599, DOI 10.4049/jimmunol.168.6.2599; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; VALENT P, 1991, P NATL ACAD SCI USA, V88, P3339, DOI 10.1073/pnas.88.8.3339; ZHOU LJ, 1992, J IMMUNOL, V149, P735; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	54	50	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4504	4515		10.1074/jbc.M608849200	http://dx.doi.org/10.1074/jbc.M608849200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17178712	hybrid			2022-12-27	WOS:000244482000032
J	Gardner, LA; Naren, AP; Bahouth, SW				Gardner, Lidia A.; Naren, Anjaparavanda P.; Bahouth, Suleiman W.			Assembly of an SAP97-AKAP79-cAMP-dependent protein kinase scaffold at the type 1 PSD-95/DLG/ZO1 motif of the human beta(1)-adrenergic receptor generates a receptosome involved in receptor recycling and networking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTOR; BETA-ARRESTIN; MEMBRANE; DOMAIN; PHOSPHORYLATION; ACTIVATION; INTERACTS; RESENSITIZATION; INTERNALIZATION	Appropriate trafficking of the beta(1)-adrenergic receptor (beta(1)-AR) after agonist-promoted internalization is crucial for the resensitization of its signaling pathway. Efficient recycling of the beta(1)-AR required the binding of the protein kinase A anchoring protein-79 (AKAP79) to the carboxyl terminus of the beta(1)-AR (Gardner, L. A., Tavalin, S. A., Goehring, A., Scott, J. D., and Bahouth, S. W. (2006) J. Biol. Chem. 281, 33537-33553). In this study we show that AKAP79 forms a complex with the type 1 PDZ-binding sequence (ESKV) at the extreme carboxyl terminus of the beta(1)-AR, which is mediated by the membrane-associated guanylate kinase (MAGUK) protein SAP97. Thus, the PDZ and its associated SAP97-AKAP79 complex are involved in targeting the cyclic AMP-dependent protein kinase (PKA) to the beta(1)-AR. The PDZ and its scaffold were required for efficient recycling of the beta(1)-AR and for PKA-mediated phosphorylation of the beta(1)-AR at Ser(312). Overexpression of the catalytic subunit of PKA or mutagenesis of Ser312 to the phosphoserine mimic aspartic acid both rescued the recycling of the trafficking-defective beta(1)-ARAPDZ mutant. Thus, trafficking signals transmitted from the PDZ-associated scaffold in the carboxyl terminus of the beta(1)-AR to Ser312 in the 3rd intracellular loop (3rd IC) were paramount in setting the trafficking itinerary of the beta(1)-AR. The data presented here show that a novel beta(1)-adrenergic receptosome is organized at the beta(1)-AR PDZ to generate a scaffold essential for trafficking and networking of the beta(1)-AR.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Bahouth, SW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@utmem.edu						Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Giles J, 2005, NATURE, V436, P448, DOI 10.1038/436448a; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall Randy A, 2004, Methods Mol Biol, V261, P167; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krueger KM, 1997, J BIOL CHEM, V272, P5; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; YU SS, 1993, J BIOL CHEM, V268, P337; Zeitoun O, 2006, MOL PHARMACOL, V70, P838, DOI 10.1124/mol.106.025346	50	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					5085	5099		10.1074/jbc.M608871200	http://dx.doi.org/10.1074/jbc.M608871200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170109	hybrid			2022-12-27	WOS:000244482000091
J	Hori, Y; Hashimoto, T; Wakutani, Y; Urakami, K; Nakashima, K; Condron, MM; Tsubuki, S; Saido, TC; Teplow, DB; Iwatsubo, T				Hori, Yukiko; Hashimoto, Tadafumi; Wakutani, Yosuke; Urakami, Katsuya; Nakashima, Kenji; Condron, Margaret M.; Tsubuki, Satoshi; Saido, Takaomi C.; Teplow, David B.; Iwatsubo, Takeshi			The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate A beta fibril formation without increasing protofibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; EARLY-ONSET; IN-VITRO; EXPERIMENTAL CONSTRAINTS; MISSENSE MUTATION; THIOFLAVINE-T; PEPTIDES; AGGREGATION; GENE	A subset of Alzheimer disease cases is caused by autosomal dominant mutations in genes encoding the amyloid beta-protein precursor or presenilins. Whereas some amyloid beta-protein precursor mutations alter its metabolism through effects on A beta production, the pathogenic effects of those that alter amino acid residues within the A beta sequence are not fully understood. Here we examined the biophysical effects of two recently described intra-A beta mutations linked to early-onset familial Alzheimer disease, the D7N Tottori-Japanese and H6R English mutations. Although these mutations do not affect A beta production, synthetic A beta(1-42) peptides carrying D7N or H6R substitutions show enhanced fibril formation. In vitro analysis using A beta(140)-based mutant peptides reveal that D7N or H6R mutations do not accelerate the nucleation phase but selectively promote the elongation phase of amyloid fibril formation. Notably, the levels of protofibrils generated from D7N or H6R A beta were markedly inhibited despite enhanced fibril formation. These N-terminal A beta mutations may accelerate amyloid fibril formation by a unique mechanism causing structural changes of A beta peptides, specifically promoting the elongation process of amyloid fibrils without increasing metastable intermediates.	Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Tottori Univ, Dept Neurol, Torrori 6838504, Japan; Tottori Univ, Dept Biol Regulat, Torrori 6838504, Japan; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	University of Tokyo; Tottori University; Tottori University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN	Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@mol.f.u-tokyo.ac.jp	Hashimoto, Tadafumi/A-7723-2013; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Hashimoto, Tadafumi/0000-0001-5442-4800	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328, R01NS044147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018921, P01AG027818] Funding Source: NIH RePORTER; NIA NIH HHS [AG027818, AG18921] Funding Source: Medline; NINDS NIH HHS [NS38328, NS44147] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1994, J BIOL CHEM, V269, P17441; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; HSAIO K, 1996, SCIENCE, V274, P99; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 1996, LAB INVEST, V74, P374; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945	51	91	93	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4916	4923		10.1074/jbc.M608220200	http://dx.doi.org/10.1074/jbc.M608220200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17170111	hybrid			2022-12-27	WOS:000244482000074
J	Que, XC; Engel, JC; Ferguson, D; Wunderlich, A; Tomavo, S; Reed, SL				Que, Xuchu; Engel, Juan C.; Ferguson, David; Wunderlich, Annette; Tomavo, Stanislas; Reed, Sharon L.			Cathepsin Cs are key for the intracellular survival of the protozoan parasite, Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-I; CONGENITAL TOXOPLASMOSIS; PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; ENDOPEPTIDASE; INHIBITION; ACTIVATION; EXPRESSION; TOXOPAIN-1; INVASION	Cysteine proteases play key roles in apicomplexan invasion, organellar biogenesis, and intracellular survival. We have now characterized five genes encoding papain family cathepsins from Toxoplasma gondii, including three cathepsin Cs, one cathepsin B, and one cathepsin L. Unlike endopeptidases cathepsin B and L, T. gondii cathepsin Cs are exopeptidases and remove dipeptides from unblocked N-terminal substrates of proteins or peptides. TgCPCl was the most highly expressed cathepsin mRNA in tachyzoites (by real-time PCR), but three cathepsins, TgCPC1, TgCPC2, and TgCPB, were undetectable in in vivo bradyzoites. The specific cathepsin C inhibitor, Gly-Phe-dimethylketone, selectively inhibited the TgCPCs activity, reducing parasite intracellular growth and proliferation. The targeted disruption of TgCPC1 does not affect the invasion and growth of tachyzoites as TgCPC2 is then up-regulated and may substitute for TgCPCl. TgCPCl and TgCPC2 localize to constitutive secretory vesicles of tachyzoites, the dense granules. T. gondii cathepsin Cs are required for peptide degradation in the parasitophorous vacuole as the degradation of the marker protein, Escherichia coli beta-lactamase, secreted into the parasitophorous vacuole of transgenic tachyzoites was completely inhibited by the cathepsin C inhibitor. Cathepsin C inhibitors also limited the in vivo infection of T. gondii in the chick embryo model of toxoplasmosis. Thus, cathepsin Cs are critical to T. gondii growth and differentiation, and their unique specificities could be exploited to develop novel chemotherapeutic agents.	Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, San Diego, CA 92103 USA; Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Med, San Diego, CA 92103 USA; Univ Calif San Francisco, Vet Adm Med Ctr, Dept Pathol, San Francisco, CA 94121 USA; Univ Oxford, Nuffield Dept Pathol, Oxford OX3 9DU, England; Univ Sci & Tech Lille, UGSF, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Reed, SL (corresponding author), Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, 200 W Arbor Dr, San Diego, CA 92103 USA.	slreed@ucsd.edu		Ferguson, David/0000-0001-5045-819X; Que, Xuchu/0000-0002-6751-5493	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41093, AI35707] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bidere N, 2002, J BIOL CHEM, V277, P32339, DOI 10.1074/jbc.M205153200; Bohne W, 1998, MOL BIOCHEM PARASIT, V92, P291, DOI 10.1016/S0166-6851(97)00236-3; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Korver GE, 2001, INT IMMUNOPHARMACOL, V1, P21, DOI 10.1016/S0162-3109(00)00267-8; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; McLeod R, 2000, CURR CLIN TOPICS INF, V20, P189; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Nakaar V, 1999, J BIOL CHEM, V274, P5083, DOI 10.1074/jbc.274.8.5083; Que XC, 2004, INFECT IMMUN, V72, P2915, DOI 10.1128/IAI.72.5.2915-2921.2004; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Sajid M, 2003, MOL BIOCHEM PARASIT, V131, P65, DOI 10.1016/S0166-6851(03)00194-4; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Shaw MK, 2002, MICROBES INFECT, V4, P119, DOI 10.1016/S1286-4579(01)01520-9; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Thiele DL, 1997, J IMMUNOL, V158, P5200; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Tran TV, 2002, ARCH BIOCHEM BIOPHYS, V403, P160, DOI 10.1016/S0003-9861(02)00217-5; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570	24	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					4994	5003		10.1074/jbc.M606764200	http://dx.doi.org/10.1074/jbc.M606764200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164247	hybrid			2022-12-27	WOS:000244482000082
J	Ryser, S; Fujita, T; Tortola, S; Piuz, I; Schlegel, W				Ryser, Stephan; Fujita, Toshitsugu; Tortola, Silvia; Piuz, Isabelle; Schlegel, Werner			The rate of c-fos transcription in vivo is continuously regulated at the level of elongation by dynamic stimulus-coupled recruitment of positive transcription elongation factor b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; IMMEDIATE-EARLY GENES; NF-KAPPA-B; P-TEFB; TERMINAL DOMAIN; HEAT-SHOCK; PROMOTER; KINASE; PHOSPHORYLATION; EXPRESSION	In mammalian cells, multiple stimuli induce the expression of the immediate early gene c-fos. The specificity of c-fos transcriptional response depends on the activation of signaling protein kinases, transcription factors, and chromatin-modifying complexes but also on a regulated block to elongation in the first intron. Here we show by chromatin immunoprecipitation that finely tuned control of c-fos gene expression by distinct stimuli is associated with a dynamic regulation of transcription elongation and differential phosphorylation of the C-terminal domain of RNA polymerase II. Comparison of two stimuli of c-fos expression in the pituitary cell line GH4C1, namely the thyrotropin-releasing hormone versus depolarizing KCl, shows that both stimuli increase initiation, but only thyrotropin-releasing hormone is efficient to stimulate elongation and thus produce high transcription rates. To control elongation, the elongation factor P-TEFb is recruited to the 5'-end of the gene in a stimuli and time-dependent manner. Transition from initiation to elongation depends also on the dynamic recruitment of the initiation factors TFIIB and TFIIE but not TFIID, which remains constitutively bound on the promoter. It thus appears that tight coupling of signaling input to transcriptional output rate is achieved by c-fos gene-specific mechanisms, which control post-initiation steps rather than pre-initiation complex assembly.	Univ Geneva, Fdn Rech Med, CH-1211 Geneva, Switzerland	University of Geneva	Schlegel, W (corresponding author), Univ Geneva, Fdn Rech Med, 64 Ave Roseraie, CH-1211 Geneva, Switzerland.	werner.schlegel@medecine.unige.ch	FUJITA, Toshitsugu/ABH-5101-2020	FUJITA, Toshitsugu/0000-0002-9536-9999				Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; AKOULITCHEV S, 1995, NATURE, V377, P557, DOI 10.1038/377557a0; Blau J, 1996, MOL CELL BIOL, V16, P2044; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Dvir A, 2001, CURR OPIN GENET DEV, V11, P209, DOI 10.1016/S0959-437X(00)00181-7; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hirose Y, 2000, GENE DEV, V14, P1415; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; MAKELA TP, 1995, P NATL ACAD SCI USA, V92, P5174, DOI 10.1073/pnas.92.11.5174; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Ryser S, 2001, J BIOL CHEM, V276, P33319, DOI 10.1074/jbc.M102326200; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Susini S, 2000, FASEB J, V14, P128, DOI 10.1096/fasebj.14.1.128; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; WERLEN G, 1993, J BIOL CHEM, V268, P16596; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	42	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2007	282	7					5075	5084		10.1074/jbc.M607847200	http://dx.doi.org/10.1074/jbc.M607847200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	140CX	17164243	hybrid			2022-12-27	WOS:000244482000090
